asian f 64 $nan$hematology blood hematocrit  26.8  %; hematology blood hematocrit  22.9  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  28  k ul; hematology blood platelet count  41  k ul; hematology blood platelet count  21  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  95  mg dl; chemistry blood urea nitrogen  96  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  7.1  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  5.4  mg dl; chemistry blood bilirubin, total  5.6  mg dl; chemistry blood glucose  202  mg dl; chemistry blood glucose  138  mg dl; chemistry blood lactate dehydrogenase (ld)  969  iu l; blood gas blood free calcium  0.88  mmol l; blood gas blood lactate  5.2  mmol l; blood gas blood lactate  5.1  mmol l$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; labetalol  5  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; sevelamer carbonate  800  mg ; lidocaine viscous 2%  15  ml ; morphine 0.2% oral rinse  15  ml ; caphosol  30  ml ; acyclovir  400  mg ; loperamide  2  mg ; micafungin  50  mg ; dexamethasone  4  mg ; lidocaine jelly 2%  1  appl ; hydrocortisone oint 1%  1  appl ; pantoprazole (granules for dr suspension)  40  mg ; daptomycin  500  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; morphine sulfate  4  mg ; ns  100  ml ; metronidazole  500  mg ; calcium gluconate  2  g ; calcium gluconate  4  g ; cyclosporine (neoral) modified  100  mg ; hydromorphone (dilaudid)  0.125  mg ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$hematology blood hematocrit  22.9  %; hematology blood hematocrit  16.6  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  5.8  g dl; hematology blood platelet count  11  k ul; hematology blood platelet count  24  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  95  mg dl; chemistry blood urea nitrogen  95  mg dl; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  2.5  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  6.7  mg dl; chemistry blood calcium, total  6.1  mg dl; chemistry blood bilirubin, total  5.6  mg dl; chemistry blood bilirubin, total  5.7  mg dl; chemistry blood glucose  120  mg dl; chemistry blood glucose  82  mg dl; chemistry blood albumin  2.3  g dl; blood gas blood free calcium  0.86  mmol l; blood gas blood lactate  4.8  mmol l; blood gas blood hematocrit, calculated  19  %; blood gas blood hemoglobin  6.2  g dl$iso-osmotic sodium chloride  100  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; labetalol  5  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; lidocaine viscous 2%  15  ml ; morphine 0.2% oral rinse  15  ml ; caphosol  30  ml ; acyclovir  400  mg ; loperamide  2  mg ; micafungin  50  mg ; dexamethasone  4  mg ; lidocaine jelly 2%  1  appl ; hydrocortisone oint 1%  1  appl ; pantoprazole (granules for dr suspension)  40  mg ; daptomycin  500  mg ; ns  100  ml ; metronidazole  500  mg ; calcium gluconate  2  g ; calcium gluconate  4  g ; cyclosporine (neoral) modified  100  mg ; hydromorphone (dilaudid)  0.125  mg ; propofol  1000  mg ; norepinephrine  8  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 5% dextrose  50  ml ; phytonadione  2.5  mg ; insulin  16  unit ; 0.9% sodium chloride  150  ml ; posaconazole  300  mg ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; daptomycin  700  mg ; fentanyl citrate  25-100  mcg ; fluconazole  200  mg ; d10w  1000  ml ; aminocaproic acid 25 % oral rinse  2.5  gm ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$hematology blood hematocrit  24.2  %; hematology blood hematocrit  25.5  %; hematology blood hematocrit  23.2  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  36  k ul; hematology blood platelet count  22  k ul; hematology blood platelet count  24  k ul; hematology blood platelet count  8  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  94  mg dl; chemistry blood urea nitrogen  99  mg dl; chemistry blood urea nitrogen  99  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  6.6  mg dl; chemistry blood bilirubin, total  7.6  mg dl; chemistry blood bilirubin, total  9.3  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  146  mg dl; chemistry blood lactate dehydrogenase (ld)  872  iu l; chemistry blood lactate dehydrogenase (ld)  979  iu l; blood gas blood free calcium  0.95  mmol l$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; labetalol  5  mg ; lidocaine viscous 2%  15  ml ; morphine 0.2% oral rinse  15  ml ; acyclovir  400  mg ; loperamide  2  mg ; dexamethasone  4  mg ; lidocaine jelly 2%  1  appl ; hydrocortisone oint 1%  1  appl ; pantoprazole (granules for dr suspension)  40  mg ; ns  100  ml ; metronidazole  500  mg ; calcium gluconate  2  g ; calcium gluconate  4  g ; propofol  1000  mg ; norepinephrine  8  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 5% dextrose  50  ml ; phytonadione  2.5  mg ; insulin  16  unit ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; daptomycin  700  mg ; fentanyl citrate  25-100  mcg ; d10w  1000  ml ; aminocaproic acid 25 % oral rinse  2.5  gm ; sterile water  100  ml ; sterile water  150  ml ; potassium chloride  60  meq ; dexmedetomidine  0.4  mg ; vial  1  vial ; pantoprazole  40  mg ; acyclovir  350  mg ; furosemide  250  mg ; quetiapine fumarate  25  mg ; bag  1  bag ; magnesium sulfate  4  gm ; acyclovir  300  mg ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$hematology blood hematocrit  20.4  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  6  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  104  mg dl; hematology blood inr(pt)  3.6  ; chemistry blood calcium, total  5.4  mg dl; chemistry blood glucose  173  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; labetalol  5  mg ; lidocaine viscous 2%  15  ml ; morphine 0.2% oral rinse  15  ml ; loperamide  2  mg ; dexamethasone  4  mg ; lidocaine jelly 2%  1  appl ; hydrocortisone oint 1%  1  appl ; calcium gluconate  2  g ; calcium gluconate  4  g ; propofol  1000  mg ; norepinephrine  8  mg ; 5% dextrose  50  ml ; phytonadione  2.5  mg ; daptomycin  700  mg ; sterile water  100  ml ; sterile water  150  ml ; potassium chloride  60  meq ; dexmedetomidine  0.4  mg ; vial  1  vial ; pantoprazole  40  mg ; furosemide  250  mg ; quetiapine fumarate  25  mg ; bag  1  bag ; magnesium sulfate  4  gm ; acyclovir  300  mg ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; labetalol  5  mg ; lidocaine viscous 2%  15  ml ; morphine 0.2% oral rinse  15  ml ; loperamide  2  mg ; dexamethasone  4  mg ; lidocaine jelly 2%  1  appl ; hydrocortisone oint 1%  1  appl ; propofol  1000  mg ; daptomycin  700  mg ; dexmedetomidine  0.4  mg ; vial  1  vial ; pantoprazole  40  mg ; quetiapine fumarate  25  mg ; acyclovir  300  mg ; scopolamine patch  1  ptch ; glycopyrrolate  0.1  mg ; lorazepam  0.5-2  mg ; haloperidol  0.5-2  mg ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
white f 65 $nan$nan$levothyroxine sodium  50  mcg ; folic acid  1  mg ; allopurinol  50  mg ; 
iron deficiency anemia secondary to blood loss (chronic) ulcerative colitis, unspecified macular degeneration (senile), unspecified acute posthemorrhagic anemia unspecified acquired hypothyroidism osteoporosis, unspecified asthma, unspecified type, unspecified 
white f 65 $nan$hematology blood hematocrit  26.0  %; hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  416  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  125  mg dl$levothyroxine sodium  50  mcg ; folic acid  1  mg ; allopurinol  50  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; zolpidem tartrate  5  mg ; methylprednisolone sodium succ  20  mg ; tuberculin protein  0.1  ml ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; 
iron deficiency anemia secondary to blood loss (chronic) ulcerative colitis, unspecified macular degeneration (senile), unspecified acute posthemorrhagic anemia unspecified acquired hypothyroidism osteoporosis, unspecified asthma, unspecified type, unspecified 
white f 65 $nan$hematology blood hematocrit  26.1  %; hematology blood hematocrit  26.3  %; hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  366  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  125  mg dl$levothyroxine sodium  50  mcg ; folic acid  1  mg ; allopurinol  50  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; zolpidem tartrate  5  mg ; methylprednisolone sodium succ  20  mg ; tuberculin protein  0.1  ml ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; mercaptopurine  25  mg ; lidocaine jelly 2%  1  appl ; mesalamine dr  1600  mg ; 
iron deficiency anemia secondary to blood loss (chronic) ulcerative colitis, unspecified macular degeneration (senile), unspecified acute posthemorrhagic anemia unspecified acquired hypothyroidism osteoporosis, unspecified asthma, unspecified type, unspecified 
white f 65 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  392  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  140  mg dl$levothyroxine sodium  50  mcg ; folic acid  1  mg ; allopurinol  50  mg ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  5  mg ; methylprednisolone sodium succ  20  mg ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; mercaptopurine  25  mg ; lidocaine jelly 2%  1  appl ; mesalamine dr  1600  mg ; 
iron deficiency anemia secondary to blood loss (chronic) ulcerative colitis, unspecified macular degeneration (senile), unspecified acute posthemorrhagic anemia unspecified acquired hypothyroidism osteoporosis, unspecified asthma, unspecified type, unspecified 
white f 65 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  403  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  118  mg dl$levothyroxine sodium  50  mcg ; folic acid  1  mg ; allopurinol  50  mg ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  5  mg ; methylprednisolone sodium succ  20  mg ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; mercaptopurine  25  mg ; lidocaine jelly 2%  1  appl ; mesalamine dr  1600  mg ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride (excel bag)  250  ml ; infliximab  350  mg ; 
iron deficiency anemia secondary to blood loss (chronic) ulcerative colitis, unspecified macular degeneration (senile), unspecified acute posthemorrhagic anemia unspecified acquired hypothyroidism osteoporosis, unspecified asthma, unspecified type, unspecified 
white f 65 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  390  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  133  mg dl$levothyroxine sodium  50  mcg ; folic acid  1  mg ; allopurinol  50  mg ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  5  mg ; methylprednisolone sodium succ  20  mg ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; mercaptopurine  25  mg ; lidocaine jelly 2%  1  appl ; mesalamine dr  1600  mg ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride (excel bag)  250  ml ; infliximab  350  mg ; prednisone  40  mg ; 
iron deficiency anemia secondary to blood loss (chronic) ulcerative colitis, unspecified macular degeneration (senile), unspecified acute posthemorrhagic anemia unspecified acquired hypothyroidism osteoporosis, unspecified asthma, unspecified type, unspecified 
white f 65 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  344  k ul$levothyroxine sodium  50  mcg ; folic acid  1  mg ; allopurinol  50  mg ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  5  mg ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; mercaptopurine  25  mg ; lidocaine jelly 2%  1  appl ; mesalamine dr  1600  mg ; prednisone  40  mg ; 
iron deficiency anemia secondary to blood loss (chronic) ulcerative colitis, unspecified macular degeneration (senile), unspecified acute posthemorrhagic anemia unspecified acquired hypothyroidism osteoporosis, unspecified asthma, unspecified type, unspecified 
white f 65 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  352  k ul$levothyroxine sodium  50  mcg ; folic acid  1  mg ; allopurinol  50  mg ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  5  mg ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; mercaptopurine  25  mg ; lidocaine jelly 2%  1  appl ; mesalamine dr  1600  mg ; prednisone  40  mg ; 
iron deficiency anemia secondary to blood loss (chronic) ulcerative colitis, unspecified macular degeneration (senile), unspecified acute posthemorrhagic anemia unspecified acquired hypothyroidism osteoporosis, unspecified asthma, unspecified type, unspecified 
white f 65 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  314  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  89  mg dl$levothyroxine sodium  50  mcg ; folic acid  1  mg ; allopurinol  50  mg ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  5  mg ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; mercaptopurine  25  mg ; lidocaine jelly 2%  1  appl ; mesalamine dr  1600  mg ; prednisone  40  mg ; 
iron deficiency anemia secondary to blood loss (chronic) ulcerative colitis, unspecified macular degeneration (senile), unspecified acute posthemorrhagic anemia unspecified acquired hypothyroidism osteoporosis, unspecified asthma, unspecified type, unspecified 
white m 67 $nan$nan$aspirin ec  325  mg ; atenolol  25  mg ; simvastatin  5  mg ; multivitamins  1  tab ; 
home accidents accidental fall from ladder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled closed fracture of shaft of femur acute posthemorrhagic anemia injury to bladder and urethra, without mention of open wound into cavity long-term (current) use of insulin accidents occurring in residential institution urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure 
white m 67 $nan$hematology blood hematocrit  39.2  %; hematology blood hematocrit  35.7  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  186  k ul; hematology blood platelet count  202  k ul; hematology blood platelet count  210  k ul; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood urea nitrogen  20  mg dl$aspirin ec  325  mg ; atenolol  25  mg ; simvastatin  5  mg ; multivitamins  1  tab ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; zolpidem tartrate  5-10  mg ; sodium chloride 0.9%  flush  3  ml ; 1 2 ns  1000  ml ; sw  100  ml ; eptifibatide  75  mg ; clopidogrel  150  mg ; ondansetron  4  mg ; insulin  0  unit ; pantoprazole  40  mg ; insulin  17  unit ; oxycodone-acetaminophen  1-2  tab ; 
home accidents accidental fall from ladder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled closed fracture of shaft of femur acute posthemorrhagic anemia injury to bladder and urethra, without mention of open wound into cavity long-term (current) use of insulin accidents occurring in residential institution urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure 
white m 67 $nan$nan$aspirin ec  325  mg ; atenolol  25  mg ; simvastatin  5  mg ; multivitamins  1  tab ; aluminum-magnesium hydrox.-simethicone  30  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; zolpidem tartrate  5-10  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; pantoprazole  40  mg ; oxycodone-acetaminophen  1-2  tab ; clopidogrel  75  mg ; 
home accidents accidental fall from ladder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled closed fracture of shaft of femur acute posthemorrhagic anemia injury to bladder and urethra, without mention of open wound into cavity long-term (current) use of insulin accidents occurring in residential institution urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure 
black african american m 91 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  107  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  33  mg dl; hematology urine wbc  >50  # hpf; chemistry blood glucose  91  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; trazodone  50  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; sulfameth trimethoprim ds  1  tab ; cosopt  1  gtt ; amlodipine  10  mg ; simvastatin  20  mg ; ferrous sulfate  325  mg ; metoprolol xl (toprol xl)  25  mg ; aspirin  325  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of prostate alzheimer's disease chronic kidney disease, unspecified dementia in conditions classified elsewhere without behavioral disturbance other complications due to genitourinary device, implant, and graft urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure urinary tract infection, site not specified unspecified deficiency anemia hematuria
black african american m 91 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; trazodone  50  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; sulfameth trimethoprim ds  1  tab ; cosopt  1  gtt ; amlodipine  10  mg ; simvastatin  20  mg ; ferrous sulfate  325  mg ; metoprolol xl (toprol xl)  25  mg ; aspirin  325  mg ; mirtazapine  7.5  mg ; donepezil  10  mg ; prednisone  20  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of prostate alzheimer's disease chronic kidney disease, unspecified dementia in conditions classified elsewhere without behavioral disturbance other complications due to genitourinary device, implant, and graft urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure urinary tract infection, site not specified unspecified deficiency anemia hematuria
black african american m 91 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood glucose  117  mg dl$sodium chloride 0.9%  flush  3  ml ; trazodone  50  mg ; ipratropium bromide neb  1  neb ; sulfameth trimethoprim ds  1  tab ; cosopt  1  gtt ; amlodipine  10  mg ; simvastatin  20  mg ; ferrous sulfate  325  mg ; metoprolol xl (toprol xl)  25  mg ; aspirin  325  mg ; mirtazapine  7.5  mg ; donepezil  10  mg ; prednisone  20  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; ciprofloxacin hcl  500  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of prostate alzheimer's disease chronic kidney disease, unspecified dementia in conditions classified elsewhere without behavioral disturbance other complications due to genitourinary device, implant, and graft urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure urinary tract infection, site not specified unspecified deficiency anemia hematuria
white m 85 $temp  98.0  heartrate  97.0  resprate  22.0  o2sat  95.0  sbp  117.0  dbp  74.0  rhythm    pain  0  $hematology blood hematocrit  41.7  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  109  mg dl$heparin  1500  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; insulin  0  unit ; clonazepam  1  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; polyethylene glycol  17  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; fluticasone propionate 110mcg  1  puff ; atorvastatin  80  mg ; aspirin  325  mg ; allopurinol  100  mg ; clopidogrel  75  mg ; cyanocobalamin  500  mcg ; folic acid  2  mg ; furosemide  20  mg ; isosorbide mononitrate (extended release)  30  mg ; lisinopril  2.5  mg ; tiotropium bromide  1  cap ; venlafaxine xr  75  mg ; vitamin d  1000  unit ; prednisone  5  mg ; multivitamins  1  tab ; levofloxacin  750  mg ; chloraseptic throat spray  1  spry ; cepacol (menthol)  1  loz ; gabapentin  600  mg ; tamsulosin  0.4  mg ; quetiapine fumarate  50  mg ; 
chronic systolic heart failure anxiety state, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified gout, unspecified pneumonia, organism unspecified cardiac pacemaker in situ other primary cardiomyopathies obstructive sleep apnea (adult)(pediatric) long-term (current) use of antiplatelet/antithrombotic hypoxemia aortic valve disorders coronary atherosclerosis of unspecified type of vessel, native or graft depressive disorder, not elsewhere classified personal history of tobacco use myotonia congenita other and unspecified angina pectoris chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cardiac pacemaker in situ aortic valve disorders anxiety state, unspecified acute on chronic systolic heart failure percutaneous transluminal coronary angioplasty status gout, unspecified thrombocytopenia, unspecified obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified myotonia congenita unspecified essential hypertension congestive heart failure, unspecified coronary atherosclerosis of native coronary artery pneumonia, organism unspecified depressive disorder, not elsewhere classified personal history of tobacco use long-term (current) use of antiplatelet/antithrombotic other abnormal blood chemistry insomnia, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft other nonspecific findings on examination of urine hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) obstructive chronic bronchitis with (acute) exacerbation unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortic valve disorders myotonia congenita obstructive sleep apnea (adult)(pediatric) other specified forms of chronic ischemic heart disease
white m 85 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  149  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; insulin  0  unit ; clonazepam  1  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; polyethylene glycol  17  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; fluticasone propionate 110mcg  1  puff ; atorvastatin  80  mg ; aspirin  325  mg ; allopurinol  100  mg ; clopidogrel  75  mg ; cyanocobalamin  500  mcg ; folic acid  2  mg ; furosemide  20  mg ; isosorbide mononitrate (extended release)  30  mg ; lisinopril  2.5  mg ; tiotropium bromide  1  cap ; venlafaxine xr  75  mg ; vitamin d  1000  unit ; prednisone  5  mg ; multivitamins  1  tab ; levofloxacin  750  mg ; chloraseptic throat spray  1  spry ; cepacol (menthol)  1  loz ; gabapentin  600  mg ; tamsulosin  0.4  mg ; quetiapine fumarate  50  mg ; 
chronic systolic heart failure anxiety state, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified gout, unspecified pneumonia, organism unspecified cardiac pacemaker in situ other primary cardiomyopathies obstructive sleep apnea (adult)(pediatric) long-term (current) use of antiplatelet/antithrombotic hypoxemia aortic valve disorders coronary atherosclerosis of unspecified type of vessel, native or graft depressive disorder, not elsewhere classified personal history of tobacco use myotonia congenita other and unspecified angina pectoris chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cardiac pacemaker in situ aortic valve disorders anxiety state, unspecified acute on chronic systolic heart failure percutaneous transluminal coronary angioplasty status gout, unspecified thrombocytopenia, unspecified obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified myotonia congenita unspecified essential hypertension congestive heart failure, unspecified coronary atherosclerosis of native coronary artery pneumonia, organism unspecified depressive disorder, not elsewhere classified personal history of tobacco use long-term (current) use of antiplatelet/antithrombotic other abnormal blood chemistry insomnia, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft other nonspecific findings on examination of urine hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) obstructive chronic bronchitis with (acute) exacerbation unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortic valve disorders myotonia congenita obstructive sleep apnea (adult)(pediatric) other specified forms of chronic ischemic heart disease
white m 85 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; insulin  0  unit ; clonazepam  1  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; polyethylene glycol  17  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; fluticasone propionate 110mcg  1  puff ; atorvastatin  80  mg ; aspirin  325  mg ; allopurinol  100  mg ; clopidogrel  75  mg ; cyanocobalamin  500  mcg ; folic acid  2  mg ; furosemide  20  mg ; isosorbide mononitrate (extended release)  30  mg ; lisinopril  2.5  mg ; tiotropium bromide  1  cap ; venlafaxine xr  75  mg ; vitamin d  1000  unit ; prednisone  5  mg ; multivitamins  1  tab ; levofloxacin  750  mg ; chloraseptic throat spray  1  spry ; cepacol (menthol)  1  loz ; gabapentin  600  mg ; tamsulosin  0.4  mg ; quetiapine fumarate  50  mg ; 
chronic systolic heart failure anxiety state, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified gout, unspecified pneumonia, organism unspecified cardiac pacemaker in situ other primary cardiomyopathies obstructive sleep apnea (adult)(pediatric) long-term (current) use of antiplatelet/antithrombotic hypoxemia aortic valve disorders coronary atherosclerosis of unspecified type of vessel, native or graft depressive disorder, not elsewhere classified personal history of tobacco use myotonia congenita other and unspecified angina pectoris chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cardiac pacemaker in situ aortic valve disorders anxiety state, unspecified acute on chronic systolic heart failure percutaneous transluminal coronary angioplasty status gout, unspecified thrombocytopenia, unspecified obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified myotonia congenita unspecified essential hypertension congestive heart failure, unspecified coronary atherosclerosis of native coronary artery pneumonia, organism unspecified depressive disorder, not elsewhere classified personal history of tobacco use long-term (current) use of antiplatelet/antithrombotic other abnormal blood chemistry insomnia, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft other nonspecific findings on examination of urine hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) obstructive chronic bronchitis with (acute) exacerbation unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortic valve disorders myotonia congenita obstructive sleep apnea (adult)(pediatric) other specified forms of chronic ischemic heart disease
white m 55 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3  ml ; fludrocortisone acetate  0.1  mg ; dexamethasone  0.5  mg ; potassium chloride  40  meq ; hydrocortisone na succ.  100  mg ; dexamethasone  1  mg ; ondansetron  4  mg ; 
dehydration other and unspecified noninfectious gastroenteritis and colitis adrenogenital disorders hypotension, unspecified
white m 55 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  119  mg dl$potassium chloride  40  meq ; hydrocortisone na succ.  100  mg ; dexamethasone  1  mg ; ondansetron  4  mg ; 
dehydration other and unspecified noninfectious gastroenteritis and colitis adrenogenital disorders hypotension, unspecified
unable to obtain f 40 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  3.0  ; hematology blood inr(pt)  3.7  ; hematology blood inr(pt)  8.7  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  3.8  mg dl; chemistry blood bilirubin, total  3.8  mg dl; chemistry blood bilirubin, total  3.8  mg dl; chemistry blood bilirubin, total  4.1  mg dl; chemistry blood glucose  62  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  5570  iu l; chemistry blood lactate dehydrogenase (ld)  4495  iu l; chemistry blood albumin  3.3  g dl; chemistry blood albumin  3.0  g dl$5% dextrose  500  ml ; acetylcysteine (iv)  6550  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  1  mg ; ondansetron  4  mg ; pantoprazole  40  mg ; hydromorphone (dilaudid)  0.5  mg ; thiamine  100  mg ; multivitamins  1  tab ; acetylcysteine (iv)  6250  mg ; neutra-phos  2  pkt ; vial  1  vial ; acetylcysteine (iv)  4100  mg ; nicotine patch  14  mg ; heparin flush (10 units ml)  2  ml ; 
 
unable to obtain f 40 $nan$hematology blood hematocrit  28.4  %; hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  190  k ul; hematology blood platelet count  201  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  3.8  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  4.4  mg dl; chemistry blood glucose  83  mg dl; chemistry blood lactate dehydrogenase (ld)  1336  iu l$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  1  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; multivitamins  1  tab ; neutra-phos  2  pkt ; vial  1  vial ; acetylcysteine (iv)  4100  mg ; nicotine patch  14  mg ; heparin flush (10 units ml)  2  ml ; thiamine  200  mg ; oxycodone (immediate release)   5-10  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; oxycodone (immediate release)   5  mg ; hydromorphone (dilaudid)  4  mg ; 
 
unable to obtain f 40 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.5  ; hematology blood inr(pt)  2.5  ; chemistry blood bilirubin, total  6.4  mg dl; chemistry blood bilirubin, total  7.2  mg dl; chemistry blood glucose  76  mg dl; chemistry blood lactate dehydrogenase (ld)  271  iu l$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; multivitamins  1  tab ; vial  1  vial ; nicotine patch  14  mg ; heparin flush (10 units ml)  2  ml ; thiamine  200  mg ; oxycodone (immediate release)   5-10  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; oxycodone (immediate release)   5  mg ; hydromorphone (dilaudid)  4  mg ; senna  1  tab ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; heparin  5000  unit ; lactulose  30  ml ; docusate sodium  100  mg ; trazodone  25  mg ; 
 
unable to obtain f 40 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  2.3  ; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  8.1  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; multivitamins  1  tab ; vial  1  vial ; nicotine patch  14  mg ; heparin flush (10 units ml)  2  ml ; thiamine  200  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; senna  1  tab ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; heparin  5000  unit ; lactulose  30  ml ; docusate sodium  100  mg ; trazodone  25  mg ; 
 
unable to obtain f 40 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  9.0  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; multivitamins  1  tab ; vial  1  vial ; nicotine patch  14  mg ; heparin flush (10 units ml)  2  ml ; thiamine  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; senna  1  tab ; heparin  5000  unit ; lactulose  30  ml ; docusate sodium  100  mg ; phytonadione  5  mg ; simethicone  40-80  mg ; 
 
unable to obtain f 40 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  8.7  mg dl; chemistry blood glucose  72  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; multivitamins  1  tab ; vial  1  vial ; nicotine patch  14  mg ; heparin flush (10 units ml)  2  ml ; thiamine  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; heparin  5000  unit ; lactulose  30  ml ; docusate sodium  100  mg ; phytonadione  5  mg ; simethicone  40-80  mg ; 
 
unknown m 59 $nan$nan$acetaminophen  1000  mg ; pregabalin  75  mg ; 
malignant neoplasm of connective and soft tissue of right lower limb, including hip major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified alcohol dependence with withdrawal, unspecified cerebral aneurysm, nonruptured other postprocedural complications and disorders of the circulatory system, not elsewhere classified nicotine dependence, cigarettes, uncomplicated restless legs syndrome body mass index (bmi) 37.0-37.9, adult obesity, unspecified patient room in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified unspecified atrial fibrillation other chronic pain anxiety disorder, unspecified essential (primary) hypertension obstructive sleep apnea (adult) (pediatric)
unknown m 59 $nan$hematology blood hematocrit  46.0  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  148  mg dl$acetaminophen  1000  mg ; pregabalin  75  mg ; ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  flush  3-10  ml ; d5 1 2ns  1000  ml ; oxycodone (immediate release)  5  mg ; flecainide acetate  100  mg ; clonazepam  2  mg ; duloxetine  30  mg ; pramipexole  0.25  mg ; heparin  5000  unit ; lorazepam  2  mg ; oxycodone (immediate release)  5-10  mg ; diltiazem extended-release  180  mg ; ipratropium-albuterol inhalation spray  1  inh ; ipratropium bromide neb  1  neb ; lisinopril  10  mg ; bag  1  bag ; magnesium sulfate  2  gm ; diltiazem  5  mg ; 
malignant neoplasm of connective and soft tissue of right lower limb, including hip major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified alcohol dependence with withdrawal, unspecified cerebral aneurysm, nonruptured other postprocedural complications and disorders of the circulatory system, not elsewhere classified nicotine dependence, cigarettes, uncomplicated restless legs syndrome body mass index (bmi) 37.0-37.9, adult obesity, unspecified patient room in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified unspecified atrial fibrillation other chronic pain anxiety disorder, unspecified essential (primary) hypertension obstructive sleep apnea (adult) (pediatric)
unknown m 59 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  97  mg dl$ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  flush  3-10  ml ; flecainide acetate  100  mg ; clonazepam  2  mg ; duloxetine  30  mg ; pramipexole  0.25  mg ; heparin  5000  unit ; lorazepam  2  mg ; oxycodone (immediate release)  5-10  mg ; diltiazem extended-release  180  mg ; ipratropium bromide neb  1  neb ; lisinopril  10  mg ; bag  1  bag ; magnesium sulfate  2  gm ; diltiazem  5  mg ; metoprolol tartrate  5  mg ; apixaban  5  mg ; diltiazem  60  mg ; 
malignant neoplasm of connective and soft tissue of right lower limb, including hip major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified alcohol dependence with withdrawal, unspecified cerebral aneurysm, nonruptured other postprocedural complications and disorders of the circulatory system, not elsewhere classified nicotine dependence, cigarettes, uncomplicated restless legs syndrome body mass index (bmi) 37.0-37.9, adult obesity, unspecified patient room in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified unspecified atrial fibrillation other chronic pain anxiety disorder, unspecified essential (primary) hypertension obstructive sleep apnea (adult) (pediatric)
unknown m 59 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3-10  ml ; clonazepam  2  mg ; duloxetine  30  mg ; pramipexole  0.25  mg ; lorazepam  2  mg ; oxycodone (immediate release)  5-10  mg ; ipratropium bromide neb  1  neb ; lisinopril  10  mg ; metoprolol tartrate  5  mg ; diltiazem  60  mg ; hydromorphone (dilaudid)  0.25  mg ; diltiazem extended-release  240  mg ; 
malignant neoplasm of connective and soft tissue of right lower limb, including hip major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified alcohol dependence with withdrawal, unspecified cerebral aneurysm, nonruptured other postprocedural complications and disorders of the circulatory system, not elsewhere classified nicotine dependence, cigarettes, uncomplicated restless legs syndrome body mass index (bmi) 37.0-37.9, adult obesity, unspecified patient room in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified unspecified atrial fibrillation other chronic pain anxiety disorder, unspecified essential (primary) hypertension obstructive sleep apnea (adult) (pediatric)
unknown m 59 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; clonazepam  2  mg ; duloxetine  30  mg ; pramipexole  0.25  mg ; lorazepam  2  mg ; oxycodone (immediate release)  5-10  mg ; ipratropium bromide neb  1  neb ; lisinopril  10  mg ; 
malignant neoplasm of connective and soft tissue of right lower limb, including hip major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified alcohol dependence with withdrawal, unspecified cerebral aneurysm, nonruptured other postprocedural complications and disorders of the circulatory system, not elsewhere classified nicotine dependence, cigarettes, uncomplicated restless legs syndrome body mass index (bmi) 37.0-37.9, adult obesity, unspecified patient room in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified unspecified atrial fibrillation other chronic pain anxiety disorder, unspecified essential (primary) hypertension obstructive sleep apnea (adult) (pediatric)
unknown m 59 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; clonazepam  2  mg ; duloxetine  30  mg ; pramipexole  0.25  mg ; lorazepam  2  mg ; oxycodone (immediate release)  5-10  mg ; ipratropium bromide neb  1  neb ; lisinopril  10  mg ; 
malignant neoplasm of connective and soft tissue of right lower limb, including hip major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified alcohol dependence with withdrawal, unspecified cerebral aneurysm, nonruptured other postprocedural complications and disorders of the circulatory system, not elsewhere classified nicotine dependence, cigarettes, uncomplicated restless legs syndrome body mass index (bmi) 37.0-37.9, adult obesity, unspecified patient room in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified unspecified atrial fibrillation other chronic pain anxiety disorder, unspecified essential (primary) hypertension obstructive sleep apnea (adult) (pediatric)
unknown m 59 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; clonazepam  2  mg ; duloxetine  30  mg ; pramipexole  0.25  mg ; lorazepam  2  mg ; oxycodone (immediate release)  5-10  mg ; ipratropium bromide neb  1  neb ; lisinopril  10  mg ; 
malignant neoplasm of connective and soft tissue of right lower limb, including hip major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified alcohol dependence with withdrawal, unspecified cerebral aneurysm, nonruptured other postprocedural complications and disorders of the circulatory system, not elsewhere classified nicotine dependence, cigarettes, uncomplicated restless legs syndrome body mass index (bmi) 37.0-37.9, adult obesity, unspecified patient room in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified unspecified atrial fibrillation other chronic pain anxiety disorder, unspecified essential (primary) hypertension obstructive sleep apnea (adult) (pediatric)
unknown m 59 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3-10  ml ; clonazepam  2  mg ; duloxetine  30  mg ; pramipexole  0.25  mg ; lorazepam  2  mg ; oxycodone (immediate release)  5-10  mg ; ipratropium bromide neb  1  neb ; lisinopril  10  mg ; lactated ringers  1000  ml ; 
malignant neoplasm of connective and soft tissue of right lower limb, including hip major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified alcohol dependence with withdrawal, unspecified cerebral aneurysm, nonruptured other postprocedural complications and disorders of the circulatory system, not elsewhere classified nicotine dependence, cigarettes, uncomplicated restless legs syndrome body mass index (bmi) 37.0-37.9, adult obesity, unspecified patient room in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified unspecified atrial fibrillation other chronic pain anxiety disorder, unspecified essential (primary) hypertension obstructive sleep apnea (adult) (pediatric)
unknown m 59 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; duloxetine  30  mg ; pramipexole  0.25  mg ; lorazepam  2  mg ; oxycodone (immediate release)  5-10  mg ; ipratropium bromide neb  1  neb ; lisinopril  10  mg ; lactated ringers  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 
malignant neoplasm of connective and soft tissue of right lower limb, including hip major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified alcohol dependence with withdrawal, unspecified cerebral aneurysm, nonruptured other postprocedural complications and disorders of the circulatory system, not elsewhere classified nicotine dependence, cigarettes, uncomplicated restless legs syndrome body mass index (bmi) 37.0-37.9, adult obesity, unspecified patient room in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified unspecified atrial fibrillation other chronic pain anxiety disorder, unspecified essential (primary) hypertension obstructive sleep apnea (adult) (pediatric)
unknown m 59 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; duloxetine  30  mg ; pramipexole  0.25  mg ; lorazepam  2  mg ; oxycodone (immediate release)  5-10  mg ; ipratropium bromide neb  1  neb ; lisinopril  10  mg ; lactated ringers  1000  ml ; 
malignant neoplasm of connective and soft tissue of right lower limb, including hip major depressive disorder, single episode, unspecified chronic obstructive pulmonary disease, unspecified alcohol dependence with withdrawal, unspecified cerebral aneurysm, nonruptured other postprocedural complications and disorders of the circulatory system, not elsewhere classified nicotine dependence, cigarettes, uncomplicated restless legs syndrome body mass index (bmi) 37.0-37.9, adult obesity, unspecified patient room in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified unspecified atrial fibrillation other chronic pain anxiety disorder, unspecified essential (primary) hypertension obstructive sleep apnea (adult) (pediatric)
white m 52 $temp  98.4  heartrate  76.0  resprate  16.0  o2sat  96.0  sbp  154.0  dbp  89.0  rhythm    pain    $hematology blood hematocrit  23.6  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  325-650  mg ; tramadol (ultram)  50  mg ; heparin  2000-4000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium  100  mg ; omeprazole  40  mg ; fexofenadine  10  mg ; fexofenadine  60  mg ; lisinopril  5  mg ; aspirin  81  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; warfarin  5  mg ; 
 
white m 52 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  108  mg dl$senna  1  tab ; acetaminophen  325-650  mg ; tramadol (ultram)  50  mg ; heparin  2000-4000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium  100  mg ; omeprazole  40  mg ; fexofenadine  60  mg ; lisinopril  5  mg ; aspirin  81  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; warfarin  5  mg ; metoprolol succinate xl  25  mg ; trazodone  25  mg ; enoxaparin sodium  100  mg ; carvedilol  6.25  mg ; 
 
white m 52 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  306  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  102  mg dl$senna  1  tab ; acetaminophen  325-650  mg ; tramadol (ultram)  50  mg ; docusate sodium  100  mg ; omeprazole  40  mg ; fexofenadine  60  mg ; lisinopril  5  mg ; aspirin  81  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; warfarin  5  mg ; metoprolol succinate xl  25  mg ; trazodone  25  mg ; enoxaparin sodium  100  mg ; 
 
white m 43 $temp  97.8  heartrate  80.0  resprate  16.0  o2sat  98.0  sbp  127.0  dbp  80.0  rhythm    pain  8  $nan$sodium chloride 0.9%  flush  3  ml ; influenza virus vaccine  0.5  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; ondansetron  4  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; oxycodone (immediate release)   5-10  mg ; 
 
white m 43 $nan$nan$sodium chloride 0.9%  flush  3  ml ; influenza virus vaccine  0.5  ml ; morphine sulfate  2-4  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; ondansetron  4  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; 
 
white f 78 $nan$hematology blood hematocrit  36.6  %; chemistry blood chloride  104  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; hydromorphone (dilaudid)  20  mg ; ketorolac  15  mg ; metoclopramide  10  mg ; lactated ringers  1000  ml ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; bag  1  bag ; magnesium sulfate  2  gm ; heparin  5000  unit ; 
acquired absence of breast and nipple benign neoplasm of colon malignant neoplasm of ascending colon personal history of irradiation, presenting hazards to health secondary malignant neoplasm of lung personal history of tobacco use cardiac pacemaker in situ personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle person boarding or alighting a pedal cycle injured in collision with pedestrian or animal accidents occurring in residential institution mechanical complication due to cardiac pacemaker (electrode) personal history of tobacco use mobitz (type) ii atrioventricular block personal history of malignant neoplasm of breast surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation other and unspecified hyperlipidemia
white f 78 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  71  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  20  mg ; ketorolac  15  mg ; metoclopramide  10  mg ; lactated ringers  1000  ml ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; bag  1  bag ; magnesium sulfate  2  gm ; heparin  5000  unit ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; 
acquired absence of breast and nipple benign neoplasm of colon malignant neoplasm of ascending colon personal history of irradiation, presenting hazards to health secondary malignant neoplasm of lung personal history of tobacco use cardiac pacemaker in situ personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle person boarding or alighting a pedal cycle injured in collision with pedestrian or animal accidents occurring in residential institution mechanical complication due to cardiac pacemaker (electrode) personal history of tobacco use mobitz (type) ii atrioventricular block personal history of malignant neoplasm of breast surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation other and unspecified hyperlipidemia
white f 78 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ketorolac  15  mg ; metoclopramide  10  mg ; heparin  5000  unit ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; 
acquired absence of breast and nipple benign neoplasm of colon malignant neoplasm of ascending colon personal history of irradiation, presenting hazards to health secondary malignant neoplasm of lung personal history of tobacco use cardiac pacemaker in situ personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle person boarding or alighting a pedal cycle injured in collision with pedestrian or animal accidents occurring in residential institution mechanical complication due to cardiac pacemaker (electrode) personal history of tobacco use mobitz (type) ii atrioventricular block personal history of malignant neoplasm of breast surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation other and unspecified hyperlipidemia
white f 78 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ketorolac  15  mg ; metoclopramide  10  mg ; heparin  5000  unit ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; 
acquired absence of breast and nipple benign neoplasm of colon malignant neoplasm of ascending colon personal history of irradiation, presenting hazards to health secondary malignant neoplasm of lung personal history of tobacco use cardiac pacemaker in situ personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle person boarding or alighting a pedal cycle injured in collision with pedestrian or animal accidents occurring in residential institution mechanical complication due to cardiac pacemaker (electrode) personal history of tobacco use mobitz (type) ii atrioventricular block personal history of malignant neoplasm of breast surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation other and unspecified hyperlipidemia
white m 92 $temp  98.0  heartrate  101.0  resprate  15.0  o2sat  94.0  sbp  173.0  dbp  99.0  rhythm    pain  8  $hematology blood hematocrit  36.8  %; hematology blood hematocrit  32.3  %; hematology blood hemoglobin  11.7  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  173  k ul; hematology blood platelet count  147  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  6.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  118  mg dl$hydromorphone (dilaudid)  0.5-1  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; tramadol  25  mg ; morphine sulfate  1-2  mg ; acetaminophen  650  mg ; rosuvastatin calcium  40  mg ; heparin  1000-1600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; aspirin  81  mg ; lidocaine jelly 2% (glydo)  1  appl ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; senna  17.2  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension aortocoronary bypass status hematoma complicating a procedure aneurysm of artery of lower extremity other complications due to other vascular device, implant, and graft coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of tobacco use arterial embolism and thrombosis of lower extremity aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified arterial embolism and thrombosis of lower extremity other complications due to other vascular device, implant, and graft chronic kidney disease, unspecified atrial fibrillation cardiac complications, not elsewhere classified atrial flutter surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation aortocoronary bypass status
white m 92 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  98  mg dl$hydromorphone (dilaudid)  0.5-1  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; rosuvastatin calcium  40  mg ; aspirin  81  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  25  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension aortocoronary bypass status hematoma complicating a procedure aneurysm of artery of lower extremity other complications due to other vascular device, implant, and graft coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of tobacco use arterial embolism and thrombosis of lower extremity aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified arterial embolism and thrombosis of lower extremity other complications due to other vascular device, implant, and graft chronic kidney disease, unspecified atrial fibrillation cardiac complications, not elsewhere classified atrial flutter surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation aortocoronary bypass status
white m 92 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  107  mg dl$hydromorphone (dilaudid)  0.5-1  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; rosuvastatin calcium  40  mg ; aspirin  81  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  25  mg ; neutra-phos  1  pkt ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension aortocoronary bypass status hematoma complicating a procedure aneurysm of artery of lower extremity other complications due to other vascular device, implant, and graft coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of tobacco use arterial embolism and thrombosis of lower extremity aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified arterial embolism and thrombosis of lower extremity other complications due to other vascular device, implant, and graft chronic kidney disease, unspecified atrial fibrillation cardiac complications, not elsewhere classified atrial flutter surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation aortocoronary bypass status
white m 92 $nan$hematology blood hematocrit  33.2  %; hematology blood hematocrit  27.0  %; hematology blood hematocrit  24.7  %; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  150  k ul; hematology blood platelet count  150  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  104  mg dl$hydromorphone (dilaudid)  0.5-1  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; rosuvastatin calcium  40  mg ; aspirin  81  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  25  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension aortocoronary bypass status hematoma complicating a procedure aneurysm of artery of lower extremity other complications due to other vascular device, implant, and graft coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of tobacco use arterial embolism and thrombosis of lower extremity aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified arterial embolism and thrombosis of lower extremity other complications due to other vascular device, implant, and graft chronic kidney disease, unspecified atrial fibrillation cardiac complications, not elsewhere classified atrial flutter surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation aortocoronary bypass status
white m 92 $nan$hematology blood hematocrit  25.7  %; hematology blood hematocrit  22.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  145  k ul; hematology blood platelet count  148  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology urine wbc  51  # hpf; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  98  mg dl; chemistry blood glucose  184  mg dl$hydromorphone (dilaudid)  0.5-1  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; rosuvastatin calcium  40  mg ; aspirin  81  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  25  mg ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  4  gm ; metoprolol tartrate  6.25  mg ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; acetaminophen  1000  mg ; sodium chloride 0.9%  1000  ml ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension aortocoronary bypass status hematoma complicating a procedure aneurysm of artery of lower extremity other complications due to other vascular device, implant, and graft coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of tobacco use arterial embolism and thrombosis of lower extremity aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified arterial embolism and thrombosis of lower extremity other complications due to other vascular device, implant, and graft chronic kidney disease, unspecified atrial fibrillation cardiac complications, not elsewhere classified atrial flutter surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation aortocoronary bypass status
white m 92 $nan$hematology blood hematocrit  22.5  %; hematology blood hematocrit  21.1  %; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  6.8  g dl; hematology blood platelet count  154  k ul; hematology blood platelet count  150  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  123  mg dl$hydromorphone (dilaudid)  0.5-1  mg ; sodium chloride 0.9%  flush  3-10  ml ; rosuvastatin calcium  40  mg ; aspirin  81  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  25  mg ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; acetaminophen  1000  mg ; sodium chloride 0.9%  1000  ml ; calcium carbonate  1500  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension aortocoronary bypass status hematoma complicating a procedure aneurysm of artery of lower extremity other complications due to other vascular device, implant, and graft coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of tobacco use arterial embolism and thrombosis of lower extremity aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified arterial embolism and thrombosis of lower extremity other complications due to other vascular device, implant, and graft chronic kidney disease, unspecified atrial fibrillation cardiac complications, not elsewhere classified atrial flutter surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation aortocoronary bypass status
white m 92 $nan$hematology blood hematocrit  22.7  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  112  mg dl$hydromorphone (dilaudid)  0.5-1  mg ; sodium chloride 0.9%  flush  3-10  ml ; rosuvastatin calcium  40  mg ; aspirin  81  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  25  mg ; acetaminophen  1000  mg ; calcium carbonate  1500  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  500  ml ; sodium phosphate  30  mmol ; tamsulosin  0.4  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension aortocoronary bypass status hematoma complicating a procedure aneurysm of artery of lower extremity other complications due to other vascular device, implant, and graft coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of tobacco use arterial embolism and thrombosis of lower extremity aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified arterial embolism and thrombosis of lower extremity other complications due to other vascular device, implant, and graft chronic kidney disease, unspecified atrial fibrillation cardiac complications, not elsewhere classified atrial flutter surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation aortocoronary bypass status
white m 92 $nan$hematology blood hematocrit  21.4  %; hematology blood hematocrit  22.8  %; hematology blood hemoglobin  6.8  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  104  mg dl$hydromorphone (dilaudid)  0.5-1  mg ; sodium chloride 0.9%  flush  3-10  ml ; rosuvastatin calcium  40  mg ; aspirin  81  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  25  mg ; acetaminophen  1000  mg ; calcium carbonate  1500  mg ; 0.9% sodium chloride  500  ml ; sodium phosphate  30  mmol ; tamsulosin  0.4  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension aortocoronary bypass status hematoma complicating a procedure aneurysm of artery of lower extremity other complications due to other vascular device, implant, and graft coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of tobacco use arterial embolism and thrombosis of lower extremity aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified arterial embolism and thrombosis of lower extremity other complications due to other vascular device, implant, and graft chronic kidney disease, unspecified atrial fibrillation cardiac complications, not elsewhere classified atrial flutter surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation aortocoronary bypass status
white m 92 $nan$hematology blood hematocrit  22.7  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  113  mg dl; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.07  mmol l$hydromorphone (dilaudid)  0.5-1  mg ; sodium chloride 0.9%  flush  3-10  ml ; rosuvastatin calcium  40  mg ; aspirin  81  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  25  mg ; acetaminophen  1000  mg ; calcium carbonate  1500  mg ; tamsulosin  0.4  mg ; neutra-phos  2  pkt ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension aortocoronary bypass status hematoma complicating a procedure aneurysm of artery of lower extremity other complications due to other vascular device, implant, and graft coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of tobacco use arterial embolism and thrombosis of lower extremity aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified arterial embolism and thrombosis of lower extremity other complications due to other vascular device, implant, and graft chronic kidney disease, unspecified atrial fibrillation cardiac complications, not elsewhere classified atrial flutter surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation aortocoronary bypass status
white m 92 $nan$hematology blood hematocrit  22.4  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  114  mg dl; blood gas blood free calcium  1.17  mmol l$hydromorphone (dilaudid)  0.5-1  mg ; sodium chloride 0.9%  flush  3-10  ml ; rosuvastatin calcium  40  mg ; aspirin  81  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  25  mg ; acetaminophen  1000  mg ; calcium carbonate  1500  mg ; tamsulosin  0.4  mg ; neutra-phos  2  pkt ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension aortocoronary bypass status hematoma complicating a procedure aneurysm of artery of lower extremity other complications due to other vascular device, implant, and graft coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of tobacco use arterial embolism and thrombosis of lower extremity aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified arterial embolism and thrombosis of lower extremity other complications due to other vascular device, implant, and graft chronic kidney disease, unspecified atrial fibrillation cardiac complications, not elsewhere classified atrial flutter surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation aortocoronary bypass status
white m 92 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  137  mg dl$hydromorphone (dilaudid)  0.5-1  mg ; sodium chloride 0.9%  flush  3-10  ml ; rosuvastatin calcium  40  mg ; aspirin  81  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  25  mg ; acetaminophen  1000  mg ; calcium carbonate  1500  mg ; tamsulosin  0.4  mg ; metoprolol tartrate  12.5  mg ; magnesium sulfate  2  gm ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension aortocoronary bypass status hematoma complicating a procedure aneurysm of artery of lower extremity other complications due to other vascular device, implant, and graft coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of tobacco use arterial embolism and thrombosis of lower extremity aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified arterial embolism and thrombosis of lower extremity other complications due to other vascular device, implant, and graft chronic kidney disease, unspecified atrial fibrillation cardiac complications, not elsewhere classified atrial flutter surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation aortocoronary bypass status
white m 92 $nan$nan$hydromorphone (dilaudid)  0.5-1  mg ; sodium chloride 0.9%  flush  3-10  ml ; rosuvastatin calcium  40  mg ; aspirin  81  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  25  mg ; acetaminophen  1000  mg ; calcium carbonate  1500  mg ; tamsulosin  0.4  mg ; metoprolol tartrate  12.5  mg ; magnesium sulfate  2  gm ; metoprolol tartrate  25  mg ; metoprolol tartrate  37.5  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension aortocoronary bypass status hematoma complicating a procedure aneurysm of artery of lower extremity other complications due to other vascular device, implant, and graft coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of tobacco use arterial embolism and thrombosis of lower extremity aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified arterial embolism and thrombosis of lower extremity other complications due to other vascular device, implant, and graft chronic kidney disease, unspecified atrial fibrillation cardiac complications, not elsewhere classified atrial flutter surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation aortocoronary bypass status
white m 92 $nan$nan$hydromorphone (dilaudid)  0.5-1  mg ; sodium chloride 0.9%  flush  3-10  ml ; rosuvastatin calcium  40  mg ; aspirin  81  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  25  mg ; acetaminophen  1000  mg ; calcium carbonate  1500  mg ; tamsulosin  0.4  mg ; magnesium sulfate  2  gm ; metoprolol succinate xl  100  mg ; metoprolol succinate xl  50  mg ; heparin  5000  unit ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension aortocoronary bypass status hematoma complicating a procedure aneurysm of artery of lower extremity other complications due to other vascular device, implant, and graft coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of tobacco use arterial embolism and thrombosis of lower extremity aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified arterial embolism and thrombosis of lower extremity other complications due to other vascular device, implant, and graft chronic kidney disease, unspecified atrial fibrillation cardiac complications, not elsewhere classified atrial flutter surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation aortocoronary bypass status
white f 38 $nan$hematology blood hematocrit  33.2  %; hematology blood hematocrit  28.3  %; hematology blood hematocrit  30.5  %; hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  107  mg dl$morphine sulfate  2-4  mg ; lr  1000  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; morphine sulfate  50  mg ; ondansetron  4  mg ; insulin  0  unit ; acetaminophen  650  mg ; 
 
white f 38 $nan$hematology blood hematocrit  31.8  %; hematology blood hematocrit  31.5  %; hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  99  mg dl$lr  1000  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; morphine sulfate  50  mg ; ondansetron  4  mg ; insulin  0  unit ; acetaminophen  650  mg ; oxycodone-acetaminophen  1-2  tab ; bisacodyl  10  mg ; oxycodone liquid  5-10  mg ; famotidine  20  mg ; docusate sodium  100  mg ; milk of magnesia  30  ml ; 
 
white f 38 $nan$hematology blood hematocrit  30.2  %; hematology blood hematocrit  28.7  %; hematology blood platelet count  132  k ul$lr  1000  ml ; acetaminophen  650  mg ; bisacodyl  10  mg ; oxycodone liquid  5-10  mg ; famotidine  20  mg ; docusate sodium  100  mg ; milk of magnesia  30  ml ; senna  2  tab ; metoclopramide  10  mg ; 
 
white f 38 $nan$nan$lr  1000  ml ; acetaminophen  650  mg ; bisacodyl  10  mg ; oxycodone liquid  5-10  mg ; famotidine  20  mg ; docusate sodium  100  mg ; milk of magnesia  30  ml ; senna  2  tab ; tramadol (ultram)  50  mg ; 
 
white f 38 $nan$nan$lr  1000  ml ; acetaminophen  650  mg ; bisacodyl  10  mg ; famotidine  20  mg ; docusate sodium  100  mg ; milk of magnesia  30  ml ; senna  2  tab ; tramadol (ultram)  50  mg ; 
 
white f 38 $nan$nan$lr  1000  ml ; bisacodyl  10  mg ; famotidine  20  mg ; docusate sodium  100  mg ; milk of magnesia  30  ml ; senna  2  tab ; 
 
black african american f 91 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  1  tab ; fleet phospho-soda  45  ml ; ns  1000  ml ; lorazepam  0.25  mg ; calcium carbonate  500  mg ; docusate sodium (liquid)  100  mg ; paroxetine  20  mg ; multivitamins  1  tab ; lactulose enema  1000  ml ; erythromycin 0.5% ophth oint  0.5  in ; 
 
white f 67 $nan$hematology blood hematocrit  30.5  %; hematology blood hematocrit  30.4  %; hematology blood hematocrit  26.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  229  k ul; hematology blood platelet count  213  k ul; hematology blood platelet count  171  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  4.6  mg dl; chemistry blood creatinine  5.7  mg dl; chemistry blood creatinine  5.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  64  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  ; hematology urine wbc  36  # hpf; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  80  mg dl; chemistry blood glucose  190  mg dl; chemistry blood glucose  82  mg dl; chemistry blood albumin  4.6  g dl$sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  50  ml ; methylprednisolone sodium succ  500  mg ; mycophenolate mofetil  1000  mg ; heparin  5000  unit ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; 5 syringes (ns)  250  ml ; anti-thymocyte globulin (rabbit)  75  mg ; omeprazole  20  mg ; simvastatin  40  mg ; alprazolam  1  mg ; topiramate (topamax)  100  mg ; lamotrigine  100  mg ; divalproex (extended release)  500  mg ; levothyroxine sodium  112  mcg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; valganciclovir  450  mg ; d5 1 2ns  1000  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  1000  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; 
solitary pulmonary nodule headache bipolar disorder, unspecified end stage renal disease essential (primary) hypertension anxiety disorder, unspecified benign neoplasm of left ovary anemia in chronic kidney disease gastro-esophageal reflux disease without esophagitis dependence on renal dialysis benign neoplasm of right ovary hypoglycemia, unspecified hypothyroidism, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease nephropathy induced by other drugs, medicaments and biological substances other specified forms of tremor unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified hyperlipidemia, unspecified 
white f 67 $nan$hematology blood hematocrit  23.3  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  107  mg dl$heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; valganciclovir  450  mg ; d5 1 2ns  1000  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  1000  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; docusate sodium  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; cepacol (sore throat lozenge)  1  loz ; methylprednisolone sodium succ  100  mg ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; escitalopram oxalate  20  mg ; nystatin oral suspension  5  ml ; transplant self medication program  1  bag ; diphenhydramine  25-50  mg ; tacrolimus  2  mg ; 
solitary pulmonary nodule headache bipolar disorder, unspecified end stage renal disease essential (primary) hypertension anxiety disorder, unspecified benign neoplasm of left ovary anemia in chronic kidney disease gastro-esophageal reflux disease without esophagitis dependence on renal dialysis benign neoplasm of right ovary hypoglycemia, unspecified hypothyroidism, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease nephropathy induced by other drugs, medicaments and biological substances other specified forms of tremor unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified hyperlipidemia, unspecified 
white f 67 $nan$hematology blood hematocrit  24.0  %; hematology blood hematocrit  22.7  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  134  k ul; hematology blood platelet count  132  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  105  mg dl$heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; d5 1 2ns  1000  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  1000  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; docusate sodium  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; cepacol (sore throat lozenge)  1  loz ; methylprednisolone sodium succ  100  mg ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; escitalopram oxalate  20  mg ; transplant self medication program  1  bag ; diphenhydramine  25-50  mg ; tacrolimus  2  mg ; methylprednisolone sodium succ  50  mg ; hydromorphone (dilaudid)  1-2  mg ; furosemide  20  mg ; furosemide  40  mg ; 
solitary pulmonary nodule headache bipolar disorder, unspecified end stage renal disease essential (primary) hypertension anxiety disorder, unspecified benign neoplasm of left ovary anemia in chronic kidney disease gastro-esophageal reflux disease without esophagitis dependence on renal dialysis benign neoplasm of right ovary hypoglycemia, unspecified hypothyroidism, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease nephropathy induced by other drugs, medicaments and biological substances other specified forms of tremor unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified hyperlipidemia, unspecified 
white f 67 $nan$hematology blood hematocrit  34.5  %; hematology blood hematocrit  31.9  %; hematology blood hemoglobin  11.4  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  141  k ul; hematology blood platelet count  125  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  113  mg dl$heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; cepacol (sore throat lozenge)  1  loz ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; escitalopram oxalate  20  mg ; transplant self medication program  1  bag ; diphenhydramine  25-50  mg ; methylprednisolone sodium succ  50  mg ; hydromorphone (dilaudid)  1-2  mg ; furosemide  20  mg ; furosemide  40  mg ; polyethylene glycol  17  g ; tacrolimus  4  mg ; 
solitary pulmonary nodule headache bipolar disorder, unspecified end stage renal disease essential (primary) hypertension anxiety disorder, unspecified benign neoplasm of left ovary anemia in chronic kidney disease gastro-esophageal reflux disease without esophagitis dependence on renal dialysis benign neoplasm of right ovary hypoglycemia, unspecified hypothyroidism, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease nephropathy induced by other drugs, medicaments and biological substances other specified forms of tremor unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified hyperlipidemia, unspecified 
white f 67 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  85  mg dl$heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; cepacol (sore throat lozenge)  1  loz ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; escitalopram oxalate  20  mg ; transplant self medication program  1  bag ; diphenhydramine  25-50  mg ; hydromorphone (dilaudid)  1-2  mg ; polyethylene glycol  17  g ; tacrolimus  4  mg ; prednisone  20  mg ; prednisone  5  mg ; tacrolimus  1  mg ; tacrolimus  5  mg ; 
solitary pulmonary nodule headache bipolar disorder, unspecified end stage renal disease essential (primary) hypertension anxiety disorder, unspecified benign neoplasm of left ovary anemia in chronic kidney disease gastro-esophageal reflux disease without esophagitis dependence on renal dialysis benign neoplasm of right ovary hypoglycemia, unspecified hypothyroidism, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease nephropathy induced by other drugs, medicaments and biological substances other specified forms of tremor unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified hyperlipidemia, unspecified 
white f 67 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  81  mg dl$acetaminophen  1000  mg ; docusate sodium  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; cepacol (sore throat lozenge)  1  loz ; escitalopram oxalate  20  mg ; transplant self medication program  1  bag ; diphenhydramine  25-50  mg ; hydromorphone (dilaudid)  1-2  mg ; polyethylene glycol  17  g ; prednisone  20  mg ; prednisone  5  mg ; tacrolimus  5  mg ; phosphorus  500  mg ; alprazolam  0.5  mg ; 
solitary pulmonary nodule headache bipolar disorder, unspecified end stage renal disease essential (primary) hypertension anxiety disorder, unspecified benign neoplasm of left ovary anemia in chronic kidney disease gastro-esophageal reflux disease without esophagitis dependence on renal dialysis benign neoplasm of right ovary hypoglycemia, unspecified hypothyroidism, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease nephropathy induced by other drugs, medicaments and biological substances other specified forms of tremor unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified hyperlipidemia, unspecified 
white f 67 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  79  mg dl$acetaminophen  1000  mg ; docusate sodium  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; cepacol (sore throat lozenge)  1  loz ; escitalopram oxalate  20  mg ; transplant self medication program  1  bag ; diphenhydramine  25-50  mg ; hydromorphone (dilaudid)  1-2  mg ; polyethylene glycol  17  g ; phosphorus  500  mg ; alprazolam  0.5  mg ; potassium chloride  40  meq ; 
solitary pulmonary nodule headache bipolar disorder, unspecified end stage renal disease essential (primary) hypertension anxiety disorder, unspecified benign neoplasm of left ovary anemia in chronic kidney disease gastro-esophageal reflux disease without esophagitis dependence on renal dialysis benign neoplasm of right ovary hypoglycemia, unspecified hypothyroidism, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease nephropathy induced by other drugs, medicaments and biological substances other specified forms of tremor unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified hyperlipidemia, unspecified 
white f 67 $nan$nan$acetaminophen  1000  mg ; docusate sodium  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; cepacol (sore throat lozenge)  1  loz ; escitalopram oxalate  20  mg ; transplant self medication program  1  bag ; diphenhydramine  25-50  mg ; hydromorphone (dilaudid)  1-2  mg ; polyethylene glycol  17  g ; phosphorus  500  mg ; alprazolam  0.5  mg ; potassium chloride  40  meq ; 
solitary pulmonary nodule headache bipolar disorder, unspecified end stage renal disease essential (primary) hypertension anxiety disorder, unspecified benign neoplasm of left ovary anemia in chronic kidney disease gastro-esophageal reflux disease without esophagitis dependence on renal dialysis benign neoplasm of right ovary hypoglycemia, unspecified hypothyroidism, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease nephropathy induced by other drugs, medicaments and biological substances other specified forms of tremor unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified hyperlipidemia, unspecified 
black african american f 45 $temp  98.7  heartrate  90.0  resprate  18.0  o2sat  98.0  sbp  111.0  dbp  72.0  rhythm    pain  9  $hematology blood hematocrit  39.4  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  405  mg dl; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  1.8  mmol l; chemistry blood % hemoglobin a1c  10.7  %$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  30  unit ; simvastatin  20  mg ; aspirin  81  mg ; 0.9% sodium chloride  500  ml ; acetaminophen  650  mg ; 
 
black african american f 45 $nan$hematology blood hematocrit  39.0  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  419  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  30  unit ; simvastatin  20  mg ; aspirin  81  mg ; 0.9% sodium chloride  500  ml ; acetaminophen  650  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; trazodone  25  mg ; amitriptyline  75  mg ; lidocaine 1%  1  ml ; morphine sulfate  2  mg ; 
 
black african american f 45 $nan$hematology blood hematocrit  40.0  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  323  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  124  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5  mg ; simvastatin  20  mg ; aspirin  81  mg ; acetaminophen  650  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; trazodone  25  mg ; amitriptyline  75  mg ; lidocaine 1%  1  ml ; morphine sulfate  2  mg ; 0.9% sodium chloride  250  ml ; sulfameth trimethoprim ds  1  tab ; senna  2  tab ; insulin  50  unit ; 
 
black african american f 45 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; simvastatin  20  mg ; aspirin  81  mg ; acetaminophen  650  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; amitriptyline  75  mg ; sulfameth trimethoprim ds  1  tab ; senna  2  tab ; insulin  60  unit ; 
 
white m 76 $nan$nan$omeprazole  20  mg ; amlodipine  10  mg ; 
 
white m 76 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  3.8  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  62  mg dl; chemistry blood glucose  86  mg dl$omeprazole  20  mg ; amlodipine  10  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; calcitriol  0.25  mcg ; metoprolol succinate xl  50  mg ; furosemide  20  mg ; iron polysaccharides complex  150  mg ; 
 
white m 76 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  284  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  56  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  85  mg dl$omeprazole  20  mg ; amlodipine  10  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; calcitriol  0.25  mcg ; metoprolol succinate xl  50  mg ; furosemide  20  mg ; iron polysaccharides complex  150  mg ; metoprolol tartrate  25  mg ; metoprolol succinate xl  100  mg ; magnesium oxide  400  mg ; 
 
white m 76 $nan$nan$omeprazole  20  mg ; amlodipine  10  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; calcitriol  0.25  mcg ; furosemide  20  mg ; iron polysaccharides complex  150  mg ; metoprolol tartrate  25  mg ; metoprolol succinate xl  100  mg ; magnesium oxide  400  mg ; 
 
white f 61 $nan$nan$insulin  30  unit ; fluoxetine  60  mg ; aspirin  81  mg ; simvastatin  20  mg ; 
personal history of noncompliance with medical treatment, presenting hazards to health other and unspecified hyperlipidemia family history of malignant neoplasm of gastrointestinal tract long-term (current) use of insulin disturbance of skin sensation personal history of other mental disorders unspecified essential hypertension diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled obesity, unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident orthostatic hypotension dizziness and giddiness diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white f 61 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  286  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  236  mg dl; blood gas blood lactate  1.3  mmol l$insulin  30  unit ; fluoxetine  60  mg ; aspirin  81  mg ; simvastatin  20  mg ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; clonazepam  2  mg ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; benzonatate  100  mg ; dextromethorphan-guaifenesin (sugar free)  5  ml ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; potassium chloride  40  meq ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; imipramine  300  mg ; albuterol inhaler  2  puff ; 
personal history of noncompliance with medical treatment, presenting hazards to health other and unspecified hyperlipidemia family history of malignant neoplasm of gastrointestinal tract long-term (current) use of insulin disturbance of skin sensation personal history of other mental disorders unspecified essential hypertension diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled obesity, unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident orthostatic hypotension dizziness and giddiness diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white f 61 $nan$nan$insulin  30  unit ; fluoxetine  60  mg ; aspirin  81  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; clonazepam  2  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; benzonatate  100  mg ; dextromethorphan-guaifenesin (sugar free)  5  ml ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; potassium chloride  40  meq ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; imipramine  300  mg ; albuterol inhaler  2  puff ; 
personal history of noncompliance with medical treatment, presenting hazards to health other and unspecified hyperlipidemia family history of malignant neoplasm of gastrointestinal tract long-term (current) use of insulin disturbance of skin sensation personal history of other mental disorders unspecified essential hypertension diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled obesity, unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident orthostatic hypotension dizziness and giddiness diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white f 67 $temp  98.4  heartrate  71.0  resprate  18.0  o2sat  99.0  sbp  115.0  dbp  62.0  rhythm    pain  0  $blood gas blood lactate  2.0  mmol l$enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  1  mg ; hydromorphone (dilaudid)  20  mg ; docusate sodium  100  mg ; omeprazole  40  mg ; senna  17.2  mg ; simethicone  40-80  mg ; lorazepam  1  mg ; polyethylene glycol  17  g ; ipratropium-albuterol neb  1  neb ; hydromorphone (dilaudid)  0.5-1  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.5  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; docusate sodium  200  mg ; dicyclomine  20  mg ; 
underdosing of other opioids, initial encounter malignant neoplasm of upper lobe, right bronchus or lung anxiety disorder, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause neoplasm related pain (acute) (chronic) personal history of nicotine dependence secondary malignant neoplasm of unspecified adrenal gland patient's unintentional underdosing of medication regimen for other reason secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of bone
white f 67 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  96  mg dl$enoxaparin sodium  40  mg ; omeprazole  40  mg ; senna  17.2  mg ; simethicone  40-80  mg ; lorazepam  1  mg ; ipratropium-albuterol neb  1  neb ; hydromorphone (dilaudid)  2-4  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; docusate sodium  200  mg ; dicyclomine  20  mg ; alprazolam  0.25  mg ; glycerin supps  1  supp ; bisacodyl  10  mg ; morphine sr (ms contin)  15  mg ; milk of magnesia  30  ml ; magnesium citrate  300  ml ; 
underdosing of other opioids, initial encounter malignant neoplasm of upper lobe, right bronchus or lung anxiety disorder, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause neoplasm related pain (acute) (chronic) personal history of nicotine dependence secondary malignant neoplasm of unspecified adrenal gland patient's unintentional underdosing of medication regimen for other reason secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of bone
white f 67 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.8  mg dl$enoxaparin sodium  40  mg ; omeprazole  40  mg ; senna  17.2  mg ; simethicone  40-80  mg ; lorazepam  1  mg ; ipratropium-albuterol neb  1  neb ; hydromorphone (dilaudid)  2-4  mg ; ondansetron  4  mg ; docusate sodium  200  mg ; dicyclomine  20  mg ; glycerin supps  1  supp ; bisacodyl  10  mg ; morphine sr (ms contin)  15  mg ; magnesium citrate  300  ml ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; 
underdosing of other opioids, initial encounter malignant neoplasm of upper lobe, right bronchus or lung anxiety disorder, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause neoplasm related pain (acute) (chronic) personal history of nicotine dependence secondary malignant neoplasm of unspecified adrenal gland patient's unintentional underdosing of medication regimen for other reason secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of bone
white f 67 $nan$hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl$enoxaparin sodium  40  mg ; omeprazole  40  mg ; senna  17.2  mg ; simethicone  40-80  mg ; lorazepam  1  mg ; ipratropium-albuterol neb  1  neb ; hydromorphone (dilaudid)  2-4  mg ; ondansetron  4  mg ; docusate sodium  200  mg ; dicyclomine  20  mg ; glycerin supps  1  supp ; bisacodyl  10  mg ; magnesium citrate  300  ml ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% patch  2  ptch ; 
underdosing of other opioids, initial encounter malignant neoplasm of upper lobe, right bronchus or lung anxiety disorder, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause neoplasm related pain (acute) (chronic) personal history of nicotine dependence secondary malignant neoplasm of unspecified adrenal gland patient's unintentional underdosing of medication regimen for other reason secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of bone
white f 67 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.1  mg dl$enoxaparin sodium  40  mg ; omeprazole  40  mg ; senna  17.2  mg ; simethicone  40-80  mg ; lorazepam  1  mg ; ipratropium-albuterol neb  1  neb ; hydromorphone (dilaudid)  2-4  mg ; ondansetron  4  mg ; docusate sodium  200  mg ; dicyclomine  20  mg ; glycerin supps  1  supp ; bisacodyl  10  mg ; magnesium citrate  300  ml ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% patch  2  ptch ; alprazolam  0.5  mg ; hydromorphone (dilaudid)  2  mg ; 
underdosing of other opioids, initial encounter malignant neoplasm of upper lobe, right bronchus or lung anxiety disorder, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause neoplasm related pain (acute) (chronic) personal history of nicotine dependence secondary malignant neoplasm of unspecified adrenal gland patient's unintentional underdosing of medication regimen for other reason secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of bone
white f 67 $nan$nan$enoxaparin sodium  40  mg ; omeprazole  40  mg ; senna  17.2  mg ; simethicone  40-80  mg ; lorazepam  1  mg ; ipratropium-albuterol neb  1  neb ; ondansetron  4  mg ; docusate sodium  200  mg ; dicyclomine  20  mg ; glycerin supps  1  supp ; bisacodyl  10  mg ; magnesium citrate  300  ml ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% patch  2  ptch ; alprazolam  0.5  mg ; hydromorphone (dilaudid)  2  mg ; 
underdosing of other opioids, initial encounter malignant neoplasm of upper lobe, right bronchus or lung anxiety disorder, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause neoplasm related pain (acute) (chronic) personal history of nicotine dependence secondary malignant neoplasm of unspecified adrenal gland patient's unintentional underdosing of medication regimen for other reason secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of bone
white f 67 $nan$nan$enoxaparin sodium  40  mg ; omeprazole  40  mg ; senna  17.2  mg ; simethicone  40-80  mg ; lorazepam  1  mg ; ipratropium-albuterol neb  1  neb ; ondansetron  4  mg ; docusate sodium  200  mg ; dicyclomine  20  mg ; glycerin supps  1  supp ; bisacodyl  10  mg ; magnesium citrate  300  ml ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% patch  2  ptch ; naproxen  500  mg ; morphine sr (ms contin)  30  mg ; 
underdosing of other opioids, initial encounter malignant neoplasm of upper lobe, right bronchus or lung anxiety disorder, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause neoplasm related pain (acute) (chronic) personal history of nicotine dependence secondary malignant neoplasm of unspecified adrenal gland patient's unintentional underdosing of medication regimen for other reason secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of bone
white f 67 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  1094  iu l; chemistry blood albumin  3.4  g dl$enoxaparin sodium  40  mg ; omeprazole  40  mg ; senna  17.2  mg ; simethicone  40-80  mg ; lorazepam  1  mg ; ipratropium-albuterol neb  1  neb ; ondansetron  4  mg ; docusate sodium  200  mg ; dicyclomine  20  mg ; glycerin supps  1  supp ; bisacodyl  10  mg ; magnesium citrate  300  ml ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% patch  2  ptch ; naproxen  500  mg ; morphine sr (ms contin)  30  mg ; hydromorphone (dilaudid)  4  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; albuterol 0.083% neb soln  1  neb ; 
underdosing of other opioids, initial encounter malignant neoplasm of upper lobe, right bronchus or lung anxiety disorder, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause neoplasm related pain (acute) (chronic) personal history of nicotine dependence secondary malignant neoplasm of unspecified adrenal gland patient's unintentional underdosing of medication regimen for other reason secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of bone
white f 67 $nan$nan$enoxaparin sodium  40  mg ; omeprazole  40  mg ; senna  17.2  mg ; simethicone  40-80  mg ; lorazepam  1  mg ; docusate sodium  200  mg ; dicyclomine  20  mg ; glycerin supps  1  supp ; bisacodyl  10  mg ; magnesium citrate  300  ml ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% patch  2  ptch ; naproxen  500  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; albuterol 0.083% neb soln  1  neb ; tiotropium bromide  1  cap ; 
underdosing of other opioids, initial encounter malignant neoplasm of upper lobe, right bronchus or lung anxiety disorder, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause neoplasm related pain (acute) (chronic) personal history of nicotine dependence secondary malignant neoplasm of unspecified adrenal gland patient's unintentional underdosing of medication regimen for other reason secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of bone
white f 67 $nan$nan$omeprazole  40  mg ; senna  17.2  mg ; simethicone  40-80  mg ; lorazepam  1  mg ; docusate sodium  200  mg ; dicyclomine  20  mg ; glycerin supps  1  supp ; bisacodyl  10  mg ; magnesium citrate  300  ml ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% patch  2  ptch ; naproxen  500  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; albuterol 0.083% neb soln  1  neb ; tiotropium bromide  1  cap ; albuterol inhaler  2-4  puff ; 
underdosing of other opioids, initial encounter malignant neoplasm of upper lobe, right bronchus or lung anxiety disorder, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause neoplasm related pain (acute) (chronic) personal history of nicotine dependence secondary malignant neoplasm of unspecified adrenal gland patient's unintentional underdosing of medication regimen for other reason secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of bone
white f 67 $nan$nan$omeprazole  40  mg ; senna  17.2  mg ; simethicone  40-80  mg ; lorazepam  1  mg ; docusate sodium  200  mg ; dicyclomine  20  mg ; glycerin supps  1  supp ; bisacodyl  10  mg ; magnesium citrate  300  ml ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% patch  2  ptch ; naproxen  500  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; albuterol 0.083% neb soln  1  neb ; tiotropium bromide  1  cap ; albuterol inhaler  2-4  puff ; mirtazapine  15  mg ; 
underdosing of other opioids, initial encounter malignant neoplasm of upper lobe, right bronchus or lung anxiety disorder, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause neoplasm related pain (acute) (chronic) personal history of nicotine dependence secondary malignant neoplasm of unspecified adrenal gland patient's unintentional underdosing of medication regimen for other reason secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of bone
white f 67 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  100  mg dl$omeprazole  40  mg ; senna  17.2  mg ; simethicone  40-80  mg ; lorazepam  1  mg ; docusate sodium  200  mg ; dicyclomine  20  mg ; glycerin supps  1  supp ; bisacodyl  10  mg ; magnesium citrate  300  ml ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% patch  2  ptch ; naproxen  500  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; albuterol 0.083% neb soln  1  neb ; tiotropium bromide  1  cap ; albuterol inhaler  2-4  puff ; mirtazapine  7.5  mg ; 
underdosing of other opioids, initial encounter malignant neoplasm of upper lobe, right bronchus or lung anxiety disorder, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause neoplasm related pain (acute) (chronic) personal history of nicotine dependence secondary malignant neoplasm of unspecified adrenal gland patient's unintentional underdosing of medication regimen for other reason secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of bone
white f 67 $nan$hematology blood hematocrit  36.4  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood glucose  82  mg dl$omeprazole  40  mg ; senna  17.2  mg ; simethicone  40-80  mg ; lorazepam  1  mg ; docusate sodium  200  mg ; dicyclomine  20  mg ; glycerin supps  1  supp ; bisacodyl  10  mg ; magnesium citrate  300  ml ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% patch  2  ptch ; naproxen  500  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; albuterol 0.083% neb soln  1  neb ; tiotropium bromide  1  cap ; albuterol inhaler  2-4  puff ; mirtazapine  7.5  mg ; 
underdosing of other opioids, initial encounter malignant neoplasm of upper lobe, right bronchus or lung anxiety disorder, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause neoplasm related pain (acute) (chronic) personal history of nicotine dependence secondary malignant neoplasm of unspecified adrenal gland patient's unintentional underdosing of medication regimen for other reason secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of bone
white f 67 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  266  k ul; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  85  mg dl$omeprazole  40  mg ; senna  17.2  mg ; simethicone  40-80  mg ; lorazepam  1  mg ; docusate sodium  200  mg ; dicyclomine  20  mg ; glycerin supps  1  supp ; bisacodyl  10  mg ; magnesium citrate  300  ml ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% patch  2  ptch ; naproxen  500  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; albuterol 0.083% neb soln  1  neb ; tiotropium bromide  1  cap ; albuterol inhaler  2-4  puff ; mirtazapine  7.5  mg ; 
underdosing of other opioids, initial encounter malignant neoplasm of upper lobe, right bronchus or lung anxiety disorder, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause neoplasm related pain (acute) (chronic) personal history of nicotine dependence secondary malignant neoplasm of unspecified adrenal gland patient's unintentional underdosing of medication regimen for other reason secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of bone
white f 67 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  256  k ul; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  78  mg dl$omeprazole  40  mg ; senna  17.2  mg ; simethicone  40-80  mg ; lorazepam  1  mg ; docusate sodium  200  mg ; dicyclomine  20  mg ; glycerin supps  1  supp ; bisacodyl  10  mg ; magnesium citrate  300  ml ; sodium chloride 0.9%  flush  3  ml ; lidocaine 5% patch  2  ptch ; naproxen  500  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; albuterol 0.083% neb soln  1  neb ; tiotropium bromide  1  cap ; albuterol inhaler  2-4  puff ; mirtazapine  7.5  mg ; 
underdosing of other opioids, initial encounter malignant neoplasm of upper lobe, right bronchus or lung anxiety disorder, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause neoplasm related pain (acute) (chronic) personal history of nicotine dependence secondary malignant neoplasm of unspecified adrenal gland patient's unintentional underdosing of medication regimen for other reason secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of bone
white m 71 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  121  mg dl$lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; morphine sulfate  2-4  mg ; acetaminophen iv  1000  mg ; hydrocortisone na succ.  100  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; insulin  0  unit ; diazepam - ciwa protocol  10  mg ; citalopram  20  mg ; gabapentin  300  mg ; ascorbic acid  500  mg ; trace elements  0.6  ml ; amino acids 4.25%-dextrose 10%  1000  ml ; multivitamin iv  10  ml ; 
 
white m 71 $nan$hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  131  mg dl$lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; morphine sulfate  2-4  mg ; acetaminophen iv  1000  mg ; hydrocortisone na succ.  100  mg ; citalopram  20  mg ; gabapentin  300  mg ; ascorbic acid  500  mg ; trace elements  0.6  ml ; amino acids 4.25%-dextrose 10%  1000  ml ; multivitamin iv  10  ml ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; morphine sulfate  4  mg ; 
 
white m 71 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  143  mg dl$vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; acetaminophen iv  1000  mg ; citalopram  20  mg ; gabapentin  300  mg ; ascorbic acid  500  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; morphine sulfate  4  mg ; calcium carbonate  500  mg ; prednisone  30  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; bag  2  bag ; magnesium sulfate  4  gm ; ramelteon  8  mg ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; 
 
white m 71 $nan$hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  262  mg dl$vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; ascorbic acid  500  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; prednisone  30  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; bag  2  bag ; magnesium sulfate  4  gm ; ramelteon  8  mg ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; 
 
white m 71 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  218  mg dl$vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; ascorbic acid  500  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; prednisone  30  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; 
 
white m 71 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  129  mg dl$bag  1  bag ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; ascorbic acid  500  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; prednisone  30  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; magnesium sulfate  2  gm ; pyridostigmine bromide  60  mg ; 
 
white m 71 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  115  mg dl; chemistry blood albumin  2.6  g dl$bag  1  bag ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; ascorbic acid  500  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; prednisone  30  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; magnesium sulfate  2  gm ; pyridostigmine bromide  60  mg ; hydromorphone (dilaudid)  0.5-1  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; 
 
white m 71 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; ascorbic acid  500  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; prednisone  30  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; hydromorphone (dilaudid)  0.5-1  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
 
white m 71 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  128  mg dl$sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; ascorbic acid  500  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; prednisone  30  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; hydromorphone (dilaudid)  0.5-1  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
 
white m 71 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  84  mg dl$sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; ascorbic acid  500  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; prednisone  30  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; hydromorphone (dilaudid)  0.5-1  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; morphine sulfate  1-2  mg ; acetaminophen  1000  mg ; 
 
white m 71 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; ascorbic acid  500  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; acetaminophen  1000  mg ; 
 
white m 71 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; acetaminophen  1000  mg ; milk of magnesia  15-30  ml ; 
 
white m 71 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; acetaminophen  1000  mg ; milk of magnesia  15-30  ml ; 
 
white m 71 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  88  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; acetaminophen  1000  mg ; milk of magnesia  15-30  ml ; lidocaine 5% patch  1  ptch ; 
 
white m 71 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  236  k ul$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; acetaminophen  1000  mg ; milk of magnesia  15-30  ml ; lidocaine 5% patch  1  ptch ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5-10  mg ; 
 
white m 71 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  96  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; milk of magnesia  15-30  ml ; lidocaine 5% patch  1  ptch ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5-10  mg ; 
 
white m 71 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  83  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; milk of magnesia  15-30  ml ; lidocaine 5% patch  1  ptch ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5-10  mg ; 
 
white m 71 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  105  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; milk of magnesia  15-30  ml ; lidocaine 5% patch  1  ptch ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5-10  mg ; glipizide  5  mg ; 
 
white m 71 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  108  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; milk of magnesia  15-30  ml ; lidocaine 5% patch  1  ptch ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5-10  mg ; glipizide  5  mg ; 
 
white m 71 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  107  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; milk of magnesia  15-30  ml ; lidocaine 5% patch  1  ptch ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5-10  mg ; glipizide  5  mg ; 
 
white m 71 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; milk of magnesia  15-30  ml ; lidocaine 5% patch  1  ptch ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5-10  mg ; glipizide  5  mg ; 
 
white m 71 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  79  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; milk of magnesia  15-30  ml ; lidocaine 5% patch  1  ptch ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5-10  mg ; glipizide  5  mg ; 
 
white m 71 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; milk of magnesia  15-30  ml ; lidocaine 5% patch  1  ptch ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5-10  mg ; glipizide  5  mg ; mineral oil  30  ml ; oxycodone (immediate release)  5-15  mg ; 
 
white m 71 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; citalopram  20  mg ; gabapentin  300  mg ; simvastatin  20  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; calcium carbonate  500  mg ; ramelteon  8  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pyridostigmine bromide  60  mg ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; omeprazole  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  20  mg ; milk of magnesia  15-30  ml ; lidocaine 5% patch  1  ptch ; multivitamins w minerals  1  tab ; glipizide  5  mg ; mineral oil  30  ml ; oxycodone (immediate release)  5-15  mg ; 
 
white f 80 $temp  98.7  heartrate  92.0  resprate  20.0  o2sat  98.0  sbp  108.0  dbp  63.0  rhythm    pain  unable  $nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 
malignant neoplasm of upper lobe, bronchus or lung person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast atrial fibrillation diverticulosis of colon (without mention of hemorrhage) 
asian f 91 $nan$hematology blood hematocrit  39.4  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  164  mg dl; chemistry blood albumin  4.4  g dl$nan
 
asian f 91 $temp  98.0  heartrate  58.0  resprate  16.0  o2sat  99.0  sbp  130.0  dbp  67.0  rhythm    pain  0 10  $hematology blood hematocrit  36.4  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  106  mg dl; blood gas blood lactate  3.5  mmol l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
 
asian f 91 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  119  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
 
asian f 91 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  171  iu l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lisinopril  5  mg ; atenolol  50  mg ; felodipine  10  mg ; acetaminophen  650  mg ; 
 
asian f 91 $nan$chemistry blood bilirubin, total  0.6  mg dl; chemistry blood albumin  4.3  g dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; lisinopril  5  mg ; atenolol  50  mg ; felodipine  10  mg ; acetaminophen  650  mg ; 
 
asian f 91 $nan$nan$
 
asian f 91 $nan$nan$
 
asian f 91 $nan$nan$
 
asian f 91 $nan$nan$
 
asian f 91 $nan$nan$
 
asian f 91 $nan$nan$
 
asian f 91 $nan$nan$
 
hispanic latino f 75 $temp    heartrate  78.0  resprate  18.0  o2sat  93.0  sbp  168.0  dbp  70.0  rhythm    pain  asleep   ; temp  98.2  heartrate  72.0  resprate  18.0  o2sat  95.0  sbp  172.0  dbp  77.0  rhythm    pain  0  $hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  226  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; donepezil  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; duloxetine  60  mg ; paroxetine  10  mg ; vial  1  vial ; ceftriaxone  1  gm ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; metoprolol succinate xl  50  mg ; azithromycin  250  mg ; olanzapine (disintegrating tablet)  2.5  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  327  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.9  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; vial  1  vial ; ceftriaxone  1  gm ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; metoprolol succinate xl  50  mg ; azithromycin  250  mg ; olanzapine (disintegrating tablet)  2.5  mg ; olanzapine  2.5  mg ; multivitamins w minerals chewable  1  tab ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  328  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  72  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; vial  1  vial ; ceftriaxone  1  gm ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; metoprolol succinate xl  50  mg ; azithromycin  250  mg ; olanzapine (disintegrating tablet)  2.5  mg ; olanzapine  2.5  mg ; multivitamins w minerals chewable  1  tab ; apixaban  5  mg ; olanzapine (disintegrating tablet)  5  mg ; haloperidol  1  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$chemistry urine creatinine, urine  108  mg dl; chemistry urine urea nitrogen, urine  566  mg dl; hematology urine wbc  2  # hpf$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; vial  1  vial ; ceftriaxone  1  gm ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; metoprolol succinate xl  50  mg ; azithromycin  250  mg ; olanzapine (disintegrating tablet)  2.5  mg ; multivitamins w minerals chewable  1  tab ; apixaban  5  mg ; haloperidol  1  mg ; olanzapine  5  mg ; lisinopril  20  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lactated ringers  1000  ml ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  78  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; vial  1  vial ; ceftriaxone  1  gm ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; metoprolol succinate xl  50  mg ; azithromycin  250  mg ; olanzapine (disintegrating tablet)  2.5  mg ; multivitamins w minerals chewable  1  tab ; apixaban  5  mg ; olanzapine  5  mg ; lisinopril  20  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lactated ringers  1000  ml ; potassium chloride  20  meq ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  74  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; metoprolol succinate xl  50  mg ; olanzapine (disintegrating tablet)  2.5  mg ; multivitamins w minerals chewable  1  tab ; apixaban  5  mg ; olanzapine  5  mg ; lisinopril  20  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; potassium chloride  20  meq ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; metoprolol succinate xl  50  mg ; olanzapine (disintegrating tablet)  2.5  mg ; multivitamins w minerals chewable  1  tab ; apixaban  5  mg ; olanzapine  5  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lisinopril  40  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; metoprolol succinate xl  50  mg ; olanzapine (disintegrating tablet)  2.5  mg ; multivitamins w minerals chewable  1  tab ; apixaban  5  mg ; olanzapine  5  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lisinopril  40  mg ; atorvastatin  40  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  142  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; olanzapine (disintegrating tablet)  2.5  mg ; multivitamins w minerals chewable  1  tab ; apixaban  5  mg ; olanzapine  5  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lisinopril  40  mg ; atorvastatin  40  mg ; carvedilol  6.25  mg ; haloperidol  0.5  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  108  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; olanzapine (disintegrating tablet)  2.5  mg ; multivitamins w minerals chewable  1  tab ; apixaban  5  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lisinopril  40  mg ; atorvastatin  40  mg ; haloperidol  0.5  mg ; carvedilol  12.5  mg ; divalproex (delayed release)  125  mg ; sodium chloride 0.9%  1000  ml ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry urine creatinine, urine  141  mg dl; chemistry urine urea nitrogen, urine  745  mg dl; hematology urine wbc  5  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  78  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; olanzapine (disintegrating tablet)  2.5  mg ; multivitamins w minerals chewable  1  tab ; polyethylene glycol  17  g ; bisacodyl  10  mg ; atorvastatin  40  mg ; carvedilol  12.5  mg ; divalproex (delayed release)  125  mg ; sodium chloride 0.9%  1000  ml ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  377  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  77  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; olanzapine (disintegrating tablet)  2.5  mg ; multivitamins w minerals chewable  1  tab ; polyethylene glycol  17  g ; bisacodyl  10  mg ; atorvastatin  40  mg ; carvedilol  12.5  mg ; divalproex (delayed release)  250  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; olanzapine (disintegrating tablet)  2.5  mg ; multivitamins w minerals chewable  1  tab ; polyethylene glycol  17  g ; bisacodyl  10  mg ; atorvastatin  40  mg ; carvedilol  12.5  mg ; divalproex (delayed release)  250  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; olanzapine (disintegrating tablet)  2.5  mg ; multivitamins w minerals chewable  1  tab ; polyethylene glycol  17  g ; bisacodyl  10  mg ; atorvastatin  40  mg ; carvedilol  12.5  mg ; divalproex (delayed release)  250  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  78  mg dl; chemistry blood lactate dehydrogenase (ld)  229  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; multivitamins w minerals chewable  1  tab ; polyethylene glycol  17  g ; bisacodyl  10  mg ; atorvastatin  40  mg ; divalproex (delayed release)  250  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; multivitamins w minerals chewable  1  tab ; polyethylene glycol  17  g ; bisacodyl  10  mg ; atorvastatin  40  mg ; divalproex (delayed release)  250  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; multivitamins w minerals chewable  1  tab ; polyethylene glycol  17  g ; bisacodyl  10  mg ; atorvastatin  40  mg ; divalproex (delayed release)  250  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; multivitamins w minerals chewable  1  tab ; polyethylene glycol  17  g ; bisacodyl  10  mg ; atorvastatin  40  mg ; divalproex (delayed release)  250  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; multivitamins w minerals chewable  1  tab ; polyethylene glycol  17  g ; bisacodyl  10  mg ; atorvastatin  40  mg ; divalproex (delayed release)  250  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; multivitamins w minerals chewable  1  tab ; polyethylene glycol  17  g ; bisacodyl  10  mg ; atorvastatin  40  mg ; divalproex (delayed release)  250  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; multivitamins w minerals chewable  1  tab ; polyethylene glycol  17  g ; bisacodyl  10  mg ; atorvastatin  40  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; multivitamins w minerals chewable  1  tab ; polyethylene glycol  17  g ; bisacodyl  10  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
hispanic latino f 75 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; ramelteon  8  mg ; amlodipine  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; paroxetine  10  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; multivitamins w minerals chewable  1  tab ; polyethylene glycol  17  g ; bisacodyl  10  mg ; divalproex sod. sprinkles  125  mg ; 
other disorders of phosphorus metabolism chronic kidney disease, stage 2 (mild) ischemia and infarction of kidney acquired absence of both cervix and uterus unspecified atrial fibrillation fall on stairs or ladders in water transport injuring unspecified person gout, unspecified hypokalemia obesity, unspecified body mass index (bmi) 31.0-31.9, adult personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diarrhea, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of anticoagulants polyneuropathy, unspecified coronary atherosclerosis of native coronary artery other chronic pain syncope and collapse unspecified essential hypertension atrial fibrillation family history of other cardiovascular diseases disturbance of skin sensation pain in limb muscle weakness (generalized) other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other alteration of consciousness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia acute kidney failure, unspecified atrial fibrillation esophageal reflux sciatica diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal infection due to other organism, not elsewhere classified need for prophylactic vaccination and inoculation against influenza unspecified essential hypertension long-term (current) use of anticoagulants headache acute kidney failure, unspecified closed fracture of metatarsal bone(s) hypovolemia atrial fibrillation hyposmolality and/or hyponatremia unspecified essential hypertension abdominal pain, unspecified site coronary atherosclerosis of native coronary artery
black african american f 30 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 30 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 30 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 30 $nan$hematology blood hematocrit  33.6  %$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
white m 48 $temp  98.8  heartrate  105.0  resprate  18.0  o2sat  97.0  sbp  137.0  dbp  84.0  rhythm    pain    $hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  416  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.4  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  104  mg dl$doxycycline hyclate  100  mg ; diazepam - ciwa protocol  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; 0.9% sodium chloride  100  ml ; thiamine  200  mg ; lorazepam  1  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; heparin  5000  unit ; folic acid  1  mg ; multivitamins  1  tab ; 
nonalcoholic steatohepatitis (nash) hypo-osmolality and hyponatremia nutritional anemia, unspecified unspecified dislocation of right shoulder joint, initial encounter accidental fall on or from other stairs or steps unspecified dislocation of right knee, initial encounter acidosis other secondary thrombocytopenia body mass index (bmi) 36.0-36.9, adult other fall from one level to another, initial encounter alcohol abuse with intoxication, unspecified acute kidney failure, unspecified other disorders of plasma-protein metabolism, not elsewhere classified obesity, unspecified hyperlipidemia, unspecified hypoxemia traumatic ischemia of muscle, initial encounter 
white m 48 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; lorazepam  1  mg ; heparin  5000  unit ; folic acid  1  mg ; multivitamins  1  tab ; 
nonalcoholic steatohepatitis (nash) hypo-osmolality and hyponatremia nutritional anemia, unspecified unspecified dislocation of right shoulder joint, initial encounter accidental fall on or from other stairs or steps unspecified dislocation of right knee, initial encounter acidosis other secondary thrombocytopenia body mass index (bmi) 36.0-36.9, adult other fall from one level to another, initial encounter alcohol abuse with intoxication, unspecified acute kidney failure, unspecified other disorders of plasma-protein metabolism, not elsewhere classified obesity, unspecified hyperlipidemia, unspecified hypoxemia traumatic ischemia of muscle, initial encounter 
other f 52 $temp  100.3  heartrate  98.0  resprate  16.0  o2sat  96.0  sbp  123.0  dbp  61.0  rhythm    pain  8  ; temp  99.8  heartrate  99.0  resprate  18.0  o2sat  98.0  sbp  117.0  dbp  84.0  rhythm    pain  6  $hematology blood hematocrit  41.6  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  142  mg dl; chemistry blood albumin  4.3  g dl$nan
 
other f 52 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  81  mg dl; blood gas blood lactate  1.0  mmol l$d5 1 2ns  1000  ml ; heparin  5000  unit ; lactated ringers  1000  ml ; ranitidine  150  mg ; morphine sulfate  1-5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; hydrochlorothiazide  12.5  mg ; lisinopril  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen iv  1000  mg ; 
 
other f 52 $nan$chemistry blood bilirubin, total  1.8  mg dl$heparin  5000  unit ; ranitidine  150  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; hydrochlorothiazide  12.5  mg ; lisinopril  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen iv  1000  mg ; morphine sulfate  2-4  mg ; acetaminophen  1000  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; gabapentin  300  mg ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; lorazepam  0.5  mg ; 
 
other f 52 $nan$nan$ranitidine  150  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; gabapentin  300  mg ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; lorazepam  0.5  mg ; bisacodyl  10  mg ; senna  1  tab ; hydromorphone (dilaudid)  2-4  mg ; docusate sodium  100  mg ; zolpidem tartrate  5  mg ; 
 
other f 52 $nan$nan$ranitidine  150  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  10  mg ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  1  tab ; hydromorphone (dilaudid)  2-4  mg ; docusate sodium  100  mg ; zolpidem tartrate  5  mg ; polyethylene glycol  17  g ; 
 
white f 63 $temp  98.7  heartrate  87.0  resprate  16.0  o2sat  97.0  sbp  132.0  dbp  69.0  rhythm    pain  4  $hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  427  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  75  mg dl; chemistry blood albumin  2.9  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; metoprolol tartrate  5  mg ; heparin  5000  unit ; fluticasone propionate 110mcg  2  puff ; venlafaxine  75  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; fleet enema  1  enema ; pantoprazole  40  mg ; 
other pulmonary insufficiency, not elsewhere classified postoperative shock, septic diaphragmatic hernia without mention of obstruction or gangrene other specified complications of procedures not elsewhere classified ventilator associated pneumonia examination of participant in clinical trial acidosis other suppurative peritonitis toxic encephalopathy esophageal reflux cervical spondylosis with myelopathy obesity, unspecified hyposmolality and/or hyponatremia severe sepsis accidents occurring in residential institution other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure with lesion of tubular necrosis other postoperative infection unspecified septicemia asthma, unspecified type, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified 
white f 63 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; metoprolol tartrate  5  mg ; heparin  5000  unit ; fluticasone propionate 110mcg  2  puff ; venlafaxine  75  mg ; pantoprazole  40  mg ; ranitidine  300  mg ; vancomycin oral liquid  125  mg ; venlafaxine  37.5  mg ; ondansetron  4  mg ; 
other pulmonary insufficiency, not elsewhere classified postoperative shock, septic diaphragmatic hernia without mention of obstruction or gangrene other specified complications of procedures not elsewhere classified ventilator associated pneumonia examination of participant in clinical trial acidosis other suppurative peritonitis toxic encephalopathy esophageal reflux cervical spondylosis with myelopathy obesity, unspecified hyposmolality and/or hyponatremia severe sepsis accidents occurring in residential institution other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure with lesion of tubular necrosis other postoperative infection unspecified septicemia asthma, unspecified type, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified 
white f 63 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; metoprolol tartrate  5  mg ; heparin  5000  unit ; fluticasone propionate 110mcg  2  puff ; venlafaxine  75  mg ; pantoprazole  40  mg ; ranitidine  300  mg ; vancomycin oral liquid  125  mg ; venlafaxine  37.5  mg ; ondansetron  4  mg ; atenolol  25  mg ; amlodipine  5  mg ; aspirin  81  mg ; metoclopramide  10  mg ; 
other pulmonary insufficiency, not elsewhere classified postoperative shock, septic diaphragmatic hernia without mention of obstruction or gangrene other specified complications of procedures not elsewhere classified ventilator associated pneumonia examination of participant in clinical trial acidosis other suppurative peritonitis toxic encephalopathy esophageal reflux cervical spondylosis with myelopathy obesity, unspecified hyposmolality and/or hyponatremia severe sepsis accidents occurring in residential institution other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure with lesion of tubular necrosis other postoperative infection unspecified septicemia asthma, unspecified type, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified 
white f 63 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; fluticasone propionate 110mcg  2  puff ; venlafaxine  75  mg ; pantoprazole  40  mg ; vancomycin oral liquid  125  mg ; venlafaxine  37.5  mg ; ondansetron  4  mg ; atenolol  25  mg ; amlodipine  5  mg ; aspirin  81  mg ; metoclopramide  10  mg ; 
other pulmonary insufficiency, not elsewhere classified postoperative shock, septic diaphragmatic hernia without mention of obstruction or gangrene other specified complications of procedures not elsewhere classified ventilator associated pneumonia examination of participant in clinical trial acidosis other suppurative peritonitis toxic encephalopathy esophageal reflux cervical spondylosis with myelopathy obesity, unspecified hyposmolality and/or hyponatremia severe sepsis accidents occurring in residential institution other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure with lesion of tubular necrosis other postoperative infection unspecified septicemia asthma, unspecified type, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified 
black african american f 79 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; hematology urine wbc  15  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  131  mg dl; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  4.4  mmol l; hematology urine glucose  70  mg dl$0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; insulin  20  unit ; dextrose 5%  150  ml ; levofloxacin  750  mg ; 5% dextrose  500  ml ; vancomycin  1500  mg ; olanzapine (disintegrating tablet)  5  mg ; furosemide  40  mg ; atorvastatin  20  mg ; citalopram  20  mg ; clopidogrel  75  mg ; fluticasone propionate nasal  1  spry ; lactulose  15  ml ; aspirin  325  mg ; metoprolol succinate xl  150  mg ; isosorbide mononitrate (extended release)  30  mg ; bag  50  ml ; magnesium sulfate  4  gm ; albuterol inhaler  6  puff ; 5% dextrose  250  ml ; phenylephrine  60  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; ipratropium bromide mdi  6  puff ; metoprolol tartrate  50  mg ; heparin  5000  unit ; senna  1  tab ; acetaminophen  650  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; 0.9% sodium chloride  500  ml ; oseltamivir  75  mg ; docusate sodium  100  mg ; imipramine  25  mg ; mirtazapine  30  mg ; 
 
black african american f 79 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  18  meq l; chemistry urine creatinine, urine  104  mg dl; chemistry urine potassium, urine  54  meq l; chemistry urine sodium, urine  30  meq l; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  187  mg dl; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.1  mmol l; chemistry urine calcium, urine  2.4  mg dl$5% dextrose  250  ml ; phenylephrine  60  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; heparin  5000  unit ; senna  1  tab ; acetaminophen  650  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; 0.9% sodium chloride  500  ml ; docusate sodium  100  mg ; sterile water  100  ml ; potassium chloride  40  meq ; bag  100  ml ; heparin  4000  unit ; heparin  1600  unit ; heparin sodium  25,000  unit ; 0.9% sodium chloride  1000  ml ; sterile water  50  ml ; potassium chloride  20  meq ; norepinephrine  8  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; atorvastatin  80  mg ; vial  1  vial ; pantoprazole  40  mg ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
 
black african american f 79 $nan$nan$soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  1000  ml ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; 
 
white f 91 $temp  98.4  heartrate  103.0  resprate  19.0  o2sat  97.0  sbp  108.0  dbp  56.0  rhythm    pain  5  ; temp    heartrate  97.0  resprate  22.0  o2sat  97.0  sbp  99.0  dbp  51.0  rhythm    pain  5  ; temp    heartrate  119.0  resprate  24.0  o2sat  98.0  sbp  131.0  dbp  80.0  rhythm    pain  5  ; temp    heartrate  112.0  resprate  27.0  o2sat  97.0  sbp  107.0  dbp  45.0  rhythm    pain  5  ; temp  98.4  heartrate  102.0  resprate  24.0  o2sat  98.0  sbp  128.0  dbp  66.0  rhythm    pain  4-5  $hematology blood hematocrit  22.4  %; hematology blood hematocrit  30.7  %; hematology blood hematocrit  30.8  %; hematology blood hemoglobin  5.9  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  136  k ul; hematology blood platelet count  165  k ul; hematology blood platelet count  159  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  81  mg dl; chemistry blood albumin  3.1  g dl$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  650  mg ; artificial tears preserv. free  2  drop ; mirtazapine  7.5  mg ; timolol maleate 0.5%  2  drop ; cyanocobalamin  1000  mcg ; phytonadione  2  mg ; 5% dextrose  50  ml ; phytonadione  5  mg ; levothyroxine sodium  75  mcg ; 
person boarding or alighting a car injured in collision with heavy transport vehicle or bus acute kidney failure, unspecified anorexia anemia, unspecified depressive disorder, not elsewhere classified anxiety state, unspecified status of other artificial opening of gastrointestinal tract ulcerative colitis, unspecified personal history of venous thrombosis and embolism loss of weight personal history of venous thrombosis and embolism acquired absence of intestine (large) (small) personal history of other malignant neoplasm of skin other and unspecified noninfectious gastroenteritis and colitis chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified esophageal reflux long-term (current) use of anticoagulants acute kidney failure, unspecified personal history of malignant neoplasm of breast osteoporosis, unspecified urinary tract infection, site not specified acidosis unspecified acquired hypothyroidism colostomy status person boarding or alighting a pedal cycle injured in collision with pedestrian or animal unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident volume depletion, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified disturbance of skin sensation altered mental status person boarding or alighting a pedal cycle injured in collision with pedestrian or animal long-term (current) use of anticoagulants unspecified acquired hypothyroidism personal history of malignant neoplasm of breast personal history of venous thrombosis and embolism anisocoria cough chronic kidney disease, unspecified long-term (current) use of anticoagulants unspecified essential hypertension personal history of venous thrombosis and embolism chondrocalcinosis, unspecified, lower leg unspecified glaucoma other disorders of calcium metabolism unspecified acquired hypothyroidism urge incontinence spasm of muscle
white f 91 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  82  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; artificial tears preserv. free  2  drop ; mirtazapine  7.5  mg ; cyanocobalamin  1000  mcg ; phytonadione  2  mg ; 5% dextrose  50  ml ; phytonadione  5  mg ; levothyroxine sodium  75  mcg ; timolol maleate 0.5%  1  drop ; bag  1  bag ; magnesium sulfate (latex free)  2  gm ; potassium chloride  40  meq ; 
person boarding or alighting a car injured in collision with heavy transport vehicle or bus acute kidney failure, unspecified anorexia anemia, unspecified depressive disorder, not elsewhere classified anxiety state, unspecified status of other artificial opening of gastrointestinal tract ulcerative colitis, unspecified personal history of venous thrombosis and embolism loss of weight personal history of venous thrombosis and embolism acquired absence of intestine (large) (small) personal history of other malignant neoplasm of skin other and unspecified noninfectious gastroenteritis and colitis chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified esophageal reflux long-term (current) use of anticoagulants acute kidney failure, unspecified personal history of malignant neoplasm of breast osteoporosis, unspecified urinary tract infection, site not specified acidosis unspecified acquired hypothyroidism colostomy status person boarding or alighting a pedal cycle injured in collision with pedestrian or animal unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident volume depletion, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified disturbance of skin sensation altered mental status person boarding or alighting a pedal cycle injured in collision with pedestrian or animal long-term (current) use of anticoagulants unspecified acquired hypothyroidism personal history of malignant neoplasm of breast personal history of venous thrombosis and embolism anisocoria cough chronic kidney disease, unspecified long-term (current) use of anticoagulants unspecified essential hypertension personal history of venous thrombosis and embolism chondrocalcinosis, unspecified, lower leg unspecified glaucoma other disorders of calcium metabolism unspecified acquired hypothyroidism urge incontinence spasm of muscle
white f 91 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; artificial tears preserv. free  2  drop ; mirtazapine  7.5  mg ; cyanocobalamin  1000  mcg ; levothyroxine sodium  75  mcg ; timolol maleate 0.5%  1  drop ; bag  1  bag ; magnesium sulfate (latex free)  2  gm ; potassium chloride  40  meq ; heparin  5000  unit ; neutra-phos  2  pkt ; acetaminophen  325  mg ; acetaminophen  1000  mg ; 
person boarding or alighting a car injured in collision with heavy transport vehicle or bus acute kidney failure, unspecified anorexia anemia, unspecified depressive disorder, not elsewhere classified anxiety state, unspecified status of other artificial opening of gastrointestinal tract ulcerative colitis, unspecified personal history of venous thrombosis and embolism loss of weight personal history of venous thrombosis and embolism acquired absence of intestine (large) (small) personal history of other malignant neoplasm of skin other and unspecified noninfectious gastroenteritis and colitis chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified esophageal reflux long-term (current) use of anticoagulants acute kidney failure, unspecified personal history of malignant neoplasm of breast osteoporosis, unspecified urinary tract infection, site not specified acidosis unspecified acquired hypothyroidism colostomy status person boarding or alighting a pedal cycle injured in collision with pedestrian or animal unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident volume depletion, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified disturbance of skin sensation altered mental status person boarding or alighting a pedal cycle injured in collision with pedestrian or animal long-term (current) use of anticoagulants unspecified acquired hypothyroidism personal history of malignant neoplasm of breast personal history of venous thrombosis and embolism anisocoria cough chronic kidney disease, unspecified long-term (current) use of anticoagulants unspecified essential hypertension personal history of venous thrombosis and embolism chondrocalcinosis, unspecified, lower leg unspecified glaucoma other disorders of calcium metabolism unspecified acquired hypothyroidism urge incontinence spasm of muscle
white f 91 $nan$nan$sodium chloride 0.9%  flush  3  ml ; artificial tears preserv. free  2  drop ; mirtazapine  7.5  mg ; cyanocobalamin  1000  mcg ; levothyroxine sodium  75  mcg ; timolol maleate 0.5%  1  drop ; heparin  5000  unit ; neutra-phos  2  pkt ; acetaminophen  325  mg ; acetaminophen  1000  mg ; 
person boarding or alighting a car injured in collision with heavy transport vehicle or bus acute kidney failure, unspecified anorexia anemia, unspecified depressive disorder, not elsewhere classified anxiety state, unspecified status of other artificial opening of gastrointestinal tract ulcerative colitis, unspecified personal history of venous thrombosis and embolism loss of weight personal history of venous thrombosis and embolism acquired absence of intestine (large) (small) personal history of other malignant neoplasm of skin other and unspecified noninfectious gastroenteritis and colitis chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified esophageal reflux long-term (current) use of anticoagulants acute kidney failure, unspecified personal history of malignant neoplasm of breast osteoporosis, unspecified urinary tract infection, site not specified acidosis unspecified acquired hypothyroidism colostomy status person boarding or alighting a pedal cycle injured in collision with pedestrian or animal unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident volume depletion, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified disturbance of skin sensation altered mental status person boarding or alighting a pedal cycle injured in collision with pedestrian or animal long-term (current) use of anticoagulants unspecified acquired hypothyroidism personal history of malignant neoplasm of breast personal history of venous thrombosis and embolism anisocoria cough chronic kidney disease, unspecified long-term (current) use of anticoagulants unspecified essential hypertension personal history of venous thrombosis and embolism chondrocalcinosis, unspecified, lower leg unspecified glaucoma other disorders of calcium metabolism unspecified acquired hypothyroidism urge incontinence spasm of muscle
white f 50 $nan$nan$prednisone  100  mg ; 
personal history of malignant neoplasm of thyroid personal history of nicotine dependence non-hodgkin lymphoma, unspecified, lymph nodes of multiple sites unspecified intestinal obstruction candidiasis, unspecified constipation, unspecified follicular lymphoma grade ii, extranodal and solid organ sites encounter for antineoplastic chemotherapy gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of thyroid nicotine dependence, cigarettes, uncomplicated unspecified abdominal pain constipation, unspecified personal history of malignant neoplasm of thyroid generalized abdominal pain candidal stomatitis hypothyroidism, unspecified follicular lymphoma, unspecified, extranodal and solid organ sites tobacco use 
white f 50 $nan$hematology blood hematocrit  27.9  %; hematology blood hematocrit  25.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  407  k ul; hematology blood platelet count  383  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  138  mg dl; chemistry blood lactate dehydrogenase (ld)  161  iu l; chemistry blood lactate dehydrogenase (ld)  171  iu l; chemistry blood albumin  4.0  g dl; chemistry blood albumin  3.4  g dl$sterile water  200  ml ; fexofenadine  180  mg ; prednisone  100  mg ; acyclovir  400  mg ; levothyroxine sodium  125  mcg ; pantoprazole  40  mg ; oxycodone (immediate release)  5  mg ; polyethylene glycol  17  g ; sulfameth trimethoprim ss  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; enoxaparin sodium  40  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  500  ml ; rituximab  600  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; doxorubicin  20  mg ; vincristine (oncovin)  0.7  mg ; 0.9% sodium chloride  1000  ml ; etoposide  100  mg ; furosemide  20  mg ; 
personal history of malignant neoplasm of thyroid personal history of nicotine dependence non-hodgkin lymphoma, unspecified, lymph nodes of multiple sites unspecified intestinal obstruction candidiasis, unspecified constipation, unspecified follicular lymphoma grade ii, extranodal and solid organ sites encounter for antineoplastic chemotherapy gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of thyroid nicotine dependence, cigarettes, uncomplicated unspecified abdominal pain constipation, unspecified personal history of malignant neoplasm of thyroid generalized abdominal pain candidal stomatitis hypothyroidism, unspecified follicular lymphoma, unspecified, extranodal and solid organ sites tobacco use 
white f 50 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  400  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  187  mg dl; chemistry blood lactate dehydrogenase (ld)  176  iu l; chemistry blood albumin  3.8  g dl$sterile water  200  ml ; fexofenadine  180  mg ; prednisone  100  mg ; acyclovir  400  mg ; levothyroxine sodium  125  mcg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; enoxaparin sodium  40  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  500  ml ; rituximab  600  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; doxorubicin  20  mg ; vincristine (oncovin)  0.7  mg ; 0.9% sodium chloride  1000  ml ; etoposide  100  mg ; furosemide  20  mg ; polyethylene glycol  34  g ; 
personal history of malignant neoplasm of thyroid personal history of nicotine dependence non-hodgkin lymphoma, unspecified, lymph nodes of multiple sites unspecified intestinal obstruction candidiasis, unspecified constipation, unspecified follicular lymphoma grade ii, extranodal and solid organ sites encounter for antineoplastic chemotherapy gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of thyroid nicotine dependence, cigarettes, uncomplicated unspecified abdominal pain constipation, unspecified personal history of malignant neoplasm of thyroid generalized abdominal pain candidal stomatitis hypothyroidism, unspecified follicular lymphoma, unspecified, extranodal and solid organ sites tobacco use 
white f 50 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  427  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  145  mg dl; chemistry blood lactate dehydrogenase (ld)  168  iu l; chemistry blood albumin  4.2  g dl$sterile water  200  ml ; fexofenadine  180  mg ; prednisone  100  mg ; acyclovir  400  mg ; levothyroxine sodium  125  mcg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; enoxaparin sodium  40  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; sodium chloride 0.9%  1000  ml ; 5% dextrose  50  ml ; ondansetron  16  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; doxorubicin  20  mg ; vincristine (oncovin)  0.7  mg ; 0.9% sodium chloride  1000  ml ; etoposide  100  mg ; polyethylene glycol  34  g ; 
personal history of malignant neoplasm of thyroid personal history of nicotine dependence non-hodgkin lymphoma, unspecified, lymph nodes of multiple sites unspecified intestinal obstruction candidiasis, unspecified constipation, unspecified follicular lymphoma grade ii, extranodal and solid organ sites encounter for antineoplastic chemotherapy gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of thyroid nicotine dependence, cigarettes, uncomplicated unspecified abdominal pain constipation, unspecified personal history of malignant neoplasm of thyroid generalized abdominal pain candidal stomatitis hypothyroidism, unspecified follicular lymphoma, unspecified, extranodal and solid organ sites tobacco use 
white f 50 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  364  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  154  mg dl; chemistry blood lactate dehydrogenase (ld)  144  iu l; chemistry blood albumin  3.8  g dl$sterile water  200  ml ; fexofenadine  180  mg ; prednisone  100  mg ; acyclovir  400  mg ; levothyroxine sodium  125  mcg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; enoxaparin sodium  40  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; sodium chloride 0.9%  1000  ml ; 5% dextrose  50  ml ; ondansetron  16  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; doxorubicin  20  mg ; vincristine (oncovin)  0.7  mg ; 0.9% sodium chloride  1000  ml ; etoposide  100  mg ; polyethylene glycol  34  g ; calcium carbonate  500  mg ; 
personal history of malignant neoplasm of thyroid personal history of nicotine dependence non-hodgkin lymphoma, unspecified, lymph nodes of multiple sites unspecified intestinal obstruction candidiasis, unspecified constipation, unspecified follicular lymphoma grade ii, extranodal and solid organ sites encounter for antineoplastic chemotherapy gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of thyroid nicotine dependence, cigarettes, uncomplicated unspecified abdominal pain constipation, unspecified personal history of malignant neoplasm of thyroid generalized abdominal pain candidal stomatitis hypothyroidism, unspecified follicular lymphoma, unspecified, extranodal and solid organ sites tobacco use 
white f 50 $nan$nan$sterile water  200  ml ; fexofenadine  180  mg ; prednisone  100  mg ; acyclovir  400  mg ; levothyroxine sodium  125  mcg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; enoxaparin sodium  40  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; sodium chloride 0.9%  1000  ml ; 5% dextrose  50  ml ; ondansetron  16  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; doxorubicin  20  mg ; vincristine (oncovin)  0.7  mg ; 0.9% sodium chloride  1000  ml ; etoposide  100  mg ; polyethylene glycol  34  g ; calcium carbonate  500  mg ; 0.9% sodium chloride  250  ml ; cyclophosphamide  1500  mg ; 
personal history of malignant neoplasm of thyroid personal history of nicotine dependence non-hodgkin lymphoma, unspecified, lymph nodes of multiple sites unspecified intestinal obstruction candidiasis, unspecified constipation, unspecified follicular lymphoma grade ii, extranodal and solid organ sites encounter for antineoplastic chemotherapy gastro-esophageal reflux disease without esophagitis personal history of malignant neoplasm of thyroid nicotine dependence, cigarettes, uncomplicated unspecified abdominal pain constipation, unspecified personal history of malignant neoplasm of thyroid generalized abdominal pain candidal stomatitis hypothyroidism, unspecified follicular lymphoma, unspecified, extranodal and solid organ sites tobacco use 
white m 64 $nan$nan$lisinopril  10  mg ; amlodipine  5  mg ; nicotine patch  14  mg ; 
 
white m 64 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  400  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  92  mg dl$lisinopril  10  mg ; amlodipine  5  mg ; nicotine patch  14  mg ; docusate sodium  100  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; levofloxacin  500  mg ; 0.9% sodium chloride  1000  ml ; oxycodone sr (oxycontin)  10  mg ; oxycodone sr (oxycontin)  20  mg ; senna  1  tab ; oxycodone (immediate release)   5  mg ; 
 
white m 64 $nan$nan$amlodipine  5  mg ; nicotine patch  14  mg ; docusate sodium  100  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; levofloxacin  500  mg ; oxycodone sr (oxycontin)  10  mg ; oxycodone sr (oxycontin)  20  mg ; senna  1  tab ; oxycodone (immediate release)   5  mg ; 
 
white f 81 $temp  98.0  heartrate  69.0  resprate  22.0  o2sat  93.0  sbp  120.0  dbp  43.0  rhythm    pain  0  $chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  238  mg dl$insulin  16  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; amlodipine  10  mg ; aspirin  81  mg ; atorvastatin  40  mg ; carvedilol  12.5  mg ; levothyroxine sodium  100  mcg ; lisinopril  40  mg ; vitamin d  2000  unit ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; furosemide  20  mg ; calcium carbonate  500  mg ; 
occlusion and stenosis of carotid artery without mention of cerebral infarction other postprocedural status other and unspecified hyperlipidemia peripheral angiopathy in diseases classified elsewhere diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism atherosclerosis of native arteries of the extremities with intermittent claudication family history of ischemic heart disease long-term (current) use of insulin osteoporosis, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object unspecified essential hypertension coronary atherosclerosis of native coronary artery overweight body mass index 27.0-27.9, adult pure hypercholesterolemia osteoporosis, unspecified atherosclerosis of native arteries of the extremities with ulceration diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of insulin acute posthemorrhagic anemia accidental cut, puncture, perforation or hemorrhage during surgical operation unspecified essential hypertension other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with rest pain unspecified acquired hypothyroidism accidental puncture or laceration during a procedure, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified
white f 81 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry urine chloride, urine  81  meq l; chemistry urine potassium, urine  12  meq l; chemistry urine sodium, urine  73  meq l; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  175  mg dl$insulin  16  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; amlodipine  10  mg ; aspirin  81  mg ; atorvastatin  40  mg ; carvedilol  12.5  mg ; levothyroxine sodium  100  mcg ; lisinopril  40  mg ; vitamin d  2000  unit ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; furosemide  20  mg ; calcium carbonate  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; cefpodoxime proxetil  400  mg ; azithromycin  250  mg ; 
occlusion and stenosis of carotid artery without mention of cerebral infarction other postprocedural status other and unspecified hyperlipidemia peripheral angiopathy in diseases classified elsewhere diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism atherosclerosis of native arteries of the extremities with intermittent claudication family history of ischemic heart disease long-term (current) use of insulin osteoporosis, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object unspecified essential hypertension coronary atherosclerosis of native coronary artery overweight body mass index 27.0-27.9, adult pure hypercholesterolemia osteoporosis, unspecified atherosclerosis of native arteries of the extremities with ulceration diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of insulin acute posthemorrhagic anemia accidental cut, puncture, perforation or hemorrhage during surgical operation unspecified essential hypertension other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with rest pain unspecified acquired hypothyroidism accidental puncture or laceration during a procedure, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified
white f 35 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  316  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; medroxyprogesterone acetate  20  mg ; diphenhydramine  25  mg ; 
 
black african american f 23 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  332  k ul$docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 23 $nan$hematology blood hematocrit  33.5  %$docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 23 $nan$nan$docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; medroxyprogesterone acetate  150  mg ; 
 
black african american f 91 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2  mg ; divalproex sod. sprinkles  125  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; prednisolone acetate 1% ophth. susp.  1  drop ; 
personal history of venous thrombosis and embolism anemia, unspecified peripheral vascular disease, unspecified cardiac pacemaker in situ esophageal reflux unspecified essential hypertension coronary atherosclerosis of native coronary artery senile dementia with delirium unspecified hearing loss unspecified glaucoma diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified glaucoma unspecified essential hypertension anemia, unspecified unspecified hemorrhoids with other complication cardiac pacemaker in situ esophageal reflux abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension senile dementia, uncomplicated cardiac pacemaker in situ unspecified hearing loss peripheral vascular disease, unspecified unspecified site injury anemia, unspecified abdominal pain, right upper quadrant unspecified essential hypertension coronary atherosclerosis of unspecified type of vessel, native or graft abdominal pain, right lower quadrant other and unspecified special symptoms or syndromes, not elsewhere classified memory loss dehydration home accidents edema unspecified fall other specified metabolic disorders esophageal reflux headache diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified cardiac pacemaker in situ unspecified fall observation following other accident other persistent mental disorders due to conditions classified elsewhere anemia, unspecified other specified metabolic disorders
black african american f 91 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 
personal history of venous thrombosis and embolism anemia, unspecified peripheral vascular disease, unspecified cardiac pacemaker in situ esophageal reflux unspecified essential hypertension coronary atherosclerosis of native coronary artery senile dementia with delirium unspecified hearing loss unspecified glaucoma diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified glaucoma unspecified essential hypertension anemia, unspecified unspecified hemorrhoids with other complication cardiac pacemaker in situ esophageal reflux abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension senile dementia, uncomplicated cardiac pacemaker in situ unspecified hearing loss peripheral vascular disease, unspecified unspecified site injury anemia, unspecified abdominal pain, right upper quadrant unspecified essential hypertension coronary atherosclerosis of unspecified type of vessel, native or graft abdominal pain, right lower quadrant other and unspecified special symptoms or syndromes, not elsewhere classified memory loss dehydration home accidents edema unspecified fall other specified metabolic disorders esophageal reflux headache diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified cardiac pacemaker in situ unspecified fall observation following other accident other persistent mental disorders due to conditions classified elsewhere anemia, unspecified other specified metabolic disorders
black african american f 91 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 
personal history of venous thrombosis and embolism anemia, unspecified peripheral vascular disease, unspecified cardiac pacemaker in situ esophageal reflux unspecified essential hypertension coronary atherosclerosis of native coronary artery senile dementia with delirium unspecified hearing loss unspecified glaucoma diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified glaucoma unspecified essential hypertension anemia, unspecified unspecified hemorrhoids with other complication cardiac pacemaker in situ esophageal reflux abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension senile dementia, uncomplicated cardiac pacemaker in situ unspecified hearing loss peripheral vascular disease, unspecified unspecified site injury anemia, unspecified abdominal pain, right upper quadrant unspecified essential hypertension coronary atherosclerosis of unspecified type of vessel, native or graft abdominal pain, right lower quadrant other and unspecified special symptoms or syndromes, not elsewhere classified memory loss dehydration home accidents edema unspecified fall other specified metabolic disorders esophageal reflux headache diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified cardiac pacemaker in situ unspecified fall observation following other accident other persistent mental disorders due to conditions classified elsewhere anemia, unspecified other specified metabolic disorders
white f 46 $nan$nan$heparin  5000  unit ; 
 
white f 46 $nan$hematology blood hematocrit  38.4  %; hematology blood hematocrit  37.3  %$heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  20  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; acetaminophen iv  1000  mg ; oxcarbazepine  900  mg ; promethazine  6.25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; levetiracetam  500  mg ; oxcarbazepine  600  mg ; 
 
white f 46 $nan$nan$heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; acetaminophen iv  1000  mg ; oxcarbazepine  900  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; levetiracetam  500  mg ; oxcarbazepine  600  mg ; 
 
white f 46 $nan$nan$heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; acetaminophen iv  1000  mg ; oxcarbazepine  900  mg ; oxcarbazepine  600  mg ; acetaminophen (liquid)  325-650  mg ; levothyroxine sodium  100  mcg ; hydromorphone (dilaudid)  2  mg ; rosuvastatin calcium  20  mg ; 
 
unknown f 19 $nan$hematology blood hematocrit  31.1  %; hematology blood hematocrit  29.8  %; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  144  k ul; hematology blood platelet count  130  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology urine wbc  16  # hpf; chemistry blood calcium, total  6.5  mg dl; chemistry blood calcium, total  6.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  131  mg dl; chemistry blood lactate dehydrogenase (ld)  1069  iu l; chemistry blood lactate dehydrogenase (ld)  1038  iu l; chemistry blood albumin  2.4  g dl; hematology blood bands  4  %; hematology blood bands  2  %; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.7  mmol l$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; propofol  1000  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; vial  1  vial ; meropenem  500  mg ; prednisone  60  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; doxycycline hyclate  100  mg ; mouth care oral rinse  7-15  ml ; 5% dextrose  100  ml ; acetaminophen  1000  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  4  gm ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10-20  ml ; dexamethasone  17.5  mg ; 5% dextrose  50  ml ; dexamethasone sod phosphate  17.5  mg ; 
 
unknown f 19 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  180  mg dl; chemistry blood glucose  175  mg dl; chemistry blood lactate dehydrogenase (ld)  907  iu l$heparin  5000  unit ; propofol  1000  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; vial  1  vial ; meropenem  500  mg ; prednisone  60  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; mouth care oral rinse  7-15  ml ; 5% dextrose  100  ml ; acetaminophen  1000  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  4  gm ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10-20  ml ; 5% dextrose  50  ml ; dexamethasone sod phosphate  17.5  mg ; neutra-phos  2  pkt ; furosemide  10  mg ; 
 
unknown f 19 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  117  mg dl$heparin  5000  unit ; propofol  1000  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; vial  1  vial ; meropenem  500  mg ; mouth care oral rinse  7-15  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  4  gm ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10-20  ml ; 5% dextrose  50  ml ; dexamethasone sod phosphate  17.5  mg ; neutra-phos  2  pkt ; furosemide  10  mg ; acetaminophen iv  1000  mg ; ipratropium-albuterol neb  1  neb ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; diphenhydramine  25  mg ; ketorolac  15  mg ; sarna lotion  1  appl ; 
 
unknown f 19 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  86  mg dl; chemistry blood lactate dehydrogenase (ld)  726  iu l$heparin  5000  unit ; propofol  1000  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; vial  1  vial ; meropenem  500  mg ; mouth care oral rinse  7-15  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  4  gm ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10-20  ml ; 5% dextrose  50  ml ; dexamethasone sod phosphate  17.5  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; diphenhydramine  25  mg ; ketorolac  15  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; 
 
unknown f 19 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  391  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  87  mg dl; chemistry blood lactate dehydrogenase (ld)  723  iu l; hematology blood bands  1  %$heparin  5000  unit ; vial  1  vial ; meropenem  500  mg ; sodium chloride 0.9%  flush  10-20  ml ; 5% dextrose  50  ml ; dexamethasone sod phosphate  17.5  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; 
 
unknown f 19 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  501  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  95  mg dl; chemistry blood albumin  2.9  g dl$heparin  5000  unit ; vial  1  vial ; meropenem  500  mg ; sodium chloride 0.9%  flush  10-20  ml ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; 
 
unknown f 19 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  10-20  ml ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; 
 
white m 48 $nan$blood gas blood free calcium  1.19  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood chloride, whole blood  102  meq l; blood gas blood glucose  110  mg dl; blood gas blood hematocrit, calculated  41  %; blood gas blood hemoglobin  13.5  g dl; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood calculated bicarbonate, whole blood  28  meq l$vitamin d  400  unit ; ferrous sulfate  325  mg ; multivitamins  1  cap ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2-6  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; enoxaparin sodium  30  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; diphenhydramine  12.5-50  mg ; lorazepam  0.5  mg ; trazodone  50  mg ; senna  1  tab ; milk of magnesia  30  ml ; bisacodyl  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; promethazine  12.5  mg ; diazepam  5  mg ; naproxen  500  mg ; calcium carbonate  500  mg ; hydromorphone (dilaudid)  0.5  mg ; 
 
white m 48 $nan$hematology blood hematocrit  31.0  %; hematology blood hematocrit  28.7  %; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  165  k ul; hematology blood platelet count  154  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  105  mg dl$vitamin d  400  unit ; ferrous sulfate  325  mg ; multivitamins  1  cap ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2-6  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; enoxaparin sodium  30  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; diphenhydramine  12.5-50  mg ; lorazepam  0.5  mg ; trazodone  50  mg ; senna  1  tab ; milk of magnesia  30  ml ; bisacodyl  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; promethazine  12.5  mg ; diazepam  5  mg ; naproxen  500  mg ; calcium carbonate  500  mg ; hydromorphone (dilaudid)  0.5  mg ; atenolol  50  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; 
 
white m 48 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  167  k ul$vitamin d  400  unit ; ferrous sulfate  325  mg ; multivitamins  1  cap ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2-6  mg ; enoxaparin sodium  30  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; diphenhydramine  12.5-50  mg ; lorazepam  0.5  mg ; trazodone  50  mg ; senna  1  tab ; milk of magnesia  30  ml ; bisacodyl  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; promethazine  12.5  mg ; diazepam  5  mg ; naproxen  500  mg ; calcium carbonate  500  mg ; atenolol  50  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; 
 
white m 48 $nan$nan$vitamin d  400  unit ; ferrous sulfate  325  mg ; multivitamins  1  cap ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2-6  mg ; enoxaparin sodium  30  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; diphenhydramine  12.5-50  mg ; lorazepam  0.5  mg ; trazodone  50  mg ; senna  1  tab ; milk of magnesia  30  ml ; bisacodyl  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; promethazine  12.5  mg ; diazepam  5  mg ; calcium carbonate  500  mg ; atenolol  50  mg ; 
 
white m 60 $temp  99.3  heartrate  83.0  resprate  18.0  o2sat  98.0  sbp  96.0  dbp  49.0  rhythm    pain  0  ; temp    heartrate  79.0  resprate  16.0  o2sat  99.0  sbp  110.0  dbp  54.0  rhythm    pain  0  ; temp  99.3  heartrate  78.0  resprate  16.0  o2sat  97.0  sbp  94.0  dbp  45.0  rhythm    pain  0  ; temp    heartrate  65.0  resprate  18.0  o2sat  100.0  sbp  103.0  dbp  50.0  rhythm    pain    ; temp  99.0  heartrate  78.0  resprate  18.0  o2sat  100.0  sbp  114.0  dbp  68.0  rhythm    pain  0  ; temp  99.1  heartrate  71.0  resprate  18.0  o2sat  100.0  sbp  104.0  dbp  58.0  rhythm    pain  0  $hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  41  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  3.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood glucose  115  mg dl$nan
bradycardia, unspecified personal history of nicotine dependence portal hypertension alcoholic hepatitis with ascites chronic kidney disease, unspecified thrombocytopenia, unspecified alcoholic cirrhosis of liver with ascites anemia, unspecified acute kidney failure, unspecified adverse effect of saline and osmotic laxatives, initial encounter hepatic failure, unspecified without coma chronic kidney disease, unspecified acute kidney failure, unspecified toxic gastroenteritis and colitis personal history of nicotine dependence thrombocytopenia, unspecified unspecified place or not applicable coagulation defect, unspecified alcohol abuse, in remission other complications following infusion, transfusion and therapeutic injection, initial encounter unspecified place in hospital as the place of occurrence of the external cause alcoholic cirrhosis of liver with ascites moderate protein-calorie malnutrition portal hypertension other diseases of stomach and duodenum unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere other specified soft tissue disorders urinary tract infection, site not specified body mass index (bmi) 32.0-32.9, adult anemia, unspecified surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure secondary esophageal varices without bleeding hypotension, unspecified anxiety disorder, unspecified alcoholic hepatic failure without coma thrombocytopenia, unspecified personal history of nicotine dependence acidosis physical restraint status acute kidney failure, unspecified alcoholic cirrhosis of liver without ascites hypo-osmolality and hyponatremia calculus of gallbladder without cholecystitis without obstruction alcohol dependence with withdrawal, unspecified hypovolemia hypotension, unspecified alcoholic hepatitis without ascites coagulation defect, unspecified
white m 60 $temp  98.6  heartrate  81.0  resprate  18.0  o2sat  100.0  sbp  120.0  dbp  72.0  rhythm    pain  0  $hematology blood hematocrit  24.4  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  27  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood glucose  109  mg dl; chemistry blood albumin  4.0  g dl$ceftriaxone  2  gm ; sodium chloride 0.9%  flush  3-10  ml ; folic acid  1  mg ; lactulose  30  ml ; pantoprazole  40  mg ; rifaximin  550  mg ; thiamine  100  mg ; nephrocaps  1  mg ; vial  1  vial ; albumin 25% (12.5g   50ml)  100  g ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; 
bradycardia, unspecified personal history of nicotine dependence portal hypertension alcoholic hepatitis with ascites chronic kidney disease, unspecified thrombocytopenia, unspecified alcoholic cirrhosis of liver with ascites anemia, unspecified acute kidney failure, unspecified adverse effect of saline and osmotic laxatives, initial encounter hepatic failure, unspecified without coma chronic kidney disease, unspecified acute kidney failure, unspecified toxic gastroenteritis and colitis personal history of nicotine dependence thrombocytopenia, unspecified unspecified place or not applicable coagulation defect, unspecified alcohol abuse, in remission other complications following infusion, transfusion and therapeutic injection, initial encounter unspecified place in hospital as the place of occurrence of the external cause alcoholic cirrhosis of liver with ascites moderate protein-calorie malnutrition portal hypertension other diseases of stomach and duodenum unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere other specified soft tissue disorders urinary tract infection, site not specified body mass index (bmi) 32.0-32.9, adult anemia, unspecified surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure secondary esophageal varices without bleeding hypotension, unspecified anxiety disorder, unspecified alcoholic hepatic failure without coma thrombocytopenia, unspecified personal history of nicotine dependence acidosis physical restraint status acute kidney failure, unspecified alcoholic cirrhosis of liver without ascites hypo-osmolality and hyponatremia calculus of gallbladder without cholecystitis without obstruction alcohol dependence with withdrawal, unspecified hypovolemia hypotension, unspecified alcoholic hepatitis without ascites coagulation defect, unspecified
white m 60 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  38  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  120  mg dl; chemistry blood albumin  4.1  g dl$ceftriaxone  2  gm ; sodium chloride 0.9%  flush  3-10  ml ; folic acid  1  mg ; lactulose  30  ml ; pantoprazole  40  mg ; rifaximin  550  mg ; thiamine  100  mg ; nephrocaps  1  mg ; vial  1  vial ; albumin 25% (12.5g   50ml)  100  g ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; 
bradycardia, unspecified personal history of nicotine dependence portal hypertension alcoholic hepatitis with ascites chronic kidney disease, unspecified thrombocytopenia, unspecified alcoholic cirrhosis of liver with ascites anemia, unspecified acute kidney failure, unspecified adverse effect of saline and osmotic laxatives, initial encounter hepatic failure, unspecified without coma chronic kidney disease, unspecified acute kidney failure, unspecified toxic gastroenteritis and colitis personal history of nicotine dependence thrombocytopenia, unspecified unspecified place or not applicable coagulation defect, unspecified alcohol abuse, in remission other complications following infusion, transfusion and therapeutic injection, initial encounter unspecified place in hospital as the place of occurrence of the external cause alcoholic cirrhosis of liver with ascites moderate protein-calorie malnutrition portal hypertension other diseases of stomach and duodenum unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere other specified soft tissue disorders urinary tract infection, site not specified body mass index (bmi) 32.0-32.9, adult anemia, unspecified surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure secondary esophageal varices without bleeding hypotension, unspecified anxiety disorder, unspecified alcoholic hepatic failure without coma thrombocytopenia, unspecified personal history of nicotine dependence acidosis physical restraint status acute kidney failure, unspecified alcoholic cirrhosis of liver without ascites hypo-osmolality and hyponatremia calculus of gallbladder without cholecystitis without obstruction alcohol dependence with withdrawal, unspecified hypovolemia hypotension, unspecified alcoholic hepatitis without ascites coagulation defect, unspecified
white m 60 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  35  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  104  mg dl$ceftriaxone  2  gm ; sodium chloride 0.9%  flush  3-10  ml ; folic acid  1  mg ; lactulose  30  ml ; pantoprazole  40  mg ; rifaximin  550  mg ; thiamine  100  mg ; nephrocaps  1  mg ; vial  1  vial ; 
bradycardia, unspecified personal history of nicotine dependence portal hypertension alcoholic hepatitis with ascites chronic kidney disease, unspecified thrombocytopenia, unspecified alcoholic cirrhosis of liver with ascites anemia, unspecified acute kidney failure, unspecified adverse effect of saline and osmotic laxatives, initial encounter hepatic failure, unspecified without coma chronic kidney disease, unspecified acute kidney failure, unspecified toxic gastroenteritis and colitis personal history of nicotine dependence thrombocytopenia, unspecified unspecified place or not applicable coagulation defect, unspecified alcohol abuse, in remission other complications following infusion, transfusion and therapeutic injection, initial encounter unspecified place in hospital as the place of occurrence of the external cause alcoholic cirrhosis of liver with ascites moderate protein-calorie malnutrition portal hypertension other diseases of stomach and duodenum unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere other specified soft tissue disorders urinary tract infection, site not specified body mass index (bmi) 32.0-32.9, adult anemia, unspecified surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure secondary esophageal varices without bleeding hypotension, unspecified anxiety disorder, unspecified alcoholic hepatic failure without coma thrombocytopenia, unspecified personal history of nicotine dependence acidosis physical restraint status acute kidney failure, unspecified alcoholic cirrhosis of liver without ascites hypo-osmolality and hyponatremia calculus of gallbladder without cholecystitis without obstruction alcohol dependence with withdrawal, unspecified hypovolemia hypotension, unspecified alcoholic hepatitis without ascites coagulation defect, unspecified
white m 60 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  41  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  96  mg dl; chemistry blood albumin  3.7  g dl$ceftriaxone  2  gm ; sodium chloride 0.9%  flush  3-10  ml ; folic acid  1  mg ; lactulose  30  ml ; pantoprazole  40  mg ; rifaximin  550  mg ; thiamine  100  mg ; nephrocaps  1  mg ; vial  1  vial ; albumin 25% (12.5g   50ml)  50  g ; 
bradycardia, unspecified personal history of nicotine dependence portal hypertension alcoholic hepatitis with ascites chronic kidney disease, unspecified thrombocytopenia, unspecified alcoholic cirrhosis of liver with ascites anemia, unspecified acute kidney failure, unspecified adverse effect of saline and osmotic laxatives, initial encounter hepatic failure, unspecified without coma chronic kidney disease, unspecified acute kidney failure, unspecified toxic gastroenteritis and colitis personal history of nicotine dependence thrombocytopenia, unspecified unspecified place or not applicable coagulation defect, unspecified alcohol abuse, in remission other complications following infusion, transfusion and therapeutic injection, initial encounter unspecified place in hospital as the place of occurrence of the external cause alcoholic cirrhosis of liver with ascites moderate protein-calorie malnutrition portal hypertension other diseases of stomach and duodenum unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere other specified soft tissue disorders urinary tract infection, site not specified body mass index (bmi) 32.0-32.9, adult anemia, unspecified surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure secondary esophageal varices without bleeding hypotension, unspecified anxiety disorder, unspecified alcoholic hepatic failure without coma thrombocytopenia, unspecified personal history of nicotine dependence acidosis physical restraint status acute kidney failure, unspecified alcoholic cirrhosis of liver without ascites hypo-osmolality and hyponatremia calculus of gallbladder without cholecystitis without obstruction alcohol dependence with withdrawal, unspecified hypovolemia hypotension, unspecified alcoholic hepatitis without ascites coagulation defect, unspecified
white m 60 $nan$nan$ceftriaxone  2  gm ; sodium chloride 0.9%  flush  3-10  ml ; folic acid  1  mg ; lactulose  30  ml ; pantoprazole  40  mg ; rifaximin  550  mg ; thiamine  100  mg ; nephrocaps  1  mg ; vial  1  vial ; albumin 25% (12.5g   50ml)  50  g ; ciprofloxacin hcl  500  mg ; 
bradycardia, unspecified personal history of nicotine dependence portal hypertension alcoholic hepatitis with ascites chronic kidney disease, unspecified thrombocytopenia, unspecified alcoholic cirrhosis of liver with ascites anemia, unspecified acute kidney failure, unspecified adverse effect of saline and osmotic laxatives, initial encounter hepatic failure, unspecified without coma chronic kidney disease, unspecified acute kidney failure, unspecified toxic gastroenteritis and colitis personal history of nicotine dependence thrombocytopenia, unspecified unspecified place or not applicable coagulation defect, unspecified alcohol abuse, in remission other complications following infusion, transfusion and therapeutic injection, initial encounter unspecified place in hospital as the place of occurrence of the external cause alcoholic cirrhosis of liver with ascites moderate protein-calorie malnutrition portal hypertension other diseases of stomach and duodenum unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere other specified soft tissue disorders urinary tract infection, site not specified body mass index (bmi) 32.0-32.9, adult anemia, unspecified surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure secondary esophageal varices without bleeding hypotension, unspecified anxiety disorder, unspecified alcoholic hepatic failure without coma thrombocytopenia, unspecified personal history of nicotine dependence acidosis physical restraint status acute kidney failure, unspecified alcoholic cirrhosis of liver without ascites hypo-osmolality and hyponatremia calculus of gallbladder without cholecystitis without obstruction alcohol dependence with withdrawal, unspecified hypovolemia hypotension, unspecified alcoholic hepatitis without ascites coagulation defect, unspecified
white f 79 $temp  98.5  heartrate  91.0  resprate  19.0  o2sat  96.0  sbp  145.0  dbp  75.0  rhythm    pain    $hematology blood hematocrit  33.6  %; hematology blood hematocrit  32.7  %; hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  204  k ul; hematology blood platelet count  197  k ul; hematology blood platelet count  189  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  129  mg dl; blood gas blood free calcium  1.17  mmol l; blood gas blood lactate  1.1  mmol l$0.9% sodium chloride  1  bag ; sodium chloride 0.9%  flush  3  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; fentanyl patch  75  mcg h ; lorazepam  0.25  mg ; ondansetron odt  8  mg ; acetaminophen  650  mg ; psyllium powder  1  pkt ; baclofen  10  mg ; gabapentin  100  mg ; omeprazole  20  mg ; sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; captopril  50  mg ; morphine sulfate  1  mg ; 
esophageal obstruction radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable hypothyroidism, unspecified essential (primary) hypertension malignant neoplasm of lower third of esophagus anemia, unspecified unspecified glaucoma unspecified severe protein-calorie malnutrition other cytomegaloviral diseases secondary and unspecified malignant neoplasm of intrathoracic lymph nodes body mass index (bmi) 26.0-26.9, adult dehydration hyperlipidemia, unspecified other esophagitis other acute postprocedural pain adverse effect of other opioids, initial encounter esophageal obstruction essential (primary) hypertension personal history of malignant neoplasm of esophagus bacteriuria dehydration unspecified severe protein-calorie malnutrition hypovolemia drug induced constipation unspecified place or not applicable radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified body mass index (bmi) 26.0-26.9, adult unspecified place in hospital as the place of occurrence of the external cause hypothyroidism, unspecified other esophagitis adverse effect of other viral vaccines, initial encounter encounter for immunization candidal stomatitis anxiety disorder, unspecified adult failure to thrive unspecified glaucoma disorder of the skin and subcutaneous tissue, unspecified unspecified severe protein-calorie malnutrition essential (primary) hypertension nausea hypokalemia other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypothyroidism, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
white f 79 $nan$hematology blood hematocrit  34.4  %; hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.2  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  197  k ul; hematology blood platelet count  192  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  146  mg dl$0.9% sodium chloride  1  bag ; sodium chloride 0.9%  flush  3  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; fentanyl patch  75  mcg h ; lorazepam  0.25  mg ; ondansetron odt  8  mg ; acetaminophen  650  mg ; psyllium powder  1  pkt ; baclofen  10  mg ; gabapentin  100  mg ; omeprazole  20  mg ; heparin  5000  unit ; captopril  50  mg ; morphine sulfate  1  mg ; bimatoprost  0.03  % ; ipratropium-albuterol neb  1  neb ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; senna  8.6  mg ; docusate sodium  100  mg ; maalox diphenhydramine lidocaine  15  ml ; acetaminophen (liquid)  650  mg ; sucralfate  1  gm ; 
esophageal obstruction radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable hypothyroidism, unspecified essential (primary) hypertension malignant neoplasm of lower third of esophagus anemia, unspecified unspecified glaucoma unspecified severe protein-calorie malnutrition other cytomegaloviral diseases secondary and unspecified malignant neoplasm of intrathoracic lymph nodes body mass index (bmi) 26.0-26.9, adult dehydration hyperlipidemia, unspecified other esophagitis other acute postprocedural pain adverse effect of other opioids, initial encounter esophageal obstruction essential (primary) hypertension personal history of malignant neoplasm of esophagus bacteriuria dehydration unspecified severe protein-calorie malnutrition hypovolemia drug induced constipation unspecified place or not applicable radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified body mass index (bmi) 26.0-26.9, adult unspecified place in hospital as the place of occurrence of the external cause hypothyroidism, unspecified other esophagitis adverse effect of other viral vaccines, initial encounter encounter for immunization candidal stomatitis anxiety disorder, unspecified adult failure to thrive unspecified glaucoma disorder of the skin and subcutaneous tissue, unspecified unspecified severe protein-calorie malnutrition essential (primary) hypertension nausea hypokalemia other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypothyroidism, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
white f 79 $nan$nan$0.9% sodium chloride  1  bag ; sodium chloride 0.9%  flush  3  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; fentanyl patch  75  mcg h ; lorazepam  0.25  mg ; ondansetron odt  8  mg ; psyllium powder  1  pkt ; baclofen  10  mg ; gabapentin  100  mg ; omeprazole  20  mg ; heparin  5000  unit ; ipratropium-albuterol neb  1  neb ; docusate sodium  100  mg ; maalox diphenhydramine lidocaine  15  ml ; acetaminophen (liquid)  650  mg ; sucralfate  1  gm ; codeine sulfate  15  mg ; 
esophageal obstruction radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable hypothyroidism, unspecified essential (primary) hypertension malignant neoplasm of lower third of esophagus anemia, unspecified unspecified glaucoma unspecified severe protein-calorie malnutrition other cytomegaloviral diseases secondary and unspecified malignant neoplasm of intrathoracic lymph nodes body mass index (bmi) 26.0-26.9, adult dehydration hyperlipidemia, unspecified other esophagitis other acute postprocedural pain adverse effect of other opioids, initial encounter esophageal obstruction essential (primary) hypertension personal history of malignant neoplasm of esophagus bacteriuria dehydration unspecified severe protein-calorie malnutrition hypovolemia drug induced constipation unspecified place or not applicable radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified body mass index (bmi) 26.0-26.9, adult unspecified place in hospital as the place of occurrence of the external cause hypothyroidism, unspecified other esophagitis adverse effect of other viral vaccines, initial encounter encounter for immunization candidal stomatitis anxiety disorder, unspecified adult failure to thrive unspecified glaucoma disorder of the skin and subcutaneous tissue, unspecified unspecified severe protein-calorie malnutrition essential (primary) hypertension nausea hypokalemia other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypothyroidism, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
white f 38 $temp  97.6  heartrate  88.0  resprate  16.0  o2sat  100.0  sbp  142.0  dbp  95.0  rhythm    pain  6  $hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  420  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood glucose  84  mg dl; blood gas blood lactate  1.1  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  200  mg ; morphine sulfate  1  mg ; oxycodone (immediate release)   5  mg ; lactated ringers  1000  ml ; ondansetron  4-8  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; clotrimazole 1% vaginal cream  1  appl ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2-4  mg ; 
 
white f 38 $nan$hematology blood hematocrit  40.4  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  428  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; lactated ringers  1000  ml ; ondansetron  4-8  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; clotrimazole 1% vaginal cream  1  appl ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2-4  mg ; sodium chloride 0.9%  1000  ml ; d5ns  1000  ml ; 
 
white f 38 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron  4-8  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; clotrimazole 1% vaginal cream  1  appl ; morphine sulfate  2-4  mg ; d5ns  1000  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; potassium chl 40 meq   1000 ml ns  1000  ml ; 
 
white f 38 $nan$hematology blood hematocrit  40.9  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  398  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  73  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron  4-8  mg ; clotrimazole 1% vaginal cream  1  appl ; morphine sulfate  2-4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; potassium chl 40 meq   1000 ml ns  1000  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; 
 
white f 38 $nan$hematology blood hematocrit  40.2  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  375  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron  4-8  mg ; clotrimazole 1% vaginal cream  1  appl ; morphine sulfate  2-4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; amino acids 4.25%-dextrose 5%  1000  ml ; prochlorperazine  5-10  mg ; 
 
white f 38 $nan$hematology blood hematocrit  41.5  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  376  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron  4-8  mg ; clotrimazole 1% vaginal cream  1  appl ; morphine sulfate  2-4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; amino acids 4.25%-dextrose 5%  1000  ml ; prochlorperazine  5-10  mg ; fat emulsion 20%  250  ml ; 
 
white f 38 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron  4-8  mg ; clotrimazole 1% vaginal cream  1  appl ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; prochlorperazine  5-10  mg ; fat emulsion 20%  250  ml ; docusate sodium  100  mg ; loperamide  2  mg ; amoxicillin-clavulanic acid  875  mg ; acetaminophen  650  mg ; 
 
white f 38 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron  4-8  mg ; clotrimazole 1% vaginal cream  1  appl ; prochlorperazine  5-10  mg ; loperamide  2  mg ; amoxicillin-clavulanic acid  875  mg ; acetaminophen  650  mg ; 
 
hispanic latino f 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; milk of magnesia  30  ml ; ibuprofen  800  mg ; clonazepam  2  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  75  mcg ; lamotrigine  25  mg ; citalopram hydrobromide  20  mg ; quetiapine extended-release  300  mg ; aripiprazole  5  mg ; quetiapine extended-release  200  mg ; lamotrigine  100  mg ; lamotrigine  50  mg ; mirtazapine  45  mg ; mirtazapine  15  mg ; mirtazapine  30  mg ; zolpidem tartrate  5-10  mg ; 
unspecified acquired hypothyroidism dysmenorrhea bipolar disorder, unspecified anxiety state, unspecified
hispanic latino f 50 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; ibuprofen  800  mg ; citalopram hydrobromide  20  mg ; aripiprazole  5  mg ; quetiapine extended-release  200  mg ; lamotrigine  100  mg ; lamotrigine  50  mg ; zolpidem tartrate  5-10  mg ; aripiprazole  10  mg ; lamotrigine  75  mg ; 
unspecified acquired hypothyroidism dysmenorrhea bipolar disorder, unspecified anxiety state, unspecified
hispanic latino f 50 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; ibuprofen  800  mg ; quetiapine extended-release  200  mg ; lamotrigine  50  mg ; zolpidem tartrate  5-10  mg ; aripiprazole  10  mg ; lamotrigine  75  mg ; 
unspecified acquired hypothyroidism dysmenorrhea bipolar disorder, unspecified anxiety state, unspecified
hispanic latino f 50 $nan$hematology blood hematocrit  38.1  %$acetaminophen  650  mg ; milk of magnesia  30  ml ; ibuprofen  800  mg ; quetiapine extended-release  200  mg ; lamotrigine  50  mg ; zolpidem tartrate  5-10  mg ; aripiprazole  10  mg ; lamotrigine  75  mg ; 
unspecified acquired hypothyroidism dysmenorrhea bipolar disorder, unspecified anxiety state, unspecified
hispanic latino f 50 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; ibuprofen  800  mg ; quetiapine extended-release  200  mg ; lamotrigine  50  mg ; zolpidem tartrate  5-10  mg ; aripiprazole  10  mg ; lamotrigine  75  mg ; 
unspecified acquired hypothyroidism dysmenorrhea bipolar disorder, unspecified anxiety state, unspecified
hispanic latino f 50 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; ibuprofen  800  mg ; quetiapine extended-release  200  mg ; lamotrigine  50  mg ; zolpidem tartrate  5-10  mg ; aripiprazole  10  mg ; lamotrigine  75  mg ; 
unspecified acquired hypothyroidism dysmenorrhea bipolar disorder, unspecified anxiety state, unspecified
hispanic latino f 50 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; ibuprofen  800  mg ; lamotrigine  50  mg ; zolpidem tartrate  5-10  mg ; aripiprazole  10  mg ; lamotrigine  75  mg ; 
unspecified acquired hypothyroidism dysmenorrhea bipolar disorder, unspecified anxiety state, unspecified
hispanic latino f 50 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; ibuprofen  800  mg ; zolpidem tartrate  5-10  mg ; aripiprazole  10  mg ; mirtazapine  37.5  mg ; 
unspecified acquired hypothyroidism dysmenorrhea bipolar disorder, unspecified anxiety state, unspecified
hispanic latino f 50 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; ibuprofen  800  mg ; zolpidem tartrate  5-10  mg ; aripiprazole  10  mg ; mirtazapine  37.5  mg ; clonazepam  1  mg ; 
unspecified acquired hypothyroidism dysmenorrhea bipolar disorder, unspecified anxiety state, unspecified
hispanic latino f 50 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; ibuprofen  800  mg ; zolpidem tartrate  5-10  mg ; aripiprazole  10  mg ; mirtazapine  37.5  mg ; clonazepam  1  mg ; 
unspecified acquired hypothyroidism dysmenorrhea bipolar disorder, unspecified anxiety state, unspecified
hispanic latino f 50 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; ibuprofen  800  mg ; zolpidem tartrate  5-10  mg ; aripiprazole  10  mg ; mirtazapine  37.5  mg ; clonazepam  1  mg ; lamotrigine  150  mg ; 
unspecified acquired hypothyroidism dysmenorrhea bipolar disorder, unspecified anxiety state, unspecified
hispanic latino f 50 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; ibuprofen  800  mg ; zolpidem tartrate  5-10  mg ; aripiprazole  10  mg ; mirtazapine  37.5  mg ; clonazepam  1  mg ; lamotrigine  150  mg ; 
unspecified acquired hypothyroidism dysmenorrhea bipolar disorder, unspecified anxiety state, unspecified
white f 87 $nan$nan$atorvastatin  10  mg ; omeprazole  40  mg ; senna  1  tab ; 
 
white f 87 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood glucose  125  mg dl$atorvastatin  10  mg ; omeprazole  40  mg ; senna  1  tab ; ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; docusate sodium  100  mg ; heparin  5000  unit ; sucralfate  1  gm ; metoclopramide  5  mg ; 
 
white f 87 $nan$nan$atorvastatin  10  mg ; omeprazole  40  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; docusate sodium  100  mg ; heparin  5000  unit ; sucralfate  1  gm ; metoclopramide  5  mg ; 
 
white f 33 $nan$nan$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white f 33 $nan$nan$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white f 33 $nan$nan$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
asian f 30 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; 
tumors of body of uterus, antepartum condition or complication unspecified symptom associated with female genital organs leiomyoma of uterus, unspecified unspecified abnormality of labor, antepartum condition or complication
asian f 30 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; 
tumors of body of uterus, antepartum condition or complication unspecified symptom associated with female genital organs leiomyoma of uterus, unspecified unspecified abnormality of labor, antepartum condition or complication
asian f 30 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; 
tumors of body of uterus, antepartum condition or complication unspecified symptom associated with female genital organs leiomyoma of uterus, unspecified unspecified abnormality of labor, antepartum condition or complication
asian f 30 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; 
tumors of body of uterus, antepartum condition or complication unspecified symptom associated with female genital organs leiomyoma of uterus, unspecified unspecified abnormality of labor, antepartum condition or complication
other m 75 $nan$nan$ezetimibe  10  mg ; 
spinal stenosis, unspecified region long-term (current) use of insulin mononeuritis of unspecified site personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerosis of native arteries of the extremities with rest pain personal history of tobacco use personal history of malignant neoplasm of other and unspecified oral cavity and pharynx diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension long-term (current) use of insulin personal history of malignant neoplasm of other and unspecified oral cavity and pharynx occlusion and stenosis of carotid artery with cerebral infarction aphasia personal history of tobacco use mononeuritis of unspecified site unspecified essential hypertension spinal stenosis, unspecified region diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
other m 75 $temp  97.7  heartrate  64.0  resprate  17.0  o2sat  94.0  sbp  153.0  dbp  73.0  rhythm    pain  8  ; temp  98.1  heartrate  64.0  resprate  18.0  o2sat  94.0  sbp  130.0  dbp  62.0  rhythm    pain    $hematology blood hematocrit  42.3  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  217  mg dl$ezetimibe  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; trazodone  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; 5% dextrose  250  ml ; vancomycin  1250  mg ; gabapentin  1200  mg ; simvastatin  10  mg ; insulin  60  unit ; acetaminophen  1000  mg ; oxycodone (immediate release)   2.5  mg ; aspirin  81  mg ; clindamycin  450  mg ; simvastatin  20  mg ; aspirin  325  mg ; 
spinal stenosis, unspecified region long-term (current) use of insulin mononeuritis of unspecified site personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerosis of native arteries of the extremities with rest pain personal history of tobacco use personal history of malignant neoplasm of other and unspecified oral cavity and pharynx diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension long-term (current) use of insulin personal history of malignant neoplasm of other and unspecified oral cavity and pharynx occlusion and stenosis of carotid artery with cerebral infarction aphasia personal history of tobacco use mononeuritis of unspecified site unspecified essential hypertension spinal stenosis, unspecified region diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
other m 75 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; trazodone  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; gabapentin  1200  mg ; insulin  60  unit ; acetaminophen  1000  mg ; oxycodone (immediate release)   2.5  mg ; aspirin  81  mg ; clindamycin  450  mg ; simvastatin  20  mg ; aspirin  325  mg ; 
spinal stenosis, unspecified region long-term (current) use of insulin mononeuritis of unspecified site personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atherosclerosis of native arteries of the extremities with rest pain personal history of tobacco use personal history of malignant neoplasm of other and unspecified oral cavity and pharynx diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension long-term (current) use of insulin personal history of malignant neoplasm of other and unspecified oral cavity and pharynx occlusion and stenosis of carotid artery with cerebral infarction aphasia personal history of tobacco use mononeuritis of unspecified site unspecified essential hypertension spinal stenosis, unspecified region diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
black african american f 36 $nan$chemistry urine creatinine, urine  48  mg dl; chemistry urine protein creatinine ratio  2.1  ratio$nephrocaps  1  cap ; 
 
black african american f 36 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  246  k ul; chemistry blood creatinine  0.8  mg dl; chemistry urine creatinine, urine  159  mg dl; chemistry urine protein creatinine ratio  1.7  ratio$nephrocaps  1  cap ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; milk of magnesia  15-30  ml ; 
 
black african american f 36 $nan$nan$nephrocaps  1  cap ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; milk of magnesia  15-30  ml ; 
 
black african american f 36 $nan$nan$nephrocaps  1  cap ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; milk of magnesia  15-30  ml ; labetalol  200  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; d5w  100  ml ; gentamicin sulfate  475  mg ; d5w  50  ml ; clindamycin  900  mg ; 
 
black african american f 36 $nan$nan$nephrocaps  1  cap ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; milk of magnesia  15-30  ml ; labetalol  200  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; d5w  100  ml ; gentamicin sulfate  475  mg ; d5w  50  ml ; clindamycin  900  mg ; 
 
white f 83 $temp  98.2  heartrate  73.0  resprate  16.0  o2sat  95.0  sbp  112.0  dbp  50.0  rhythm    pain  sleeping  $hematology blood hematocrit  34.0  %; hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  139  k ul; hematology blood platelet count  131  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  4.0  mg dl; chemistry blood creatinine  4.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  140  mg dl; chemistry blood glucose  111  mg dl; blood gas blood lactate  1.6  mmol l$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  650  mg ; docusate sodium  100  mg ; vitamin d  1000  unit ; atorvastatin  20  mg ; trazodone  50  mg ; sertraline  100  mg ; sertraline  25  mg ; prednisone  5  mg ; gabapentin  100  mg ; linezolid  600  mg ; lactated ringers  1000  ml ; d5w  300  ml ; vancomycin oral liquid  125  mg ; epoetin alfa  3000  unit ; epoetin alfa  4000  unit ; heparin dwell (1000 units ml)  1000-4000  unit ; sodium chloride 0.9%  1000  ml ; vial  1  vial ; ceftriaxone  1  gm ; sodium chloride nasal  1-2  spry ; 
kidney transplant failure carrier of other specified bacterial diseases essential (primary) hypertension adverse effect of other antihypertensive drugs, initial encounter insomnia, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure kidney transplant status major depressive disorder, single episode, unspecified trigeminal neuralgia dependence on renal dialysis gaucher disease personal history of urinary (tract) infections end stage renal disease unspecified place or not applicable anemia, unspecified constipation, unspecified hypotension due to drugs end stage renal disease adult sexual abuse, suspected, initial encounter anemia in chronic kidney disease kidney transplant status personal history of urinary (tract) infections dependence on renal dialysis urinary tract infection, site not specified gaucher disease anemia in chronic kidney disease sepsis due to enterococcus dependence on renal dialysis resistance to other single specified antibiotic kidney transplant failure unspecified asthma, uncomplicated urinary tract infection, site not specified enterocolitis due to clostridium difficile, recurrent acute respiratory failure with hypoxia vertebral artery compression syndromes, cervical region age-related osteoporosis without current pathological fracture major depressive disorder, single episode, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease encephalopathy, unspecified trigeminal neuralgia gaucher disease end stage renal disease gastro-esophageal reflux disease without esophagitis cystocele, unspecified hypotension, unspecified encounter for immunization pneumonia, unspecified organism constipation, unspecified
white f 83 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  3.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  94  mg dl; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  650  mg ; docusate sodium  100  mg ; vitamin d  1000  unit ; atorvastatin  20  mg ; trazodone  50  mg ; sertraline  100  mg ; sertraline  25  mg ; prednisone  5  mg ; gabapentin  100  mg ; lactated ringers  1000  ml ; vancomycin oral liquid  125  mg ; epoetin alfa  3000  unit ; epoetin alfa  4000  unit ; heparin dwell (1000 units ml)  1000-4000  unit ; sodium chloride 0.9%  1000  ml ; vial  1  vial ; ceftriaxone  1  gm ; sodium chloride nasal  1-2  spry ; ramelteon  8  mg ; trazodone  25  mg ; 
kidney transplant failure carrier of other specified bacterial diseases essential (primary) hypertension adverse effect of other antihypertensive drugs, initial encounter insomnia, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure kidney transplant status major depressive disorder, single episode, unspecified trigeminal neuralgia dependence on renal dialysis gaucher disease personal history of urinary (tract) infections end stage renal disease unspecified place or not applicable anemia, unspecified constipation, unspecified hypotension due to drugs end stage renal disease adult sexual abuse, suspected, initial encounter anemia in chronic kidney disease kidney transplant status personal history of urinary (tract) infections dependence on renal dialysis urinary tract infection, site not specified gaucher disease anemia in chronic kidney disease sepsis due to enterococcus dependence on renal dialysis resistance to other single specified antibiotic kidney transplant failure unspecified asthma, uncomplicated urinary tract infection, site not specified enterocolitis due to clostridium difficile, recurrent acute respiratory failure with hypoxia vertebral artery compression syndromes, cervical region age-related osteoporosis without current pathological fracture major depressive disorder, single episode, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease encephalopathy, unspecified trigeminal neuralgia gaucher disease end stage renal disease gastro-esophageal reflux disease without esophagitis cystocele, unspecified hypotension, unspecified encounter for immunization pneumonia, unspecified organism constipation, unspecified
white f 83 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  4.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  88  mg dl; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  650  mg ; docusate sodium  100  mg ; vitamin d  1000  unit ; atorvastatin  20  mg ; trazodone  50  mg ; sertraline  100  mg ; sertraline  25  mg ; prednisone  5  mg ; gabapentin  100  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  1000  ml ; vial  1  vial ; ceftriaxone  1  gm ; sodium chloride nasal  1-2  spry ; ramelteon  8  mg ; trazodone  25  mg ; benzonatate  100  mg ; guaifenesin er  600  mg ; cepacol (sore throat lozenge)  1  loz ; carvedilol  25  mg ; ciprofloxacin hcl  250  mg ; fluticasone propionate nasal  1  spry ; ipratropium-albuterol neb  1  neb ; 
kidney transplant failure carrier of other specified bacterial diseases essential (primary) hypertension adverse effect of other antihypertensive drugs, initial encounter insomnia, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure kidney transplant status major depressive disorder, single episode, unspecified trigeminal neuralgia dependence on renal dialysis gaucher disease personal history of urinary (tract) infections end stage renal disease unspecified place or not applicable anemia, unspecified constipation, unspecified hypotension due to drugs end stage renal disease adult sexual abuse, suspected, initial encounter anemia in chronic kidney disease kidney transplant status personal history of urinary (tract) infections dependence on renal dialysis urinary tract infection, site not specified gaucher disease anemia in chronic kidney disease sepsis due to enterococcus dependence on renal dialysis resistance to other single specified antibiotic kidney transplant failure unspecified asthma, uncomplicated urinary tract infection, site not specified enterocolitis due to clostridium difficile, recurrent acute respiratory failure with hypoxia vertebral artery compression syndromes, cervical region age-related osteoporosis without current pathological fracture major depressive disorder, single episode, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease encephalopathy, unspecified trigeminal neuralgia gaucher disease end stage renal disease gastro-esophageal reflux disease without esophagitis cystocele, unspecified hypotension, unspecified encounter for immunization pneumonia, unspecified organism constipation, unspecified
white f 83 $nan$hematology blood hematocrit  31.3  %; hematology blood hematocrit  32.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  152  k ul; hematology blood platelet count  141  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  4.5  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  167  mg dl; chemistry blood glucose  105  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  650  mg ; docusate sodium  100  mg ; vitamin d  1000  unit ; atorvastatin  20  mg ; trazodone  50  mg ; sertraline  100  mg ; sertraline  25  mg ; prednisone  5  mg ; gabapentin  100  mg ; vancomycin oral liquid  125  mg ; sodium chloride 0.9%  1000  ml ; sodium chloride nasal  1-2  spry ; ramelteon  8  mg ; benzonatate  100  mg ; guaifenesin er  600  mg ; cepacol (sore throat lozenge)  1  loz ; carvedilol  25  mg ; ciprofloxacin hcl  250  mg ; fluticasone propionate nasal  1  spry ; ipratropium-albuterol neb  1  neb ; losartan potassium  100  mg ; 
kidney transplant failure carrier of other specified bacterial diseases essential (primary) hypertension adverse effect of other antihypertensive drugs, initial encounter insomnia, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure kidney transplant status major depressive disorder, single episode, unspecified trigeminal neuralgia dependence on renal dialysis gaucher disease personal history of urinary (tract) infections end stage renal disease unspecified place or not applicable anemia, unspecified constipation, unspecified hypotension due to drugs end stage renal disease adult sexual abuse, suspected, initial encounter anemia in chronic kidney disease kidney transplant status personal history of urinary (tract) infections dependence on renal dialysis urinary tract infection, site not specified gaucher disease anemia in chronic kidney disease sepsis due to enterococcus dependence on renal dialysis resistance to other single specified antibiotic kidney transplant failure unspecified asthma, uncomplicated urinary tract infection, site not specified enterocolitis due to clostridium difficile, recurrent acute respiratory failure with hypoxia vertebral artery compression syndromes, cervical region age-related osteoporosis without current pathological fracture major depressive disorder, single episode, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease encephalopathy, unspecified trigeminal neuralgia gaucher disease end stage renal disease gastro-esophageal reflux disease without esophagitis cystocele, unspecified hypotension, unspecified encounter for immunization pneumonia, unspecified organism constipation, unspecified
other m 58 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  ua  ; temp  99.0  heartrate  90.0  resprate  16.0  o2sat  95.0  sbp  155.0  dbp  76.0  rhythm    pain  8  ; temp  98.2  heartrate  110.0  resprate  20.0  o2sat  91.0  sbp  143.0  dbp  94.0  rhythm    pain    $hematology blood hematocrit  44.6  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  338  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  151  mg dl$nan
 
white m 36 $nan$hematology blood hematocrit  39.6  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  8  k ul$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; prednisone  100  mg ; 
 
white m 36 $nan$hematology blood hematocrit  42.0  %; hematology blood hemoglobin  15.2  g dl; hematology blood platelet count  16  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  97  mg dl; hematology blood wbc count  7.3  k ul$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; prednisone  100  mg ; atovaquone suspension  1500  mg ; 
 
white m 36 $nan$hematology blood hematocrit  40.0  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  21  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  143  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; prednisone  100  mg ; atovaquone suspension  1500  mg ; 
 
white m 36 $nan$hematology blood hematocrit  40.1  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  28  k ul$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; prednisone  100  mg ; atovaquone suspension  1500  mg ; 
 
white m 36 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  25  k ul$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; prednisone  100  mg ; atovaquone suspension  1500  mg ; 
 
white m 36 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  27  k ul$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; prednisone  100  mg ; atovaquone suspension  1500  mg ; 
 
white f 47 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  571  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; albuterol inhaler  1-2  puff ; docusate sodium  100  mg ; furosemide  20  mg ; heparin  5000  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; labetalol  200  mg ; ferrous sulfate  325  mg ; 
other immediate postpartum hemorrhage, delivered, with mention of postpartum complication pregnancy resulting from assisted reproductive technology body mass index 45.0-49.9, adult outcome of delivery, single liveborn elderly primigravida, delivered, with or without mention of antepartum condition abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition obstructive sleep apnea (adult)(pediatric) motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other specified malposition or malpresentation, delivered, with or without mention of antepartum condition esophageal reflux asthma, unspecified type, unspecified obesity complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition long-term (current) use of insulin morbid obesity other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition 
white f 47 $nan$hematology blood hematocrit  22.3  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  515  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; albuterol inhaler  1-2  puff ; docusate sodium  100  mg ; heparin  5000  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; labetalol  200  mg ; ferrous sulfate  325  mg ; 
other immediate postpartum hemorrhage, delivered, with mention of postpartum complication pregnancy resulting from assisted reproductive technology body mass index 45.0-49.9, adult outcome of delivery, single liveborn elderly primigravida, delivered, with or without mention of antepartum condition abnormal glucose tolerance of mother, delivered, with or without mention of antepartum condition obstructive sleep apnea (adult)(pediatric) motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other specified malposition or malpresentation, delivered, with or without mention of antepartum condition esophageal reflux asthma, unspecified type, unspecified obesity complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition long-term (current) use of insulin morbid obesity other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition 
white f 81 $temp    heartrate  122.0  resprate  22.0  o2sat  95.0  sbp  142.0  dbp  53.0  rhythm    pain    ; temp  98.0  heartrate  118.0  resprate  22.0  o2sat  97.0  sbp  165.0  dbp  72.0  rhythm    pain  6  $hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  300  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  96  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; lorazepam  0.25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; simvastatin  20  mg ; multivitamins  1  tab ; meclizine  12.5  mg ; metoprolol tartrate  50  mg ; lorazepam  0.5  mg ; latanoprost 0.005% ophth. soln.  1  drop ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; fluticasone-salmeterol diskus (500 50)   1  inh ; fluoxetine  40  mg ; calcium acetate  667  mg ; albuterol 0.083% neb soln  1  neb ; doxepin hcl  50  mg ; ipratropium bromide neb  1  neb ; nitrofurantoin monohyd (macrobid)  100  mg ; calcium carbonate  500  mg ; 
 
white f 81 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; simvastatin  20  mg ; multivitamins  1  tab ; meclizine  12.5  mg ; metoprolol tartrate  50  mg ; lorazepam  0.5  mg ; latanoprost 0.005% ophth. soln.  1  drop ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; fluticasone-salmeterol diskus (500 50)   1  inh ; fluoxetine  40  mg ; calcium acetate  667  mg ; albuterol 0.083% neb soln  1  neb ; doxepin hcl  50  mg ; ipratropium bromide neb  1  neb ; nitrofurantoin monohyd (macrobid)  100  mg ; calcium carbonate  500  mg ; 
 
hispanic latino m 85 $nan$nan$docusate sodium  100  mg ; clopidogrel  75  mg ; isosorbide mononitrate (extended release)  30  mg ; amlodipine  10  mg ; metoprolol succinate xl  75  mg ; rosuvastatin calcium  10  mg ; aspirin  325  mg ; 
 
hispanic latino m 85 $temp  97.8  heartrate  50.0  resprate  16.0  o2sat  100.0  sbp  115.0  dbp  44.0  rhythm    pain  0 10  $hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  85  mg dl$docusate sodium  100  mg ; clopidogrel  75  mg ; isosorbide mononitrate (extended release)  30  mg ; amlodipine  10  mg ; metoprolol succinate xl  75  mg ; rosuvastatin calcium  10  mg ; aspirin  325  mg ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; oxycodone (immediate release)   5  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; albuterol-ipratropium  1-2  puff ; tamsulosin  0.4  mg ; senna  2  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 
 
hispanic latino m 85 $nan$nan$metoprolol succinate xl  75  mg ; rosuvastatin calcium  10  mg ; aspirin  325  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; albuterol-ipratropium  1-2  puff ; senna  2  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 
 
white m 66 $nan$nan$acetaminophen  1000  mg ; pregabalin  50  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; ketorolac  15  mg ; senna  8.6  mg ; docusate sodium  100  mg ; gabapentin  300  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 
hyperlipidemia, unspecified essential (primary) hypertension gross hematuria other arterial embolism and thrombosis of abdominal aorta gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs infection following a procedure, initial encounter unspecified place in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure cellulitis of groin exposure to other specified factors, subsequent encounter unspecified fracture of shaft of left femur, subsequent encounter for closed fracture with nonunion peripheral vascular disease, unspecified closed fracture of lumbar vertebra without mention of spinal cord injury open wound of finger(s), without mention of complication other closed fractures of distal end of radius (alone) tachycardia, unspecified lipomatosis, not elsewhere classified accidents occurring in industrial places and premises solitary pulmonary nodule personal history of tobacco use need for prophylactic vaccination and inoculation against tetanus-diphtheria [td] (dt) closed fracture of middle or proximal phalanx or phalanges of hand fracture of calcaneus, closed accidental fall from or out of building or other structure closed supracondylar fracture of femur 
white m 66 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  146  mg dl$acetaminophen  1000  mg ; pregabalin  50  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; ketorolac  15  mg ; senna  8.6  mg ; docusate sodium  100  mg ; gabapentin  300  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; aspirin  81  mg ; irbesartan  75  mg ; bag  1  bag ; magnesium sulfate  2  gm ; pantoprazole  40  mg ; 
hyperlipidemia, unspecified essential (primary) hypertension gross hematuria other arterial embolism and thrombosis of abdominal aorta gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs infection following a procedure, initial encounter unspecified place in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure cellulitis of groin exposure to other specified factors, subsequent encounter unspecified fracture of shaft of left femur, subsequent encounter for closed fracture with nonunion peripheral vascular disease, unspecified closed fracture of lumbar vertebra without mention of spinal cord injury open wound of finger(s), without mention of complication other closed fractures of distal end of radius (alone) tachycardia, unspecified lipomatosis, not elsewhere classified accidents occurring in industrial places and premises solitary pulmonary nodule personal history of tobacco use need for prophylactic vaccination and inoculation against tetanus-diphtheria [td] (dt) closed fracture of middle or proximal phalanx or phalanges of hand fracture of calcaneus, closed accidental fall from or out of building or other structure closed supracondylar fracture of femur 
white m 66 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  150  k ul$simvastatin  20  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; ketorolac  15  mg ; senna  8.6  mg ; docusate sodium  100  mg ; gabapentin  300  mg ; aspirin  81  mg ; irbesartan  75  mg ; bag  1  bag ; magnesium sulfate  2  gm ; pantoprazole  40  mg ; 
hyperlipidemia, unspecified essential (primary) hypertension gross hematuria other arterial embolism and thrombosis of abdominal aorta gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs infection following a procedure, initial encounter unspecified place in hospital as the place of occurrence of the external cause other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure cellulitis of groin exposure to other specified factors, subsequent encounter unspecified fracture of shaft of left femur, subsequent encounter for closed fracture with nonunion peripheral vascular disease, unspecified closed fracture of lumbar vertebra without mention of spinal cord injury open wound of finger(s), without mention of complication other closed fractures of distal end of radius (alone) tachycardia, unspecified lipomatosis, not elsewhere classified accidents occurring in industrial places and premises solitary pulmonary nodule personal history of tobacco use need for prophylactic vaccination and inoculation against tetanus-diphtheria [td] (dt) closed fracture of middle or proximal phalanx or phalanges of hand fracture of calcaneus, closed accidental fall from or out of building or other structure closed supracondylar fracture of femur 
black african american f 73 $nan$hematology blood hematocrit  46.9  %; hematology blood hemoglobin  15.0  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  125  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; propylthiouracil  50  mg ; ondansetron  4  mg ; trazodone  25  mg ; lactated ringers  1000  ml ; amlodipine  5  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 
tobacco use disorder orthostatic hypotension infectious colitis, enteritis, and gastroenteritis thrombocytopenia, unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident toxic diffuse goiter without mention of thyrotoxic crisis or storm elevated blood pressure reading without diagnosis of hypertension unspecified viral hepatitis c without hepatic coma other specified vaccinations against streptococcus pneumoniae [pneumococcus] malignant neoplasm of liver, primary family history of malignant neoplasm of gastrointestinal tract 
black african american f 73 $nan$hematology blood hematocrit  46.8  %; hematology blood hemoglobin  15.0  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; propylthiouracil  50  mg ; ondansetron  4  mg ; trazodone  25  mg ; amlodipine  5  mg ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride  40  meq ; 
tobacco use disorder orthostatic hypotension infectious colitis, enteritis, and gastroenteritis thrombocytopenia, unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident toxic diffuse goiter without mention of thyrotoxic crisis or storm elevated blood pressure reading without diagnosis of hypertension unspecified viral hepatitis c without hepatic coma other specified vaccinations against streptococcus pneumoniae [pneumococcus] malignant neoplasm of liver, primary family history of malignant neoplasm of gastrointestinal tract 
black african american f 73 $nan$hematology blood hematocrit  43.7  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; propylthiouracil  50  mg ; ondansetron  4  mg ; trazodone  25  mg ; amlodipine  5  mg ; potassium chloride  40  meq ; 
tobacco use disorder orthostatic hypotension infectious colitis, enteritis, and gastroenteritis thrombocytopenia, unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident toxic diffuse goiter without mention of thyrotoxic crisis or storm elevated blood pressure reading without diagnosis of hypertension unspecified viral hepatitis c without hepatic coma other specified vaccinations against streptococcus pneumoniae [pneumococcus] malignant neoplasm of liver, primary family history of malignant neoplasm of gastrointestinal tract 
white f 50 $temp  98.9  heartrate  99.0  resprate  18.0  o2sat  99.0  sbp  105.0  dbp  61.0  rhythm    pain  4  $hematology blood hematocrit  38.6  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  296  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  101  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; cyclobenzaprine  10  mg ; docusate sodium  200  mg ; gabapentin  1200  mg ; hydromorphone (dilaudid)  8-12  mg ; levothyroxine sodium  25  mcg ; lidocaine 5% patch  1  ptch ; lorazepam  0.5  mg ; mupirocin ointment 2%  1  appl ; pantoprazole  40  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; simethicone  80  mg ; zolpidem tartrate  5  mg ; dicyclomine  10  mg ; lubiprostone  24  mcg ; promethazine  25  mg ; warfarin  8  mg ; warfarin  4  mg ; 
esophageal reflux other specified analgesics and antipyretics causing adverse effects in therapeutic use unspecified acquired hypothyroidism migraine, unspecified, without mention of intractable migraine without mention of status migrainosus car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of venous thrombosis and embolism bariatric surgery status long-term (current) use of anticoagulants aortic valve disorders other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure gastrostomy status personal history of pulmonary embolism unspecified personality disorder mechanical complication of other vascular device, implant, and graft pneumonia, organism unspecified other chronic pain acquired partial absence of pancreas other and unspecified postsurgical nonabsorption tobacco use disorder dyspepsia and other specified disorders of function of stomach body mass index between 19-24, adult migraine, unspecified, without mention of intractable migraine without mention of status migrainosus personal history of venous thrombosis and embolism personal history of pulmonary embolism esophageal reflux unspecified personality disorder other and unspecified postsurgical nonabsorption paralytic ileus other chronic pain bariatric surgery status aortic valve disorders long-term (current) use of anticoagulants other functional disorders of intestine bipolar disorder, unspecified unspecified acquired hypothyroidism passenger of special construction vehicle injured in traffic accident other specified hypoglycemia nausea with vomiting tobacco use disorder disorders of magnesium metabolism other constipation other specified analgesics and antipyretics causing adverse effects in therapeutic use long-term (current) use of anticoagulants unspecified personality disorder other chronic pain essential thrombocythemia body mass index 26.0-26.9, adult personal history of pulmonary embolism
white f 50 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  3.7  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  97  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; cyclobenzaprine  10  mg ; docusate sodium  200  mg ; hydromorphone (dilaudid)  8-12  mg ; levothyroxine sodium  25  mcg ; lidocaine 5% patch  1  ptch ; lorazepam  0.5  mg ; mupirocin ointment 2%  1  appl ; pantoprazole  40  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; zolpidem tartrate  5  mg ; lubiprostone  24  mcg ; promethazine  25  mg ; sodium chloride 0.9%  1000  ml ; 
esophageal reflux other specified analgesics and antipyretics causing adverse effects in therapeutic use unspecified acquired hypothyroidism migraine, unspecified, without mention of intractable migraine without mention of status migrainosus car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of venous thrombosis and embolism bariatric surgery status long-term (current) use of anticoagulants aortic valve disorders other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure gastrostomy status personal history of pulmonary embolism unspecified personality disorder mechanical complication of other vascular device, implant, and graft pneumonia, organism unspecified other chronic pain acquired partial absence of pancreas other and unspecified postsurgical nonabsorption tobacco use disorder dyspepsia and other specified disorders of function of stomach body mass index between 19-24, adult migraine, unspecified, without mention of intractable migraine without mention of status migrainosus personal history of venous thrombosis and embolism personal history of pulmonary embolism esophageal reflux unspecified personality disorder other and unspecified postsurgical nonabsorption paralytic ileus other chronic pain bariatric surgery status aortic valve disorders long-term (current) use of anticoagulants other functional disorders of intestine bipolar disorder, unspecified unspecified acquired hypothyroidism passenger of special construction vehicle injured in traffic accident other specified hypoglycemia nausea with vomiting tobacco use disorder disorders of magnesium metabolism other constipation other specified analgesics and antipyretics causing adverse effects in therapeutic use long-term (current) use of anticoagulants unspecified personality disorder other chronic pain essential thrombocythemia body mass index 26.0-26.9, adult personal history of pulmonary embolism
white m 31 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; heparin  5000  unit ; nystatin oral suspension  5  ml ; 

white m 31 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; heparin  5000  unit ; nystatin oral suspension  5  ml ; ramelteon  8  mg ; omeprazole  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; methylprednisolone sodium succ  60  mg ; 

white m 31 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; nystatin oral suspension  5  ml ; ramelteon  8  mg ; omeprazole  20  mg ; bag  1  bag ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; methylprednisolone sodium succ  60  mg ; dexamethasone  12  mg ; 

white f 74 $temp  98.6  heartrate  98.0  resprate  20.0  o2sat  99.0  sbp  124.0  dbp  76.0  rhythm    pain  5 10  $hematology blood hematocrit  39.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  282  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  136  mg dl; chemistry blood albumin  3.9  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; vial  1  vial ; pantoprazole  40  mg ; acetaminophen iv  1000  mg ; enoxaparin sodium  40  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; cepastat (phenol) lozenge  1  loz ; chloraseptic throat spray  1  spry ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 
acute posthemorrhagic anemia secondary malignant neoplasm of other specified sites unspecified pleural effusion secondary malignant neoplasm of large intestine and rectum pulmonary collapse secondary malignant neoplasm of retroperitoneum and peritoneum hypovolemia secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes heartburn unspecified acquired hypothyroidism malignant neoplasm of liver, secondary hypopotassemia malignant neoplasm of ovary need for prophylactic vaccination and inoculation against streptococcus pneumoniae [pneumococcus] and influenza secondary malignant neoplasm of other digestive organs and spleen malignant ascites
white f 74 $nan$hematology blood hematocrit  38.7  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  130  mg dl$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; vial  1  vial ; pantoprazole  40  mg ; acetaminophen iv  1000  mg ; enoxaparin sodium  40  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; cepastat (phenol) lozenge  1  loz ; chloraseptic throat spray  1  spry ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1000  ml ; sw  400  ml ; potassium chloride  40  meq ; 
acute posthemorrhagic anemia secondary malignant neoplasm of other specified sites unspecified pleural effusion secondary malignant neoplasm of large intestine and rectum pulmonary collapse secondary malignant neoplasm of retroperitoneum and peritoneum hypovolemia secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes heartburn unspecified acquired hypothyroidism malignant neoplasm of liver, secondary hypopotassemia malignant neoplasm of ovary need for prophylactic vaccination and inoculation against streptococcus pneumoniae [pneumococcus] and influenza secondary malignant neoplasm of other digestive organs and spleen malignant ascites
white f 74 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; acetaminophen iv  1000  mg ; enoxaparin sodium  40  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; cepastat (phenol) lozenge  1  loz ; chloraseptic throat spray  1  spry ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; 
acute posthemorrhagic anemia secondary malignant neoplasm of other specified sites unspecified pleural effusion secondary malignant neoplasm of large intestine and rectum pulmonary collapse secondary malignant neoplasm of retroperitoneum and peritoneum hypovolemia secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes heartburn unspecified acquired hypothyroidism malignant neoplasm of liver, secondary hypopotassemia malignant neoplasm of ovary need for prophylactic vaccination and inoculation against streptococcus pneumoniae [pneumococcus] and influenza secondary malignant neoplasm of other digestive organs and spleen malignant ascites
white f 74 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  128  mg dl$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; acetaminophen iv  1000  mg ; enoxaparin sodium  40  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; cepastat (phenol) lozenge  1  loz ; chloraseptic throat spray  1  spry ; 0.9% sodium chloride  500  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
acute posthemorrhagic anemia secondary malignant neoplasm of other specified sites unspecified pleural effusion secondary malignant neoplasm of large intestine and rectum pulmonary collapse secondary malignant neoplasm of retroperitoneum and peritoneum hypovolemia secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes heartburn unspecified acquired hypothyroidism malignant neoplasm of liver, secondary hypopotassemia malignant neoplasm of ovary need for prophylactic vaccination and inoculation against streptococcus pneumoniae [pneumococcus] and influenza secondary malignant neoplasm of other digestive organs and spleen malignant ascites
white f 74 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  135  mg dl$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; acetaminophen iv  1000  mg ; enoxaparin sodium  40  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; cepastat (phenol) lozenge  1  loz ; chloraseptic throat spray  1  spry ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
acute posthemorrhagic anemia secondary malignant neoplasm of other specified sites unspecified pleural effusion secondary malignant neoplasm of large intestine and rectum pulmonary collapse secondary malignant neoplasm of retroperitoneum and peritoneum hypovolemia secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes heartburn unspecified acquired hypothyroidism malignant neoplasm of liver, secondary hypopotassemia malignant neoplasm of ovary need for prophylactic vaccination and inoculation against streptococcus pneumoniae [pneumococcus] and influenza secondary malignant neoplasm of other digestive organs and spleen malignant ascites
white f 74 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; acetaminophen iv  1000  mg ; enoxaparin sodium  40  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; cepastat (phenol) lozenge  1  loz ; chloraseptic throat spray  1  spry ; diphenhydramine  25  mg ; levothyroxine sodium  100  mcg ; citalopram  10  mg ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   5-10  mg ; 
acute posthemorrhagic anemia secondary malignant neoplasm of other specified sites unspecified pleural effusion secondary malignant neoplasm of large intestine and rectum pulmonary collapse secondary malignant neoplasm of retroperitoneum and peritoneum hypovolemia secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes heartburn unspecified acquired hypothyroidism malignant neoplasm of liver, secondary hypopotassemia malignant neoplasm of ovary need for prophylactic vaccination and inoculation against streptococcus pneumoniae [pneumococcus] and influenza secondary malignant neoplasm of other digestive organs and spleen malignant ascites
white f 74 $nan$nan$sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  40  mg ; cepastat (phenol) lozenge  1  loz ; chloraseptic throat spray  1  spry ; diphenhydramine  25  mg ; levothyroxine sodium  100  mcg ; citalopram  10  mg ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   5-10  mg ; 
acute posthemorrhagic anemia secondary malignant neoplasm of other specified sites unspecified pleural effusion secondary malignant neoplasm of large intestine and rectum pulmonary collapse secondary malignant neoplasm of retroperitoneum and peritoneum hypovolemia secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes heartburn unspecified acquired hypothyroidism malignant neoplasm of liver, secondary hypopotassemia malignant neoplasm of ovary need for prophylactic vaccination and inoculation against streptococcus pneumoniae [pneumococcus] and influenza secondary malignant neoplasm of other digestive organs and spleen malignant ascites
white f 45 $nan$hematology blood hematocrit  30.5  %; hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  577  k ul; hematology blood platelet count  591  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  69  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; doxycycline hyclate  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  2  mg ; zolpidem tartrate  5  mg ; lorazepam  0.25  mg ; 
 
white f 45 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  642  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; doxycycline hyclate  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; hydromorphone (dilaudid)  2  mg ; zolpidem tartrate  5  mg ; lorazepam  0.25  mg ; 
 
white f 45 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  659  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; doxycycline hyclate  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; zolpidem tartrate  5  mg ; lorazepam  0.25  mg ; 
 
white f 45 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  588  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; doxycycline hyclate  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; zolpidem tartrate  5  mg ; lorazepam  0.25  mg ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; levofloxacin  750  mg ; 
 
white f 45 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  556  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; zolpidem tartrate  5  mg ; lorazepam  0.25  mg ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; levofloxacin  750  mg ; ciprofloxacin hcl  500  mg ; 
 
white f 45 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; zolpidem tartrate  5  mg ; lorazepam  0.25  mg ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; ciprofloxacin hcl  500  mg ; 
 
white f 33 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  80  mg dl$0.9% sodium chloride  1000  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; potassium chloride  60  meq ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; heparin  5000  unit ; 
 
white f 33 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  72  mg dl; chemistry blood lactate dehydrogenase (ld)  123  iu l$ondansetron  4  mg ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; acetaminophen  500-1000  mg ; 
 
black african american f 84 $temp  98.0  heartrate  72.0  resprate  18.0  o2sat  98.0  sbp  112.0  dbp  70.0  rhythm    pain  0  $hematology blood hematocrit  36.4  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  50  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; d5 1 2ns  1000  ml ; carvedilol  25  mg ; insulin  26  unit ; aspirin  81  mg ; warfarin  2.5  mg ; hydralazine  10  mg ; atorvastatin  80  mg ; senna  17.2  mg ; 
thrombocytopenia, unspecified long term (current) use of insulin anemia, unspecified type 2 diabetes mellitus without complications obesity, unspecified body mass index (bmi) 31.0-31.9, adult chronic kidney disease, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease epigastric pain gastrointestinal hemorrhage, unspecified gastro-esophageal reflux disease without esophagitis chronic diastolic (congestive) heart failure obstructive sleep apnea (adult) (pediatric) paroxysmal atrial fibrillation long term (current) use of anticoagulants 
black african american f 84 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  242  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; carvedilol  25  mg ; insulin  26  unit ; aspirin  81  mg ; atorvastatin  80  mg ; senna  17.2  mg ; sodium chloride 0.9%  1000  ml ; 
thrombocytopenia, unspecified long term (current) use of insulin anemia, unspecified type 2 diabetes mellitus without complications obesity, unspecified body mass index (bmi) 31.0-31.9, adult chronic kidney disease, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease epigastric pain gastrointestinal hemorrhage, unspecified gastro-esophageal reflux disease without esophagitis chronic diastolic (congestive) heart failure obstructive sleep apnea (adult) (pediatric) paroxysmal atrial fibrillation long term (current) use of anticoagulants 
black african american f 84 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  127  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; carvedilol  25  mg ; insulin  26  unit ; aspirin  81  mg ; atorvastatin  80  mg ; senna  17.2  mg ; torsemide  20  mg ; nitroglycerin sl  0.3  mg ; 
thrombocytopenia, unspecified long term (current) use of insulin anemia, unspecified type 2 diabetes mellitus without complications obesity, unspecified body mass index (bmi) 31.0-31.9, adult chronic kidney disease, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease epigastric pain gastrointestinal hemorrhage, unspecified gastro-esophageal reflux disease without esophagitis chronic diastolic (congestive) heart failure obstructive sleep apnea (adult) (pediatric) paroxysmal atrial fibrillation long term (current) use of anticoagulants 
black african american f 84 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  58  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; carvedilol  25  mg ; insulin  26  unit ; aspirin  81  mg ; atorvastatin  80  mg ; senna  17.2  mg ; nitroglycerin sl  0.3  mg ; clopidogrel  600  mg ; aspirin  325  mg ; 
thrombocytopenia, unspecified long term (current) use of insulin anemia, unspecified type 2 diabetes mellitus without complications obesity, unspecified body mass index (bmi) 31.0-31.9, adult chronic kidney disease, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease epigastric pain gastrointestinal hemorrhage, unspecified gastro-esophageal reflux disease without esophagitis chronic diastolic (congestive) heart failure obstructive sleep apnea (adult) (pediatric) paroxysmal atrial fibrillation long term (current) use of anticoagulants 
black african american f 84 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  130  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; carvedilol  25  mg ; insulin  26  unit ; aspirin  81  mg ; atorvastatin  80  mg ; senna  17.2  mg ; nitroglycerin sl  0.3  mg ; clopidogrel  75  mg ; torsemide  40  mg ; potassium chloride  40  meq ; magnesium oxide  400  mg ; 
thrombocytopenia, unspecified long term (current) use of insulin anemia, unspecified type 2 diabetes mellitus without complications obesity, unspecified body mass index (bmi) 31.0-31.9, adult chronic kidney disease, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease epigastric pain gastrointestinal hemorrhage, unspecified gastro-esophageal reflux disease without esophagitis chronic diastolic (congestive) heart failure obstructive sleep apnea (adult) (pediatric) paroxysmal atrial fibrillation long term (current) use of anticoagulants 
black african american f 84 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; carvedilol  25  mg ; insulin  26  unit ; aspirin  81  mg ; atorvastatin  80  mg ; senna  17.2  mg ; nitroglycerin sl  0.3  mg ; clopidogrel  75  mg ; torsemide  40  mg ; potassium chloride  40  meq ; magnesium oxide  400  mg ; 
thrombocytopenia, unspecified long term (current) use of insulin anemia, unspecified type 2 diabetes mellitus without complications obesity, unspecified body mass index (bmi) 31.0-31.9, adult chronic kidney disease, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease epigastric pain gastrointestinal hemorrhage, unspecified gastro-esophageal reflux disease without esophagitis chronic diastolic (congestive) heart failure obstructive sleep apnea (adult) (pediatric) paroxysmal atrial fibrillation long term (current) use of anticoagulants 
white f 60 $nan$nan$citalopram hydrobromide  80  mg ; furosemide  80  mg ; spironolactone  50  mg ; 
 
white f 60 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  42  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  105  mg dl; chemistry blood albumin  3.2  g dl$citalopram hydrobromide  80  mg ; furosemide  80  mg ; spironolactone  50  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  100  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  500  mg ; heparin  5000  unit ; oxycodone (immediate release)   10-15  mg ; oxycodone (immediate release)   5-10  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; miconazole powder 2%  1  appl ; spironolactone  100  mg ; gabapentin  300  mg ; 
 
white f 60 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  50  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  110  mg dl; chemistry blood albumin  3.2  g dl$citalopram hydrobromide  80  mg ; furosemide  80  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  100  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  500  mg ; heparin  5000  unit ; oxycodone (immediate release)   5-10  mg ; miconazole powder 2%  1  appl ; spironolactone  100  mg ; gabapentin  300  mg ; clindamycin  300  mg ; sarna lotion  1  appl ; triamcinolone acetonide 0.1% cream  1  appl ; 
 
white f 60 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  46  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  85  mg dl$citalopram hydrobromide  80  mg ; furosemide  80  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  100  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  500  mg ; heparin  5000  unit ; oxycodone (immediate release)   5-10  mg ; miconazole powder 2%  1  appl ; spironolactone  100  mg ; gabapentin  300  mg ; clindamycin  300  mg ; triamcinolone acetonide 0.1% cream  1  appl ; potassium chloride  40  meq ; 
 
white f 60 $nan$nan$citalopram hydrobromide  80  mg ; furosemide  80  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  100  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  500  mg ; heparin  5000  unit ; oxycodone (immediate release)   5-10  mg ; miconazole powder 2%  1  appl ; spironolactone  100  mg ; gabapentin  300  mg ; clindamycin  300  mg ; triamcinolone acetonide 0.1% cream  1  appl ; potassium chloride  40  meq ; 
 
white f 76 $nan$hematology blood hematocrit  35.4  %; hematology blood hematocrit  36.6  %; hematology blood hematocrit  35.0  %; hematology blood hemoglobin  12.3  g dl; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  211  k ul; hematology blood platelet count  236  k ul; hematology blood platelet count  226  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  231  mg dl; chemistry blood glucose  175  mg dl; chemistry blood glucose  168  mg dl; chemistry blood glucose  112  mg dl; hematology blood bands  2  %; hematology blood bands  0  %; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood glucose  172  mg dl$iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; famotidine  20  mg ; propofol  1000  mg ; propofol  200  mg ; lactated ringers  1000  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; insulin  0  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; insulin human regular  1-10  units ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; 
 
white f 76 $nan$hematology blood hematocrit  34.6  %; hematology blood hematocrit  30.2  %; hematology blood hematocrit  29.3  %; hematology blood hematocrit  28.6  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  227  k ul; hematology blood platelet count  176  k ul; hematology blood platelet count  175  k ul; hematology blood platelet count  156  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood potassium  5.3  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  166  mg dl; chemistry blood glucose  234  mg dl; chemistry blood glucose  197  mg dl; chemistry blood glucose  160  mg dl; blood gas blood lactate  2.1  mmol l; blood gas blood glucose  156  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; propofol  1000  mg ; propofol  200  mg ; lactated ringers  1000  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; hydromorphone (dilaudid)  20  mg ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; sodium chloride 0.9%  1000  ml ; d5 1 2ns  1000  ml ; iso-osmotic sodium chloride  1  bag ; metoprolol tartrate  6.25  mg ; 
 
white f 76 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  20  mg ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; iso-osmotic sodium chloride  1  bag ; metoprolol tartrate  6.25  mg ; aspirin  81  mg ; metoprolol tartrate  12.5  mg ; enoxaparin sodium  40  mg ; 
 
white f 76 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  20  mg ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; iso-osmotic sodium chloride  1  bag ; aspirin  81  mg ; metoprolol tartrate  12.5  mg ; enoxaparin sodium  40  mg ; neutra-phos  1  pkt ; furosemide  20  mg ; 
 
white f 76 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  20  mg ; acetaminophen  325-650  mg ; iso-osmotic sodium chloride  1  bag ; aspirin  81  mg ; enoxaparin sodium  40  mg ; neutra-phos  1  pkt ; furosemide  20  mg ; metoprolol succinate xl  50  mg ; amlodipine  2.5  mg ; losartan potassium  100  mg ; hydrochlorothiazide  12.5  mg ; glyburide  5  mg ; metformin xr (glucophage xr)  1000  mg ; ibuprofen  400  mg ; hydromorphone (dilaudid)  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; pravastatin  80  mg ; 
 
white f 76 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; iso-osmotic sodium chloride  1  bag ; aspirin  81  mg ; enoxaparin sodium  40  mg ; metoprolol succinate xl  50  mg ; amlodipine  2.5  mg ; losartan potassium  100  mg ; hydrochlorothiazide  12.5  mg ; glyburide  5  mg ; metformin xr (glucophage xr)  1000  mg ; ibuprofen  400  mg ; hydromorphone (dilaudid)  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; pravastatin  80  mg ; magnesium oxide  400  mg ; 
 
white f 76 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; iso-osmotic sodium chloride  1  bag ; aspirin  81  mg ; enoxaparin sodium  40  mg ; metoprolol succinate xl  50  mg ; amlodipine  2.5  mg ; losartan potassium  100  mg ; hydrochlorothiazide  12.5  mg ; glyburide  5  mg ; metformin xr (glucophage xr)  1000  mg ; ibuprofen  400  mg ; hydromorphone (dilaudid)  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; pravastatin  80  mg ; magnesium oxide  400  mg ; 
 
white f 76 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; iso-osmotic sodium chloride  1  bag ; aspirin  81  mg ; enoxaparin sodium  40  mg ; metoprolol succinate xl  50  mg ; amlodipine  2.5  mg ; losartan potassium  100  mg ; hydrochlorothiazide  12.5  mg ; glyburide  5  mg ; metformin xr (glucophage xr)  1000  mg ; ibuprofen  400  mg ; hydromorphone (dilaudid)  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; pravastatin  80  mg ; 
 
white f 22 $nan$nan$docusate sodium  100  mg ; chlorhexidine gluconate 0.12% oral rinse  30  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2-4  mg ; oxycodone-acetaminophen  1-2  tab ; ondansetron  4  mg ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; 
closed fracture of sacrum and coccyx without mention of spinal cord injury alcohol abuse, unspecified accidental fall from or out of building or other structure lipomatosis, not elsewhere classified closed fracture of malar and maxillary bones closed fracture of pubis closed fracture of orbital floor (blow-out) 
white m 75 $nan$hematology blood hematocrit  48.1  %; hematology blood hemoglobin  16.3  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood glucose  94  mg dl$nan
 
white f 63 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  332  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  6.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  268  mg dl; hematology blood bands  0  %; blood gas blood potassium, whole blood  4.7  meq l$nan
 
white f 63 $nan$hematology blood hematocrit  34.2  %; hematology blood hematocrit  31.4  %; hematology blood hematocrit  32.4  %; hematology blood hemoglobin  11.4  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  315  k ul; hematology blood platelet count  303  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  4.1  mg dl; chemistry blood creatinine  4.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  6-10  # hpf; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  330  mg dl; chemistry blood glucose  466  mg dl; chemistry blood lactate dehydrogenase (ld)  209  iu l; blood gas blood lactate  1.6  mmol l; hematology urine glucose  1000  mg dl; blood gas blood calculated bicarbonate, whole blood  36  meq l; hematology urine bilirubin  neg  mg dl$influenza virus vaccine  0.5  ml ; d5w  250  ml ; nitroglycerin  100  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; vancomycin  1000  mg ; haloperidol  0.5  mg ; lorazepam  1  mg ; d5w  200  ml ; labetalol  200  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; insulin  12  unit ; d5w  100  ml ; acyclovir  700  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; ns  100  ml ; insulin human regular  100  unit ; acetaminophen  325-650  mg ; labetalol  600  mg ; haloperidol  1  mg ; insulin  0  unit ; lorazepam  0.5  mg ; metoprolol  25  mg ; 
 
white f 63 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  135  mg dl; chemistry blood albumin  3.1  g dl$influenza virus vaccine  0.5  ml ; d5w  250  ml ; nitroglycerin  100  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; vancomycin  1000  mg ; haloperidol  0.5  mg ; lorazepam  1  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; insulin  12  unit ; d5w  100  ml ; acyclovir  700  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; ns  100  ml ; insulin human regular  100  unit ; acetaminophen  325-650  mg ; labetalol  600  mg ; haloperidol  1  mg ; lorazepam  0.5  mg ; metoprolol  25  mg ; dextrose 50%  25  gm ; ns  250  ml ; phenytoin sodium  1000  mg ; metoprolol  12.5  mg ; phenytoin  100  mg ; heparin flush cvl  (100 units ml)  1  ml ; 
 
white f 63 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  5.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  126  mg dl$influenza virus vaccine  0.5  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; d5w  100  ml ; acyclovir  700  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; ns  100  ml ; insulin human regular  100  unit ; acetaminophen  325-650  mg ; haloperidol  1  mg ; dextrose 50%  25  gm ; ns  250  ml ; phenytoin sodium  1000  mg ; phenytoin  100  mg ; heparin flush cvl  (100 units ml)  1  ml ; haloperidol  3  mg ; labetalol  10  mg ; d5w  1000  ml ; pantoprazole  40  mg ; 
 
white f 63 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  4.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  121  mg dl$influenza virus vaccine  0.5  ml ; d5w  100  ml ; acyclovir  700  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; ns  100  ml ; insulin human regular  100  unit ; acetaminophen  325-650  mg ; haloperidol  1  mg ; phenytoin  100  mg ; heparin flush cvl  (100 units ml)  1  ml ; labetalol  10  mg ; d5w  1000  ml ; pantoprazole  40  mg ; d5w  500  ml ; insulin  6  unit ; lansoprazole oral disintegrating tab  30  mg ; phenytoin  400  mg ; 
 
white f 63 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  326  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  5.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood glucose  92  mg dl$iso-osmotic dextrose  200  ml ; influenza virus vaccine  0.5  ml ; d5w  100  ml ; acyclovir  700  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; ns  100  ml ; insulin human regular  100  unit ; acetaminophen  325-650  mg ; haloperidol  1  mg ; phenytoin  100  mg ; heparin flush cvl  (100 units ml)  1  ml ; pantoprazole  40  mg ; d5w  500  ml ; insulin  6  unit ; lansoprazole oral disintegrating tab  30  mg ; phenytoin  400  mg ; dipyridamole-aspirin  1  cap ; metoprolol  37.5  mg ; labetalol  100  mg ; nitroglycerin ointment  2%  0.5  in ; insulin  10  unit ; 
 
white f 63 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  440  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  5.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood glucose  92  mg dl$iso-osmotic dextrose  200  ml ; influenza virus vaccine  0.5  ml ; d5w  100  ml ; acyclovir  700  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; acetaminophen  325-650  mg ; phenytoin  100  mg ; heparin flush cvl  (100 units ml)  1  ml ; lansoprazole oral disintegrating tab  30  mg ; dipyridamole-aspirin  1  cap ; metoprolol  37.5  mg ; labetalol  100  mg ; nitroglycerin ointment  2%  0.5  in ; insulin  10  unit ; metoprolol  5  mg ; nitroglycerin ointment  2%  1  in ; phenytoin sodium  100  mg ; hydralazine  10  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; d5w  150  ml ; vancomycin  500  mg ; 
 
white f 63 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  407  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  4.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  83  mg dl$iso-osmotic dextrose  200  ml ; influenza virus vaccine  0.5  ml ; d5w  100  ml ; acyclovir  700  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; acetaminophen  325-650  mg ; heparin flush cvl  (100 units ml)  1  ml ; lansoprazole oral disintegrating tab  30  mg ; dipyridamole-aspirin  1  cap ; metoprolol  37.5  mg ; insulin  10  unit ; metoprolol  5  mg ; nitroglycerin ointment  2%  1  in ; phenytoin sodium  100  mg ; hydralazine  10  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; d5w  150  ml ; vancomycin  500  mg ; ceftriaxone  1  gm ; phenytoin sodium  500  mg ; 
 
white f 63 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  451  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  4.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  103  mg dl$iso-osmotic dextrose  200  ml ; influenza virus vaccine  0.5  ml ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; acetaminophen  325-650  mg ; heparin flush cvl  (100 units ml)  1  ml ; lansoprazole oral disintegrating tab  30  mg ; dipyridamole-aspirin  1  cap ; metoprolol  37.5  mg ; insulin  10  unit ; metoprolol  5  mg ; phenytoin sodium  100  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; ceftriaxone  1  gm ; phenytoin sodium  500  mg ; 
 
white f 63 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  505  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  92  mg dl; chemistry blood albumin  3.2  g dl$iso-osmotic dextrose  200  ml ; influenza virus vaccine  0.5  ml ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; acetaminophen  325-650  mg ; heparin flush cvl  (100 units ml)  1  ml ; dipyridamole-aspirin  1  cap ; metoprolol  37.5  mg ; insulin  10  unit ; metoprolol  5  mg ; phenytoin sodium  100  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; ceftriaxone  1  gm ; aspirin  325  mg ; golytely  4  l ; 
 
white f 63 $nan$hematology blood hematocrit  27.4  %; hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  519  k ul; hematology blood platelet count  510  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  4.5  mg dl; chemistry blood creatinine  4.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  72  mg dl; chemistry blood glucose  104  mg dl$iso-osmotic dextrose  200  ml ; influenza virus vaccine  0.5  ml ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; acetaminophen  325-650  mg ; heparin flush cvl  (100 units ml)  1  ml ; dipyridamole-aspirin  1  cap ; metoprolol  37.5  mg ; insulin  10  unit ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; ceftriaxone  1  gm ; aspirin  325  mg ; 
 
white f 63 $nan$nan$iso-osmotic dextrose  200  ml ; influenza virus vaccine  0.5  ml ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; acetaminophen  325-650  mg ; heparin flush cvl  (100 units ml)  1  ml ; dipyridamole-aspirin  1  cap ; metoprolol  37.5  mg ; insulin  10  unit ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; ceftriaxone  1  gm ; aspirin  325  mg ; heparin  5000  unit ; 
 
white f 61 $nan$hematology blood hematocrit  29.4  %; hematology blood hematocrit  27.4  %; hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  253  k ul; hematology blood platelet count  252  k ul; hematology blood platelet count  270  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, indirect  3.7  mg dl; chemistry blood bilirubin, total  3.7  mg dl; chemistry blood bilirubin, total  5.8  mg dl; chemistry blood bilirubin, total  3.7  mg dl; chemistry blood glucose  150  mg dl; chemistry blood glucose  151  mg dl; chemistry blood glucose  143  mg dl; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  2.0  mmol l; chemistry blood bilirubin, direct  2.1  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.45% sodium chloride  1000  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  0.25-1  mg ; lorazepam  0.5  mg ; vial  1  vial ; pantoprazole  40  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; bag  1  bag ; magnesium sulfate  2  gm ; lactulose enema  1000  ml ; syringe  0.2  ml ; folic acid  1  mg ; 5% dextrose  50  ml ; thiamine  100  mg ; 
 
white f 61 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood calcium, total  10.3  mg dl; chemistry blood bilirubin, indirect  1.4  mg dl; chemistry blood bilirubin, total  3.3  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  149  mg dl; chemistry blood albumin  3.5  g dl; blood gas blood lactate  1.9  mmol l; chemistry blood bilirubin, direct  1.9  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  0.25-1  mg ; lorazepam  0.5  mg ; vial  1  vial ; pantoprazole  40  mg ; bag  1  bag ; magnesium sulfate  2  gm ; lactulose enema  1000  ml ; syringe  0.2  ml ; folic acid  1  mg ; 5% dextrose  50  ml ; thiamine  100  mg ; sodium chloride 0.9%  1000  ml ; fentanyl citrate  12.5-25  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; propofol  1000  mg ; propofol  200  mg ; albumin 5% (12.5g   250ml)  12.5  g ; metoprolol tartrate  5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; clotrimazole cream  1  appl ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; 
 
white f 61 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  118  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.0  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  10.4  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood bilirubin, indirect  0.7  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  142  mg dl; chemistry blood glucose  113  mg dl; chemistry blood bilirubin, direct  1.1  mg dl$dextrose 5%  1000  ml ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  0.25-1  mg ; lorazepam  0.5  mg ; vial  1  vial ; pantoprazole  40  mg ; syringe  0.2  ml ; folic acid  1  mg ; 5% dextrose  50  ml ; thiamine  100  mg ; fentanyl citrate  12.5-25  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; metoprolol tartrate  5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; lactulose  30  ml ; nystatin oral suspension  5  ml ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; neutra-phos  1  pkt ; 
 
white f 61 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood bilirubin, indirect  0.6  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  94  mg dl; chemistry blood bilirubin, direct  0.7  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  0.25-1  mg ; lorazepam  0.5  mg ; vial  1  vial ; pantoprazole  40  mg ; syringe  0.2  ml ; folic acid  1  mg ; fentanyl citrate  12.5-25  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; nystatin oral suspension  5  ml ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; furosemide  20  mg ; spironolactone  25  mg ; 
 
white f 61 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  98  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  0.25-1  mg ; lorazepam  0.5  mg ; vial  1  vial ; pantoprazole  40  mg ; nystatin oral suspension  5  ml ; furosemide  20  mg ; spironolactone  25  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; amoxicillin-clavulanic acid  875  mg ; 
 
white f 61 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  0.25-1  mg ; lorazepam  0.5  mg ; vial  1  vial ; pantoprazole  40  mg ; nystatin oral suspension  5  ml ; furosemide  20  mg ; spironolactone  25  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; amoxicillin-clavulanic acid  875  mg ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; 
 
white m 81 $nan$nan$atorvastatin  80  mg ; furosemide  80  mg ; omeprazole  40  mg ; glipizide xl  5  mg ; levothyroxine sodium  100  mcg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (250 50)   1  inh ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; nitroglycerin sl  0.4  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; 
coronary atherosclerosis of native coronary artery chronic systolic heart failure atrial fibrillation escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site coronary atherosclerosis of artery bypass graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled fitting and adjustment of other cardiac device subendocardial infarction, initial episode of care hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified chronic kidney disease, unspecified congestive heart failure, unspecified urinary tract infection, site not specified coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation other specified forms of chronic ischemic heart disease aortocoronary bypass status atrial fibrillation automatic implantable cardiac defibrillator in situ diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled rheumatoid arthritis other specified forms of chronic ischemic heart disease cardiac pacemaker in situ coronary atherosclerosis of native coronary artery congestive heart failure, unspecified coronary atherosclerosis of native coronary artery atrial fibrillation automatic implantable cardiac defibrillator in situ chronic combined systolic and diastolic heart failure other chronic pulmonary heart diseases other and unspecified angina pectoris other specified forms of chronic ischemic heart disease automatic implantable cardiac defibrillator in situ coronary atherosclerosis of native coronary artery other primary cardiomyopathies rheumatoid arthritis coronary atherosclerosis of autologous vein bypass graft 
white m 81 $nan$hematology blood hematocrit  32.1  %; hematology blood platelet count  222  k ul; hematology blood platelet count  217  k ul; chemistry blood chloride  102  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.4  $atorvastatin  80  mg ; furosemide  80  mg ; omeprazole  40  mg ; glipizide xl  5  mg ; levothyroxine sodium  100  mcg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (250 50)   1  inh ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; nitroglycerin sl  0.4  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; temazepam  15  mg ; 0.45% sodium chloride  1000  ml ; insulin  0  unit ; ranitidine  300  mg ; warfarin  5  mg ; carvedilol  25  mg ; clopidogrel  75  mg ; aspirin  81  mg ; 
coronary atherosclerosis of native coronary artery chronic systolic heart failure atrial fibrillation escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site coronary atherosclerosis of artery bypass graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled fitting and adjustment of other cardiac device subendocardial infarction, initial episode of care hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified chronic kidney disease, unspecified congestive heart failure, unspecified urinary tract infection, site not specified coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial fibrillation other specified forms of chronic ischemic heart disease aortocoronary bypass status atrial fibrillation automatic implantable cardiac defibrillator in situ diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled rheumatoid arthritis other specified forms of chronic ischemic heart disease cardiac pacemaker in situ coronary atherosclerosis of native coronary artery congestive heart failure, unspecified coronary atherosclerosis of native coronary artery atrial fibrillation automatic implantable cardiac defibrillator in situ chronic combined systolic and diastolic heart failure other chronic pulmonary heart diseases other and unspecified angina pectoris other specified forms of chronic ischemic heart disease automatic implantable cardiac defibrillator in situ coronary atherosclerosis of native coronary artery other primary cardiomyopathies rheumatoid arthritis coronary atherosclerosis of autologous vein bypass graft 
white f 46 $nan$nan$levothyroxine sodium  100  mcg ; levothyroxine sodium  75  mcg ; multivitamins  1  cap ; escitalopram oxalate  10  mg ; 
 
white f 46 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  146  mg dl; chemistry blood albumin  4.0  g dl$levothyroxine sodium  100  mcg ; levothyroxine sodium  75  mcg ; multivitamins  1  cap ; escitalopram oxalate  10  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; acetaminophen  325-650  mg ; diphenhydramine  25  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; pantoprazole  40  mg ; milk of magnesia  30  ml ; lorazepam  0.5  mg ; hydrocodone-acetaminophen  1-2  tab ; sarna lotion  1  appl ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  gm ; 
 
white f 46 $nan$nan$levothyroxine sodium  100  mcg ; levothyroxine sodium  75  mcg ; multivitamins  1  cap ; escitalopram oxalate  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; diphenhydramine  25  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; pantoprazole  40  mg ; milk of magnesia  30  ml ; lorazepam  0.5  mg ; hydrocodone-acetaminophen  1-2  tab ; sarna lotion  1  appl ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  gm ; 
 
white f 67 $temp  98.0  heartrate  78.0  resprate  20.0  o2sat  93.0  sbp  110.0  dbp  60.0  rhythm    pain  0  $hematology blood hematocrit  38.3  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  295  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; levetiracetam  750  mg ; atenolol  25  mg ; clopidogrel  75  mg ; atorvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5-2  mg ; nicotine patch  14  mg ; insulin  0  unit ; bag  1  bag ; magnesium sulfate  2  gm ; aspirin  81  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
 
white f 67 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; atenolol  25  mg ; clopidogrel  75  mg ; atorvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5-2  mg ; nicotine patch  14  mg ; insulin  0  unit ; bag  1  bag ; magnesium sulfate  2  gm ; aspirin  81  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
 
white f 67 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  164  mg dl; chemistry blood % hemoglobin a1c  7.3  %$sodium chloride 0.9%  flush  3-10  ml ; atenolol  25  mg ; clopidogrel  75  mg ; atorvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5-2  mg ; nicotine patch  14  mg ; insulin  0  unit ; aspirin  81  mg ; vitamin d  1000  unit ; 
 
white f 67 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; atenolol  25  mg ; clopidogrel  75  mg ; atorvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5-2  mg ; nicotine patch  14  mg ; insulin  0  unit ; aspirin  81  mg ; vitamin d  1000  unit ; 
 
white m 64 $nan$nan$fludrocortisone acetate  0.1  mg ; 
tachycardia, unspecified examination of participant in clinical trial unspecified essential hypertension other and unspecified hyperlipidemia rash and other nonspecific skin eruption other acquired absence of organ diarrhea acute kidney failure, unspecified acquired absence of kidney disorders of magnesium metabolism secondary malignant neoplasm of other digestive organs and spleen glucocorticoid deficiency personal history of malignant neoplasm of kidney nausea alone encounter for antineoplastic immunotherapy anemia, unspecified secondary malignant neoplasm of other specified sites toxic encephalopathy gout, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] person on outside of bus injured in collision with pedestrian or animal in traffic accident hypotension, unspecified
white m 64 $nan$hematology blood hematocrit  41.4  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  732  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  124  mg dl; chemistry blood lactate dehydrogenase (ld)  236  iu l; chemistry blood albumin  4.0  g dl; chemistry blood albumin  3.2  g dl$fludrocortisone acetate  0.1  mg ; 5% dextrose  50  ml ; aldesleukin  53.6  million units ; 5% dextrose  500  ml ; heparin flush (10 units ml)  1  ml ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  250  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; naproxen  375  mg ; hydrocerin  1  appl ; sarna lotion  1  appl ; maalox diphenhydramine lidocaine  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; sterile water  150  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; ondansetron  8  mg ; phosphorus  500  mg ; hydrocortisone  20  mg ; hydrocortisone  5  mg ; morphine sr (ms contin)  15  mg ; oxycodone (immediate release)   5-10  mg ; ranitidine  150  mg ; cephalexin  500  mg ; 
tachycardia, unspecified examination of participant in clinical trial unspecified essential hypertension other and unspecified hyperlipidemia rash and other nonspecific skin eruption other acquired absence of organ diarrhea acute kidney failure, unspecified acquired absence of kidney disorders of magnesium metabolism secondary malignant neoplasm of other digestive organs and spleen glucocorticoid deficiency personal history of malignant neoplasm of kidney nausea alone encounter for antineoplastic immunotherapy anemia, unspecified secondary malignant neoplasm of other specified sites toxic encephalopathy gout, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] person on outside of bus injured in collision with pedestrian or animal in traffic accident hypotension, unspecified
white m 64 $nan$hematology blood hematocrit  40.9  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  532  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  110  mg dl; chemistry blood albumin  2.5  g dl$fludrocortisone acetate  0.1  mg ; 5% dextrose  50  ml ; aldesleukin  53.6  million units ; 5% dextrose  500  ml ; heparin flush (10 units ml)  1  ml ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  250  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; naproxen  375  mg ; hydrocerin  1  appl ; sarna lotion  1  appl ; maalox diphenhydramine lidocaine  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; sterile water  150  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; ondansetron  8  mg ; phosphorus  500  mg ; hydrocortisone  20  mg ; hydrocortisone  5  mg ; morphine sr (ms contin)  15  mg ; oxycodone (immediate release)   5-10  mg ; ranitidine  150  mg ; cephalexin  500  mg ; 
tachycardia, unspecified examination of participant in clinical trial unspecified essential hypertension other and unspecified hyperlipidemia rash and other nonspecific skin eruption other acquired absence of organ diarrhea acute kidney failure, unspecified acquired absence of kidney disorders of magnesium metabolism secondary malignant neoplasm of other digestive organs and spleen glucocorticoid deficiency personal history of malignant neoplasm of kidney nausea alone encounter for antineoplastic immunotherapy anemia, unspecified secondary malignant neoplasm of other specified sites toxic encephalopathy gout, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] person on outside of bus injured in collision with pedestrian or animal in traffic accident hypotension, unspecified
white m 64 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  481  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  129  mg dl; chemistry blood albumin  2.7  g dl$fludrocortisone acetate  0.1  mg ; 5% dextrose  50  ml ; aldesleukin  53.6  million units ; 5% dextrose  500  ml ; heparin flush (10 units ml)  1  ml ; 0.9% sodium chloride  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; naproxen  375  mg ; hydrocerin  1  appl ; sarna lotion  1  appl ; maalox diphenhydramine lidocaine  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; sterile water  150  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; ondansetron  8  mg ; phosphorus  500  mg ; hydrocortisone  20  mg ; hydrocortisone  5  mg ; morphine sr (ms contin)  15  mg ; oxycodone (immediate release)   5-10  mg ; ranitidine  150  mg ; cephalexin  500  mg ; 
tachycardia, unspecified examination of participant in clinical trial unspecified essential hypertension other and unspecified hyperlipidemia rash and other nonspecific skin eruption other acquired absence of organ diarrhea acute kidney failure, unspecified acquired absence of kidney disorders of magnesium metabolism secondary malignant neoplasm of other digestive organs and spleen glucocorticoid deficiency personal history of malignant neoplasm of kidney nausea alone encounter for antineoplastic immunotherapy anemia, unspecified secondary malignant neoplasm of other specified sites toxic encephalopathy gout, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] person on outside of bus injured in collision with pedestrian or animal in traffic accident hypotension, unspecified
white m 64 $nan$hematology blood hematocrit  38.6  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  440  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  105  mg dl; chemistry blood albumin  2.4  g dl$fludrocortisone acetate  0.1  mg ; 5% dextrose  50  ml ; aldesleukin  53.6  million units ; 5% dextrose  500  ml ; heparin flush (10 units ml)  1  ml ; 0.9% sodium chloride  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; naproxen  375  mg ; hydrocerin  1  appl ; sarna lotion  1  appl ; maalox diphenhydramine lidocaine  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; sterile water  150  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; ondansetron  8  mg ; phosphorus  500  mg ; hydrocortisone  20  mg ; hydrocortisone  5  mg ; morphine sr (ms contin)  15  mg ; oxycodone (immediate release)   5-10  mg ; ranitidine  150  mg ; cephalexin  500  mg ; simethicone  40-80  mg ; alteplase 1mg 1ml ( clearance ie. temp tlcl )  1  mg ; loperamide  2-4  mg ; 
tachycardia, unspecified examination of participant in clinical trial unspecified essential hypertension other and unspecified hyperlipidemia rash and other nonspecific skin eruption other acquired absence of organ diarrhea acute kidney failure, unspecified acquired absence of kidney disorders of magnesium metabolism secondary malignant neoplasm of other digestive organs and spleen glucocorticoid deficiency personal history of malignant neoplasm of kidney nausea alone encounter for antineoplastic immunotherapy anemia, unspecified secondary malignant neoplasm of other specified sites toxic encephalopathy gout, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] person on outside of bus injured in collision with pedestrian or animal in traffic accident hypotension, unspecified
white m 64 $nan$hematology blood hematocrit  38.7  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  287  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.4  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  131  mg dl; chemistry blood albumin  2.3  g dl; hematology blood bands  4  %$fludrocortisone acetate  0.1  mg ; 5% dextrose  50  ml ; aldesleukin  53.6  million units ; 5% dextrose  500  ml ; heparin flush (10 units ml)  1  ml ; 0.9% sodium chloride  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; naproxen  375  mg ; hydrocerin  1  appl ; sarna lotion  1  appl ; maalox diphenhydramine lidocaine  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; sterile water  150  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; ondansetron  8  mg ; phosphorus  500  mg ; hydrocortisone  20  mg ; hydrocortisone  5  mg ; morphine sr (ms contin)  15  mg ; oxycodone (immediate release)   5-10  mg ; ranitidine  150  mg ; cephalexin  500  mg ; simethicone  40-80  mg ; alteplase 1mg 1ml ( clearance ie. temp tlcl )  1  mg ; loperamide  2-4  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
tachycardia, unspecified examination of participant in clinical trial unspecified essential hypertension other and unspecified hyperlipidemia rash and other nonspecific skin eruption other acquired absence of organ diarrhea acute kidney failure, unspecified acquired absence of kidney disorders of magnesium metabolism secondary malignant neoplasm of other digestive organs and spleen glucocorticoid deficiency personal history of malignant neoplasm of kidney nausea alone encounter for antineoplastic immunotherapy anemia, unspecified secondary malignant neoplasm of other specified sites toxic encephalopathy gout, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] person on outside of bus injured in collision with pedestrian or animal in traffic accident hypotension, unspecified
white m 64 $nan$nan$fludrocortisone acetate  0.1  mg ; 5% dextrose  500  ml ; heparin flush (10 units ml)  1  ml ; 0.9% sodium chloride  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; naproxen  375  mg ; hydrocerin  1  appl ; sarna lotion  1  appl ; maalox diphenhydramine lidocaine  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; sterile water  150  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; ondansetron  8  mg ; phosphorus  500  mg ; hydrocortisone  20  mg ; hydrocortisone  5  mg ; morphine sr (ms contin)  15  mg ; oxycodone (immediate release)   5-10  mg ; ranitidine  150  mg ; cephalexin  500  mg ; simethicone  40-80  mg ; loperamide  2-4  mg ; furosemide  20  mg ; 
tachycardia, unspecified examination of participant in clinical trial unspecified essential hypertension other and unspecified hyperlipidemia rash and other nonspecific skin eruption other acquired absence of organ diarrhea acute kidney failure, unspecified acquired absence of kidney disorders of magnesium metabolism secondary malignant neoplasm of other digestive organs and spleen glucocorticoid deficiency personal history of malignant neoplasm of kidney nausea alone encounter for antineoplastic immunotherapy anemia, unspecified secondary malignant neoplasm of other specified sites toxic encephalopathy gout, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] person on outside of bus injured in collision with pedestrian or animal in traffic accident hypotension, unspecified
white m 64 $nan$nan$fludrocortisone acetate  0.1  mg ; 5% dextrose  500  ml ; heparin flush (10 units ml)  1  ml ; acetaminophen  975  mg ; lorazepam  0.5-1  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; naproxen  375  mg ; hydrocerin  1  appl ; sarna lotion  1  appl ; maalox diphenhydramine lidocaine  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; sterile water  150  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; ondansetron  8  mg ; phosphorus  500  mg ; hydrocortisone  20  mg ; hydrocortisone  5  mg ; morphine sr (ms contin)  15  mg ; oxycodone (immediate release)   5-10  mg ; ranitidine  150  mg ; cephalexin  500  mg ; simethicone  40-80  mg ; loperamide  2-4  mg ; furosemide  20  mg ; 
tachycardia, unspecified examination of participant in clinical trial unspecified essential hypertension other and unspecified hyperlipidemia rash and other nonspecific skin eruption other acquired absence of organ diarrhea acute kidney failure, unspecified acquired absence of kidney disorders of magnesium metabolism secondary malignant neoplasm of other digestive organs and spleen glucocorticoid deficiency personal history of malignant neoplasm of kidney nausea alone encounter for antineoplastic immunotherapy anemia, unspecified secondary malignant neoplasm of other specified sites toxic encephalopathy gout, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] person on outside of bus injured in collision with pedestrian or animal in traffic accident hypotension, unspecified
hispanic latino f 50 $temp  96.7  heartrate  69.0  resprate  18.0  o2sat  95.0  sbp  128.0  dbp  84.0  rhythm    pain  0  ; temp    heartrate  66.0  resprate  15.0  o2sat  97.0  sbp  133.0  dbp  83.0  rhythm    pain  6  ; temp  99.1  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp    heartrate  68.0  resprate  17.0  o2sat  94.0  sbp  134.0  dbp  87.0  rhythm    pain  4  $nan$levothyroxine sodium  125  mcg ; 
unspecified essential hypertension other specified cardiac dysrhythmias subendocardial infarction, initial episode of care unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery family history of ischemic heart disease person boarding or alighting a pedal cycle injured in collision with fixed or stationary object hypopotassemia
hispanic latino f 50 $nan$hematology blood hematocrit  38.8  %; hematology blood hematocrit  37.9  %; hematology blood hemoglobin  12.7  g dl; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  219  k ul; hematology blood platelet count  214  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  138  mg dl; chemistry blood lactate dehydrogenase (ld)  202  iu l; chemistry blood albumin  4.5  g dl$levothyroxine sodium  125  mcg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; amlodipine  5  mg ; aspirin  81  mg ; atorvastatin  80  mg ; metoprolol succinate xl  12.5  mg ; acetaminophen  650  mg ; 
unspecified essential hypertension other specified cardiac dysrhythmias subendocardial infarction, initial episode of care unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery family history of ischemic heart disease person boarding or alighting a pedal cycle injured in collision with fixed or stationary object hypopotassemia
hispanic latino f 50 $nan$nan$levothyroxine sodium  125  mcg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; amlodipine  5  mg ; aspirin  81  mg ; atorvastatin  80  mg ; acetaminophen  650  mg ; 
unspecified essential hypertension other specified cardiac dysrhythmias subendocardial infarction, initial episode of care unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery family history of ischemic heart disease person boarding or alighting a pedal cycle injured in collision with fixed or stationary object hypopotassemia
white f 74 $nan$hematology blood hematocrit  25.3  %; hematology blood hematocrit  23.6  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  85  mg dl; chemistry blood lactate dehydrogenase (ld)  339  iu l$docusate sodium  100  mg ; carbidopa-levodopa (25-100)  1  tab ; bupropion  75  mg ; disopyramide phosphate  150  mg ; metoprolol tartrate  50  mg ; disopyramide phosphate  100  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; quetiapine fumarate  100  mg ; guaifenesin  5-10  ml ; quetiapine fumarate  12.5  mg ; escitalopram oxalate  20  mg ; carbidopa-levodopa (25-100)  0.5  tab ; 
paralysis agitans unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders contusion of thigh mitral valve disorders car passenger injured in collision with van in traffic accident peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction atrial fibrillation unspecified fall dehydration knee joint replacement ulcerative colitis, unspecified acute kidney failure, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of anticoagulants anemia of other chronic disease hip joint replacement iron deficiency anemia, unspecified acute kidney failure, unspecified chronic kidney disease, unspecified unspecified fall unspecified gastritis and gastroduodenitis, without mention of hemorrhage other persistent mental disorders due to conditions classified elsewhere mitral valve disorders hyperpotassemia sprain of hand, unspecified site ulcerative colitis, unspecified long-term (current) use of anticoagulants paralysis agitans depressive disorder, not elsewhere classified other specified metabolic disorders car passenger injured in collision with van in traffic accident hip joint replacement knee joint replacement atrial fibrillation anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified cellulitis and abscess of face car passenger injured in collision with van in traffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage knee joint replacement mitral valve disorders chronic kidney disease, stage iii (moderate) hip joint replacement ulcerative colitis, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atrial fibrillation
white f 74 $nan$hematology blood hematocrit  31.0  %; hematology blood hematocrit  28.0  %; hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  203  k ul; hematology blood platelet count  215  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  75  mg dl$docusate sodium  100  mg ; bupropion  75  mg ; metoprolol tartrate  50  mg ; disopyramide phosphate  100  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; quetiapine fumarate  100  mg ; guaifenesin  5-10  ml ; quetiapine fumarate  12.5  mg ; escitalopram oxalate  20  mg ; carbidopa-levodopa (25-100)  0.5  tab ; diphenhydramine  12.5  mg ; albuterol 0.083% neb soln  1  neb ; furosemide  10  mg ; cyanocobalamin  250  mcg ; 
paralysis agitans unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders contusion of thigh mitral valve disorders car passenger injured in collision with van in traffic accident peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction atrial fibrillation unspecified fall dehydration knee joint replacement ulcerative colitis, unspecified acute kidney failure, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of anticoagulants anemia of other chronic disease hip joint replacement iron deficiency anemia, unspecified acute kidney failure, unspecified chronic kidney disease, unspecified unspecified fall unspecified gastritis and gastroduodenitis, without mention of hemorrhage other persistent mental disorders due to conditions classified elsewhere mitral valve disorders hyperpotassemia sprain of hand, unspecified site ulcerative colitis, unspecified long-term (current) use of anticoagulants paralysis agitans depressive disorder, not elsewhere classified other specified metabolic disorders car passenger injured in collision with van in traffic accident hip joint replacement knee joint replacement atrial fibrillation anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified cellulitis and abscess of face car passenger injured in collision with van in traffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage knee joint replacement mitral valve disorders chronic kidney disease, stage iii (moderate) hip joint replacement ulcerative colitis, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atrial fibrillation
white f 74 $nan$nan$docusate sodium  100  mg ; bupropion  75  mg ; metoprolol tartrate  50  mg ; disopyramide phosphate  100  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; quetiapine fumarate  100  mg ; guaifenesin  5-10  ml ; quetiapine fumarate  12.5  mg ; escitalopram oxalate  20  mg ; carbidopa-levodopa (25-100)  0.5  tab ; diphenhydramine  12.5  mg ; albuterol 0.083% neb soln  1  neb ; furosemide  10  mg ; cyanocobalamin  250  mcg ; 
paralysis agitans unspecified gastritis and gastroduodenitis, without mention of hemorrhage other specified metabolic disorders contusion of thigh mitral valve disorders car passenger injured in collision with van in traffic accident peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction atrial fibrillation unspecified fall dehydration knee joint replacement ulcerative colitis, unspecified acute kidney failure, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of anticoagulants anemia of other chronic disease hip joint replacement iron deficiency anemia, unspecified acute kidney failure, unspecified chronic kidney disease, unspecified unspecified fall unspecified gastritis and gastroduodenitis, without mention of hemorrhage other persistent mental disorders due to conditions classified elsewhere mitral valve disorders hyperpotassemia sprain of hand, unspecified site ulcerative colitis, unspecified long-term (current) use of anticoagulants paralysis agitans depressive disorder, not elsewhere classified other specified metabolic disorders car passenger injured in collision with van in traffic accident hip joint replacement knee joint replacement atrial fibrillation anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified cellulitis and abscess of face car passenger injured in collision with van in traffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage knee joint replacement mitral valve disorders chronic kidney disease, stage iii (moderate) hip joint replacement ulcerative colitis, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atrial fibrillation
white m 57 $nan$nan$ibuprofen  800  mg ; sodium chloride 0.9%  flush  3  ml ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  gm ; oxycodone-acetaminophen  1-2  tab ; cholestyramine  4  gm ; 
cellulitis and abscess of leg, except foot 
white m 57 $nan$hematology blood hematocrit  38.7  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  105  mg dl$ibuprofen  800  mg ; sodium chloride 0.9%  flush  3  ml ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  gm ; oxycodone-acetaminophen  1-2  tab ; cholestyramine  4  gm ; 
cellulitis and abscess of leg, except foot 
other m 70 $temp    heartrate  98.0  resprate  18.0  o2sat  98.0  sbp  157.0  dbp  87.0  rhythm    pain  0  $hematology blood hematocrit  46.9  %; hematology blood hematocrit  49.5  %; hematology blood hemoglobin  14.5  g dl; hematology blood hemoglobin  15.4  g dl; hematology blood platelet count  309  k ul; hematology blood platelet count  315  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry urine creatinine, urine  28  mg dl; chemistry urine sodium, urine  107  meq l; chemistry urine sodium, urine  51  meq l; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  186  mg dl; blood gas blood sodium, whole blood  130  meq l$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; influenza vaccine quadrivalent  0.5  ml ; hydrocortisone  20  mg ; levothyroxine sodium  75  mcg ; vitamin d  1000  unit ; calcium carbonate  500  mg ; hydrocortisone  40  mg ; hydrocortisone  5  mg ; hydrocortisone  10  mg ; 
essential (primary) hypertension long term (current) use of oral hypoglycemic drugs type 2 diabetes mellitus without complications other adrenocortical insufficiency hyperlipidemia, unspecified overdose of radiation given during therapy postprocedural hypothyroidism hypopituitarism syndrome of inappropriate secretion of antidiuretic hormone therapeutic (nonsurgical) and rehabilitative radiological devices associated with adverse incidents benign neoplasm of pituitary gland and craniopharyngeal duct unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
other m 70 $nan$hematology blood hematocrit  49.2  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  316  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  133  mg dl; chemistry blood glucose  174  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; influenza vaccine quadrivalent  0.5  ml ; levothyroxine sodium  75  mcg ; vitamin d  1000  unit ; calcium carbonate  500  mg ; hydrocortisone  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
essential (primary) hypertension long term (current) use of oral hypoglycemic drugs type 2 diabetes mellitus without complications other adrenocortical insufficiency hyperlipidemia, unspecified overdose of radiation given during therapy postprocedural hypothyroidism hypopituitarism syndrome of inappropriate secretion of antidiuretic hormone therapeutic (nonsurgical) and rehabilitative radiological devices associated with adverse incidents benign neoplasm of pituitary gland and craniopharyngeal duct unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
other m 70 $nan$hematology blood hematocrit  47.3  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  299  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  139  mg dl; chemistry blood glucose  174  mg dl$sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  17.2  mg ; influenza vaccine quadrivalent  0.5  ml ; levothyroxine sodium  75  mcg ; vitamin d  1000  unit ; calcium carbonate  500  mg ; hydrocortisone  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; dextrose 5%  1000  ml ; enalapril maleate  5  mg ; 
essential (primary) hypertension long term (current) use of oral hypoglycemic drugs type 2 diabetes mellitus without complications other adrenocortical insufficiency hyperlipidemia, unspecified overdose of radiation given during therapy postprocedural hypothyroidism hypopituitarism syndrome of inappropriate secretion of antidiuretic hormone therapeutic (nonsurgical) and rehabilitative radiological devices associated with adverse incidents benign neoplasm of pituitary gland and craniopharyngeal duct unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
other m 70 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  17.2  mg ; influenza vaccine quadrivalent  0.5  ml ; levothyroxine sodium  75  mcg ; vitamin d  1000  unit ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; cosyntropin  250  mcg ; 
essential (primary) hypertension long term (current) use of oral hypoglycemic drugs type 2 diabetes mellitus without complications other adrenocortical insufficiency hyperlipidemia, unspecified overdose of radiation given during therapy postprocedural hypothyroidism hypopituitarism syndrome of inappropriate secretion of antidiuretic hormone therapeutic (nonsurgical) and rehabilitative radiological devices associated with adverse incidents benign neoplasm of pituitary gland and craniopharyngeal duct unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white m 47 $nan$nan$atorvastatin  10  mg ; enalapril maleate  20  mg ; furosemide  20  mg ; aspirin  325  mg ; omeprazole  20  mg ; 
 
white m 47 $nan$hematology blood hematocrit  48.1  %; hematology blood hemoglobin  16.0  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  6.2  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.6  ; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  206  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$atorvastatin  10  mg ; enalapril maleate  20  mg ; furosemide  20  mg ; aspirin  325  mg ; omeprazole  20  mg ; senna  1  tab ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  800  mg ; zolpidem tartrate  10  mg ; lidocaine  100  mg ; acetaminophen  325-650  mg ; sodium polystyrene sulfonate  30  gm ; docusate sodium (liquid)  100  mg ; docusate sodium  100  mg ; heparin  5000  unit ; oxycodone-acetaminophen  2  tab ; d5w  500  ml ; lidocaine  2000  mg ; magnesium sulfate  2  gm ; metoprolol tartrate  5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; furosemide  40  mg ; lorazepam  1  mg ; lorazepam  2  mg ; fentanyl citrate  12.5-25  mcg ; lorazepam  1-2  mg ; 
 
white m 47 $nan$hematology blood hematocrit  43.2  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  109  mg dl$atorvastatin  10  mg ; enalapril maleate  20  mg ; furosemide  20  mg ; aspirin  325  mg ; omeprazole  20  mg ; senna  1  tab ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  800  mg ; zolpidem tartrate  10  mg ; lidocaine  100  mg ; acetaminophen  325-650  mg ; sodium polystyrene sulfonate  30  gm ; docusate sodium  100  mg ; heparin  5000  unit ; oxycodone-acetaminophen  2  tab ; magnesium sulfate  2  gm ; metoprolol tartrate  5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; furosemide  40  mg ; lorazepam  1  mg ; lorazepam  2  mg ; fentanyl citrate  12.5-25  mcg ; lorazepam  1-2  mg ; atropine sulfate  1  mg ; nicotine patch  21  mg ; potassium chloride  40  meq ; spironolactone  25  mg ; 
 
white m 47 $nan$nan$atorvastatin  10  mg ; enalapril maleate  20  mg ; furosemide  20  mg ; aspirin  325  mg ; omeprazole  20  mg ; senna  1  tab ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  800  mg ; zolpidem tartrate  10  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; fentanyl citrate  12.5-25  mcg ; lorazepam  1-2  mg ; nicotine patch  21  mg ; potassium chloride  40  meq ; spironolactone  25  mg ; metoprolol tartrate  25  mg ; 
 
white m 49 $nan$hematology blood hematocrit  40.4  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  311  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood glucose  108  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$nan
 
white m 59 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  206  mg dl; chemistry blood albumin  4.4  g dl$nan
personal history of malignant neoplasm of prostate diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) chronic pancreatitis other and unspecified alcohol dependence, in remission other chronic pain long-term (current) use of insulin acute pancreatitis acute pancreatitis chronic pancreatitis hypovolemia depressive disorder, not elsewhere classified iron deficiency anemia, unspecified long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled personal history of malignant neoplasm of prostate personal history of malignant neoplasm of prostate hematuria depressive disorder, not elsewhere classified chronic pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled backache, unspecified rectal prolapse urinary tract infection, site not specified malignant neoplasm of prostate chronic pancreatitis person boarding or alighting a car injured in collision with railway train or railway vehicle diverticulum of bladder long-term (current) use of insulin embolism and thrombosis of other specified artery other nonspecific findings on examination of urine varices of other sites calculus of kidney other specified disorders of pancreatic internal secretion arthrodesis status alcohol abuse, in remission backache, unspecified other specified disorders of pancreatic internal secretion other specified diseases of pancreas arthrodesis status diarrhea person boarding or alighting a car injured in collision with railway train or railway vehicle rectal prolapse acute pancreatitis chronic pancreatitis malignant neoplasm of prostate long-term (current) use of insulin hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts)
white m 59 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  86  mg dl$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; d5ns  1000  ml ; ondansetron odt  8  mg ; pantoprazole  40  mg ; morphine sulfate  2-4  mg ; gabapentin  300  mg ; azithromycin  250  mg ; hydromorphone (dilaudid)  0.5-1  mg ; dextrose 50%  25  gm ; insulin  0  unit ; ciprofloxacin hcl  500  mg ; ciprofloxacin 0.3% ophth soln  3  drop ; pancrease mt 16  2  cap ; heparin  5000  unit ; insulin  25  unit ; potassium chl 40 meq   1000 ml ns  1000  ml ; sw  50  ml ; magnesium sulfate  2  gm ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; dextrose 50%  12.5  gm ; sertraline  100  mg ; hydromorphone (dilaudid)  2  mg ; acetaminophen  325-650  mg ; potassium chloride  60  meq ; insulin  8  unit ; 
personal history of malignant neoplasm of prostate diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) chronic pancreatitis other and unspecified alcohol dependence, in remission other chronic pain long-term (current) use of insulin acute pancreatitis acute pancreatitis chronic pancreatitis hypovolemia depressive disorder, not elsewhere classified iron deficiency anemia, unspecified long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled personal history of malignant neoplasm of prostate personal history of malignant neoplasm of prostate hematuria depressive disorder, not elsewhere classified chronic pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled backache, unspecified rectal prolapse urinary tract infection, site not specified malignant neoplasm of prostate chronic pancreatitis person boarding or alighting a car injured in collision with railway train or railway vehicle diverticulum of bladder long-term (current) use of insulin embolism and thrombosis of other specified artery other nonspecific findings on examination of urine varices of other sites calculus of kidney other specified disorders of pancreatic internal secretion arthrodesis status alcohol abuse, in remission backache, unspecified other specified disorders of pancreatic internal secretion other specified diseases of pancreas arthrodesis status diarrhea person boarding or alighting a car injured in collision with railway train or railway vehicle rectal prolapse acute pancreatitis chronic pancreatitis malignant neoplasm of prostate long-term (current) use of insulin hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts)
white m 77 $temp  98.6  heartrate  66.0  resprate  18.0  o2sat  98.0  sbp  161.0  dbp  76.0  rhythm    pain  0  $hematology blood hematocrit  40.9  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  194  mg dl; chemistry blood lactate dehydrogenase (ld)  220  iu l$sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; apixaban  5  mg ; bupropion (sustained release)  150  mg ; docusate sodium  100  mg ; timolol maleate 0.5%  1  drop ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; donepezil  5  mg ; ns  100  ml ; metronidazole  500  mg ; vial  1  vial ; cefepime  1  g ; simvastatin  20  mg ; vitamin d  2000  unit ; nicotine lozenge  2  mg ; 
esophageal reflux chronic kidney disease, stage iii (moderate) alcohol abuse, unspecified obstructive sleep apnea (adult)(pediatric) personal history of malignant neoplasm of bronchus and lung chronic obstructive asthma, unspecified accidents occurring in residential institution other specified forms of hearing loss below knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation cardiac pacemaker in situ long-term (current) use of anticoagulants atherosclerosis of native arteries of the extremities with gangrene infection (chronic) of amputation stump amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of malignant neoplasm of other respiratory and intrathoracic organs diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits urinary tract infection, site not specified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia, unspecified other and unspecified hyperlipidemia polyneuropathy in diabetes nonspecific reaction to tuberculin skin test without active tuberculosis long-term (current) use of insulin tobacco use disorder accidents occurring in residential institution amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified nonspecific reaction to tuberculin skin test without active tuberculosis atrial fibrillation unspecified erythematous condition obstructive sleep apnea (adult)(pediatric) other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities, unspecified below knee amputation status chronic obstructive asthma, unspecified personal history of malignant neoplasm of other respiratory and intrathoracic organs depressive disorder, not elsewhere classified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tobacco use disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, stage iii (moderate) cardiac pacemaker in situ personal history of malignant neoplasm of bronchus and lung
white m 77 $nan$hematology blood hematocrit  39.6  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; apixaban  5  mg ; bupropion (sustained release)  150  mg ; docusate sodium  100  mg ; timolol maleate 0.5%  1  drop ; donepezil  5  mg ; vial  1  vial ; cefepime  1  g ; simvastatin  20  mg ; vitamin d  2000  unit ; nicotine lozenge  2  mg ; acetaminophen  650  mg ; divalproex (delayed release)  125  mg ; nicotine patch  7  mg day ; valproic acid  125  mg ; 
esophageal reflux chronic kidney disease, stage iii (moderate) alcohol abuse, unspecified obstructive sleep apnea (adult)(pediatric) personal history of malignant neoplasm of bronchus and lung chronic obstructive asthma, unspecified accidents occurring in residential institution other specified forms of hearing loss below knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation cardiac pacemaker in situ long-term (current) use of anticoagulants atherosclerosis of native arteries of the extremities with gangrene infection (chronic) of amputation stump amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of malignant neoplasm of other respiratory and intrathoracic organs diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits urinary tract infection, site not specified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia, unspecified other and unspecified hyperlipidemia polyneuropathy in diabetes nonspecific reaction to tuberculin skin test without active tuberculosis long-term (current) use of insulin tobacco use disorder accidents occurring in residential institution amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified nonspecific reaction to tuberculin skin test without active tuberculosis atrial fibrillation unspecified erythematous condition obstructive sleep apnea (adult)(pediatric) other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities, unspecified below knee amputation status chronic obstructive asthma, unspecified personal history of malignant neoplasm of other respiratory and intrathoracic organs depressive disorder, not elsewhere classified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tobacco use disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, stage iii (moderate) cardiac pacemaker in situ personal history of malignant neoplasm of bronchus and lung
white m 77 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; timolol maleate 0.5%  1  drop ; donepezil  5  mg ; simvastatin  20  mg ; vitamin d  2000  unit ; nicotine lozenge  2  mg ; acetaminophen  650  mg ; nicotine patch  7  mg day ; 
esophageal reflux chronic kidney disease, stage iii (moderate) alcohol abuse, unspecified obstructive sleep apnea (adult)(pediatric) personal history of malignant neoplasm of bronchus and lung chronic obstructive asthma, unspecified accidents occurring in residential institution other specified forms of hearing loss below knee amputation status diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation cardiac pacemaker in situ long-term (current) use of anticoagulants atherosclerosis of native arteries of the extremities with gangrene infection (chronic) of amputation stump amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of malignant neoplasm of other respiratory and intrathoracic organs diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits urinary tract infection, site not specified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia, unspecified other and unspecified hyperlipidemia polyneuropathy in diabetes nonspecific reaction to tuberculin skin test without active tuberculosis long-term (current) use of insulin tobacco use disorder accidents occurring in residential institution amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified nonspecific reaction to tuberculin skin test without active tuberculosis atrial fibrillation unspecified erythematous condition obstructive sleep apnea (adult)(pediatric) other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities, unspecified below knee amputation status chronic obstructive asthma, unspecified personal history of malignant neoplasm of other respiratory and intrathoracic organs depressive disorder, not elsewhere classified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tobacco use disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, stage iii (moderate) cardiac pacemaker in situ personal history of malignant neoplasm of bronchus and lung
white m 74 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  3.8  mg dl; chemistry blood glucose  63  mg dl; chemistry blood lactate dehydrogenase (ld)  147  iu l; chemistry blood albumin  2.8  g dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetylcysteine 20%  3-5  ml ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; colchicine  0.6  mg ; guaifenesin  5-10  ml ; acetaminophen  650  mg ; milk of magnesia  30  ml ; morphine sulfate  2-4  mg ; zolpidem tartrate  5  mg ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; omeprazole  20  mg ; probenecid  250  mg ; insulin  18  unit ; cyanocobalamin  500  mcg ; losartan potassium  25  mg ; methadone  5  mg ; 0.9% sodium chloride  1000  ml ; 
 
white m 74 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  163  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  3.0  mg dl; chemistry blood glucose  84  mg dl; chemistry blood albumin  2.4  g dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetylcysteine 20%  3-5  ml ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; colchicine  0.6  mg ; guaifenesin  5-10  ml ; acetaminophen  650  mg ; milk of magnesia  30  ml ; morphine sulfate  2-4  mg ; zolpidem tartrate  5  mg ; docusate sodium  100  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; omeprazole  20  mg ; probenecid  250  mg ; cyanocobalamin  500  mcg ; losartan potassium  25  mg ; methadone  5  mg ; 0.9% sodium chloride  1000  ml ; senna  2  tab ; warfarin  1  dose ; warfarin  5  mg ; 
 
white m 74 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  132  mg dl; chemistry blood albumin  2.4  g dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetylcysteine 20%  3-5  ml ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; guaifenesin  5-10  ml ; acetaminophen  650  mg ; milk of magnesia  30  ml ; morphine sulfate  2-4  mg ; zolpidem tartrate  5  mg ; docusate sodium  100  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; omeprazole  20  mg ; probenecid  250  mg ; cyanocobalamin  500  mcg ; losartan potassium  25  mg ; methadone  5  mg ; senna  2  tab ; warfarin  1  dose ; warfarin  5  mg ; nitroglycerin ointment  2%  0.5  in ; aspirin  650  mg ; furosemide  10  mg ; warfarin  0  mg ; neutra-phos  1  pkt ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; lr  1000  ml ; morphine sulfate  2-5  mg ; 
 
white m 74 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  117  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  5.0  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  110  mg dl; chemistry blood albumin  2.2  g dl; blood gas blood lactate  1.0  mmol l; blood gas blood hematocrit, calculated  26  %; blood gas blood hemoglobin  8.6  g dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetylcysteine 20%  3-5  ml ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; guaifenesin  5-10  ml ; acetaminophen  650  mg ; milk of magnesia  30  ml ; zolpidem tartrate  5  mg ; docusate sodium  100  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; omeprazole  20  mg ; probenecid  250  mg ; cyanocobalamin  500  mcg ; losartan potassium  25  mg ; methadone  5  mg ; senna  2  tab ; warfarin  1  dose ; nitroglycerin ointment  2%  0.5  in ; aspirin  650  mg ; furosemide  10  mg ; warfarin  0  mg ; neutra-phos  1  pkt ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; lr  1000  ml ; morphine sulfate  2-5  mg ; furosemide  20  mg ; phytonadione  2  mg ; phytonadione  10  mg ; 
 
white m 74 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  4.5  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  173  mg dl; chemistry blood albumin  2.5  g dl$5% dextrose  250  ml ; norepinephrine  8  mg ; hydromorphone (dilaudid)  0.5  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; oxycodone (immediate release)   5  mg ; albumin 5% (12.5g   250ml)  12.5  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin iv  400  mg ; furosemide  5  mg ; 5% dextrose  100  ml ; furosemide  100  mg ; albumin 25% (12.5g   50ml)  25  g ; 
 
white m 74 $nan$hematology blood hematocrit  28.8  %; hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  107  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, indirect  0.8  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  135  mg dl; chemistry blood albumin  2.9  g dl; chemistry blood bilirubin, direct  1.5  mg dl$hydromorphone (dilaudid)  0.5  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; oxycodone (immediate release)   5  mg ; albumin 5% (12.5g   250ml)  12.5  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin iv  400  mg ; furosemide  5  mg ; 5% dextrose  100  ml ; furosemide  100  mg ; albumin 25% (12.5g   50ml)  25  g ; 
 
white m 74 $nan$hematology blood hematocrit  29.7  %; hematology blood hematocrit  25.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  105  k ul; hematology blood platelet count  87  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  39  mg dl; chemistry urine chloride, urine  19  meq l; chemistry urine creatinine, urine  167  mg dl; chemistry urine potassium, urine  61  meq l; chemistry urine sodium, urine  25  meq l; chemistry urine urea nitrogen, urine  202  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, indirect  0.9  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood glucose  165  mg dl; chemistry blood glucose  169  mg dl; chemistry blood lactate dehydrogenase (ld)  279  iu l; chemistry blood albumin  2.6  g dl; chemistry blood bilirubin, direct  1.7  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$0.9% sodium chloride  2  bag ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; oxycodone (immediate release)   5  mg ; oxycodone (immediate release)   10-15  mg ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50-100  ml ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; potassium phosphate  15  mmol ; 5% dextrose  500  ml ; potassium phosphate  30  mmol ; 0.9% sodium chloride  500  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; furosemide  40  mg ; 
 
white m 74 $nan$hematology blood hematocrit  27  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  82  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, indirect  0.6  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood glucose  174  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  132  iu l; chemistry blood albumin  2.8  g dl; chemistry blood bilirubin, direct  2.0  mg dl$0.9% sodium chloride  2  bag ; oxycodone (immediate release)   10-15  mg ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50-100  ml ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; potassium phosphate  15  mmol ; 5% dextrose  500  ml ; potassium phosphate  30  mmol ; 0.9% sodium chloride  500  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; furosemide  40  mg ; furosemide  80  mg ; pancrelipase 5000  1  cap ; midodrine  2.5  mg ; lidocaine jelly 2% (urojet)  1  appl ; sodium chloride 0.9%  flush  10  ml ; acetaminophen (liquid)  650  mg ; oxycodone liquid  10-15  mg ; docusate sodium (liquid)  100  mg ; 
 
white m 74 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  67  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood glucose  141  mg dl; chemistry blood lactate dehydrogenase (ld)  128  iu l; hematology blood bands  4  %$0.9% sodium chloride  2  bag ; 5% dextrose  200  ml ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50-100  ml ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; potassium phosphate  15  mmol ; 5% dextrose  500  ml ; potassium phosphate  30  mmol ; 0.9% sodium chloride  500  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; furosemide  80  mg ; pancrelipase 5000  1  cap ; midodrine  2.5  mg ; lidocaine jelly 2% (urojet)  1  appl ; sodium chloride 0.9%  flush  10  ml ; acetaminophen (liquid)  650  mg ; oxycodone liquid  10-15  mg ; docusate sodium (liquid)  100  mg ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; 
 
white m 74 $nan$nan$5% dextrose  200  ml ; docusate sodium (liquid)  100  mg ; ipratropium bromide neb  1  neb ; hydromorphone (dilaudid)  2  mg ; 
 
white m 90 $nan$nan$finasteride  5  mg ; isosorbide dinitrate er  40  mg ; lisinopril  20  mg ; polyethylene glycol  17  g ; simvastatin  20  mg ; torsemide  40  mg ; aspirin  325  mg ; 
hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) aortocoronary bypass status other diseases of lung, not elsewhere classified anemia in chronic kidney disease sensorineural hearing loss, unspecified other lymphedema chronic airway obstruction, not elsewhere classified unspecified cataract chronic systolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified personal history of venous thrombosis and embolism chronic kidney disease, unspecified cellulitis and abscess of leg, except foot coronary atherosclerosis of unspecified type of vessel, native or graft osteoarthrosis, unspecified whether generalized or localized, site unspecified other and unspecified hyperlipidemia congestive heart failure, unspecified thrombocytopenia, unspecified peripheral angiopathy in diseases classified elsewhere sensorineural hearing loss, unspecified aortocoronary bypass status atrial fibrillation personal history of venous thrombosis and embolism acute kidney failure, unspecified gross hematuria chronic systolic heart failure chronic kidney disease, stage iii (moderate) diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified venous (peripheral) insufficiency, unspecified other specified retention of urine coronary atherosclerosis of unspecified type of vessel, native or graft cellulitis and abscess of leg, except foot osteoarthrosis, unspecified whether generalized or localized, site unspecified cellulitis and abscess of leg, except foot chronic kidney disease, unspecified cellulitis and abscess of toe, unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation coronary atherosclerosis of native coronary artery dermatophytosis of foot congestive heart failure, unspecified hypotension, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) chronic diastolic heart failure other specified cardiac dysrhythmias venous (peripheral) insufficiency, unspecified
white m 90 $nan$hematology blood hematocrit  34.6  %; hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.8  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  136  k ul; hematology blood platelet count  142  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  156  mg dl; chemistry blood lactate dehydrogenase (ld)  180  iu l; chemistry blood albumin  3.5  g dl; chemistry blood % hemoglobin a1c  6.9  %$finasteride  5  mg ; isosorbide dinitrate er  40  mg ; lisinopril  20  mg ; polyethylene glycol  17  g ; simvastatin  20  mg ; torsemide  40  mg ; aspirin  325  mg ; atropine sulfate  0.5  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; doxycycline hyclate  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; amlactin  1  appl ; metronidazole topical 1 % gel  1  appl ; acetylcysteine 20%  600  mg ; terazosin  5  mg ; 
hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) aortocoronary bypass status other diseases of lung, not elsewhere classified anemia in chronic kidney disease sensorineural hearing loss, unspecified other lymphedema chronic airway obstruction, not elsewhere classified unspecified cataract chronic systolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified personal history of venous thrombosis and embolism chronic kidney disease, unspecified cellulitis and abscess of leg, except foot coronary atherosclerosis of unspecified type of vessel, native or graft osteoarthrosis, unspecified whether generalized or localized, site unspecified other and unspecified hyperlipidemia congestive heart failure, unspecified thrombocytopenia, unspecified peripheral angiopathy in diseases classified elsewhere sensorineural hearing loss, unspecified aortocoronary bypass status atrial fibrillation personal history of venous thrombosis and embolism acute kidney failure, unspecified gross hematuria chronic systolic heart failure chronic kidney disease, stage iii (moderate) diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified venous (peripheral) insufficiency, unspecified other specified retention of urine coronary atherosclerosis of unspecified type of vessel, native or graft cellulitis and abscess of leg, except foot osteoarthrosis, unspecified whether generalized or localized, site unspecified cellulitis and abscess of leg, except foot chronic kidney disease, unspecified cellulitis and abscess of toe, unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation coronary atherosclerosis of native coronary artery dermatophytosis of foot congestive heart failure, unspecified hypotension, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) chronic diastolic heart failure other specified cardiac dysrhythmias venous (peripheral) insufficiency, unspecified
white m 90 $nan$nan$finasteride  5  mg ; isosorbide dinitrate er  40  mg ; lisinopril  20  mg ; polyethylene glycol  17  g ; simvastatin  20  mg ; torsemide  40  mg ; aspirin  325  mg ; atropine sulfate  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; doxycycline hyclate  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; amlactin  1  appl ; metronidazole topical 1 % gel  1  appl ; acetylcysteine 20%  600  mg ; terazosin  5  mg ; 
hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) aortocoronary bypass status other diseases of lung, not elsewhere classified anemia in chronic kidney disease sensorineural hearing loss, unspecified other lymphedema chronic airway obstruction, not elsewhere classified unspecified cataract chronic systolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified personal history of venous thrombosis and embolism chronic kidney disease, unspecified cellulitis and abscess of leg, except foot coronary atherosclerosis of unspecified type of vessel, native or graft osteoarthrosis, unspecified whether generalized or localized, site unspecified other and unspecified hyperlipidemia congestive heart failure, unspecified thrombocytopenia, unspecified peripheral angiopathy in diseases classified elsewhere sensorineural hearing loss, unspecified aortocoronary bypass status atrial fibrillation personal history of venous thrombosis and embolism acute kidney failure, unspecified gross hematuria chronic systolic heart failure chronic kidney disease, stage iii (moderate) diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified venous (peripheral) insufficiency, unspecified other specified retention of urine coronary atherosclerosis of unspecified type of vessel, native or graft cellulitis and abscess of leg, except foot osteoarthrosis, unspecified whether generalized or localized, site unspecified cellulitis and abscess of leg, except foot chronic kidney disease, unspecified cellulitis and abscess of toe, unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation coronary atherosclerosis of native coronary artery dermatophytosis of foot congestive heart failure, unspecified hypotension, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) chronic diastolic heart failure other specified cardiac dysrhythmias venous (peripheral) insufficiency, unspecified
white m 39 $nan$nan$influenza virus vaccine  0.5  ml ; acetaminophen  325-650  mg ; ibuprofen  400  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  2-4  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; nicotine patch  21  mg ; clonidine  0.1  mg ; docusate sodium  100  mg ; 
opioid abuse, unspecified suicidal ideation depressive disorder, not elsewhere classified gender identity disorder in adolescents or adults cocaine abuse, unspecified unspecified viral hepatitis c without hepatic coma long-term (current) use of other medications combinations of opioid type drug with any other drug dependence, continuous suicidal ideation drug-induced mood disorder depressive disorder, not elsewhere classified unspecified viral hepatitis c without hepatic coma opioid abuse, unspecified pain in limb cellulitis and abscess of upper arm and forearm chronic hepatitis c without mention of hepatic coma tobacco use disorder trans-sexualism with unspecified sexual history gender identity disorder in adolescents or adults cocaine abuse, continuous opioid abuse, continuous trans-sexualism with unspecified sexual history opioid abuse, continuous cellulitis and abscess of foot, except toes impetigo cellulitis and abscess of upper arm and forearm chronic hepatitis c without mention of hepatic coma tobacco use disorder cocaine abuse, continuous suicidal ideation depressive disorder, not elsewhere classified 
white m 39 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  72  mg dl$influenza virus vaccine  0.5  ml ; acetaminophen  325-650  mg ; ibuprofen  400  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; nicotine patch  21  mg ; clonidine  0.1  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; 
opioid abuse, unspecified suicidal ideation depressive disorder, not elsewhere classified gender identity disorder in adolescents or adults cocaine abuse, unspecified unspecified viral hepatitis c without hepatic coma long-term (current) use of other medications combinations of opioid type drug with any other drug dependence, continuous suicidal ideation drug-induced mood disorder depressive disorder, not elsewhere classified unspecified viral hepatitis c without hepatic coma opioid abuse, unspecified pain in limb cellulitis and abscess of upper arm and forearm chronic hepatitis c without mention of hepatic coma tobacco use disorder trans-sexualism with unspecified sexual history gender identity disorder in adolescents or adults cocaine abuse, continuous opioid abuse, continuous trans-sexualism with unspecified sexual history opioid abuse, continuous cellulitis and abscess of foot, except toes impetigo cellulitis and abscess of upper arm and forearm chronic hepatitis c without mention of hepatic coma tobacco use disorder cocaine abuse, continuous suicidal ideation depressive disorder, not elsewhere classified 
white m 39 $nan$hematology blood hematocrit  41.1  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  235  k ul$acetaminophen  325-650  mg ; ibuprofen  400  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; nicotine patch  21  mg ; clonidine  0.1  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; dicloxacillin  500  mg ; probenecid  250  mg ; clotrimazole cream  1  appl ; linezolid  600  mg ; 
opioid abuse, unspecified suicidal ideation depressive disorder, not elsewhere classified gender identity disorder in adolescents or adults cocaine abuse, unspecified unspecified viral hepatitis c without hepatic coma long-term (current) use of other medications combinations of opioid type drug with any other drug dependence, continuous suicidal ideation drug-induced mood disorder depressive disorder, not elsewhere classified unspecified viral hepatitis c without hepatic coma opioid abuse, unspecified pain in limb cellulitis and abscess of upper arm and forearm chronic hepatitis c without mention of hepatic coma tobacco use disorder trans-sexualism with unspecified sexual history gender identity disorder in adolescents or adults cocaine abuse, continuous opioid abuse, continuous trans-sexualism with unspecified sexual history opioid abuse, continuous cellulitis and abscess of foot, except toes impetigo cellulitis and abscess of upper arm and forearm chronic hepatitis c without mention of hepatic coma tobacco use disorder cocaine abuse, continuous suicidal ideation depressive disorder, not elsewhere classified 
white m 39 $nan$nan$acetaminophen  325-650  mg ; ibuprofen  400  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; nicotine patch  21  mg ; clonidine  0.1  mg ; docusate sodium  100  mg ; clotrimazole cream  1  appl ; linezolid  600  mg ; 
opioid abuse, unspecified suicidal ideation depressive disorder, not elsewhere classified gender identity disorder in adolescents or adults cocaine abuse, unspecified unspecified viral hepatitis c without hepatic coma long-term (current) use of other medications combinations of opioid type drug with any other drug dependence, continuous suicidal ideation drug-induced mood disorder depressive disorder, not elsewhere classified unspecified viral hepatitis c without hepatic coma opioid abuse, unspecified pain in limb cellulitis and abscess of upper arm and forearm chronic hepatitis c without mention of hepatic coma tobacco use disorder trans-sexualism with unspecified sexual history gender identity disorder in adolescents or adults cocaine abuse, continuous opioid abuse, continuous trans-sexualism with unspecified sexual history opioid abuse, continuous cellulitis and abscess of foot, except toes impetigo cellulitis and abscess of upper arm and forearm chronic hepatitis c without mention of hepatic coma tobacco use disorder cocaine abuse, continuous suicidal ideation depressive disorder, not elsewhere classified 
white f 85 $temp  100.9  heartrate  74.0  resprate  18.0  o2sat  97.0  sbp  122.0  dbp  60.0  rhythm    pain  unable  ; temp  97.8  heartrate  75.0  resprate  18.0  o2sat  98.0  sbp  129.0  dbp  73.0  rhythm    pain    ; temp  99.0  heartrate  78.0  resprate  16.0  o2sat  98.0  sbp  120.0  dbp  67.0  rhythm    pain  0  ; temp  98.4  heartrate  81.0  resprate  16.0  o2sat  100.0  sbp  119.0  dbp  55.0  rhythm    pain    $hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  32  mg dl; hematology urine wbc  1  # hpf; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  97  mg dl; chemistry blood albumin  2.8  g dl; blood gas blood lactate  0.9  mmol l$nan
anemia in neoplastic disease hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic myeloid leukemia, bcr/abl-positive, not having achieved remission diverticulitis of large intestine with perforation and abscess without bleeding paroxysmal atrial fibrillation retention of urine, unspecified chronic diastolic (congestive) heart failure personal history of nicotine dependence chronic kidney disease, stage 3 (moderate) unspecified osteoarthritis, unspecified site hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified hearing loss, unspecified ear streptococcus, group b, as the cause of diseases classified elsewhere chronic lymphocytic leukemia of b-cell type not having achieved remission urinary tract infection, site not specified insomnia, unspecified unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere unspecified osteoarthritis, unspecified site personal history of nicotine dependence chronic myeloid leukemia, bcr/abl-positive, not having achieved remission rectal abscess unspecified diastolic (congestive) heart failure paroxysmal atrial fibrillation chronic kidney disease, stage 3 (moderate) retention of urine, unspecified unspecified intestinal obstruction hyperlipidemia, unspecified old myocardial infarction other chronic nonalcoholic liver disease personal history of antineoplastic chemotherapy acquired coagulation factor deficiency unspecified pleural effusion long-term (current) use of aspirin nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] chronic lymphoid leukemia, without mention of having achieved remission personal history of tobacco use acute posthemorrhagic anemia unspecified intestinal obstruction chronic kidney disease, stage iii (moderate) atrial fibrillation diarrhea other disorders of plasma protein metabolism acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified constipation, unspecified urinary tract infection, site not specified thrombocytopenia, unspecified other acute and subacute forms of ischemic heart disease, other
white f 85 $temp  98.1  heartrate  84.0  resprate  16.0  o2sat  100.0  sbp  114.0  dbp  61.0  rhythm    pain  0  $nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; tramadol  50  mg ; zolpidem tartrate  5  mg ; lactated ringers  1000  ml ; heparin  5000  unit ; simvastatin  20  mg ; vancomycin oral liquid  125  mg ; 
anemia in neoplastic disease hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic myeloid leukemia, bcr/abl-positive, not having achieved remission diverticulitis of large intestine with perforation and abscess without bleeding paroxysmal atrial fibrillation retention of urine, unspecified chronic diastolic (congestive) heart failure personal history of nicotine dependence chronic kidney disease, stage 3 (moderate) unspecified osteoarthritis, unspecified site hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified hearing loss, unspecified ear streptococcus, group b, as the cause of diseases classified elsewhere chronic lymphocytic leukemia of b-cell type not having achieved remission urinary tract infection, site not specified insomnia, unspecified unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere unspecified osteoarthritis, unspecified site personal history of nicotine dependence chronic myeloid leukemia, bcr/abl-positive, not having achieved remission rectal abscess unspecified diastolic (congestive) heart failure paroxysmal atrial fibrillation chronic kidney disease, stage 3 (moderate) retention of urine, unspecified unspecified intestinal obstruction hyperlipidemia, unspecified old myocardial infarction other chronic nonalcoholic liver disease personal history of antineoplastic chemotherapy acquired coagulation factor deficiency unspecified pleural effusion long-term (current) use of aspirin nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] chronic lymphoid leukemia, without mention of having achieved remission personal history of tobacco use acute posthemorrhagic anemia unspecified intestinal obstruction chronic kidney disease, stage iii (moderate) atrial fibrillation diarrhea other disorders of plasma protein metabolism acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified constipation, unspecified urinary tract infection, site not specified thrombocytopenia, unspecified other acute and subacute forms of ischemic heart disease, other
white f 85 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  317  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  117  mg dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; tramadol  50  mg ; zolpidem tartrate  5  mg ; heparin  5000  unit ; simvastatin  20  mg ; vancomycin oral liquid  125  mg ; amiodarone  200  mg ; 
anemia in neoplastic disease hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic myeloid leukemia, bcr/abl-positive, not having achieved remission diverticulitis of large intestine with perforation and abscess without bleeding paroxysmal atrial fibrillation retention of urine, unspecified chronic diastolic (congestive) heart failure personal history of nicotine dependence chronic kidney disease, stage 3 (moderate) unspecified osteoarthritis, unspecified site hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified hearing loss, unspecified ear streptococcus, group b, as the cause of diseases classified elsewhere chronic lymphocytic leukemia of b-cell type not having achieved remission urinary tract infection, site not specified insomnia, unspecified unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere unspecified osteoarthritis, unspecified site personal history of nicotine dependence chronic myeloid leukemia, bcr/abl-positive, not having achieved remission rectal abscess unspecified diastolic (congestive) heart failure paroxysmal atrial fibrillation chronic kidney disease, stage 3 (moderate) retention of urine, unspecified unspecified intestinal obstruction hyperlipidemia, unspecified old myocardial infarction other chronic nonalcoholic liver disease personal history of antineoplastic chemotherapy acquired coagulation factor deficiency unspecified pleural effusion long-term (current) use of aspirin nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] chronic lymphoid leukemia, without mention of having achieved remission personal history of tobacco use acute posthemorrhagic anemia unspecified intestinal obstruction chronic kidney disease, stage iii (moderate) atrial fibrillation diarrhea other disorders of plasma protein metabolism acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified constipation, unspecified urinary tract infection, site not specified thrombocytopenia, unspecified other acute and subacute forms of ischemic heart disease, other
white f 85 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  339  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; tramadol  50  mg ; zolpidem tartrate  5  mg ; heparin  5000  unit ; simvastatin  20  mg ; vancomycin oral liquid  125  mg ; amiodarone  200  mg ; 
anemia in neoplastic disease hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic myeloid leukemia, bcr/abl-positive, not having achieved remission diverticulitis of large intestine with perforation and abscess without bleeding paroxysmal atrial fibrillation retention of urine, unspecified chronic diastolic (congestive) heart failure personal history of nicotine dependence chronic kidney disease, stage 3 (moderate) unspecified osteoarthritis, unspecified site hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified hearing loss, unspecified ear streptococcus, group b, as the cause of diseases classified elsewhere chronic lymphocytic leukemia of b-cell type not having achieved remission urinary tract infection, site not specified insomnia, unspecified unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere unspecified osteoarthritis, unspecified site personal history of nicotine dependence chronic myeloid leukemia, bcr/abl-positive, not having achieved remission rectal abscess unspecified diastolic (congestive) heart failure paroxysmal atrial fibrillation chronic kidney disease, stage 3 (moderate) retention of urine, unspecified unspecified intestinal obstruction hyperlipidemia, unspecified old myocardial infarction other chronic nonalcoholic liver disease personal history of antineoplastic chemotherapy acquired coagulation factor deficiency unspecified pleural effusion long-term (current) use of aspirin nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] chronic lymphoid leukemia, without mention of having achieved remission personal history of tobacco use acute posthemorrhagic anemia unspecified intestinal obstruction chronic kidney disease, stage iii (moderate) atrial fibrillation diarrhea other disorders of plasma protein metabolism acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified constipation, unspecified urinary tract infection, site not specified thrombocytopenia, unspecified other acute and subacute forms of ischemic heart disease, other
white m 26 $nan$hematology blood hematocrit  43.3  %; hematology blood hemoglobin  15.2  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; hematology urine wbc  24  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  82  mg dl; chemistry blood lactate dehydrogenase (ld)  204  iu l; chemistry blood albumin  4.6  g dl$lorazepam  0.5-2  mg ; lacosamide  100  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; zolpidem tartrate  5  mg ; lacosamide  150  mg ; docusate sodium  100  mg ; ibuprofen  400  mg ; 
epilepsy, unspecified, not intractable, without status epilepticus 
white m 26 $nan$nan$lorazepam  0.5-2  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; ibuprofen  400  mg ; lacosamide  50  mg ; acetaminophen  650  mg ; 
epilepsy, unspecified, not intractable, without status epilepticus 
white m 26 $nan$nan$lorazepam  0.5-2  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; ibuprofen  400  mg ; acetaminophen  650  mg ; zolpidem tartrate  5-10  mg ; 
epilepsy, unspecified, not intractable, without status epilepticus 
white m 26 $nan$nan$lorazepam  0.5-2  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; ibuprofen  400  mg ; acetaminophen  650  mg ; zolpidem tartrate  5-10  mg ; 
epilepsy, unspecified, not intractable, without status epilepticus 
white m 81 $nan$hematology blood hematocrit  40.7  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  0.9  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  98  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  250  ml ; heparin sodium  25,000  unit ; lactated ringers  1000  ml ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; valsartan  160  mg ; 
 
white m 81 $nan$hematology blood hematocrit  33.4  %; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l$5% dextrose  250  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; valsartan  160  mg ; 0.45% sodium chloride  1000  ml ; phenylephrine  60  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; nitroglycerin  100  mg ; simvastatin  20  mg ; heparin  5000  unit ; lorazepam  0.5  mg ; 
 
white m 81 $nan$nan$5% dextrose  250  ml ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; valsartan  160  mg ; phenylephrine  60  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; nitroglycerin  100  mg ; heparin  5000  unit ; 
 
other m 68 $nan$nan$bisacodyl  10  mg ; atenolol  25  mg ; allopurinol  150  mg ; phytonadione  10  mg ; 
 
other m 68 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  8.8  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  124  mg dl$bisacodyl  10  mg ; atenolol  25  mg ; allopurinol  150  mg ; phytonadione  10  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  0.5  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; acetaminophen  650  mg ; 
 
other m 68 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  145  mg dl$bisacodyl  10  mg ; atenolol  25  mg ; allopurinol  150  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; neutra-phos  2  pkt ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
 
other m 68 $nan$hematology blood hematocrit  41.6  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  172  mg dl$bisacodyl  10  mg ; atenolol  25  mg ; allopurinol  150  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; neutra-phos  2  pkt ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
 
other m 68 $nan$hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  $bisacodyl  10  mg ; atenolol  25  mg ; allopurinol  150  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; 
 
other m 68 $nan$hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  $bisacodyl  10  mg ; atenolol  25  mg ; allopurinol  150  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; oxycodone (immediate release)   5-10  mg ; 
 
other m 68 $nan$hematology blood hematocrit  41.3  %; hematology blood hematocrit  41.9  %; hematology blood hemoglobin  14.1  g dl; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  236  k ul; hematology blood platelet count  226  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  116  mg dl$bisacodyl  10  mg ; atenolol  25  mg ; allopurinol  150  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; oxycodone (immediate release)   5-10  mg ; zolpidem tartrate  5  mg ; metoprolol tartrate  5  mg ; warfarin  4  mg ; 
 
other m 68 $nan$hematology blood hematocrit  42.3  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  154  mg dl$bisacodyl  10  mg ; allopurinol  150  mg ; pneumococcal vac polyvalent  0.5  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; oxycodone (immediate release)   5-10  mg ; zolpidem tartrate  5  mg ; warfarin  4  mg ; potassium chloride  20  meq ; 
 
other m 68 $nan$hematology blood hematocrit  44.5  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  99  mg dl$bisacodyl  10  mg ; allopurinol  150  mg ; pneumococcal vac polyvalent  0.5  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; oxycodone (immediate release)   5-10  mg ; zolpidem tartrate  5  mg ; warfarin  4  mg ; potassium chloride  20  meq ; 
 
other m 68 $nan$nan$bisacodyl  10  mg ; allopurinol  150  mg ; pneumococcal vac polyvalent  0.5  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; acetaminophen-caff-butalbital  1-2  tab ; oxycodone (immediate release)   5-10  mg ; zolpidem tartrate  5  mg ; warfarin  4  mg ; 
 
white f 23 $nan$nan$sertraline  150  mg ; folic acid  1  mg ; 
other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy depressive disorder, not elsewhere classified thoracic or lumbosacral neuritis or radiculitis, unspecified 
white f 23 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  314  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  80  mg dl$sertraline  150  mg ; folic acid  1  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-1  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; metoclopramide  10  mg ; topiramate (topamax)  50  mg ; heparin  5000  unit ; lamictal xr  1000  mg ; acetaminophen-caff-butalbital  1-2  tab ; 
other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy depressive disorder, not elsewhere classified thoracic or lumbosacral neuritis or radiculitis, unspecified 
white f 23 $nan$nan$sertraline  150  mg ; folic acid  1  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-1  mg ; docusate sodium  100  mg ; metoclopramide  10  mg ; topiramate (topamax)  50  mg ; heparin  5000  unit ; acetaminophen-caff-butalbital  1-2  tab ; lamictal xr  600  mg ; 
other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy depressive disorder, not elsewhere classified thoracic or lumbosacral neuritis or radiculitis, unspecified 
white f 23 $nan$nan$sertraline  150  mg ; folic acid  1  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-1  mg ; docusate sodium  100  mg ; metoclopramide  10  mg ; topiramate (topamax)  50  mg ; heparin  5000  unit ; acetaminophen-caff-butalbital  1-2  tab ; lamictal xr  200  mg ; 
other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy depressive disorder, not elsewhere classified thoracic or lumbosacral neuritis or radiculitis, unspecified 
white f 23 $nan$nan$sertraline  150  mg ; folic acid  1  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-1  mg ; docusate sodium  100  mg ; metoclopramide  10  mg ; topiramate (topamax)  50  mg ; heparin  5000  unit ; acetaminophen-caff-butalbital  1-2  tab ; lamictal xr  200  mg ; 
other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy depressive disorder, not elsewhere classified thoracic or lumbosacral neuritis or radiculitis, unspecified 
white f 23 $nan$nan$sertraline  150  mg ; folic acid  1  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-1  mg ; docusate sodium  100  mg ; metoclopramide  10  mg ; topiramate (topamax)  50  mg ; heparin  5000  unit ; acetaminophen-caff-butalbital  1-2  tab ; lamotrigine  100  mg ; lamictal xr  1000  mg ; ondansetron  4  mg ; 
other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy depressive disorder, not elsewhere classified thoracic or lumbosacral neuritis or radiculitis, unspecified 
white f 23 $nan$nan$sertraline  150  mg ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-1  mg ; docusate sodium  100  mg ; metoclopramide  10  mg ; topiramate (topamax)  50  mg ; heparin  5000  unit ; acetaminophen-caff-butalbital  1-2  tab ; lamictal xr  1000  mg ; ondansetron  4  mg ; lorazepam  0.5  mg ; famotidine  20  mg ; diphenhydramine  25  mg ; 
other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy depressive disorder, not elsewhere classified thoracic or lumbosacral neuritis or radiculitis, unspecified 
white f 23 $nan$nan$sertraline  150  mg ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; metoclopramide  10  mg ; topiramate (topamax)  50  mg ; heparin  5000  unit ; acetaminophen-caff-butalbital  1-2  tab ; lamictal xr  1000  mg ; ondansetron  4  mg ; famotidine  20  mg ; diphenhydramine  25  mg ; 
other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy depressive disorder, not elsewhere classified thoracic or lumbosacral neuritis or radiculitis, unspecified 
hispanic latino m 47 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  5.2  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  78  mg dl; blood gas blood lactate  1.7  mmol l$nan
long-term (current) use of insulin cirrhosis of liver without mention of alcohol myalgia and myositis, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled calculus of gallbladder without mention of cholecystitis, without mention of obstruction chronic diastolic heart failure congestive heart failure, unspecified gastroparesis renal dialysis status end stage renal disease abdominal pain, epigastric hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease myalgia and myositis, unspecified renal dialysis status unspecified persistent mental disorders due to conditions classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled depressive disorder, not elsewhere classified gastroparesis congestive heart failure, unspecified chronic diastolic heart failure polyneuropathy in diabetes end stage renal disease migraine, unspecified, without mention of intractable migraine without mention of status migrainosus hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease chest pain, unspecified chronic diastolic heart failure congestive heart failure, unspecified unspecified episodic mood disorder nausea with vomiting diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease suicidal ideation hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease abdominal pain, unspecified site renal dialysis status gastroparesis other chronic pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other specified hypotension chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta suicidal ideation depressive disorder, not elsewhere classified end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled myalgia and myositis, unspecified
hispanic latino m 47 $nan$hematology blood hematocrit  31.8  %$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; acetaminophen  325  mg ; glucagon  1  mg ; dextrose 50%  12.5  gm ; verapamil sr  240  mg ; insulin  0  unit ; senna  1  tab ; heparin  5000  unit ; carvedilol  12.5  mg ; sevelamer hydrochloride  800  mg ; metoclopramide  10  mg ; docusate sodium  100  mg ; insulin  8  unit ; citalopram  20  mg ; lisinopril  20  mg ; sucralfate  1  gm ; lidocaine 5% patch  1  ptch ; omeprazole  20  mg ; minoxidil  15  mg ; vial  1  vial ; pantoprazole  40  mg ; oxycodone (immediate release)   5  mg ; doxepin hcl  25  mg ; zolpidem tartrate  5  mg ; insulin  6  unit ; 
long-term (current) use of insulin cirrhosis of liver without mention of alcohol myalgia and myositis, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled calculus of gallbladder without mention of cholecystitis, without mention of obstruction chronic diastolic heart failure congestive heart failure, unspecified gastroparesis renal dialysis status end stage renal disease abdominal pain, epigastric hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease myalgia and myositis, unspecified renal dialysis status unspecified persistent mental disorders due to conditions classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled depressive disorder, not elsewhere classified gastroparesis congestive heart failure, unspecified chronic diastolic heart failure polyneuropathy in diabetes end stage renal disease migraine, unspecified, without mention of intractable migraine without mention of status migrainosus hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease chest pain, unspecified chronic diastolic heart failure congestive heart failure, unspecified unspecified episodic mood disorder nausea with vomiting diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease suicidal ideation hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease abdominal pain, unspecified site renal dialysis status gastroparesis other chronic pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other specified hypotension chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta suicidal ideation depressive disorder, not elsewhere classified end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled myalgia and myositis, unspecified
hispanic latino m 47 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  8.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  76  mg dl; chemistry blood lactate dehydrogenase (ld)  216  iu l$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; acetaminophen  325  mg ; glucagon  1  mg ; dextrose 50%  12.5  gm ; verapamil sr  240  mg ; insulin  0  unit ; senna  1  tab ; heparin  5000  unit ; carvedilol  12.5  mg ; sevelamer hydrochloride  800  mg ; metoclopramide  10  mg ; docusate sodium  100  mg ; insulin  8  unit ; citalopram  20  mg ; lisinopril  20  mg ; sucralfate  1  gm ; lidocaine 5% patch  1  ptch ; minoxidil  15  mg ; vial  1  vial ; pantoprazole  40  mg ; oxycodone (immediate release)   5  mg ; doxepin hcl  25  mg ; zolpidem tartrate  5  mg ; insulin  6  unit ; omeprazole  40  mg ; 
long-term (current) use of insulin cirrhosis of liver without mention of alcohol myalgia and myositis, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled calculus of gallbladder without mention of cholecystitis, without mention of obstruction chronic diastolic heart failure congestive heart failure, unspecified gastroparesis renal dialysis status end stage renal disease abdominal pain, epigastric hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease myalgia and myositis, unspecified renal dialysis status unspecified persistent mental disorders due to conditions classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled depressive disorder, not elsewhere classified gastroparesis congestive heart failure, unspecified chronic diastolic heart failure polyneuropathy in diabetes end stage renal disease migraine, unspecified, without mention of intractable migraine without mention of status migrainosus hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease chest pain, unspecified chronic diastolic heart failure congestive heart failure, unspecified unspecified episodic mood disorder nausea with vomiting diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease suicidal ideation hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease abdominal pain, unspecified site renal dialysis status gastroparesis other chronic pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other specified hypotension chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta suicidal ideation depressive disorder, not elsewhere classified end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled myalgia and myositis, unspecified
hispanic latino m 47 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  139  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  10.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; acetaminophen  325  mg ; glucagon  1  mg ; dextrose 50%  12.5  gm ; verapamil sr  240  mg ; insulin  0  unit ; senna  1  tab ; heparin  5000  unit ; carvedilol  12.5  mg ; sevelamer hydrochloride  800  mg ; metoclopramide  10  mg ; docusate sodium  100  mg ; insulin  8  unit ; citalopram  20  mg ; lisinopril  20  mg ; sucralfate  1  gm ; lidocaine 5% patch  1  ptch ; minoxidil  15  mg ; oxycodone (immediate release)   5  mg ; doxepin hcl  25  mg ; zolpidem tartrate  5  mg ; insulin  6  unit ; omeprazole  40  mg ; vial  2  vial ; epoetin alfa  7700  unit ; 
long-term (current) use of insulin cirrhosis of liver without mention of alcohol myalgia and myositis, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled calculus of gallbladder without mention of cholecystitis, without mention of obstruction chronic diastolic heart failure congestive heart failure, unspecified gastroparesis renal dialysis status end stage renal disease abdominal pain, epigastric hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease myalgia and myositis, unspecified renal dialysis status unspecified persistent mental disorders due to conditions classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled depressive disorder, not elsewhere classified gastroparesis congestive heart failure, unspecified chronic diastolic heart failure polyneuropathy in diabetes end stage renal disease migraine, unspecified, without mention of intractable migraine without mention of status migrainosus hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease chest pain, unspecified chronic diastolic heart failure congestive heart failure, unspecified unspecified episodic mood disorder nausea with vomiting diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease suicidal ideation hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease abdominal pain, unspecified site renal dialysis status gastroparesis other chronic pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other specified hypotension chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta suicidal ideation depressive disorder, not elsewhere classified end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled myalgia and myositis, unspecified
hispanic latino m 47 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; acetaminophen  325  mg ; glucagon  1  mg ; dextrose 50%  12.5  gm ; verapamil sr  240  mg ; insulin  0  unit ; senna  1  tab ; heparin  5000  unit ; carvedilol  12.5  mg ; sevelamer hydrochloride  800  mg ; metoclopramide  10  mg ; docusate sodium  100  mg ; insulin  8  unit ; citalopram  20  mg ; lisinopril  20  mg ; sucralfate  1  gm ; lidocaine 5% patch  1  ptch ; minoxidil  15  mg ; oxycodone (immediate release)   5  mg ; doxepin hcl  25  mg ; zolpidem tartrate  5  mg ; insulin  6  unit ; omeprazole  40  mg ; vial  2  vial ; epoetin alfa  7700  unit ; citalopram  40  mg ; 
long-term (current) use of insulin cirrhosis of liver without mention of alcohol myalgia and myositis, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled calculus of gallbladder without mention of cholecystitis, without mention of obstruction chronic diastolic heart failure congestive heart failure, unspecified gastroparesis renal dialysis status end stage renal disease abdominal pain, epigastric hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease myalgia and myositis, unspecified renal dialysis status unspecified persistent mental disorders due to conditions classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled depressive disorder, not elsewhere classified gastroparesis congestive heart failure, unspecified chronic diastolic heart failure polyneuropathy in diabetes end stage renal disease migraine, unspecified, without mention of intractable migraine without mention of status migrainosus hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease chest pain, unspecified chronic diastolic heart failure congestive heart failure, unspecified unspecified episodic mood disorder nausea with vomiting diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease suicidal ideation hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease abdominal pain, unspecified site renal dialysis status gastroparesis other chronic pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other specified hypotension chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta suicidal ideation depressive disorder, not elsewhere classified end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled myalgia and myositis, unspecified
hispanic latino m 47 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  9.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  107  mg dl; chemistry blood albumin  4.1  g dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; acetaminophen  325  mg ; glucagon  1  mg ; dextrose 50%  12.5  gm ; verapamil sr  240  mg ; insulin  0  unit ; senna  1  tab ; heparin  5000  unit ; carvedilol  12.5  mg ; sevelamer hydrochloride  800  mg ; docusate sodium  100  mg ; insulin  8  unit ; lisinopril  20  mg ; sucralfate  1  gm ; lidocaine 5% patch  1  ptch ; minoxidil  15  mg ; oxycodone (immediate release)   5  mg ; zolpidem tartrate  5  mg ; insulin  6  unit ; omeprazole  40  mg ; citalopram  40  mg ; epoetin alfa  10,000  unit ; nephrocaps  1  cap ; diphenhydramine  25  mg ; sarna lotion  1  appl ; 
long-term (current) use of insulin cirrhosis of liver without mention of alcohol myalgia and myositis, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled calculus of gallbladder without mention of cholecystitis, without mention of obstruction chronic diastolic heart failure congestive heart failure, unspecified gastroparesis renal dialysis status end stage renal disease abdominal pain, epigastric hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease myalgia and myositis, unspecified renal dialysis status unspecified persistent mental disorders due to conditions classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled depressive disorder, not elsewhere classified gastroparesis congestive heart failure, unspecified chronic diastolic heart failure polyneuropathy in diabetes end stage renal disease migraine, unspecified, without mention of intractable migraine without mention of status migrainosus hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease chest pain, unspecified chronic diastolic heart failure congestive heart failure, unspecified unspecified episodic mood disorder nausea with vomiting diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease suicidal ideation hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease abdominal pain, unspecified site renal dialysis status gastroparesis other chronic pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other specified hypotension chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta suicidal ideation depressive disorder, not elsewhere classified end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled myalgia and myositis, unspecified
black african american m 74 $temp  98.0  heartrate  75.0  resprate  18.0  o2sat  100.0  sbp  154.0  dbp  90.0  rhythm    pain  0  $hematology blood hematocrit  43.1  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  401  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  37  mg dl; hematology urine wbc  5  # hpf; chemistry blood glucose  115  mg dl; blood gas blood lactate  2.8  mmol l$nan
other and unspecified hyperlipidemia unspecified gastritis and gastroduodenitis, with hemorrhage personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction helicobacter pylori [h. pylori] unspecified essential hypertension acute posthemorrhagic anemia 
black african american m 74 $temp  98.6  heartrate  69.0  resprate  18.0  o2sat  97.0  sbp  127.0  dbp  77.0  rhythm    pain    $hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  335  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  106  mg dl$0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; amlodipine  10  mg ; aspirin  81  mg ; simvastatin  20  mg ; sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; aquaphor ointment  1  appl ; senna  8.6  mg ; docusate sodium  100  mg ; lactulose  30  ml ; lactated ringers  1000  ml ; tamsulosin  0.4  mg ; 
other and unspecified hyperlipidemia unspecified gastritis and gastroduodenitis, with hemorrhage personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction helicobacter pylori [h. pylori] unspecified essential hypertension acute posthemorrhagic anemia 
black african american m 74 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  325  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  104  mg dl$0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; amlodipine  10  mg ; aspirin  81  mg ; simvastatin  20  mg ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; lactulose  30  ml ; tamsulosin  0.4  mg ; potassium chloride  40  meq ; ciprofloxacin hcl  500  mg ; 
other and unspecified hyperlipidemia unspecified gastritis and gastroduodenitis, with hemorrhage personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction helicobacter pylori [h. pylori] unspecified essential hypertension acute posthemorrhagic anemia 
black african american m 74 $nan$nan$amlodipine  10  mg ; aspirin  81  mg ; simvastatin  20  mg ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; lactulose  30  ml ; tamsulosin  0.4  mg ; ciprofloxacin hcl  500  mg ; 
other and unspecified hyperlipidemia unspecified gastritis and gastroduodenitis, with hemorrhage personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction helicobacter pylori [h. pylori] unspecified essential hypertension acute posthemorrhagic anemia 
black african american m 74 $nan$nan$amlodipine  10  mg ; aspirin  81  mg ; simvastatin  20  mg ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; lactulose  30  ml ; tamsulosin  0.4  mg ; ciprofloxacin hcl  500  mg ; 
other and unspecified hyperlipidemia unspecified gastritis and gastroduodenitis, with hemorrhage personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction helicobacter pylori [h. pylori] unspecified essential hypertension acute posthemorrhagic anemia 
white m 60 $temp    heartrate  101.0  resprate  20.0  o2sat  94.0  sbp  118.0  dbp  63.0  rhythm    pain  0  ; temp    heartrate  107.0  resprate  22.0  o2sat  96.0  sbp  115.0  dbp  63.0  rhythm    pain    ; temp    heartrate  110.0  resprate  24.0  o2sat  96.0  sbp  100.0  dbp  75.0  rhythm    pain    ; temp    heartrate  98.0  resprate  22.0  o2sat  97.0  sbp  124.0  dbp  68.0  rhythm    pain    ; temp    heartrate  118.0  resprate  20.0  o2sat  95.0  sbp  112.0  dbp  84.0  rhythm    pain  4  ; temp    heartrate  118.0  resprate  20.0  o2sat  96.0  sbp  129.0  dbp  76.0  rhythm    pain  1  ; temp  98.3  heartrate  129.0  resprate    o2sat    sbp    dbp    rhythm    pain  1  ; temp    heartrate  112.0  resprate  18.0  o2sat  96.0  sbp  137.0  dbp  78.0  rhythm    pain  0  ; temp  98.2  heartrate  127.0  resprate  18.0  o2sat  97.0  sbp  138.0  dbp  95.0  rhythm    pain    ; temp  98.0  heartrate  113.0  resprate  16.0  o2sat  96.0  sbp  134.0  dbp  91.0  rhythm    pain    $chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  182  mg dl$folic acid  1  mg ; thiamine  100  mg ; nicotine patch  14  mg ; aspirin  81  mg ; simvastatin  20  mg ; lisinopril  40  mg ; metoprolol succinate xl  100  mg ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; albuterol inhaler  2  puff ; diazepam  5  mg ; 
history of fall alcoholic polyneuropathy old myocardial infarction chronic hepatitis c without mention of hepatic coma unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident unspecified essential hypertension other and unspecified hyperlipidemia alcohol abuse, in remission tobacco use disorder coronary atherosclerosis of native coronary artery wheelchair dependence chronic airway obstruction, not elsewhere classified percutaneous transluminal coronary angioplasty status 
white m 60 $nan$hematology blood hematocrit  38.9  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  290  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  123  mg dl$folic acid  1  mg ; thiamine  100  mg ; nicotine patch  14  mg ; aspirin  81  mg ; simvastatin  20  mg ; lisinopril  40  mg ; metoprolol succinate xl  100  mg ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; albuterol inhaler  2  puff ; diazepam  5  mg ; diazepam  10  mg ; 
history of fall alcoholic polyneuropathy old myocardial infarction chronic hepatitis c without mention of hepatic coma unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident unspecified essential hypertension other and unspecified hyperlipidemia alcohol abuse, in remission tobacco use disorder coronary atherosclerosis of native coronary artery wheelchair dependence chronic airway obstruction, not elsewhere classified percutaneous transluminal coronary angioplasty status 
white m 77 $nan$hematology blood hematocrit  29.1  %; hematology blood platelet count  157  k ul; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood urea nitrogen  17  mg dl$sodium chloride 0.9%  1000  ml ; nitroglycerin sl  0.4  mg ; omeprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; trazodone  25  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; atorvastatin  40  mg ; donepezil  10  mg ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  125  mcg ; lisinopril  40  mg ; metoprolol succinate xl  25  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; fluticasone propionate nasal  2  spry ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  81  mg ; clopidogrel  75  mg ; apixaban  5  mg ; fluoxetine  80  mg ; folic acid  0.5  mg ; 
anemia, unspecified presence of coronary angioplasty implant and graft long term (current) use of anticoagulants malignant neoplasm of prostate left bundle-branch block, unspecified chest pain, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation old myocardial infarction other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery retention of urine, unspecified unspecified acquired hypothyroidism unspecified essential hypertension chronic airway obstruction, not elsewhere classified umbilical hernia without mention of obstruction or gangrene
white m 77 $nan$nan$nitroglycerin sl  0.4  mg ; omeprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; trazodone  25  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; atorvastatin  40  mg ; donepezil  10  mg ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  125  mcg ; lisinopril  40  mg ; metoprolol succinate xl  25  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; fluticasone propionate nasal  2  spry ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  81  mg ; clopidogrel  75  mg ; apixaban  5  mg ; fluoxetine  80  mg ; folic acid  0.5  mg ; 
anemia, unspecified presence of coronary angioplasty implant and graft long term (current) use of anticoagulants malignant neoplasm of prostate left bundle-branch block, unspecified chest pain, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation old myocardial infarction other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery retention of urine, unspecified unspecified acquired hypothyroidism unspecified essential hypertension chronic airway obstruction, not elsewhere classified umbilical hernia without mention of obstruction or gangrene
white m 52 $nan$nan$5% dextrose  250  ml ; vancomycin  750  mg ; aspirin  325  mg ; 
compression of vein acute venous embolism and thrombosis of subclavian veins brachial plexus lesions 
white m 52 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  343  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  135  mg dl$5% dextrose  250  ml ; vancomycin  750  mg ; aspirin  325  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone-acetaminophen  1-2  tab ; heparin  5000  unit ; hydromorphone (dilaudid)  0.5  mg ; heparin sodium  25,000  unit ; acetaminophen  325-650  mg ; 
compression of vein acute venous embolism and thrombosis of subclavian veins brachial plexus lesions 
white m 52 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  354  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  99  mg dl$aspirin  325  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; hydromorphone (dilaudid)  0.5  mg ; heparin sodium  25,000  unit ; acetaminophen  325-650  mg ; warfarin  5  mg ; 
compression of vein acute venous embolism and thrombosis of subclavian veins brachial plexus lesions 
white m 52 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  364  k ul; hematology blood inr(pt)  1.1  $aspirin  325  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; hydromorphone (dilaudid)  0.5  mg ; acetaminophen  325-650  mg ; warfarin  5  mg ; enoxaparin sodium  60  mg ; 
compression of vein acute venous embolism and thrombosis of subclavian veins brachial plexus lesions 
white m 52 $nan$nan$aspirin  325  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; hydromorphone (dilaudid)  0.5  mg ; acetaminophen  325-650  mg ; warfarin  5  mg ; enoxaparin sodium  60  mg ; 
compression of vein acute venous embolism and thrombosis of subclavian veins brachial plexus lesions 
asian m 64 $nan$nan$aspirin  81  mg ; simvastatin  20  mg ; 
 
asian m 64 $nan$hematology blood hematocrit  40.8  %; hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.26  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  3.7  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood chloride, whole blood  109  meq l; blood gas blood glucose  107  mg dl; blood gas blood glucose  107  mg dl; blood gas blood glucose  118  mg dl; blood gas blood glucose  112  mg dl; blood gas blood glucose  102  mg dl; blood gas blood hematocrit, calculated  47  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hemoglobin  15.5  g dl; blood gas blood hemoglobin  10.7  g dl; blood gas blood hemoglobin  11.1  g dl; blood gas blood hemoglobin  11.1  g dl; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  137  meq l$aspirin  81  mg ; simvastatin  20  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; metoprolol tartrate  25  mg ; mupirocin nasal ointment 2%  1  appl ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin ec  81  mg ; lactated ringers  1000  ml ; 5% dextrose  250  ml ; sodium chloride 0.9%  flush  10  ml ; propofol  1000  mg ; propofol  200  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen  1-2  tab ; milk of magnesia  30  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; cefazolin  2  g ; 
 
asian m 64 $nan$hematology blood hematocrit  36.4  %; hematology blood hematocrit  34.2  %; hematology blood hematocrit  32.9  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.3  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  120  mg dl; chemistry blood glucose  154  mg dl; blood gas blood free calcium  1.21  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood lactate  3.7  mmol l; blood gas blood lactate  3.4  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood glucose  161  mg dl; blood gas blood glucose  156  mg dl; blood gas blood glucose  129  mg dl; blood gas blood glucose  100  mg dl; blood gas blood glucose  113  mg dl; blood gas blood glucose  111  mg dl; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  4.9  meq l$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin ec  81  mg ; 5% dextrose  250  ml ; sodium chloride 0.9%  flush  10  ml ; propofol  1000  mg ; propofol  200  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen  1-2  tab ; milk of magnesia  30  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; cefazolin  2  g ; ketorolac  30  mg ; ketorolac  15  mg ; furosemide  20  mg ; naloxone  0.4  mg ; acetaminophen iv  1000  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; docusate sodium (liquid)  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; metoprolol tartrate  2.5  mg ; metoprolol tartrate  12.5  mg ; metformin xr (glucophage xr)  500  mg ; 
 
asian m 64 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  101  mg dl$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin ec  81  mg ; 5% dextrose  250  ml ; sodium chloride 0.9%  flush  10  ml ; propofol  1000  mg ; propofol  200  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; metoclopramide  10  mg ; milk of magnesia  30  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; cefazolin  2  g ; ketorolac  30  mg ; ketorolac  15  mg ; furosemide  20  mg ; naloxone  0.4  mg ; acetaminophen iv  1000  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; docusate sodium (liquid)  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; metoprolol tartrate  2.5  mg ; metoprolol tartrate  12.5  mg ; metformin xr (glucophage xr)  500  mg ; 
 
asian m 64 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  113  mg dl; blood gas blood free calcium  1.10  mmol l$aspirin ec  81  mg ; 5% dextrose  250  ml ; sodium chloride 0.9%  flush  10  ml ; propofol  1000  mg ; propofol  200  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; metoclopramide  10  mg ; milk of magnesia  30  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; acetaminophen iv  1000  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; docusate sodium (liquid)  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; metformin xr (glucophage xr)  500  mg ; metformin xr (glucophage xr)  1000  mg ; acetaminophen  325-650  mg ; 
 
asian m 64 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  126  mg dl$aspirin ec  81  mg ; 5% dextrose  250  ml ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; metoclopramide  10  mg ; milk of magnesia  30  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; ranitidine  150  mg ; docusate sodium  100  mg ; metformin xr (glucophage xr)  500  mg ; metformin xr (glucophage xr)  1000  mg ; acetaminophen  325-650  mg ; albumin 5% (25g   500ml)  25  g ; insulin  10  unit ; metformin (glucophage)  500  mg ; bisacodyl  10  mg ; 
 
asian m 64 $nan$chemistry blood chloride  101  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  28  mg dl$bisacodyl  10  mg ; 
 
asian m 64 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  269  k ul; chemistry blood chloride  96  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  34  mg dl$bisacodyl  10  mg ; tramadol (ultram)  25-50  mg ; albumin 5% (12.5g   250ml)  12.5  g ; 
 
asian m 64 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  297  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood glucose  111  mg dl$bisacodyl  10  mg ; tramadol (ultram)  25-50  mg ; albumin 5% (12.5g   250ml)  12.5  g ; ondansetron  4  mg ; 
 
asian m 64 $nan$nan$bisacodyl  10  mg ; tramadol (ultram)  25-50  mg ; ondansetron  4  mg ; 
 
black african american f 62 $temp  98.4  heartrate  87.0  resprate  18.0  o2sat  94.0  sbp  128.0  dbp  50.0  rhythm    pain  0  ; temp    heartrate  89.0  resprate  18.0  o2sat  77.0  sbp  125.0  dbp  51.0  rhythm    pain    ; temp    heartrate    resprate    o2sat  100.0  sbp    dbp    rhythm    pain    ; temp  97.8  heartrate  78.0  resprate  18.0  o2sat  100.0  sbp  138.0  dbp  47.0  rhythm    pain  0  ; temp  98.0  heartrate  81.0  resprate  18.0  o2sat  100.0  sbp  128.0  dbp  56.0  rhythm    pain  0  $hematology blood hematocrit  19.1  %; hematology blood hemoglobin  5.2  g dl; hematology blood platelet count  440  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  120  mg dl$nan
nausea with vomiting, unspecified idiopathic gout, right hand hyperlipidemia, unspecified other nonspecific abnormal finding of lung field hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other secondary pulmonary hypertension angiodysplasia of stomach and duodenum without bleeding long qt syndrome chronic kidney disease, stage 2 (mild) benign neoplasm of cerebral meninges hyperkalemia dependence on supplemental oxygen obstructive sleep apnea (adult) (pediatric) do not resuscitate pruritus, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease anemia in other chronic diseases classified elsewhere personal history of other venous thrombosis and embolism dehydration personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long term (current) use of insulin chronic obstructive pulmonary disease, unspecified acute kidney failure, unspecified hereditary hemorrhagic telangiectasia idiopathic gout, left hand other migraine, not intractable, without status migrainosus chronic diastolic (congestive) heart failure bloodstream infection due to central venous catheter, initial encounter type 2 diabetes mellitus with diabetic polyneuropathy nicotine dependence, cigarettes, uncomplicated other staphylococcus as the cause of diseases classified elsewhere heart failure, unspecified type 2 diabetes mellitus without complications iron deficiency anemia secondary to blood loss (chronic) long term (current) use of insulin angiodysplasia of colon without hemorrhage febrile nonhemolytic transfusion reaction chronic diastolic (congestive) heart failure tinnitus, unspecified ear migraine, unspecified, not intractable, without status migrainosus gout, unspecified hereditary hemorrhagic telangiectasia personal history of other venous thrombosis and embolism unspecified asthma, uncomplicated type 2 diabetes mellitus with unspecified complications obesity, unspecified acute posthemorrhagic anemia elevated white blood cell count, unspecified
black african american f 62 $temp  97.8  heartrate  89.0  resprate  16.0  o2sat  100.0  sbp  142.0  dbp  71.0  rhythm    pain  0  ; temp  98.6  heartrate  78.0  resprate  16.0  o2sat  94.0  sbp  141.0  dbp  77.0  rhythm    pain    ; temp    heartrate    resprate    o2sat  100.0  sbp    dbp    rhythm    pain    $hematology blood hematocrit  21.8  %; hematology blood hematocrit  23.6  %; hematology blood hematocrit  23.6  %; hematology blood hemoglobin  6.0  g dl; hematology blood hemoglobin  6.8  g dl; hematology blood hemoglobin  6.8  g dl; hematology blood platelet count  434  k ul; hematology blood platelet count  369  k ul; hematology blood platelet count  375  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  141  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  1-2  puff ; gabapentin  800  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone--acetaminophen (5mg-325mg)  1-2  tab ; pantoprazole  40  mg ; sarna lotion  1  appl ; senna  8.6  mg ; simvastatin  40  mg ; torsemide  20  mg ; insulin  0  unit ; insulin  30  unit ; triamcinolone acetonide 0.1% cream  1  appl ; bag  1  bag ; magnesium sulfate  2  gm ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; diphenhydramine  25  mg ; acetaminophen  325-650  mg ; gabapentin  800  mg ; zolpidem tartrate  10  mg ; 
nausea with vomiting, unspecified idiopathic gout, right hand hyperlipidemia, unspecified other nonspecific abnormal finding of lung field hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other secondary pulmonary hypertension angiodysplasia of stomach and duodenum without bleeding long qt syndrome chronic kidney disease, stage 2 (mild) benign neoplasm of cerebral meninges hyperkalemia dependence on supplemental oxygen obstructive sleep apnea (adult) (pediatric) do not resuscitate pruritus, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease anemia in other chronic diseases classified elsewhere personal history of other venous thrombosis and embolism dehydration personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long term (current) use of insulin chronic obstructive pulmonary disease, unspecified acute kidney failure, unspecified hereditary hemorrhagic telangiectasia idiopathic gout, left hand other migraine, not intractable, without status migrainosus chronic diastolic (congestive) heart failure bloodstream infection due to central venous catheter, initial encounter type 2 diabetes mellitus with diabetic polyneuropathy nicotine dependence, cigarettes, uncomplicated other staphylococcus as the cause of diseases classified elsewhere heart failure, unspecified type 2 diabetes mellitus without complications iron deficiency anemia secondary to blood loss (chronic) long term (current) use of insulin angiodysplasia of colon without hemorrhage febrile nonhemolytic transfusion reaction chronic diastolic (congestive) heart failure tinnitus, unspecified ear migraine, unspecified, not intractable, without status migrainosus gout, unspecified hereditary hemorrhagic telangiectasia personal history of other venous thrombosis and embolism unspecified asthma, uncomplicated type 2 diabetes mellitus with unspecified complications obesity, unspecified acute posthemorrhagic anemia elevated white blood cell count, unspecified
black african american f 62 $nan$hematology blood hematocrit  26.1  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  353  k ul; hematology blood platelet count  385  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  178  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  1-2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone--acetaminophen (5mg-325mg)  1-2  tab ; pantoprazole  40  mg ; sarna lotion  1  appl ; senna  8.6  mg ; simvastatin  40  mg ; torsemide  20  mg ; insulin  0  unit ; insulin  30  unit ; triamcinolone acetonide 0.1% cream  1  appl ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; diphenhydramine  25  mg ; acetaminophen  325-650  mg ; gabapentin  800  mg ; zolpidem tartrate  10  mg ; 
nausea with vomiting, unspecified idiopathic gout, right hand hyperlipidemia, unspecified other nonspecific abnormal finding of lung field hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other secondary pulmonary hypertension angiodysplasia of stomach and duodenum without bleeding long qt syndrome chronic kidney disease, stage 2 (mild) benign neoplasm of cerebral meninges hyperkalemia dependence on supplemental oxygen obstructive sleep apnea (adult) (pediatric) do not resuscitate pruritus, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease anemia in other chronic diseases classified elsewhere personal history of other venous thrombosis and embolism dehydration personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long term (current) use of insulin chronic obstructive pulmonary disease, unspecified acute kidney failure, unspecified hereditary hemorrhagic telangiectasia idiopathic gout, left hand other migraine, not intractable, without status migrainosus chronic diastolic (congestive) heart failure bloodstream infection due to central venous catheter, initial encounter type 2 diabetes mellitus with diabetic polyneuropathy nicotine dependence, cigarettes, uncomplicated other staphylococcus as the cause of diseases classified elsewhere heart failure, unspecified type 2 diabetes mellitus without complications iron deficiency anemia secondary to blood loss (chronic) long term (current) use of insulin angiodysplasia of colon without hemorrhage febrile nonhemolytic transfusion reaction chronic diastolic (congestive) heart failure tinnitus, unspecified ear migraine, unspecified, not intractable, without status migrainosus gout, unspecified hereditary hemorrhagic telangiectasia personal history of other venous thrombosis and embolism unspecified asthma, uncomplicated type 2 diabetes mellitus with unspecified complications obesity, unspecified acute posthemorrhagic anemia elevated white blood cell count, unspecified
white f 55 $nan$hematology urine wbc  5  # hpf$ns  1000  ml ; efavirenz  600  mg ; sulfameth trimethoprim ds  1  tab ; albuterol  1-2  puff ; pantoprazole  40  mg ; oxycodone sr (oxycontin)  80  mg ; oxycodone (immediate release)   5  mg ; clonazepam  0.5  mg ; soma  350  mg ; posaconazole suspension  400  mg ; fluticasone-salmeterol (250 50)   1  inh ; lamivudine-zidovudine (combivir)  1  tab ; zolpidem tartrate  10  mg ; 
 
white f 55 $nan$hematology blood hematocrit  25.3  %; hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  48  k ul; hematology blood platelet count  76  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  108  mg dl$efavirenz  600  mg ; sulfameth trimethoprim ds  1  tab ; albuterol  1-2  puff ; pantoprazole  40  mg ; oxycodone sr (oxycontin)  80  mg ; oxycodone (immediate release)   5  mg ; clonazepam  0.5  mg ; soma  350  mg ; posaconazole suspension  400  mg ; fluticasone-salmeterol (250 50)   1  inh ; lamivudine-zidovudine (combivir)  1  tab ; zolpidem tartrate  10  mg ; ondansetron  4-8  mg ; ns  500  ml ; 
 
white f 55 $nan$nan$efavirenz  600  mg ; sulfameth trimethoprim ds  1  tab ; albuterol  1-2  puff ; pantoprazole  40  mg ; oxycodone sr (oxycontin)  80  mg ; oxycodone (immediate release)   5  mg ; clonazepam  0.5  mg ; soma  350  mg ; posaconazole suspension  400  mg ; fluticasone-salmeterol (250 50)   1  inh ; lamivudine-zidovudine (combivir)  1  tab ; zolpidem tartrate  10  mg ; ondansetron  4-8  mg ; ns  500  ml ; miconazole nitrate (combo pack)  1  supp ; hydromorphone (dilaudid)  1-2  mg ; 
 
white f 55 $nan$hematology blood hematocrit  30.3  %; hematology blood hematocrit  28.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  111  k ul; hematology blood platelet count  97  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  169  mg dl; chemistry blood glucose  177  mg dl$efavirenz  600  mg ; sulfameth trimethoprim ds  1  tab ; albuterol  1-2  puff ; pantoprazole  40  mg ; oxycodone (immediate release)   5  mg ; clonazepam  0.5  mg ; soma  350  mg ; posaconazole suspension  400  mg ; fluticasone-salmeterol (250 50)   1  inh ; lamivudine-zidovudine (combivir)  1  tab ; zolpidem tartrate  10  mg ; ondansetron  4-8  mg ; miconazole nitrate (combo pack)  1  supp ; hydromorphone (dilaudid)  1-2  mg ; metoprolol tartrate  12.5  mg ; d5 1 2ns  1000  ml ; 
 
white f 55 $nan$nan$efavirenz  600  mg ; sulfameth trimethoprim ds  1  tab ; albuterol  1-2  puff ; pantoprazole  40  mg ; oxycodone (immediate release)   5  mg ; clonazepam  0.5  mg ; soma  350  mg ; posaconazole suspension  400  mg ; fluticasone-salmeterol (250 50)   1  inh ; lamivudine-zidovudine (combivir)  1  tab ; zolpidem tartrate  10  mg ; ondansetron  4-8  mg ; miconazole nitrate (combo pack)  1  supp ; metoprolol tartrate  12.5  mg ; d5 1 2ns  1000  ml ; 
 
white f 55 $nan$nan$efavirenz  600  mg ; sulfameth trimethoprim ds  1  tab ; albuterol  1-2  puff ; pantoprazole  40  mg ; oxycodone (immediate release)   5  mg ; clonazepam  0.5  mg ; soma  350  mg ; posaconazole suspension  400  mg ; fluticasone-salmeterol (250 50)   1  inh ; lamivudine-zidovudine (combivir)  1  tab ; zolpidem tartrate  10  mg ; ondansetron  4-8  mg ; miconazole nitrate (combo pack)  1  supp ; metoprolol tartrate  25  mg ; 
 
white f 55 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  138  mg dl; chemistry blood albumin  3.2  g dl; hematology blood wbc count  1.1  k ul$efavirenz  600  mg ; sulfameth trimethoprim ds  1  tab ; albuterol  1-2  puff ; pantoprazole  40  mg ; oxycodone (immediate release)   5  mg ; clonazepam  0.5  mg ; soma  350  mg ; posaconazole suspension  400  mg ; fluticasone-salmeterol (250 50)   1  inh ; lamivudine-zidovudine (combivir)  1  tab ; zolpidem tartrate  10  mg ; ondansetron  4-8  mg ; metoprolol tartrate  25  mg ; tiotropium bromide  1  cap ; albuterol  2  puff ; clonazepam  0.25  mg ; loperamide  4  mg ; trazodone  25  mg ; acetaminophen  500-1000  mg ; trazodone  50  mg ; 
 
white f 55 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  178  mg dl$sulfameth trimethoprim ds  1  tab ; posaconazole suspension  400  mg ; fluticasone-salmeterol (250 50)   1  inh ; lamivudine-zidovudine (combivir)  1  tab ; tiotropium bromide  1  cap ; albuterol  2  puff ; clonazepam  0.25  mg ; loperamide  4  mg ; acetaminophen  500-1000  mg ; trazodone  50  mg ; potassium chloride  40  meq ; lorazepam  2  mg ; loperamide  2  mg ; 
 
white f 55 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  148  mg dl; hematology blood bands  2  %$sulfameth trimethoprim ds  1  tab ; posaconazole suspension  400  mg ; fluticasone-salmeterol (250 50)   1  inh ; lamivudine-zidovudine (combivir)  1  tab ; tiotropium bromide  1  cap ; albuterol  2  puff ; acetaminophen  500-1000  mg ; potassium chloride  40  meq ; lorazepam  2  mg ; loperamide  2  mg ; olanzapine (disintegrating tablet)  5  mg ; 
 
white f 55 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  138  mg dl; chemistry blood albumin  3.3  g dl$sulfameth trimethoprim ds  1  tab ; posaconazole suspension  400  mg ; fluticasone-salmeterol (250 50)   1  inh ; lamivudine-zidovudine (combivir)  1  tab ; tiotropium bromide  1  cap ; albuterol  2  puff ; acetaminophen  500-1000  mg ; olanzapine (disintegrating tablet)  5  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; 
 
white f 55 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  147  mg dl; hematology blood bands  0  %$sulfameth trimethoprim ds  1  tab ; posaconazole suspension  400  mg ; fluticasone-salmeterol (250 50)   1  inh ; lamivudine-zidovudine (combivir)  1  tab ; tiotropium bromide  1  cap ; albuterol  2  puff ; acetaminophen  500-1000  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; 
 
white f 55 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  152  mg dl$sulfameth trimethoprim ds  1  tab ; posaconazole suspension  400  mg ; lamivudine-zidovudine (combivir)  1  tab ; acetaminophen  500-1000  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; azithromycin  1200  mg ; 
 
white f 55 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  133  mg dl; chemistry blood albumin  3.8  g dl$sulfameth trimethoprim ds  1  tab ; posaconazole suspension  400  mg ; lamivudine-zidovudine (combivir)  1  tab ; acetaminophen  500-1000  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; azithromycin  1200  mg ; emtricitabine-tenofovir (truvada)  1  tab ; ondansetron  8  mg ; ondansetron odt  4-8  mg ; darunavir  600  mg ; ritonavir  100  mg ; raltegravir  400  mg ; 
 
white f 55 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood bilirubin, total  0.3  mg dl$sulfameth trimethoprim ds  1  tab ; posaconazole suspension  400  mg ; acetaminophen  500-1000  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; azithromycin  1200  mg ; emtricitabine-tenofovir (truvada)  1  tab ; ondansetron  8  mg ; ondansetron odt  4-8  mg ; darunavir  600  mg ; ritonavir  100  mg ; raltegravir  400  mg ; 
 
white f 55 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  142  mg dl$sulfameth trimethoprim ds  1  tab ; posaconazole suspension  400  mg ; acetaminophen  500-1000  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; azithromycin  1200  mg ; emtricitabine-tenofovir (truvada)  1  tab ; ondansetron  8  mg ; ondansetron odt  4-8  mg ; darunavir  600  mg ; ritonavir  100  mg ; raltegravir  400  mg ; 
 
white f 55 $nan$nan$sulfameth trimethoprim ds  1  tab ; posaconazole suspension  400  mg ; acetaminophen  500-1000  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; azithromycin  1200  mg ; emtricitabine-tenofovir (truvada)  1  tab ; ondansetron  8  mg ; ondansetron odt  4-8  mg ; darunavir  600  mg ; ritonavir  100  mg ; raltegravir  400  mg ; megestrol acetate  400  mg ; 
 
white f 55 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  212  k ul; chemistry blood bilirubin, total  0.2  mg dl$sulfameth trimethoprim ds  1  tab ; posaconazole suspension  400  mg ; acetaminophen  500-1000  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; azithromycin  1200  mg ; emtricitabine-tenofovir (truvada)  1  tab ; ondansetron  8  mg ; ondansetron odt  4-8  mg ; darunavir  600  mg ; ritonavir  100  mg ; raltegravir  400  mg ; megestrol acetate  400  mg ; 
 
white f 55 $nan$nan$sulfameth trimethoprim ds  1  tab ; posaconazole suspension  400  mg ; acetaminophen  500-1000  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; azithromycin  1200  mg ; emtricitabine-tenofovir (truvada)  1  tab ; ondansetron  8  mg ; ondansetron odt  4-8  mg ; darunavir  600  mg ; ritonavir  100  mg ; raltegravir  400  mg ; megestrol acetate  400  mg ; 
 
asian m 34 $nan$hematology blood hematocrit  27.4  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  114  k ul; hematology blood platelet count  120  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  6.8  mg dl; chemistry blood creatinine  5.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  93  mg dl; chemistry blood urea nitrogen  74  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  176  mg dl; chemistry blood glucose  153  mg dl$sulfameth trimethoprim ss  1  tab ; valganciclovir  450  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; famotidine  20  mg ; d5 1 2ns  1000  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; metoprolol tartrate  10  mg ; 0.9% sodium chloride  2  bag ; magnesium sulfate  4  gm ; mycophenolate mofetil  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; nystatin oral suspension  5  ml ; 
dermatitis due to drugs and medicines taken internally gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia of other chronic disease eosinophilia uric acid metabolism drugs causing adverse effects in therapeutic use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney chronic kidney disease, stage iv (severe) hepatitis, unspecified acute kidney failure, unspecified
asian m 34 $nan$hematology blood hematocrit  24.2  %; hematology blood hematocrit  24.6  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  93  k ul; hematology blood platelet count  99  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  55  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  136  mg dl$sulfameth trimethoprim ss  1  tab ; valganciclovir  450  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; famotidine  20  mg ; d5 1 2ns  1000  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; metoprolol tartrate  10  mg ; 0.9% sodium chloride  2  bag ; magnesium sulfate  4  gm ; mycophenolate mofetil  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; nystatin oral suspension  5  ml ; tacrolimus  2  mg ; methylprednisolone sodium succ  100  mg ; nifedipine cr  90  mg ; amlodipine  10  mg ; anti-thymocyte globulin (rabbit)  100  mg ; nifedipine cr  30  mg ; 
dermatitis due to drugs and medicines taken internally gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia of other chronic disease eosinophilia uric acid metabolism drugs causing adverse effects in therapeutic use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney chronic kidney disease, stage iv (severe) hepatitis, unspecified acute kidney failure, unspecified
asian m 34 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  89  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  155  mg dl$sulfameth trimethoprim ss  1  tab ; valganciclovir  450  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; famotidine  20  mg ; d5 1 2ns  1000  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; metoprolol tartrate  10  mg ; mycophenolate mofetil  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; nystatin oral suspension  5  ml ; tacrolimus  2  mg ; methylprednisolone sodium succ  100  mg ; anti-thymocyte globulin (rabbit)  100  mg ; nifedipine cr  30  mg ; methylprednisolone sodium succ  50  mg ; nifedipine cr  120  mg ; transplant self medication program  1  bag ; tacrolimus  3  mg ; simethicone  40  mg ; 
dermatitis due to drugs and medicines taken internally gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia of other chronic disease eosinophilia uric acid metabolism drugs causing adverse effects in therapeutic use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney chronic kidney disease, stage iv (severe) hepatitis, unspecified acute kidney failure, unspecified
asian m 34 $nan$hematology blood hematocrit  22.5  %; hematology blood hematocrit  24.3  %; hematology blood hemoglobin  7.3  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  85  k ul; hematology blood platelet count  81  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  27  mg dl; hematology urine wbc  4  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  107  mg dl$heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; d5 1 2ns  1000  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; metoprolol tartrate  10  mg ; docusate sodium  100  mg ; heparin  5000  unit ; methylprednisolone sodium succ  50  mg ; nifedipine cr  120  mg ; transplant self medication program  1  bag ; tacrolimus  3  mg ; simethicone  40  mg ; oxycodone (immediate release)  5-10  mg ; 5% dextrose  250  ml ; sodium phosphate  30  mmol ; carvedilol  12.5  mg ; mycophenolate mofetil  500  mg ; tacrolimus  1  mg ; tacrolimus  5  mg ; trazodone  25  mg ; 
dermatitis due to drugs and medicines taken internally gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia of other chronic disease eosinophilia uric acid metabolism drugs causing adverse effects in therapeutic use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney chronic kidney disease, stage iv (severe) hepatitis, unspecified acute kidney failure, unspecified
asian m 34 $nan$hematology blood hematocrit  20.1  %; hematology blood hematocrit  22.7  %; hematology blood hemoglobin  6.5  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  62  k ul; hematology blood platelet count  76  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  136  mg dl$heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; metoprolol tartrate  10  mg ; docusate sodium  100  mg ; heparin  5000  unit ; nifedipine cr  120  mg ; transplant self medication program  1  bag ; oxycodone (immediate release)  5-10  mg ; 5% dextrose  250  ml ; sodium phosphate  30  mmol ; carvedilol  12.5  mg ; mycophenolate mofetil  500  mg ; tacrolimus  1  mg ; tacrolimus  5  mg ; trazodone  25  mg ; prednisone  25  mg ; 
dermatitis due to drugs and medicines taken internally gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia of other chronic disease eosinophilia uric acid metabolism drugs causing adverse effects in therapeutic use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney chronic kidney disease, stage iv (severe) hepatitis, unspecified acute kidney failure, unspecified
asian m 34 $nan$hematology blood hematocrit  22.2  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  88  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  102  mg dl$heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; metoprolol tartrate  10  mg ; docusate sodium  100  mg ; heparin  5000  unit ; nifedipine cr  120  mg ; transplant self medication program  1  bag ; oxycodone (immediate release)  5-10  mg ; carvedilol  12.5  mg ; mycophenolate mofetil  500  mg ; prednisone  25  mg ; 
dermatitis due to drugs and medicines taken internally gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia of other chronic disease eosinophilia uric acid metabolism drugs causing adverse effects in therapeutic use nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney chronic kidney disease, stage iv (severe) hepatitis, unspecified acute kidney failure, unspecified
white f 77 $nan$nan$aspirin  325  mg ; hydrochlorothiazide  25  mg ; amlodipine  5  mg ; calcium carbonate  500  mg ; olanzapine  20  mg ; 
 
white f 77 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  81  mg dl$aspirin  325  mg ; hydrochlorothiazide  25  mg ; amlodipine  5  mg ; calcium carbonate  500  mg ; olanzapine  20  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; simvastatin  10  mg ; diphenhydramine  12.5  mg ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; milk of magnesia  30  ml ; potassium chloride  80  meq ; 
 
white f 77 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  121  mg dl$aspirin  325  mg ; hydrochlorothiazide  25  mg ; amlodipine  5  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; simvastatin  10  mg ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; milk of magnesia  30  ml ; neutra-phos  1  pkt ; potassium chloride  40  meq ; 
 
white f 77 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  85  mg dl$aspirin  325  mg ; hydrochlorothiazide  25  mg ; amlodipine  5  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; simvastatin  10  mg ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; milk of magnesia  30  ml ; neutra-phos  1  pkt ; potassium chloride  40  meq ; potassium chloride  20  meq ; 
 
white f 77 $nan$nan$aspirin  325  mg ; amlodipine  5  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; simvastatin  10  mg ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; milk of magnesia  30  ml ; potassium chloride  20  meq ; metoprolol tartrate  12.5  mg ; 
 
white f 77 $nan$hematology urine wbc  82  # hpf$aspirin  325  mg ; amlodipine  5  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; simvastatin  10  mg ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; milk of magnesia  30  ml ; metoprolol tartrate  25  mg ; ciprofloxacin hcl  500  mg ; 
 
white f 77 $nan$nan$aspirin  325  mg ; amlodipine  5  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; simvastatin  10  mg ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; milk of magnesia  30  ml ; metoprolol tartrate  25  mg ; ciprofloxacin hcl  500  mg ; 
 
white m 58 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  114  mg dl; chemistry blood lactate dehydrogenase (ld)  286  iu l$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol-ipratropium  1-2  puff ; senna  1  tab ; ondansetron  4  mg ; lactulose enema  1000  ml ; heparin  5000  unit ; rifaximin  400  mg ; bupropion  75  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; levothyroxine sodium  100  mcg ; thiamine  100  mg ; lactulose  60  ml ; folic acid  1  mg ; cyanocobalamin  500  mcg ; calcium carbonate  500  mg ; venlafaxine xr  75  mg ; methylphenidate sr  20  mg ; furosemide  60  mg ; spironolactone  150  mg ; 
hepatic encephalopathy acute kidney failure, unspecified other and unspecified alcohol dependence, in remission other sequelae of chronic liver disease diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism alcoholic cirrhosis of liver dehydration chronic kidney disease, unspecified depressive disorder, not elsewhere classified diverticulosis of colon (without mention of hemorrhage) chronic airway obstruction, not elsewhere classified personal history of noncompliance with medical treatment, presenting hazards to health other specified disorders of stomach and duodenum constipation, unspecified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia of other chronic disease unspecified acquired hypothyroidism esophageal reflux other and unspecified alcohol dependence, in remission hepatic encephalopathy alcoholic cirrhosis of liver chronic airway obstruction, not elsewhere classified depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified personal history of noncompliance with medical treatment, presenting hazards to health unspecified pleural effusion tobacco use disorder anemia, unspecified hematemesis other and unspecified alcohol dependence, in remission alcoholic cirrhosis of liver unspecified acquired hypothyroidism chronic airway obstruction, not elsewhere classified malignant neoplasm of liver, primary diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other chest pain esophageal reflux awaiting organ transplant status diverticulosis of colon (without mention of hemorrhage) other and unspecified diseases of the oral soft tissues diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified acute kidney failure, unspecified malignant neoplasm of liver, primary
white m 58 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  122  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  146  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol-ipratropium  1-2  puff ; senna  1  tab ; ondansetron  4  mg ; lactulose enema  1000  ml ; heparin  5000  unit ; rifaximin  400  mg ; bupropion  75  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; levothyroxine sodium  100  mcg ; thiamine  100  mg ; lactulose  60  ml ; folic acid  1  mg ; cyanocobalamin  500  mcg ; calcium carbonate  500  mg ; venlafaxine xr  75  mg ; methylphenidate sr  20  mg ; furosemide  60  mg ; spironolactone  150  mg ; mucinex  1200  mg ; 
hepatic encephalopathy acute kidney failure, unspecified other and unspecified alcohol dependence, in remission other sequelae of chronic liver disease diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism alcoholic cirrhosis of liver dehydration chronic kidney disease, unspecified depressive disorder, not elsewhere classified diverticulosis of colon (without mention of hemorrhage) chronic airway obstruction, not elsewhere classified personal history of noncompliance with medical treatment, presenting hazards to health other specified disorders of stomach and duodenum constipation, unspecified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia of other chronic disease unspecified acquired hypothyroidism esophageal reflux other and unspecified alcohol dependence, in remission hepatic encephalopathy alcoholic cirrhosis of liver chronic airway obstruction, not elsewhere classified depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified personal history of noncompliance with medical treatment, presenting hazards to health unspecified pleural effusion tobacco use disorder anemia, unspecified hematemesis other and unspecified alcohol dependence, in remission alcoholic cirrhosis of liver unspecified acquired hypothyroidism chronic airway obstruction, not elsewhere classified malignant neoplasm of liver, primary diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other chest pain esophageal reflux awaiting organ transplant status diverticulosis of colon (without mention of hemorrhage) other and unspecified diseases of the oral soft tissues diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified acute kidney failure, unspecified malignant neoplasm of liver, primary
white m 58 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  34  mg dl; chemistry urine creatinine, urine  197  mg dl; chemistry urine sodium, urine  12  meq l; chemistry urine urea nitrogen, urine  709  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  117  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol-ipratropium  1-2  puff ; senna  1  tab ; ondansetron  4  mg ; heparin  5000  unit ; rifaximin  400  mg ; bupropion  75  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; levothyroxine sodium  100  mcg ; thiamine  100  mg ; lactulose  60  ml ; folic acid  1  mg ; cyanocobalamin  500  mcg ; calcium carbonate  500  mg ; venlafaxine xr  75  mg ; methylphenidate sr  20  mg ; furosemide  60  mg ; spironolactone  150  mg ; mucinex  1200  mg ; albumin 25% (12.5g   50ml)  100  g ; 
hepatic encephalopathy acute kidney failure, unspecified other and unspecified alcohol dependence, in remission other sequelae of chronic liver disease diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism alcoholic cirrhosis of liver dehydration chronic kidney disease, unspecified depressive disorder, not elsewhere classified diverticulosis of colon (without mention of hemorrhage) chronic airway obstruction, not elsewhere classified personal history of noncompliance with medical treatment, presenting hazards to health other specified disorders of stomach and duodenum constipation, unspecified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia of other chronic disease unspecified acquired hypothyroidism esophageal reflux other and unspecified alcohol dependence, in remission hepatic encephalopathy alcoholic cirrhosis of liver chronic airway obstruction, not elsewhere classified depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified personal history of noncompliance with medical treatment, presenting hazards to health unspecified pleural effusion tobacco use disorder anemia, unspecified hematemesis other and unspecified alcohol dependence, in remission alcoholic cirrhosis of liver unspecified acquired hypothyroidism chronic airway obstruction, not elsewhere classified malignant neoplasm of liver, primary diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other chest pain esophageal reflux awaiting organ transplant status diverticulosis of colon (without mention of hemorrhage) other and unspecified diseases of the oral soft tissues diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified acute kidney failure, unspecified malignant neoplasm of liver, primary
white m 58 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  110  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol-ipratropium  1-2  puff ; senna  1  tab ; ondansetron  4  mg ; heparin  5000  unit ; rifaximin  400  mg ; bupropion  75  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; levothyroxine sodium  100  mcg ; thiamine  100  mg ; lactulose  60  ml ; folic acid  1  mg ; cyanocobalamin  500  mcg ; calcium carbonate  500  mg ; venlafaxine xr  75  mg ; methylphenidate sr  20  mg ; mucinex  1200  mg ; albumin 25% (12.5g   50ml)  100  g ; 
hepatic encephalopathy acute kidney failure, unspecified other and unspecified alcohol dependence, in remission other sequelae of chronic liver disease diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism alcoholic cirrhosis of liver dehydration chronic kidney disease, unspecified depressive disorder, not elsewhere classified diverticulosis of colon (without mention of hemorrhage) chronic airway obstruction, not elsewhere classified personal history of noncompliance with medical treatment, presenting hazards to health other specified disorders of stomach and duodenum constipation, unspecified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia of other chronic disease unspecified acquired hypothyroidism esophageal reflux other and unspecified alcohol dependence, in remission hepatic encephalopathy alcoholic cirrhosis of liver chronic airway obstruction, not elsewhere classified depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified personal history of noncompliance with medical treatment, presenting hazards to health unspecified pleural effusion tobacco use disorder anemia, unspecified hematemesis other and unspecified alcohol dependence, in remission alcoholic cirrhosis of liver unspecified acquired hypothyroidism chronic airway obstruction, not elsewhere classified malignant neoplasm of liver, primary diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other chest pain esophageal reflux awaiting organ transplant status diverticulosis of colon (without mention of hemorrhage) other and unspecified diseases of the oral soft tissues diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified acute kidney failure, unspecified malignant neoplasm of liver, primary
white m 58 $nan$hematology blood hematocrit  22.6  %; hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  107  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol-ipratropium  1-2  puff ; senna  1  tab ; ondansetron  4  mg ; heparin  5000  unit ; rifaximin  400  mg ; bupropion  75  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; levothyroxine sodium  100  mcg ; thiamine  100  mg ; folic acid  1  mg ; cyanocobalamin  500  mcg ; calcium carbonate  500  mg ; venlafaxine xr  75  mg ; methylphenidate sr  20  mg ; mucinex  1200  mg ; 
hepatic encephalopathy acute kidney failure, unspecified other and unspecified alcohol dependence, in remission other sequelae of chronic liver disease diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism alcoholic cirrhosis of liver dehydration chronic kidney disease, unspecified depressive disorder, not elsewhere classified diverticulosis of colon (without mention of hemorrhage) chronic airway obstruction, not elsewhere classified personal history of noncompliance with medical treatment, presenting hazards to health other specified disorders of stomach and duodenum constipation, unspecified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia of other chronic disease unspecified acquired hypothyroidism esophageal reflux other and unspecified alcohol dependence, in remission hepatic encephalopathy alcoholic cirrhosis of liver chronic airway obstruction, not elsewhere classified depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified personal history of noncompliance with medical treatment, presenting hazards to health unspecified pleural effusion tobacco use disorder anemia, unspecified hematemesis other and unspecified alcohol dependence, in remission alcoholic cirrhosis of liver unspecified acquired hypothyroidism chronic airway obstruction, not elsewhere classified malignant neoplasm of liver, primary diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other chest pain esophageal reflux awaiting organ transplant status diverticulosis of colon (without mention of hemorrhage) other and unspecified diseases of the oral soft tissues diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified acute kidney failure, unspecified malignant neoplasm of liver, primary
white m 34 $temp  98.2  heartrate  80.0  resprate  18.0  o2sat  99.0  sbp  111.0  dbp  66.0  rhythm    pain  9  $hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  158  iu l; chemistry blood albumin  4.0  g dl$sodium chloride 0.9%  flush  3-10  ml ; morphine sulfate  4  mg ; senna  8.6  mg ; heparin  7800  unit ; heparin  2000-3900  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; fentanyl patch  50  mcg h ; levetiracetam  750  mg ; warfarin  7.5  mg ; fentanyl patch  25  mcg h ; sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)  5  mg ; 
fall on same level, unspecified, initial encounter nicotine dependence, cigarettes, uncomplicated homelessness unspecified place or not applicable chest pain, unspecified transient cerebral ischemic attack, unspecified patient's other noncompliance with medication regimen factitious disorder imposed on self, unspecified hereditary deficiency of other clotting factors headache old myocardial infarction other chest pain weakness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anxiety disorder, unspecified tobacco use other chronic pain personal history of other venous thrombosis and embolism epilepsy, unspecified, not intractable, without status epilepticus activated protein c resistance dorsalgia, unspecified homelessness acidosis major depressive disorder, single episode, unspecified factitious disorder imposed on self, unspecified schizoaffective disorder, unspecified personal history of pulmonary embolism hereditary deficiency of other clotting factors old myocardial infarction schizoaffective disorder, unspecified personal history of other venous thrombosis and embolism hemiplegia and hemiparesis following cerebral infarction affecting right dominant side nicotine dependence, cigarettes, uncomplicated hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side personal history of pulmonary embolism tachycardia, unspecified long term (current) use of anticoagulants other chest pain epilepsy, unspecified, not intractable, without status epilepticus other chronic pain chest pain, unspecified other malaise and fatigue depressive disorder, not elsewhere classified congenital deficiency of other clotting factors personal history of noncompliance with medical treatment, presenting hazards to health long-term (current) use of anticoagulants schizoaffective disorder, unspecified other musculoskeletal symptoms referable to limbs
white m 34 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3-10  ml ; morphine sulfate  4  mg ; senna  8.6  mg ; heparin  7800  unit ; heparin  2000-3900  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; levetiracetam  750  mg ; warfarin  7.5  mg ; fentanyl patch  25  mcg h ; sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)  5  mg ; 
fall on same level, unspecified, initial encounter nicotine dependence, cigarettes, uncomplicated homelessness unspecified place or not applicable chest pain, unspecified transient cerebral ischemic attack, unspecified patient's other noncompliance with medication regimen factitious disorder imposed on self, unspecified hereditary deficiency of other clotting factors headache old myocardial infarction other chest pain weakness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anxiety disorder, unspecified tobacco use other chronic pain personal history of other venous thrombosis and embolism epilepsy, unspecified, not intractable, without status epilepticus activated protein c resistance dorsalgia, unspecified homelessness acidosis major depressive disorder, single episode, unspecified factitious disorder imposed on self, unspecified schizoaffective disorder, unspecified personal history of pulmonary embolism hereditary deficiency of other clotting factors old myocardial infarction schizoaffective disorder, unspecified personal history of other venous thrombosis and embolism hemiplegia and hemiparesis following cerebral infarction affecting right dominant side nicotine dependence, cigarettes, uncomplicated hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side personal history of pulmonary embolism tachycardia, unspecified long term (current) use of anticoagulants other chest pain epilepsy, unspecified, not intractable, without status epilepticus other chronic pain chest pain, unspecified other malaise and fatigue depressive disorder, not elsewhere classified congenital deficiency of other clotting factors personal history of noncompliance with medical treatment, presenting hazards to health long-term (current) use of anticoagulants schizoaffective disorder, unspecified other musculoskeletal symptoms referable to limbs
white m 34 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; heparin  2000-3900  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; levetiracetam  750  mg ; warfarin  7.5  mg ; fentanyl patch  25  mcg h ; sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)  5  mg ; trazodone  25  mg ; guaifenesin  5-10  ml ; 
fall on same level, unspecified, initial encounter nicotine dependence, cigarettes, uncomplicated homelessness unspecified place or not applicable chest pain, unspecified transient cerebral ischemic attack, unspecified patient's other noncompliance with medication regimen factitious disorder imposed on self, unspecified hereditary deficiency of other clotting factors headache old myocardial infarction other chest pain weakness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anxiety disorder, unspecified tobacco use other chronic pain personal history of other venous thrombosis and embolism epilepsy, unspecified, not intractable, without status epilepticus activated protein c resistance dorsalgia, unspecified homelessness acidosis major depressive disorder, single episode, unspecified factitious disorder imposed on self, unspecified schizoaffective disorder, unspecified personal history of pulmonary embolism hereditary deficiency of other clotting factors old myocardial infarction schizoaffective disorder, unspecified personal history of other venous thrombosis and embolism hemiplegia and hemiparesis following cerebral infarction affecting right dominant side nicotine dependence, cigarettes, uncomplicated hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side personal history of pulmonary embolism tachycardia, unspecified long term (current) use of anticoagulants other chest pain epilepsy, unspecified, not intractable, without status epilepticus other chronic pain chest pain, unspecified other malaise and fatigue depressive disorder, not elsewhere classified congenital deficiency of other clotting factors personal history of noncompliance with medical treatment, presenting hazards to health long-term (current) use of anticoagulants schizoaffective disorder, unspecified other musculoskeletal symptoms referable to limbs
white m 34 $nan$hematology blood inr(pt)  1.5  $sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; heparin  2000-3900  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; levetiracetam  750  mg ; warfarin  7.5  mg ; fentanyl patch  25  mcg h ; sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)  5  mg ; trazodone  25  mg ; guaifenesin  5-10  ml ; heparin flush (5000 units ml)  5000  unit ; heparin flush (100 units ml)  5  ml ; 
fall on same level, unspecified, initial encounter nicotine dependence, cigarettes, uncomplicated homelessness unspecified place or not applicable chest pain, unspecified transient cerebral ischemic attack, unspecified patient's other noncompliance with medication regimen factitious disorder imposed on self, unspecified hereditary deficiency of other clotting factors headache old myocardial infarction other chest pain weakness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anxiety disorder, unspecified tobacco use other chronic pain personal history of other venous thrombosis and embolism epilepsy, unspecified, not intractable, without status epilepticus activated protein c resistance dorsalgia, unspecified homelessness acidosis major depressive disorder, single episode, unspecified factitious disorder imposed on self, unspecified schizoaffective disorder, unspecified personal history of pulmonary embolism hereditary deficiency of other clotting factors old myocardial infarction schizoaffective disorder, unspecified personal history of other venous thrombosis and embolism hemiplegia and hemiparesis following cerebral infarction affecting right dominant side nicotine dependence, cigarettes, uncomplicated hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side personal history of pulmonary embolism tachycardia, unspecified long term (current) use of anticoagulants other chest pain epilepsy, unspecified, not intractable, without status epilepticus other chronic pain chest pain, unspecified other malaise and fatigue depressive disorder, not elsewhere classified congenital deficiency of other clotting factors personal history of noncompliance with medical treatment, presenting hazards to health long-term (current) use of anticoagulants schizoaffective disorder, unspecified other musculoskeletal symptoms referable to limbs
white f 88 $temp  98.1  heartrate  94.0  resprate  18.0  o2sat  95.0  sbp  143.0  dbp  69.0  rhythm    pain    $nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  1-2  mg ; docusate sodium  100  mg ; senna  17.2  mg ; hydroxyurea  500  mg ; metoprolol tartrate  5  mg ; sertraline  50  mg ; omeprazole  40  mg ; heparin  5000  unit ; levothyroxine sodium  50  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; amlodipine  5  mg ; multivitamins  1  tab ; furosemide  20  mg ; pravastatin  20  mg ; metoprolol tartrate  50  mg ; 
other specified disorders of bone density and structure, unspecified site presence of xenogenic heart valve calculus of gallbladder with chronic cholecystitis without obstruction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified hypothyroidism, unspecified gastro-esophageal reflux disease without esophagitis personal history of traumatic brain injury major depressive disorder, single episode, unspecified personal history of other malignant neoplasm of skin hyperlipidemia, unspecified polycythemia vera unspecified atrial fibrillation dehydration hyperosmolality and hypernatremia calculus of bile duct without cholangitis or cholecystitis with obstruction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease disorientation, unspecified major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis long term (current) use of aspirin presence of prosthetic heart valve do not resuscitate palpitations personal history of nicotine dependence personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits encounter for examination for normal comparison and control in clinical research program personal history of other malignant neoplasm of skin hypothyroidism, unspecified chronic kidney disease, unspecified hyperlipidemia, unspecified diverticulosis of small intestine without perforation or abscess without bleeding pure hypercholesterolemia polycythemia vera
white f 88 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  362  k ul$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  1-2  mg ; docusate sodium  100  mg ; senna  17.2  mg ; hydroxyurea  500  mg ; sertraline  50  mg ; omeprazole  40  mg ; heparin  5000  unit ; levothyroxine sodium  50  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; amlodipine  5  mg ; multivitamins  1  tab ; furosemide  20  mg ; pravastatin  20  mg ; metoprolol tartrate  50  mg ; aspirin  81  mg ; amoxicillin-clavulanic acid  875  mg ; 
other specified disorders of bone density and structure, unspecified site presence of xenogenic heart valve calculus of gallbladder with chronic cholecystitis without obstruction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified hypothyroidism, unspecified gastro-esophageal reflux disease without esophagitis personal history of traumatic brain injury major depressive disorder, single episode, unspecified personal history of other malignant neoplasm of skin hyperlipidemia, unspecified polycythemia vera unspecified atrial fibrillation dehydration hyperosmolality and hypernatremia calculus of bile duct without cholangitis or cholecystitis with obstruction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease disorientation, unspecified major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis long term (current) use of aspirin presence of prosthetic heart valve do not resuscitate palpitations personal history of nicotine dependence personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits encounter for examination for normal comparison and control in clinical research program personal history of other malignant neoplasm of skin hypothyroidism, unspecified chronic kidney disease, unspecified hyperlipidemia, unspecified diverticulosis of small intestine without perforation or abscess without bleeding pure hypercholesterolemia polycythemia vera
white f 53 $nan$nan$citalopram hydrobromide  40  mg ; levothyroxine sodium  50  mcg ; 
paralytic ileus posttraumatic stress disorder myalgia and myositis, unspecified other chronic nonalcoholic liver disease other b-complex deficiencies unspecified acquired hypothyroidism iron deficiency anemia, unspecified dysthymic disorder pneumonitis due to inhalation of food or vomitus regional enteritis of unspecified site unspecified acquired hypothyroidism other and unspecified postsurgical nonabsorption iron deficiency anemia, unspecified herpes simplex without mention of complication regional enteritis of unspecified site posttraumatic stress disorder other chronic pain staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus bacteremia abdominal pain, right lower quadrant secondary hyperparathyroidism (of renal origin) dysthymic disorder pneumonia, organism unspecified other and unspecified infection due to central venous catheter
white f 53 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  2.8  ; hematology blood inr(pt)  2.9  ; hematology blood inr(pt)  2.9  ; hematology urine wbc  12  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  219  iu l; chemistry blood albumin  4.3  g dl$citalopram hydrobromide  40  mg ; levothyroxine sodium  50  mcg ; d5w  250  ml ; argatroban  250  mg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; senna  1  tab ; vitamin d  50,000  unit ; hydromorphone (dilaudid)  2-4  mg ; oxazepam  15  mg ; promethazine  6.25  mg ; tramadol (ultram)  50  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; d5w  200  ml ; ciprofloxacin iv  400  mg ; ethanol 70% catheter lock  5  ml ; hydromorphone (dilaudid)  3  mg ; diazepam  5  mg ; diphenhydramine  50  mg ; diazepam  10  mg ; ethanol (ethyl alcohol)  3  ml ; sw  50  ml ; magnesium sulfate  4  gm ; docusate sodium (liquid)  100  mg ; ciprofloxacin hcl  500  mg ; potassium chloride  60  meq ; magnesium oxide  800  mg ; hydromorphone (dilaudid)  3-4  mg ; aspirin  325  mg ; 
paralytic ileus posttraumatic stress disorder myalgia and myositis, unspecified other chronic nonalcoholic liver disease other b-complex deficiencies unspecified acquired hypothyroidism iron deficiency anemia, unspecified dysthymic disorder pneumonitis due to inhalation of food or vomitus regional enteritis of unspecified site unspecified acquired hypothyroidism other and unspecified postsurgical nonabsorption iron deficiency anemia, unspecified herpes simplex without mention of complication regional enteritis of unspecified site posttraumatic stress disorder other chronic pain staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus bacteremia abdominal pain, right lower quadrant secondary hyperparathyroidism (of renal origin) dysthymic disorder pneumonia, organism unspecified other and unspecified infection due to central venous catheter
white f 53 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  3.1  ; hematology blood inr(pt)  3.5  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  103  mg dl$warfarin  1  mg ; warfarin  2  mg ; warfarin  10  mg ; warfarin  5  mg ; citalopram hydrobromide  40  mg ; levothyroxine sodium  50  mcg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; senna  1  tab ; vitamin d  50,000  unit ; oxazepam  15  mg ; promethazine  6.25  mg ; tramadol (ultram)  50  mg ; diazepam  5  mg ; diphenhydramine  50  mg ; diazepam  10  mg ; ethanol (ethyl alcohol)  3  ml ; docusate sodium (liquid)  100  mg ; magnesium oxide  800  mg ; hydromorphone (dilaudid)  3-4  mg ; aspirin  325  mg ; hydromorphone (dilaudid)  1  mg ; warfarin  8  mg ; promethazine  12.5  mg ; potassium chloride  40  meq ; 
paralytic ileus posttraumatic stress disorder myalgia and myositis, unspecified other chronic nonalcoholic liver disease other b-complex deficiencies unspecified acquired hypothyroidism iron deficiency anemia, unspecified dysthymic disorder pneumonitis due to inhalation of food or vomitus regional enteritis of unspecified site unspecified acquired hypothyroidism other and unspecified postsurgical nonabsorption iron deficiency anemia, unspecified herpes simplex without mention of complication regional enteritis of unspecified site posttraumatic stress disorder other chronic pain staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus bacteremia abdominal pain, right lower quadrant secondary hyperparathyroidism (of renal origin) dysthymic disorder pneumonia, organism unspecified other and unspecified infection due to central venous catheter
white f 53 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  93  mg dl$warfarin  5  mg ; citalopram hydrobromide  40  mg ; levothyroxine sodium  50  mcg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; senna  1  tab ; vitamin d  50,000  unit ; oxazepam  15  mg ; tramadol (ultram)  50  mg ; diazepam  5  mg ; diazepam  10  mg ; docusate sodium (liquid)  100  mg ; hydromorphone (dilaudid)  1  mg ; promethazine  12.5  mg ; potassium chloride  40  meq ; diphenhydramine  25  mg ; 
paralytic ileus posttraumatic stress disorder myalgia and myositis, unspecified other chronic nonalcoholic liver disease other b-complex deficiencies unspecified acquired hypothyroidism iron deficiency anemia, unspecified dysthymic disorder pneumonitis due to inhalation of food or vomitus regional enteritis of unspecified site unspecified acquired hypothyroidism other and unspecified postsurgical nonabsorption iron deficiency anemia, unspecified herpes simplex without mention of complication regional enteritis of unspecified site posttraumatic stress disorder other chronic pain staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus bacteremia abdominal pain, right lower quadrant secondary hyperparathyroidism (of renal origin) dysthymic disorder pneumonia, organism unspecified other and unspecified infection due to central venous catheter
white f 53 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  3.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  98  mg dl$warfarin  5  mg ; citalopram hydrobromide  40  mg ; levothyroxine sodium  50  mcg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; senna  1  tab ; vitamin d  50,000  unit ; oxazepam  15  mg ; tramadol (ultram)  50  mg ; diazepam  5  mg ; diazepam  10  mg ; docusate sodium (liquid)  100  mg ; hydromorphone (dilaudid)  1  mg ; promethazine  12.5  mg ; diphenhydramine  25  mg ; sw  100  ml ; 
paralytic ileus posttraumatic stress disorder myalgia and myositis, unspecified other chronic nonalcoholic liver disease other b-complex deficiencies unspecified acquired hypothyroidism iron deficiency anemia, unspecified dysthymic disorder pneumonitis due to inhalation of food or vomitus regional enteritis of unspecified site unspecified acquired hypothyroidism other and unspecified postsurgical nonabsorption iron deficiency anemia, unspecified herpes simplex without mention of complication regional enteritis of unspecified site posttraumatic stress disorder other chronic pain staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus bacteremia abdominal pain, right lower quadrant secondary hyperparathyroidism (of renal origin) dysthymic disorder pneumonia, organism unspecified other and unspecified infection due to central venous catheter
white f 53 $nan$nan$warfarin  5  mg ; citalopram hydrobromide  40  mg ; levothyroxine sodium  50  mcg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; senna  1  tab ; vitamin d  50,000  unit ; oxazepam  15  mg ; tramadol (ultram)  50  mg ; diazepam  5  mg ; diazepam  10  mg ; docusate sodium (liquid)  100  mg ; hydromorphone (dilaudid)  1  mg ; promethazine  12.5  mg ; 
paralytic ileus posttraumatic stress disorder myalgia and myositis, unspecified other chronic nonalcoholic liver disease other b-complex deficiencies unspecified acquired hypothyroidism iron deficiency anemia, unspecified dysthymic disorder pneumonitis due to inhalation of food or vomitus regional enteritis of unspecified site unspecified acquired hypothyroidism other and unspecified postsurgical nonabsorption iron deficiency anemia, unspecified herpes simplex without mention of complication regional enteritis of unspecified site posttraumatic stress disorder other chronic pain staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus bacteremia abdominal pain, right lower quadrant secondary hyperparathyroidism (of renal origin) dysthymic disorder pneumonia, organism unspecified other and unspecified infection due to central venous catheter
white f 73 $temp  98.1  heartrate  97.0  resprate  16.0  o2sat  97.0  sbp  131.0  dbp  56.0  rhythm    pain  5  $hematology blood hematocrit  39.6  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  403  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  266  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; allopurinol  300  mg ; aspirin  81  mg ; atorvastatin  10  mg ; bupropion  75  mg ; creon 12  1  cap ; ferrous sulfate  325  mg ; sertraline  100  mg ; tramadol (ultram)  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  20  unit ; bag  1  bag ; magnesium sulfate  2  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; ciprofloxacin hcl  250  mg ; 
 
white f 73 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; allopurinol  300  mg ; aspirin  81  mg ; atorvastatin  10  mg ; bupropion  75  mg ; ferrous sulfate  325  mg ; sertraline  100  mg ; tramadol (ultram)  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  20  unit ; bag  1  bag ; magnesium sulfate  2  gm ; ciprofloxacin hcl  250  mg ; creon 12  2  cap ; 
 
white m 84 $temp  97.8  heartrate  62.0  resprate  20.0  o2sat  97.0  sbp  92.0  dbp  61.0  rhythm    pain    ; temp    heartrate    resprate    o2sat    sbp  119.0  dbp  65.0  rhythm    pain    ; temp  97.5  heartrate  54.0  resprate  16.0  o2sat  99.0  sbp  109.0  dbp  55.0  rhythm    pain  0  ; temp  98.0  heartrate  57.0  resprate  14.0  o2sat  99.0  sbp  107.0  dbp  56.0  rhythm    pain  0  ; temp  97.4  heartrate  66.0  resprate  16.0  o2sat  96.0  sbp  105.0  dbp  53.0  rhythm    pain    $hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  65  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  1  # hpf; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  209  mg dl; chemistry blood albumin  3.3  g dl$nan
other ascites angiodysplasia of stomach and duodenum with hemorrhage unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery esophageal varices in diseases classified elsewhere, without mention of bleeding percutaneous transluminal coronary angioplasty status other and unspecified noninfectious gastroenteritis and colitis cirrhosis of liver without mention of alcohol hepatic encephalopathy long-term (current) use of insulin peripheral vascular disease, unspecified acute kidney failure, unspecified personal history of malignant neoplasm of liver personal history of tobacco use acidosis benign neoplasm of stomach dehydration unspecified hereditary and idiopathic peripheral neuropathy angiodysplasia of stomach and duodenum with hemorrhage personal history of malignant neoplasm of liver long-term (current) use of insulin peripheral vascular disease, unspecified unspecified essential hypertension percutaneous transluminal coronary angioplasty status personal history of tobacco use essential and other specified forms of tremor other ascites hepatic encephalopathy long-term (current) use of aspirin staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus polyneuropathy in diabetes cirrhosis of liver without mention of alcohol personal history of colonic polyps coronary atherosclerosis of native coronary artery diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified personal history of tobacco use hyposmolality and/or hyponatremia personal history of colonic polyps peripheral vascular disease, unspecified urinary tract infection, site not specified esophageal reflux other ascites external hemorrhoids without mention of complication iron and its compounds causing adverse effects in therapeutic use other constipation acquired absence of organ, genital organs
white m 84 $temp  97.9  heartrate  61.0  resprate  16.0  o2sat  99.0  sbp  107.0  dbp  89.0  rhythm    pain    $hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  45  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  141  mg dl; chemistry blood albumin  2.7  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; lactulose  30  ml ; multivitamins  1  tab ; nadolol  40  mg ; omeprazole  20  mg ; repaglinide  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; rifaximin  550  mg ; spironolactone  50  mg ; vitamin e  400  unit ; ciprofloxacin hcl  250  mg ; torsemide  10  mg ; insulin  0  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; albumin 25% (12.5g   50ml)  25  g ; 
other ascites angiodysplasia of stomach and duodenum with hemorrhage unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery esophageal varices in diseases classified elsewhere, without mention of bleeding percutaneous transluminal coronary angioplasty status other and unspecified noninfectious gastroenteritis and colitis cirrhosis of liver without mention of alcohol hepatic encephalopathy long-term (current) use of insulin peripheral vascular disease, unspecified acute kidney failure, unspecified personal history of malignant neoplasm of liver personal history of tobacco use acidosis benign neoplasm of stomach dehydration unspecified hereditary and idiopathic peripheral neuropathy angiodysplasia of stomach and duodenum with hemorrhage personal history of malignant neoplasm of liver long-term (current) use of insulin peripheral vascular disease, unspecified unspecified essential hypertension percutaneous transluminal coronary angioplasty status personal history of tobacco use essential and other specified forms of tremor other ascites hepatic encephalopathy long-term (current) use of aspirin staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus polyneuropathy in diabetes cirrhosis of liver without mention of alcohol personal history of colonic polyps coronary atherosclerosis of native coronary artery diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified personal history of tobacco use hyposmolality and/or hyponatremia personal history of colonic polyps peripheral vascular disease, unspecified urinary tract infection, site not specified esophageal reflux other ascites external hemorrhoids without mention of complication iron and its compounds causing adverse effects in therapeutic use other constipation acquired absence of organ, genital organs
white m 84 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  47  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  136  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; lactulose  30  ml ; multivitamins  1  tab ; omeprazole  20  mg ; repaglinide  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; rifaximin  550  mg ; vitamin e  400  unit ; ciprofloxacin hcl  250  mg ; insulin  0  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; albumin 25% (12.5g   50ml)  25  g ; metformin (glucophage)  1000  mg ; 
other ascites angiodysplasia of stomach and duodenum with hemorrhage unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery esophageal varices in diseases classified elsewhere, without mention of bleeding percutaneous transluminal coronary angioplasty status other and unspecified noninfectious gastroenteritis and colitis cirrhosis of liver without mention of alcohol hepatic encephalopathy long-term (current) use of insulin peripheral vascular disease, unspecified acute kidney failure, unspecified personal history of malignant neoplasm of liver personal history of tobacco use acidosis benign neoplasm of stomach dehydration unspecified hereditary and idiopathic peripheral neuropathy angiodysplasia of stomach and duodenum with hemorrhage personal history of malignant neoplasm of liver long-term (current) use of insulin peripheral vascular disease, unspecified unspecified essential hypertension percutaneous transluminal coronary angioplasty status personal history of tobacco use essential and other specified forms of tremor other ascites hepatic encephalopathy long-term (current) use of aspirin staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus polyneuropathy in diabetes cirrhosis of liver without mention of alcohol personal history of colonic polyps coronary atherosclerosis of native coronary artery diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified personal history of tobacco use hyposmolality and/or hyponatremia personal history of colonic polyps peripheral vascular disease, unspecified urinary tract infection, site not specified esophageal reflux other ascites external hemorrhoids without mention of complication iron and its compounds causing adverse effects in therapeutic use other constipation acquired absence of organ, genital organs
white m 84 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  50  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  185  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; lactulose  30  ml ; multivitamins  1  tab ; omeprazole  20  mg ; repaglinide  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; rifaximin  550  mg ; vitamin e  400  unit ; ciprofloxacin hcl  250  mg ; insulin  0  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; metformin (glucophage)  1000  mg ; 
other ascites angiodysplasia of stomach and duodenum with hemorrhage unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery esophageal varices in diseases classified elsewhere, without mention of bleeding percutaneous transluminal coronary angioplasty status other and unspecified noninfectious gastroenteritis and colitis cirrhosis of liver without mention of alcohol hepatic encephalopathy long-term (current) use of insulin peripheral vascular disease, unspecified acute kidney failure, unspecified personal history of malignant neoplasm of liver personal history of tobacco use acidosis benign neoplasm of stomach dehydration unspecified hereditary and idiopathic peripheral neuropathy angiodysplasia of stomach and duodenum with hemorrhage personal history of malignant neoplasm of liver long-term (current) use of insulin peripheral vascular disease, unspecified unspecified essential hypertension percutaneous transluminal coronary angioplasty status personal history of tobacco use essential and other specified forms of tremor other ascites hepatic encephalopathy long-term (current) use of aspirin staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus polyneuropathy in diabetes cirrhosis of liver without mention of alcohol personal history of colonic polyps coronary atherosclerosis of native coronary artery diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified personal history of tobacco use hyposmolality and/or hyponatremia personal history of colonic polyps peripheral vascular disease, unspecified urinary tract infection, site not specified esophageal reflux other ascites external hemorrhoids without mention of complication iron and its compounds causing adverse effects in therapeutic use other constipation acquired absence of organ, genital organs
white m 84 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  55  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  180  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; multivitamins  1  tab ; omeprazole  20  mg ; repaglinide  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; rifaximin  550  mg ; vitamin e  400  unit ; ciprofloxacin hcl  250  mg ; insulin  0  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; metformin (glucophage)  1000  mg ; 
other ascites angiodysplasia of stomach and duodenum with hemorrhage unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery esophageal varices in diseases classified elsewhere, without mention of bleeding percutaneous transluminal coronary angioplasty status other and unspecified noninfectious gastroenteritis and colitis cirrhosis of liver without mention of alcohol hepatic encephalopathy long-term (current) use of insulin peripheral vascular disease, unspecified acute kidney failure, unspecified personal history of malignant neoplasm of liver personal history of tobacco use acidosis benign neoplasm of stomach dehydration unspecified hereditary and idiopathic peripheral neuropathy angiodysplasia of stomach and duodenum with hemorrhage personal history of malignant neoplasm of liver long-term (current) use of insulin peripheral vascular disease, unspecified unspecified essential hypertension percutaneous transluminal coronary angioplasty status personal history of tobacco use essential and other specified forms of tremor other ascites hepatic encephalopathy long-term (current) use of aspirin staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus polyneuropathy in diabetes cirrhosis of liver without mention of alcohol personal history of colonic polyps coronary atherosclerosis of native coronary artery diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified personal history of tobacco use hyposmolality and/or hyponatremia personal history of colonic polyps peripheral vascular disease, unspecified urinary tract infection, site not specified esophageal reflux other ascites external hemorrhoids without mention of complication iron and its compounds causing adverse effects in therapeutic use other constipation acquired absence of organ, genital organs
white m 84 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  45  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  160  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; multivitamins  1  tab ; omeprazole  20  mg ; repaglinide  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; rifaximin  550  mg ; vitamin e  400  unit ; ciprofloxacin hcl  250  mg ; insulin  0  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; metformin (glucophage)  1000  mg ; albumin 25% (12.5g   50ml)  50  g ; lactulose enema  1000  ml ; potassium chloride (powder)  40  meq ; potassium chloride  40  meq ; 
other ascites angiodysplasia of stomach and duodenum with hemorrhage unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery esophageal varices in diseases classified elsewhere, without mention of bleeding percutaneous transluminal coronary angioplasty status other and unspecified noninfectious gastroenteritis and colitis cirrhosis of liver without mention of alcohol hepatic encephalopathy long-term (current) use of insulin peripheral vascular disease, unspecified acute kidney failure, unspecified personal history of malignant neoplasm of liver personal history of tobacco use acidosis benign neoplasm of stomach dehydration unspecified hereditary and idiopathic peripheral neuropathy angiodysplasia of stomach and duodenum with hemorrhage personal history of malignant neoplasm of liver long-term (current) use of insulin peripheral vascular disease, unspecified unspecified essential hypertension percutaneous transluminal coronary angioplasty status personal history of tobacco use essential and other specified forms of tremor other ascites hepatic encephalopathy long-term (current) use of aspirin staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus polyneuropathy in diabetes cirrhosis of liver without mention of alcohol personal history of colonic polyps coronary atherosclerosis of native coronary artery diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified personal history of tobacco use hyposmolality and/or hyponatremia personal history of colonic polyps peripheral vascular disease, unspecified urinary tract infection, site not specified esophageal reflux other ascites external hemorrhoids without mention of complication iron and its compounds causing adverse effects in therapeutic use other constipation acquired absence of organ, genital organs
white m 84 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  49  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  180  mg dl; chemistry blood albumin  3.1  g dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; multivitamins  1  tab ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; rifaximin  550  mg ; vitamin e  400  unit ; ciprofloxacin hcl  250  mg ; insulin  0  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; albumin 25% (12.5g   50ml)  50  g ; lactulose enema  1000  ml ; potassium chloride  40  meq ; 
other ascites angiodysplasia of stomach and duodenum with hemorrhage unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery esophageal varices in diseases classified elsewhere, without mention of bleeding percutaneous transluminal coronary angioplasty status other and unspecified noninfectious gastroenteritis and colitis cirrhosis of liver without mention of alcohol hepatic encephalopathy long-term (current) use of insulin peripheral vascular disease, unspecified acute kidney failure, unspecified personal history of malignant neoplasm of liver personal history of tobacco use acidosis benign neoplasm of stomach dehydration unspecified hereditary and idiopathic peripheral neuropathy angiodysplasia of stomach and duodenum with hemorrhage personal history of malignant neoplasm of liver long-term (current) use of insulin peripheral vascular disease, unspecified unspecified essential hypertension percutaneous transluminal coronary angioplasty status personal history of tobacco use essential and other specified forms of tremor other ascites hepatic encephalopathy long-term (current) use of aspirin staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus polyneuropathy in diabetes cirrhosis of liver without mention of alcohol personal history of colonic polyps coronary atherosclerosis of native coronary artery diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified personal history of tobacco use hyposmolality and/or hyponatremia personal history of colonic polyps peripheral vascular disease, unspecified urinary tract infection, site not specified esophageal reflux other ascites external hemorrhoids without mention of complication iron and its compounds causing adverse effects in therapeutic use other constipation acquired absence of organ, genital organs
white m 84 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  48  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  139  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; multivitamins  1  tab ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; rifaximin  550  mg ; vitamin e  400  unit ; ciprofloxacin hcl  250  mg ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; 
other ascites angiodysplasia of stomach and duodenum with hemorrhage unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery esophageal varices in diseases classified elsewhere, without mention of bleeding percutaneous transluminal coronary angioplasty status other and unspecified noninfectious gastroenteritis and colitis cirrhosis of liver without mention of alcohol hepatic encephalopathy long-term (current) use of insulin peripheral vascular disease, unspecified acute kidney failure, unspecified personal history of malignant neoplasm of liver personal history of tobacco use acidosis benign neoplasm of stomach dehydration unspecified hereditary and idiopathic peripheral neuropathy angiodysplasia of stomach and duodenum with hemorrhage personal history of malignant neoplasm of liver long-term (current) use of insulin peripheral vascular disease, unspecified unspecified essential hypertension percutaneous transluminal coronary angioplasty status personal history of tobacco use essential and other specified forms of tremor other ascites hepatic encephalopathy long-term (current) use of aspirin staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus polyneuropathy in diabetes cirrhosis of liver without mention of alcohol personal history of colonic polyps coronary atherosclerosis of native coronary artery diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified personal history of tobacco use hyposmolality and/or hyponatremia personal history of colonic polyps peripheral vascular disease, unspecified urinary tract infection, site not specified esophageal reflux other ascites external hemorrhoids without mention of complication iron and its compounds causing adverse effects in therapeutic use other constipation acquired absence of organ, genital organs
white m 84 $nan$nan$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; multivitamins  1  tab ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; rifaximin  550  mg ; vitamin e  400  unit ; ciprofloxacin hcl  250  mg ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; 
other ascites angiodysplasia of stomach and duodenum with hemorrhage unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery esophageal varices in diseases classified elsewhere, without mention of bleeding percutaneous transluminal coronary angioplasty status other and unspecified noninfectious gastroenteritis and colitis cirrhosis of liver without mention of alcohol hepatic encephalopathy long-term (current) use of insulin peripheral vascular disease, unspecified acute kidney failure, unspecified personal history of malignant neoplasm of liver personal history of tobacco use acidosis benign neoplasm of stomach dehydration unspecified hereditary and idiopathic peripheral neuropathy angiodysplasia of stomach and duodenum with hemorrhage personal history of malignant neoplasm of liver long-term (current) use of insulin peripheral vascular disease, unspecified unspecified essential hypertension percutaneous transluminal coronary angioplasty status personal history of tobacco use essential and other specified forms of tremor other ascites hepatic encephalopathy long-term (current) use of aspirin staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus polyneuropathy in diabetes cirrhosis of liver without mention of alcohol personal history of colonic polyps coronary atherosclerosis of native coronary artery diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled urinary tract infection, site not specified personal history of tobacco use hyposmolality and/or hyponatremia personal history of colonic polyps peripheral vascular disease, unspecified urinary tract infection, site not specified esophageal reflux other ascites external hemorrhoids without mention of complication iron and its compounds causing adverse effects in therapeutic use other constipation acquired absence of organ, genital organs
white m 80 $nan$hematology blood hematocrit  42.2  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood glucose  103  mg dl$nan
 
white m 80 $temp  97.9  heartrate  54.0  resprate  20.0  o2sat    sbp  155.0  dbp  84.0  rhythm    pain  0  $nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 
 
white m 79 $temp  98.0  heartrate  59.0  resprate  18.0  o2sat  98.0  sbp  130.0  dbp  65.0  rhythm    pain    $hematology blood inr(pt)  1.4  $sodium chloride 0.9%  flush  3-10  ml ; levothyroxine sodium  125  mcg ; vitamin d  1000  unit ; amlodipine  5  mg ; 
spondylosis, unspecified presence of cardiac pacemaker family history of leukemia long term (current) use of anticoagulants family history of malignant neoplasm of trachea, bronchus and lung family history of malignant neoplasm of other organs or systems essential (primary) hypertension chronic atrial fibrillation personal history of nicotine dependence hyperlipidemia, unspecified presence of prosthetic heart valve malignant neoplasm of thyroid gland
white m 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  8.6  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ibuprofen  600  mg ; 
other and unspecified hyperlipidemia person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident body mass index 34.0-34.9, adult other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms personal history of tobacco use other dependence on machines, supplemental oxygen other specified forms of effusion, except tuberculous malignant carcinoid tumor of the bronchus and lung other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) obesity, unspecified hemorrhage complicating a procedure hypoxemia pneumonia, organism unspecified acidosis asthma, unspecified type, unspecified other chronic nonalcoholic liver disease pulmonary collapse acute posthemorrhagic anemia 
white m 50 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  8.6  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ibuprofen  600  mg ; enoxaparin sodium  40  mg ; 
other and unspecified hyperlipidemia person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident body mass index 34.0-34.9, adult other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms personal history of tobacco use other dependence on machines, supplemental oxygen other specified forms of effusion, except tuberculous malignant carcinoid tumor of the bronchus and lung other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) obesity, unspecified hemorrhage complicating a procedure hypoxemia pneumonia, organism unspecified acidosis asthma, unspecified type, unspecified other chronic nonalcoholic liver disease pulmonary collapse acute posthemorrhagic anemia 
white m 50 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  211  k ul$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  8.6  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; ondansetron  4  mg ; ibuprofen  600  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  1000  ml ; diphenhydramine  25  mg ; sarna lotion  1  appl ; 
other and unspecified hyperlipidemia person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident body mass index 34.0-34.9, adult other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms personal history of tobacco use other dependence on machines, supplemental oxygen other specified forms of effusion, except tuberculous malignant carcinoid tumor of the bronchus and lung other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) obesity, unspecified hemorrhage complicating a procedure hypoxemia pneumonia, organism unspecified acidosis asthma, unspecified type, unspecified other chronic nonalcoholic liver disease pulmonary collapse acute posthemorrhagic anemia 
white m 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  8.6  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; ondansetron  4  mg ; ibuprofen  600  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  1000  ml ; diphenhydramine  25  mg ; sarna lotion  1  appl ; milk of magnesia  30  ml ; bisacodyl  10  mg ; 
other and unspecified hyperlipidemia person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident body mass index 34.0-34.9, adult other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms personal history of tobacco use other dependence on machines, supplemental oxygen other specified forms of effusion, except tuberculous malignant carcinoid tumor of the bronchus and lung other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) obesity, unspecified hemorrhage complicating a procedure hypoxemia pneumonia, organism unspecified acidosis asthma, unspecified type, unspecified other chronic nonalcoholic liver disease pulmonary collapse acute posthemorrhagic anemia 
white f 75 $nan$nan$ranitidine  75  mg ; dexamethasone  2  mg ; folic acid  1  mg ; furosemide  10  mg ; levothyroxine sodium  112  mcg ; ascorbic acid  500  mg ; vitamin d  400  unit ; 
peripheral stem cells replaced by transplant dehydration pathologic fracture of humerus mitral valve disorders unspecified adverse effect of other drug, medicinal and biological substance atrial fibrillation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anemia, unspecified chronic kidney disease, unspecified multiple myeloma, without mention of having achieved remission pathologic fracture of other specified site chronic kidney disease, unspecified unspecified acquired hypothyroidism backache, unspecified peripheral stem cells replaced by transplant atrial fibrillation pathologic fracture of vertebrae dehydration other chronic pain mitral valve disorders multiple myeloma, without mention of having achieved remission influenza with pneumonia herpes zoster without mention of complication atrial fibrillation pneumonia, organism unspecified peripheral stem cells replaced by transplant multiple myeloma, without mention of having achieved remission 
white f 75 $nan$hematology blood hematocrit  21.2  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  35  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  86  mg dl; chemistry blood albumin  2.9  g dl; hematology blood bands  0  %$ranitidine  75  mg ; dexamethasone  2  mg ; folic acid  1  mg ; furosemide  10  mg ; levothyroxine sodium  112  mcg ; ascorbic acid  500  mg ; vitamin d  400  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; lorazepam  0.5-1  mg ; ondansetron odt  4  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone sr (oxycontin)  10  mg ; prochlorperazine  5-10  mg ; acetaminophen  325-650  mg ; senna  1  tab ; acyclovir  400  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; 5% dextrose  500  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; bag  50-100  ml ; 0.9% sodium chloride  1000  ml ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; guaifenesin  5-10  ml ; bag  200  ml ; gammagard liquid  20  g ; acetaminophen  650  mg ; 
peripheral stem cells replaced by transplant dehydration pathologic fracture of humerus mitral valve disorders unspecified adverse effect of other drug, medicinal and biological substance atrial fibrillation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anemia, unspecified chronic kidney disease, unspecified multiple myeloma, without mention of having achieved remission pathologic fracture of other specified site chronic kidney disease, unspecified unspecified acquired hypothyroidism backache, unspecified peripheral stem cells replaced by transplant atrial fibrillation pathologic fracture of vertebrae dehydration other chronic pain mitral valve disorders multiple myeloma, without mention of having achieved remission influenza with pneumonia herpes zoster without mention of complication atrial fibrillation pneumonia, organism unspecified peripheral stem cells replaced by transplant multiple myeloma, without mention of having achieved remission 
white f 75 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  21  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  226  iu l; chemistry blood albumin  2.6  g dl; hematology blood bands  3  %$ranitidine  75  mg ; dexamethasone  2  mg ; folic acid  1  mg ; levothyroxine sodium  112  mcg ; vitamin d  400  unit ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron odt  4  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone sr (oxycontin)  10  mg ; prochlorperazine  5-10  mg ; acetaminophen  325-650  mg ; senna  1  tab ; acyclovir  400  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; 5% dextrose  500  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; bag  50-100  ml ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; guaifenesin  5-10  ml ; bag  200  ml ; gammagard liquid  20  g ; acetaminophen  650  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; cefepime  2  g ; 
peripheral stem cells replaced by transplant dehydration pathologic fracture of humerus mitral valve disorders unspecified adverse effect of other drug, medicinal and biological substance atrial fibrillation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anemia, unspecified chronic kidney disease, unspecified multiple myeloma, without mention of having achieved remission pathologic fracture of other specified site chronic kidney disease, unspecified unspecified acquired hypothyroidism backache, unspecified peripheral stem cells replaced by transplant atrial fibrillation pathologic fracture of vertebrae dehydration other chronic pain mitral valve disorders multiple myeloma, without mention of having achieved remission influenza with pneumonia herpes zoster without mention of complication atrial fibrillation pneumonia, organism unspecified peripheral stem cells replaced by transplant multiple myeloma, without mention of having achieved remission 
white f 75 $nan$hematology blood hematocrit  27.0  %; hematology blood hematocrit  27.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  16  k ul; hematology blood platelet count  17  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  85  mg dl; chemistry blood lactate dehydrogenase (ld)  242  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  3  %$ranitidine  75  mg ; dexamethasone  2  mg ; folic acid  1  mg ; levothyroxine sodium  112  mcg ; vitamin d  400  unit ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron odt  4  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone sr (oxycontin)  10  mg ; prochlorperazine  5-10  mg ; acetaminophen  325-650  mg ; senna  1  tab ; acyclovir  400  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; 5% dextrose  500  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; bag  50-100  ml ; milk of magnesia  30  ml ; guaifenesin  5-10  ml ; cefepime  2  g ; ranitidine  150  mg ; 
peripheral stem cells replaced by transplant dehydration pathologic fracture of humerus mitral valve disorders unspecified adverse effect of other drug, medicinal and biological substance atrial fibrillation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anemia, unspecified chronic kidney disease, unspecified multiple myeloma, without mention of having achieved remission pathologic fracture of other specified site chronic kidney disease, unspecified unspecified acquired hypothyroidism backache, unspecified peripheral stem cells replaced by transplant atrial fibrillation pathologic fracture of vertebrae dehydration other chronic pain mitral valve disorders multiple myeloma, without mention of having achieved remission influenza with pneumonia herpes zoster without mention of complication atrial fibrillation pneumonia, organism unspecified peripheral stem cells replaced by transplant multiple myeloma, without mention of having achieved remission 
white f 75 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  14  k ul; hematology blood platelet count  40  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  84  mg dl; hematology blood bands  1  %$0.9% sodium chloride  50  ml ; dexamethasone  2  mg ; folic acid  1  mg ; levothyroxine sodium  112  mcg ; vitamin d  400  unit ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron odt  4  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone sr (oxycontin)  10  mg ; prochlorperazine  5-10  mg ; acetaminophen  325-650  mg ; senna  1  tab ; acyclovir  400  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; 5% dextrose  500  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; bag  50-100  ml ; milk of magnesia  30  ml ; guaifenesin  5-10  ml ; ranitidine  150  mg ; cefepime  500  mg ; 
peripheral stem cells replaced by transplant dehydration pathologic fracture of humerus mitral valve disorders unspecified adverse effect of other drug, medicinal and biological substance atrial fibrillation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anemia, unspecified chronic kidney disease, unspecified multiple myeloma, without mention of having achieved remission pathologic fracture of other specified site chronic kidney disease, unspecified unspecified acquired hypothyroidism backache, unspecified peripheral stem cells replaced by transplant atrial fibrillation pathologic fracture of vertebrae dehydration other chronic pain mitral valve disorders multiple myeloma, without mention of having achieved remission influenza with pneumonia herpes zoster without mention of complication atrial fibrillation pneumonia, organism unspecified peripheral stem cells replaced by transplant multiple myeloma, without mention of having achieved remission 
white f 75 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  34  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  81  mg dl; hematology blood bands  0  %$dexamethasone  2  mg ; folic acid  1  mg ; levothyroxine sodium  112  mcg ; vitamin d  400  unit ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron odt  4  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone sr (oxycontin)  10  mg ; prochlorperazine  5-10  mg ; acetaminophen  325-650  mg ; senna  1  tab ; acyclovir  400  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; 5% dextrose  500  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; bag  50-100  ml ; milk of magnesia  30  ml ; guaifenesin  5-10  ml ; ranitidine  150  mg ; cefpodoxime proxetil  200  mg ; aztreonam  1000  mg ; meropenem  500  mg ; 
peripheral stem cells replaced by transplant dehydration pathologic fracture of humerus mitral valve disorders unspecified adverse effect of other drug, medicinal and biological substance atrial fibrillation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anemia, unspecified chronic kidney disease, unspecified multiple myeloma, without mention of having achieved remission pathologic fracture of other specified site chronic kidney disease, unspecified unspecified acquired hypothyroidism backache, unspecified peripheral stem cells replaced by transplant atrial fibrillation pathologic fracture of vertebrae dehydration other chronic pain mitral valve disorders multiple myeloma, without mention of having achieved remission influenza with pneumonia herpes zoster without mention of complication atrial fibrillation pneumonia, organism unspecified peripheral stem cells replaced by transplant multiple myeloma, without mention of having achieved remission 
white f 75 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  34  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  228  iu l; chemistry blood albumin  3.2  g dl; hematology blood bands  4  %$dexamethasone  2  mg ; folic acid  1  mg ; levothyroxine sodium  112  mcg ; vitamin d  400  unit ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron odt  4  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone sr (oxycontin)  10  mg ; prochlorperazine  5-10  mg ; acetaminophen  325-650  mg ; senna  1  tab ; acyclovir  400  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; 5% dextrose  500  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; bag  50-100  ml ; milk of magnesia  30  ml ; guaifenesin  5-10  ml ; ranitidine  150  mg ; meropenem  500  mg ; 
peripheral stem cells replaced by transplant dehydration pathologic fracture of humerus mitral valve disorders unspecified adverse effect of other drug, medicinal and biological substance atrial fibrillation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anemia, unspecified chronic kidney disease, unspecified multiple myeloma, without mention of having achieved remission pathologic fracture of other specified site chronic kidney disease, unspecified unspecified acquired hypothyroidism backache, unspecified peripheral stem cells replaced by transplant atrial fibrillation pathologic fracture of vertebrae dehydration other chronic pain mitral valve disorders multiple myeloma, without mention of having achieved remission influenza with pneumonia herpes zoster without mention of complication atrial fibrillation pneumonia, organism unspecified peripheral stem cells replaced by transplant multiple myeloma, without mention of having achieved remission 
white f 75 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  28  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  87  mg dl; chemistry blood lactate dehydrogenase (ld)  236  iu l; hematology blood bands  1  %$dexamethasone  2  mg ; folic acid  1  mg ; levothyroxine sodium  112  mcg ; vitamin d  400  unit ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron odt  4  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone sr (oxycontin)  10  mg ; prochlorperazine  5-10  mg ; acetaminophen  325-650  mg ; senna  1  tab ; acyclovir  400  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; 5% dextrose  500  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; bag  50-100  ml ; milk of magnesia  30  ml ; guaifenesin  5-10  ml ; ranitidine  150  mg ; 
peripheral stem cells replaced by transplant dehydration pathologic fracture of humerus mitral valve disorders unspecified adverse effect of other drug, medicinal and biological substance atrial fibrillation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anemia, unspecified chronic kidney disease, unspecified multiple myeloma, without mention of having achieved remission pathologic fracture of other specified site chronic kidney disease, unspecified unspecified acquired hypothyroidism backache, unspecified peripheral stem cells replaced by transplant atrial fibrillation pathologic fracture of vertebrae dehydration other chronic pain mitral valve disorders multiple myeloma, without mention of having achieved remission influenza with pneumonia herpes zoster without mention of complication atrial fibrillation pneumonia, organism unspecified peripheral stem cells replaced by transplant multiple myeloma, without mention of having achieved remission 
white f 75 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  26  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  90  mg dl; chemistry blood albumin  3.4  g dl; hematology blood bands  2  %$dexamethasone  2  mg ; folic acid  1  mg ; levothyroxine sodium  112  mcg ; vitamin d  400  unit ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron odt  4  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone sr (oxycontin)  10  mg ; prochlorperazine  5-10  mg ; acetaminophen  325-650  mg ; senna  1  tab ; acyclovir  400  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; 5% dextrose  500  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; bag  50-100  ml ; milk of magnesia  30  ml ; guaifenesin  5-10  ml ; ranitidine  150  mg ; 
peripheral stem cells replaced by transplant dehydration pathologic fracture of humerus mitral valve disorders unspecified adverse effect of other drug, medicinal and biological substance atrial fibrillation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anemia, unspecified chronic kidney disease, unspecified multiple myeloma, without mention of having achieved remission pathologic fracture of other specified site chronic kidney disease, unspecified unspecified acquired hypothyroidism backache, unspecified peripheral stem cells replaced by transplant atrial fibrillation pathologic fracture of vertebrae dehydration other chronic pain mitral valve disorders multiple myeloma, without mention of having achieved remission influenza with pneumonia herpes zoster without mention of complication atrial fibrillation pneumonia, organism unspecified peripheral stem cells replaced by transplant multiple myeloma, without mention of having achieved remission 
white f 75 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  19  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  90  mg dl; chemistry blood albumin  3.3  g dl; hematology blood bands  1  %$dexamethasone  2  mg ; folic acid  1  mg ; levothyroxine sodium  112  mcg ; vitamin d  400  unit ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron odt  4  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone sr (oxycontin)  10  mg ; prochlorperazine  5-10  mg ; acetaminophen  325-650  mg ; senna  1  tab ; acyclovir  400  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; 5% dextrose  500  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; bag  50-100  ml ; milk of magnesia  30  ml ; guaifenesin  5-10  ml ; ranitidine  150  mg ; nystatin oral suspension  5  ml ; 
peripheral stem cells replaced by transplant dehydration pathologic fracture of humerus mitral valve disorders unspecified adverse effect of other drug, medicinal and biological substance atrial fibrillation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anemia, unspecified chronic kidney disease, unspecified multiple myeloma, without mention of having achieved remission pathologic fracture of other specified site chronic kidney disease, unspecified unspecified acquired hypothyroidism backache, unspecified peripheral stem cells replaced by transplant atrial fibrillation pathologic fracture of vertebrae dehydration other chronic pain mitral valve disorders multiple myeloma, without mention of having achieved remission influenza with pneumonia herpes zoster without mention of complication atrial fibrillation pneumonia, organism unspecified peripheral stem cells replaced by transplant multiple myeloma, without mention of having achieved remission 
white f 75 $nan$nan$dexamethasone  2  mg ; folic acid  1  mg ; levothyroxine sodium  112  mcg ; vitamin d  400  unit ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron odt  4  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone sr (oxycontin)  10  mg ; prochlorperazine  5-10  mg ; acetaminophen  325-650  mg ; senna  1  tab ; acyclovir  400  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; 5% dextrose  500  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; bag  50-100  ml ; milk of magnesia  30  ml ; guaifenesin  5-10  ml ; ranitidine  150  mg ; nystatin oral suspension  5  ml ; 
peripheral stem cells replaced by transplant dehydration pathologic fracture of humerus mitral valve disorders unspecified adverse effect of other drug, medicinal and biological substance atrial fibrillation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use anemia, unspecified chronic kidney disease, unspecified multiple myeloma, without mention of having achieved remission pathologic fracture of other specified site chronic kidney disease, unspecified unspecified acquired hypothyroidism backache, unspecified peripheral stem cells replaced by transplant atrial fibrillation pathologic fracture of vertebrae dehydration other chronic pain mitral valve disorders multiple myeloma, without mention of having achieved remission influenza with pneumonia herpes zoster without mention of complication atrial fibrillation pneumonia, organism unspecified peripheral stem cells replaced by transplant multiple myeloma, without mention of having achieved remission 
white f 83 $temp  97.5  heartrate  98.0  resprate  20.0  o2sat  95.0  sbp  153.0  dbp  107.0  rhythm    pain  uta  ; temp  97.9  heartrate  65.0  resprate  18.0  o2sat  100.0  sbp  148.0  dbp  56.0  rhythm    pain  sleeping  ; temp    heartrate  63.0  resprate  14.0  o2sat  96.0  sbp  163.0  dbp  45.0  rhythm    pain  uta  ; temp  97.8  heartrate  72.0  resprate  19.0  o2sat  95.0  sbp  137.0  dbp  114.0  rhythm    pain  uta  ; temp    heartrate  84.0  resprate  18.0  o2sat  93.0  sbp  123.0  dbp  94.0  rhythm    pain    $hematology blood hematocrit  38.7  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  258  mg dl; chemistry blood albumin  3.7  g dl$hydralazine  10  mg ; aspirin  81  mg ; levothyroxine sodium  62.5  mcg ; insulin  5  unit ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with hypoglycemia without coma dorsalgia, unspecified solitary pulmonary nodule parkinson's disease unspecified asthma, uncomplicated hypothyroidism, unspecified acute kidney failure, unspecified vascular dementia without behavioral disturbance toxic encephalopathy heart failure, unspecified obesity, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris body mass index (bmi) 45.0-49.9, adult hyperosmolality and hypernatremia type 2 diabetes mellitus with diabetic polyneuropathy dehydration pressure ulcer of right heel, unstageable major depressive disorder, single episode, severe with psychotic features pressure ulcer of sacral region, stage 2 anxiety disorder, unspecified insomnia, unspecified hypertensive heart disease with heart failure old myocardial infarction hyperlipidemia, unspecified sepsis due to escherichia coli [e. coli] pain in right hip urinary tract infection, site not specified fatty (change of) liver, not elsewhere classified long term (current) use of insulin pressure ulcer of other site, unstageable old myocardial infarction transient cerebral ischemic attack, unspecified obesity, unspecified body mass index (bmi) 45.0-49.9, adult bed confinement status hypertensive heart disease with heart failure dementia in other diseases classified elsewhere without behavioral disturbance type 2 diabetes mellitus with diabetic polyneuropathy dementia with lewy bodies hyperlipidemia, unspecified long term (current) use of insulin atherosclerotic heart disease of native coronary artery without angina pectoris heart failure, unspecified anxiety state, unspecified other and unspecified hyperlipidemia acute kidney failure, unspecified subendocardial infarction, initial episode of care
white f 83 $temp  98.0  heartrate  76.0  resprate  16.0  o2sat  95.0  sbp  133.0  dbp  74.0  rhythm    pain  asleep  $hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  225  mg dl; blood gas blood lactate  1.8  mmol l$hydralazine  10  mg ; aspirin  81  mg ; levothyroxine sodium  62.5  mcg ; insulin  5  unit ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; lactated ringers  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iohexol 240  50  ml ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; acetaminophen  650  mg ; pravastatin  40  mg ; insulin  12  unit ; losartan potassium  25  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with hypoglycemia without coma dorsalgia, unspecified solitary pulmonary nodule parkinson's disease unspecified asthma, uncomplicated hypothyroidism, unspecified acute kidney failure, unspecified vascular dementia without behavioral disturbance toxic encephalopathy heart failure, unspecified obesity, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris body mass index (bmi) 45.0-49.9, adult hyperosmolality and hypernatremia type 2 diabetes mellitus with diabetic polyneuropathy dehydration pressure ulcer of right heel, unstageable major depressive disorder, single episode, severe with psychotic features pressure ulcer of sacral region, stage 2 anxiety disorder, unspecified insomnia, unspecified hypertensive heart disease with heart failure old myocardial infarction hyperlipidemia, unspecified sepsis due to escherichia coli [e. coli] pain in right hip urinary tract infection, site not specified fatty (change of) liver, not elsewhere classified long term (current) use of insulin pressure ulcer of other site, unstageable old myocardial infarction transient cerebral ischemic attack, unspecified obesity, unspecified body mass index (bmi) 45.0-49.9, adult bed confinement status hypertensive heart disease with heart failure dementia in other diseases classified elsewhere without behavioral disturbance type 2 diabetes mellitus with diabetic polyneuropathy dementia with lewy bodies hyperlipidemia, unspecified long term (current) use of insulin atherosclerotic heart disease of native coronary artery without angina pectoris heart failure, unspecified anxiety state, unspecified other and unspecified hyperlipidemia acute kidney failure, unspecified subendocardial infarction, initial episode of care
white f 83 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  190  mg dl$aspirin  81  mg ; levothyroxine sodium  62.5  mcg ; insulin  5  unit ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; lactated ringers  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iohexol 240  50  ml ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; acetaminophen  650  mg ; pravastatin  40  mg ; insulin  12  unit ; losartan potassium  25  mg ; clonazepam  0.5  mg ; clonazepam  0.25  mg ; ziprasidone hydrochloride  40  mg ; topiramate (topamax)  100  mg ; senna  17.2  mg ; polyethylene glycol  17  g ; acetaminophen iv  1000  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with hypoglycemia without coma dorsalgia, unspecified solitary pulmonary nodule parkinson's disease unspecified asthma, uncomplicated hypothyroidism, unspecified acute kidney failure, unspecified vascular dementia without behavioral disturbance toxic encephalopathy heart failure, unspecified obesity, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris body mass index (bmi) 45.0-49.9, adult hyperosmolality and hypernatremia type 2 diabetes mellitus with diabetic polyneuropathy dehydration pressure ulcer of right heel, unstageable major depressive disorder, single episode, severe with psychotic features pressure ulcer of sacral region, stage 2 anxiety disorder, unspecified insomnia, unspecified hypertensive heart disease with heart failure old myocardial infarction hyperlipidemia, unspecified sepsis due to escherichia coli [e. coli] pain in right hip urinary tract infection, site not specified fatty (change of) liver, not elsewhere classified long term (current) use of insulin pressure ulcer of other site, unstageable old myocardial infarction transient cerebral ischemic attack, unspecified obesity, unspecified body mass index (bmi) 45.0-49.9, adult bed confinement status hypertensive heart disease with heart failure dementia in other diseases classified elsewhere without behavioral disturbance type 2 diabetes mellitus with diabetic polyneuropathy dementia with lewy bodies hyperlipidemia, unspecified long term (current) use of insulin atherosclerotic heart disease of native coronary artery without angina pectoris heart failure, unspecified anxiety state, unspecified other and unspecified hyperlipidemia acute kidney failure, unspecified subendocardial infarction, initial episode of care
white f 83 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  139  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  195  mg dl$aspirin  81  mg ; levothyroxine sodium  62.5  mcg ; insulin  5  unit ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  650  mg ; pravastatin  40  mg ; insulin  12  unit ; losartan potassium  25  mg ; clonazepam  0.5  mg ; clonazepam  0.25  mg ; ziprasidone hydrochloride  40  mg ; topiramate (topamax)  100  mg ; senna  17.2  mg ; polyethylene glycol  17  g ; acetaminophen iv  1000  mg ; olanzapine (disintegrating tablet)  5  mg ; soln  100  ml ; gabapentin  200  mg ; lidocaine 5% patch  1  ptch ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with hypoglycemia without coma dorsalgia, unspecified solitary pulmonary nodule parkinson's disease unspecified asthma, uncomplicated hypothyroidism, unspecified acute kidney failure, unspecified vascular dementia without behavioral disturbance toxic encephalopathy heart failure, unspecified obesity, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris body mass index (bmi) 45.0-49.9, adult hyperosmolality and hypernatremia type 2 diabetes mellitus with diabetic polyneuropathy dehydration pressure ulcer of right heel, unstageable major depressive disorder, single episode, severe with psychotic features pressure ulcer of sacral region, stage 2 anxiety disorder, unspecified insomnia, unspecified hypertensive heart disease with heart failure old myocardial infarction hyperlipidemia, unspecified sepsis due to escherichia coli [e. coli] pain in right hip urinary tract infection, site not specified fatty (change of) liver, not elsewhere classified long term (current) use of insulin pressure ulcer of other site, unstageable old myocardial infarction transient cerebral ischemic attack, unspecified obesity, unspecified body mass index (bmi) 45.0-49.9, adult bed confinement status hypertensive heart disease with heart failure dementia in other diseases classified elsewhere without behavioral disturbance type 2 diabetes mellitus with diabetic polyneuropathy dementia with lewy bodies hyperlipidemia, unspecified long term (current) use of insulin atherosclerotic heart disease of native coronary artery without angina pectoris heart failure, unspecified anxiety state, unspecified other and unspecified hyperlipidemia acute kidney failure, unspecified subendocardial infarction, initial episode of care
white f 83 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  181  mg dl$aspirin  81  mg ; levothyroxine sodium  62.5  mcg ; insulin  5  unit ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; pravastatin  40  mg ; insulin  12  unit ; losartan potassium  25  mg ; clonazepam  0.5  mg ; clonazepam  0.25  mg ; ziprasidone hydrochloride  40  mg ; topiramate (topamax)  100  mg ; senna  17.2  mg ; olanzapine (disintegrating tablet)  5  mg ; lidocaine 5% patch  1  ptch ; lactulose  15  ml ; bisacodyl  10  mg ; fleet enema (mineral oil)  1  enema ; gabapentin  100  mg ; simethicone  40-80  mg ; furosemide  40  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with hypoglycemia without coma dorsalgia, unspecified solitary pulmonary nodule parkinson's disease unspecified asthma, uncomplicated hypothyroidism, unspecified acute kidney failure, unspecified vascular dementia without behavioral disturbance toxic encephalopathy heart failure, unspecified obesity, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris body mass index (bmi) 45.0-49.9, adult hyperosmolality and hypernatremia type 2 diabetes mellitus with diabetic polyneuropathy dehydration pressure ulcer of right heel, unstageable major depressive disorder, single episode, severe with psychotic features pressure ulcer of sacral region, stage 2 anxiety disorder, unspecified insomnia, unspecified hypertensive heart disease with heart failure old myocardial infarction hyperlipidemia, unspecified sepsis due to escherichia coli [e. coli] pain in right hip urinary tract infection, site not specified fatty (change of) liver, not elsewhere classified long term (current) use of insulin pressure ulcer of other site, unstageable old myocardial infarction transient cerebral ischemic attack, unspecified obesity, unspecified body mass index (bmi) 45.0-49.9, adult bed confinement status hypertensive heart disease with heart failure dementia in other diseases classified elsewhere without behavioral disturbance type 2 diabetes mellitus with diabetic polyneuropathy dementia with lewy bodies hyperlipidemia, unspecified long term (current) use of insulin atherosclerotic heart disease of native coronary artery without angina pectoris heart failure, unspecified anxiety state, unspecified other and unspecified hyperlipidemia acute kidney failure, unspecified subendocardial infarction, initial episode of care
white f 83 $nan$nan$aspirin  81  mg ; levothyroxine sodium  62.5  mcg ; insulin  5  unit ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; pravastatin  40  mg ; insulin  12  unit ; losartan potassium  25  mg ; clonazepam  0.5  mg ; clonazepam  0.25  mg ; ziprasidone hydrochloride  40  mg ; topiramate (topamax)  100  mg ; senna  17.2  mg ; lidocaine 5% patch  1  ptch ; lactulose  15  ml ; fleet enema (mineral oil)  1  enema ; gabapentin  100  mg ; simethicone  40-80  mg ; furosemide  40  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with hypoglycemia without coma dorsalgia, unspecified solitary pulmonary nodule parkinson's disease unspecified asthma, uncomplicated hypothyroidism, unspecified acute kidney failure, unspecified vascular dementia without behavioral disturbance toxic encephalopathy heart failure, unspecified obesity, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris body mass index (bmi) 45.0-49.9, adult hyperosmolality and hypernatremia type 2 diabetes mellitus with diabetic polyneuropathy dehydration pressure ulcer of right heel, unstageable major depressive disorder, single episode, severe with psychotic features pressure ulcer of sacral region, stage 2 anxiety disorder, unspecified insomnia, unspecified hypertensive heart disease with heart failure old myocardial infarction hyperlipidemia, unspecified sepsis due to escherichia coli [e. coli] pain in right hip urinary tract infection, site not specified fatty (change of) liver, not elsewhere classified long term (current) use of insulin pressure ulcer of other site, unstageable old myocardial infarction transient cerebral ischemic attack, unspecified obesity, unspecified body mass index (bmi) 45.0-49.9, adult bed confinement status hypertensive heart disease with heart failure dementia in other diseases classified elsewhere without behavioral disturbance type 2 diabetes mellitus with diabetic polyneuropathy dementia with lewy bodies hyperlipidemia, unspecified long term (current) use of insulin atherosclerotic heart disease of native coronary artery without angina pectoris heart failure, unspecified anxiety state, unspecified other and unspecified hyperlipidemia acute kidney failure, unspecified subendocardial infarction, initial episode of care
white f 83 $nan$nan$aspirin  81  mg ; levothyroxine sodium  62.5  mcg ; insulin  5  unit ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; pravastatin  40  mg ; insulin  12  unit ; losartan potassium  25  mg ; clonazepam  0.5  mg ; clonazepam  0.25  mg ; ziprasidone hydrochloride  40  mg ; topiramate (topamax)  100  mg ; lidocaine 5% patch  1  ptch ; gabapentin  100  mg ; furosemide  40  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with hypoglycemia without coma dorsalgia, unspecified solitary pulmonary nodule parkinson's disease unspecified asthma, uncomplicated hypothyroidism, unspecified acute kidney failure, unspecified vascular dementia without behavioral disturbance toxic encephalopathy heart failure, unspecified obesity, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris body mass index (bmi) 45.0-49.9, adult hyperosmolality and hypernatremia type 2 diabetes mellitus with diabetic polyneuropathy dehydration pressure ulcer of right heel, unstageable major depressive disorder, single episode, severe with psychotic features pressure ulcer of sacral region, stage 2 anxiety disorder, unspecified insomnia, unspecified hypertensive heart disease with heart failure old myocardial infarction hyperlipidemia, unspecified sepsis due to escherichia coli [e. coli] pain in right hip urinary tract infection, site not specified fatty (change of) liver, not elsewhere classified long term (current) use of insulin pressure ulcer of other site, unstageable old myocardial infarction transient cerebral ischemic attack, unspecified obesity, unspecified body mass index (bmi) 45.0-49.9, adult bed confinement status hypertensive heart disease with heart failure dementia in other diseases classified elsewhere without behavioral disturbance type 2 diabetes mellitus with diabetic polyneuropathy dementia with lewy bodies hyperlipidemia, unspecified long term (current) use of insulin atherosclerotic heart disease of native coronary artery without angina pectoris heart failure, unspecified anxiety state, unspecified other and unspecified hyperlipidemia acute kidney failure, unspecified subendocardial infarction, initial episode of care
white m 46 $nan$hematology blood hematocrit  46.0  %; hematology blood hematocrit  43.5  %; hematology blood hemoglobin  16.6  g dl; hematology blood hemoglobin  15.4  g dl; hematology blood platelet count  207  k ul; hematology blood platelet count  204  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  161  mg dl; chemistry blood albumin  4.0  g dl; chemistry blood % hemoglobin a1c  5.6  %$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; aspirin  325  mg ; atorvastatin  80  mg ; lisinopril  5  mg ; d5 1 2ns  1000  ml ; atropine sulfate  0.5  mg ; tramadol (ultram)  50  mg ; metoprolol tartrate  12.5  mg ; mupirocin nasal ointment 2%  1  appl ; 
 
white m 46 $nan$hematology blood hematocrit  47.3  %; hematology blood hematocrit  37.7  %; hematology blood hematocrit  32.4  %; hematology blood hemoglobin  16.1  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  254  k ul; hematology blood platelet count  197  k ul; hematology blood platelet count  195  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  106  mg dl; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood chloride, whole blood  106  meq l; blood gas blood glucose  93  mg dl; blood gas blood glucose  109  mg dl; blood gas blood glucose  126  mg dl; blood gas blood glucose  128  mg dl; blood gas blood glucose  105  mg dl; blood gas blood glucose  139  mg dl; blood gas blood hematocrit, calculated  43  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hemoglobin  14.2  g dl; blood gas blood hemoglobin  11.1  g dl; blood gas blood hemoglobin  11.7  g dl; blood gas blood hemoglobin  11.8  g dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  5.6  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  137  meq l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; aspirin  325  mg ; atorvastatin  80  mg ; lisinopril  5  mg ; atropine sulfate  0.5  mg ; tramadol (ultram)  50  mg ; metoprolol tartrate  12.5  mg ; mupirocin nasal ointment 2%  1  appl ; oxycodone (immediate release)   5  mg ; sodium chloride 0.9%  flush  10  ml ; lr  1000  ml ; 5% dextrose  250  ml ; propofol  1000  mg ; propofol  200  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; meperidine  12.5  mg ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; cefazolin  2  g ; metoprolol tartrate  5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium (liquid)  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
white m 46 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  105  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; propofol  1000  mg ; propofol  200  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; meperidine  12.5  mg ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; cefazolin  2  g ; metoprolol tartrate  5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium (liquid)  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ketorolac  15  mg ; hydromorphone (dilaudid)  0.25  mg ; aspirin ec  81  mg ; aspirin  81  mg ; hydromorphone (dilaudid)  2-4  mg ; furosemide  20  mg ; bisacodyl  10  mg ; insulin  0  unit ; hydromorphone (dilaudid)  6  mg ; metoprolol tartrate  25  mg ; 
 
white m 46 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; hematology urine wbc  8  # hpf; chemistry blood glucose  126  mg dl$glucagon  1  mg ; furosemide  20  mg ; bisacodyl  10  mg ; insulin  0  unit ; hydromorphone (dilaudid)  6  mg ; 
 
white m 46 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  116  mg dl$glucagon  1  mg ; furosemide  20  mg ; bisacodyl  10  mg ; insulin  0  unit ; hydromorphone (dilaudid)  6  mg ; ciprofloxacin hcl  500  mg ; 
 
white m 46 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  231  k ul; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl$glucagon  1  mg ; bisacodyl  10  mg ; insulin  0  unit ; hydromorphone (dilaudid)  6  mg ; ciprofloxacin hcl  500  mg ; albuterol-ipratropium  2  puff ; metoprolol tartrate  50  mg ; 
 
white m 46 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  339  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  162  mg dl; chemistry blood lactate dehydrogenase (ld)  216  iu l; chemistry blood albumin  3.9  g dl$glucagon  1  mg ; bisacodyl  10  mg ; insulin  0  unit ; hydromorphone (dilaudid)  6  mg ; albuterol-ipratropium  2  puff ; metoprolol tartrate  50  mg ; cepacol (menthol)  1  loz ; hydromorphone (dilaudid)  2-6  mg ; metoprolol tartrate  75  mg ; 
 
white m 46 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  375  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  103  mg dl$bisacodyl  10  mg ; cepacol (menthol)  1  loz ; hydromorphone (dilaudid)  2-6  mg ; metoprolol tartrate  75  mg ; atorvastatin  10  mg ; 
 
white m 46 $nan$nan$bisacodyl  10  mg ; cepacol (menthol)  1  loz ; hydromorphone (dilaudid)  2-6  mg ; metoprolol tartrate  75  mg ; atorvastatin  10  mg ; 
 
hispanic latino f 57 $temp  97.7  heartrate  107.0  resprate  17.0  o2sat  95.0  sbp  86.0  dbp  58.0  rhythm    pain  5  ; temp    heartrate  111.0  resprate  16.0  o2sat  94.0  sbp  94.0  dbp  59.0  rhythm    pain  8  ; temp  101.4  heartrate  103.0  resprate  25.0  o2sat  94.0  sbp  98.0  dbp  61.0  rhythm    pain  8  ; temp    heartrate  102.0  resprate  20.0  o2sat  94.0  sbp  90.0  dbp  57.0  rhythm    pain  0  ; temp    heartrate  103.0  resprate  20.0  o2sat  95.0  sbp  95.0  dbp  55.0  rhythm    pain  0  ; temp  98.5  heartrate  95.0  resprate  24.0  o2sat  95.0  sbp  82.0  dbp  45.0  rhythm    pain  0  ; temp    heartrate  95.0  resprate  20.0  o2sat  93.0  sbp  85.0  dbp  51.0  rhythm    pain  0  ; temp    heartrate  93.0  resprate  16.0  o2sat  95.0  sbp  89.0  dbp  49.0  rhythm    pain  0  ; temp    heartrate  94.0  resprate  25.0  o2sat  94.0  sbp  96.0  dbp  52.0  rhythm    pain  0  ; temp  98.3  heartrate  92.0  resprate  18.0  o2sat  95.0  sbp  106.0  dbp  73.0  rhythm    pain  5  ; temp    heartrate  97.0  resprate  20.0  o2sat  98.0  sbp  92.0  dbp  75.0  rhythm    pain  5  $hematology blood hematocrit  42.5  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology urine wbc  3  # hpf; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  177  mg dl; chemistry blood glucose  154  mg dl; chemistry blood albumin  4.5  g dl; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  1.7  mmol l$nan
essential (primary) hypertension dehydration severe sepsis without septic shock fever, unspecified elevated white blood cell count, unspecified gastro-esophageal reflux disease without esophagitis sepsis, unspecified organism tachycardia, unspecified type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere unspecified asthma, uncomplicated cough major depressive disorder, single episode, unspecified essential (primary) hypertension urinary tract infection, site not specified gastro-esophageal reflux disease without esophagitis nicotine dependence, cigarettes, uncomplicated other specified postprocedural states cough diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified anxiety state, unspecified alcohol abuse, unspecified herpes simplex meningitis unspecified essential hypertension personal history of infections of the central nervous system tobacco use disorder cocaine abuse, unspecified asthma, unspecified type, unspecified esophageal reflux asthma, unspecified type, unspecified dysthymic disorder influenza with pneumonia unspecified essential hypertension
hispanic latino f 57 $temp    heartrate  101.0  resprate  20.0  o2sat  95.0  sbp  111.0  dbp  74.0  rhythm    pain  0  ; temp  100.9  heartrate  102.0  resprate  22.0  o2sat  95.0  sbp  112.0  dbp  79.0  rhythm    pain  0  $hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  155  mg dl; chemistry blood glucose  137  mg dl; chemistry blood lactate dehydrogenase (ld)  166  iu l; chemistry blood albumin  3.6  g dl; hematology blood bands  4  %; blood gas blood lactate  1.9  mmol l$0.9% sodium chloride  100  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen iv  1000  mg ; sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; ns  100  ml ; metronidazole  500  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  4  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; diazepam - ciwa protocol  10  mg ; sterile water  100  ml ; potassium chloride  40  meq ; vial  1  vial ; cefepime  1  g ; sodium chloride 0.9%  flush  10  ml ; lactated ringers  1000  ml ; ciprofloxacin hcl  500  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lidocaine viscous 2%  15  ml ; ceftriaxone  2  gm ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; ramelteon  8  mg ; diazepam  10  mg ; 
essential (primary) hypertension dehydration severe sepsis without septic shock fever, unspecified elevated white blood cell count, unspecified gastro-esophageal reflux disease without esophagitis sepsis, unspecified organism tachycardia, unspecified type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere unspecified asthma, uncomplicated cough major depressive disorder, single episode, unspecified essential (primary) hypertension urinary tract infection, site not specified gastro-esophageal reflux disease without esophagitis nicotine dependence, cigarettes, uncomplicated other specified postprocedural states cough diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified anxiety state, unspecified alcohol abuse, unspecified herpes simplex meningitis unspecified essential hypertension personal history of infections of the central nervous system tobacco use disorder cocaine abuse, unspecified asthma, unspecified type, unspecified esophageal reflux asthma, unspecified type, unspecified dysthymic disorder influenza with pneumonia unspecified essential hypertension
hispanic latino f 57 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  110  mg dl; chemistry blood lactate dehydrogenase (ld)  185  iu l$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen iv  1000  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10  ml ; ceftriaxone  2  gm ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; ramelteon  8  mg ; diazepam  10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; citalopram  20  mg ; neutra-phos  2  pkt ; triamcinolone acetonide 0.025% cream  1  appl ; prochlorperazine  10  mg ; 
essential (primary) hypertension dehydration severe sepsis without septic shock fever, unspecified elevated white blood cell count, unspecified gastro-esophageal reflux disease without esophagitis sepsis, unspecified organism tachycardia, unspecified type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere unspecified asthma, uncomplicated cough major depressive disorder, single episode, unspecified essential (primary) hypertension urinary tract infection, site not specified gastro-esophageal reflux disease without esophagitis nicotine dependence, cigarettes, uncomplicated other specified postprocedural states cough diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified anxiety state, unspecified alcohol abuse, unspecified herpes simplex meningitis unspecified essential hypertension personal history of infections of the central nervous system tobacco use disorder cocaine abuse, unspecified asthma, unspecified type, unspecified esophageal reflux asthma, unspecified type, unspecified dysthymic disorder influenza with pneumonia unspecified essential hypertension
hispanic latino f 57 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  105  mg dl; chemistry blood lactate dehydrogenase (ld)  184  iu l; chemistry blood albumin  3.7  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10  ml ; ceftriaxone  2  gm ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; ramelteon  8  mg ; diazepam  10  mg ; citalopram  20  mg ; neutra-phos  2  pkt ; triamcinolone acetonide 0.025% cream  1  appl ; prochlorperazine  10  mg ; potassium chloride (powder)  40  meq ; magnesium sulfate  2  gm ; guaifenesin  5-10  ml ; magnesium oxide  400  mg ; triamcinolone acetonide 0.1% cream  1  appl ; 
essential (primary) hypertension dehydration severe sepsis without septic shock fever, unspecified elevated white blood cell count, unspecified gastro-esophageal reflux disease without esophagitis sepsis, unspecified organism tachycardia, unspecified type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere unspecified asthma, uncomplicated cough major depressive disorder, single episode, unspecified essential (primary) hypertension urinary tract infection, site not specified gastro-esophageal reflux disease without esophagitis nicotine dependence, cigarettes, uncomplicated other specified postprocedural states cough diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified anxiety state, unspecified alcohol abuse, unspecified herpes simplex meningitis unspecified essential hypertension personal history of infections of the central nervous system tobacco use disorder cocaine abuse, unspecified asthma, unspecified type, unspecified esophageal reflux asthma, unspecified type, unspecified dysthymic disorder influenza with pneumonia unspecified essential hypertension
hispanic latino f 57 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  105  mg dl; chemistry blood lactate dehydrogenase (ld)  194  iu l; chemistry blood albumin  3.9  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10  ml ; ceftriaxone  2  gm ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; ramelteon  8  mg ; citalopram  20  mg ; prochlorperazine  10  mg ; guaifenesin  5-10  ml ; magnesium oxide  400  mg ; triamcinolone acetonide 0.1% cream  1  appl ; 
essential (primary) hypertension dehydration severe sepsis without septic shock fever, unspecified elevated white blood cell count, unspecified gastro-esophageal reflux disease without esophagitis sepsis, unspecified organism tachycardia, unspecified type 2 diabetes mellitus without complications enterococcus as the cause of diseases classified elsewhere unspecified asthma, uncomplicated cough major depressive disorder, single episode, unspecified essential (primary) hypertension urinary tract infection, site not specified gastro-esophageal reflux disease without esophagitis nicotine dependence, cigarettes, uncomplicated other specified postprocedural states cough diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified anxiety state, unspecified alcohol abuse, unspecified herpes simplex meningitis unspecified essential hypertension personal history of infections of the central nervous system tobacco use disorder cocaine abuse, unspecified asthma, unspecified type, unspecified esophageal reflux asthma, unspecified type, unspecified dysthymic disorder influenza with pneumonia unspecified essential hypertension
black african american f 62 $nan$nan$atorvastatin  40  mg ; tamoxifen citrate  20  mg ; 
 
black african american f 62 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  95  mg dl$atorvastatin  40  mg ; tamoxifen citrate  20  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; oxycodone-acetaminophen  1-2  tab ; ciprofloxacin hcl  500  mg ; milk of magnesia  30  ml ; pantoprazole  40  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; zolpidem tartrate  5-10  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; diphenhydramine  12.5  mg ; 
 
black african american f 62 $nan$nan$atorvastatin  40  mg ; tamoxifen citrate  20  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; oxycodone-acetaminophen  1-2  tab ; ciprofloxacin hcl  500  mg ; milk of magnesia  30  ml ; pantoprazole  40  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; zolpidem tartrate  5-10  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; diphenhydramine  12.5  mg ; 
 
black african american m 53 $temp  97.9  heartrate  70.0  resprate  16.0  o2sat  99.0  sbp  136.0  dbp  59.0  rhythm    pain    $nan$insulin  42  unit ; 
 
black african american m 53 $temp  98.6  heartrate  70.0  resprate  17.0  o2sat  100.0  sbp  130.0  dbp  65.0  rhythm    pain  0  $hematology blood hematocrit  38.3  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  98  mg dl$insulin  42  unit ; carvedilol  25  mg ; enalapril maleate  40  mg ; ferrous sulfate  325  mg ; furosemide  60  mg ; simvastatin  40  mg ; vitamin d  1000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; senna  1  tab ; nateglinide  60  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; aspirin  81  mg ; isosorbide mononitrate (extended release)  30  mg ; 
 
black african american m 53 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; aspirin  81  mg ; isosorbide mononitrate (extended release)  30  mg ; 
 
white f 76 $nan$nan$folic acid  1  mg ; multivitamins  1  tab ; sulfameth trimethoprim ds  1  tab ; sodium chloride 0.9%  flush  3  ml ; 
epilepsy, unspecified, without mention of intractable epilepsy malignant neoplasm of temporal lobe personal history of other infectious and parasitic diseases unspecified essential hypertension personal history of allergy to penicillin pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident unspecified condition of brain depressive disorder, not elsewhere classified cerebral edema encephalopathy, unspecified
white f 76 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  107  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  92  mg dl; chemistry blood albumin  3.4  g dl$folic acid  1  mg ; multivitamins  1  tab ; sulfameth trimethoprim ds  1  tab ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; filgrastim  300  mcg ; hydromorphone (dilaudid)  2  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; heparin  1300-2500  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; trazodone  25  mg ; levetiracetam  500  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; 
epilepsy, unspecified, without mention of intractable epilepsy malignant neoplasm of temporal lobe personal history of other infectious and parasitic diseases unspecified essential hypertension personal history of allergy to penicillin pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident unspecified condition of brain depressive disorder, not elsewhere classified cerebral edema encephalopathy, unspecified
white f 76 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  89  mg dl$folic acid  1  mg ; multivitamins  1  tab ; sulfameth trimethoprim ds  1  tab ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; filgrastim  300  mcg ; hydromorphone (dilaudid)  2  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; heparin  1300-2500  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; trazodone  25  mg ; levetiracetam  500  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; potassium chloride replacement (oncology)  20  meq ; 0.9% sodium chloride  1000  ml ; 
epilepsy, unspecified, without mention of intractable epilepsy malignant neoplasm of temporal lobe personal history of other infectious and parasitic diseases unspecified essential hypertension personal history of allergy to penicillin pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident unspecified condition of brain depressive disorder, not elsewhere classified cerebral edema encephalopathy, unspecified
white f 76 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  100  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  86  mg dl$folic acid  1  mg ; multivitamins  1  tab ; sulfameth trimethoprim ds  1  tab ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  2  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; heparin  1300-2500  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; trazodone  25  mg ; levetiracetam  500  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  1000  ml ; acetylcysteine 20%  600  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; 
epilepsy, unspecified, without mention of intractable epilepsy malignant neoplasm of temporal lobe personal history of other infectious and parasitic diseases unspecified essential hypertension personal history of allergy to penicillin pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident unspecified condition of brain depressive disorder, not elsewhere classified cerebral edema encephalopathy, unspecified
white f 76 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  158  mg dl$folic acid  1  mg ; multivitamins  1  tab ; sulfameth trimethoprim ds  1  tab ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  2  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; d5w  250  ml ; heparin sodium  25,000  unit ; trazodone  25  mg ; levetiracetam  500  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; acetylcysteine 20%  600  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; heparin  5000  unit ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; 
epilepsy, unspecified, without mention of intractable epilepsy malignant neoplasm of temporal lobe personal history of other infectious and parasitic diseases unspecified essential hypertension personal history of allergy to penicillin pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident unspecified condition of brain depressive disorder, not elsewhere classified cerebral edema encephalopathy, unspecified
white f 76 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  93  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  107  mg dl; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood chloride, whole blood  97  meq l; blood gas blood chloride, whole blood  97  meq l; blood gas blood glucose  130  mg dl; blood gas blood glucose  111  mg dl; blood gas blood hematocrit, calculated  34  %; blood gas blood hematocrit, calculated  39  %; blood gas blood hemoglobin  11.2  g dl; blood gas blood hemoglobin  13.1  g dl; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  128  meq l; blood gas blood sodium, whole blood  130  meq l$folic acid  1  mg ; multivitamins  1  tab ; sulfameth trimethoprim ds  1  tab ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  2  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; d5w  250  ml ; heparin sodium  25,000  unit ; trazodone  25  mg ; levetiracetam  500  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; acetylcysteine 20%  600  mg ; sw  50  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  500  ml ; 
epilepsy, unspecified, without mention of intractable epilepsy malignant neoplasm of temporal lobe personal history of other infectious and parasitic diseases unspecified essential hypertension personal history of allergy to penicillin pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident unspecified condition of brain depressive disorder, not elsewhere classified cerebral edema encephalopathy, unspecified
white f 76 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  140  mg dl; blood gas blood free calcium  1.14  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood chloride, whole blood  99  meq l; blood gas blood glucose  126  mg dl; blood gas blood hematocrit, calculated  38  %; blood gas blood hemoglobin  12.6  g dl; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood sodium, whole blood  133  meq l$folic acid  1  mg ; multivitamins  1  tab ; sulfameth trimethoprim ds  1  tab ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  2  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; d5w  250  ml ; heparin sodium  25,000  unit ; trazodone  25  mg ; levetiracetam  500  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; potassium chloride  60  meq ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; 0.9% sodium chloride  500  ml ; dexamethasone  4  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  100  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  2-4  mg ; hydralazine  5-10  mg ; senna  1  tab ; 0.9% sodium chloride  250  ml ; nicardipine iv  125  mg ; acetaminophen (liquid)  650  mg ; insulin  0  unit ; pantoprazole sodium  40  mg ; 
epilepsy, unspecified, without mention of intractable epilepsy malignant neoplasm of temporal lobe personal history of other infectious and parasitic diseases unspecified essential hypertension personal history of allergy to penicillin pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident unspecified condition of brain depressive disorder, not elsewhere classified cerebral edema encephalopathy, unspecified
white f 76 $nan$hematology blood hematocrit  28.7  %; hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  88  k ul; hematology blood platelet count  112  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  124  mg dl$multivitamins  1  tab ; sulfameth trimethoprim ds  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; trazodone  25  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  100  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  2-4  mg ; hydralazine  5-10  mg ; senna  1  tab ; 0.9% sodium chloride  250  ml ; nicardipine iv  125  mg ; acetaminophen (liquid)  650  mg ; insulin  0  unit ; pantoprazole sodium  40  mg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  0.125  mg ; dexamethasone  3  mg ; pantoprazole  40  mg ; 
epilepsy, unspecified, without mention of intractable epilepsy malignant neoplasm of temporal lobe personal history of other infectious and parasitic diseases unspecified essential hypertension personal history of allergy to penicillin pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident unspecified condition of brain depressive disorder, not elsewhere classified cerebral edema encephalopathy, unspecified
white f 76 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  94  k ul; hematology blood platelet count  93  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  116  mg dl; chemistry blood albumin  3.6  g dl$multivitamins  1  tab ; sulfameth trimethoprim ds  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; trazodone  25  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  2-4  mg ; hydralazine  5-10  mg ; senna  1  tab ; acetaminophen (liquid)  650  mg ; insulin  0  unit ; hydromorphone (dilaudid)  0.125  mg ; dexamethasone  3  mg ; pantoprazole  40  mg ; 
epilepsy, unspecified, without mention of intractable epilepsy malignant neoplasm of temporal lobe personal history of other infectious and parasitic diseases unspecified essential hypertension personal history of allergy to penicillin pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident unspecified condition of brain depressive disorder, not elsewhere classified cerebral edema encephalopathy, unspecified
white f 76 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  110  k ul; hematology blood platelet count  149  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  163  mg dl$multivitamins  1  tab ; sulfameth trimethoprim ds  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; trazodone  25  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  2-4  mg ; senna  1  tab ; acetaminophen (liquid)  650  mg ; insulin  0  unit ; hydromorphone (dilaudid)  0.125  mg ; dexamethasone  3  mg ; pantoprazole  40  mg ; 
epilepsy, unspecified, without mention of intractable epilepsy malignant neoplasm of temporal lobe personal history of other infectious and parasitic diseases unspecified essential hypertension personal history of allergy to penicillin pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident unspecified condition of brain depressive disorder, not elsewhere classified cerebral edema encephalopathy, unspecified
white f 76 $nan$hematology blood platelet count  149  k ul$multivitamins  1  tab ; sulfameth trimethoprim ds  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; trazodone  25  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  2-4  mg ; senna  1  tab ; acetaminophen (liquid)  650  mg ; insulin  0  unit ; hydromorphone (dilaudid)  0.125  mg ; pantoprazole  40  mg ; dexamethasone  2  mg ; 
epilepsy, unspecified, without mention of intractable epilepsy malignant neoplasm of temporal lobe personal history of other infectious and parasitic diseases unspecified essential hypertension personal history of allergy to penicillin pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident unspecified condition of brain depressive disorder, not elsewhere classified cerebral edema encephalopathy, unspecified
white f 76 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  161  k ul$multivitamins  1  tab ; sulfameth trimethoprim ds  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; trazodone  25  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  2-4  mg ; senna  1  tab ; acetaminophen (liquid)  650  mg ; insulin  0  unit ; hydromorphone (dilaudid)  0.125  mg ; pantoprazole  40  mg ; dexamethasone  2  mg ; dexamethasone  1  mg ; 
epilepsy, unspecified, without mention of intractable epilepsy malignant neoplasm of temporal lobe personal history of other infectious and parasitic diseases unspecified essential hypertension personal history of allergy to penicillin pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident unspecified condition of brain depressive disorder, not elsewhere classified cerebral edema encephalopathy, unspecified
white f 76 $nan$nan$multivitamins  1  tab ; sulfameth trimethoprim ds  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; trazodone  25  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  2-4  mg ; senna  1  tab ; acetaminophen (liquid)  650  mg ; insulin  0  unit ; hydromorphone (dilaudid)  0.125  mg ; pantoprazole  40  mg ; dexamethasone  1  mg ; 
epilepsy, unspecified, without mention of intractable epilepsy malignant neoplasm of temporal lobe personal history of other infectious and parasitic diseases unspecified essential hypertension personal history of allergy to penicillin pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident unspecified condition of brain depressive disorder, not elsewhere classified cerebral edema encephalopathy, unspecified
unknown m 51 $nan$hematology blood hematocrit  29.7  %; hematology blood hematocrit  28.8  %; hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  288  k ul; hematology blood platelet count  276  k ul; hematology blood platelet count  294  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  84  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; lactated ringers  1000  ml ; diltiazem extended-release  240  mg ; bag  1  bag ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; diltiazem  60  mg ; 
 
unknown m 51 $nan$hematology blood hematocrit  30.9  %; hematology blood hematocrit  34.8  %; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  85  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bag  1  bag ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; ferrous sulfate  325  mg ; moviprep  1  l ; 
 
unknown m 51 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  85  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ferrous sulfate  325  mg ; moviprep  1  l ; 
 
white m 75 $temp    heartrate  81.0  resprate  18.0  o2sat  97.0  sbp  131.0  dbp  62.0  rhythm    pain  0  $hematology blood hematocrit  35.5  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  3.0  ; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  132  mg dl; chemistry blood lactate dehydrogenase (ld)  225  iu l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; metoprolol tartrate  100  mg ; ranitidine  150  mg ; insulin  22  unit ; phytonadione  5  mg ; furosemide  80  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; digoxin  0.125  mg ; lisinopril  10  mg ; mexiletine  150  mg ; warfarin  2  mg ; insulin  8  unit ; d5w  500  ml ; lidocaine  2000  mg ; lorazepam  0.5  mg ; acetaminophen  325-650  mg ; 
chronic kidney disease, stage iii (moderate) coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic systolic heart failure anemia, unspecified atrial flutter malignant neoplasm of prostate diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux abdominal aneurysm without mention of rupture palpitations automatic implantable cardiac defibrillator in situ percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified paroxysmal ventricular tachycardia peripheral vascular complications, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atherosclerosis of native arteries of the extremities, unspecified chronic systolic heart failure chronic kidney disease, unspecified atrioventricular block, complete diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified atrial fibrillation
white m 75 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  416  mg dl; chemistry blood glucose  176  mg dl$senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; metoprolol tartrate  100  mg ; ranitidine  150  mg ; insulin  22  unit ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; digoxin  0.125  mg ; lisinopril  10  mg ; insulin  8  unit ; lorazepam  0.5  mg ; acetaminophen  325-650  mg ; tamsulosin  0.4  mg ; potassium chloride  10  meq ; warfarin  3  mg ; 
chronic kidney disease, stage iii (moderate) coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic systolic heart failure anemia, unspecified atrial flutter malignant neoplasm of prostate diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux abdominal aneurysm without mention of rupture palpitations automatic implantable cardiac defibrillator in situ percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified paroxysmal ventricular tachycardia peripheral vascular complications, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atherosclerosis of native arteries of the extremities, unspecified chronic systolic heart failure chronic kidney disease, unspecified atrioventricular block, complete diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified atrial fibrillation
white m 75 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  203  mg dl$senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; docusate sodium  100  mg ; metoprolol tartrate  100  mg ; ranitidine  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; digoxin  0.125  mg ; lisinopril  10  mg ; acetaminophen  325-650  mg ; tamsulosin  0.4  mg ; warfarin  3  mg ; digoxin  0.0625  mg ; potassium chloride  40  meq ; quinidine gluconate e.r.  324  mg ; 
chronic kidney disease, stage iii (moderate) coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic systolic heart failure anemia, unspecified atrial flutter malignant neoplasm of prostate diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux abdominal aneurysm without mention of rupture palpitations automatic implantable cardiac defibrillator in situ percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified paroxysmal ventricular tachycardia peripheral vascular complications, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atherosclerosis of native arteries of the extremities, unspecified chronic systolic heart failure chronic kidney disease, unspecified atrioventricular block, complete diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified atrial fibrillation
white m 75 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  3.7  ; chemistry blood glucose  122  mg dl$senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; docusate sodium  100  mg ; metoprolol tartrate  100  mg ; ranitidine  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; acetaminophen  325-650  mg ; tamsulosin  0.4  mg ; warfarin  3  mg ; digoxin  0.0625  mg ; potassium chloride  40  meq ; quinidine gluconate e.r.  324  mg ; 0.9% sodium chloride  250  ml ; 
chronic kidney disease, stage iii (moderate) coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic systolic heart failure anemia, unspecified atrial flutter malignant neoplasm of prostate diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux abdominal aneurysm without mention of rupture palpitations automatic implantable cardiac defibrillator in situ percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified paroxysmal ventricular tachycardia peripheral vascular complications, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atherosclerosis of native arteries of the extremities, unspecified chronic systolic heart failure chronic kidney disease, unspecified atrioventricular block, complete diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified atrial fibrillation
white m 75 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  3.5  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  117  mg dl$senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; docusate sodium  100  mg ; metoprolol tartrate  100  mg ; ranitidine  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; acetaminophen  325-650  mg ; tamsulosin  0.4  mg ; digoxin  0.0625  mg ; quinidine gluconate e.r.  324  mg ; 0.9% sodium chloride  250  ml ; lisinopril  5  mg ; metoprolol succinate xl  100  mg ; 
chronic kidney disease, stage iii (moderate) coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic systolic heart failure anemia, unspecified atrial flutter malignant neoplasm of prostate diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux abdominal aneurysm without mention of rupture palpitations automatic implantable cardiac defibrillator in situ percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified paroxysmal ventricular tachycardia peripheral vascular complications, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atherosclerosis of native arteries of the extremities, unspecified chronic systolic heart failure chronic kidney disease, unspecified atrioventricular block, complete diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified atrial fibrillation
white m 67 $nan$hematology blood hematocrit  26.0  %; hematology blood hematocrit  24.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  260  k ul; hematology blood platelet count  231  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.8  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  91  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  383  iu l; hematology blood bands  4  %; blood gas blood free calcium  0.95  mmol l$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; tacrolimus  0.5  mg ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  423.33  ml ; foscarnet sodium  5080  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  107  mg dl; blood gas blood free calcium  1.01  mmol l; blood gas blood free calcium  0.99  mmol l$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  423.33  ml ; foscarnet sodium  5080  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; 0.9% sodium chloride  264.58  ml ; foscarnet sodium  3175  mg ; bag  2  bag ; magnesium sulfate  4  gm ; neutra-phos  2  pkt ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  83  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; 0.9% sodium chloride  264.58  ml ; foscarnet sodium  3175  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; fludrocortisone acetate  0.1  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  82  mg dl; chemistry blood albumin  3.6  g dl; blood gas blood free calcium  1.00  mmol l$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; 0.9% sodium chloride  264.58  ml ; foscarnet sodium  3175  mg ; fludrocortisone acetate  0.1  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  22.4  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  86  mg dl$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; 0.9% sodium chloride  264.58  ml ; foscarnet sodium  3175  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  88  mg dl$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; 0.9% sodium chloride  264.58  ml ; foscarnet sodium  3175  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  22.5  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  87  mg dl$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; 0.9% sodium chloride  264.58  ml ; foscarnet sodium  3175  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  21.9  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  89  mg dl; blood gas blood free calcium  1.16  mmol l$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; 0.9% sodium chloride  264.58  ml ; foscarnet sodium  3175  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  21.7  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  87  mg dl; chemistry blood albumin  3.8  g dl; blood gas blood free calcium  1.12  mmol l$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; 0.9% sodium chloride  264.58  ml ; foscarnet sodium  3175  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  22.3  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  325  iu l$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; 0.9% sodium chloride  264.58  ml ; foscarnet sodium  3175  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; magnesium oxide  400  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  21.4  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine creatinine, urine  54  mg dl; chemistry urine sodium, urine  152  meq l; chemistry urine urea nitrogen, urine  251  mg dl; hematology urine wbc  0  # hpf; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  90  mg dl; blood gas blood free calcium  1.05  mmol l$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; 0.9% sodium chloride  264.58  ml ; foscarnet sodium  3175  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; magnesium oxide  400  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  21.4  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  3.5  g dl$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  8.6  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$nan$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  8.6  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  19.8  %; hematology blood hematocrit  21.0  %; hematology blood hemoglobin  6.7  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  220  k ul; hematology blood platelet count  238  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  88  mg dl; chemistry blood albumin  3.8  g dl; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  0.96  mmol l$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  8.6  mg ; potassium chloride  60  meq ; polyethylene glycol  17  g ; potassium chloride  40  meq ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  23.1  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  87  mg dl; chemistry blood albumin  3.7  g dl; blood gas blood free calcium  1.29  mmol l$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  8.6  mg ; potassium chloride  60  meq ; polyethylene glycol  17  g ; potassium chloride  40  meq ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  22.7  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  4.0  g dl; blood gas blood free calcium  1.05  mmol l$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; magnesium sulfate  2  gm ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  22.2  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  84  mg dl; chemistry blood albumin  3.8  g dl$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; magnesium sulfate  2  gm ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  21.9  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  88  mg dl; chemistry blood albumin  3.7  g dl$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  80  mg dl; chemistry blood albumin  3.9  g dl$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  22.7  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine creatinine, urine  58  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  87  mg dl; chemistry blood albumin  3.6  g dl; chemistry urine creatinine clearance  66  ml min; chemistry urine creatinine, serum  1.4  mg dl; chemistry urine urine creatinine  58  mg dl; chemistry urine 24 hr creatinine  1334  mg 24hr$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  21.9  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  3.9  g dl$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  21.3  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  90  mg dl$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  21.9  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  88  mg dl; chemistry blood albumin  3.8  g dl$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; 0.9% sodium chloride  355.83  ml ; foscarnet sodium  4270  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  21.6  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  373  iu l; chemistry blood albumin  3.7  g dl$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; 0.9% sodium chloride  355.83  ml ; foscarnet sodium  4270  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  20.9  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  86  mg dl; chemistry blood albumin  3.6  g dl$heparin  5000  unit ; tacrolimus  2  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; 0.9% sodium chloride  355.83  ml ; foscarnet sodium  4270  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  21.0  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  3.9  g dl$heparin  5000  unit ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; 0.9% sodium chloride  355.83  ml ; foscarnet sodium  4270  mg ; potassium chloride  20  meq ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  20.2  %; hematology blood hemoglobin  6.7  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  85  mg dl; chemistry blood albumin  3.7  g dl$heparin  5000  unit ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; 0.9% sodium chloride  355.83  ml ; foscarnet sodium  4270  mg ; potassium chloride  20  meq ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  23.3  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  88  mg dl; chemistry blood albumin  3.7  g dl$bag  1  bag ; heparin  5000  unit ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; 0.9% sodium chloride  355.83  ml ; foscarnet sodium  4270  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  3.8  g dl$bag  1  bag ; heparin  5000  unit ; simvastatin  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; letermovir  480  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  10.4  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  94  mg dl; chemistry blood albumin  4.1  g dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; letermovir  480  mg ; acetaminophen  650  mg ; potassium chloride (powder)  40  meq ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine creatinine, urine  154  mg dl; chemistry urine sodium, urine  65  meq l; chemistry blood calcium, total  10.5  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  83  mg dl; chemistry blood albumin  4.0  g dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; letermovir  480  mg ; acetaminophen  650  mg ; potassium chloride (powder)  40  meq ; tacrolimus  1  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  85  mg dl; chemistry blood albumin  3.8  g dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; tacrolimus  1  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  82  mg dl; chemistry blood albumin  3.9  g dl$heparin  5000  unit ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white m 67 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  10-20  ml ; aspirin  81  mg ; atovaquone suspension  1500  mg ; escitalopram oxalate  10  mg ; multivitamins w minerals  1  tab ; omeprazole  40  mg ; fludrocortisone acetate  0.1  mg ; docusate sodium  100  mg ; senna  17.2  mg ; 
major depressive disorder, single episode, unspecified anemia, unspecified personal history of malignant neoplasm of liver other cytomegaloviral diseases liver transplant infection personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of antiviral drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hyperlipidemia, unspecified nicotine dependence, cigarettes, uncomplicated celiac disease other drug-induced agranulocytosis viral infection, unspecified liver transplant rejection adult failure to thrive unspecified severe protein-calorie malnutrition body mass index (bmi) 19.9 or less, adult celiac disease unspecified mental disorder due to known physiological condition cerebral infarction due to embolism of unspecified cerebral artery other cytomegaloviral diseases major depressive disorder, single episode, unspecified surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure nicotine dependence, cigarettes, uncomplicated anemia in other chronic diseases classified elsewhere personal history of malignant neoplasm of liver cachexia hyperlipidemia, unspecified liver transplant infection hyperkalemia major depressive disorder, single episode, unspecified personal history of malignant neoplasm of liver hyperlipidemia, unspecified other cytomegaloviral diseases celiac disease nicotine dependence, cigarettes, uncomplicated unspecified severe protein-calorie malnutrition chronic kidney disease, unspecified body mass index (bmi) 19.9 or less, adult unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure liver transplant rejection acute kidney failure, unspecified adverse effect of glucocorticoids and synthetic analogues, initial encounter physical restraint status other cirrhosis of liver unspecified right bundle-branch block unspecified place in hospital as the place of occurrence of the external cause
white f 52 $temp  99.5  heartrate  85.0  resprate  17.0  o2sat  98.0  sbp  111.0  dbp  56.0  rhythm    pain  3  $hematology blood hematocrit  31.6  %; hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  417  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  103  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; morphine sulfate  2-4  mg ; 
 
white f 52 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  415  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  107  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; morphine sulfate  2-4  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  325-650  mg ; 
 
white m 59 $nan$hematology blood hematocrit  27.6  %; hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  140  k ul; hematology blood platelet count  138  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  0.97  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood chloride, whole blood  105  meq l; blood gas blood glucose  123  mg dl; blood gas blood glucose  146  mg dl; blood gas blood glucose  148  mg dl; blood gas blood glucose  137  mg dl; blood gas blood hematocrit, calculated  42  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  30  %; blood gas blood hemoglobin  14.1  g dl; blood gas blood hemoglobin  9.8  g dl; blood gas blood hemoglobin  9.9  g dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  135  meq l$sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; soln  100  ml ; acetaminophen iv  1000  mg ; 
coronary atherosclerosis of native coronary artery other and unspecified angina pectoris other and unspecified hyperlipidemia 
white m 59 $nan$hematology blood hematocrit  31.3  %; hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  124  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood glucose  110  mg dl; blood gas blood glucose  123  mg dl; blood gas blood glucose  128  mg dl; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  4.1  meq l$sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; soln  100  ml ; acetaminophen iv  1000  mg ; dexmedetomidine  0.4  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; atorvastatin  40  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; ketorolac  15  mg ; insulin  30  unit ; 
coronary atherosclerosis of native coronary artery other and unspecified angina pectoris other and unspecified hyperlipidemia 
white m 59 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  127  mg dl$sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; dexmedetomidine  0.4  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; atorvastatin  40  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; ketorolac  15  mg ; insulin  30  unit ; furosemide  20  mg ; metoprolol tartrate  12.5  mg ; bisacodyl  10  mg ; insulin  0  unit ; artificial tears preserv. free  1-2  drop ; 
coronary atherosclerosis of native coronary artery other and unspecified angina pectoris other and unspecified hyperlipidemia 
white m 59 $nan$hematology blood hematocrit  25.2  %; hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  105  mg dl$insulin  30  unit ; furosemide  20  mg ; metoprolol tartrate  12.5  mg ; bisacodyl  10  mg ; insulin  0  unit ; artificial tears preserv. free  1-2  drop ; 
coronary atherosclerosis of native coronary artery other and unspecified angina pectoris other and unspecified hyperlipidemia 
white m 59 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  107  mg dl$insulin  30  unit ; furosemide  20  mg ; metoprolol tartrate  12.5  mg ; bisacodyl  10  mg ; insulin  0  unit ; artificial tears preserv. free  1-2  drop ; metoprolol tartrate  25  mg ; 
coronary atherosclerosis of native coronary artery other and unspecified angina pectoris other and unspecified hyperlipidemia 
white m 59 $nan$nan$furosemide  20  mg ; bisacodyl  10  mg ; artificial tears preserv. free  1-2  drop ; metoprolol tartrate  25  mg ; 
coronary atherosclerosis of native coronary artery other and unspecified angina pectoris other and unspecified hyperlipidemia 
hispanic latino m 51 $temp    heartrate  78.0  resprate  23.0  o2sat  98.0  sbp  157.0  dbp  75.0  rhythm    pain    ; temp    heartrate  79.0  resprate  22.0  o2sat  98.0  sbp  151.0  dbp  72.0  rhythm    pain    ; temp    heartrate  77.0  resprate  24.0  o2sat  94.0  sbp  145.0  dbp  68.0  rhythm    pain    ; temp    heartrate  22.0  resprate  77.0  o2sat  99.0  sbp  134.0  dbp  57.0  rhythm    pain    $nan$nephrocaps  1  cap ; vitamin d  400  unit ; amlodipine  10  mg ; isosorbide mononitrate (extended release)  60  mg ; losartan potassium  100  mg ; levothyroxine sodium  25  mcg ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $temp  102.9  heartrate  77.0  resprate  27.0  o2sat  100.0  sbp  148.0  dbp  71.0  rhythm  sinus rhythm  pain    $hematology blood hematocrit  39.8  %; hematology blood hematocrit  41.7  %; hematology blood hemoglobin  13.2  g dl; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  70  k ul; hematology blood platelet count  74  k ul; chemistry blood anion gap  23  meq l; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  8.1  mg dl; chemistry blood creatinine  9.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  143  mg dl; chemistry blood glucose  132  mg dl; chemistry blood lactate dehydrogenase (ld)  335  iu l; chemistry blood albumin  4.3  g dl; blood gas blood lactate  1.4  mmol l$nephrocaps  1  cap ; vitamin d  400  unit ; amlodipine  10  mg ; isosorbide mononitrate (extended release)  60  mg ; losartan potassium  100  mg ; levothyroxine sodium  25  mcg ; sevelamer carbonate  800  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; ondansetron  8  mg ; acetaminophen  650  mg ; vial  1  vial ; pantoprazole  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; doxepin hcl  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; carvedilol  25  mg ; ondansetron  4  mg ; insulin  3  unit ; prochlorperazine  25  mg ; 0.9% sodium chloride  1000  ml ; promethazine  12.5  mg ; 5% dextrose  150  ml ; vancomycin  500  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; acetaminophen  325  mg ; acetaminophen  1000  mg ; clonidine patch 0.1 mg 24 hr  1  ptch ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  38.7  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  63  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  11.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  71  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  122  mg dl$nephrocaps  1  cap ; vitamin d  400  unit ; amlodipine  10  mg ; isosorbide mononitrate (extended release)  60  mg ; losartan potassium  100  mg ; levothyroxine sodium  25  mcg ; sevelamer carbonate  800  mg ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; carvedilol  25  mg ; ondansetron  4  mg ; insulin  3  unit ; promethazine  12.5  mg ; 5% dextrose  150  ml ; vancomycin  500  mg ; acetaminophen  325  mg ; acetaminophen  1000  mg ; clonidine patch 0.1 mg 24 hr  1  ptch ; sevelamer carbonate  1600  mg ; omeprazole  40  mg ; trazodone  25  mg ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  76  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  14.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  84  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  175  mg dl$nephrocaps  1  cap ; vitamin d  400  unit ; amlodipine  10  mg ; isosorbide mononitrate (extended release)  60  mg ; losartan potassium  100  mg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; carvedilol  25  mg ; ondansetron  4  mg ; insulin  3  unit ; clonidine patch 0.1 mg 24 hr  1  ptch ; sevelamer carbonate  1600  mg ; omeprazole  40  mg ; trazodone  25  mg ; sevelamer carbonate  2400  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; oxycodone (immediate release)   5  mg ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$nan$nephrocaps  1  cap ; vitamin d  400  unit ; amlodipine  10  mg ; isosorbide mononitrate (extended release)  60  mg ; losartan potassium  100  mg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; carvedilol  25  mg ; ondansetron  4  mg ; insulin  3  unit ; clonidine patch 0.1 mg 24 hr  1  ptch ; omeprazole  40  mg ; sevelamer carbonate  2400  mg ; oxycodone (immediate release)   5  mg ; heparin  5000  unit ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  35.6  %; hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.6  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  101  k ul; hematology blood platelet count  118  k ul; chemistry blood anion gap  26  meq l; chemistry blood anion gap  27  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  17.2  mg dl; chemistry blood creatinine  17.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  88  mg dl; chemistry blood urea nitrogen  92  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  146  mg dl$nephrocaps  1  cap ; vitamin d  400  unit ; amlodipine  10  mg ; isosorbide mononitrate (extended release)  60  mg ; losartan potassium  100  mg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; carvedilol  25  mg ; ondansetron  4  mg ; insulin  3  unit ; clonidine patch 0.1 mg 24 hr  1  ptch ; omeprazole  40  mg ; sevelamer carbonate  2400  mg ; oxycodone (immediate release)   5  mg ; heparin  5000  unit ; sevelamer carbonate  3200  mg ; hydromorphone (dilaudid)  2  mg ; diazepam  2  mg ; dextromethorphan-guaifenesin (sugar free)  5-10  ml ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  27  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  17.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  102  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  115  mg dl$nephrocaps  1  cap ; vitamin d  400  unit ; amlodipine  10  mg ; isosorbide mononitrate (extended release)  60  mg ; losartan potassium  100  mg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; carvedilol  25  mg ; ondansetron  4  mg ; insulin  3  unit ; clonidine patch 0.1 mg 24 hr  1  ptch ; omeprazole  40  mg ; oxycodone (immediate release)   5  mg ; heparin  5000  unit ; sevelamer carbonate  3200  mg ; diazepam  2  mg ; dextromethorphan-guaifenesin (sugar free)  5-10  ml ; diazepam  2.5  mg ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  12.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  159  mg dl; hematology blood bands  0  %$nephrocaps  1  cap ; vitamin d  400  unit ; amlodipine  10  mg ; isosorbide mononitrate (extended release)  60  mg ; losartan potassium  100  mg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; carvedilol  25  mg ; ondansetron  4  mg ; insulin  3  unit ; clonidine patch 0.1 mg 24 hr  1  ptch ; omeprazole  40  mg ; oxycodone (immediate release)   5  mg ; heparin  5000  unit ; sevelamer carbonate  3200  mg ; dextromethorphan-guaifenesin (sugar free)  5-10  ml ; 0.9% sodium chloride  250  ml ; neomycin-polymyxin-bacitracin  1  appl ; heparin dwell (1000 units ml)  2000-8000  unit ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  8.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  152  mg dl; chemistry blood lactate dehydrogenase (ld)  260  iu l$nephrocaps  1  cap ; vitamin d  400  unit ; amlodipine  10  mg ; isosorbide mononitrate (extended release)  60  mg ; losartan potassium  100  mg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; carvedilol  25  mg ; ondansetron  4  mg ; insulin  3  unit ; clonidine patch 0.1 mg 24 hr  1  ptch ; omeprazole  40  mg ; oxycodone (immediate release)   5  mg ; heparin  5000  unit ; sevelamer carbonate  3200  mg ; dextromethorphan-guaifenesin (sugar free)  5-10  ml ; 0.9% sodium chloride  500  ml ; aspirin  325  mg ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  10.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  160  mg dl$nephrocaps  1  cap ; vitamin d  400  unit ; amlodipine  10  mg ; isosorbide mononitrate (extended release)  60  mg ; losartan potassium  100  mg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; carvedilol  25  mg ; ondansetron  4  mg ; insulin  3  unit ; clonidine patch 0.1 mg 24 hr  1  ptch ; omeprazole  40  mg ; oxycodone (immediate release)   5  mg ; heparin  5000  unit ; sevelamer carbonate  3200  mg ; dextromethorphan-guaifenesin (sugar free)  5-10  ml ; 0.9% sodium chloride  500  ml ; aspirin  325  mg ; heparin flush (1000 units ml)  4000-11000  unit ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  12.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  65  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  10.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  140  mg dl; chemistry blood albumin  3.8  g dl$nephrocaps  1  cap ; vitamin d  400  unit ; amlodipine  10  mg ; isosorbide mononitrate (extended release)  60  mg ; losartan potassium  100  mg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ondansetron  4  mg ; insulin  3  unit ; clonidine patch 0.1 mg 24 hr  1  ptch ; omeprazole  40  mg ; oxycodone (immediate release)   5  mg ; heparin  5000  unit ; sevelamer carbonate  3200  mg ; dextromethorphan-guaifenesin (sugar free)  5-10  ml ; aspirin  325  mg ; heparin flush (1000 units ml)  4000-11000  unit ; d5w  250  ml ; dopamine  400  mg ; bisacodyl  10  mg ; senna  1  tab ; lidocaine jelly 2% (urojet)  2  appl ; fentanyl citrate  25-100  mcg ; midazolam  0.5-2  mg ; docusate sodium (liquid)  100  mg ; atropine sulfate  1  mg ; ibuprofen  400  mg ; 5% dextrose  250  ml ; isoproterenol  2  mg ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$nan$bisacodyl  10  mg ; senna  1  tab ; lidocaine jelly 2% (urojet)  2  appl ; fentanyl citrate  25-100  mcg ; midazolam  0.5-2  mg ; atropine sulfate  1  mg ; ibuprofen  400  mg ; 5% dextrose  250  ml ; isoproterenol  2  mg ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  32.7  %; hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  238  k ul; hematology blood platelet count  272  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  8.8  mg dl; chemistry blood creatinine  6.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  10.4  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  240  mg dl; chemistry blood glucose  233  mg dl$bisacodyl  10  mg ; senna  1  tab ; lidocaine jelly 2% (urojet)  2  appl ; 5% dextrose  250  ml ; isoproterenol  2  mg ; epoetin alfa  3300  unit ; ibuprofen  800  mg ; cefazolin  3  g ; colchicine  0.6  mg ; glycopyrrolate  1  mg ; guaifenesin-dextromethorphan  5-10  ml ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  8.2  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  10.3  mg dl; chemistry blood glucose  178  mg dl; chemistry blood % hemoglobin a1c  6.8  %$bisacodyl  10  mg ; senna  1  tab ; lidocaine jelly 2% (urojet)  2  appl ; 5% dextrose  250  ml ; isoproterenol  2  mg ; ibuprofen  800  mg ; cefazolin  3  g ; colchicine  0.6  mg ; guaifenesin-dextromethorphan  5-10  ml ; glycopyrrolate  2  mg ; atropine sulfate  0.25  mg ; fluticasone propionate nasal  1  spry ; atorvastatin  80  mg ; codeine sulfate  15-30  mg ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  5.3  mg dl; chemistry blood creatinine  6.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  119  mg dl$bisacodyl  10  mg ; senna  1  tab ; lidocaine jelly 2% (urojet)  2  appl ; ibuprofen  800  mg ; guaifenesin-dextromethorphan  5-10  ml ; atropine sulfate  0.25  mg ; fluticasone propionate nasal  1  spry ; atorvastatin  80  mg ; codeine sulfate  15-30  mg ; syringe  10  ml ; heparin flush (10 units ml)  2  ml ; theophylline sr  200  mg ; benzonatate  100  mg ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  7.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  205  mg dl; blood gas blood free calcium  1.24  mmol l; blood gas blood free calcium  1.24  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood chloride, whole blood  98  meq l; blood gas blood chloride, whole blood  98  meq l; blood gas blood glucose  199  mg dl; blood gas blood glucose  342  mg dl; blood gas blood glucose  254  mg dl; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  25  %; blood gas blood hemoglobin  8.7  g dl; blood gas blood hemoglobin  8.4  g dl; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  6.4  meq l; blood gas blood sodium, whole blood  128  meq l; blood gas blood sodium, whole blood  127  meq l$bisacodyl  10  mg ; senna  1  tab ; lidocaine jelly 2% (urojet)  2  appl ; ibuprofen  800  mg ; guaifenesin-dextromethorphan  5-10  ml ; fluticasone propionate nasal  1  spry ; atorvastatin  80  mg ; heparin flush (10 units ml)  2  ml ; benzonatate  100  mg ; sarna lotion  1  appl ; diphenhydramine  25  mg ; methylprednisolone sodium succ  125  mg ; norepinephrine  8  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; midazolam  100  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  7.4  mg dl; chemistry blood creatinine  8.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  5.3  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  146  mg dl; chemistry blood glucose  167  mg dl$bisacodyl  10  mg ; senna  1  tab ; lidocaine jelly 2% (urojet)  2  appl ; ibuprofen  800  mg ; guaifenesin-dextromethorphan  5-10  ml ; fluticasone propionate nasal  1  spry ; atorvastatin  80  mg ; heparin flush (10 units ml)  2  ml ; benzonatate  100  mg ; sarna lotion  1  appl ; diphenhydramine  25  mg ; methylprednisolone sodium succ  125  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; midazolam  100  mg ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  6.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  127  mg dl$bisacodyl  10  mg ; senna  1  tab ; lidocaine jelly 2% (urojet)  2  appl ; ibuprofen  800  mg ; guaifenesin-dextromethorphan  5-10  ml ; fluticasone propionate nasal  1  spry ; atorvastatin  80  mg ; heparin flush (10 units ml)  2  ml ; benzonatate  100  mg ; sarna lotion  1  appl ; carvedilol  12.5  mg ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  8.1  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  65  mg dl$bisacodyl  10  mg ; senna  1  tab ; lidocaine jelly 2% (urojet)  2  appl ; guaifenesin-dextromethorphan  5-10  ml ; fluticasone propionate nasal  1  spry ; atorvastatin  80  mg ; heparin flush (10 units ml)  2  ml ; benzonatate  100  mg ; sarna lotion  1  appl ; carvedilol  12.5  mg ; 0.9% sodium chloride  150  ml ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  29.1  %; hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  5.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  76  mg dl$bisacodyl  10  mg ; senna  1  tab ; lidocaine jelly 2% (urojet)  2  appl ; guaifenesin-dextromethorphan  5-10  ml ; fluticasone propionate nasal  1  spry ; atorvastatin  80  mg ; heparin flush (10 units ml)  2  ml ; benzonatate  100  mg ; sarna lotion  1  appl ; carvedilol  12.5  mg ; 0.9% sodium chloride  150  ml ; hydromorphone (dilaudid)  0.125  mg ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  7.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  10.4  mg dl; chemistry blood glucose  67  mg dl$bisacodyl  10  mg ; lidocaine jelly 2% (urojet)  2  appl ; guaifenesin-dextromethorphan  5-10  ml ; fluticasone propionate nasal  1  spry ; atorvastatin  80  mg ; heparin flush (10 units ml)  2  ml ; benzonatate  100  mg ; sarna lotion  1  appl ; carvedilol  12.5  mg ; 0.9% sodium chloride  150  ml ; hydromorphone (dilaudid)  0.125  mg ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
hispanic latino m 51 $nan$nan$bisacodyl  10  mg ; lidocaine jelly 2% (urojet)  2  appl ; guaifenesin-dextromethorphan  5-10  ml ; fluticasone propionate nasal  1  spry ; atorvastatin  80  mg ; heparin flush (10 units ml)  2  ml ; benzonatate  100  mg ; sarna lotion  1  appl ; carvedilol  12.5  mg ; 0.9% sodium chloride  150  ml ; 
esophagitis, unspecified legal blindness, as defined in u.s.a. hematemesis old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified gastritis and gastroduodenitis, without mention of hemorrhage congestive heart failure, unspecified diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled gastroparesis background diabetic retinopathy renal dialysis status polyneuropathy in diabetes coronary atherosclerosis of native coronary artery epilepsy, unspecified, without mention of intractable epilepsy end stage renal disease personal history of tuberculosis chronic diastolic heart failure long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unspecified gastritis and gastroduodenitis, with hemorrhage polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy gastroparesis esophagitis, unspecified background diabetic retinopathy chronic systolic heart failure congestive heart failure, unspecified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled anoxic brain damage old myocardial infarction esophageal reflux acute upper respiratory infections of unspecified site unspecified glaucoma diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled coronary atherosclerosis of native coronary artery end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy epilepsy, unspecified, without mention of intractable epilepsy chronic systolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
white f 65 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  193  k ul$aspirin  121.5  mg ; atenolol  25  mg ; heparin  5000  unit ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  50  mg ; aspirin  150  mg ; ns  100  ml ; cefazolin  2  gm ; acetaminophen  650  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; hydralazine  10  mg ; lr  1000  ml ; morphine sulfate  1-5  mg ; hydromorphone (dilaudid)  0.2-0.6  mg ; labetalol  10-20  mg ; 
 
white f 65 $nan$nan$aspirin  121.5  mg ; atenolol  25  mg ; heparin  5000  unit ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  50  mg ; aspirin  150  mg ; ns  100  ml ; cefazolin  2  gm ; acetaminophen  650  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; hydralazine  10  mg ; lr  1000  ml ; morphine sulfate  1-5  mg ; hydromorphone (dilaudid)  0.2-0.6  mg ; labetalol  10-20  mg ; hyoscyamine so4 (time release)  0.375  mg ; fluoxetine  30  mg ; lisinopril  5  mg ; ns  250  ml ; clonazepam  1  mg ; 
 
white f 65 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  181  k ul$aspirin  121.5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  50  mg ; ns  100  ml ; cefazolin  2  gm ; acetaminophen  650  mg ; ondansetron  4  mg ; fluoxetine  30  mg ; clonazepam  1  mg ; mupirocin cream 2%  1  appl ; prochlorperazine  2.5-5  mg ; haloperidol  0.25-0.5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; cefazolin  2  g ; oxycodone-acetaminophen  1-2  tab ; morphine sulfate  2-4  mg ; bisacodyl  10  mg ; senna  1  tab ; psyllium  1  pkt ; polyethylene glycol  17  g ; 
 
white f 65 $nan$nan$potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; cefazolin  2  g ; oxycodone-acetaminophen  1-2  tab ; morphine sulfate  2-4  mg ; bisacodyl  10  mg ; senna  1  tab ; psyllium  1  pkt ; polyethylene glycol  17  g ; trazodone  100  mg ; 
 
white f 65 $nan$nan$potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; cefazolin  2  g ; oxycodone-acetaminophen  1-2  tab ; morphine sulfate  2-4  mg ; bisacodyl  10  mg ; psyllium  1  pkt ; polyethylene glycol  17  g ; trazodone  100  mg ; amitriptyline  10  mg ; 
 
white f 65 $nan$nan$potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; cefazolin  2  g ; oxycodone-acetaminophen  1-2  tab ; morphine sulfate  2-4  mg ; bisacodyl  10  mg ; psyllium  1  pkt ; polyethylene glycol  17  g ; trazodone  100  mg ; amitriptyline  10  mg ; pneumococcal vac polyvalent  0.5  ml ; alendronate sodium  70  mg ; 
 
white f 86 $nan$hematology blood hematocrit  22.8  %; hematology blood hematocrit  33.0  %; hematology blood hematocrit  30.7  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  417  k ul; hematology blood platelet count  279  k ul; hematology blood platelet count  283  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  117  meq l; chemistry blood chloride  118  meq l; chemistry blood chloride  119  meq l; chemistry blood chloride  117  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  148  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  3.7  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  101  mg dl; chemistry blood albumin  2.2  g dl; hematology blood bands  39  %; blood gas blood free calcium  1.04  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood chloride, whole blood  119  meq l; blood gas blood chloride, whole blood  119  meq l; blood gas blood chloride, whole blood  118  meq l; blood gas blood glucose  97  mg dl; blood gas blood glucose  113  mg dl; blood gas blood glucose  104  mg dl; blood gas blood hematocrit, calculated  22  %; blood gas blood hematocrit, calculated  31  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hemoglobin  7.2  g dl; blood gas blood hemoglobin  10.3  g dl; blood gas blood hemoglobin  10.9  g dl; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood sodium, whole blood  142  meq l; blood gas blood sodium, whole blood  143  meq l; blood gas blood sodium, whole blood  145  meq l; blood gas blood sodium, whole blood  144  meq l; blood gas blood calculated bicarbonate, whole blood  19  meq l; blood gas blood calculated bicarbonate, whole blood  21  meq l$0.9% sodium chloride  250  ml ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fentanyl citrate  25-100  mcg ; propofol  1000  mg ; propofol  200  mg ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; lactated ringers  1000  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; norepinephrine  8  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; albumin 5% (25g   500ml)  25  g ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 
 
white f 86 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  120  meq l; chemistry blood chloride  120  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  148  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  3.5  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  84  mg dl; chemistry blood glucose  86  mg dl; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.4  mmol l$0.9% sodium chloride  250  ml ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; propofol  1000  mg ; propofol  200  mg ; heparin  5000  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; lactated ringers  1000  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; norepinephrine  8  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; albumin 5% (25g   500ml)  25  g ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; d5 1 2ns  1000  ml ; sodium chloride 0.9%  flush  10  ml ; neutra-phos  2  pkt ; 
 
white f 86 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  120  meq l; chemistry blood chloride  120  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  105  mg dl; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  1.1  mmol l$0.9% sodium chloride  250  ml ; syringe  2  ml ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; propofol  1000  mg ; propofol  200  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; norepinephrine  8  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; sodium chloride 0.9%  flush  10  ml ; neutra-phos  2  pkt ; albumin 5% (12.5g   250ml)  12.5  g ; potassium phosphate  30  mmol ; labetalol  10  mg ; furosemide  20  mg ; morphine sulfate  0.5  mg ; 
 
white f 86 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  2.6  ; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  76  mg dl; chemistry blood glucose  93  mg dl; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood glucose  85  mg dl$0.9% sodium chloride  250  ml ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; propofol  1000  mg ; propofol  200  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  10  ml ; albumin 5% (12.5g   250ml)  12.5  g ; potassium phosphate  30  mmol ; labetalol  10  mg ; morphine sulfate  0.5  mg ; potassium phosphate  15-30  mmol ; 
 
white f 86 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  3.4  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  84  mg dl; chemistry blood glucose  78  mg dl; blood gas blood free calcium  1.19  mmol l; blood gas blood glucose  86  mg dl$0.9% sodium chloride  250  ml ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; propofol  1000  mg ; propofol  200  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  10  ml ; potassium phosphate  15-30  mmol ; sodium phosphate  15  mmol ; 
 
white f 86 $nan$nan$0.9% sodium chloride  250  ml ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  10  ml ; potassium phosphate  15-30  mmol ; sodium phosphate  15  mmol ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lorazepam  0.5-2  mg ; morphine sulfate  1-4  mg ; 
 
black african american f 31 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; bisacodyl  10  mg ; hydromorphone (dilaudid)  2  mg ; acetaminophen  325-650  mg ; diphenhydramine  25  mg ; ondansetron odt  4-8  mg ; heparin  5000  unit ; docusate sodium  100  mg ; quetiapine fumarate  100  mg ; 
paraplegia urinary tract infection, site not specified acidosis other impaction of intestine neurogenic bowel cauda equina syndrome with neurogenic bladder infection and inflammatory reaction due to indwelling urinary catheter late effect of spinal cord injury
black african american f 31 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; bisacodyl  10  mg ; hydromorphone (dilaudid)  2  mg ; acetaminophen  325-650  mg ; diphenhydramine  25  mg ; ondansetron odt  4-8  mg ; heparin  5000  unit ; docusate sodium  100  mg ; quetiapine fumarate  100  mg ; tramadol (ultram)  50  mg ; 
paraplegia urinary tract infection, site not specified acidosis other impaction of intestine neurogenic bowel cauda equina syndrome with neurogenic bladder infection and inflammatory reaction due to indwelling urinary catheter late effect of spinal cord injury
white f 70 $nan$hematology blood hematocrit  41.2  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; hematology urine wbc  8  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  119  mg dl; chemistry blood lactate dehydrogenase (ld)  163  iu l$prochlorperazine  10  mg ; ondansetron  4  mg ; 0.9% sodium chloride  1000  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  1  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; heparin  5000  unit ; lr  1000  ml ; 
 
white f 70 $nan$hematology blood hematocrit  38.9  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  346  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  82  mg dl$prochlorperazine  10  mg ; ondansetron  4  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  1  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; heparin  5000  unit ; lr  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; sw  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 
 
white f 70 $nan$hematology blood hematocrit  39.9  %; hematology blood hematocrit  46.1  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  347  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  90  mg dl$pneumococcal vac polyvalent  0.5  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; heparin  5000  unit ; lr  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; sw  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; metoclopramide  10  mg ; hydromorphone (dilaudid)  12.5  mg ; insulin  0  unit ; ketorolac  15  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 
 
white f 70 $nan$hematology blood hematocrit  37.9  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  337  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  87  mg dl$pneumococcal vac polyvalent  0.5  ml ; metoclopramide  10  mg ; hydromorphone (dilaudid)  12.5  mg ; insulin  0  unit ; ketorolac  15  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; lr  500  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 
 
white f 70 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  77  mg dl$pneumococcal vac polyvalent  0.5  ml ; metoclopramide  10  mg ; hydromorphone (dilaudid)  12.5  mg ; insulin  0  unit ; ketorolac  15  mg ; lr  500  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 
 
white f 70 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  102  mg dl$metoclopramide  10  mg ; hydromorphone (dilaudid)  12.5  mg ; insulin  0  unit ; ketorolac  15  mg ; zolpidem tartrate  5  mg ; hydromorphone (dilaudid)  2-4  mg ; potassium phosphate  15  mmol ; neutra-phos  1  pkt ; 
 
white f 70 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  98  mg dl$insulin  0  unit ; zolpidem tartrate  5  mg ; hydromorphone (dilaudid)  2-4  mg ; neutra-phos  1  pkt ; 
 
white f 70 $nan$nan$insulin  0  unit ; hydromorphone (dilaudid)  2-4  mg ; 
 
white f 32 $nan$nan$docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; prenatal vitamins  1  tab ; bisacodyl  10  mg ; syringe  2  ml ; betamethasone na. phos acet  12  mg ; 
 
white f 32 $nan$nan$docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; prenatal vitamins  1  tab ; bisacodyl  10  mg ; syringe  2  ml ; betamethasone na. phos acet  12  mg ; 
 
other f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; sodium citrate  30  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
second-degree perineal laceration, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn 
other f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; sodium citrate  30  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
second-degree perineal laceration, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn 
other f 36 $nan$hematology blood fetal hemoglobin  0  %$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; sodium citrate  30  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
second-degree perineal laceration, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn 
hispanic latino m 81 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  394  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  3.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  225  mg dl; hematology blood bands  0  %; blood gas blood lactate  2.8  mmol l$nan
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  301  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  4.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  273  mg dl; chemistry blood lactate dehydrogenase (ld)  285  iu l; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood glucose  273  mg dl$1 2 ns  1000  ml ; albuterol  6-8  puff ; ipratropium bromide mdi  6-8  puff ; influenza virus vaccine  0.5  ml ; heparin flush picc (100 units ml)  2  ml ; albuterol  4  puff ; acetaminophen (liquid)  650  mg ; allopurinol  100  mg ; insulin  0  unit ; allopurinol  150  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol (250 50)   1  inh ; heparin  5000  unit ; captopril  6.25  mg ; lanthanum  500  mg ; metronidazole (flagyl)  500  mg ; insulin  10  unit ; lansoprazole oral disintegrating tab  30  mg ; aspirin  325  mg ; tiotropium bromide  1  cap ; nephrocaps  1  cap ; beclomethasone dipropionate  1  puff ; ipratropium bromide mdi  2  puff ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  317  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  6.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  96  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  187  mg dl$influenza virus vaccine  0.5  ml ; heparin flush picc (100 units ml)  2  ml ; acetaminophen (liquid)  650  mg ; insulin  0  unit ; allopurinol  150  mg ; heparin  5000  unit ; captopril  6.25  mg ; lanthanum  500  mg ; metronidazole (flagyl)  500  mg ; insulin  10  unit ; lansoprazole oral disintegrating tab  30  mg ; aspirin  325  mg ; nephrocaps  1  cap ; beclomethasone dipropionate  1  puff ; ipratropium bromide mdi  2  puff ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  279  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  72  mg dl; chemistry blood lactate dehydrogenase (ld)  291  iu l$influenza virus vaccine  0.5  ml ; heparin flush picc (100 units ml)  2  ml ; acetaminophen (liquid)  650  mg ; insulin  0  unit ; allopurinol  150  mg ; heparin  5000  unit ; captopril  6.25  mg ; lanthanum  500  mg ; insulin  10  unit ; lansoprazole oral disintegrating tab  30  mg ; aspirin  325  mg ; nephrocaps  1  cap ; beclomethasone dipropionate  1  puff ; ipratropium bromide mdi  2  puff ; insulin  12  unit ; ns  500  ml ; ns  250  ml ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  5.7  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  68  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  153  mg dl; hematology urine glucose  300  mg dl$influenza virus vaccine  0.5  ml ; heparin flush picc (100 units ml)  2  ml ; acetaminophen (liquid)  650  mg ; insulin  0  unit ; allopurinol  150  mg ; heparin  5000  unit ; insulin  10  unit ; lansoprazole oral disintegrating tab  30  mg ; aspirin  325  mg ; nephrocaps  1  cap ; beclomethasone dipropionate  1  puff ; ipratropium bromide mdi  2  puff ; insulin  12  unit ; ns  500  ml ; ns  250  ml ; insulin  14  unit ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  28.4  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  212  k ul; hematology blood platelet count  218  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  7.5  mg dl; chemistry blood creatinine  4.8  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  98  mg dl; chemistry blood urea nitrogen  61  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  280  mg dl; chemistry blood glucose  210  mg dl$influenza virus vaccine  0.5  ml ; heparin flush picc (100 units ml)  2  ml ; acetaminophen (liquid)  650  mg ; insulin  0  unit ; allopurinol  150  mg ; heparin  5000  unit ; insulin  10  unit ; lansoprazole oral disintegrating tab  30  mg ; aspirin  325  mg ; nephrocaps  1  cap ; beclomethasone dipropionate  1  puff ; ipratropium bromide mdi  2  puff ; insulin  12  unit ; insulin  14  unit ; insulin  18  unit ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam na  2.25  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$chemistry blood chloride  104  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  140  meq l; blood gas blood lactate  2.2  mmol l$influenza virus vaccine  0.5  ml ; heparin flush picc (100 units ml)  2  ml ; acetaminophen (liquid)  650  mg ; insulin  0  unit ; allopurinol  150  mg ; heparin  5000  unit ; insulin  10  unit ; lansoprazole oral disintegrating tab  30  mg ; aspirin  325  mg ; nephrocaps  1  cap ; beclomethasone dipropionate  1  puff ; ipratropium bromide mdi  2  puff ; insulin  12  unit ; insulin  14  unit ; insulin  18  unit ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam na  2.25  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; lr  1000  ml ; magnesium oxide  400  mg ; insulin  26  unit ; multi  5  ml ; folic acid  1  mg ; cosyntropin  250  mcg ; vial  1  vial ; epoetin alfa  1  dose ; hydrocortisone (rectal) 2.5% cream  1  appl ; alteplase (catheter clearance)  1  mg ; hydrocortisone na succ.  100  mg ; insulin  16  unit ; insulin  22  unit ; humalog  10  unit ; beclomethasone dipropionate  2  puff ; ns  100  ml ; insulin human regular  100  unit ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  6.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  81  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  131  mg dl$influenza virus vaccine  0.5  ml ; heparin flush picc (100 units ml)  2  ml ; acetaminophen (liquid)  650  mg ; allopurinol  150  mg ; heparin  5000  unit ; lansoprazole oral disintegrating tab  30  mg ; aspirin  325  mg ; ipratropium bromide mdi  2  puff ; lr  1000  ml ; magnesium oxide  400  mg ; multi  5  ml ; folic acid  1  mg ; cosyntropin  250  mcg ; vial  1  vial ; epoetin alfa  1  dose ; hydrocortisone (rectal) 2.5% cream  1  appl ; alteplase (catheter clearance)  1  mg ; humalog  10  unit ; beclomethasone dipropionate  2  puff ; ns  100  ml ; insulin human regular  100  unit ; mult  5  ml ; insulin  30  unit ; insulin  40  unit ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  3.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  128  mg dl$influenza virus vaccine  0.5  ml ; heparin flush picc (100 units ml)  2  ml ; acetaminophen (liquid)  650  mg ; allopurinol  150  mg ; heparin  5000  unit ; lansoprazole oral disintegrating tab  30  mg ; aspirin  325  mg ; ipratropium bromide mdi  2  puff ; folic acid  1  mg ; vial  1  vial ; epoetin alfa  1  dose ; hydrocortisone (rectal) 2.5% cream  1  appl ; beclomethasone dipropionate  2  puff ; mult  5  ml ; insulin  40  unit ; viokase 8  1-2  tab ; sodium bicarbonate  650  mg ; vitamin b complex  1  cap ; vitamin b complex  1  tab ; ascorbic acid (liquid)  100  mg ; d5w  1000  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  5.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  65  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  207  mg dl$influenza virus vaccine  0.5  ml ; heparin flush picc (100 units ml)  2  ml ; acetaminophen (liquid)  650  mg ; allopurinol  150  mg ; heparin  5000  unit ; lansoprazole oral disintegrating tab  30  mg ; aspirin  325  mg ; ipratropium bromide mdi  2  puff ; folic acid  1  mg ; vial  1  vial ; epoetin alfa  1  dose ; hydrocortisone (rectal) 2.5% cream  1  appl ; beclomethasone dipropionate  2  puff ; ascorbic acid (liquid)  100  mg ; d5w  1000  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; d5w  150  ml ; vancomycin  500  mg ; albuterol  2  puff ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  3.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  152  mg dl; chemistry blood albumin  2.5  g dl$ascorbic acid (liquid)  100  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol  2  puff ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  5.5  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  72  mg dl; hematology urine wbc  15  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  187  mg dl; hematology urine glucose  300  mg dl$ascorbic acid (liquid)  100  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol  2  puff ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$nan$ascorbic acid (liquid)  100  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol  2  puff ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  4.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  167  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol  2  puff ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  6.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  84  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  73  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol  2  puff ; heparin  1900-3900  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  4.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  181  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol  2  puff ; heparin  1900-3900  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; warfarin  5  mg ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  5.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  61  mg dl; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  1.1  ; hematology urine wbc  21-50  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  380  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol  2  puff ; heparin  1900-3900  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; warfarin  5  mg ; heparin flush midline (100 units ml)  2  ml ; miconazole powder 2%  1  appl ; warfarin  2.5  mg ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  314  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol  2  puff ; heparin  1900-3900  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; heparin flush midline (100 units ml)  2  ml ; miconazole powder 2%  1  appl ; warfarin  2.5  mg ; morphine sulfate  1  mg ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  366  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  4.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  204  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol  2  puff ; heparin  1900-3900  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; heparin flush midline (100 units ml)  2  ml ; miconazole powder 2%  1  appl ; warfarin  2.5  mg ; morphine sulfate  1  mg ; albuterol 0.083% neb soln  1  neb ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  391  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  5.8  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  181  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol  2  puff ; heparin  1900-3900  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; heparin flush midline (100 units ml)  2  ml ; miconazole powder 2%  1  appl ; albuterol 0.083% neb soln  1  neb ; artificial tears  1-2  drop ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  403  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  213  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol  2  puff ; heparin  1900-3900  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; heparin flush midline (100 units ml)  2  ml ; miconazole powder 2%  1  appl ; albuterol 0.083% neb soln  1  neb ; artificial tears  1-2  drop ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
hispanic latino m 81 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  386  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  4.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  51  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  129  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol  2  puff ; heparin  1900-3900  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; heparin flush midline (100 units ml)  2  ml ; miconazole powder 2%  1  appl ; albuterol 0.083% neb soln  1  neb ; artificial tears  1-2  drop ; 
fever acute respiratory failure personal history of malignant neoplasm of prostate hemiplegia, unspecified, affecting unspecified side other and unspecified hyperlipidemia aphasia aortic valve disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified complications of medical care, not elsewhere classified cerebral embolism with cerebral infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled end stage renal disease chronic airway obstruction, not elsewhere classified pneumonitis due to inhalation of food or vomitus mitral valve disorders unspecified sleep apnea anemia in chronic kidney disease hypotension, unspecified
black african american f 30 $nan$nan$nephrocaps  1  cap ; 
 
black african american f 30 $nan$nan$oxazepam  15-30  mg ; nephrocaps  1  cap ; docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; syringe  1  syr ; betamethasone sodium phos acet  12  mg ; progesterone micronized  200  mg ; 
 
black african american f 30 $nan$nan$oxazepam  15-30  mg ; nephrocaps  1  cap ; docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; progesterone micronized  200  mg ; 
 
white m 54 $nan$nan$aspirin  325  mg ; clopidogrel  75  mg ; pravastatin  10  mg ; 
hemorrhage of gastrointestinal tract, unspecified acute posthemorrhagic anemia barrett's esophagus percutaneous transluminal coronary angioplasty status hypertrophic obstructive cardiomyopathy unspecified disorder of esophagus unspecified essential hypertension coronary atherosclerosis of native coronary artery other primary cardiomyopathies unspecified essential hypertension other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery chronic total occlusion of coronary artery 
white m 54 $nan$hematology blood hematocrit  31.0  %$vial  1  vial ; pantoprazole  40  mg ; aspirin  325  mg ; clopidogrel  75  mg ; pravastatin  10  mg ; metoprolol tartrate  12.5  mg ; famotidine  20  mg ; sodium chloride 0.9%  flush  3  ml ; sucralfate  1  gm ; iso-osmotic sodium chloride  50  ml ; trazodone  25  mg ; zolpidem tartrate  5  mg ; d5 1 2ns  1000  ml ; senna  1  tab ; docusate sodium  100  mg ; valsartan  80  mg ; metoprolol succinate xl  25  mg ; verapamil sr  360  mg ; 
hemorrhage of gastrointestinal tract, unspecified acute posthemorrhagic anemia barrett's esophagus percutaneous transluminal coronary angioplasty status hypertrophic obstructive cardiomyopathy unspecified disorder of esophagus unspecified essential hypertension coronary atherosclerosis of native coronary artery other primary cardiomyopathies unspecified essential hypertension other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery chronic total occlusion of coronary artery 
white m 54 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  386  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  96  mg dl$aspirin  325  mg ; clopidogrel  75  mg ; pravastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; sucralfate  1  gm ; iso-osmotic sodium chloride  50  ml ; zolpidem tartrate  5  mg ; senna  1  tab ; docusate sodium  100  mg ; valsartan  80  mg ; metoprolol succinate xl  25  mg ; verapamil sr  360  mg ; 
hemorrhage of gastrointestinal tract, unspecified acute posthemorrhagic anemia barrett's esophagus percutaneous transluminal coronary angioplasty status hypertrophic obstructive cardiomyopathy unspecified disorder of esophagus unspecified essential hypertension coronary atherosclerosis of native coronary artery other primary cardiomyopathies unspecified essential hypertension other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery chronic total occlusion of coronary artery 
white m 52 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  108  mg dl; blood gas blood lactate  2.5  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood lactate  2.1  mmol l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  500  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; bisacodyl  10  mg ; heparin  5000  unit ; pantoprazole  40  mg ; phenylephrine  60  mg ; vasopressin  100  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns (mini bag plus)  100  ml ; cefepime  2  g ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; sw  100  ml ; magnesium sulfate  4  gm ; potassium chloride  40  meq ; lr  1000  ml ; acetaminophen  325-650  mg ; 
 
white m 52 $nan$hematology blood hematocrit  32.9  %; hematology blood hematocrit  31.9  %; hematology blood hemoglobin  11.8  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  129  k ul; hematology blood platelet count  126  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  101  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  1.6  mmol l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  500  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; bisacodyl  10  mg ; heparin  5000  unit ; pantoprazole  40  mg ; phenylephrine  60  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns (mini bag plus)  100  ml ; cefepime  2  g ; docusate sodium  100  mg ; sw  100  ml ; magnesium sulfate  4  gm ; potassium chloride  40  meq ; lr  1000  ml ; acetaminophen  325-650  mg ; morphine sulfate  1-2  mg ; lorazepam  0.5  mg ; vancomycin  1250  mg ; 
 
white m 52 $nan$hematology blood hematocrit  30.9  %; hematology blood hematocrit  30.8  %; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  101  k ul; hematology blood platelet count  113  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  97  mg dl; chemistry blood albumin  2.9  g dl$sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; bisacodyl  10  mg ; heparin  5000  unit ; phenylephrine  60  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; morphine sulfate  1-2  mg ; lorazepam  0.5  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  g ; acetaminophen-caff-butalbital  1-2  tab ; ranitidine  150  mg ; neutra-phos  2  pkt ; potassium chloride  60  meq ; 
 
white m 52 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; morphine sulfate  1-2  mg ; lorazepam  0.5  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  g ; acetaminophen-caff-butalbital  1-2  tab ; neutra-phos  2  pkt ; potassium chloride  60  meq ; meperidine  25-50  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; neutra-phos  1  pkt ; diphenhydramine  25  mg ; 
 
white m 52 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; morphine sulfate  1-2  mg ; lorazepam  0.5  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  g ; acetaminophen-caff-butalbital  1-2  tab ; meperidine  25-50  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; neutra-phos  1  pkt ; diphenhydramine  25  mg ; 
 
white m 52 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  121  mg dl$sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  g ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; heparin flush (10 units ml)  2  ml ; 
 
white m 52 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  327  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  g ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; heparin flush (10 units ml)  2  ml ; 
 
white m 52 $nan$nan$sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  g ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; heparin flush (10 units ml)  2  ml ; 
 
white m 52 $nan$nan$sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  g ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; heparin flush (10 units ml)  2  ml ; 
 
white f 90 $temp  97.4  heartrate  92.0  resprate  13.0  o2sat  99.0  sbp  131.0  dbp  66.0  rhythm    pain  0  $hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; dexamethasone  10  mg ; racepinephrine  0.5  ml ; levothyroxine sodium  25  mcg ; furosemide  40  mg ; 
acute pharyngitis hypoxemia urinary incontinence, unspecified peritonsillar abscess do not resuscitate status diarrhea esophageal reflux unspecified acquired hypothyroidism edema of pharynx or nasopharynx unspecified essential hypertension osteoporosis, unspecified right bundle branch block osteoarthrosis, localized, not specified whether primary or secondary, lower leg do not resuscitate status fall from other slipping, tripping, or stumbling disorder of bone and cartilage, unspecified other and unspecified escherichia coli [e. coli] unspecified essential hypertension contusion of knee esophageal reflux history of fall dehydration unspecified acquired hypothyroidism anemia, unspecified acute kidney failure, unspecified polymyositis osteoporosis, unspecified spinal stenosis, unspecified region rhabdomyolysis asthma, unspecified type, unspecified anemia, unspecified polymyositis bacterial infection, unspecified, in conditions classified elsewhere and of unspecified site unspecified acquired hypothyroidism urinary tract infection, site not specified unspecified essential hypertension esophageal reflux osteoarthrosis, unspecified whether generalized or localized, site unspecified other specified disorders of gallbladder fever, unspecified
white f 90 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  136  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; racepinephrine  0.5  ml ; levothyroxine sodium  25  mcg ; furosemide  40  mg ; docusate sodium  100  mg ; tramadol  50  mg ; furosemide  20  mg ; vitamin d  1000  unit ; verapamil  80  mg ; oxybutynin  5  mg ; 
acute pharyngitis hypoxemia urinary incontinence, unspecified peritonsillar abscess do not resuscitate status diarrhea esophageal reflux unspecified acquired hypothyroidism edema of pharynx or nasopharynx unspecified essential hypertension osteoporosis, unspecified right bundle branch block osteoarthrosis, localized, not specified whether primary or secondary, lower leg do not resuscitate status fall from other slipping, tripping, or stumbling disorder of bone and cartilage, unspecified other and unspecified escherichia coli [e. coli] unspecified essential hypertension contusion of knee esophageal reflux history of fall dehydration unspecified acquired hypothyroidism anemia, unspecified acute kidney failure, unspecified polymyositis osteoporosis, unspecified spinal stenosis, unspecified region rhabdomyolysis asthma, unspecified type, unspecified anemia, unspecified polymyositis bacterial infection, unspecified, in conditions classified elsewhere and of unspecified site unspecified acquired hypothyroidism urinary tract infection, site not specified unspecified essential hypertension esophageal reflux osteoarthrosis, unspecified whether generalized or localized, site unspecified other specified disorders of gallbladder fever, unspecified
white f 90 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  70  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; docusate sodium  100  mg ; tramadol  50  mg ; vitamin d  1000  unit ; verapamil  80  mg ; oxybutynin  5  mg ; aspirin  81  mg ; levothyroxine sodium  50  mcg ; ferrous sulfate  325  mg ; potassium chloride  60  meq ; 
acute pharyngitis hypoxemia urinary incontinence, unspecified peritonsillar abscess do not resuscitate status diarrhea esophageal reflux unspecified acquired hypothyroidism edema of pharynx or nasopharynx unspecified essential hypertension osteoporosis, unspecified right bundle branch block osteoarthrosis, localized, not specified whether primary or secondary, lower leg do not resuscitate status fall from other slipping, tripping, or stumbling disorder of bone and cartilage, unspecified other and unspecified escherichia coli [e. coli] unspecified essential hypertension contusion of knee esophageal reflux history of fall dehydration unspecified acquired hypothyroidism anemia, unspecified acute kidney failure, unspecified polymyositis osteoporosis, unspecified spinal stenosis, unspecified region rhabdomyolysis asthma, unspecified type, unspecified anemia, unspecified polymyositis bacterial infection, unspecified, in conditions classified elsewhere and of unspecified site unspecified acquired hypothyroidism urinary tract infection, site not specified unspecified essential hypertension esophageal reflux osteoarthrosis, unspecified whether generalized or localized, site unspecified other specified disorders of gallbladder fever, unspecified
white f 90 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  62  mg dl; chemistry blood urea nitrogen  52  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  83  mg dl; chemistry blood glucose  158  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; docusate sodium  100  mg ; tramadol  50  mg ; vitamin d  1000  unit ; verapamil  80  mg ; oxybutynin  5  mg ; aspirin  81  mg ; levothyroxine sodium  50  mcg ; ferrous sulfate  325  mg ; potassium chloride  60  meq ; 
acute pharyngitis hypoxemia urinary incontinence, unspecified peritonsillar abscess do not resuscitate status diarrhea esophageal reflux unspecified acquired hypothyroidism edema of pharynx or nasopharynx unspecified essential hypertension osteoporosis, unspecified right bundle branch block osteoarthrosis, localized, not specified whether primary or secondary, lower leg do not resuscitate status fall from other slipping, tripping, or stumbling disorder of bone and cartilage, unspecified other and unspecified escherichia coli [e. coli] unspecified essential hypertension contusion of knee esophageal reflux history of fall dehydration unspecified acquired hypothyroidism anemia, unspecified acute kidney failure, unspecified polymyositis osteoporosis, unspecified spinal stenosis, unspecified region rhabdomyolysis asthma, unspecified type, unspecified anemia, unspecified polymyositis bacterial infection, unspecified, in conditions classified elsewhere and of unspecified site unspecified acquired hypothyroidism urinary tract infection, site not specified unspecified essential hypertension esophageal reflux osteoarthrosis, unspecified whether generalized or localized, site unspecified other specified disorders of gallbladder fever, unspecified
white f 90 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; docusate sodium  100  mg ; tramadol  50  mg ; vitamin d  1000  unit ; verapamil  80  mg ; oxybutynin  5  mg ; aspirin  81  mg ; levothyroxine sodium  50  mcg ; ferrous sulfate  325  mg ; 
acute pharyngitis hypoxemia urinary incontinence, unspecified peritonsillar abscess do not resuscitate status diarrhea esophageal reflux unspecified acquired hypothyroidism edema of pharynx or nasopharynx unspecified essential hypertension osteoporosis, unspecified right bundle branch block osteoarthrosis, localized, not specified whether primary or secondary, lower leg do not resuscitate status fall from other slipping, tripping, or stumbling disorder of bone and cartilage, unspecified other and unspecified escherichia coli [e. coli] unspecified essential hypertension contusion of knee esophageal reflux history of fall dehydration unspecified acquired hypothyroidism anemia, unspecified acute kidney failure, unspecified polymyositis osteoporosis, unspecified spinal stenosis, unspecified region rhabdomyolysis asthma, unspecified type, unspecified anemia, unspecified polymyositis bacterial infection, unspecified, in conditions classified elsewhere and of unspecified site unspecified acquired hypothyroidism urinary tract infection, site not specified unspecified essential hypertension esophageal reflux osteoarthrosis, unspecified whether generalized or localized, site unspecified other specified disorders of gallbladder fever, unspecified
asian m 40 $nan$nan$topiramate (topamax)  50  mg ; levetiracetam  1500  mg ; 
 
asian m 40 $nan$nan$topiramate (topamax)  50  mg ; levetiracetam  1500  mg ; topiramate (topamax)  25  mg ; 
 
asian m 40 $nan$nan$levetiracetam  1500  mg ; topiramate (topamax)  25  mg ; botox  100  unit ; 
 
asian m 40 $nan$nan$levetiracetam  1000  mg ; 
 
asian m 40 $nan$nan$levetiracetam  1000  mg ; lorazepam  2-4  mg ; 
 
asian m 40 $nan$nan$levetiracetam  1000  mg ; lorazepam  2-4  mg ; levetiracetam  500  mg ; lorazepam  1  mg ; senna  1  tab ; 
 
asian m 40 $nan$nan$lorazepam  2-4  mg ; levetiracetam  500  mg ; lorazepam  1  mg ; senna  1  tab ; oxcarbazepine  300  mg ; oxycodone-acetaminophen  1-2  tab ; lorazepam  0.5  mg ; 
 
asian m 40 $nan$nan$lorazepam  2-4  mg ; lorazepam  1  mg ; senna  1  tab ; oxcarbazepine  300  mg ; oxycodone-acetaminophen  1-2  tab ; lorazepam  0.5  mg ; 
 
asian m 40 $nan$nan$lorazepam  2-4  mg ; lorazepam  1  mg ; senna  1  tab ; oxcarbazepine  300  mg ; oxycodone-acetaminophen  1-2  tab ; 
 
white m 34 $temp  98.2  heartrate  110.0  resprate  18.0  o2sat  99.0  sbp  115.0  dbp  71.0  rhythm    pain  0  ; temp  98.1  heartrate  102.0  resprate  16.0  o2sat  98.0  sbp  110.0  dbp  79.0  rhythm    pain    ; temp  98.2  heartrate  91.0  resprate  16.0  o2sat  100.0  sbp  98.0  dbp  52.0  rhythm    pain    $hematology blood hematocrit  39.5  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  6.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; hematology urine wbc  1  # hpf; chemistry blood glucose  106  mg dl; blood gas blood potassium, whole blood  4.2  meq l$nan
gastro-esophageal reflux disease without esophagitis migraine, unspecified, not intractable, without status migrainosus epilepsy, unspecified, not intractable, without status epilepticus major depressive disorder, single episode, unspecified suicidal ideations vomiting, unspecified homicidal ideations homelessness pain in left foot post-traumatic stress disorder, unspecified other psychoactive substance abuse, uncomplicated tachycardia, unspecified bipolar disorder, unspecified epigastric pain nicotine dependence, cigarettes, uncomplicated epilepsy, unspecified, not intractable, without status epilepticus homicidal ideation suicidal ideation
asian m 57 $temp    heartrate  88.0  resprate  16.0  o2sat  100.0  sbp  117.0  dbp  57.0  rhythm    pain    ; temp    heartrate  88.0  resprate  18.0  o2sat  100.0  sbp  98.0  dbp  49.0  rhythm    pain  0  ; temp  97.2  heartrate  85.0  resprate  18.0  o2sat  100.0  sbp  104.0  dbp  54.0  rhythm    pain    $hematology blood hematocrit  28.3  %; hematology blood hematocrit  28.9  %; hematology blood hematocrit  28.3  %; hematology blood hematocrit  18.0  %; hematology blood hematocrit  17.1  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  6.0  g dl; hematology blood hemoglobin  5.7  g dl; hematology blood platelet count  186  k ul; hematology blood platelet count  158  k ul; hematology blood platelet count  173  k ul; hematology blood platelet count  54  k ul; hematology blood platelet count  45  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  8  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  6.0  meq l; chemistry blood potassium  7.6  meq l; chemistry blood potassium  6.1  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood urea nitrogen  58  mg dl; chemistry blood urea nitrogen  61  mg dl; hematology blood inr(pt)  2.5  ; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, indirect  6.0  mg dl; chemistry blood bilirubin, total  25.8  mg dl; chemistry blood bilirubin, total  22.7  mg dl; chemistry blood bilirubin, total  24.4  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  212  mg dl; chemistry blood glucose  226  mg dl; chemistry blood lactate dehydrogenase (ld)  591  iu l; chemistry blood lactate dehydrogenase (ld)  498  iu l; chemistry blood lactate dehydrogenase (ld)  574  iu l; chemistry blood albumin  2.2  g dl; chemistry blood albumin  2.2  g dl; chemistry blood albumin  2.3  g dl; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  3.9  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  2.6  mmol l; chemistry blood bilirubin, direct  19.8  mg dl; blood gas blood potassium, whole blood  5.8  meq l; blood gas blood potassium, whole blood  5.7  meq l; blood gas blood potassium, whole blood  5.6  meq l; blood gas blood potassium, whole blood  6.9  meq l; blood gas blood sodium, whole blood  127  meq l$0.9% sodium chloride  250  ml ; sodium chloride 0.9%  flush  3-10  ml ; lidocaine jelly 2% (glydo)  1  appl ; sodium chloride 0.9%  1000  ml ; norepinephrine  8  mg ; 0.9% sodium chloride  100  ml ; octreotide acetate  500  mcg ; ceftriaxone  1  gm ; soln  50  ml ; fentanyl citrate  2.5  mg ; dextrose 50%  25  gm ; insulin (regular) for hyperkalemia  10  unit ; calcium gluconate  2  g ; albuterol inhaler  1-2  puff ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; albumin 25% (12.5g   50ml)  50  g ; ceftriaxone  2  gm ; albumin 25% (12.5g   50ml)  12.5  g ; cefepime  2  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose enema  1000  ml ; insulin  0  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; docusate sodium  100  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$hematology blood hematocrit  22.8  %; hematology blood hematocrit  22.9  %; hematology blood hematocrit  21.8  %; hematology blood hematocrit  22.1  %; hematology blood hematocrit  21.3  %; hematology blood hematocrit  20.8  %; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  43  k ul; hematology blood platelet count  49  k ul; hematology blood platelet count  39  k ul; hematology blood platelet count  38  k ul; hematology blood platelet count  43  k ul; hematology blood platelet count  36  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  9  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  59  mg dl; chemistry blood urea nitrogen  58  mg dl; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  2.5  ; hematology blood inr(pt)  2.5  ; hematology blood inr(pt)  2.7  ; hematology urine wbc  20  # hpf; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, indirect  5.8  mg dl; chemistry blood bilirubin, total  21.7  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  150  mg dl; chemistry blood glucose  148  mg dl; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.7  mmol l; chemistry blood bilirubin, direct  15.9  mg dl; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood sodium, whole blood  131  meq l$0.9% sodium chloride  250  ml ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  100  ml ; octreotide acetate  500  mcg ; soln  50  ml ; fentanyl citrate  2.5  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; albumin 25% (12.5g   50ml)  12.5  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose enema  1000  ml ; insulin  0  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; docusate sodium  100  mg ; dexmedetomidine  0.4  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole  500  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$hematology blood hematocrit  22.6  %; hematology blood hematocrit  23.2  %; hematology blood hematocrit  21.6  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  37  k ul; hematology blood platelet count  46  k ul; hematology blood platelet count  44  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  57  mg dl; chemistry blood urea nitrogen  52  mg dl; hematology blood inr(pt)  2.7  ; hematology blood inr(pt)  2.6  ; hematology urine wbc  9  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  25.2  mg dl; chemistry blood glucose  148  mg dl; chemistry blood glucose  152  mg dl; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.9  mmol l; hematology urine wbc casts  3  # lpf$0.9% sodium chloride  250  ml ; vial  1  vial ; meropenem  500  mg ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  100  ml ; octreotide acetate  500  mcg ; soln  50  ml ; fentanyl citrate  2.5  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; albumin 25% (12.5g   50ml)  12.5  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; docusate sodium  100  mg ; dexmedetomidine  0.4  mg ; ns  100  ml ; metronidazole  500  mg ; cefepime  1  g ; acetaminophen  650  mg ; bag  1  bag ; vancomycin  0  md to order daily dose ; lactulose  30  ml ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$hematology blood hematocrit  22.7  %; hematology blood hematocrit  22.7  %; hematology blood hematocrit  23.3  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  48  k ul; hematology blood platelet count  50  k ul; hematology blood platelet count  46  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  3.2  ; hematology blood inr(pt)  3.4  ; hematology urine wbc  14  # hpf; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  29.4  mg dl; chemistry blood glucose  204  mg dl$0.9% sodium chloride  250  ml ; vial  1  vial ; meropenem  500  mg ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  100  ml ; octreotide acetate  500  mcg ; soln  50  ml ; fentanyl citrate  2.5  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; docusate sodium  100  mg ; dexmedetomidine  0.4  mg ; acetaminophen  650  mg ; bag  1  bag ; vancomycin  0  md to order daily dose ; lactulose  30  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; hydromorphone (dilaudid)  0.25-0.5  mg ; glycopyrrolate  0.1-0.2  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$nan$hydromorphone (dilaudid)  0.25-0.5  mg ; glycopyrrolate  0.1-0.2  mg ; propranolol  10  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$nan$hydromorphone (dilaudid)  0.25-0.5  mg ; glycopyrrolate  0.1-0.2  mg ; propranolol  10  mg ; oxycodone (immediate release)  5  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$nan$hydromorphone (dilaudid)  0.25-0.5  mg ; glycopyrrolate  0.1-0.2  mg ; propranolol  10  mg ; oxycodone (immediate release)  5  mg ; oxycodone (immediate release)  5-10  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$nan$glycopyrrolate  0.1-0.2  mg ; propranolol  10  mg ; oxycodone (immediate release)  5-10  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$nan$glycopyrrolate  0.1-0.2  mg ; propranolol  10  mg ; oxycodone (immediate release)  5-10  mg ; simethicone  40-80  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$nan$glycopyrrolate  0.1-0.2  mg ; propranolol  10  mg ; oxycodone (immediate release)  5-10  mg ; simethicone  40-80  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$nan$glycopyrrolate  0.1-0.2  mg ; propranolol  10  mg ; oxycodone (immediate release)  5-10  mg ; simethicone  40-80  mg ; hydromorphone (dilaudid)  2-4  mg ; rifaximin  550  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$nan$glycopyrrolate  0.1-0.2  mg ; propranolol  10  mg ; oxycodone (immediate release)  5-10  mg ; simethicone  40-80  mg ; hydromorphone (dilaudid)  2-4  mg ; rifaximin  550  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$nan$glycopyrrolate  0.1-0.2  mg ; propranolol  10  mg ; oxycodone (immediate release)  5-10  mg ; simethicone  40-80  mg ; hydromorphone (dilaudid)  2-4  mg ; rifaximin  550  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$nan$glycopyrrolate  0.1-0.2  mg ; propranolol  10  mg ; oxycodone (immediate release)  5-10  mg ; simethicone  40-80  mg ; hydromorphone (dilaudid)  2-4  mg ; rifaximin  550  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$nan$glycopyrrolate  0.1-0.2  mg ; propranolol  10  mg ; oxycodone (immediate release)  5-10  mg ; simethicone  40-80  mg ; hydromorphone (dilaudid)  2-4  mg ; rifaximin  550  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$nan$glycopyrrolate  0.1-0.2  mg ; propranolol  10  mg ; oxycodone (immediate release)  5-10  mg ; simethicone  40-80  mg ; hydromorphone (dilaudid)  2-4  mg ; rifaximin  550  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
asian m 57 $nan$nan$glycopyrrolate  0.1-0.2  mg ; propranolol  10  mg ; oxycodone (immediate release)  5-10  mg ; simethicone  40-80  mg ; hydromorphone (dilaudid)  2-4  mg ; rifaximin  550  mg ; 
liver cell carcinoma other cirrhosis of liver other specified disorders of bone density and structure, unspecified site unspecified viral hepatitis b without hepatic coma personal history of nicotine dependence other ascites secondary malignant neoplasm of right lung elevated white blood cell count, unspecified secondary malignant neoplasm of left lung left bundle-branch block, unspecified chronic congestive splenomegaly cardiomegaly chronic viral hepatitis b without delta-agent secondary esophageal varices without bleeding unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent acute embolism and thrombosis of other specified veins hyperglycemia, unspecified personal history of antineoplastic chemotherapy portal hypertension portal vein thrombosis family history of malignant neoplasm of other respiratory and intrathoracic organs personal history of nicotine dependence anemia, unspecified other secondary thrombocytopenia other cirrhosis of liver liver cell carcinoma acute kidney failure, unspecified varicose veins of other specified sites pneumonia, unspecified organism chronic viral hepatitis b without delta-agent encounter for antineoplastic chemotherapy personal history of nicotine dependence secondary esophageal varices without bleeding anemia, unspecified unspecified cirrhosis of liver liver cell carcinoma thrombocytopenia, unspecified secondary esophageal varices with bleeding chronic viral hepatitis b without delta-agent thrombocytopenia, unspecified personal history of nicotine dependence unspecified cirrhosis of liver iron deficiency anemia secondary to blood loss (chronic) laryngeal spasm
white f 24 $nan$nan$prenatal vitamins  1  tab ; 
anemia, unspecified carrier or suspected carrier of group b streptococcus other and unspecified cord entanglement, without mention of compression, complicating labor and delivery, delivered, with or without mention of antepartum condition oligohydramnios, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition anemia of mother, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn 
white f 24 $nan$nan$prenatal vitamins  1  tab ; metronidazole (flagyl)  500  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; syringe  1  syr ; betamethasone sodium phos acet  12  mg ; folic acid  1  mg ; 
anemia, unspecified carrier or suspected carrier of group b streptococcus other and unspecified cord entanglement, without mention of compression, complicating labor and delivery, delivered, with or without mention of antepartum condition oligohydramnios, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition anemia of mother, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn 
white f 24 $nan$nan$prenatal vitamins  1  tab ; metronidazole (flagyl)  500  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; syringe  1  syr ; betamethasone sodium phos acet  12  mg ; folic acid  1  mg ; 
anemia, unspecified carrier or suspected carrier of group b streptococcus other and unspecified cord entanglement, without mention of compression, complicating labor and delivery, delivered, with or without mention of antepartum condition oligohydramnios, delivered, with or without mention of antepartum condition first-degree perineal laceration, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition anemia of mother, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident outcome of delivery, single liveborn 
white m 36 $nan$hematology blood hematocrit  39.0  %; hematology blood hematocrit  41.0  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  0.25  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  12.5  mg ; ketorolac  15  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; lr  1000  ml ; lorazepam  0.5  mg ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; sw  50  ml ; magnesium sulfate  2  gm ; 
 
white m 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  12.5  mg ; ketorolac  15  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; lr  1000  ml ; lorazepam  0.5  mg ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; sw  50  ml ; magnesium sulfate  2  gm ; cyclobenzaprine  10  mg ; diphenhydramine  25  mg ; 
 
white m 36 $nan$nan$hydromorphone (dilaudid)  12.5  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; lr  1000  ml ; cyclobenzaprine  10  mg ; diphenhydramine  25  mg ; sarna lotion  1  appl ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ketorolac  15-30  mg ; hydromorphone (dilaudid)  2-4  mg ; fexofenadine  60  mg ; 
 
white m 36 $nan$nan$cyclobenzaprine  10  mg ; sarna lotion  1  appl ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ketorolac  15-30  mg ; hydromorphone (dilaudid)  2-4  mg ; fexofenadine  60  mg ; oxycodone-acetaminophen  1-2  tab ; docusate sodium  100  mg ; 
 
white m 36 $nan$nan$cyclobenzaprine  10  mg ; sarna lotion  1  appl ; ketorolac  15-30  mg ; fexofenadine  60  mg ; oxycodone-acetaminophen  1-2  tab ; docusate sodium  100  mg ; 
 
other f 53 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  83  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  11.8  mg dl; chemistry blood calcium, total  10.9  mg dl; chemistry blood calcium, total  14.0  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  159  mg dl; chemistry blood glucose  143  mg dl; chemistry blood lactate dehydrogenase (ld)  1022  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  1  %$revlimid  25  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; pregabalin  50  mg ; oxycodone (immediate release)  5-10  mg ; docusate sodium  100  mg ; senna  17.2  mg ; polyethylene glycol  17  g ; heparin  5000  unit ; sodium chloride 0.9%  1000  ml ; nystatin  500,000  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; aspirin  81  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; syringe  1.25  ml ; calcitonin salmon  250  unit ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; phosphorus  500  mg ; 
polyneuropathy, unspecified anemia in neoplastic disease adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission hypercalcemia other and unspecified fall in water transport injuring occupant of other watercraft -- crew essential (primary) hypertension adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission essential (primary) hypertension other secondary thrombocytopenia hypovolemia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypokalemia unspecified place or not applicable hypotension, unspecified polyneuropathy, unspecified fever presenting with conditions classified elsewhere tachycardia, unspecified agranulocytosis secondary to cancer chemotherapy other specified disorders of nose and nasal sinuses anemia due to antineoplastic chemotherapy sickle-cell trait epistaxis tropical spastic paraplegia drug-induced polyneuropathy other esophagitis oral mucositis (ulcerative), unspecified myopathy in diseases classified elsewhere adverse effect of antineoplastic and immunosuppressive drugs, sequela adult t-cell lymphoma/leukemia (htlv-1-associated), in relapse body mass index (bmi) 24.0-24.9, adult abnormal weight loss other and unspecified fall in water transport injuring occupant of other watercraft -- crew myelopathy in diseases classified elsewhere essential (primary) hypertension fever presenting with conditions classified elsewhere hypercalcemia oral mucositis (ulcerative) due to antineoplastic therapy candidal stomatitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter asymptomatic menopausal state essential (primary) hypertension peripheral t-cell lymphoma, not classified, lymph nodes of axilla and upper limb anemia due to antineoplastic chemotherapy constipation, unspecified personal history of antineoplastic chemotherapy neutropenia, unspecified urinary tract infection, site not specified sickle-cell trait
other f 53 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  64  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  2.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  10.5  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  111  mg dl; chemistry blood lactate dehydrogenase (ld)  838  iu l; hematology blood bands  3  %$revlimid  25  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; pregabalin  50  mg ; oxycodone (immediate release)  5-10  mg ; docusate sodium  100  mg ; senna  17.2  mg ; polyethylene glycol  17  g ; nystatin  500,000  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; aspirin  81  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; syringe  1.25  ml ; calcitonin salmon  250  unit ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; phosphorus  500  mg ; syringe  1.71  ml ; denosumab (xgeva)  120  mg ; valganciclovir  900  mg ; cepacol (sore throat lozenge)  1  loz ; 
polyneuropathy, unspecified anemia in neoplastic disease adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission hypercalcemia other and unspecified fall in water transport injuring occupant of other watercraft -- crew essential (primary) hypertension adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission essential (primary) hypertension other secondary thrombocytopenia hypovolemia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypokalemia unspecified place or not applicable hypotension, unspecified polyneuropathy, unspecified fever presenting with conditions classified elsewhere tachycardia, unspecified agranulocytosis secondary to cancer chemotherapy other specified disorders of nose and nasal sinuses anemia due to antineoplastic chemotherapy sickle-cell trait epistaxis tropical spastic paraplegia drug-induced polyneuropathy other esophagitis oral mucositis (ulcerative), unspecified myopathy in diseases classified elsewhere adverse effect of antineoplastic and immunosuppressive drugs, sequela adult t-cell lymphoma/leukemia (htlv-1-associated), in relapse body mass index (bmi) 24.0-24.9, adult abnormal weight loss other and unspecified fall in water transport injuring occupant of other watercraft -- crew myelopathy in diseases classified elsewhere essential (primary) hypertension fever presenting with conditions classified elsewhere hypercalcemia oral mucositis (ulcerative) due to antineoplastic therapy candidal stomatitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter asymptomatic menopausal state essential (primary) hypertension peripheral t-cell lymphoma, not classified, lymph nodes of axilla and upper limb anemia due to antineoplastic chemotherapy constipation, unspecified personal history of antineoplastic chemotherapy neutropenia, unspecified urinary tract infection, site not specified sickle-cell trait
other f 53 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  63  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  955  iu l; hematology blood bands  0  %$revlimid  25  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; pregabalin  50  mg ; oxycodone (immediate release)  5-10  mg ; docusate sodium  100  mg ; senna  17.2  mg ; polyethylene glycol  17  g ; nystatin  500,000  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; aspirin  81  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; phosphorus  500  mg ; valganciclovir  900  mg ; cepacol (sore throat lozenge)  1  loz ; 
polyneuropathy, unspecified anemia in neoplastic disease adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission hypercalcemia other and unspecified fall in water transport injuring occupant of other watercraft -- crew essential (primary) hypertension adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission essential (primary) hypertension other secondary thrombocytopenia hypovolemia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypokalemia unspecified place or not applicable hypotension, unspecified polyneuropathy, unspecified fever presenting with conditions classified elsewhere tachycardia, unspecified agranulocytosis secondary to cancer chemotherapy other specified disorders of nose and nasal sinuses anemia due to antineoplastic chemotherapy sickle-cell trait epistaxis tropical spastic paraplegia drug-induced polyneuropathy other esophagitis oral mucositis (ulcerative), unspecified myopathy in diseases classified elsewhere adverse effect of antineoplastic and immunosuppressive drugs, sequela adult t-cell lymphoma/leukemia (htlv-1-associated), in relapse body mass index (bmi) 24.0-24.9, adult abnormal weight loss other and unspecified fall in water transport injuring occupant of other watercraft -- crew myelopathy in diseases classified elsewhere essential (primary) hypertension fever presenting with conditions classified elsewhere hypercalcemia oral mucositis (ulcerative) due to antineoplastic therapy candidal stomatitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter asymptomatic menopausal state essential (primary) hypertension peripheral t-cell lymphoma, not classified, lymph nodes of axilla and upper limb anemia due to antineoplastic chemotherapy constipation, unspecified personal history of antineoplastic chemotherapy neutropenia, unspecified urinary tract infection, site not specified sickle-cell trait
other f 53 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  59  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  122  mg dl; chemistry blood lactate dehydrogenase (ld)  987  iu l; hematology blood bands  2  %$revlimid  25  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; pregabalin  50  mg ; oxycodone (immediate release)  5-10  mg ; docusate sodium  100  mg ; senna  17.2  mg ; polyethylene glycol  17  g ; nystatin  500,000  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; aspirin  81  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; phosphorus  500  mg ; valganciclovir  900  mg ; cepacol (sore throat lozenge)  1  loz ; acetaminophen  650  mg ; fluconazole  200  mg ; atovaquone suspension  1500  mg ; 
polyneuropathy, unspecified anemia in neoplastic disease adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission hypercalcemia other and unspecified fall in water transport injuring occupant of other watercraft -- crew essential (primary) hypertension adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission essential (primary) hypertension other secondary thrombocytopenia hypovolemia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypokalemia unspecified place or not applicable hypotension, unspecified polyneuropathy, unspecified fever presenting with conditions classified elsewhere tachycardia, unspecified agranulocytosis secondary to cancer chemotherapy other specified disorders of nose and nasal sinuses anemia due to antineoplastic chemotherapy sickle-cell trait epistaxis tropical spastic paraplegia drug-induced polyneuropathy other esophagitis oral mucositis (ulcerative), unspecified myopathy in diseases classified elsewhere adverse effect of antineoplastic and immunosuppressive drugs, sequela adult t-cell lymphoma/leukemia (htlv-1-associated), in relapse body mass index (bmi) 24.0-24.9, adult abnormal weight loss other and unspecified fall in water transport injuring occupant of other watercraft -- crew myelopathy in diseases classified elsewhere essential (primary) hypertension fever presenting with conditions classified elsewhere hypercalcemia oral mucositis (ulcerative) due to antineoplastic therapy candidal stomatitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter asymptomatic menopausal state essential (primary) hypertension peripheral t-cell lymphoma, not classified, lymph nodes of axilla and upper limb anemia due to antineoplastic chemotherapy constipation, unspecified personal history of antineoplastic chemotherapy neutropenia, unspecified urinary tract infection, site not specified sickle-cell trait
other f 53 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  61  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  2.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  1078  iu l; chemistry blood albumin  2.9  g dl$revlimid  25  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; pregabalin  50  mg ; oxycodone (immediate release)  5-10  mg ; docusate sodium  100  mg ; senna  17.2  mg ; polyethylene glycol  17  g ; nystatin  500,000  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; phosphorus  500  mg ; valganciclovir  900  mg ; cepacol (sore throat lozenge)  1  loz ; fluconazole  200  mg ; atovaquone suspension  1500  mg ; enoxaparin sodium  30  mg ; acyclovir  400  mg ; 
polyneuropathy, unspecified anemia in neoplastic disease adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission hypercalcemia other and unspecified fall in water transport injuring occupant of other watercraft -- crew essential (primary) hypertension adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission essential (primary) hypertension other secondary thrombocytopenia hypovolemia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypokalemia unspecified place or not applicable hypotension, unspecified polyneuropathy, unspecified fever presenting with conditions classified elsewhere tachycardia, unspecified agranulocytosis secondary to cancer chemotherapy other specified disorders of nose and nasal sinuses anemia due to antineoplastic chemotherapy sickle-cell trait epistaxis tropical spastic paraplegia drug-induced polyneuropathy other esophagitis oral mucositis (ulcerative), unspecified myopathy in diseases classified elsewhere adverse effect of antineoplastic and immunosuppressive drugs, sequela adult t-cell lymphoma/leukemia (htlv-1-associated), in relapse body mass index (bmi) 24.0-24.9, adult abnormal weight loss other and unspecified fall in water transport injuring occupant of other watercraft -- crew myelopathy in diseases classified elsewhere essential (primary) hypertension fever presenting with conditions classified elsewhere hypercalcemia oral mucositis (ulcerative) due to antineoplastic therapy candidal stomatitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter asymptomatic menopausal state essential (primary) hypertension peripheral t-cell lymphoma, not classified, lymph nodes of axilla and upper limb anemia due to antineoplastic chemotherapy constipation, unspecified personal history of antineoplastic chemotherapy neutropenia, unspecified urinary tract infection, site not specified sickle-cell trait
other f 53 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  63  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  1348  iu l; hematology blood bands  1  %$revlimid  25  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; pregabalin  50  mg ; oxycodone (immediate release)  5-10  mg ; docusate sodium  100  mg ; senna  17.2  mg ; polyethylene glycol  17  g ; nystatin  500,000  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; 0.9% sodium chloride  1  bag ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; phosphorus  500  mg ; cepacol (sore throat lozenge)  1  loz ; fluconazole  200  mg ; atovaquone suspension  1500  mg ; enoxaparin sodium  30  mg ; acyclovir  400  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 
polyneuropathy, unspecified anemia in neoplastic disease adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission hypercalcemia other and unspecified fall in water transport injuring occupant of other watercraft -- crew essential (primary) hypertension adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission essential (primary) hypertension other secondary thrombocytopenia hypovolemia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypokalemia unspecified place or not applicable hypotension, unspecified polyneuropathy, unspecified fever presenting with conditions classified elsewhere tachycardia, unspecified agranulocytosis secondary to cancer chemotherapy other specified disorders of nose and nasal sinuses anemia due to antineoplastic chemotherapy sickle-cell trait epistaxis tropical spastic paraplegia drug-induced polyneuropathy other esophagitis oral mucositis (ulcerative), unspecified myopathy in diseases classified elsewhere adverse effect of antineoplastic and immunosuppressive drugs, sequela adult t-cell lymphoma/leukemia (htlv-1-associated), in relapse body mass index (bmi) 24.0-24.9, adult abnormal weight loss other and unspecified fall in water transport injuring occupant of other watercraft -- crew myelopathy in diseases classified elsewhere essential (primary) hypertension fever presenting with conditions classified elsewhere hypercalcemia oral mucositis (ulcerative) due to antineoplastic therapy candidal stomatitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter asymptomatic menopausal state essential (primary) hypertension peripheral t-cell lymphoma, not classified, lymph nodes of axilla and upper limb anemia due to antineoplastic chemotherapy constipation, unspecified personal history of antineoplastic chemotherapy neutropenia, unspecified urinary tract infection, site not specified sickle-cell trait
other f 53 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  54  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  180  mg dl; chemistry blood lactate dehydrogenase (ld)  1492  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  0  %$revlimid  25  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; pregabalin  50  mg ; oxycodone (immediate release)  5-10  mg ; docusate sodium  100  mg ; senna  17.2  mg ; polyethylene glycol  17  g ; nystatin  500,000  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; 0.9% sodium chloride  1  bag ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; phosphorus  500  mg ; cepacol (sore throat lozenge)  1  loz ; fluconazole  200  mg ; atovaquone suspension  1500  mg ; enoxaparin sodium  30  mg ; acyclovir  400  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; ascorbic acid  1000  mg ; diphenhydramine  50  mg ; dextrose 5%  1000  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; methylprednisolone sodium succ  30  mg ; 0.9% sodium chloride  100  ml ; alemtuzumab  3  mg ; 
polyneuropathy, unspecified anemia in neoplastic disease adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission hypercalcemia other and unspecified fall in water transport injuring occupant of other watercraft -- crew essential (primary) hypertension adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission essential (primary) hypertension other secondary thrombocytopenia hypovolemia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypokalemia unspecified place or not applicable hypotension, unspecified polyneuropathy, unspecified fever presenting with conditions classified elsewhere tachycardia, unspecified agranulocytosis secondary to cancer chemotherapy other specified disorders of nose and nasal sinuses anemia due to antineoplastic chemotherapy sickle-cell trait epistaxis tropical spastic paraplegia drug-induced polyneuropathy other esophagitis oral mucositis (ulcerative), unspecified myopathy in diseases classified elsewhere adverse effect of antineoplastic and immunosuppressive drugs, sequela adult t-cell lymphoma/leukemia (htlv-1-associated), in relapse body mass index (bmi) 24.0-24.9, adult abnormal weight loss other and unspecified fall in water transport injuring occupant of other watercraft -- crew myelopathy in diseases classified elsewhere essential (primary) hypertension fever presenting with conditions classified elsewhere hypercalcemia oral mucositis (ulcerative) due to antineoplastic therapy candidal stomatitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter asymptomatic menopausal state essential (primary) hypertension peripheral t-cell lymphoma, not classified, lymph nodes of axilla and upper limb anemia due to antineoplastic chemotherapy constipation, unspecified personal history of antineoplastic chemotherapy neutropenia, unspecified urinary tract infection, site not specified sickle-cell trait
other f 53 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  42  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  247  mg dl; chemistry blood glucose  144  mg dl; chemistry blood lactate dehydrogenase (ld)  1840  iu l; hematology blood bands  1  %$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; pregabalin  50  mg ; oxycodone (immediate release)  5-10  mg ; docusate sodium  100  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; 0.9% sodium chloride  1  bag ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; phosphorus  500  mg ; cepacol (sore throat lozenge)  1  loz ; fluconazole  200  mg ; atovaquone suspension  1500  mg ; enoxaparin sodium  30  mg ; acyclovir  400  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; ascorbic acid  1000  mg ; diphenhydramine  50  mg ; dextrose 5%  1000  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; methylprednisolone sodium succ  30  mg ; 0.9% sodium chloride  100  ml ; alemtuzumab  3  mg ; epinephrine (epipen)  0.3  mg ; iso-osmotic sodium chloride  2  bag ; famotidine  40  mg ; hydrocortisone na succ.  50  mg ; meperidine  12.5  mg ; 
polyneuropathy, unspecified anemia in neoplastic disease adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission hypercalcemia other and unspecified fall in water transport injuring occupant of other watercraft -- crew essential (primary) hypertension adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission essential (primary) hypertension other secondary thrombocytopenia hypovolemia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypokalemia unspecified place or not applicable hypotension, unspecified polyneuropathy, unspecified fever presenting with conditions classified elsewhere tachycardia, unspecified agranulocytosis secondary to cancer chemotherapy other specified disorders of nose and nasal sinuses anemia due to antineoplastic chemotherapy sickle-cell trait epistaxis tropical spastic paraplegia drug-induced polyneuropathy other esophagitis oral mucositis (ulcerative), unspecified myopathy in diseases classified elsewhere adverse effect of antineoplastic and immunosuppressive drugs, sequela adult t-cell lymphoma/leukemia (htlv-1-associated), in relapse body mass index (bmi) 24.0-24.9, adult abnormal weight loss other and unspecified fall in water transport injuring occupant of other watercraft -- crew myelopathy in diseases classified elsewhere essential (primary) hypertension fever presenting with conditions classified elsewhere hypercalcemia oral mucositis (ulcerative) due to antineoplastic therapy candidal stomatitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter asymptomatic menopausal state essential (primary) hypertension peripheral t-cell lymphoma, not classified, lymph nodes of axilla and upper limb anemia due to antineoplastic chemotherapy constipation, unspecified personal history of antineoplastic chemotherapy neutropenia, unspecified urinary tract infection, site not specified sickle-cell trait
other f 53 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  32  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  6.9  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  269  mg dl; chemistry blood lactate dehydrogenase (ld)  1411  iu l; chemistry blood albumin  2.8  g dl; hematology blood bands  1  %$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; pregabalin  50  mg ; oxycodone (immediate release)  5-10  mg ; docusate sodium  100  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; 0.9% sodium chloride  1  bag ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; phosphorus  500  mg ; cepacol (sore throat lozenge)  1  loz ; fluconazole  200  mg ; atovaquone suspension  1500  mg ; acyclovir  400  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; ascorbic acid  1000  mg ; diphenhydramine  50  mg ; dextrose 5%  1000  ml ; epinephrine (epipen)  0.3  mg ; hydrocortisone na succ.  50  mg ; alemtuzumab  10  mg ; azithromycin  1200  mg ; calcium carbonate  500  mg ; 
polyneuropathy, unspecified anemia in neoplastic disease adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission hypercalcemia other and unspecified fall in water transport injuring occupant of other watercraft -- crew essential (primary) hypertension adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission essential (primary) hypertension other secondary thrombocytopenia hypovolemia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypokalemia unspecified place or not applicable hypotension, unspecified polyneuropathy, unspecified fever presenting with conditions classified elsewhere tachycardia, unspecified agranulocytosis secondary to cancer chemotherapy other specified disorders of nose and nasal sinuses anemia due to antineoplastic chemotherapy sickle-cell trait epistaxis tropical spastic paraplegia drug-induced polyneuropathy other esophagitis oral mucositis (ulcerative), unspecified myopathy in diseases classified elsewhere adverse effect of antineoplastic and immunosuppressive drugs, sequela adult t-cell lymphoma/leukemia (htlv-1-associated), in relapse body mass index (bmi) 24.0-24.9, adult abnormal weight loss other and unspecified fall in water transport injuring occupant of other watercraft -- crew myelopathy in diseases classified elsewhere essential (primary) hypertension fever presenting with conditions classified elsewhere hypercalcemia oral mucositis (ulcerative) due to antineoplastic therapy candidal stomatitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter asymptomatic menopausal state essential (primary) hypertension peripheral t-cell lymphoma, not classified, lymph nodes of axilla and upper limb anemia due to antineoplastic chemotherapy constipation, unspecified personal history of antineoplastic chemotherapy neutropenia, unspecified urinary tract infection, site not specified sickle-cell trait
other f 53 $nan$hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  31  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  277  mg dl; chemistry blood lactate dehydrogenase (ld)  1204  iu l; hematology blood bands  1  %$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; pregabalin  50  mg ; oxycodone (immediate release)  5-10  mg ; docusate sodium  100  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; 0.9% sodium chloride  1  bag ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; phosphorus  500  mg ; cepacol (sore throat lozenge)  1  loz ; fluconazole  200  mg ; atovaquone suspension  1500  mg ; acyclovir  400  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; ascorbic acid  1000  mg ; diphenhydramine  50  mg ; dextrose 5%  1000  ml ; hydrocortisone na succ.  50  mg ; alemtuzumab  10  mg ; azithromycin  1200  mg ; calcium carbonate  500  mg ; phosphorus  1000  mg ; 
polyneuropathy, unspecified anemia in neoplastic disease adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission hypercalcemia other and unspecified fall in water transport injuring occupant of other watercraft -- crew essential (primary) hypertension adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission essential (primary) hypertension other secondary thrombocytopenia hypovolemia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypokalemia unspecified place or not applicable hypotension, unspecified polyneuropathy, unspecified fever presenting with conditions classified elsewhere tachycardia, unspecified agranulocytosis secondary to cancer chemotherapy other specified disorders of nose and nasal sinuses anemia due to antineoplastic chemotherapy sickle-cell trait epistaxis tropical spastic paraplegia drug-induced polyneuropathy other esophagitis oral mucositis (ulcerative), unspecified myopathy in diseases classified elsewhere adverse effect of antineoplastic and immunosuppressive drugs, sequela adult t-cell lymphoma/leukemia (htlv-1-associated), in relapse body mass index (bmi) 24.0-24.9, adult abnormal weight loss other and unspecified fall in water transport injuring occupant of other watercraft -- crew myelopathy in diseases classified elsewhere essential (primary) hypertension fever presenting with conditions classified elsewhere hypercalcemia oral mucositis (ulcerative) due to antineoplastic therapy candidal stomatitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter asymptomatic menopausal state essential (primary) hypertension peripheral t-cell lymphoma, not classified, lymph nodes of axilla and upper limb anemia due to antineoplastic chemotherapy constipation, unspecified personal history of antineoplastic chemotherapy neutropenia, unspecified urinary tract infection, site not specified sickle-cell trait
other f 53 $nan$nan$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; pregabalin  50  mg ; oxycodone (immediate release)  5-10  mg ; docusate sodium  100  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; 0.9% sodium chloride  1  bag ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; cepacol (sore throat lozenge)  1  loz ; fluconazole  200  mg ; atovaquone suspension  1500  mg ; acyclovir  400  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; ascorbic acid  1000  mg ; diphenhydramine  50  mg ; dextrose 5%  1000  ml ; hydrocortisone na succ.  50  mg ; alemtuzumab  10  mg ; azithromycin  1200  mg ; calcium carbonate  500  mg ; phosphorus  1000  mg ; 
polyneuropathy, unspecified anemia in neoplastic disease adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission hypercalcemia other and unspecified fall in water transport injuring occupant of other watercraft -- crew essential (primary) hypertension adult t-cell lymphoma/leukemia (htlv-1-associated) not having achieved remission essential (primary) hypertension other secondary thrombocytopenia hypovolemia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter hypokalemia unspecified place or not applicable hypotension, unspecified polyneuropathy, unspecified fever presenting with conditions classified elsewhere tachycardia, unspecified agranulocytosis secondary to cancer chemotherapy other specified disorders of nose and nasal sinuses anemia due to antineoplastic chemotherapy sickle-cell trait epistaxis tropical spastic paraplegia drug-induced polyneuropathy other esophagitis oral mucositis (ulcerative), unspecified myopathy in diseases classified elsewhere adverse effect of antineoplastic and immunosuppressive drugs, sequela adult t-cell lymphoma/leukemia (htlv-1-associated), in relapse body mass index (bmi) 24.0-24.9, adult abnormal weight loss other and unspecified fall in water transport injuring occupant of other watercraft -- crew myelopathy in diseases classified elsewhere essential (primary) hypertension fever presenting with conditions classified elsewhere hypercalcemia oral mucositis (ulcerative) due to antineoplastic therapy candidal stomatitis adverse effect of antineoplastic and immunosuppressive drugs, initial encounter asymptomatic menopausal state essential (primary) hypertension peripheral t-cell lymphoma, not classified, lymph nodes of axilla and upper limb anemia due to antineoplastic chemotherapy constipation, unspecified personal history of antineoplastic chemotherapy neutropenia, unspecified urinary tract infection, site not specified sickle-cell trait
white f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; diphenhydramine  25  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; oxycodone-acetaminophen  1-2  tab ; venlafaxine xr  75  mg ; venlafaxine  75  mg ; tamoxifen citrate  20  mg ; heparin  5000  unit ; 
 
white f 37 $nan$nan$ciprofloxacin hcl  500  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; oxycodone-acetaminophen  1-2  tab ; venlafaxine  75  mg ; tamoxifen citrate  20  mg ; heparin  5000  unit ; morphine sulfate  2-4  mg ; 
 
white f 37 $nan$nan$ciprofloxacin hcl  500  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; oxycodone-acetaminophen  1-2  tab ; venlafaxine  75  mg ; tamoxifen citrate  20  mg ; heparin  5000  unit ; morphine sulfate  2-4  mg ; d5w  250  ml ; sulfameth trimethoprim  250  mg ; bisacodyl  10  mg ; 
 
white f 37 $nan$nan$oxycodone-acetaminophen  1-2  tab ; venlafaxine  75  mg ; tamoxifen citrate  20  mg ; heparin  5000  unit ; bisacodyl  10  mg ; sulfameth trimethoprim ds  1  tab ; 
 
white f 37 $nan$nan$oxycodone-acetaminophen  1-2  tab ; venlafaxine  75  mg ; tamoxifen citrate  20  mg ; heparin  5000  unit ; bisacodyl  10  mg ; sulfameth trimethoprim ds  1  tab ; 
 
white f 36 $temp  97.7  heartrate  112.0  resprate  20.0  o2sat  95.0  sbp  100.0  dbp  55.0  rhythm    pain  0  $hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  415  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  114  mg dl; blood gas blood lactate  2.8  mmol l$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; diphenoxylate-atropine  2  tab ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; repaglinide  1  mg ; mesalamine  1000  mg ; prednisone  20  mg ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; diphenoxylate-atropine  2  tab ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; repaglinide  1  mg ; mesalamine  1000  mg ; prednisone  20  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; hydrocortisone na succ.  75  mg ; sarna lotion  1  appl ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; diphenoxylate-atropine  2  tab ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; repaglinide  1  mg ; mesalamine  1000  mg ; prednisone  20  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sarna lotion  1  appl ; heparin  5000  unit ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  453  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; diphenoxylate-atropine  2  tab ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; repaglinide  1  mg ; mesalamine  1000  mg ; prednisone  20  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sarna lotion  1  appl ; heparin  5000  unit ; d5lr  1000  ml ; morphine sulfate  2-4  mg ; hydrocortisone na succ.  100  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  160  mg dl; chemistry blood glucose  157  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; diphenoxylate-atropine  2  tab ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; prednisone  20  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sarna lotion  1  appl ; heparin  5000  unit ; d5lr  1000  ml ; morphine sulfate  2-4  mg ; hydrocortisone na succ.  100  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; insulin  6  unit ; insulin  0  unit ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  341  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; diphenoxylate-atropine  2  tab ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; prednisone  20  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sarna lotion  1  appl ; heparin  5000  unit ; morphine sulfate  2-4  mg ; sodium chloride 0.9%  flush  10-20  ml ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; ondansetron  4  mg ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  109  mg dl; chemistry blood albumin  2.0  g dl; blood gas blood hematocrit, calculated  18  %; blood gas blood hematocrit, calculated  20  %; blood gas blood hemoglobin  6.1  g dl; blood gas blood hemoglobin  6.7  g dl$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sarna lotion  1  appl ; heparin  5000  unit ; morphine sulfate  2-4  mg ; sodium chloride 0.9%  flush  10-20  ml ; ondansetron  4  mg ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  23.6  %; hematology blood hemoglobin  6.2  g dl; hematology blood platelet count  295  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  96  mg dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sarna lotion  1  appl ; heparin  5000  unit ; morphine sulfate  2-4  mg ; sodium chloride 0.9%  flush  10-20  ml ; ondansetron  4  mg ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  95  mg dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sarna lotion  1  appl ; heparin  5000  unit ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  22.6  %; hematology blood hemoglobin  6.4  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  92  mg dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sarna lotion  1  appl ; heparin  5000  unit ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; 5% dextrose  500  ml ; sulfamethoxazole-trimethoprim  240  mg ; morphine sulfate  1  mg ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  26.7  %; hematology blood hematocrit  26.1  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  270  k ul; hematology blood platelet count  239  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  148  mg dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sarna lotion  1  appl ; heparin  5000  unit ; ondansetron  4  mg ; morphine sulfate  1  mg ; sulfameth trimethoprim ds  2  tab ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  93  mg dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; heparin  5000  unit ; ondansetron  4  mg ; morphine sulfate  1  mg ; sulfameth trimethoprim ds  2  tab ; enoxaparin sodium  90  mg ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  23.6  %; hematology blood hematocrit  25.8  %; hematology blood hemoglobin  7.1  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  218  k ul; hematology blood platelet count  223  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  90  mg dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; ondansetron  4  mg ; morphine sulfate  1  mg ; sulfameth trimethoprim ds  2  tab ; enoxaparin sodium  90  mg ; vitamin a  50,000  unit ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  87  mg dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; ondansetron  4  mg ; morphine sulfate  1  mg ; sulfameth trimethoprim ds  2  tab ; enoxaparin sodium  90  mg ; vitamin a  50,000  unit ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  100  mg dl; chemistry blood albumin  2.4  g dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; ondansetron  4  mg ; morphine sulfate  1  mg ; sulfameth trimethoprim ds  2  tab ; enoxaparin sodium  90  mg ; vitamin a  50,000  unit ; octreotide acetate  100  mcg ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  121  mg dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; ondansetron  4  mg ; morphine sulfate  1  mg ; sulfameth trimethoprim ds  2  tab ; enoxaparin sodium  90  mg ; vitamin a  50,000  unit ; octreotide acetate  100  mcg ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  97  mg dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; ondansetron  4  mg ; morphine sulfate  1  mg ; sulfameth trimethoprim ds  2  tab ; enoxaparin sodium  90  mg ; vitamin a  50,000  unit ; octreotide acetate  100  mcg ; bag  1  bag ; magnesium sulfate  2  gm ; potassium chloride  20  meq ; 0.9% sodium chloride  250  ml ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  23.4  %; hematology blood hemoglobin  6.7  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  110  mg dl; chemistry blood albumin  2.6  g dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; ondansetron  4  mg ; morphine sulfate  1  mg ; sulfameth trimethoprim ds  2  tab ; enoxaparin sodium  90  mg ; vitamin a  50,000  unit ; octreotide acetate  100  mcg ; 0.9% sodium chloride  250  ml ; 5% dextrose  250  ml ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  128  mg dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; atenolol  25  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; ondansetron  4  mg ; morphine sulfate  1  mg ; sulfameth trimethoprim ds  2  tab ; enoxaparin sodium  90  mg ; vitamin a  50,000  unit ; octreotide acetate  100  mcg ; 5% dextrose  250  ml ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  96  mg dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; mesalamine (rectal)  1000  mg ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; ondansetron  4  mg ; morphine sulfate  1  mg ; sulfameth trimethoprim ds  2  tab ; enoxaparin sodium  90  mg ; vitamin a  50,000  unit ; octreotide acetate  100  mcg ; multivitamins w minerals  1  tab ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  25.6  %; hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.3  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  337  k ul; hematology blood platelet count  304  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.6  ; hematology urine wbc  11  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  98  mg dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; ondansetron  4  mg ; enoxaparin sodium  90  mg ; vitamin a  50,000  unit ; octreotide acetate  100  mcg ; multivitamins w minerals  1  tab ; warfarin  5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; diphenhydramine  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; calcium carbonate  500  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; acetaminophen iv  1000  mg ; promethazine  6.25  mg ; lactated ringers  1000  ml ; ferrous sulfate  325  mg ; magnesium oxide  400  mg ; neutra-phos  2  pkt ; acetaminophen  650  mg ; phosphorus  500  mg ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  309  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  127  mg dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; atenolol  50  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; ondansetron  4  mg ; enoxaparin sodium  90  mg ; vitamin a  50,000  unit ; octreotide acetate  100  mcg ; multivitamins w minerals  1  tab ; warfarin  5  mg ; diphenhydramine  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; calcium carbonate  500  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; acetaminophen iv  1000  mg ; promethazine  6.25  mg ; lactated ringers  1000  ml ; ferrous sulfate  325  mg ; magnesium oxide  400  mg ; acetaminophen  650  mg ; phosphorus  500  mg ; vancomycin  750  mg ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  145  mg dl$iso-osmotic dextrose  150  ml ; albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; ondansetron  4  mg ; enoxaparin sodium  90  mg ; vitamin a  50,000  unit ; octreotide acetate  100  mcg ; multivitamins w minerals  1  tab ; warfarin  5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; calcium carbonate  500  mg ; ferrous sulfate  325  mg ; acetaminophen  650  mg ; vancomycin  750  mg ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  337  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  100  mg dl$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; ondansetron  4  mg ; enoxaparin sodium  90  mg ; vitamin a  50,000  unit ; octreotide acetate  100  mcg ; multivitamins w minerals  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; calcium carbonate  500  mg ; ferrous sulfate  325  mg ; acetaminophen  650  mg ; warfarin  7.5  mg ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood inr(pt)  2.0  $albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; ondansetron  4  mg ; enoxaparin sodium  90  mg ; vitamin a  50,000  unit ; octreotide acetate  100  mcg ; multivitamins w minerals  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; calcium carbonate  500  mg ; ferrous sulfate  325  mg ; acetaminophen  650  mg ; warfarin  7.5  mg ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$hematology blood inr(pt)  2.8  $albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; ondansetron  4  mg ; vitamin a  50,000  unit ; octreotide acetate  100  mcg ; multivitamins w minerals  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; calcium carbonate  500  mg ; ferrous sulfate  325  mg ; acetaminophen  650  mg ; warfarin  7.5  mg ; repaglinide  0.5  mg ; *nf* ertapenem sodium  1  gm ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
white f 36 $nan$nan$albuterol inhaler  1-2  puff ; amitriptyline  10  mg ; nystatin cream  1  appl ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; tamsulosin  0.4  mg ; sarna lotion  1  appl ; ondansetron  4  mg ; vitamin a  50,000  unit ; octreotide acetate  100  mcg ; multivitamins w minerals  1  tab ; calcium carbonate  500  mg ; ferrous sulfate  325  mg ; acetaminophen  650  mg ; repaglinide  0.5  mg ; *nf* ertapenem sodium  1  gm ; warfarin  6  mg ; 
obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult ventral, unspecified, hernia without mention of obstruction or gangrene adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, unspecified long-term (current) use of steroids other osteoporosis home accidents pathologic fracture of other specified site paroxysmal ventricular tachycardia other specified cardiac dysrhythmias regional enteritis of unspecified site obesity, unspecified acquired absence of intestine (large) (small) other adrenal hypofunction secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of gastrointestinal tract regional enteritis of small intestine with large intestine other colostomy and enterostomy complication asthma, unspecified type, unspecified personal history of tobacco use disorder of bone and cartilage, unspecified long-term (current) use of steroids migraine, unspecified, without mention of intractable migraine without mention of status migrainosus morbid obesity personal history of methicillin resistant staphylococcus aureus obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux other convulsions regional enteritis of small intestine with large intestine obstructive sleep apnea (adult)(pediatric) depressive disorder, not elsewhere classified colostomy status other postprocedural status asthma, unspecified type, unspecified adrenal cortical steroids causing adverse effects in therapeutic use migraine, unspecified, without mention of intractable migraine without mention of status migrainosus palpitations disorder of bone and cartilage, unspecified unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of other diseases of digestive system disorder of bone and cartilage, unspecified cellulitis and abscess of trunk infection of colostomy or enterostomy dermatitis due to drugs and medicines taken internally other specified antibiotics causing adverse effects in therapeutic use
black african american f 53 $temp  98.2  heartrate  55.0  resprate  16.0  o2sat    sbp  99.0  dbp  60.0  rhythm    pain    $nan$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25  mg ; cyclopentolate 1%  1  drop ; fleet enema  1  enema ; senna  1  tab ; valacyclovir  1000  mg ; docusate sodium  100  mg ; ferrous gluconate  325  mg ; digoxin  0.25  mg ; diltiazem extended-release  120  mg ; multivitamins  1  tab ; omeprazole  20  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; simvastatin  40  mg ; hydromorphone (dilaudid)  1  mg ; warfarin  4  mg ; warfarin  5  mg ; warfarin  8  mg ; warfarin  6  mg ; 
 
black african american f 53 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  262  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  2.2  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; cyclopentolate 1%  1  drop ; fleet enema  1  enema ; senna  1  tab ; docusate sodium  100  mg ; ferrous gluconate  325  mg ; digoxin  0.25  mg ; diltiazem extended-release  120  mg ; multivitamins  1  tab ; omeprazole  20  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; simvastatin  40  mg ; hydromorphone (dilaudid)  1  mg ; 
 
black african american f 53 $nan$nan$sodium chloride 0.9%  flush  3  ml ; cyclopentolate 1%  1  drop ; fleet enema  1  enema ; senna  1  tab ; docusate sodium  100  mg ; ferrous gluconate  325  mg ; digoxin  0.25  mg ; diltiazem extended-release  120  mg ; multivitamins  1  tab ; omeprazole  20  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; simvastatin  40  mg ; hydromorphone (dilaudid)  1  mg ; 
 
white m 48 $nan$nan$thiamine  100  mg ; folic acid  1  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; multivitamins  1  tab ; clonazepam  2  mg ; simvastatin  20  mg ; risperidone  1  mg ; metformin (glucophage)  1000  mg ; escitalopram oxalate  20  mg ; hydrochlorothiazide  25  mg ; glyburide  5  mg ; phenobarbital alcohol withdrawal dose taper (days 2-7)  16  mg ; clonazepam  1  mg ; benazepril  20  mg ; bupropion (sustained release)  150  mg ; nicotine patch  21  mg ; diazepam  5  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified counseling sedative, hypnotic or anxiolytic abuse, continuous anxiety state, unspecified other and unspecified alcohol dependence, continuous major depressive affective disorder, recurrent episode, unspecified unspecified essential hypertension alcohol withdrawal other and unspecified hyperlipidemia tobacco use disorder drug withdrawal depressive disorder, not elsewhere classified unspecified essential hypertension alcohol withdrawal sedative, hypnotic or anxiolytic dependence, unspecified 
white m 48 $nan$nan$thiamine  100  mg ; folic acid  1  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; multivitamins  1  tab ; clonazepam  2  mg ; simvastatin  20  mg ; risperidone  1  mg ; metformin (glucophage)  1000  mg ; escitalopram oxalate  20  mg ; hydrochlorothiazide  25  mg ; glyburide  5  mg ; clonazepam  1  mg ; benazepril  20  mg ; bupropion (sustained release)  150  mg ; nicotine patch  21  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified counseling sedative, hypnotic or anxiolytic abuse, continuous anxiety state, unspecified other and unspecified alcohol dependence, continuous major depressive affective disorder, recurrent episode, unspecified unspecified essential hypertension alcohol withdrawal other and unspecified hyperlipidemia tobacco use disorder drug withdrawal depressive disorder, not elsewhere classified unspecified essential hypertension alcohol withdrawal sedative, hypnotic or anxiolytic dependence, unspecified 
white m 48 $nan$nan$thiamine  100  mg ; folic acid  1  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; multivitamins  1  tab ; clonazepam  2  mg ; simvastatin  20  mg ; risperidone  1  mg ; metformin (glucophage)  1000  mg ; escitalopram oxalate  20  mg ; hydrochlorothiazide  25  mg ; glyburide  5  mg ; clonazepam  1  mg ; benazepril  20  mg ; bupropion (sustained release)  150  mg ; nicotine patch  21  mg ; nicotine patch  14  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified counseling sedative, hypnotic or anxiolytic abuse, continuous anxiety state, unspecified other and unspecified alcohol dependence, continuous major depressive affective disorder, recurrent episode, unspecified unspecified essential hypertension alcohol withdrawal other and unspecified hyperlipidemia tobacco use disorder drug withdrawal depressive disorder, not elsewhere classified unspecified essential hypertension alcohol withdrawal sedative, hypnotic or anxiolytic dependence, unspecified 
white m 48 $nan$nan$thiamine  100  mg ; folic acid  1  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; multivitamins  1  tab ; clonazepam  2  mg ; simvastatin  20  mg ; risperidone  1  mg ; metformin (glucophage)  1000  mg ; escitalopram oxalate  20  mg ; hydrochlorothiazide  25  mg ; glyburide  5  mg ; clonazepam  1  mg ; benazepril  20  mg ; bupropion (sustained release)  150  mg ; nicotine patch  14  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified counseling sedative, hypnotic or anxiolytic abuse, continuous anxiety state, unspecified other and unspecified alcohol dependence, continuous major depressive affective disorder, recurrent episode, unspecified unspecified essential hypertension alcohol withdrawal other and unspecified hyperlipidemia tobacco use disorder drug withdrawal depressive disorder, not elsewhere classified unspecified essential hypertension alcohol withdrawal sedative, hypnotic or anxiolytic dependence, unspecified 
white m 48 $nan$nan$thiamine  100  mg ; folic acid  1  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; multivitamins  1  tab ; clonazepam  2  mg ; simvastatin  20  mg ; risperidone  1  mg ; metformin (glucophage)  1000  mg ; escitalopram oxalate  20  mg ; hydrochlorothiazide  25  mg ; glyburide  5  mg ; clonazepam  1  mg ; benazepril  20  mg ; bupropion (sustained release)  150  mg ; nicotine patch  14  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified counseling sedative, hypnotic or anxiolytic abuse, continuous anxiety state, unspecified other and unspecified alcohol dependence, continuous major depressive affective disorder, recurrent episode, unspecified unspecified essential hypertension alcohol withdrawal other and unspecified hyperlipidemia tobacco use disorder drug withdrawal depressive disorder, not elsewhere classified unspecified essential hypertension alcohol withdrawal sedative, hypnotic or anxiolytic dependence, unspecified 
white m 82 $nan$nan$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; oxycodone--acetaminophen (5mg-325mg)  1  tab ; ondansetron  4  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; morphine sulfate  1-2  mg ; senna  17.2  mg ; 
personal history of malignant neoplasm of prostate other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension other mechanical complication of genitourinary device, implant, and graft impotence of organic origin 
white m 82 $nan$nan$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; morphine sulfate  1-2  mg ; senna  17.2  mg ; allopurinol  300  mg ; amlodipine  10  mg ; colchicine  0.6  mg ; gemfibrozil  600  mg ; oxycodone (immediate release)  5  mg ; 
personal history of malignant neoplasm of prostate other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension other mechanical complication of genitourinary device, implant, and graft impotence of organic origin 
black african american f 81 $temp  98.8  heartrate  114.0  resprate  26.0  o2sat  99.0  sbp  153.0  dbp  122.0  rhythm    pain  0  ; temp    heartrate  124.0  resprate  35.0  o2sat  100.0  sbp  111.0  dbp  58.0  rhythm    pain    ; temp  100.5  heartrate  127.0  resprate  26.0  o2sat  100.0  sbp  129.0  dbp  61.0  rhythm    pain    ; temp    heartrate  105.0  resprate  30.0  o2sat  100.0  sbp  125.0  dbp  55.0  rhythm    pain    ; temp  98.9  heartrate  105.0  resprate  32.0  o2sat  99.0  sbp  132.0  dbp  48.0  rhythm    pain  0  ; temp  104.0  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    $hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  79  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; aspirin  81  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; hydralazine  10  mg ; furosemide  40  mg ; metoprolol tartrate  25  mg ; pantoprazole  40  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; acetaminophen iv  1000  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; diphenhydramine  12.5  mg ; 
adverse effect of diagnostic agents, initial encounter other acute kidney failure nonrheumatic mitral (valve) insufficiency atherosclerotic heart disease of native coronary artery with unspecified angina pectoris non-st elevation (nstemi) myocardial infarction hypertensive heart disease with heart failure rheumatic tricuspid insufficiency presence of aortocoronary bypass graft hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere pneumonia, unspecified organism gastro-esophageal reflux disease without esophagitis chronic systolic (congestive) heart failure unspecified osteoarthritis, unspecified site long-term (current) use of aspirin subendocardial infarction, initial episode of care hypotension, unspecified other specified cardiac dysrhythmias esophageal reflux congestive heart failure, unspecified anemia, unspecified acute systolic heart failure atrial fibrillation syncope and collapse knee joint replacement disorder of bone and cartilage, unspecified acute kidney failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve other specified forms of chronic ischemic heart disease mitral valve disorders coronary atherosclerosis of autologous vein bypass graft osteoporosis, unspecified altered mental status unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery nonspecific reaction to tuberculin skin test without active tuberculosis osteoarthrosis, unspecified whether generalized or localized, lower leg disorder of bone and cartilage, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension esophageal reflux other and unspecified hyperlipidemia vitiligo aortocoronary bypass status congestive heart failure, unspecified chronic systolic heart failure
black african american f 81 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  111  mg dl; chemistry blood % hemoglobin a1c  6.3  %$iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; diphenhydramine  12.5  mg ; magnesium oxide  400  mg ; sodium chloride 0.9%  1000  ml ; metoprolol tartrate  5  mg ; metoprolol tartrate  37.5  mg ; 
adverse effect of diagnostic agents, initial encounter other acute kidney failure nonrheumatic mitral (valve) insufficiency atherosclerotic heart disease of native coronary artery with unspecified angina pectoris non-st elevation (nstemi) myocardial infarction hypertensive heart disease with heart failure rheumatic tricuspid insufficiency presence of aortocoronary bypass graft hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere pneumonia, unspecified organism gastro-esophageal reflux disease without esophagitis chronic systolic (congestive) heart failure unspecified osteoarthritis, unspecified site long-term (current) use of aspirin subendocardial infarction, initial episode of care hypotension, unspecified other specified cardiac dysrhythmias esophageal reflux congestive heart failure, unspecified anemia, unspecified acute systolic heart failure atrial fibrillation syncope and collapse knee joint replacement disorder of bone and cartilage, unspecified acute kidney failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve other specified forms of chronic ischemic heart disease mitral valve disorders coronary atherosclerosis of autologous vein bypass graft osteoporosis, unspecified altered mental status unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery nonspecific reaction to tuberculin skin test without active tuberculosis osteoarthrosis, unspecified whether generalized or localized, lower leg disorder of bone and cartilage, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension esophageal reflux other and unspecified hyperlipidemia vitiligo aortocoronary bypass status congestive heart failure, unspecified chronic systolic heart failure
black african american f 81 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  109  mg dl$iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; magnesium oxide  400  mg ; sodium chloride 0.9%  1000  ml ; metoprolol tartrate  5  mg ; metoprolol tartrate  37.5  mg ; polyethylene glycol  17  g ; 
adverse effect of diagnostic agents, initial encounter other acute kidney failure nonrheumatic mitral (valve) insufficiency atherosclerotic heart disease of native coronary artery with unspecified angina pectoris non-st elevation (nstemi) myocardial infarction hypertensive heart disease with heart failure rheumatic tricuspid insufficiency presence of aortocoronary bypass graft hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere pneumonia, unspecified organism gastro-esophageal reflux disease without esophagitis chronic systolic (congestive) heart failure unspecified osteoarthritis, unspecified site long-term (current) use of aspirin subendocardial infarction, initial episode of care hypotension, unspecified other specified cardiac dysrhythmias esophageal reflux congestive heart failure, unspecified anemia, unspecified acute systolic heart failure atrial fibrillation syncope and collapse knee joint replacement disorder of bone and cartilage, unspecified acute kidney failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve other specified forms of chronic ischemic heart disease mitral valve disorders coronary atherosclerosis of autologous vein bypass graft osteoporosis, unspecified altered mental status unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery nonspecific reaction to tuberculin skin test without active tuberculosis osteoarthrosis, unspecified whether generalized or localized, lower leg disorder of bone and cartilage, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension esophageal reflux other and unspecified hyperlipidemia vitiligo aortocoronary bypass status congestive heart failure, unspecified chronic systolic heart failure
black african american f 81 $nan$nan$iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; sodium chloride 0.9%  1000  ml ; metoprolol tartrate  37.5  mg ; polyethylene glycol  17  g ; pantoprazole (granules for dr suspension)  40  mg ; bisacodyl  10  mg ; 
adverse effect of diagnostic agents, initial encounter other acute kidney failure nonrheumatic mitral (valve) insufficiency atherosclerotic heart disease of native coronary artery with unspecified angina pectoris non-st elevation (nstemi) myocardial infarction hypertensive heart disease with heart failure rheumatic tricuspid insufficiency presence of aortocoronary bypass graft hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere pneumonia, unspecified organism gastro-esophageal reflux disease without esophagitis chronic systolic (congestive) heart failure unspecified osteoarthritis, unspecified site long-term (current) use of aspirin subendocardial infarction, initial episode of care hypotension, unspecified other specified cardiac dysrhythmias esophageal reflux congestive heart failure, unspecified anemia, unspecified acute systolic heart failure atrial fibrillation syncope and collapse knee joint replacement disorder of bone and cartilage, unspecified acute kidney failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve other specified forms of chronic ischemic heart disease mitral valve disorders coronary atherosclerosis of autologous vein bypass graft osteoporosis, unspecified altered mental status unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery nonspecific reaction to tuberculin skin test without active tuberculosis osteoarthrosis, unspecified whether generalized or localized, lower leg disorder of bone and cartilage, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension esophageal reflux other and unspecified hyperlipidemia vitiligo aortocoronary bypass status congestive heart failure, unspecified chronic systolic heart failure
black african american f 81 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  151  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  1000  ml ; metoprolol tartrate  37.5  mg ; pantoprazole (granules for dr suspension)  40  mg ; bisacodyl  10  mg ; potassium chloride  40  meq ; 
adverse effect of diagnostic agents, initial encounter other acute kidney failure nonrheumatic mitral (valve) insufficiency atherosclerotic heart disease of native coronary artery with unspecified angina pectoris non-st elevation (nstemi) myocardial infarction hypertensive heart disease with heart failure rheumatic tricuspid insufficiency presence of aortocoronary bypass graft hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere pneumonia, unspecified organism gastro-esophageal reflux disease without esophagitis chronic systolic (congestive) heart failure unspecified osteoarthritis, unspecified site long-term (current) use of aspirin subendocardial infarction, initial episode of care hypotension, unspecified other specified cardiac dysrhythmias esophageal reflux congestive heart failure, unspecified anemia, unspecified acute systolic heart failure atrial fibrillation syncope and collapse knee joint replacement disorder of bone and cartilage, unspecified acute kidney failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve other specified forms of chronic ischemic heart disease mitral valve disorders coronary atherosclerosis of autologous vein bypass graft osteoporosis, unspecified altered mental status unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery nonspecific reaction to tuberculin skin test without active tuberculosis osteoarthrosis, unspecified whether generalized or localized, lower leg disorder of bone and cartilage, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension esophageal reflux other and unspecified hyperlipidemia vitiligo aortocoronary bypass status congestive heart failure, unspecified chronic systolic heart failure
black african american f 81 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  107  mg dl$metoprolol tartrate  37.5  mg ; pantoprazole (granules for dr suspension)  40  mg ; bisacodyl  10  mg ; potassium chloride  40  meq ; 
adverse effect of diagnostic agents, initial encounter other acute kidney failure nonrheumatic mitral (valve) insufficiency atherosclerotic heart disease of native coronary artery with unspecified angina pectoris non-st elevation (nstemi) myocardial infarction hypertensive heart disease with heart failure rheumatic tricuspid insufficiency presence of aortocoronary bypass graft hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere pneumonia, unspecified organism gastro-esophageal reflux disease without esophagitis chronic systolic (congestive) heart failure unspecified osteoarthritis, unspecified site long-term (current) use of aspirin subendocardial infarction, initial episode of care hypotension, unspecified other specified cardiac dysrhythmias esophageal reflux congestive heart failure, unspecified anemia, unspecified acute systolic heart failure atrial fibrillation syncope and collapse knee joint replacement disorder of bone and cartilage, unspecified acute kidney failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve other specified forms of chronic ischemic heart disease mitral valve disorders coronary atherosclerosis of autologous vein bypass graft osteoporosis, unspecified altered mental status unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery nonspecific reaction to tuberculin skin test without active tuberculosis osteoarthrosis, unspecified whether generalized or localized, lower leg disorder of bone and cartilage, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension esophageal reflux other and unspecified hyperlipidemia vitiligo aortocoronary bypass status congestive heart failure, unspecified chronic systolic heart failure
black african american f 81 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  111  mg dl$metoprolol tartrate  37.5  mg ; pantoprazole (granules for dr suspension)  40  mg ; bisacodyl  10  mg ; 
adverse effect of diagnostic agents, initial encounter other acute kidney failure nonrheumatic mitral (valve) insufficiency atherosclerotic heart disease of native coronary artery with unspecified angina pectoris non-st elevation (nstemi) myocardial infarction hypertensive heart disease with heart failure rheumatic tricuspid insufficiency presence of aortocoronary bypass graft hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere pneumonia, unspecified organism gastro-esophageal reflux disease without esophagitis chronic systolic (congestive) heart failure unspecified osteoarthritis, unspecified site long-term (current) use of aspirin subendocardial infarction, initial episode of care hypotension, unspecified other specified cardiac dysrhythmias esophageal reflux congestive heart failure, unspecified anemia, unspecified acute systolic heart failure atrial fibrillation syncope and collapse knee joint replacement disorder of bone and cartilage, unspecified acute kidney failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve other specified forms of chronic ischemic heart disease mitral valve disorders coronary atherosclerosis of autologous vein bypass graft osteoporosis, unspecified altered mental status unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery nonspecific reaction to tuberculin skin test without active tuberculosis osteoarthrosis, unspecified whether generalized or localized, lower leg disorder of bone and cartilage, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension esophageal reflux other and unspecified hyperlipidemia vitiligo aortocoronary bypass status congestive heart failure, unspecified chronic systolic heart failure
black african american f 81 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  102  mg dl$pantoprazole (granules for dr suspension)  40  mg ; bisacodyl  10  mg ; 
adverse effect of diagnostic agents, initial encounter other acute kidney failure nonrheumatic mitral (valve) insufficiency atherosclerotic heart disease of native coronary artery with unspecified angina pectoris non-st elevation (nstemi) myocardial infarction hypertensive heart disease with heart failure rheumatic tricuspid insufficiency presence of aortocoronary bypass graft hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere pneumonia, unspecified organism gastro-esophageal reflux disease without esophagitis chronic systolic (congestive) heart failure unspecified osteoarthritis, unspecified site long-term (current) use of aspirin subendocardial infarction, initial episode of care hypotension, unspecified other specified cardiac dysrhythmias esophageal reflux congestive heart failure, unspecified anemia, unspecified acute systolic heart failure atrial fibrillation syncope and collapse knee joint replacement disorder of bone and cartilage, unspecified acute kidney failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve other specified forms of chronic ischemic heart disease mitral valve disorders coronary atherosclerosis of autologous vein bypass graft osteoporosis, unspecified altered mental status unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery nonspecific reaction to tuberculin skin test without active tuberculosis osteoarthrosis, unspecified whether generalized or localized, lower leg disorder of bone and cartilage, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension esophageal reflux other and unspecified hyperlipidemia vitiligo aortocoronary bypass status congestive heart failure, unspecified chronic systolic heart failure
black african american f 81 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  113  mg dl$pantoprazole (granules for dr suspension)  40  mg ; bisacodyl  10  mg ; 
adverse effect of diagnostic agents, initial encounter other acute kidney failure nonrheumatic mitral (valve) insufficiency atherosclerotic heart disease of native coronary artery with unspecified angina pectoris non-st elevation (nstemi) myocardial infarction hypertensive heart disease with heart failure rheumatic tricuspid insufficiency presence of aortocoronary bypass graft hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere pneumonia, unspecified organism gastro-esophageal reflux disease without esophagitis chronic systolic (congestive) heart failure unspecified osteoarthritis, unspecified site long-term (current) use of aspirin subendocardial infarction, initial episode of care hypotension, unspecified other specified cardiac dysrhythmias esophageal reflux congestive heart failure, unspecified anemia, unspecified acute systolic heart failure atrial fibrillation syncope and collapse knee joint replacement disorder of bone and cartilage, unspecified acute kidney failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve other specified forms of chronic ischemic heart disease mitral valve disorders coronary atherosclerosis of autologous vein bypass graft osteoporosis, unspecified altered mental status unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery nonspecific reaction to tuberculin skin test without active tuberculosis osteoarthrosis, unspecified whether generalized or localized, lower leg disorder of bone and cartilage, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension esophageal reflux other and unspecified hyperlipidemia vitiligo aortocoronary bypass status congestive heart failure, unspecified chronic systolic heart failure
black african american f 81 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  97  mg dl$pantoprazole (granules for dr suspension)  40  mg ; bisacodyl  10  mg ; 
adverse effect of diagnostic agents, initial encounter other acute kidney failure nonrheumatic mitral (valve) insufficiency atherosclerotic heart disease of native coronary artery with unspecified angina pectoris non-st elevation (nstemi) myocardial infarction hypertensive heart disease with heart failure rheumatic tricuspid insufficiency presence of aortocoronary bypass graft hyperlipidemia, unspecified anemia in other chronic diseases classified elsewhere pneumonia, unspecified organism gastro-esophageal reflux disease without esophagitis chronic systolic (congestive) heart failure unspecified osteoarthritis, unspecified site long-term (current) use of aspirin subendocardial infarction, initial episode of care hypotension, unspecified other specified cardiac dysrhythmias esophageal reflux congestive heart failure, unspecified anemia, unspecified acute systolic heart failure atrial fibrillation syncope and collapse knee joint replacement disorder of bone and cartilage, unspecified acute kidney failure, unspecified other and unspecified hyperlipidemia diseases of tricuspid valve other specified forms of chronic ischemic heart disease mitral valve disorders coronary atherosclerosis of autologous vein bypass graft osteoporosis, unspecified altered mental status unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery nonspecific reaction to tuberculin skin test without active tuberculosis osteoarthrosis, unspecified whether generalized or localized, lower leg disorder of bone and cartilage, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension esophageal reflux other and unspecified hyperlipidemia vitiligo aortocoronary bypass status congestive heart failure, unspecified chronic systolic heart failure
white f 91 $temp    heartrate    resprate  16.0  o2sat  97.0  sbp    dbp    rhythm    pain  0  ; temp  97.5  heartrate    resprate  16.0  o2sat  99.0  sbp  116.0  dbp  75.0  rhythm    pain  0  ; temp    heartrate    resprate  17.0  o2sat  100.0  sbp  138.0  dbp  92.0  rhythm    pain  0  $hematology blood hematocrit  40.0  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  68  mg dl; chemistry blood urea nitrogen  67  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  117  mg dl; chemistry blood albumin  3.6  g dl; blood gas blood lactate  1.7  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; amiodarone  100  mg ; artificial tears preserv. free  1-2  drop ; capsaicin 0.025%  1  appl ; ferrous sulfate  325  mg ; fish oil (omega 3)  1000  mg ; furosemide  20  mg ; omeprazole  40  mg ; vitamin d  3000  unit ; metoprolol tartrate  12.5  mg ; lorazepam  0.5  mg ; sodium chloride 0.9%  1000  ml ; metoprolol tartrate  25  mg ; 
hypotension, unspecified adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter insomnia, unspecified paroxysmal atrial fibrillation other elevated white blood cell count venous insufficiency (chronic) (peripheral) nonrheumatic aortic (valve) stenosis low back pain hypertensive heart disease with heart failure other chronic pain disorder of kidney and ureter, unspecified unspecified place in hospital as the place of occurrence of the external cause acute on chronic diastolic (congestive) heart failure hyperkalemia adverse effect of beta-adrenoreceptor antagonists, initial encounter bradycardia, unspecified long term (current) use of anticoagulants personal history of malignant neoplasm of bladder age-related osteoporosis without current pathological fracture unspecified osteoarthritis, unspecified site personal history of other malignant neoplasm of kidney 
white f 91 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  61  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  87  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; amiodarone  100  mg ; artificial tears preserv. free  1-2  drop ; capsaicin 0.025%  1  appl ; ferrous sulfate  325  mg ; fish oil (omega 3)  1000  mg ; omeprazole  40  mg ; vitamin d  3000  unit ; lorazepam  0.5  mg ; metoprolol tartrate  25  mg ; haloperidol  0.25  mg ; 
hypotension, unspecified adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter insomnia, unspecified paroxysmal atrial fibrillation other elevated white blood cell count venous insufficiency (chronic) (peripheral) nonrheumatic aortic (valve) stenosis low back pain hypertensive heart disease with heart failure other chronic pain disorder of kidney and ureter, unspecified unspecified place in hospital as the place of occurrence of the external cause acute on chronic diastolic (congestive) heart failure hyperkalemia adverse effect of beta-adrenoreceptor antagonists, initial encounter bradycardia, unspecified long term (current) use of anticoagulants personal history of malignant neoplasm of bladder age-related osteoporosis without current pathological fracture unspecified osteoarthritis, unspecified site personal history of other malignant neoplasm of kidney 
white f 91 $nan$hematology blood hematocrit  38.7  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  106  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; amiodarone  100  mg ; artificial tears preserv. free  1-2  drop ; capsaicin 0.025%  1  appl ; ferrous sulfate  325  mg ; fish oil (omega 3)  1000  mg ; omeprazole  40  mg ; vitamin d  3000  unit ; metoprolol tartrate  25  mg ; apixaban  2.5  mg ; metoprolol tartrate  37.5  mg ; 
hypotension, unspecified adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter insomnia, unspecified paroxysmal atrial fibrillation other elevated white blood cell count venous insufficiency (chronic) (peripheral) nonrheumatic aortic (valve) stenosis low back pain hypertensive heart disease with heart failure other chronic pain disorder of kidney and ureter, unspecified unspecified place in hospital as the place of occurrence of the external cause acute on chronic diastolic (congestive) heart failure hyperkalemia adverse effect of beta-adrenoreceptor antagonists, initial encounter bradycardia, unspecified long term (current) use of anticoagulants personal history of malignant neoplasm of bladder age-related osteoporosis without current pathological fracture unspecified osteoarthritis, unspecified site personal history of other malignant neoplasm of kidney 
white f 91 $nan$hematology blood hematocrit  41.0  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  105  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; amiodarone  100  mg ; artificial tears preserv. free  1-2  drop ; capsaicin 0.025%  1  appl ; ferrous sulfate  325  mg ; fish oil (omega 3)  1000  mg ; omeprazole  40  mg ; vitamin d  3000  unit ; apixaban  2.5  mg ; 
hypotension, unspecified adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter insomnia, unspecified paroxysmal atrial fibrillation other elevated white blood cell count venous insufficiency (chronic) (peripheral) nonrheumatic aortic (valve) stenosis low back pain hypertensive heart disease with heart failure other chronic pain disorder of kidney and ureter, unspecified unspecified place in hospital as the place of occurrence of the external cause acute on chronic diastolic (congestive) heart failure hyperkalemia adverse effect of beta-adrenoreceptor antagonists, initial encounter bradycardia, unspecified long term (current) use of anticoagulants personal history of malignant neoplasm of bladder age-related osteoporosis without current pathological fracture unspecified osteoarthritis, unspecified site personal history of other malignant neoplasm of kidney 
white f 91 $nan$hematology blood hematocrit  41.6  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  109  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; amiodarone  100  mg ; artificial tears preserv. free  1-2  drop ; capsaicin 0.025%  1  appl ; ferrous sulfate  325  mg ; fish oil (omega 3)  1000  mg ; omeprazole  40  mg ; vitamin d  3000  unit ; apixaban  2.5  mg ; digoxin  0.25  mg ; 
hypotension, unspecified adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter insomnia, unspecified paroxysmal atrial fibrillation other elevated white blood cell count venous insufficiency (chronic) (peripheral) nonrheumatic aortic (valve) stenosis low back pain hypertensive heart disease with heart failure other chronic pain disorder of kidney and ureter, unspecified unspecified place in hospital as the place of occurrence of the external cause acute on chronic diastolic (congestive) heart failure hyperkalemia adverse effect of beta-adrenoreceptor antagonists, initial encounter bradycardia, unspecified long term (current) use of anticoagulants personal history of malignant neoplasm of bladder age-related osteoporosis without current pathological fracture unspecified osteoarthritis, unspecified site personal history of other malignant neoplasm of kidney 
white f 91 $nan$hematology blood hematocrit  38.3  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  91  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; amiodarone  100  mg ; artificial tears preserv. free  1-2  drop ; capsaicin 0.025%  1  appl ; ferrous sulfate  325  mg ; fish oil (omega 3)  1000  mg ; omeprazole  40  mg ; vitamin d  3000  unit ; apixaban  2.5  mg ; digoxin  0.25  mg ; metoprolol succinate xl  100  mg ; metoprolol succinate xl  50  mg ; lisinopril  2.5  mg ; 
hypotension, unspecified adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter insomnia, unspecified paroxysmal atrial fibrillation other elevated white blood cell count venous insufficiency (chronic) (peripheral) nonrheumatic aortic (valve) stenosis low back pain hypertensive heart disease with heart failure other chronic pain disorder of kidney and ureter, unspecified unspecified place in hospital as the place of occurrence of the external cause acute on chronic diastolic (congestive) heart failure hyperkalemia adverse effect of beta-adrenoreceptor antagonists, initial encounter bradycardia, unspecified long term (current) use of anticoagulants personal history of malignant neoplasm of bladder age-related osteoporosis without current pathological fracture unspecified osteoarthritis, unspecified site personal history of other malignant neoplasm of kidney 
white f 91 $nan$hematology blood hematocrit  43.5  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  83  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; amiodarone  100  mg ; artificial tears preserv. free  1-2  drop ; capsaicin 0.025%  1  appl ; fish oil (omega 3)  1000  mg ; omeprazole  40  mg ; vitamin d  3000  unit ; apixaban  2.5  mg ; lisinopril  2.5  mg ; lisinopril  5  mg ; 
hypotension, unspecified adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter insomnia, unspecified paroxysmal atrial fibrillation other elevated white blood cell count venous insufficiency (chronic) (peripheral) nonrheumatic aortic (valve) stenosis low back pain hypertensive heart disease with heart failure other chronic pain disorder of kidney and ureter, unspecified unspecified place in hospital as the place of occurrence of the external cause acute on chronic diastolic (congestive) heart failure hyperkalemia adverse effect of beta-adrenoreceptor antagonists, initial encounter bradycardia, unspecified long term (current) use of anticoagulants personal history of malignant neoplasm of bladder age-related osteoporosis without current pathological fracture unspecified osteoarthritis, unspecified site personal history of other malignant neoplasm of kidney 
white f 91 $nan$hematology blood hematocrit  39.4  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  99  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; amiodarone  100  mg ; artificial tears preserv. free  1-2  drop ; capsaicin 0.025%  1  appl ; fish oil (omega 3)  1000  mg ; omeprazole  40  mg ; vitamin d  3000  unit ; apixaban  2.5  mg ; lisinopril  5  mg ; 
hypotension, unspecified adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter insomnia, unspecified paroxysmal atrial fibrillation other elevated white blood cell count venous insufficiency (chronic) (peripheral) nonrheumatic aortic (valve) stenosis low back pain hypertensive heart disease with heart failure other chronic pain disorder of kidney and ureter, unspecified unspecified place in hospital as the place of occurrence of the external cause acute on chronic diastolic (congestive) heart failure hyperkalemia adverse effect of beta-adrenoreceptor antagonists, initial encounter bradycardia, unspecified long term (current) use of anticoagulants personal history of malignant neoplasm of bladder age-related osteoporosis without current pathological fracture unspecified osteoarthritis, unspecified site personal history of other malignant neoplasm of kidney 
white f 91 $nan$hematology blood hematocrit  37.9  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  88  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; amiodarone  100  mg ; artificial tears preserv. free  1-2  drop ; capsaicin 0.025%  1  appl ; fish oil (omega 3)  1000  mg ; omeprazole  40  mg ; vitamin d  3000  unit ; apixaban  2.5  mg ; lisinopril  5  mg ; 
hypotension, unspecified adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter insomnia, unspecified paroxysmal atrial fibrillation other elevated white blood cell count venous insufficiency (chronic) (peripheral) nonrheumatic aortic (valve) stenosis low back pain hypertensive heart disease with heart failure other chronic pain disorder of kidney and ureter, unspecified unspecified place in hospital as the place of occurrence of the external cause acute on chronic diastolic (congestive) heart failure hyperkalemia adverse effect of beta-adrenoreceptor antagonists, initial encounter bradycardia, unspecified long term (current) use of anticoagulants personal history of malignant neoplasm of bladder age-related osteoporosis without current pathological fracture unspecified osteoarthritis, unspecified site personal history of other malignant neoplasm of kidney 
white f 91 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; polyethylene glycol  17  g ; amiodarone  100  mg ; artificial tears preserv. free  1-2  drop ; capsaicin 0.025%  1  appl ; fish oil (omega 3)  1000  mg ; omeprazole  40  mg ; vitamin d  3000  unit ; apixaban  2.5  mg ; lisinopril  5  mg ; 
hypotension, unspecified adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter insomnia, unspecified paroxysmal atrial fibrillation other elevated white blood cell count venous insufficiency (chronic) (peripheral) nonrheumatic aortic (valve) stenosis low back pain hypertensive heart disease with heart failure other chronic pain disorder of kidney and ureter, unspecified unspecified place in hospital as the place of occurrence of the external cause acute on chronic diastolic (congestive) heart failure hyperkalemia adverse effect of beta-adrenoreceptor antagonists, initial encounter bradycardia, unspecified long term (current) use of anticoagulants personal history of malignant neoplasm of bladder age-related osteoporosis without current pathological fracture unspecified osteoarthritis, unspecified site personal history of other malignant neoplasm of kidney 
white f 95 $temp  98.6  heartrate  69.0  resprate  22.0  o2sat  90.0  sbp  173.0  dbp  90.0  rhythm    pain  4  ; temp  98.5  heartrate  82.0  resprate  20.0  o2sat  94.0  sbp  142.0  dbp  80.0  rhythm    pain    ; temp  98.1  heartrate  90.0  resprate  16.0  o2sat  94.0  sbp  153.0  dbp  90.0  rhythm    pain    ; temp  98.2  heartrate  95.0  resprate  20.0  o2sat  92.0  sbp  173.0  dbp  95.0  rhythm    pain  0  ; temp  98.1  heartrate  95.0  resprate  16.0  o2sat  97.0  sbp  183.0  dbp  84.0  rhythm    pain  6  $nan$multivitamins  1  tab ; vitamin d  400  unit ; 
coronary atherosclerosis of native coronary artery acute myocardial infarction of unspecified site, initial episode of care unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia 
white f 95 $nan$hematology blood hematocrit  36.7  %; hematology blood hematocrit  31.8  %; hematology blood hemoglobin  11.7  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  255  k ul; hematology blood platelet count  199  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  160  mg dl; chemistry blood glucose  213  mg dl$multivitamins  1  tab ; vitamin d  400  unit ; senna  8.6  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)  2.5-5  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; aspirin  81  mg ; gabapentin  300  mg ; metoprolol succinate xl  25  mg ; trazodone  50  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; clopidogrel  75  mg ; duloxetine  30  mg ; tramadol  25  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 
coronary atherosclerosis of native coronary artery acute myocardial infarction of unspecified site, initial episode of care unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia 
white f 95 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  144  mg dl$multivitamins  1  tab ; vitamin d  400  unit ; senna  8.6  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; bisacodyl  10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; aspirin  81  mg ; gabapentin  300  mg ; metoprolol succinate xl  25  mg ; trazodone  50  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; clopidogrel  75  mg ; duloxetine  30  mg ; tramadol  25  mg ; bag  2  bag ; magnesium sulfate  4  gm ; tramadol  25-50  mg ; 
coronary atherosclerosis of native coronary artery acute myocardial infarction of unspecified site, initial episode of care unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia 
white f 95 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood glucose  134  mg dl$multivitamins  1  tab ; vitamin d  400  unit ; senna  8.6  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; bisacodyl  10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; aspirin  81  mg ; gabapentin  300  mg ; metoprolol succinate xl  25  mg ; trazodone  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; clopidogrel  75  mg ; duloxetine  30  mg ; tramadol  25-50  mg ; acetaminophen  650  mg ; 
coronary atherosclerosis of native coronary artery acute myocardial infarction of unspecified site, initial episode of care unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia 
white f 95 $nan$nan$multivitamins  1  tab ; vitamin d  400  unit ; senna  8.6  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; bisacodyl  10  mg ; ondansetron  4  mg ; aspirin  81  mg ; gabapentin  300  mg ; metoprolol succinate xl  25  mg ; trazodone  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; clopidogrel  75  mg ; duloxetine  30  mg ; tramadol  25-50  mg ; acetaminophen  650  mg ; 
coronary atherosclerosis of native coronary artery acute myocardial infarction of unspecified site, initial episode of care unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia 
white f 95 $nan$nan$multivitamins  1  tab ; vitamin d  400  unit ; senna  8.6  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; bisacodyl  10  mg ; ondansetron  4  mg ; aspirin  81  mg ; gabapentin  300  mg ; metoprolol succinate xl  25  mg ; trazodone  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; clopidogrel  75  mg ; duloxetine  30  mg ; tramadol  25-50  mg ; acetaminophen  650  mg ; 
coronary atherosclerosis of native coronary artery acute myocardial infarction of unspecified site, initial episode of care unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia 
black african american f 52 $temp  97.0  heartrate  104.0  resprate  16.0  o2sat  99.0  sbp  132.0  dbp  86.0  rhythm    pain  0  ; temp    heartrate  72.0  resprate  12.0  o2sat  99.0  sbp  140.0  dbp  70.0  rhythm    pain    ; temp  98.0  heartrate  83.0  resprate  18.0  o2sat  100.0  sbp  144.0  dbp  88.0  rhythm    pain    $hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  222  mg dl$nan
schizoaffective disorder, unspecified abdominal pain, unspecified site posttraumatic stress disorder coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health asthma, unspecified type, unspecified unspecified disorder of the teeth and supporting structures depressive disorder, not elsewhere classified anxiety state, unspecified unspecified essential hypertension obesity, unspecified suicidal ideation chronic hepatitis c without mention of hepatic coma other and unspecified hyperlipidemia long-term (current) use of insulin asthma, unspecified type, unspecified other and unspecified alcohol dependence, in remission personal history of noncompliance with medical treatment, presenting hazards to health constipation, unspecified unspecified essential hypertension bipolar i disorder, most recent episode (or current) manic, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled schizoaffective disorder, unspecified coronary atherosclerosis of native coronary artery unspecified schizophrenia, unspecified unspecified disturbance of conduct unspecified schizophrenia, unspecified chronic hepatitis c without mention of hepatic coma schizoaffective disorder, unspecified obesity, unspecified other and unspecified hyperlipidemia benign essential hypertension personal history of noncompliance with medical treatment, presenting hazards to health asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified other and unspecified alcohol dependence, in remission anxiety state, unspecified depressive disorder, not elsewhere classified body mass index 40.0-44.9, adult diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled dysmetabolic syndrome x coronary atherosclerosis of native coronary artery constipation, unspecified long-term (current) use of insulin obesity, unspecified other and unspecified anticonvulsants causing adverse effects in therapeutic use
unable to obtain m 31 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  123  mg dl; chemistry blood lactate dehydrogenase (ld)  252  iu l; blood gas blood lactate  1.0  mmol l$1 2 ns  1000  ml ; propofol  1000  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; 0.9% sodium chloride  1000  ml ; pantoprazole  40  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; vial  1  vial ; d5 1 2ns  1000  ml ; thiamine  100  mg ; folic acid  1  mg ; propofol  20  mg ; haloperidol  0.5-1  mg ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; haloperidol  1-5  mg ; haloperidol  3  mg ; potassium chloride  60  meq ; lr  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 
 
unable to obtain m 31 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  93  mg dl$heparin  5000  unit ; vial  1  vial ; thiamine  100  mg ; folic acid  1  mg ; propofol  20  mg ; lr  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5ns  1000  ml ; buprenorphine-naloxone (8mg-2mg)  1  tab ; neutra-phos  2  pkt ; acetaminophen  325-650  mg ; clonidine  0.1  mg ; methocarbamol  750  mg ; dicyclomine  20  mg ; hydroxyzine  25  mg ; diphenoxylate-atropine  1  tab ; 
 
unable to obtain m 31 $nan$chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  89  mg dl$heparin  5000  unit ; thiamine  100  mg ; folic acid  1  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5ns  1000  ml ; buprenorphine-naloxone (8mg-2mg)  1  tab ; neutra-phos  2  pkt ; acetaminophen  325-650  mg ; methocarbamol  750  mg ; dicyclomine  20  mg ; hydroxyzine  25  mg ; diphenoxylate-atropine  1  tab ; 
 
other m 35 $nan$hematology blood hematocrit  33.4  %; hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  54  k ul; hematology blood platelet count  72  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  3.1  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  6.2  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  38  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  73  mg dl; chemistry blood lactate dehydrogenase (ld)  657  iu l; chemistry blood albumin  2.7  g dl; blood gas blood lactate  1.9  mmol l$influenza virus vaccine  0.5  ml ; metronidazole (flagyl)  500  mg ; levofloxacin  750  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1000  ml ; heparin  5000  unit ; nicotine patch  14  mg ; folic acid  1  mg ; multivitamins  1  tab ; oxycodone (immediate release)   5  mg ; d5 1 2ns  1000  ml ; ipratropium bromide neb  1  neb ; lorazepam  1  mg ; acetylcysteine 20%  1-10  ml ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  2-4  mg ; d5ns  1000  ml ; mucinex  1200  mg ; 
 
other m 35 $nan$hematology blood hematocrit  31.9  %; hematology blood hematocrit  30.1  %; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  70  k ul; hematology blood platelet count  77  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  62  mg dl; chemistry blood lactate dehydrogenase (ld)  323  iu l; chemistry blood lactate dehydrogenase (ld)  431  iu l; hematology blood bands  2  %; blood gas blood lactate  1.5  mmol l$influenza virus vaccine  0.5  ml ; levofloxacin  750  mg ; 0.9% sodium chloride  1000  ml ; nicotine patch  14  mg ; folic acid  1  mg ; multivitamins  1  tab ; ipratropium bromide neb  1  neb ; lorazepam  1  mg ; acetylcysteine 20%  1-10  ml ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  2-4  mg ; d5ns  1000  ml ; mucinex  1200  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; levofloxacin  250  mg ; levofloxacin  500  mg ; lorazepam  0.5  mg ; olanzapine (disintegrating tablet)  5  mg ; haloperidol  5  mg ; diazepam  20  mg ; diazepam  10  mg ; haloperidol  10  mg ; multivitamin iv  10  ml ; thiamine  100  mg ; diazepam  5-10  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
 
other m 35 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  83  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  81  mg dl; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  0.8  mmol l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$influenza virus vaccine  0.5  ml ; nicotine patch  14  mg ; folic acid  1  mg ; multivitamins  1  tab ; ipratropium bromide neb  1  neb ; acetylcysteine 20%  1-10  ml ; hydromorphone (dilaudid)  2-4  mg ; d5ns  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; levofloxacin  250  mg ; levofloxacin  500  mg ; lorazepam  0.5  mg ; olanzapine (disintegrating tablet)  5  mg ; haloperidol  5  mg ; diazepam  20  mg ; haloperidol  10  mg ; diazepam  5-10  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; potassium chloride  40  meq ; potassium chloride (powder)  20  meq ; lansoprazole oral disintegrating tab  30  mg ; dextrose 5%  150  ml ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; 5% dextrose  150  ml ; vancomycin  500  mg ; quetiapine fumarate  50  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; 
 
other m 35 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  88  mg dl; chemistry blood lactate dehydrogenase (ld)  238  iu l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$influenza virus vaccine  0.5  ml ; multivitamins  1  tab ; ipratropium bromide neb  1  neb ; acetylcysteine 20%  1-10  ml ; hydromorphone (dilaudid)  2-4  mg ; d5ns  1000  ml ; diazepam  5-10  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  500  ml ; potassium chloride  40  meq ; potassium chloride (powder)  20  meq ; lansoprazole oral disintegrating tab  30  mg ; dextrose 5%  150  ml ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; 5% dextrose  150  ml ; vancomycin  500  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; bag  100  ml ; magnesium sulfate  4  gm ; acetaminophen  650  mg ; multivitamins  5  ml ; ns  100  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 0.9% sodium chloride  250  ml ; propofol  1000  mg ; acetylcysteine 20%  600  mg ; ipratropium bromide mdi  6  puff ; norepinephrine  8  mg ; 
 
other m 35 $nan$hematology blood hematocrit  29.6  %; hematology blood hematocrit  27.5  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  135  k ul; hematology blood platelet count  123  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  163  mg dl; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.1  mmol l; hematology blood wbc count  10.9  k ul$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; bag  100  ml ; magnesium sulfate  4  gm ; acetaminophen  650  mg ; multivitamins  5  ml ; ns  100  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; propofol  1000  mg ; acetylcysteine 20%  600  mg ; ipratropium bromide mdi  6  puff ; norepinephrine  8  mg ; metoclopramide  10  mg ; 0.9% sodium chloride  250-500  ml ; potassium chloride  20-40  meq ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; vancomycin  1750  mg ; 
 
other m 35 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  101  mg dl; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  0.9  mmol l$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; multivitamins  5  ml ; ns  100  ml ; propofol  1000  mg ; acetylcysteine 20%  600  mg ; ipratropium bromide mdi  6  puff ; norepinephrine  8  mg ; metoclopramide  10  mg ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; vancomycin  1750  mg ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 
 
other m 35 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  92  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood lactate  0.7  mmol l$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; multivitamins  5  ml ; ns  100  ml ; propofol  1000  mg ; ipratropium bromide mdi  6  puff ; norepinephrine  8  mg ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; vancomycin  1750  mg ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; miconazole powder 2%  1  appl ; 
 
other m 35 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  105  mg dl; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.04  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  0.8  mmol l$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; multivitamins  5  ml ; ns  100  ml ; propofol  1000  mg ; ipratropium bromide mdi  6  puff ; norepinephrine  8  mg ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; vancomycin  1750  mg ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; miconazole powder 2%  1  appl ; furosemide  20  mg ; albuterol inhaler  1  puff ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 
 
other m 35 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  334  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  111  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.15  mmol l$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; multivitamins  5  ml ; propofol  1000  mg ; ipratropium bromide mdi  6  puff ; norepinephrine  8  mg ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; vancomycin  1750  mg ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; miconazole powder 2%  1  appl ; furosemide  20  mg ; albuterol inhaler  1  puff ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2-4  gm ; ibuprofen  400  mg ; quetiapine fumarate  100  mg ; 
 
other m 35 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  452  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  240  iu l; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  0.7  mmol l$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; multivitamins  5  ml ; propofol  1000  mg ; ipratropium bromide mdi  6  puff ; norepinephrine  8  mg ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; miconazole powder 2%  1  appl ; albuterol inhaler  1  puff ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2-4  gm ; ibuprofen  400  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  200  mg ; 
 
other m 35 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  485  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  125  mg dl$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; multivitamins  5  ml ; propofol  1000  mg ; ipratropium bromide mdi  6  puff ; norepinephrine  8  mg ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; miconazole powder 2%  1  appl ; albuterol inhaler  1  puff ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2-4  gm ; ibuprofen  400  mg ; quetiapine fumarate  200  mg ; propofol  200  mg ; 
 
other m 35 $nan$hematology blood hematocrit  23.6  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  528  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  93  mg dl; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  0.5  mmol l$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; multivitamins  5  ml ; ipratropium bromide mdi  6  puff ; norepinephrine  8  mg ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; miconazole powder 2%  1  appl ; albuterol inhaler  1  puff ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2-4  gm ; ibuprofen  400  mg ; quetiapine fumarate  200  mg ; propofol  200  mg ; methadone  20  mg ; 
 
other m 35 $nan$hematology blood hematocrit  23.7  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  549  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  95  mg dl$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; multivitamins  5  ml ; ipratropium bromide mdi  6  puff ; norepinephrine  8  mg ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; miconazole powder 2%  1  appl ; albuterol inhaler  1  puff ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2-4  gm ; ibuprofen  400  mg ; quetiapine fumarate  200  mg ; propofol  200  mg ; methadone  20  mg ; 
 
other m 35 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  542  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  101  mg dl$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; multivitamins  5  ml ; ipratropium bromide mdi  6  puff ; norepinephrine  8  mg ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; miconazole powder 2%  1  appl ; albuterol inhaler  1  puff ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2-4  gm ; quetiapine fumarate  200  mg ; propofol  200  mg ; methadone  20  mg ; 
 
other m 35 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  583  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  93  mg dl$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; multivitamins  5  ml ; ipratropium bromide mdi  6  puff ; norepinephrine  8  mg ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; miconazole powder 2%  1  appl ; albuterol inhaler  1  puff ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2-4  gm ; propofol  200  mg ; methadone  20  mg ; 
 
other m 35 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  644  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  106  mg dl$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lansoprazole oral disintegrating tab  30  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; multivitamins  5  ml ; ipratropium bromide mdi  6  puff ; norepinephrine  8  mg ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; miconazole powder 2%  1  appl ; albuterol inhaler  1  puff ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2-4  gm ; propofol  200  mg ; methadone  20  mg ; dexamethasone  10  mg ; racepinephrine  0.5  ml ; dexamethasone  4  mg ; syringe  0.5  ml ; methadone  5  mg ; olanzapine (disintegrating tablet)  10  mg ; docusate sodium  100  mg ; albuterol 0.083% neb soln  1  neb ; 
 
other m 35 $nan$hematology blood hematocrit  29.3  %; hematology blood hematocrit  29.5  %; hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  775  k ul; hematology blood platelet count  837  k ul; hematology blood platelet count  790  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  120  mg dl; chemistry blood glucose  105  mg dl$influenza virus vaccine  0.5  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; multivitamins  5  ml ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; miconazole powder 2%  1  appl ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2-4  gm ; dexamethasone  10  mg ; racepinephrine  0.5  ml ; dexamethasone  4  mg ; docusate sodium  100  mg ; albuterol 0.083% neb soln  1  neb ; lorazepam  2  mg ; lorazepam  1-2  mg ; levetiracetam  1000  mg ; acyclovir  800  mg ; 
 
other m 35 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  28  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood glucose  130  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$influenza virus vaccine  0.5  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; multivitamins  5  ml ; 0.9% sodium chloride  500-1000  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; miconazole powder 2%  1  appl ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2-4  gm ; docusate sodium  100  mg ; albuterol 0.083% neb soln  1  neb ; levetiracetam  1000  mg ; acyclovir  800  mg ; iso-osmotic sodium chloride  100  ml ; levetiracetam  500  mg ; 
 
other m 35 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  701  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  120  mg dl; hematology blood wbc count  6.2  k ul$influenza virus vaccine  0.5  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; multivitamins  5  ml ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; miconazole powder 2%  1  appl ; albuterol 0.083% neb soln  1  neb ; acyclovir  800  mg ; 
 
other m 35 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  656  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  106  mg dl$influenza virus vaccine  0.5  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; multivitamins  5  ml ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; miconazole powder 2%  1  appl ; albuterol 0.083% neb soln  1  neb ; acyclovir  800  mg ; sodium chloride nasal  1-2  spry ; sodium chloride 0.9%  flush  3  ml ; 
 
other m 35 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  565  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  108  mg dl$influenza virus vaccine  0.5  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; multivitamins  5  ml ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; miconazole powder 2%  1  appl ; albuterol 0.083% neb soln  1  neb ; acyclovir  800  mg ; sodium chloride nasal  1-2  spry ; sodium chloride 0.9%  flush  3  ml ; 
 
other m 35 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  493  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  112  mg dl$influenza virus vaccine  0.5  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; multivitamins  5  ml ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; miconazole powder 2%  1  appl ; albuterol 0.083% neb soln  1  neb ; acyclovir  800  mg ; sodium chloride nasal  1-2  spry ; sodium chloride 0.9%  flush  3  ml ; 
 
other m 35 $nan$nan$influenza virus vaccine  0.5  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; multivitamins  5  ml ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; miconazole powder 2%  1  appl ; albuterol 0.083% neb soln  1  neb ; acyclovir  800  mg ; sodium chloride nasal  1-2  spry ; sodium chloride 0.9%  flush  3  ml ; chloraseptic throat spray  1  spry ; 
 
other m 35 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  395  k ul; chemistry blood creatinine  0.7  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  $influenza virus vaccine  0.5  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; multivitamins  5  ml ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; miconazole powder 2%  1  appl ; albuterol 0.083% neb soln  1  neb ; sodium chloride nasal  1-2  spry ; sodium chloride 0.9%  flush  3  ml ; chloraseptic throat spray  1  spry ; 
 
other m 35 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  338  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  $influenza virus vaccine  0.5  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; multivitamins  5  ml ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; miconazole powder 2%  1  appl ; albuterol 0.083% neb soln  1  neb ; sodium chloride nasal  1-2  spry ; sodium chloride 0.9%  flush  3  ml ; chloraseptic throat spray  1  spry ; 
 
other m 35 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  283  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  $influenza virus vaccine  0.5  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; multivitamins  5  ml ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; miconazole powder 2%  1  appl ; albuterol 0.083% neb soln  1  neb ; sodium chloride nasal  1-2  spry ; sodium chloride 0.9%  flush  3  ml ; chloraseptic throat spray  1  spry ; morphine sulfate  2-4  mg ; 
 
other m 35 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  242  k ul; hematology blood inr(pt)  1.1  $influenza virus vaccine  0.5  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; multivitamins  5  ml ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; miconazole powder 2%  1  appl ; albuterol 0.083% neb soln  1  neb ; sodium chloride nasal  1-2  spry ; sodium chloride 0.9%  flush  3  ml ; chloraseptic throat spray  1  spry ; morphine sulfate  2-4  mg ; 
 
other m 35 $nan$nan$influenza virus vaccine  0.5  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; multivitamins  5  ml ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; miconazole powder 2%  1  appl ; albuterol 0.083% neb soln  1  neb ; sodium chloride nasal  1-2  spry ; sodium chloride 0.9%  flush  3  ml ; chloraseptic throat spray  1  spry ; morphine sulfate  2-4  mg ; 
 
other m 35 $nan$nan$influenza virus vaccine  0.5  ml ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; multivitamins  5  ml ; artificial tears  1-2  drop ; dextrose 50%  12.5  gm ; glucagon  1  mg ; miconazole powder 2%  1  appl ; albuterol 0.083% neb soln  1  neb ; sodium chloride nasal  1-2  spry ; sodium chloride 0.9%  flush  3  ml ; chloraseptic throat spray  1  spry ; morphine sulfate  2-4  mg ; tramadol (ultram)  50  mg ; 
 
black african american m 51 $nan$nan$heparin  5000  unit ; 

black african american m 51 $nan$nan$heparin  5000  unit ; lr  1000  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; oxycodone-acetaminophen elixir  5-10  ml ; prochlorperazine  10  mg ; ondansetron  8  mg ; metoprolol tartrate  5  mg ; 

black african american m 51 $nan$nan$heparin  5000  unit ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; oxycodone-acetaminophen elixir  5-10  ml ; prochlorperazine  10  mg ; ondansetron  8  mg ; metoprolol tartrate  5  mg ; bisacodyl  10  mg ; senna  2  tab ; docusate sodium (liquid)  100  mg ; hydromorphone (dilaudid)  0.125  mg ; 

black african american m 51 $nan$nan$heparin  5000  unit ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; oxycodone-acetaminophen elixir  5-10  ml ; prochlorperazine  10  mg ; senna  2  tab ; docusate sodium (liquid)  100  mg ; hydromorphone (dilaudid)  0.125  mg ; 

black african american m 51 $nan$nan$heparin  5000  unit ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; oxycodone-acetaminophen elixir  5-10  ml ; prochlorperazine  10  mg ; docusate sodium (liquid)  100  mg ; 

white f 38 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; hematology urine wbc  34  # hpf; chemistry blood glucose  93  mg dl; blood gas blood lactate  0.6  mmol l$nan
home accidents personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site acquired absence of breast and nipple infected postoperative seroma staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation family history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb malignant neoplasm of upper-inner quadrant of female breast personal history of tobacco use estrogen receptor positive status [er+] benign neoplasm of breast driver of special all-terrain or other off-road motor vehicle injured in traffic accident prophylactic breast removal 
white f 38 $temp  98.3  heartrate  91.0  resprate  15.0  o2sat  96.0  sbp  113.0  dbp  74.0  rhythm    pain  0  $hematology blood hematocrit  28.6  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  156  k ul; hematology blood bands  2  %$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; enoxaparin sodium  40  mg ; gabapentin  200  mg ; loratadine  10  mg ; lorazepam  1  mg ; metformin xr (glucophage xr)  2000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; pyridoxine  50  mg ; ciprofloxacin hcl  500  mg ; 
home accidents personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site acquired absence of breast and nipple infected postoperative seroma staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation family history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb malignant neoplasm of upper-inner quadrant of female breast personal history of tobacco use estrogen receptor positive status [er+] benign neoplasm of breast driver of special all-terrain or other off-road motor vehicle injured in traffic accident prophylactic breast removal 
white f 38 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  147  k ul; hematology blood bands  1  %$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; enoxaparin sodium  40  mg ; gabapentin  200  mg ; loratadine  10  mg ; lorazepam  1  mg ; metformin xr (glucophage xr)  2000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; pyridoxine  50  mg ; ciprofloxacin hcl  500  mg ; 300 mcg vial  1  vial ; filgrastim  300  mcg ; 
home accidents personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site acquired absence of breast and nipple infected postoperative seroma staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation family history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb malignant neoplasm of upper-inner quadrant of female breast personal history of tobacco use estrogen receptor positive status [er+] benign neoplasm of breast driver of special all-terrain or other off-road motor vehicle injured in traffic accident prophylactic breast removal 
hispanic latino m 46 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  10.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  81  mg dl; chemistry blood glucose  141  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acyclovir  400  mg ; amlodipine  10  mg ; hydrochlorothiazide  25  mg ; lisinopril  40  mg ; oxycodone (immediate release)  5-10  mg ; fosaprepitant  150  mg ; ondansetron  8  mg ; 0.9% sodium chloride  150  ml ; dexamethasone sod phosphate  12  mg ; lorazepam  0.5-1  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  50  ml ; mesna  1150  mg ; 0.9% sodium chloride  250  ml ; cyclophosphamide  1940  mg ; enoxaparin sodium  150  mg ; allopurinol  100  mg ; dexamethasone  8  mg ; acetaminophen  1000  mg ; phosphorus  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
hispanic latino m 46 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; amlodipine  10  mg ; lisinopril  40  mg ; oxycodone (immediate release)  5-10  mg ; fosaprepitant  150  mg ; ondansetron  8  mg ; 0.9% sodium chloride  150  ml ; dexamethasone sod phosphate  12  mg ; lorazepam  0.5-1  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  50  ml ; mesna  1150  mg ; enoxaparin sodium  150  mg ; dexamethasone  8  mg ; acetaminophen  1000  mg ; phosphorus  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
white f 84 $temp  97.8  heartrate  81.0  resprate  22.0  o2sat  94.0  sbp  131.0  dbp  74.0  rhythm    pain  3  $hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  135  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; diltiazem extended-release  180  mg ; nadolol  40  mg ; nadolol  80  mg ; torsemide  20  mg ; torsemide  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; ondansetron  4  mg ; insulin  0  unit ; omeprazole  40  mg ; insulin  32  unit ; irbesartan  300  mg ; aspirin  81  mg ; insulin  7  unit ; 
nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation congestive heart failure, unspecified esophageal reflux malignant neoplasm of liver, primary long-term (current) use of insulin other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast coronary atherosclerosis of native coronary artery chronic kidney disease, unspecified unspecified viral hepatitis c without hepatic coma car passenger injured in collision with van in traffic accident cirrhosis of liver without mention of alcohol solitary pulmonary nodule hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified nontoxic uninodular goiter hip joint replacement acute on chronic combined systolic and diastolic heart failure aortic valve disorders other malaise and fatigue coronary vasodilators causing adverse effects in therapeutic use iron deficiency anemia, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled acute on chronic diastolic heart failure chronic kidney disease, unspecified esophageal varices in diseases classified elsewhere, without mention of bleeding swelling of limb atrial fibrillation hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified nonspecific abnormal findings in stool contents chronic hepatitis c without mention of hepatic coma cirrhosis of liver without mention of alcohol other antihypertensive agents causing adverse effects in therapeutic use home accidents long-term (current) use of insulin personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux coronary atherosclerosis of native coronary artery unspecified essential hypertension atrial fibrillation cirrhosis of liver without mention of alcohol hepatitis, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal
white f 84 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; diltiazem extended-release  180  mg ; nadolol  40  mg ; nadolol  80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; ondansetron  4  mg ; insulin  0  unit ; omeprazole  40  mg ; insulin  32  unit ; aspirin  81  mg ; insulin  7  unit ; 
nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation congestive heart failure, unspecified esophageal reflux malignant neoplasm of liver, primary long-term (current) use of insulin other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast coronary atherosclerosis of native coronary artery chronic kidney disease, unspecified unspecified viral hepatitis c without hepatic coma car passenger injured in collision with van in traffic accident cirrhosis of liver without mention of alcohol solitary pulmonary nodule hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified nontoxic uninodular goiter hip joint replacement acute on chronic combined systolic and diastolic heart failure aortic valve disorders other malaise and fatigue coronary vasodilators causing adverse effects in therapeutic use iron deficiency anemia, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled acute on chronic diastolic heart failure chronic kidney disease, unspecified esophageal varices in diseases classified elsewhere, without mention of bleeding swelling of limb atrial fibrillation hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified nonspecific abnormal findings in stool contents chronic hepatitis c without mention of hepatic coma cirrhosis of liver without mention of alcohol other antihypertensive agents causing adverse effects in therapeutic use home accidents long-term (current) use of insulin personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux coronary atherosclerosis of native coronary artery unspecified essential hypertension atrial fibrillation cirrhosis of liver without mention of alcohol hepatitis, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal
white f 84 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood glucose  141  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; diltiazem extended-release  180  mg ; nadolol  40  mg ; nadolol  80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; ondansetron  4  mg ; insulin  0  unit ; omeprazole  40  mg ; insulin  32  unit ; insulin  7  unit ; 
nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled atrial fibrillation congestive heart failure, unspecified esophageal reflux malignant neoplasm of liver, primary long-term (current) use of insulin other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast coronary atherosclerosis of native coronary artery chronic kidney disease, unspecified unspecified viral hepatitis c without hepatic coma car passenger injured in collision with van in traffic accident cirrhosis of liver without mention of alcohol solitary pulmonary nodule hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified nontoxic uninodular goiter hip joint replacement acute on chronic combined systolic and diastolic heart failure aortic valve disorders other malaise and fatigue coronary vasodilators causing adverse effects in therapeutic use iron deficiency anemia, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled acute on chronic diastolic heart failure chronic kidney disease, unspecified esophageal varices in diseases classified elsewhere, without mention of bleeding swelling of limb atrial fibrillation hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified nonspecific abnormal findings in stool contents chronic hepatitis c without mention of hepatic coma cirrhosis of liver without mention of alcohol other antihypertensive agents causing adverse effects in therapeutic use home accidents long-term (current) use of insulin personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux coronary atherosclerosis of native coronary artery unspecified essential hypertension atrial fibrillation cirrhosis of liver without mention of alcohol hepatitis, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal
white f 79 $nan$nan$atenolol  50  mg ; digoxin  0.25  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; 
pneumonitis due to inhalation of food or vomitus osteoporosis, unspecified atrial fibrillation congestive heart failure, unspecified acquired absence of both cervix and uterus stricture and stenosis of esophagus mitral valve disorders other chronic pulmonary heart diseases essential thrombocythemia unspecified essential hypertension long-term (current) use of anticoagulants achalasia and cardiospasm acute diastolic heart failure leukocytosis, unspecified unspecified essential hypertension constipation, unspecified other chronic pulmonary heart diseases essential thrombocythemia acute respiratory failure congestive heart failure, unspecified other disorders of bone and cartilage mitral valve disorders hyposmolality and/or hyponatremia acute on chronic systolic heart failure acute kidney failure, unspecified paroxysmal ventricular tachycardia pneumonia, organism unspecified unspecified pleural effusion atrial fibrillation 
white f 79 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  291  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  2.3  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  102  mg dl$atenolol  50  mg ; digoxin  0.25  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; warfarin  5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  1  tab ; docusate sodium  100  mg ; 
pneumonitis due to inhalation of food or vomitus osteoporosis, unspecified atrial fibrillation congestive heart failure, unspecified acquired absence of both cervix and uterus stricture and stenosis of esophagus mitral valve disorders other chronic pulmonary heart diseases essential thrombocythemia unspecified essential hypertension long-term (current) use of anticoagulants achalasia and cardiospasm acute diastolic heart failure leukocytosis, unspecified unspecified essential hypertension constipation, unspecified other chronic pulmonary heart diseases essential thrombocythemia acute respiratory failure congestive heart failure, unspecified other disorders of bone and cartilage mitral valve disorders hyposmolality and/or hyponatremia acute on chronic systolic heart failure acute kidney failure, unspecified paroxysmal ventricular tachycardia pneumonia, organism unspecified unspecified pleural effusion atrial fibrillation 
white f 79 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  2.3  ; hematology urine wbc  6  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  88  mg dl$atenolol  50  mg ; digoxin  0.25  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; warfarin  5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  1  tab ; docusate sodium  100  mg ; 
pneumonitis due to inhalation of food or vomitus osteoporosis, unspecified atrial fibrillation congestive heart failure, unspecified acquired absence of both cervix and uterus stricture and stenosis of esophagus mitral valve disorders other chronic pulmonary heart diseases essential thrombocythemia unspecified essential hypertension long-term (current) use of anticoagulants achalasia and cardiospasm acute diastolic heart failure leukocytosis, unspecified unspecified essential hypertension constipation, unspecified other chronic pulmonary heart diseases essential thrombocythemia acute respiratory failure congestive heart failure, unspecified other disorders of bone and cartilage mitral valve disorders hyposmolality and/or hyponatremia acute on chronic systolic heart failure acute kidney failure, unspecified paroxysmal ventricular tachycardia pneumonia, organism unspecified unspecified pleural effusion atrial fibrillation 
white f 79 $nan$nan$atenolol  50  mg ; digoxin  0.25  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  1  tab ; docusate sodium  100  mg ; 
pneumonitis due to inhalation of food or vomitus osteoporosis, unspecified atrial fibrillation congestive heart failure, unspecified acquired absence of both cervix and uterus stricture and stenosis of esophagus mitral valve disorders other chronic pulmonary heart diseases essential thrombocythemia unspecified essential hypertension long-term (current) use of anticoagulants achalasia and cardiospasm acute diastolic heart failure leukocytosis, unspecified unspecified essential hypertension constipation, unspecified other chronic pulmonary heart diseases essential thrombocythemia acute respiratory failure congestive heart failure, unspecified other disorders of bone and cartilage mitral valve disorders hyposmolality and/or hyponatremia acute on chronic systolic heart failure acute kidney failure, unspecified paroxysmal ventricular tachycardia pneumonia, organism unspecified unspecified pleural effusion atrial fibrillation 
white f 61 $nan$nan$polyethylene glycol  17  g ; calcium carbonate  500  mg ; multivitamins  1  tab ; omeprazole  40  mg ; vitamin d  800  unit ; 
secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal malnutrition of mild degree other specified disorders of liver benign essential hypertension tobacco use disorder other specified disorders of biliary tract body mass index 33.0-33.9, adult long-term (current) use of anticoagulants obstruction of bile duct personal history of venous thrombosis and embolism other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure malignant neoplasm of duodenum acute posthemorrhagic anemia mechanical complication due to other implant and internal device, not elsewhere classified personal history of malignant neoplasm of breast cholangitis hematemesis 
white f 61 $nan$hematology blood hematocrit  29.6  %; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood bilirubin, total  3.5  mg dl; chemistry blood glucose  309  mg dl; chemistry blood albumin  2.5  g dl$polyethylene glycol  17  g ; calcium carbonate  500  mg ; multivitamins  1  tab ; omeprazole  40  mg ; vitamin d  800  unit ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; ondansetron  4  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5  mg ; senna  1  tab ; docusate sodium  100  mg ; atenolol  25  mg ; 
secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal malnutrition of mild degree other specified disorders of liver benign essential hypertension tobacco use disorder other specified disorders of biliary tract body mass index 33.0-33.9, adult long-term (current) use of anticoagulants obstruction of bile duct personal history of venous thrombosis and embolism other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure malignant neoplasm of duodenum acute posthemorrhagic anemia mechanical complication due to other implant and internal device, not elsewhere classified personal history of malignant neoplasm of breast cholangitis hematemesis 
white f 61 $nan$hematology blood hematocrit  29.1  %; chemistry blood bilirubin, total  3.4  mg dl; chemistry blood glucose  103  mg dl$polyethylene glycol  17  g ; calcium carbonate  500  mg ; multivitamins  1  tab ; vitamin d  800  unit ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; lorazepam  0.5-1  mg ; senna  1  tab ; docusate sodium  100  mg ; atenolol  25  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; 
secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal malnutrition of mild degree other specified disorders of liver benign essential hypertension tobacco use disorder other specified disorders of biliary tract body mass index 33.0-33.9, adult long-term (current) use of anticoagulants obstruction of bile duct personal history of venous thrombosis and embolism other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure malignant neoplasm of duodenum acute posthemorrhagic anemia mechanical complication due to other implant and internal device, not elsewhere classified personal history of malignant neoplasm of breast cholangitis hematemesis 
white f 61 $nan$nan$polyethylene glycol  17  g ; calcium carbonate  500  mg ; multivitamins  1  tab ; vitamin d  800  unit ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; lorazepam  0.5-1  mg ; senna  1  tab ; docusate sodium  100  mg ; atenolol  25  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; 
secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal malnutrition of mild degree other specified disorders of liver benign essential hypertension tobacco use disorder other specified disorders of biliary tract body mass index 33.0-33.9, adult long-term (current) use of anticoagulants obstruction of bile duct personal history of venous thrombosis and embolism other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure malignant neoplasm of duodenum acute posthemorrhagic anemia mechanical complication due to other implant and internal device, not elsewhere classified personal history of malignant neoplasm of breast cholangitis hematemesis 
other m 53 $nan$hematology blood hematocrit  34.4  %; hematology blood hematocrit  33.2  %; hematology blood hematocrit  30.3  %; hematology blood hemoglobin  12.7  g dl; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  183  k ul; hematology blood platelet count  185  k ul; hematology blood platelet count  141  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; chemistry blood glucose  131  mg dl; blood gas blood free calcium  1.21  mmol l; blood gas blood free calcium  1.29  mmol l; blood gas blood free calcium  1.30  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood chloride, whole blood  108  meq l; blood gas blood chloride, whole blood  109  meq l; blood gas blood chloride, whole blood  104  meq l; blood gas blood glucose  106  mg dl; blood gas blood glucose  116  mg dl; blood gas blood glucose  131  mg dl; blood gas blood glucose  127  mg dl; blood gas blood glucose  150  mg dl; blood gas blood glucose  140  mg dl; blood gas blood glucose  114  mg dl; blood gas blood glucose  102  mg dl; blood gas blood glucose  119  mg dl; blood gas blood glucose  99  mg dl; blood gas blood hematocrit, calculated  43  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  34  %; blood gas blood hematocrit, calculated  34  %; blood gas blood hemoglobin  14.4  g dl; blood gas blood hemoglobin  10.8  g dl; blood gas blood hemoglobin  11.7  g dl; blood gas blood hemoglobin  10.6  g dl; blood gas blood hemoglobin  11.2  g dl; blood gas blood hemoglobin  11.3  g dl; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  5.3  meq l; blood gas blood potassium, whole blood  5.8  meq l; blood gas blood potassium, whole blood  5.9  meq l; blood gas blood potassium, whole blood  5.1  meq l; blood gas blood potassium, whole blood  5.2  meq l; blood gas blood potassium, whole blood  5.5  meq l; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood sodium, whole blood  141  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood calculated bicarbonate, whole blood  24  meq l$sw  50  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; lr  1000  ml ; 5% dextrose  250  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; potassium chloride  20  meq ; calcium gluconate  2  gm ; magnesium sulfate  2  gm ; meperidine  12.5  mg ; morphine sulfate  0.5-5.0  mg ; metoclopramide  10  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; insulin human regular  100  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; docusate sodium (liquid)  100  mg ; ketorolac  30  mg ; 
 
other m 53 $nan$hematology blood hematocrit  25.3  %; blood gas blood free calcium  1.10  mmol l; blood gas blood glucose  96  mg dl; blood gas blood potassium, whole blood  3.8  meq l$sw  50  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; d5w  250  ml ; nitroglycerin  100  mg ; phenylephrine  60  mg ; potassium chloride  20  meq ; calcium gluconate  2  gm ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5.0  mg ; metoclopramide  10  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; insulin human regular  100  unit ; ranitidine  150  mg ; docusate sodium  100  mg ; ketorolac  30  mg ; ns  500  ml ; hespan  500  ml ; aspirin ec  81  mg ; warfarin  1  dose ; furosemide  20  mg ; ketorolac  15  mg ; warfarin  5  mg ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; cefazolin  2  gm ; insulin  0  unit ; ondansetron  4  mg ; 
 
other m 53 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  2.7  ; chemistry blood glucose  141  mg dl$influenza virus vaccine  0.5  ml ; furosemide  20  mg ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; cefazolin  2  gm ; insulin  0  unit ; ondansetron  4  mg ; warfarin  4  mg ; 
 
other m 53 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  285  iu l; chemistry blood albumin  2.8  g dl$influenza virus vaccine  0.5  ml ; furosemide  20  mg ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; insulin  0  unit ; ondansetron  4  mg ; warfarin  4  mg ; lactulose  30  ml ; warfarin  0  mg ; 
 
other m 53 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; insulin  0  unit ; ondansetron  4  mg ; lactulose  30  ml ; warfarin  0  mg ; heparin sodium  25,000  unit ; 
 
other m 53 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  98  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; insulin  0  unit ; ondansetron  4  mg ; lactulose  30  ml ; warfarin  0  mg ; heparin sodium  25,000  unit ; warfarin  2  mg ; metoprolol tartrate  12.5  mg ; metoprolol tartrate  25  mg ; 
 
other m 53 $nan$hematology blood inr(pt)  3.2  $influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; insulin  0  unit ; ondansetron  4  mg ; lactulose  30  ml ; warfarin  2  mg ; metoprolol tartrate  25  mg ; warfarin  0.5  mg ; warfarin  1  mg ; 
 
black african american f 59 $temp  97.4  heartrate  64.0  resprate  15.0  o2sat  100.0  sbp  198.0  dbp  67.0  rhythm    pain  0  ; temp    heartrate  60.0  resprate  16.0  o2sat  100.0  sbp  148.0  dbp  78.0  rhythm    pain    $hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  13.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  99  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  56  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oxycodone (immediate release)   5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; polyethylene glycol  17  g ; senna  1  tab ; simethicone  80  mg ; bisacodyl  5  mg ; acetaminophen  650  mg ; insulin  0  unit ; nephrocaps  1  cap ; calcitriol  0.25  mcg ; docusate sodium  100  mg ; calcium acetate  2001  mg ; aspirin  81  mg ; valsartan  160  mg ; vitamin b complex w c  1  tab ; acetaminophen  1000  mg ; sevelamer carbonate  800  mg ; simvastatin  40  mg ; valsartan  80  mg ; levothyroxine sodium  50  mcg ; 
end stage renal disease other and unspecified hyperlipidemia depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled trimalleolar fracture, closed hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease long-term (current) use of other medications overexertion from sudden strenuous movement chronic diastolic heart failure anemia in chronic kidney disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin long-term (current) use of insulin congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease background diabetic retinopathy hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease congestive heart failure, unspecified secondary hyperparathyroidism (of renal origin) long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled diabetes with neurological manifestations, type ii or unspecified type, uncontrolled anemia in chronic kidney disease orthostatic hypotension renal dialysis status diabetes with renal manifestations, type ii or unspecified type, uncontrolled pedal cycle driver injured in noncollision transport accident in nontraffic accident nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere constipation, unspecified hypovolemia hypercalcemia chronic diastolic heart failure depressive disorder, not elsewhere classified hyperpotassemia peripheral autonomic neuropathy in disorders classified elsewhere tubal ligation status end stage renal disease pure hypercholesterolemia family history of diabetes mellitus background diabetic retinopathy hyperpotassemia anemia in chronic kidney disease body mass index 35.0-35.9, adult diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
black african american f 59 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  12.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  92  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  33  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oxycodone (immediate release)   5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simethicone  80  mg ; bisacodyl  5  mg ; nephrocaps  1  cap ; calcitriol  0.25  mcg ; docusate sodium  100  mg ; calcium acetate  2001  mg ; aspirin  81  mg ; vitamin b complex w c  1  tab ; acetaminophen  1000  mg ; sevelamer carbonate  800  mg ; simvastatin  40  mg ; valsartan  80  mg ; levothyroxine sodium  50  mcg ; insulin  15  unit ; insulin  7  unit ; sarna lotion  1  appl ; oxymetazoline  1  spry ; furosemide  80  mg ; magnesium citrate  300  ml ; labetalol  100  mg ; hydralazine  5  mg ; 
end stage renal disease other and unspecified hyperlipidemia depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled trimalleolar fracture, closed hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease long-term (current) use of other medications overexertion from sudden strenuous movement chronic diastolic heart failure anemia in chronic kidney disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin long-term (current) use of insulin congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease background diabetic retinopathy hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease congestive heart failure, unspecified secondary hyperparathyroidism (of renal origin) long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled diabetes with neurological manifestations, type ii or unspecified type, uncontrolled anemia in chronic kidney disease orthostatic hypotension renal dialysis status diabetes with renal manifestations, type ii or unspecified type, uncontrolled pedal cycle driver injured in noncollision transport accident in nontraffic accident nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere constipation, unspecified hypovolemia hypercalcemia chronic diastolic heart failure depressive disorder, not elsewhere classified hyperpotassemia peripheral autonomic neuropathy in disorders classified elsewhere tubal ligation status end stage renal disease pure hypercholesterolemia family history of diabetes mellitus background diabetic retinopathy hyperpotassemia anemia in chronic kidney disease body mass index 35.0-35.9, adult diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
black african american f 59 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  11.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  80  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  168  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oxycodone (immediate release)   5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simethicone  80  mg ; bisacodyl  5  mg ; nephrocaps  1  cap ; calcitriol  0.25  mcg ; docusate sodium  100  mg ; calcium acetate  2001  mg ; aspirin  81  mg ; vitamin b complex w c  1  tab ; acetaminophen  1000  mg ; sevelamer carbonate  800  mg ; simvastatin  40  mg ; levothyroxine sodium  50  mcg ; insulin  7  unit ; sarna lotion  1  appl ; oxymetazoline  1  spry ; furosemide  80  mg ; magnesium citrate  300  ml ; labetalol  100  mg ; hydralazine  5  mg ; ondansetron  4  mg ; vitamin d  50,000  unit ; 
end stage renal disease other and unspecified hyperlipidemia depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled trimalleolar fracture, closed hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease long-term (current) use of other medications overexertion from sudden strenuous movement chronic diastolic heart failure anemia in chronic kidney disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin long-term (current) use of insulin congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease background diabetic retinopathy hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease congestive heart failure, unspecified secondary hyperparathyroidism (of renal origin) long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled diabetes with neurological manifestations, type ii or unspecified type, uncontrolled anemia in chronic kidney disease orthostatic hypotension renal dialysis status diabetes with renal manifestations, type ii or unspecified type, uncontrolled pedal cycle driver injured in noncollision transport accident in nontraffic accident nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere constipation, unspecified hypovolemia hypercalcemia chronic diastolic heart failure depressive disorder, not elsewhere classified hyperpotassemia peripheral autonomic neuropathy in disorders classified elsewhere tubal ligation status end stage renal disease pure hypercholesterolemia family history of diabetes mellitus background diabetic retinopathy hyperpotassemia anemia in chronic kidney disease body mass index 35.0-35.9, adult diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
black african american f 59 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  10.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  73  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  242  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oxycodone (immediate release)   5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simethicone  80  mg ; bisacodyl  5  mg ; nephrocaps  1  cap ; calcitriol  0.25  mcg ; docusate sodium  100  mg ; aspirin  81  mg ; vitamin b complex w c  1  tab ; acetaminophen  1000  mg ; sevelamer carbonate  800  mg ; simvastatin  40  mg ; levothyroxine sodium  50  mcg ; insulin  7  unit ; sarna lotion  1  appl ; oxymetazoline  1  spry ; furosemide  80  mg ; ondansetron  4  mg ; vitamin d  50,000  unit ; 
end stage renal disease other and unspecified hyperlipidemia depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled trimalleolar fracture, closed hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease long-term (current) use of other medications overexertion from sudden strenuous movement chronic diastolic heart failure anemia in chronic kidney disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin long-term (current) use of insulin congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease background diabetic retinopathy hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease congestive heart failure, unspecified secondary hyperparathyroidism (of renal origin) long-term (current) use of insulin diabetes with ophthalmic manifestations, type ii or unspecified type, uncontrolled diabetes with neurological manifestations, type ii or unspecified type, uncontrolled anemia in chronic kidney disease orthostatic hypotension renal dialysis status diabetes with renal manifestations, type ii or unspecified type, uncontrolled pedal cycle driver injured in noncollision transport accident in nontraffic accident nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere constipation, unspecified hypovolemia hypercalcemia chronic diastolic heart failure depressive disorder, not elsewhere classified hyperpotassemia peripheral autonomic neuropathy in disorders classified elsewhere tubal ligation status end stage renal disease pure hypercholesterolemia family history of diabetes mellitus background diabetic retinopathy hyperpotassemia anemia in chronic kidney disease body mass index 35.0-35.9, adult diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled
white f 55 $temp  99.3  heartrate  91.0  resprate  18.0  o2sat  94.0  sbp  103.0  dbp  69.0  rhythm    pain  0  $hematology blood hematocrit  34.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; lorazepam  0.5-2  mg ; heparin  5000  unit ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; lorazepam  0.5  mg ; 
iron deficiency anemia, unspecified emphysema, unspecified encounter for immunization sepsis due to other specified staphylococcus personal history of malignant neoplasm of breast coagulation defect, unspecified dorsalgia, unspecified personal history of malignant neoplasm of ovary personal history of pulmonary embolism other microscopic hematuria irritable bowel syndrome without diarrhea other chest pain hyperlipidemia, unspecified pneumonia, unspecified organism age-related osteoporosis without current pathological fracture tremor, unspecified unspecified convulsions post-traumatic stress disorder, unspecified alcohol dependence, in remission other chronic pain respiratory failure, unspecified with hypoxia major depressive disorder, single episode, unspecified tobacco use esophageal reflux other and unspecified alcohol dependence, in remission asthma, unspecified type, unspecified personal history of malignant neoplasm of breast posttraumatic stress disorder obstructive sleep apnea (adult)(pediatric) arthropathy, unspecified, ankle and foot person boarding or alighting a pedal cycle injured in collision with pedestrian or animal tobacco use disorder generalized convulsive epilepsy, without mention of intractable epilepsy epilepsy, unspecified, without mention of intractable epilepsy alcohol abuse, in remission personal history of malignant neoplasm of breast osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot person boarding or alighting a pedal cycle injured in collision with pedestrian or animal bunion posttraumatic stress disorder asthma, unspecified type, unspecified obstructive sleep apnea (adult)(pediatric) posttraumatic stress disorder personal history of malignant neoplasm of ovary generalized convulsive epilepsy, without mention of intractable epilepsy benign neoplasm of cerebral meninges personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal
white f 55 $nan$nan$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; lorazepam  0.5-2  mg ; heparin  5000  unit ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; lorazepam  0.5  mg ; levetiracetam  1000  mg ; acetaminophen  325-650  mg ; 
iron deficiency anemia, unspecified emphysema, unspecified encounter for immunization sepsis due to other specified staphylococcus personal history of malignant neoplasm of breast coagulation defect, unspecified dorsalgia, unspecified personal history of malignant neoplasm of ovary personal history of pulmonary embolism other microscopic hematuria irritable bowel syndrome without diarrhea other chest pain hyperlipidemia, unspecified pneumonia, unspecified organism age-related osteoporosis without current pathological fracture tremor, unspecified unspecified convulsions post-traumatic stress disorder, unspecified alcohol dependence, in remission other chronic pain respiratory failure, unspecified with hypoxia major depressive disorder, single episode, unspecified tobacco use esophageal reflux other and unspecified alcohol dependence, in remission asthma, unspecified type, unspecified personal history of malignant neoplasm of breast posttraumatic stress disorder obstructive sleep apnea (adult)(pediatric) arthropathy, unspecified, ankle and foot person boarding or alighting a pedal cycle injured in collision with pedestrian or animal tobacco use disorder generalized convulsive epilepsy, without mention of intractable epilepsy epilepsy, unspecified, without mention of intractable epilepsy alcohol abuse, in remission personal history of malignant neoplasm of breast osteoarthrosis, localized, not specified whether primary or secondary, ankle and foot person boarding or alighting a pedal cycle injured in collision with pedestrian or animal bunion posttraumatic stress disorder asthma, unspecified type, unspecified obstructive sleep apnea (adult)(pediatric) posttraumatic stress disorder personal history of malignant neoplasm of ovary generalized convulsive epilepsy, without mention of intractable epilepsy benign neoplasm of cerebral meninges personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal
white m 55 $nan$hematology blood hematocrit  44.9  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  324  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  125  mg dl$d5 1 2ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; 
 
white m 55 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; 
 
white m 24 $temp  100.2  heartrate  125.0  resprate  20.0  o2sat  97.0  sbp  133.0  dbp  82.0  rhythm    pain  0  ; temp    heartrate  96.0  resprate  14.0  o2sat  89.0  sbp  110.0  dbp  68.0  rhythm    pain  0  ; temp    heartrate    resprate    o2sat  98.0  sbp    dbp    rhythm    pain    ; temp    heartrate  81.0  resprate  6.0  o2sat  97.0  sbp  121.0  dbp  69.0  rhythm    pain    ; temp  99.1  heartrate  85.0  resprate  10.0  o2sat  98.0  sbp  119.0  dbp  65.0  rhythm    pain  0  ; temp    heartrate  89.0  resprate  10.0  o2sat  89.0  sbp  114.0  dbp  67.0  rhythm    pain  0  $hematology blood hematocrit  43.4  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  102  mg dl; chemistry blood albumin  4.5  g dl; blood gas blood lactate  0.9  mmol l$nan
pedestrian injured in nontraffic accident involving unspecified motor vehicles, initial encounter traumatic subdural hemorrhage without loss of consciousness, initial encounter traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter epidural hemorrhage without loss of consciousness, initial encounter nicotine dependence, cigarettes, uncomplicated hypoxemia parking lot as the place of occurrence of the external cause 
white m 24 $temp    heartrate  82.0  resprate  8.0  o2sat  96.0  sbp  101.0  dbp  44.0  rhythm    pain  0  ; temp  98.4  heartrate  78.0  resprate  8.0  o2sat  97.0  sbp  107.0  dbp  52.0  rhythm    pain  0  $hematology blood hematocrit  42.1  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  107  mg dl; chemistry blood albumin  4.5  g dl$senna  8.6  mg ; heparin  5000  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; sodium chloride 0.9%  flush  3-10  ml ; 
pedestrian injured in nontraffic accident involving unspecified motor vehicles, initial encounter traumatic subdural hemorrhage without loss of consciousness, initial encounter traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter epidural hemorrhage without loss of consciousness, initial encounter nicotine dependence, cigarettes, uncomplicated hypoxemia parking lot as the place of occurrence of the external cause 
asian m 78 $temp  97.9  heartrate  73.0  resprate  16.0  o2sat  98.0  sbp  133.0  dbp  48.0  rhythm    pain  8  ; temp  98.8  heartrate  82.0  resprate  16.0  o2sat  97.0  sbp  124.0  dbp  55.0  rhythm    pain    $nan$insulin  38  unit ; 
removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute venous embolism and thrombosis of superficial veins of upper extremity streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus hyperosmolality and/or hypernatremia acidosis atrial fibrillation physical restraints status acute appendicitis with peritoneal abscess other chronic nonalcoholic liver disease severe sepsis laparoscopic surgical procedure converted to open procedure cardiac complications, not elsewhere classified hyperpotassemia diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diarrhea other and unspecified angina pectoris other and unspecified escherichia coli [e. coli] chronic kidney disease, stage iv (severe) septic shock accidents occurring in residential institution unspecified septicemia toxic encephalopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere swelling, mass, or lump in chest 
asian m 78 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  290  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  78  mg dl; hematology blood inr(pt)  3.3  ; chemistry blood glucose  154  mg dl; blood gas blood lactate  2.5  mmol l$insulin  38  unit ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  10  unit ; allopurinol  200  mg ; calcitriol  0.25  mcg ; docusate sodium  100  mg ; fenofibrate  145  mg ; metoprolol succinate xl  100  mg ; multivitamins  1  tab ; nitroglycerin sl  0.4  mg ; simvastatin  20  mg ; acetaminophen  650  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; furosemide  40  mg ; sevelamer carbonate  800  mg ; torsemide  40  mg ; olanzapine (disintegrating tablet)  5  mg ; isosorbide  60  mg ; lisinopril  5  mg ; phytonadione  10  mg ; ondansetron  4-8  mg ; tramadol (ultram)  25  mg ; 
removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute venous embolism and thrombosis of superficial veins of upper extremity streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus hyperosmolality and/or hypernatremia acidosis atrial fibrillation physical restraints status acute appendicitis with peritoneal abscess other chronic nonalcoholic liver disease severe sepsis laparoscopic surgical procedure converted to open procedure cardiac complications, not elsewhere classified hyperpotassemia diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diarrhea other and unspecified angina pectoris other and unspecified escherichia coli [e. coli] chronic kidney disease, stage iv (severe) septic shock accidents occurring in residential institution unspecified septicemia toxic encephalopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere swelling, mass, or lump in chest 
asian m 78 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  79  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  10.7  mg dl; chemistry blood glucose  164  mg dl; blood gas blood lactate  2.4  mmol l$insulin  38  unit ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  10  unit ; allopurinol  200  mg ; calcitriol  0.25  mcg ; docusate sodium  100  mg ; fenofibrate  145  mg ; metoprolol succinate xl  100  mg ; multivitamins  1  tab ; nitroglycerin sl  0.4  mg ; simvastatin  20  mg ; acetaminophen  650  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; furosemide  40  mg ; sevelamer carbonate  800  mg ; olanzapine (disintegrating tablet)  5  mg ; isosorbide  60  mg ; lisinopril  5  mg ; phytonadione  10  mg ; ondansetron  4-8  mg ; tramadol (ultram)  25  mg ; oxycodone (immediate release)   5  mg ; sodium chloride 0.9%  1000  ml ; 
removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute venous embolism and thrombosis of superficial veins of upper extremity streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus hyperosmolality and/or hypernatremia acidosis atrial fibrillation physical restraints status acute appendicitis with peritoneal abscess other chronic nonalcoholic liver disease severe sepsis laparoscopic surgical procedure converted to open procedure cardiac complications, not elsewhere classified hyperpotassemia diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diarrhea other and unspecified angina pectoris other and unspecified escherichia coli [e. coli] chronic kidney disease, stage iv (severe) septic shock accidents occurring in residential institution unspecified septicemia toxic encephalopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere swelling, mass, or lump in chest 
asian m 78 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  78  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  10.5  mg dl; chemistry blood glucose  221  mg dl; blood gas blood lactate  2.2  mmol l$insulin  38  unit ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  10  unit ; allopurinol  200  mg ; calcitriol  0.25  mcg ; docusate sodium  100  mg ; fenofibrate  145  mg ; metoprolol succinate xl  100  mg ; multivitamins  1  tab ; nitroglycerin sl  0.4  mg ; simvastatin  20  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; sevelamer carbonate  800  mg ; olanzapine (disintegrating tablet)  5  mg ; isosorbide  60  mg ; lisinopril  5  mg ; ondansetron  4-8  mg ; oxycodone (immediate release)   5  mg ; sodium chloride 0.9%  1000  ml ; acetaminophen iv  1000  mg ; aspirin  325  mg ; lidocaine 5% patch  1  ptch ; aspirin  81  mg ; insulin  12  unit ; d5 1 2ns  1000  ml ; albuterol 0.083% neb soln  1  neb ; 
removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute venous embolism and thrombosis of superficial veins of upper extremity streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus hyperosmolality and/or hypernatremia acidosis atrial fibrillation physical restraints status acute appendicitis with peritoneal abscess other chronic nonalcoholic liver disease severe sepsis laparoscopic surgical procedure converted to open procedure cardiac complications, not elsewhere classified hyperpotassemia diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diarrhea other and unspecified angina pectoris other and unspecified escherichia coli [e. coli] chronic kidney disease, stage iv (severe) septic shock accidents occurring in residential institution unspecified septicemia toxic encephalopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere swelling, mass, or lump in chest 
asian m 78 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  85  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  11.2  mg dl; chemistry blood glucose  245  mg dl$insulin  38  unit ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  10  unit ; allopurinol  200  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; nitroglycerin sl  0.4  mg ; simvastatin  20  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; sevelamer carbonate  800  mg ; olanzapine (disintegrating tablet)  5  mg ; ondansetron  4-8  mg ; acetaminophen iv  1000  mg ; aspirin  325  mg ; lidocaine 5% patch  1  ptch ; albuterol 0.083% neb soln  1  neb ; hydromorphone (dilaudid)  0.5  mg ; heparin  1600-3300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; dexamethasone  4  mg ; warfarin  2.5  mg ; 
removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute venous embolism and thrombosis of superficial veins of upper extremity streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus hyperosmolality and/or hypernatremia acidosis atrial fibrillation physical restraints status acute appendicitis with peritoneal abscess other chronic nonalcoholic liver disease severe sepsis laparoscopic surgical procedure converted to open procedure cardiac complications, not elsewhere classified hyperpotassemia diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diarrhea other and unspecified angina pectoris other and unspecified escherichia coli [e. coli] chronic kidney disease, stage iv (severe) septic shock accidents occurring in residential institution unspecified septicemia toxic encephalopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere swelling, mass, or lump in chest 
asian m 78 $nan$hematology blood hematocrit  36.3  %; hematology blood hematocrit  37.6  %; hematology blood hemoglobin  11.6  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  173  k ul; hematology blood platelet count  196  k ul; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  3.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  93  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  11.4  mg dl; chemistry blood glucose  291  mg dl; blood gas blood lactate  2.5  mmol l$insulin  38  unit ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  10  unit ; allopurinol  200  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; nitroglycerin sl  0.4  mg ; simvastatin  20  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; sevelamer carbonate  800  mg ; olanzapine (disintegrating tablet)  5  mg ; ondansetron  4-8  mg ; lidocaine 5% patch  1  ptch ; albuterol 0.083% neb soln  1  neb ; hydromorphone (dilaudid)  0.5  mg ; heparin  1600-3300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; dexamethasone  4  mg ; warfarin  2.5  mg ; warfarin  2  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; warfarin  1.25  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute venous embolism and thrombosis of superficial veins of upper extremity streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus hyperosmolality and/or hypernatremia acidosis atrial fibrillation physical restraints status acute appendicitis with peritoneal abscess other chronic nonalcoholic liver disease severe sepsis laparoscopic surgical procedure converted to open procedure cardiac complications, not elsewhere classified hyperpotassemia diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diarrhea other and unspecified angina pectoris other and unspecified escherichia coli [e. coli] chronic kidney disease, stage iv (severe) septic shock accidents occurring in residential institution unspecified septicemia toxic encephalopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere swelling, mass, or lump in chest 
asian m 78 $nan$nan$insulin  38  unit ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  10  unit ; allopurinol  200  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; nitroglycerin sl  0.4  mg ; simvastatin  20  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; sevelamer carbonate  800  mg ; olanzapine (disintegrating tablet)  5  mg ; ondansetron  4-8  mg ; lidocaine 5% patch  1  ptch ; albuterol 0.083% neb soln  1  neb ; hydromorphone (dilaudid)  0.5  mg ; heparin  1600-3300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; dexamethasone  4  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; warfarin  1.25  mg ; scopolamine patch  1  ptch ; lorazepam  0.5-2  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; 
removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute venous embolism and thrombosis of superficial veins of upper extremity streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus hyperosmolality and/or hypernatremia acidosis atrial fibrillation physical restraints status acute appendicitis with peritoneal abscess other chronic nonalcoholic liver disease severe sepsis laparoscopic surgical procedure converted to open procedure cardiac complications, not elsewhere classified hyperpotassemia diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diarrhea other and unspecified angina pectoris other and unspecified escherichia coli [e. coli] chronic kidney disease, stage iv (severe) septic shock accidents occurring in residential institution unspecified septicemia toxic encephalopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere swelling, mass, or lump in chest 
white f 51 $temp    heartrate    resprate    o2sat    sbp  112.0  dbp  71.0  rhythm    pain  9  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  7  ; temp  98.1  heartrate  94.0  resprate  18.0  o2sat  98.0  sbp  113.0  dbp  74.0  rhythm    pain  5  ; temp  98.4  heartrate  88.0  resprate  17.0  o2sat  98.0  sbp  105.0  dbp  72.0  rhythm    pain  7  $hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; hematology urine wbc  10  # hpf; chemistry blood glucose  84  mg dl$nan
iron deficiency anemia, unspecified persistent vomiting benign neoplasm of spinal meninges esophageal reflux hiccough lumbago unspecified gastritis and gastroduodenitis, without mention of hemorrhage orthostatic hypotension other postprocedural status other constipation personal history of tobacco use urinary tract infection, site not specified other and unspecified escherichia coli [e. coli] 
white f 51 $temp  98.2  heartrate  89.0  resprate  16.0  o2sat  98.0  sbp  123.0  dbp  75.0  rhythm    pain  5  $nan$hydromorphone (dilaudid)  1  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  325-650  mg ; gabapentin  300  mg ; ondansetron  4  mg ; heparin  5000  unit ; dexamethasone  4  mg ; famotidine  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; hydromorphone (dilaudid)  4  mg ; hydromorphone (dilaudid)  2  mg ; acetaminophen  1000  mg ; bisacodyl  10  mg ; duloxetine  30  mg ; 
iron deficiency anemia, unspecified persistent vomiting benign neoplasm of spinal meninges esophageal reflux hiccough lumbago unspecified gastritis and gastroduodenitis, without mention of hemorrhage orthostatic hypotension other postprocedural status other constipation personal history of tobacco use urinary tract infection, site not specified other and unspecified escherichia coli [e. coli] 
white f 51 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  121  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; ondansetron  4  mg ; heparin  5000  unit ; dexamethasone  4  mg ; famotidine  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; hydromorphone (dilaudid)  4  mg ; hydromorphone (dilaudid)  2  mg ; acetaminophen  1000  mg ; bisacodyl  10  mg ; senna  8.6  mg ; cyanocobalamin  100  mcg ; gabapentin  600  mg ; lorazepam  1  mg ; 
iron deficiency anemia, unspecified persistent vomiting benign neoplasm of spinal meninges esophageal reflux hiccough lumbago unspecified gastritis and gastroduodenitis, without mention of hemorrhage orthostatic hypotension other postprocedural status other constipation personal history of tobacco use urinary tract infection, site not specified other and unspecified escherichia coli [e. coli] 
white f 51 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; dexamethasone  4  mg ; famotidine  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  1000  mg ; bisacodyl  10  mg ; senna  8.6  mg ; cyanocobalamin  100  mcg ; gabapentin  600  mg ; lorazepam  1  mg ; hydroxyzine  25  mg ; 
iron deficiency anemia, unspecified persistent vomiting benign neoplasm of spinal meninges esophageal reflux hiccough lumbago unspecified gastritis and gastroduodenitis, without mention of hemorrhage orthostatic hypotension other postprocedural status other constipation personal history of tobacco use urinary tract infection, site not specified other and unspecified escherichia coli [e. coli] 
white f 51 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  153  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; dexamethasone  4  mg ; famotidine  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  1000  mg ; senna  8.6  mg ; hydroxyzine  25  mg ; folic acid  1  mg ; polyethylene glycol  17  g ; dexamethasone  2  mg ; 
iron deficiency anemia, unspecified persistent vomiting benign neoplasm of spinal meninges esophageal reflux hiccough lumbago unspecified gastritis and gastroduodenitis, without mention of hemorrhage orthostatic hypotension other postprocedural status other constipation personal history of tobacco use urinary tract infection, site not specified other and unspecified escherichia coli [e. coli] 
white f 51 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; famotidine  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  1000  mg ; senna  8.6  mg ; hydroxyzine  25  mg ; folic acid  1  mg ; polyethylene glycol  17  g ; dexamethasone  2  mg ; 0.9% sodium chloride  100  ml ; methylprednisolone na suc  1000  mg ; 
iron deficiency anemia, unspecified persistent vomiting benign neoplasm of spinal meninges esophageal reflux hiccough lumbago unspecified gastritis and gastroduodenitis, without mention of hemorrhage orthostatic hypotension other postprocedural status other constipation personal history of tobacco use urinary tract infection, site not specified other and unspecified escherichia coli [e. coli] 
white f 51 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  137  mg dl; chemistry blood lactate dehydrogenase (ld)  326  iu l; chemistry blood albumin  3.8  g dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; famotidine  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  1000  mg ; senna  8.6  mg ; hydroxyzine  25  mg ; folic acid  1  mg ; polyethylene glycol  17  g ; 0.9% sodium chloride  100  ml ; methylprednisolone na suc  1000  mg ; magnesium citrate  300  ml ; 
iron deficiency anemia, unspecified persistent vomiting benign neoplasm of spinal meninges esophageal reflux hiccough lumbago unspecified gastritis and gastroduodenitis, without mention of hemorrhage orthostatic hypotension other postprocedural status other constipation personal history of tobacco use urinary tract infection, site not specified other and unspecified escherichia coli [e. coli] 
white f 51 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  171  mg dl; chemistry blood lactate dehydrogenase (ld)  226  iu l; chemistry blood albumin  3.8  g dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; famotidine  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; senna  8.6  mg ; hydroxyzine  25  mg ; folic acid  1  mg ; polyethylene glycol  17  g ; 0.9% sodium chloride  100  ml ; methylprednisolone na suc  1000  mg ; magnesium citrate  300  ml ; fleet enema  1  enema ; docusate sodium  100  mg ; 
iron deficiency anemia, unspecified persistent vomiting benign neoplasm of spinal meninges esophageal reflux hiccough lumbago unspecified gastritis and gastroduodenitis, without mention of hemorrhage orthostatic hypotension other postprocedural status other constipation personal history of tobacco use urinary tract infection, site not specified other and unspecified escherichia coli [e. coli] 
white f 51 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  131  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; famotidine  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; senna  8.6  mg ; hydroxyzine  25  mg ; folic acid  1  mg ; polyethylene glycol  17  g ; 0.9% sodium chloride  100  ml ; methylprednisolone na suc  1000  mg ; fleet enema  1  enema ; docusate sodium  100  mg ; 
iron deficiency anemia, unspecified persistent vomiting benign neoplasm of spinal meninges esophageal reflux hiccough lumbago unspecified gastritis and gastroduodenitis, without mention of hemorrhage orthostatic hypotension other postprocedural status other constipation personal history of tobacco use urinary tract infection, site not specified other and unspecified escherichia coli [e. coli] 
white f 51 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  0.9  ; hematology urine wbc  45  # hpf; hematology urine wbc  19  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  120  mg dl; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin  5000  unit ; famotidine  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; senna  8.6  mg ; hydroxyzine  25  mg ; folic acid  1  mg ; polyethylene glycol  17  g ; 0.9% sodium chloride  100  ml ; methylprednisolone na suc  1000  mg ; fleet enema  1  enema ; docusate sodium  100  mg ; pantoprazole  40  mg ; gabapentin  200  mg ; 
iron deficiency anemia, unspecified persistent vomiting benign neoplasm of spinal meninges esophageal reflux hiccough lumbago unspecified gastritis and gastroduodenitis, without mention of hemorrhage orthostatic hypotension other postprocedural status other constipation personal history of tobacco use urinary tract infection, site not specified other and unspecified escherichia coli [e. coli] 
white f 51 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  114  mg dl; chemistry blood albumin  3.0  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; senna  8.6  mg ; hydroxyzine  25  mg ; folic acid  1  mg ; polyethylene glycol  17  g ; 0.9% sodium chloride  100  ml ; methylprednisolone na suc  1000  mg ; fleet enema  1  enema ; docusate sodium  100  mg ; pantoprazole  40  mg ; gabapentin  200  mg ; prednisone  60  mg ; ciprofloxacin hcl  500  mg ; 
iron deficiency anemia, unspecified persistent vomiting benign neoplasm of spinal meninges esophageal reflux hiccough lumbago unspecified gastritis and gastroduodenitis, without mention of hemorrhage orthostatic hypotension other postprocedural status other constipation personal history of tobacco use urinary tract infection, site not specified other and unspecified escherichia coli [e. coli] 
white f 51 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  146  iu l; chemistry blood albumin  3.1  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; senna  8.6  mg ; hydroxyzine  25  mg ; folic acid  1  mg ; polyethylene glycol  17  g ; fleet enema  1  enema ; docusate sodium  100  mg ; pantoprazole  40  mg ; prednisone  60  mg ; ciprofloxacin hcl  500  mg ; 
iron deficiency anemia, unspecified persistent vomiting benign neoplasm of spinal meninges esophageal reflux hiccough lumbago unspecified gastritis and gastroduodenitis, without mention of hemorrhage orthostatic hypotension other postprocedural status other constipation personal history of tobacco use urinary tract infection, site not specified other and unspecified escherichia coli [e. coli] 
white f 51 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  84  mg dl; chemistry blood glucose  126  mg dl; chemistry blood albumin  3.6  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; hydroxyzine  25  mg ; folic acid  1  mg ; polyethylene glycol  17  g ; fleet enema  1  enema ; docusate sodium  100  mg ; pantoprazole  40  mg ; prednisone  60  mg ; ciprofloxacin hcl  500  mg ; prednisone  40  mg ; 
iron deficiency anemia, unspecified persistent vomiting benign neoplasm of spinal meninges esophageal reflux hiccough lumbago unspecified gastritis and gastroduodenitis, without mention of hemorrhage orthostatic hypotension other postprocedural status other constipation personal history of tobacco use urinary tract infection, site not specified other and unspecified escherichia coli [e. coli] 
white m 73 $temp  98.2  heartrate  74.0  resprate  18.0  o2sat  94.0  sbp  124.0  dbp  59.0  rhythm    pain  0  $hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  3.7  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  164  mg dl$glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; aspirin  81  mg ; amlodipine  5  mg ; fluoxetine  40  mg ; allopurinol  300  mg ; gabapentin  400  mg ; tiotropium bromide  1  cap ; vitamin d  1000  unit ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; torsemide  40  mg ; spironolactone  25  mg ; atorvastatin  20  mg ; 
hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease systemic lupus erythematosus, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits personal history of nicotine dependence rheumatoid arthritis, unspecified chronic obstructive pulmonary disease with (acute) exacerbation type 2 diabetes mellitus without complications hyperlipidemia, unspecified personal history of pulmonary embolism presence of prosthetic heart valve long term (current) use of anticoagulants personal history of malignant neoplasm of renal pelvis chronic kidney disease, unspecified acquired absence of kidney acute on chronic diastolic (congestive) heart failure obstructive sleep apnea (adult) (pediatric) dilated cardiomyopathy hypokalemia pulmonary hypertension, unspecified acquired absence of kidney non-st elevation (nstemi) myocardial infarction dyskinesia of esophagus chronic total occlusion of coronary artery disorder of thyroid, unspecified other secondary pulmonary hypertension rheumatoid arthritis, unspecified obesity, unspecified obstructive sleep apnea (adult) (pediatric) unspecified macular degeneration personal history of nicotine dependence cerebral infarction, unspecified chronic kidney disease, stage 3 (moderate) retention of urine, unspecified acute on chronic systolic (congestive) heart failure dilated cardiomyopathy antiphospholipid syndrome other pulmonary embolism without acute cor pulmonale personal history of other malignant neoplasm of kidney atherosclerotic heart disease of native coronary artery without angina pectoris pneumoconiosis due to asbestos and other mineral fibers encounter for examination for normal comparison and control in clinical research program nonrheumatic aortic (valve) insufficiency type 2 diabetes mellitus with diabetic chronic kidney disease infection and inflammatory reaction due to indwelling urinary catheter, initial encounter rheumatoid arthritis, unspecified major depressive disorder, single episode, unspecified spinal stenosis, lumbar region
white m 73 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  3.1  ; chemistry blood glucose  197  mg dl$glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; aspirin  81  mg ; amlodipine  5  mg ; fluoxetine  40  mg ; allopurinol  300  mg ; gabapentin  400  mg ; tiotropium bromide  1  cap ; vitamin d  1000  unit ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; torsemide  40  mg ; spironolactone  25  mg ; atorvastatin  20  mg ; tamsulosin  0.4  mg ; warfarin  2  mg ; albuterol 0.083% neb soln  1  neb ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease systemic lupus erythematosus, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits personal history of nicotine dependence rheumatoid arthritis, unspecified chronic obstructive pulmonary disease with (acute) exacerbation type 2 diabetes mellitus without complications hyperlipidemia, unspecified personal history of pulmonary embolism presence of prosthetic heart valve long term (current) use of anticoagulants personal history of malignant neoplasm of renal pelvis chronic kidney disease, unspecified acquired absence of kidney acute on chronic diastolic (congestive) heart failure obstructive sleep apnea (adult) (pediatric) dilated cardiomyopathy hypokalemia pulmonary hypertension, unspecified acquired absence of kidney non-st elevation (nstemi) myocardial infarction dyskinesia of esophagus chronic total occlusion of coronary artery disorder of thyroid, unspecified other secondary pulmonary hypertension rheumatoid arthritis, unspecified obesity, unspecified obstructive sleep apnea (adult) (pediatric) unspecified macular degeneration personal history of nicotine dependence cerebral infarction, unspecified chronic kidney disease, stage 3 (moderate) retention of urine, unspecified acute on chronic systolic (congestive) heart failure dilated cardiomyopathy antiphospholipid syndrome other pulmonary embolism without acute cor pulmonale personal history of other malignant neoplasm of kidney atherosclerotic heart disease of native coronary artery without angina pectoris pneumoconiosis due to asbestos and other mineral fibers encounter for examination for normal comparison and control in clinical research program nonrheumatic aortic (valve) insufficiency type 2 diabetes mellitus with diabetic chronic kidney disease infection and inflammatory reaction due to indwelling urinary catheter, initial encounter rheumatoid arthritis, unspecified major depressive disorder, single episode, unspecified spinal stenosis, lumbar region
white m 73 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  2.8  ; chemistry blood glucose  191  mg dl$glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; aspirin  81  mg ; amlodipine  5  mg ; fluoxetine  40  mg ; allopurinol  300  mg ; gabapentin  400  mg ; tiotropium bromide  1  cap ; vitamin d  1000  unit ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; torsemide  40  mg ; spironolactone  25  mg ; atorvastatin  20  mg ; tamsulosin  0.4  mg ; warfarin  2  mg ; albuterol 0.083% neb soln  1  neb ; fluticasone-salmeterol diskus (250 50)   1  inh ; latanoprost 0.005% ophth. soln.  1  drop ; temazepam  15  mg ; sulfameth trimethoprim ds  1  tab ; 
hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease systemic lupus erythematosus, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits personal history of nicotine dependence rheumatoid arthritis, unspecified chronic obstructive pulmonary disease with (acute) exacerbation type 2 diabetes mellitus without complications hyperlipidemia, unspecified personal history of pulmonary embolism presence of prosthetic heart valve long term (current) use of anticoagulants personal history of malignant neoplasm of renal pelvis chronic kidney disease, unspecified acquired absence of kidney acute on chronic diastolic (congestive) heart failure obstructive sleep apnea (adult) (pediatric) dilated cardiomyopathy hypokalemia pulmonary hypertension, unspecified acquired absence of kidney non-st elevation (nstemi) myocardial infarction dyskinesia of esophagus chronic total occlusion of coronary artery disorder of thyroid, unspecified other secondary pulmonary hypertension rheumatoid arthritis, unspecified obesity, unspecified obstructive sleep apnea (adult) (pediatric) unspecified macular degeneration personal history of nicotine dependence cerebral infarction, unspecified chronic kidney disease, stage 3 (moderate) retention of urine, unspecified acute on chronic systolic (congestive) heart failure dilated cardiomyopathy antiphospholipid syndrome other pulmonary embolism without acute cor pulmonale personal history of other malignant neoplasm of kidney atherosclerotic heart disease of native coronary artery without angina pectoris pneumoconiosis due to asbestos and other mineral fibers encounter for examination for normal comparison and control in clinical research program nonrheumatic aortic (valve) insufficiency type 2 diabetes mellitus with diabetic chronic kidney disease infection and inflammatory reaction due to indwelling urinary catheter, initial encounter rheumatoid arthritis, unspecified major depressive disorder, single episode, unspecified spinal stenosis, lumbar region
white m 73 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  296  k ul; hematology blood inr(pt)  2.1  $glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; aspirin  81  mg ; amlodipine  5  mg ; fluoxetine  40  mg ; allopurinol  300  mg ; gabapentin  400  mg ; tiotropium bromide  1  cap ; vitamin d  1000  unit ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; torsemide  40  mg ; spironolactone  25  mg ; atorvastatin  20  mg ; tamsulosin  0.4  mg ; albuterol 0.083% neb soln  1  neb ; fluticasone-salmeterol diskus (250 50)   1  inh ; latanoprost 0.005% ophth. soln.  1  drop ; temazepam  15  mg ; sulfameth trimethoprim ds  1  tab ; warfarin  2.5  mg ; 
hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease systemic lupus erythematosus, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits personal history of nicotine dependence rheumatoid arthritis, unspecified chronic obstructive pulmonary disease with (acute) exacerbation type 2 diabetes mellitus without complications hyperlipidemia, unspecified personal history of pulmonary embolism presence of prosthetic heart valve long term (current) use of anticoagulants personal history of malignant neoplasm of renal pelvis chronic kidney disease, unspecified acquired absence of kidney acute on chronic diastolic (congestive) heart failure obstructive sleep apnea (adult) (pediatric) dilated cardiomyopathy hypokalemia pulmonary hypertension, unspecified acquired absence of kidney non-st elevation (nstemi) myocardial infarction dyskinesia of esophagus chronic total occlusion of coronary artery disorder of thyroid, unspecified other secondary pulmonary hypertension rheumatoid arthritis, unspecified obesity, unspecified obstructive sleep apnea (adult) (pediatric) unspecified macular degeneration personal history of nicotine dependence cerebral infarction, unspecified chronic kidney disease, stage 3 (moderate) retention of urine, unspecified acute on chronic systolic (congestive) heart failure dilated cardiomyopathy antiphospholipid syndrome other pulmonary embolism without acute cor pulmonale personal history of other malignant neoplasm of kidney atherosclerotic heart disease of native coronary artery without angina pectoris pneumoconiosis due to asbestos and other mineral fibers encounter for examination for normal comparison and control in clinical research program nonrheumatic aortic (valve) insufficiency type 2 diabetes mellitus with diabetic chronic kidney disease infection and inflammatory reaction due to indwelling urinary catheter, initial encounter rheumatoid arthritis, unspecified major depressive disorder, single episode, unspecified spinal stenosis, lumbar region
white m 73 $nan$nan$glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; aspirin  81  mg ; amlodipine  5  mg ; fluoxetine  40  mg ; allopurinol  300  mg ; gabapentin  400  mg ; tiotropium bromide  1  cap ; vitamin d  1000  unit ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; torsemide  40  mg ; spironolactone  25  mg ; atorvastatin  20  mg ; tamsulosin  0.4  mg ; albuterol 0.083% neb soln  1  neb ; fluticasone-salmeterol diskus (250 50)   1  inh ; latanoprost 0.005% ophth. soln.  1  drop ; temazepam  15  mg ; sulfameth trimethoprim ds  1  tab ; warfarin  2.5  mg ; 
hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease systemic lupus erythematosus, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits personal history of nicotine dependence rheumatoid arthritis, unspecified chronic obstructive pulmonary disease with (acute) exacerbation type 2 diabetes mellitus without complications hyperlipidemia, unspecified personal history of pulmonary embolism presence of prosthetic heart valve long term (current) use of anticoagulants personal history of malignant neoplasm of renal pelvis chronic kidney disease, unspecified acquired absence of kidney acute on chronic diastolic (congestive) heart failure obstructive sleep apnea (adult) (pediatric) dilated cardiomyopathy hypokalemia pulmonary hypertension, unspecified acquired absence of kidney non-st elevation (nstemi) myocardial infarction dyskinesia of esophagus chronic total occlusion of coronary artery disorder of thyroid, unspecified other secondary pulmonary hypertension rheumatoid arthritis, unspecified obesity, unspecified obstructive sleep apnea (adult) (pediatric) unspecified macular degeneration personal history of nicotine dependence cerebral infarction, unspecified chronic kidney disease, stage 3 (moderate) retention of urine, unspecified acute on chronic systolic (congestive) heart failure dilated cardiomyopathy antiphospholipid syndrome other pulmonary embolism without acute cor pulmonale personal history of other malignant neoplasm of kidney atherosclerotic heart disease of native coronary artery without angina pectoris pneumoconiosis due to asbestos and other mineral fibers encounter for examination for normal comparison and control in clinical research program nonrheumatic aortic (valve) insufficiency type 2 diabetes mellitus with diabetic chronic kidney disease infection and inflammatory reaction due to indwelling urinary catheter, initial encounter rheumatoid arthritis, unspecified major depressive disorder, single episode, unspecified spinal stenosis, lumbar region
black african american f 62 $temp  97.9  heartrate  135.0  resprate  25.0  o2sat  98.0  sbp  135.0  dbp  66.0  rhythm    pain  0  ; temp  98.5  heartrate  128.0  resprate  24.0  o2sat  98.0  sbp  136.0  dbp  64.0  rhythm    pain    $hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  2.8  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  404  iu l; chemistry blood albumin  2.2  g dl; blood gas blood free calcium  1.22  mmol l$bisacodyl  5  mg ; docusate sodium  100-300  mg ; gabapentin  200  mg ; oxycodone (immediate release)  5  mg ; polyethylene glycol  17  g ; acetaminophen  500  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  4  gm ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; vial  1  vial ; cefepime  2  g ; sodium chloride 0.9%  flush  3-10  ml ; heparin flush (100 units ml)  5  ml ; heparin  5000  unit ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metronidazole  500  mg ; ceftazidime  2  g ; guaifenesin  5-10  ml ; benzonatate  100  mg ; 
crossing vessel and stricture of ureter without hydronephrosis other specified anemias malignant neoplasm of gallbladder secondary malignant neoplasm of genital organs secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of retroperitoneum and peritoneum obstruction of bile duct secondary malignant neoplasm of large intestine and rectum encounter for immunization hydronephrosis with ureteral stricture, not elsewhere classified secondary malignant neoplasm of liver and intrahepatic bile duct malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
black african american f 62 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  4.6  mg dl; chemistry blood glucose  94  mg dl$bisacodyl  5  mg ; docusate sodium  100-300  mg ; gabapentin  200  mg ; oxycodone (immediate release)  5  mg ; polyethylene glycol  17  g ; acetaminophen  500  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  4  gm ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  3-10  ml ; heparin flush (100 units ml)  5  ml ; heparin  5000  unit ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metronidazole  500  mg ; ceftazidime  2  g ; guaifenesin  5-10  ml ; benzonatate  100  mg ; 
crossing vessel and stricture of ureter without hydronephrosis other specified anemias malignant neoplasm of gallbladder secondary malignant neoplasm of genital organs secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of retroperitoneum and peritoneum obstruction of bile duct secondary malignant neoplasm of large intestine and rectum encounter for immunization hydronephrosis with ureteral stricture, not elsewhere classified secondary malignant neoplasm of liver and intrahepatic bile duct malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
black african american f 62 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  6.5  mg dl; chemistry blood glucose  114  mg dl; chemistry blood lactate dehydrogenase (ld)  634  iu l; chemistry blood albumin  2.2  g dl$bisacodyl  5  mg ; docusate sodium  100-300  mg ; gabapentin  200  mg ; oxycodone (immediate release)  5  mg ; polyethylene glycol  17  g ; acetaminophen  500  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  4  gm ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  3-10  ml ; heparin flush (100 units ml)  5  ml ; heparin  5000  unit ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metronidazole  500  mg ; ceftazidime  2  g ; guaifenesin  5-10  ml ; benzonatate  100  mg ; lorazepam  1  mg ; sterile water  100  ml ; potassium chloride  40  meq ; neutra-phos  1  pkt ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
crossing vessel and stricture of ureter without hydronephrosis other specified anemias malignant neoplasm of gallbladder secondary malignant neoplasm of genital organs secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of retroperitoneum and peritoneum obstruction of bile duct secondary malignant neoplasm of large intestine and rectum encounter for immunization hydronephrosis with ureteral stricture, not elsewhere classified secondary malignant neoplasm of liver and intrahepatic bile duct malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
black african american f 62 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  7.6  mg dl; chemistry blood glucose  91  mg dl; chemistry blood lactate dehydrogenase (ld)  546  iu l; chemistry blood albumin  2.3  g dl$bisacodyl  5  mg ; docusate sodium  100-300  mg ; gabapentin  200  mg ; oxycodone (immediate release)  5  mg ; polyethylene glycol  17  g ; acetaminophen  500  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  4  gm ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  3-10  ml ; heparin flush (100 units ml)  5  ml ; heparin  5000  unit ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metronidazole  500  mg ; ceftazidime  2  g ; guaifenesin  5-10  ml ; benzonatate  100  mg ; lorazepam  1  mg ; sterile water  100  ml ; potassium chloride  40  meq ; neutra-phos  1  pkt ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; oxycodone (immediate release)  5-10  mg ; 
crossing vessel and stricture of ureter without hydronephrosis other specified anemias malignant neoplasm of gallbladder secondary malignant neoplasm of genital organs secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of retroperitoneum and peritoneum obstruction of bile duct secondary malignant neoplasm of large intestine and rectum encounter for immunization hydronephrosis with ureteral stricture, not elsewhere classified secondary malignant neoplasm of liver and intrahepatic bile duct malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
black african american f 62 $nan$nan$bisacodyl  5  mg ; docusate sodium  100-300  mg ; gabapentin  200  mg ; polyethylene glycol  17  g ; acetaminophen  500  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  4  gm ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; heparin  5000  unit ; guaifenesin  5-10  ml ; benzonatate  100  mg ; oxycodone (immediate release)  5-10  mg ; ramelteon  8  mg ; 
crossing vessel and stricture of ureter without hydronephrosis other specified anemias malignant neoplasm of gallbladder secondary malignant neoplasm of genital organs secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of retroperitoneum and peritoneum obstruction of bile duct secondary malignant neoplasm of large intestine and rectum encounter for immunization hydronephrosis with ureteral stricture, not elsewhere classified secondary malignant neoplasm of liver and intrahepatic bile duct malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
black african american f 62 $nan$nan$bisacodyl  5  mg ; docusate sodium  100-300  mg ; gabapentin  200  mg ; polyethylene glycol  17  g ; acetaminophen  500  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  4  gm ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; heparin  5000  unit ; guaifenesin  5-10  ml ; benzonatate  100  mg ; oxycodone (immediate release)  5-10  mg ; ramelteon  8  mg ; 
crossing vessel and stricture of ureter without hydronephrosis other specified anemias malignant neoplasm of gallbladder secondary malignant neoplasm of genital organs secondary malignant neoplasm of liver and intrahepatic bile duct secondary malignant neoplasm of retroperitoneum and peritoneum obstruction of bile duct secondary malignant neoplasm of large intestine and rectum encounter for immunization hydronephrosis with ureteral stricture, not elsewhere classified secondary malignant neoplasm of liver and intrahepatic bile duct malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
white f 63 $nan$nan$prednisone  5  mg ; levothyroxine sodium  100  mcg ; omeprazole  40  mg ; sertraline  100  mg ; bupropion  100  mg ; propafenone hcl  150  mg ; bumetanide  1  mg ; 
 
white f 63 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  319  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  121  mg dl$prednisone  5  mg ; levothyroxine sodium  100  mcg ; omeprazole  40  mg ; sertraline  100  mg ; bupropion  100  mg ; propafenone hcl  150  mg ; bumetanide  1  mg ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; acetaminophen  650  mg ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  gm ; diltiazem extended-release  120  mg ; naproxen  375  mg ; senna  1  tab ; bupropion (sustained release)  100  mg ; heparin  5000  unit ; docusate sodium  100  mg ; atorvastatin  40  mg ; folic acid  1  mg ; multivitamins  1  tab ; avapro  300  mg ; 
 
white f 52 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  47  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  3.2  g dl$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; furosemide  20  mg ; spironolactone  50  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  500  mg ; lactulose  30  ml ; rifaximin  550  mg ; heparin  5000  unit ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  48  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  3.1  mg dl; chemistry blood glucose  113  mg dl; chemistry blood lactate dehydrogenase (ld)  142  iu l$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; furosemide  20  mg ; spironolactone  50  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  500  mg ; lactulose  30  ml ; rifaximin  550  mg ; heparin  5000  unit ; 0.9% sodium chloride  500  ml ; phytonadione  5  mg ; albumin 5%   25  g ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  46  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; furosemide  20  mg ; spironolactone  50  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  500  mg ; lactulose  30  ml ; rifaximin  550  mg ; heparin  5000  unit ; phytonadione  5  mg ; albumin 5%   25  g ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  42  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; furosemide  20  mg ; spironolactone  50  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  500  mg ; lactulose  30  ml ; rifaximin  550  mg ; heparin  5000  unit ; phytonadione  5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; furosemide  20  mg ; spironolactone  50  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  500  mg ; lactulose  30  ml ; rifaximin  550  mg ; heparin  5000  unit ; phytonadione  5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; furosemide  20  mg ; spironolactone  50  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  500  mg ; lactulose  30  ml ; rifaximin  550  mg ; heparin  5000  unit ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  29.8  %; hematology blood hematocrit  23.8  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  57  k ul; hematology blood platelet count  46  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  3.2  mg dl; chemistry blood bilirubin, total  3.3  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  87  mg dl; chemistry blood albumin  3.8  g dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; furosemide  20  mg ; spironolactone  50  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  500  mg ; lactulose  30  ml ; rifaximin  550  mg ; heparin  5000  unit ; olanzapine  2.5  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  48  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.7  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  3.3  mg dl; chemistry blood glucose  117  mg dl; chemistry blood albumin  3.1  g dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; furosemide  20  mg ; spironolactone  50  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  500  mg ; lactulose  30  ml ; rifaximin  550  mg ; heparin  5000  unit ; olanzapine  2.5  mg ; oxycodone (immediate release)   2.5  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  40  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood glucose  100  mg dl; chemistry blood albumin  3.1  g dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; furosemide  20  mg ; spironolactone  50  mg ; acetaminophen  500  mg ; lactulose  30  ml ; rifaximin  550  mg ; heparin  5000  unit ; oxycodone (immediate release)   2.5  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  43  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.7  ; chemistry urine creatinine, urine  90  mg dl; chemistry blood bilirubin, total  2.5  mg dl; chemistry blood glucose  126  mg dl; chemistry urine 24 hr creatinine  810  mg 24hr$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; furosemide  20  mg ; spironolactone  50  mg ; acetaminophen  500  mg ; lactulose  30  ml ; rifaximin  550  mg ; heparin  5000  unit ; bag  50  ml ; magnesium sulfate  2  gm ; spironolactone  100  mg ; furosemide  40  mg ; fluocinonide 0.05% cream  1  appl ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; acetaminophen  500  mg ; lactulose  30  ml ; rifaximin  550  mg ; heparin  5000  unit ; spironolactone  100  mg ; furosemide  40  mg ; fluocinonide 0.05% cream  1  appl ; neutra-phos  1  pkt ; tuberculin protein  0.1  ml ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  23  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; acetaminophen  500  mg ; lactulose  30  ml ; rifaximin  550  mg ; heparin  5000  unit ; spironolactone  100  mg ; furosemide  40  mg ; fluocinonide 0.05% cream  1  appl ; neutra-phos  1  pkt ; tuberculin protein  0.1  ml ; furosemide  80  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; acetaminophen  500  mg ; rifaximin  550  mg ; heparin  5000  unit ; spironolactone  100  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  80  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  128  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; spironolactone  100  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  80  mg ; calcium carbonate  500  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; spironolactone  100  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  80  mg ; calcium carbonate  500  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  29.5  %; hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  40  k ul; hematology blood platelet count  43  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; ondansetron odt  4  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  28  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; ondansetron odt  4  mg ; furosemide  60  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  49  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood glucose  130  mg dl; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood glucose  117  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  58  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  48  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  50  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.6  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  3.4  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  58  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  33.1  %; hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  54  k ul; hematology blood platelet count  55  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  3.2  mg dl; chemistry blood bilirubin, total  3.4  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  120  mg dl; chemistry blood lactate dehydrogenase (ld)  181  iu l; chemistry blood albumin  3.6  g dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; polyethylene glycol  17  g ; bisacodyl  10  mg ; olanzapine  5  mg ; lactulose enema  1000  ml ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$chemistry urine chloride, urine  31  meq l; chemistry urine creatinine, urine  111  mg dl; chemistry urine potassium, urine  47  meq l; chemistry urine sodium, urine  35  meq l; chemistry urine urea nitrogen, urine  897  mg dl; hematology urine wbc  3  # hpf; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lactulose enema  1000  ml ; olanzapine (disintegrating tablet)  2.5  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  49  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; polyethylene glycol  17  g ; bisacodyl  10  mg ; olanzapine (disintegrating tablet)  2.5  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$hematology blood hematocrit  37.8  %; hematology blood hematocrit  36.4  %; hematology blood hemoglobin  12.9  g dl; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  57  k ul; hematology blood platelet count  46  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  4.7  mg dl; chemistry blood bilirubin, total  4.5  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  244  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; polyethylene glycol  17  g ; bisacodyl  10  mg ; olanzapine (disintegrating tablet)  2.5  mg ; potassium chloride  60  meq ; olanzapine (disintegrating tablet)  5  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; polyethylene glycol  17  g ; bisacodyl  10  mg ; potassium chloride  60  meq ; olanzapine (disintegrating tablet)  5  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; bisacodyl  10  mg ; olanzapine (disintegrating tablet)  5  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; bisacodyl  10  mg ; olanzapine (disintegrating tablet)  5  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
white f 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  500  mg ; rifaximin  550  mg ; fluocinonide 0.05% cream  1  appl ; furosemide  60  mg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; bisacodyl  10  mg ; olanzapine (disintegrating tablet)  5  mg ; 
acute kidney failure, unspecified anemia, unspecified full incontinence of feces thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled awaiting organ transplant status other chronic nonalcoholic liver disease urinary tract infection, site not specified cirrhosis of liver without mention of alcohol hepatic encephalopathy
black african american m 82 $temp  98.9  heartrate  86.0  resprate  17.0  o2sat  99.0  sbp  117.0  dbp  57.0  rhythm    pain  0  $hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  164  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; atorvastatin  10  mg ; carvedilol  12.5  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  2.5  mg ; omeprazole  20  mg ; pramipexole  0.125  mg ; ranitidine  150  mg ; tramadol (ultram)  50  mg ; torsemide  40  mg ; insulin  0  unit ; insulin  20  unit ; insulin  14  unit ; levalbuterol neb  0.63  mg ; allopurinol  400  mg ; aspirin  81  mg ; folic acid  1  mg ; methylprednisolone  4  mg ; vitamin d  1000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; 
congestive heart failure, unspecified chronic kidney disease, unspecified palpitations other and unspecified hyperlipidemia heart disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified adrenal cortical steroids causing adverse effects in therapeutic use gout, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled anxiety state, unspecified chronic obstructive asthma, unspecified pure hypercholesterolemia diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled personal history of tobacco use chronic pain syndrome old myocardial infarction polyneuropathy in diabetes chronic kidney disease, unspecified obesity, unspecified dysphagia, unspecified aortic valve disorders body mass index 34.0-34.9, adult hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified other specified cardiac dysrhythmias acute on chronic systolic heart failure congestive heart failure, unspecified esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified congestive heart failure, unspecified chronic airway obstruction, not elsewhere classified coronary atherosclerosis of native coronary artery aortic valve disorders personal history of tobacco use acute on chronic diastolic heart failure other and unspecified hyperlipidemia family history of ischemic heart disease acute on chronic diastolic heart failure first degree atrioventricular block unspecified essential hypertension congestive heart failure, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health chronic kidney disease, unspecified other and unspecified hyperlipidemia acute on chronic systolic heart failure
black african american m 82 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.4  mg dl; chemistry blood glucose  137  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; atorvastatin  10  mg ; carvedilol  12.5  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  2.5  mg ; omeprazole  20  mg ; pramipexole  0.125  mg ; ranitidine  150  mg ; tramadol (ultram)  50  mg ; insulin  0  unit ; insulin  20  unit ; insulin  14  unit ; levalbuterol neb  0.63  mg ; allopurinol  400  mg ; aspirin  81  mg ; folic acid  1  mg ; methylprednisolone  4  mg ; vitamin d  1000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; torsemide  60  mg ; hemorrhoidal suppository  1  supp ; miconazole powder 2%  1  appl ; 
congestive heart failure, unspecified chronic kidney disease, unspecified palpitations other and unspecified hyperlipidemia heart disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified adrenal cortical steroids causing adverse effects in therapeutic use gout, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled anxiety state, unspecified chronic obstructive asthma, unspecified pure hypercholesterolemia diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled personal history of tobacco use chronic pain syndrome old myocardial infarction polyneuropathy in diabetes chronic kidney disease, unspecified obesity, unspecified dysphagia, unspecified aortic valve disorders body mass index 34.0-34.9, adult hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified other specified cardiac dysrhythmias acute on chronic systolic heart failure congestive heart failure, unspecified esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified congestive heart failure, unspecified chronic airway obstruction, not elsewhere classified coronary atherosclerosis of native coronary artery aortic valve disorders personal history of tobacco use acute on chronic diastolic heart failure other and unspecified hyperlipidemia family history of ischemic heart disease acute on chronic diastolic heart failure first degree atrioventricular block unspecified essential hypertension congestive heart failure, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health chronic kidney disease, unspecified other and unspecified hyperlipidemia acute on chronic systolic heart failure
white f 86 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; enoxaparin sodium  30  mg ; ondansetron  4  mg ; senna  1  tab ; multivitamins  1  cap ; vitamin d  800  unit ; simvastatin  20  mg ; levothyroxine sodium  75  mcg ; estrogens conjugated  0.3  mg ; d5 1 2ns  1000  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)   2.5  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; docusate sodium  100  mg ; calcium carbonate  1250  mg ; 
 
white f 86 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  141  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; multivitamins  1  cap ; vitamin d  800  unit ; simvastatin  20  mg ; levothyroxine sodium  75  mcg ; d5 1 2ns  1000  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)   2.5  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; docusate sodium  100  mg ; calcium carbonate  1250  mg ; 
 
white f 86 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  161  k ul$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; multivitamins  1  cap ; vitamin d  800  unit ; simvastatin  20  mg ; levothyroxine sodium  75  mcg ; d5 1 2ns  1000  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)   2.5  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; docusate sodium  100  mg ; calcium carbonate  1250  mg ; 
 
white f 86 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  177  k ul$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; multivitamins  1  cap ; vitamin d  800  unit ; simvastatin  20  mg ; levothyroxine sodium  75  mcg ; d5 1 2ns  1000  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)   2.5  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; docusate sodium  100  mg ; calcium carbonate  1250  mg ; 
 
white m 56 $nan$nan$aspirin  325  mg ; atorvastatin  80  mg ; escitalopram oxalate  30  mg ; modafinil  200  mg ; atorvastatin  40  mg ; 
encephalopathy, unspecified other psoriasis cerebral embolism with cerebral infarction unspecified essential hypertension intracerebral hemorrhage aphasia
white m 56 $nan$hematology blood hematocrit  35.5  %; hematology blood hematocrit  32.7  %; hematology blood hemoglobin  12.1  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  425  k ul; hematology blood platelet count  412  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  84  mg dl; chemistry blood albumin  4.1  g dl$aspirin  325  mg ; atorvastatin  80  mg ; escitalopram oxalate  30  mg ; modafinil  200  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; metoprolol tartrate  25  mg ; insulin  0  unit ; hydralazine  10  mg ; 
encephalopathy, unspecified other psoriasis cerebral embolism with cerebral infarction unspecified essential hypertension intracerebral hemorrhage aphasia
white m 56 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  418  k ul$aspirin  325  mg ; escitalopram oxalate  30  mg ; modafinil  200  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; metoprolol tartrate  25  mg ; insulin  0  unit ; hydralazine  10  mg ; 
encephalopathy, unspecified other psoriasis cerebral embolism with cerebral infarction unspecified essential hypertension intracerebral hemorrhage aphasia
white m 56 $nan$nan$aspirin  325  mg ; escitalopram oxalate  30  mg ; modafinil  200  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; metoprolol tartrate  25  mg ; hydralazine  10  mg ; metoprolol tartrate  12.5  mg ; 
encephalopathy, unspecified other psoriasis cerebral embolism with cerebral infarction unspecified essential hypertension intracerebral hemorrhage aphasia
white m 56 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  494  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  78  mg dl$aspirin  325  mg ; escitalopram oxalate  30  mg ; modafinil  200  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; hydralazine  10  mg ; metoprolol tartrate  12.5  mg ; 
encephalopathy, unspecified other psoriasis cerebral embolism with cerebral infarction unspecified essential hypertension intracerebral hemorrhage aphasia
white m 56 $nan$nan$aspirin  325  mg ; escitalopram oxalate  30  mg ; modafinil  200  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; hydralazine  10  mg ; metoprolol tartrate  12.5  mg ; 
encephalopathy, unspecified other psoriasis cerebral embolism with cerebral infarction unspecified essential hypertension intracerebral hemorrhage aphasia
white m 56 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  501  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  80  mg dl$aspirin  325  mg ; escitalopram oxalate  30  mg ; modafinil  200  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; hydralazine  10  mg ; metoprolol tartrate  12.5  mg ; 
encephalopathy, unspecified other psoriasis cerebral embolism with cerebral infarction unspecified essential hypertension intracerebral hemorrhage aphasia
white m 56 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  507  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  83  mg dl$aspirin  325  mg ; escitalopram oxalate  30  mg ; modafinil  200  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; hydralazine  10  mg ; metoprolol tartrate  12.5  mg ; 
encephalopathy, unspecified other psoriasis cerebral embolism with cerebral infarction unspecified essential hypertension intracerebral hemorrhage aphasia
white m 56 $nan$nan$aspirin  325  mg ; escitalopram oxalate  30  mg ; modafinil  200  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; hydralazine  10  mg ; metoprolol tartrate  12.5  mg ; 
encephalopathy, unspecified other psoriasis cerebral embolism with cerebral infarction unspecified essential hypertension intracerebral hemorrhage aphasia
white m 56 $nan$nan$aspirin  325  mg ; escitalopram oxalate  30  mg ; modafinil  200  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; hydralazine  10  mg ; metoprolol tartrate  12.5  mg ; 
encephalopathy, unspecified other psoriasis cerebral embolism with cerebral infarction unspecified essential hypertension intracerebral hemorrhage aphasia
white m 56 $nan$nan$aspirin  325  mg ; escitalopram oxalate  30  mg ; modafinil  200  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; hydralazine  10  mg ; 
encephalopathy, unspecified other psoriasis cerebral embolism with cerebral infarction unspecified essential hypertension intracerebral hemorrhage aphasia
white m 56 $nan$nan$aspirin  325  mg ; escitalopram oxalate  30  mg ; modafinil  200  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; hydralazine  10  mg ; 
encephalopathy, unspecified other psoriasis cerebral embolism with cerebral infarction unspecified essential hypertension intracerebral hemorrhage aphasia
white m 56 $nan$nan$aspirin  325  mg ; escitalopram oxalate  30  mg ; modafinil  200  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; hydralazine  10  mg ; 
encephalopathy, unspecified other psoriasis cerebral embolism with cerebral infarction unspecified essential hypertension intracerebral hemorrhage aphasia
white m 68 $temp  97.6  heartrate  76.0  resprate  18.0  o2sat  97.0  sbp  101.0  dbp  53.0  rhythm    pain  5  ; temp    heartrate  71.0  resprate  18.0  o2sat  99.0  sbp  107.0  dbp  50.0  rhythm    pain  0  ; temp  98.6  heartrate  66.0  resprate  18.0  o2sat  99.0  sbp  121.0  dbp  53.0  rhythm    pain  6  ; temp  98.8  heartrate  69.0  resprate  18.0  o2sat  96.0  sbp  131.0  dbp  65.0  rhythm    pain  0  ; temp    heartrate  71.0  resprate  18.0  o2sat  97.0  sbp  135.0  dbp  68.0  rhythm    pain  7  ; temp    heartrate  70.0  resprate  18.0  o2sat  94.0  sbp  137.0  dbp  67.0  rhythm    pain  4  ; temp  98.9  heartrate  72.0  resprate  18.0  o2sat  95.0  sbp  142.0  dbp  69.0  rhythm    pain  denies  $hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  623  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  6.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  124  mg dl; blood gas blood lactate  1.4  mmol l; blood gas blood potassium, whole blood  3.7  meq l$nan
fall on same level, unspecified, initial encounter removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure calculus of gallbladder with chronic cholecystitis without obstruction unspecified place or not applicable dehydration traumatic subarachnoid hemorrhage with loss of consciousness of 30 minutes or less, initial encounter gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence postprocedural hemorrhage of a digestive system organ or structure following a digestive system procedure immune thrombocytopenic purpura unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause 
white m 68 $temp    heartrate  74.0  resprate  18.0  o2sat  97.0  sbp  141.0  dbp  72.0  rhythm    pain  6  ; temp  98.2  heartrate  72.0  resprate  20.0  o2sat  98.0  sbp  126.0  dbp  57.0  rhythm    pain  6  ; temp    heartrate  71.0  resprate  18.0  o2sat  95.0  sbp  129.0  dbp  59.0  rhythm    pain  sleeping  ; temp    heartrate  76.0  resprate  17.0  o2sat  99.0  sbp  138.0  dbp  64.0  rhythm    pain  7  ; temp    heartrate  69.0  resprate  18.0  o2sat  95.0  sbp  132.0  dbp  51.0  rhythm    pain    ; temp    heartrate  72.0  resprate  22.0  o2sat  96.0  sbp  125.0  dbp  59.0  rhythm    pain  8  ; temp  98.0  heartrate  70.0  resprate  18.0  o2sat  97.0  sbp  115.0  dbp  90.0  rhythm    pain  7  ; temp  98.1  heartrate  74.0  resprate  16.0  o2sat  97.0  sbp  130.0  dbp  62.0  rhythm    pain    $hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  654  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.125  mg ; oxycodone (immediate release)  5-10  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; senna  8.6  mg ; enoxaparin sodium  40  mg ; 
fall on same level, unspecified, initial encounter removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure calculus of gallbladder with chronic cholecystitis without obstruction unspecified place or not applicable dehydration traumatic subarachnoid hemorrhage with loss of consciousness of 30 minutes or less, initial encounter gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence postprocedural hemorrhage of a digestive system organ or structure following a digestive system procedure immune thrombocytopenic purpura unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause 
white m 68 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  776  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.125  mg ; oxycodone (immediate release)  5-10  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; senna  8.6  mg ; enoxaparin sodium  40  mg ; sulfameth trimethoprim ds  2  tab ; 
fall on same level, unspecified, initial encounter removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure calculus of gallbladder with chronic cholecystitis without obstruction unspecified place or not applicable dehydration traumatic subarachnoid hemorrhage with loss of consciousness of 30 minutes or less, initial encounter gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence postprocedural hemorrhage of a digestive system organ or structure following a digestive system procedure immune thrombocytopenic purpura unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause 
white m 68 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.125  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; senna  8.6  mg ; enoxaparin sodium  40  mg ; sulfameth trimethoprim ds  2  tab ; 
fall on same level, unspecified, initial encounter removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure calculus of gallbladder with chronic cholecystitis without obstruction unspecified place or not applicable dehydration traumatic subarachnoid hemorrhage with loss of consciousness of 30 minutes or less, initial encounter gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence postprocedural hemorrhage of a digestive system organ or structure following a digestive system procedure immune thrombocytopenic purpura unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause 
black african american f 22 $nan$nan$gabapentin  300  mg ; scopolamine patch  1  ptch ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; ondansetron  4  mg ; prochlorperazine  10  mg ; acetaminophen iv  1000  mg ; albuterol 0.083% neb soln  1  neb ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; ketorolac  15  mg ; 

black african american f 22 $nan$nan$iso-osmotic dextrose  100  ml ; cefazolin  2  g ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; ondansetron  4  mg ; prochlorperazine  10  mg ; acetaminophen iv  1000  mg ; albuterol 0.083% neb soln  1  neb ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; ketorolac  15  mg ; simethicone  40-80  mg ; acetaminophen (liquid)  650  mg ; 

white f 41 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  271  k ul; hematology blood inr(pt)  1.1  $prednisone  5  mg ; escitalopram oxalate  20  mg ; 
endometriosis of uterus multiple sclerosis nausea with vomiting iron deficiency anemia, unspecified excessive or frequent menstruation other constipation esophageal reflux autoimmune disease nec systemic lupus erythematosus myasthenia gravis without (acute) exacerbation sicca syndrome 
white f 41 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  100  mg dl$prednisone  5  mg ; escitalopram oxalate  20  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; hydrocortisone na succ.  50  mg ; clonazepam  2  mg ; clonazepam  1  mg ; hydroxychloroquine sulfate  200  mg ; venlafaxine  75  mg ; docusate sodium  100  mg ; oxycodone sr (oxycontin)  40  mg ; ketorolac  15  mg ; ketorolac  30  mg ; ondansetron  4  mg ; heparin  5000  unit ; senna  1  tab ; vial  1  vial ; pantoprazole  40  mg ; milk of magnesia  30  ml ; quetiapine fumarate  50  mg ; 
endometriosis of uterus multiple sclerosis nausea with vomiting iron deficiency anemia, unspecified excessive or frequent menstruation other constipation esophageal reflux autoimmune disease nec systemic lupus erythematosus myasthenia gravis without (acute) exacerbation sicca syndrome 
white f 41 $nan$nan$prednisone  5  mg ; escitalopram oxalate  20  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; hydrocortisone na succ.  50  mg ; clonazepam  2  mg ; clonazepam  1  mg ; hydroxychloroquine sulfate  200  mg ; venlafaxine  75  mg ; docusate sodium  100  mg ; oxycodone sr (oxycontin)  40  mg ; ketorolac  15  mg ; ketorolac  30  mg ; ondansetron  4  mg ; heparin  5000  unit ; senna  1  tab ; vial  1  vial ; pantoprazole  40  mg ; milk of magnesia  30  ml ; quetiapine fumarate  50  mg ; hydromorphone (dilaudid)  2-4  mg ; ibuprofen  600  mg ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  2-6  mg ; 
endometriosis of uterus multiple sclerosis nausea with vomiting iron deficiency anemia, unspecified excessive or frequent menstruation other constipation esophageal reflux autoimmune disease nec systemic lupus erythematosus myasthenia gravis without (acute) exacerbation sicca syndrome 
white f 41 $nan$nan$prednisone  5  mg ; escitalopram oxalate  20  mg ; sodium chloride 0.9%  flush  3  ml ; clonazepam  2  mg ; clonazepam  1  mg ; hydroxychloroquine sulfate  200  mg ; venlafaxine  75  mg ; oxycodone sr (oxycontin)  40  mg ; heparin  5000  unit ; ibuprofen  600  mg ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  2-6  mg ; loperamide  2  mg ; 
endometriosis of uterus multiple sclerosis nausea with vomiting iron deficiency anemia, unspecified excessive or frequent menstruation other constipation esophageal reflux autoimmune disease nec systemic lupus erythematosus myasthenia gravis without (acute) exacerbation sicca syndrome 
hispanic latino m 64 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  117  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  231  mg dl; chemistry blood albumin  3.2  g dl; blood gas blood lactate  2.5  mmol l; hematology urine glucose  tr  mg dl; hematology urine bilirubin  neg  mg dl$nan
portal hypertension universal ulcerative (chronic) colitis chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled cirrhosis of liver without mention of alcohol benign essential hypertension
hispanic latino m 64 $nan$hematology blood hematocrit  35.6  %; hematology blood hematocrit  32.9  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  301  mg dl; chemistry blood lactate dehydrogenase (ld)  263  iu l; chemistry blood lactate dehydrogenase (ld)  262  iu l; chemistry blood albumin  2.8  g dl; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  1.6  mmol l$ceftriaxone  1  gm ; ns  100  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; heparin flush (10 units ml)  1  ml ; ns  1000  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; iso-osmotic dextrose  50  ml ; metronidazole (flagyl)  500  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; insulin  0  unit ; morphine sulfate  2-4  mg ; morphine sr (ms contin)  100  mg ; heparin  5000  unit ; insulin  70  unit ; nadolol  20  mg ; lisinopril  80  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; morphine sulfate  4-6  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; insulin  25  unit ; d5 1 2ns  1000  ml ; morphine sulfate  2-6  mg ; docusate sodium  100  mg ; 
portal hypertension universal ulcerative (chronic) colitis chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled cirrhosis of liver without mention of alcohol benign essential hypertension
hispanic latino m 64 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  117  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  63  mg dl; blood gas blood lactate  1.6  mmol l$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; heparin  5000  unit ; nadolol  20  mg ; lisinopril  80  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; d5 1 2ns  1000  ml ; morphine sulfate  2-6  mg ; docusate sodium  100  mg ; potassium chloride  40  meq ; 
portal hypertension universal ulcerative (chronic) colitis chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled cirrhosis of liver without mention of alcohol benign essential hypertension
hispanic latino m 64 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  104  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  223  iu l; chemistry blood albumin  2.8  g dl; blood gas blood lactate  1.8  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; heparin  5000  unit ; nadolol  20  mg ; lisinopril  80  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; morphine sulfate  2-6  mg ; docusate sodium  100  mg ; potassium chloride  40  meq ; insulin  60  unit ; sw  50  ml ; magnesium sulfate  2  gm ; calcium carbonate  500  mg ; heparin flush (10 units ml)  2  ml ; 
portal hypertension universal ulcerative (chronic) colitis chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled cirrhosis of liver without mention of alcohol benign essential hypertension
hispanic latino m 64 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  104  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; heparin  5000  unit ; nadolol  20  mg ; lisinopril  80  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; morphine sulfate  2-6  mg ; docusate sodium  100  mg ; insulin  60  unit ; sw  50  ml ; magnesium sulfate  2  gm ; calcium carbonate  500  mg ; heparin flush (10 units ml)  2  ml ; insulin  50  unit ; furosemide  20  mg ; pantoprazole  40  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; senna  1  tab ; 
portal hypertension universal ulcerative (chronic) colitis chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled cirrhosis of liver without mention of alcohol benign essential hypertension
hispanic latino m 64 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  124  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  133  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; heparin  5000  unit ; nadolol  20  mg ; lisinopril  80  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; docusate sodium  100  mg ; calcium carbonate  500  mg ; heparin flush (10 units ml)  2  ml ; insulin  50  unit ; furosemide  20  mg ; pantoprazole  40  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; senna  1  tab ; dextrose 50%  25  gm ; furosemide  40  mg ; spironolactone  100  mg ; morphine sulfate ir  15  mg ; levofloxacin  500  mg ; insulin  18  unit ; 
portal hypertension universal ulcerative (chronic) colitis chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled cirrhosis of liver without mention of alcohol benign essential hypertension
hispanic latino m 64 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  124  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  76  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; heparin  5000  unit ; nadolol  20  mg ; lisinopril  80  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; heparin flush (10 units ml)  2  ml ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; senna  1  tab ; dextrose 50%  25  gm ; spironolactone  100  mg ; morphine sulfate ir  15  mg ; insulin  18  unit ; amlodipine  5  mg ; 
portal hypertension universal ulcerative (chronic) colitis chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled cirrhosis of liver without mention of alcohol benign essential hypertension
hispanic latino m 64 $nan$chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood glucose  217  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; heparin  5000  unit ; nadolol  20  mg ; lisinopril  80  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; heparin flush (10 units ml)  2  ml ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; senna  1  tab ; spironolactone  100  mg ; morphine sulfate ir  15  mg ; insulin  18  unit ; amlodipine  5  mg ; 
portal hypertension universal ulcerative (chronic) colitis chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled cirrhosis of liver without mention of alcohol benign essential hypertension
hispanic latino m 64 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  124  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  68  mg dl$heparin flush (10 units ml)  1  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; heparin  5000  unit ; nadolol  20  mg ; lisinopril  80  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; heparin flush (10 units ml)  2  ml ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; senna  1  tab ; spironolactone  100  mg ; morphine sulfate ir  15  mg ; insulin  18  unit ; amlodipine  5  mg ; potassium chloride  20  meq ; 
portal hypertension universal ulcerative (chronic) colitis chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled cirrhosis of liver without mention of alcohol benign essential hypertension
hispanic latino m 64 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  105  mg dl$heparin flush (10 units ml)  1  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; heparin  5000  unit ; nadolol  20  mg ; lisinopril  80  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; heparin flush (10 units ml)  2  ml ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; senna  1  tab ; spironolactone  100  mg ; morphine sulfate ir  15  mg ; amlodipine  5  mg ; potassium chloride  20  meq ; insulin  55  unit ; insulin  15  unit ; 
portal hypertension universal ulcerative (chronic) colitis chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled cirrhosis of liver without mention of alcohol benign essential hypertension
hispanic latino m 64 $nan$chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  178  mg dl$heparin flush (10 units ml)  1  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; heparin  5000  unit ; nadolol  20  mg ; lisinopril  80  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; heparin flush (10 units ml)  2  ml ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; senna  1  tab ; spironolactone  100  mg ; amlodipine  5  mg ; insulin  55  unit ; 
portal hypertension universal ulcerative (chronic) colitis chronic hepatitis c without mention of hepatic coma diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled cirrhosis of liver without mention of alcohol benign essential hypertension
white f 70 $nan$nan$sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; propranolol  10  mg ; pravastatin  10  mg ; gabapentin  100  mg ; albuterol inhaler  1-2  puff ; morphine sulfate  1-4  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; diazepam  2  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; bisacodyl  10  mg ; 
hypertrophy of breast methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of finger, unspecified unspecified acquired hypothyroidism unspecified essential hypertension 
white f 70 $nan$hematology blood hematocrit  40.3  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  301  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; propranolol  10  mg ; pravastatin  10  mg ; gabapentin  100  mg ; albuterol inhaler  1-2  puff ; morphine sulfate  1-4  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; diazepam  2  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; bisacodyl  10  mg ; hydralazine  25  mg ; diltiazem extended-release  240  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 0.9% sodium chloride  1000  ml ; levothyroxine sodium  75  mcg ; furosemide  20  mg ; spironolactone  50  mg ; montelukast sodium  10  mg ; hydrochlorothiazide  25  mg ; heparin  5000  unit ; leflunomide  20  mg ; 
hypertrophy of breast methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of finger, unspecified unspecified acquired hypothyroidism unspecified essential hypertension 
white f 70 $nan$nan$sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; propranolol  10  mg ; pravastatin  10  mg ; gabapentin  100  mg ; albuterol inhaler  1-2  puff ; morphine sulfate  1-4  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; diazepam  2  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; bisacodyl  10  mg ; hydralazine  25  mg ; diltiazem extended-release  240  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; levothyroxine sodium  75  mcg ; furosemide  20  mg ; spironolactone  50  mg ; montelukast sodium  10  mg ; hydrochlorothiazide  25  mg ; heparin  5000  unit ; leflunomide  20  mg ; 
hypertrophy of breast methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of finger, unspecified unspecified acquired hypothyroidism unspecified essential hypertension 
white f 70 $nan$nan$sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; propranolol  10  mg ; pravastatin  10  mg ; gabapentin  100  mg ; albuterol inhaler  1-2  puff ; morphine sulfate  1-4  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; diazepam  2  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; bisacodyl  10  mg ; hydralazine  25  mg ; diltiazem extended-release  240  mg ; levothyroxine sodium  75  mcg ; furosemide  20  mg ; spironolactone  50  mg ; montelukast sodium  10  mg ; hydrochlorothiazide  25  mg ; heparin  5000  unit ; leflunomide  20  mg ; 
hypertrophy of breast methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of finger, unspecified unspecified acquired hypothyroidism unspecified essential hypertension 
white f 70 $nan$hematology blood hematocrit  41.0  %; hematology blood hematocrit  41.5  %; hematology blood hematocrit  40.3  %; hematology blood hemoglobin  14.2  g dl; hematology blood hemoglobin  14.3  g dl; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  305  k ul; hematology blood platelet count  344  k ul; hematology blood platelet count  314  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  83  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  138  mg dl$sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; propranolol  10  mg ; pravastatin  10  mg ; gabapentin  100  mg ; albuterol inhaler  1-2  puff ; morphine sulfate  1-4  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; diazepam  2  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; bisacodyl  10  mg ; hydralazine  25  mg ; diltiazem extended-release  240  mg ; levothyroxine sodium  75  mcg ; furosemide  20  mg ; spironolactone  50  mg ; montelukast sodium  10  mg ; hydrochlorothiazide  25  mg ; heparin  5000  unit ; leflunomide  20  mg ; diltiazem  15  mg ; 0.9% sodium chloride  250  ml ; morphine sulfate  1-2  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
hypertrophy of breast methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of finger, unspecified unspecified acquired hypothyroidism unspecified essential hypertension 
white f 70 $nan$chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  5.4  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry urine chloride, urine  77  meq l; chemistry urine creatinine, urine  31  mg dl; chemistry urine potassium, urine  45  meq l; chemistry urine sodium, urine  93  meq l; chemistry urine urea nitrogen, urine  378  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; propranolol  10  mg ; pravastatin  10  mg ; gabapentin  100  mg ; albuterol inhaler  1-2  puff ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; diazepam  2  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; hydralazine  25  mg ; diltiazem extended-release  240  mg ; levothyroxine sodium  75  mcg ; furosemide  20  mg ; spironolactone  50  mg ; montelukast sodium  10  mg ; hydrochlorothiazide  25  mg ; heparin  5000  unit ; leflunomide  20  mg ; 0.9% sodium chloride  250  ml ; morphine sulfate  1-2  mg ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; neutra-phos  1  pkt ; potassium chloride (powder)  30  meq ; 
hypertrophy of breast methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of finger, unspecified unspecified acquired hypothyroidism unspecified essential hypertension 
white f 70 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  100  mg dl$omeprazole  20  mg ; propranolol  10  mg ; pravastatin  10  mg ; gabapentin  100  mg ; albuterol inhaler  1-2  puff ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; hydralazine  25  mg ; diltiazem extended-release  240  mg ; levothyroxine sodium  75  mcg ; montelukast sodium  10  mg ; heparin  5000  unit ; leflunomide  20  mg ; morphine sulfate  1-2  mg ; polyethylene glycol  17  g ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; potassium chloride (powder)  30  meq ; lactulose  30  ml ; oxycodone (immediate release)   10  mg ; acetaminophen  1000  mg ; phosphorus  500  mg ; propranolol  20  mg ; lorazepam  0.5  mg ; propranolol  30  mg ; 
hypertrophy of breast methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of finger, unspecified unspecified acquired hypothyroidism unspecified essential hypertension 
white f 70 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  92  mg dl$omeprazole  20  mg ; pravastatin  10  mg ; gabapentin  100  mg ; albuterol inhaler  1-2  puff ; docusate sodium  100  mg ; senna  1  tab ; hydralazine  25  mg ; propranolol la  60  mg ; diltiazem extended-release  240  mg ; levothyroxine sodium  75  mcg ; montelukast sodium  10  mg ; heparin  5000  unit ; leflunomide  20  mg ; morphine sulfate  1-2  mg ; polyethylene glycol  17  g ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; oxycodone (immediate release)   10  mg ; acetaminophen  1000  mg ; phosphorus  500  mg ; lorazepam  0.5  mg ; propranolol  30  mg ; miconazole powder 2%  1  appl ; 
hypertrophy of breast methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of finger, unspecified unspecified acquired hypothyroidism unspecified essential hypertension 
white f 70 $nan$chemistry blood anion gap  20  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry urine chloride, urine  11  meq l; chemistry urine creatinine, urine  71  mg dl; chemistry urine potassium, urine  26  meq l; chemistry urine sodium, urine  11  meq l; chemistry urine urea nitrogen, urine  541  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  58  mg dl; chemistry blood glucose  110  mg dl$omeprazole  20  mg ; pravastatin  10  mg ; gabapentin  100  mg ; albuterol inhaler  1-2  puff ; docusate sodium  100  mg ; senna  1  tab ; propranolol la  60  mg ; diltiazem extended-release  240  mg ; levothyroxine sodium  75  mcg ; montelukast sodium  10  mg ; heparin  5000  unit ; leflunomide  20  mg ; morphine sulfate  1-2  mg ; polyethylene glycol  17  g ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; oxycodone (immediate release)   10  mg ; acetaminophen  1000  mg ; miconazole powder 2%  1  appl ; oxycodone (immediate release)   5  mg ; ketorolac  15  mg ; 
hypertrophy of breast methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of finger, unspecified unspecified acquired hypothyroidism unspecified essential hypertension 
white f 70 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  365  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  79  mg dl$omeprazole  20  mg ; pravastatin  10  mg ; gabapentin  100  mg ; albuterol inhaler  1-2  puff ; docusate sodium  100  mg ; senna  1  tab ; propranolol la  60  mg ; diltiazem extended-release  240  mg ; levothyroxine sodium  75  mcg ; montelukast sodium  10  mg ; heparin  5000  unit ; leflunomide  20  mg ; morphine sulfate  1-2  mg ; polyethylene glycol  17  g ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  1000  mg ; miconazole powder 2%  1  appl ; oxycodone (immediate release)   5  mg ; ketorolac  15  mg ; tramadol (ultram)  50  mg ; 
hypertrophy of breast methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of finger, unspecified unspecified acquired hypothyroidism unspecified essential hypertension 
white f 70 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry urine creatinine, urine  78  mg dl; chemistry urine potassium, urine  23  meq l; chemistry urine sodium, urine  13  meq l; chemistry urine urea nitrogen, urine  596  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  88  mg dl$omeprazole  20  mg ; pravastatin  10  mg ; gabapentin  100  mg ; albuterol inhaler  1-2  puff ; docusate sodium  100  mg ; senna  1  tab ; propranolol la  60  mg ; diltiazem extended-release  240  mg ; levothyroxine sodium  75  mcg ; montelukast sodium  10  mg ; heparin  5000  unit ; leflunomide  20  mg ; morphine sulfate  1-2  mg ; polyethylene glycol  17  g ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  1000  mg ; miconazole powder 2%  1  appl ; ketorolac  15  mg ; tramadol (ultram)  50  mg ; 
hypertrophy of breast methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of finger, unspecified unspecified acquired hypothyroidism unspecified essential hypertension 
white f 70 $nan$nan$omeprazole  20  mg ; pravastatin  10  mg ; gabapentin  100  mg ; albuterol inhaler  1-2  puff ; docusate sodium  100  mg ; senna  1  tab ; propranolol la  60  mg ; diltiazem extended-release  240  mg ; levothyroxine sodium  75  mcg ; montelukast sodium  10  mg ; heparin  5000  unit ; leflunomide  20  mg ; morphine sulfate  1-2  mg ; polyethylene glycol  17  g ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  1000  mg ; miconazole powder 2%  1  appl ; tramadol (ultram)  50  mg ; 
hypertrophy of breast methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of finger, unspecified unspecified acquired hypothyroidism unspecified essential hypertension 
black african american f 71 $temp  99.6  heartrate  92.0  resprate  18.0  o2sat  97.0  sbp  173.0  dbp  67.0  rhythm    pain  uta  $hematology blood hematocrit  37.9  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  157  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; acetaminophen  650  mg ; atorvastatin  10  mg ; bisacodyl  5  mg ; bupropion xl (once daily)  300  mg ; furosemide  20  mg ; lactulose  15  ml ; polyethylene glycol  17  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; lisinopril  10  mg ; lisinopril  20  mg ; potassium chloride  40  meq ; diltiazem extended-release  120  mg ; 
white matter disease, unspecified acute kidney failure, unspecified personal history of urinary (tract) infections organ-limited amyloidosis schizophrenia, unspecified other specified places as the place of occurrence of the external cause fall from bed, initial encounter other chest pain unspecified urinary incontinence history of falling essential (primary) hypertension hypokalemia personal history of nicotine dependence urinary tract infection, site not specified unsteadiness on feet type 2 diabetes mellitus without complications major depressive disorder, single episode, unspecified hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right dominant side pain in left elbow hyperlipidemia, unspecified constipation, unspecified pain in left hip nicotine dependence, cigarettes, uncomplicated type 2 diabetes mellitus without complications unspecified abnormalities of gait and mobility unspecified abnormal findings in urine unspecified urinary incontinence major depressive disorder, single episode, unspecified altered mental status, unspecified history of falling essential (primary) hypertension pain in right hip schizophrenia, unspecified hyperlipidemia, unspecified other chronic pain pain in leg, unspecified other constipation personal history of urinary (tract) infections low back pain hemiplegia and hemiparesis following cerebral infarction affecting right dominant side personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits ostium secundum type atrial septal defect pure hypercholesterolemia urinary incontinence, unspecified bell's palsy pain in joint, pelvic region and thigh chronic airway obstruction, not elsewhere classified depressive disorder, not elsewhere classified
black african american f 71 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  128  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; acetaminophen  650  mg ; atorvastatin  10  mg ; bisacodyl  5  mg ; bupropion xl (once daily)  300  mg ; furosemide  20  mg ; lactulose  15  ml ; polyethylene glycol  17  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; lisinopril  10  mg ; lisinopril  20  mg ; potassium chloride  40  meq ; diltiazem extended-release  120  mg ; risperidone  2  mg ; potassium chloride  20  meq ; lorazepam  0.5  mg ; ciprofloxacin hcl  500  mg ; 
white matter disease, unspecified acute kidney failure, unspecified personal history of urinary (tract) infections organ-limited amyloidosis schizophrenia, unspecified other specified places as the place of occurrence of the external cause fall from bed, initial encounter other chest pain unspecified urinary incontinence history of falling essential (primary) hypertension hypokalemia personal history of nicotine dependence urinary tract infection, site not specified unsteadiness on feet type 2 diabetes mellitus without complications major depressive disorder, single episode, unspecified hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right dominant side pain in left elbow hyperlipidemia, unspecified constipation, unspecified pain in left hip nicotine dependence, cigarettes, uncomplicated type 2 diabetes mellitus without complications unspecified abnormalities of gait and mobility unspecified abnormal findings in urine unspecified urinary incontinence major depressive disorder, single episode, unspecified altered mental status, unspecified history of falling essential (primary) hypertension pain in right hip schizophrenia, unspecified hyperlipidemia, unspecified other chronic pain pain in leg, unspecified other constipation personal history of urinary (tract) infections low back pain hemiplegia and hemiparesis following cerebral infarction affecting right dominant side personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits ostium secundum type atrial septal defect pure hypercholesterolemia urinary incontinence, unspecified bell's palsy pain in joint, pelvic region and thigh chronic airway obstruction, not elsewhere classified depressive disorder, not elsewhere classified
black african american f 71 $nan$hematology blood hematocrit  39.6  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  126  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; acetaminophen  650  mg ; atorvastatin  10  mg ; bisacodyl  5  mg ; bupropion xl (once daily)  300  mg ; furosemide  20  mg ; lactulose  15  ml ; polyethylene glycol  17  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lisinopril  10  mg ; lisinopril  20  mg ; diltiazem extended-release  120  mg ; risperidone  2  mg ; potassium chloride  20  meq ; lorazepam  0.5  mg ; ciprofloxacin hcl  500  mg ; 
white matter disease, unspecified acute kidney failure, unspecified personal history of urinary (tract) infections organ-limited amyloidosis schizophrenia, unspecified other specified places as the place of occurrence of the external cause fall from bed, initial encounter other chest pain unspecified urinary incontinence history of falling essential (primary) hypertension hypokalemia personal history of nicotine dependence urinary tract infection, site not specified unsteadiness on feet type 2 diabetes mellitus without complications major depressive disorder, single episode, unspecified hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right dominant side pain in left elbow hyperlipidemia, unspecified constipation, unspecified pain in left hip nicotine dependence, cigarettes, uncomplicated type 2 diabetes mellitus without complications unspecified abnormalities of gait and mobility unspecified abnormal findings in urine unspecified urinary incontinence major depressive disorder, single episode, unspecified altered mental status, unspecified history of falling essential (primary) hypertension pain in right hip schizophrenia, unspecified hyperlipidemia, unspecified other chronic pain pain in leg, unspecified other constipation personal history of urinary (tract) infections low back pain hemiplegia and hemiparesis following cerebral infarction affecting right dominant side personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits ostium secundum type atrial septal defect pure hypercholesterolemia urinary incontinence, unspecified bell's palsy pain in joint, pelvic region and thigh chronic airway obstruction, not elsewhere classified depressive disorder, not elsewhere classified
black african american f 71 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; acetaminophen  650  mg ; atorvastatin  10  mg ; bisacodyl  5  mg ; bupropion xl (once daily)  300  mg ; furosemide  20  mg ; lactulose  15  ml ; polyethylene glycol  17  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lisinopril  10  mg ; lisinopril  20  mg ; diltiazem extended-release  120  mg ; risperidone  2  mg ; lorazepam  0.5  mg ; ciprofloxacin hcl  500  mg ; 
white matter disease, unspecified acute kidney failure, unspecified personal history of urinary (tract) infections organ-limited amyloidosis schizophrenia, unspecified other specified places as the place of occurrence of the external cause fall from bed, initial encounter other chest pain unspecified urinary incontinence history of falling essential (primary) hypertension hypokalemia personal history of nicotine dependence urinary tract infection, site not specified unsteadiness on feet type 2 diabetes mellitus without complications major depressive disorder, single episode, unspecified hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right dominant side pain in left elbow hyperlipidemia, unspecified constipation, unspecified pain in left hip nicotine dependence, cigarettes, uncomplicated type 2 diabetes mellitus without complications unspecified abnormalities of gait and mobility unspecified abnormal findings in urine unspecified urinary incontinence major depressive disorder, single episode, unspecified altered mental status, unspecified history of falling essential (primary) hypertension pain in right hip schizophrenia, unspecified hyperlipidemia, unspecified other chronic pain pain in leg, unspecified other constipation personal history of urinary (tract) infections low back pain hemiplegia and hemiparesis following cerebral infarction affecting right dominant side personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits ostium secundum type atrial septal defect pure hypercholesterolemia urinary incontinence, unspecified bell's palsy pain in joint, pelvic region and thigh chronic airway obstruction, not elsewhere classified depressive disorder, not elsewhere classified
black african american f 70 $nan$nan$0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 
hypercalcemia antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use autoimmune hemolytic anemias congestive heart failure, unspecified nonspecific abnormal results of other endocrine function study long-term (current) use of anticoagulants vaccination not carried out because of patient refusal diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled friedländer's bacillus infection in conditions classified elsewhere and of unspecified site unspecified glaucoma car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident long-term (current) use of steroids kidney replaced by transplant hyperpotassemia urinary tract infection, site not specified long-term (current) use of insulin other late effects of cerebrovascular disease other acquired absence of organ tobacco use disorder acute on chronic diastolic heart failure unspecified essential hypertension atrial fibrillation other drugs and medicinal substances causing adverse effects in therapeutic use other musculoskeletal symptoms referable to limbs atrial flutter diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident muscle weakness (generalized) unspecified essential hypertension anticoagulants causing adverse effects in therapeutic use other late effects of cerebrovascular disease tobacco use disorder kidney replaced by transplant atrial fibrillation other postprocedural status other acquired absence of organ long-term (current) use of insulin long-term (current) use of anticoagulants abnormal coagulation profile other late effects of cerebrovascular disease acute edema of lung, unspecified atrial fibrillation long-term (current) use of anticoagulants long-term (current) use of steroids nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other left bundle branch block kidney replaced by transplant other musculoskeletal symptoms referable to limbs
black african american f 70 $temp  98.8  heartrate  67.0  resprate  16.0  o2sat  99.0  sbp  122.0  dbp  62.0  rhythm    pain  0  $hematology blood hematocrit  22.2  %; hematology blood hemoglobin  6.2  g dl; hematology blood platelet count  297  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  2.1  ; chemistry urine chloride, urine  27  meq l; chemistry urine creatinine, urine  50  mg dl; chemistry urine potassium, urine  13  meq l; chemistry urine sodium, urine  45  meq l; chemistry urine urea nitrogen, urine  561  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  160  mg dl; blood gas blood lactate  1.6  mmol l$0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  10  unit ; sodium polystyrene sulfonate  15  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; dextrose 50%  25  gm ; phenazopyridine  100  mg ; tacrolimus  3  mg ; folic acid  5  mg ; aspirin  81  mg ; nicotine patch  14  mg ; prednisone  5  mg ; simvastatin  20  mg ; metoprolol tartrate  37.5  mg ; sirolimus  4  mg ; erythromycin 0.5% ophth oint  0.5  in ; warfarin  5  mg ; travatan z  1  gtt ; 
hypercalcemia antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use autoimmune hemolytic anemias congestive heart failure, unspecified nonspecific abnormal results of other endocrine function study long-term (current) use of anticoagulants vaccination not carried out because of patient refusal diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled friedländer's bacillus infection in conditions classified elsewhere and of unspecified site unspecified glaucoma car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident long-term (current) use of steroids kidney replaced by transplant hyperpotassemia urinary tract infection, site not specified long-term (current) use of insulin other late effects of cerebrovascular disease other acquired absence of organ tobacco use disorder acute on chronic diastolic heart failure unspecified essential hypertension atrial fibrillation other drugs and medicinal substances causing adverse effects in therapeutic use other musculoskeletal symptoms referable to limbs atrial flutter diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident muscle weakness (generalized) unspecified essential hypertension anticoagulants causing adverse effects in therapeutic use other late effects of cerebrovascular disease tobacco use disorder kidney replaced by transplant atrial fibrillation other postprocedural status other acquired absence of organ long-term (current) use of insulin long-term (current) use of anticoagulants abnormal coagulation profile other late effects of cerebrovascular disease acute edema of lung, unspecified atrial fibrillation long-term (current) use of anticoagulants long-term (current) use of steroids nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other left bundle branch block kidney replaced by transplant other musculoskeletal symptoms referable to limbs
black african american f 70 $nan$hematology blood hematocrit  21.0  %; hematology blood hematocrit  27.1  %; hematology blood hemoglobin  5.9  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  313  k ul; hematology blood platelet count  339  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  72  mg dl; chemistry blood lactate dehydrogenase (ld)  419  iu l; hematology blood bands  5  %$cefepime  1  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  10  unit ; sodium polystyrene sulfonate  15  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; dextrose 50%  25  gm ; phenazopyridine  100  mg ; folic acid  5  mg ; aspirin  81  mg ; nicotine patch  14  mg ; prednisone  5  mg ; simvastatin  20  mg ; metoprolol tartrate  37.5  mg ; sirolimus  4  mg ; erythromycin 0.5% ophth oint  0.5  in ; warfarin  5  mg ; travatan z  1  gtt ; sulfameth trimethoprim ss  1  tab ; warfarin  6  mg ; 
hypercalcemia antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use autoimmune hemolytic anemias congestive heart failure, unspecified nonspecific abnormal results of other endocrine function study long-term (current) use of anticoagulants vaccination not carried out because of patient refusal diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled friedländer's bacillus infection in conditions classified elsewhere and of unspecified site unspecified glaucoma car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident long-term (current) use of steroids kidney replaced by transplant hyperpotassemia urinary tract infection, site not specified long-term (current) use of insulin other late effects of cerebrovascular disease other acquired absence of organ tobacco use disorder acute on chronic diastolic heart failure unspecified essential hypertension atrial fibrillation other drugs and medicinal substances causing adverse effects in therapeutic use other musculoskeletal symptoms referable to limbs atrial flutter diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident muscle weakness (generalized) unspecified essential hypertension anticoagulants causing adverse effects in therapeutic use other late effects of cerebrovascular disease tobacco use disorder kidney replaced by transplant atrial fibrillation other postprocedural status other acquired absence of organ long-term (current) use of insulin long-term (current) use of anticoagulants abnormal coagulation profile other late effects of cerebrovascular disease acute edema of lung, unspecified atrial fibrillation long-term (current) use of anticoagulants long-term (current) use of steroids nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other left bundle branch block kidney replaced by transplant other musculoskeletal symptoms referable to limbs
black african american f 70 $nan$hematology blood hematocrit  25.9  %; hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  326  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, indirect  0.5  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  78  mg dl; chemistry blood lactate dehydrogenase (ld)  472  iu l; chemistry blood bilirubin, direct  0.4  mg dl$cefepime  1  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  10  unit ; folic acid  5  mg ; aspirin  81  mg ; nicotine patch  14  mg ; prednisone  5  mg ; simvastatin  20  mg ; metoprolol tartrate  37.5  mg ; erythromycin 0.5% ophth oint  0.5  in ; warfarin  5  mg ; travatan z  1  gtt ; sulfameth trimethoprim ss  1  tab ; warfarin  6  mg ; 
hypercalcemia antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use autoimmune hemolytic anemias congestive heart failure, unspecified nonspecific abnormal results of other endocrine function study long-term (current) use of anticoagulants vaccination not carried out because of patient refusal diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled friedländer's bacillus infection in conditions classified elsewhere and of unspecified site unspecified glaucoma car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident long-term (current) use of steroids kidney replaced by transplant hyperpotassemia urinary tract infection, site not specified long-term (current) use of insulin other late effects of cerebrovascular disease other acquired absence of organ tobacco use disorder acute on chronic diastolic heart failure unspecified essential hypertension atrial fibrillation other drugs and medicinal substances causing adverse effects in therapeutic use other musculoskeletal symptoms referable to limbs atrial flutter diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident muscle weakness (generalized) unspecified essential hypertension anticoagulants causing adverse effects in therapeutic use other late effects of cerebrovascular disease tobacco use disorder kidney replaced by transplant atrial fibrillation other postprocedural status other acquired absence of organ long-term (current) use of insulin long-term (current) use of anticoagulants abnormal coagulation profile other late effects of cerebrovascular disease acute edema of lung, unspecified atrial fibrillation long-term (current) use of anticoagulants long-term (current) use of steroids nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other left bundle branch block kidney replaced by transplant other musculoskeletal symptoms referable to limbs
black african american f 70 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  338  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, indirect  0.5  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  640  iu l; chemistry blood bilirubin, direct  0.3  mg dl$cefepime  1  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  10  unit ; folic acid  5  mg ; aspirin  81  mg ; nicotine patch  14  mg ; prednisone  5  mg ; simvastatin  20  mg ; metoprolol tartrate  37.5  mg ; erythromycin 0.5% ophth oint  0.5  in ; warfarin  5  mg ; travatan z  1  gtt ; sulfameth trimethoprim ss  1  tab ; warfarin  6  mg ; sirolimus  3  mg ; *nf* ertapenem sodium  1  gm ; 
hypercalcemia antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use autoimmune hemolytic anemias congestive heart failure, unspecified nonspecific abnormal results of other endocrine function study long-term (current) use of anticoagulants vaccination not carried out because of patient refusal diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled friedländer's bacillus infection in conditions classified elsewhere and of unspecified site unspecified glaucoma car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident long-term (current) use of steroids kidney replaced by transplant hyperpotassemia urinary tract infection, site not specified long-term (current) use of insulin other late effects of cerebrovascular disease other acquired absence of organ tobacco use disorder acute on chronic diastolic heart failure unspecified essential hypertension atrial fibrillation other drugs and medicinal substances causing adverse effects in therapeutic use other musculoskeletal symptoms referable to limbs atrial flutter diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident muscle weakness (generalized) unspecified essential hypertension anticoagulants causing adverse effects in therapeutic use other late effects of cerebrovascular disease tobacco use disorder kidney replaced by transplant atrial fibrillation other postprocedural status other acquired absence of organ long-term (current) use of insulin long-term (current) use of anticoagulants abnormal coagulation profile other late effects of cerebrovascular disease acute edema of lung, unspecified atrial fibrillation long-term (current) use of anticoagulants long-term (current) use of steroids nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other left bundle branch block kidney replaced by transplant other musculoskeletal symptoms referable to limbs
black african american f 70 $nan$hematology blood hematocrit  22.5  %; hematology blood hematocrit  24.0  %; hematology blood hemoglobin  6.2  g dl; hematology blood platelet count  311  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, indirect  0.4  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  386  iu l; chemistry blood lactate dehydrogenase (ld)  386  iu l; chemistry blood bilirubin, direct  0.3  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  10  unit ; folic acid  5  mg ; aspirin  81  mg ; nicotine patch  14  mg ; prednisone  5  mg ; simvastatin  20  mg ; metoprolol tartrate  37.5  mg ; erythromycin 0.5% ophth oint  0.5  in ; warfarin  5  mg ; travatan z  1  gtt ; sulfameth trimethoprim ss  1  tab ; warfarin  6  mg ; sirolimus  3  mg ; *nf* ertapenem sodium  1  gm ; 
hypercalcemia antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use autoimmune hemolytic anemias congestive heart failure, unspecified nonspecific abnormal results of other endocrine function study long-term (current) use of anticoagulants vaccination not carried out because of patient refusal diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled friedländer's bacillus infection in conditions classified elsewhere and of unspecified site unspecified glaucoma car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident long-term (current) use of steroids kidney replaced by transplant hyperpotassemia urinary tract infection, site not specified long-term (current) use of insulin other late effects of cerebrovascular disease other acquired absence of organ tobacco use disorder acute on chronic diastolic heart failure unspecified essential hypertension atrial fibrillation other drugs and medicinal substances causing adverse effects in therapeutic use other musculoskeletal symptoms referable to limbs atrial flutter diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident muscle weakness (generalized) unspecified essential hypertension anticoagulants causing adverse effects in therapeutic use other late effects of cerebrovascular disease tobacco use disorder kidney replaced by transplant atrial fibrillation other postprocedural status other acquired absence of organ long-term (current) use of insulin long-term (current) use of anticoagulants abnormal coagulation profile other late effects of cerebrovascular disease acute edema of lung, unspecified atrial fibrillation long-term (current) use of anticoagulants long-term (current) use of steroids nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other left bundle branch block kidney replaced by transplant other musculoskeletal symptoms referable to limbs
unknown m 60 $nan$hematology blood hematocrit  33.0  %; hematology blood hematocrit  28.2  %; hematology blood hematocrit  28.8  %; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  20  k ul; hematology blood platelet count  40  k ul; hematology blood platelet count  46  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  116  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  107  mg dl; chemistry blood urea nitrogen  112  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.3  ; chemistry urine chloride, urine  13  meq l; chemistry urine creatinine, urine  54  mg dl; chemistry urine potassium, urine  41  meq l; chemistry urine urea nitrogen, urine  818  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  6.9  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  136  mg dl; chemistry blood glucose  198  mg dl; chemistry blood lactate dehydrogenase (ld)  742  iu l; chemistry blood albumin  2.2  g dl; chemistry blood albumin  1.8  g dl; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  0.92  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  0.9  mmol l$sodium chloride 0.9%  flush  10  ml ; propofol  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; imipenem-cilastatin  500  mg ; methylprednisolone sodium succ  40  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; heparin  5000  unit ; labetalol  10  mg ; lactated ringers  1000  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; carvedilol  12.5  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; micafungin  100  mg ; midazolam  100  mg ; iso-osmotic sodium chloride  50  ml ; 
 
unknown m 60 $nan$hematology blood hematocrit  26.8  %; hematology blood hematocrit  25.0  %; hematology blood hematocrit  26.0  %; hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  37  k ul; hematology blood platelet count  52  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  112  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  169  mg dl; chemistry blood albumin  1.9  g dl; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  0.8  mmol l$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  1000  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; heparin  5000  unit ; labetalol  10  mg ; lactated ringers  1000  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; micafungin  100  mg ; midazolam  100  mg ; iso-osmotic sodium chloride  50  ml ; vial  2  vial ; pantoprazole  80  mg ; vial  1  vial ; pantoprazole  40  mg ; 
 
unknown m 60 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  28  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  119  meq l; chemistry blood chloride  116  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  148  meq l; chemistry blood sodium  151  meq l; chemistry blood urea nitrogen  102  mg dl; chemistry blood urea nitrogen  106  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  133  mg dl; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.5  mmol l$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; heparin  5000  unit ; 5% dextrose  250  ml ; norepinephrine  8  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; micafungin  100  mg ; vial  1  vial ; pantoprazole  40  mg ; acetaminophen iv  500  mg ; vancomycin  750  mg ; 5% dextrose  1000  ml ; soln  100  ml ; acetaminophen iv  1000  mg ; 5% dextrose  500  ml ; 
 
unknown m 60 $nan$hematology blood hematocrit  28.5  %; hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  14  k ul; hematology blood platelet count  35  k ul; hematology blood platelet count  24  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  117  meq l; chemistry blood chloride  117  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood creatinine  3.8  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  5.3  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  150  meq l; chemistry blood urea nitrogen  113  mg dl; chemistry blood urea nitrogen  111  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  176  mg dl; chemistry blood lactate dehydrogenase (ld)  597  iu l; chemistry blood albumin  1.4  g dl; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.2  mmol l$soln  50  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; heparin  5000  unit ; 5% dextrose  250  ml ; norepinephrine  8  mg ; micafungin  100  mg ; vial  1  vial ; pantoprazole  40  mg ; vancomycin  750  mg ; 5% dextrose  1000  ml ; soln  100  ml ; acetaminophen iv  1000  mg ; 5% dextrose  500  ml ; 
 
unknown m 60 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  10  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  117  meq l; chemistry blood creatinine  4.0  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  133  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood glucose  73  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.06  mmol l; blood gas blood lactate  1.1  mmol l$soln  50  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; heparin  5000  unit ; 5% dextrose  250  ml ; norepinephrine  8  mg ; micafungin  100  mg ; vial  1  vial ; pantoprazole  40  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; 
 
unknown m 60 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  13  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  5.0  mg dl; chemistry blood potassium  7.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  126  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood glucose  193  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  1.1  mmol l$soln  50  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; micafungin  100  mg ; insulin  10  unit ; dextrose 50%  25  gm ; sodium polystyrene sulfonate  60  gm ; sodium bicarbonate  100  meq ; calcium gluconate  2  gm ; phenylephrine  60  mg ; morphine sulfate  100  mg ; morphine sulfate  2-4  mg ; lorazepam  1-2  mg ; 
 
black african american f 63 $temp    heartrate  76.0  resprate  16.0  o2sat  99.0  sbp  133.0  dbp  75.0  rhythm    pain  7  ; temp    heartrate  101.0  resprate  18.0  o2sat  100.0  sbp  159.0  dbp  92.0  rhythm    pain  10  $hematology blood hematocrit  38.9  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  10.3  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; fluticasone propionate 110mcg  1  puff ; clonidine  0.1  mg ; clonidine  0.2  mg ; labetalol  100  mg ; labetalol  200  mg ; hydromorphone (dilaudid)  0.5  mg ; ondansetron  4  mg ; aspirin  81  mg ; chlorthalidone  25  mg ; vitamin d  1000  unit ; lidocaine 1%  20  ml ; hydromorphone (dilaudid)  2-4  mg ; 
 
asian f 63 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  132  mg dl; chemistry blood albumin  4.3  g dl; blood gas blood lactate  1.8  mmol l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$nan
hyposmolality and/or hyponatremia infection and inflammatory reaction due to other internal prosthetic device, implant, and graft anemia of other chronic disease escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bacteremia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obstruction of bile duct diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis acidosis other disorders of neurohypophysis hypovolemia malignant neoplasm of extrahepatic bile ducts chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction anemia, unspecified hyposmolality and/or hyponatremia cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified 
asian f 63 $nan$hematology blood hematocrit  31.5  %; hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  209  k ul; hematology blood platelet count  181  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  107  mg dl; chemistry blood lactate dehydrogenase (ld)  170  iu l; chemistry blood albumin  3.8  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; albuterol inhaler  1-2  puff ; pantoprazole  40  mg ; ondansetron  4-8  mg ; fluticasone propionate 110mcg  2  puff ; ursodiol  300  mg ; docusate sodium  100  mg ; heparin  5000  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; vitamin d  800  unit ; pravastatin  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ursodiol  600  mg ; 5% dextrose  250  ml ; vancomycin  750  mg ; zolpidem tartrate  5  mg ; 
hyposmolality and/or hyponatremia infection and inflammatory reaction due to other internal prosthetic device, implant, and graft anemia of other chronic disease escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bacteremia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obstruction of bile duct diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis acidosis other disorders of neurohypophysis hypovolemia malignant neoplasm of extrahepatic bile ducts chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction anemia, unspecified hyposmolality and/or hyponatremia cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified 
asian f 63 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  184  iu l; chemistry blood albumin  3.8  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; pantoprazole  40  mg ; ondansetron  4-8  mg ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; heparin  5000  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; vitamin d  800  unit ; pravastatin  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ursodiol  600  mg ; 5% dextrose  250  ml ; vancomycin  750  mg ; zolpidem tartrate  5  mg ; senna  1  tab ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; simethicone  80  mg ; 
hyposmolality and/or hyponatremia infection and inflammatory reaction due to other internal prosthetic device, implant, and graft anemia of other chronic disease escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bacteremia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obstruction of bile duct diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis acidosis other disorders of neurohypophysis hypovolemia malignant neoplasm of extrahepatic bile ducts chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction anemia, unspecified hyposmolality and/or hyponatremia cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified 
asian f 63 $nan$hematology blood inr(pt)  1.0  $influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; pantoprazole  40  mg ; ondansetron  4-8  mg ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; heparin  5000  unit ; vitamin d  800  unit ; pravastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ursodiol  600  mg ; zolpidem tartrate  5  mg ; senna  1  tab ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; simethicone  80  mg ; milk of magnesia  30  ml ; 
hyposmolality and/or hyponatremia infection and inflammatory reaction due to other internal prosthetic device, implant, and graft anemia of other chronic disease escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bacteremia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obstruction of bile duct diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis acidosis other disorders of neurohypophysis hypovolemia malignant neoplasm of extrahepatic bile ducts chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction anemia, unspecified hyposmolality and/or hyponatremia cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified 
asian f 63 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  79  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; pantoprazole  40  mg ; ondansetron  4-8  mg ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; heparin  5000  unit ; vitamin d  800  unit ; pravastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ursodiol  600  mg ; zolpidem tartrate  5  mg ; senna  1  tab ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; simethicone  80  mg ; milk of magnesia  30  ml ; 
hyposmolality and/or hyponatremia infection and inflammatory reaction due to other internal prosthetic device, implant, and graft anemia of other chronic disease escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bacteremia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obstruction of bile duct diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis acidosis other disorders of neurohypophysis hypovolemia malignant neoplasm of extrahepatic bile ducts chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction anemia, unspecified hyposmolality and/or hyponatremia cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified 
asian f 63 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; pantoprazole  40  mg ; ondansetron  4-8  mg ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; heparin  5000  unit ; vitamin d  800  unit ; pravastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ursodiol  600  mg ; zolpidem tartrate  5  mg ; senna  1  tab ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; simethicone  80  mg ; milk of magnesia  30  ml ; zolpidem tartrate  2.5  mg ; oxycodone (immediate release)   5  mg ; 
hyposmolality and/or hyponatremia infection and inflammatory reaction due to other internal prosthetic device, implant, and graft anemia of other chronic disease escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bacteremia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obstruction of bile duct diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis acidosis other disorders of neurohypophysis hypovolemia malignant neoplasm of extrahepatic bile ducts chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction anemia, unspecified hyposmolality and/or hyponatremia cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified 
asian f 63 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; pantoprazole  40  mg ; ondansetron  4-8  mg ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; heparin  5000  unit ; vitamin d  800  unit ; pravastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ursodiol  600  mg ; zolpidem tartrate  5  mg ; senna  1  tab ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; simethicone  80  mg ; milk of magnesia  30  ml ; oxycodone (immediate release)   5  mg ; 
hyposmolality and/or hyponatremia infection and inflammatory reaction due to other internal prosthetic device, implant, and graft anemia of other chronic disease escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bacteremia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure obstruction of bile duct diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis acidosis other disorders of neurohypophysis hypovolemia malignant neoplasm of extrahepatic bile ducts chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction anemia, unspecified hyposmolality and/or hyponatremia cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified 
white m 75 $nan$nan$bisacodyl  10  mg ; escitalopram oxalate  20  mg ; losartan potassium  25  mg ; atorvastatin  20  mg ; 
backache, unspecified pain in limb malignant neoplasm of bladder, part unspecified history of fall asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other chronic pain 
white m 75 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  111  mg dl$bisacodyl  10  mg ; escitalopram oxalate  20  mg ; losartan potassium  25  mg ; atorvastatin  20  mg ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; docusate sodium  100  mg ; famotidine  20  mg ; metformin (glucophage)  500  mg ; insulin  0  unit ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
backache, unspecified pain in limb malignant neoplasm of bladder, part unspecified history of fall asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other chronic pain 
white m 75 $nan$nan$bisacodyl  10  mg ; escitalopram oxalate  20  mg ; losartan potassium  25  mg ; atorvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; morphine sulfate  2-4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; famotidine  20  mg ; metformin (glucophage)  500  mg ; insulin  0  unit ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; bag  1  bag ; magnesium sulfate  2  gm ; polyethylene glycol  17  g ; hydromorphone (dilaudid)  2  mg ; 
backache, unspecified pain in limb malignant neoplasm of bladder, part unspecified history of fall asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other chronic pain 
black african american f 32 $nan$nan$folic acid  1  mg ; 
chronic pancreatitis other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms hydroureter bacteremia hydronephrosis hydroureter unspecified intestinal obstruction hydronephrosis malignant neoplasm of peritoneum, unspecified hypovolemia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other vascular complications of medical care, not elsewhere classified phlebitis and thrombophlebitis of superficial veins of upper extremities malignant neoplasm of specified parts of peritoneum other specified intestinal obstruction dehydration person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident neoplasm related pain (acute) (chronic) ileostomy status 
black african american f 32 $nan$hematology blood hematocrit  28.1  %; hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  415  k ul; hematology blood platelet count  432  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  148  mg dl; chemistry blood glucose  175  mg dl; chemistry blood lactate dehydrogenase (ld)  293  iu l; chemistry blood albumin  3.9  g dl; hematology blood bands  0  %; blood gas blood lactate  2.6  mmol l$folic acid  1  mg ; heparin flush (10 units ml)  2  ml ; d5 1 2ns  1000  ml ; fentanyl patch  100  mcg hr ; fentanyl patch  25  mcg hr ; hydromorphone (dilaudid)  2  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; pantoprazole  40  mg ; metoclopramide  10  mg ; ns (mini bag plus)  100  ml ; cefepime  2  g ; ondansetron  4  mg ; prochlorperazine  10  mg ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; ns  250  ml ; potassium phosphate  15  mmol ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; d5w  250  ml ; sulfameth trimethoprim  150  mg ; ns  1000  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; syringe  1  syr ; docusate sodium  100  mg ; senna  1  tab ; heparin  5000  unit ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  4-6  mg ; morphine sulfate  2-4  mg ; hydromorphone (dilaudid)  12.5  mg ; amp  1  amp ; octreotide acetate  100  mcg ; hydromorphone (dilaudid)  0.5  mg ; ketorolac  15-30  mg ; d5w  100  ml ; hydromorphone-hp  50  mg ; 
chronic pancreatitis other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms hydroureter bacteremia hydronephrosis hydroureter unspecified intestinal obstruction hydronephrosis malignant neoplasm of peritoneum, unspecified hypovolemia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other vascular complications of medical care, not elsewhere classified phlebitis and thrombophlebitis of superficial veins of upper extremities malignant neoplasm of specified parts of peritoneum other specified intestinal obstruction dehydration person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident neoplasm related pain (acute) (chronic) ileostomy status 
black african american f 32 $nan$hematology blood hematocrit  30.3  %; hematology blood hematocrit  24.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  449  k ul; hematology blood platelet count  307  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  190  mg dl; hematology blood bands  35  %; hematology blood bands  31  %; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  2.2  mmol l$heparin flush (10 units ml)  2  ml ; fentanyl patch  100  mcg hr ; fentanyl patch  25  mcg hr ; bisacodyl  10  mg ; lorazepam  0.5  mg ; metoclopramide  10  mg ; ns (mini bag plus)  100  ml ; cefepime  2  g ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; ns  250  ml ; potassium phosphate  15  mmol ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; ns  1000  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; syringe  1  syr ; docusate sodium  100  mg ; senna  1  tab ; heparin  5000  unit ; hydromorphone (dilaudid)  0.5  mg ; ketorolac  15-30  mg ; d5w  100  ml ; hydromorphone-hp  50  mg ; amino acids 4.25% w  dextrose 5%  1000  ml ; multivitamin iv  10  ml ; ns  500  ml ; acetaminophen  650  mg ; lr  1000  ml ; lidocaine jelly 2%  1  appl ; 
chronic pancreatitis other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms hydroureter bacteremia hydronephrosis hydroureter unspecified intestinal obstruction hydronephrosis malignant neoplasm of peritoneum, unspecified hypovolemia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other vascular complications of medical care, not elsewhere classified phlebitis and thrombophlebitis of superficial veins of upper extremities malignant neoplasm of specified parts of peritoneum other specified intestinal obstruction dehydration person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident neoplasm related pain (acute) (chronic) ileostomy status 
black african american f 32 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  341  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  156  mg dl; hematology blood bands  19  %; blood gas blood lactate  1.9  mmol l$heparin flush (10 units ml)  2  ml ; fentanyl patch  100  mcg hr ; fentanyl patch  25  mcg hr ; bisacodyl  10  mg ; lorazepam  0.5  mg ; ns (mini bag plus)  100  ml ; cefepime  2  g ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; ns  250  ml ; potassium phosphate  15  mmol ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; vial  1  vial ; pantoprazole sodium  40  mg ; syringe  1  syr ; docusate sodium  100  mg ; senna  1  tab ; heparin  5000  unit ; amino acids 4.25% w  dextrose 5%  1000  ml ; multivitamin iv  10  ml ; acetaminophen  650  mg ; lr  1000  ml ; lidocaine jelly 2%  1  appl ; sodium phosphate  15  mmol ; syringe (pca)  50  ml ; hydromorphone-hp  250  mg ; 
chronic pancreatitis other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms hydroureter bacteremia hydronephrosis hydroureter unspecified intestinal obstruction hydronephrosis malignant neoplasm of peritoneum, unspecified hypovolemia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other vascular complications of medical care, not elsewhere classified phlebitis and thrombophlebitis of superficial veins of upper extremities malignant neoplasm of specified parts of peritoneum other specified intestinal obstruction dehydration person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident neoplasm related pain (acute) (chronic) ileostomy status 
black african american f 32 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  346  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  94  mg dl$heparin flush (10 units ml)  2  ml ; fentanyl patch  100  mcg hr ; fentanyl patch  25  mcg hr ; bisacodyl  10  mg ; lorazepam  0.5  mg ; ns (mini bag plus)  100  ml ; cefepime  2  g ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; vial  1  vial ; pantoprazole sodium  40  mg ; syringe  1  syr ; docusate sodium  100  mg ; senna  1  tab ; heparin  5000  unit ; acetaminophen  650  mg ; syringe (pca)  50  ml ; hydromorphone-hp  250  mg ; fentanyl patch  50  mcg hr ; fentanyl patch  75  mcg hr ; hydromorphone (dilaudid)  1  mg ; syringe (pca)  25  ml ; 
chronic pancreatitis other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms hydroureter bacteremia hydronephrosis hydroureter unspecified intestinal obstruction hydronephrosis malignant neoplasm of peritoneum, unspecified hypovolemia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other vascular complications of medical care, not elsewhere classified phlebitis and thrombophlebitis of superficial veins of upper extremities malignant neoplasm of specified parts of peritoneum other specified intestinal obstruction dehydration person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident neoplasm related pain (acute) (chronic) ileostomy status 
black african american f 32 $nan$hematology blood hematocrit  23.7  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  301  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  101  mg dl$heparin flush (10 units ml)  2  ml ; fentanyl patch  25  mcg hr ; lorazepam  0.5  mg ; ns (mini bag plus)  100  ml ; cefepime  2  g ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; vial  1  vial ; pantoprazole sodium  40  mg ; syringe  1  syr ; heparin  5000  unit ; acetaminophen  650  mg ; fentanyl patch  50  mcg hr ; fentanyl patch  75  mcg hr ; hydromorphone (dilaudid)  1  mg ; meperidine  12.5-25  mg ; promethazine hcl  6.25-12.5  mg ; prochlorperazine  2.5-5  mg ; haloperidol  0.25-0.5  mg ; hydromorphone (dilaudid)  0.2-0.6  mg ; lidocaine 5% patch  1  ptch ; 
chronic pancreatitis other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms hydroureter bacteremia hydronephrosis hydroureter unspecified intestinal obstruction hydronephrosis malignant neoplasm of peritoneum, unspecified hypovolemia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other vascular complications of medical care, not elsewhere classified phlebitis and thrombophlebitis of superficial veins of upper extremities malignant neoplasm of specified parts of peritoneum other specified intestinal obstruction dehydration person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident neoplasm related pain (acute) (chronic) ileostomy status 
black african american f 32 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  322  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  66  mg dl; hematology blood bands  1  %$heparin flush (10 units ml)  2  ml ; lorazepam  0.5  mg ; ns (mini bag plus)  100  ml ; cefepime  2  g ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; vial  1  vial ; pantoprazole sodium  40  mg ; syringe  1  syr ; heparin  5000  unit ; acetaminophen  650  mg ; lidocaine 5% patch  1  ptch ; amitriptyline  25  mg ; 
chronic pancreatitis other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms hydroureter bacteremia hydronephrosis hydroureter unspecified intestinal obstruction hydronephrosis malignant neoplasm of peritoneum, unspecified hypovolemia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other vascular complications of medical care, not elsewhere classified phlebitis and thrombophlebitis of superficial veins of upper extremities malignant neoplasm of specified parts of peritoneum other specified intestinal obstruction dehydration person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident neoplasm related pain (acute) (chronic) ileostomy status 
black african american f 32 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  299  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  5.3  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  235  mg dl$heparin flush (10 units ml)  2  ml ; lorazepam  0.5  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; vial  1  vial ; pantoprazole sodium  40  mg ; syringe  1  syr ; heparin  5000  unit ; acetaminophen  650  mg ; lidocaine 5% patch  1  ptch ; amitriptyline  25  mg ; 
chronic pancreatitis other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms hydroureter bacteremia hydronephrosis hydroureter unspecified intestinal obstruction hydronephrosis malignant neoplasm of peritoneum, unspecified hypovolemia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other vascular complications of medical care, not elsewhere classified phlebitis and thrombophlebitis of superficial veins of upper extremities malignant neoplasm of specified parts of peritoneum other specified intestinal obstruction dehydration person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident neoplasm related pain (acute) (chronic) ileostomy status 
black african american f 32 $nan$nan$heparin flush (10 units ml)  2  ml ; lorazepam  0.5  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; calcium replacement (oncology)  1  gm ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; vial  1  vial ; pantoprazole sodium  40  mg ; syringe  1  syr ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; amitriptyline  25  mg ; 
chronic pancreatitis other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms hydroureter bacteremia hydronephrosis hydroureter unspecified intestinal obstruction hydronephrosis malignant neoplasm of peritoneum, unspecified hypovolemia other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other vascular complications of medical care, not elsewhere classified phlebitis and thrombophlebitis of superficial veins of upper extremities malignant neoplasm of specified parts of peritoneum other specified intestinal obstruction dehydration person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident neoplasm related pain (acute) (chronic) ileostomy status 
black african american m 38 $temp  98.2  heartrate  86.0  resprate  16.0  o2sat  100.0  sbp  165.0  dbp  100.0  rhythm    pain  0  $hematology blood hematocrit  25.5  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  187  mg dl; chemistry blood albumin  2.6  g dl$sucralfate  1  gm ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  8  unit ; insulin  10  unit ; insulin  18  unit ; insulin  0  unit ; bag  50  ml ; magnesium sulfate  2  gm ; potassium chloride  30  meq ; lisinopril  5  mg ; 
unspecified vitamin d deficiency osteoarthrosis, unspecified whether generalized or localized, site unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other shock without mention of trauma acute posthemorrhagic anemia iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled other esophagitis long-term (current) use of insulin polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled chronic kidney disease, stage iii (moderate) diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy acute kidney failure, unspecified gastroparesis diabetes with ketoacidosis, type i [juvenile type], uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health candidal esophagitis candidiasis of other urogenital sites diabetes with neurological manifestations, type i [juvenile type], uncontrolled prinzmetal angina hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other shock without mention of trauma systemic inflammatory response syndrome due to noninfectious process with acute organ dysfunction chronic kidney disease, stage iv (severe) acute esophagitis other toe(s) amputation status long-term (current) use of insulin gastroparesis iron deficiency anemia secondary to blood loss (chronic) acute kidney failure, unspecified other toe(s) amputation status acute kidney failure, unspecified acute respiratory failure septic shock hyposmolality and/or hyponatremia pneumonitis due to inhalation of food or vomitus severe sepsis methicillin resistant pneumonia due to staphylococcus aureus disorders of phosphorus metabolism unspecified septicemia arthropathy, unspecified, site unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled benign neoplasm of colon unspecified gastritis and gastroduodenitis, with hemorrhage unspecified gastritis and gastroduodenitis, without mention of hemorrhage
black african american m 38 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  58  mg dl$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  8  unit ; insulin  10  unit ; insulin  0  unit ; bag  50  ml ; magnesium sulfate  2  gm ; lisinopril  5  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; neutra-phos  1  pkt ; 
unspecified vitamin d deficiency osteoarthrosis, unspecified whether generalized or localized, site unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other shock without mention of trauma acute posthemorrhagic anemia iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled other esophagitis long-term (current) use of insulin polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled chronic kidney disease, stage iii (moderate) diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy acute kidney failure, unspecified gastroparesis diabetes with ketoacidosis, type i [juvenile type], uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health candidal esophagitis candidiasis of other urogenital sites diabetes with neurological manifestations, type i [juvenile type], uncontrolled prinzmetal angina hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other shock without mention of trauma systemic inflammatory response syndrome due to noninfectious process with acute organ dysfunction chronic kidney disease, stage iv (severe) acute esophagitis other toe(s) amputation status long-term (current) use of insulin gastroparesis iron deficiency anemia secondary to blood loss (chronic) acute kidney failure, unspecified other toe(s) amputation status acute kidney failure, unspecified acute respiratory failure septic shock hyposmolality and/or hyponatremia pneumonitis due to inhalation of food or vomitus severe sepsis methicillin resistant pneumonia due to staphylococcus aureus disorders of phosphorus metabolism unspecified septicemia arthropathy, unspecified, site unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled benign neoplasm of colon unspecified gastritis and gastroduodenitis, with hemorrhage unspecified gastritis and gastroduodenitis, without mention of hemorrhage
black african american m 38 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  55  mg dl$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; lisinopril  5  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; neutra-phos  1  pkt ; insulin  15  unit ; 
unspecified vitamin d deficiency osteoarthrosis, unspecified whether generalized or localized, site unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other shock without mention of trauma acute posthemorrhagic anemia iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled other esophagitis long-term (current) use of insulin polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled chronic kidney disease, stage iii (moderate) diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy acute kidney failure, unspecified gastroparesis diabetes with ketoacidosis, type i [juvenile type], uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health candidal esophagitis candidiasis of other urogenital sites diabetes with neurological manifestations, type i [juvenile type], uncontrolled prinzmetal angina hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other shock without mention of trauma systemic inflammatory response syndrome due to noninfectious process with acute organ dysfunction chronic kidney disease, stage iv (severe) acute esophagitis other toe(s) amputation status long-term (current) use of insulin gastroparesis iron deficiency anemia secondary to blood loss (chronic) acute kidney failure, unspecified other toe(s) amputation status acute kidney failure, unspecified acute respiratory failure septic shock hyposmolality and/or hyponatremia pneumonitis due to inhalation of food or vomitus severe sepsis methicillin resistant pneumonia due to staphylococcus aureus disorders of phosphorus metabolism unspecified septicemia arthropathy, unspecified, site unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled benign neoplasm of colon unspecified gastritis and gastroduodenitis, with hemorrhage unspecified gastritis and gastroduodenitis, without mention of hemorrhage
black african american m 38 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  8  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  6.0  meq l; chemistry blood potassium  6.1  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  52  mg dl; chemistry blood glucose  78  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lisinopril  5  mg ; insulin  15  unit ; insulin  14  unit ; d5 1 2ns  1000  ml ; lidocaine jelly 2% (urojet)  1  appl ; sodium polystyrene sulfonate  30  gm ; 
unspecified vitamin d deficiency osteoarthrosis, unspecified whether generalized or localized, site unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other shock without mention of trauma acute posthemorrhagic anemia iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled other esophagitis long-term (current) use of insulin polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled chronic kidney disease, stage iii (moderate) diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy acute kidney failure, unspecified gastroparesis diabetes with ketoacidosis, type i [juvenile type], uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health candidal esophagitis candidiasis of other urogenital sites diabetes with neurological manifestations, type i [juvenile type], uncontrolled prinzmetal angina hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other shock without mention of trauma systemic inflammatory response syndrome due to noninfectious process with acute organ dysfunction chronic kidney disease, stage iv (severe) acute esophagitis other toe(s) amputation status long-term (current) use of insulin gastroparesis iron deficiency anemia secondary to blood loss (chronic) acute kidney failure, unspecified other toe(s) amputation status acute kidney failure, unspecified acute respiratory failure septic shock hyposmolality and/or hyponatremia pneumonitis due to inhalation of food or vomitus severe sepsis methicillin resistant pneumonia due to staphylococcus aureus disorders of phosphorus metabolism unspecified septicemia arthropathy, unspecified, site unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled benign neoplasm of colon unspecified gastritis and gastroduodenitis, with hemorrhage unspecified gastritis and gastroduodenitis, without mention of hemorrhage
black african american m 38 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  280  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.4  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  64  mg dl; chemistry blood glucose  57  mg dl$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lisinopril  5  mg ; insulin  14  unit ; lidocaine jelly 2% (urojet)  1  appl ; sodium polystyrene sulfonate  30  gm ; 0.9% sodium chloride  1000  ml ; sodium polystyrene sulfonate  60  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; insulin  6  unit ; insulin  3  unit ; dextrose 50%  25  gm ; sodium polystyrene sulfonate  15  gm ; 
unspecified vitamin d deficiency osteoarthrosis, unspecified whether generalized or localized, site unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other shock without mention of trauma acute posthemorrhagic anemia iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled other esophagitis long-term (current) use of insulin polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled chronic kidney disease, stage iii (moderate) diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy acute kidney failure, unspecified gastroparesis diabetes with ketoacidosis, type i [juvenile type], uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health candidal esophagitis candidiasis of other urogenital sites diabetes with neurological manifestations, type i [juvenile type], uncontrolled prinzmetal angina hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other shock without mention of trauma systemic inflammatory response syndrome due to noninfectious process with acute organ dysfunction chronic kidney disease, stage iv (severe) acute esophagitis other toe(s) amputation status long-term (current) use of insulin gastroparesis iron deficiency anemia secondary to blood loss (chronic) acute kidney failure, unspecified other toe(s) amputation status acute kidney failure, unspecified acute respiratory failure septic shock hyposmolality and/or hyponatremia pneumonitis due to inhalation of food or vomitus severe sepsis methicillin resistant pneumonia due to staphylococcus aureus disorders of phosphorus metabolism unspecified septicemia arthropathy, unspecified, site unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled benign neoplasm of colon unspecified gastritis and gastroduodenitis, with hemorrhage unspecified gastritis and gastroduodenitis, without mention of hemorrhage
black african american m 38 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  309  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood potassium  5.8  meq l; chemistry blood potassium  5.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  164  mg dl; chemistry blood glucose  145  mg dl$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; glucagon  1  mg ; 0.9% sodium chloride  1000  ml ; sodium polystyrene sulfonate  60  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; insulin  3  unit ; dextrose 50%  25  gm ; sodium polystyrene sulfonate  15  gm ; 
unspecified vitamin d deficiency osteoarthrosis, unspecified whether generalized or localized, site unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other shock without mention of trauma acute posthemorrhagic anemia iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled other esophagitis long-term (current) use of insulin polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled chronic kidney disease, stage iii (moderate) diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy acute kidney failure, unspecified gastroparesis diabetes with ketoacidosis, type i [juvenile type], uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health candidal esophagitis candidiasis of other urogenital sites diabetes with neurological manifestations, type i [juvenile type], uncontrolled prinzmetal angina hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other shock without mention of trauma systemic inflammatory response syndrome due to noninfectious process with acute organ dysfunction chronic kidney disease, stage iv (severe) acute esophagitis other toe(s) amputation status long-term (current) use of insulin gastroparesis iron deficiency anemia secondary to blood loss (chronic) acute kidney failure, unspecified other toe(s) amputation status acute kidney failure, unspecified acute respiratory failure septic shock hyposmolality and/or hyponatremia pneumonitis due to inhalation of food or vomitus severe sepsis methicillin resistant pneumonia due to staphylococcus aureus disorders of phosphorus metabolism unspecified septicemia arthropathy, unspecified, site unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled benign neoplasm of colon unspecified gastritis and gastroduodenitis, with hemorrhage unspecified gastritis and gastroduodenitis, without mention of hemorrhage
black african american m 38 $nan$nan$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; glucagon  1  mg ; insulin  3  unit ; dextrose 50%  25  gm ; 
unspecified vitamin d deficiency osteoarthrosis, unspecified whether generalized or localized, site unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other shock without mention of trauma acute posthemorrhagic anemia iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled other esophagitis long-term (current) use of insulin polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], uncontrolled chronic kidney disease, stage iii (moderate) diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy acute kidney failure, unspecified gastroparesis diabetes with ketoacidosis, type i [juvenile type], uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health candidal esophagitis candidiasis of other urogenital sites diabetes with neurological manifestations, type i [juvenile type], uncontrolled prinzmetal angina hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other shock without mention of trauma systemic inflammatory response syndrome due to noninfectious process with acute organ dysfunction chronic kidney disease, stage iv (severe) acute esophagitis other toe(s) amputation status long-term (current) use of insulin gastroparesis iron deficiency anemia secondary to blood loss (chronic) acute kidney failure, unspecified other toe(s) amputation status acute kidney failure, unspecified acute respiratory failure septic shock hyposmolality and/or hyponatremia pneumonitis due to inhalation of food or vomitus severe sepsis methicillin resistant pneumonia due to staphylococcus aureus disorders of phosphorus metabolism unspecified septicemia arthropathy, unspecified, site unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled benign neoplasm of colon unspecified gastritis and gastroduodenitis, with hemorrhage unspecified gastritis and gastroduodenitis, without mention of hemorrhage
white m 51 $temp  98.1  heartrate  72.0  resprate  16.0  o2sat  100.0  sbp  138.0  dbp  64.0  rhythm    pain  6  $chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  119  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; alprazolam  0.5  mg ; mirtazapine  15  mg ; heparin  5000  unit ; acetaminophen  650  mg ; 
other spondylosis, cervical region post-traumatic stress disorder, unspecified pedestrian with other conveyance injured in collision with car, pick-up truck or van, unspecified whether traffic or nontraffic accident, initial encounter opioid dependence, in remission bipolar disorder, unspecified other paved roadways as the place of occurrence of the external cause abrasion of other part of head, initial encounter concussion with loss of consciousness of unspecified duration, initial encounter unspecified convulsions panic disorder [episodic paroxysmal anxiety] personal history of nicotine dependence long term (current) use of aspirin anesthesia of skin essential (primary) hypertension alcohol dependence, in remission orthostatic hypotension
white m 51 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; alprazolam  0.5  mg ; mirtazapine  15  mg ; heparin  5000  unit ; acetaminophen  650  mg ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; methadone  90  mg ; polyethylene glycol  17  g ; 
other spondylosis, cervical region post-traumatic stress disorder, unspecified pedestrian with other conveyance injured in collision with car, pick-up truck or van, unspecified whether traffic or nontraffic accident, initial encounter opioid dependence, in remission bipolar disorder, unspecified other paved roadways as the place of occurrence of the external cause abrasion of other part of head, initial encounter concussion with loss of consciousness of unspecified duration, initial encounter unspecified convulsions panic disorder [episodic paroxysmal anxiety] personal history of nicotine dependence long term (current) use of aspirin anesthesia of skin essential (primary) hypertension alcohol dependence, in remission orthostatic hypotension
other m 77 $temp  98.1  heartrate  87.0  resprate  19.0  o2sat  98.0  sbp  112.0  dbp  86.0  rhythm    pain  0  $hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  464  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  98  mg dl; chemistry blood lactate dehydrogenase (ld)  136  iu l$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; diazepam  2.5  mg ; polyethylene glycol  17  g ; allopurinol  100  mg ; lisinopril  40  mg ; metoprolol succinate xl  25  mg ; simvastatin  40  mg ; 
 
other m 77 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  500  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  115  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; diazepam  2.5  mg ; polyethylene glycol  17  g ; allopurinol  100  mg ; lisinopril  40  mg ; metoprolol succinate xl  25  mg ; simvastatin  40  mg ; albumin 25% (12.5g   50ml)  25  g ; 
 
other m 77 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  455  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  116  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; diazepam  2.5  mg ; polyethylene glycol  17  g ; allopurinol  100  mg ; lisinopril  40  mg ; metoprolol succinate xl  25  mg ; simvastatin  40  mg ; albumin 25% (12.5g   50ml)  25  g ; 
 
other m 77 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  493  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  116  iu l$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; diazepam  2.5  mg ; allopurinol  100  mg ; lisinopril  40  mg ; metoprolol succinate xl  25  mg ; simvastatin  40  mg ; senna  8.6  mg ; bisacodyl  10  mg ; 
 
other m 77 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  496  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  123  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; diazepam  2.5  mg ; allopurinol  100  mg ; lisinopril  40  mg ; metoprolol succinate xl  25  mg ; simvastatin  40  mg ; senna  8.6  mg ; bisacodyl  10  mg ; 
 
other m 77 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  593  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  131  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; diazepam  2.5  mg ; allopurinol  100  mg ; lisinopril  40  mg ; metoprolol succinate xl  25  mg ; simvastatin  40  mg ; senna  8.6  mg ; bisacodyl  10  mg ; simethicone  40-80  mg ; d5 1 2ns  1000  ml ; 
 
other m 77 $nan$hematology blood hematocrit  34.9  %; hematology blood hematocrit  35.0  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  488  k ul; hematology blood platelet count  488  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  137  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; diazepam  2.5  mg ; allopurinol  100  mg ; metoprolol succinate xl  25  mg ; simvastatin  40  mg ; senna  8.6  mg ; bisacodyl  10  mg ; simethicone  40-80  mg ; d5 1 2ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; pantoprazole  40  mg ; furosemide  20  mg ; 
 
other m 77 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  497  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  109  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; diazepam  2.5  mg ; allopurinol  100  mg ; simvastatin  40  mg ; senna  8.6  mg ; bisacodyl  10  mg ; simethicone  40-80  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; pantoprazole  40  mg ; furosemide  20  mg ; moviprep  1  l ; 
 
other m 77 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  454  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  138  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; diazepam  2.5  mg ; allopurinol  100  mg ; simvastatin  40  mg ; senna  8.6  mg ; bisacodyl  10  mg ; simethicone  40-80  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; pantoprazole  40  mg ; moviprep  1  l ; 
 
other m 77 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  466  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  112  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; diazepam  2.5  mg ; allopurinol  100  mg ; simvastatin  40  mg ; senna  8.6  mg ; bisacodyl  10  mg ; simethicone  40-80  mg ; pantoprazole  40  mg ; 
 
other m 77 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  453  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  118  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; diazepam  2.5  mg ; allopurinol  100  mg ; simvastatin  40  mg ; senna  8.6  mg ; bisacodyl  10  mg ; simethicone  40-80  mg ; pantoprazole  40  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
other m 77 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  466  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  127  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; allopurinol  100  mg ; simvastatin  40  mg ; senna  8.6  mg ; bisacodyl  10  mg ; simethicone  40-80  mg ; pantoprazole  40  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
other m 77 $nan$hematology blood hematocrit  32.8  %; hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  459  k ul; hematology blood platelet count  483  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  117  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; allopurinol  100  mg ; simvastatin  40  mg ; senna  8.6  mg ; bisacodyl  10  mg ; simethicone  40-80  mg ; pantoprazole  40  mg ; 
 
other m 77 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  484  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  124  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; allopurinol  100  mg ; simvastatin  40  mg ; senna  8.6  mg ; bisacodyl  10  mg ; simethicone  40-80  mg ; pantoprazole  40  mg ; 
 
other m 77 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  444  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  140  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; allopurinol  100  mg ; simvastatin  40  mg ; senna  8.6  mg ; bisacodyl  10  mg ; simethicone  40-80  mg ; pantoprazole  40  mg ; neutra-phos  1  pkt ; 
 
other m 77 $nan$nan$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; allopurinol  100  mg ; simvastatin  40  mg ; senna  8.6  mg ; bisacodyl  10  mg ; simethicone  40-80  mg ; pantoprazole  40  mg ; neutra-phos  1  pkt ; 
 
white m 27 $nan$hematology blood hematocrit  36.4  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; metoclopramide  10  mg ; acetaminophen  325-650  mg ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  gm ; ciprofloxacin hcl  500  mg ; senna  1  tab ; docusate sodium  100  mg ; prochlorperazine  10  mg ; bisacodyl  10  mg ; zolpidem tartrate  5-10  mg ; albuterol  1-2  puff ; lorazepam  0.5-1  mg ; lorazepam  0.5  mg ; lorazepam  1  mg ; hydromorphone (dilaudid)  0.5  mg ; heparin  5000  unit ; fluticasone-salmeterol (100 50)  1  inh ; morphine sulfate  2-4  mg ; ketorolac  30  mg ; oxycodone-acetaminophen  1-2  tab ; 
 
white m 27 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; metoclopramide  10  mg ; acetaminophen  325-650  mg ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  gm ; ciprofloxacin hcl  500  mg ; senna  1  tab ; docusate sodium  100  mg ; prochlorperazine  10  mg ; bisacodyl  10  mg ; zolpidem tartrate  5-10  mg ; albuterol  1-2  puff ; lorazepam  0.5-1  mg ; lorazepam  0.5  mg ; lorazepam  1  mg ; heparin  5000  unit ; fluticasone-salmeterol (100 50)  1  inh ; morphine sulfate  2-4  mg ; ketorolac  30  mg ; oxycodone-acetaminophen  1-2  tab ; 
 
white f 61 $nan$nan$atorvastatin  20  mg ; 
 
white f 61 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  305  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  111  mg dl$atorvastatin  20  mg ; morphine sulfate  2-4  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; zolpidem tartrate  5-10  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; atenolol  25  mg ; docusate sodium  100  mg ; enoxaparin sodium  40  mg ; oxycodone (immediate release)   5-10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; cepacol (menthol)  1  loz ; 
 
white f 61 $nan$nan$atorvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; zolpidem tartrate  5-10  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; enoxaparin sodium  40  mg ; oxycodone (immediate release)   5-10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; cepacol (menthol)  1  loz ; 
 
white f 61 $nan$nan$atorvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; zolpidem tartrate  5-10  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; enoxaparin sodium  40  mg ; oxycodone (immediate release)   5-10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; cepacol (menthol)  1  loz ; 
 
white f 74 $temp  95.7  heartrate  82.0  resprate  17.0  o2sat  99.0  sbp  163.0  dbp  83.0  rhythm    pain  9  ; temp  98.2  heartrate  77.0  resprate  17.0  o2sat  97.0  sbp  165.0  dbp  97.0  rhythm    pain  8  ; temp  98.3  heartrate  97.0  resprate  18.0  o2sat  99.0  sbp  134.0  dbp  98.0  rhythm    pain  5  ; temp  98.0  heartrate  81.0  resprate  16.0  o2sat  93.0  sbp  112.0  dbp  70.0  rhythm    pain  "better"  $hematology blood hematocrit  41.4  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; hematology urine wbc  9  # hpf; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  141  mg dl; chemistry blood albumin  4.4  g dl; blood gas blood lactate  2.4  mmol l$nan
accidents occurring in residential institution biliary cirrhosis obesity, unspecified body mass index 32.0-32.9, adult asthma, unspecified type, unspecified long-term (current) use of steroids paralytic ileus other digestive system complications barrett's esophagus disorder of bone and cartilage, unspecified esophageal reflux unspecified polyarthropathy or polyarthritis, site unspecified candidiasis of mouth other psoriasis diverticulitis of colon (without mention of hemorrhage) personal history of colonic polyps other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified polyarthropathy or polyarthritis, site unspecified intestinal infection due to clostridium difficile biliary cirrhosis barrett's esophagus long-term (current) use of steroids diverticulitis of colon (without mention of hemorrhage) esophageal reflux diverticulitis of colon (without mention of hemorrhage) other psoriasis esophageal reflux unspecified inflammatory polyarthropathy biliary cirrhosis personal history of colonic polyps swelling, mass, or lump in chest obesity, unspecified disorder of bone and cartilage, unspecified long-term (current) use of steroids body mass index 33.0-33.9, adult family history of other digestive disorders barrett's esophagus intestinal disaccharidase deficiencies and disaccharide malabsorption
white f 35 $temp  98.0  heartrate  115.0  resprate  18.0  o2sat  100.0  sbp  141.0  dbp  89.0  rhythm    pain  8  ; temp  98.2  heartrate  120.0  resprate  16.0  o2sat  98.0  sbp  142.0  dbp  78.0  rhythm    pain    ; temp  99.0  heartrate  75.0  resprate  16.0  o2sat  98.0  sbp  133.0  dbp  82.0  rhythm    pain    ; temp  98.6  heartrate  76.0  resprate  16.0  o2sat  98.0  sbp  131.0  dbp  78.0  rhythm    pain    $nan$lisinopril  40  mg ; 
essential (primary) hypertension opioid use, unspecified with withdrawal acquired absence of spleen phlebitis and thrombophlebitis of other sites major depressive disorder, single episode, unspecified post-traumatic stress disorder, unspecified tobacco use acute pulmonary edema gastro-esophageal reflux disease without esophagitis homelessness borderline personality disorder anxiety disorder, unspecified hb-ss disease with crisis, unspecified suicidal ideations major depressive disorder, recurrent, unspecified gastro-esophageal reflux disease without esophagitis sickle-cell disease without crisis nicotine dependence, cigarettes, uncomplicated acquired absence of spleen acquired absence of other specified parts of digestive tract patient's unintentional underdosing of medication regimen for other reason other chest pain procedure and treatment not carried out because of patient's decision for other reasons underdosing of other opioids, initial encounter homelessness opioid use, unspecified with opioid-induced mood disorder unspecified place or not applicable physical restraint status hypertensive urgency opioid use, unspecified, uncomplicated hb-ss disease with acute chest syndrome adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter long qt syndrome gastro-esophageal reflux disease without esophagitis sickle-cell/hb-c disease without crisis chest pain, unspecified homelessness opioid dependence, uncomplicated bradycardia, unspecified unspecified place in hospital as the place of occurrence of the external cause essential (primary) hypertension sickle-cell/hb-c disease with acute chest syndrome acquired absence of spleen nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] influenza due to other identified influenza virus with unspecified type of pneumonia transfusion associated circulatory overload homelessness adverse effect of other opioids, initial encounter
white f 35 $temp  97.2  heartrate  75.0  resprate  16.0  o2sat  98.0  sbp  129.0  dbp  72.0  rhythm    pain    $hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  539  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  174  iu l$lisinopril  40  mg ; influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; folic acid  1  mg ; ondansetron  4  mg ; diphenhydramine  25  mg ; oxycodone (immediate release)  30  mg ; oxycodone sr (oxycontin)  20  mg ; hydromorphone (dilaudid)  2-4  mg ; tizanidine  8  mg ; pantoprazole  40  mg ; 
essential (primary) hypertension opioid use, unspecified with withdrawal acquired absence of spleen phlebitis and thrombophlebitis of other sites major depressive disorder, single episode, unspecified post-traumatic stress disorder, unspecified tobacco use acute pulmonary edema gastro-esophageal reflux disease without esophagitis homelessness borderline personality disorder anxiety disorder, unspecified hb-ss disease with crisis, unspecified suicidal ideations major depressive disorder, recurrent, unspecified gastro-esophageal reflux disease without esophagitis sickle-cell disease without crisis nicotine dependence, cigarettes, uncomplicated acquired absence of spleen acquired absence of other specified parts of digestive tract patient's unintentional underdosing of medication regimen for other reason other chest pain procedure and treatment not carried out because of patient's decision for other reasons underdosing of other opioids, initial encounter homelessness opioid use, unspecified with opioid-induced mood disorder unspecified place or not applicable physical restraint status hypertensive urgency opioid use, unspecified, uncomplicated hb-ss disease with acute chest syndrome adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter long qt syndrome gastro-esophageal reflux disease without esophagitis sickle-cell/hb-c disease without crisis chest pain, unspecified homelessness opioid dependence, uncomplicated bradycardia, unspecified unspecified place in hospital as the place of occurrence of the external cause essential (primary) hypertension sickle-cell/hb-c disease with acute chest syndrome acquired absence of spleen nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] influenza due to other identified influenza virus with unspecified type of pneumonia transfusion associated circulatory overload homelessness adverse effect of other opioids, initial encounter
white f 35 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  491  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  95  mg dl$lisinopril  40  mg ; influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; acetaminophen  1000  mg ; folic acid  1  mg ; ondansetron  4  mg ; oxycodone (immediate release)  30  mg ; oxycodone sr (oxycontin)  20  mg ; tizanidine  8  mg ; pantoprazole  40  mg ; 
essential (primary) hypertension opioid use, unspecified with withdrawal acquired absence of spleen phlebitis and thrombophlebitis of other sites major depressive disorder, single episode, unspecified post-traumatic stress disorder, unspecified tobacco use acute pulmonary edema gastro-esophageal reflux disease without esophagitis homelessness borderline personality disorder anxiety disorder, unspecified hb-ss disease with crisis, unspecified suicidal ideations major depressive disorder, recurrent, unspecified gastro-esophageal reflux disease without esophagitis sickle-cell disease without crisis nicotine dependence, cigarettes, uncomplicated acquired absence of spleen acquired absence of other specified parts of digestive tract patient's unintentional underdosing of medication regimen for other reason other chest pain procedure and treatment not carried out because of patient's decision for other reasons underdosing of other opioids, initial encounter homelessness opioid use, unspecified with opioid-induced mood disorder unspecified place or not applicable physical restraint status hypertensive urgency opioid use, unspecified, uncomplicated hb-ss disease with acute chest syndrome adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter long qt syndrome gastro-esophageal reflux disease without esophagitis sickle-cell/hb-c disease without crisis chest pain, unspecified homelessness opioid dependence, uncomplicated bradycardia, unspecified unspecified place in hospital as the place of occurrence of the external cause essential (primary) hypertension sickle-cell/hb-c disease with acute chest syndrome acquired absence of spleen nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] influenza due to other identified influenza virus with unspecified type of pneumonia transfusion associated circulatory overload homelessness adverse effect of other opioids, initial encounter
white f 35 $nan$nan$lisinopril  40  mg ; influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; acetaminophen  1000  mg ; ondansetron  4  mg ; oxycodone (immediate release)  30  mg ; oxycodone sr (oxycontin)  20  mg ; tizanidine  8  mg ; pantoprazole  40  mg ; folic acid  5  mg ; hydromorphone (dilaudid)  3  mg ; 
essential (primary) hypertension opioid use, unspecified with withdrawal acquired absence of spleen phlebitis and thrombophlebitis of other sites major depressive disorder, single episode, unspecified post-traumatic stress disorder, unspecified tobacco use acute pulmonary edema gastro-esophageal reflux disease without esophagitis homelessness borderline personality disorder anxiety disorder, unspecified hb-ss disease with crisis, unspecified suicidal ideations major depressive disorder, recurrent, unspecified gastro-esophageal reflux disease without esophagitis sickle-cell disease without crisis nicotine dependence, cigarettes, uncomplicated acquired absence of spleen acquired absence of other specified parts of digestive tract patient's unintentional underdosing of medication regimen for other reason other chest pain procedure and treatment not carried out because of patient's decision for other reasons underdosing of other opioids, initial encounter homelessness opioid use, unspecified with opioid-induced mood disorder unspecified place or not applicable physical restraint status hypertensive urgency opioid use, unspecified, uncomplicated hb-ss disease with acute chest syndrome adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter long qt syndrome gastro-esophageal reflux disease without esophagitis sickle-cell/hb-c disease without crisis chest pain, unspecified homelessness opioid dependence, uncomplicated bradycardia, unspecified unspecified place in hospital as the place of occurrence of the external cause essential (primary) hypertension sickle-cell/hb-c disease with acute chest syndrome acquired absence of spleen nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] influenza due to other identified influenza virus with unspecified type of pneumonia transfusion associated circulatory overload homelessness adverse effect of other opioids, initial encounter
white f 35 $nan$nan$lisinopril  40  mg ; influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; acetaminophen  1000  mg ; ondansetron  4  mg ; oxycodone (immediate release)  30  mg ; oxycodone sr (oxycontin)  20  mg ; tizanidine  8  mg ; pantoprazole  40  mg ; folic acid  5  mg ; hydromorphone (dilaudid)  3  mg ; 
essential (primary) hypertension opioid use, unspecified with withdrawal acquired absence of spleen phlebitis and thrombophlebitis of other sites major depressive disorder, single episode, unspecified post-traumatic stress disorder, unspecified tobacco use acute pulmonary edema gastro-esophageal reflux disease without esophagitis homelessness borderline personality disorder anxiety disorder, unspecified hb-ss disease with crisis, unspecified suicidal ideations major depressive disorder, recurrent, unspecified gastro-esophageal reflux disease without esophagitis sickle-cell disease without crisis nicotine dependence, cigarettes, uncomplicated acquired absence of spleen acquired absence of other specified parts of digestive tract patient's unintentional underdosing of medication regimen for other reason other chest pain procedure and treatment not carried out because of patient's decision for other reasons underdosing of other opioids, initial encounter homelessness opioid use, unspecified with opioid-induced mood disorder unspecified place or not applicable physical restraint status hypertensive urgency opioid use, unspecified, uncomplicated hb-ss disease with acute chest syndrome adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter long qt syndrome gastro-esophageal reflux disease without esophagitis sickle-cell/hb-c disease without crisis chest pain, unspecified homelessness opioid dependence, uncomplicated bradycardia, unspecified unspecified place in hospital as the place of occurrence of the external cause essential (primary) hypertension sickle-cell/hb-c disease with acute chest syndrome acquired absence of spleen nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] influenza due to other identified influenza virus with unspecified type of pneumonia transfusion associated circulatory overload homelessness adverse effect of other opioids, initial encounter
other m 77 $nan$nan$insulin  20  unit ; aspirin  81  mg ; clopidogrel  75  mg ; simvastatin  40  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified osteomyelitis, ankle and foot diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled unspecified cataract ulcer of other part of foot other amputation stump complication other and unspecified hyperlipidemia peripheral angiopathy in diseases classified elsewhere atherosclerosis of native arteries of the extremities with ulceration unspecified hereditary and idiopathic peripheral neuropathy proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of insulin chronic kidney disease, unspecified amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension cellulitis and abscess of foot, except toes other postprocedural status long-term (current) use of insulin other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atherosclerosis of native arteries of the extremities, unspecified infection (chronic) of amputation stump diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled arterial embolism and thrombosis of lower extremity other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of insulin atherosclerosis of native arteries of the extremities, unspecified unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified ulcer of other part of foot streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site chronic kidney disease, unspecified cellulitis and abscess of leg, except foot atherosclerosis of native arteries of the extremities with gangrene diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled
other m 77 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  61  mg dl; chemistry blood % hemoglobin a1c  6.9  %$insulin  20  unit ; aspirin  81  mg ; clopidogrel  75  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; insulin  0  unit ; heparin  5000  unit ; metoprolol tartrate  50  mg ; insulin  22  unit ; magnesium oxide  800  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified osteomyelitis, ankle and foot diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled unspecified cataract ulcer of other part of foot other amputation stump complication other and unspecified hyperlipidemia peripheral angiopathy in diseases classified elsewhere atherosclerosis of native arteries of the extremities with ulceration unspecified hereditary and idiopathic peripheral neuropathy proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of insulin chronic kidney disease, unspecified amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension cellulitis and abscess of foot, except toes other postprocedural status long-term (current) use of insulin other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atherosclerosis of native arteries of the extremities, unspecified infection (chronic) of amputation stump diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled arterial embolism and thrombosis of lower extremity other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of insulin atherosclerosis of native arteries of the extremities, unspecified unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified ulcer of other part of foot streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site chronic kidney disease, unspecified cellulitis and abscess of leg, except foot atherosclerosis of native arteries of the extremities with gangrene diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled
white m 73 $nan$hematology blood hematocrit  34.7  %; hematology blood hematocrit  31.8  %; hematology blood hemoglobin  11.4  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  72  k ul; hematology blood platelet count  48  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  24  meq l; chemistry blood anion gap  25  meq l; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  4.5  mg dl; chemistry blood creatinine  5.0  mg dl; chemistry blood creatinine  4.2  mg dl; chemistry blood potassium  5.9  meq l; chemistry blood potassium  5.3  meq l; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood urea nitrogen  65  mg dl; chemistry blood urea nitrogen  58  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  6.2  mg dl; chemistry blood calcium, total  6.1  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, indirect  0.2  mg dl; chemistry blood bilirubin, indirect  0.2  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  98  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  634  iu l; chemistry blood lactate dehydrogenase (ld)  539  iu l; chemistry blood albumin  2.0  g dl; chemistry blood albumin  1.8  g dl; hematology blood bands  3  %; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  0.94  mmol l; blood gas blood free calcium  0.94  mmol l; blood gas blood free calcium  0.92  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  1.8  mmol l; chemistry blood bilirubin, direct  2.2  mg dl; chemistry blood bilirubin, direct  2.2  mg dl; blood gas blood chloride, whole blood  102  meq l; blood gas blood glucose  107  mg dl; blood gas blood hematocrit, calculated  34  %; blood gas blood hemoglobin  11.3  g dl; blood gas blood potassium, whole blood  5.4  meq l; blood gas blood potassium, whole blood  5.9  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood sodium, whole blood  126  meq l; blood gas blood calculated bicarbonate, whole blood  16  meq l$5% dextrose  50  ml ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; lidocaine jelly 2% (urojet)  1  appl ; sodium chloride 0.9%  flush  10  ml ; famotidine  20  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; bag  50  ml ; fentanyl citrate  2.5  mg ; propofol  1000  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; furosemide  100  mg ; chlorothiazide sodium  500  mg ; 0.9% sodium chloride  500  ml ; calcium gluconate  20  g ; sodium chloride 0.9%  flush  100-200  ml ; sodium citrate 4%  2.4  ml ; bag  5000  ml ; prismasate (b22 k4)  5000  ml ; prismasate (b32 k2)  5000  ml ; sw  100  ml ; potassium chloride  10  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; heparin (crrt machine priming)  5000  unit ; neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; hydrocortisone na succ.  100  mg ; 5% dextrose  100  ml ; doxycycline hyclate  100  mg ; albuterol inhaler  2  puff ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; ipratropium bromide mdi  6  puff ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; argatroban  50  mg ; thiamine  100  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  26.7  %; hematology blood hematocrit  26.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  22  k ul; hematology blood platelet count  20  k ul; chemistry blood anion gap  23  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  4.2  mg dl; chemistry blood creatinine  3.2  mg dl; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  57  mg dl; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  133  mg dl; chemistry blood lactate dehydrogenase (ld)  378  iu l; chemistry blood albumin  1.6  g dl; hematology blood bands  1  %; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.23  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.6  meq l$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; bag  50  ml ; fentanyl citrate  2.5  mg ; propofol  1000  mg ; 0.9% sodium chloride  500  ml ; calcium gluconate  20  g ; sodium chloride 0.9%  flush  100-200  ml ; sodium citrate 4%  2.4  ml ; bag  5000  ml ; prismasate (b22 k4)  5000  ml ; prismasate (b32 k2)  5000  ml ; sw  100  ml ; potassium chloride  10  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; hydrocortisone na succ.  100  mg ; albuterol inhaler  2  puff ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; ipratropium bromide mdi  6  puff ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; thiamine  100  mg ; heparin flush (5000 units ml)  5000  unit ; folic acid  1  mg ; ascorbic acid  250  mg ; dorzolamide 2% ophth. soln.  1  drop ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; syringe (sw)  1  ml ; alteplase (catheter clearance)  1  mg ; 0.9% sodium chloride  50  ml ; desmopressin acetate  25  mcg ; ns  100  ml ; metronidazole  500  mg ; azopt  1  gtt ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  26.9  %; hematology blood hematocrit  26.4  %; hematology blood hematocrit  25.6  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  34  k ul; hematology blood platelet count  21  k ul; hematology blood platelet count  21  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  186  mg dl; chemistry blood glucose  165  mg dl; chemistry blood glucose  169  mg dl; chemistry blood albumin  2.1  g dl; hematology blood bands  0  %; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  4.2  meq l$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; bag  50  ml ; fentanyl citrate  2.5  mg ; propofol  1000  mg ; 0.9% sodium chloride  500  ml ; calcium gluconate  20  g ; sodium chloride 0.9%  flush  100-200  ml ; sodium citrate 4%  2.4  ml ; bag  5000  ml ; prismasate (b22 k4)  5000  ml ; prismasate (b32 k2)  5000  ml ; sw  100  ml ; potassium chloride  10  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; hydrocortisone na succ.  100  mg ; albuterol inhaler  2  puff ; ipratropium bromide mdi  6  puff ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; thiamine  100  mg ; heparin flush (5000 units ml)  5000  unit ; folic acid  1  mg ; ascorbic acid  250  mg ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; syringe (sw)  1  ml ; alteplase (catheter clearance)  1  mg ; 0.9% sodium chloride  50  ml ; desmopressin acetate  25  mcg ; ns  100  ml ; metronidazole  500  mg ; azopt  1  gtt ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; nystatin oral suspension  5  ml ; hydrocortisone na succ.  50  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  27.1  %; hematology blood hematocrit  24.7  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  18  k ul; hematology blood platelet count  26  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  138  mg dl; chemistry blood lactate dehydrogenase (ld)  382  iu l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.4  meq l$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  500  ml ; calcium gluconate  20  g ; sodium chloride 0.9%  flush  100-200  ml ; sodium citrate 4%  2.4  ml ; bag  5000  ml ; prismasate (b22 k4)  5000  ml ; prismasate (b32 k2)  5000  ml ; sw  100  ml ; potassium chloride  10  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; albuterol inhaler  2  puff ; ipratropium bromide mdi  6  puff ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; thiamine  100  mg ; folic acid  1  mg ; ascorbic acid  250  mg ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; ns  100  ml ; metronidazole  500  mg ; azopt  1  gtt ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; nystatin oral suspension  5  ml ; hydrocortisone na succ.  50  mg ; metoprolol tartrate  12.5  mg ; trazodone  25  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  24.4  %; hematology blood hematocrit  22.9  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  22  k ul; hematology blood platelet count  21  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  4.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  75  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  100  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  500  ml ; calcium gluconate  20  g ; sodium chloride 0.9%  flush  100-200  ml ; sodium citrate 4%  2.4  ml ; sw  100  ml ; potassium chloride  10  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; albuterol inhaler  2  puff ; ipratropium bromide mdi  6  puff ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; thiamine  100  mg ; folic acid  1  mg ; ascorbic acid  250  mg ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; azopt  1  gtt ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; nystatin oral suspension  5  ml ; metoprolol tartrate  12.5  mg ; trazodone  25  mg ; prednisone  20  mg ; ipratropium bromide mdi  2  puff ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; olanzapine  2.5  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  22.1  %; hematology blood hematocrit  21.0  %; hematology blood hematocrit  23.1  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  40  k ul; hematology blood platelet count  36  k ul; hematology blood platelet count  29  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  5.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  100  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  79  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  500  ml ; calcium gluconate  20  g ; sw  100  ml ; potassium chloride  10  meq ; neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; folic acid  1  mg ; ascorbic acid  250  mg ; azopt  1  gtt ; nystatin oral suspension  5  ml ; metoprolol tartrate  12.5  mg ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; olanzapine  2.5  mg ; heparin flush (10 units ml)  1  ml ; quetiapine fumarate  25  mg ; nephrocaps  1  cap ; heparin dwell (1000 units ml)  2000-8000  unit ; sodium chloride 0.9%  1000  ml ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  21.0  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  44  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  5.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  77  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  94  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; folic acid  1  mg ; ascorbic acid  250  mg ; azopt  1  gtt ; nystatin oral suspension  5  ml ; metoprolol tartrate  12.5  mg ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; quetiapine fumarate  25  mg ; nephrocaps  1  cap ; heparin dwell (1000 units ml)  2000-8000  unit ; sodium chloride 0.9%  1000  ml ; tuberculin protein  0.1  ml ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  120  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  6.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  99  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  89  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; folic acid  1  mg ; ascorbic acid  250  mg ; azopt  1  gtt ; nystatin oral suspension  5  ml ; metoprolol tartrate  12.5  mg ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; quetiapine fumarate  25  mg ; nephrocaps  1  cap ; heparin dwell (1000 units ml)  2000-8000  unit ; tuberculin protein  0.1  ml ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  22.7  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  108  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  4.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  103  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; folic acid  1  mg ; ascorbic acid  250  mg ; azopt  1  gtt ; nystatin oral suspension  5  ml ; metoprolol tartrate  12.5  mg ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; quetiapine fumarate  25  mg ; nephrocaps  1  cap ; tamsulosin  0.4  mg ; heparin  5000  unit ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  6.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  74  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  87  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; folic acid  1  mg ; ascorbic acid  250  mg ; azopt  1  gtt ; nystatin oral suspension  5  ml ; metoprolol tartrate  12.5  mg ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; quetiapine fumarate  25  mg ; nephrocaps  1  cap ; tamsulosin  0.4  mg ; heparin  5000  unit ; fluticasone propionate nasal  1  spry ; sodium chloride nasal  1-2  spry ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  21.3  %; hematology blood hematocrit  22.7  %; hematology blood hemoglobin  7.3  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  99  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  4.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood glucose  91  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; folic acid  1  mg ; ascorbic acid  250  mg ; azopt  1  gtt ; nystatin oral suspension  5  ml ; metoprolol tartrate  12.5  mg ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; quetiapine fumarate  25  mg ; nephrocaps  1  cap ; tamsulosin  0.4  mg ; heparin  5000  unit ; fluticasone propionate nasal  1  spry ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  21.8  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  95  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  5.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  89  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; folic acid  1  mg ; ascorbic acid  250  mg ; azopt  1  gtt ; nystatin oral suspension  5  ml ; metoprolol tartrate  12.5  mg ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; quetiapine fumarate  25  mg ; nephrocaps  1  cap ; tamsulosin  0.4  mg ; heparin  5000  unit ; fluticasone propionate nasal  1  spry ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin  81  mg ; simvastatin  20  mg ; metoprolol tartrate  25  mg ; metoprolol tartrate  5  mg ; furosemide  80  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  22.6  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  6.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood glucose  87  mg dl$neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; azopt  1  gtt ; nystatin oral suspension  5  ml ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; quetiapine fumarate  25  mg ; nephrocaps  1  cap ; tamsulosin  0.4  mg ; heparin  5000  unit ; fluticasone propionate nasal  1  spry ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin  81  mg ; simvastatin  20  mg ; furosemide  80  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  6.1  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  69  mg dl; chemistry blood glucose  89  mg dl$neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; azopt  1  gtt ; nystatin oral suspension  5  ml ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; quetiapine fumarate  25  mg ; nephrocaps  1  cap ; tamsulosin  0.4  mg ; heparin  5000  unit ; fluticasone propionate nasal  1  spry ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin  81  mg ; simvastatin  20  mg ; metoprolol tartrate  50  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  5.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  68  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  124  mg dl$neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; azopt  1  gtt ; nystatin oral suspension  5  ml ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; quetiapine fumarate  25  mg ; nephrocaps  1  cap ; tamsulosin  0.4  mg ; heparin  5000  unit ; fluticasone propionate nasal  1  spry ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin  81  mg ; simvastatin  20  mg ; metoprolol tartrate  50  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  5.5  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  67  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  90  mg dl; chemistry blood albumin  2.9  g dl$neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; azopt  1  gtt ; nystatin oral suspension  5  ml ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; quetiapine fumarate  25  mg ; nephrocaps  1  cap ; tamsulosin  0.4  mg ; heparin  5000  unit ; fluticasone propionate nasal  1  spry ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin  81  mg ; metoprolol tartrate  50  mg ; isosorbide dinitrate  10  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  4.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  2.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  86  mg dl$neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; azopt  1  gtt ; nystatin oral suspension  5  ml ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; quetiapine fumarate  25  mg ; nephrocaps  1  cap ; tamsulosin  0.4  mg ; heparin  5000  unit ; fluticasone propionate nasal  1  spry ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin  81  mg ; metoprolol tartrate  50  mg ; isosorbide dinitrate  10  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; metoprolol tartrate  75  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  4.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  56  mg dl; chemistry blood glucose  91  mg dl$neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; azopt  1  gtt ; nystatin oral suspension  5  ml ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; quetiapine fumarate  25  mg ; nephrocaps  1  cap ; tamsulosin  0.4  mg ; heparin  5000  unit ; fluticasone propionate nasal  1  spry ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin  81  mg ; isosorbide dinitrate  10  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; metoprolol tartrate  75  mg ; acetaminophen  650  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  92  mg dl$neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; azopt  1  gtt ; nystatin oral suspension  5  ml ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; quetiapine fumarate  25  mg ; nephrocaps  1  cap ; tamsulosin  0.4  mg ; heparin  5000  unit ; fluticasone propionate nasal  1  spry ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin  81  mg ; isosorbide dinitrate  10  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  75  mg ; acetaminophen  650  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  2.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  98  mg dl$neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; azopt  1  gtt ; nystatin oral suspension  5  ml ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; quetiapine fumarate  25  mg ; nephrocaps  1  cap ; tamsulosin  0.4  mg ; heparin  5000  unit ; fluticasone propionate nasal  1  spry ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin  81  mg ; isosorbide dinitrate  10  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  75  mg ; acetaminophen  650  mg ; heparin  6900  unit ; heparin  1700-3400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; warfarin  5  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  77  mg dl$neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; azopt  1  gtt ; nystatin oral suspension  5  ml ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; nephrocaps  1  cap ; tamsulosin  0.4  mg ; fluticasone propionate nasal  1  spry ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin  81  mg ; isosorbide dinitrate  10  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  75  mg ; acetaminophen  650  mg ; heparin  6900  unit ; heparin  1700-3400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; warfarin  5  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  85  mg dl; chemistry blood glucose  84  mg dl$neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; azopt  1  gtt ; nystatin oral suspension  5  ml ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; nephrocaps  1  cap ; tamsulosin  0.4  mg ; fluticasone propionate nasal  1  spry ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin  81  mg ; isosorbide dinitrate  10  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  1700-3400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; warfarin  5  mg ; vitamin d  1000  unit ; metoprolol succinate xl  100  mg ; sulfameth trimethoprim ss  0.5  tab ; isosorbide mononitrate (extended release)  30  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 73 $nan$nan$neomycin-polymyxin-bacitracin  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; timolol maleate 0.5%  1  drop ; azopt  1  gtt ; nystatin oral suspension  5  ml ; prednisone  20  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin flush (10 units ml)  1  ml ; nephrocaps  1  cap ; tamsulosin  0.4  mg ; fluticasone propionate nasal  1  spry ; sodium chloride nasal  1-2  spry ; senna  8.6  mg ; docusate sodium  100  mg ; aspirin  81  mg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  1700-3400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; warfarin  5  mg ; vitamin d  1000  unit ; metoprolol succinate xl  100  mg ; sulfameth trimethoprim ss  0.5  tab ; isosorbide mononitrate (extended release)  30  mg ; 
family history of malignant neoplasm, unspecified personal history of colonic polyps noninfective gastroenteritis and colitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unspecified abdominal pain abnormal weight loss unspecified protein-calorie malnutrition essential (primary) hypertension unspecified glaucoma nicotine dependence, cigarettes, uncomplicated personal history of malignant neoplasm of bladder anemia, unspecified 
white m 68 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  107  mg dl; chemistry blood glucose  88  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; pantoprazole  40  mg ; heparin  5000  unit ; metoprolol succinate xl  50  mg ; lisinopril  20  mg ; niacin sr  500  mg ; simvastatin  40  mg ; aspirin  325  mg ; multivitamins  1  tab ; amiodarone  200  mg ; docusate sodium  100  mg ; furosemide  40  mg ; imipramine  200  mg ; perphenazine  6  mg ; 
congestive heart failure, unspecified chronic systolic heart failure other and unspecified hyperlipidemia automatic implantable cardiac defibrillator in situ acute kidney failure, unspecified paroxysmal ventricular tachycardia unspecified essential hypertension other primary cardiomyopathies dehydration other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension automatic implantable cardiac defibrillator in situ peripheral vascular disease, unspecified intestinal infection due to other organism, not elsewhere classified other primary cardiomyopathies congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled abdominal aneurysm without mention of rupture other specified cystic kidney disease other and unspecified hyperlipidemia tobacco use disorder paroxysmal ventricular tachycardia calculus of gallbladder without mention of cholecystitis, without mention of obstruction other diseases of lung, not elsewhere classified dehydration other and unspecified hyperlipidemia other primary cardiomyopathies diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension acute kidney failure, unspecified automatic implantable cardiac defibrillator in situ other primary cardiomyopathies diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled paroxysmal ventricular tachycardia acute kidney failure, unspecified peripheral vascular disease, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified automatic implantable cardiac defibrillator in situ dehydration chronic systolic heart failure congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other primary cardiomyopathies congestive heart failure, unspecified acute on chronic systolic heart failure paroxysmal ventricular tachycardia unspecified essential hypertension
white m 68 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  95  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; pantoprazole  40  mg ; heparin  5000  unit ; lisinopril  20  mg ; niacin sr  500  mg ; simvastatin  40  mg ; aspirin  325  mg ; multivitamins  1  tab ; amiodarone  200  mg ; docusate sodium  100  mg ; imipramine  200  mg ; perphenazine  6  mg ; potassium chloride  40  meq ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; metoprolol tartrate  50  mg ; sw  50  ml ; magnesium sulfate  2  gm ; furosemide  20  mg ; 
congestive heart failure, unspecified chronic systolic heart failure other and unspecified hyperlipidemia automatic implantable cardiac defibrillator in situ acute kidney failure, unspecified paroxysmal ventricular tachycardia unspecified essential hypertension other primary cardiomyopathies dehydration other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension automatic implantable cardiac defibrillator in situ peripheral vascular disease, unspecified intestinal infection due to other organism, not elsewhere classified other primary cardiomyopathies congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled abdominal aneurysm without mention of rupture other specified cystic kidney disease other and unspecified hyperlipidemia tobacco use disorder paroxysmal ventricular tachycardia calculus of gallbladder without mention of cholecystitis, without mention of obstruction other diseases of lung, not elsewhere classified dehydration other and unspecified hyperlipidemia other primary cardiomyopathies diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension acute kidney failure, unspecified automatic implantable cardiac defibrillator in situ other primary cardiomyopathies diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled paroxysmal ventricular tachycardia acute kidney failure, unspecified peripheral vascular disease, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified automatic implantable cardiac defibrillator in situ dehydration chronic systolic heart failure congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other primary cardiomyopathies congestive heart failure, unspecified acute on chronic systolic heart failure paroxysmal ventricular tachycardia unspecified essential hypertension
white m 68 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  122  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; pantoprazole  40  mg ; heparin  5000  unit ; lisinopril  20  mg ; niacin sr  500  mg ; simvastatin  40  mg ; aspirin  325  mg ; multivitamins  1  tab ; amiodarone  200  mg ; docusate sodium  100  mg ; imipramine  200  mg ; perphenazine  6  mg ; potassium chloride  40  meq ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; metoprolol tartrate  50  mg ; sw  50  ml ; magnesium sulfate  2  gm ; furosemide  20  mg ; bupropion (sustained release)  150  mg ; 
congestive heart failure, unspecified chronic systolic heart failure other and unspecified hyperlipidemia automatic implantable cardiac defibrillator in situ acute kidney failure, unspecified paroxysmal ventricular tachycardia unspecified essential hypertension other primary cardiomyopathies dehydration other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension automatic implantable cardiac defibrillator in situ peripheral vascular disease, unspecified intestinal infection due to other organism, not elsewhere classified other primary cardiomyopathies congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled abdominal aneurysm without mention of rupture other specified cystic kidney disease other and unspecified hyperlipidemia tobacco use disorder paroxysmal ventricular tachycardia calculus of gallbladder without mention of cholecystitis, without mention of obstruction other diseases of lung, not elsewhere classified dehydration other and unspecified hyperlipidemia other primary cardiomyopathies diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension acute kidney failure, unspecified automatic implantable cardiac defibrillator in situ other primary cardiomyopathies diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled paroxysmal ventricular tachycardia acute kidney failure, unspecified peripheral vascular disease, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified automatic implantable cardiac defibrillator in situ dehydration chronic systolic heart failure congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other primary cardiomyopathies congestive heart failure, unspecified acute on chronic systolic heart failure paroxysmal ventricular tachycardia unspecified essential hypertension
white f 58 $temp  97.6  heartrate  113.0  resprate  22.0  o2sat  100.0  sbp  116.0  dbp  77.0  rhythm    pain  0  ; temp    heartrate  96.0  resprate  20.0  o2sat  97.0  sbp  111.0  dbp  72.0  rhythm    pain  0  $nan$levothyroxine sodium  200  mcg ; 
personal history of other malignant neoplasm of large intestine old myocardial infarction secondary malignant neoplasm of liver and intrahepatic bile duct hyperlipidemia, unspecified secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft malignant neoplasm of rectosigmoid junction disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter age-related osteoporosis without current pathological fracture fatty (change of) liver, not elsewhere classified unspecified protein-calorie malnutrition essential (primary) hypertension hypothyroidism, unspecified personal history of other venous thrombosis and embolism other specified soft tissue disorders neoplasm related pain (acute) (chronic) other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure body mass index (bmi) 21.0-21.9, adult ileostomy status other place in single-family (private) house as the place of occurrence of the external cause hypoglycemia, unspecified anemia in neoplastic disease secondary malignant neoplasm of unspecified lung surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia pathological fracture, other site, initial encounter for fracture other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension presence of coronary angioplasty implant and graft eosinophilic esophagitis turner's syndrome, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified ileostomy status other postprocedural complications and disorders of digestive system secondary malignant neoplasm of liver and intrahepatic bile duct retention of urine, unspecified personal history of other venous thrombosis and embolism hypothyroidism, unspecified osteomyelitis of vertebra, sacral and sacrococcygeal region gangrene, not elsewhere classified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter old myocardial infarction patient room in hospital as the place of occurrence of the external cause malignant neoplasm of rectosigmoid junction unspecified severe protein-calorie malnutrition long term (current) use of anticoagulants
white f 58 $temp  97.8  heartrate  92.0  resprate  18.0  o2sat  96.0  sbp  121.0  dbp  66.0  rhythm    pain  0  $hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  71  mg dl; chemistry blood lactate dehydrogenase (ld)  426  iu l$levothyroxine sodium  200  mcg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ascorbic acid  500  mg ; morphine sr (ms contin)  30  mg ; oxycodone (immediate release)  2.5-5  mg ; cholestyramine  4  gm ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; magnesium oxide  400  mg ; omeprazole  20  mg ; ondansetron odt  8  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; rosuvastatin calcium  40  mg ; senna  8.6  mg ; tamsulosin  0.4  mg ; vitamin e  400  unit ; amoxicillin-clavulanic acid  875  mg ; doxycycline hyclate  100  mg ; heparin  4100  unit ; heparin  1000-2000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; aspirin  81  mg ; enoxaparin sodium  80  mg ; bag  1  bag ; magnesium sulfate  4  gm ; levothyroxine sodium  100  mcg ; lidocaine 1%  20  ml ; 
personal history of other malignant neoplasm of large intestine old myocardial infarction secondary malignant neoplasm of liver and intrahepatic bile duct hyperlipidemia, unspecified secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft malignant neoplasm of rectosigmoid junction disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter age-related osteoporosis without current pathological fracture fatty (change of) liver, not elsewhere classified unspecified protein-calorie malnutrition essential (primary) hypertension hypothyroidism, unspecified personal history of other venous thrombosis and embolism other specified soft tissue disorders neoplasm related pain (acute) (chronic) other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure body mass index (bmi) 21.0-21.9, adult ileostomy status other place in single-family (private) house as the place of occurrence of the external cause hypoglycemia, unspecified anemia in neoplastic disease secondary malignant neoplasm of unspecified lung surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia pathological fracture, other site, initial encounter for fracture other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension presence of coronary angioplasty implant and graft eosinophilic esophagitis turner's syndrome, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified ileostomy status other postprocedural complications and disorders of digestive system secondary malignant neoplasm of liver and intrahepatic bile duct retention of urine, unspecified personal history of other venous thrombosis and embolism hypothyroidism, unspecified osteomyelitis of vertebra, sacral and sacrococcygeal region gangrene, not elsewhere classified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter old myocardial infarction patient room in hospital as the place of occurrence of the external cause malignant neoplasm of rectosigmoid junction unspecified severe protein-calorie malnutrition long term (current) use of anticoagulants
white f 58 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  151  mg dl$levothyroxine sodium  200  mcg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ascorbic acid  500  mg ; morphine sr (ms contin)  30  mg ; oxycodone (immediate release)  2.5-5  mg ; cholestyramine  4  gm ; cyanocobalamin  1000  mcg ; omeprazole  20  mg ; ondansetron odt  8  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; rosuvastatin calcium  40  mg ; senna  8.6  mg ; tamsulosin  0.4  mg ; vitamin e  400  unit ; amoxicillin-clavulanic acid  875  mg ; doxycycline hyclate  100  mg ; aspirin  81  mg ; bag  1  bag ; magnesium sulfate  4  gm ; levothyroxine sodium  100  mcg ; lidocaine 1%  20  ml ; ipratropium-albuterol neb  1  neb ; enoxaparin sodium  70  mg ; 
personal history of other malignant neoplasm of large intestine old myocardial infarction secondary malignant neoplasm of liver and intrahepatic bile duct hyperlipidemia, unspecified secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft malignant neoplasm of rectosigmoid junction disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter age-related osteoporosis without current pathological fracture fatty (change of) liver, not elsewhere classified unspecified protein-calorie malnutrition essential (primary) hypertension hypothyroidism, unspecified personal history of other venous thrombosis and embolism other specified soft tissue disorders neoplasm related pain (acute) (chronic) other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure body mass index (bmi) 21.0-21.9, adult ileostomy status other place in single-family (private) house as the place of occurrence of the external cause hypoglycemia, unspecified anemia in neoplastic disease secondary malignant neoplasm of unspecified lung surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia pathological fracture, other site, initial encounter for fracture other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension presence of coronary angioplasty implant and graft eosinophilic esophagitis turner's syndrome, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified ileostomy status other postprocedural complications and disorders of digestive system secondary malignant neoplasm of liver and intrahepatic bile duct retention of urine, unspecified personal history of other venous thrombosis and embolism hypothyroidism, unspecified osteomyelitis of vertebra, sacral and sacrococcygeal region gangrene, not elsewhere classified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter old myocardial infarction patient room in hospital as the place of occurrence of the external cause malignant neoplasm of rectosigmoid junction unspecified severe protein-calorie malnutrition long term (current) use of anticoagulants
white f 58 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  83  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  120  meq l; chemistry blood sodium  122  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.3  ; chemistry urine creatinine, urine  95  mg dl; chemistry urine urea nitrogen, urine  701  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  89  mg dl$levothyroxine sodium  200  mcg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ascorbic acid  500  mg ; morphine sr (ms contin)  30  mg ; oxycodone (immediate release)  2.5-5  mg ; cholestyramine  4  gm ; cyanocobalamin  1000  mcg ; omeprazole  20  mg ; ondansetron odt  8  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; rosuvastatin calcium  40  mg ; senna  8.6  mg ; tamsulosin  0.4  mg ; vitamin e  400  unit ; amoxicillin-clavulanic acid  875  mg ; doxycycline hyclate  100  mg ; aspirin  81  mg ; levothyroxine sodium  100  mcg ; ipratropium-albuterol neb  1  neb ; enoxaparin sodium  70  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  1000  ml ; 
personal history of other malignant neoplasm of large intestine old myocardial infarction secondary malignant neoplasm of liver and intrahepatic bile duct hyperlipidemia, unspecified secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft malignant neoplasm of rectosigmoid junction disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter age-related osteoporosis without current pathological fracture fatty (change of) liver, not elsewhere classified unspecified protein-calorie malnutrition essential (primary) hypertension hypothyroidism, unspecified personal history of other venous thrombosis and embolism other specified soft tissue disorders neoplasm related pain (acute) (chronic) other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure body mass index (bmi) 21.0-21.9, adult ileostomy status other place in single-family (private) house as the place of occurrence of the external cause hypoglycemia, unspecified anemia in neoplastic disease secondary malignant neoplasm of unspecified lung surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia pathological fracture, other site, initial encounter for fracture other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension presence of coronary angioplasty implant and graft eosinophilic esophagitis turner's syndrome, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified ileostomy status other postprocedural complications and disorders of digestive system secondary malignant neoplasm of liver and intrahepatic bile duct retention of urine, unspecified personal history of other venous thrombosis and embolism hypothyroidism, unspecified osteomyelitis of vertebra, sacral and sacrococcygeal region gangrene, not elsewhere classified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter old myocardial infarction patient room in hospital as the place of occurrence of the external cause malignant neoplasm of rectosigmoid junction unspecified severe protein-calorie malnutrition long term (current) use of anticoagulants
white f 58 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  83  meq l; chemistry blood chloride  83  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  119  meq l; chemistry blood sodium  122  meq l; chemistry blood sodium  124  meq l; chemistry blood sodium  119  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  88  mg dl$levothyroxine sodium  200  mcg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ascorbic acid  500  mg ; morphine sr (ms contin)  30  mg ; oxycodone (immediate release)  2.5-5  mg ; cholestyramine  4  gm ; cyanocobalamin  1000  mcg ; omeprazole  20  mg ; ondansetron odt  8  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; rosuvastatin calcium  40  mg ; senna  8.6  mg ; tamsulosin  0.4  mg ; vitamin e  400  unit ; amoxicillin-clavulanic acid  875  mg ; doxycycline hyclate  100  mg ; aspirin  81  mg ; levothyroxine sodium  100  mcg ; ipratropium-albuterol neb  1  neb ; enoxaparin sodium  70  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  1000  ml ; neutra-phos  2  pkt ; magnesium sulfate  2  gm ; bag  2  bag ; 
personal history of other malignant neoplasm of large intestine old myocardial infarction secondary malignant neoplasm of liver and intrahepatic bile duct hyperlipidemia, unspecified secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft malignant neoplasm of rectosigmoid junction disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter age-related osteoporosis without current pathological fracture fatty (change of) liver, not elsewhere classified unspecified protein-calorie malnutrition essential (primary) hypertension hypothyroidism, unspecified personal history of other venous thrombosis and embolism other specified soft tissue disorders neoplasm related pain (acute) (chronic) other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure body mass index (bmi) 21.0-21.9, adult ileostomy status other place in single-family (private) house as the place of occurrence of the external cause hypoglycemia, unspecified anemia in neoplastic disease secondary malignant neoplasm of unspecified lung surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia pathological fracture, other site, initial encounter for fracture other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension presence of coronary angioplasty implant and graft eosinophilic esophagitis turner's syndrome, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified ileostomy status other postprocedural complications and disorders of digestive system secondary malignant neoplasm of liver and intrahepatic bile duct retention of urine, unspecified personal history of other venous thrombosis and embolism hypothyroidism, unspecified osteomyelitis of vertebra, sacral and sacrococcygeal region gangrene, not elsewhere classified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter old myocardial infarction patient room in hospital as the place of occurrence of the external cause malignant neoplasm of rectosigmoid junction unspecified severe protein-calorie malnutrition long term (current) use of anticoagulants
white f 58 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.3  meq l; chemistry blood sodium  116  meq l; chemistry blood sodium  122  meq l; chemistry blood sodium  121  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry urine creatinine, urine  102  mg dl; hematology urine wbc  27  # hpf; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  73  mg dl; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood sodium, whole blood  118  meq l$levothyroxine sodium  200  mcg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ascorbic acid  500  mg ; morphine sr (ms contin)  30  mg ; oxycodone (immediate release)  2.5-5  mg ; cholestyramine  4  gm ; cyanocobalamin  1000  mcg ; omeprazole  20  mg ; ondansetron odt  8  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; rosuvastatin calcium  40  mg ; senna  8.6  mg ; tamsulosin  0.4  mg ; vitamin e  400  unit ; amoxicillin-clavulanic acid  875  mg ; doxycycline hyclate  100  mg ; aspirin  81  mg ; levothyroxine sodium  100  mcg ; ipratropium-albuterol neb  1  neb ; enoxaparin sodium  70  mg ; lidocaine 5% patch  1  ptch ; neutra-phos  2  pkt ; magnesium sulfate  2  gm ; bag  2  bag ; sodium chloride  1  gm ; 
personal history of other malignant neoplasm of large intestine old myocardial infarction secondary malignant neoplasm of liver and intrahepatic bile duct hyperlipidemia, unspecified secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft malignant neoplasm of rectosigmoid junction disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter age-related osteoporosis without current pathological fracture fatty (change of) liver, not elsewhere classified unspecified protein-calorie malnutrition essential (primary) hypertension hypothyroidism, unspecified personal history of other venous thrombosis and embolism other specified soft tissue disorders neoplasm related pain (acute) (chronic) other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure body mass index (bmi) 21.0-21.9, adult ileostomy status other place in single-family (private) house as the place of occurrence of the external cause hypoglycemia, unspecified anemia in neoplastic disease secondary malignant neoplasm of unspecified lung surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia pathological fracture, other site, initial encounter for fracture other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension presence of coronary angioplasty implant and graft eosinophilic esophagitis turner's syndrome, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified ileostomy status other postprocedural complications and disorders of digestive system secondary malignant neoplasm of liver and intrahepatic bile duct retention of urine, unspecified personal history of other venous thrombosis and embolism hypothyroidism, unspecified osteomyelitis of vertebra, sacral and sacrococcygeal region gangrene, not elsewhere classified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter old myocardial infarction patient room in hospital as the place of occurrence of the external cause malignant neoplasm of rectosigmoid junction unspecified severe protein-calorie malnutrition long term (current) use of anticoagulants
white f 58 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  122  meq l; chemistry blood sodium  123  meq l; chemistry blood sodium  122  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  82  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  117  mg dl$levothyroxine sodium  200  mcg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ascorbic acid  500  mg ; morphine sr (ms contin)  30  mg ; oxycodone (immediate release)  2.5-5  mg ; cholestyramine  4  gm ; cyanocobalamin  1000  mcg ; omeprazole  20  mg ; ondansetron odt  8  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; rosuvastatin calcium  40  mg ; senna  8.6  mg ; tamsulosin  0.4  mg ; vitamin e  400  unit ; amoxicillin-clavulanic acid  875  mg ; doxycycline hyclate  100  mg ; aspirin  81  mg ; levothyroxine sodium  100  mcg ; ipratropium-albuterol neb  1  neb ; enoxaparin sodium  70  mg ; lidocaine 5% patch  1  ptch ; magnesium sulfate  2  gm ; bag  2  bag ; sodium chloride  1  gm ; sodium chloride  2  gm ; albuterol 0.083% neb soln  1  neb ; 
personal history of other malignant neoplasm of large intestine old myocardial infarction secondary malignant neoplasm of liver and intrahepatic bile duct hyperlipidemia, unspecified secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft malignant neoplasm of rectosigmoid junction disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter age-related osteoporosis without current pathological fracture fatty (change of) liver, not elsewhere classified unspecified protein-calorie malnutrition essential (primary) hypertension hypothyroidism, unspecified personal history of other venous thrombosis and embolism other specified soft tissue disorders neoplasm related pain (acute) (chronic) other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure body mass index (bmi) 21.0-21.9, adult ileostomy status other place in single-family (private) house as the place of occurrence of the external cause hypoglycemia, unspecified anemia in neoplastic disease secondary malignant neoplasm of unspecified lung surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia pathological fracture, other site, initial encounter for fracture other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension presence of coronary angioplasty implant and graft eosinophilic esophagitis turner's syndrome, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified ileostomy status other postprocedural complications and disorders of digestive system secondary malignant neoplasm of liver and intrahepatic bile duct retention of urine, unspecified personal history of other venous thrombosis and embolism hypothyroidism, unspecified osteomyelitis of vertebra, sacral and sacrococcygeal region gangrene, not elsewhere classified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter old myocardial infarction patient room in hospital as the place of occurrence of the external cause malignant neoplasm of rectosigmoid junction unspecified severe protein-calorie malnutrition long term (current) use of anticoagulants
white f 58 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  9  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.3  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  121  meq l; chemistry blood sodium  122  meq l; chemistry blood sodium  121  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  111  mg dl; chemistry blood glucose  79  mg dl; chemistry blood glucose  102  mg dl$levothyroxine sodium  200  mcg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ascorbic acid  500  mg ; morphine sr (ms contin)  30  mg ; oxycodone (immediate release)  2.5-5  mg ; cholestyramine  4  gm ; cyanocobalamin  1000  mcg ; omeprazole  20  mg ; ondansetron odt  8  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; rosuvastatin calcium  40  mg ; senna  8.6  mg ; tamsulosin  0.4  mg ; vitamin e  400  unit ; amoxicillin-clavulanic acid  875  mg ; doxycycline hyclate  100  mg ; aspirin  81  mg ; levothyroxine sodium  100  mcg ; ipratropium-albuterol neb  1  neb ; enoxaparin sodium  70  mg ; lidocaine 5% patch  1  ptch ; magnesium sulfate  2  gm ; bag  2  bag ; sodium chloride  2  gm ; albuterol 0.083% neb soln  1  neb ; lorazepam  0.5  mg ; 
personal history of other malignant neoplasm of large intestine old myocardial infarction secondary malignant neoplasm of liver and intrahepatic bile duct hyperlipidemia, unspecified secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft malignant neoplasm of rectosigmoid junction disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter age-related osteoporosis without current pathological fracture fatty (change of) liver, not elsewhere classified unspecified protein-calorie malnutrition essential (primary) hypertension hypothyroidism, unspecified personal history of other venous thrombosis and embolism other specified soft tissue disorders neoplasm related pain (acute) (chronic) other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure body mass index (bmi) 21.0-21.9, adult ileostomy status other place in single-family (private) house as the place of occurrence of the external cause hypoglycemia, unspecified anemia in neoplastic disease secondary malignant neoplasm of unspecified lung surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia pathological fracture, other site, initial encounter for fracture other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension presence of coronary angioplasty implant and graft eosinophilic esophagitis turner's syndrome, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified ileostomy status other postprocedural complications and disorders of digestive system secondary malignant neoplasm of liver and intrahepatic bile duct retention of urine, unspecified personal history of other venous thrombosis and embolism hypothyroidism, unspecified osteomyelitis of vertebra, sacral and sacrococcygeal region gangrene, not elsewhere classified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter old myocardial infarction patient room in hospital as the place of occurrence of the external cause malignant neoplasm of rectosigmoid junction unspecified severe protein-calorie malnutrition long term (current) use of anticoagulants
white f 58 $nan$hematology blood hematocrit  23.1  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  121  meq l; chemistry blood sodium  119  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology urine wbc  72  # hpf; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  79  mg dl; chemistry blood glucose  83  mg dl$levothyroxine sodium  200  mcg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ascorbic acid  500  mg ; morphine sr (ms contin)  30  mg ; oxycodone (immediate release)  2.5-5  mg ; cholestyramine  4  gm ; cyanocobalamin  1000  mcg ; omeprazole  20  mg ; ondansetron odt  8  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; rosuvastatin calcium  40  mg ; senna  8.6  mg ; tamsulosin  0.4  mg ; vitamin e  400  unit ; amoxicillin-clavulanic acid  875  mg ; doxycycline hyclate  100  mg ; aspirin  81  mg ; levothyroxine sodium  100  mcg ; ipratropium-albuterol neb  1  neb ; enoxaparin sodium  70  mg ; lidocaine 5% patch  1  ptch ; magnesium sulfate  2  gm ; bag  2  bag ; sodium chloride  2  gm ; albuterol 0.083% neb soln  1  neb ; lorazepam  0.5  mg ; 
personal history of other malignant neoplasm of large intestine old myocardial infarction secondary malignant neoplasm of liver and intrahepatic bile duct hyperlipidemia, unspecified secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft malignant neoplasm of rectosigmoid junction disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter age-related osteoporosis without current pathological fracture fatty (change of) liver, not elsewhere classified unspecified protein-calorie malnutrition essential (primary) hypertension hypothyroidism, unspecified personal history of other venous thrombosis and embolism other specified soft tissue disorders neoplasm related pain (acute) (chronic) other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure body mass index (bmi) 21.0-21.9, adult ileostomy status other place in single-family (private) house as the place of occurrence of the external cause hypoglycemia, unspecified anemia in neoplastic disease secondary malignant neoplasm of unspecified lung surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia pathological fracture, other site, initial encounter for fracture other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension presence of coronary angioplasty implant and graft eosinophilic esophagitis turner's syndrome, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified ileostomy status other postprocedural complications and disorders of digestive system secondary malignant neoplasm of liver and intrahepatic bile duct retention of urine, unspecified personal history of other venous thrombosis and embolism hypothyroidism, unspecified osteomyelitis of vertebra, sacral and sacrococcygeal region gangrene, not elsewhere classified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter old myocardial infarction patient room in hospital as the place of occurrence of the external cause malignant neoplasm of rectosigmoid junction unspecified severe protein-calorie malnutrition long term (current) use of anticoagulants
white f 58 $nan$hematology blood hematocrit  21.7  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  5  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.3  meq l; chemistry blood sodium  117  meq l; chemistry blood sodium  120  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  95  mg dl; chemistry blood albumin  1.8  g dl$levothyroxine sodium  200  mcg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ascorbic acid  500  mg ; morphine sr (ms contin)  30  mg ; oxycodone (immediate release)  2.5-5  mg ; cholestyramine  4  gm ; cyanocobalamin  1000  mcg ; omeprazole  20  mg ; ondansetron odt  8  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; rosuvastatin calcium  40  mg ; senna  8.6  mg ; tamsulosin  0.4  mg ; vitamin e  400  unit ; amoxicillin-clavulanic acid  875  mg ; doxycycline hyclate  100  mg ; aspirin  81  mg ; levothyroxine sodium  100  mcg ; ipratropium-albuterol neb  1  neb ; enoxaparin sodium  70  mg ; lidocaine 5% patch  1  ptch ; magnesium sulfate  2  gm ; bag  2  bag ; sodium chloride  2  gm ; albuterol 0.083% neb soln  1  neb ; lorazepam  0.5  mg ; morphine sulfate  2-10  mg ; morphine sulfate  2-6  mg ; morphine sulfate (oral solution) 2 mg ml  5-10  mg ; lorazepam  0.5-2  mg ; 
personal history of other malignant neoplasm of large intestine old myocardial infarction secondary malignant neoplasm of liver and intrahepatic bile duct hyperlipidemia, unspecified secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft malignant neoplasm of rectosigmoid junction disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter age-related osteoporosis without current pathological fracture fatty (change of) liver, not elsewhere classified unspecified protein-calorie malnutrition essential (primary) hypertension hypothyroidism, unspecified personal history of other venous thrombosis and embolism other specified soft tissue disorders neoplasm related pain (acute) (chronic) other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure body mass index (bmi) 21.0-21.9, adult ileostomy status other place in single-family (private) house as the place of occurrence of the external cause hypoglycemia, unspecified anemia in neoplastic disease secondary malignant neoplasm of unspecified lung surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia pathological fracture, other site, initial encounter for fracture other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension presence of coronary angioplasty implant and graft eosinophilic esophagitis turner's syndrome, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified ileostomy status other postprocedural complications and disorders of digestive system secondary malignant neoplasm of liver and intrahepatic bile duct retention of urine, unspecified personal history of other venous thrombosis and embolism hypothyroidism, unspecified osteomyelitis of vertebra, sacral and sacrococcygeal region gangrene, not elsewhere classified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter old myocardial infarction patient room in hospital as the place of occurrence of the external cause malignant neoplasm of rectosigmoid junction unspecified severe protein-calorie malnutrition long term (current) use of anticoagulants
white f 58 $nan$nan$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; morphine sr (ms contin)  30  mg ; ondansetron odt  8  mg ; ipratropium-albuterol neb  1  neb ; lidocaine 5% patch  1  ptch ; sodium chloride  2  gm ; albuterol 0.083% neb soln  1  neb ; morphine sulfate (oral solution) 2 mg ml  5-10  mg ; lorazepam  0.5-2  mg ; morphine sulfate  2-4  mg ; morphine sulfate  4-8  mg ; morphine sulfate (concentrated oral solution) 20 mg ml  10  mg ; 0.9% sodium chloride  100  ml ; morphine sulfate  100  mg ; scopolamine patch  1  ptch ; 
personal history of other malignant neoplasm of large intestine old myocardial infarction secondary malignant neoplasm of liver and intrahepatic bile duct hyperlipidemia, unspecified secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft malignant neoplasm of rectosigmoid junction disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter age-related osteoporosis without current pathological fracture fatty (change of) liver, not elsewhere classified unspecified protein-calorie malnutrition essential (primary) hypertension hypothyroidism, unspecified personal history of other venous thrombosis and embolism other specified soft tissue disorders neoplasm related pain (acute) (chronic) other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure body mass index (bmi) 21.0-21.9, adult ileostomy status other place in single-family (private) house as the place of occurrence of the external cause hypoglycemia, unspecified anemia in neoplastic disease secondary malignant neoplasm of unspecified lung surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia pathological fracture, other site, initial encounter for fracture other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension presence of coronary angioplasty implant and graft eosinophilic esophagitis turner's syndrome, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified ileostomy status other postprocedural complications and disorders of digestive system secondary malignant neoplasm of liver and intrahepatic bile duct retention of urine, unspecified personal history of other venous thrombosis and embolism hypothyroidism, unspecified osteomyelitis of vertebra, sacral and sacrococcygeal region gangrene, not elsewhere classified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter old myocardial infarction patient room in hospital as the place of occurrence of the external cause malignant neoplasm of rectosigmoid junction unspecified severe protein-calorie malnutrition long term (current) use of anticoagulants
white f 58 $nan$nan$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron odt  8  mg ; ipratropium-albuterol neb  1  neb ; lidocaine 5% patch  1  ptch ; sodium chloride  2  gm ; albuterol 0.083% neb soln  1  neb ; lorazepam  0.5-2  mg ; scopolamine patch  1  ptch ; 
personal history of other malignant neoplasm of large intestine old myocardial infarction secondary malignant neoplasm of liver and intrahepatic bile duct hyperlipidemia, unspecified secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft malignant neoplasm of rectosigmoid junction disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter age-related osteoporosis without current pathological fracture fatty (change of) liver, not elsewhere classified unspecified protein-calorie malnutrition essential (primary) hypertension hypothyroidism, unspecified personal history of other venous thrombosis and embolism other specified soft tissue disorders neoplasm related pain (acute) (chronic) other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure body mass index (bmi) 21.0-21.9, adult ileostomy status other place in single-family (private) house as the place of occurrence of the external cause hypoglycemia, unspecified anemia in neoplastic disease secondary malignant neoplasm of unspecified lung surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia pathological fracture, other site, initial encounter for fracture other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension presence of coronary angioplasty implant and graft eosinophilic esophagitis turner's syndrome, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified ileostomy status other postprocedural complications and disorders of digestive system secondary malignant neoplasm of liver and intrahepatic bile duct retention of urine, unspecified personal history of other venous thrombosis and embolism hypothyroidism, unspecified osteomyelitis of vertebra, sacral and sacrococcygeal region gangrene, not elsewhere classified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter old myocardial infarction patient room in hospital as the place of occurrence of the external cause malignant neoplasm of rectosigmoid junction unspecified severe protein-calorie malnutrition long term (current) use of anticoagulants
white f 58 $nan$nan$heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ipratropium-albuterol neb  1  neb ; lidocaine 5% patch  1  ptch ; albuterol 0.083% neb soln  1  neb ; lorazepam  0.5-2  mg ; scopolamine patch  1  ptch ; glycopyrrolate  0.2  mg ; 
personal history of other malignant neoplasm of large intestine old myocardial infarction secondary malignant neoplasm of liver and intrahepatic bile duct hyperlipidemia, unspecified secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft malignant neoplasm of rectosigmoid junction disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter age-related osteoporosis without current pathological fracture fatty (change of) liver, not elsewhere classified unspecified protein-calorie malnutrition essential (primary) hypertension hypothyroidism, unspecified personal history of other venous thrombosis and embolism other specified soft tissue disorders neoplasm related pain (acute) (chronic) other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure body mass index (bmi) 21.0-21.9, adult ileostomy status other place in single-family (private) house as the place of occurrence of the external cause hypoglycemia, unspecified anemia in neoplastic disease secondary malignant neoplasm of unspecified lung surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypo-osmolality and hyponatremia pathological fracture, other site, initial encounter for fracture other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension presence of coronary angioplasty implant and graft eosinophilic esophagitis turner's syndrome, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified ileostomy status other postprocedural complications and disorders of digestive system secondary malignant neoplasm of liver and intrahepatic bile duct retention of urine, unspecified personal history of other venous thrombosis and embolism hypothyroidism, unspecified osteomyelitis of vertebra, sacral and sacrococcygeal region gangrene, not elsewhere classified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter old myocardial infarction patient room in hospital as the place of occurrence of the external cause malignant neoplasm of rectosigmoid junction unspecified severe protein-calorie malnutrition long term (current) use of anticoagulants
other f 25 $temp    heartrate  50.0  resprate  17.0  o2sat  100.0  sbp  96.0  dbp  65.0  rhythm    pain  0  ; temp    heartrate  51.0  resprate  17.0  o2sat  100.0  sbp  98.0  dbp  66.0  rhythm    pain  0  $hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  71  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; d5 1 2ns  1000  ml ; heparin  5000  unit ; cetirizine  10  mg ; acetaminophen  500-1000  mg ; 
 
other f 25 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  73  mg dl; chemistry blood albumin  5.1  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cetirizine  10  mg ; acetaminophen  500-1000  mg ; verapamil sr  240  mg ; thiamine  100  mg ; sodium chloride 0.9%  1000  ml ; 
 
other f 25 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  5.0  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cetirizine  10  mg ; acetaminophen  500-1000  mg ; verapamil sr  240  mg ; thiamine  100  mg ; sodium chloride 0.9%  1000  ml ; 
 
other f 25 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cetirizine  10  mg ; acetaminophen  500-1000  mg ; verapamil sr  240  mg ; thiamine  100  mg ; metoclopramide  5  mg ; mirtazapine  15  mg ; lactated ringers  1000  ml ; 
 
other f 25 $nan$hematology blood hematocrit  38.7  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  64  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cetirizine  10  mg ; acetaminophen  500-1000  mg ; verapamil sr  240  mg ; thiamine  100  mg ; metoclopramide  5  mg ; mirtazapine  15  mg ; lactated ringers  1000  ml ; lidocaine jelly 2% (glydo)  1  appl ; glucose gel  15  g ; 0.9% sodium chloride  100  ml ; thiamine  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 
 
other f 25 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  80  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cetirizine  10  mg ; acetaminophen  500-1000  mg ; verapamil sr  240  mg ; thiamine  100  mg ; metoclopramide  5  mg ; mirtazapine  15  mg ; lidocaine jelly 2% (glydo)  1  appl ; glucose gel  15  g ; 0.9% sodium chloride  100  ml ; thiamine  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 
 
other f 25 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  84  mg dl; chemistry blood glucose  72  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cetirizine  10  mg ; acetaminophen  500-1000  mg ; verapamil sr  240  mg ; thiamine  100  mg ; metoclopramide  5  mg ; mirtazapine  15  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen (liquid)  650  mg ; glycerin supps  1  supp ; bisacodyl  15  mg ; 
 
other f 25 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  75  mg dl; chemistry blood glucose  82  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cetirizine  10  mg ; acetaminophen  500-1000  mg ; verapamil sr  240  mg ; metoclopramide  5  mg ; mirtazapine  15  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen (liquid)  650  mg ; glycerin supps  1  supp ; bisacodyl  15  mg ; d5ns  1000  ml ; 
 
other f 25 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  57  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cetirizine  10  mg ; acetaminophen  500-1000  mg ; verapamil sr  240  mg ; metoclopramide  5  mg ; mirtazapine  15  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen (liquid)  650  mg ; d5ns  1000  ml ; 
 
other f 25 $nan$chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cetirizine  10  mg ; acetaminophen  500-1000  mg ; verapamil sr  240  mg ; metoclopramide  5  mg ; mirtazapine  15  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen (liquid)  650  mg ; simethicone  120  mg ; glycerin supps  3  supp ; 
 
other f 25 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cetirizine  10  mg ; acetaminophen  500-1000  mg ; verapamil sr  240  mg ; metoclopramide  5  mg ; mirtazapine  15  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen (liquid)  650  mg ; simethicone  120  mg ; glycerin supps  3  supp ; 
 
black african american f 34 $nan$nan$docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; codeine sulfate  30-60  mg ; bisacodyl  10  mg ; dibucaine  1  appl ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; calcium carbonate  500  mg ; 
 
black african american f 34 $nan$hematology blood hematocrit  35.5  %; hematology blood hematocrit  32.5  %$docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; codeine sulfate  30-60  mg ; bisacodyl  10  mg ; dibucaine  1  appl ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; calcium carbonate  500  mg ; 
 
black african american f 34 $nan$nan$docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; codeine sulfate  30-60  mg ; bisacodyl  10  mg ; dibucaine  1  appl ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; calcium carbonate  500  mg ; 
 
white m 88 $temp  97.6  heartrate  65.0  resprate  16.0  o2sat  97.0  sbp  163.0  dbp  70.0  rhythm    pain  3  $hematology blood hematocrit  32.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood glucose  86  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood glucose  148  mg dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood sodium, whole blood  134  meq l$metoprolol tartrate  25  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  650  mg ; senna  17.2  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; morphine sulfate  1-4  mg ; folic acid  1  mg ; pantoprazole  40  mg ; atorvastatin  80  mg ; hydroxychloroquine sulfate  200  mg ; tamsulosin  0.4  mg ; prednisone  1  mg ; hydroxyurea  500  mg ; sodium chloride 0.9%  1000  ml ; oxycodone (immediate release)  5  mg ; milk of magnesia  30  ml ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; morphine sulfate  1-2  mg ; enoxaparin sodium  40  mg ; 
 
white m 88 $nan$hematology blood hematocrit  37.7  %; hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  346  k ul; hematology blood platelet count  308  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  31  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  142  mg dl; chemistry blood lactate dehydrogenase (ld)  423  iu l; chemistry blood albumin  3.3  g dl; hematology blood bands  1  %; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  154  mg dl; blood gas blood hematocrit, calculated  38  %; blood gas blood hemoglobin  12.6  g dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood sodium, whole blood  135  meq l$metoprolol tartrate  25  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  17.2  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-10  mg ; morphine sulfate  1-4  mg ; folic acid  1  mg ; pantoprazole  40  mg ; atorvastatin  80  mg ; hydroxychloroquine sulfate  200  mg ; tamsulosin  0.4  mg ; prednisone  1  mg ; hydroxyurea  500  mg ; sodium chloride 0.9%  1000  ml ; oxycodone (immediate release)  5  mg ; milk of magnesia  30  ml ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; morphine sulfate  1-2  mg ; enoxaparin sodium  40  mg ; aspirin  81  mg ; lidocaine jelly 2% (glydo)  1  appl ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; hyoscyamine  0.125  mg ; lorazepam  0.5-2  mg ; olanzapine (disintegrating tablet)  5  mg ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; ondansetron  4-8  mg ; morphine sulfate (concentrated oral solution) 20 mg ml  5-15  mg ; morphine sulfate  2  mg ; 
 
white m 88 $nan$nan$hyoscyamine  0.125  mg ; lorazepam  0.5-2  mg ; olanzapine (disintegrating tablet)  5  mg ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; ondansetron  4-8  mg ; morphine sulfate (concentrated oral solution) 20 mg ml  5-15  mg ; morphine sulfate  2  mg ; 
 
white m 88 $nan$nan$hyoscyamine  0.125  mg ; lorazepam  0.5-2  mg ; olanzapine (disintegrating tablet)  5  mg ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; ondansetron  4-8  mg ; morphine sulfate (concentrated oral solution) 20 mg ml  5-15  mg ; 
 
white m 88 $nan$nan$hyoscyamine  0.125  mg ; lorazepam  0.5-2  mg ; olanzapine (disintegrating tablet)  5  mg ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; ondansetron  4-8  mg ; morphine sulfate (concentrated oral solution) 20 mg ml  5-15  mg ; 
 
black african american m 98 $temp  100.6  heartrate  60.0  resprate  16.0  o2sat  99.0  sbp  146.0  dbp  56.0  rhythm    pain  8  ; temp    heartrate  78.0  resprate  19.0  o2sat  100.0  sbp  126.0  dbp  68.0  rhythm    pain  8  ; temp    heartrate  88.0  resprate  20.0  o2sat  93.0  sbp  136.0  dbp  83.0  rhythm    pain  8  ; temp    heartrate  69.0  resprate  15.0  o2sat  99.0  sbp  153.0  dbp  55.0  rhythm    pain  4  $blood gas blood glucose  240  mg dl; blood gas blood hematocrit, calculated  31  %; blood gas blood hemoglobin  10.4  g dl; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood sodium, whole blood  137  meq l$nan
coronary atherosclerosis of unspecified type of vessel, native or graft unspecified acquired hypothyroidism congestive heart failure, unspecified peripheral vascular disease, unspecified aortocoronary bypass status acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, stage iii (moderate) chronic systolic heart failure pneumonia, organism unspecified other and unspecified hyperlipidemia long-term (current) use of aspirin gout, unspecified congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other external cause status other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other activity coronary atherosclerosis of unspecified type of vessel, native or graft accidents occurring in residential institution injury to bladder and urethra, without mention of open wound into cavity unspecified septicemia chronic kidney disease, stage iii (moderate) other respiratory abnormalities gout, unspecified subendocardial infarction, initial episode of care gross hematuria peripheral vascular disease, unspecified sepsis do not resuscitate status acute on chronic systolic heart failure unspecified accident acute kidney failure, unspecified aortocoronary bypass status pneumonia, organism unspecified obstructive chronic bronchitis with (acute) exacerbation unspecified acquired hypothyroidism accidents occurring in residential institution gout, unspecified diabetes with other specified manifestations, type ii or unspecified type, uncontrolled do not resuscitate status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified intestinal infection due to other organism, not elsewhere classified chronic systolic heart failure aortocoronary bypass status
black african american m 98 $temp  98.9  heartrate  68.0  resprate  16.0  o2sat  98.0  sbp  126.0  dbp  89.0  rhythm    pain  sleeping  $hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  94  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  54  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  137  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood chloride, whole blood  100  meq l; blood gas blood glucose  241  mg dl; blood gas blood hematocrit, calculated  26  %; blood gas blood hemoglobin  8.5  g dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood carboxyhemoglobin  1  %; blood gas blood methemoglobin  0  %$morphine sulfate  0.5  mg ; morphine sulfate  1-2  mg ; acetaminophen  1000  mg ; albuterol 0.083% neb soln  1  neb ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; colchicine  0.6  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; levothyroxine sodium  75  mcg ; lisinopril  20  mg ; metoprolol tartrate  75  mg ; multivitamins  1  tab ; senna  8.6  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; allopurinol  100  mg ; ferrous sulfate  325  mg ; glimepiride  1  mg ; isosorbide mononitrate  10  mg ; 
coronary atherosclerosis of unspecified type of vessel, native or graft unspecified acquired hypothyroidism congestive heart failure, unspecified peripheral vascular disease, unspecified aortocoronary bypass status acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, stage iii (moderate) chronic systolic heart failure pneumonia, organism unspecified other and unspecified hyperlipidemia long-term (current) use of aspirin gout, unspecified congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other external cause status other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other activity coronary atherosclerosis of unspecified type of vessel, native or graft accidents occurring in residential institution injury to bladder and urethra, without mention of open wound into cavity unspecified septicemia chronic kidney disease, stage iii (moderate) other respiratory abnormalities gout, unspecified subendocardial infarction, initial episode of care gross hematuria peripheral vascular disease, unspecified sepsis do not resuscitate status acute on chronic systolic heart failure unspecified accident acute kidney failure, unspecified aortocoronary bypass status pneumonia, organism unspecified obstructive chronic bronchitis with (acute) exacerbation unspecified acquired hypothyroidism accidents occurring in residential institution gout, unspecified diabetes with other specified manifestations, type ii or unspecified type, uncontrolled do not resuscitate status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified intestinal infection due to other organism, not elsewhere classified chronic systolic heart failure aortocoronary bypass status
black african american m 98 $nan$nan$morphine sulfate  1-2  mg ; acetaminophen  1000  mg ; albuterol 0.083% neb soln  1  neb ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; colchicine  0.6  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; levothyroxine sodium  75  mcg ; metoprolol tartrate  75  mg ; multivitamins  1  tab ; senna  8.6  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; allopurinol  100  mg ; ferrous sulfate  325  mg ; glimepiride  1  mg ; prednisone  40  mg ; 
coronary atherosclerosis of unspecified type of vessel, native or graft unspecified acquired hypothyroidism congestive heart failure, unspecified peripheral vascular disease, unspecified aortocoronary bypass status acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic airway obstruction, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, stage iii (moderate) chronic systolic heart failure pneumonia, organism unspecified other and unspecified hyperlipidemia long-term (current) use of aspirin gout, unspecified congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other external cause status other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other activity coronary atherosclerosis of unspecified type of vessel, native or graft accidents occurring in residential institution injury to bladder and urethra, without mention of open wound into cavity unspecified septicemia chronic kidney disease, stage iii (moderate) other respiratory abnormalities gout, unspecified subendocardial infarction, initial episode of care gross hematuria peripheral vascular disease, unspecified sepsis do not resuscitate status acute on chronic systolic heart failure unspecified accident acute kidney failure, unspecified aortocoronary bypass status pneumonia, organism unspecified obstructive chronic bronchitis with (acute) exacerbation unspecified acquired hypothyroidism accidents occurring in residential institution gout, unspecified diabetes with other specified manifestations, type ii or unspecified type, uncontrolled do not resuscitate status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified intestinal infection due to other organism, not elsewhere classified chronic systolic heart failure aortocoronary bypass status
white f 48 $temp  97.9  heartrate  88.0  resprate  18.0  o2sat  97.0  sbp  124.0  dbp  69.0  rhythm    pain  0  $hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  61  mg dl$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; escitalopram oxalate  20  mg ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; ns  100  ml ; metronidazole  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; d5 1 2ns  1000  ml ; 
ulceration of intestine headache regional enteritis of small intestine anxiety state, unspecified acquired absence of intestine (large) (small) depressive disorder, not elsewhere classified first-degree perineal laceration, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition carrier or suspected carrier of group b streptococcus elderly multigravida, delivered with or without mention of antepartum condition outcome of delivery, single liveborn
white f 48 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; escitalopram oxalate  20  mg ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; ns  100  ml ; metronidazole  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; d5 1 2ns  1000  ml ; ondansetron  8  mg ; tramadol  50  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; mineral oil  15  ml ; 
ulceration of intestine headache regional enteritis of small intestine anxiety state, unspecified acquired absence of intestine (large) (small) depressive disorder, not elsewhere classified first-degree perineal laceration, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition carrier or suspected carrier of group b streptococcus elderly multigravida, delivered with or without mention of antepartum condition outcome of delivery, single liveborn
white f 48 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; escitalopram oxalate  20  mg ; ns  100  ml ; metronidazole  500  mg ; ondansetron  8  mg ; tramadol  50  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; mineral oil  15  ml ; senna  8.6  mg ; 
ulceration of intestine headache regional enteritis of small intestine anxiety state, unspecified acquired absence of intestine (large) (small) depressive disorder, not elsewhere classified first-degree perineal laceration, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition carrier or suspected carrier of group b streptococcus elderly multigravida, delivered with or without mention of antepartum condition outcome of delivery, single liveborn
white f 48 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  274  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; escitalopram oxalate  20  mg ; ns  100  ml ; metronidazole  500  mg ; ondansetron  8  mg ; tramadol  50  mg ; docusate sodium  100  mg ; senna  8.6  mg ; 
ulceration of intestine headache regional enteritis of small intestine anxiety state, unspecified acquired absence of intestine (large) (small) depressive disorder, not elsewhere classified first-degree perineal laceration, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition carrier or suspected carrier of group b streptococcus elderly multigravida, delivered with or without mention of antepartum condition outcome of delivery, single liveborn
white f 48 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; escitalopram oxalate  20  mg ; ns  100  ml ; metronidazole  500  mg ; ondansetron  8  mg ; tramadol  50  mg ; docusate sodium  100  mg ; 
ulceration of intestine headache regional enteritis of small intestine anxiety state, unspecified acquired absence of intestine (large) (small) depressive disorder, not elsewhere classified first-degree perineal laceration, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition carrier or suspected carrier of group b streptococcus elderly multigravida, delivered with or without mention of antepartum condition outcome of delivery, single liveborn
white m 82 $temp    heartrate  66.0  resprate  16.0  o2sat  96.0  sbp  152.0  dbp  60.0  rhythm    pain    ; temp    heartrate  67.0  resprate    o2sat  97.0  sbp  141.0  dbp  51.0  rhythm    pain    ; temp    heartrate  59.0  resprate  16.0  o2sat  97.0  sbp  135.0  dbp  54.0  rhythm    pain    $hematology blood hematocrit  39.6  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  113  mg dl$nan
 
white m 82 $temp  99.5  heartrate  72.0  resprate  16.0  o2sat    sbp  134.0  dbp  90.0  rhythm    pain    $hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  106  mg dl$0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; pneumococcal vac polyvalent  0.5  ml ; hydralazine  10  mg ; 0.9% sodium chloride  1000  ml ; famotidine  20  mg ; levetiracetam  500  mg ; acetaminophen  500-1000  mg ; 
 
white m 82 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; hematology urine wbc  13  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  139  mg dl$0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; pneumococcal vac polyvalent  0.5  ml ; hydralazine  10  mg ; 0.9% sodium chloride  1000  ml ; famotidine  20  mg ; levetiracetam  500  mg ; acetaminophen  500-1000  mg ; ciprofloxacin hcl  500  mg ; sodium chloride 0.9%  flush  3  ml ; labetalol  10-20  mg ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  2-4  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; neutra-phos  1  pkt ; 
 
white m 82 $nan$hematology blood hematocrit  34.4  %; hematology blood hematocrit  33.1  %; hematology blood hemoglobin  12.1  g dl; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  241  k ul; hematology blood platelet count  239  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  153  mg dl$pneumococcal vac polyvalent  0.5  ml ; famotidine  20  mg ; levetiracetam  500  mg ; acetaminophen  500-1000  mg ; ciprofloxacin hcl  500  mg ; sodium chloride 0.9%  flush  3  ml ; labetalol  10-20  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; neutra-phos  1  pkt ; magnesium oxide  400  mg ; senna  1  tab ; docusate sodium  100  mg ; bisacodyl  10  mg ; bag  50  ml ; magnesium sulfate  2  gm ; polyethylene glycol  17  g ; heparin  5000  unit ; senna  2  tab ; albuterol 0.083% neb soln  1  neb ; 
 
white m 82 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  127  mg dl$pneumococcal vac polyvalent  0.5  ml ; famotidine  20  mg ; levetiracetam  500  mg ; acetaminophen  500-1000  mg ; ciprofloxacin hcl  500  mg ; sodium chloride 0.9%  flush  3  ml ; magnesium oxide  400  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; bag  50  ml ; magnesium sulfate  2  gm ; polyethylene glycol  17  g ; senna  2  tab ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; furosemide  10  mg ; diphenhydramine  12.5  mg ; artificial tears  1-2  drop ; tramadol (ultram)  25  mg ; 
 
white m 82 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  98  mg dl$pneumococcal vac polyvalent  0.5  ml ; levetiracetam  500  mg ; acetaminophen  500-1000  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  2  tab ; tramadol (ultram)  25  mg ; 
 
white m 82 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  95  mg dl$pneumococcal vac polyvalent  0.5  ml ; levetiracetam  500  mg ; acetaminophen  500-1000  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  2  tab ; tramadol (ultram)  25  mg ; 
 
white m 82 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; levetiracetam  500  mg ; acetaminophen  500-1000  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  2  tab ; tramadol (ultram)  25  mg ; 
 
white m 82 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; levetiracetam  500  mg ; acetaminophen  500-1000  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  2  tab ; tramadol (ultram)  25  mg ; simvastatin  20  mg ; lisinopril  20  mg ; hydrochlorothiazide  25  mg ; 
 
white m 62 $nan$nan$5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; 
hypothyroidism, unspecified hypomagnesemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew body mass index (bmi) 37.0-37.9, adult other specified types of non-hodgkin lymphoma, extranodal and solid organ sites essential (primary) hypertension unspecified mood [affective] disorder type 2 diabetes mellitus without complications hereditary motor and sensory neuropathy encephalopathy, unspecified unspecified fall, initial encounter hyperlipidemia, unspecified other constipation encounter for antineoplastic chemotherapy patient bathroom in hospital as the place of occurrence of the external cause obesity, unspecified insomnia, unspecified gastro-esophageal reflux disease without esophagitis hypokalemia unspecified convulsions family history of malignant neoplasm of other organs or systems other encephalopathy type 2 diabetes mellitus without complications family history of malignant neoplasm of digestive organs essential (primary) hypertension body mass index (bmi) 39.0-39.9, adult encounter for antineoplastic chemotherapy hereditary motor and sensory neuropathy gastro-esophageal reflux disease without esophagitis other hyperlipidemia constipation, unspecified obesity, unspecified non-hodgkin lymphoma, unspecified, extranodal and solid organ sites anemia in neoplastic disease unspecified mood [affective] disorder dental caries, unspecified type 2 diabetes mellitus with unspecified complications patient room in hospital as the place of occurrence of the external cause other secondary thrombocytopenia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter gastro-esophageal reflux disease without esophagitis hereditary motor and sensory neuropathy anemia, unspecified non-hodgkin lymphoma, unspecified, extranodal and solid organ sites encephalopathy, unspecified encounter for antineoplastic chemotherapy long term (current) use of oral hypoglycemic drugs unspecified mood [affective] disorder
white m 62 $nan$hematology blood hematocrit  38.1  %; hematology blood hematocrit  35.5  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  177  k ul; hematology blood platelet count  154  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  154  mg dl; chemistry blood glucose  201  mg dl; chemistry blood lactate dehydrogenase (ld)  177  iu l$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  4  gm ; sodium bicarbonate  1300  mg ; ondansetron  8  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; polyethylene glycol  17  g ; divalproex (extended release)  1000  mg ; metformin (glucophage)  1000  mg ; divalproex (extended release)  250  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; famotidine  20  mg ; ramelteon  8  mg ; sodium bicarbonate  25  meq ; viaflex bag  831.4  ml ; methotrexate  20,160  mg ; 5% dextrose  250  ml ; sodium bicarbonate  130  meq ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; 
hypothyroidism, unspecified hypomagnesemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew body mass index (bmi) 37.0-37.9, adult other specified types of non-hodgkin lymphoma, extranodal and solid organ sites essential (primary) hypertension unspecified mood [affective] disorder type 2 diabetes mellitus without complications hereditary motor and sensory neuropathy encephalopathy, unspecified unspecified fall, initial encounter hyperlipidemia, unspecified other constipation encounter for antineoplastic chemotherapy patient bathroom in hospital as the place of occurrence of the external cause obesity, unspecified insomnia, unspecified gastro-esophageal reflux disease without esophagitis hypokalemia unspecified convulsions family history of malignant neoplasm of other organs or systems other encephalopathy type 2 diabetes mellitus without complications family history of malignant neoplasm of digestive organs essential (primary) hypertension body mass index (bmi) 39.0-39.9, adult encounter for antineoplastic chemotherapy hereditary motor and sensory neuropathy gastro-esophageal reflux disease without esophagitis other hyperlipidemia constipation, unspecified obesity, unspecified non-hodgkin lymphoma, unspecified, extranodal and solid organ sites anemia in neoplastic disease unspecified mood [affective] disorder dental caries, unspecified type 2 diabetes mellitus with unspecified complications patient room in hospital as the place of occurrence of the external cause other secondary thrombocytopenia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter gastro-esophageal reflux disease without esophagitis hereditary motor and sensory neuropathy anemia, unspecified non-hodgkin lymphoma, unspecified, extranodal and solid organ sites encephalopathy, unspecified encounter for antineoplastic chemotherapy long term (current) use of oral hypoglycemic drugs unspecified mood [affective] disorder
white m 62 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  241  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; ondansetron  8  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; polyethylene glycol  17  g ; divalproex (extended release)  1000  mg ; metformin (glucophage)  1000  mg ; divalproex (extended release)  250  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; famotidine  20  mg ; ramelteon  8  mg ; sodium bicarbonate  25  meq ; viaflex bag  831.4  ml ; methotrexate  20,160  mg ; 5% dextrose  250  ml ; sodium bicarbonate  130  meq ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; 0.9% sodium chloride  50  ml ; leucovorin calcium  40  mg ; leucovorin calcium  100  mg ; 
hypothyroidism, unspecified hypomagnesemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew body mass index (bmi) 37.0-37.9, adult other specified types of non-hodgkin lymphoma, extranodal and solid organ sites essential (primary) hypertension unspecified mood [affective] disorder type 2 diabetes mellitus without complications hereditary motor and sensory neuropathy encephalopathy, unspecified unspecified fall, initial encounter hyperlipidemia, unspecified other constipation encounter for antineoplastic chemotherapy patient bathroom in hospital as the place of occurrence of the external cause obesity, unspecified insomnia, unspecified gastro-esophageal reflux disease without esophagitis hypokalemia unspecified convulsions family history of malignant neoplasm of other organs or systems other encephalopathy type 2 diabetes mellitus without complications family history of malignant neoplasm of digestive organs essential (primary) hypertension body mass index (bmi) 39.0-39.9, adult encounter for antineoplastic chemotherapy hereditary motor and sensory neuropathy gastro-esophageal reflux disease without esophagitis other hyperlipidemia constipation, unspecified obesity, unspecified non-hodgkin lymphoma, unspecified, extranodal and solid organ sites anemia in neoplastic disease unspecified mood [affective] disorder dental caries, unspecified type 2 diabetes mellitus with unspecified complications patient room in hospital as the place of occurrence of the external cause other secondary thrombocytopenia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter gastro-esophageal reflux disease without esophagitis hereditary motor and sensory neuropathy anemia, unspecified non-hodgkin lymphoma, unspecified, extranodal and solid organ sites encephalopathy, unspecified encounter for antineoplastic chemotherapy long term (current) use of oral hypoglycemic drugs unspecified mood [affective] disorder
white m 62 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  170  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; ondansetron  8  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; polyethylene glycol  17  g ; divalproex (extended release)  1000  mg ; metformin (glucophage)  1000  mg ; divalproex (extended release)  250  mg ; famotidine  20  mg ; ramelteon  8  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; dapagliflozin  2.5  mg ; 0.45% sodium chloride  1000  ml ; sodium bicarbonate  75  meq ; 
hypothyroidism, unspecified hypomagnesemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew body mass index (bmi) 37.0-37.9, adult other specified types of non-hodgkin lymphoma, extranodal and solid organ sites essential (primary) hypertension unspecified mood [affective] disorder type 2 diabetes mellitus without complications hereditary motor and sensory neuropathy encephalopathy, unspecified unspecified fall, initial encounter hyperlipidemia, unspecified other constipation encounter for antineoplastic chemotherapy patient bathroom in hospital as the place of occurrence of the external cause obesity, unspecified insomnia, unspecified gastro-esophageal reflux disease without esophagitis hypokalemia unspecified convulsions family history of malignant neoplasm of other organs or systems other encephalopathy type 2 diabetes mellitus without complications family history of malignant neoplasm of digestive organs essential (primary) hypertension body mass index (bmi) 39.0-39.9, adult encounter for antineoplastic chemotherapy hereditary motor and sensory neuropathy gastro-esophageal reflux disease without esophagitis other hyperlipidemia constipation, unspecified obesity, unspecified non-hodgkin lymphoma, unspecified, extranodal and solid organ sites anemia in neoplastic disease unspecified mood [affective] disorder dental caries, unspecified type 2 diabetes mellitus with unspecified complications patient room in hospital as the place of occurrence of the external cause other secondary thrombocytopenia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter gastro-esophageal reflux disease without esophagitis hereditary motor and sensory neuropathy anemia, unspecified non-hodgkin lymphoma, unspecified, extranodal and solid organ sites encephalopathy, unspecified encounter for antineoplastic chemotherapy long term (current) use of oral hypoglycemic drugs unspecified mood [affective] disorder
white m 62 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  139  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  157  iu l; chemistry blood albumin  3.4  g dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; ondansetron  8  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; polyethylene glycol  17  g ; divalproex (extended release)  1000  mg ; metformin (glucophage)  1000  mg ; divalproex (extended release)  250  mg ; famotidine  20  mg ; ramelteon  8  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; dapagliflozin  2.5  mg ; 0.45% sodium chloride  1000  ml ; sodium bicarbonate  75  meq ; 
hypothyroidism, unspecified hypomagnesemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew body mass index (bmi) 37.0-37.9, adult other specified types of non-hodgkin lymphoma, extranodal and solid organ sites essential (primary) hypertension unspecified mood [affective] disorder type 2 diabetes mellitus without complications hereditary motor and sensory neuropathy encephalopathy, unspecified unspecified fall, initial encounter hyperlipidemia, unspecified other constipation encounter for antineoplastic chemotherapy patient bathroom in hospital as the place of occurrence of the external cause obesity, unspecified insomnia, unspecified gastro-esophageal reflux disease without esophagitis hypokalemia unspecified convulsions family history of malignant neoplasm of other organs or systems other encephalopathy type 2 diabetes mellitus without complications family history of malignant neoplasm of digestive organs essential (primary) hypertension body mass index (bmi) 39.0-39.9, adult encounter for antineoplastic chemotherapy hereditary motor and sensory neuropathy gastro-esophageal reflux disease without esophagitis other hyperlipidemia constipation, unspecified obesity, unspecified non-hodgkin lymphoma, unspecified, extranodal and solid organ sites anemia in neoplastic disease unspecified mood [affective] disorder dental caries, unspecified type 2 diabetes mellitus with unspecified complications patient room in hospital as the place of occurrence of the external cause other secondary thrombocytopenia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter gastro-esophageal reflux disease without esophagitis hereditary motor and sensory neuropathy anemia, unspecified non-hodgkin lymphoma, unspecified, extranodal and solid organ sites encephalopathy, unspecified encounter for antineoplastic chemotherapy long term (current) use of oral hypoglycemic drugs unspecified mood [affective] disorder
white m 62 $nan$nan$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; ondansetron  8  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; polyethylene glycol  17  g ; divalproex (extended release)  1000  mg ; metformin (glucophage)  1000  mg ; divalproex (extended release)  250  mg ; famotidine  20  mg ; ramelteon  8  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; dapagliflozin  2.5  mg ; 0.45% sodium chloride  1000  ml ; sodium bicarbonate  75  meq ; 
hypothyroidism, unspecified hypomagnesemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew body mass index (bmi) 37.0-37.9, adult other specified types of non-hodgkin lymphoma, extranodal and solid organ sites essential (primary) hypertension unspecified mood [affective] disorder type 2 diabetes mellitus without complications hereditary motor and sensory neuropathy encephalopathy, unspecified unspecified fall, initial encounter hyperlipidemia, unspecified other constipation encounter for antineoplastic chemotherapy patient bathroom in hospital as the place of occurrence of the external cause obesity, unspecified insomnia, unspecified gastro-esophageal reflux disease without esophagitis hypokalemia unspecified convulsions family history of malignant neoplasm of other organs or systems other encephalopathy type 2 diabetes mellitus without complications family history of malignant neoplasm of digestive organs essential (primary) hypertension body mass index (bmi) 39.0-39.9, adult encounter for antineoplastic chemotherapy hereditary motor and sensory neuropathy gastro-esophageal reflux disease without esophagitis other hyperlipidemia constipation, unspecified obesity, unspecified non-hodgkin lymphoma, unspecified, extranodal and solid organ sites anemia in neoplastic disease unspecified mood [affective] disorder dental caries, unspecified type 2 diabetes mellitus with unspecified complications patient room in hospital as the place of occurrence of the external cause other secondary thrombocytopenia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter gastro-esophageal reflux disease without esophagitis hereditary motor and sensory neuropathy anemia, unspecified non-hodgkin lymphoma, unspecified, extranodal and solid organ sites encephalopathy, unspecified encounter for antineoplastic chemotherapy long term (current) use of oral hypoglycemic drugs unspecified mood [affective] disorder
white m 56 $temp  97.5  heartrate  96.0  resprate  20.0  o2sat  96.0  sbp  154.0  dbp  84.0  rhythm    pain  10  $nan$diltiazem  60  mg ; 
chronic obstructive pulmonary disease, unspecified acute on chronic diastolic (congestive) heart failure unspecified atrial fibrillation cardiac tamponade postprocedural hypotension long term (current) use of anticoagulants hypertensive heart disease with heart failure acidosis nutritional anemia, unspecified hypoxemia unspecified fracture of t11-t12 vertebra, subsequent encounter for fracture with routine healing exposure to other specified factors, subsequent encounter hypo-osmolality and hyponatremia pericardial effusion (noninflammatory) personal history of sudden cardiac arrest pneumonia, unspecified organism dehydration fatigue fracture of vertebra, thoracic region, initial encounter for fracture hypo-osmolality and hyponatremia acute respiratory failure with hypoxia unspecified atrial fibrillation anemia, unspecified pericardial effusion (noninflammatory) acute on chronic diastolic (congestive) heart failure respiratory arrest dysphagia, unspecified chronic obstructive pulmonary disease, unspecified essential (primary) hypertension nosocomial condition 
white m 56 $temp  98.7  heartrate  109.0  resprate  19.0  o2sat  96.0  sbp  147.0  dbp  92.0  rhythm    pain  8  $hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  475  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  131  mg dl; chemistry blood albumin  3.8  g dl; blood gas blood potassium, whole blood  3.0  meq l$diltiazem  60  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; albuterol 0.083% neb soln  1  neb ; folic acid  1  mg ; multivitamins  1  tab ; senna  8.6  mg ; oxycodone (immediate release)  5  mg ; atorvastatin  80  mg ; escitalopram oxalate  20  mg ; omeprazole  40  mg ; rivaroxaban  20  mg ; thiamine  200  mg ; potassium chloride  80  meq ; ramelteon  8  mg ; 
chronic obstructive pulmonary disease, unspecified acute on chronic diastolic (congestive) heart failure unspecified atrial fibrillation cardiac tamponade postprocedural hypotension long term (current) use of anticoagulants hypertensive heart disease with heart failure acidosis nutritional anemia, unspecified hypoxemia unspecified fracture of t11-t12 vertebra, subsequent encounter for fracture with routine healing exposure to other specified factors, subsequent encounter hypo-osmolality and hyponatremia pericardial effusion (noninflammatory) personal history of sudden cardiac arrest pneumonia, unspecified organism dehydration fatigue fracture of vertebra, thoracic region, initial encounter for fracture hypo-osmolality and hyponatremia acute respiratory failure with hypoxia unspecified atrial fibrillation anemia, unspecified pericardial effusion (noninflammatory) acute on chronic diastolic (congestive) heart failure respiratory arrest dysphagia, unspecified chronic obstructive pulmonary disease, unspecified essential (primary) hypertension nosocomial condition 
white m 56 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  441  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry urine creatinine, urine  89  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  127  mg dl$diltiazem  60  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; albuterol 0.083% neb soln  1  neb ; folic acid  1  mg ; multivitamins  1  tab ; senna  8.6  mg ; oxycodone (immediate release)  5  mg ; atorvastatin  80  mg ; escitalopram oxalate  20  mg ; omeprazole  40  mg ; rivaroxaban  20  mg ; thiamine  200  mg ; potassium chloride  80  meq ; ramelteon  8  mg ; lidocaine 5% patch  1  ptch ; lactated ringers  1000  ml ; cyclobenzaprine  10  mg ; 
chronic obstructive pulmonary disease, unspecified acute on chronic diastolic (congestive) heart failure unspecified atrial fibrillation cardiac tamponade postprocedural hypotension long term (current) use of anticoagulants hypertensive heart disease with heart failure acidosis nutritional anemia, unspecified hypoxemia unspecified fracture of t11-t12 vertebra, subsequent encounter for fracture with routine healing exposure to other specified factors, subsequent encounter hypo-osmolality and hyponatremia pericardial effusion (noninflammatory) personal history of sudden cardiac arrest pneumonia, unspecified organism dehydration fatigue fracture of vertebra, thoracic region, initial encounter for fracture hypo-osmolality and hyponatremia acute respiratory failure with hypoxia unspecified atrial fibrillation anemia, unspecified pericardial effusion (noninflammatory) acute on chronic diastolic (congestive) heart failure respiratory arrest dysphagia, unspecified chronic obstructive pulmonary disease, unspecified essential (primary) hypertension nosocomial condition 
white m 56 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry urine creatinine, urine  30  mg dl; chemistry urine potassium, urine  15  meq l; chemistry urine sodium, urine  23  meq l; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  116  mg dl$diltiazem  60  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; albuterol 0.083% neb soln  1  neb ; folic acid  1  mg ; multivitamins  1  tab ; senna  8.6  mg ; atorvastatin  80  mg ; escitalopram oxalate  20  mg ; omeprazole  40  mg ; rivaroxaban  20  mg ; thiamine  200  mg ; ramelteon  8  mg ; lidocaine 5% patch  1  ptch ; lactated ringers  1000  ml ; cyclobenzaprine  10  mg ; 0.9% sodium chloride  100  ml ; ferric gluconate  250  mg ; diltiazem extended-release  120  mg ; 
chronic obstructive pulmonary disease, unspecified acute on chronic diastolic (congestive) heart failure unspecified atrial fibrillation cardiac tamponade postprocedural hypotension long term (current) use of anticoagulants hypertensive heart disease with heart failure acidosis nutritional anemia, unspecified hypoxemia unspecified fracture of t11-t12 vertebra, subsequent encounter for fracture with routine healing exposure to other specified factors, subsequent encounter hypo-osmolality and hyponatremia pericardial effusion (noninflammatory) personal history of sudden cardiac arrest pneumonia, unspecified organism dehydration fatigue fracture of vertebra, thoracic region, initial encounter for fracture hypo-osmolality and hyponatremia acute respiratory failure with hypoxia unspecified atrial fibrillation anemia, unspecified pericardial effusion (noninflammatory) acute on chronic diastolic (congestive) heart failure respiratory arrest dysphagia, unspecified chronic obstructive pulmonary disease, unspecified essential (primary) hypertension nosocomial condition 
white m 56 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  433  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; albuterol 0.083% neb soln  1  neb ; folic acid  1  mg ; multivitamins  1  tab ; senna  8.6  mg ; atorvastatin  80  mg ; escitalopram oxalate  20  mg ; omeprazole  40  mg ; rivaroxaban  20  mg ; thiamine  200  mg ; ramelteon  8  mg ; lidocaine 5% patch  1  ptch ; cyclobenzaprine  10  mg ; 0.9% sodium chloride  100  ml ; ferric gluconate  250  mg ; diltiazem extended-release  120  mg ; diltiazem extended-release  180  mg ; magnesium oxide  400  mg ; 
chronic obstructive pulmonary disease, unspecified acute on chronic diastolic (congestive) heart failure unspecified atrial fibrillation cardiac tamponade postprocedural hypotension long term (current) use of anticoagulants hypertensive heart disease with heart failure acidosis nutritional anemia, unspecified hypoxemia unspecified fracture of t11-t12 vertebra, subsequent encounter for fracture with routine healing exposure to other specified factors, subsequent encounter hypo-osmolality and hyponatremia pericardial effusion (noninflammatory) personal history of sudden cardiac arrest pneumonia, unspecified organism dehydration fatigue fracture of vertebra, thoracic region, initial encounter for fracture hypo-osmolality and hyponatremia acute respiratory failure with hypoxia unspecified atrial fibrillation anemia, unspecified pericardial effusion (noninflammatory) acute on chronic diastolic (congestive) heart failure respiratory arrest dysphagia, unspecified chronic obstructive pulmonary disease, unspecified essential (primary) hypertension nosocomial condition 
white m 56 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  375  k ul$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; albuterol 0.083% neb soln  1  neb ; folic acid  1  mg ; multivitamins  1  tab ; senna  8.6  mg ; atorvastatin  80  mg ; escitalopram oxalate  20  mg ; omeprazole  40  mg ; rivaroxaban  20  mg ; thiamine  200  mg ; ramelteon  8  mg ; lidocaine 5% patch  1  ptch ; cyclobenzaprine  10  mg ; 0.9% sodium chloride  100  ml ; ferric gluconate  250  mg ; diltiazem extended-release  180  mg ; magnesium oxide  400  mg ; torsemide  20  mg ; 
chronic obstructive pulmonary disease, unspecified acute on chronic diastolic (congestive) heart failure unspecified atrial fibrillation cardiac tamponade postprocedural hypotension long term (current) use of anticoagulants hypertensive heart disease with heart failure acidosis nutritional anemia, unspecified hypoxemia unspecified fracture of t11-t12 vertebra, subsequent encounter for fracture with routine healing exposure to other specified factors, subsequent encounter hypo-osmolality and hyponatremia pericardial effusion (noninflammatory) personal history of sudden cardiac arrest pneumonia, unspecified organism dehydration fatigue fracture of vertebra, thoracic region, initial encounter for fracture hypo-osmolality and hyponatremia acute respiratory failure with hypoxia unspecified atrial fibrillation anemia, unspecified pericardial effusion (noninflammatory) acute on chronic diastolic (congestive) heart failure respiratory arrest dysphagia, unspecified chronic obstructive pulmonary disease, unspecified essential (primary) hypertension nosocomial condition 
white f 69 $nan$nan$amlodipine  2.5  mg ; atorvastatin  10  mg ; cyanocobalamin  1000  mcg ; levothyroxine sodium  125  mcg ; 
 
white f 69 $nan$hematology blood hematocrit  29.1  %; hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  332  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  150  mg dl$amlodipine  2.5  mg ; atorvastatin  10  mg ; cyanocobalamin  1000  mcg ; levothyroxine sodium  125  mcg ; 1 2 ns  1000  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; clotrimazole cream  1  appl ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; coreg cr  80  mg ; lidocaine 5% patch  1  ptch ; amlodipine  10  mg ; micardis hct  80  mg ; bisacodyl  10  mg ; insulin  12  unit ; carvedilol  25  mg ; gabapentin  100  mg ; heparin  5000  unit ; 
 
white f 69 $nan$hematology blood hematocrit  31.2  %; hematology blood hematocrit  28.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  296  k ul; hematology blood platelet count  256  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  134  mg dl$cyanocobalamin  1000  mcg ; levothyroxine sodium  125  mcg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; clotrimazole cream  1  appl ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; coreg cr  80  mg ; lidocaine 5% patch  1  ptch ; amlodipine  10  mg ; micardis hct  80  mg ; bisacodyl  10  mg ; insulin  12  unit ; carvedilol  25  mg ; gabapentin  100  mg ; magnesium oxide  400  mg ; docusate sodium  100  mg ; metformin (glucophage)  1000  mg ; glyburide  10  mg ; 
 
white f 69 $nan$nan$cyanocobalamin  1000  mcg ; levothyroxine sodium  125  mcg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; clotrimazole cream  1  appl ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; coreg cr  80  mg ; lidocaine 5% patch  1  ptch ; amlodipine  10  mg ; micardis hct  80  mg ; bisacodyl  10  mg ; gabapentin  100  mg ; magnesium oxide  400  mg ; docusate sodium  100  mg ; metformin (glucophage)  1000  mg ; glyburide  10  mg ; 
 
white f 57 $nan$nan$estrogens conjugated  0.3  mg ; levothyroxine sodium  125  mcg ; lisinopril  5  mg ; omeprazole  20  mg ; multivitamins  1  cap ; fexofenadine  60  mg ; vitamin d  1000  unit ; 
 
white f 57 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  120  mg dl$estrogens conjugated  0.3  mg ; levothyroxine sodium  125  mcg ; lisinopril  5  mg ; omeprazole  20  mg ; multivitamins  1  cap ; fexofenadine  60  mg ; vitamin d  1000  unit ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; enoxaparin sodium  30  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; diphenhydramine  12.5-50  mg ; ondansetron  4  mg ; ketorolac  15  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; hydromorphone (dilaudid)  20  mg ; 0.9% sodium chloride  500  ml ; 
 
white f 57 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  122  mg dl$estrogens conjugated  0.3  mg ; levothyroxine sodium  125  mcg ; lisinopril  5  mg ; omeprazole  20  mg ; multivitamins  1  cap ; fexofenadine  60  mg ; vitamin d  1000  unit ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; enoxaparin sodium  30  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; diphenhydramine  12.5-50  mg ; ketorolac  15  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 0.9% sodium chloride  500  ml ; ondansetron  4-8  mg ; metoclopramide  10  mg ; 
 
white f 57 $nan$nan$estrogens conjugated  0.3  mg ; levothyroxine sodium  125  mcg ; lisinopril  5  mg ; omeprazole  20  mg ; multivitamins  1  cap ; fexofenadine  60  mg ; vitamin d  1000  unit ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; enoxaparin sodium  30  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; diphenhydramine  12.5-50  mg ; ketorolac  15  mg ; ondansetron  4-8  mg ; metoclopramide  10  mg ; 
 
white f 19 $nan$nan$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; penicillin g potassium  3  million units ; oxytocin  10  unit ; nalbuphine hcl  10  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white f 19 $nan$hematology blood hematocrit  29.2  %$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white f 19 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white f 85 $nan$nan$verapamil  240  mg ; atorvastatin  20  mg ; hydrochlorothiazide  12.5  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  25  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension abdominal pain, other specified site 
white f 85 $nan$hematology blood hematocrit  21.4  %; hematology blood hematocrit  24.9  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  245  k ul; hematology blood platelet count  215  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  7.5  ; hematology blood inr(pt)  10.5  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  131  mg dl; chemistry blood lactate dehydrogenase (ld)  191  iu l$verapamil  240  mg ; atorvastatin  20  mg ; hydrochlorothiazide  12.5  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  25  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; phytonadione  5  mg ; oxycodone-acetaminophen  1-2  tab ; verapamil  120  mg ; lisinopril  20  mg ; 0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; magnesium sulfate  2  gm ; ciprofloxacin hcl  500  mg ; trazodone  25  mg ; phytonadione  10  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension abdominal pain, other specified site 
white f 85 $nan$hematology blood hematocrit  26.6  %; hematology blood hematocrit  26.8  %; hematology blood hematocrit  23.5  %; hematology blood hematocrit  24.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  200  k ul; hematology blood platelet count  187  k ul; hematology blood platelet count  194  k ul; hematology blood platelet count  213  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  6.0  ; hematology blood inr(pt)  7.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  154  mg dl; chemistry blood glucose  131  mg dl; chemistry blood lactate dehydrogenase (ld)  271  iu l; chemistry blood lactate dehydrogenase (ld)  300  iu l$verapamil  240  mg ; atorvastatin  20  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  25  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; phytonadione  5  mg ; oxycodone-acetaminophen  1-2  tab ; verapamil  120  mg ; lisinopril  20  mg ; 0.9% sodium chloride  1000  ml ; magnesium sulfate  2  gm ; ciprofloxacin hcl  500  mg ; trazodone  25  mg ; phytonadione  10  mg ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 0.9% sodium chloride  500  ml ; oxycodone-acetaminophen  1  tab ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension abdominal pain, other specified site 
white f 85 $nan$hematology blood hematocrit  23.4  %; hematology blood hematocrit  29.1  %; hematology blood hematocrit  29.5  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  196  k ul; hematology blood platelet count  251  k ul; hematology blood platelet count  202  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  4.0  ; hematology blood inr(pt)  4.2  ; hematology blood inr(pt)  5.2  ; chemistry urine creatinine, urine  31  mg dl; chemistry urine sodium, urine  94  meq l; hematology urine wbc  97  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  159  mg dl$verapamil  240  mg ; atorvastatin  20  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  25  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; verapamil  120  mg ; lisinopril  20  mg ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 0.9% sodium chloride  500  ml ; oxycodone-acetaminophen  1  tab ; bisacodyl  10  mg ; ondansetron  4  mg ; calcium carbonate  500  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension abdominal pain, other specified site 
white f 85 $nan$hematology blood hematocrit  27.0  %; hematology blood hematocrit  25.4  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  265  k ul; hematology blood platelet count  251  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  3.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  138  mg dl$verapamil  240  mg ; atorvastatin  20  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  25  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; verapamil  120  mg ; lisinopril  20  mg ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; bisacodyl  10  mg ; ondansetron  4  mg ; calcium carbonate  500  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; sw  100  ml ; magnesium sulfate  4  gm ; neutra-phos  1  pkt ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension abdominal pain, other specified site 
white f 85 $nan$hematology blood hematocrit  23.2  %; hematology blood hematocrit  29.4  %; hematology blood hematocrit  29.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  273  k ul; hematology blood platelet count  292  k ul; hematology blood platelet count  271  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  2.2  ; hematology blood inr(pt)  2.2  ; hematology blood inr(pt)  1.9  ; chemistry blood glucose  112  mg dl$verapamil  240  mg ; atorvastatin  20  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  25  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; verapamil  120  mg ; lisinopril  20  mg ; acetaminophen  650  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; sw  100  ml ; magnesium sulfate  4  gm ; neutra-phos  1  pkt ; tramadol (ultram)  25  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension abdominal pain, other specified site 
white f 85 $nan$hematology blood hematocrit  30.2  %; hematology blood hematocrit  33.0  %; hematology blood hematocrit  36.0  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  223  k ul; hematology blood platelet count  241  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  164  mg dl; chemistry blood glucose  185  mg dl$verapamil  240  mg ; atorvastatin  20  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  25  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; verapamil  120  mg ; lisinopril  20  mg ; acetaminophen  650  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; labetalol  5  mg ; hydromorphone (dilaudid)  0.05  mg ; oxycodone (immediate release)   2.5 - 5  mg ; cefazolin  1  g ; docusate sodium  100  mg ; metoprolol tartrate  2.5  mg ; metoprolol tartrate  12.5  mg ; 1 2 ns  1000  ml ; enoxaparin sodium  30  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension abdominal pain, other specified site 
white f 85 $nan$hematology blood hematocrit  24.6  %; hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  234  k ul; hematology blood platelet count  287  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  2.5  ; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  139  mg dl$verapamil  240  mg ; atorvastatin  20  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  25  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; verapamil  120  mg ; lisinopril  20  mg ; labetalol  5  mg ; cefazolin  1  g ; docusate sodium  100  mg ; metoprolol tartrate  2.5  mg ; metoprolol tartrate  12.5  mg ; 1 2 ns  1000  ml ; enoxaparin sodium  30  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension abdominal pain, other specified site 
white f 85 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  3.0  ; hematology urine wbc  53  # hpf; chemistry blood glucose  133  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$verapamil  240  mg ; atorvastatin  20  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  25  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; verapamil  120  mg ; lisinopril  20  mg ; cefazolin  1  g ; docusate sodium  100  mg ; senna  2  tab ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension abdominal pain, other specified site 
white f 85 $nan$hematology blood hematocrit  28.6  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  305  k ul; hematology blood platelet count  305  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  3.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  169  mg dl$verapamil  240  mg ; atorvastatin  20  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  25  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; verapamil  120  mg ; lisinopril  20  mg ; cefazolin  1  g ; docusate sodium  100  mg ; senna  2  tab ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension abdominal pain, other specified site 
white f 85 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood glucose  108  mg dl$verapamil  240  mg ; atorvastatin  20  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  25  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; verapamil  120  mg ; lisinopril  20  mg ; cefazolin  1  g ; docusate sodium  100  mg ; senna  2  tab ; pantoprazole  40  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension abdominal pain, other specified site 
white f 85 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  351  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  99  mg dl$verapamil  240  mg ; atorvastatin  20  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  25  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; verapamil  120  mg ; lisinopril  20  mg ; cefazolin  1  g ; docusate sodium  100  mg ; senna  2  tab ; pantoprazole  40  mg ; oxycodone-acetaminophen  0.5  tab ; sw  50  ml ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension abdominal pain, other specified site 
white f 85 $nan$nan$verapamil  240  mg ; atorvastatin  20  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  50  mcg ; metoprolol succinate xl  25  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; verapamil  120  mg ; lisinopril  20  mg ; cefazolin  1  g ; docusate sodium  100  mg ; senna  2  tab ; pantoprazole  40  mg ; oxycodone-acetaminophen  0.5  tab ; sw  50  ml ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension abdominal pain, other specified site 
white m 62 $nan$hematology blood hematocrit  35.8  %; hematology blood hematocrit  37.7  %; hematology blood hemoglobin  11.8  g dl; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  209  k ul; hematology blood platelet count  221  k ul; hematology blood platelet count  214  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  192  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  148  mg dl; chemistry blood glucose  197  mg dl; chemistry blood glucose  159  mg dl; chemistry blood lactate dehydrogenase (ld)  213  iu l; chemistry blood lactate dehydrogenase (ld)  245  iu l; chemistry blood albumin  3.2  g dl; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  0.7  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  0.7  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  153  mg dl; blood gas blood hematocrit, calculated  36  %; blood gas blood hemoglobin  12.0  g dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood sodium, whole blood  137  meq l$vial  1  vial ; pantoprazole  40  mg ; aspirin  81  mg ; atorvastatin  80  mg ; carvedilol  12.5  mg ; digoxin  0.125  mg ; digoxin  0.25  mg ; furosemide  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; rivaroxaban  20  mg ; spironolactone  12.5  mg ; venlafaxine xr  225  mg ; senna  8.6  mg ; insulin  0  unit ; lidocaine jelly 2% (urojet)  1  appl ; furosemide  60  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; d5w  250  ml ; dopamine  400  mg ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; docusate sodium (liquid)  100  mg ; enoxaparin sodium  80  mg ; sodium chloride 0.9%  flush  3  ml ; sterile water  50  ml ; sterile water  100  ml ; sterile water  150  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; digoxin  0.1875  mg ; 
cardiogenic shock disorders of phosphorus metabolism acute and subacute necrosis of liver septic shock polycythemia vera cyst and pseudocyst of pancreas unspecified essential hypertension congestive heart failure, unspecified acute respiratory failure acidosis other chronic pulmonary heart diseases tobacco use disorder acute kidney failure with lesion of tubular necrosis acute on chronic combined systolic and diastolic heart failure other pulmonary embolism and infarction depressive disorder, not elsewhere classified anxiety state, unspecified mitral valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled thrombocytopenia, unspecified atrial flutter other abnormal blood chemistry other ill-defined heart diseases unspecified septicemia hyperpotassemia rash and other nonspecific skin eruption chronic total occlusion of coronary artery severe sepsis diplopia coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia leukocytosis, unspecified
white m 62 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  81  mg dl$aspirin  81  mg ; atorvastatin  80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; venlafaxine xr  225  mg ; senna  8.6  mg ; insulin  0  unit ; lidocaine jelly 2% (urojet)  1  appl ; furosemide  60  mg ; d5w  250  ml ; dopamine  400  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  flush  3  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; digoxin  0.1875  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; carvedilol  3.125  mg ; polyethylene glycol  17  g ; omeprazole  40  mg ; 
cardiogenic shock disorders of phosphorus metabolism acute and subacute necrosis of liver septic shock polycythemia vera cyst and pseudocyst of pancreas unspecified essential hypertension congestive heart failure, unspecified acute respiratory failure acidosis other chronic pulmonary heart diseases tobacco use disorder acute kidney failure with lesion of tubular necrosis acute on chronic combined systolic and diastolic heart failure other pulmonary embolism and infarction depressive disorder, not elsewhere classified anxiety state, unspecified mitral valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled thrombocytopenia, unspecified atrial flutter other abnormal blood chemistry other ill-defined heart diseases unspecified septicemia hyperpotassemia rash and other nonspecific skin eruption chronic total occlusion of coronary artery severe sepsis diplopia coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia leukocytosis, unspecified
white m 62 $nan$nan$aspirin  81  mg ; atorvastatin  80  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; venlafaxine xr  225  mg ; senna  8.6  mg ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; carvedilol  3.125  mg ; polyethylene glycol  17  g ; omeprazole  40  mg ; 
cardiogenic shock disorders of phosphorus metabolism acute and subacute necrosis of liver septic shock polycythemia vera cyst and pseudocyst of pancreas unspecified essential hypertension congestive heart failure, unspecified acute respiratory failure acidosis other chronic pulmonary heart diseases tobacco use disorder acute kidney failure with lesion of tubular necrosis acute on chronic combined systolic and diastolic heart failure other pulmonary embolism and infarction depressive disorder, not elsewhere classified anxiety state, unspecified mitral valve disorders diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled thrombocytopenia, unspecified atrial flutter other abnormal blood chemistry other ill-defined heart diseases unspecified septicemia hyperpotassemia rash and other nonspecific skin eruption chronic total occlusion of coronary artery severe sepsis diplopia coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia leukocytosis, unspecified
white m 94 $temp  97.7  heartrate  78.0  resprate  18.0  o2sat  98.0  sbp  156.0  dbp  103.0  rhythm    pain  0  ; temp    heartrate  85.0  resprate  16.0  o2sat  98.0  sbp  155.0  dbp  89.0  rhythm    pain  0  ; temp    heartrate  78.0  resprate  20.0  o2sat  99.0  sbp  122.0  dbp  71.0  rhythm    pain  0  ; temp  97.8  heartrate  78.0  resprate  18.0  o2sat  99.0  sbp  129.0  dbp  78.0  rhythm    pain  0  ; temp  97.8  heartrate  72.0  resprate  18.0  o2sat  99.0  sbp  126.0  dbp  88.0  rhythm    pain  0  $hematology blood hematocrit  45.2  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  143  k ul; chemistry blood creatinine  1.4  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood albumin  4.1  g dl; blood gas blood lactate  1.1  mmol l; blood gas blood chloride, whole blood  98  meq l; blood gas blood glucose  122  mg dl; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood calculated bicarbonate, whole blood  25  meq l$nan
unspecified hearing loss, unspecified ear gastro-esophageal reflux disease without esophagitis unspecified symptoms and signs involving cognitive functions and awareness presence of other heart-valve replacement pure hypercholesterolemia, unspecified essential (primary) hypertension paroxysmal atrial fibrillation atherosclerotic heart disease of native coronary artery without angina pectoris toxic encephalopathy delirium due to known physiological condition benign prostatic hyperplasia without lower urinary tract symptoms hallucinations, unspecified personal history of nicotine dependence long term (current) use of anticoagulants restlessness and agitation calculus of bile duct with acute cholangitis without obstruction essential (primary) hypertension weakness toxic encephalopathy unsteadiness on feet personal history of colonic polyps cholangitis paroxysmal atrial fibrillation long term (current) use of antithrombotics/antiplatelets anxiety disorder, unspecified spinal stenosis, site unspecified mild cognitive impairment, so stated personal history of nicotine dependence pneumonia, unspecified organism male erectile dysfunction, unspecified decreased white blood cell count, unspecified gastro-esophageal reflux disease without esophagitis thrombocytopenia, unspecified presence of xenogenic heart valve other specified disorders of biliary tract thrombocytopenia, unspecified esophageal reflux benign essential hypertension atrial fibrillation cholangitis obstruction of bile duct hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anxiety state, unspecified heart valve replaced by transplant other and unspecified hyperlipidemia bronchiectasis without acute exacerbation person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident nausea with vomiting
white m 94 $temp  97.6  heartrate  71.0  resprate  14.0  o2sat  98.0  sbp  167.0  dbp  85.0  rhythm    pain  0  $nan$sodium chloride 0.9%  flush  3-10  ml ; spironolactone  12.5  mg ; ferrous sulfate  325  mg ; psyllium powder  1  pkt ; vitamin d  1000  unit ; diltiazem extended-release  120  mg ; finasteride  5  mg ; pantoprazole  40  mg ; apixaban  5  mg ; cyanocobalamin  1000  mcg ; haloperidol  0.5  mg ; tamsulosin  0.4  mg ; pravastatin  60  mg ; ursodiol  300  mg ; risperidone  0.5  mg ; 
unspecified hearing loss, unspecified ear gastro-esophageal reflux disease without esophagitis unspecified symptoms and signs involving cognitive functions and awareness presence of other heart-valve replacement pure hypercholesterolemia, unspecified essential (primary) hypertension paroxysmal atrial fibrillation atherosclerotic heart disease of native coronary artery without angina pectoris toxic encephalopathy delirium due to known physiological condition benign prostatic hyperplasia without lower urinary tract symptoms hallucinations, unspecified personal history of nicotine dependence long term (current) use of anticoagulants restlessness and agitation calculus of bile duct with acute cholangitis without obstruction essential (primary) hypertension weakness toxic encephalopathy unsteadiness on feet personal history of colonic polyps cholangitis paroxysmal atrial fibrillation long term (current) use of antithrombotics/antiplatelets anxiety disorder, unspecified spinal stenosis, site unspecified mild cognitive impairment, so stated personal history of nicotine dependence pneumonia, unspecified organism male erectile dysfunction, unspecified decreased white blood cell count, unspecified gastro-esophageal reflux disease without esophagitis thrombocytopenia, unspecified presence of xenogenic heart valve other specified disorders of biliary tract thrombocytopenia, unspecified esophageal reflux benign essential hypertension atrial fibrillation cholangitis obstruction of bile duct hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anxiety state, unspecified heart valve replaced by transplant other and unspecified hyperlipidemia bronchiectasis without acute exacerbation person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident nausea with vomiting
white m 94 $nan$hematology blood hematocrit  49.3  %; hematology blood hemoglobin  15.9  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3-10  ml ; spironolactone  12.5  mg ; ferrous sulfate  325  mg ; psyllium powder  1  pkt ; vitamin d  1000  unit ; diltiazem extended-release  120  mg ; finasteride  5  mg ; pantoprazole  40  mg ; apixaban  5  mg ; cyanocobalamin  1000  mcg ; haloperidol  0.5  mg ; tamsulosin  0.4  mg ; pravastatin  60  mg ; ursodiol  300  mg ; risperidone  0.5  mg ; 
unspecified hearing loss, unspecified ear gastro-esophageal reflux disease without esophagitis unspecified symptoms and signs involving cognitive functions and awareness presence of other heart-valve replacement pure hypercholesterolemia, unspecified essential (primary) hypertension paroxysmal atrial fibrillation atherosclerotic heart disease of native coronary artery without angina pectoris toxic encephalopathy delirium due to known physiological condition benign prostatic hyperplasia without lower urinary tract symptoms hallucinations, unspecified personal history of nicotine dependence long term (current) use of anticoagulants restlessness and agitation calculus of bile duct with acute cholangitis without obstruction essential (primary) hypertension weakness toxic encephalopathy unsteadiness on feet personal history of colonic polyps cholangitis paroxysmal atrial fibrillation long term (current) use of antithrombotics/antiplatelets anxiety disorder, unspecified spinal stenosis, site unspecified mild cognitive impairment, so stated personal history of nicotine dependence pneumonia, unspecified organism male erectile dysfunction, unspecified decreased white blood cell count, unspecified gastro-esophageal reflux disease without esophagitis thrombocytopenia, unspecified presence of xenogenic heart valve other specified disorders of biliary tract thrombocytopenia, unspecified esophageal reflux benign essential hypertension atrial fibrillation cholangitis obstruction of bile duct hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anxiety state, unspecified heart valve replaced by transplant other and unspecified hyperlipidemia bronchiectasis without acute exacerbation person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident nausea with vomiting
white m 94 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  flush  3-10  ml ; spironolactone  12.5  mg ; ferrous sulfate  325  mg ; psyllium powder  1  pkt ; vitamin d  1000  unit ; diltiazem extended-release  120  mg ; finasteride  5  mg ; pantoprazole  40  mg ; apixaban  5  mg ; haloperidol  0.5  mg ; tamsulosin  0.4  mg ; pravastatin  60  mg ; ursodiol  300  mg ; risperidone  0.5  mg ; 
unspecified hearing loss, unspecified ear gastro-esophageal reflux disease without esophagitis unspecified symptoms and signs involving cognitive functions and awareness presence of other heart-valve replacement pure hypercholesterolemia, unspecified essential (primary) hypertension paroxysmal atrial fibrillation atherosclerotic heart disease of native coronary artery without angina pectoris toxic encephalopathy delirium due to known physiological condition benign prostatic hyperplasia without lower urinary tract symptoms hallucinations, unspecified personal history of nicotine dependence long term (current) use of anticoagulants restlessness and agitation calculus of bile duct with acute cholangitis without obstruction essential (primary) hypertension weakness toxic encephalopathy unsteadiness on feet personal history of colonic polyps cholangitis paroxysmal atrial fibrillation long term (current) use of antithrombotics/antiplatelets anxiety disorder, unspecified spinal stenosis, site unspecified mild cognitive impairment, so stated personal history of nicotine dependence pneumonia, unspecified organism male erectile dysfunction, unspecified decreased white blood cell count, unspecified gastro-esophageal reflux disease without esophagitis thrombocytopenia, unspecified presence of xenogenic heart valve other specified disorders of biliary tract thrombocytopenia, unspecified esophageal reflux benign essential hypertension atrial fibrillation cholangitis obstruction of bile duct hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anxiety state, unspecified heart valve replaced by transplant other and unspecified hyperlipidemia bronchiectasis without acute exacerbation person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident nausea with vomiting
white f 91 $nan$nan$hydrochlorothiazide  6.25  mg ; vitamin d  800  unit ; multivitamins  1  tab ; 
 
white f 91 $nan$hematology blood hematocrit  34.7  %; hematology blood hematocrit  35.5  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  3.4  ; chemistry urine creatinine, urine  137  mg dl; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  111  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$hydrochlorothiazide  6.25  mg ; vitamin d  800  unit ; multivitamins  1  tab ; warfarin  2.5  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; digoxin  0.125  mg ; 0.9% sodium chloride  1000  ml ; senna  2  tab ; latanoprost 0.005% ophth. soln.  1  drop ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; potassium chloride  20  meq ; neutra-phos  2  pkt ; sw  50  ml ; magnesium sulfate  2  gm ; hydralazine  10  mg ; 
 
white f 91 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  116  mg dl$hydrochlorothiazide  6.25  mg ; vitamin d  800  unit ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; digoxin  0.125  mg ; senna  2  tab ; latanoprost 0.005% ophth. soln.  1  drop ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; potassium chloride  20  meq ; neutra-phos  2  pkt ; sw  50  ml ; magnesium sulfate  2  gm ; hydralazine  10  mg ; cefpodoxime proxetil  200  mg ; 
 
white f 91 $nan$nan$hydrochlorothiazide  6.25  mg ; vitamin d  800  unit ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; digoxin  0.125  mg ; senna  2  tab ; latanoprost 0.005% ophth. soln.  1  drop ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; azithromycin  250  mg ; cefpodoxime proxetil  200  mg ; warfarin  1.5  mg ; 
 
white f 79 $nan$hematology blood hematocrit  34.1  %; hematology blood hematocrit  32.2  %; hematology blood hematocrit  32.6  %; hematology blood hematocrit  32.1  %; hematology blood hematocrit  32.2  %; hematology blood hematocrit  31.0  %; hematology blood hematocrit  31.1  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  41  k ul; hematology blood platelet count  60  k ul; hematology blood platelet count  57  k ul; hematology blood platelet count  46  k ul; hematology blood platelet count  43  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  75  mg dl; chemistry blood urea nitrogen  79  mg dl; chemistry blood urea nitrogen  83  mg dl; chemistry blood urea nitrogen  90  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.5  ; chemistry urine creatinine, urine  53  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  82  mg dl; chemistry blood glucose  65  mg dl; chemistry blood glucose  67  mg dl; chemistry blood glucose  83  mg dl; chemistry blood lactate dehydrogenase (ld)  209  iu l; chemistry blood albumin  3.2  g dl; hematology blood bands  5  %; chemistry urine protein creatinine ratio  0.5  ratio; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  0.9  mmol l$sodium chloride 0.9%  flush  3  ml ; influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  100  ml ; octreotide acetate  0.6  mg ; pantoprazole sodium  80  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; fentanyl citrate  25-100  mcg ; midazolam  0.5-2  mg ; d10w  1000  ml ; insulin human regular  100  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ns  150  ml ; erythromycin  250  mg ; 0.9% sodium chloride  50  ml ; desmopressin acetate  22  mcg ; calcium gluconate  2  gm ; 5% dextrose  250  ml ; calcium gluconate  3  gm ; calcium gluconate  4  gm ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast atrial fibrillation acute on chronic diastolic heart failure other chronic pulmonary heart diseases pancytopenia unspecified essential hypertension congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status chronic kidney disease, unspecified urinary tract infection, site not specified long-term (current) use of insulin cardiotonic glycosides and drugs of similar action causing adverse effects in therapeutic use anemia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal atrial fibrillation acute kidney failure, unspecified personal history of malignant neoplasm of breast unspecified essential hypertension acute on chronic diastolic heart failure other and unspecified hyperlipidemia other chronic pulmonary heart diseases postsurgical hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other specified cardiac dysrhythmias esophageal reflux 
white f 79 $nan$hematology blood hematocrit  30.0  %; hematology blood hematocrit  31.2  %; hematology blood hematocrit  34.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  42  k ul; hematology blood platelet count  40  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  92  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  109  mg dl; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  0.7  mmol l$sodium chloride 0.9%  flush  3  ml ; influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  100  ml ; octreotide acetate  0.6  mg ; pantoprazole sodium  80  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  50  ml ; desmopressin acetate  22  mcg ; calcium gluconate  2  gm ; 5% dextrose  250  ml ; calcium gluconate  3  gm ; calcium gluconate  4  gm ; 0.9% sodium chloride  250  ml ; fentanyl citrate  2.5  mg ; midazolam  100  mg ; erythromycin  125  mg ; ns  100  ml ; heparin flush (5000 units ml)  5000  unit ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast atrial fibrillation acute on chronic diastolic heart failure other chronic pulmonary heart diseases pancytopenia unspecified essential hypertension congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status chronic kidney disease, unspecified urinary tract infection, site not specified long-term (current) use of insulin cardiotonic glycosides and drugs of similar action causing adverse effects in therapeutic use anemia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal atrial fibrillation acute kidney failure, unspecified personal history of malignant neoplasm of breast unspecified essential hypertension acute on chronic diastolic heart failure other and unspecified hyperlipidemia other chronic pulmonary heart diseases postsurgical hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other specified cardiac dysrhythmias esophageal reflux 
white f 79 $nan$hematology blood hematocrit  31.0  %; hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  36  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  63  mg dl; hematology blood inr(pt)  1.4  ; hematology urine wbc     # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  154  mg dl; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  0.8  mmol l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$sodium chloride 0.9%  flush  3  ml ; influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  100  ml ; octreotide acetate  0.6  mg ; pantoprazole sodium  80  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium gluconate  2  gm ; 5% dextrose  250  ml ; calcium gluconate  3  gm ; calcium gluconate  4  gm ; 0.9% sodium chloride  250  ml ; fentanyl citrate  2.5  mg ; midazolam  100  mg ; heparin flush (5000 units ml)  5000  unit ; vial  1  vial ; pantoprazole sodium  40  mg ; norepinephrine  8  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast atrial fibrillation acute on chronic diastolic heart failure other chronic pulmonary heart diseases pancytopenia unspecified essential hypertension congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status chronic kidney disease, unspecified urinary tract infection, site not specified long-term (current) use of insulin cardiotonic glycosides and drugs of similar action causing adverse effects in therapeutic use anemia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal atrial fibrillation acute kidney failure, unspecified personal history of malignant neoplasm of breast unspecified essential hypertension acute on chronic diastolic heart failure other and unspecified hyperlipidemia other chronic pulmonary heart diseases postsurgical hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other specified cardiac dysrhythmias esophageal reflux 
white f 79 $nan$hematology blood hematocrit  30.6  %; hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  36  k ul; hematology blood platelet count  28  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  202  mg dl$sodium chloride 0.9%  flush  3  ml ; influenza virus vaccine  0.5  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium gluconate  2  gm ; 5% dextrose  250  ml ; calcium gluconate  3  gm ; calcium gluconate  4  gm ; 0.9% sodium chloride  250  ml ; fentanyl citrate  2.5  mg ; midazolam  100  mg ; heparin flush (5000 units ml)  5000  unit ; vial  1  vial ; pantoprazole sodium  40  mg ; norepinephrine  8  mg ; epoetin alfa  1  dose ; insulin  0  unit ; albuterol-ipratropium  1-2  puff ; levothyroxine sodium  25  mcg ; fentanyl citrate  100  mcg ; midazolam  2.5  mg ; sucralfate  1  gm ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lansoprazole oral disintegrating tab  30  mg ; pantoprazole  40  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast atrial fibrillation acute on chronic diastolic heart failure other chronic pulmonary heart diseases pancytopenia unspecified essential hypertension congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status chronic kidney disease, unspecified urinary tract infection, site not specified long-term (current) use of insulin cardiotonic glycosides and drugs of similar action causing adverse effects in therapeutic use anemia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal atrial fibrillation acute kidney failure, unspecified personal history of malignant neoplasm of breast unspecified essential hypertension acute on chronic diastolic heart failure other and unspecified hyperlipidemia other chronic pulmonary heart diseases postsurgical hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other specified cardiac dysrhythmias esophageal reflux 
white f 79 $nan$hematology blood hematocrit  33.6  %; hematology blood hematocrit  32.4  %; hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  27  k ul; hematology blood platelet count  38  k ul; hematology blood platelet count  28  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  58  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  160  mg dl; blood gas blood free calcium  1.24  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood hematocrit, calculated  36  %; blood gas blood hemoglobin  12.1  g dl; blood gas blood potassium, whole blood  3.8  meq l$sodium chloride 0.9%  flush  3  ml ; influenza virus vaccine  0.5  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; calcium gluconate  2  gm ; 5% dextrose  250  ml ; calcium gluconate  3  gm ; calcium gluconate  4  gm ; 0.9% sodium chloride  250  ml ; fentanyl citrate  2.5  mg ; midazolam  100  mg ; heparin flush (5000 units ml)  5000  unit ; norepinephrine  8  mg ; insulin  0  unit ; albuterol-ipratropium  1-2  puff ; levothyroxine sodium  25  mcg ; fentanyl citrate  100  mcg ; midazolam  2.5  mg ; sucralfate  1  gm ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; pantoprazole  40  mg ; magnesium sulfate  2  gm ; d5w  250  ml ; nitroglycerin  100  mg ; morphine sulfate  1-2  mg ; furosemide  80  mg ; nadolol  20  mg ; ferrous sulfate  325  mg ; folic acid  1  mg ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; sodium chloride 0.9%  flush  10  ml ; sodium citrate 4%  4  ml ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast atrial fibrillation acute on chronic diastolic heart failure other chronic pulmonary heart diseases pancytopenia unspecified essential hypertension congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status chronic kidney disease, unspecified urinary tract infection, site not specified long-term (current) use of insulin cardiotonic glycosides and drugs of similar action causing adverse effects in therapeutic use anemia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal atrial fibrillation acute kidney failure, unspecified personal history of malignant neoplasm of breast unspecified essential hypertension acute on chronic diastolic heart failure other and unspecified hyperlipidemia other chronic pulmonary heart diseases postsurgical hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other specified cardiac dysrhythmias esophageal reflux 
white f 79 $nan$hematology blood hematocrit  29.8  %; hematology blood hematocrit  32.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  30  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  68  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; influenza virus vaccine  0.5  ml ; calcium gluconate  2  gm ; 5% dextrose  250  ml ; calcium gluconate  3  gm ; calcium gluconate  4  gm ; heparin flush (5000 units ml)  5000  unit ; norepinephrine  8  mg ; insulin  0  unit ; albuterol-ipratropium  1-2  puff ; levothyroxine sodium  25  mcg ; sucralfate  1  gm ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; pantoprazole  40  mg ; magnesium sulfate  2  gm ; d5w  250  ml ; nitroglycerin  100  mg ; morphine sulfate  1-2  mg ; furosemide  80  mg ; nadolol  20  mg ; ferrous sulfate  325  mg ; folic acid  1  mg ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; sodium chloride 0.9%  flush  10  ml ; sodium citrate 4%  4  ml ; levothyroxine sodium  50  mcg ; miconazole powder 2%  1  appl ; epoetin alfa  10,000  unit ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast atrial fibrillation acute on chronic diastolic heart failure other chronic pulmonary heart diseases pancytopenia unspecified essential hypertension congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status chronic kidney disease, unspecified urinary tract infection, site not specified long-term (current) use of insulin cardiotonic glycosides and drugs of similar action causing adverse effects in therapeutic use anemia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal atrial fibrillation acute kidney failure, unspecified personal history of malignant neoplasm of breast unspecified essential hypertension acute on chronic diastolic heart failure other and unspecified hyperlipidemia other chronic pulmonary heart diseases postsurgical hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other specified cardiac dysrhythmias esophageal reflux 
white f 79 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  33  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  118  mg dl$sodium chloride 0.9%  flush  3  ml ; influenza virus vaccine  0.5  ml ; insulin  0  unit ; albuterol-ipratropium  1-2  puff ; sucralfate  1  gm ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; pantoprazole  40  mg ; nadolol  20  mg ; ferrous sulfate  325  mg ; folic acid  1  mg ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; sodium chloride 0.9%  flush  10  ml ; levothyroxine sodium  50  mcg ; miconazole powder 2%  1  appl ; epoetin alfa  10,000  unit ; tuberculin protein  0.1  ml ; sodium citrate 4%  2.2  ml ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast atrial fibrillation acute on chronic diastolic heart failure other chronic pulmonary heart diseases pancytopenia unspecified essential hypertension congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status chronic kidney disease, unspecified urinary tract infection, site not specified long-term (current) use of insulin cardiotonic glycosides and drugs of similar action causing adverse effects in therapeutic use anemia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal atrial fibrillation acute kidney failure, unspecified personal history of malignant neoplasm of breast unspecified essential hypertension acute on chronic diastolic heart failure other and unspecified hyperlipidemia other chronic pulmonary heart diseases postsurgical hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other specified cardiac dysrhythmias esophageal reflux 
white f 79 $nan$hematology blood hematocrit  33.1  %; hematology blood hematocrit  35.4  %; hematology blood hematocrit  36.0  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  38  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  58  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3  ml ; influenza virus vaccine  0.5  ml ; insulin  0  unit ; albuterol-ipratropium  1-2  puff ; sucralfate  1  gm ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; nadolol  20  mg ; ferrous sulfate  325  mg ; folic acid  1  mg ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; sodium chloride 0.9%  flush  10  ml ; levothyroxine sodium  50  mcg ; miconazole powder 2%  1  appl ; epoetin alfa  10,000  unit ; tuberculin protein  0.1  ml ; sodium citrate 4%  2.2  ml ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast atrial fibrillation acute on chronic diastolic heart failure other chronic pulmonary heart diseases pancytopenia unspecified essential hypertension congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status chronic kidney disease, unspecified urinary tract infection, site not specified long-term (current) use of insulin cardiotonic glycosides and drugs of similar action causing adverse effects in therapeutic use anemia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal atrial fibrillation acute kidney failure, unspecified personal history of malignant neoplasm of breast unspecified essential hypertension acute on chronic diastolic heart failure other and unspecified hyperlipidemia other chronic pulmonary heart diseases postsurgical hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other specified cardiac dysrhythmias esophageal reflux 
white f 79 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  41  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; influenza virus vaccine  0.5  ml ; insulin  0  unit ; albuterol-ipratropium  1-2  puff ; sucralfate  1  gm ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; nadolol  20  mg ; ferrous sulfate  325  mg ; folic acid  1  mg ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; sodium chloride 0.9%  flush  10  ml ; levothyroxine sodium  50  mcg ; miconazole powder 2%  1  appl ; epoetin alfa  10,000  unit ; sodium citrate 4%  2.2  ml ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast atrial fibrillation acute on chronic diastolic heart failure other chronic pulmonary heart diseases pancytopenia unspecified essential hypertension congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status chronic kidney disease, unspecified urinary tract infection, site not specified long-term (current) use of insulin cardiotonic glycosides and drugs of similar action causing adverse effects in therapeutic use anemia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal atrial fibrillation acute kidney failure, unspecified personal history of malignant neoplasm of breast unspecified essential hypertension acute on chronic diastolic heart failure other and unspecified hyperlipidemia other chronic pulmonary heart diseases postsurgical hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other specified cardiac dysrhythmias esophageal reflux 
white f 74 $temp  97.6  heartrate  58.0  resprate  16.0  o2sat  100.0  sbp  138.0  dbp  71.0  rhythm    pain  0  ; temp    heartrate  61.0  resprate  16.0  o2sat  98.0  sbp  119.0  dbp  73.0  rhythm    pain  0  ; temp  97.7  heartrate  58.0  resprate  15.0  o2sat  95.0  sbp  108.0  dbp  64.0  rhythm    pain    $hematology blood hematocrit  40.3  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  338  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  100  mg dl; chemistry blood albumin  4.5  g dl$nan
unspecified essential hypertension dysthymic disorder acquired absence of intestine (large) (small) acquired absence of both cervix and uterus other acquired absence of organ unspecified intestinal obstruction irritable bowel syndrome 
white f 74 $temp  97.9  heartrate  64.0  resprate  15.0  o2sat  96.0  sbp  93.0  dbp  58.0  rhythm    pain  0  ; temp  97.9  heartrate  64.0  resprate  15.0  o2sat  95.0  sbp  100.0  dbp  57.0  rhythm    pain  0  ; temp  97.8  heartrate  64.0  resprate  18.0  o2sat    sbp  118.0  dbp  69.0  rhythm    pain  0  ; temp  97.8  heartrate  64.0  resprate  18.0  o2sat  95.0  sbp  118.0  dbp  69.0  rhythm    pain    $hematology blood hematocrit  39.9  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  296  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  90  mg dl; blood gas blood lactate  0.7  mmol l$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; aspirin  81  mg ; lamotrigine  200  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; ondansetron  4  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; lorazepam  1  mg ; potassium chloride  40  meq ; 
unspecified essential hypertension dysthymic disorder acquired absence of intestine (large) (small) acquired absence of both cervix and uterus other acquired absence of organ unspecified intestinal obstruction irritable bowel syndrome 
white m 73 $temp  97.8  heartrate  78.0  resprate  18.0  o2sat  98.0  sbp  144.0  dbp  88.0  rhythm    pain  0  ; temp    heartrate  64.0  resprate  18.0  o2sat  98.0  sbp  130.0  dbp  79.0  rhythm    pain  0  $hematology blood hematocrit  39.3  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  106  mg dl$nan
 
white f 91 $nan$nan$nifedipine cr  30  mg ; aspirin  81  mg ; omeprazole  40  mg ; tiotropium bromide  1  cap ; 
adjustment disorder with mixed anxiety and depressed mood congestive heart failure, unspecified methicillin resistant pneumonia due to staphylococcus aureus bronchiectasis without acute exacerbation unspecified essential hypertension escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary tract infection, site not specified obstructive chronic bronchitis with (acute) exacerbation mitral valve disorders acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure acute respiratory failure other chest pain other alteration of consciousness bronchiectasis with acute exacerbation backache, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled leukocytosis, unspecified congestive heart failure, unspecified urinary tract infection, site not specified esophageal reflux chronic diastolic heart failure unspecified essential hypertension aortic valve disorders 
white f 91 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; hematology urine wbc  >50  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  73  mg dl; blood gas blood lactate  1.0  mmol l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$nifedipine cr  30  mg ; aspirin  81  mg ; omeprazole  40  mg ; tiotropium bromide  1  cap ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns (mini bag plus)  100  ml ; cefepime  1  g ; heparin  5000  unit ; furosemide  40  mg ; ciprofloxacin hcl  500  mg ; insulin  0  unit ; hydralazine  25  mg ; albuterol 0.083% neb soln  1  neb ; polyethylene glycol  17  g ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; metoprolol tartrate  25  mg ; senna  1  tab ; fluticasone propionate 110mcg  2  puff ; ondansetron  4  mg ; hydralazine  5  mg ; 
adjustment disorder with mixed anxiety and depressed mood congestive heart failure, unspecified methicillin resistant pneumonia due to staphylococcus aureus bronchiectasis without acute exacerbation unspecified essential hypertension escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary tract infection, site not specified obstructive chronic bronchitis with (acute) exacerbation mitral valve disorders acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure acute respiratory failure other chest pain other alteration of consciousness bronchiectasis with acute exacerbation backache, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled leukocytosis, unspecified congestive heart failure, unspecified urinary tract infection, site not specified esophageal reflux chronic diastolic heart failure unspecified essential hypertension aortic valve disorders 
white f 91 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  25  mg dl; hematology urine wbc  10  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  89  mg dl$nifedipine cr  30  mg ; aspirin  81  mg ; omeprazole  40  mg ; tiotropium bromide  1  cap ; heparin  5000  unit ; furosemide  40  mg ; insulin  0  unit ; hydralazine  25  mg ; albuterol 0.083% neb soln  1  neb ; polyethylene glycol  17  g ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; metoprolol tartrate  25  mg ; senna  1  tab ; fluticasone propionate 110mcg  2  puff ; ondansetron  4  mg ; hydralazine  5  mg ; prochlorperazine  10  mg ; lorazepam  0.25  mg ; multivitamins  1  tab ; 
adjustment disorder with mixed anxiety and depressed mood congestive heart failure, unspecified methicillin resistant pneumonia due to staphylococcus aureus bronchiectasis without acute exacerbation unspecified essential hypertension escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary tract infection, site not specified obstructive chronic bronchitis with (acute) exacerbation mitral valve disorders acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure acute respiratory failure other chest pain other alteration of consciousness bronchiectasis with acute exacerbation backache, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled leukocytosis, unspecified congestive heart failure, unspecified urinary tract infection, site not specified esophageal reflux chronic diastolic heart failure unspecified essential hypertension aortic valve disorders 
white f 91 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  314  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  105  mg dl; chemistry blood albumin  3.1  g dl$nifedipine cr  30  mg ; aspirin  81  mg ; omeprazole  40  mg ; tiotropium bromide  1  cap ; heparin  5000  unit ; insulin  0  unit ; hydralazine  25  mg ; albuterol 0.083% neb soln  1  neb ; polyethylene glycol  17  g ; metoprolol tartrate  25  mg ; senna  1  tab ; fluticasone propionate 110mcg  2  puff ; ondansetron  4  mg ; prochlorperazine  10  mg ; lorazepam  0.25  mg ; multivitamins  1  tab ; acetaminophen  325  mg ; milk of magnesia  30  ml ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; trazodone  25  mg ; furosemide  20  mg ; docusate sodium  100  mg ; isosorbide dinitrate  10  mg ; 
adjustment disorder with mixed anxiety and depressed mood congestive heart failure, unspecified methicillin resistant pneumonia due to staphylococcus aureus bronchiectasis without acute exacerbation unspecified essential hypertension escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary tract infection, site not specified obstructive chronic bronchitis with (acute) exacerbation mitral valve disorders acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure acute respiratory failure other chest pain other alteration of consciousness bronchiectasis with acute exacerbation backache, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled leukocytosis, unspecified congestive heart failure, unspecified urinary tract infection, site not specified esophageal reflux chronic diastolic heart failure unspecified essential hypertension aortic valve disorders 
white f 91 $nan$chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  101  mg dl$nifedipine cr  30  mg ; aspirin  81  mg ; omeprazole  40  mg ; tiotropium bromide  1  cap ; heparin  5000  unit ; insulin  0  unit ; hydralazine  25  mg ; albuterol 0.083% neb soln  1  neb ; metoprolol tartrate  25  mg ; senna  1  tab ; fluticasone propionate 110mcg  2  puff ; ondansetron  4  mg ; prochlorperazine  10  mg ; multivitamins  1  tab ; acetaminophen  325  mg ; milk of magnesia  30  ml ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; trazodone  25  mg ; furosemide  20  mg ; docusate sodium  100  mg ; isosorbide dinitrate  10  mg ; simethicone  40-80  mg ; lisinopril  2.5  mg ; 
adjustment disorder with mixed anxiety and depressed mood congestive heart failure, unspecified methicillin resistant pneumonia due to staphylococcus aureus bronchiectasis without acute exacerbation unspecified essential hypertension escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary tract infection, site not specified obstructive chronic bronchitis with (acute) exacerbation mitral valve disorders acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure acute respiratory failure other chest pain other alteration of consciousness bronchiectasis with acute exacerbation backache, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled leukocytosis, unspecified congestive heart failure, unspecified urinary tract infection, site not specified esophageal reflux chronic diastolic heart failure unspecified essential hypertension aortic valve disorders 
white f 91 $nan$nan$nifedipine cr  30  mg ; aspirin  81  mg ; omeprazole  40  mg ; tiotropium bromide  1  cap ; heparin  5000  unit ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; metoprolol tartrate  25  mg ; fluticasone propionate 110mcg  2  puff ; ondansetron  4  mg ; prochlorperazine  10  mg ; multivitamins  1  tab ; milk of magnesia  30  ml ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; trazodone  25  mg ; isosorbide dinitrate  10  mg ; simethicone  40-80  mg ; lisinopril  2.5  mg ; lisinopril  10  mg ; 
adjustment disorder with mixed anxiety and depressed mood congestive heart failure, unspecified methicillin resistant pneumonia due to staphylococcus aureus bronchiectasis without acute exacerbation unspecified essential hypertension escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary tract infection, site not specified obstructive chronic bronchitis with (acute) exacerbation mitral valve disorders acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure acute respiratory failure other chest pain other alteration of consciousness bronchiectasis with acute exacerbation backache, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled leukocytosis, unspecified congestive heart failure, unspecified urinary tract infection, site not specified esophageal reflux chronic diastolic heart failure unspecified essential hypertension aortic valve disorders 
white f 91 $nan$nan$nifedipine cr  30  mg ; aspirin  81  mg ; omeprazole  40  mg ; tiotropium bromide  1  cap ; heparin  5000  unit ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; metoprolol tartrate  25  mg ; fluticasone propionate 110mcg  2  puff ; ondansetron  4  mg ; prochlorperazine  10  mg ; multivitamins  1  tab ; milk of magnesia  30  ml ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; trazodone  25  mg ; isosorbide dinitrate  10  mg ; simethicone  40-80  mg ; lisinopril  10  mg ; lisinopril  5  mg ; 
adjustment disorder with mixed anxiety and depressed mood congestive heart failure, unspecified methicillin resistant pneumonia due to staphylococcus aureus bronchiectasis without acute exacerbation unspecified essential hypertension escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary tract infection, site not specified obstructive chronic bronchitis with (acute) exacerbation mitral valve disorders acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure acute respiratory failure other chest pain other alteration of consciousness bronchiectasis with acute exacerbation backache, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled leukocytosis, unspecified congestive heart failure, unspecified urinary tract infection, site not specified esophageal reflux chronic diastolic heart failure unspecified essential hypertension aortic valve disorders 
white f 91 $nan$nan$aspirin  81  mg ; omeprazole  40  mg ; tiotropium bromide  1  cap ; heparin  5000  unit ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; fluticasone propionate 110mcg  2  puff ; ondansetron  4  mg ; prochlorperazine  10  mg ; multivitamins  1  tab ; milk of magnesia  30  ml ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; trazodone  25  mg ; isosorbide dinitrate  10  mg ; simethicone  40-80  mg ; lisinopril  10  mg ; 
adjustment disorder with mixed anxiety and depressed mood congestive heart failure, unspecified methicillin resistant pneumonia due to staphylococcus aureus bronchiectasis without acute exacerbation unspecified essential hypertension escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary tract infection, site not specified obstructive chronic bronchitis with (acute) exacerbation mitral valve disorders acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure acute respiratory failure other chest pain other alteration of consciousness bronchiectasis with acute exacerbation backache, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled leukocytosis, unspecified congestive heart failure, unspecified urinary tract infection, site not specified esophageal reflux chronic diastolic heart failure unspecified essential hypertension aortic valve disorders 
white f 91 $nan$nan$aspirin  81  mg ; omeprazole  40  mg ; tiotropium bromide  1  cap ; heparin  5000  unit ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; fluticasone propionate 110mcg  2  puff ; ondansetron  4  mg ; prochlorperazine  10  mg ; multivitamins  1  tab ; milk of magnesia  30  ml ; bisacodyl  10  mg ; trazodone  25  mg ; isosorbide dinitrate  10  mg ; simethicone  40-80  mg ; lisinopril  10  mg ; acetaminophen  1000  mg ; 
adjustment disorder with mixed anxiety and depressed mood congestive heart failure, unspecified methicillin resistant pneumonia due to staphylococcus aureus bronchiectasis without acute exacerbation unspecified essential hypertension escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary tract infection, site not specified obstructive chronic bronchitis with (acute) exacerbation mitral valve disorders acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure acute respiratory failure other chest pain other alteration of consciousness bronchiectasis with acute exacerbation backache, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled leukocytosis, unspecified congestive heart failure, unspecified urinary tract infection, site not specified esophageal reflux chronic diastolic heart failure unspecified essential hypertension aortic valve disorders 
white f 59 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  171  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; morphine sulfate  1-2  mg ; morphine sulfate  1-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; magnesium sulfate  2  gm ; 
 
white f 59 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; magnesium sulfate  2  gm ; docusate sodium  100  mg ; 
 
white f 59 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; docusate sodium  100  mg ; morphine sulfate  2  mg ; 
 
white m 61 $nan$nan$aspirin ec  325  mg ; clopidogrel  75  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  40  mg ; 
 
white m 61 $nan$hematology blood hematocrit  43.4  %; hematology blood platelet count  190  k ul; hematology blood platelet count  218  k ul; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  $aspirin ec  325  mg ; clopidogrel  75  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  40  mg ; 1 2 ns  1000  ml ; atropine sulfate  0.5  mg ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; warfarin  7.5  mg ; atenolol  50  mg ; dronedarone  400  mg ; simvastatin  40  mg ; 
 
white m 61 $nan$nan$aspirin ec  325  mg ; clopidogrel  75  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  40  mg ; atropine sulfate  0.5  mg ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; warfarin  7.5  mg ; atenolol  50  mg ; dronedarone  400  mg ; simvastatin  40  mg ; 
 
white f 73 $temp  97.5  heartrate  74.0  resprate  14.0  o2sat  98.0  sbp  158.0  dbp  51.0  rhythm    pain  7  $hematology blood hematocrit  32.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  644  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; enoxaparin sodium  40  mg ; levothyroxine sodium  88  mcg ; alendronate sodium  70  mg ; oxycodone (immediate release)  2.5-5  mg ; sodium chloride 0.9%  1000  ml ; lisinopril  10  mg ; apixaban  5  mg ; 
nausea heart failure, unspecified autoimmune thyroiditis anemia, unspecified chronic kidney disease, unspecified other postprocedural complications and disorders of respiratory system, not elsewhere classified retention of urine, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of irradiation unspecified place in hospital as the place of occurrence of the external cause body mass index (bmi) 31.0-31.9, adult dizziness and giddiness paroxysmal atrial fibrillation surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure obesity, unspecified personal history of malignant neoplasm of breast atelectasis personal history of urinary (tract) infections elevated white blood cell count, unspecified unilateral primary osteoarthritis, right hip personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits 
white f 73 $nan$nan$enoxaparin sodium  40  mg ; levothyroxine sodium  88  mcg ; lisinopril  10  mg ; apixaban  5  mg ; lorazepam  1.5  mg ; lorazepam  1  mg ; lidocaine 5% patch  1  ptch ; 
nausea heart failure, unspecified autoimmune thyroiditis anemia, unspecified chronic kidney disease, unspecified other postprocedural complications and disorders of respiratory system, not elsewhere classified retention of urine, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of irradiation unspecified place in hospital as the place of occurrence of the external cause body mass index (bmi) 31.0-31.9, adult dizziness and giddiness paroxysmal atrial fibrillation surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure obesity, unspecified personal history of malignant neoplasm of breast atelectasis personal history of urinary (tract) infections elevated white blood cell count, unspecified unilateral primary osteoarthritis, right hip personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits 
white f 73 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  600  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  74  mg dl$lisinopril  10  mg ; apixaban  5  mg ; lorazepam  1.5  mg ; lorazepam  1  mg ; lidocaine 5% patch  1  ptch ; 
nausea heart failure, unspecified autoimmune thyroiditis anemia, unspecified chronic kidney disease, unspecified other postprocedural complications and disorders of respiratory system, not elsewhere classified retention of urine, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of irradiation unspecified place in hospital as the place of occurrence of the external cause body mass index (bmi) 31.0-31.9, adult dizziness and giddiness paroxysmal atrial fibrillation surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure obesity, unspecified personal history of malignant neoplasm of breast atelectasis personal history of urinary (tract) infections elevated white blood cell count, unspecified unilateral primary osteoarthritis, right hip personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits 
white f 80 $nan$nan$ranitidine  150  mg ; felodipine  10  mg ; omeprazole  40  mg ; 
sicca syndrome esophageal reflux dizziness and giddiness unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified other malaise and fatigue cervical spondylosis without myelopathy irritable bowel syndrome esophageal reflux osteoporosis, unspecified syncope and collapse sicca syndrome sciatica spasmodic torticollis other specified cardiac dysrhythmias monoclonal paraproteinemia
white f 80 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  377  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  91  mg dl$ranitidine  150  mg ; felodipine  10  mg ; omeprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; clonazepam  0.5  mg ; hydrocodone-acetaminophen  1  tab ; tramadol (ultram)  50  mg ; metoprolol tartrate  25  mg ; cyclosporine  1  drop ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  600  mg ; tizanidine  2  mg ; bisacodyl  5  mg ; ranitidine  300  mg ; pilocarpine hcl  5  mg ; sodium chloride nasal  1-2  spry ; 
sicca syndrome esophageal reflux dizziness and giddiness unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified other malaise and fatigue cervical spondylosis without myelopathy irritable bowel syndrome esophageal reflux osteoporosis, unspecified syncope and collapse sicca syndrome sciatica spasmodic torticollis other specified cardiac dysrhythmias monoclonal paraproteinemia
white f 80 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  428  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  107  mg dl$ranitidine  150  mg ; felodipine  10  mg ; omeprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; tramadol (ultram)  50  mg ; cyclosporine  1  drop ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  600  mg ; tizanidine  2  mg ; bisacodyl  5  mg ; ranitidine  300  mg ; pilocarpine hcl  5  mg ; sodium chloride nasal  1-2  spry ; quinidine gluconate e.r.  324  mg ; sarna lotion  1  appl ; acetaminophen  650  mg ; 
sicca syndrome esophageal reflux dizziness and giddiness unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified other malaise and fatigue cervical spondylosis without myelopathy irritable bowel syndrome esophageal reflux osteoporosis, unspecified syncope and collapse sicca syndrome sciatica spasmodic torticollis other specified cardiac dysrhythmias monoclonal paraproteinemia
white f 80 $nan$chemistry blood chloride  96  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  132  meq l$ranitidine  150  mg ; felodipine  10  mg ; omeprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; tramadol (ultram)  50  mg ; cyclosporine  1  drop ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  600  mg ; tizanidine  2  mg ; bisacodyl  5  mg ; ranitidine  300  mg ; pilocarpine hcl  5  mg ; sodium chloride nasal  1-2  spry ; quinidine gluconate e.r.  324  mg ; sarna lotion  1  appl ; acetaminophen  650  mg ; 
sicca syndrome esophageal reflux dizziness and giddiness unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified other malaise and fatigue cervical spondylosis without myelopathy irritable bowel syndrome esophageal reflux osteoporosis, unspecified syncope and collapse sicca syndrome sciatica spasmodic torticollis other specified cardiac dysrhythmias monoclonal paraproteinemia
white f 80 $nan$nan$ranitidine  150  mg ; felodipine  10  mg ; omeprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; tramadol (ultram)  50  mg ; cyclosporine  1  drop ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  600  mg ; tizanidine  2  mg ; bisacodyl  5  mg ; ranitidine  300  mg ; pilocarpine hcl  5  mg ; sodium chloride nasal  1-2  spry ; quinidine gluconate e.r.  324  mg ; sarna lotion  1  appl ; acetaminophen  650  mg ; 
sicca syndrome esophageal reflux dizziness and giddiness unspecified essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified other malaise and fatigue cervical spondylosis without myelopathy irritable bowel syndrome esophageal reflux osteoporosis, unspecified syncope and collapse sicca syndrome sciatica spasmodic torticollis other specified cardiac dysrhythmias monoclonal paraproteinemia
white m 48 $nan$hematology blood hematocrit  40.4  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  112  mg dl; blood gas blood lactate  1.3  mmol l$sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; ondansetron  8  mg ; acetaminophen  1000  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; 5% dextrose  100  ml ; acyclovir  700  mg ; 0.9% sodium chloride  500  ml ; pantoprazole  40  mg ; heparin  5000  unit ; 0.9% sodium chloride  1000  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 
 
white m 48 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  105  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; acetaminophen  1000  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; 5% dextrose  100  ml ; acyclovir  700  mg ; 0.9% sodium chloride  500  ml ; heparin  5000  unit ; 0.9% sodium chloride  1000  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; sucralfate  1  gm ; amoxicillin-clavulanic acid  500  mg ; valacyclovir  1000  mg ; 
 
white m 48 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; sucralfate  1  gm ; amoxicillin-clavulanic acid  500  mg ; valacyclovir  1000  mg ; 
 
black african american f 41 $nan$chemistry urine creatinine, urine  45  mg dl; chemistry urine protein creatinine ratio  0.4  mg mg; chemistry urine 24 hr creatinine  1103  mg 24hr$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; prenatal vitamins  1  tab ; heparin  5000  unit ; lactated ringers  1000  ml ; syringe  2  ml ; betamethasone na. phos acet  12  mg ; ranitidine  75  mg ; sodium chloride 0.9%  flush  3-10  ml ; 
female infertility of other origin nausea with vomiting, unspecified intramural leiomyoma of uterus 
black african american f 41 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; prenatal vitamins  1  tab ; heparin  5000  unit ; syringe  2  ml ; betamethasone na. phos acet  12  mg ; ranitidine  75  mg ; sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; 
female infertility of other origin nausea with vomiting, unspecified intramural leiomyoma of uterus 
black african american f 41 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; prenatal vitamins  1  tab ; heparin  5000  unit ; syringe  2  ml ; betamethasone na. phos acet  12  mg ; ranitidine  75  mg ; sodium chloride 0.9%  flush  3-10  ml ; calcium carbonate  500  mg ; 
female infertility of other origin nausea with vomiting, unspecified intramural leiomyoma of uterus 
white m 63 $nan$hematology blood hematocrit  32.7  %; hematology blood hematocrit  33.0  %; hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  279  k ul; hematology blood platelet count  244  k ul; hematology blood platelet count  245  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  79  mg dl; chemistry blood glucose  155  mg dl; chemistry blood glucose  120  mg dl; chemistry blood albumin  3.9  g dl; chemistry blood albumin  3.8  g dl$sulfameth trimethoprim ss  1  tab ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; tacrolimus  0.5  mg ; tacrolimus  2  mg ; tacrolimus  1.5  mg ; sarna lotion  1  appl ; mycophenolate mofetil  1000  mg ; ursodiol  600  mg ; sodium bicarbonate  1950  mg ; 
complications of transplanted liver diarrhea anemia, unspecified chronic kidney disease, stage iii (moderate) bacteremia kidney replaced by transplant dehydration surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other and unspecified alcohol dependence, in remission alcoholic cirrhosis of liver obstruction of bile duct car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant fever, unspecified personal history of tobacco use person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident liver replaced by transplant other abnormal blood chemistry car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other and unspecified alcohol dependence, in remission person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident other malaise and fatigue personal history of tobacco use liver replaced by transplant other and unspecified alcohol dependence, in remission diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified nutritional marasmus kidney replaced by transplant dehydration hyperpotassemia other abnormal blood chemistry other nonspecific abnormal serum enzyme levels car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant personal history of tobacco use other and unspecified alcohol dependence, in remission other specified disorders of biliary tract car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident liver replaced by transplant cholangitis obstruction of bile duct person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use abnormality of gait
white m 63 $nan$nan$sulfameth trimethoprim ss  1  tab ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; sarna lotion  1  appl ; mycophenolate mofetil  1000  mg ; ursodiol  600  mg ; 
complications of transplanted liver diarrhea anemia, unspecified chronic kidney disease, stage iii (moderate) bacteremia kidney replaced by transplant dehydration surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other and unspecified alcohol dependence, in remission alcoholic cirrhosis of liver obstruction of bile duct car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant fever, unspecified personal history of tobacco use person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident liver replaced by transplant other abnormal blood chemistry car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other and unspecified alcohol dependence, in remission person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident other malaise and fatigue personal history of tobacco use liver replaced by transplant other and unspecified alcohol dependence, in remission diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified nutritional marasmus kidney replaced by transplant dehydration hyperpotassemia other abnormal blood chemistry other nonspecific abnormal serum enzyme levels car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident kidney replaced by transplant personal history of tobacco use other and unspecified alcohol dependence, in remission other specified disorders of biliary tract car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident liver replaced by transplant cholangitis obstruction of bile duct person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use abnormality of gait
white f 43 $nan$nan$fluoxetine  20  mg ; omeprazole  20  mg ; d5lr  1000  ml ; oxycodone-acetaminophen  1-2  tab ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; promethazine  6.25  mg ; promethazine  12.5  mg ; 
 
white f 43 $nan$nan$fluoxetine  20  mg ; omeprazole  20  mg ; d5lr  1000  ml ; oxycodone-acetaminophen  1-2  tab ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; ondansetron  4  mg ; promethazine  6.25  mg ; promethazine  12.5  mg ; scopolamine patch  1  ptch ; omeprazole  40  mg ; acetaminophen  500-1000  mg ; ibuprofen  400-600  mg ; hydrocodone-acetaminophen  1-2  tab ; morphine sulfate  2-4  mg ; lorazepam  0.25  mg ; lorazepam  0.5  mg ; lorazepam  1  mg ; 
 
white f 43 $nan$nan$fluoxetine  20  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; ondansetron  4  mg ; scopolamine patch  1  ptch ; acetaminophen  500-1000  mg ; ibuprofen  400-600  mg ; hydrocodone-acetaminophen  1-2  tab ; morphine sulfate  2-4  mg ; lorazepam  0.5  mg ; lorazepam  1  mg ; 
 
white f 60 $nan$hematology blood hematocrit  35.8  %; hematology blood hematocrit  29.4  %; hematology blood hematocrit  31.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  307  k ul; hematology blood platelet count  252  k ul; hematology blood platelet count  250  k ul; hematology blood platelet count  240  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  1000  ml ; heparin  1200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; d5w  250  ml ; nitroglycerin  100  mg ; hydromorphone (dilaudid)  4  mg ; hydromorphone (dilaudid)  1  mg ; hydromorphone (dilaudid)  2-4  mg ; atorvastatin  80  mg ; omeprazole  20  mg ; vitamin d  1000  unit ; ondansetron  4  mg ; acetaminophen  1000  mg ; 0.9% sodium chloride  0  bag ; calcium gluconate  0  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; senna  8.6  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; docusate sodium  100  mg ; oxycodone (immediate release)  5  mg ; aspirin  81  mg ; labetalol  150  mg ; isosorbide mononitrate  10  mg ; nicotine patch  14  mg ; nitroglycerin sl  0.3  mg ; 
tobacco use disorder unspecified essential hypertension pure hypercholesterolemia coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia 
white f 60 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  118  mg dl$heparin  1200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; atorvastatin  80  mg ; omeprazole  20  mg ; vitamin d  1000  unit ; ondansetron  4  mg ; acetaminophen  1000  mg ; 0.9% sodium chloride  0  bag ; calcium gluconate  0  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; senna  8.6  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; docusate sodium  100  mg ; oxycodone (immediate release)  5  mg ; aspirin  81  mg ; labetalol  150  mg ; isosorbide mononitrate  10  mg ; nicotine patch  14  mg ; nitroglycerin sl  0.3  mg ; isosorbide dinitrate  20  mg ; trazodone  25  mg ; lorazepam  0.5  mg ; isosorbide dinitrate  10  mg ; lorazepam  1  mg ; valsartan  160  mg ; isosorbide mononitrate (extended release)  30  mg ; isosorbide mononitrate (extended release)  60  mg ; 
tobacco use disorder unspecified essential hypertension pure hypercholesterolemia coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia 
white f 60 $nan$nan$atorvastatin  80  mg ; omeprazole  20  mg ; vitamin d  1000  unit ; ondansetron  4  mg ; senna  8.6  mg ; aspirin  81  mg ; labetalol  150  mg ; nicotine patch  14  mg ; nitroglycerin sl  0.3  mg ; trazodone  25  mg ; lorazepam  0.5  mg ; lorazepam  1  mg ; valsartan  160  mg ; isosorbide mononitrate (extended release)  30  mg ; isosorbide mononitrate (extended release)  60  mg ; 
tobacco use disorder unspecified essential hypertension pure hypercholesterolemia coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia 
other m 67 $nan$nan$dexamethasone  12  mg ; ondansetron odt  8  mg ; sodium chloride 0.9%  1000  ml ; allopurinol  300  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  93  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  194  iu l; chemistry blood albumin  3.9  g dl; hematology blood bands  0  %$dexamethasone  12  mg ; ondansetron odt  8  mg ; sodium chloride 0.9%  1000  ml ; allopurinol  300  mg ; sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  40  mg ; clonazepam  1-2  mg ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; 0.9% sodium chloride  500  ml ; etoposide  190  mg ; cytarabine  1910  mg ; 5% dextrose  50  ml ; mitoxantrone  15  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  38.9  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  108  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  209  iu l; chemistry blood albumin  4.2  g dl$dexamethasone  12  mg ; ondansetron odt  8  mg ; sodium chloride 0.9%  1000  ml ; allopurinol  300  mg ; sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  40  mg ; clonazepam  1-2  mg ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; 0.9% sodium chloride  500  ml ; etoposide  190  mg ; cytarabine  1910  mg ; 5% dextrose  50  ml ; mitoxantrone  15  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  96  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  163  mg dl; chemistry blood lactate dehydrogenase (ld)  165  iu l; chemistry blood albumin  3.7  g dl$dexamethasone  12  mg ; ondansetron odt  8  mg ; sodium chloride 0.9%  1000  ml ; allopurinol  300  mg ; enoxaparin sodium  40  mg ; clonazepam  1-2  mg ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; 0.9% sodium chloride  500  ml ; etoposide  190  mg ; cytarabine  1910  mg ; 5% dextrose  50  ml ; mitoxantrone  15  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  75  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  192  mg dl; chemistry blood lactate dehydrogenase (ld)  189  iu l; chemistry blood albumin  3.9  g dl; hematology blood bands  0  %$dexamethasone  12  mg ; ondansetron odt  8  mg ; sodium chloride 0.9%  1000  ml ; allopurinol  300  mg ; enoxaparin sodium  40  mg ; clonazepam  1-2  mg ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; 0.9% sodium chloride  500  ml ; etoposide  190  mg ; cytarabine  1910  mg ; 5% dextrose  50  ml ; mitoxantrone  15  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; furosemide  20  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  78  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  193  mg dl; chemistry blood lactate dehydrogenase (ld)  174  iu l; chemistry blood albumin  3.7  g dl$dexamethasone  12  mg ; ondansetron odt  8  mg ; sodium chloride 0.9%  1000  ml ; allopurinol  300  mg ; enoxaparin sodium  40  mg ; clonazepam  1-2  mg ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; 0.9% sodium chloride  500  ml ; etoposide  190  mg ; cytarabine  1910  mg ; 5% dextrose  50  ml ; mitoxantrone  15  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; furosemide  20  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  64  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  157  mg dl; chemistry blood lactate dehydrogenase (ld)  191  iu l; chemistry blood albumin  3.6  g dl$sodium chloride 0.9%  1000  ml ; allopurinol  300  mg ; enoxaparin sodium  40  mg ; clonazepam  1-2  mg ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; 0.9% sodium chloride  500  ml ; etoposide  190  mg ; cytarabine  1910  mg ; 5% dextrose  50  ml ; mitoxantrone  15  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  50  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  129  mg dl; chemistry blood lactate dehydrogenase (ld)  192  iu l; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  1000  ml ; allopurinol  300  mg ; enoxaparin sodium  40  mg ; clonazepam  1-2  mg ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  34  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  126  mg dl; chemistry blood lactate dehydrogenase (ld)  184  iu l; chemistry blood albumin  3.5  g dl; hematology blood bands  0  %$sodium chloride 0.9%  1000  ml ; allopurinol  300  mg ; clonazepam  1-2  mg ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; fluconazole  400  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  27  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  174  iu l; chemistry blood albumin  3.7  g dl; hematology blood bands  0  %$sodium chloride 0.9%  1000  ml ; allopurinol  300  mg ; clonazepam  1-2  mg ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; fluconazole  400  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  17  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  136  mg dl; chemistry blood lactate dehydrogenase (ld)  172  iu l; chemistry blood albumin  3.7  g dl; hematology blood bands  0  %$sodium chloride 0.9%  1000  ml ; clonazepam  1-2  mg ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; fluconazole  400  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  10  k ul; hematology blood platelet count  27  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  178  iu l; chemistry blood albumin  3.8  g dl; hematology blood bands  0  %$clonazepam  1-2  mg ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; fluconazole  400  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  18  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  179  iu l; chemistry blood albumin  3.8  g dl; hematology blood bands  0  %$clonazepam  1-2  mg ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; fluconazole  400  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  14  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  162  iu l; chemistry blood albumin  3.8  g dl; hematology blood bands  0  %$clonazepam  1-2  mg ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; fluconazole  400  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  7  k ul; hematology blood platelet count  24  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  137  iu l; chemistry blood albumin  3.8  g dl; hematology blood bands  0  %$clonazepam  1-2  mg ; multivitamins  1  tab ; omeprazole  20  mg ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; fluconazole  400  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; pantoprazole  20  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  20  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  146  mg dl; chemistry blood lactate dehydrogenase (ld)  137  iu l; chemistry blood albumin  3.6  g dl; hematology blood bands  0  %$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; pantoprazole  20  mg ; voriconazole  400  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  14  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  105  iu l; chemistry blood albumin  3.5  g dl; hematology blood bands  0  %$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; pantoprazole  20  mg ; voriconazole  400  mg ; voriconazole  200  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  8  k ul; hematology blood platelet count  30  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  119  mg dl; chemistry blood lactate dehydrogenase (ld)  96  iu l; chemistry blood albumin  3.4  g dl; hematology blood bands  0  %$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; pantoprazole  20  mg ; voriconazole  200  mg ; oxycodone (immediate release)  5  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  23.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  29  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  174  mg dl; chemistry blood lactate dehydrogenase (ld)  106  iu l; chemistry blood albumin  3.5  g dl; hematology blood bands  0  %$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; pantoprazole  20  mg ; voriconazole  200  mg ; oxycodone (immediate release)  5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  20.3  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  19  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  118  mg dl; chemistry blood lactate dehydrogenase (ld)  99  iu l; chemistry blood albumin  3.2  g dl; hematology blood bands  15  %$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; pantoprazole  20  mg ; voriconazole  200  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; oxycodone (immediate release)  2.5  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  21.5  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  25  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  120  mg dl; chemistry blood lactate dehydrogenase (ld)  101  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  0  %$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; pantoprazole  20  mg ; voriconazole  200  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; oxycodone (immediate release)  2.5  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  20.7  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  35  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  118  mg dl; chemistry blood lactate dehydrogenase (ld)  110  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  0  %$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; pantoprazole  20  mg ; voriconazole  200  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; lactated ringers  1000  ml ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  20.3  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  50  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  120  mg dl; chemistry blood lactate dehydrogenase (ld)  112  iu l; chemistry blood albumin  2.8  g dl; hematology blood bands  1  %$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; pantoprazole  20  mg ; voriconazole  200  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; ns  100  ml ; metronidazole  500  mg ; magnesium oxide  400  mg ; enoxaparin sodium  80  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  18.9  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  77  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  115  mg dl$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; pantoprazole  20  mg ; voriconazole  200  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; magnesium oxide  400  mg ; enoxaparin sodium  80  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  110  mg dl$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; pantoprazole  20  mg ; voriconazole  200  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; magnesium oxide  400  mg ; acetaminophen iv  1000  mg ; soln  100  ml ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  21.4  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  125  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  102  mg dl$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; acyclovir  400  mg ; calcium carbonate  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; pantoprazole  20  mg ; voriconazole  200  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; magnesium oxide  400  mg ; ceftriaxone  2  gm ; pantoprazole  40  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  21.3  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  100  mg dl$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; acyclovir  400  mg ; calcium carbonate  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; voriconazole  200  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; magnesium oxide  400  mg ; ceftriaxone  2  gm ; hydromorphone (dilaudid)  0.5  mg ; lidocaine 2%  2  ml ; phosphorus  250  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  21.7  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  107  mg dl$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; calcium carbonate  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; voriconazole  200  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; ceftriaxone  2  gm ; lidocaine 2%  2  ml ; phosphorus  250  mg ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  22.6  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  105  mg dl$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; calcium carbonate  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; voriconazole  200  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; ceftriaxone  2  gm ; phosphorus  250  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$hematology blood hematocrit  23.3  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood glucose  101  mg dl$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; lorazepam  0.5-1  mg ; calcium carbonate  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; voriconazole  200  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; ceftriaxone  2  gm ; phosphorus  250  mg ; sulfameth trimethoprim ss  1  tab ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
other m 67 $nan$nan$clonazepam  1-2  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; calcium carbonate  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; voriconazole  200  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; ceftriaxone  2  gm ; phosphorus  250  mg ; sulfameth trimethoprim ss  1  tab ; 
esophageal reflux encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident insomnia, unspecified examination of participant in clinical trial acute myeloid leukemia, in remission anxiety state, unspecified encounter for antineoplastic chemotherapy person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial acute myeloid leukemia, in remission esophageal reflux anxiety state, unspecified esophageal reflux awaiting organ transplant status anxiety state, unspecified acute myeloid leukemia, in remission encounter for antineoplastic chemotherapy fever presenting with conditions classified elsewhere anxiety state, unspecified acute myeloid leukemia, in remission neutropenia, unspecified encounter for antineoplastic chemotherapy attention deficit disorder with hyperactivity acute myeloid leukemia, in remission generalized anxiety disorder person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified accidents occurring in residential institution family history of leukemia adrenal cortical steroids causing adverse effects in therapeutic use unspecified drug-induced mental disorder examination of participant in clinical trial fever presenting with conditions classified elsewhere obstructive sleep apnea (adult)(pediatric) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure generalized anxiety disorder other diseases of vocal cords other and unspecified infection due to central venous catheter acute myeloid leukemia, without mention of having achieved remission attention deficit disorder with hyperactivity examination of participant in clinical trial person on outside of bus injured in collision with pedestrian or animal in traffic accident tobacco use disorder cellulitis and abscess of neck other pancytopenia pneumonia, organism unspecified family history of leukemia
white f 91 $nan$nan$quetiapine fumarate  12.5  mg ; 
 
white f 91 $nan$nan$quetiapine fumarate  12.5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; morphine sulfate  1-2  mg ; heparin  5000  unit ; docusate sodium  100  mg ; oxycodone (immediate release)   2.5  mg ; quetiapine fumarate  25  mg ; haloperidol  0.5  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; 
 
white f 91 $nan$nan$quetiapine fumarate  12.5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; heparin  5000  unit ; docusate sodium  100  mg ; oxycodone (immediate release)   2.5  mg ; quetiapine fumarate  25  mg ; haloperidol  0.5  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; olanzapine (disintegrating tablet)  2.5  mg ; vitamin d  800  unit ; 
 
white f 91 $nan$nan$quetiapine fumarate  12.5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; heparin  5000  unit ; docusate sodium  100  mg ; oxycodone (immediate release)   2.5  mg ; quetiapine fumarate  25  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; olanzapine (disintegrating tablet)  2.5  mg ; vitamin d  800  unit ; calcium carbonate  500  mg ; 
 
white f 91 $nan$nan$quetiapine fumarate  12.5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; heparin  5000  unit ; docusate sodium  100  mg ; oxycodone (immediate release)   2.5  mg ; quetiapine fumarate  25  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; olanzapine (disintegrating tablet)  2.5  mg ; vitamin d  800  unit ; calcium carbonate  500  mg ; 
 
black african american f 42 $temp  98.6  heartrate  102.0  resprate  18.0  o2sat  100.0  sbp  146.0  dbp  86.0  rhythm    pain  9  ; temp  98.8  heartrate  95.0  resprate  18.0  o2sat  100.0  sbp  143.0  dbp  83.0  rhythm    pain    ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  9  ; temp    heartrate  100.0  resprate  18.0  o2sat  100.0  sbp    dbp    rhythm    pain  sleep  ; temp    heartrate  100.0  resprate  18.0  o2sat  97.0  sbp  144.0  dbp  81.0  rhythm    pain  sleep  ; temp  98.4  heartrate  98.0  resprate  18.0  o2sat  100.0  sbp  138.0  dbp  84.0  rhythm    pain    ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  sleep  $hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  291  k ul; hematology blood inr(pt)  1.2  ; hematology urine wbc  1  # hpf$nan
other chronic nonalcoholic liver disease other forms of migraine, without mention of intractable migraine without mention of status migrainosus unspecified essential hypertension lumbago morbid obesity body mass index 50.0-59.9, adult depressive disorder, not elsewhere classified 
black african american f 42 $temp  98.2  heartrate  95.0  resprate  17.0  o2sat  99.0  sbp  134.0  dbp  82.0  rhythm    pain  4  $hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  157  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  0.25  mg ; oxycodone (immediate release)  5  mg ; sodium chloride 0.9%  1000  ml ; prochlorperazine  10  mg ; 
other chronic nonalcoholic liver disease other forms of migraine, without mention of intractable migraine without mention of status migrainosus unspecified essential hypertension lumbago morbid obesity body mass index 50.0-59.9, adult depressive disorder, not elsewhere classified 
black african american f 42 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; sodium chloride 0.9%  1000  ml ; prochlorperazine  10  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  500  mg ; ondansetron  4  mg ; ibuprofen  600  mg ; 5% dextrose  100  ml ; acyclovir  500  mg ; 
other chronic nonalcoholic liver disease other forms of migraine, without mention of intractable migraine without mention of status migrainosus unspecified essential hypertension lumbago morbid obesity body mass index 50.0-59.9, adult depressive disorder, not elsewhere classified 
black african american f 42 $nan$hematology blood hematocrit  31.0  %; hematology blood hematocrit  31.9  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  299  k ul; hematology blood platelet count  312  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  90  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  500  mg ; ondansetron  4  mg ; 5% dextrose  100  ml ; acyclovir  500  mg ; metoclopramide  10  mg ; lactated ringers  1000  ml ; carbamide peroxide 6.5%  5-10  drop ; omeprazole  40  mg ; 
other chronic nonalcoholic liver disease other forms of migraine, without mention of intractable migraine without mention of status migrainosus unspecified essential hypertension lumbago morbid obesity body mass index 50.0-59.9, adult depressive disorder, not elsewhere classified 
black african american f 42 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; ondansetron  4  mg ; 5% dextrose  100  ml ; acyclovir  500  mg ; metoclopramide  10  mg ; lactated ringers  1000  ml ; carbamide peroxide 6.5%  5-10  drop ; omeprazole  40  mg ; 
other chronic nonalcoholic liver disease other forms of migraine, without mention of intractable migraine without mention of status migrainosus unspecified essential hypertension lumbago morbid obesity body mass index 50.0-59.9, adult depressive disorder, not elsewhere classified 
white m 83 $temp  98.5  heartrate  78.0  resprate  16.0  o2sat  97.0  sbp  146.0  dbp  65.0  rhythm    pain  0  ; temp    heartrate  70.0  resprate  14.0  o2sat  95.0  sbp  136.0  dbp  86.0  rhythm    pain  0  ; temp    heartrate  48.0  resprate  18.0  o2sat  98.0  sbp  138.0  dbp  60.0  rhythm    pain  0  ; temp  98.0  heartrate  49.0  resprate  17.0  o2sat  97.0  sbp  134.0  dbp  77.0  rhythm  2nd degree  pain  0  $hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  93  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; lisinopril  40  mg ; simvastatin  20  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; 
cyst and pseudocyst of pancreas paralytic ileus esophageal reflux other left bundle branch block early satiety surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site calculus of gallbladder with other cholecystitis, without mention of obstruction hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] unspecified essential hypertension acute pancreatitis non-healing surgical wound diaphragmatic hernia without mention of obstruction or gangrene pulmonary collapse other and unspecified hyperlipidemia other specified cardiac dysrhythmias paralytic ileus escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site acute pancreatitis unspecified essential hypertension pulmonary collapse other and unspecified hyperlipidemia urinary tract infection, site not specified esophageal reflux cyst and pseudocyst of pancreas unspecified pleural effusion 
white m 83 $nan$nan$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; lisinopril  40  mg ; simvastatin  20  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; sulfameth trimethoprim ds  1  tab ; 
cyst and pseudocyst of pancreas paralytic ileus esophageal reflux other left bundle branch block early satiety surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site calculus of gallbladder with other cholecystitis, without mention of obstruction hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] unspecified essential hypertension acute pancreatitis non-healing surgical wound diaphragmatic hernia without mention of obstruction or gangrene pulmonary collapse other and unspecified hyperlipidemia other specified cardiac dysrhythmias paralytic ileus escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site acute pancreatitis unspecified essential hypertension pulmonary collapse other and unspecified hyperlipidemia urinary tract infection, site not specified esophageal reflux cyst and pseudocyst of pancreas unspecified pleural effusion 
white f 24 $temp  97.8  heartrate  93.0  resprate  18.0  o2sat  99.0  sbp  115.0  dbp  68.0  rhythm    pain  0  $hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  79  mg dl$sodium chloride 0.9%  flush  3  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; acetaminophen  650  mg ; fentanyl patch  25  mcg h ; prednisone  5  mg ; tacrolimus  2  mg ; tramadol (ultram)  50  mg ; 0.9% sodium chloride  1000  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium  100  mg ; gabapentin  200  mg ; mycophenolate mofetil  125  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; calcium carbonate  750  mg ; escitalopram oxalate  20  mg ; vitamin d  800  unit ; amlodipine  5  mg ; ondansetron  4  mg ; tacrolimus  1  mg ; senna  1  tab ; atorvastatin  10  mg ; gabapentin  100  mg ; trazodone  50  mg ; lorazepam  2  mg ; 
late effects of intracranial abscess or pyogenic infection other acute postoperative pain car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status below knee amputation status other amputation stump complication unspecified essential hypertension posttraumatic stress disorder kidney replaced by transplant other acute postoperative pain cellulitis and abscess of leg, except foot car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident below knee amputation status pyogenic arthritis, lower leg unspecified osteomyelitis, lower leg depressive disorder, not elsewhere classified diarrhea derangement of posterior horn of lateral meniscus synovitis and tenosynovitis, unspecified kidney replaced by transplant posttraumatic stress disorder benign essential hypertension anxiety state, unspecified disturbance of skin sensation below knee amputation status anxiety state, unspecified other disorders of bone and cartilage late effects of intracranial abscess or pyogenic infection villonodular synovitis, lower leg neuroma of amputation stump kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other acute postoperative pain 
white f 24 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  77  mg dl$sodium chloride 0.9%  flush  3  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; acetaminophen  650  mg ; fentanyl patch  25  mcg h ; prednisone  5  mg ; tramadol (ultram)  50  mg ; 0.9% sodium chloride  1000  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium  100  mg ; gabapentin  200  mg ; mycophenolate mofetil  125  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; calcium carbonate  750  mg ; escitalopram oxalate  20  mg ; vitamin d  800  unit ; ondansetron  4  mg ; tacrolimus  1  mg ; senna  1  tab ; atorvastatin  10  mg ; gabapentin  100  mg ; trazodone  50  mg ; lorazepam  2  mg ; syringe (0.9% sodium chloride)  1.25  ml ; methylprednisolone sod succ   5  mg ; ranitidine  150  mg ; labetalol  50  mg ; 5% dextrose  250  ml ; vancomycin  750  mg ; 
late effects of intracranial abscess or pyogenic infection other acute postoperative pain car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status below knee amputation status other amputation stump complication unspecified essential hypertension posttraumatic stress disorder kidney replaced by transplant other acute postoperative pain cellulitis and abscess of leg, except foot car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident below knee amputation status pyogenic arthritis, lower leg unspecified osteomyelitis, lower leg depressive disorder, not elsewhere classified diarrhea derangement of posterior horn of lateral meniscus synovitis and tenosynovitis, unspecified kidney replaced by transplant posttraumatic stress disorder benign essential hypertension anxiety state, unspecified disturbance of skin sensation below knee amputation status anxiety state, unspecified other disorders of bone and cartilage late effects of intracranial abscess or pyogenic infection villonodular synovitis, lower leg neuroma of amputation stump kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other acute postoperative pain 
white f 24 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; fentanyl patch  25  mcg h ; tramadol (ultram)  50  mg ; heparin  5000  unit ; docusate sodium  100  mg ; gabapentin  200  mg ; mycophenolate mofetil  125  mg ; calcium carbonate  750  mg ; escitalopram oxalate  20  mg ; vitamin d  800  unit ; ondansetron  4  mg ; senna  1  tab ; atorvastatin  10  mg ; gabapentin  100  mg ; trazodone  50  mg ; ranitidine  150  mg ; labetalol  50  mg ; 5% dextrose  250  ml ; vancomycin  750  mg ; hydrocortisone na succ.  50  mg ; hydroxyzine  25  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  50  ml ; ketamine  100  mg ; acetaminophen iv  1000  mg ; 0.45% sodium chloride  1000  ml ; 
late effects of intracranial abscess or pyogenic infection other acute postoperative pain car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status below knee amputation status other amputation stump complication unspecified essential hypertension posttraumatic stress disorder kidney replaced by transplant other acute postoperative pain cellulitis and abscess of leg, except foot car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident below knee amputation status pyogenic arthritis, lower leg unspecified osteomyelitis, lower leg depressive disorder, not elsewhere classified diarrhea derangement of posterior horn of lateral meniscus synovitis and tenosynovitis, unspecified kidney replaced by transplant posttraumatic stress disorder benign essential hypertension anxiety state, unspecified disturbance of skin sensation below knee amputation status anxiety state, unspecified other disorders of bone and cartilage late effects of intracranial abscess or pyogenic infection villonodular synovitis, lower leg neuroma of amputation stump kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other acute postoperative pain 
white f 24 $nan$nan$sodium chloride 0.9%  flush  3  ml ; fentanyl patch  25  mcg h ; heparin  5000  unit ; docusate sodium  100  mg ; gabapentin  200  mg ; mycophenolate mofetil  125  mg ; calcium carbonate  750  mg ; escitalopram oxalate  20  mg ; vitamin d  800  unit ; ondansetron  4  mg ; senna  1  tab ; atorvastatin  10  mg ; gabapentin  100  mg ; trazodone  50  mg ; ranitidine  150  mg ; labetalol  50  mg ; 5% dextrose  250  ml ; vancomycin  750  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  50  ml ; ketamine  100  mg ; acetaminophen iv  1000  mg ; lorazepam  1  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; 
late effects of intracranial abscess or pyogenic infection other acute postoperative pain car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status below knee amputation status other amputation stump complication unspecified essential hypertension posttraumatic stress disorder kidney replaced by transplant other acute postoperative pain cellulitis and abscess of leg, except foot car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident below knee amputation status pyogenic arthritis, lower leg unspecified osteomyelitis, lower leg depressive disorder, not elsewhere classified diarrhea derangement of posterior horn of lateral meniscus synovitis and tenosynovitis, unspecified kidney replaced by transplant posttraumatic stress disorder benign essential hypertension anxiety state, unspecified disturbance of skin sensation below knee amputation status anxiety state, unspecified other disorders of bone and cartilage late effects of intracranial abscess or pyogenic infection villonodular synovitis, lower leg neuroma of amputation stump kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other acute postoperative pain 
white f 24 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; fentanyl patch  25  mcg h ; heparin  5000  unit ; docusate sodium  100  mg ; gabapentin  200  mg ; mycophenolate mofetil  125  mg ; calcium carbonate  750  mg ; escitalopram oxalate  20  mg ; vitamin d  800  unit ; ondansetron  4  mg ; senna  1  tab ; atorvastatin  10  mg ; gabapentin  100  mg ; trazodone  50  mg ; ranitidine  150  mg ; labetalol  50  mg ; 5% dextrose  250  ml ; vancomycin  750  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; hydromorphone (dilaudid)  2  mg ; 0.9% sodium chloride  250  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 
late effects of intracranial abscess or pyogenic infection other acute postoperative pain car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status below knee amputation status other amputation stump complication unspecified essential hypertension posttraumatic stress disorder kidney replaced by transplant other acute postoperative pain cellulitis and abscess of leg, except foot car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident below knee amputation status pyogenic arthritis, lower leg unspecified osteomyelitis, lower leg depressive disorder, not elsewhere classified diarrhea derangement of posterior horn of lateral meniscus synovitis and tenosynovitis, unspecified kidney replaced by transplant posttraumatic stress disorder benign essential hypertension anxiety state, unspecified disturbance of skin sensation below knee amputation status anxiety state, unspecified other disorders of bone and cartilage late effects of intracranial abscess or pyogenic infection villonodular synovitis, lower leg neuroma of amputation stump kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other acute postoperative pain 
white f 24 $nan$hematology blood hematocrit  30.2  %; hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  164  k ul; hematology blood platelet count  180  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  109  mg dl$bag  1  bag ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; mycophenolate mofetil  125  mg ; calcium carbonate  750  mg ; escitalopram oxalate  20  mg ; vitamin d  800  unit ; ondansetron  4  mg ; senna  1  tab ; atorvastatin  10  mg ; ranitidine  150  mg ; labetalol  50  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; 0.9% sodium chloride  250  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; magnesium sulfate (latex free)  2  gm ; bag  50  ml ; magnesium sulfate  2  gm ; aspirin  121.5  mg ; gabapentin  300  mg ; tacrolimus  1.5  mg ; tacrolimus suspension  1.5  mg ; aspirin  150  mg ; cefazolin  2  gm ; dexmedetomidine  0.2  mg ; propofol  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; lactated ringers  1000  ml ; 
late effects of intracranial abscess or pyogenic infection other acute postoperative pain car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status below knee amputation status other amputation stump complication unspecified essential hypertension posttraumatic stress disorder kidney replaced by transplant other acute postoperative pain cellulitis and abscess of leg, except foot car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident below knee amputation status pyogenic arthritis, lower leg unspecified osteomyelitis, lower leg depressive disorder, not elsewhere classified diarrhea derangement of posterior horn of lateral meniscus synovitis and tenosynovitis, unspecified kidney replaced by transplant posttraumatic stress disorder benign essential hypertension anxiety state, unspecified disturbance of skin sensation below knee amputation status anxiety state, unspecified other disorders of bone and cartilage late effects of intracranial abscess or pyogenic infection villonodular synovitis, lower leg neuroma of amputation stump kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other acute postoperative pain 
white f 24 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  95  mg dl$aspirin  121.5  mg ; tacrolimus suspension  1.5  mg ; aspirin  150  mg ; cefazolin  2  gm ; dexmedetomidine  0.2  mg ; propofol  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 0.9% sodium chloride  500  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fentanyl patch  50  mcg h ; 
late effects of intracranial abscess or pyogenic infection other acute postoperative pain car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status below knee amputation status other amputation stump complication unspecified essential hypertension posttraumatic stress disorder kidney replaced by transplant other acute postoperative pain cellulitis and abscess of leg, except foot car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident below knee amputation status pyogenic arthritis, lower leg unspecified osteomyelitis, lower leg depressive disorder, not elsewhere classified diarrhea derangement of posterior horn of lateral meniscus synovitis and tenosynovitis, unspecified kidney replaced by transplant posttraumatic stress disorder benign essential hypertension anxiety state, unspecified disturbance of skin sensation below knee amputation status anxiety state, unspecified other disorders of bone and cartilage late effects of intracranial abscess or pyogenic infection villonodular synovitis, lower leg neuroma of amputation stump kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other acute postoperative pain 
white f 24 $nan$hematology blood hematocrit  24.9  %; hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  170  k ul; hematology blood platelet count  164  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  107  mg dl$aspirin  121.5  mg ; cefazolin  2  gm ; dexmedetomidine  0.2  mg ; propofol  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fentanyl patch  50  mcg h ; diazepam  5  mg ; tacrolimus  3  mg ; 
late effects of intracranial abscess or pyogenic infection other acute postoperative pain car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status below knee amputation status other amputation stump complication unspecified essential hypertension posttraumatic stress disorder kidney replaced by transplant other acute postoperative pain cellulitis and abscess of leg, except foot car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident below knee amputation status pyogenic arthritis, lower leg unspecified osteomyelitis, lower leg depressive disorder, not elsewhere classified diarrhea derangement of posterior horn of lateral meniscus synovitis and tenosynovitis, unspecified kidney replaced by transplant posttraumatic stress disorder benign essential hypertension anxiety state, unspecified disturbance of skin sensation below knee amputation status anxiety state, unspecified other disorders of bone and cartilage late effects of intracranial abscess or pyogenic infection villonodular synovitis, lower leg neuroma of amputation stump kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other acute postoperative pain 
white f 24 $nan$nan$aspirin  121.5  mg ; cefazolin  2  gm ; fentanyl patch  50  mcg h ; diazepam  5  mg ; tacrolimus  5  mg ; 
late effects of intracranial abscess or pyogenic infection other acute postoperative pain car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status below knee amputation status other amputation stump complication unspecified essential hypertension posttraumatic stress disorder kidney replaced by transplant other acute postoperative pain cellulitis and abscess of leg, except foot car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident below knee amputation status pyogenic arthritis, lower leg unspecified osteomyelitis, lower leg depressive disorder, not elsewhere classified diarrhea derangement of posterior horn of lateral meniscus synovitis and tenosynovitis, unspecified kidney replaced by transplant posttraumatic stress disorder benign essential hypertension anxiety state, unspecified disturbance of skin sensation below knee amputation status anxiety state, unspecified other disorders of bone and cartilage late effects of intracranial abscess or pyogenic infection villonodular synovitis, lower leg neuroma of amputation stump kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other acute postoperative pain 
white f 24 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  85  mg dl$aspirin  121.5  mg ; cefazolin  2  gm ; fentanyl patch  50  mcg h ; diazepam  5  mg ; tacrolimus  5  mg ; 
late effects of intracranial abscess or pyogenic infection other acute postoperative pain car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status below knee amputation status other amputation stump complication unspecified essential hypertension posttraumatic stress disorder kidney replaced by transplant other acute postoperative pain cellulitis and abscess of leg, except foot car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident below knee amputation status pyogenic arthritis, lower leg unspecified osteomyelitis, lower leg depressive disorder, not elsewhere classified diarrhea derangement of posterior horn of lateral meniscus synovitis and tenosynovitis, unspecified kidney replaced by transplant posttraumatic stress disorder benign essential hypertension anxiety state, unspecified disturbance of skin sensation below knee amputation status anxiety state, unspecified other disorders of bone and cartilage late effects of intracranial abscess or pyogenic infection villonodular synovitis, lower leg neuroma of amputation stump kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other acute postoperative pain 
white f 24 $nan$nan$aspirin  121.5  mg ; cefazolin  2  gm ; fentanyl patch  50  mcg h ; diazepam  5  mg ; tacrolimus  5  mg ; acetaminophen  1000  mg ; fentanyl pca  2.5  mg ; 
late effects of intracranial abscess or pyogenic infection other acute postoperative pain car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status below knee amputation status other amputation stump complication unspecified essential hypertension posttraumatic stress disorder kidney replaced by transplant other acute postoperative pain cellulitis and abscess of leg, except foot car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident below knee amputation status pyogenic arthritis, lower leg unspecified osteomyelitis, lower leg depressive disorder, not elsewhere classified diarrhea derangement of posterior horn of lateral meniscus synovitis and tenosynovitis, unspecified kidney replaced by transplant posttraumatic stress disorder benign essential hypertension anxiety state, unspecified disturbance of skin sensation below knee amputation status anxiety state, unspecified other disorders of bone and cartilage late effects of intracranial abscess or pyogenic infection villonodular synovitis, lower leg neuroma of amputation stump kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other acute postoperative pain 
white f 24 $nan$nan$cefazolin  2  gm ; fentanyl patch  50  mcg h ; diazepam  5  mg ; tacrolimus  5  mg ; acetaminophen  1000  mg ; fentanyl pca  2.5  mg ; multivitamins  1  tab ; 
late effects of intracranial abscess or pyogenic infection other acute postoperative pain car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status below knee amputation status other amputation stump complication unspecified essential hypertension posttraumatic stress disorder kidney replaced by transplant other acute postoperative pain cellulitis and abscess of leg, except foot car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident below knee amputation status pyogenic arthritis, lower leg unspecified osteomyelitis, lower leg depressive disorder, not elsewhere classified diarrhea derangement of posterior horn of lateral meniscus synovitis and tenosynovitis, unspecified kidney replaced by transplant posttraumatic stress disorder benign essential hypertension anxiety state, unspecified disturbance of skin sensation below knee amputation status anxiety state, unspecified other disorders of bone and cartilage late effects of intracranial abscess or pyogenic infection villonodular synovitis, lower leg neuroma of amputation stump kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other acute postoperative pain 
white f 24 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  88  mg dl$cefazolin  2  gm ; fentanyl patch  50  mcg h ; diazepam  5  mg ; tacrolimus  5  mg ; acetaminophen  1000  mg ; multivitamins  1  tab ; tacrolimus  4  mg ; 
late effects of intracranial abscess or pyogenic infection other acute postoperative pain car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status below knee amputation status other amputation stump complication unspecified essential hypertension posttraumatic stress disorder kidney replaced by transplant other acute postoperative pain cellulitis and abscess of leg, except foot car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident below knee amputation status pyogenic arthritis, lower leg unspecified osteomyelitis, lower leg depressive disorder, not elsewhere classified diarrhea derangement of posterior horn of lateral meniscus synovitis and tenosynovitis, unspecified kidney replaced by transplant posttraumatic stress disorder benign essential hypertension anxiety state, unspecified disturbance of skin sensation below knee amputation status anxiety state, unspecified other disorders of bone and cartilage late effects of intracranial abscess or pyogenic infection villonodular synovitis, lower leg neuroma of amputation stump kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other acute postoperative pain 
white f 24 $nan$nan$cefazolin  2  gm ; fentanyl patch  50  mcg h ; diazepam  5  mg ; acetaminophen  1000  mg ; multivitamins  1  tab ; tacrolimus  4  mg ; 
late effects of intracranial abscess or pyogenic infection other acute postoperative pain car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status below knee amputation status other amputation stump complication unspecified essential hypertension posttraumatic stress disorder kidney replaced by transplant other acute postoperative pain cellulitis and abscess of leg, except foot car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident below knee amputation status pyogenic arthritis, lower leg unspecified osteomyelitis, lower leg depressive disorder, not elsewhere classified diarrhea derangement of posterior horn of lateral meniscus synovitis and tenosynovitis, unspecified kidney replaced by transplant posttraumatic stress disorder benign essential hypertension anxiety state, unspecified disturbance of skin sensation below knee amputation status anxiety state, unspecified other disorders of bone and cartilage late effects of intracranial abscess or pyogenic infection villonodular synovitis, lower leg neuroma of amputation stump kidney replaced by transplant car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident other finger(s) amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other acute postoperative pain 
white f 61 $nan$nan$ropinirole  0.25  mg ; insulin  90  unit ; tiotropium bromide  1  cap ; spironolactone  12.5  mg ; furosemide  40  mg ; montelukast sodium  10  mg ; duloxetine  60  mg ; omeprazole  20  mg ; tolterodine  2  mg ; celebrex  200  mg ; ezetimibe  10  mg ; simvastatin  40  mg ; 
mechanical complication due to other implant and internal device, not elsewhere classified diastolic heart failure, unspecified pulmonary collapse chronic airway obstruction, not elsewhere classified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other diseases of trachea and bronchus diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified chronic respiratory failure obstructive sleep apnea (adult)(pediatric) morbid obesity 
white f 61 $nan$nan$ropinirole  0.25  mg ; insulin  90  unit ; tiotropium bromide  1  cap ; spironolactone  12.5  mg ; furosemide  40  mg ; montelukast sodium  10  mg ; duloxetine  60  mg ; omeprazole  20  mg ; tolterodine  2  mg ; celebrex  200  mg ; ezetimibe  10  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  50  mg ; oxycodone-acetaminophen  1-2  tab ; gabapentin  800  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  12.5  mg ; ropinirole  1  mg ; insulin  0  unit ; heparin  5000  unit ; azithromycin  250  mg ; 
mechanical complication due to other implant and internal device, not elsewhere classified diastolic heart failure, unspecified pulmonary collapse chronic airway obstruction, not elsewhere classified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other diseases of trachea and bronchus diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified chronic respiratory failure obstructive sleep apnea (adult)(pediatric) morbid obesity 
white f 61 $nan$nan$ropinirole  0.25  mg ; tiotropium bromide  1  cap ; spironolactone  12.5  mg ; furosemide  40  mg ; montelukast sodium  10  mg ; duloxetine  60  mg ; omeprazole  20  mg ; tolterodine  2  mg ; celebrex  200  mg ; ezetimibe  10  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  50  mg ; oxycodone-acetaminophen  1-2  tab ; gabapentin  800  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  12.5  mg ; ropinirole  1  mg ; insulin  0  unit ; heparin  5000  unit ; azithromycin  250  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; aquaphor ointment  1  appl ; 
mechanical complication due to other implant and internal device, not elsewhere classified diastolic heart failure, unspecified pulmonary collapse chronic airway obstruction, not elsewhere classified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other diseases of trachea and bronchus diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified chronic respiratory failure obstructive sleep apnea (adult)(pediatric) morbid obesity 
white f 61 $nan$nan$ropinirole  0.25  mg ; tiotropium bromide  1  cap ; spironolactone  12.5  mg ; furosemide  40  mg ; montelukast sodium  10  mg ; duloxetine  60  mg ; omeprazole  20  mg ; tolterodine  2  mg ; celebrex  200  mg ; ezetimibe  10  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  50  mg ; oxycodone-acetaminophen  1-2  tab ; gabapentin  800  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  12.5  mg ; ropinirole  1  mg ; insulin  0  unit ; heparin  5000  unit ; azithromycin  250  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; aquaphor ointment  1  appl ; diphenhydramine  25  mg ; 
mechanical complication due to other implant and internal device, not elsewhere classified diastolic heart failure, unspecified pulmonary collapse chronic airway obstruction, not elsewhere classified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other diseases of trachea and bronchus diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified chronic respiratory failure obstructive sleep apnea (adult)(pediatric) morbid obesity 
unable to obtain m 75 $nan$hematology blood hematocrit  30.1  %; hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  214  k ul; hematology blood platelet count  238  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  136  mg dl; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  96  mg dl; blood gas blood glucose  91  mg dl; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hemoglobin  11.8  g dl; blood gas blood hemoglobin  8.7  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  2.9  meq l; blood gas blood sodium, whole blood  140  meq l; blood gas blood sodium, whole blood  141  meq l$benztropine mesylate  0.5  mg ; aspirin  325  mg ; propranolol  20  mg ; quetiapine fumarate  50  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 1 2 ns  1000  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; benztropine mesylate  1  mg ; lorazepam  1  mg ; bisacodyl  10  mg ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; heparin  5000  unit ; sw  100  ml ; magnesium sulfate  4  gm ; tamsulosin  0.4  mg ; mirtazapine  22.5  mg ; lorazepam  0.5  mg ; 
 
unable to obtain m 75 $nan$nan$aspirin  325  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 1 2 ns  1000  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; benztropine mesylate  1  mg ; lorazepam  1  mg ; bisacodyl  10  mg ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; heparin  5000  unit ; sw  100  ml ; magnesium sulfate  4  gm ; tamsulosin  0.4  mg ; mirtazapine  22.5  mg ; lorazepam  0.5  mg ; 0.9% sodium chloride  500  ml ; 
 
unable to obtain m 75 $nan$hematology blood hematocrit  30.3  %; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  101  mg dl$aspirin  325  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 1 2 ns  1000  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; benztropine mesylate  1  mg ; lorazepam  1  mg ; bisacodyl  10  mg ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; heparin  5000  unit ; tamsulosin  0.4  mg ; mirtazapine  22.5  mg ; 0.9% sodium chloride  500  ml ; pantoprazole  40  mg ; artificial tears  1-2  drop ; neutra-phos  2  pkt ; potassium chloride  20  meq ; magnesium sulfate  2  gm ; 
 
unable to obtain m 75 $nan$nan$aspirin  325  mg ; sodium chloride 0.9%  flush  3  ml ; 1 2 ns  1000  ml ; benztropine mesylate  1  mg ; lorazepam  1  mg ; bisacodyl  10  mg ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; heparin  5000  unit ; tamsulosin  0.4  mg ; mirtazapine  22.5  mg ; pantoprazole  40  mg ; artificial tears  1-2  drop ; neutra-phos  2  pkt ; potassium chloride  20  meq ; magnesium sulfate  2  gm ; 
 
black african american f 60 $nan$nan$insulin  45  unit ; calcitriol  0.25  mcg ; omeprazole  40  mg ; ezetimibe  10  mg ; fluoxetine  60  mg ; montelukast sodium  10  mg ; cholestyramine  4  gm ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified automatic implantable cardiac defibrillator in situ acute kidney failure, unspecified long-term (current) use of anticoagulants abnormal coagulation profile congestive heart failure, unspecified personal history of venous thrombosis and embolism diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, stage iii (moderate) depressive disorder, not elsewhere classified asthma, unspecified type, unspecified acute on chronic diastolic heart failure backache, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure morbid obesity hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified obstructive sleep apnea (adult)(pediatric) cardiac pacemaker in situ long-term (current) use of insulin umbilical hernia with obstruction long-term (current) use of anticoagulants bipolar disorder, unspecified personal history of venous thrombosis and embolism congestive heart failure, unspecified chronic kidney disease, stage iii (moderate) anemia of other chronic disease bipolar disorder, unspecified personal history of venous thrombosis and embolism atrioventricular block, complete insomnia, unspecified chronic kidney disease, unspecified obstructive sleep apnea (adult)(pediatric) chronic obstructive asthma, unspecified myalgia and myositis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus congestive heart failure, unspecified cardiac pacemaker in situ contact dermatitis and other eczema, unspecified cause coronary atherosclerosis of unspecified type of vessel, native or graft chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin obesity, unspecified lumbago tietze's disease acute kidney failure, unspecified
black african american f 60 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  69  mg dl; hematology blood inr(pt)  2.9  ; chemistry urine chloride, urine  54  meq l; chemistry urine creatinine, urine  36  mg dl; chemistry urine potassium, urine  12  meq l; chemistry urine sodium, urine  54  meq l; chemistry urine urea nitrogen, urine  216  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  169  mg dl; chemistry blood lactate dehydrogenase (ld)  242  iu l$insulin  45  unit ; calcitriol  0.25  mcg ; omeprazole  40  mg ; ezetimibe  10  mg ; fluoxetine  60  mg ; montelukast sodium  10  mg ; cholestyramine  4  gm ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; lactulose  30  ml ; senna  1  tab ; torsemide  20  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; clonazepam  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; polyethylene glycol  17  g ; tizanidine  2  mg ; trazodone  25  mg ; insulin  0  unit ; lactulose enema  1000  ml ; torsemide  40  mg ; warfarin  2  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified automatic implantable cardiac defibrillator in situ acute kidney failure, unspecified long-term (current) use of anticoagulants abnormal coagulation profile congestive heart failure, unspecified personal history of venous thrombosis and embolism diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, stage iii (moderate) depressive disorder, not elsewhere classified asthma, unspecified type, unspecified acute on chronic diastolic heart failure backache, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure morbid obesity hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified obstructive sleep apnea (adult)(pediatric) cardiac pacemaker in situ long-term (current) use of insulin umbilical hernia with obstruction long-term (current) use of anticoagulants bipolar disorder, unspecified personal history of venous thrombosis and embolism congestive heart failure, unspecified chronic kidney disease, stage iii (moderate) anemia of other chronic disease bipolar disorder, unspecified personal history of venous thrombosis and embolism atrioventricular block, complete insomnia, unspecified chronic kidney disease, unspecified obstructive sleep apnea (adult)(pediatric) chronic obstructive asthma, unspecified myalgia and myositis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus congestive heart failure, unspecified cardiac pacemaker in situ contact dermatitis and other eczema, unspecified cause coronary atherosclerosis of unspecified type of vessel, native or graft chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin obesity, unspecified lumbago tietze's disease acute kidney failure, unspecified
black african american f 60 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  69  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  235  mg dl$calcitriol  0.25  mcg ; omeprazole  40  mg ; ezetimibe  10  mg ; fluoxetine  60  mg ; montelukast sodium  10  mg ; docusate sodium  100  mg ; lactulose  30  ml ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; clonazepam  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; polyethylene glycol  17  g ; tizanidine  2  mg ; trazodone  25  mg ; lactulose enema  1000  ml ; torsemide  40  mg ; warfarin  2  mg ; lisinopril  10  mg ; warfarin  7.5  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified automatic implantable cardiac defibrillator in situ acute kidney failure, unspecified long-term (current) use of anticoagulants abnormal coagulation profile congestive heart failure, unspecified personal history of venous thrombosis and embolism diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, stage iii (moderate) depressive disorder, not elsewhere classified asthma, unspecified type, unspecified acute on chronic diastolic heart failure backache, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure morbid obesity hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified obstructive sleep apnea (adult)(pediatric) cardiac pacemaker in situ long-term (current) use of insulin umbilical hernia with obstruction long-term (current) use of anticoagulants bipolar disorder, unspecified personal history of venous thrombosis and embolism congestive heart failure, unspecified chronic kidney disease, stage iii (moderate) anemia of other chronic disease bipolar disorder, unspecified personal history of venous thrombosis and embolism atrioventricular block, complete insomnia, unspecified chronic kidney disease, unspecified obstructive sleep apnea (adult)(pediatric) chronic obstructive asthma, unspecified myalgia and myositis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus congestive heart failure, unspecified cardiac pacemaker in situ contact dermatitis and other eczema, unspecified cause coronary atherosclerosis of unspecified type of vessel, native or graft chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin obesity, unspecified lumbago tietze's disease acute kidney failure, unspecified
black african american f 60 $nan$nan$calcitriol  0.25  mcg ; omeprazole  40  mg ; ezetimibe  10  mg ; fluoxetine  60  mg ; montelukast sodium  10  mg ; docusate sodium  100  mg ; lactulose  30  ml ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; clonazepam  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; polyethylene glycol  17  g ; tizanidine  2  mg ; trazodone  25  mg ; torsemide  40  mg ; lisinopril  10  mg ; warfarin  7.5  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified automatic implantable cardiac defibrillator in situ acute kidney failure, unspecified long-term (current) use of anticoagulants abnormal coagulation profile congestive heart failure, unspecified personal history of venous thrombosis and embolism diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, stage iii (moderate) depressive disorder, not elsewhere classified asthma, unspecified type, unspecified acute on chronic diastolic heart failure backache, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure morbid obesity hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified obstructive sleep apnea (adult)(pediatric) cardiac pacemaker in situ long-term (current) use of insulin umbilical hernia with obstruction long-term (current) use of anticoagulants bipolar disorder, unspecified personal history of venous thrombosis and embolism congestive heart failure, unspecified chronic kidney disease, stage iii (moderate) anemia of other chronic disease bipolar disorder, unspecified personal history of venous thrombosis and embolism atrioventricular block, complete insomnia, unspecified chronic kidney disease, unspecified obstructive sleep apnea (adult)(pediatric) chronic obstructive asthma, unspecified myalgia and myositis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus congestive heart failure, unspecified cardiac pacemaker in situ contact dermatitis and other eczema, unspecified cause coronary atherosclerosis of unspecified type of vessel, native or graft chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin obesity, unspecified lumbago tietze's disease acute kidney failure, unspecified
white f 87 $nan$hematology blood hematocrit  37.0  %; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  10.5  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; aspirin  81  mg ; docusate sodium  200  mg ; ferrous sulfate  325  mg ; multivitamins  1  tab ; omeprazole  20  mg ; senna  17.2  mg ; vitamin d  1000  unit ; heparin  1000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; albuterol inhaler  2  puff ; ipratropium-albuterol neb  1  neb ; atorvastatin  80  mg ; docusate sodium  100  mg ; furosemide  60  mg ; amlodipine  7.5  mg ; 
unspecified visual loss other chronic pulmonary heart diseases persistent disorder of initiating or maintaining sleep enlargement of lymph nodes personal history of other malignant neoplasm of skin atrial fibrillation congestive heart failure, unspecified do not resuscitate status long-term (current) use of aspirin hypoxemia anxiety state, unspecified chronic kidney disease, unspecified old myocardial infarction urinary tract infection, site not specified mitral valve disorders person boarding or alighting a pedal cycle injured in collision with pedestrian or animal hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other (abnormal) findings on radiological examination of breast accidental fall from chair antidepressants causing adverse effects in therapeutic use merrf syndrome need for prophylactic vaccination and inoculation against influenza acute on chronic diastolic heart failure long-term (current) use of anticoagulants history of fall home accidents other and unspecified hyperlipidemia other and unspecified escherichia coli [e. coli] coronary atherosclerosis of native coronary artery acute kidney failure, unspecified personal history of malignant neoplasm of breast contusion of lower leg osteoarthrosis, localized, not specified whether primary or secondary, lower leg 
white f 87 $nan$hematology blood hematocrit  37.5  %; hematology blood hematocrit  35.6  %; hematology blood hemoglobin  12.1  g dl; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  214  k ul; hematology blood platelet count  208  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology urine wbc  55  # hpf; chemistry blood calcium, total  10.5  mg dl; chemistry blood calcium, total  10.4  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood glucose  111  mg dl; chemistry blood glucose  143  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; aspirin  81  mg ; ferrous sulfate  325  mg ; multivitamins  1  tab ; omeprazole  20  mg ; senna  17.2  mg ; vitamin d  1000  unit ; atorvastatin  80  mg ; docusate sodium  100  mg ; furosemide  60  mg ; amlodipine  7.5  mg ; furosemide  80  mg ; trazodone  25  mg ; heparin  5000  unit ; potassium chloride  40  meq ; 
unspecified visual loss other chronic pulmonary heart diseases persistent disorder of initiating or maintaining sleep enlargement of lymph nodes personal history of other malignant neoplasm of skin atrial fibrillation congestive heart failure, unspecified do not resuscitate status long-term (current) use of aspirin hypoxemia anxiety state, unspecified chronic kidney disease, unspecified old myocardial infarction urinary tract infection, site not specified mitral valve disorders person boarding or alighting a pedal cycle injured in collision with pedestrian or animal hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other (abnormal) findings on radiological examination of breast accidental fall from chair antidepressants causing adverse effects in therapeutic use merrf syndrome need for prophylactic vaccination and inoculation against influenza acute on chronic diastolic heart failure long-term (current) use of anticoagulants history of fall home accidents other and unspecified hyperlipidemia other and unspecified escherichia coli [e. coli] coronary atherosclerosis of native coronary artery acute kidney failure, unspecified personal history of malignant neoplasm of breast contusion of lower leg osteoarthrosis, localized, not specified whether primary or secondary, lower leg 
white f 87 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; aspirin  81  mg ; ferrous sulfate  325  mg ; multivitamins  1  tab ; omeprazole  20  mg ; senna  17.2  mg ; vitamin d  1000  unit ; atorvastatin  80  mg ; docusate sodium  100  mg ; furosemide  60  mg ; amlodipine  7.5  mg ; furosemide  80  mg ; trazodone  25  mg ; heparin  5000  unit ; potassium chloride  40  meq ; miconazole powder 2%  1  appl ; 
unspecified visual loss other chronic pulmonary heart diseases persistent disorder of initiating or maintaining sleep enlargement of lymph nodes personal history of other malignant neoplasm of skin atrial fibrillation congestive heart failure, unspecified do not resuscitate status long-term (current) use of aspirin hypoxemia anxiety state, unspecified chronic kidney disease, unspecified old myocardial infarction urinary tract infection, site not specified mitral valve disorders person boarding or alighting a pedal cycle injured in collision with pedestrian or animal hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other (abnormal) findings on radiological examination of breast accidental fall from chair antidepressants causing adverse effects in therapeutic use merrf syndrome need for prophylactic vaccination and inoculation against influenza acute on chronic diastolic heart failure long-term (current) use of anticoagulants history of fall home accidents other and unspecified hyperlipidemia other and unspecified escherichia coli [e. coli] coronary atherosclerosis of native coronary artery acute kidney failure, unspecified personal history of malignant neoplasm of breast contusion of lower leg osteoarthrosis, localized, not specified whether primary or secondary, lower leg 
white f 87 $nan$chemistry blood anion gap  17  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  10.4  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; aspirin  81  mg ; ferrous sulfate  325  mg ; multivitamins  1  tab ; omeprazole  20  mg ; senna  17.2  mg ; vitamin d  1000  unit ; atorvastatin  80  mg ; docusate sodium  100  mg ; amlodipine  7.5  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; lorazepam  0.5  mg ; 
unspecified visual loss other chronic pulmonary heart diseases persistent disorder of initiating or maintaining sleep enlargement of lymph nodes personal history of other malignant neoplasm of skin atrial fibrillation congestive heart failure, unspecified do not resuscitate status long-term (current) use of aspirin hypoxemia anxiety state, unspecified chronic kidney disease, unspecified old myocardial infarction urinary tract infection, site not specified mitral valve disorders person boarding or alighting a pedal cycle injured in collision with pedestrian or animal hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other (abnormal) findings on radiological examination of breast accidental fall from chair antidepressants causing adverse effects in therapeutic use merrf syndrome need for prophylactic vaccination and inoculation against influenza acute on chronic diastolic heart failure long-term (current) use of anticoagulants history of fall home accidents other and unspecified hyperlipidemia other and unspecified escherichia coli [e. coli] coronary atherosclerosis of native coronary artery acute kidney failure, unspecified personal history of malignant neoplasm of breast contusion of lower leg osteoarthrosis, localized, not specified whether primary or secondary, lower leg 
white f 87 $nan$nan$sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; aspirin  81  mg ; ferrous sulfate  325  mg ; multivitamins  1  tab ; omeprazole  20  mg ; senna  17.2  mg ; vitamin d  1000  unit ; atorvastatin  80  mg ; docusate sodium  100  mg ; amlodipine  7.5  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; lorazepam  0.5  mg ; clopidogrel  75  mg ; lorazepam  0.25  mg ; 
unspecified visual loss other chronic pulmonary heart diseases persistent disorder of initiating or maintaining sleep enlargement of lymph nodes personal history of other malignant neoplasm of skin atrial fibrillation congestive heart failure, unspecified do not resuscitate status long-term (current) use of aspirin hypoxemia anxiety state, unspecified chronic kidney disease, unspecified old myocardial infarction urinary tract infection, site not specified mitral valve disorders person boarding or alighting a pedal cycle injured in collision with pedestrian or animal hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other (abnormal) findings on radiological examination of breast accidental fall from chair antidepressants causing adverse effects in therapeutic use merrf syndrome need for prophylactic vaccination and inoculation against influenza acute on chronic diastolic heart failure long-term (current) use of anticoagulants history of fall home accidents other and unspecified hyperlipidemia other and unspecified escherichia coli [e. coli] coronary atherosclerosis of native coronary artery acute kidney failure, unspecified personal history of malignant neoplasm of breast contusion of lower leg osteoarthrosis, localized, not specified whether primary or secondary, lower leg 
white f 87 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  281  k ul$sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; aspirin  81  mg ; ferrous sulfate  325  mg ; multivitamins  1  tab ; omeprazole  20  mg ; senna  17.2  mg ; vitamin d  1000  unit ; atorvastatin  80  mg ; docusate sodium  100  mg ; amlodipine  7.5  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; clopidogrel  75  mg ; lorazepam  0.25  mg ; 
unspecified visual loss other chronic pulmonary heart diseases persistent disorder of initiating or maintaining sleep enlargement of lymph nodes personal history of other malignant neoplasm of skin atrial fibrillation congestive heart failure, unspecified do not resuscitate status long-term (current) use of aspirin hypoxemia anxiety state, unspecified chronic kidney disease, unspecified old myocardial infarction urinary tract infection, site not specified mitral valve disorders person boarding or alighting a pedal cycle injured in collision with pedestrian or animal hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other (abnormal) findings on radiological examination of breast accidental fall from chair antidepressants causing adverse effects in therapeutic use merrf syndrome need for prophylactic vaccination and inoculation against influenza acute on chronic diastolic heart failure long-term (current) use of anticoagulants history of fall home accidents other and unspecified hyperlipidemia other and unspecified escherichia coli [e. coli] coronary atherosclerosis of native coronary artery acute kidney failure, unspecified personal history of malignant neoplasm of breast contusion of lower leg osteoarthrosis, localized, not specified whether primary or secondary, lower leg 
other f 63 $nan$hematology blood hematocrit  40.3  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  94  mg dl$nan
 
other f 63 $nan$nan$aspirin  325  mg ; metoprolol succinate xl  25  mg ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  5-10  mg ; calcium carbonate  500  mg ; dabigatran etexilate  150  mg ; mesalamine dr  1200  mg ; vitamin d  1000  unit ; fish oil (omega 3)  1000  mg ; 
 
other f 63 $nan$nan$aspirin  325  mg ; metoprolol succinate xl  25  mg ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  5-10  mg ; calcium carbonate  500  mg ; dabigatran etexilate  150  mg ; mesalamine dr  1200  mg ; vitamin d  1000  unit ; fish oil (omega 3)  1000  mg ; 
 
white f 65 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  290  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  6.5  mg dl; chemistry blood glucose  36  mg dl; chemistry blood albumin  2.8  g dl$acyclovir  200  mg ; acetaminophen iv  1000  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; ondansetron  4  mg ; metoclopramide  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ns  100  ml ; metronidazole  500  mg ; 0.9% sodium chl (yellow cadd)  1  cadd ; bupivacaine 0.1%  250  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; heparin  5000  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; d5 1 2ns  1000  ml ; bag  1  bag ; magnesium sulfate  4  gm ; calcium carbonate  500  mg ; dextrose 50%  25  gm ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  298  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  6.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  123  mg dl; blood gas blood free calcium  0.92  mmol l$acyclovir  200  mg ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; metoclopramide  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ns  100  ml ; metronidazole  500  mg ; 0.9% sodium chl (yellow cadd)  1  cadd ; bupivacaine 0.1%  250  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; d5 1 2ns  1000  ml ; dextrose 50%  25  gm ; vial  1  vial ; pantoprazole  40  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  295  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  120  mg dl$acyclovir  200  mg ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; metoclopramide  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ns  100  ml ; metronidazole  500  mg ; 0.9% sodium chl (yellow cadd)  1  cadd ; bupivacaine 0.1%  250  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; d5 1 2ns  1000  ml ; vial  1  vial ; pantoprazole  40  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  10-20  ml ; potassium phosphate  30  mmol ; sodium chloride 0.9%  1000  ml ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; hematology urine wbc  6  # hpf; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  107  mg dl$acyclovir  200  mg ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; metoclopramide  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ns  100  ml ; metronidazole  500  mg ; 0.9% sodium chl (yellow cadd)  1  cadd ; bupivacaine 0.1%  250  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; d5 1 2ns  1000  ml ; vial  1  vial ; pantoprazole  40  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  10-20  ml ; potassium phosphate  30  mmol ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  114  mg dl$acyclovir  200  mg ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; metoclopramide  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ns  100  ml ; metronidazole  500  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vial  1  vial ; pantoprazole  40  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  10-20  ml ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  113  mg dl$acyclovir  200  mg ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; metoclopramide  10  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vial  1  vial ; pantoprazole  40  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; gastroview (diatrizoate meglumine & sodium)  30  ml ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; hematology urine wbc  3  # hpf; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  110  mg dl; blood gas blood free calcium  1.05  mmol l$acyclovir  200  mg ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; metoclopramide  10  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vial  1  vial ; pantoprazole  40  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; gastroview (diatrizoate meglumine & sodium)  30  ml ; lorazepam  0.25  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  390  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  111  mg dl$acyclovir  200  mg ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; metoclopramide  10  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vial  1  vial ; pantoprazole  40  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; diphenhydramine  12.5  mg ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  430  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  84  mg dl$acyclovir  200  mg ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vial  1  vial ; pantoprazole  40  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; volumen (barium sulfate 0.1% suspension)  900  ml ; vancomycin  1250  mg ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  456  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  85  mg dl$acyclovir  200  mg ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vial  1  vial ; pantoprazole  40  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; volumen (barium sulfate 0.1% suspension)  900  ml ; vancomycin  1250  mg ; loperamide  2  mg ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  684  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  85  mg dl$acyclovir  200  mg ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vial  1  vial ; pantoprazole  40  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; loperamide  2  mg ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  752  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  67  mg dl; chemistry blood albumin  2.3  g dl$acyclovir  200  mg ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vial  1  vial ; pantoprazole  40  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; acyclovir  400  mg ; acetaminophen  1000  mg ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  837  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  76  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; acyclovir  400  mg ; acetaminophen  1000  mg ; lidocaine 5% patch  1  ptch ; enoxaparin sodium  40  mg ; enoxaparin sodium  30  mg ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; acyclovir  400  mg ; acetaminophen  1000  mg ; lidocaine 5% patch  1  ptch ; enoxaparin sodium  30  mg ; loperamide  4  mg ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; acyclovir  400  mg ; acetaminophen  1000  mg ; lidocaine 5% patch  1  ptch ; enoxaparin sodium  30  mg ; loperamide  4  mg ; psyllium powder  1  pkt ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  122  mg dl; chemistry blood albumin  2.5  g dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; acyclovir  400  mg ; acetaminophen  1000  mg ; lidocaine 5% patch  1  ptch ; enoxaparin sodium  30  mg ; psyllium powder  1  pkt ; diphenoxylate-atropine  1  tab ; magnesium oxide  400  mg ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; acyclovir  400  mg ; acetaminophen  1000  mg ; lidocaine 5% patch  1  ptch ; enoxaparin sodium  30  mg ; diphenoxylate-atropine  1  tab ; magnesium oxide  400  mg ; cvs fiber laxative plus calcium  625  mg ; fibercon  625  mg ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; acyclovir  400  mg ; acetaminophen  1000  mg ; lidocaine 5% patch  1  ptch ; enoxaparin sodium  30  mg ; diphenoxylate-atropine  1  tab ; fibercon  625  mg ; diphenoxylate-atropine  2  tab ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; acyclovir  400  mg ; acetaminophen  1000  mg ; lidocaine 5% patch  1  ptch ; enoxaparin sodium  30  mg ; fibercon  625  mg ; diphenoxylate-atropine  2  tab ; sodium chloride 0.9%  flush  10  ml ; opium tincture (morphine 10 mg ml)  3  mg ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  69  mg dl; chemistry blood albumin  2.6  g dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; acyclovir  400  mg ; acetaminophen  1000  mg ; lidocaine 5% patch  1  ptch ; enoxaparin sodium  30  mg ; fibercon  625  mg ; diphenoxylate-atropine  2  tab ; sodium chloride 0.9%  flush  10  ml ; opium tincture (morphine 10 mg ml)  3  mg ; humira  40  mg ; opium tincture (morphine 10 mg ml)  1.5  mg ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  70  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; acyclovir  400  mg ; acetaminophen  1000  mg ; lidocaine 5% patch  1  ptch ; enoxaparin sodium  30  mg ; fibercon  625  mg ; diphenoxylate-atropine  2  tab ; sodium chloride 0.9%  flush  10  ml ; humira  40  mg ; opium tincture (morphine 10 mg ml)  1.5  mg ; omeprazole  40  mg ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white f 65 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  70  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10-20  ml ; chloraseptic throat spray  1  spry ; acyclovir  400  mg ; acetaminophen  1000  mg ; lidocaine 5% patch  1  ptch ; enoxaparin sodium  30  mg ; fibercon  625  mg ; diphenoxylate-atropine  2  tab ; sodium chloride 0.9%  flush  10  ml ; humira  40  mg ; opium tincture (morphine 10 mg ml)  1.5  mg ; omeprazole  40  mg ; magnesium sulfate  2  gm ; 
herpesviral infection, unspecified calculus of gallbladder without cholecystitis without obstruction crohn's disease, unspecified, with intestinal obstruction nonrheumatic mitral (valve) prolapse vitamin b12 deficiency anemia, unspecified age-related osteoporosis without current pathological fracture hypotension, unspecified calculus of kidney personal history of nicotine dependence bradycardia, unspecified crohn's disease, unspecified, without complications personal history of other malignant neoplasm of skin other ascites insomnia, unspecified regional enteritis of small intestine osteoporosis, unspecified unspecified intestinal obstruction herpes simplex without mention of complication mitral valve disorders unspecified vitamin d deficiency abscess of anal and rectal regions migraine, unspecified, without mention of intractable migraine without mention of status migrainosus dehydration anal fistula hemangioma of intra-abdominal structures regional enteritis of unspecified site abdominal pain, unspecified site unspecified intestinal obstruction osteoporosis, unspecified other vitamin b12 deficiency anemia
white m 91 $nan$nan$citalopram  40  mg ; tolterodine  2  mg ; furosemide  20  mg ; lisinopril  20  mg ; isosorbide dinitrate  20  mg ; docusate sodium  100  mg ; metoprolol tartrate  50  mg ; 
 
white m 91 $nan$hematology blood hematocrit  41.9  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  84  mg dl$citalopram  40  mg ; tolterodine  2  mg ; furosemide  20  mg ; lisinopril  20  mg ; isosorbide dinitrate  20  mg ; docusate sodium  100  mg ; metoprolol tartrate  50  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; tamsulosin  0.4  mg ; hydralazine  10  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  1  tab ; 
 
white m 91 $nan$hematology blood hematocrit  40.0  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  52  mg dl; hematology urine wbc  6  # hpf; chemistry blood glucose  131  mg dl$citalopram  40  mg ; tolterodine  2  mg ; furosemide  20  mg ; lisinopril  20  mg ; isosorbide dinitrate  20  mg ; docusate sodium  100  mg ; metoprolol tartrate  50  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; tamsulosin  0.4  mg ; hydralazine  10  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  1  tab ; insulin  24  unit ; heparin  5000  unit ; 
 
black african american f 72 $temp    heartrate  72.0  resprate  22.0  o2sat  95.0  sbp  154.0  dbp  85.0  rhythm    pain  0  ; temp    heartrate  76.0  resprate  23.0  o2sat  94.0  sbp  173.0  dbp  42.0  rhythm    pain  0  ; temp    heartrate  73.0  resprate  15.0  o2sat  96.0  sbp  171.0  dbp  69.0  rhythm    pain  0  ; temp  97.8  heartrate  68.0  resprate  22.0  o2sat    sbp  162.0  dbp  58.0  rhythm    pain    ; temp    heartrate  69.0  resprate  19.0  o2sat  100.0  sbp  157.0  dbp  53.0  rhythm  sinus rhythm  pain  0  ; temp    heartrate  75.0  resprate  22.0  o2sat  100.0  sbp  178.0  dbp  52.0  rhythm  sinus rhythm  pain  0  $hematology blood hematocrit  42.6  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  411  k ul; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  70  mg dl; chemistry blood albumin  4.0  g dl$nan
personal history of allergy to other specified medicinal agents obstructive chronic bronchitis with (acute) exacerbation tobacco use disorder hypoxemia other diseases of lung, not elsewhere classified hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of allergy to narcotic agent chronic kidney disease, stage iii (moderate) coronary atherosclerosis of native coronary artery anemia in chronic kidney disease personal history of allergy to other antibiotic agent acute kidney failure, unspecified pedal cycle passenger injured in collision with heavy transport vehicle or bus in nontraffic accident acute respiratory failure hyposmolality and/or hyponatremia pedal cycle passenger injured in collision with heavy transport vehicle or bus in traffic accident pneumonia, organism unspecified congestive heart failure, unspecified acute on chronic diastolic heart failure hyperpotassemia nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute on chronic diastolic heart failure hyposmolality and/or hyponatremia agoraphobia without mention of panic attacks other chronic pain acute kidney failure, unspecified other b-complex deficiencies chronic obstructive asthma with (acute) exacerbation chronic kidney disease, stage iii (moderate) acute respiratory failure congestive heart failure, unspecified mineralocorticoid deficiency anemia of other chronic disease personal history of colonic polyps abdominal pain, unspecified site urinary tract infection, site not specified long-term (current) use of steroids postinflammatory pulmonary fibrosis unspecified gastritis and gastroduodenitis, without mention of hemorrhage unspecified vascular insufficiency of intestine personal history of tobacco use unspecified essential hypertension other and unspecified alcohol dependence, continuous pneumonia, organism unspecified lumbago hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified contact dermatitis and other eczema, unspecified cause
black african american f 72 $temp  97.8  heartrate  84.0  resprate  20.0  o2sat  98.0  sbp  170.0  dbp  52.0  rhythm  sinus rhythm  pain  0  $hematology blood hematocrit  37.4  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  352  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  141  mg dl$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; ipratropium-albuterol neb  1  neb ; diazepam  5  mg ; acetaminophen  500  mg ; aspirin  325  mg ; bisacodyl  10  mg ; calcium carbonate  1000  mg ; docusate sodium  100  mg ; theophylline er  400  mg ; amlodipine  10  mg ; ferrous sulfate  325  mg ; guaifenesin  10  ml ; metoprolol succinate xl  100  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; hydroxyzine  25  mg ; miconazole powder 2%  1  appl ; montelukast  10  mg ; nystatin cream  1  appl ; pantoprazole  40  mg ; ranitidine  150  mg ; dronabinol  2.5  mg ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; hydralazine  50  mg ; isosorbide mononitrate (extended release)  60  mg ; hydralazine  25  mg ; ipratropium bromide mdi  2  puff ; azithromycin  250  mg ; 
personal history of allergy to other specified medicinal agents obstructive chronic bronchitis with (acute) exacerbation tobacco use disorder hypoxemia other diseases of lung, not elsewhere classified hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of allergy to narcotic agent chronic kidney disease, stage iii (moderate) coronary atherosclerosis of native coronary artery anemia in chronic kidney disease personal history of allergy to other antibiotic agent acute kidney failure, unspecified pedal cycle passenger injured in collision with heavy transport vehicle or bus in nontraffic accident acute respiratory failure hyposmolality and/or hyponatremia pedal cycle passenger injured in collision with heavy transport vehicle or bus in traffic accident pneumonia, organism unspecified congestive heart failure, unspecified acute on chronic diastolic heart failure hyperpotassemia nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute on chronic diastolic heart failure hyposmolality and/or hyponatremia agoraphobia without mention of panic attacks other chronic pain acute kidney failure, unspecified other b-complex deficiencies chronic obstructive asthma with (acute) exacerbation chronic kidney disease, stage iii (moderate) acute respiratory failure congestive heart failure, unspecified mineralocorticoid deficiency anemia of other chronic disease personal history of colonic polyps abdominal pain, unspecified site urinary tract infection, site not specified long-term (current) use of steroids postinflammatory pulmonary fibrosis unspecified gastritis and gastroduodenitis, without mention of hemorrhage unspecified vascular insufficiency of intestine personal history of tobacco use unspecified essential hypertension other and unspecified alcohol dependence, continuous pneumonia, organism unspecified lumbago hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified contact dermatitis and other eczema, unspecified cause
black african american f 72 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  336  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  137  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ipratropium-albuterol neb  1  neb ; acetaminophen  500  mg ; aspirin  325  mg ; bisacodyl  10  mg ; calcium carbonate  1000  mg ; docusate sodium  100  mg ; theophylline er  400  mg ; ferrous sulfate  325  mg ; guaifenesin  10  ml ; polyethylene glycol  17  g ; senna  17.2  mg ; thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; miconazole powder 2%  1  appl ; montelukast  10  mg ; nystatin cream  1  appl ; pantoprazole  40  mg ; ranitidine  150  mg ; dronabinol  2.5  mg ; fluticasone propionate nasal  1  spry ; isosorbide mononitrate (extended release)  60  mg ; hydralazine  25  mg ; ipratropium bromide mdi  2  puff ; azithromycin  250  mg ; artificial tears  1-2  drop ; fluticasone-salmeterol diskus (250 50)   1  inh ; nephrocaps  1  cap ; metoprolol succinate xl  200  mg ; metoprolol succinate xl  25  mg ; torsemide  20  mg ; 
personal history of allergy to other specified medicinal agents obstructive chronic bronchitis with (acute) exacerbation tobacco use disorder hypoxemia other diseases of lung, not elsewhere classified hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of allergy to narcotic agent chronic kidney disease, stage iii (moderate) coronary atherosclerosis of native coronary artery anemia in chronic kidney disease personal history of allergy to other antibiotic agent acute kidney failure, unspecified pedal cycle passenger injured in collision with heavy transport vehicle or bus in nontraffic accident acute respiratory failure hyposmolality and/or hyponatremia pedal cycle passenger injured in collision with heavy transport vehicle or bus in traffic accident pneumonia, organism unspecified congestive heart failure, unspecified acute on chronic diastolic heart failure hyperpotassemia nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute on chronic diastolic heart failure hyposmolality and/or hyponatremia agoraphobia without mention of panic attacks other chronic pain acute kidney failure, unspecified other b-complex deficiencies chronic obstructive asthma with (acute) exacerbation chronic kidney disease, stage iii (moderate) acute respiratory failure congestive heart failure, unspecified mineralocorticoid deficiency anemia of other chronic disease personal history of colonic polyps abdominal pain, unspecified site urinary tract infection, site not specified long-term (current) use of steroids postinflammatory pulmonary fibrosis unspecified gastritis and gastroduodenitis, without mention of hemorrhage unspecified vascular insufficiency of intestine personal history of tobacco use unspecified essential hypertension other and unspecified alcohol dependence, continuous pneumonia, organism unspecified lumbago hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified contact dermatitis and other eczema, unspecified cause
black african american f 72 $nan$hematology blood hematocrit  40.2  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  378  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  5.9  meq l; chemistry blood potassium  5.7  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  49  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  80  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ipratropium-albuterol neb  1  neb ; acetaminophen  500  mg ; aspirin  325  mg ; bisacodyl  10  mg ; calcium carbonate  1000  mg ; docusate sodium  100  mg ; theophylline er  400  mg ; ferrous sulfate  325  mg ; guaifenesin  10  ml ; polyethylene glycol  17  g ; senna  17.2  mg ; thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; miconazole powder 2%  1  appl ; montelukast  10  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; dronabinol  2.5  mg ; fluticasone propionate nasal  1  spry ; isosorbide mononitrate (extended release)  60  mg ; hydralazine  25  mg ; ipratropium bromide mdi  2  puff ; azithromycin  250  mg ; artificial tears  1-2  drop ; fluticasone-salmeterol diskus (250 50)   1  inh ; nephrocaps  1  cap ; metoprolol succinate xl  200  mg ; metoprolol succinate xl  25  mg ; torsemide  20  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; sodium polystyrene sulfonate  30  gm ; albuterol 0.083% neb soln  1  neb ; calcium carbonate  500  mg ; nystatin oral suspension  10  ml ; 
personal history of allergy to other specified medicinal agents obstructive chronic bronchitis with (acute) exacerbation tobacco use disorder hypoxemia other diseases of lung, not elsewhere classified hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of allergy to narcotic agent chronic kidney disease, stage iii (moderate) coronary atherosclerosis of native coronary artery anemia in chronic kidney disease personal history of allergy to other antibiotic agent acute kidney failure, unspecified pedal cycle passenger injured in collision with heavy transport vehicle or bus in nontraffic accident acute respiratory failure hyposmolality and/or hyponatremia pedal cycle passenger injured in collision with heavy transport vehicle or bus in traffic accident pneumonia, organism unspecified congestive heart failure, unspecified acute on chronic diastolic heart failure hyperpotassemia nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute on chronic diastolic heart failure hyposmolality and/or hyponatremia agoraphobia without mention of panic attacks other chronic pain acute kidney failure, unspecified other b-complex deficiencies chronic obstructive asthma with (acute) exacerbation chronic kidney disease, stage iii (moderate) acute respiratory failure congestive heart failure, unspecified mineralocorticoid deficiency anemia of other chronic disease personal history of colonic polyps abdominal pain, unspecified site urinary tract infection, site not specified long-term (current) use of steroids postinflammatory pulmonary fibrosis unspecified gastritis and gastroduodenitis, without mention of hemorrhage unspecified vascular insufficiency of intestine personal history of tobacco use unspecified essential hypertension other and unspecified alcohol dependence, continuous pneumonia, organism unspecified lumbago hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified contact dermatitis and other eczema, unspecified cause
black african american f 72 $nan$chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  5.5  meq l; chemistry blood potassium  5.6  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  45  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; ipratropium-albuterol neb  1  neb ; acetaminophen  500  mg ; aspirin  325  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; theophylline er  400  mg ; ferrous sulfate  325  mg ; guaifenesin  10  ml ; polyethylene glycol  17  g ; senna  17.2  mg ; thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; montelukast  10  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; dronabinol  2.5  mg ; fluticasone propionate nasal  1  spry ; isosorbide mononitrate (extended release)  60  mg ; hydralazine  25  mg ; ipratropium bromide mdi  2  puff ; azithromycin  250  mg ; artificial tears  1-2  drop ; fluticasone-salmeterol diskus (250 50)   1  inh ; nephrocaps  1  cap ; metoprolol succinate xl  200  mg ; metoprolol succinate xl  25  mg ; calcium carbonate  500  mg ; nystatin oral suspension  10  ml ; hydralazine  5  mg ; furosemide  20  mg ; 
personal history of allergy to other specified medicinal agents obstructive chronic bronchitis with (acute) exacerbation tobacco use disorder hypoxemia other diseases of lung, not elsewhere classified hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of allergy to narcotic agent chronic kidney disease, stage iii (moderate) coronary atherosclerosis of native coronary artery anemia in chronic kidney disease personal history of allergy to other antibiotic agent acute kidney failure, unspecified pedal cycle passenger injured in collision with heavy transport vehicle or bus in nontraffic accident acute respiratory failure hyposmolality and/or hyponatremia pedal cycle passenger injured in collision with heavy transport vehicle or bus in traffic accident pneumonia, organism unspecified congestive heart failure, unspecified acute on chronic diastolic heart failure hyperpotassemia nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute on chronic diastolic heart failure hyposmolality and/or hyponatremia agoraphobia without mention of panic attacks other chronic pain acute kidney failure, unspecified other b-complex deficiencies chronic obstructive asthma with (acute) exacerbation chronic kidney disease, stage iii (moderate) acute respiratory failure congestive heart failure, unspecified mineralocorticoid deficiency anemia of other chronic disease personal history of colonic polyps abdominal pain, unspecified site urinary tract infection, site not specified long-term (current) use of steroids postinflammatory pulmonary fibrosis unspecified gastritis and gastroduodenitis, without mention of hemorrhage unspecified vascular insufficiency of intestine personal history of tobacco use unspecified essential hypertension other and unspecified alcohol dependence, continuous pneumonia, organism unspecified lumbago hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified contact dermatitis and other eczema, unspecified cause
black african american f 72 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ipratropium-albuterol neb  1  neb ; acetaminophen  500  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; theophylline er  400  mg ; ferrous sulfate  325  mg ; guaifenesin  10  ml ; polyethylene glycol  17  g ; senna  17.2  mg ; thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; montelukast  10  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; dronabinol  2.5  mg ; fluticasone propionate nasal  1  spry ; isosorbide mononitrate (extended release)  60  mg ; ipratropium bromide mdi  2  puff ; azithromycin  250  mg ; artificial tears  1-2  drop ; fluticasone-salmeterol diskus (250 50)   1  inh ; nephrocaps  1  cap ; metoprolol succinate xl  200  mg ; metoprolol succinate xl  25  mg ; calcium carbonate  500  mg ; nystatin oral suspension  10  ml ; hydralazine  5  mg ; furosemide  20  mg ; 
personal history of allergy to other specified medicinal agents obstructive chronic bronchitis with (acute) exacerbation tobacco use disorder hypoxemia other diseases of lung, not elsewhere classified hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of allergy to narcotic agent chronic kidney disease, stage iii (moderate) coronary atherosclerosis of native coronary artery anemia in chronic kidney disease personal history of allergy to other antibiotic agent acute kidney failure, unspecified pedal cycle passenger injured in collision with heavy transport vehicle or bus in nontraffic accident acute respiratory failure hyposmolality and/or hyponatremia pedal cycle passenger injured in collision with heavy transport vehicle or bus in traffic accident pneumonia, organism unspecified congestive heart failure, unspecified acute on chronic diastolic heart failure hyperpotassemia nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute on chronic diastolic heart failure hyposmolality and/or hyponatremia agoraphobia without mention of panic attacks other chronic pain acute kidney failure, unspecified other b-complex deficiencies chronic obstructive asthma with (acute) exacerbation chronic kidney disease, stage iii (moderate) acute respiratory failure congestive heart failure, unspecified mineralocorticoid deficiency anemia of other chronic disease personal history of colonic polyps abdominal pain, unspecified site urinary tract infection, site not specified long-term (current) use of steroids postinflammatory pulmonary fibrosis unspecified gastritis and gastroduodenitis, without mention of hemorrhage unspecified vascular insufficiency of intestine personal history of tobacco use unspecified essential hypertension other and unspecified alcohol dependence, continuous pneumonia, organism unspecified lumbago hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified contact dermatitis and other eczema, unspecified cause
white f 76 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  122  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; nitroglycerin sl  0.3  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; heparin  5000  unit ; docusate sodium  100  mg ; atenolol  25  mg ; atorvastatin  20  mg ; clopidogrel  75  mg ; lisinopril  5  mg ; aspirin  325  mg ; 
 
white f 61 $temp  98.2  heartrate  58.0  resprate  16.0  o2sat  99.0  sbp  130.0  dbp  66.0  rhythm    pain  0  $nan$levothyroxine sodium  50  mcg ; 
 
white f 61 $temp  98.6  heartrate  60.0  resprate  16.0  o2sat  100.0  sbp  119.0  dbp  56.0  rhythm    pain  0  $nan$levothyroxine sodium  50  mcg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; lactated ringers  1000  ml ; heparin  5000  unit ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; 
 
white f 61 $nan$chemistry blood chloride  102  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l$levothyroxine sodium  50  mcg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; potassium chloride  20  meq ; 
 
white f 61 $nan$nan$levothyroxine sodium  50  mcg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; potassium chloride  20  meq ; 
 
other f 81 $nan$nan$lisinopril  20  mg ; simvastatin  20  mg ; aspirin  81  mg ; vitamin d  800  unit ; multivitamins  1  tab ; calcium carbonate  1500  mg ; heparin  5000  unit ; 
 
other f 81 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  88  mg dl$lisinopril  20  mg ; simvastatin  20  mg ; aspirin  81  mg ; vitamin d  800  unit ; multivitamins  1  tab ; calcium carbonate  1500  mg ; heparin  5000  unit ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; gabapentin  300  mg ; lorazepam  1  mg ; 0.9% sodium chloride  1000  ml ; loperamide  2  mg ; 
 
other f 81 $nan$nan$lisinopril  20  mg ; simvastatin  20  mg ; aspirin  81  mg ; vitamin d  800  unit ; multivitamins  1  tab ; calcium carbonate  1500  mg ; heparin  5000  unit ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; gabapentin  300  mg ; lorazepam  1  mg ; 0.9% sodium chloride  1000  ml ; loperamide  2  mg ; 
 
white m 87 $nan$hematology blood hematocrit  34.9  %; hematology blood hematocrit  37.5  %$pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; oxycodone-acetaminophen  1-2  tab ; morphine sulfate  2  mg ; morphine sulfate  4  mg ; lr  1000  ml ; hydrocodone-acetaminophen  1  tab ; pantoprazole  40  mg ; 
 
white m 87 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; morphine sulfate  2  mg ; morphine sulfate  4  mg ; hydrocodone-acetaminophen  1  tab ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; 
 
white m 87 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; morphine sulfate  2  mg ; morphine sulfate  4  mg ; hydrocodone-acetaminophen  1  tab ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; 
 
white m 87 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; morphine sulfate  2  mg ; morphine sulfate  4  mg ; hydrocodone-acetaminophen  1  tab ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; 
 
white m 52 $temp    heartrate  89.0  resprate  16.0  o2sat  97.0  sbp  161.0  dbp  83.0  rhythm    pain  0  ; temp    heartrate  98.0  resprate  12.0  o2sat  96.0  sbp  134.0  dbp  67.0  rhythm    pain  0  $hematology blood hematocrit  45.1  %; hematology blood hematocrit  44.9  %; hematology blood hemoglobin  15.2  g dl; hematology blood hemoglobin  15.0  g dl; hematology blood platelet count  227  k ul; hematology blood platelet count  222  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  223  iu l$simvastatin  40  mg ; aspirin  325  mg ; ezetimibe  10  mg ; aspirin  81  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  1  mg ; lorazepam  2  mg ; 0.45% sodium chloride  1000  ml ; 0.9% sodium chloride  1000  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; d5 1 2ns  1000  ml ; acebutolol  200  mg ; heparin  5000  unit ; 
 
white m 52 $nan$hematology blood hematocrit  44.1  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  203  iu l; chemistry blood albumin  3.7  g dl$albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; d5 1 2ns  1000  ml ; heparin  5000  unit ; nicotine patch  14  mg ; haloperidol  5  mg ; 
 
white m 52 $nan$hematology blood hematocrit  44.9  %; hematology blood hemoglobin  15.5  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  148  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  82  mg dl; blood gas blood free calcium  0.94  mmol l; blood gas blood lactate  1.1  mmol l$albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; d5 1 2ns  1000  ml ; heparin  5000  unit ; nicotine patch  14  mg ; haloperidol  5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; haloperidol  2  mg ; 5% dextrose  1000  ml ; 
 
white m 52 $nan$hematology blood hematocrit  42.4  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  240  iu l; chemistry blood albumin  3.8  g dl$d5 1 2ns  1000  ml ; heparin  5000  unit ; nicotine patch  14  mg ; haloperidol  2  mg ; 5% dextrose  1000  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; potassium chl 40 meq   1000 ml ns  1000  ml ; dextrose 5%  150  ml ; levofloxacin  750  mg ; dextrose 5%  100  ml ; levofloxacin  500  mg ; lorazepam  0.5-1  mg ; 
 
white m 52 $nan$hematology blood hematocrit  41.8  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  446  mg dl; chemistry blood lactate dehydrogenase (ld)  227  iu l; chemistry blood albumin  3.4  g dl$d5 1 2ns  1000  ml ; heparin  5000  unit ; nicotine patch  14  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; dextrose 5%  100  ml ; levofloxacin  500  mg ; lorazepam  0.5-1  mg ; diphenhydramine  25  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; azithromycin  500  mg ; 5% dextrose  250  ml ; azithromycin   500  mg ; sodium chloride 3% inhalation soln  15  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 
 
white m 52 $nan$hematology blood hematocrit  45.7  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  82  mg dl; chemistry blood lactate dehydrogenase (ld)  293  iu l$heparin  5000  unit ; nicotine patch  14  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; diphenhydramine  25  mg ; sodium chloride 3% inhalation soln  15  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; haloperidol  10  mg ; haloperidol  2.5  mg ; haloperidol  7  mg ; 
 
white m 52 $nan$hematology blood hematocrit  43.7  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  309  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  72  mg dl; chemistry blood % hemoglobin a1c  5.5  %$heparin  5000  unit ; nicotine patch  14  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; diphenhydramine  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; furosemide  10  mg ; risperidone (disintegrating tablet)  4  mg ; 
 
white m 52 $nan$hematology blood hematocrit  47.9  %; hematology blood hemoglobin  15.9  g dl; hematology blood platelet count  345  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  83  mg dl$heparin  5000  unit ; nicotine patch  14  mg ; diphenhydramine  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; risperidone (disintegrating tablet)  4  mg ; atorvastatin  20  mg ; olanzapine (disintegrating tablet)  10  mg ; 
 
white m 52 $nan$nan$heparin  5000  unit ; nicotine patch  14  mg ; diphenhydramine  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; atorvastatin  20  mg ; 
 
white f 40 $nan$nan$citalopram hydrobromide  20  mg ; sodium chloride 0.9%  flush  3  ml ; 1 2 ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  50  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; docusate sodium  100  mg ; hydromorphone (dilaudid)  12.5  mg ; 
 
white f 40 $nan$nan$citalopram hydrobromide  20  mg ; sodium chloride 0.9%  flush  3  ml ; 1 2 ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; hydromorphone (dilaudid)  12.5  mg ; prochlorperazine  10  mg ; 
 
white f 40 $nan$hematology urine wbc  0-2  # hpf; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$citalopram hydrobromide  20  mg ; sodium chloride 0.9%  flush  3  ml ; 1 2 ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; prochlorperazine  10  mg ; 
 
white f 40 $nan$nan$citalopram hydrobromide  20  mg ; sodium chloride 0.9%  flush  3  ml ; 1 2 ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; prochlorperazine  10  mg ; 
 
black african american f 41 $temp  97.7  heartrate  87.0  resprate  19.0  o2sat  100.0  sbp  131.0  dbp  72.0  rhythm    pain  10  ; temp    heartrate  83.0  resprate  17.0  o2sat  100.0  sbp  149.0  dbp  100.0  rhythm    pain    $nan$multivitamins  1  tab ; 
major depressive disorder, single episode, unspecified long term (current) use of insulin gastroparesis gastro-esophageal reflux disease without esophagitis constipation, unspecified essential (primary) hypertension obesity, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified benign lipomatous neoplasm of skin and subcutaneous tissue of trunk dehydration personal history of other venous thrombosis and embolism anorexia type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy fibromyalgia body mass index (bmi) 38.0-38.9, adult anxiety disorder, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified type 2 diabetes mellitus with hyperglycemia patient's other noncompliance with medication regimen constipation, unspecified weakness gastro-esophageal reflux disease without esophagitis dyskinesia of esophagus obesity, unspecified hyperlipidemia, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema iron deficiency anemia, unspecified essential (primary) hypertension body mass index (bmi) 39.0-39.9, adult type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy mild protein-calorie malnutrition long term (current) use of insulin gastroparesis fibromyalgia long term (current) use of insulin type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy essential (primary) hypertension anemia, unspecified gastroparesis personal history of other venous thrombosis and embolism fibromyalgia abdominal pain, unspecified site obesity, unspecified myalgia and myositis, unspecified other acute pain other and unspecified hyperlipidemia unspecified essential hypertension mononeuritis of unspecified site
black african american f 41 $temp  98.4  heartrate  82.0  resprate  16.0  o2sat  100.0  sbp  133.0  dbp  93.0  rhythm    pain  8  ; temp    heartrate  86.0  resprate  21.0  o2sat  100.0  sbp  122.0  dbp  74.0  rhythm    pain  8  $hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  330  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  145  mg dl; chemistry blood lactate dehydrogenase (ld)  106  iu l; chemistry blood albumin  3.5  g dl; chemistry blood % hemoglobin a1c  10.4  %$multivitamins  1  tab ; influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  1000  ml ; ondansetron  4  mg ; ranitidine  150  mg ; magnesium oxide  400  mg ; senna  8.6  mg ; docusate sodium  100  mg ; tramadol  50  mg ; trazodone  50  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; duloxetine  60  mg ; lisinopril  5  mg ; lubiprostone  24  mcg ; mirtazapine  15  mg ; omeprazole  40  mg ; pregabalin  75  mg ; topiramate (topamax)  50  mg ; insulin  12  unit ; lorazepam  0.5  mg ; d5 1 2ns  1000  ml ; d5ns  1000  ml ; 
major depressive disorder, single episode, unspecified long term (current) use of insulin gastroparesis gastro-esophageal reflux disease without esophagitis constipation, unspecified essential (primary) hypertension obesity, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified benign lipomatous neoplasm of skin and subcutaneous tissue of trunk dehydration personal history of other venous thrombosis and embolism anorexia type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy fibromyalgia body mass index (bmi) 38.0-38.9, adult anxiety disorder, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified type 2 diabetes mellitus with hyperglycemia patient's other noncompliance with medication regimen constipation, unspecified weakness gastro-esophageal reflux disease without esophagitis dyskinesia of esophagus obesity, unspecified hyperlipidemia, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema iron deficiency anemia, unspecified essential (primary) hypertension body mass index (bmi) 39.0-39.9, adult type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy mild protein-calorie malnutrition long term (current) use of insulin gastroparesis fibromyalgia long term (current) use of insulin type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy essential (primary) hypertension anemia, unspecified gastroparesis personal history of other venous thrombosis and embolism fibromyalgia abdominal pain, unspecified site obesity, unspecified myalgia and myositis, unspecified other acute pain other and unspecified hyperlipidemia unspecified essential hypertension mononeuritis of unspecified site
black african american f 41 $nan$nan$multivitamins  1  tab ; influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  1000  ml ; ranitidine  150  mg ; magnesium oxide  400  mg ; senna  8.6  mg ; docusate sodium  100  mg ; tramadol  50  mg ; trazodone  50  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; duloxetine  60  mg ; lisinopril  5  mg ; lubiprostone  24  mcg ; mirtazapine  15  mg ; omeprazole  40  mg ; pregabalin  75  mg ; topiramate (topamax)  50  mg ; insulin  12  unit ; lorazepam  0.5  mg ; 
major depressive disorder, single episode, unspecified long term (current) use of insulin gastroparesis gastro-esophageal reflux disease without esophagitis constipation, unspecified essential (primary) hypertension obesity, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified benign lipomatous neoplasm of skin and subcutaneous tissue of trunk dehydration personal history of other venous thrombosis and embolism anorexia type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy fibromyalgia body mass index (bmi) 38.0-38.9, adult anxiety disorder, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified type 2 diabetes mellitus with hyperglycemia patient's other noncompliance with medication regimen constipation, unspecified weakness gastro-esophageal reflux disease without esophagitis dyskinesia of esophagus obesity, unspecified hyperlipidemia, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema iron deficiency anemia, unspecified essential (primary) hypertension body mass index (bmi) 39.0-39.9, adult type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy mild protein-calorie malnutrition long term (current) use of insulin gastroparesis fibromyalgia long term (current) use of insulin type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy essential (primary) hypertension anemia, unspecified gastroparesis personal history of other venous thrombosis and embolism fibromyalgia abdominal pain, unspecified site obesity, unspecified myalgia and myositis, unspecified other acute pain other and unspecified hyperlipidemia unspecified essential hypertension mononeuritis of unspecified site
black african american f 41 $nan$hematology blood inr(pt)  1.1  $multivitamins  1  tab ; influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; ranitidine  150  mg ; magnesium oxide  400  mg ; senna  8.6  mg ; docusate sodium  100  mg ; tramadol  50  mg ; trazodone  50  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; duloxetine  60  mg ; lisinopril  5  mg ; lubiprostone  24  mcg ; mirtazapine  15  mg ; omeprazole  40  mg ; pregabalin  75  mg ; topiramate (topamax)  50  mg ; atorvastatin  20  mg ; 
major depressive disorder, single episode, unspecified long term (current) use of insulin gastroparesis gastro-esophageal reflux disease without esophagitis constipation, unspecified essential (primary) hypertension obesity, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified benign lipomatous neoplasm of skin and subcutaneous tissue of trunk dehydration personal history of other venous thrombosis and embolism anorexia type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy fibromyalgia body mass index (bmi) 38.0-38.9, adult anxiety disorder, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified type 2 diabetes mellitus with hyperglycemia patient's other noncompliance with medication regimen constipation, unspecified weakness gastro-esophageal reflux disease without esophagitis dyskinesia of esophagus obesity, unspecified hyperlipidemia, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema iron deficiency anemia, unspecified essential (primary) hypertension body mass index (bmi) 39.0-39.9, adult type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy mild protein-calorie malnutrition long term (current) use of insulin gastroparesis fibromyalgia long term (current) use of insulin type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy essential (primary) hypertension anemia, unspecified gastroparesis personal history of other venous thrombosis and embolism fibromyalgia abdominal pain, unspecified site obesity, unspecified myalgia and myositis, unspecified other acute pain other and unspecified hyperlipidemia unspecified essential hypertension mononeuritis of unspecified site
black african american f 41 $nan$nan$multivitamins  1  tab ; influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; ranitidine  150  mg ; magnesium oxide  400  mg ; senna  8.6  mg ; docusate sodium  100  mg ; tramadol  50  mg ; trazodone  50  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; duloxetine  60  mg ; lisinopril  5  mg ; lubiprostone  24  mcg ; mirtazapine  15  mg ; omeprazole  40  mg ; pregabalin  75  mg ; topiramate (topamax)  50  mg ; atorvastatin  20  mg ; insulin  13  unit ; 
major depressive disorder, single episode, unspecified long term (current) use of insulin gastroparesis gastro-esophageal reflux disease without esophagitis constipation, unspecified essential (primary) hypertension obesity, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified benign lipomatous neoplasm of skin and subcutaneous tissue of trunk dehydration personal history of other venous thrombosis and embolism anorexia type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy fibromyalgia body mass index (bmi) 38.0-38.9, adult anxiety disorder, unspecified type 2 diabetes mellitus with diabetic neuropathy, unspecified type 2 diabetes mellitus with hyperglycemia patient's other noncompliance with medication regimen constipation, unspecified weakness gastro-esophageal reflux disease without esophagitis dyskinesia of esophagus obesity, unspecified hyperlipidemia, unspecified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema iron deficiency anemia, unspecified essential (primary) hypertension body mass index (bmi) 39.0-39.9, adult type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy mild protein-calorie malnutrition long term (current) use of insulin gastroparesis fibromyalgia long term (current) use of insulin type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy essential (primary) hypertension anemia, unspecified gastroparesis personal history of other venous thrombosis and embolism fibromyalgia abdominal pain, unspecified site obesity, unspecified myalgia and myositis, unspecified other acute pain other and unspecified hyperlipidemia unspecified essential hypertension mononeuritis of unspecified site
other m 83 $nan$hematology blood hematocrit  43.0  %; hematology blood hematocrit  39.8  %; hematology blood hemoglobin  14.9  g dl; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  175  k ul; hematology blood platelet count  163  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  4.2  g dl$aspirin  325  mg ; citalopram  30  mg ; isosorbide mononitrate (extended release)  30  mg ; cyanocobalamin  100  mcg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; trazodone  50  mg ; albuterol inhaler  2  puff ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; clindamycin  300  mg ; docusate sodium  100  mg ; mupirocin nasal ointment 2%  1  appl ; omeprazole  20  mg ; fluticasone propionate 110mcg  2  puff ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  2  tab ; simvastatin  40  mg ; 
 
other m 83 $nan$hematology blood hematocrit  34.5  %; hematology blood hematocrit  35.5  %; hematology blood hematocrit  37.2  %; hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.7  g dl; hematology blood hemoglobin  12.4  g dl; hematology blood hemoglobin  13.1  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  124  k ul; hematology blood platelet count  144  k ul; hematology blood platelet count  133  k ul; hematology blood platelet count  117  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  161  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  144  mg dl; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  1.02  mmol l; blood gas blood free calcium  1.24  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  2.6  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  2.8  mmol l; blood gas blood lactate  3.9  mmol l; blood gas blood lactate  3.8  mmol l; blood gas blood lactate  5.6  mmol l; blood gas blood lactate  4.4  mmol l; blood gas blood chloride, whole blood  96  meq l; blood gas blood chloride, whole blood  101  meq l; blood gas blood chloride, whole blood  102  meq l; blood gas blood chloride, whole blood  98  meq l; blood gas blood chloride, whole blood  100  meq l; blood gas blood glucose  97  mg dl; blood gas blood glucose  97  mg dl; blood gas blood glucose  130  mg dl; blood gas blood glucose  112  mg dl; blood gas blood glucose  110  mg dl; blood gas blood glucose  100  mg dl; blood gas blood glucose  87  mg dl; blood gas blood glucose  127  mg dl; blood gas blood glucose  126  mg dl; blood gas blood glucose  130  mg dl; blood gas blood glucose  118  mg dl; blood gas blood glucose  101  mg dl; blood gas blood hematocrit, calculated  40  %; blood gas blood hematocrit, calculated  37  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hematocrit, calculated  38  %; blood gas blood hematocrit, calculated  36  %; blood gas blood hemoglobin  13.3  g dl; blood gas blood hemoglobin  12.4  g dl; blood gas blood hemoglobin  11.6  g dl; blood gas blood hemoglobin  11.0  g dl; blood gas blood hemoglobin  12.8  g dl; blood gas blood hemoglobin  12.1  g dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  140  meq l; blood gas blood sodium, whole blood  140  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  133  meq l; blood gas blood sodium, whole blood  135  meq l$aspirin  325  mg ; isosorbide mononitrate (extended release)  30  mg ; cyanocobalamin  100  mcg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; trazodone  50  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; clindamycin  300  mg ; docusate sodium  100  mg ; mupirocin nasal ointment 2%  1  appl ; omeprazole  20  mg ; fluticasone propionate 110mcg  2  puff ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  2  tab ; simvastatin  40  mg ; aspirin ec  81  mg ; aspirin  81  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; 5% dextrose  250  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; oxycodone-acetaminophen  1-2  tab ; insulin human regular  100  unit ; ondansetron  4  mg ; phenylephrine  12  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium (liquid)  100  mg ; nitroprusside sodium  50  mg ; qvar  80  mcg ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; vial  1  vial ; pantoprazole  40  mg ; midazolam  1  mg ; vecuronium bromide  10  mg ; cisatracurium besylate  100  mg ; 0.9% sodium chloride  250  ml ; lactated ringers  500  ml ; 0.9% sodium chloride  500  ml ; 
 
other m 83 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  5.4  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  98  mg dl; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.04  mmol l; blood gas blood free calcium  1.23  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  5.5  mmol l; blood gas blood lactate  4.0  mmol l; blood gas blood lactate  3.5  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  4.6  mmol l; blood gas blood lactate  6.0  mmol l; blood gas blood lactate  5.0  mmol l; blood gas blood lactate  4.9  mmol l; blood gas blood lactate  5.7  mmol l; blood gas blood lactate  6.4  mmol l; blood gas blood glucose  95  mg dl; blood gas blood glucose  101  mg dl; blood gas blood glucose  83  mg dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  3.1  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  3.6  meq l$aspirin ec  81  mg ; aspirin  81  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; 5% dextrose  250  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; oxycodone-acetaminophen  1-2  tab ; insulin human regular  100  unit ; ondansetron  4  mg ; phenylephrine  12  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium (liquid)  100  mg ; nitroprusside sodium  50  mg ; qvar  80  mcg ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; vial  1  vial ; pantoprazole  40  mg ; midazolam  1  mg ; vecuronium bromide  10  mg ; cisatracurium besylate  100  mg ; 0.9% sodium chloride  250  ml ; lactated ringers  500  ml ; 0.9% sodium chloride  500  ml ; clopidogrel  75  mg ; sodium bicarbonate  50  meq ; lactated ringers  1000  ml ; 
 
other m 83 $nan$hematology blood hematocrit  37.2  %; hematology blood hematocrit  35.7  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  124  k ul; hematology blood platelet count  139  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood potassium  4.8  meq l; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  119  mg dl; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.30  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.28  mmol l; blood gas blood free calcium  0.84  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  0.5  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood glucose  95  mg dl; blood gas blood glucose  144  mg dl; blood gas blood glucose  94  mg dl; blood gas blood glucose  105  mg dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  5.2  meq l; blood gas blood potassium, whole blood  2.6  meq l$aspirin ec  81  mg ; aspirin  81  mg ; 5% dextrose  250  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; oxycodone-acetaminophen  1-2  tab ; insulin human regular  100  unit ; ondansetron  4  mg ; phenylephrine  12  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium (liquid)  100  mg ; nitroprusside sodium  50  mg ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  25  gm ; insulin  10  unit ; 
 
other m 83 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  89  mg dl; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.28  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.26  mmol l; blood gas blood free calcium  1.24  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood glucose  81  mg dl; blood gas blood glucose  81  mg dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  4.5  meq l$aspirin ec  81  mg ; aspirin  81  mg ; 5% dextrose  250  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; oxycodone-acetaminophen  1-2  tab ; insulin human regular  100  unit ; ondansetron  4  mg ; phenylephrine  12  mg ; docusate sodium (liquid)  100  mg ; nitroprusside sodium  50  mg ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  25  gm ; insulin  10  unit ; furosemide  20  mg ; amoxicillin  500  mg ; 
 
other m 83 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  9.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood glucose  80  mg dl; chemistry blood glucose  85  mg dl$aspirin ec  81  mg ; aspirin  81  mg ; 5% dextrose  250  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; oxycodone-acetaminophen  1-2  tab ; insulin human regular  100  unit ; ondansetron  4  mg ; phenylephrine  12  mg ; docusate sodium (liquid)  100  mg ; nitroprusside sodium  50  mg ; albuterol inhaler  6  puff ; ipratropium bromide mdi  6  puff ; vial  1  vial ; pantoprazole  40  mg ; furosemide  20  mg ; amoxicillin  500  mg ; metoprolol tartrate  12.5  mg ; metoprolol tartrate  25  mg ; 
 
other m 83 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  79  mg dl$aspirin ec  81  mg ; aspirin  81  mg ; 5% dextrose  250  ml ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; oxycodone-acetaminophen  1-2  tab ; insulin human regular  100  unit ; ondansetron  4  mg ; phenylephrine  12  mg ; nitroprusside sodium  50  mg ; vial  1  vial ; pantoprazole  40  mg ; citalopram  10  mg ; lansoprazole oral disintegrating tab  30  mg ; oxycodone-acetaminophen  1  tab ; metoprolol tartrate  50  mg ; haloperidol  2  mg ; trazodone  25  mg ; hydralazine  10  mg ; hydralazine  25  mg ; hydromorphone (dilaudid)  0.5  mg ; 
 
other m 83 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  24  mg dl$aspirin ec  81  mg ; 5% dextrose  250  ml ; sterile water  50  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; insulin human regular  100  unit ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; oxycodone-acetaminophen  1  tab ; hydralazine  10  mg ; hydralazine  25  mg ; citalopram  20  mg ; lisinopril  5  mg ; metoclopramide  5  mg ; 
 
other m 83 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry urine creatinine, urine  98  mg dl; chemistry blood glucose  102  mg dl; chemistry urine 24 hr creatinine  637  mg 24hr$sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; 5% dextrose  250  ml ; sterile water  50  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; insulin human regular  100  unit ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; oxycodone-acetaminophen  1  tab ; hydralazine  10  mg ; hydralazine  25  mg ; citalopram  20  mg ; lisinopril  5  mg ; metoclopramide  5  mg ; furosemide  40  mg ; glucagon  1  mg ; bisacodyl  10  mg ; heparin flush (10 units ml)  1  ml ; insulin  0  unit ; 
 
other m 83 $nan$hematology blood hematocrit  41.2  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  313  k ul; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  32  mg dl$furosemide  40  mg ; glucagon  1  mg ; bisacodyl  10  mg ; heparin flush (10 units ml)  1  ml ; insulin  0  unit ; lisinopril  10  mg ; influenza virus vaccine  0.5  ml ; 
 
other m 83 $nan$nan$glucagon  1  mg ; bisacodyl  10  mg ; heparin flush (10 units ml)  1  ml ; insulin  0  unit ; lisinopril  10  mg ; influenza virus vaccine  0.5  ml ; trazodone  75  mg ; furosemide  80  mg ; 
 
asian m 46 $nan$hematology blood hematocrit  42.2  %; hematology blood hematocrit  42.9  %; hematology blood hematocrit  37.0  %; hematology blood hematocrit  29.6  %; hematology blood hematocrit  32.3  %; hematology blood hematocrit  30.3  %; hematology blood hemoglobin  14.6  g dl; hematology blood hemoglobin  14.2  g dl; hematology blood hemoglobin  12.4  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  202  k ul; hematology blood platelet count  191  k ul; hematology blood platelet count  167  k ul; hematology blood platelet count  129  k ul; hematology blood platelet count  176  k ul; hematology blood platelet count  169  k ul; hematology blood platelet count  154  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.4  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, indirect  1.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  214  mg dl; chemistry blood albumin  4.4  g dl; chemistry blood albumin  2.9  g dl; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.01  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.25  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  0.99  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  3.5  mmol l; blood gas blood lactate  6.9  mmol l; blood gas blood lactate  5.0  mmol l; blood gas blood lactate  5.9  mmol l; blood gas blood lactate  5.4  mmol l; blood gas blood lactate  7.8  mmol l; blood gas blood lactate  6.1  mmol l; blood gas blood lactate  4.5  mmol l; chemistry blood bilirubin, direct  0.9  mg dl; blood gas blood chloride, whole blood  102  meq l; blood gas blood chloride, whole blood  106  meq l; blood gas blood chloride, whole blood  105  meq l; blood gas blood chloride, whole blood  105  meq l; blood gas blood chloride, whole blood  104  meq l; blood gas blood chloride, whole blood  105  meq l; blood gas blood chloride, whole blood  106  meq l; blood gas blood glucose  104  mg dl; blood gas blood glucose  186  mg dl; blood gas blood glucose  176  mg dl; blood gas blood glucose  147  mg dl; blood gas blood glucose  167  mg dl; blood gas blood glucose  195  mg dl; blood gas blood glucose  204  mg dl; blood gas blood hematocrit, calculated  47  %; blood gas blood hematocrit, calculated  41  %; blood gas blood hematocrit, calculated  43  %; blood gas blood hematocrit, calculated  41  %; blood gas blood hematocrit, calculated  39  %; blood gas blood hematocrit, calculated  36  %; blood gas blood hematocrit, calculated  34  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  15.7  g dl; blood gas blood hemoglobin  13.5  g dl; blood gas blood hemoglobin  14.2  g dl; blood gas blood hemoglobin  13.6  g dl; blood gas blood hemoglobin  13.0  g dl; blood gas blood hemoglobin  12.0  g dl; blood gas blood hemoglobin  11.2  g dl; blood gas blood hemoglobin  10.6  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  6.1  meq l; blood gas blood sodium, whole blood  140  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood sodium, whole blood  138  meq l; hematology urine glucose  neg  mg dl; blood gas blood carboxyhemoglobin  0.1  %; hematology urine bilirubin  neg  mg dl$0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  gm ; fluconazole  400  mg ; 0.9% sodium chloride  50  ml ; methylprednisolone sodium succ  500  mg ; mycophenolate mofetil  1000  mg ; heparin  5000  unit ; hepatitis b immu glob (hepagam b)  10,000  unit ; sulfameth trimethoprim suspension  10  ml ; valganciclovir suspension  450  mg ; tenofovir disoproxil (viread)  300  mg ; sodium chloride 0.9%  flush  10  ml ; d5 1 2ns  1000  ml ; morphine sulfate  1-4  mg ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; mycophenolate mofetil suspension  1000  mg ; 1 2 ns  1000  ml ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta other hamartoses, not elsewhere classified unspecified essential hypertension malignant neoplasm of liver, primary
asian m 46 $nan$hematology blood hematocrit  30.8  %; hematology blood hematocrit  28.5  %; hematology blood hematocrit  28.6  %; hematology blood hematocrit  28.7  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  167  k ul; hematology blood platelet count  133  k ul; hematology blood platelet count  132  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  242  mg dl; chemistry blood glucose  170  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  861  iu l; chemistry blood albumin  3.0  g dl; chemistry blood albumin  2.9  g dl; blood gas blood free calcium  1.15  mmol l; blood gas blood lactate  4.4  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  1.7  mmol l$hepatitis b immu glob (hepagam b)  10,000  unit ; valganciclovir suspension  450  mg ; tenofovir disoproxil (viread)  300  mg ; sodium chloride 0.9%  flush  10  ml ; d5 1 2ns  1000  ml ; morphine sulfate  1-4  mg ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; mycophenolate mofetil suspension  1000  mg ; 1 2 ns  1000  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; 0.9% sodium chloride  500  ml ; methylprednisolone sodium succ  200  mg ; 0.9% sodium chloride  25  ml ; hepatitis b immu glob (hepagam b)  5000  unit ; tacrolimus  2  mg ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta other hamartoses, not elsewhere classified unspecified essential hypertension malignant neoplasm of liver, primary
asian m 46 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  112  k ul; hematology blood platelet count  122  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  81  mg dl; chemistry blood glucose  116  mg dl$valganciclovir suspension  450  mg ; tenofovir disoproxil (viread)  300  mg ; sodium chloride 0.9%  flush  10  ml ; d5 1 2ns  1000  ml ; morphine sulfate  1-4  mg ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; mycophenolate mofetil suspension  1000  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; methylprednisolone sodium succ  200  mg ; tacrolimus  2  mg ; valganciclovir  900  mg ; sulfameth trimethoprim ss  1  tab ; insulin  35  unit ; insulin  0  unit ; furosemide  20  mg ; insulin  20  unit ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta other hamartoses, not elsewhere classified unspecified essential hypertension malignant neoplasm of liver, primary
asian m 46 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  120  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  125  mg dl$tenofovir disoproxil (viread)  300  mg ; sodium chloride 0.9%  flush  10  ml ; morphine sulfate  1-4  mg ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; valganciclovir  900  mg ; sulfameth trimethoprim ss  1  tab ; furosemide  20  mg ; insulin  20  unit ; methylprednisolone sodium succ  100  mg ; morphine sulfate ir  15  mg ; heparin flush (10 units ml)  1  ml ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta other hamartoses, not elsewhere classified unspecified essential hypertension malignant neoplasm of liver, primary
asian m 46 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  135  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  104  mg dl; chemistry blood albumin  3.2  g dl$tenofovir disoproxil (viread)  300  mg ; sodium chloride 0.9%  flush  10  ml ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; valganciclovir  900  mg ; sulfameth trimethoprim ss  1  tab ; methylprednisolone sodium succ  100  mg ; morphine sulfate ir  15  mg ; heparin flush (10 units ml)  1  ml ; methylprednisolone sodium succ  70  mg ; transplant self medication program  1  bag ; tacrolimus  0.5  mg ; insulin  14  unit ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta other hamartoses, not elsewhere classified unspecified essential hypertension malignant neoplasm of liver, primary
asian m 46 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  109  mg dl; chemistry blood albumin  3.6  g dl$tenofovir disoproxil (viread)  300  mg ; sodium chloride 0.9%  flush  10  ml ; prochlorperazine  5-10  mg ; ondansetron  4  mg ; morphine sulfate ir  15  mg ; heparin flush (10 units ml)  1  ml ; methylprednisolone sodium succ  70  mg ; transplant self medication program  1  bag ; tacrolimus  0.5  mg ; insulin  14  unit ; prednisone  35  mg ; tacrolimus  5  mg ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta other hamartoses, not elsewhere classified unspecified essential hypertension malignant neoplasm of liver, primary
white f 91 $temp    heartrate  78.0  resprate  15.0  o2sat  97.0  sbp  173.0  dbp  71.0  rhythm    pain    ; temp    heartrate  80.0  resprate  16.0  o2sat  96.0  sbp  179.0  dbp  69.0  rhythm    pain    $nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; carvedilol  6.25  mg ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  50  mcg ; valsartan  160  mg ; aspirin  81  mg ; citalopram  20  mg ; heparin  5000  unit ; 
hyperlipidemia, unspecified deficiency of other specified b group vitamins presence of coronary angioplasty implant and graft unspecified urinary incontinence vitamin d deficiency, unspecified hypothyroidism, unspecified myalgia shortness of breath constipation, unspecified chronic systolic (congestive) heart failure type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene hypertensive heart disease with heart failure aneurysm of artery of lower extremity personal history of methicillin resistant staphylococcus aureus infection atherosclerotic heart disease of native coronary artery without angina pectoris disorientation, unspecified major depressive disorder, single episode, unspecified cough old myocardial infarction unspecified urinary incontinence adverse effect of loop [high-ceiling] diuretics, initial encounter hyperlipidemia, unspecified hypoxemia hypotension, unspecified peripheral vascular disease, unspecified infection following a procedure, initial encounter unspecified dementia without behavioral disturbance hypertensive heart disease with heart failure major depressive disorder, single episode, unspecified old myocardial infarction unspecified osteoarthritis, unspecified site atherosclerotic heart disease of native coronary artery without angina pectoris acute on chronic systolic (congestive) heart failure presence of coronary angioplasty implant and graft patient room in hospital as the place of occurrence of the external cause hypertensive urgency patient's noncompliance with dietary regimen unspecified place or not applicable acute kidney failure, unspecified cellulitis of right lower limb delirium due to known physiological condition hypothyroidism, unspecified unspecified place or not applicable essential (primary) hypertension presence of coronary angioplasty implant and graft hypothyroidism, unspecified surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure peripheral vascular angioplasty status with implants and grafts
white f 91 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; carvedilol  6.25  mg ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  50  mcg ; valsartan  160  mg ; aspirin  81  mg ; citalopram  20  mg ; heparin  5000  unit ; atorvastatin  40  mg ; senna  8.6  mg ; 
hyperlipidemia, unspecified deficiency of other specified b group vitamins presence of coronary angioplasty implant and graft unspecified urinary incontinence vitamin d deficiency, unspecified hypothyroidism, unspecified myalgia shortness of breath constipation, unspecified chronic systolic (congestive) heart failure type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene hypertensive heart disease with heart failure aneurysm of artery of lower extremity personal history of methicillin resistant staphylococcus aureus infection atherosclerotic heart disease of native coronary artery without angina pectoris disorientation, unspecified major depressive disorder, single episode, unspecified cough old myocardial infarction unspecified urinary incontinence adverse effect of loop [high-ceiling] diuretics, initial encounter hyperlipidemia, unspecified hypoxemia hypotension, unspecified peripheral vascular disease, unspecified infection following a procedure, initial encounter unspecified dementia without behavioral disturbance hypertensive heart disease with heart failure major depressive disorder, single episode, unspecified old myocardial infarction unspecified osteoarthritis, unspecified site atherosclerotic heart disease of native coronary artery without angina pectoris acute on chronic systolic (congestive) heart failure presence of coronary angioplasty implant and graft patient room in hospital as the place of occurrence of the external cause hypertensive urgency patient's noncompliance with dietary regimen unspecified place or not applicable acute kidney failure, unspecified cellulitis of right lower limb delirium due to known physiological condition hypothyroidism, unspecified unspecified place or not applicable essential (primary) hypertension presence of coronary angioplasty implant and graft hypothyroidism, unspecified surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure peripheral vascular angioplasty status with implants and grafts
white f 91 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; carvedilol  6.25  mg ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  50  mcg ; valsartan  160  mg ; aspirin  81  mg ; citalopram  20  mg ; heparin  5000  unit ; atorvastatin  40  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
hyperlipidemia, unspecified deficiency of other specified b group vitamins presence of coronary angioplasty implant and graft unspecified urinary incontinence vitamin d deficiency, unspecified hypothyroidism, unspecified myalgia shortness of breath constipation, unspecified chronic systolic (congestive) heart failure type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene hypertensive heart disease with heart failure aneurysm of artery of lower extremity personal history of methicillin resistant staphylococcus aureus infection atherosclerotic heart disease of native coronary artery without angina pectoris disorientation, unspecified major depressive disorder, single episode, unspecified cough old myocardial infarction unspecified urinary incontinence adverse effect of loop [high-ceiling] diuretics, initial encounter hyperlipidemia, unspecified hypoxemia hypotension, unspecified peripheral vascular disease, unspecified infection following a procedure, initial encounter unspecified dementia without behavioral disturbance hypertensive heart disease with heart failure major depressive disorder, single episode, unspecified old myocardial infarction unspecified osteoarthritis, unspecified site atherosclerotic heart disease of native coronary artery without angina pectoris acute on chronic systolic (congestive) heart failure presence of coronary angioplasty implant and graft patient room in hospital as the place of occurrence of the external cause hypertensive urgency patient's noncompliance with dietary regimen unspecified place or not applicable acute kidney failure, unspecified cellulitis of right lower limb delirium due to known physiological condition hypothyroidism, unspecified unspecified place or not applicable essential (primary) hypertension presence of coronary angioplasty implant and graft hypothyroidism, unspecified surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure peripheral vascular angioplasty status with implants and grafts
white f 83 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.4  ; hematology blood inr(pt)  2.3  ; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ipratropium bromide neb  1  neb ; metoprolol tartrate  50  mg ; pantoprazole  40  mg ; morphine sulfate  2-4  mg ; nitroglycerin sl  0.4  mg ; milk of magnesia  30  ml ; atorvastatin  80  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium  100  mg ; furosemide  20  mg ; potassium chloride  20  meq ; heparin  5000  unit ; gabapentin  300  mg ; ropinirole  0.5  mg ; warfarin  0.5  mg ; colchicine  0.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; aspirin ec  81  mg ; lisinopril  10  mg ; ibuprofen  600  mg ; cyclobenzaprine  5  mg ; warfarin  1  dose ; 
unspecified hereditary and idiopathic peripheral neuropathy other complications due to other cardiac device, implant, and graft coronary atherosclerosis of native coronary artery asthma, unspecified type, unspecified anxiety state, unspecified intermediate coronary syndrome unspecified essential hypertension barrett's esophagus acute venous embolism and thrombosis of unspecified deep vessels of lower extremity other and unspecified hyperlipidemia depressive disorder, not elsewhere classified acquired absence of intestine (large) (small) restless legs syndrome (rls) iron deficiency anemia, unspecified personal history of malignant neoplasm of large intestine 
white f 83 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ipratropium bromide neb  1  neb ; metoprolol tartrate  50  mg ; pantoprazole  40  mg ; morphine sulfate  2-4  mg ; nitroglycerin sl  0.4  mg ; milk of magnesia  30  ml ; atorvastatin  80  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium  100  mg ; furosemide  20  mg ; potassium chloride  20  meq ; gabapentin  300  mg ; ropinirole  0.5  mg ; aspirin ec  81  mg ; lisinopril  10  mg ; ibuprofen  600  mg ; cyclobenzaprine  5  mg ; warfarin  1  dose ; 
unspecified hereditary and idiopathic peripheral neuropathy other complications due to other cardiac device, implant, and graft coronary atherosclerosis of native coronary artery asthma, unspecified type, unspecified anxiety state, unspecified intermediate coronary syndrome unspecified essential hypertension barrett's esophagus acute venous embolism and thrombosis of unspecified deep vessels of lower extremity other and unspecified hyperlipidemia depressive disorder, not elsewhere classified acquired absence of intestine (large) (small) restless legs syndrome (rls) iron deficiency anemia, unspecified personal history of malignant neoplasm of large intestine 
black african american m 47 $temp  98.2  heartrate  97.0  resprate  18.0  o2sat  97.0  sbp  130.0  dbp  94.0  rhythm    pain  0  $hematology blood hematocrit  42.7  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  120  mg dl; chemistry blood lactate dehydrogenase (ld)  146  iu l$bag  350  ml ; gammagard liquid  35  g ; acetaminophen  650  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; 
 
black african american m 47 $nan$hematology blood hematocrit  44.1  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  113  mg dl$bag  350  ml ; gammagard liquid  35  g ; acetaminophen  650  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; 
 
black african american m 47 $nan$hematology blood hematocrit  44.0  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  100  mg dl$bag  350  ml ; gammagard liquid  35  g ; acetaminophen  650  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; 
 
black african american m 47 $nan$chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  96  mg dl$bag  350  ml ; gammagard liquid  35  g ; acetaminophen  650  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; 
 
black african american m 47 $nan$hematology blood hematocrit  42.0  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  112  mg dl$bag  350  ml ; gammagard liquid  35  g ; acetaminophen  650  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; bisacodyl  10  mg ; prochlorperazine  10  mg ; tramadol  50  mg ; 
 
black african american m 47 $nan$hematology blood hematocrit  43.9  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  91  mg dl$bag  350  ml ; gammagard liquid  35  g ; acetaminophen  650  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; bisacodyl  10  mg ; prochlorperazine  10  mg ; tramadol  50  mg ; lidocaine jelly 2% (glydo)  1  appl ; ondansetron  4  mg ; fleet enema (mineral oil)  1  enema ; 
 
black african american m 47 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; prochlorperazine  10  mg ; lidocaine jelly 2% (glydo)  1  appl ; ondansetron  4  mg ; fleet enema (saline)  1  enema ; 
 
black african american f 32 $temp  98.1  heartrate  90.0  resprate  12.0  o2sat  98.0  sbp  118.0  dbp  77.0  rhythm    pain  8  ; temp    heartrate  88.0  resprate  15.0  o2sat  96.0  sbp  111.0  dbp  81.0  rhythm    pain    ; temp    heartrate  91.0  resprate  12.0  o2sat  97.0  sbp  124.0  dbp  93.0  rhythm    pain    ; temp  98.1  heartrate  90.0  resprate  12.0  o2sat  95.0  sbp  110.0  dbp  65.0  rhythm    pain  0  $hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  414  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  110  mg dl; chemistry blood lactate dehydrogenase (ld)  703  iu l; blood gas blood lactate  2.6  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood potassium, whole blood  4.5  meq l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; morphine sulfate  2-4  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; guaifenesin  5-10  ml ; ipratropium-albuterol neb  1  neb ; ondansetron  4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; folic acid  1  mg ; sertraline  100  mg ; lactated ringers  1000  ml ; 
allergic rhinitis, unspecified unspecified place or not applicable obstructive sleep apnea (adult) (pediatric) major depressive disorder, single episode, unspecified anxiety disorder, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits postprocedural seroma of a musculoskeletal structure following a musculoskeletal system procedure presence of left artificial hip joint other acute postprocedural pain fever, unspecified atelectasis hb-ss disease with crisis, unspecified essential (primary) hypertension splenomegaly, not elsewhere classified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits body mass index (bmi) 35.0-35.9, adult anxiety disorder, unspecified presence of right artificial hip joint sickle-cell disease without crisis hypomagnesemia osteonecrosis in diseases classified elsewhere, left thigh other pruritus obstructive sleep apnea (adult) (pediatric) obesity, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew unilateral primary osteoarthritis, left hip osteonecrosis, unspecified family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism sickle-cell disease without crisis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits body mass index (bmi) 35.0-35.9, adult unilateral primary osteoarthritis, right hip splenomegaly, not elsewhere classified obesity, unspecified obstructive sleep apnea (adult) (pediatric) acute posthemorrhagic anemia 
black african american f 32 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  412  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  228  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; morphine sulfate  2-4  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; guaifenesin  5-10  ml ; ipratropium-albuterol neb  1  neb ; ondansetron  4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; folic acid  1  mg ; sertraline  100  mg ; amoxicillin-clavulanic acid  875  mg ; 
allergic rhinitis, unspecified unspecified place or not applicable obstructive sleep apnea (adult) (pediatric) major depressive disorder, single episode, unspecified anxiety disorder, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits postprocedural seroma of a musculoskeletal structure following a musculoskeletal system procedure presence of left artificial hip joint other acute postprocedural pain fever, unspecified atelectasis hb-ss disease with crisis, unspecified essential (primary) hypertension splenomegaly, not elsewhere classified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits body mass index (bmi) 35.0-35.9, adult anxiety disorder, unspecified presence of right artificial hip joint sickle-cell disease without crisis hypomagnesemia osteonecrosis in diseases classified elsewhere, left thigh other pruritus obstructive sleep apnea (adult) (pediatric) obesity, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew unilateral primary osteoarthritis, left hip osteonecrosis, unspecified family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism sickle-cell disease without crisis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits body mass index (bmi) 35.0-35.9, adult unilateral primary osteoarthritis, right hip splenomegaly, not elsewhere classified obesity, unspecified obstructive sleep apnea (adult) (pediatric) acute posthemorrhagic anemia 
black african american f 32 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; morphine sulfate  2-4  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; guaifenesin  5-10  ml ; ipratropium-albuterol neb  1  neb ; ondansetron  4  mg ; folic acid  1  mg ; sertraline  100  mg ; amoxicillin-clavulanic acid  875  mg ; 
allergic rhinitis, unspecified unspecified place or not applicable obstructive sleep apnea (adult) (pediatric) major depressive disorder, single episode, unspecified anxiety disorder, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits postprocedural seroma of a musculoskeletal structure following a musculoskeletal system procedure presence of left artificial hip joint other acute postprocedural pain fever, unspecified atelectasis hb-ss disease with crisis, unspecified essential (primary) hypertension splenomegaly, not elsewhere classified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits body mass index (bmi) 35.0-35.9, adult anxiety disorder, unspecified presence of right artificial hip joint sickle-cell disease without crisis hypomagnesemia osteonecrosis in diseases classified elsewhere, left thigh other pruritus obstructive sleep apnea (adult) (pediatric) obesity, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew unilateral primary osteoarthritis, left hip osteonecrosis, unspecified family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism sickle-cell disease without crisis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits body mass index (bmi) 35.0-35.9, adult unilateral primary osteoarthritis, right hip splenomegaly, not elsewhere classified obesity, unspecified obstructive sleep apnea (adult) (pediatric) acute posthemorrhagic anemia 
white f 44 $nan$nan$emtricitabine-tenofovir (truvada)  1  tab ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  73  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  8.6  mg dl; chemistry blood glucose  87  mg dl; chemistry blood albumin  1.9  g dl$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  250  mg ; clotrimazole  1  troc ; lactulose  30  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; furosemide  60  mg ; spironolactone  200  mg ; magnesium oxide  400  mg ; furosemide  80  mg ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  57  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  7.2  mg dl; chemistry blood glucose  118  mg dl; chemistry blood albumin  1.6  g dl$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; clotrimazole  1  troc ; lactulose  30  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; magnesium oxide  400  mg ; furosemide  80  mg ; trazodone  25  mg ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood bilirubin, total  8.9  mg dl; chemistry blood glucose  84  mg dl; hematology blood wbc count  9.6  k ul$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; clotrimazole  1  troc ; lactulose  30  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; magnesium oxide  400  mg ; furosemide  80  mg ; trazodone  25  mg ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  49  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  123  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  87  mg dl$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; clotrimazole  1  troc ; lactulose  30  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; magnesium oxide  400  mg ; furosemide  80  mg ; trazodone  25  mg ; tolvaptan  15  mg ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  70  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  8.3  mg dl; chemistry blood glucose  90  mg dl; chemistry blood albumin  1.7  g dl$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; lactulose  30  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; magnesium oxide  400  mg ; trazodone  25  mg ; tolvaptan  15  mg ; simethicone  40-80  mg ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  63  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  8.1  mg dl; chemistry blood glucose  121  mg dl; chemistry blood albumin  2.4  g dl$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; lactulose  30  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; magnesium oxide  400  mg ; trazodone  25  mg ; tolvaptan  15  mg ; simethicone  40-80  mg ; albumin 25% (12.5g   50ml)  25  g ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  64  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  77  mg dl$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; lactulose  30  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; magnesium oxide  400  mg ; trazodone  25  mg ; tolvaptan  15  mg ; simethicone  40-80  mg ; albumin 25% (12.5g   50ml)  25  g ; furosemide  40  mg ; spironolactone  100  mg ; neutra-phos  2  pkt ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$hematology blood hematocrit  21.5  %; hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  55  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  10.3  mg dl; chemistry blood glucose  77  mg dl; chemistry blood albumin  2.7  g dl$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; magnesium oxide  400  mg ; trazodone  25  mg ; tolvaptan  15  mg ; simethicone  40-80  mg ; albumin 25% (12.5g   50ml)  25  g ; furosemide  40  mg ; spironolactone  100  mg ; neutra-phos  2  pkt ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$hematology blood hematocrit  22.2  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  60  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, indirect  6.7  mg dl; chemistry blood bilirubin, total  11.9  mg dl; chemistry blood glucose  70  mg dl; chemistry blood lactate dehydrogenase (ld)  254  iu l; chemistry blood albumin  2.7  g dl; chemistry blood bilirubin, direct  5.2  mg dl$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; magnesium oxide  400  mg ; trazodone  25  mg ; tolvaptan  15  mg ; simethicone  40-80  mg ; furosemide  40  mg ; spironolactone  100  mg ; lactulose  15  ml ; hydroxyzine  50  mg ; sarna lotion  1  appl ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  62  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  11.4  mg dl; chemistry blood glucose  81  mg dl; chemistry blood albumin  2.6  g dl$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; magnesium oxide  400  mg ; trazodone  25  mg ; tolvaptan  15  mg ; simethicone  40-80  mg ; furosemide  40  mg ; spironolactone  100  mg ; lactulose  15  ml ; hydroxyzine  50  mg ; sarna lotion  1  appl ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  51  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  11.9  mg dl; chemistry blood glucose  72  mg dl; chemistry blood albumin  2.9  g dl$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; magnesium oxide  400  mg ; trazodone  25  mg ; tolvaptan  15  mg ; simethicone  40-80  mg ; furosemide  40  mg ; spironolactone  100  mg ; lactulose  15  ml ; hydroxyzine  50  mg ; sarna lotion  1  appl ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  63  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  10.5  mg dl; chemistry blood glucose  72  mg dl; chemistry blood lactate dehydrogenase (ld)  290  iu l; chemistry blood albumin  2.6  g dl$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; magnesium oxide  400  mg ; trazodone  25  mg ; tolvaptan  15  mg ; simethicone  40-80  mg ; furosemide  40  mg ; spironolactone  100  mg ; lactulose  15  ml ; hydroxyzine  50  mg ; sarna lotion  1  appl ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  54  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  9.5  mg dl; chemistry blood glucose  104  mg dl$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; magnesium oxide  400  mg ; trazodone  25  mg ; tolvaptan  15  mg ; simethicone  40-80  mg ; furosemide  40  mg ; spironolactone  100  mg ; lactulose  15  ml ; hydroxyzine  50  mg ; sarna lotion  1  appl ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  53  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  9.5  mg dl; chemistry blood glucose  91  mg dl; chemistry blood albumin  2.4  g dl$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; magnesium oxide  400  mg ; trazodone  25  mg ; tolvaptan  15  mg ; simethicone  40-80  mg ; furosemide  40  mg ; spironolactone  100  mg ; lactulose  15  ml ; hydroxyzine  50  mg ; sarna lotion  1  appl ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  55  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  9.3  mg dl; chemistry blood glucose  80  mg dl; chemistry blood albumin  2.4  g dl$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; magnesium oxide  400  mg ; trazodone  25  mg ; tolvaptan  15  mg ; simethicone  40-80  mg ; furosemide  40  mg ; spironolactone  100  mg ; lactulose  15  ml ; hydroxyzine  50  mg ; sarna lotion  1  appl ; furosemide  20  mg ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 44 $nan$nan$emtricitabine-tenofovir (truvada)  1  tab ; sodium chloride 0.9%  flush  3  ml ; raltegravir  400  mg ; ascorbic acid  1000  mg ; calcium carbonate  500  mg ; vitamin d  400  unit ; magnesium oxide  400  mg ; trazodone  25  mg ; tolvaptan  15  mg ; simethicone  40-80  mg ; spironolactone  100  mg ; lactulose  15  ml ; hydroxyzine  50  mg ; sarna lotion  1  appl ; furosemide  20  mg ; 
diarrhea chronic hepatitis c without mention of hepatic coma other specified forms of effusion, except tuberculous asymptomatic human immunodeficiency virus [hiv] infection status cirrhosis of liver without mention of alcohol awaiting organ transplant status pulmonary collapse tachycardia, unspecified other ascites anemia of other chronic disease hyposmolality and/or hyponatremia pulmonary collapse other sequelae of chronic liver disease unspecified pleural effusion human immunodeficiency virus [hiv] disease unspecified viral hepatitis c without hepatic coma hyposmolality and/or hyponatremia chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status acute kidney failure, unspecified other diseases of lung, not elsewhere classified acute posthemorrhagic anemia cirrhosis of liver without mention of alcohol other specified forms of effusion, except tuberculous unspecified pleural effusion hemorrhage complicating a procedure other ascites cirrhosis of liver without mention of alcohol unspecified pleural effusion chronic hepatitis c without mention of hepatic coma asymptomatic human immunodeficiency virus [hiv] infection status awaiting organ transplant status anemia, unspecified hyposmolality and/or hyponatremia
white f 68 $temp  97.2  heartrate  77.0  resprate  15.0  o2sat  100.0  sbp  168.0  dbp  72.0  rhythm    pain  0  ; temp    heartrate  72.0  resprate  16.0  o2sat  100.0  sbp  142.0  dbp  81.0  rhythm    pain  4  ; temp    heartrate  68.0  resprate  12.0  o2sat  97.0  sbp  140.0  dbp  78.0  rhythm    pain  4  ; temp    heartrate  75.0  resprate  20.0  o2sat  100.0  sbp  142.0  dbp  75.0  rhythm    pain  4  $nan$aspirin  81  mg ; lisinopril  20  mg ; topiramate (topamax)  200  mg ; venlafaxine  150  mg ; 
 
white f 68 $temp    heartrate  72.0  resprate  16.0  o2sat  100.0  sbp  150.0  dbp  80.0  rhythm    pain  1 10  ; temp    heartrate  72.0  resprate  18.0  o2sat  100.0  sbp  153.0  dbp  78.0  rhythm    pain  0 10  $hematology blood hematocrit  44.5  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood glucose  90  mg dl$aspirin  81  mg ; lisinopril  20  mg ; topiramate (topamax)  200  mg ; venlafaxine  150  mg ; warfarin  5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; carbidopa-levodopa (25-100)  1  tab ; clobetasol propionate 0.05% ointment  1  appl ; albuterol inhaler  1  puff ; levothyroxine sodium  150  mcg ; levothyroxine sodium  75  mcg ; 
 
white f 68 $nan$nan$aspirin  81  mg ; lisinopril  20  mg ; topiramate (topamax)  200  mg ; venlafaxine  150  mg ; warfarin  5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; carbidopa-levodopa (25-100)  1  tab ; clobetasol propionate 0.05% ointment  1  appl ; albuterol inhaler  1  puff ; levothyroxine sodium  150  mcg ; levothyroxine sodium  75  mcg ; 
 
hispanic latino m 75 $temp  98.2  heartrate  64.0  resprate  17.0  o2sat  94.0  sbp  149.0  dbp  71.0  rhythm    pain  0  ; temp    heartrate  64.0  resprate  24.0  o2sat  96.0  sbp  176.0  dbp  76.0  rhythm    pain  0  ; temp  98.1  heartrate  61.0  resprate  21.0  o2sat  97.0  sbp  160.0  dbp  53.0  rhythm    pain  0  ; temp    heartrate  58.0  resprate  22.0  o2sat  98.0  sbp  158.0  dbp  56.0  rhythm    pain  0  ; temp    heartrate  57.0  resprate  21.0  o2sat  99.0  sbp  153.0  dbp  89.0  rhythm    pain  0  $hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  3.7  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  94  mg dl; chemistry blood albumin  4.0  g dl; blood gas blood potassium, whole blood  4.7  meq l; chemistry blood % hemoglobin a1c  5.0  %$nan
hyperlipidemia, unspecified end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease unspecified asthma, uncomplicated rheumatic disorders of both mitral and aortic valves long term (current) use of antithrombotics/antiplatelets hyperparathyroidism, unspecified heart failure, unspecified fluid overload, unspecified dependence on renal dialysis unspecified atrial fibrillation kidney transplant status chest pain, unspecified presence of coronary angioplasty implant and graft hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease rheumatic disorders of both mitral and aortic valves long term (current) use of antithrombotics/antiplatelets end stage renal disease dependence on renal dialysis atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified end stage renal disease hyperparathyroidism, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease gout, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris dependence on renal dialysis other chest pain interstitial pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified unspecified atrial fibrillation rheumatic disorders of both mitral and aortic valves shortness of breath anemia, unspecified presence of coronary angioplasty implant and graft other forms of acute ischemic heart disease anemia in other chronic diseases classified elsewhere hypocalcemia other and unspecified fall in water transport injuring occupant of small boat, powered melena atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of antithrombotics/antiplatelets chronic diastolic (congestive) heart failure rheumatic disorders of both mitral and aortic valves
hispanic latino m 75 $temp    heartrate  57.0  resprate  18.0  o2sat  97.0  sbp  147.0  dbp  58.0  rhythm    pain  0  $hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  4.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  187  iu l; chemistry blood albumin  3.7  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; atorvastatin  80  mg ; nephrocaps  1  cap ; clopidogrel  75  mg ; sevelamer carbonate  2400  mg ; cinacalcet  60  mg ; aspirin  81  mg ; metoprolol tartrate  12.5  mg ; ranitidine  300  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; allopurinol  100  mg ; docusate sodium  100  mg ; ipratropium-albuterol inhalation spray  1  inh ; montelukast  10  mg ; senna  17.2  mg ; naphazoline-pheniramine ophth. solution  1  drop ; digoxin  0.0625  mg ; 
hyperlipidemia, unspecified end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease unspecified asthma, uncomplicated rheumatic disorders of both mitral and aortic valves long term (current) use of antithrombotics/antiplatelets hyperparathyroidism, unspecified heart failure, unspecified fluid overload, unspecified dependence on renal dialysis unspecified atrial fibrillation kidney transplant status chest pain, unspecified presence of coronary angioplasty implant and graft hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease rheumatic disorders of both mitral and aortic valves long term (current) use of antithrombotics/antiplatelets end stage renal disease dependence on renal dialysis atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified end stage renal disease hyperparathyroidism, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease gout, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris dependence on renal dialysis other chest pain interstitial pulmonary disease, unspecified long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified unspecified atrial fibrillation rheumatic disorders of both mitral and aortic valves shortness of breath anemia, unspecified presence of coronary angioplasty implant and graft other forms of acute ischemic heart disease anemia in other chronic diseases classified elsewhere hypocalcemia other and unspecified fall in water transport injuring occupant of small boat, powered melena atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of antithrombotics/antiplatelets chronic diastolic (congestive) heart failure rheumatic disorders of both mitral and aortic valves
hispanic latino f 65 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  84  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  119  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood glucose  610  mg dl$nan
pure hypercholesterolemia unspecified essential hypertension chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified chest pain, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status esophageal reflux other and unspecified hyperlipidemia congestive heart failure, unspecified other and unspecified hyperlipidemia iron deficiency anemia, unspecified coronary atherosclerosis of native coronary artery chronic systolic heart failure esophageal reflux chest pain, unspecified disturbance of skin sensation depressive disorder, not elsewhere classified tachycardia, unspecified shortness of breath diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other primary cardiomyopathies coronary atherosclerosis of native coronary artery other left bundle branch block chest pain, unspecified unspecified essential hypertension shortness of breath hyposmolality and/or hyponatremia chest pain, unspecified coronary atherosclerosis of native coronary artery hyposmolality and/or hyponatremia congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia, unspecified chronic systolic heart failure alcohol abuse, unspecified depressive disorder, not elsewhere classified nonspecific abnormal electrocardiogram [ecg] [ekg] chest pain, unspecified other chest pain alcohol abuse, unspecified nonspecific abnormal electrocardiogram [ecg] [ekg] coronary atherosclerosis of native coronary artery systolic heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled unspecified essential hypertension
hispanic latino f 65 $temp  97.5  heartrate  86.0  resprate  18.0  o2sat  99.0  sbp  135.0  dbp  88.0  rhythm    pain    ; temp  97.5  heartrate  102.0  resprate  16.0  o2sat  100.0  sbp  161.0  dbp  108.0  rhythm    pain    ; temp  97.7  heartrate  108.0  resprate  24.0  o2sat  97.0  sbp  156.0  dbp  93.0  rhythm    pain  0  ; temp  98.2  heartrate  112.0  resprate  20.0  o2sat  96.0  sbp  171.0  dbp  117.0  rhythm    pain  0  ; temp  98.6  heartrate  110.0  resprate  20.0  o2sat  98.0  sbp  176.0  dbp  100.0  rhythm    pain  0  ; temp  98.7  heartrate  86.0  resprate  18.0  o2sat  100.0  sbp  126.0  dbp  85.0  rhythm    pain    ; temp    heartrate  92.0  resprate  18.0  o2sat  100.0  sbp  135.0  dbp  80.0  rhythm    pain  ua  ; temp  98.6  heartrate  96.0  resprate  16.0  o2sat  100.0  sbp  135.0  dbp  80.0  rhythm    pain  ua  ; temp  98.0  heartrate  101.0  resprate  18.0  o2sat  100.0  sbp  159.0  dbp  98.0  rhythm    pain  ua  $hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  20  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.1  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry urine chloride, urine  58  meq l; chemistry urine creatinine, urine  25  mg dl; chemistry urine potassium, urine  21  meq l; chemistry urine sodium, urine  59  meq l; chemistry urine urea nitrogen, urine  273  mg dl; hematology urine wbc  105  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  461  mg dl; chemistry blood glucose  24  mg dl; chemistry blood glucose  418  mg dl; chemistry blood glucose  392  mg dl; chemistry blood glucose  416  mg dl; chemistry blood albumin  3.4  g dl; blood gas blood lactate  3.2  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood glucose  370  mg dl; blood gas blood glucose  396  mg dl; hematology urine glucose  1000  mg dl; chemistry urine calcium, urine  2.6  mg dl; chemistry blood % hemoglobin a1c  13.7  %$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  650  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; ferrous sulfate  325  mg ; fluoxetine  40  mg ; folic acid  1  mg ; multivitamins  1  tab ; ranitidine  150  mg ; thiamine  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; heparin  5000  unit ; carvedilol  6.25  mg ; diazepam  5  mg ; 
pure hypercholesterolemia unspecified essential hypertension chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified chest pain, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status esophageal reflux other and unspecified hyperlipidemia congestive heart failure, unspecified other and unspecified hyperlipidemia iron deficiency anemia, unspecified coronary atherosclerosis of native coronary artery chronic systolic heart failure esophageal reflux chest pain, unspecified disturbance of skin sensation depressive disorder, not elsewhere classified tachycardia, unspecified shortness of breath diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other primary cardiomyopathies coronary atherosclerosis of native coronary artery other left bundle branch block chest pain, unspecified unspecified essential hypertension shortness of breath hyposmolality and/or hyponatremia chest pain, unspecified coronary atherosclerosis of native coronary artery hyposmolality and/or hyponatremia congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia, unspecified chronic systolic heart failure alcohol abuse, unspecified depressive disorder, not elsewhere classified nonspecific abnormal electrocardiogram [ecg] [ekg] chest pain, unspecified other chest pain alcohol abuse, unspecified nonspecific abnormal electrocardiogram [ecg] [ekg] coronary atherosclerosis of native coronary artery systolic heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled unspecified essential hypertension
hispanic latino f 65 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  121  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  464  mg dl; chemistry blood glucose  162  mg dl; chemistry blood glucose  182  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; ferrous sulfate  325  mg ; fluoxetine  40  mg ; folic acid  1  mg ; multivitamins  1  tab ; ranitidine  150  mg ; thiamine  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; heparin  5000  unit ; carvedilol  6.25  mg ; diazepam  5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; neutra-phos  2  pkt ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; losartan potassium  50  mg ; insulin  10  unit ; insulin  3  unit ; insulin  0  unit ; insulin  5  unit ; 
pure hypercholesterolemia unspecified essential hypertension chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified chest pain, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status esophageal reflux other and unspecified hyperlipidemia congestive heart failure, unspecified other and unspecified hyperlipidemia iron deficiency anemia, unspecified coronary atherosclerosis of native coronary artery chronic systolic heart failure esophageal reflux chest pain, unspecified disturbance of skin sensation depressive disorder, not elsewhere classified tachycardia, unspecified shortness of breath diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other primary cardiomyopathies coronary atherosclerosis of native coronary artery other left bundle branch block chest pain, unspecified unspecified essential hypertension shortness of breath hyposmolality and/or hyponatremia chest pain, unspecified coronary atherosclerosis of native coronary artery hyposmolality and/or hyponatremia congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia, unspecified chronic systolic heart failure alcohol abuse, unspecified depressive disorder, not elsewhere classified nonspecific abnormal electrocardiogram [ecg] [ekg] chest pain, unspecified other chest pain alcohol abuse, unspecified nonspecific abnormal electrocardiogram [ecg] [ekg] coronary atherosclerosis of native coronary artery systolic heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled unspecified essential hypertension
hispanic latino f 65 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  267  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  122  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  248  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; ferrous sulfate  325  mg ; fluoxetine  40  mg ; folic acid  1  mg ; multivitamins  1  tab ; ranitidine  150  mg ; thiamine  100  mg ; heparin  5000  unit ; carvedilol  6.25  mg ; diazepam  5  mg ; neutra-phos  2  pkt ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; losartan potassium  50  mg ; insulin  3  unit ; insulin  5  unit ; trazodone  25  mg ; insulin  12  unit ; 
pure hypercholesterolemia unspecified essential hypertension chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified chest pain, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status esophageal reflux other and unspecified hyperlipidemia congestive heart failure, unspecified other and unspecified hyperlipidemia iron deficiency anemia, unspecified coronary atherosclerosis of native coronary artery chronic systolic heart failure esophageal reflux chest pain, unspecified disturbance of skin sensation depressive disorder, not elsewhere classified tachycardia, unspecified shortness of breath diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other primary cardiomyopathies coronary atherosclerosis of native coronary artery other left bundle branch block chest pain, unspecified unspecified essential hypertension shortness of breath hyposmolality and/or hyponatremia chest pain, unspecified coronary atherosclerosis of native coronary artery hyposmolality and/or hyponatremia congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia, unspecified chronic systolic heart failure alcohol abuse, unspecified depressive disorder, not elsewhere classified nonspecific abnormal electrocardiogram [ecg] [ekg] chest pain, unspecified other chest pain alcohol abuse, unspecified nonspecific abnormal electrocardiogram [ecg] [ekg] coronary atherosclerosis of native coronary artery systolic heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled unspecified essential hypertension
hispanic latino f 65 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  121  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  281  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; ferrous sulfate  325  mg ; fluoxetine  40  mg ; folic acid  1  mg ; multivitamins  1  tab ; ranitidine  150  mg ; thiamine  100  mg ; heparin  5000  unit ; carvedilol  6.25  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; losartan potassium  50  mg ; trazodone  25  mg ; insulin  15  unit ; amitriptyline  10-20  mg ; furosemide  10  mg ; 
pure hypercholesterolemia unspecified essential hypertension chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified chest pain, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status esophageal reflux other and unspecified hyperlipidemia congestive heart failure, unspecified other and unspecified hyperlipidemia iron deficiency anemia, unspecified coronary atherosclerosis of native coronary artery chronic systolic heart failure esophageal reflux chest pain, unspecified disturbance of skin sensation depressive disorder, not elsewhere classified tachycardia, unspecified shortness of breath diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other primary cardiomyopathies coronary atherosclerosis of native coronary artery other left bundle branch block chest pain, unspecified unspecified essential hypertension shortness of breath hyposmolality and/or hyponatremia chest pain, unspecified coronary atherosclerosis of native coronary artery hyposmolality and/or hyponatremia congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia, unspecified chronic systolic heart failure alcohol abuse, unspecified depressive disorder, not elsewhere classified nonspecific abnormal electrocardiogram [ecg] [ekg] chest pain, unspecified other chest pain alcohol abuse, unspecified nonspecific abnormal electrocardiogram [ecg] [ekg] coronary atherosclerosis of native coronary artery systolic heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled unspecified essential hypertension
hispanic latino f 65 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  166  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; ferrous sulfate  325  mg ; fluoxetine  40  mg ; folic acid  1  mg ; multivitamins  1  tab ; ranitidine  150  mg ; thiamine  100  mg ; heparin  5000  unit ; carvedilol  6.25  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; losartan potassium  50  mg ; trazodone  25  mg ; insulin  15  unit ; amitriptyline  10-20  mg ; furosemide  10  mg ; 
pure hypercholesterolemia unspecified essential hypertension chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified chest pain, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status esophageal reflux other and unspecified hyperlipidemia congestive heart failure, unspecified other and unspecified hyperlipidemia iron deficiency anemia, unspecified coronary atherosclerosis of native coronary artery chronic systolic heart failure esophageal reflux chest pain, unspecified disturbance of skin sensation depressive disorder, not elsewhere classified tachycardia, unspecified shortness of breath diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other primary cardiomyopathies coronary atherosclerosis of native coronary artery other left bundle branch block chest pain, unspecified unspecified essential hypertension shortness of breath hyposmolality and/or hyponatremia chest pain, unspecified coronary atherosclerosis of native coronary artery hyposmolality and/or hyponatremia congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia, unspecified chronic systolic heart failure alcohol abuse, unspecified depressive disorder, not elsewhere classified nonspecific abnormal electrocardiogram [ecg] [ekg] chest pain, unspecified other chest pain alcohol abuse, unspecified nonspecific abnormal electrocardiogram [ecg] [ekg] coronary atherosclerosis of native coronary artery systolic heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled unspecified essential hypertension
white m 76 $temp    heartrate  78.0  resprate  18.0  o2sat  99.0  sbp  100.0  dbp  72.0  rhythm    pain    $hematology blood hematocrit  43.4  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  106  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; aspirin  325  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  250  ml ; heparin sodium  25,000  unit ; levothyroxine sodium  100  mcg ; metoprolol tartrate  12.5  mg ; docusate sodium  100  mg ; allopurinol  300  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; sw  200  ml ; potassium chloride  20  meq ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; atorvastatin  80  mg ; 
intermediate coronary syndrome coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism unspecified essential hypertension coronary atherosclerosis of artery bypass graft dizziness and giddiness gout, unspecified coronary atherosclerosis of native coronary artery other disorders of lipoid metabolism other testicular hypofunction unspecified essential hypertension paroxysmal ventricular tachycardia cough esophageal reflux gout, unspecified unspecified acquired hypothyroidism intermediate coronary syndrome 
white m 76 $nan$hematology blood hematocrit  41.1  %; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  130  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  325  mg ; acetaminophen  650  mg ; levothyroxine sodium  100  mcg ; metoprolol tartrate  12.5  mg ; docusate sodium  100  mg ; allopurinol  300  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; atorvastatin  80  mg ; 0.45% sodium chloride  1000  ml ; lactated ringers  1000  ml ; phenylephrine  60  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; d5w  250  ml ; nitroglycerin  100  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; acetaminophen iv  1000  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 
intermediate coronary syndrome coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism unspecified essential hypertension coronary atherosclerosis of artery bypass graft dizziness and giddiness gout, unspecified coronary atherosclerosis of native coronary artery other disorders of lipoid metabolism other testicular hypofunction unspecified essential hypertension paroxysmal ventricular tachycardia cough esophageal reflux gout, unspecified unspecified acquired hypothyroidism intermediate coronary syndrome 
white m 76 $nan$nan$phenylephrine  60  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; d5w  250  ml ; nitroglycerin  100  mg ; ondansetron  4  mg ; 
intermediate coronary syndrome coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism unspecified essential hypertension coronary atherosclerosis of artery bypass graft dizziness and giddiness gout, unspecified coronary atherosclerosis of native coronary artery other disorders of lipoid metabolism other testicular hypofunction unspecified essential hypertension paroxysmal ventricular tachycardia cough esophageal reflux gout, unspecified unspecified acquired hypothyroidism intermediate coronary syndrome 
white m 51 $temp  98.5  heartrate  101.0  resprate  12.0  o2sat  98.0  sbp  139.0  dbp  90.0  rhythm    pain  0  $hematology blood hematocrit  24.0  %; hematology blood hematocrit  20.4  %; hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  51  k ul; hematology blood platelet count  34  k ul; hematology blood platelet count  30  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  7.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  88  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  4.3  mg dl; chemistry blood glucose  79  mg dl; chemistry blood lactate dehydrogenase (ld)  193  iu l; chemistry blood albumin  3.2  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; creon 12  2  cap ; folic acid  1  mg ; hydromorphone (dilaudid)  2-4  mg ; lactulose  30  ml ; levetiracetam  1000  mg ; multivitamins  1  tab ; ondansetron  4  mg ; rifaximin  550  mg ; thiamine  100  mg ; ursodiol  500  mg ; nadolol  40  mg ; albumin 5%   50  g ; lorazepam  2  mg ; ondansetron  4-8  mg ; hydromorphone (dilaudid)  2  mg ; 
alcohol abuse, unspecified unspecified essential hypertension abdominal pain, unspecified site depressive disorder, not elsewhere classified alcoholic cirrhosis of liver other convulsions other ascites anxiety state, unspecified other chronic pain unspecified viral hepatitis c without hepatic coma hepatorenal syndrome other and unspecified alcohol dependence, continuous personal history of other infectious and parasitic diseases anemia in chronic kidney disease generalized convulsive epilepsy, without mention of intractable epilepsy abdominal pain, other specified site alcoholic cirrhosis of liver encounter for palliative care esophageal varices in diseases classified elsewhere, without mention of bleeding person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident other ascites hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified coagulation defects tobacco use disorder acute kidney failure, unspecified chronic kidney disease, unspecified jaundice, unspecified, not of newborn portal hypertension hepatic encephalopathy pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident chronic kidney disease, unspecified unspecified viral hepatitis c without hepatic coma alcoholic cirrhosis of liver personal history of allergy to penicillin other and unspecified alcohol dependence, unspecified tobacco use disorder other ascites umbilical hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified flatulence, eructation, and gas pain chronic kidney disease, unspecified unemployment driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident tobacco use disorder posttraumatic stress disorder alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified hepatorenal syndrome
white m 51 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  41  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  7.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  96  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  4.3  mg dl; chemistry blood glucose  157  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4-8  mg ; hydromorphone (dilaudid)  2  mg ; potassium chloride  20  meq ; d5 1 2ns  1000  ml ; 
alcohol abuse, unspecified unspecified essential hypertension abdominal pain, unspecified site depressive disorder, not elsewhere classified alcoholic cirrhosis of liver other convulsions other ascites anxiety state, unspecified other chronic pain unspecified viral hepatitis c without hepatic coma hepatorenal syndrome other and unspecified alcohol dependence, continuous personal history of other infectious and parasitic diseases anemia in chronic kidney disease generalized convulsive epilepsy, without mention of intractable epilepsy abdominal pain, other specified site alcoholic cirrhosis of liver encounter for palliative care esophageal varices in diseases classified elsewhere, without mention of bleeding person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident other ascites hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified coagulation defects tobacco use disorder acute kidney failure, unspecified chronic kidney disease, unspecified jaundice, unspecified, not of newborn portal hypertension hepatic encephalopathy pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident chronic kidney disease, unspecified unspecified viral hepatitis c without hepatic coma alcoholic cirrhosis of liver personal history of allergy to penicillin other and unspecified alcohol dependence, unspecified tobacco use disorder other ascites umbilical hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified flatulence, eructation, and gas pain chronic kidney disease, unspecified unemployment driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident tobacco use disorder posttraumatic stress disorder alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified hepatorenal syndrome
white m 51 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4-8  mg ; hydromorphone (dilaudid)  2  mg ; potassium chloride  20  meq ; d5 1 2ns  1000  ml ; 
alcohol abuse, unspecified unspecified essential hypertension abdominal pain, unspecified site depressive disorder, not elsewhere classified alcoholic cirrhosis of liver other convulsions other ascites anxiety state, unspecified other chronic pain unspecified viral hepatitis c without hepatic coma hepatorenal syndrome other and unspecified alcohol dependence, continuous personal history of other infectious and parasitic diseases anemia in chronic kidney disease generalized convulsive epilepsy, without mention of intractable epilepsy abdominal pain, other specified site alcoholic cirrhosis of liver encounter for palliative care esophageal varices in diseases classified elsewhere, without mention of bleeding person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident other ascites hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified coagulation defects tobacco use disorder acute kidney failure, unspecified chronic kidney disease, unspecified jaundice, unspecified, not of newborn portal hypertension hepatic encephalopathy pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident chronic kidney disease, unspecified unspecified viral hepatitis c without hepatic coma alcoholic cirrhosis of liver personal history of allergy to penicillin other and unspecified alcohol dependence, unspecified tobacco use disorder other ascites umbilical hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified flatulence, eructation, and gas pain chronic kidney disease, unspecified unemployment driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident tobacco use disorder posttraumatic stress disorder alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified hepatorenal syndrome
white m 51 $nan$hematology blood hematocrit  21.5  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  35  k ul; hematology blood inr(pt)  1.9  $sodium chloride 0.9%  flush  3  ml ; ondansetron  4-8  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  1-2  mg ; 
alcohol abuse, unspecified unspecified essential hypertension abdominal pain, unspecified site depressive disorder, not elsewhere classified alcoholic cirrhosis of liver other convulsions other ascites anxiety state, unspecified other chronic pain unspecified viral hepatitis c without hepatic coma hepatorenal syndrome other and unspecified alcohol dependence, continuous personal history of other infectious and parasitic diseases anemia in chronic kidney disease generalized convulsive epilepsy, without mention of intractable epilepsy abdominal pain, other specified site alcoholic cirrhosis of liver encounter for palliative care esophageal varices in diseases classified elsewhere, without mention of bleeding person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident other ascites hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified coagulation defects tobacco use disorder acute kidney failure, unspecified chronic kidney disease, unspecified jaundice, unspecified, not of newborn portal hypertension hepatic encephalopathy pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident chronic kidney disease, unspecified unspecified viral hepatitis c without hepatic coma alcoholic cirrhosis of liver personal history of allergy to penicillin other and unspecified alcohol dependence, unspecified tobacco use disorder other ascites umbilical hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified flatulence, eructation, and gas pain chronic kidney disease, unspecified unemployment driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident tobacco use disorder posttraumatic stress disorder alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified hepatorenal syndrome
white m 51 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  1-2  mg ; hyoscyamine  0.125  mg ; 
alcohol abuse, unspecified unspecified essential hypertension abdominal pain, unspecified site depressive disorder, not elsewhere classified alcoholic cirrhosis of liver other convulsions other ascites anxiety state, unspecified other chronic pain unspecified viral hepatitis c without hepatic coma hepatorenal syndrome other and unspecified alcohol dependence, continuous personal history of other infectious and parasitic diseases anemia in chronic kidney disease generalized convulsive epilepsy, without mention of intractable epilepsy abdominal pain, other specified site alcoholic cirrhosis of liver encounter for palliative care esophageal varices in diseases classified elsewhere, without mention of bleeding person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident other ascites hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified coagulation defects tobacco use disorder acute kidney failure, unspecified chronic kidney disease, unspecified jaundice, unspecified, not of newborn portal hypertension hepatic encephalopathy pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident chronic kidney disease, unspecified unspecified viral hepatitis c without hepatic coma alcoholic cirrhosis of liver personal history of allergy to penicillin other and unspecified alcohol dependence, unspecified tobacco use disorder other ascites umbilical hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified flatulence, eructation, and gas pain chronic kidney disease, unspecified unemployment driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident tobacco use disorder posttraumatic stress disorder alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified hepatorenal syndrome
white m 51 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hyoscyamine  0.125  mg ; 
alcohol abuse, unspecified unspecified essential hypertension abdominal pain, unspecified site depressive disorder, not elsewhere classified alcoholic cirrhosis of liver other convulsions other ascites anxiety state, unspecified other chronic pain unspecified viral hepatitis c without hepatic coma hepatorenal syndrome other and unspecified alcohol dependence, continuous personal history of other infectious and parasitic diseases anemia in chronic kidney disease generalized convulsive epilepsy, without mention of intractable epilepsy abdominal pain, other specified site alcoholic cirrhosis of liver encounter for palliative care esophageal varices in diseases classified elsewhere, without mention of bleeding person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident other ascites hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified coagulation defects tobacco use disorder acute kidney failure, unspecified chronic kidney disease, unspecified jaundice, unspecified, not of newborn portal hypertension hepatic encephalopathy pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident chronic kidney disease, unspecified unspecified viral hepatitis c without hepatic coma alcoholic cirrhosis of liver personal history of allergy to penicillin other and unspecified alcohol dependence, unspecified tobacco use disorder other ascites umbilical hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified flatulence, eructation, and gas pain chronic kidney disease, unspecified unemployment driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident tobacco use disorder posttraumatic stress disorder alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified hepatorenal syndrome
white m 51 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hyoscyamine  0.125  mg ; 
alcohol abuse, unspecified unspecified essential hypertension abdominal pain, unspecified site depressive disorder, not elsewhere classified alcoholic cirrhosis of liver other convulsions other ascites anxiety state, unspecified other chronic pain unspecified viral hepatitis c without hepatic coma hepatorenal syndrome other and unspecified alcohol dependence, continuous personal history of other infectious and parasitic diseases anemia in chronic kidney disease generalized convulsive epilepsy, without mention of intractable epilepsy abdominal pain, other specified site alcoholic cirrhosis of liver encounter for palliative care esophageal varices in diseases classified elsewhere, without mention of bleeding person on outside of heavy transport vehicle injured in collision with other nonmotor vehicle in traffic accident other ascites hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified coagulation defects tobacco use disorder acute kidney failure, unspecified chronic kidney disease, unspecified jaundice, unspecified, not of newborn portal hypertension hepatic encephalopathy pedal cycle driver injured in collision with heavy transport vehicle or bus in nontraffic accident chronic kidney disease, unspecified unspecified viral hepatitis c without hepatic coma alcoholic cirrhosis of liver personal history of allergy to penicillin other and unspecified alcohol dependence, unspecified tobacco use disorder other ascites umbilical hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified flatulence, eructation, and gas pain chronic kidney disease, unspecified unemployment driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident tobacco use disorder posttraumatic stress disorder alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified hepatorenal syndrome
white f 72 $temp  97.8  heartrate  62.0  resprate  19.0  o2sat  96.0  sbp  129.0  dbp  76.0  rhythm    pain    $hematology blood hematocrit  39.1  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  300  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  67  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  217  mg dl$sodium chloride 0.9%  flush  3-10  ml ; d5ns  1000  ml ; heparin  5000  unit ; acetaminophen iv  1000  mg ; albuterol 0.083% neb soln  1  neb ; metoprolol succinate xl  25  mg ; torsemide  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; gabapentin  600  mg ; ns  100  ml ; metronidazole  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; gabapentin  300  mg ; iohexol 240  50  ml ; lactated ringers  1000  ml ; 
pulmonary hypertension, unspecified diverticulitis of large intestine with perforation and abscess without bleeding type 2 diabetes mellitus with diabetic chronic kidney disease barrett's esophagus without dysplasia emphysema, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other sleep apnea dependence on supplemental oxygen hyperlipidemia, unspecified personal history of nicotine dependence body mass index (bmi) 45.0-49.9, adult gastro-esophageal reflux disease without esophagitis long term (current) use of insulin presence of prosthetic heart valve chronic kidney disease, unspecified chronic diastolic (congestive) heart failure obesity, unspecified left bundle-branch block, unspecified fistula of intestine long term (current) use of insulin chronic diastolic (congestive) heart failure diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding acute kidney failure, unspecified barrett's esophagus without dysplasia chronic obstructive pulmonary disease, unspecified acidosis portal hypertension body mass index (bmi) 45.0-49.9, adult obesity, unspecified gastro-esophageal reflux disease without esophagitis hyperkalemia chronic kidney disease, stage 3 (moderate) chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis presence of prosthetic heart valve hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease barrett's esophagus without dysplasia morbid (severe) obesity due to excess calories type 2 diabetes mellitus with diabetic chronic kidney disease hyperlipidemia, unspecified chronic diastolic (congestive) heart failure pulmonary hypertension, unspecified body mass index (bmi) 45.0-49.9, adult long term (current) use of insulin emphysema, unspecified sleep apnea, unspecified acute kidney failure, unspecified diverticulitis of large intestine with perforation and abscess without bleeding
white f 72 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  59  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  244  mg dl$sodium chloride 0.9%  flush  3-10  ml ; d5ns  1000  ml ; heparin  5000  unit ; acetaminophen iv  1000  mg ; albuterol 0.083% neb soln  1  neb ; metoprolol succinate xl  25  mg ; torsemide  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; gabapentin  600  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; gabapentin  300  mg ; iohexol 240  50  ml ; lactated ringers  1000  ml ; insulin  6  unit ; oxycodone (immediate release)  5  mg ; d5 1 2ns  1000  ml ; 
pulmonary hypertension, unspecified diverticulitis of large intestine with perforation and abscess without bleeding type 2 diabetes mellitus with diabetic chronic kidney disease barrett's esophagus without dysplasia emphysema, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other sleep apnea dependence on supplemental oxygen hyperlipidemia, unspecified personal history of nicotine dependence body mass index (bmi) 45.0-49.9, adult gastro-esophageal reflux disease without esophagitis long term (current) use of insulin presence of prosthetic heart valve chronic kidney disease, unspecified chronic diastolic (congestive) heart failure obesity, unspecified left bundle-branch block, unspecified fistula of intestine long term (current) use of insulin chronic diastolic (congestive) heart failure diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding acute kidney failure, unspecified barrett's esophagus without dysplasia chronic obstructive pulmonary disease, unspecified acidosis portal hypertension body mass index (bmi) 45.0-49.9, adult obesity, unspecified gastro-esophageal reflux disease without esophagitis hyperkalemia chronic kidney disease, stage 3 (moderate) chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis presence of prosthetic heart valve hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease barrett's esophagus without dysplasia morbid (severe) obesity due to excess calories type 2 diabetes mellitus with diabetic chronic kidney disease hyperlipidemia, unspecified chronic diastolic (congestive) heart failure pulmonary hypertension, unspecified body mass index (bmi) 45.0-49.9, adult long term (current) use of insulin emphysema, unspecified sleep apnea, unspecified acute kidney failure, unspecified diverticulitis of large intestine with perforation and abscess without bleeding
white f 72 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  54  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  298  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; metoprolol succinate xl  25  mg ; torsemide  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; gabapentin  600  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; gabapentin  300  mg ; iohexol 240  50  ml ; insulin  6  unit ; oxycodone (immediate release)  5  mg ; d5 1 2ns  1000  ml ; insulin  30  unit ; insulin  15  unit ; potassium chloride  20  meq ; acetaminophen  1000  mg ; insulin  8  unit ; 
pulmonary hypertension, unspecified diverticulitis of large intestine with perforation and abscess without bleeding type 2 diabetes mellitus with diabetic chronic kidney disease barrett's esophagus without dysplasia emphysema, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other sleep apnea dependence on supplemental oxygen hyperlipidemia, unspecified personal history of nicotine dependence body mass index (bmi) 45.0-49.9, adult gastro-esophageal reflux disease without esophagitis long term (current) use of insulin presence of prosthetic heart valve chronic kidney disease, unspecified chronic diastolic (congestive) heart failure obesity, unspecified left bundle-branch block, unspecified fistula of intestine long term (current) use of insulin chronic diastolic (congestive) heart failure diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding acute kidney failure, unspecified barrett's esophagus without dysplasia chronic obstructive pulmonary disease, unspecified acidosis portal hypertension body mass index (bmi) 45.0-49.9, adult obesity, unspecified gastro-esophageal reflux disease without esophagitis hyperkalemia chronic kidney disease, stage 3 (moderate) chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis presence of prosthetic heart valve hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease barrett's esophagus without dysplasia morbid (severe) obesity due to excess calories type 2 diabetes mellitus with diabetic chronic kidney disease hyperlipidemia, unspecified chronic diastolic (congestive) heart failure pulmonary hypertension, unspecified body mass index (bmi) 45.0-49.9, adult long term (current) use of insulin emphysema, unspecified sleep apnea, unspecified acute kidney failure, unspecified diverticulitis of large intestine with perforation and abscess without bleeding
white f 72 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  241  mg dl$famotidine  20  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; metoprolol succinate xl  25  mg ; torsemide  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; gabapentin  600  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; gabapentin  300  mg ; oxycodone (immediate release)  5  mg ; insulin  30  unit ; insulin  15  unit ; potassium chloride  20  meq ; acetaminophen  1000  mg ; insulin  8  unit ; insulin  22  unit ; insulin  35  unit ; insulin  18  unit ; omeprazole  20  mg ; ciprofloxacin hcl  500  mg ; iso-osmotic sodium chloride  1  bag ; 
pulmonary hypertension, unspecified diverticulitis of large intestine with perforation and abscess without bleeding type 2 diabetes mellitus with diabetic chronic kidney disease barrett's esophagus without dysplasia emphysema, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other sleep apnea dependence on supplemental oxygen hyperlipidemia, unspecified personal history of nicotine dependence body mass index (bmi) 45.0-49.9, adult gastro-esophageal reflux disease without esophagitis long term (current) use of insulin presence of prosthetic heart valve chronic kidney disease, unspecified chronic diastolic (congestive) heart failure obesity, unspecified left bundle-branch block, unspecified fistula of intestine long term (current) use of insulin chronic diastolic (congestive) heart failure diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding acute kidney failure, unspecified barrett's esophagus without dysplasia chronic obstructive pulmonary disease, unspecified acidosis portal hypertension body mass index (bmi) 45.0-49.9, adult obesity, unspecified gastro-esophageal reflux disease without esophagitis hyperkalemia chronic kidney disease, stage 3 (moderate) chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis presence of prosthetic heart valve hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease barrett's esophagus without dysplasia morbid (severe) obesity due to excess calories type 2 diabetes mellitus with diabetic chronic kidney disease hyperlipidemia, unspecified chronic diastolic (congestive) heart failure pulmonary hypertension, unspecified body mass index (bmi) 45.0-49.9, adult long term (current) use of insulin emphysema, unspecified sleep apnea, unspecified acute kidney failure, unspecified diverticulitis of large intestine with perforation and abscess without bleeding
white f 72 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  220  mg dl$famotidine  20  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; metoprolol succinate xl  25  mg ; torsemide  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; gabapentin  600  mg ; gabapentin  300  mg ; oxycodone (immediate release)  5  mg ; acetaminophen  1000  mg ; insulin  35  unit ; insulin  18  unit ; omeprazole  20  mg ; ciprofloxacin hcl  500  mg ; iso-osmotic sodium chloride  1  bag ; calcium carbonate  500  mg ; lidocaine 1%  1  ml ; insulin  26  unit ; insulin  40  unit ; insulin  7  unit ; insulin  25  unit ; 
pulmonary hypertension, unspecified diverticulitis of large intestine with perforation and abscess without bleeding type 2 diabetes mellitus with diabetic chronic kidney disease barrett's esophagus without dysplasia emphysema, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other sleep apnea dependence on supplemental oxygen hyperlipidemia, unspecified personal history of nicotine dependence body mass index (bmi) 45.0-49.9, adult gastro-esophageal reflux disease without esophagitis long term (current) use of insulin presence of prosthetic heart valve chronic kidney disease, unspecified chronic diastolic (congestive) heart failure obesity, unspecified left bundle-branch block, unspecified fistula of intestine long term (current) use of insulin chronic diastolic (congestive) heart failure diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding acute kidney failure, unspecified barrett's esophagus without dysplasia chronic obstructive pulmonary disease, unspecified acidosis portal hypertension body mass index (bmi) 45.0-49.9, adult obesity, unspecified gastro-esophageal reflux disease without esophagitis hyperkalemia chronic kidney disease, stage 3 (moderate) chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis presence of prosthetic heart valve hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease barrett's esophagus without dysplasia morbid (severe) obesity due to excess calories type 2 diabetes mellitus with diabetic chronic kidney disease hyperlipidemia, unspecified chronic diastolic (congestive) heart failure pulmonary hypertension, unspecified body mass index (bmi) 45.0-49.9, adult long term (current) use of insulin emphysema, unspecified sleep apnea, unspecified acute kidney failure, unspecified diverticulitis of large intestine with perforation and abscess without bleeding
white f 72 $nan$nan$famotidine  20  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; metoprolol succinate xl  25  mg ; torsemide  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; gabapentin  600  mg ; gabapentin  300  mg ; oxycodone (immediate release)  5  mg ; acetaminophen  1000  mg ; omeprazole  20  mg ; ciprofloxacin hcl  500  mg ; iso-osmotic sodium chloride  1  bag ; calcium carbonate  500  mg ; lidocaine 1%  1  ml ; insulin  40  unit ; insulin  7  unit ; insulin  25  unit ; 
pulmonary hypertension, unspecified diverticulitis of large intestine with perforation and abscess without bleeding type 2 diabetes mellitus with diabetic chronic kidney disease barrett's esophagus without dysplasia emphysema, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other sleep apnea dependence on supplemental oxygen hyperlipidemia, unspecified personal history of nicotine dependence body mass index (bmi) 45.0-49.9, adult gastro-esophageal reflux disease without esophagitis long term (current) use of insulin presence of prosthetic heart valve chronic kidney disease, unspecified chronic diastolic (congestive) heart failure obesity, unspecified left bundle-branch block, unspecified fistula of intestine long term (current) use of insulin chronic diastolic (congestive) heart failure diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding acute kidney failure, unspecified barrett's esophagus without dysplasia chronic obstructive pulmonary disease, unspecified acidosis portal hypertension body mass index (bmi) 45.0-49.9, adult obesity, unspecified gastro-esophageal reflux disease without esophagitis hyperkalemia chronic kidney disease, stage 3 (moderate) chronic kidney disease, unspecified gastro-esophageal reflux disease without esophagitis presence of prosthetic heart valve hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease barrett's esophagus without dysplasia morbid (severe) obesity due to excess calories type 2 diabetes mellitus with diabetic chronic kidney disease hyperlipidemia, unspecified chronic diastolic (congestive) heart failure pulmonary hypertension, unspecified body mass index (bmi) 45.0-49.9, adult long term (current) use of insulin emphysema, unspecified sleep apnea, unspecified acute kidney failure, unspecified diverticulitis of large intestine with perforation and abscess without bleeding
white f 51 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  319  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  102  mg dl; blood gas blood lactate  0.9  mmol l; hematology urine glucose  neg  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl; hematology urine bilirubin  neg  mg dl$nan
 
white f 51 $nan$hematology blood hematocrit  29.1  %; hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  122  mg dl; chemistry blood lactate dehydrogenase (ld)  484  iu l$sodium chloride 0.9%  flush  3  ml ; ibuprofen  800  mg ; acetaminophen  1000  mg ; multivitamins  1  tab ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; ns  1000  ml ; ipratropium bromide neb  1  neb ; ondansetron  4  mg ; 
 
white f 51 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  191  iu l; chemistry blood albumin  3.3  g dl; hematology blood bands  13  %$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; multivitamins  1  tab ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ondansetron  4  mg ; citalopram hydrobromide  20  mg ; neutra-phos  2  pkt ; calcium gluconate  2  gm ; prochlorperazine  10  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; azithromycin  500  mg ; lorazepam  0.5-1  mg ; doxycycline hyclate  100  mg ; 
 
white f 51 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  218  iu l; chemistry blood albumin  3.0  g dl; hematology blood bands  18  %; blood gas blood lactate  1.8  mmol l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; multivitamins  1  tab ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; ondansetron  4  mg ; citalopram hydrobromide  20  mg ; neutra-phos  2  pkt ; calcium gluconate  2  gm ; prochlorperazine  10  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; azithromycin  500  mg ; lorazepam  0.5-1  mg ; doxycycline hyclate  100  mg ; xopenex  0.63  mg ; magnesium oxide  400  mg ; ceftriaxone  2  gm ; dextrose 5%  150  ml ; levofloxacin  750  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; benzonatate  100  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; 
 
white f 51 $nan$hematology blood hematocrit  31.1  %; hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  313  k ul; hematology blood platelet count  334  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  352  iu l$iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; acetaminophen  325-650  mg ; d5w  100  ml ; ibuprofen  400  mg ; d5w  250  ml ; azithromycin   500  mg ; d5 1 2ns  1000  ml ; 
 
white f 51 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  351  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  124  mg dl; hematology blood bands  0  %$acetaminophen  325-650  mg ; d5w  100  ml ; ibuprofen  400  mg ; d5w  250  ml ; azithromycin   500  mg ; d5 1 2ns  1000  ml ; potassium chloride  80  meq ; promethazine  6.25  mg ; azithromycin  250  mg ; albuterol mdi  2  puff ; 
 
white f 51 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  362  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  112  mg dl$acetaminophen  325-650  mg ; ibuprofen  400  mg ; potassium chloride  80  meq ; promethazine  6.25  mg ; azithromycin  250  mg ; albuterol mdi  2  puff ; potassium chloride  40  meq ; potassium chloride  60  meq ; 
 
white f 51 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  360  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  133  mg dl; chemistry blood lactate dehydrogenase (ld)  578  iu l$acetaminophen  325-650  mg ; ibuprofen  400  mg ; promethazine  6.25  mg ; azithromycin  250  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; trazodone  25  mg ; enoxaparin sodium  40  mg ; ns  500  ml ; lidocaine 1%  1  ml ; 1 2 ns  1000  ml ; lorazepam  0.5  mg ; 
 
white f 51 $nan$hematology blood hematocrit  26.7  %; hematology blood hematocrit  26.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  366  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.2  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  94  mg dl; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood hematocrit, calculated  34  %; blood gas blood hemoglobin  11.2  g dl$acetaminophen  325-650  mg ; ibuprofen  400  mg ; promethazine  6.25  mg ; enoxaparin sodium  40  mg ; ns  500  ml ; lidocaine 1%  1  ml ; 1 2 ns  1000  ml ; lorazepam  0.5  mg ; d5w  500  ml ; guaifenesin-dextromethorphan  10  ml ; ns  250  ml ; potassium chloride  20  meq ; oxycodone (immediate release)   5  mg ; 
 
white f 51 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  464  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  121  mg dl; blood gas blood potassium, whole blood  3.7  meq l$acetaminophen  325-650  mg ; ibuprofen  400  mg ; promethazine  6.25  mg ; enoxaparin sodium  40  mg ; d5w  500  ml ; guaifenesin-dextromethorphan  10  ml ; ns  250  ml ; potassium chloride  20  meq ; oxycodone (immediate release)   5  mg ; heparin flush (10 units ml)  2  ml ; dextrose 5%  100  ml ; levofloxacin  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  650  mg ; 
 
white f 51 $nan$hematology blood hematocrit  24.8  %; hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  470  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  354  iu l; blood gas blood potassium, whole blood  4.0  meq l$ibuprofen  400  mg ; enoxaparin sodium  40  mg ; guaifenesin-dextromethorphan  10  ml ; heparin flush (10 units ml)  2  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  650  mg ; 
 
white f 51 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  540  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  113  mg dl$ibuprofen  400  mg ; enoxaparin sodium  40  mg ; guaifenesin-dextromethorphan  10  ml ; heparin flush (10 units ml)  2  ml ; acetaminophen  650  mg ; zolpidem tartrate  5  mg ; zolpidem tartrate  10  mg ; calcium carbonate  500  mg ; 
 
white f 51 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  623  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  92  mg dl$ibuprofen  400  mg ; enoxaparin sodium  40  mg ; guaifenesin-dextromethorphan  10  ml ; heparin flush (10 units ml)  2  ml ; acetaminophen  650  mg ; zolpidem tartrate  10  mg ; calcium carbonate  500  mg ; fluconazole  150  mg ; 
 
white f 51 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  632  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  92  mg dl$ibuprofen  400  mg ; enoxaparin sodium  40  mg ; guaifenesin-dextromethorphan  10  ml ; heparin flush (10 units ml)  2  ml ; acetaminophen  650  mg ; zolpidem tartrate  10  mg ; calcium carbonate  500  mg ; fluconazole  150  mg ; guaifenesin  5-10  ml ; ondansetron odt  4  mg ; 
 
white f 51 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  731  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  86  mg dl$ibuprofen  400  mg ; guaifenesin-dextromethorphan  10  ml ; heparin flush (10 units ml)  2  ml ; acetaminophen  650  mg ; zolpidem tartrate  10  mg ; calcium carbonate  500  mg ; guaifenesin  5-10  ml ; ondansetron odt  4  mg ; 
 
white m 51 $temp  97.9  heartrate  65.0  resprate  16.0  o2sat  100.0  sbp  124.0  dbp  73.0  rhythm    pain    ; temp  97.5  heartrate  53.0  resprate  16.0  o2sat  99.0  sbp  140.0  dbp  70.0  rhythm    pain  0  $nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; ketorolac  30  mg ; cyclobenzaprine  10  mg ; cyclobenzaprine  5-10  mg ; oxycodone (immediate release)  5  mg ; 
 
white m 51 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; ketorolac  30  mg ; cyclobenzaprine  5-10  mg ; oxycodone (immediate release)  5  mg ; lidocaine 5% patch  1  ptch ; 
 
black african american m 50 $nan$chemistry blood chloride  100  meq l; chemistry blood creatinine  9.5  mg dl; chemistry blood potassium  6.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood calcium, total  10.4  mg dl; chemistry blood glucose  174  mg dl; blood gas blood potassium, whole blood  8.3  meq l$nan
below knee amputation status hemoptysis glucocorticoid deficiency sarcoidosis aspergillosis diarrhea end stage renal disease epistaxis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere atrial fibrillation other amyloidosis chronic hepatitis c without mention of hepatic coma hyperpotassemia hemoptysis chest pain, unspecified atrial fibrillation personal history of tobacco use kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure end stage renal disease chronic hepatitis c without mention of hepatic coma other finger(s) amputation status below knee amputation status methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site endocarditis, valve unspecified, unspecified cause hypotension of hemodialysis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other amyloidosis sarcoidosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease pedestrian injured in nontraffic accident involving other and unspecified motor vehicles glucocorticoid deficiency aspergillosis epistaxis infection with microorganisms resistant to penicillins acute posthemorrhagic anemia endocarditis, valve unspecified, unspecified cause epistaxis long-term (current) use of anticoagulants end stage renal disease nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere glucocorticoid deficiency atrial fibrillation unspecified viral hepatitis c without hepatic coma tachycardia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease aspergillosis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled
black african american m 50 $nan$hematology blood hematocrit  34.3  %; hematology blood hematocrit  37.5  %; hematology blood hemoglobin  10.9  g dl; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  238  k ul; hematology blood platelet count  239  k ul; chemistry blood anion gap  5  meq l; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  116  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  5.2  mg dl; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  2.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  155  mg dl; chemistry blood glucose  93  mg dl; blood gas blood free calcium  1.15  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood chloride, whole blood  104  meq l; blood gas blood glucose  142  mg dl; blood gas blood hematocrit, calculated  36  %; blood gas blood hemoglobin  12.0  g dl; blood gas blood potassium, whole blood  3.0  meq l; blood gas blood potassium, whole blood  2.0  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood calculated bicarbonate, whole blood  25  meq l$amoxicillin-clavulanic acid  250  mg ; cinacalcet hcl  30  mg ; folic acid  1  mg ; vitamin b complex  1  tab ; ascorbic acid  500  mg ; prednisone  5  mg ; senna  1  tab ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; sevelamer  800  mg ; ns  1000  ml ; sulfameth trimethoprim ds  4  tab ; ns  500  ml ; insulin  0  unit ; voriconazole  200  mg ; ns  250  ml ; docusate sodium  100  mg ; prednisone  2.5  mg ; insulin  12  unit ; 
below knee amputation status hemoptysis glucocorticoid deficiency sarcoidosis aspergillosis diarrhea end stage renal disease epistaxis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere atrial fibrillation other amyloidosis chronic hepatitis c without mention of hepatic coma hyperpotassemia hemoptysis chest pain, unspecified atrial fibrillation personal history of tobacco use kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure end stage renal disease chronic hepatitis c without mention of hepatic coma other finger(s) amputation status below knee amputation status methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site endocarditis, valve unspecified, unspecified cause hypotension of hemodialysis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other amyloidosis sarcoidosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease pedestrian injured in nontraffic accident involving other and unspecified motor vehicles glucocorticoid deficiency aspergillosis epistaxis infection with microorganisms resistant to penicillins acute posthemorrhagic anemia endocarditis, valve unspecified, unspecified cause epistaxis long-term (current) use of anticoagulants end stage renal disease nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere glucocorticoid deficiency atrial fibrillation unspecified viral hepatitis c without hepatic coma tachycardia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease aspergillosis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled
black african american m 50 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  7.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  61  mg dl$amoxicillin-clavulanic acid  250  mg ; cinacalcet hcl  30  mg ; folic acid  1  mg ; vitamin b complex  1  tab ; ascorbic acid  500  mg ; prednisone  5  mg ; senna  1  tab ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; sevelamer  800  mg ; ns  1000  ml ; sulfameth trimethoprim ds  4  tab ; ns  500  ml ; insulin  0  unit ; voriconazole  200  mg ; ns  250  ml ; docusate sodium  100  mg ; prednisone  2.5  mg ; insulin  12  unit ; sodium chloride nasal  2  spry ; amoxicillin  500  mg ; bacitracin ointment  1  appl ; oxymetazoline  0  spry ; 
below knee amputation status hemoptysis glucocorticoid deficiency sarcoidosis aspergillosis diarrhea end stage renal disease epistaxis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere atrial fibrillation other amyloidosis chronic hepatitis c without mention of hepatic coma hyperpotassemia hemoptysis chest pain, unspecified atrial fibrillation personal history of tobacco use kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure end stage renal disease chronic hepatitis c without mention of hepatic coma other finger(s) amputation status below knee amputation status methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site endocarditis, valve unspecified, unspecified cause hypotension of hemodialysis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other amyloidosis sarcoidosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease pedestrian injured in nontraffic accident involving other and unspecified motor vehicles glucocorticoid deficiency aspergillosis epistaxis infection with microorganisms resistant to penicillins acute posthemorrhagic anemia endocarditis, valve unspecified, unspecified cause epistaxis long-term (current) use of anticoagulants end stage renal disease nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere glucocorticoid deficiency atrial fibrillation unspecified viral hepatitis c without hepatic coma tachycardia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease aspergillosis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled
black african american m 50 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  267  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  5.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  55  mg dl$amoxicillin-clavulanic acid  250  mg ; cinacalcet hcl  30  mg ; folic acid  1  mg ; vitamin b complex  1  tab ; ascorbic acid  500  mg ; prednisone  5  mg ; senna  1  tab ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; sevelamer  800  mg ; sulfameth trimethoprim ds  4  tab ; insulin  0  unit ; voriconazole  200  mg ; prednisone  2.5  mg ; insulin  12  unit ; sodium chloride nasal  2  spry ; amoxicillin  500  mg ; bacitracin ointment  1  appl ; oxymetazoline  0  spry ; insulin  10  unit ; 
below knee amputation status hemoptysis glucocorticoid deficiency sarcoidosis aspergillosis diarrhea end stage renal disease epistaxis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere atrial fibrillation other amyloidosis chronic hepatitis c without mention of hepatic coma hyperpotassemia hemoptysis chest pain, unspecified atrial fibrillation personal history of tobacco use kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure end stage renal disease chronic hepatitis c without mention of hepatic coma other finger(s) amputation status below knee amputation status methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site endocarditis, valve unspecified, unspecified cause hypotension of hemodialysis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other amyloidosis sarcoidosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease pedestrian injured in nontraffic accident involving other and unspecified motor vehicles glucocorticoid deficiency aspergillosis epistaxis infection with microorganisms resistant to penicillins acute posthemorrhagic anemia endocarditis, valve unspecified, unspecified cause epistaxis long-term (current) use of anticoagulants end stage renal disease nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere glucocorticoid deficiency atrial fibrillation unspecified viral hepatitis c without hepatic coma tachycardia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease aspergillosis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled
black african american m 50 $nan$nan$amoxicillin-clavulanic acid  250  mg ; cinacalcet hcl  30  mg ; folic acid  1  mg ; vitamin b complex  1  tab ; ascorbic acid  500  mg ; prednisone  5  mg ; senna  1  tab ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; sevelamer  800  mg ; sulfameth trimethoprim ds  4  tab ; voriconazole  200  mg ; prednisone  2.5  mg ; bacitracin ointment  1  appl ; oxymetazoline  0  spry ; insulin  10  unit ; 
below knee amputation status hemoptysis glucocorticoid deficiency sarcoidosis aspergillosis diarrhea end stage renal disease epistaxis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere atrial fibrillation other amyloidosis chronic hepatitis c without mention of hepatic coma hyperpotassemia hemoptysis chest pain, unspecified atrial fibrillation personal history of tobacco use kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure end stage renal disease chronic hepatitis c without mention of hepatic coma other finger(s) amputation status below knee amputation status methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site endocarditis, valve unspecified, unspecified cause hypotension of hemodialysis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other amyloidosis sarcoidosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease pedestrian injured in nontraffic accident involving other and unspecified motor vehicles glucocorticoid deficiency aspergillosis epistaxis infection with microorganisms resistant to penicillins acute posthemorrhagic anemia endocarditis, valve unspecified, unspecified cause epistaxis long-term (current) use of anticoagulants end stage renal disease nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere glucocorticoid deficiency atrial fibrillation unspecified viral hepatitis c without hepatic coma tachycardia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease aspergillosis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled
other f 79 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  uta  ; temp  95.9  heartrate  94.0  resprate  24.0  o2sat  100.0  sbp  128.0  dbp  79.0  rhythm    pain  uta  $nan$heparin  5000  unit ; 
 
other f 79 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  143  mg dl; blood gas blood free calcium  1.02  mmol l$0.9% sodium chloride  250  ml ; heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  4  gm ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; morphine sulfate  1-4  mg ; glycopyrrolate  0.1-0.2  mg ; haloperidol  0.5-2  mg ; lorazepam  0.5-2  mg ; 
 
other f 79 $nan$nan$0.9% sodium chloride  250  ml ; influenza vaccine quadrivalent  0.5  ml ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  4  gm ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; morphine sulfate  1-4  mg ; glycopyrrolate  0.1-0.2  mg ; haloperidol  0.5-2  mg ; lorazepam  0.5-2  mg ; 
 
black african american f 56 $nan$nan$fluoxetine  40  mg ; levothyroxine sodium  200  mcg ; 
postsurgical hypothyroidism epilepsy, unspecified, without mention of intractable epilepsy renal dialysis status end stage renal disease acute pancreatitis asthma, unspecified type, unspecified anemia, unspecified abdominal pain, left lower quadrant diarrhea fever presenting with conditions classified elsewhere other specified symptoms associated with female genital organs cirrhosis of liver without mention of alcohol unspecified viral hepatitis c without hepatic coma spinal stenosis, lumbar region, with neurogenic claudication loss of weight leukocytopenia, unspecified complications of transplanted kidney hypocalcemia combinations of opioid type drug with any other drug dependence, in remission unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy depressive disorder, not elsewhere classified chronic hepatitis c without mention of hepatic coma congestive heart failure, unspecified acute on chronic systolic heart failure asthma, unspecified type, unspecified other, mixed, or unspecified drug abuse, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident automatic implantable cardiac defibrillator in situ unspecified acquired hypothyroidism kidney replaced by transplant chest pain, unspecified renal dialysis status surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation epilepsy, unspecified, without mention of intractable epilepsy depressive disorder, not elsewhere classified cirrhosis of liver without mention of alcohol hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease complications of transplanted kidney other alteration of consciousness postsurgical hypothyroidism asthma, unspecified type, unspecified end stage renal disease chronic hepatitis c without mention of hepatic coma
black african american f 56 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  119  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  7.8  mg dl; chemistry blood creatinine  8.5  mg dl; chemistry blood creatinine  4.2  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  7.4  meq l; chemistry blood potassium  7.2  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.1  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  73  mg dl$fluoxetine  40  mg ; levothyroxine sodium  200  mcg ; docusate sodium  100  mg ; levetiracetam  250  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; senna  1  tab ; 5% dextrose  250  ml ; norepinephrine  8  mg ; insulin  10  unit ; sodium polystyrene sulfonate  60  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; dextrose 50%  50  gm ; heparin  5000  unit ; gabapentin  300  mg ; methadone  44  mg ; 
postsurgical hypothyroidism epilepsy, unspecified, without mention of intractable epilepsy renal dialysis status end stage renal disease acute pancreatitis asthma, unspecified type, unspecified anemia, unspecified abdominal pain, left lower quadrant diarrhea fever presenting with conditions classified elsewhere other specified symptoms associated with female genital organs cirrhosis of liver without mention of alcohol unspecified viral hepatitis c without hepatic coma spinal stenosis, lumbar region, with neurogenic claudication loss of weight leukocytopenia, unspecified complications of transplanted kidney hypocalcemia combinations of opioid type drug with any other drug dependence, in remission unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy depressive disorder, not elsewhere classified chronic hepatitis c without mention of hepatic coma congestive heart failure, unspecified acute on chronic systolic heart failure asthma, unspecified type, unspecified other, mixed, or unspecified drug abuse, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident automatic implantable cardiac defibrillator in situ unspecified acquired hypothyroidism kidney replaced by transplant chest pain, unspecified renal dialysis status surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation epilepsy, unspecified, without mention of intractable epilepsy depressive disorder, not elsewhere classified cirrhosis of liver without mention of alcohol hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease complications of transplanted kidney other alteration of consciousness postsurgical hypothyroidism asthma, unspecified type, unspecified end stage renal disease chronic hepatitis c without mention of hepatic coma
black african american f 56 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  88  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  5.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  6.9  mg dl; chemistry blood glucose  93  mg dl$fluoxetine  40  mg ; levothyroxine sodium  200  mcg ; docusate sodium  100  mg ; levetiracetam  250  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; senna  1  tab ; 5% dextrose  250  ml ; norepinephrine  8  mg ; sodium polystyrene sulfonate  60  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; dextrose 50%  50  gm ; heparin  5000  unit ; gabapentin  300  mg ; methadone  44  mg ; clonazepam  0.5  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3  ml ; tramadol (ultram)  25  mg ; fluoxetine  60  mg ; calcium acetate  667  mg ; 
postsurgical hypothyroidism epilepsy, unspecified, without mention of intractable epilepsy renal dialysis status end stage renal disease acute pancreatitis asthma, unspecified type, unspecified anemia, unspecified abdominal pain, left lower quadrant diarrhea fever presenting with conditions classified elsewhere other specified symptoms associated with female genital organs cirrhosis of liver without mention of alcohol unspecified viral hepatitis c without hepatic coma spinal stenosis, lumbar region, with neurogenic claudication loss of weight leukocytopenia, unspecified complications of transplanted kidney hypocalcemia combinations of opioid type drug with any other drug dependence, in remission unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy depressive disorder, not elsewhere classified chronic hepatitis c without mention of hepatic coma congestive heart failure, unspecified acute on chronic systolic heart failure asthma, unspecified type, unspecified other, mixed, or unspecified drug abuse, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident automatic implantable cardiac defibrillator in situ unspecified acquired hypothyroidism kidney replaced by transplant chest pain, unspecified renal dialysis status surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation epilepsy, unspecified, without mention of intractable epilepsy depressive disorder, not elsewhere classified cirrhosis of liver without mention of alcohol hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease complications of transplanted kidney other alteration of consciousness postsurgical hypothyroidism asthma, unspecified type, unspecified end stage renal disease chronic hepatitis c without mention of hepatic coma
black african american f 56 $nan$nan$levothyroxine sodium  200  mcg ; docusate sodium  100  mg ; levetiracetam  250  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; sodium chloride 0.9%  flush  10  ml ; senna  1  tab ; heparin  5000  unit ; gabapentin  300  mg ; methadone  44  mg ; clonazepam  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; tramadol (ultram)  25  mg ; fluoxetine  60  mg ; calcium acetate  667  mg ; lorazepam  1  mg ; 
postsurgical hypothyroidism epilepsy, unspecified, without mention of intractable epilepsy renal dialysis status end stage renal disease acute pancreatitis asthma, unspecified type, unspecified anemia, unspecified abdominal pain, left lower quadrant diarrhea fever presenting with conditions classified elsewhere other specified symptoms associated with female genital organs cirrhosis of liver without mention of alcohol unspecified viral hepatitis c without hepatic coma spinal stenosis, lumbar region, with neurogenic claudication loss of weight leukocytopenia, unspecified complications of transplanted kidney hypocalcemia combinations of opioid type drug with any other drug dependence, in remission unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy depressive disorder, not elsewhere classified chronic hepatitis c without mention of hepatic coma congestive heart failure, unspecified acute on chronic systolic heart failure asthma, unspecified type, unspecified other, mixed, or unspecified drug abuse, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident automatic implantable cardiac defibrillator in situ unspecified acquired hypothyroidism kidney replaced by transplant chest pain, unspecified renal dialysis status surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation epilepsy, unspecified, without mention of intractable epilepsy depressive disorder, not elsewhere classified cirrhosis of liver without mention of alcohol hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease complications of transplanted kidney other alteration of consciousness postsurgical hypothyroidism asthma, unspecified type, unspecified end stage renal disease chronic hepatitis c without mention of hepatic coma
unknown f 78 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  98  mg dl$0.45% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; bisacodyl  10  mg ; senna  1  tab ; acetaminophen  650  mg ; heparin  5000  unit ; docusate sodium  100  mg ; morphine sulfate  2-4  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 
 
unknown f 78 $nan$hematology blood hematocrit  30.2  %; hematology blood hematocrit  26.8  %; hematology blood hematocrit  27.4  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  217  k ul; hematology blood platelet count  198  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  536  iu l$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; morphine sulfate  2-4  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; tramadol (ultram)  25-50  mg ; neutra-phos  2  pkt ; atenolol  50  mg ; lisinopril  40  mg ; aspirin  81  mg ; 
 
unknown f 78 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  98  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; tramadol (ultram)  25-50  mg ; neutra-phos  2  pkt ; atenolol  50  mg ; lisinopril  40  mg ; aspirin  81  mg ; ondansetron  4  mg ; 
 
unknown f 78 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; tramadol (ultram)  25-50  mg ; atenolol  50  mg ; lisinopril  40  mg ; aspirin  81  mg ; ondansetron  4  mg ; 
 
white m 58 $nan$nan$clopidogrel  75  mg ; fluticasone propionate nasal  1  spry ; lisinopril  20  mg ; paroxetine  20  mg ; simvastatin  80  mg ; tiotropium bromide  1  cap ; aspirin  325  mg ; ferrous sulfate  325  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) systolic heart failure, unspecified other emphysema unspecified essential hypertension congestive heart failure, unspecified anxiety state, unspecified esophageal reflux old myocardial infarction coronary atherosclerosis of native coronary artery automatic implantable cardiac defibrillator in situ other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status tobacco use disorder
white m 58 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  143  mg dl$clopidogrel  75  mg ; fluticasone propionate nasal  1  spry ; lisinopril  20  mg ; paroxetine  20  mg ; simvastatin  80  mg ; tiotropium bromide  1  cap ; aspirin  325  mg ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; furosemide  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; metoprolol tartrate  12.5  mg ; ranitidine  150  mg ; trazodone  25-50  mg ; oxycodone-acetaminophen  1-2  tab ; insulin  0  unit ; insulin  60  unit ; aspirin  81  mg ; magnesium oxide  800  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) systolic heart failure, unspecified other emphysema unspecified essential hypertension congestive heart failure, unspecified anxiety state, unspecified esophageal reflux old myocardial infarction coronary atherosclerosis of native coronary artery automatic implantable cardiac defibrillator in situ other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status tobacco use disorder
white m 58 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  165  mg dl$clopidogrel  75  mg ; fluticasone propionate nasal  1  spry ; lisinopril  20  mg ; paroxetine  20  mg ; simvastatin  80  mg ; tiotropium bromide  1  cap ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; metoprolol tartrate  12.5  mg ; ranitidine  150  mg ; trazodone  25-50  mg ; oxycodone-acetaminophen  1-2  tab ; insulin  0  unit ; insulin  60  unit ; aspirin  81  mg ; magnesium oxide  800  mg ; magnesium sulfate  2  gm ; magnesium oxide  400  mg ; sw  50  ml ; ibuprofen  400  mg ; furosemide  60  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) systolic heart failure, unspecified other emphysema unspecified essential hypertension congestive heart failure, unspecified anxiety state, unspecified esophageal reflux old myocardial infarction coronary atherosclerosis of native coronary artery automatic implantable cardiac defibrillator in situ other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status tobacco use disorder
white m 58 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  162  mg dl$clopidogrel  75  mg ; fluticasone propionate nasal  1  spry ; lisinopril  20  mg ; paroxetine  20  mg ; simvastatin  80  mg ; tiotropium bromide  1  cap ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ranitidine  150  mg ; trazodone  25-50  mg ; oxycodone-acetaminophen  1-2  tab ; insulin  0  unit ; insulin  60  unit ; aspirin  81  mg ; magnesium sulfate  2  gm ; sw  50  ml ; ibuprofen  400  mg ; furosemide  60  mg ; metoprolol tartrate  25  mg ; metoprolol succinate xl  50  mg ; metoprolol succinate xl  25  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) systolic heart failure, unspecified other emphysema unspecified essential hypertension congestive heart failure, unspecified anxiety state, unspecified esophageal reflux old myocardial infarction coronary atherosclerosis of native coronary artery automatic implantable cardiac defibrillator in situ other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status tobacco use disorder
white m 58 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  154  mg dl$clopidogrel  75  mg ; fluticasone propionate nasal  1  spry ; lisinopril  20  mg ; paroxetine  20  mg ; simvastatin  80  mg ; tiotropium bromide  1  cap ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ranitidine  150  mg ; trazodone  25-50  mg ; oxycodone-acetaminophen  1-2  tab ; insulin  0  unit ; insulin  60  unit ; aspirin  81  mg ; furosemide  60  mg ; metoprolol succinate xl  50  mg ; metoprolol succinate xl  25  mg ; furosemide  80  mg ; atorvastatin  40  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) systolic heart failure, unspecified other emphysema unspecified essential hypertension congestive heart failure, unspecified anxiety state, unspecified esophageal reflux old myocardial infarction coronary atherosclerosis of native coronary artery automatic implantable cardiac defibrillator in situ other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status tobacco use disorder
white m 58 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  157  mg dl$clopidogrel  75  mg ; fluticasone propionate nasal  1  spry ; lisinopril  20  mg ; paroxetine  20  mg ; tiotropium bromide  1  cap ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ranitidine  150  mg ; trazodone  25-50  mg ; oxycodone-acetaminophen  1-2  tab ; insulin  0  unit ; insulin  60  unit ; aspirin  81  mg ; metoprolol succinate xl  50  mg ; furosemide  80  mg ; atorvastatin  40  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) systolic heart failure, unspecified other emphysema unspecified essential hypertension congestive heart failure, unspecified anxiety state, unspecified esophageal reflux old myocardial infarction coronary atherosclerosis of native coronary artery automatic implantable cardiac defibrillator in situ other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status tobacco use disorder
white m 58 $nan$nan$clopidogrel  75  mg ; fluticasone propionate nasal  1  spry ; lisinopril  20  mg ; paroxetine  20  mg ; tiotropium bromide  1  cap ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ranitidine  150  mg ; trazodone  25-50  mg ; oxycodone-acetaminophen  1-2  tab ; insulin  0  unit ; insulin  60  unit ; aspirin  81  mg ; metoprolol succinate xl  50  mg ; atorvastatin  40  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) systolic heart failure, unspecified other emphysema unspecified essential hypertension congestive heart failure, unspecified anxiety state, unspecified esophageal reflux old myocardial infarction coronary atherosclerosis of native coronary artery automatic implantable cardiac defibrillator in situ other and unspecified hyperlipidemia percutaneous transluminal coronary angioplasty status tobacco use disorder
white f 57 $temp  98.2  heartrate  96.0  resprate  14.0  o2sat  100.0  sbp  138.0  dbp  62.0  rhythm    pain  0  ; temp    heartrate  81.0  resprate  15.0  o2sat  100.0  sbp  147.0  dbp  65.0  rhythm    pain  0  ; temp    heartrate  84.0  resprate  17.0  o2sat  99.0  sbp  131.0  dbp  58.0  rhythm    pain  0  ; temp    heartrate  80.0  resprate  16.0  o2sat  99.0  sbp  134.0  dbp  64.0  rhythm    pain  0  ; temp    heartrate  74.0  resprate  13.0  o2sat  100.0  sbp  139.0  dbp  64.0  rhythm    pain  3  $hematology blood hematocrit  29.2  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  710  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  573  mg dl$nan
 
white f 57 $temp    heartrate  69.0  resprate  21.0  o2sat  99.0  sbp  128.0  dbp  70.0  rhythm    pain    $hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  626  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  5  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  414  mg dl; chemistry blood glucose  353  mg dl$insulin  5  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  40  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  5  mg ; pantoprazole  40  mg ; insulin  0  unit ; insulin  15  unit ; clobetasol propionate 0.05% cream  1  appl ; acetaminophen  1000  mg ; insulin  160  unit ; insulin  70  unit ; pramipexole  1  mg ; 
 
white f 57 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  652  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  6.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  325  mg dl$insulin  5  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  40  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  5  mg ; pantoprazole  40  mg ; insulin  0  unit ; insulin  15  unit ; clobetasol propionate 0.05% cream  1  appl ; acetaminophen  1000  mg ; insulin  160  unit ; insulin  70  unit ; pramipexole  1  mg ; bag  1  bag ; magnesium sulfate  2  gm ; atropine sulfate  0.5  mg ; isosorbide dinitrate  10  mg ; insulin  13  unit ; 
 
white f 57 $nan$blood gas blood potassium, whole blood  4.9  meq l$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  40  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  5  mg ; pantoprazole  40  mg ; clobetasol propionate 0.05% cream  1  appl ; acetaminophen  1000  mg ; atropine sulfate  0.5  mg ; isosorbide dinitrate  10  mg ; insulin  13  unit ; metoprolol succinate xl  25  mg ; insulin  18  unit ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; sodium polystyrene sulfonate  30  gm ; insulin  17  unit ; insulin  20  unit ; 
 
white f 76 $temp  99.1  heartrate  113.0  resprate  18.0  o2sat  100.0  sbp  176.0  dbp  117.0  rhythm    pain  5  ; temp    heartrate  97.0  resprate  17.0  o2sat  98.0  sbp  173.0  dbp  100.0  rhythm    pain    ; temp    heartrate  102.0  resprate  13.0  o2sat  98.0  sbp  172.0  dbp  96.0  rhythm    pain    ; temp  98.3  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    $hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  347  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  38  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  134  mg dl; blood gas blood lactate  1.3  mmol l; blood gas blood potassium, whole blood  4.3  meq l$nan
hypokalemia myositis, unspecified proteinuria, unspecified hypertensive heart disease with heart failure raynaud's syndrome without gangrene bronchiectasis, uncomplicated anemia, unspecified allergic rhinitis, unspecified hypo-osmolality and hyponatremia unspecified diastolic (congestive) heart failure body mass index (bmi) 21.0-21.9, adult essential (hemorrhagic) thrombocythemia hypothyroidism, unspecified other microscopic hematuria acute kidney failure, unspecified unspecified severe protein-calorie malnutrition
white f 76 $temp    heartrate  92.0  resprate  13.0  o2sat  97.0  sbp  167.0  dbp  96.0  rhythm    pain  asleep  $hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  336  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine creatinine, urine  68  mg dl; chemistry urine potassium, urine  67  meq l; chemistry urine sodium, urine  26  meq l; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  117  mg dl; chemistry blood albumin  3.1  g dl; chemistry urine protein creatinine ratio  5.6  mg mg$sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; tramadol  25  mg ; furosemide  20  mg ; nystatin  500,000  unit ; captopril  12.5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; amlodipine  5  mg ; levothyroxine sodium  75  mcg ; multivitamins w minerals  1  tab ; prednisone  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
hypokalemia myositis, unspecified proteinuria, unspecified hypertensive heart disease with heart failure raynaud's syndrome without gangrene bronchiectasis, uncomplicated anemia, unspecified allergic rhinitis, unspecified hypo-osmolality and hyponatremia unspecified diastolic (congestive) heart failure body mass index (bmi) 21.0-21.9, adult essential (hemorrhagic) thrombocythemia hypothyroidism, unspecified other microscopic hematuria acute kidney failure, unspecified unspecified severe protein-calorie malnutrition
white f 76 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  332  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry urine creatinine, urine  33  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  96  mg dl; chemistry urine protein creatinine ratio  3.8  mg mg$sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; tramadol  25  mg ; furosemide  20  mg ; nystatin  500,000  unit ; heparin  5000  unit ; docusate sodium  100  mg ; amlodipine  5  mg ; levothyroxine sodium  75  mcg ; multivitamins w minerals  1  tab ; prednisone  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; potassium chloride  60  meq ; labetalol  200  mg ; 
hypokalemia myositis, unspecified proteinuria, unspecified hypertensive heart disease with heart failure raynaud's syndrome without gangrene bronchiectasis, uncomplicated anemia, unspecified allergic rhinitis, unspecified hypo-osmolality and hyponatremia unspecified diastolic (congestive) heart failure body mass index (bmi) 21.0-21.9, adult essential (hemorrhagic) thrombocythemia hypothyroidism, unspecified other microscopic hematuria acute kidney failure, unspecified unspecified severe protein-calorie malnutrition
white f 76 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  302  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry urine creatinine, urine  89  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  112  mg dl; chemistry urine protein creatinine ratio  1.6  mg mg$sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; tramadol  25  mg ; nystatin  500,000  unit ; heparin  5000  unit ; docusate sodium  100  mg ; levothyroxine sodium  75  mcg ; multivitamins w minerals  1  tab ; prednisone  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; potassium chloride  60  meq ; labetalol  200  mg ; albuterol inhaler  1-2  puff ; ranitidine  150  mg ; 
hypokalemia myositis, unspecified proteinuria, unspecified hypertensive heart disease with heart failure raynaud's syndrome without gangrene bronchiectasis, uncomplicated anemia, unspecified allergic rhinitis, unspecified hypo-osmolality and hyponatremia unspecified diastolic (congestive) heart failure body mass index (bmi) 21.0-21.9, adult essential (hemorrhagic) thrombocythemia hypothyroidism, unspecified other microscopic hematuria acute kidney failure, unspecified unspecified severe protein-calorie malnutrition
white f 76 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  64  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  110  mg dl$sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; tramadol  25  mg ; nystatin  500,000  unit ; docusate sodium  100  mg ; levothyroxine sodium  75  mcg ; multivitamins w minerals  1  tab ; prednisone  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; labetalol  200  mg ; albuterol inhaler  1-2  puff ; ranitidine  150  mg ; 
hypokalemia myositis, unspecified proteinuria, unspecified hypertensive heart disease with heart failure raynaud's syndrome without gangrene bronchiectasis, uncomplicated anemia, unspecified allergic rhinitis, unspecified hypo-osmolality and hyponatremia unspecified diastolic (congestive) heart failure body mass index (bmi) 21.0-21.9, adult essential (hemorrhagic) thrombocythemia hypothyroidism, unspecified other microscopic hematuria acute kidney failure, unspecified unspecified severe protein-calorie malnutrition
white f 76 $nan$hematology blood hematocrit  22.7  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  340  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  62  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; tramadol  25  mg ; nystatin  500,000  unit ; docusate sodium  100  mg ; levothyroxine sodium  75  mcg ; multivitamins w minerals  1  tab ; prednisone  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; labetalol  200  mg ; albuterol inhaler  1-2  puff ; ranitidine  150  mg ; 
hypokalemia myositis, unspecified proteinuria, unspecified hypertensive heart disease with heart failure raynaud's syndrome without gangrene bronchiectasis, uncomplicated anemia, unspecified allergic rhinitis, unspecified hypo-osmolality and hyponatremia unspecified diastolic (congestive) heart failure body mass index (bmi) 21.0-21.9, adult essential (hemorrhagic) thrombocythemia hypothyroidism, unspecified other microscopic hematuria acute kidney failure, unspecified unspecified severe protein-calorie malnutrition
white f 76 $nan$hematology blood hematocrit  22.3  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  370  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; tramadol  25  mg ; nystatin  500,000  unit ; docusate sodium  100  mg ; levothyroxine sodium  75  mcg ; multivitamins w minerals  1  tab ; prednisone  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; labetalol  200  mg ; albuterol inhaler  1-2  puff ; ranitidine  150  mg ; sodium chloride 0.9%  1000  ml ; ondansetron odt  4  mg ; 
hypokalemia myositis, unspecified proteinuria, unspecified hypertensive heart disease with heart failure raynaud's syndrome without gangrene bronchiectasis, uncomplicated anemia, unspecified allergic rhinitis, unspecified hypo-osmolality and hyponatremia unspecified diastolic (congestive) heart failure body mass index (bmi) 21.0-21.9, adult essential (hemorrhagic) thrombocythemia hypothyroidism, unspecified other microscopic hematuria acute kidney failure, unspecified unspecified severe protein-calorie malnutrition
white f 76 $nan$hematology blood hematocrit  21.8  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  413  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  218  iu l$sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; tramadol  25  mg ; nystatin  500,000  unit ; docusate sodium  100  mg ; levothyroxine sodium  75  mcg ; multivitamins w minerals  1  tab ; prednisone  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; labetalol  200  mg ; albuterol inhaler  1-2  puff ; ranitidine  150  mg ; ondansetron odt  4  mg ; 
hypokalemia myositis, unspecified proteinuria, unspecified hypertensive heart disease with heart failure raynaud's syndrome without gangrene bronchiectasis, uncomplicated anemia, unspecified allergic rhinitis, unspecified hypo-osmolality and hyponatremia unspecified diastolic (congestive) heart failure body mass index (bmi) 21.0-21.9, adult essential (hemorrhagic) thrombocythemia hypothyroidism, unspecified other microscopic hematuria acute kidney failure, unspecified unspecified severe protein-calorie malnutrition
white m 70 $temp  98.3  heartrate  64.0  resprate  18.0  o2sat  99.0  sbp  138.0  dbp  82.0  rhythm    pain  0  $hematology blood hematocrit  42.3  %; hematology blood hemoglobin  14.8  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  130  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; heparin  1300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; atorvastatin  80  mg ; aspirin  81  mg ; omeprazole  20  mg ; acetaminophen  650  mg ; metoprolol tartrate  12.5  mg ; polyethylene glycol  17  g ; 
diplopia other and unspecified hyperlipidemia hypoxemia vestibular neuronitis unspecified essential hypertension 
white m 70 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  143  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; heparin  1300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; atorvastatin  80  mg ; aspirin  81  mg ; omeprazole  20  mg ; acetaminophen  650  mg ; metoprolol tartrate  12.5  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; nitroglycerin sl  0.4  mg ; 0.9% sodium chloride  250  ml ; cangrelor  50  mg ; sodium chloride 0.9%  1000  ml ; clopidogrel  600  mg ; ondansetron  4  mg ; 
diplopia other and unspecified hyperlipidemia hypoxemia vestibular neuronitis unspecified essential hypertension 
white m 70 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  231  k ul; hematology blood platelet count  214  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  111  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; heparin  1300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; atorvastatin  80  mg ; aspirin  81  mg ; omeprazole  20  mg ; acetaminophen  650  mg ; metoprolol tartrate  12.5  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; nitroglycerin sl  0.4  mg ; sodium chloride 0.9%  1000  ml ; clopidogrel  600  mg ; ondansetron  4  mg ; clopidogrel  75  mg ; 
diplopia other and unspecified hyperlipidemia hypoxemia vestibular neuronitis unspecified essential hypertension 
white m 70 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; ramelteon  8  mg ; atorvastatin  80  mg ; aspirin  81  mg ; omeprazole  20  mg ; acetaminophen  650  mg ; metoprolol tartrate  12.5  mg ; polyethylene glycol  17  g ; nitroglycerin sl  0.4  mg ; ondansetron  4  mg ; clopidogrel  75  mg ; 
diplopia other and unspecified hyperlipidemia hypoxemia vestibular neuronitis unspecified essential hypertension 
white f 40 $temp  99.2  heartrate  74.0  resprate  16.0  o2sat  100.0  sbp  111.0  dbp  72.0  rhythm    pain  6  $hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  358  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  86  mg dl$ns  100  ml ; metronidazole  500  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)  5  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; oxycodone (immediate release)  5-10  mg ; bag  1  bag ; magnesium sulfate  2  gm ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
 
white f 40 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  342  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  2  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  98  mg dl$ns  100  ml ; metronidazole  500  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ondansetron  4  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; bag  1  bag ; magnesium sulfate  2  gm ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; metoclopramide  10  mg ; hydromorphone (dilaudid)  0.5  mg ; 
 
white f 40 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  354  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  2  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  93  mg dl$ns  100  ml ; metronidazole  500  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; acetaminophen  1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ondansetron  8  mg ; scopolamine patch  1  ptch ; moviprep  1  l ; fleet enema (saline)  1  enema ; promethazine  6.25  mg ; acetaminophen iv  1000  mg ; 
 
white f 40 $nan$nan$acetaminophen iv  1000  mg ; ketorolac  30  mg ; docusate sodium  100  mg ; 
 
white f 40 $nan$nan$acetaminophen iv  1000  mg ; ketorolac  30  mg ; docusate sodium  100  mg ; 
 
white m 55 $nan$hematology blood hematocrit  24.4  %; hematology blood hematocrit  23.0  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  179  k ul; hematology blood platelet count  162  k ul; chemistry blood anion gap  7  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  4.4  mg dl; chemistry blood creatinine  4.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine creatinine, urine  102  mg dl; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  12.8  mg dl; chemistry blood calcium, total  11.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  144  iu l; chemistry blood albumin  2.8  g dl; chemistry urine protein creatinine ratio  0.8  ratio; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$0.9% sodium chloride  1000  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; allopurinol  100  mg ; oxycodone-acetaminophen  1  tab ; 
 
white m 55 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  9  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood creatinine  3.6  mg dl; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  11.3  mg dl; chemistry blood calcium, total  11.7  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  145  mg dl; chemistry blood glucose  117  mg dl; chemistry blood lactate dehydrogenase (ld)  147  iu l$0.9% sodium chloride  1000  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; allopurinol  100  mg ; oxycodone-acetaminophen  1  tab ; potassium chloride  20  meq ; sw  50  ml ; magnesium sulfate  2  gm ; pneumococcal vac polyvalent  0.5  ml ; tuberculin protein  0.1  ml ; potassium chloride  40  meq ; sodium chloride 0.9%  flush  3  ml ; metronidazole (flagyl)  250  mg ; 5% dextrose  50  ml ; dexamethasone sod phosphate  40  mg ; ivermectin  6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; calcitonin salmon  360  unit ; 
 
white m 55 $nan$hematology blood hematocrit  22.1  %; hematology blood hematocrit  23.2  %; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  142  k ul; hematology blood platelet count  129  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood creatinine  3.0  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  10.6  mg dl; chemistry blood calcium, total  10.6  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  144  mg dl; chemistry blood lactate dehydrogenase (ld)  148  iu l; chemistry blood lactate dehydrogenase (ld)  180  iu l$allopurinol  100  mg ; pneumococcal vac polyvalent  0.5  ml ; tuberculin protein  0.1  ml ; sodium chloride 0.9%  flush  3  ml ; metronidazole (flagyl)  250  mg ; 5% dextrose  50  ml ; dexamethasone sod phosphate  40  mg ; ivermectin  6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; calcitonin salmon  360  unit ; sw  100  ml ; magnesium sulfate  4  gm ; syringe (chemo)  2.7  ml ; bortezomib  2.7  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; 
 
white m 55 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood calcium, total  10.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  157  mg dl; chemistry blood glucose  98  mg dl; chemistry blood lactate dehydrogenase (ld)  150  iu l; chemistry blood albumin  2.9  g dl$allopurinol  100  mg ; sodium chloride 0.9%  flush  3  ml ; metronidazole (flagyl)  250  mg ; 5% dextrose  50  ml ; dexamethasone sod phosphate  40  mg ; ivermectin  6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; syringe (chemo)  2.7  ml ; bortezomib  2.7  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; allopurinol  150  mg ; 
 
white m 55 $nan$hematology blood hematocrit  23.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  7  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.5  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  128  mg dl; chemistry blood lactate dehydrogenase (ld)  164  iu l; chemistry blood albumin  2.7  g dl$allopurinol  100  mg ; sodium chloride 0.9%  flush  3  ml ; metronidazole (flagyl)  250  mg ; 5% dextrose  50  ml ; dexamethasone sod phosphate  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; syringe (chemo)  2.7  ml ; bortezomib  2.7  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; allopurinol  150  mg ; allopurinol  50  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; pamidronate  60  mg ; furosemide  20  mg ; 
 
white m 55 $nan$hematology blood hematocrit  24.2  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  165  k ul; hematology blood platelet count  157  k ul; chemistry blood anion gap  6  meq l; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  82  mg dl; chemistry blood glucose  132  mg dl; chemistry blood lactate dehydrogenase (ld)  241  iu l; hematology blood bands  1  %$sodium chloride 0.9%  flush  3  ml ; syringe (chemo)  2.7  ml ; bortezomib  2.7  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; allopurinol  150  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; pamidronate  60  mg ; furosemide  20  mg ; dexamethasone  20  mg ; 5% dextrose  250  ml ; lorazepam  0.5-1  mg ; furosemide  40  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  250  ml ; 
 
white m 55 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  141  mg dl; chemistry blood lactate dehydrogenase (ld)  369  iu l; chemistry blood albumin  2.5  g dl; hematology blood bands  6  %; blood gas blood free calcium  1.04  mmol l$sodium chloride 0.9%  flush  3  ml ; syringe (chemo)  2.7  ml ; bortezomib  2.7  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; allopurinol  150  mg ; dexamethasone  20  mg ; 5% dextrose  250  ml ; lorazepam  0.5-1  mg ; furosemide  40  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  250  ml ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; neutra-phos  2  pkt ; 
 
white m 55 $nan$hematology blood hematocrit  22.2  %; hematology blood hematocrit  23.6  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  119  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine creatinine, urine  43  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  305  iu l; hematology blood bands  4  %; chemistry urine protein creatinine ratio  1.0  ratio$sodium chloride 0.9%  flush  3  ml ; syringe (chemo)  2.7  ml ; bortezomib  2.7  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; allopurinol  150  mg ; dexamethasone  20  mg ; lorazepam  0.5-1  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; neutra-phos  2  pkt ; 
 
white m 55 $nan$nan$sodium chloride 0.9%  flush  3  ml ; syringe (chemo)  2.7  ml ; bortezomib  2.7  mg ; prochlorperazine  10  mg ; ondansetron  8  mg ; allopurinol  150  mg ; dexamethasone  20  mg ; lorazepam  0.5-1  mg ; acetaminophen  650  mg ; 
 
asian f 71 $nan$hematology blood hematocrit  30.4  %; hematology blood hematocrit  27.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  39  k ul; hematology blood platelet count  41  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  105  mg dl; chemistry blood lactate dehydrogenase (ld)  2053  iu l; chemistry blood albumin  2.9  g dl; blood gas blood lactate  1.1  mmol l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; vitamin d  400  unit ; ranitidine  150  mg ; calcium carbonate  500  mg ; valsartan  320  mg ; 0.9% sodium chloride  1000  ml ; ciprofloxacin hcl  500  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; acetaminophen  325  mg ; morphine sulfate  1  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; acetaminophen  1000  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; simvastatin  20  mg ; 
 
asian f 71 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  35  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine creatinine, urine  93  mg dl; hematology urine wbc  7  # hpf; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  156  mg dl; chemistry blood lactate dehydrogenase (ld)  2700  iu l; chemistry blood lactate dehydrogenase (ld)  2580  iu l; chemistry blood albumin  2.9  g dl; chemistry blood albumin  2.8  g dl; chemistry urine protein creatinine ratio  1.7  ratio$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; vitamin d  400  unit ; ranitidine  150  mg ; calcium carbonate  500  mg ; valsartan  320  mg ; 0.9% sodium chloride  1000  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; acetaminophen  325  mg ; morphine sulfate  1  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; acetaminophen  1000  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; simvastatin  20  mg ; acetaminophen iv  1000  mg ; alendronate sodium  70  mg ; neutra-phos  1  pkt ; 
 
asian f 71 $nan$hematology blood hematocrit  26.4  %; hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  35  k ul; hematology blood platelet count  40  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; vitamin d  400  unit ; ranitidine  150  mg ; calcium carbonate  500  mg ; valsartan  320  mg ; morphine sulfate  1  mg ; alendronate sodium  70  mg ; neutra-phos  1  pkt ; neutra-phos  2  pkt ; valsartan  160  mg ; 
 
asian f 71 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  43  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  3178  iu l; chemistry blood albumin  2.7  g dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; vitamin d  400  unit ; ranitidine  150  mg ; calcium carbonate  500  mg ; morphine sulfate  1  mg ; alendronate sodium  70  mg ; neutra-phos  2  pkt ; valsartan  160  mg ; potassium chl 40 meq   1000 ml ns  1000  ml ; nystatin oral suspension  5  ml ; sodium bicarbonate  650  mg ; sodium chloride 0.9%  flush  10  ml ; 
 
asian f 71 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  40  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  3264  iu l$5% dextrose  100  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; vitamin d  400  unit ; ranitidine  150  mg ; calcium carbonate  500  mg ; morphine sulfate  1  mg ; alendronate sodium  70  mg ; valsartan  160  mg ; nystatin oral suspension  5  ml ; sodium bicarbonate  650  mg ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.5  mg ; morphine sulfate  1-2  mg ; lidocaine 1%  10  ml ; lactated ringers  1000  ml ; doxycycline hyclate  100  mg ; 
 
asian f 71 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  35  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine chloride, urine  74  meq l; chemistry urine creatinine, urine  184  mg dl; chemistry urine potassium, urine  25  meq l; chemistry urine sodium, urine  37  meq l; chemistry urine urea nitrogen, urine  549  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  122  mg dl; chemistry blood lactate dehydrogenase (ld)  3205  iu l$5% dextrose  100  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; vitamin d  400  unit ; ranitidine  150  mg ; calcium carbonate  500  mg ; alendronate sodium  70  mg ; valsartan  160  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.5  mg ; morphine sulfate  1-2  mg ; lidocaine 1%  10  ml ; doxycycline hyclate  100  mg ; potassium chloride (powder)  60  meq ; loperamide  2  mg ; diphenhydramine  12.5  mg ; 
 
asian f 71 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  49  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  6.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  2658  iu l$5% dextrose  100  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; vitamin d  400  unit ; ranitidine  150  mg ; calcium carbonate  500  mg ; alendronate sodium  70  mg ; valsartan  160  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.5  mg ; morphine sulfate  1-2  mg ; doxycycline hyclate  100  mg ; loperamide  2  mg ; diphenhydramine  12.5  mg ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; sodium bicarbonate  1300  mg ; sarna lotion  1  appl ; 
 
asian f 71 $nan$hematology blood hematocrit  22.5  %; hematology blood hematocrit  23.7  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  35  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  2382  iu l; chemistry blood albumin  2.1  g dl$5% dextrose  100  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; vitamin d  400  unit ; ranitidine  150  mg ; alendronate sodium  70  mg ; valsartan  160  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.5  mg ; morphine sulfate  1-2  mg ; doxycycline hyclate  100  mg ; loperamide  2  mg ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; sodium bicarbonate  1300  mg ; sarna lotion  1  appl ; acetaminophen  325-650  mg ; 
 
asian f 71 $nan$hematology blood hematocrit  22.6  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  32  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  98  mg dl; chemistry blood lactate dehydrogenase (ld)  2291  iu l; chemistry blood albumin  2.1  g dl$5% dextrose  100  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; vitamin d  400  unit ; ranitidine  150  mg ; alendronate sodium  70  mg ; valsartan  160  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.5  mg ; morphine sulfate  1-2  mg ; doxycycline hyclate  100  mg ; loperamide  2  mg ; sodium bicarbonate  1300  mg ; sarna lotion  1  appl ; acetaminophen  325-650  mg ; 
 
asian f 71 $nan$hematology blood hematocrit  20.6  %; hematology blood hemoglobin  6.7  g dl; hematology blood platelet count  74  k ul; chemistry blood anion gap  7  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine creatinine, urine  31  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  119  mg dl; chemistry blood lactate dehydrogenase (ld)  2070  iu l; chemistry blood albumin  2.1  g dl; chemistry urine protein creatinine ratio  0.6  ratio$5% dextrose  100  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; alendronate sodium  70  mg ; valsartan  160  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.5  mg ; morphine sulfate  1-2  mg ; doxycycline hyclate  100  mg ; loperamide  2  mg ; sodium bicarbonate  1300  mg ; sarna lotion  1  appl ; acetaminophen  325-650  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; potassium chloride  40  meq ; magnesium oxide  400  mg ; 
 
asian f 71 $nan$hematology blood hematocrit  24.4  %; hematology blood hematocrit  22.6  %; hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  38  k ul; hematology blood platelet count  45  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.1  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  124  mg dl; chemistry blood lactate dehydrogenase (ld)  1940  iu l; chemistry blood albumin  2.3  g dl$5% dextrose  100  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; alendronate sodium  70  mg ; valsartan  160  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.5  mg ; morphine sulfate  1-2  mg ; doxycycline hyclate  100  mg ; loperamide  2  mg ; sodium bicarbonate  1300  mg ; sarna lotion  1  appl ; acetaminophen  325-650  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; potassium chloride  40  meq ; magnesium oxide  400  mg ; potassium chloride  20  meq ; potassium chloride (powder)  20  meq ; sterile water  50  ml ; bag  50  ml ; magnesium sulfate  2  gm ; 
 
asian f 71 $nan$hematology blood hematocrit  22.5  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  45  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  130  mg dl; chemistry blood lactate dehydrogenase (ld)  1963  iu l; chemistry blood albumin  2.5  g dl$5% dextrose  100  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; alendronate sodium  70  mg ; valsartan  160  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.5  mg ; morphine sulfate  1-2  mg ; doxycycline hyclate  100  mg ; loperamide  2  mg ; sodium bicarbonate  1300  mg ; sarna lotion  1  appl ; sterile water  50  ml ; bag  50  ml ; magnesium sulfate  2  gm ; trazodone  25  mg ; folic acid  5  mg ; 
 
asian f 71 $nan$hematology blood hematocrit  26.7  %; hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  43  k ul; hematology blood platelet count  44  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  2304  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  1  %; hematology blood bands  3  %$5% dextrose  100  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; alendronate sodium  70  mg ; valsartan  160  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.5  mg ; morphine sulfate  1-2  mg ; doxycycline hyclate  100  mg ; loperamide  2  mg ; sodium bicarbonate  1300  mg ; sarna lotion  1  appl ; trazodone  25  mg ; folic acid  5  mg ; albuterol 0.083% neb soln  1  neb ; furosemide  20  mg ; ivermectin  13.5  mg ; prednisone  20  mg ; prednisone  50  mg ; lamivudine  100  mg ; 
 
asian f 71 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  47  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  195  mg dl; chemistry blood lactate dehydrogenase (ld)  2371  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  3  %$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; alendronate sodium  70  mg ; valsartan  160  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.5  mg ; morphine sulfate  1-2  mg ; loperamide  2  mg ; sodium bicarbonate  1300  mg ; sarna lotion  1  appl ; folic acid  5  mg ; albuterol 0.083% neb soln  1  neb ; furosemide  20  mg ; ivermectin  13.5  mg ; prednisone  20  mg ; prednisone  50  mg ; lamivudine  100  mg ; sulfameth trimethoprim ss  1  tab ; vitamin d  800  unit ; furosemide  10  mg ; potassium chloride (powder)  40  meq ; 
 
asian f 71 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  62  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  1783  iu l; chemistry blood albumin  2.8  g dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; alendronate sodium  70  mg ; valsartan  160  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.5  mg ; morphine sulfate  1-2  mg ; loperamide  2  mg ; sodium bicarbonate  1300  mg ; sarna lotion  1  appl ; folic acid  5  mg ; albuterol 0.083% neb soln  1  neb ; ivermectin  13.5  mg ; lamivudine  100  mg ; vitamin d  800  unit ; furosemide  10  mg ; potassium chloride (powder)  40  meq ; 
 
asian f 71 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  93  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  1493  iu l; hematology blood bands  2  %$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; alendronate sodium  70  mg ; valsartan  160  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.5  mg ; morphine sulfate  1-2  mg ; loperamide  2  mg ; sodium bicarbonate  1300  mg ; sarna lotion  1  appl ; folic acid  5  mg ; albuterol 0.083% neb soln  1  neb ; lamivudine  100  mg ; vitamin d  800  unit ; 
 
asian f 71 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  108  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  90  mg dl; chemistry blood lactate dehydrogenase (ld)  1190  iu l$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; alendronate sodium  70  mg ; valsartan  160  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; lorazepam  0.5  mg ; morphine sulfate  1-2  mg ; loperamide  2  mg ; sodium bicarbonate  1300  mg ; sarna lotion  1  appl ; folic acid  5  mg ; albuterol 0.083% neb soln  1  neb ; lamivudine  100  mg ; vitamin d  800  unit ; omeprazole  20  mg ; 
 
hispanic latino f 92 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  84  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  94  mg dl$ascorbic acid  500  mg ; aspirin  81  mg ; citalopram  10  mg ; fluticasone propionate nasal  1  spry ; folic acid  1  mg ; multivitamins  1  tab ; omeprazole  20  mg ; propran  60  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; gabapentin  600  mg ; hydrocodone-acetaminophen (5mg-500mg)  1  tab ; lorazepam  0.25  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; ipratropium bromide neb  1  neb ; simethicone  80  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; oseltamivir  75  mg ; acetaminophen  1000  mg ; levofloxacin  750  mg ; tramadol (ultram)  50  mg ; pancrelipase 5000  4  cap ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; senna  2  tab ; propranolol  20  mg ; sodium chloride nasal  1-2  spry ; guaifenesin  5-10  ml ; 
dizziness and giddiness nausea with vomiting fever, unspecified 
hispanic latino f 92 $nan$nan$ascorbic acid  500  mg ; aspirin  81  mg ; citalopram  10  mg ; fluticasone propionate nasal  1  spry ; folic acid  1  mg ; multivitamins  1  tab ; omeprazole  20  mg ; propran  60  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; gabapentin  600  mg ; hydrocodone-acetaminophen (5mg-500mg)  1  tab ; lorazepam  0.25  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; ipratropium bromide neb  1  neb ; simethicone  80  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; levofloxacin  750  mg ; tramadol (ultram)  50  mg ; pancrelipase 5000  4  cap ; docusate sodium  100  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; senna  2  tab ; propranolol  20  mg ; sodium chloride nasal  1-2  spry ; guaifenesin  5-10  ml ; 
dizziness and giddiness nausea with vomiting fever, unspecified 
white f 66 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  291  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  136  mg dl; blood gas blood potassium, whole blood  3.7  meq l$nan
 
white f 66 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  99  mg dl; chemistry blood % hemoglobin a1c  6.2  %$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; omeprazole  20  mg ; multivitamins  1  tab ; aspirin  81  mg ; atorvastatin  10  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; zolpidem tartrate  5  mg ; 
 
white f 66 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; omeprazole  20  mg ; multivitamins  1  tab ; aspirin  81  mg ; atorvastatin  10  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; zolpidem tartrate  5  mg ; levothyroxine sodium  25  mcg ; 
 
white f 66 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; omeprazole  20  mg ; multivitamins  1  tab ; aspirin  81  mg ; atorvastatin  10  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; levothyroxine sodium  25  mcg ; 
 
white f 51 $temp    heartrate  105.0  resprate  19.0  o2sat  99.0  sbp  149.0  dbp  83.0  rhythm    pain  0  ; temp  98.6  heartrate  104.0  resprate  18.0  o2sat  99.0  sbp  154.0  dbp  90.0  rhythm    pain  0  $nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ibuprofen  400  mg ; acetaminophen  325-650  mg ; cyclobenzaprine  5  mg ; 
 
white f 51 $nan$hematology blood hematocrit  38.7  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cyclobenzaprine  5  mg ; paliperidone er  6  mg ; vial  1  vial ; ceftriaxone  1  gm ; 
 
white f 51 $nan$chemistry blood % hemoglobin a1c  6.2  %$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cyclobenzaprine  5  mg ; paliperidone er  6  mg ; lactated ringers  1000  ml ; 0.9% sodium chloride  1  vial ; 0.9% sodium chloride  100  ml ; 0.9% sodium chloride  1  bag ; 
 
white f 51 $nan$hematology blood hematocrit  39.4  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cyclobenzaprine  5  mg ; paliperidone er  6  mg ; 0.9% sodium chloride  100  ml ; 
 
white f 51 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cyclobenzaprine  5  mg ; paliperidone er  6  mg ; 
 
white f 51 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cyclobenzaprine  5  mg ; paliperidone er  9  mg ; 
 
white f 51 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cyclobenzaprine  5  mg ; paliperidone er  9  mg ; 
 
white f 51 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cyclobenzaprine  5  mg ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  0.5  mg ; haloperidol  2.5  mg ; lorazepam  1  mg ; 
 
white f 51 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  2.5  mg ; lorazepam  1  mg ; 
 
white f 51 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  2.5  mg ; lorazepam  1  mg ; sodium chloride nasal  1-2  spry ; 
 
white f 51 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  2.5  mg ; lorazepam  1  mg ; sodium chloride nasal  1-2  spry ; 
 
white f 51 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  2.5  mg ; lorazepam  1  mg ; sodium chloride nasal  1-2  spry ; ranitidine  75  mg ; 
 
white f 51 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  121  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  2.5  mg ; lorazepam  1  mg ; sodium chloride nasal  1-2  spry ; ranitidine  75  mg ; furosemide  20  mg ; 
 
white f 51 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  139  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  2.5  mg ; lorazepam  1  mg ; sodium chloride nasal  1-2  spry ; ranitidine  75  mg ; furosemide  20  mg ; 
 
white f 51 $nan$chemistry blood anion gap  14  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  134  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  2.5  mg ; lorazepam  1  mg ; sodium chloride nasal  1-2  spry ; 
 
white f 51 $nan$chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  132  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  2.5  mg ; lorazepam  1  mg ; sodium chloride nasal  1-2  spry ; 
 
white f 51 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  2.5  mg ; lorazepam  1  mg ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; 
 
white f 51 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  2.5  mg ; lorazepam  1  mg ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; 
 
white f 51 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  2.5  mg ; lorazepam  1  mg ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; 
 
white f 51 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  2.5  mg ; lorazepam  1  mg ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; 
 
white f 51 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  2.5  mg ; lorazepam  1  mg ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; 
 
white f 51 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  129  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  2.5  mg ; lorazepam  1  mg ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; 
 
white f 51 $nan$chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  141  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; haloperidol  2.5  mg ; lorazepam  1  mg ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; 
 
white f 51 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; 
 
white f 51 $nan$chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  118  mg dl; chemistry blood albumin  3.8  g dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; 
 
white f 51 $nan$chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  81  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; magnesium oxide  400  mg ; 
 
white f 51 $nan$chemistry blood anion gap  10  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  90  mg dl; chemistry blood glucose  120  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; magnesium oxide  400  mg ; 
 
white f 51 $nan$chemistry blood anion gap  10  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; 
 
white f 51 $nan$chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  120  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; furosemide  40  mg ; 
 
white f 51 $nan$chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; 
 
white f 51 $nan$chemistry blood anion gap  17  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  129  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  2.5  mg ; 
 
white f 51 $nan$chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  91  mg dl; chemistry blood glucose  140  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  2.5  mg ; 
 
white f 51 $nan$chemistry blood anion gap  11  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; fluticasone propionate nasal  1  spry ; 
 
white f 51 $nan$chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; fluticasone propionate nasal  1  spry ; 
 
white f 51 $nan$chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  124  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; 
 
white f 51 $nan$chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; 
 
white f 51 $nan$chemistry blood anion gap  11  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  158  mg dl; chemistry blood glucose  110  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; 
 
white f 51 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; furosemide  60  mg ; potassium chloride  20  meq ; 
 
white f 51 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; furosemide  60  mg ; potassium chloride  20  meq ; 
 
white f 51 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3-10  ml ; paliperidone er  9  mg ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; 
 
white f 51 $nan$chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; polyethylene glycol  17  g ; paliperidone palmitate  234  mg ; 
 
white f 51 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; polyethylene glycol  17  g ; paliperidone palmitate  234  mg ; 
 
white f 51 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; polyethylene glycol  17  g ; 
 
white f 51 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; polyethylene glycol  17  g ; 
 
white f 51 $nan$chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  126  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; polyethylene glycol  17  g ; 
 
white f 51 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; polyethylene glycol  17  g ; ramelteon  8  mg ; 
 
white f 51 $nan$chemistry blood anion gap  21  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  110  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; polyethylene glycol  17  g ; ramelteon  8  mg ; furosemide  80  mg ; furosemide  160  mg ; furosemide  120  mg ; 
 
white f 51 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; polyethylene glycol  17  g ; ramelteon  8  mg ; furosemide  120  mg ; paliperidone palmitate  156  mg ; torsemide  80  mg ; 
 
white f 51 $nan$chemistry blood anion gap  22  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  149  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; polyethylene glycol  17  g ; ramelteon  8  mg ; torsemide  80  mg ; 
 
white f 51 $nan$chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; polyethylene glycol  17  g ; ramelteon  8  mg ; torsemide  80  mg ; potassium chloride  80  meq ; 
 
white f 51 $nan$chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sarna lotion  1  appl ; sodium chloride nasal  1-2  spry ; cetirizine  10  mg ; senna  8.6  mg ; amlodipine  5  mg ; polyethylene glycol  17  g ; ramelteon  8  mg ; torsemide  60  mg ; torsemide  20  mg ; 
 
white f 76 $temp  97.9  heartrate  60.0  resprate  16.0  o2sat  97.0  sbp  131.0  dbp  48.0  rhythm    pain    ; temp  98.6  heartrate  62.0  resprate  18.0  o2sat  98.0  sbp  123.0  dbp  56.0  rhythm    pain  0  $chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood glucose  112  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; amoxicillin-clavulanic acid  500  mg ; aspirin  81  mg ; carvedilol  12.5  mg ; hydrochlorothiazide  25  mg ; levothyroxine sodium  100  mcg ; pantoprazole  40  mg ; vitamin d  1000  unit ; carbamazepine  200  mg ; carbamazepine  300  mg ; zolpidem tartrate  10  mg ; senna  8.6  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  1000  ml ; nitroglycerin sl  0.3  mg ; 
chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction coronary atherosclerosis of unspecified type of vessel, native or graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pneumonia, organism unspecified aortic valve disorders old myocardial infarction other specified cardiac dysrhythmias ostium secundum type atrial septal defect anxiety state, unspecified other fluid overload acidosis other pulmonary insufficiency, not elsewhere classified, following trauma and surgery coronary atherosclerosis of native coronary artery anemia of other chronic disease unspecified essential hypertension percutaneous transluminal coronary angioplasty status bipolar disorder, unspecified acute kidney failure, unspecified other and unspecified angina pectoris other and unspecified hyperlipidemia other diuretics causing adverse effects in therapeutic use other postablative hypothyroidism benign paroxysmal positional vertigo anemia, unspecified bipolar disorder, unspecified unspecified essential hypertension coronary atherosclerosis of unspecified type of vessel, native or graft old myocardial infarction unspecified acquired hypothyroidism other and unspecified hyperlipidemia
white f 76 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; amoxicillin-clavulanic acid  500  mg ; aspirin  81  mg ; levothyroxine sodium  100  mcg ; pantoprazole  40  mg ; vitamin d  1000  unit ; carbamazepine  200  mg ; carbamazepine  300  mg ; zolpidem tartrate  10  mg ; senna  8.6  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  1000  ml ; nitroglycerin sl  0.3  mg ; 
chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction coronary atherosclerosis of unspecified type of vessel, native or graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pneumonia, organism unspecified aortic valve disorders old myocardial infarction other specified cardiac dysrhythmias ostium secundum type atrial septal defect anxiety state, unspecified other fluid overload acidosis other pulmonary insufficiency, not elsewhere classified, following trauma and surgery coronary atherosclerosis of native coronary artery anemia of other chronic disease unspecified essential hypertension percutaneous transluminal coronary angioplasty status bipolar disorder, unspecified acute kidney failure, unspecified other and unspecified angina pectoris other and unspecified hyperlipidemia other diuretics causing adverse effects in therapeutic use other postablative hypothyroidism benign paroxysmal positional vertigo anemia, unspecified bipolar disorder, unspecified unspecified essential hypertension coronary atherosclerosis of unspecified type of vessel, native or graft old myocardial infarction unspecified acquired hypothyroidism other and unspecified hyperlipidemia
white m 60 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  81  mg dl$fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.12  mg ; acetaminophen iv  1000  mg ; ketorolac  15  mg ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; heparin  5000  unit ; lansoprazole oral disintegrating tab  30  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ranitidine (liquid)  75  mg ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$nan$fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.12  mg ; acetaminophen iv  1000  mg ; ketorolac  15  mg ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; heparin  5000  unit ; lansoprazole oral disintegrating tab  30  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ranitidine (liquid)  75  mg ; azelastine  2  spry ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ketorolac  30  mg ; diphenhydramine  25  mg ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$nan$fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.12  mg ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; heparin  5000  unit ; lansoprazole oral disintegrating tab  30  mg ; ranitidine (liquid)  75  mg ; azelastine  2  spry ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ketorolac  30  mg ; diphenhydramine  25  mg ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$nan$fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; heparin  5000  unit ; lansoprazole oral disintegrating tab  30  mg ; ranitidine (liquid)  75  mg ; azelastine  2  spry ; ketorolac  30  mg ; oxycodone (immediate release)   5-10  mg ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$nan$fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; ranitidine (liquid)  75  mg ; azelastine  2  spry ; ketorolac  30  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$nan$fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; ranitidine (liquid)  75  mg ; azelastine  2  spry ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; d5 1 2ns  1000  ml ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  106  mg dl$fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; ranitidine (liquid)  75  mg ; azelastine  2  spry ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; d5 1 2ns  1000  ml ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$nan$fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; ranitidine (liquid)  75  mg ; azelastine  2  spry ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; d5 1 2ns  1000  ml ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$nan$fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; ranitidine (liquid)  75  mg ; azelastine  2  spry ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; d5 1 2ns  1000  ml ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  107  mg dl$fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; ranitidine (liquid)  75  mg ; azelastine  2  spry ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; d5 1 2ns  1000  ml ; metoclopramide  10  mg ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$nan$fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; ranitidine (liquid)  75  mg ; azelastine  2  spry ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; metoclopramide  10  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; lorazepam  0.125-0.25  mg ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  116  mg dl$fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; ranitidine (liquid)  75  mg ; azelastine  2  spry ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; metoclopramide  10  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; lorazepam  0.125-0.25  mg ; heparin flush (10 units ml)  2  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$nan$fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; ranitidine (liquid)  75  mg ; azelastine  2  spry ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; metoclopramide  10  mg ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  98  mg dl; chemistry blood glucose  118  mg dl; chemistry blood albumin  3.8  g dl$sodium chloride 0.9%  flush  20  ml ; fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; ranitidine (liquid)  75  mg ; oxycodone (immediate release)   5-10  mg ; metoclopramide  10  mg ; lorazepam  0.5-1  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; methylnaltrexone  12  mg ; ranitidine (liquid)  150  mg ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  20  ml ; fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; oxycodone (immediate release)   5-10  mg ; metoclopramide  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; methylnaltrexone  12  mg ; ranitidine (liquid)  150  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  flush  20  ml ; fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; oxycodone (immediate release)   5-10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; ranitidine (liquid)  150  mg ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5  mg ; calcium carbonate  1000  mg ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  20  ml ; fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; oxycodone (immediate release)   5-10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5  mg ; sucralfate  1  gm ; nystatin oral suspension  5  ml ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
white m 60 $nan$nan$sodium chloride 0.9%  flush  20  ml ; fexofenadine  180  mg ; fluticasone propionate nasal  2  spry ; montelukast  10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; benzonatate  200  mg ; ondansetron  4  mg ; lansoprazole oral disintegrating tab  30  mg ; oxycodone (immediate release)   5-10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5  mg ; sucralfate  1  gm ; nystatin oral suspension  5  ml ; 
intestinal bypass or anastomosis status person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle asthma, unspecified type, unspecified other specified intestinal obstruction personal history of irradiation, presenting hazards to health unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident brachial neuritis or radiculitis nos esophageal reflux paralytic ileus unspecified intestinal obstruction esophageal reflux brachial neuritis or radiculitis nos asthma, unspecified type, unspecified personal history of irradiation, presenting hazards to health unspecified sedatives and hypnotics causing adverse effects in therapeutic use person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle
unknown m 72 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  127  mg dl$lactated ringers  1000  ml ; atorvastatin  20  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; pantoprazole  40  mg ; polyethylene glycol  17  g ; carbidopa-levodopa (25-100)  2.5  tab ; citalopram  20  mg ; insulin  0  unit ; heparin  5000  unit ; miconazole 2% cream  1  appl ; donepezil  10  mg ; quetiapine fumarate  12.5  mg ; trazodone  150  mg ; 
chronic pulmonary edema severe sepsis without septic shock essential (primary) hypertension dementia in other diseases classified elsewhere without behavioral disturbance acute kidney failure, unspecified anemia, unspecified gastro-esophageal reflux disease without esophagitis parkinson's disease benign prostatic hyperplasia without lower urinary tract symptoms major depressive disorder, single episode, unspecified calculus of gallbladder with acute cholecystitis with obstruction sepsis due to enterococcus type 2 diabetes mellitus without complications hypoxemia unspecified place in hospital as the place of occurrence of the external cause toxic encephalopathy personal history of other venous thrombosis and embolism diverticulosis of small intestine without perforation or abscess without bleeding pure hypercholesterolemia, unspecified acidosis coagulation defect, unspecified adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter nonrheumatic aortic (valve) stenosis long term (current) use of anticoagulants other cholangitis 
unknown m 72 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  129  mg dl$atorvastatin  20  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; pantoprazole  40  mg ; polyethylene glycol  17  g ; carbidopa-levodopa (25-100)  2.5  tab ; citalopram  20  mg ; insulin  0  unit ; heparin  5000  unit ; miconazole 2% cream  1  appl ; donepezil  10  mg ; quetiapine fumarate  12.5  mg ; trazodone  150  mg ; lisinopril  2.5  mg ; potassium citrate  40  meq ; warfarin  2.5  mg ; 
chronic pulmonary edema severe sepsis without septic shock essential (primary) hypertension dementia in other diseases classified elsewhere without behavioral disturbance acute kidney failure, unspecified anemia, unspecified gastro-esophageal reflux disease without esophagitis parkinson's disease benign prostatic hyperplasia without lower urinary tract symptoms major depressive disorder, single episode, unspecified calculus of gallbladder with acute cholecystitis with obstruction sepsis due to enterococcus type 2 diabetes mellitus without complications hypoxemia unspecified place in hospital as the place of occurrence of the external cause toxic encephalopathy personal history of other venous thrombosis and embolism diverticulosis of small intestine without perforation or abscess without bleeding pure hypercholesterolemia, unspecified acidosis coagulation defect, unspecified adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter nonrheumatic aortic (valve) stenosis long term (current) use of anticoagulants other cholangitis 
unknown m 72 $nan$nan$atorvastatin  20  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; pantoprazole  40  mg ; polyethylene glycol  17  g ; carbidopa-levodopa (25-100)  2.5  tab ; citalopram  20  mg ; insulin  0  unit ; heparin  5000  unit ; miconazole 2% cream  1  appl ; donepezil  10  mg ; quetiapine fumarate  12.5  mg ; trazodone  150  mg ; potassium citrate  40  meq ; warfarin  2.5  mg ; warfarin  5  mg ; 
chronic pulmonary edema severe sepsis without septic shock essential (primary) hypertension dementia in other diseases classified elsewhere without behavioral disturbance acute kidney failure, unspecified anemia, unspecified gastro-esophageal reflux disease without esophagitis parkinson's disease benign prostatic hyperplasia without lower urinary tract symptoms major depressive disorder, single episode, unspecified calculus of gallbladder with acute cholecystitis with obstruction sepsis due to enterococcus type 2 diabetes mellitus without complications hypoxemia unspecified place in hospital as the place of occurrence of the external cause toxic encephalopathy personal history of other venous thrombosis and embolism diverticulosis of small intestine without perforation or abscess without bleeding pure hypercholesterolemia, unspecified acidosis coagulation defect, unspecified adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter nonrheumatic aortic (valve) stenosis long term (current) use of anticoagulants other cholangitis 
other m 42 $nan$nan$enoxaparin sodium  30  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5-10  mg ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; sodium chloride 0.9%  1000  ml ; amoxicillin-clavulanic acid  500  mg ; 
 
other m 42 $nan$nan$enoxaparin sodium  30  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5-10  mg ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; amoxicillin-clavulanic acid  500  mg ; 
 
other m 57 $temp  98.4  heartrate  104.0  resprate  20.0  o2sat  99.0  sbp  122.0  dbp  91.0  rhythm    pain  0  $hematology blood hematocrit  34.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  515  k ul; hematology blood inr(pt)  2.3  $acetaminophen  650  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; warfarin  8  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; lansoprazole oral disintegrating tab  30  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 
motorcycle driver injured in collision with car, pick-up truck or van in traffic accident, initial encounter acute posthemorrhagic anemia thrombocytopenia, unspecified rhabdomyolysis multiple fractures of ribs, unspecified side, initial encounter for closed fracture displaced fracture of body of scapula, right shoulder, initial encounter for closed fracture type 2 diabetes mellitus without complications acute kidney failure, unspecified other fracture of upper and lower end of right fibula, initial encounter for open fracture type iiia, iiib, or iiic hyperkalemia obstructive sleep apnea (adult) (pediatric) unspecified fracture of upper end of right tibia, initial encounter for open fracture type iiia, iiib, or iiic unspecified street and highway as the place of occurrence of the external cause traumatic pneumothorax, initial encounter
other m 57 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  480  k ul; hematology blood inr(pt)  2.3  ; hematology blood inr(pt)  2.4  $acetaminophen  650  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; warfarin  8  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; lansoprazole oral disintegrating tab  30  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; heparin  1600-3200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; d5lr  1000  ml ; 
motorcycle driver injured in collision with car, pick-up truck or van in traffic accident, initial encounter acute posthemorrhagic anemia thrombocytopenia, unspecified rhabdomyolysis multiple fractures of ribs, unspecified side, initial encounter for closed fracture displaced fracture of body of scapula, right shoulder, initial encounter for closed fracture type 2 diabetes mellitus without complications acute kidney failure, unspecified other fracture of upper and lower end of right fibula, initial encounter for open fracture type iiia, iiib, or iiic hyperkalemia obstructive sleep apnea (adult) (pediatric) unspecified fracture of upper end of right tibia, initial encounter for open fracture type iiia, iiib, or iiic unspecified street and highway as the place of occurrence of the external cause traumatic pneumothorax, initial encounter
other m 57 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  508  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  96  mg dl$docusate sodium  100  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; lansoprazole oral disintegrating tab  30  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; heparin  1600-3200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; d5lr  1000  ml ; 
motorcycle driver injured in collision with car, pick-up truck or van in traffic accident, initial encounter acute posthemorrhagic anemia thrombocytopenia, unspecified rhabdomyolysis multiple fractures of ribs, unspecified side, initial encounter for closed fracture displaced fracture of body of scapula, right shoulder, initial encounter for closed fracture type 2 diabetes mellitus without complications acute kidney failure, unspecified other fracture of upper and lower end of right fibula, initial encounter for open fracture type iiia, iiib, or iiic hyperkalemia obstructive sleep apnea (adult) (pediatric) unspecified fracture of upper end of right tibia, initial encounter for open fracture type iiia, iiib, or iiic unspecified street and highway as the place of occurrence of the external cause traumatic pneumothorax, initial encounter
other m 57 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  87  mg dl$docusate sodium  100  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; lansoprazole oral disintegrating tab  30  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; 
motorcycle driver injured in collision with car, pick-up truck or van in traffic accident, initial encounter acute posthemorrhagic anemia thrombocytopenia, unspecified rhabdomyolysis multiple fractures of ribs, unspecified side, initial encounter for closed fracture displaced fracture of body of scapula, right shoulder, initial encounter for closed fracture type 2 diabetes mellitus without complications acute kidney failure, unspecified other fracture of upper and lower end of right fibula, initial encounter for open fracture type iiia, iiib, or iiic hyperkalemia obstructive sleep apnea (adult) (pediatric) unspecified fracture of upper end of right tibia, initial encounter for open fracture type iiia, iiib, or iiic unspecified street and highway as the place of occurrence of the external cause traumatic pneumothorax, initial encounter
other m 57 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  529  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  89  mg dl$docusate sodium  100  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; lansoprazole oral disintegrating tab  30  mg ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; heparin  6500  unit ; d5 1 2ns  1000  ml ; morphine sulfate  2-4  mg ; 
motorcycle driver injured in collision with car, pick-up truck or van in traffic accident, initial encounter acute posthemorrhagic anemia thrombocytopenia, unspecified rhabdomyolysis multiple fractures of ribs, unspecified side, initial encounter for closed fracture displaced fracture of body of scapula, right shoulder, initial encounter for closed fracture type 2 diabetes mellitus without complications acute kidney failure, unspecified other fracture of upper and lower end of right fibula, initial encounter for open fracture type iiia, iiib, or iiic hyperkalemia obstructive sleep apnea (adult) (pediatric) unspecified fracture of upper end of right tibia, initial encounter for open fracture type iiia, iiib, or iiic unspecified street and highway as the place of occurrence of the external cause traumatic pneumothorax, initial encounter
other m 57 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  467  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  102  mg dl$docusate sodium  100  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; lansoprazole oral disintegrating tab  30  mg ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; d5 1 2ns  1000  ml ; morphine sulfate  2-4  mg ; 
motorcycle driver injured in collision with car, pick-up truck or van in traffic accident, initial encounter acute posthemorrhagic anemia thrombocytopenia, unspecified rhabdomyolysis multiple fractures of ribs, unspecified side, initial encounter for closed fracture displaced fracture of body of scapula, right shoulder, initial encounter for closed fracture type 2 diabetes mellitus without complications acute kidney failure, unspecified other fracture of upper and lower end of right fibula, initial encounter for open fracture type iiia, iiib, or iiic hyperkalemia obstructive sleep apnea (adult) (pediatric) unspecified fracture of upper end of right tibia, initial encounter for open fracture type iiia, iiib, or iiic unspecified street and highway as the place of occurrence of the external cause traumatic pneumothorax, initial encounter
other m 57 $nan$hematology blood hematocrit  30.1  %; hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  465  k ul; hematology blood platelet count  426  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  100  mg dl$docusate sodium  100  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; lansoprazole oral disintegrating tab  30  mg ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; d5 1 2ns  1000  ml ; morphine sulfate  2-4  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; 
motorcycle driver injured in collision with car, pick-up truck or van in traffic accident, initial encounter acute posthemorrhagic anemia thrombocytopenia, unspecified rhabdomyolysis multiple fractures of ribs, unspecified side, initial encounter for closed fracture displaced fracture of body of scapula, right shoulder, initial encounter for closed fracture type 2 diabetes mellitus without complications acute kidney failure, unspecified other fracture of upper and lower end of right fibula, initial encounter for open fracture type iiia, iiib, or iiic hyperkalemia obstructive sleep apnea (adult) (pediatric) unspecified fracture of upper end of right tibia, initial encounter for open fracture type iiia, iiib, or iiic unspecified street and highway as the place of occurrence of the external cause traumatic pneumothorax, initial encounter
other m 57 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  462  k ul; hematology blood inr(pt)  2.3  $docusate sodium  100  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; lansoprazole oral disintegrating tab  30  mg ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; d5 1 2ns  1000  ml ; morphine sulfate  2-4  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; warfarin  10  mg ; 
motorcycle driver injured in collision with car, pick-up truck or van in traffic accident, initial encounter acute posthemorrhagic anemia thrombocytopenia, unspecified rhabdomyolysis multiple fractures of ribs, unspecified side, initial encounter for closed fracture displaced fracture of body of scapula, right shoulder, initial encounter for closed fracture type 2 diabetes mellitus without complications acute kidney failure, unspecified other fracture of upper and lower end of right fibula, initial encounter for open fracture type iiia, iiib, or iiic hyperkalemia obstructive sleep apnea (adult) (pediatric) unspecified fracture of upper end of right tibia, initial encounter for open fracture type iiia, iiib, or iiic unspecified street and highway as the place of occurrence of the external cause traumatic pneumothorax, initial encounter
other m 57 $nan$hematology blood inr(pt)  2.6  $docusate sodium  100  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; lansoprazole oral disintegrating tab  30  mg ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; morphine sulfate  2-4  mg ; sodium chloride 0.9%  flush  10-20  ml ; warfarin  10  mg ; ferrous sulfate  325  mg ; 
motorcycle driver injured in collision with car, pick-up truck or van in traffic accident, initial encounter acute posthemorrhagic anemia thrombocytopenia, unspecified rhabdomyolysis multiple fractures of ribs, unspecified side, initial encounter for closed fracture displaced fracture of body of scapula, right shoulder, initial encounter for closed fracture type 2 diabetes mellitus without complications acute kidney failure, unspecified other fracture of upper and lower end of right fibula, initial encounter for open fracture type iiia, iiib, or iiic hyperkalemia obstructive sleep apnea (adult) (pediatric) unspecified fracture of upper end of right tibia, initial encounter for open fracture type iiia, iiib, or iiic unspecified street and highway as the place of occurrence of the external cause traumatic pneumothorax, initial encounter
other m 57 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  401  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  351  mg dl; chemistry blood glucose  112  mg dl$docusate sodium  100  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; lansoprazole oral disintegrating tab  30  mg ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; morphine sulfate  2-4  mg ; sodium chloride 0.9%  flush  10-20  ml ; ferrous sulfate  325  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ertapenem sodium  1  g ; potassium chloride  40  meq ; hydromorphone (dilaudid)  0.25  mg ; 
motorcycle driver injured in collision with car, pick-up truck or van in traffic accident, initial encounter acute posthemorrhagic anemia thrombocytopenia, unspecified rhabdomyolysis multiple fractures of ribs, unspecified side, initial encounter for closed fracture displaced fracture of body of scapula, right shoulder, initial encounter for closed fracture type 2 diabetes mellitus without complications acute kidney failure, unspecified other fracture of upper and lower end of right fibula, initial encounter for open fracture type iiia, iiib, or iiic hyperkalemia obstructive sleep apnea (adult) (pediatric) unspecified fracture of upper end of right tibia, initial encounter for open fracture type iiia, iiib, or iiic unspecified street and highway as the place of occurrence of the external cause traumatic pneumothorax, initial encounter
other m 57 $nan$nan$docusate sodium  100  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; lansoprazole oral disintegrating tab  30  mg ; sodium chloride 0.9%  flush  10-20  ml ; ferrous sulfate  325  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ertapenem sodium  1  g ; potassium chloride  40  meq ; hydromorphone (dilaudid)  0.25  mg ; 
motorcycle driver injured in collision with car, pick-up truck or van in traffic accident, initial encounter acute posthemorrhagic anemia thrombocytopenia, unspecified rhabdomyolysis multiple fractures of ribs, unspecified side, initial encounter for closed fracture displaced fracture of body of scapula, right shoulder, initial encounter for closed fracture type 2 diabetes mellitus without complications acute kidney failure, unspecified other fracture of upper and lower end of right fibula, initial encounter for open fracture type iiia, iiib, or iiic hyperkalemia obstructive sleep apnea (adult) (pediatric) unspecified fracture of upper end of right tibia, initial encounter for open fracture type iiia, iiib, or iiic unspecified street and highway as the place of occurrence of the external cause traumatic pneumothorax, initial encounter
white f 74 $nan$nan$aspirin  81  mg ; dexamethasone  1  mg ; lidocaine 5% patch  1  ptch ; metoprolol succinate xl  50  mg ; sulfameth trimethoprim ss  1  tab ; dexamethasone  0.5  mg ; 
myelopathy in other diseases classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal pathologic fracture of vertebrae personal history of malignant neoplasm of breast atrial fibrillation multiple myeloma, without mention of having achieved remission congestive heart failure, unspecified anemia, unspecified pathologic fracture of other specified site thrombocytopenia, unspecified chronic diastolic heart failure diarrhea
white f 74 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  39  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  91  mg dl; chemistry blood lactate dehydrogenase (ld)  177  iu l; chemistry blood albumin  3.3  g dl; blood gas blood lactate  1.2  mmol l$aspirin  81  mg ; dexamethasone  1  mg ; lidocaine 5% patch  1  ptch ; metoprolol succinate xl  50  mg ; sulfameth trimethoprim ss  1  tab ; dexamethasone  0.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; prochlorperazine  5  mg ; simethicone  40-80  mg ; benzonatate  100  mg ; docusate sodium  100  mg ; senna  1  tab ; metoprolol tartrate  25  mg ; aquaphor ointment  1  appl ; heparin  5000  unit ; oxycodone sr (oxycontin)  10  mg ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ipratropium bromide neb  1-2  neb ; ns  100  ml ; metronidazole (flagyl)  500  mg ; vial  1  vial ; cefepime  1  g ; gastroview (diatrizoate meglumine & sodium)  30  ml ; metoprolol tartrate  5  mg ; 
myelopathy in other diseases classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal pathologic fracture of vertebrae personal history of malignant neoplasm of breast atrial fibrillation multiple myeloma, without mention of having achieved remission congestive heart failure, unspecified anemia, unspecified pathologic fracture of other specified site thrombocytopenia, unspecified chronic diastolic heart failure diarrhea
white f 74 $nan$hematology blood hematocrit  23.1  %; hematology blood hematocrit  21.7  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  35  k ul; hematology blood platelet count  56  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  0.9  ; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  81  mg dl; chemistry blood glucose  83  mg dl; chemistry blood lactate dehydrogenase (ld)  182  iu l; chemistry blood lactate dehydrogenase (ld)  240  iu l; chemistry blood albumin  3.2  g dl; chemistry blood albumin  3.2  g dl; blood gas blood lactate  0.7  mmol l; blood gas blood lactate  0.9  mmol l$lidocaine 5% patch  1  ptch ; sulfameth trimethoprim ss  1  tab ; dexamethasone  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; prochlorperazine  5  mg ; benzonatate  100  mg ; aquaphor ointment  1  appl ; oxycodone sr (oxycontin)  10  mg ; 0.9% sodium chloride  1000  ml ; ipratropium bromide neb  1-2  neb ; ns  100  ml ; metronidazole (flagyl)  500  mg ; vial  1  vial ; cefepime  1  g ; d5 1 2ns  1000  ml ; guaifenesin-dextromethorphan  5-10  ml ; d5ns  1000  ml ; caphosol  30  ml ; 
myelopathy in other diseases classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal pathologic fracture of vertebrae personal history of malignant neoplasm of breast atrial fibrillation multiple myeloma, without mention of having achieved remission congestive heart failure, unspecified anemia, unspecified pathologic fracture of other specified site thrombocytopenia, unspecified chronic diastolic heart failure diarrhea
white f 74 $nan$hematology blood hematocrit  27.2  %; hematology blood hematocrit  28.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  58  k ul; hematology blood platelet count  45  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  69  mg dl; chemistry blood glucose  77  mg dl; chemistry blood lactate dehydrogenase (ld)  228  iu l; blood gas blood lactate  1.1  mmol l$lidocaine 5% patch  1  ptch ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; prochlorperazine  5  mg ; benzonatate  100  mg ; aquaphor ointment  1  appl ; oxycodone sr (oxycontin)  10  mg ; ipratropium bromide neb  1-2  neb ; ns  100  ml ; metronidazole (flagyl)  500  mg ; cefepime  1  g ; d5 1 2ns  1000  ml ; guaifenesin-dextromethorphan  5-10  ml ; caphosol  30  ml ; oseltamivir  75  mg ; metoprolol tartrate  12.5  mg ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 5% dextrose  500  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; sw  100  ml ; potassium chloride  10  meq ; 
myelopathy in other diseases classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal pathologic fracture of vertebrae personal history of malignant neoplasm of breast atrial fibrillation multiple myeloma, without mention of having achieved remission congestive heart failure, unspecified anemia, unspecified pathologic fracture of other specified site thrombocytopenia, unspecified chronic diastolic heart failure diarrhea
white f 74 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  38  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  52  mg dl; chemistry blood lactate dehydrogenase (ld)  244  iu l$lidocaine 5% patch  1  ptch ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; prochlorperazine  5  mg ; benzonatate  100  mg ; aquaphor ointment  1  appl ; oxycodone sr (oxycontin)  10  mg ; ipratropium bromide neb  1-2  neb ; ns  100  ml ; metronidazole (flagyl)  500  mg ; cefepime  1  g ; caphosol  30  ml ; oseltamivir  75  mg ; albuterol 0.083% neb soln  1  neb ; sw  100  ml ; potassium chloride  10  meq ; diltiazem  30  mg ; budesonide  0.5  mg ; digoxin  0.25  mg ; guaifenesin-codeine phosphate  5-10  ml ; 
myelopathy in other diseases classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal pathologic fracture of vertebrae personal history of malignant neoplasm of breast atrial fibrillation multiple myeloma, without mention of having achieved remission congestive heart failure, unspecified anemia, unspecified pathologic fracture of other specified site thrombocytopenia, unspecified chronic diastolic heart failure diarrhea
white f 74 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  36  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  91  mg dl; chemistry blood lactate dehydrogenase (ld)  208  iu l; hematology blood bands  0  %$lidocaine 5% patch  1  ptch ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; prochlorperazine  5  mg ; benzonatate  100  mg ; aquaphor ointment  1  appl ; oxycodone sr (oxycontin)  10  mg ; ipratropium bromide neb  1-2  neb ; ns  100  ml ; metronidazole (flagyl)  500  mg ; cefepime  1  g ; caphosol  30  ml ; oseltamivir  75  mg ; albuterol 0.083% neb soln  1  neb ; sw  100  ml ; potassium chloride  10  meq ; budesonide  0.5  mg ; digoxin  0.25  mg ; guaifenesin-codeine phosphate  5-10  ml ; digoxin  0.125  mg ; 
myelopathy in other diseases classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal pathologic fracture of vertebrae personal history of malignant neoplasm of breast atrial fibrillation multiple myeloma, without mention of having achieved remission congestive heart failure, unspecified anemia, unspecified pathologic fracture of other specified site thrombocytopenia, unspecified chronic diastolic heart failure diarrhea
white f 74 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  32  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  385  iu l$lidocaine 5% patch  1  ptch ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; prochlorperazine  5  mg ; benzonatate  100  mg ; aquaphor ointment  1  appl ; oxycodone sr (oxycontin)  10  mg ; ipratropium bromide neb  1-2  neb ; ns  100  ml ; metronidazole (flagyl)  500  mg ; cefepime  1  g ; caphosol  30  ml ; oseltamivir  75  mg ; albuterol 0.083% neb soln  1  neb ; sw  100  ml ; potassium chloride  10  meq ; budesonide  0.5  mg ; guaifenesin-codeine phosphate  5-10  ml ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; folic acid  1  mg ; cyanocobalamin  50  mcg ; 
myelopathy in other diseases classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal pathologic fracture of vertebrae personal history of malignant neoplasm of breast atrial fibrillation multiple myeloma, without mention of having achieved remission congestive heart failure, unspecified anemia, unspecified pathologic fracture of other specified site thrombocytopenia, unspecified chronic diastolic heart failure diarrhea
white f 74 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  29  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  83  mg dl; chemistry blood lactate dehydrogenase (ld)  222  iu l$lidocaine 5% patch  1  ptch ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; prochlorperazine  5  mg ; benzonatate  100  mg ; aquaphor ointment  1  appl ; oxycodone sr (oxycontin)  10  mg ; ipratropium bromide neb  1-2  neb ; ns  100  ml ; metronidazole (flagyl)  500  mg ; cefepime  1  g ; caphosol  30  ml ; oseltamivir  75  mg ; albuterol 0.083% neb soln  1  neb ; sw  100  ml ; potassium chloride  10  meq ; budesonide  0.5  mg ; guaifenesin-codeine phosphate  5-10  ml ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; folic acid  1  mg ; cyanocobalamin  50  mcg ; ciprofloxacin hcl  500  mg ; 
myelopathy in other diseases classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal pathologic fracture of vertebrae personal history of malignant neoplasm of breast atrial fibrillation multiple myeloma, without mention of having achieved remission congestive heart failure, unspecified anemia, unspecified pathologic fracture of other specified site thrombocytopenia, unspecified chronic diastolic heart failure diarrhea
white f 74 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  26  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  82  mg dl; chemistry blood lactate dehydrogenase (ld)  195  iu l; hematology blood bands  0  %$lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; prochlorperazine  5  mg ; benzonatate  100  mg ; aquaphor ointment  1  appl ; oxycodone sr (oxycontin)  10  mg ; ipratropium bromide neb  1-2  neb ; caphosol  30  ml ; oseltamivir  75  mg ; albuterol 0.083% neb soln  1  neb ; sw  100  ml ; potassium chloride  10  meq ; budesonide  0.5  mg ; guaifenesin-codeine phosphate  5-10  ml ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; folic acid  1  mg ; cyanocobalamin  50  mcg ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; 
myelopathy in other diseases classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal pathologic fracture of vertebrae personal history of malignant neoplasm of breast atrial fibrillation multiple myeloma, without mention of having achieved remission congestive heart failure, unspecified anemia, unspecified pathologic fracture of other specified site thrombocytopenia, unspecified chronic diastolic heart failure diarrhea
white f 74 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  30  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  91  mg dl; chemistry blood lactate dehydrogenase (ld)  219  iu l$lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; prochlorperazine  5  mg ; benzonatate  100  mg ; aquaphor ointment  1  appl ; oxycodone sr (oxycontin)  10  mg ; ipratropium bromide neb  1-2  neb ; caphosol  30  ml ; oseltamivir  75  mg ; albuterol 0.083% neb soln  1  neb ; sw  100  ml ; potassium chloride  10  meq ; budesonide  0.5  mg ; guaifenesin-codeine phosphate  5-10  ml ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; folic acid  1  mg ; cyanocobalamin  50  mcg ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; digoxin  0.0625  mg ; 
myelopathy in other diseases classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal pathologic fracture of vertebrae personal history of malignant neoplasm of breast atrial fibrillation multiple myeloma, without mention of having achieved remission congestive heart failure, unspecified anemia, unspecified pathologic fracture of other specified site thrombocytopenia, unspecified chronic diastolic heart failure diarrhea
white f 74 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  32  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  88  mg dl; chemistry blood lactate dehydrogenase (ld)  190  iu l; hematology blood bands  0  %$lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; prochlorperazine  5  mg ; benzonatate  100  mg ; aquaphor ointment  1  appl ; oxycodone sr (oxycontin)  10  mg ; ipratropium bromide neb  1-2  neb ; caphosol  30  ml ; oseltamivir  75  mg ; albuterol 0.083% neb soln  1  neb ; sw  100  ml ; potassium chloride  10  meq ; budesonide  0.5  mg ; guaifenesin-codeine phosphate  5-10  ml ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; folic acid  1  mg ; cyanocobalamin  50  mcg ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; digoxin  0.0625  mg ; metoprolol succinate xl  100  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; furosemide  20  mg ; 
myelopathy in other diseases classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal pathologic fracture of vertebrae personal history of malignant neoplasm of breast atrial fibrillation multiple myeloma, without mention of having achieved remission congestive heart failure, unspecified anemia, unspecified pathologic fracture of other specified site thrombocytopenia, unspecified chronic diastolic heart failure diarrhea
white f 74 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  29  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  85  mg dl$lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; prochlorperazine  5  mg ; benzonatate  100  mg ; aquaphor ointment  1  appl ; oxycodone sr (oxycontin)  10  mg ; ipratropium bromide neb  1-2  neb ; caphosol  30  ml ; oseltamivir  75  mg ; albuterol 0.083% neb soln  1  neb ; sw  100  ml ; potassium chloride  10  meq ; budesonide  0.5  mg ; guaifenesin-codeine phosphate  5-10  ml ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; folic acid  1  mg ; cyanocobalamin  50  mcg ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; digoxin  0.0625  mg ; metoprolol succinate xl  100  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; furosemide  20  mg ; 
myelopathy in other diseases classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal pathologic fracture of vertebrae personal history of malignant neoplasm of breast atrial fibrillation multiple myeloma, without mention of having achieved remission congestive heart failure, unspecified anemia, unspecified pathologic fracture of other specified site thrombocytopenia, unspecified chronic diastolic heart failure diarrhea
white f 74 $nan$nan$lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; prochlorperazine  5  mg ; benzonatate  100  mg ; aquaphor ointment  1  appl ; oxycodone sr (oxycontin)  10  mg ; ipratropium bromide neb  1-2  neb ; caphosol  30  ml ; oseltamivir  75  mg ; albuterol 0.083% neb soln  1  neb ; sw  100  ml ; potassium chloride  10  meq ; budesonide  0.5  mg ; guaifenesin-codeine phosphate  5-10  ml ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; folic acid  1  mg ; cyanocobalamin  50  mcg ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; digoxin  0.0625  mg ; metoprolol succinate xl  100  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; 
myelopathy in other diseases classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal pathologic fracture of vertebrae personal history of malignant neoplasm of breast atrial fibrillation multiple myeloma, without mention of having achieved remission congestive heart failure, unspecified anemia, unspecified pathologic fracture of other specified site thrombocytopenia, unspecified chronic diastolic heart failure diarrhea
other f 27 $temp  98.0  heartrate  80.0  resprate  16.0  o2sat  100.0  sbp  125.0  dbp  83.0  rhythm    pain    $chemistry blood bilirubin, total  0.3  mg dl$sodium chloride 0.9%  flush  3  ml ; promethazine  6.25  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; docusate sodium  100  mg ; bupropion (sustained release)  100  mg ; gabapentin  800  mg ; polyethylene glycol  17  g ; estrogens conjugated  0.625  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; hydromorphone (dilaudid)  0.125  mg ; 0.9% sodium chloride  1000  ml ; promethazine  12.5  mg ; 
 
other f 27 $nan$hematology blood hematocrit  38.9  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood glucose  82  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; heparin  5000  unit ; docusate sodium  100  mg ; bupropion (sustained release)  100  mg ; gabapentin  800  mg ; polyethylene glycol  17  g ; estrogens conjugated  0.625  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; hydromorphone (dilaudid)  0.125  mg ; 0.9% sodium chloride  1000  ml ; promethazine  12.5  mg ; acetaminophen-caff-butalbital  1-2  tab ; omeprazole  40  mg ; acetaminophen-caff-butalbital  1  tab ; oxycodone (immediate release)   5  mg ; promethazine  25  mg ; 
 
other f 27 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; bupropion (sustained release)  100  mg ; gabapentin  800  mg ; polyethylene glycol  17  g ; estrogens conjugated  0.625  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; omeprazole  40  mg ; acetaminophen-caff-butalbital  1  tab ; oxycodone (immediate release)   5  mg ; promethazine  25  mg ; tramadol (ultram)  50  mg ; acetaminophen  500  mg ; 
 
black african american m 46 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  630  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  261  mg dl$1 2 ns  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; gabapentin  300  mg ; senna  1  tab ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  1000  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; hydromorphone (dilaudid)  0.5-1  mg ; insulin  0  unit ; hydromorphone (dilaudid)  1-1.5  mg ; ziprasidone hydrochloride  80  mg ; docusate sodium  100  mg ; pancrelipase 5000  3  cap ; haloperidol  5  mg ; heparin  5000  unit ; simvastatin  10  mg ; omeprazole  20  mg ; lisinopril  10  mg ; amitriptyline  25  mg ; duloxetine  60  mg ; aspirin  81  mg ; mirtazapine  15  mg ; zolpidem tartrate  10  mg ; prazosin  2  mg ; 
bipolar disorder, unspecified gastroparesis lumbago other convulsions posttraumatic stress disorder other chronic pain diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension keloid scar incisional hernia without mention of obstruction or gangrene other and unspecified hyperlipidemia unspecified intestinal obstruction other postprocedural status other convulsions chronic pancreatitis major depressive affective disorder, recurrent episode, severe, specified as with psychotic behavior unspecified essential hypertension esophageal reflux diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled posttraumatic stress disorder gastroparesis other and unspecified hyperlipidemia suicidal ideation ventral, unspecified, hernia without mention of obstruction or gangrene personal history of venous thrombosis and embolism posttraumatic stress disorder personal history of venous thrombosis and embolism bipolar disorder, unspecified tobacco use disorder unspecified essential hypertension epilepsy, unspecified, without mention of intractable epilepsy chronic pancreatitis long-term (current) use of insulin pain in joint, lower leg syncope and collapse diabetes with other specified manifestations, type ii or unspecified type, uncontrolled anemia, unspecified chronic pancreatitis dehydration unspecified essential hypertension long-term (current) use of insulin lumbago bipolar disorder, unspecified other convulsions alcohol abuse, in remission syncope and collapse diabetes with other specified manifestations, type ii or unspecified type, uncontrolled iron deficiency anemia, unspecified
black african american m 46 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; gabapentin  300  mg ; senna  1  tab ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  1000  ml ; insulin  0  unit ; hydromorphone (dilaudid)  1-1.5  mg ; ziprasidone hydrochloride  80  mg ; docusate sodium  100  mg ; pancrelipase 5000  3  cap ; haloperidol  5  mg ; heparin  5000  unit ; simvastatin  10  mg ; omeprazole  20  mg ; lisinopril  10  mg ; amitriptyline  25  mg ; duloxetine  60  mg ; aspirin  81  mg ; mirtazapine  15  mg ; zolpidem tartrate  10  mg ; prazosin  2  mg ; hydromorphone (dilaudid)  1  mg ; hydromorphone (dilaudid)  2  mg ; 
bipolar disorder, unspecified gastroparesis lumbago other convulsions posttraumatic stress disorder other chronic pain diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension keloid scar incisional hernia without mention of obstruction or gangrene other and unspecified hyperlipidemia unspecified intestinal obstruction other postprocedural status other convulsions chronic pancreatitis major depressive affective disorder, recurrent episode, severe, specified as with psychotic behavior unspecified essential hypertension esophageal reflux diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled posttraumatic stress disorder gastroparesis other and unspecified hyperlipidemia suicidal ideation ventral, unspecified, hernia without mention of obstruction or gangrene personal history of venous thrombosis and embolism posttraumatic stress disorder personal history of venous thrombosis and embolism bipolar disorder, unspecified tobacco use disorder unspecified essential hypertension epilepsy, unspecified, without mention of intractable epilepsy chronic pancreatitis long-term (current) use of insulin pain in joint, lower leg syncope and collapse diabetes with other specified manifestations, type ii or unspecified type, uncontrolled anemia, unspecified chronic pancreatitis dehydration unspecified essential hypertension long-term (current) use of insulin lumbago bipolar disorder, unspecified other convulsions alcohol abuse, in remission syncope and collapse diabetes with other specified manifestations, type ii or unspecified type, uncontrolled iron deficiency anemia, unspecified
white m 55 $nan$hematology blood hematocrit  41.9  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  3.2  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  212  iu l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  mod  mg dl$nan
esophageal reflux coronary atherosclerosis of native coronary artery unspecified essential hypertension acute kidney failure, unspecified pure hypercholesterolemia percutaneous transluminal coronary angioplasty status esophageal reflux old myocardial infarction
white m 55 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  58  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  0.25  mg ; ondansetron  4  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; simvastatin  40  mg ; atenolol  25  mg ; lisinopril  10  mg ; tricor  145  mg ; 
esophageal reflux coronary atherosclerosis of native coronary artery unspecified essential hypertension acute kidney failure, unspecified pure hypercholesterolemia percutaneous transluminal coronary angioplasty status esophageal reflux old myocardial infarction
white m 55 $nan$hematology blood hematocrit  32.1  %; hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, indirect  0.8  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  145  mg dl; chemistry blood bilirubin, direct  1.1  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; hydromorphone (dilaudid)  12.5  mg ; metoprolol tartrate  5  mg ; 
esophageal reflux coronary atherosclerosis of native coronary artery unspecified essential hypertension acute kidney failure, unspecified pure hypercholesterolemia percutaneous transluminal coronary angioplasty status esophageal reflux old myocardial infarction
white m 55 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; hydromorphone (dilaudid)  12.5  mg ; metoprolol tartrate  5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  1000  mg ; 
esophageal reflux coronary atherosclerosis of native coronary artery unspecified essential hypertension acute kidney failure, unspecified pure hypercholesterolemia percutaneous transluminal coronary angioplasty status esophageal reflux old myocardial infarction
white m 55 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; metoprolol tartrate  5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  1000  mg ; simvastatin  20  mg ; aspirin  325  mg ; 
esophageal reflux coronary atherosclerosis of native coronary artery unspecified essential hypertension acute kidney failure, unspecified pure hypercholesterolemia percutaneous transluminal coronary angioplasty status esophageal reflux old myocardial infarction
white m 55 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; simvastatin  20  mg ; aspirin  325  mg ; 
esophageal reflux coronary atherosclerosis of native coronary artery unspecified essential hypertension acute kidney failure, unspecified pure hypercholesterolemia percutaneous transluminal coronary angioplasty status esophageal reflux old myocardial infarction
white m 53 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  437  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  109  mg dl; blood gas blood lactate  0.8  mmol l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$nan
iron deficiency anemia, unspecified other diseases of spleen depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia hyposmolality and/or hyponatremia tobacco use disorder obesity, unspecified depressive disorder, not elsewhere classified other tenosynovitis of hand and wrist obstructive sleep apnea (adult)(pediatric) backache, unspecified unspecified essential hypertension other and unspecified hyperlipidemia cellulitis and abscess of finger, unspecified other chronic pain open wound of hand except finger(s) alone, complicated unspecified essential hypertension obesity, unspecified regional enteritis of unspecified site peritoneal abscess obesity, unspecified regional enteritis of unspecified site unspecified essential hypertension perforation of intestine depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia spondylosis with myelopathy, lumbar region obstructive sleep apnea (adult)(pediatric) personal history of venous thrombosis and embolism unspecified essential hypertension venous thrombosis nec unspecified essential hypertension regional enteritis of unspecified site anemia of other chronic disease pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft depressive disorder, not elsewhere classified tachycardia, unspecified nonspecific abnormal findings in stool contents acute kidney failure, unspecified obesity, unspecified severe sepsis unspecified essential hypertension
white m 53 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  405  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  93  mg dl$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; simvastatin  20  mg ; duloxetine  60  mg ; risperidone  1  mg ; 
iron deficiency anemia, unspecified other diseases of spleen depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia hyposmolality and/or hyponatremia tobacco use disorder obesity, unspecified depressive disorder, not elsewhere classified other tenosynovitis of hand and wrist obstructive sleep apnea (adult)(pediatric) backache, unspecified unspecified essential hypertension other and unspecified hyperlipidemia cellulitis and abscess of finger, unspecified other chronic pain open wound of hand except finger(s) alone, complicated unspecified essential hypertension obesity, unspecified regional enteritis of unspecified site peritoneal abscess obesity, unspecified regional enteritis of unspecified site unspecified essential hypertension perforation of intestine depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia spondylosis with myelopathy, lumbar region obstructive sleep apnea (adult)(pediatric) personal history of venous thrombosis and embolism unspecified essential hypertension venous thrombosis nec unspecified essential hypertension regional enteritis of unspecified site anemia of other chronic disease pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft depressive disorder, not elsewhere classified tachycardia, unspecified nonspecific abnormal findings in stool contents acute kidney failure, unspecified obesity, unspecified severe sepsis unspecified essential hypertension
white m 53 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  399  k ul$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; simvastatin  20  mg ; duloxetine  60  mg ; risperidone  1  mg ; magnesium oxide  800  mg ; sw  50  ml ; magnesium sulfate  2  gm ; nicotine patch  14  mg ; 
iron deficiency anemia, unspecified other diseases of spleen depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia hyposmolality and/or hyponatremia tobacco use disorder obesity, unspecified depressive disorder, not elsewhere classified other tenosynovitis of hand and wrist obstructive sleep apnea (adult)(pediatric) backache, unspecified unspecified essential hypertension other and unspecified hyperlipidemia cellulitis and abscess of finger, unspecified other chronic pain open wound of hand except finger(s) alone, complicated unspecified essential hypertension obesity, unspecified regional enteritis of unspecified site peritoneal abscess obesity, unspecified regional enteritis of unspecified site unspecified essential hypertension perforation of intestine depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia spondylosis with myelopathy, lumbar region obstructive sleep apnea (adult)(pediatric) personal history of venous thrombosis and embolism unspecified essential hypertension venous thrombosis nec unspecified essential hypertension regional enteritis of unspecified site anemia of other chronic disease pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft depressive disorder, not elsewhere classified tachycardia, unspecified nonspecific abnormal findings in stool contents acute kidney failure, unspecified obesity, unspecified severe sepsis unspecified essential hypertension
white m 53 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  404  k ul; chemistry blood albumin  2.8  g dl$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; simvastatin  20  mg ; duloxetine  60  mg ; risperidone  1  mg ; sw  50  ml ; magnesium sulfate  2  gm ; nicotine patch  14  mg ; 
iron deficiency anemia, unspecified other diseases of spleen depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia hyposmolality and/or hyponatremia tobacco use disorder obesity, unspecified depressive disorder, not elsewhere classified other tenosynovitis of hand and wrist obstructive sleep apnea (adult)(pediatric) backache, unspecified unspecified essential hypertension other and unspecified hyperlipidemia cellulitis and abscess of finger, unspecified other chronic pain open wound of hand except finger(s) alone, complicated unspecified essential hypertension obesity, unspecified regional enteritis of unspecified site peritoneal abscess obesity, unspecified regional enteritis of unspecified site unspecified essential hypertension perforation of intestine depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia spondylosis with myelopathy, lumbar region obstructive sleep apnea (adult)(pediatric) personal history of venous thrombosis and embolism unspecified essential hypertension venous thrombosis nec unspecified essential hypertension regional enteritis of unspecified site anemia of other chronic disease pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft depressive disorder, not elsewhere classified tachycardia, unspecified nonspecific abnormal findings in stool contents acute kidney failure, unspecified obesity, unspecified severe sepsis unspecified essential hypertension
white m 53 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  408  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  3  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  103  mg dl$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; simvastatin  20  mg ; duloxetine  60  mg ; risperidone  1  mg ; nicotine patch  14  mg ; 
iron deficiency anemia, unspecified other diseases of spleen depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia hyposmolality and/or hyponatremia tobacco use disorder obesity, unspecified depressive disorder, not elsewhere classified other tenosynovitis of hand and wrist obstructive sleep apnea (adult)(pediatric) backache, unspecified unspecified essential hypertension other and unspecified hyperlipidemia cellulitis and abscess of finger, unspecified other chronic pain open wound of hand except finger(s) alone, complicated unspecified essential hypertension obesity, unspecified regional enteritis of unspecified site peritoneal abscess obesity, unspecified regional enteritis of unspecified site unspecified essential hypertension perforation of intestine depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia spondylosis with myelopathy, lumbar region obstructive sleep apnea (adult)(pediatric) personal history of venous thrombosis and embolism unspecified essential hypertension venous thrombosis nec unspecified essential hypertension regional enteritis of unspecified site anemia of other chronic disease pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft depressive disorder, not elsewhere classified tachycardia, unspecified nonspecific abnormal findings in stool contents acute kidney failure, unspecified obesity, unspecified severe sepsis unspecified essential hypertension
white m 53 $nan$hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood lactate dehydrogenase (ld)  108  iu l; chemistry blood albumin  2.8  g dl$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; simvastatin  20  mg ; duloxetine  60  mg ; risperidone  1  mg ; nicotine patch  14  mg ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  4  g ; fluticasone propionate 110mcg  1  puff ; phytonadione  5  mg ; 5% dextrose  50  ml ; phytonadione  2  mg ; albuterol inhaler  1-2  puff ; 
iron deficiency anemia, unspecified other diseases of spleen depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia hyposmolality and/or hyponatremia tobacco use disorder obesity, unspecified depressive disorder, not elsewhere classified other tenosynovitis of hand and wrist obstructive sleep apnea (adult)(pediatric) backache, unspecified unspecified essential hypertension other and unspecified hyperlipidemia cellulitis and abscess of finger, unspecified other chronic pain open wound of hand except finger(s) alone, complicated unspecified essential hypertension obesity, unspecified regional enteritis of unspecified site peritoneal abscess obesity, unspecified regional enteritis of unspecified site unspecified essential hypertension perforation of intestine depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia spondylosis with myelopathy, lumbar region obstructive sleep apnea (adult)(pediatric) personal history of venous thrombosis and embolism unspecified essential hypertension venous thrombosis nec unspecified essential hypertension regional enteritis of unspecified site anemia of other chronic disease pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft depressive disorder, not elsewhere classified tachycardia, unspecified nonspecific abnormal findings in stool contents acute kidney failure, unspecified obesity, unspecified severe sepsis unspecified essential hypertension
white m 53 $nan$hematology blood hematocrit  28.8  %; hematology blood hematocrit  34.9  %; hematology blood hematocrit  33.6  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  420  k ul; hematology blood platelet count  423  k ul; hematology blood platelet count  436  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  2  mg dl; chemistry blood urea nitrogen  2  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  171  mg dl; chemistry blood glucose  176  mg dl; chemistry blood albumin  3.0  g dl; hematology blood bands  13  %; hematology blood bands  3  %; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.22  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood chloride, whole blood  102  meq l; blood gas blood glucose  120  mg dl; blood gas blood glucose  168  mg dl; blood gas blood glucose  167  mg dl; blood gas blood glucose  134  mg dl; blood gas blood hematocrit, calculated  36  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hemoglobin  12.0  g dl; blood gas blood hemoglobin  11.7  g dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood calculated bicarbonate, whole blood  27  meq l$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; simvastatin  20  mg ; duloxetine  60  mg ; risperidone  1  mg ; nicotine patch  14  mg ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  4  g ; fluticasone propionate 110mcg  1  puff ; 5% dextrose  50  ml ; phytonadione  2  mg ; albuterol inhaler  1-2  puff ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fentanyl citrate  25-100  mcg ; propofol  1000  mg ; famotidine  20  mg ; bag  100  ml ; iso-osmotic sodium chloride  50  ml ; calcium gluconate  2  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 
iron deficiency anemia, unspecified other diseases of spleen depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia hyposmolality and/or hyponatremia tobacco use disorder obesity, unspecified depressive disorder, not elsewhere classified other tenosynovitis of hand and wrist obstructive sleep apnea (adult)(pediatric) backache, unspecified unspecified essential hypertension other and unspecified hyperlipidemia cellulitis and abscess of finger, unspecified other chronic pain open wound of hand except finger(s) alone, complicated unspecified essential hypertension obesity, unspecified regional enteritis of unspecified site peritoneal abscess obesity, unspecified regional enteritis of unspecified site unspecified essential hypertension perforation of intestine depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia spondylosis with myelopathy, lumbar region obstructive sleep apnea (adult)(pediatric) personal history of venous thrombosis and embolism unspecified essential hypertension venous thrombosis nec unspecified essential hypertension regional enteritis of unspecified site anemia of other chronic disease pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft depressive disorder, not elsewhere classified tachycardia, unspecified nonspecific abnormal findings in stool contents acute kidney failure, unspecified obesity, unspecified severe sepsis unspecified essential hypertension
white m 53 $nan$hematology blood hematocrit  33.2  %; hematology blood hematocrit  29.3  %; hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  517  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  160  iu l$cefazolin  2  g ; influenza virus vaccine  0.5  ml ; lr  1000  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; bag  100  ml ; iso-osmotic sodium chloride  50  ml ; calcium gluconate  2  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; furosemide  10  mg ; d5w  250  ml ; nitroglycerin  100  mg ; hydromorphone (dilaudid)  12.5  mg ; hydrochlorothiazide  12.5  mg ; hydromorphone (dilaudid)  0.5  mg ; 0.9% sodium chloride  100  ml ; 
iron deficiency anemia, unspecified other diseases of spleen depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia hyposmolality and/or hyponatremia tobacco use disorder obesity, unspecified depressive disorder, not elsewhere classified other tenosynovitis of hand and wrist obstructive sleep apnea (adult)(pediatric) backache, unspecified unspecified essential hypertension other and unspecified hyperlipidemia cellulitis and abscess of finger, unspecified other chronic pain open wound of hand except finger(s) alone, complicated unspecified essential hypertension obesity, unspecified regional enteritis of unspecified site peritoneal abscess obesity, unspecified regional enteritis of unspecified site unspecified essential hypertension perforation of intestine depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia spondylosis with myelopathy, lumbar region obstructive sleep apnea (adult)(pediatric) personal history of venous thrombosis and embolism unspecified essential hypertension venous thrombosis nec unspecified essential hypertension regional enteritis of unspecified site anemia of other chronic disease pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft depressive disorder, not elsewhere classified tachycardia, unspecified nonspecific abnormal findings in stool contents acute kidney failure, unspecified obesity, unspecified severe sepsis unspecified essential hypertension
white m 53 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  561  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  106  mg dl$cefazolin  2  g ; influenza virus vaccine  0.5  ml ; lr  1000  ml ; iso-osmotic sodium chloride  50  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; furosemide  10  mg ; hydromorphone (dilaudid)  12.5  mg ; hydromorphone (dilaudid)  0.5  mg ; 0.9% sodium chloride  100  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
iron deficiency anemia, unspecified other diseases of spleen depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia hyposmolality and/or hyponatremia tobacco use disorder obesity, unspecified depressive disorder, not elsewhere classified other tenosynovitis of hand and wrist obstructive sleep apnea (adult)(pediatric) backache, unspecified unspecified essential hypertension other and unspecified hyperlipidemia cellulitis and abscess of finger, unspecified other chronic pain open wound of hand except finger(s) alone, complicated unspecified essential hypertension obesity, unspecified regional enteritis of unspecified site peritoneal abscess obesity, unspecified regional enteritis of unspecified site unspecified essential hypertension perforation of intestine depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia spondylosis with myelopathy, lumbar region obstructive sleep apnea (adult)(pediatric) personal history of venous thrombosis and embolism unspecified essential hypertension venous thrombosis nec unspecified essential hypertension regional enteritis of unspecified site anemia of other chronic disease pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft depressive disorder, not elsewhere classified tachycardia, unspecified nonspecific abnormal findings in stool contents acute kidney failure, unspecified obesity, unspecified severe sepsis unspecified essential hypertension
white m 53 $nan$hematology blood inr(pt)  1.2  $cefazolin  2  g ; influenza virus vaccine  0.5  ml ; iso-osmotic sodium chloride  50  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; hydromorphone (dilaudid)  12.5  mg ; 0.9% sodium chloride  100  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; bag  50  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 
iron deficiency anemia, unspecified other diseases of spleen depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia hyposmolality and/or hyponatremia tobacco use disorder obesity, unspecified depressive disorder, not elsewhere classified other tenosynovitis of hand and wrist obstructive sleep apnea (adult)(pediatric) backache, unspecified unspecified essential hypertension other and unspecified hyperlipidemia cellulitis and abscess of finger, unspecified other chronic pain open wound of hand except finger(s) alone, complicated unspecified essential hypertension obesity, unspecified regional enteritis of unspecified site peritoneal abscess obesity, unspecified regional enteritis of unspecified site unspecified essential hypertension perforation of intestine depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia spondylosis with myelopathy, lumbar region obstructive sleep apnea (adult)(pediatric) personal history of venous thrombosis and embolism unspecified essential hypertension venous thrombosis nec unspecified essential hypertension regional enteritis of unspecified site anemia of other chronic disease pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft depressive disorder, not elsewhere classified tachycardia, unspecified nonspecific abnormal findings in stool contents acute kidney failure, unspecified obesity, unspecified severe sepsis unspecified essential hypertension
white m 53 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  782  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  148  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  106  mg dl$influenza virus vaccine  0.5  ml ; iso-osmotic sodium chloride  50  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; hydromorphone (dilaudid)  12.5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ipratropium bromide neb  1  neb ; bag  50  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 
iron deficiency anemia, unspecified other diseases of spleen depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia hyposmolality and/or hyponatremia tobacco use disorder obesity, unspecified depressive disorder, not elsewhere classified other tenosynovitis of hand and wrist obstructive sleep apnea (adult)(pediatric) backache, unspecified unspecified essential hypertension other and unspecified hyperlipidemia cellulitis and abscess of finger, unspecified other chronic pain open wound of hand except finger(s) alone, complicated unspecified essential hypertension obesity, unspecified regional enteritis of unspecified site peritoneal abscess obesity, unspecified regional enteritis of unspecified site unspecified essential hypertension perforation of intestine depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia spondylosis with myelopathy, lumbar region obstructive sleep apnea (adult)(pediatric) personal history of venous thrombosis and embolism unspecified essential hypertension venous thrombosis nec unspecified essential hypertension regional enteritis of unspecified site anemia of other chronic disease pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft depressive disorder, not elsewhere classified tachycardia, unspecified nonspecific abnormal findings in stool contents acute kidney failure, unspecified obesity, unspecified severe sepsis unspecified essential hypertension
white m 53 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  829  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  114  mg dl$influenza virus vaccine  0.5  ml ; iso-osmotic sodium chloride  50  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; hydromorphone (dilaudid)  12.5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ipratropium bromide neb  1  neb ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; artificial tears  1-2  drop ; 
iron deficiency anemia, unspecified other diseases of spleen depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia hyposmolality and/or hyponatremia tobacco use disorder obesity, unspecified depressive disorder, not elsewhere classified other tenosynovitis of hand and wrist obstructive sleep apnea (adult)(pediatric) backache, unspecified unspecified essential hypertension other and unspecified hyperlipidemia cellulitis and abscess of finger, unspecified other chronic pain open wound of hand except finger(s) alone, complicated unspecified essential hypertension obesity, unspecified regional enteritis of unspecified site peritoneal abscess obesity, unspecified regional enteritis of unspecified site unspecified essential hypertension perforation of intestine depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia spondylosis with myelopathy, lumbar region obstructive sleep apnea (adult)(pediatric) personal history of venous thrombosis and embolism unspecified essential hypertension venous thrombosis nec unspecified essential hypertension regional enteritis of unspecified site anemia of other chronic disease pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft depressive disorder, not elsewhere classified tachycardia, unspecified nonspecific abnormal findings in stool contents acute kidney failure, unspecified obesity, unspecified severe sepsis unspecified essential hypertension
white m 53 $nan$hematology blood hematocrit  29.7  %; hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  910  k ul; hematology blood platelet count  860  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood urea nitrogen  2  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  114  mg dl$influenza virus vaccine  0.5  ml ; iso-osmotic sodium chloride  50  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ipratropium bromide neb  1  neb ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; artificial tears  1-2  drop ; oxycodone-acetaminophen  1-2  tab ; amoxicillin-clavulanic acid  500  mg ; ferrous sulfate  325  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; 
iron deficiency anemia, unspecified other diseases of spleen depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia hyposmolality and/or hyponatremia tobacco use disorder obesity, unspecified depressive disorder, not elsewhere classified other tenosynovitis of hand and wrist obstructive sleep apnea (adult)(pediatric) backache, unspecified unspecified essential hypertension other and unspecified hyperlipidemia cellulitis and abscess of finger, unspecified other chronic pain open wound of hand except finger(s) alone, complicated unspecified essential hypertension obesity, unspecified regional enteritis of unspecified site peritoneal abscess obesity, unspecified regional enteritis of unspecified site unspecified essential hypertension perforation of intestine depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia spondylosis with myelopathy, lumbar region obstructive sleep apnea (adult)(pediatric) personal history of venous thrombosis and embolism unspecified essential hypertension venous thrombosis nec unspecified essential hypertension regional enteritis of unspecified site anemia of other chronic disease pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft depressive disorder, not elsewhere classified tachycardia, unspecified nonspecific abnormal findings in stool contents acute kidney failure, unspecified obesity, unspecified severe sepsis unspecified essential hypertension
white m 53 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  986  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  2  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  102  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; ipratropium bromide neb  1  neb ; artificial tears  1-2  drop ; amoxicillin-clavulanic acid  500  mg ; ferrous sulfate  325  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; metoclopramide  10  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  2-4  mg ; ketorolac  15  mg ; acetaminophen  1000  mg ; 
iron deficiency anemia, unspecified other diseases of spleen depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia hyposmolality and/or hyponatremia tobacco use disorder obesity, unspecified depressive disorder, not elsewhere classified other tenosynovitis of hand and wrist obstructive sleep apnea (adult)(pediatric) backache, unspecified unspecified essential hypertension other and unspecified hyperlipidemia cellulitis and abscess of finger, unspecified other chronic pain open wound of hand except finger(s) alone, complicated unspecified essential hypertension obesity, unspecified regional enteritis of unspecified site peritoneal abscess obesity, unspecified regional enteritis of unspecified site unspecified essential hypertension perforation of intestine depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia spondylosis with myelopathy, lumbar region obstructive sleep apnea (adult)(pediatric) personal history of venous thrombosis and embolism unspecified essential hypertension venous thrombosis nec unspecified essential hypertension regional enteritis of unspecified site anemia of other chronic disease pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft depressive disorder, not elsewhere classified tachycardia, unspecified nonspecific abnormal findings in stool contents acute kidney failure, unspecified obesity, unspecified severe sepsis unspecified essential hypertension
white m 53 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; ipratropium bromide neb  1  neb ; artificial tears  1-2  drop ; amoxicillin-clavulanic acid  500  mg ; ferrous sulfate  325  mg ; metoclopramide  10  mg ; ketorolac  15  mg ; acetaminophen  1000  mg ; 
iron deficiency anemia, unspecified other diseases of spleen depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia hyposmolality and/or hyponatremia tobacco use disorder obesity, unspecified depressive disorder, not elsewhere classified other tenosynovitis of hand and wrist obstructive sleep apnea (adult)(pediatric) backache, unspecified unspecified essential hypertension other and unspecified hyperlipidemia cellulitis and abscess of finger, unspecified other chronic pain open wound of hand except finger(s) alone, complicated unspecified essential hypertension obesity, unspecified regional enteritis of unspecified site peritoneal abscess obesity, unspecified regional enteritis of unspecified site unspecified essential hypertension perforation of intestine depressive disorder, not elsewhere classified unspecified essential hypertension regional enteritis of unspecified site other and unspecified hyperlipidemia spondylosis with myelopathy, lumbar region obstructive sleep apnea (adult)(pediatric) personal history of venous thrombosis and embolism unspecified essential hypertension venous thrombosis nec unspecified essential hypertension regional enteritis of unspecified site anemia of other chronic disease pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft depressive disorder, not elsewhere classified tachycardia, unspecified nonspecific abnormal findings in stool contents acute kidney failure, unspecified obesity, unspecified severe sepsis unspecified essential hypertension
white m 83 $temp  98.0  heartrate  71.0  resprate  18.0  o2sat  96.0  sbp  136.0  dbp  65.0  rhythm    pain  0  $hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  83  mg dl$atorvastatin  80  mg ; doxazosin  8  mg ; enoxaparin sodium  80  mg ; warfarin  5  mg ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; gabapentin  100  mg ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; amlodipine  5  mg ; lisinopril  40  mg ; atenolol  100  mg ; finasteride  5  mg ; hydralazine  10  mg ; 
dysarthria and anarthria essential (primary) hypertension gastro-esophageal reflux disease without esophagitis other secondary pulmonary hypertension hyperlipidemia, unspecified unspecified atrial fibrillation hemiplegia, unspecified affecting left nondominant side unspecified atherosclerosis of native arteries of extremities, left leg personal history of nicotine dependence chronic total occlusion of artery of the extremities cerebral infarction, unspecified polyp of stomach and duodenum hypotension, unspecified solitary pulmonary nodule long term (current) use of anticoagulants facial weakness hypoxemia esophageal obstruction personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits obstructive sleep apnea (adult) (pediatric)
white m 83 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  100  mg dl$atorvastatin  80  mg ; doxazosin  8  mg ; warfarin  5  mg ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; gabapentin  100  mg ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atenolol  100  mg ; finasteride  5  mg ; hydralazine  10  mg ; potassium chloride  40  meq ; 
dysarthria and anarthria essential (primary) hypertension gastro-esophageal reflux disease without esophagitis other secondary pulmonary hypertension hyperlipidemia, unspecified unspecified atrial fibrillation hemiplegia, unspecified affecting left nondominant side unspecified atherosclerosis of native arteries of extremities, left leg personal history of nicotine dependence chronic total occlusion of artery of the extremities cerebral infarction, unspecified polyp of stomach and duodenum hypotension, unspecified solitary pulmonary nodule long term (current) use of anticoagulants facial weakness hypoxemia esophageal obstruction personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits obstructive sleep apnea (adult) (pediatric)
white m 83 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  99  mg dl$atorvastatin  80  mg ; doxazosin  8  mg ; warfarin  5  mg ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; gabapentin  100  mg ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atenolol  100  mg ; finasteride  5  mg ; hydralazine  10  mg ; potassium chloride  40  meq ; potassium chloride (powder)  20  meq ; 
dysarthria and anarthria essential (primary) hypertension gastro-esophageal reflux disease without esophagitis other secondary pulmonary hypertension hyperlipidemia, unspecified unspecified atrial fibrillation hemiplegia, unspecified affecting left nondominant side unspecified atherosclerosis of native arteries of extremities, left leg personal history of nicotine dependence chronic total occlusion of artery of the extremities cerebral infarction, unspecified polyp of stomach and duodenum hypotension, unspecified solitary pulmonary nodule long term (current) use of anticoagulants facial weakness hypoxemia esophageal obstruction personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits obstructive sleep apnea (adult) (pediatric)
white m 83 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  94  mg dl$atorvastatin  80  mg ; doxazosin  8  mg ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; gabapentin  100  mg ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atenolol  100  mg ; finasteride  5  mg ; hydralazine  10  mg ; warfarin  7.5  mg ; 
dysarthria and anarthria essential (primary) hypertension gastro-esophageal reflux disease without esophagitis other secondary pulmonary hypertension hyperlipidemia, unspecified unspecified atrial fibrillation hemiplegia, unspecified affecting left nondominant side unspecified atherosclerosis of native arteries of extremities, left leg personal history of nicotine dependence chronic total occlusion of artery of the extremities cerebral infarction, unspecified polyp of stomach and duodenum hypotension, unspecified solitary pulmonary nodule long term (current) use of anticoagulants facial weakness hypoxemia esophageal obstruction personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits obstructive sleep apnea (adult) (pediatric)
white m 84 $nan$hematology blood hematocrit  39.9  %; hematology blood hematocrit  38.7  %; hematology blood hematocrit  38.0  %; hematology blood hematocrit  36.9  %; hematology blood hematocrit  38.3  %; hematology blood hematocrit  35.8  %; hematology blood hemoglobin  13.4  g dl; hematology blood hemoglobin  13.0  g dl; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  12.7  g dl; hematology blood hemoglobin  12.9  g dl; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  127  k ul; hematology blood platelet count  119  k ul; hematology blood platelet count  119  k ul; hematology blood platelet count  108  k ul; hematology blood platelet count  97  k ul; hematology blood platelet count  95  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  6.9  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  113  mg dl; blood gas blood free calcium  1.03  mmol l; blood gas blood free calcium  1.03  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  3.8  mmol l; blood gas blood lactate  3.2  mmol l; blood gas blood lactate  2.6  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  1.9  mmol l$influenza vaccine quadrivalent  0.5  ml ; lidocaine jelly 2% (glydo)  1  appl ; sodium chloride 0.9%  flush  10  ml ; mouth care oral rinse  7-15  ml ; heparin  5000  unit ; vial  1  vial ; ceftriaxone  2  gm ; ns  100  ml ; metronidazole  500  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; propofol  1000  mg ; pantoprazole  40  mg ; esmolol  2000  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; bag  50  ml ; fentanyl citrate  2.5  mg ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; metoprolol tartrate  5  mg ; lactated ringers  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; norepinephrine  8  mg ; cefepime  1  g ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$hematology blood hematocrit  35.5  %; hematology blood hematocrit  36.3  %; hematology blood hematocrit  34.8  %; hematology blood hemoglobin  12.1  g dl; hematology blood hemoglobin  12.4  g dl; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  102  k ul; hematology blood platelet count  93  k ul; hematology blood platelet count  91  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  139  mg dl; chemistry blood glucose  146  mg dl; chemistry blood glucose  114  mg dl; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.6  mmol l$influenza vaccine quadrivalent  0.5  ml ; lidocaine jelly 2% (glydo)  1  appl ; sodium chloride 0.9%  flush  10  ml ; mouth care oral rinse  7-15  ml ; heparin  5000  unit ; ns  100  ml ; metronidazole  500  mg ; propofol  1000  mg ; pantoprazole  40  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; bag  50  ml ; fentanyl citrate  2.5  mg ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; lactated ringers  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; norepinephrine  8  mg ; cefepime  1  g ; iso-osmotic dextrose  100  ml ; cefepime  2  g ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  100  ml ; vasopressin  40  unit ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$hematology blood hematocrit  32.9  %; hematology blood hematocrit  32.3  %; hematology blood hematocrit  31.5  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  97  k ul; hematology blood platelet count  96  k ul; hematology blood platelet count  98  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  133  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  144  mg dl; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.5  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; mouth care oral rinse  7-15  ml ; heparin  5000  unit ; ns  100  ml ; metronidazole  500  mg ; propofol  1000  mg ; pantoprazole  40  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; bag  50  ml ; fentanyl citrate  2.5  mg ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; lactated ringers  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; norepinephrine  8  mg ; iso-osmotic dextrose  100  ml ; cefepime  2  g ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  100  ml ; vasopressin  40  unit ; soln  100  ml ; acetaminophen iv  1000  mg ; morphine sulfate  2-4  mg ; heparin  1400-2700  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; neutra-phos  2  pkt ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  155  mg dl; chemistry blood glucose  128  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  1.6  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; mouth care oral rinse  7-15  ml ; ns  100  ml ; metronidazole  500  mg ; pantoprazole  40  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; lactated ringers  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic dextrose  100  ml ; cefepime  2  g ; sodium chloride 0.9%  flush  3-10  ml ; soln  100  ml ; acetaminophen iv  1000  mg ; morphine sulfate  2-4  mg ; heparin  1400-2700  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; neutra-phos  2  pkt ; ondansetron  4  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; chloraseptic throat spray  1  spry ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  123  mg dl; blood gas blood lactate  1.7  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; mouth care oral rinse  7-15  ml ; ns  100  ml ; metronidazole  500  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic dextrose  100  ml ; cefepime  2  g ; sodium chloride 0.9%  flush  3-10  ml ; morphine sulfate  2-4  mg ; heparin  1400-2700  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; ondansetron  4  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; chloraseptic throat spray  1  spry ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; omeprazole  40  mg ; oxycodone liquid  2.5-5  mg ; morphine sulfate  1  mg ; acetaminophen (liquid)  650  mg ; metoprolol tartrate  2.5  mg ; apixaban  5  mg ; metoprolol tartrate  6.25  mg ; metoprolol tartrate  12.5  mg ; furosemide  10  mg ; esmolol  34  mg ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  140  mg dl; chemistry blood glucose  141  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; ns  100  ml ; metronidazole  500  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic dextrose  100  ml ; cefepime  2  g ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; omeprazole  40  mg ; apixaban  5  mg ; esmolol  34  mg ; furosemide  20  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; enoxaparin sodium  80  mg ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$hematology blood hematocrit  37.9  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  143  mg dl; chemistry blood glucose  131  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; ns  100  ml ; metronidazole  500  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic dextrose  100  ml ; cefepime  2  g ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; furosemide  20  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; enoxaparin sodium  80  mg ; metoprolol tartrate  25  mg ; acetaminophen  1000  mg ; ramelteon  8  mg ; calcium carbonate  500  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.5  ; hematology urine wbc  96  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  155  mg dl; chemistry blood glucose  186  mg dl; chemistry blood albumin  2.5  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; enoxaparin sodium  80  mg ; acetaminophen  1000  mg ; ramelteon  8  mg ; calcium carbonate  500  mg ; lansoprazole oral disintegrating tab  30  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; metoprolol tartrate  50  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; potassium phosphate  15  mmol ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  170  mg dl; chemistry blood glucose  165  mg dl; chemistry blood glucose  174  mg dl; blood gas blood free calcium  1.04  mmol l; blood gas blood free calcium  1.03  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; ramelteon  8  mg ; calcium carbonate  500  mg ; lansoprazole oral disintegrating tab  30  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; metoprolol tartrate  50  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; potassium phosphate  15  mmol ; metoprolol tartrate  75  mg ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  142  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; ramelteon  8  mg ; calcium carbonate  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; sodium chloride 0.9%  1000  ml ; d5 1 2ns  1000  ml ; ciprofloxacin hcl  500  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; metoprolol tartrate  100  mg ; ipratropium bromide neb  1  neb ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  128  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; ramelteon  8  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; ciprofloxacin hcl  500  mg ; metoprolol tartrate  100  mg ; ipratropium bromide neb  1  neb ; simethicone  40-80  mg ; furosemide  40  mg ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$nan$bag  1  bag ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; ramelteon  8  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; ciprofloxacin hcl  500  mg ; ipratropium bromide neb  1  neb ; simethicone  40-80  mg ; furosemide  40  mg ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$hematology blood hematocrit  33.9  %; hematology blood hematocrit  31.5  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  149  k ul; hematology blood platelet count  150  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  154  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; ramelteon  8  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; ciprofloxacin hcl  500  mg ; ipratropium bromide neb  1  neb ; simethicone  40-80  mg ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; ramelteon  8  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; ciprofloxacin hcl  500  mg ; ipratropium bromide neb  1  neb ; simethicone  40-80  mg ; magnesium oxide  140  mg ; potassium chloride (powder)  10  meq ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  109  mg dl$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; ramelteon  8  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; ciprofloxacin hcl  500  mg ; ipratropium bromide neb  1  neb ; simethicone  40-80  mg ; magnesium oxide  140  mg ; potassium chloride (powder)  10  meq ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$nan$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; ramelteon  8  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; ciprofloxacin hcl  500  mg ; ipratropium bromide neb  1  neb ; simethicone  40-80  mg ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$nan$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; ramelteon  8  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; ipratropium bromide neb  1  neb ; simethicone  40-80  mg ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  121  mg dl; blood gas blood lactate  1.8  mmol l$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; ramelteon  8  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; ipratropium bromide neb  1  neb ; simethicone  40-80  mg ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 84 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; acetaminophen  1000  mg ; ramelteon  8  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; ipratropium bromide neb  1  neb ; simethicone  40-80  mg ; atorvastatin  20  mg ; 
long term (current) use of anticoagulants retention of urine, unspecified thrombocytopenia, unspecified paroxysmal atrial fibrillation bradycardia, unspecified chronic pulmonary edema old myocardial infarction gastro-esophageal reflux disease without esophagitis unspecified glaucoma calculus of kidney atherosclerotic heart disease of native coronary artery without angina pectoris 
white m 68 $nan$nan$cephalexin  500  mg ; 
 
white m 68 $nan$nan$cephalexin  500  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; ramelteon  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; brimonidine tartrate 0.15% ophth.  1  drop ; colchicine  0.6  mg ; acetaminophen  500-1000  mg ; lorazepam  0.5  mg ; heparin  5000  unit ; lisinopril  40  mg ; gabapentin  300  mg ; allopurinol  100  mg ; propranolol  20  mg ; metformin (glucophage)  500  mg ; psyllium powder  1  pkt ; potassium chloride  10  meq ; amlodipine  10  mg ; furosemide  40  mg ; glipizide  2.5  mg ; 
 
white f 73 $temp  97.9  heartrate  60.0  resprate  13.0  o2sat  99.0  sbp  104.0  dbp  81.0  rhythm  sinus rhythm  pain  0  $hematology blood hematocrit  35.1  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  83  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; atorvastatin  80  mg ; metoprolol tartrate  12.5  mg ; aspirin  325  mg ; omeprazole  40  mg ; acetaminophen  500-1000  mg ; heparin  900  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; citalopram  10  mg ; citalopram  20  mg ; aspirin  81  mg ; clopidogrel  75  mg ; 
 
white f 73 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  97  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; atorvastatin  80  mg ; metoprolol tartrate  12.5  mg ; omeprazole  40  mg ; acetaminophen  500-1000  mg ; heparin  900  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; citalopram  10  mg ; citalopram  20  mg ; aspirin  81  mg ; clopidogrel  75  mg ; nitroglycerin sl  0.3  mg ; 
 
white m 91 $temp  98.7  heartrate  94.0  resprate  23.0  o2sat  98.0  sbp  128.0  dbp  74.0  rhythm    pain  0  ; temp    heartrate  91.0  resprate  25.0  o2sat  96.0  sbp  125.0  dbp  73.0  rhythm    pain  0  ; temp    heartrate  86.0  resprate  23.0  o2sat  97.0  sbp  107.0  dbp  52.0  rhythm    pain  0  ; temp  97.7  heartrate  71.0  resprate  18.0  o2sat  97.0  sbp  108.0  dbp  57.0  rhythm    pain  0  ; temp    heartrate  91.0  resprate  16.0  o2sat  96.0  sbp  116.0  dbp  60.0  rhythm    pain  0  ; temp  98.0  heartrate  82.0  resprate  18.0  o2sat  96.0  sbp  109.0  dbp  58.0  rhythm    pain  0  ; temp  98.0  heartrate  85.0  resprate  20.0  o2sat  97.0  sbp  131.0  dbp  67.0  rhythm    pain  0  $hematology blood hematocrit  37.3  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  126  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; hematology urine wbc  120  # hpf; chemistry blood glucose  132  mg dl; blood gas blood lactate  1.9  mmol l$metoprolol succinate xl  50  mg ; rivaroxaban  20  mg ; 
nonrheumatic aortic (valve) insufficiency unspecified atrial fibrillation rheumatic tricuspid insufficiency malignant neoplasm of prostate personal history of nicotine dependence malignant neoplasm of bladder, unspecified long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified benign prostatic hyperplasia with lower urinary tract symptoms nonrheumatic mitral (valve) insufficiency chronic diastolic (congestive) heart failure anemia, unspecified unspecified dementia without behavioral disturbance family history of stroke
white m 91 $temp  98.6  heartrate  98.0  resprate  23.0  o2sat  92.0  sbp  101.0  dbp  61.0  rhythm    pain    $hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  123  mg dl; chemistry blood albumin  2.9  g dl$metoprolol succinate xl  50  mg ; rivaroxaban  20  mg ; donepezil  10  mg ; influenza vaccine quadrivalent  0.5  ml ; vial  1  vial ; cefepime  1  g ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; acetaminophen  650  mg ; potassium chloride  40  meq ; furosemide  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; phenazopyridine  100  mg ; 
nonrheumatic aortic (valve) insufficiency unspecified atrial fibrillation rheumatic tricuspid insufficiency malignant neoplasm of prostate personal history of nicotine dependence malignant neoplasm of bladder, unspecified long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified benign prostatic hyperplasia with lower urinary tract symptoms nonrheumatic mitral (valve) insufficiency chronic diastolic (congestive) heart failure anemia, unspecified unspecified dementia without behavioral disturbance family history of stroke
white m 91 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  124  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  113  mg dl$metoprolol succinate xl  50  mg ; rivaroxaban  20  mg ; donepezil  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; potassium chloride  40  meq ; furosemide  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; phenazopyridine  100  mg ; acetaminophen  1000  mg ; potassium chloride  20  meq ; furosemide  40  mg ; 
nonrheumatic aortic (valve) insufficiency unspecified atrial fibrillation rheumatic tricuspid insufficiency malignant neoplasm of prostate personal history of nicotine dependence malignant neoplasm of bladder, unspecified long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified benign prostatic hyperplasia with lower urinary tract symptoms nonrheumatic mitral (valve) insufficiency chronic diastolic (congestive) heart failure anemia, unspecified unspecified dementia without behavioral disturbance family history of stroke
white m 91 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  117  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  141  mg dl; chemistry blood glucose  103  mg dl$metoprolol succinate xl  50  mg ; rivaroxaban  20  mg ; donepezil  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; phenazopyridine  100  mg ; potassium chloride  20  meq ; furosemide  40  mg ; magnesium oxide  400  mg ; furosemide  80  mg ; 
nonrheumatic aortic (valve) insufficiency unspecified atrial fibrillation rheumatic tricuspid insufficiency malignant neoplasm of prostate personal history of nicotine dependence malignant neoplasm of bladder, unspecified long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified benign prostatic hyperplasia with lower urinary tract symptoms nonrheumatic mitral (valve) insufficiency chronic diastolic (congestive) heart failure anemia, unspecified unspecified dementia without behavioral disturbance family history of stroke
white m 91 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  107  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  180  mg dl; chemistry blood glucose  111  mg dl$metoprolol succinate xl  50  mg ; rivaroxaban  20  mg ; donepezil  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; phenazopyridine  100  mg ; furosemide  40  mg ; magnesium oxide  400  mg ; furosemide  80  mg ; 
nonrheumatic aortic (valve) insufficiency unspecified atrial fibrillation rheumatic tricuspid insufficiency malignant neoplasm of prostate personal history of nicotine dependence malignant neoplasm of bladder, unspecified long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified benign prostatic hyperplasia with lower urinary tract symptoms nonrheumatic mitral (valve) insufficiency chronic diastolic (congestive) heart failure anemia, unspecified unspecified dementia without behavioral disturbance family history of stroke
white m 91 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  139  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  101  mg dl$metoprolol succinate xl  50  mg ; rivaroxaban  20  mg ; donepezil  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
nonrheumatic aortic (valve) insufficiency unspecified atrial fibrillation rheumatic tricuspid insufficiency malignant neoplasm of prostate personal history of nicotine dependence malignant neoplasm of bladder, unspecified long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified benign prostatic hyperplasia with lower urinary tract symptoms nonrheumatic mitral (valve) insufficiency chronic diastolic (congestive) heart failure anemia, unspecified unspecified dementia without behavioral disturbance family history of stroke
white m 91 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology urine wbc  76  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  115  mg dl$metoprolol succinate xl  50  mg ; rivaroxaban  20  mg ; donepezil  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; lidocaine jelly 2% (glydo)  1  appl ; 
nonrheumatic aortic (valve) insufficiency unspecified atrial fibrillation rheumatic tricuspid insufficiency malignant neoplasm of prostate personal history of nicotine dependence malignant neoplasm of bladder, unspecified long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified benign prostatic hyperplasia with lower urinary tract symptoms nonrheumatic mitral (valve) insufficiency chronic diastolic (congestive) heart failure anemia, unspecified unspecified dementia without behavioral disturbance family history of stroke
white m 91 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  109  mg dl$metoprolol succinate xl  50  mg ; rivaroxaban  20  mg ; donepezil  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; lidocaine jelly 2% (glydo)  1  appl ; 
nonrheumatic aortic (valve) insufficiency unspecified atrial fibrillation rheumatic tricuspid insufficiency malignant neoplasm of prostate personal history of nicotine dependence malignant neoplasm of bladder, unspecified long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified benign prostatic hyperplasia with lower urinary tract symptoms nonrheumatic mitral (valve) insufficiency chronic diastolic (congestive) heart failure anemia, unspecified unspecified dementia without behavioral disturbance family history of stroke
white m 91 $nan$nan$metoprolol succinate xl  50  mg ; rivaroxaban  20  mg ; donepezil  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; lidocaine jelly 2% (glydo)  1  appl ; 
nonrheumatic aortic (valve) insufficiency unspecified atrial fibrillation rheumatic tricuspid insufficiency malignant neoplasm of prostate personal history of nicotine dependence malignant neoplasm of bladder, unspecified long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified benign prostatic hyperplasia with lower urinary tract symptoms nonrheumatic mitral (valve) insufficiency chronic diastolic (congestive) heart failure anemia, unspecified unspecified dementia without behavioral disturbance family history of stroke
black african american f 31 $temp    heartrate  95.0  resprate  15.0  o2sat  98.0  sbp  129.0  dbp  92.0  rhythm    pain    $hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  85  mg dl$heparin  5000  unit ; ondansetron  4  mg ; fluoxetine  40  mg ; gabapentin  100  mg ; hydromorphone (dilaudid)  2  mg ; ipratropium-albuterol neb  1  neb ; loratadine  10  mg ; oxycodone liquid  5  mg ; sodium chloride 3% inhalation soln  15  ml ; guaifenesin er  1200  mg ; omeprazole  40  mg ; ciprofloxacin hcl  500  mg ; lidocaine viscous 2%  15  ml ; morphine sulfate  2-4  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; guaifenesin  5-10  ml ; sodium chloride 0.9%  1000  ml ; 
acute tracheitis without obstruction unspecified chronic bronchitis gastro-esophageal reflux disease without esophagitis tracheostomy status pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere congenital tracheomalacia anemia, unspecified other congenital malformations of trachea dizziness and giddiness major depressive disorder, single episode, unspecified anemia, unspecified gastro-esophageal reflux disease without esophagitis hypovolemia major depressive disorder, single episode, unspecified tracheostomy status congenital tracheomalacia acute upper respiratory infection, unspecified other congenital malformations of trachea other diseases of trachea and bronchus accidents occurring in residential institution tracheostomy status esophageal reflux other anomalies of larynx, trachea, and bronchus car driver injured in collision with heavy transport vehicle or bus in nontraffic accident chronic obstructive asthma, unspecified depressive disorder, not elsewhere classified constipation, unspecified dehydration other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation stenosis of larynx throat pain unspecified disorder of liver other anomalies of larynx, trachea, and bronchus car driver injured in collision with heavy transport vehicle or bus in nontraffic accident dehydration stenosis of larynx iron deficiency anemia, unspecified other acute postoperative pain tracheostomy status accidents occurring in residential institution esophageal reflux other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other chronic bronchitis other diseases of trachea and bronchus iron deficiency anemia, unspecified stenosis of larynx esophageal reflux depressive disorder, not elsewhere classified
black african american f 31 $nan$nan$heparin  5000  unit ; ondansetron  4  mg ; fluoxetine  40  mg ; gabapentin  100  mg ; hydromorphone (dilaudid)  2  mg ; ipratropium-albuterol neb  1  neb ; loratadine  10  mg ; oxycodone liquid  5  mg ; omeprazole  40  mg ; ciprofloxacin hcl  500  mg ; lidocaine viscous 2%  15  ml ; morphine sulfate  2-4  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; guaifenesin  5-10  ml ; sodium chloride 0.9%  1000  ml ; 
acute tracheitis without obstruction unspecified chronic bronchitis gastro-esophageal reflux disease without esophagitis tracheostomy status pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere congenital tracheomalacia anemia, unspecified other congenital malformations of trachea dizziness and giddiness major depressive disorder, single episode, unspecified anemia, unspecified gastro-esophageal reflux disease without esophagitis hypovolemia major depressive disorder, single episode, unspecified tracheostomy status congenital tracheomalacia acute upper respiratory infection, unspecified other congenital malformations of trachea other diseases of trachea and bronchus accidents occurring in residential institution tracheostomy status esophageal reflux other anomalies of larynx, trachea, and bronchus car driver injured in collision with heavy transport vehicle or bus in nontraffic accident chronic obstructive asthma, unspecified depressive disorder, not elsewhere classified constipation, unspecified dehydration other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation stenosis of larynx throat pain unspecified disorder of liver other anomalies of larynx, trachea, and bronchus car driver injured in collision with heavy transport vehicle or bus in nontraffic accident dehydration stenosis of larynx iron deficiency anemia, unspecified other acute postoperative pain tracheostomy status accidents occurring in residential institution esophageal reflux other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other chronic bronchitis other diseases of trachea and bronchus iron deficiency anemia, unspecified stenosis of larynx esophageal reflux depressive disorder, not elsewhere classified
white m 75 $temp    heartrate  97.0  resprate  16.0  o2sat  99.0  sbp  152.0  dbp  69.0  rhythm    pain  0  ; temp  102.9  heartrate  88.0  resprate  16.0  o2sat  97.0  sbp  127.0  dbp  49.0  rhythm    pain  0  ; temp  102.8  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    $hematology blood hematocrit  18.0  %; hematology blood hemoglobin  6.3  g dl; hematology blood platelet count  21  k ul; hematology blood platelet count  10  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  128  mg dl; chemistry blood lactate dehydrogenase (ld)  136  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acyclovir  400  mg ; isavuconazonium sulfate  372  mg ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; syringe  1  syr ; filgrastim-sndz  480  mcg ; meperidine  12.5  mg ; heparin flush (100 units ml)  5  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  650  mg ; 
emphysema, unspecified neutropenia, unspecified headache acute myeloblastic leukemia, not having achieved remission contact with and (suspected) exposure to mold (toxic) other pancytopenia personal history of nicotine dependence fall on stairs or ladders in water transport injuring unspecified person fever presenting with conditions classified elsewhere chronic sinusitis, unspecified visual hallucinations erythema intertrigo candidiasis of skin and nail hypoxemia unspecified place in hospital as the place of occurrence of the external cause encounter for examination for normal comparison and control in clinical research program other disorders of phosphorus metabolism fluid overload, unspecified generalized hyperhidrosis adverse effect of antifungal antibiotics, systemically used, initial encounter
white m 75 $nan$hematology blood hematocrit  19.1  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  20  k ul; hematology blood platelet count  16  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  120  mg dl; chemistry blood lactate dehydrogenase (ld)  132  iu l; chemistry blood albumin  3.0  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acyclovir  400  mg ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; syringe  1  syr ; filgrastim-sndz  480  mcg ; heparin flush (100 units ml)  5  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  650  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; 
emphysema, unspecified neutropenia, unspecified headache acute myeloblastic leukemia, not having achieved remission contact with and (suspected) exposure to mold (toxic) other pancytopenia personal history of nicotine dependence fall on stairs or ladders in water transport injuring unspecified person fever presenting with conditions classified elsewhere chronic sinusitis, unspecified visual hallucinations erythema intertrigo candidiasis of skin and nail hypoxemia unspecified place in hospital as the place of occurrence of the external cause encounter for examination for normal comparison and control in clinical research program other disorders of phosphorus metabolism fluid overload, unspecified generalized hyperhidrosis adverse effect of antifungal antibiotics, systemically used, initial encounter
white m 75 $nan$hematology blood hematocrit  20.4  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  10  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  211  mg dl; chemistry blood lactate dehydrogenase (ld)  130  iu l; chemistry blood albumin  3.1  g dl$sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acyclovir  400  mg ; docusate sodium  100  mg ; syringe  1  syr ; filgrastim-sndz  480  mcg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; vial  1  vial ; meropenem  1000  mg ; methylprednisolone sodium succ  20  mg ; morphine sulfate  2-4  mg ; 
emphysema, unspecified neutropenia, unspecified headache acute myeloblastic leukemia, not having achieved remission contact with and (suspected) exposure to mold (toxic) other pancytopenia personal history of nicotine dependence fall on stairs or ladders in water transport injuring unspecified person fever presenting with conditions classified elsewhere chronic sinusitis, unspecified visual hallucinations erythema intertrigo candidiasis of skin and nail hypoxemia unspecified place in hospital as the place of occurrence of the external cause encounter for examination for normal comparison and control in clinical research program other disorders of phosphorus metabolism fluid overload, unspecified generalized hyperhidrosis adverse effect of antifungal antibiotics, systemically used, initial encounter
white m 75 $nan$hematology blood hematocrit  21.5  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  22  k ul; hematology blood platelet count  13  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  250  mg dl; chemistry blood glucose  140  mg dl; chemistry blood lactate dehydrogenase (ld)  160  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  1  %$sodium chloride 0.9%  flush  3-10  ml ; acyclovir  400  mg ; docusate sodium  100  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; vial  1  vial ; meropenem  1000  mg ; methylprednisolone sodium succ  20  mg ; morphine sulfate  2-4  mg ; neutra-phos  1  pkt ; furosemide  20  mg ; heparin sodium  50  unit ; syringe (0.9% sodium chloride)  5  ml ; vancomycin antibiotic lock  10  mg ; phosphorus  500  mg ; 
emphysema, unspecified neutropenia, unspecified headache acute myeloblastic leukemia, not having achieved remission contact with and (suspected) exposure to mold (toxic) other pancytopenia personal history of nicotine dependence fall on stairs or ladders in water transport injuring unspecified person fever presenting with conditions classified elsewhere chronic sinusitis, unspecified visual hallucinations erythema intertrigo candidiasis of skin and nail hypoxemia unspecified place in hospital as the place of occurrence of the external cause encounter for examination for normal comparison and control in clinical research program other disorders of phosphorus metabolism fluid overload, unspecified generalized hyperhidrosis adverse effect of antifungal antibiotics, systemically used, initial encounter
white m 75 $nan$hematology blood hematocrit  21.3  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  9  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  143  mg dl; chemistry blood lactate dehydrogenase (ld)  131  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3-10  ml ; acyclovir  400  mg ; docusate sodium  100  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; neutra-phos  1  pkt ; furosemide  20  mg ; heparin sodium  50  unit ; syringe (0.9% sodium chloride)  5  ml ; vancomycin antibiotic lock  10  mg ; phosphorus  500  mg ; acetaminophen  1000  mg ; lorazepam  0.5  mg ; 
emphysema, unspecified neutropenia, unspecified headache acute myeloblastic leukemia, not having achieved remission contact with and (suspected) exposure to mold (toxic) other pancytopenia personal history of nicotine dependence fall on stairs or ladders in water transport injuring unspecified person fever presenting with conditions classified elsewhere chronic sinusitis, unspecified visual hallucinations erythema intertrigo candidiasis of skin and nail hypoxemia unspecified place in hospital as the place of occurrence of the external cause encounter for examination for normal comparison and control in clinical research program other disorders of phosphorus metabolism fluid overload, unspecified generalized hyperhidrosis adverse effect of antifungal antibiotics, systemically used, initial encounter
white m 75 $nan$hematology blood hematocrit  21.1  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  20  k ul; hematology blood platelet count  16  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  133  mg dl; chemistry blood lactate dehydrogenase (ld)  131  iu l; chemistry blood albumin  2.7  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3-10  ml ; acyclovir  400  mg ; docusate sodium  100  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; lorazepam  0.5  mg ; levofloxacin  500  mg ; 
emphysema, unspecified neutropenia, unspecified headache acute myeloblastic leukemia, not having achieved remission contact with and (suspected) exposure to mold (toxic) other pancytopenia personal history of nicotine dependence fall on stairs or ladders in water transport injuring unspecified person fever presenting with conditions classified elsewhere chronic sinusitis, unspecified visual hallucinations erythema intertrigo candidiasis of skin and nail hypoxemia unspecified place in hospital as the place of occurrence of the external cause encounter for examination for normal comparison and control in clinical research program other disorders of phosphorus metabolism fluid overload, unspecified generalized hyperhidrosis adverse effect of antifungal antibiotics, systemically used, initial encounter
white m 75 $nan$hematology blood hematocrit  18.8  %; hematology blood hemoglobin  6.5  g dl; hematology blood platelet count  14  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  163  mg dl; chemistry blood lactate dehydrogenase (ld)  125  iu l; chemistry blood albumin  2.8  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3-10  ml ; acyclovir  400  mg ; docusate sodium  100  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; lorazepam  0.5  mg ; levofloxacin  500  mg ; 
emphysema, unspecified neutropenia, unspecified headache acute myeloblastic leukemia, not having achieved remission contact with and (suspected) exposure to mold (toxic) other pancytopenia personal history of nicotine dependence fall on stairs or ladders in water transport injuring unspecified person fever presenting with conditions classified elsewhere chronic sinusitis, unspecified visual hallucinations erythema intertrigo candidiasis of skin and nail hypoxemia unspecified place in hospital as the place of occurrence of the external cause encounter for examination for normal comparison and control in clinical research program other disorders of phosphorus metabolism fluid overload, unspecified generalized hyperhidrosis adverse effect of antifungal antibiotics, systemically used, initial encounter
white m 75 $nan$hematology blood hematocrit  21.4  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  10  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  113  mg dl; chemistry blood lactate dehydrogenase (ld)  142  iu l; hematology blood bands  1  %$sodium chloride 0.9%  flush  3-10  ml ; acyclovir  400  mg ; docusate sodium  100  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; lorazepam  0.5  mg ; levofloxacin  500  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; 
emphysema, unspecified neutropenia, unspecified headache acute myeloblastic leukemia, not having achieved remission contact with and (suspected) exposure to mold (toxic) other pancytopenia personal history of nicotine dependence fall on stairs or ladders in water transport injuring unspecified person fever presenting with conditions classified elsewhere chronic sinusitis, unspecified visual hallucinations erythema intertrigo candidiasis of skin and nail hypoxemia unspecified place in hospital as the place of occurrence of the external cause encounter for examination for normal comparison and control in clinical research program other disorders of phosphorus metabolism fluid overload, unspecified generalized hyperhidrosis adverse effect of antifungal antibiotics, systemically used, initial encounter
white m 75 $nan$hematology blood hematocrit  21.5  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  8  k ul; hematology blood platelet count  16  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  134  mg dl; chemistry blood lactate dehydrogenase (ld)  146  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  1  %$sodium chloride 0.9%  flush  3-10  ml ; acyclovir  400  mg ; docusate sodium  100  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; lorazepam  0.5  mg ; levofloxacin  500  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; diphenhydramine  25  mg ; 
emphysema, unspecified neutropenia, unspecified headache acute myeloblastic leukemia, not having achieved remission contact with and (suspected) exposure to mold (toxic) other pancytopenia personal history of nicotine dependence fall on stairs or ladders in water transport injuring unspecified person fever presenting with conditions classified elsewhere chronic sinusitis, unspecified visual hallucinations erythema intertrigo candidiasis of skin and nail hypoxemia unspecified place in hospital as the place of occurrence of the external cause encounter for examination for normal comparison and control in clinical research program other disorders of phosphorus metabolism fluid overload, unspecified generalized hyperhidrosis adverse effect of antifungal antibiotics, systemically used, initial encounter
white m 75 $nan$hematology blood hematocrit  21.0  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  13  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  180  iu l; hematology blood bands  1  %$sodium chloride 0.9%  flush  3-10  ml ; acyclovir  400  mg ; docusate sodium  100  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; lorazepam  0.5  mg ; levofloxacin  500  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; diphenhydramine  25  mg ; 
emphysema, unspecified neutropenia, unspecified headache acute myeloblastic leukemia, not having achieved remission contact with and (suspected) exposure to mold (toxic) other pancytopenia personal history of nicotine dependence fall on stairs or ladders in water transport injuring unspecified person fever presenting with conditions classified elsewhere chronic sinusitis, unspecified visual hallucinations erythema intertrigo candidiasis of skin and nail hypoxemia unspecified place in hospital as the place of occurrence of the external cause encounter for examination for normal comparison and control in clinical research program other disorders of phosphorus metabolism fluid overload, unspecified generalized hyperhidrosis adverse effect of antifungal antibiotics, systemically used, initial encounter
white m 75 $nan$hematology blood hematocrit  21.8  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  17  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  117  mg dl; chemistry blood lactate dehydrogenase (ld)  168  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  2  %$sodium chloride 0.9%  flush  3-10  ml ; acyclovir  400  mg ; docusate sodium  100  mg ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; lorazepam  0.5  mg ; levofloxacin  500  mg ; 
emphysema, unspecified neutropenia, unspecified headache acute myeloblastic leukemia, not having achieved remission contact with and (suspected) exposure to mold (toxic) other pancytopenia personal history of nicotine dependence fall on stairs or ladders in water transport injuring unspecified person fever presenting with conditions classified elsewhere chronic sinusitis, unspecified visual hallucinations erythema intertrigo candidiasis of skin and nail hypoxemia unspecified place in hospital as the place of occurrence of the external cause encounter for examination for normal comparison and control in clinical research program other disorders of phosphorus metabolism fluid overload, unspecified generalized hyperhidrosis adverse effect of antifungal antibiotics, systemically used, initial encounter
white m 75 $nan$hematology blood hematocrit  21.0  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  22  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  121  mg dl; chemistry blood lactate dehydrogenase (ld)  181  iu l; chemistry blood albumin  3.1  g dl$sodium chloride 0.9%  flush  3-10  ml ; acyclovir  400  mg ; docusate sodium  100  mg ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; lorazepam  0.5  mg ; levofloxacin  500  mg ; 
emphysema, unspecified neutropenia, unspecified headache acute myeloblastic leukemia, not having achieved remission contact with and (suspected) exposure to mold (toxic) other pancytopenia personal history of nicotine dependence fall on stairs or ladders in water transport injuring unspecified person fever presenting with conditions classified elsewhere chronic sinusitis, unspecified visual hallucinations erythema intertrigo candidiasis of skin and nail hypoxemia unspecified place in hospital as the place of occurrence of the external cause encounter for examination for normal comparison and control in clinical research program other disorders of phosphorus metabolism fluid overload, unspecified generalized hyperhidrosis adverse effect of antifungal antibiotics, systemically used, initial encounter
white m 75 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acyclovir  400  mg ; docusate sodium  100  mg ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; lorazepam  0.5  mg ; 
emphysema, unspecified neutropenia, unspecified headache acute myeloblastic leukemia, not having achieved remission contact with and (suspected) exposure to mold (toxic) other pancytopenia personal history of nicotine dependence fall on stairs or ladders in water transport injuring unspecified person fever presenting with conditions classified elsewhere chronic sinusitis, unspecified visual hallucinations erythema intertrigo candidiasis of skin and nail hypoxemia unspecified place in hospital as the place of occurrence of the external cause encounter for examination for normal comparison and control in clinical research program other disorders of phosphorus metabolism fluid overload, unspecified generalized hyperhidrosis adverse effect of antifungal antibiotics, systemically used, initial encounter
unknown f 77 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  critical  ; temp    heartrate  77.0  resprate  30.0  o2sat  80.0  sbp  114.0  dbp  70.0  rhythm    pain    ; temp    heartrate  73.0  resprate  30.0  o2sat  97.0  sbp  108.0  dbp  64.0  rhythm    pain  1  $nan$sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; 
 
unknown f 77 $nan$hematology blood hematocrit  15.1  %; hematology blood hematocrit  19.3  %; hematology blood hematocrit  21.5  %; hematology blood hematocrit  28.0  %; hematology blood hematocrit  29.3  %; hematology blood hematocrit  28.0  %; hematology blood hematocrit  26.7  %; hematology blood hematocrit  28.1  %; hematology blood hemoglobin  6.1  g dl; hematology blood hemoglobin  6.9  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  4.7  g dl; hematology blood platelet count  136  k ul; hematology blood platelet count  119  k ul; hematology blood platelet count  75  k ul; hematology blood platelet count  72  k ul; hematology blood platelet count  95  k ul; hematology blood platelet count  115  k ul; hematology blood platelet count  94  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  11.9  mg dl; chemistry blood glucose  110  mg dl; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.28  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.35  mmol l; blood gas blood free calcium  1.61  mmol l; blood gas blood free calcium  1.76  mmol l; blood gas blood free calcium  0.97  mmol l; blood gas blood free calcium  1.69  mmol l; blood gas blood free calcium  1.63  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  7.4  mmol l; blood gas blood lactate  8.8  mmol l; blood gas blood lactate  7.8  mmol l; blood gas blood lactate  8.2  mmol l; blood gas blood lactate  8.0  mmol l; blood gas blood lactate  6.6  mmol l; blood gas blood chloride, whole blood  110  meq l; blood gas blood chloride, whole blood  109  meq l; blood gas blood chloride, whole blood  108  meq l; blood gas blood chloride, whole blood  104  meq l; blood gas blood chloride, whole blood  109  meq l; blood gas blood glucose  127  mg dl; blood gas blood glucose  137  mg dl; blood gas blood glucose  125  mg dl; blood gas blood glucose  215  mg dl; blood gas blood glucose  210  mg dl; blood gas blood glucose  217  mg dl; blood gas blood glucose  210  mg dl; blood gas blood glucose  192  mg dl; blood gas blood glucose  163  mg dl; blood gas blood glucose  137  mg dl; blood gas blood glucose  108  mg dl; blood gas blood glucose  93  mg dl; blood gas blood glucose  105  mg dl; blood gas blood hematocrit, calculated  33  %; blood gas blood hematocrit, calculated  25  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  24  %; blood gas blood hematocrit, calculated  15  %; blood gas blood hematocrit, calculated  19  %; blood gas blood hematocrit, calculated  22  %; blood gas blood hematocrit, calculated  30  %; blood gas blood hemoglobin  11.1  g dl; blood gas blood hemoglobin  8.4  g dl; blood gas blood hemoglobin  8.5  g dl; blood gas blood hemoglobin  8.6  g dl; blood gas blood hemoglobin  8.1  g dl; blood gas blood hemoglobin  6.3  g dl; blood gas blood hemoglobin  7.3  g dl; blood gas blood hemoglobin  10.0  g dl; blood gas blood hemoglobin  4.9  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  5.4  meq l; blood gas blood potassium, whole blood  6.0  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  140  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  143  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  143  meq l; chemistry blood % hemoglobin a1c  5.5  %$sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; 0.9 % sodium chloride  25  ml ; phenylephrine  6  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; insulin human regular  100  unit ; mouth care oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; mupirocin ointment 2%  1  appl ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; cisatracurium besylate  100  mg ; vial  1  vial ; pantoprazole  40  mg ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; aspirin ec  81  mg ; aspirin  81  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; artificial tears gel 1%  1-2  drop ; furosemide  20  mg ; furosemide  40  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; furosemide  80  mg ; 
 
unknown f 77 $nan$hematology blood hematocrit  27.1  %; hematology blood hematocrit  25.5  %; hematology blood hematocrit  27.9  %; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  103  k ul; hematology blood platelet count  112  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  5.7  meq l; chemistry blood potassium  5.4  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  10.8  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  113  mg dl; blood gas blood free calcium  1.51  mmol l; blood gas blood free calcium  1.33  mmol l; blood gas blood free calcium  1.51  mmol l; blood gas blood free calcium  1.48  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood lactate  4.6  mmol l; blood gas blood lactate  4.4  mmol l; blood gas blood glucose  110  mg dl; blood gas blood glucose  106  mg dl; blood gas blood glucose  132  mg dl; blood gas blood glucose  114  mg dl; blood gas blood hematocrit, calculated  33  %; blood gas blood hemoglobin  11.1  g dl; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood potassium, whole blood  5.2  meq l$sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; insulin human regular  100  unit ; mouth care oral rinse  15  ml ; docusate sodium  100  mg ; mupirocin ointment 2%  1  appl ; cisatracurium besylate  100  mg ; vial  1  vial ; pantoprazole  40  mg ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; aspirin ec  81  mg ; aspirin  81  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; artificial tears gel 1%  1-2  drop ; furosemide  40  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; furosemide  80  mg ; acetaminophen  1000  mg ; chlorothiazide sodium  500  mg ; fentanyl citrate  25-100  mcg ; insulin (regular) for hyperkalemia  10  unit ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; sodium chloride 0.9%  flush for crrt  100-200  ml ; sodium citrate 4%  1.2  ml ; 0.9% sodium chloride  500  ml ; calcium gluconate  20  g ; sw  100  ml ; potassium chloride  10  meq ; sterile water  100  ml ; potassium chloride  40  meq ; heparin (crrt machine priming)  5000  unit ; neomycin-polymyxin-bacitracin  1  appl ; 
 
unknown f 77 $nan$hematology blood hematocrit  27.4  %; hematology blood hematocrit  28.8  %; hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  103  k ul; hematology blood platelet count  88  k ul; hematology blood platelet count  70  k ul; chemistry blood anion gap  26  meq l; chemistry blood anion gap  26  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  3.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood bilirubin, total  4.8  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  87  mg dl; chemistry blood glucose  180  mg dl; chemistry blood lactate dehydrogenase (ld)  268  iu l; chemistry blood lactate dehydrogenase (ld)  5400  iu l; chemistry blood albumin  2.5  g dl; blood gas blood free calcium  1.29  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.25  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.04  mmol l; blood gas blood free calcium  0.89  mmol l; blood gas blood free calcium  0.93  mmol l; blood gas blood free calcium  0.82  mmol l; blood gas blood free calcium  0.84  mmol l; blood gas blood free calcium  0.99  mmol l; blood gas blood lactate  3.7  mmol l; blood gas blood lactate  6.4  mmol l; blood gas blood lactate  8.6  mmol l; blood gas blood lactate  7.1  mmol l; blood gas blood lactate  9.7  mmol l; blood gas blood lactate  7.7  mmol l; blood gas blood lactate  9.4  mmol l; blood gas blood lactate  7.3  mmol l; blood gas blood lactate  8.0  mmol l; blood gas blood lactate  12.5  mmol l; blood gas blood lactate  7.9  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood glucose  126  mg dl; blood gas blood glucose  172  mg dl; blood gas blood glucose  117  mg dl; blood gas blood glucose  81  mg dl; blood gas blood glucose  99  mg dl; blood gas blood glucose  59  mg dl; blood gas blood glucose  92  mg dl; blood gas blood glucose  65  mg dl; blood gas blood glucose  123  mg dl; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  24  %; blood gas blood hemoglobin  8.6  g dl; blood gas blood hemoglobin  8.0  g dl; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood calculated bicarbonate, whole blood  18.5  meq l; blood gas blood creatinine, whole blood  2.0  mg dl; blood gas blood creatinine, whole blood  1.7  mg dl$sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; insulin human regular  100  unit ; mouth care oral rinse  15  ml ; docusate sodium  100  mg ; mupirocin ointment 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; aspirin ec  81  mg ; aspirin  81  mg ; artificial tears gel 1%  1-2  drop ; fentanyl citrate  25-100  mcg ; insulin (regular) for hyperkalemia  10  unit ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; sodium chloride 0.9%  flush for crrt  100-200  ml ; sodium citrate 4%  1.2  ml ; 0.9% sodium chloride  500  ml ; calcium gluconate  20  g ; sw  100  ml ; potassium chloride  10  meq ; sterile water  100  ml ; potassium chloride  40  meq ; heparin (crrt machine priming)  5000  unit ; neomycin-polymyxin-bacitracin  1  appl ; sodium chloride 0.9%  1000  ml ; albumin 5% (12.5g   250ml)  12.5  g ; rocuronium  100  mg ; sodium bicarbonate  100  meq ; amiodarone  150  mg ; 
 
unknown f 77 $nan$hematology blood hematocrit  24.4  %; hematology blood hematocrit  25.6  %; hematology blood hematocrit  27.4  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  74  k ul; hematology blood platelet count  50  k ul; hematology blood platelet count  51  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  26  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  3.0  ; hematology blood inr(pt)  3.4  ; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  5.1  mg dl; chemistry blood glucose  52  mg dl; chemistry blood glucose  124  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.00  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.04  mmol l; blood gas blood free calcium  0.84  mmol l; blood gas blood lactate  12.3  mmol l; blood gas blood lactate  13.5  mmol l; blood gas blood lactate  13.7  mmol l; blood gas blood lactate  14.0  mmol l; blood gas blood lactate  11.8  mmol l; blood gas blood lactate  13.2  mmol l; blood gas blood lactate  12.2  mmol l; blood gas blood lactate  13.4  mmol l; blood gas blood lactate  9.3  mmol l; blood gas blood lactate  13.5  mmol l; blood gas blood lactate  12.3  mmol l; blood gas blood chloride, whole blood  97  meq l; blood gas blood chloride, whole blood  99  meq l; blood gas blood glucose  96  mg dl; blood gas blood glucose  68  mg dl; blood gas blood glucose  109  mg dl; blood gas blood glucose  113  mg dl; blood gas blood glucose  113  mg dl; blood gas blood glucose  113  mg dl; blood gas blood glucose  138  mg dl; blood gas blood glucose  132  mg dl; blood gas blood glucose  120  mg dl; blood gas blood glucose  45  mg dl; blood gas blood hematocrit, calculated  27  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hematocrit, calculated  24  %; blood gas blood hematocrit, calculated  24  %; blood gas blood hemoglobin  9.0  g dl; blood gas blood hemoglobin  9.1  g dl; blood gas blood hemoglobin  8.1  g dl; blood gas blood hemoglobin  8.0  g dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  135  meq l$sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; insulin human regular  100  unit ; mouth care oral rinse  15  ml ; docusate sodium  100  mg ; mupirocin ointment 2%  1  appl ; vial  1  vial ; pantoprazole  40  mg ; aspirin ec  81  mg ; aspirin  81  mg ; fentanyl citrate  25-100  mcg ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; sodium chloride 0.9%  flush for crrt  100-200  ml ; 0.9% sodium chloride  500  ml ; calcium gluconate  20  g ; sw  100  ml ; potassium chloride  10  meq ; sterile water  100  ml ; potassium chloride  40  meq ; heparin (crrt machine priming)  5000  unit ; neomycin-polymyxin-bacitracin  1  appl ; sodium bicarbonate  100  meq ; amiodarone  150  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; d10w  1000  ml ; sodium bicarbonate  50  meq ; norepinephrine  8  mg ; morphine sulfate  2-4  mg ; 
 
unknown f 77 $nan$nan$morphine sulfate  2-4  mg ; 
 
white m 75 $temp    heartrate  45.0  resprate  10.0  o2sat  97.0  sbp  149.0  dbp  54.0  rhythm    pain  0  $nan$lisinopril  10  mg ; simvastatin  40  mg ; aspirin  81  mg ; 
 
white m 75 $temp  97.4  heartrate  57.0  resprate  18.0  o2sat  97.0  sbp  176.0  dbp  80.0  rhythm    pain    ; temp  98.0  heartrate  49.0  resprate  16.0  o2sat  98.0  sbp  145.0  dbp  63.0  rhythm  97%  pain    $hematology blood hematocrit  39.5  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  132  mg dl$lisinopril  10  mg ; simvastatin  40  mg ; aspirin  81  mg ; metoprolol tartrate  12.5  mg ; latanoprost 0.005% ophth. soln.  1  drop ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium polystyrene sulfonate  15  gm ; heparin  1000-2500  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; heparin  1000-2000  unit ; enoxaparin sodium  70  mg ; 
 
white m 75 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  96  mg dl$lisinopril  10  mg ; simvastatin  40  mg ; aspirin  81  mg ; metoprolol tartrate  12.5  mg ; latanoprost 0.005% ophth. soln.  1  drop ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium polystyrene sulfonate  15  gm ; enoxaparin sodium  70  mg ; warfarin  4  mg ; 
 
white m 75 $nan$nan$lisinopril  10  mg ; simvastatin  40  mg ; aspirin  81  mg ; metoprolol tartrate  12.5  mg ; latanoprost 0.005% ophth. soln.  1  drop ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium polystyrene sulfonate  15  gm ; enoxaparin sodium  70  mg ; warfarin  4  mg ; 
 
white f 57 $nan$chemistry blood % hemoglobin a1c  5.5  %$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; risperidone  1  mg ; lorazepam  1  mg ; propranolol  40  mg ; risperidone  2  mg ; psyllium wafer  1-2  waf ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; propranolol  40  mg ; psyllium wafer  1-2  waf ; propranolol  60  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; psyllium wafer  1-2  waf ; propranolol  60  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; psyllium wafer  1-2  waf ; propranolol  60  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; psyllium wafer  1-2  waf ; propranolol  60  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; psyllium wafer  1-2  waf ; propranolol  60  mg ; latuda  20  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; psyllium wafer  1-2  waf ; latuda  20  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; psyllium wafer  1-2  waf ; latuda  20  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; psyllium wafer  1-2  waf ; latuda  20  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; psyllium wafer  1-2  waf ; latuda  20  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  20  mg ; latuda  40  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  40  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  40  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  40  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  40  mg ; latuda  60  mg ; haloperidol  5  mg ; benztropine mesylate  1  mg ; lorazepam  2  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  60  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  60  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  60  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  60  mg ; latuda  80  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  80  mg ; propranolol  20  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  80  mg ; propranolol  20  mg ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  80  mg ; propranolol  20  mg ; loratadine  10  mg ; sodium chloride nasal  1-2  spry ; cepacol (sore throat lozenge)  1  loz ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  80  mg ; propranolol  20  mg ; loratadine  10  mg ; sodium chloride nasal  1-2  spry ; cepacol (sore throat lozenge)  1  loz ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  80  mg ; propranolol  20  mg ; loratadine  10  mg ; sodium chloride nasal  1-2  spry ; cepacol (sore throat lozenge)  1  loz ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  80  mg ; propranolol  20  mg ; loratadine  10  mg ; sodium chloride nasal  1-2  spry ; cepacol (sore throat lozenge)  1  loz ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  80  mg ; propranolol  20  mg ; loratadine  10  mg ; sodium chloride nasal  1-2  spry ; cepacol (sore throat lozenge)  1  loz ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  80  mg ; propranolol  20  mg ; loratadine  10  mg ; sodium chloride nasal  1-2  spry ; cepacol (sore throat lozenge)  1  loz ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  80  mg ; propranolol  20  mg ; loratadine  10  mg ; sodium chloride nasal  1-2  spry ; cepacol (sore throat lozenge)  1  loz ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  80  mg ; propranolol  20  mg ; loratadine  10  mg ; sodium chloride nasal  1-2  spry ; cepacol (sore throat lozenge)  1  loz ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  80  mg ; propranolol  20  mg ; loratadine  10  mg ; sodium chloride nasal  1-2  spry ; cepacol (sore throat lozenge)  1  loz ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  80  mg ; propranolol  20  mg ; loratadine  10  mg ; sodium chloride nasal  1-2  spry ; cepacol (sore throat lozenge)  1  loz ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  80  mg ; propranolol  20  mg ; loratadine  10  mg ; sodium chloride nasal  1-2  spry ; cepacol (sore throat lozenge)  1  loz ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white f 57 $nan$nan$acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; latuda  80  mg ; propranolol  20  mg ; loratadine  10  mg ; sodium chloride nasal  1-2  spry ; cepacol (sore throat lozenge)  1  loz ; 
anxiety disorder, unspecified essential (primary) hypertension post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified unspecified psychosis not due to a substance or known physiological condition driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing unspecified psychosis anxiety state, unspecified insomnia, unspecified chest pain, unspecified posttraumatic stress disorder
white m 27 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  87  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  86  mg dl; chemistry blood lactate dehydrogenase (ld)  270  iu l; chemistry blood albumin  3.6  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; tramadol (ultram)  50  mg ; ondansetron  4  mg ; 5% dextrose  250  ml ; acetylcysteine (iv)  3320  mg ; 5% dextrose  500  ml ; acetylcysteine (iv)  6640  mg ; ciprofloxacin hcl  500  mg ; ibuprofen  400-600  mg ; diphenhydramine  25  mg ; 
 
white m 27 $nan$hematology blood hematocrit  38.9  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  86  mg dl; chemistry blood lactate dehydrogenase (ld)  270  iu l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; tramadol (ultram)  50  mg ; ondansetron  4  mg ; ciprofloxacin hcl  500  mg ; ibuprofen  400-600  mg ; diphenhydramine  25  mg ; 
 
black african american f 29 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; albuterol inhaler  1-2  puff ; 
first-degree perineal laceration, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn motorcycle driver injured in collision with fixed or stationary object in nontraffic accident 
black african american f 29 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; albuterol inhaler  1-2  puff ; 
first-degree perineal laceration, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn motorcycle driver injured in collision with fixed or stationary object in nontraffic accident 
black african american f 29 $nan$hematology blood hematocrit  33.0  %$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; albuterol inhaler  1-2  puff ; 
first-degree perineal laceration, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn motorcycle driver injured in collision with fixed or stationary object in nontraffic accident 
white m 61 $nan$nan$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; aspirin  81  mg ; lamivudine  150  mg ; ritonavir  100  mg ; isosorbide mononitrate (extended release)  90  mg ; metoprolol succinate xl  100  mg ; torsemide  20  mg ; vitamin d  1000  unit ; sodium chloride 0.9%  flush  10-20  ml ; insulin  45  unit ; 
atherosclerosis of native arteries of the extremities with gangrene acute kidney failure, unspecified polyneuropathy in diabetes methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site subendocardial infarction, initial episode of care congestive heart failure, unspecified personal history of tobacco use nausea with vomiting other bone involvement in diseases classified elsewhere iron deficiency anemia, unspecified long-term (current) use of insulin coronary atherosclerosis of native coronary artery other toe(s) amputation status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled candidal esophagitis chronic kidney disease, stage iii (moderate) below knee amputation status other and unspecified hyperlipidemia personal history of noncompliance with medical treatment, presenting hazards to health diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled asymptomatic human immunodeficiency virus [hiv] infection status attention deficit disorder with hyperactivity long-term (current) use of aspirin nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere anemia of other chronic disease bacteroides fragilis dysphagia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified ulcer of heel and midfoot long qt syndrome depressive disorder, not elsewhere classified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled acute on chronic systolic heart failure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of heel and midfoot diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy other and unspecified hyperlipidemia polyneuropathy in diabetes below knee amputation status long-term (current) use of insulin calculus of gallbladder without mention of cholecystitis, without mention of obstruction asymptomatic human immunodeficiency virus [hiv] infection status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities polyneuropathy in diabetes ulcer of heel and midfoot below knee amputation status
white m 61 $nan$hematology blood hematocrit  21.8  %; hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  54  mg dl$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; aspirin  81  mg ; lamivudine  150  mg ; ritonavir  100  mg ; isosorbide mononitrate (extended release)  90  mg ; metoprolol succinate xl  100  mg ; torsemide  20  mg ; vitamin d  1000  unit ; sodium chloride 0.9%  flush  10-20  ml ; insulin  45  unit ; 0.45% sodium chloride  1000  ml ; abacavir sulfate  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; fish oil (omega 3)  2000  mg ; insulin  0  unit ; hydralazine  50  mg ; atorvastatin  80  mg ; efavirenz  600  mg ; atazanavir  400  mg ; hydralazine  10  mg ; furosemide  40  mg ; 
atherosclerosis of native arteries of the extremities with gangrene acute kidney failure, unspecified polyneuropathy in diabetes methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site subendocardial infarction, initial episode of care congestive heart failure, unspecified personal history of tobacco use nausea with vomiting other bone involvement in diseases classified elsewhere iron deficiency anemia, unspecified long-term (current) use of insulin coronary atherosclerosis of native coronary artery other toe(s) amputation status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled candidal esophagitis chronic kidney disease, stage iii (moderate) below knee amputation status other and unspecified hyperlipidemia personal history of noncompliance with medical treatment, presenting hazards to health diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled asymptomatic human immunodeficiency virus [hiv] infection status attention deficit disorder with hyperactivity long-term (current) use of aspirin nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere anemia of other chronic disease bacteroides fragilis dysphagia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified ulcer of heel and midfoot long qt syndrome depressive disorder, not elsewhere classified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled acute on chronic systolic heart failure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of heel and midfoot diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy other and unspecified hyperlipidemia polyneuropathy in diabetes below knee amputation status long-term (current) use of insulin calculus of gallbladder without mention of cholecystitis, without mention of obstruction asymptomatic human immunodeficiency virus [hiv] infection status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities polyneuropathy in diabetes ulcer of heel and midfoot below knee amputation status
white m 61 $nan$hematology blood hematocrit  26.6  %$heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; aspirin  81  mg ; lamivudine  150  mg ; ritonavir  100  mg ; isosorbide mononitrate (extended release)  90  mg ; metoprolol succinate xl  100  mg ; torsemide  20  mg ; vitamin d  1000  unit ; sodium chloride 0.9%  flush  10-20  ml ; insulin  45  unit ; abacavir sulfate  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; fish oil (omega 3)  2000  mg ; insulin  0  unit ; hydralazine  50  mg ; atorvastatin  80  mg ; efavirenz  600  mg ; atazanavir  400  mg ; hydralazine  10  mg ; furosemide  40  mg ; 0.9% sodium chloride  50  ml ; daptomycin  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; *nf* ertapenem sodium  1  g ; 
atherosclerosis of native arteries of the extremities with gangrene acute kidney failure, unspecified polyneuropathy in diabetes methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site subendocardial infarction, initial episode of care congestive heart failure, unspecified personal history of tobacco use nausea with vomiting other bone involvement in diseases classified elsewhere iron deficiency anemia, unspecified long-term (current) use of insulin coronary atherosclerosis of native coronary artery other toe(s) amputation status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled candidal esophagitis chronic kidney disease, stage iii (moderate) below knee amputation status other and unspecified hyperlipidemia personal history of noncompliance with medical treatment, presenting hazards to health diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled asymptomatic human immunodeficiency virus [hiv] infection status attention deficit disorder with hyperactivity long-term (current) use of aspirin nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere anemia of other chronic disease bacteroides fragilis dysphagia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified ulcer of heel and midfoot long qt syndrome depressive disorder, not elsewhere classified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled acute on chronic systolic heart failure diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of heel and midfoot diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy other and unspecified hyperlipidemia polyneuropathy in diabetes below knee amputation status long-term (current) use of insulin calculus of gallbladder without mention of cholecystitis, without mention of obstruction asymptomatic human immunodeficiency virus [hiv] infection status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities polyneuropathy in diabetes ulcer of heel and midfoot below knee amputation status
white m 92 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  269  k ul$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; senna  1  tab ; calcium carbonate  1000  mg ; docusate sodium  100  mg ; fosinopril  20  mg ; heparin  5000  unit ; amlodipine  5  mg ; aspirin  81  mg ; omeprazole  20  mg ; vitamin d  800  unit ; simvastatin  10  mg ; cyanocobalamin  100  mcg ; olanzapine  2.5  mg ; levothyroxine sodium  125  mcg ; 
other persistent mental disorders due to conditions classified elsewhere home accidents coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism other mitochondrial metabolism disorders closed fracture of two ribs urinary incontinence, unspecified unspecified essential hypertension cardiac pacemaker in situ other accidental fall from one level to another closed fracture of nasal bones benign essential hypertension other persistent mental disorders due to conditions classified elsewhere fall from other slipping, tripping, or stumbling orthostatic hypotension urinary incontinence, unspecified cardiac pacemaker in situ hyposmolality and/or hyponatremia closed fracture of dorsal [thoracic] vertebra without mention of spinal cord injury degeneration of lumbar or lumbosacral intervertebral disc other and unspecified hyperlipidemia abnormality of gait other persistent mental disorders due to conditions classified elsewhere mobitz (type) ii atrioventricular block unspecified acquired hypothyroidism hyposmolality and/or hyponatremia unspecified essential hypertension anemia, unspecified
white m 79 $nan$hematology blood hematocrit  42.3  %; hematology blood hematocrit  41.4  %; hematology blood hematocrit  38.9  %; hematology blood hematocrit  37.1  %; hematology blood hemoglobin  12.7  g dl; hematology blood hemoglobin  14.3  g dl; hematology blood hemoglobin  14.0  g dl; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  154  k ul; hematology blood platelet count  139  k ul; hematology blood platelet count  127  k ul; hematology blood platelet count  109  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  22  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  5.1  mg dl; chemistry blood creatinine  4.8  mg dl; chemistry blood creatinine  4.9  mg dl; chemistry blood creatinine  4.7  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  2.6  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  52  mg dl; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  3.3  ; hematology blood inr(pt)  3.6  ; hematology blood inr(pt)  4.1  ; chemistry urine chloride, urine  14  meq l; chemistry urine creatinine, urine  111  mg dl; chemistry urine potassium, urine  52  meq l; chemistry urine sodium, urine  19  meq l; hematology urine wbc  159  # hpf; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  152  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  106  mg dl; hematology blood bands  20  %; blood gas blood free calcium  1.28  mmol l; blood gas blood free calcium  1.26  mmol l; blood gas blood free calcium  1.23  mmol l; blood gas blood free calcium  0.98  mmol l; blood gas blood free calcium  0.97  mmol l; blood gas blood lactate  2.6  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood potassium, whole blood  4.1  meq l$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; propofol  1000  mg ; propofol  200  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; phenylephrine  60  mg ; lactated ringers  1000  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; potassium chloride (powder)  40  meq ; acetaminophen iv  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; albumin 5%   25  g ; albumin 5% (25g   500ml)  25  g ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; albumin 25% (12.5g   50ml)  25  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
white m 79 $nan$hematology blood hematocrit  36.9  %; hematology blood hematocrit  35.5  %; hematology blood hemoglobin  12.3  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  90  k ul; hematology blood platelet count  98  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  4.6  mg dl; chemistry blood creatinine  4.3  mg dl; chemistry blood creatinine  4.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  61  mg dl; chemistry blood urea nitrogen  62  mg dl; hematology blood inr(pt)  2.4  ; hematology blood inr(pt)  1.4  ; chemistry urine chloride, urine  20  meq l; chemistry urine creatinine, urine  54  mg dl; chemistry urine potassium, urine  29  meq l; chemistry urine sodium, urine  21  meq l; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  97  mg dl; chemistry blood albumin  3.1  g dl; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood glucose  77  mg dl; blood gas blood potassium, whole blood  4.0  meq l$propofol  1000  mg ; propofol  200  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; acetaminophen iv  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; albumin 25% (12.5g   50ml)  25  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  50  ml ; phytonadione  5  mg ; 0.9% sodium chloride  1000  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; cisatracurium besylate  100  mg ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; 
 
white m 79 $nan$hematology blood hematocrit  33.7  %; hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.4  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  75  k ul; hematology blood platelet count  81  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  4.2  mg dl; chemistry blood creatinine  4.1  mg dl; chemistry blood creatinine  4.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood urea nitrogen  67  mg dl; chemistry blood urea nitrogen  66  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine chloride, urine  10  meq l; chemistry urine creatinine, urine  69  mg dl; chemistry urine potassium, urine  32  meq l; chemistry urine urea nitrogen, urine  435  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  101  mg dl; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.21  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood glucose  87  mg dl$propofol  1000  mg ; propofol  200  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; acetaminophen iv  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; lidocaine  100  mg ; sodium chloride  1  gm ; 0.9% sodium chloride  500  ml ; 
 
white m 79 $nan$hematology blood hematocrit  29.4  %; hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  68  k ul; hematology blood platelet count  83  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  4.0  mg dl; chemistry blood creatinine  3.8  mg dl; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  67  mg dl; chemistry blood urea nitrogen  65  mg dl; chemistry blood urea nitrogen  64  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  107  mg dl; chemistry blood glucose  83  mg dl; chemistry blood glucose  72  mg dl; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.22  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood glucose  67  mg dl; blood gas blood glucose  75  mg dl; blood gas blood potassium, whole blood  3.1  meq l$propofol  1000  mg ; propofol  200  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; acetaminophen iv  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sodium chloride  1  gm ; 0.9% sodium chloride  500  ml ; d5ns  1000  ml ; albumin 5%  25  g ; 0.9% sodium chloride  250  ml ; sodium glycerophosphate  20  mmol ; artificial tears  1-2  drop ; 
 
white m 79 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  80  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood creatinine  3.3  mg dl; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood urea nitrogen  65  mg dl; chemistry blood urea nitrogen  68  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine chloride, urine  27  meq l; chemistry urine creatinine, urine  61  mg dl; chemistry urine potassium, urine  20  meq l; chemistry urine sodium, urine  21  meq l; chemistry urine urea nitrogen, urine  670  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  90  mg dl; chemistry blood glucose  97  mg dl$propofol  1000  mg ; propofol  200  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; acetaminophen iv  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; albumin 5%  25  g ; 0.9% sodium chloride  250  ml ; sodium glycerophosphate  20  mmol ; artificial tears  1-2  drop ; furosemide  40  mg ; 
 
white m 79 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  3.1  mg dl; chemistry blood creatinine  3.1  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  71  mg dl; chemistry blood urea nitrogen  74  mg dl; chemistry blood urea nitrogen  78  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  2.8  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  105  mg dl$propofol  1000  mg ; propofol  200  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; acetaminophen iv  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; artificial tears  1-2  drop ; furosemide  40  mg ; fentanyl citrate  25-100  mcg ; furosemide  20  mg ; 
 
white m 79 $nan$hematology blood hematocrit  35.8  %; hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  184  k ul; hematology blood platelet count  199  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  151  meq l; chemistry blood urea nitrogen  80  mg dl; chemistry blood urea nitrogen  85  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  114  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; furosemide  20  mg ; 5% dextrose  1000  ml ; warfarin  2  mg ; 
 
white m 79 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  152  meq l; chemistry blood urea nitrogen  85  mg dl; chemistry blood urea nitrogen  84  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  141  mg dl; chemistry blood glucose  164  mg dl; blood gas blood free calcium  1.19  mmol l$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; 5% dextrose  1000  ml ; warfarin  2  mg ; amiodarone  200  mg ; acetaminophen  1000  mg ; rosuvastatin calcium  20  mg ; 
 
white m 79 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  148  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  89  mg dl; chemistry blood urea nitrogen  92  mg dl; chemistry blood urea nitrogen  99  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  136  mg dl; chemistry blood glucose  140  mg dl; chemistry blood glucose  130  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin  5000  unit ; warfarin  2  mg ; amiodarone  200  mg ; acetaminophen  1000  mg ; rosuvastatin calcium  20  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; 
 
white m 79 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  360  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood creatinine  3.7  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  107  mg dl; chemistry blood urea nitrogen  116  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine chloride, urine  11  meq l; chemistry urine creatinine, urine  118  mg dl; chemistry urine potassium, urine  80  meq l; chemistry urine sodium, urine  10  meq l; chemistry urine urea nitrogen, urine  771  mg dl; hematology urine wbc  4  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  120  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin  5000  unit ; warfarin  2  mg ; amiodarone  200  mg ; acetaminophen  1000  mg ; rosuvastatin calcium  20  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; ondansetron  4  mg ; 
 
white m 79 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  484  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  3.7  mg dl; chemistry blood creatinine  3.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  123  mg dl; chemistry blood urea nitrogen  132  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  111  mg dl; chemistry blood glucose  120  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin  5000  unit ; warfarin  2  mg ; amiodarone  200  mg ; acetaminophen  1000  mg ; rosuvastatin calcium  20  mg ; ondansetron  4  mg ; loperamide  2  mg ; warfarin  4  mg ; 
 
white m 79 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  582  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  132  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  128  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin  5000  unit ; acetaminophen  1000  mg ; rosuvastatin calcium  20  mg ; warfarin  4  mg ; opium tincture  10  drop ; 
 
white m 79 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  666  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  124  mg dl; chemistry blood urea nitrogen  115  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  106  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin  5000  unit ; acetaminophen  1000  mg ; rosuvastatin calcium  20  mg ; warfarin  4  mg ; opium tincture  10  drop ; erythromycin  250  mg ; 
 
white m 79 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  741  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  103  mg dl; chemistry blood urea nitrogen  109  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  127  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin  5000  unit ; acetaminophen  1000  mg ; rosuvastatin calcium  20  mg ; warfarin  4  mg ; opium tincture  10  drop ; erythromycin  250  mg ; warfarin  5  mg ; 
 
white m 79 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  755  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  93  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  112  mg dl$potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
 
white m 79 $nan$hematology blood hematocrit  31.4  %; hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  792  k ul; hematology blood platelet count  782  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  76  mg dl; chemistry blood urea nitrogen  74  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  122  mg dl; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood chloride, whole blood  102  meq l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  134  mg dl; blood gas blood glucose  140  mg dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  142  meq l$5% dextrose  500  ml ; vancomycin  1500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; 
 
white m 79 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  739  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  68  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  125  mg dl$0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; 
 
white m 79 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  812  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  73  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  119  mg dl$0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; soln  100  ml ; warfarin  6  mg ; 
 
white m 79 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  719  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  81  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  131  mg dl$0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; soln  100  ml ; warfarin  6  mg ; 
 
white m 79 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  656  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  91  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  128  mg dl$0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; soln  100  ml ; warfarin  6  mg ; 
 
white m 79 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  629  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  97  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  129  mg dl$soln  100  ml ; warfarin  6  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; opium tincture  5  drop ; lidocaine jelly 2% (urojet)  1  appl ; 
 
white m 79 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  597  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  93  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  83  mg dl$soln  100  ml ; warfarin  6  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; opium tincture  5  drop ; lidocaine jelly 2% (urojet)  1  appl ; heparin sodium  25,000  unit ; warfarin  10  mg ; 
 
white m 79 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  623  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  75  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  86  mg dl$opium tincture  5  drop ; heparin sodium  25,000  unit ; warfarin  10  mg ; acetaminophen (liquid)  650  mg ; 
 
white m 79 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  550  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  66  mg dl; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  139  mg dl; chemistry blood glucose  133  mg dl$opium tincture  5  drop ; warfarin  10  mg ; acetaminophen (liquid)  650  mg ; nystatin oral suspension  5  ml ; warfarin  8  mg ; 
 
white m 79 $nan$chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  133  mg dl; chemistry blood glucose  122  mg dl$opium tincture  5  drop ; acetaminophen (liquid)  650  mg ; nystatin oral suspension  5  ml ; warfarin  8  mg ; 
 
white m 48 $nan$nan$pravastatin  40  mg ; lisinopril  10  mg ; methadone  20  mg ; methadone  80  mg ; 
other chest pain long-term (current) use of other medications asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled panic disorder without agoraphobia other chronic pain history of physical abuse posttraumatic stress disorder opioid abuse, unspecified other and unspecified hyperlipidemia lumbago unspecified essential hypertension unspecified episodic mood disorder 
white m 48 $nan$nan$pravastatin  40  mg ; lisinopril  10  mg ; methadone  20  mg ; methadone  80  mg ; tuberculin protein  0.1  ml ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; promethazine  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; clonazepam  2  mg ; promethazine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; diphenhydramine  25  mg ; 
other chest pain long-term (current) use of other medications asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled panic disorder without agoraphobia other chronic pain history of physical abuse posttraumatic stress disorder opioid abuse, unspecified other and unspecified hyperlipidemia lumbago unspecified essential hypertension unspecified episodic mood disorder 
white m 48 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  130  k ul; hematology blood inr(pt)  1.0  $pravastatin  40  mg ; lisinopril  10  mg ; methadone  20  mg ; methadone  80  mg ; tuberculin protein  0.1  ml ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; clonazepam  2  mg ; promethazine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; diphenhydramine  25  mg ; 
other chest pain long-term (current) use of other medications asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled panic disorder without agoraphobia other chronic pain history of physical abuse posttraumatic stress disorder opioid abuse, unspecified other and unspecified hyperlipidemia lumbago unspecified essential hypertension unspecified episodic mood disorder 
white m 48 $nan$nan$pravastatin  40  mg ; lisinopril  10  mg ; methadone  20  mg ; methadone  80  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; clonazepam  2  mg ; promethazine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; diphenhydramine  25  mg ; quetiapine fumarate  12.5  mg ; aripiprazole  7.5  mg ; 
other chest pain long-term (current) use of other medications asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled panic disorder without agoraphobia other chronic pain history of physical abuse posttraumatic stress disorder opioid abuse, unspecified other and unspecified hyperlipidemia lumbago unspecified essential hypertension unspecified episodic mood disorder 
white m 48 $nan$nan$pravastatin  40  mg ; lisinopril  10  mg ; methadone  20  mg ; methadone  80  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; clonazepam  2  mg ; promethazine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; diphenhydramine  25  mg ; quetiapine fumarate  12.5  mg ; aripiprazole  7.5  mg ; gabapentin  600  mg ; clonidine  0.1  mg ; 
other chest pain long-term (current) use of other medications asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled panic disorder without agoraphobia other chronic pain history of physical abuse posttraumatic stress disorder opioid abuse, unspecified other and unspecified hyperlipidemia lumbago unspecified essential hypertension unspecified episodic mood disorder 
white m 48 $nan$nan$pravastatin  40  mg ; lisinopril  10  mg ; methadone  20  mg ; methadone  80  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; clonazepam  2  mg ; promethazine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; diphenhydramine  25  mg ; aripiprazole  7.5  mg ; gabapentin  600  mg ; clonidine  0.1  mg ; quetiapine fumarate  25  mg ; 
other chest pain long-term (current) use of other medications asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled panic disorder without agoraphobia other chronic pain history of physical abuse posttraumatic stress disorder opioid abuse, unspecified other and unspecified hyperlipidemia lumbago unspecified essential hypertension unspecified episodic mood disorder 
white m 48 $nan$hematology blood hematocrit  32.9  %; hematology blood inr(pt)  1.0  $pravastatin  40  mg ; lisinopril  10  mg ; methadone  20  mg ; methadone  80  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; clonazepam  2  mg ; promethazine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; diphenhydramine  25  mg ; aripiprazole  7.5  mg ; clonidine  0.1  mg ; quetiapine fumarate  25  mg ; metformin (glucophage)  500  mg ; tucks hemorrhoidal oint 1%  1  appl ; 
other chest pain long-term (current) use of other medications asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled panic disorder without agoraphobia other chronic pain history of physical abuse posttraumatic stress disorder opioid abuse, unspecified other and unspecified hyperlipidemia lumbago unspecified essential hypertension unspecified episodic mood disorder 
white m 48 $nan$nan$pravastatin  40  mg ; lisinopril  10  mg ; methadone  20  mg ; methadone  80  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; clonazepam  2  mg ; promethazine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; diphenhydramine  25  mg ; aripiprazole  7.5  mg ; clonidine  0.1  mg ; quetiapine fumarate  25  mg ; metformin (glucophage)  500  mg ; tucks hemorrhoidal oint 1%  1  appl ; albuterol inhaler  2  puff ; 
other chest pain long-term (current) use of other medications asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled panic disorder without agoraphobia other chronic pain history of physical abuse posttraumatic stress disorder opioid abuse, unspecified other and unspecified hyperlipidemia lumbago unspecified essential hypertension unspecified episodic mood disorder 
white m 48 $nan$nan$pravastatin  40  mg ; lisinopril  10  mg ; methadone  20  mg ; methadone  80  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; clonazepam  2  mg ; promethazine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; diphenhydramine  25  mg ; aripiprazole  7.5  mg ; clonidine  0.1  mg ; quetiapine fumarate  25  mg ; metformin (glucophage)  500  mg ; tucks hemorrhoidal oint 1%  1  appl ; albuterol inhaler  2  puff ; 
other chest pain long-term (current) use of other medications asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled panic disorder without agoraphobia other chronic pain history of physical abuse posttraumatic stress disorder opioid abuse, unspecified other and unspecified hyperlipidemia lumbago unspecified essential hypertension unspecified episodic mood disorder 
white m 48 $nan$nan$pravastatin  40  mg ; lisinopril  10  mg ; methadone  20  mg ; methadone  80  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; clonazepam  2  mg ; promethazine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; diphenhydramine  25  mg ; aripiprazole  7.5  mg ; clonidine  0.1  mg ; quetiapine fumarate  25  mg ; metformin (glucophage)  500  mg ; tucks hemorrhoidal oint 1%  1  appl ; albuterol inhaler  2  puff ; clonazepam  1  mg ; aripiprazole  10  mg ; metformin (glucophage)  1000  mg ; 
other chest pain long-term (current) use of other medications asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled panic disorder without agoraphobia other chronic pain history of physical abuse posttraumatic stress disorder opioid abuse, unspecified other and unspecified hyperlipidemia lumbago unspecified essential hypertension unspecified episodic mood disorder 
white m 48 $nan$nan$pravastatin  40  mg ; lisinopril  10  mg ; methadone  20  mg ; methadone  80  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; promethazine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; diphenhydramine  25  mg ; aripiprazole  7.5  mg ; clonidine  0.1  mg ; quetiapine fumarate  25  mg ; metformin (glucophage)  500  mg ; tucks hemorrhoidal oint 1%  1  appl ; albuterol inhaler  2  puff ; aripiprazole  10  mg ; metformin (glucophage)  1000  mg ; 
other chest pain long-term (current) use of other medications asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled panic disorder without agoraphobia other chronic pain history of physical abuse posttraumatic stress disorder opioid abuse, unspecified other and unspecified hyperlipidemia lumbago unspecified essential hypertension unspecified episodic mood disorder 
white m 48 $nan$nan$pravastatin  40  mg ; lisinopril  10  mg ; methadone  20  mg ; methadone  80  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; promethazine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; diphenhydramine  25  mg ; clonidine  0.1  mg ; quetiapine fumarate  25  mg ; tucks hemorrhoidal oint 1%  1  appl ; albuterol inhaler  2  puff ; aripiprazole  10  mg ; metformin (glucophage)  1000  mg ; cepacol (menthol)  1  loz ; 
other chest pain long-term (current) use of other medications asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled panic disorder without agoraphobia other chronic pain history of physical abuse posttraumatic stress disorder opioid abuse, unspecified other and unspecified hyperlipidemia lumbago unspecified essential hypertension unspecified episodic mood disorder 
white m 48 $nan$nan$pravastatin  40  mg ; lisinopril  10  mg ; methadone  20  mg ; methadone  80  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; promethazine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; diphenhydramine  25  mg ; clonidine  0.1  mg ; quetiapine fumarate  25  mg ; tucks hemorrhoidal oint 1%  1  appl ; albuterol inhaler  2  puff ; aripiprazole  10  mg ; metformin (glucophage)  1000  mg ; cepacol (menthol)  1  loz ; 
other chest pain long-term (current) use of other medications asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled panic disorder without agoraphobia other chronic pain history of physical abuse posttraumatic stress disorder opioid abuse, unspecified other and unspecified hyperlipidemia lumbago unspecified essential hypertension unspecified episodic mood disorder 
white m 48 $nan$nan$pravastatin  40  mg ; lisinopril  10  mg ; methadone  20  mg ; methadone  80  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; promethazine  25  mg ; docusate sodium  100  mg ; senna  1  tab ; diphenhydramine  25  mg ; clonidine  0.1  mg ; quetiapine fumarate  25  mg ; tucks hemorrhoidal oint 1%  1  appl ; albuterol inhaler  2  puff ; aripiprazole  10  mg ; metformin (glucophage)  1000  mg ; cepacol (menthol)  1  loz ; 
other chest pain long-term (current) use of other medications asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled panic disorder without agoraphobia other chronic pain history of physical abuse posttraumatic stress disorder opioid abuse, unspecified other and unspecified hyperlipidemia lumbago unspecified essential hypertension unspecified episodic mood disorder 
white m 87 $temp    heartrate  94.0  resprate  15.0  o2sat  97.0  sbp  80.0  dbp  36.0  rhythm    pain  3  ; temp  98.9  heartrate  80.0  resprate  15.0  o2sat  95.0  sbp  81.0  dbp  35.0  rhythm    pain  0  $hematology blood hematocrit  33.6  %; hematology blood hematocrit  31.5  %; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  281  k ul; hematology blood platelet count  225  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  4.0  mg dl; chemistry blood creatinine  4.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  10.6  mg dl; chemistry blood calcium, total  10.7  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  75  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; amiodarone  200  mg ; sevelamer carbonate  1600  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; aspirin  81  mg ; nephrocaps  1  cap ; sertraline  25  mg ; alprazolam  0.5  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; acetaminophen w codeine  1-2  tab ; xtandi  160  mg ; sodium chloride 0.9%  1000  ml ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  5.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  10.6  mg dl; chemistry blood glucose  93  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; amiodarone  200  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; aspirin  81  mg ; nephrocaps  1  cap ; sertraline  25  mg ; alprazolam  0.5  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; acetaminophen w codeine  1-2  tab ; xtandi  160  mg ; sodium chloride 0.9%  1000  ml ; midodrine  15  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; erythromycin 0.5% ophth oint  0.5  in ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  6.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood calcium, total  10.7  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; amiodarone  200  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; aspirin  81  mg ; nephrocaps  1  cap ; sertraline  25  mg ; alprazolam  0.5  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; acetaminophen w codeine  1-2  tab ; xtandi  160  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; erythromycin 0.5% ophth oint  0.5  in ; paricalcitol  6  mcg ; heparin (hemodialysis)  2000  unit ; epoetin alfa  18,000  unit ; vancomycin  500  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  70  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; amiodarone  200  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; aspirin  81  mg ; nephrocaps  1  cap ; sertraline  25  mg ; alprazolam  0.5  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; acetaminophen w codeine  1-2  tab ; xtandi  160  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; erythromycin 0.5% ophth oint  0.5  in ; albumin 5% (12.5g   250ml)  12.5  g ; soln  100  ml ; acetaminophen iv  1000  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  5.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  10.4  mg dl; chemistry blood glucose  84  mg dl; chemistry blood albumin  3.0  g dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; amiodarone  200  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; aspirin  81  mg ; nephrocaps  1  cap ; sertraline  25  mg ; alprazolam  0.5  mg ; heparin  5000  unit ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; acetaminophen w codeine  1-2  tab ; xtandi  160  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; erythromycin 0.5% ophth oint  0.5  in ; soln  100  ml ; acetaminophen iv  1000  mg ; lidocaine 1%  1  ml ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  4.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood glucose  74  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; amiodarone  200  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; aspirin  81  mg ; nephrocaps  1  cap ; sertraline  25  mg ; alprazolam  0.5  mg ; heparin  5000  unit ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; acetaminophen w codeine  1-2  tab ; xtandi  160  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; erythromycin 0.5% ophth oint  0.5  in ; oxycodone (immediate release)   2.5-5  mg ; polyethylene glycol  17  g ; midodrine  5  mg ; sulfameth trimethoprim ds  2  tab ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$hematology blood hematocrit  28.5  %; hematology blood hematocrit  30.1  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  155  k ul; hematology blood platelet count  173  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  5.7  mg dl; chemistry blood creatinine  6.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  72  mg dl; chemistry blood albumin  3.1  g dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; amiodarone  200  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; aspirin  81  mg ; nephrocaps  1  cap ; sertraline  25  mg ; alprazolam  0.5  mg ; heparin  5000  unit ; xtandi  160  mg ; iso-osmotic dextrose  100  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; erythromycin 0.5% ophth oint  0.5  in ; polyethylene glycol  17  g ; midodrine  5  mg ; sulfameth trimethoprim ds  2  tab ; epoetin alfa  10,000  unit ; epoetin alfa  8000  unit ; atorvastatin  80  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  6.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  75  mg dl; chemistry blood albumin  2.9  g dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; amiodarone  200  mg ; pantoprazole  40  mg ; aspirin  81  mg ; nephrocaps  1  cap ; alprazolam  0.5  mg ; heparin  5000  unit ; xtandi  160  mg ; iso-osmotic dextrose  100  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; erythromycin 0.5% ophth oint  0.5  in ; polyethylene glycol  17  g ; epoetin alfa  10,000  unit ; epoetin alfa  8000  unit ; atorvastatin  80  mg ; sertraline  50  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  4.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  76  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; amiodarone  200  mg ; pantoprazole  40  mg ; aspirin  81  mg ; nephrocaps  1  cap ; alprazolam  0.5  mg ; heparin  5000  unit ; xtandi  160  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; erythromycin 0.5% ophth oint  0.5  in ; polyethylene glycol  17  g ; atorvastatin  80  mg ; sertraline  50  mg ; oxycodone (immediate release)   2.5  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  6.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  10.4  mg dl; chemistry blood glucose  81  mg dl; chemistry blood albumin  3.1  g dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; amiodarone  200  mg ; pantoprazole  40  mg ; aspirin  81  mg ; nephrocaps  1  cap ; alprazolam  0.5  mg ; heparin  5000  unit ; xtandi  160  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; erythromycin 0.5% ophth oint  0.5  in ; polyethylene glycol  17  g ; atorvastatin  80  mg ; sertraline  50  mg ; oxycodone (immediate release)   2.5  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  4.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  67  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; amiodarone  200  mg ; pantoprazole  40  mg ; aspirin  81  mg ; nephrocaps  1  cap ; alprazolam  0.5  mg ; heparin  5000  unit ; xtandi  160  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; erythromycin 0.5% ophth oint  0.5  in ; polyethylene glycol  17  g ; atorvastatin  80  mg ; sertraline  50  mg ; oxycodone (immediate release)   2.5  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  5.9  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood glucose  65  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; amiodarone  200  mg ; pantoprazole  40  mg ; aspirin  81  mg ; nephrocaps  1  cap ; alprazolam  0.5  mg ; heparin  5000  unit ; xtandi  160  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; erythromycin 0.5% ophth oint  0.5  in ; polyethylene glycol  17  g ; atorvastatin  80  mg ; sertraline  50  mg ; oxycodone (immediate release)   2.5  mg ; nitroglycerin sl  0.4  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  4.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  79  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; multivitamins  1  tab ; amiodarone  200  mg ; pantoprazole  40  mg ; aspirin  81  mg ; nephrocaps  1  cap ; alprazolam  0.5  mg ; heparin  5000  unit ; xtandi  160  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; erythromycin 0.5% ophth oint  0.5  in ; polyethylene glycol  17  g ; atorvastatin  80  mg ; sertraline  50  mg ; nitroglycerin sl  0.4  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$nan$alprazolam  0.5  mg ; oxycodone (immediate release)   5  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$nan$alprazolam  0.5  mg ; oxycodone (immediate release)   5  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$nan$alprazolam  0.5  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$nan$alprazolam  0.5  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; oxycodone (concentrated oral soln)  2.5-5.0  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$nan$alprazolam  0.5  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; oxycodone (concentrated oral soln)  2.5-5.0  mg ; oxycodone (concentrated oral soln)  2.5-10.0  mg ; fentanyl patch  12  mcg h ; scopolamine patch  1  ptch ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 87 $nan$nan$alprazolam  0.5  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; oxycodone (concentrated oral soln)  2.5-10.0  mg ; fentanyl patch  12  mcg h ; scopolamine patch  1  ptch ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ old myocardial infarction other iatrogenic hypotension end stage renal disease esophageal reflux congestive heart failure, unspecified other complications due to renal dialysis device, implant, and graft systolic heart failure, unspecified arteriovenous fistula, acquired other and unspecified hyperlipidemia anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease cardiac pacemaker in situ hyperpotassemia mitral valve disorders congestive heart failure, unspecified other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery constipation, unspecified anemia in chronic kidney disease pure hypercholesterolemia renal dialysis status chronic systolic heart failure end stage renal disease other iatrogenic hypotension acute posthemorrhagic anemia esophageal reflux hallucinations esophageal reflux anemia in chronic kidney disease inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease urinary tract infection, site not specified secondary malignant neoplasm of other urinary organs congestive heart failure, unspecified renal dialysis status chronic diastolic heart failure end stage renal disease secondary and unspecified malignant neoplasm of lymph nodes of multiple sites malignant neoplasm of prostate atrioventricular block, complete coronary atherosclerosis of native coronary artery
white m 41 $temp  98.9  heartrate  78.0  resprate  16.0  o2sat  95.0  sbp  125.0  dbp  67.0  rhythm    pain  "im fine"  ; temp    heartrate  88.0  resprate  8.0  o2sat  100.0  sbp  138.0  dbp  70.0  rhythm    pain  etco2 32  ; temp    heartrate  86.0  resprate  11.0  o2sat  100.0  sbp  125.0  dbp  73.0  rhythm    pain  etc02 36  ; temp    heartrate  87.0  resprate  19.0  o2sat  99.0  sbp  133.0  dbp  62.0  rhythm    pain    ; temp    heartrate  95.0  resprate  16.0  o2sat  97.0  sbp  137.0  dbp  71.0  rhythm    pain  etc02 30  ; temp    heartrate  87.0  resprate  18.0  o2sat  97.0  sbp  117.0  dbp  49.0  rhythm    pain  etco2 26  ; temp  98.7  heartrate  88.0  resprate  18.0  o2sat  97.0  sbp  126.0  dbp  58.0  rhythm    pain  etc02 44  ; temp    heartrate  95.0  resprate  18.0  o2sat  94.0  sbp  129.0  dbp  65.0  rhythm    pain  etc02 35  ; temp  99.3  heartrate  100.0  resprate  11.0  o2sat  97.0  sbp  133.0  dbp  68.0  rhythm    pain    $hematology blood hematocrit  48.4  %; hematology blood hemoglobin  16.2  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  98  mg dl$nan
opioid abuse with intoxication, unspecified alcoholic hepatitis without ascites physical restraint status alcohol dependence with intoxication, unspecified unspecified mononeuropathy of bilateral upper limbs poisoning by other opioids, accidental (unintentional), initial encounter unspecified viral hepatitis c without hepatic coma toxic effect of ethanol, accidental (unintentional), initial encounter unspecified place or not applicable hypoxemia homelessness alcohol dependence with withdrawal, unspecified
black african american f 69 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  509  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  78  mg dl; chemistry blood albumin  3.0  g dl; blood gas blood lactate  1.3  mmol l$nan
neoplasm related pain (acute) (chronic) osteoporosis, unspecified malignant ascites secondary malignant neoplasm of other specified sites diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use unspecified essential hypertension asthma, unspecified type, unspecified long-term (current) use of insulin malignant neoplasm of body of pancreas postprocedural fever unspecified acquired hypothyroidism hematemesis constipation, unspecified orthostatic hypotension benign essential hypertension osteoporosis, unspecified constipation, unspecified unspecified acquired hypothyroidism obesity, unspecified hemorrhage of rectum and anus asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant neoplasm of tail of pancreas diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin constipation, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified obesity, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified aplastic anemias hyperpotassemia malignant neoplasm of tail of pancreas long-term (current) use of insulin antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use osteoarthrosis, unspecified whether generalized or localized, site unspecified nausea with vomiting unspecified acquired hypothyroidism acute vascular insufficiency of intestine malignant neoplasm of pancreas, part unspecified obesity, unspecified benign essential hypertension esophageal reflux unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified dehydration
black african american f 69 $nan$hematology blood hematocrit  26.6  %; hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  423  k ul; hematology blood platelet count  400  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  133  mg dl; chemistry blood albumin  2.7  g dl$1 2 ns  1000  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; morphine sulfate  4-8  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; nystatin oral suspension  5  ml ; insulin  0  unit ; heparin  5000  unit ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; senna  1  tab ; dronabinol  2.5  mg ; montelukast sodium  10  mg ; polyethylene glycol  17  g ; enoxaparin sodium  120  mg ; omeprazole  40  mg ; prochlorperazine  5-10  mg ; 
neoplasm related pain (acute) (chronic) osteoporosis, unspecified malignant ascites secondary malignant neoplasm of other specified sites diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use unspecified essential hypertension asthma, unspecified type, unspecified long-term (current) use of insulin malignant neoplasm of body of pancreas postprocedural fever unspecified acquired hypothyroidism hematemesis constipation, unspecified orthostatic hypotension benign essential hypertension osteoporosis, unspecified constipation, unspecified unspecified acquired hypothyroidism obesity, unspecified hemorrhage of rectum and anus asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant neoplasm of tail of pancreas diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin constipation, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified obesity, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified aplastic anemias hyperpotassemia malignant neoplasm of tail of pancreas long-term (current) use of insulin antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use osteoarthrosis, unspecified whether generalized or localized, site unspecified nausea with vomiting unspecified acquired hypothyroidism acute vascular insufficiency of intestine malignant neoplasm of pancreas, part unspecified obesity, unspecified benign essential hypertension esophageal reflux unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified dehydration
black african american f 69 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  387  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  164  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; morphine sulfate  4-8  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; nystatin oral suspension  5  ml ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; senna  1  tab ; dronabinol  2.5  mg ; montelukast sodium  10  mg ; polyethylene glycol  17  g ; enoxaparin sodium  120  mg ; omeprazole  40  mg ; prochlorperazine  5-10  mg ; morphine sr (ms contin)  15  mg ; phytonadione  5  mg ; oxycodone (immediate release)   10  mg ; gabapentin  300  mg ; acetaminophen  1000  mg ; morphine sulfate ir  7.5-15  mg ; oxycodone sr (oxycontin)  10  mg ; oxycodone (immediate release)   5-10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; 
neoplasm related pain (acute) (chronic) osteoporosis, unspecified malignant ascites secondary malignant neoplasm of other specified sites diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use unspecified essential hypertension asthma, unspecified type, unspecified long-term (current) use of insulin malignant neoplasm of body of pancreas postprocedural fever unspecified acquired hypothyroidism hematemesis constipation, unspecified orthostatic hypotension benign essential hypertension osteoporosis, unspecified constipation, unspecified unspecified acquired hypothyroidism obesity, unspecified hemorrhage of rectum and anus asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant neoplasm of tail of pancreas diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin constipation, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified obesity, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified aplastic anemias hyperpotassemia malignant neoplasm of tail of pancreas long-term (current) use of insulin antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use osteoarthrosis, unspecified whether generalized or localized, site unspecified nausea with vomiting unspecified acquired hypothyroidism acute vascular insufficiency of intestine malignant neoplasm of pancreas, part unspecified obesity, unspecified benign essential hypertension esophageal reflux unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified dehydration
black african american f 69 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  400  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  115  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; morphine sulfate  4-8  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; nystatin oral suspension  5  ml ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; senna  1  tab ; dronabinol  2.5  mg ; montelukast sodium  10  mg ; polyethylene glycol  17  g ; enoxaparin sodium  120  mg ; omeprazole  40  mg ; prochlorperazine  5-10  mg ; gabapentin  300  mg ; acetaminophen  1000  mg ; oxycodone sr (oxycontin)  10  mg ; oxycodone (immediate release)   5-10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; lactulose  30  ml ; 
neoplasm related pain (acute) (chronic) osteoporosis, unspecified malignant ascites secondary malignant neoplasm of other specified sites diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use unspecified essential hypertension asthma, unspecified type, unspecified long-term (current) use of insulin malignant neoplasm of body of pancreas postprocedural fever unspecified acquired hypothyroidism hematemesis constipation, unspecified orthostatic hypotension benign essential hypertension osteoporosis, unspecified constipation, unspecified unspecified acquired hypothyroidism obesity, unspecified hemorrhage of rectum and anus asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant neoplasm of tail of pancreas diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin constipation, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified obesity, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified aplastic anemias hyperpotassemia malignant neoplasm of tail of pancreas long-term (current) use of insulin antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use osteoarthrosis, unspecified whether generalized or localized, site unspecified nausea with vomiting unspecified acquired hypothyroidism acute vascular insufficiency of intestine malignant neoplasm of pancreas, part unspecified obesity, unspecified benign essential hypertension esophageal reflux unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified dehydration
black african american f 69 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  396  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  169  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; nystatin oral suspension  5  ml ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; senna  1  tab ; dronabinol  2.5  mg ; montelukast sodium  10  mg ; polyethylene glycol  17  g ; omeprazole  40  mg ; prochlorperazine  5-10  mg ; gabapentin  300  mg ; acetaminophen  1000  mg ; oxycodone sr (oxycontin)  10  mg ; oxycodone (immediate release)   5-10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; lactulose  30  ml ; 
neoplasm related pain (acute) (chronic) osteoporosis, unspecified malignant ascites secondary malignant neoplasm of other specified sites diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use unspecified essential hypertension asthma, unspecified type, unspecified long-term (current) use of insulin malignant neoplasm of body of pancreas postprocedural fever unspecified acquired hypothyroidism hematemesis constipation, unspecified orthostatic hypotension benign essential hypertension osteoporosis, unspecified constipation, unspecified unspecified acquired hypothyroidism obesity, unspecified hemorrhage of rectum and anus asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant neoplasm of tail of pancreas diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin constipation, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified obesity, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified aplastic anemias hyperpotassemia malignant neoplasm of tail of pancreas long-term (current) use of insulin antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use osteoarthrosis, unspecified whether generalized or localized, site unspecified nausea with vomiting unspecified acquired hypothyroidism acute vascular insufficiency of intestine malignant neoplasm of pancreas, part unspecified obesity, unspecified benign essential hypertension esophageal reflux unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified dehydration
black african american f 69 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  356  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  188  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; nystatin oral suspension  5  ml ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; senna  1  tab ; dronabinol  2.5  mg ; montelukast sodium  10  mg ; polyethylene glycol  17  g ; omeprazole  40  mg ; prochlorperazine  5-10  mg ; gabapentin  300  mg ; acetaminophen  1000  mg ; oxycodone sr (oxycontin)  10  mg ; oxycodone (immediate release)   5-10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; lactulose  30  ml ; 0.9% sodium chloride  500  ml ; 
neoplasm related pain (acute) (chronic) osteoporosis, unspecified malignant ascites secondary malignant neoplasm of other specified sites diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use unspecified essential hypertension asthma, unspecified type, unspecified long-term (current) use of insulin malignant neoplasm of body of pancreas postprocedural fever unspecified acquired hypothyroidism hematemesis constipation, unspecified orthostatic hypotension benign essential hypertension osteoporosis, unspecified constipation, unspecified unspecified acquired hypothyroidism obesity, unspecified hemorrhage of rectum and anus asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant neoplasm of tail of pancreas diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin constipation, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified obesity, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified aplastic anemias hyperpotassemia malignant neoplasm of tail of pancreas long-term (current) use of insulin antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use osteoarthrosis, unspecified whether generalized or localized, site unspecified nausea with vomiting unspecified acquired hypothyroidism acute vascular insufficiency of intestine malignant neoplasm of pancreas, part unspecified obesity, unspecified benign essential hypertension esophageal reflux unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified dehydration
black african american f 69 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  326  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  205  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; senna  1  tab ; dronabinol  2.5  mg ; montelukast sodium  10  mg ; polyethylene glycol  17  g ; omeprazole  40  mg ; prochlorperazine  5-10  mg ; gabapentin  300  mg ; acetaminophen  1000  mg ; oxycodone sr (oxycontin)  10  mg ; oxycodone (immediate release)   5-10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; 0.9% sodium chloride  500  ml ; morphine sulfate  2-4  mg ; methylnaltrexone  8  mg ; 
neoplasm related pain (acute) (chronic) osteoporosis, unspecified malignant ascites secondary malignant neoplasm of other specified sites diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use unspecified essential hypertension asthma, unspecified type, unspecified long-term (current) use of insulin malignant neoplasm of body of pancreas postprocedural fever unspecified acquired hypothyroidism hematemesis constipation, unspecified orthostatic hypotension benign essential hypertension osteoporosis, unspecified constipation, unspecified unspecified acquired hypothyroidism obesity, unspecified hemorrhage of rectum and anus asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant neoplasm of tail of pancreas diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin constipation, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified obesity, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified aplastic anemias hyperpotassemia malignant neoplasm of tail of pancreas long-term (current) use of insulin antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use osteoarthrosis, unspecified whether generalized or localized, site unspecified nausea with vomiting unspecified acquired hypothyroidism acute vascular insufficiency of intestine malignant neoplasm of pancreas, part unspecified obesity, unspecified benign essential hypertension esophageal reflux unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified dehydration
black african american f 69 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  327  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  204  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; senna  1  tab ; dronabinol  2.5  mg ; montelukast sodium  10  mg ; polyethylene glycol  17  g ; omeprazole  40  mg ; prochlorperazine  5-10  mg ; gabapentin  300  mg ; acetaminophen  1000  mg ; oxycodone sr (oxycontin)  10  mg ; oxycodone (immediate release)   5-10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; morphine sulfate  2-4  mg ; methylnaltrexone  8  mg ; 
neoplasm related pain (acute) (chronic) osteoporosis, unspecified malignant ascites secondary malignant neoplasm of other specified sites diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use unspecified essential hypertension asthma, unspecified type, unspecified long-term (current) use of insulin malignant neoplasm of body of pancreas postprocedural fever unspecified acquired hypothyroidism hematemesis constipation, unspecified orthostatic hypotension benign essential hypertension osteoporosis, unspecified constipation, unspecified unspecified acquired hypothyroidism obesity, unspecified hemorrhage of rectum and anus asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant neoplasm of tail of pancreas diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin constipation, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified obesity, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified aplastic anemias hyperpotassemia malignant neoplasm of tail of pancreas long-term (current) use of insulin antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use osteoarthrosis, unspecified whether generalized or localized, site unspecified nausea with vomiting unspecified acquired hypothyroidism acute vascular insufficiency of intestine malignant neoplasm of pancreas, part unspecified obesity, unspecified benign essential hypertension esophageal reflux unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified dehydration
black african american f 69 $nan$nan$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; senna  1  tab ; dronabinol  2.5  mg ; montelukast sodium  10  mg ; polyethylene glycol  17  g ; omeprazole  40  mg ; prochlorperazine  5-10  mg ; gabapentin  300  mg ; acetaminophen  1000  mg ; oxycodone sr (oxycontin)  10  mg ; oxycodone (immediate release)   5-10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; oxycodone sr (oxycontin)  20  mg ; 
neoplasm related pain (acute) (chronic) osteoporosis, unspecified malignant ascites secondary malignant neoplasm of other specified sites diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use unspecified essential hypertension asthma, unspecified type, unspecified long-term (current) use of insulin malignant neoplasm of body of pancreas postprocedural fever unspecified acquired hypothyroidism hematemesis constipation, unspecified orthostatic hypotension benign essential hypertension osteoporosis, unspecified constipation, unspecified unspecified acquired hypothyroidism obesity, unspecified hemorrhage of rectum and anus asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant neoplasm of tail of pancreas diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin constipation, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified obesity, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified aplastic anemias hyperpotassemia malignant neoplasm of tail of pancreas long-term (current) use of insulin antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use osteoarthrosis, unspecified whether generalized or localized, site unspecified nausea with vomiting unspecified acquired hypothyroidism acute vascular insufficiency of intestine malignant neoplasm of pancreas, part unspecified obesity, unspecified benign essential hypertension esophageal reflux unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified dehydration
black african american f 69 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  290  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  181  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; senna  1  tab ; montelukast sodium  10  mg ; polyethylene glycol  17  g ; omeprazole  40  mg ; prochlorperazine  5-10  mg ; gabapentin  300  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone sr (oxycontin)  20  mg ; 0.9% sodium chloride  1000  ml ; 
neoplasm related pain (acute) (chronic) osteoporosis, unspecified malignant ascites secondary malignant neoplasm of other specified sites diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use unspecified essential hypertension asthma, unspecified type, unspecified long-term (current) use of insulin malignant neoplasm of body of pancreas postprocedural fever unspecified acquired hypothyroidism hematemesis constipation, unspecified orthostatic hypotension benign essential hypertension osteoporosis, unspecified constipation, unspecified unspecified acquired hypothyroidism obesity, unspecified hemorrhage of rectum and anus asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant neoplasm of tail of pancreas diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin constipation, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified obesity, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified aplastic anemias hyperpotassemia malignant neoplasm of tail of pancreas long-term (current) use of insulin antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use osteoarthrosis, unspecified whether generalized or localized, site unspecified nausea with vomiting unspecified acquired hypothyroidism acute vascular insufficiency of intestine malignant neoplasm of pancreas, part unspecified obesity, unspecified benign essential hypertension esophageal reflux unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified dehydration
black african american f 69 $nan$nan$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; senna  1  tab ; montelukast sodium  10  mg ; polyethylene glycol  17  g ; omeprazole  40  mg ; prochlorperazine  5-10  mg ; gabapentin  300  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone sr (oxycontin)  20  mg ; oxycodone sr (oxycontin)  30  mg ; hydromorphone (dilaudid)  2  mg ; 
neoplasm related pain (acute) (chronic) osteoporosis, unspecified malignant ascites secondary malignant neoplasm of other specified sites diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use unspecified essential hypertension asthma, unspecified type, unspecified long-term (current) use of insulin malignant neoplasm of body of pancreas postprocedural fever unspecified acquired hypothyroidism hematemesis constipation, unspecified orthostatic hypotension benign essential hypertension osteoporosis, unspecified constipation, unspecified unspecified acquired hypothyroidism obesity, unspecified hemorrhage of rectum and anus asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant neoplasm of tail of pancreas diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin constipation, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified obesity, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified aplastic anemias hyperpotassemia malignant neoplasm of tail of pancreas long-term (current) use of insulin antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use osteoarthrosis, unspecified whether generalized or localized, site unspecified nausea with vomiting unspecified acquired hypothyroidism acute vascular insufficiency of intestine malignant neoplasm of pancreas, part unspecified obesity, unspecified benign essential hypertension esophageal reflux unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified dehydration
black african american f 69 $nan$nan$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; senna  1  tab ; montelukast sodium  10  mg ; polyethylene glycol  17  g ; omeprazole  40  mg ; prochlorperazine  5-10  mg ; gabapentin  300  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone sr (oxycontin)  30  mg ; hydromorphone (dilaudid)  2  mg ; methylphenidate (ritalin)  5  mg ; 
neoplasm related pain (acute) (chronic) osteoporosis, unspecified malignant ascites secondary malignant neoplasm of other specified sites diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use unspecified essential hypertension asthma, unspecified type, unspecified long-term (current) use of insulin malignant neoplasm of body of pancreas postprocedural fever unspecified acquired hypothyroidism hematemesis constipation, unspecified orthostatic hypotension benign essential hypertension osteoporosis, unspecified constipation, unspecified unspecified acquired hypothyroidism obesity, unspecified hemorrhage of rectum and anus asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant neoplasm of tail of pancreas diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin constipation, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified obesity, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified aplastic anemias hyperpotassemia malignant neoplasm of tail of pancreas long-term (current) use of insulin antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use osteoarthrosis, unspecified whether generalized or localized, site unspecified nausea with vomiting unspecified acquired hypothyroidism acute vascular insufficiency of intestine malignant neoplasm of pancreas, part unspecified obesity, unspecified benign essential hypertension esophageal reflux unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified dehydration
black african american f 69 $nan$nan$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; senna  1  tab ; montelukast sodium  10  mg ; polyethylene glycol  17  g ; omeprazole  40  mg ; prochlorperazine  5-10  mg ; gabapentin  300  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone sr (oxycontin)  30  mg ; 
neoplasm related pain (acute) (chronic) osteoporosis, unspecified malignant ascites secondary malignant neoplasm of other specified sites diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use unspecified essential hypertension asthma, unspecified type, unspecified long-term (current) use of insulin malignant neoplasm of body of pancreas postprocedural fever unspecified acquired hypothyroidism hematemesis constipation, unspecified orthostatic hypotension benign essential hypertension osteoporosis, unspecified constipation, unspecified unspecified acquired hypothyroidism obesity, unspecified hemorrhage of rectum and anus asthma, unspecified type, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant neoplasm of tail of pancreas diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin constipation, unspecified osteoporosis, unspecified asthma, unspecified type, unspecified obesity, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified aplastic anemias hyperpotassemia malignant neoplasm of tail of pancreas long-term (current) use of insulin antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use osteoarthrosis, unspecified whether generalized or localized, site unspecified nausea with vomiting unspecified acquired hypothyroidism acute vascular insufficiency of intestine malignant neoplasm of pancreas, part unspecified obesity, unspecified benign essential hypertension esophageal reflux unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified dehydration
white m 76 $temp  99.0  heartrate  70.0  resprate  18.0  o2sat  99.0  sbp  139.0  dbp  88.0  rhythm    pain  0  $hematology blood hematocrit  33.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  66  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; ondansetron  4-8  mg ; metronidazole  500  mg ; metoprolol succinate xl  100  mg ; amiodarone  200  mg ; digoxin  0.125  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; magnesium oxide  400  mg ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; vial  1  vial ; ceftriaxone  1  gm ; d5 1 2ns  1000  ml ; 
 
white m 76 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; ondansetron  4-8  mg ; metronidazole  500  mg ; amiodarone  200  mg ; digoxin  0.125  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; magnesium oxide  400  mg ; 0.9% sodium chloride  500  ml ; vial  1  vial ; ceftriaxone  1  gm ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; bag  1  bag ; magnesium sulfate  2  gm ; d5lr  1000  ml ; prochlorperazine  10  mg ; ramelteon  8  mg ; 
 
white m 76 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  229  iu l; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; ondansetron  4-8  mg ; metronidazole  500  mg ; amiodarone  200  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; vial  1  vial ; ceftriaxone  1  gm ; d5lr  1000  ml ; prochlorperazine  10  mg ; ramelteon  8  mg ; 
 
white m 76 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; ondansetron  4-8  mg ; metronidazole  500  mg ; amiodarone  200  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; vial  1  vial ; ceftriaxone  1  gm ; ramelteon  8  mg ; magnesium sulfate  4  gm ; trazodone  50  mg ; 
 
white m 76 $nan$hematology blood hematocrit  31.7  %; hematology blood hematocrit  32.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  165  k ul; hematology blood platelet count  170  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, indirect  0.4  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  96  mg dl; chemistry blood albumin  3.4  g dl; chemistry blood bilirubin, direct  0.8  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; ondansetron  4-8  mg ; metronidazole  500  mg ; amiodarone  200  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; vial  1  vial ; ceftriaxone  1  gm ; ramelteon  8  mg ; magnesium sulfate  4  gm ; trazodone  50  mg ; lactated ringers  1000  ml ; sodium chloride 0.9%  1000  ml ; hydromorphone (dilaudid)  0.25-0.5  mg ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; 
 
white m 76 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; ondansetron  4-8  mg ; amiodarone  200  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; ramelteon  8  mg ; sodium chloride 0.9%  1000  ml ; hydromorphone (dilaudid)  0.25-0.5  mg ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; furosemide  20  mg ; omeprazole  40  mg ; multivitamins w minerals  1  tab ; potassium chloride  10  meq ; warfarin  5  mg ; 
 
white m 76 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  262  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; ondansetron  4-8  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; ramelteon  8  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; furosemide  20  mg ; omeprazole  40  mg ; multivitamins w minerals  1  tab ; potassium chloride  10  meq ; senna  8.6  mg ; 
 
white m 76 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  282  k ul$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; ondansetron  4-8  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; ramelteon  8  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; furosemide  20  mg ; omeprazole  40  mg ; multivitamins w minerals  1  tab ; potassium chloride  10  meq ; senna  8.6  mg ; lidocaine 2%  1  ml ; polyethylene glycol  17  g ; 
 
hispanic latino f 60 $temp  99.0  heartrate  86.0  resprate  24.0  o2sat  100.0  sbp  157.0  dbp  90.0  rhythm    pain    ; temp    heartrate  86.0  resprate  24.0  o2sat  100.0  sbp  152.0  dbp  88.0  rhythm    pain    ; temp    heartrate  99.0  resprate  24.0  o2sat  100.0  sbp  128.0  dbp  87.0  rhythm    pain  0  ; temp    heartrate  97.0  resprate  22.0  o2sat  100.0  sbp    dbp    rhythm    pain    ; temp  99.8  heartrate  108.0  resprate  18.0  o2sat  100.0  sbp  116.0  dbp  73.0  rhythm    pain    ; temp    heartrate  108.0  resprate  22.0  o2sat  100.0  sbp  99.0  dbp  61.0  rhythm    pain  0  ; temp    heartrate  92.0  resprate  20.0  o2sat  100.0  sbp  98.0  dbp  67.0  rhythm    pain    ; temp  99.2  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp    heartrate  95.0  resprate  22.0  o2sat  100.0  sbp  110.0  dbp  70.0  rhythm    pain  0  ; temp  98.8  heartrate  91.0  resprate  22.0  o2sat  100.0  sbp  127.0  dbp  74.0  rhythm    pain  0  ; temp  101.0  heartrate  92.0  resprate  18.0  o2sat  100.0  sbp  117.0  dbp  76.0  rhythm    pain  0  $hematology blood hematocrit  26.7  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  479  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  3  # hpf; chemistry blood glucose  72  mg dl; chemistry blood lactate dehydrogenase (ld)  305  iu l; chemistry blood albumin  3.4  g dl; hematology blood bands  1  %; blood gas blood lactate  1.7  mmol l$apixaban  5  mg ; amlodipine  5  mg ; 
major depressive disorder, single episode, unspecified interstitial pulmonary disease, unspecified blindness, one eye, unspecified eye iron deficiency anemia, unspecified chronic kidney disease, stage 3 (moderate) functional dyspepsia myocardial infarction type 2 other overlap syndromes pneumonia, unspecified organism pain in left shoulder acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis anemia in other chronic diseases classified elsewhere thalassemia minor dysphagia, unspecified pulmonary hypertension, unspecified chronic diastolic (congestive) heart failure decreased white blood cell count, unspecified other secondary pulmonary hypertension pneumonia, unspecified organism severe sepsis without septic shock presence of right artificial hip joint chronic diastolic (congestive) heart failure toxic encephalopathy iron deficiency anemia, unspecified candidal stomatitis long term (current) use of systemic steroids acute kidney failure, unspecified unqualified visual loss, left eye, normal vision right eye enterocolitis due to clostridium difficile, recurrent age-related osteoporosis without current pathological fracture other overlap syndromes nosocomial condition other specified sepsis gastro-esophageal reflux disease without esophagitis hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, stage 3 (moderate) acidosis pulmonary hypertension, unspecified constipation, unspecified acute kidney failure, unspecified age-related osteoporosis without current pathological fracture iron deficiency anemia, unspecified enterocolitis due to clostridium difficile, not specified as recurrent chronic kidney disease, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
hispanic latino f 60 $temp  100.5  heartrate  102.0  resprate  2.0  o2sat  100.0  sbp  110.0  dbp  76.0  rhythm    pain  0  $hematology blood hematocrit  23.2  %; hematology blood hemoglobin  6.5  g dl; hematology blood platelet count  346  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.4  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  87  mg dl; chemistry blood lactate dehydrogenase (ld)  211  iu l; chemistry blood albumin  2.6  g dl$apixaban  5  mg ; amlodipine  5  mg ; sodium chloride 0.9%  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; oxymetazoline  1  spry ; acetaminophen  650  mg ; ascorbic acid  500  mg ; atorvastatin  40  mg ; azathioprine  50  mg ; ferrous sulfate  325  mg ; prednisone  3  mg ; prednisone  5  mg ; tramadol  50  mg ; calcium carbonate  500  mg ; vial  1  vial ; ceftriaxone  1  gm ; azithromycin  250  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; aspirin  81  mg ; famotidine  20  mg ; 
major depressive disorder, single episode, unspecified interstitial pulmonary disease, unspecified blindness, one eye, unspecified eye iron deficiency anemia, unspecified chronic kidney disease, stage 3 (moderate) functional dyspepsia myocardial infarction type 2 other overlap syndromes pneumonia, unspecified organism pain in left shoulder acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis anemia in other chronic diseases classified elsewhere thalassemia minor dysphagia, unspecified pulmonary hypertension, unspecified chronic diastolic (congestive) heart failure decreased white blood cell count, unspecified other secondary pulmonary hypertension pneumonia, unspecified organism severe sepsis without septic shock presence of right artificial hip joint chronic diastolic (congestive) heart failure toxic encephalopathy iron deficiency anemia, unspecified candidal stomatitis long term (current) use of systemic steroids acute kidney failure, unspecified unqualified visual loss, left eye, normal vision right eye enterocolitis due to clostridium difficile, recurrent age-related osteoporosis without current pathological fracture other overlap syndromes nosocomial condition other specified sepsis gastro-esophageal reflux disease without esophagitis hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, stage 3 (moderate) acidosis pulmonary hypertension, unspecified constipation, unspecified acute kidney failure, unspecified age-related osteoporosis without current pathological fracture iron deficiency anemia, unspecified enterocolitis due to clostridium difficile, not specified as recurrent chronic kidney disease, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
hispanic latino f 60 $nan$hematology blood hematocrit  26.9  %; hematology blood hematocrit  26.1  %; hematology blood hematocrit  26.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  320  k ul; hematology blood platelet count  289  k ul; hematology blood platelet count  325  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.5  ; chemistry urine chloride, urine  57  meq l; chemistry urine creatinine, urine  82  mg dl; chemistry urine potassium, urine  35  meq l; chemistry urine sodium, urine  69  meq l; chemistry urine urea nitrogen, urine  396  mg dl; hematology urine wbc  19  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  89  mg dl; chemistry urine protein creatinine ratio  0.8  mg mg$apixaban  5  mg ; amlodipine  5  mg ; sodium chloride 0.9%  flush  3-10  ml ; oxymetazoline  1  spry ; acetaminophen  650  mg ; ascorbic acid  500  mg ; atorvastatin  40  mg ; azathioprine  50  mg ; ferrous sulfate  325  mg ; prednisone  3  mg ; prednisone  5  mg ; tramadol  50  mg ; calcium carbonate  500  mg ; vial  1  vial ; ceftriaxone  1  gm ; azithromycin  250  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin  81  mg ; famotidine  20  mg ; bag  1  bag ; magnesium sulfate  4  gm ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; 
major depressive disorder, single episode, unspecified interstitial pulmonary disease, unspecified blindness, one eye, unspecified eye iron deficiency anemia, unspecified chronic kidney disease, stage 3 (moderate) functional dyspepsia myocardial infarction type 2 other overlap syndromes pneumonia, unspecified organism pain in left shoulder acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis anemia in other chronic diseases classified elsewhere thalassemia minor dysphagia, unspecified pulmonary hypertension, unspecified chronic diastolic (congestive) heart failure decreased white blood cell count, unspecified other secondary pulmonary hypertension pneumonia, unspecified organism severe sepsis without septic shock presence of right artificial hip joint chronic diastolic (congestive) heart failure toxic encephalopathy iron deficiency anemia, unspecified candidal stomatitis long term (current) use of systemic steroids acute kidney failure, unspecified unqualified visual loss, left eye, normal vision right eye enterocolitis due to clostridium difficile, recurrent age-related osteoporosis without current pathological fracture other overlap syndromes nosocomial condition other specified sepsis gastro-esophageal reflux disease without esophagitis hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, stage 3 (moderate) acidosis pulmonary hypertension, unspecified constipation, unspecified acute kidney failure, unspecified age-related osteoporosis without current pathological fracture iron deficiency anemia, unspecified enterocolitis due to clostridium difficile, not specified as recurrent chronic kidney disease, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
hispanic latino f 60 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  329  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  78  mg dl$apixaban  5  mg ; amlodipine  5  mg ; sodium chloride 0.9%  flush  3-10  ml ; oxymetazoline  1  spry ; acetaminophen  650  mg ; ascorbic acid  500  mg ; atorvastatin  40  mg ; azathioprine  50  mg ; ferrous sulfate  325  mg ; prednisone  3  mg ; prednisone  5  mg ; tramadol  50  mg ; calcium carbonate  500  mg ; famotidine  20  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; pantoprazole  40  mg ; 
major depressive disorder, single episode, unspecified interstitial pulmonary disease, unspecified blindness, one eye, unspecified eye iron deficiency anemia, unspecified chronic kidney disease, stage 3 (moderate) functional dyspepsia myocardial infarction type 2 other overlap syndromes pneumonia, unspecified organism pain in left shoulder acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis anemia in other chronic diseases classified elsewhere thalassemia minor dysphagia, unspecified pulmonary hypertension, unspecified chronic diastolic (congestive) heart failure decreased white blood cell count, unspecified other secondary pulmonary hypertension pneumonia, unspecified organism severe sepsis without septic shock presence of right artificial hip joint chronic diastolic (congestive) heart failure toxic encephalopathy iron deficiency anemia, unspecified candidal stomatitis long term (current) use of systemic steroids acute kidney failure, unspecified unqualified visual loss, left eye, normal vision right eye enterocolitis due to clostridium difficile, recurrent age-related osteoporosis without current pathological fracture other overlap syndromes nosocomial condition other specified sepsis gastro-esophageal reflux disease without esophagitis hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, stage 3 (moderate) acidosis pulmonary hypertension, unspecified constipation, unspecified acute kidney failure, unspecified age-related osteoporosis without current pathological fracture iron deficiency anemia, unspecified enterocolitis due to clostridium difficile, not specified as recurrent chronic kidney disease, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
hispanic latino f 60 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  317  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  8  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  180  iu l; chemistry blood albumin  2.8  g dl$sodium chloride 0.9%  flush  3-10  ml ; oxymetazoline  1  spry ; acetaminophen  650  mg ; ascorbic acid  500  mg ; atorvastatin  40  mg ; azathioprine  50  mg ; ferrous sulfate  325  mg ; prednisone  3  mg ; prednisone  5  mg ; tramadol  50  mg ; calcium carbonate  500  mg ; famotidine  20  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; lactated ringers  1000  ml ; 
major depressive disorder, single episode, unspecified interstitial pulmonary disease, unspecified blindness, one eye, unspecified eye iron deficiency anemia, unspecified chronic kidney disease, stage 3 (moderate) functional dyspepsia myocardial infarction type 2 other overlap syndromes pneumonia, unspecified organism pain in left shoulder acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis anemia in other chronic diseases classified elsewhere thalassemia minor dysphagia, unspecified pulmonary hypertension, unspecified chronic diastolic (congestive) heart failure decreased white blood cell count, unspecified other secondary pulmonary hypertension pneumonia, unspecified organism severe sepsis without septic shock presence of right artificial hip joint chronic diastolic (congestive) heart failure toxic encephalopathy iron deficiency anemia, unspecified candidal stomatitis long term (current) use of systemic steroids acute kidney failure, unspecified unqualified visual loss, left eye, normal vision right eye enterocolitis due to clostridium difficile, recurrent age-related osteoporosis without current pathological fracture other overlap syndromes nosocomial condition other specified sepsis gastro-esophageal reflux disease without esophagitis hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, stage 3 (moderate) acidosis pulmonary hypertension, unspecified constipation, unspecified acute kidney failure, unspecified age-related osteoporosis without current pathological fracture iron deficiency anemia, unspecified enterocolitis due to clostridium difficile, not specified as recurrent chronic kidney disease, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
hispanic latino f 60 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  319  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; ascorbic acid  500  mg ; atorvastatin  40  mg ; azathioprine  50  mg ; ferrous sulfate  325  mg ; prednisone  3  mg ; prednisone  5  mg ; tramadol  50  mg ; calcium carbonate  500  mg ; famotidine  20  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; sildenafil  10  mg ; apixaban  2.5  mg ; 
major depressive disorder, single episode, unspecified interstitial pulmonary disease, unspecified blindness, one eye, unspecified eye iron deficiency anemia, unspecified chronic kidney disease, stage 3 (moderate) functional dyspepsia myocardial infarction type 2 other overlap syndromes pneumonia, unspecified organism pain in left shoulder acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis anemia in other chronic diseases classified elsewhere thalassemia minor dysphagia, unspecified pulmonary hypertension, unspecified chronic diastolic (congestive) heart failure decreased white blood cell count, unspecified other secondary pulmonary hypertension pneumonia, unspecified organism severe sepsis without septic shock presence of right artificial hip joint chronic diastolic (congestive) heart failure toxic encephalopathy iron deficiency anemia, unspecified candidal stomatitis long term (current) use of systemic steroids acute kidney failure, unspecified unqualified visual loss, left eye, normal vision right eye enterocolitis due to clostridium difficile, recurrent age-related osteoporosis without current pathological fracture other overlap syndromes nosocomial condition other specified sepsis gastro-esophageal reflux disease without esophagitis hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, stage 3 (moderate) acidosis pulmonary hypertension, unspecified constipation, unspecified acute kidney failure, unspecified age-related osteoporosis without current pathological fracture iron deficiency anemia, unspecified enterocolitis due to clostridium difficile, not specified as recurrent chronic kidney disease, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
hispanic latino f 60 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; atorvastatin  40  mg ; azathioprine  50  mg ; ferrous sulfate  325  mg ; prednisone  3  mg ; prednisone  5  mg ; tramadol  50  mg ; calcium carbonate  500  mg ; famotidine  20  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; sildenafil  10  mg ; apixaban  2.5  mg ; 
major depressive disorder, single episode, unspecified interstitial pulmonary disease, unspecified blindness, one eye, unspecified eye iron deficiency anemia, unspecified chronic kidney disease, stage 3 (moderate) functional dyspepsia myocardial infarction type 2 other overlap syndromes pneumonia, unspecified organism pain in left shoulder acute kidney failure, unspecified other pulmonary embolism without acute cor pulmonale hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis anemia in other chronic diseases classified elsewhere thalassemia minor dysphagia, unspecified pulmonary hypertension, unspecified chronic diastolic (congestive) heart failure decreased white blood cell count, unspecified other secondary pulmonary hypertension pneumonia, unspecified organism severe sepsis without septic shock presence of right artificial hip joint chronic diastolic (congestive) heart failure toxic encephalopathy iron deficiency anemia, unspecified candidal stomatitis long term (current) use of systemic steroids acute kidney failure, unspecified unqualified visual loss, left eye, normal vision right eye enterocolitis due to clostridium difficile, recurrent age-related osteoporosis without current pathological fracture other overlap syndromes nosocomial condition other specified sepsis gastro-esophageal reflux disease without esophagitis hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, stage 3 (moderate) acidosis pulmonary hypertension, unspecified constipation, unspecified acute kidney failure, unspecified age-related osteoporosis without current pathological fracture iron deficiency anemia, unspecified enterocolitis due to clostridium difficile, not specified as recurrent chronic kidney disease, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
white m 60 $nan$hematology blood hematocrit  45.0  %; hematology blood hemoglobin  15.6  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  182  iu l; chemistry blood % hemoglobin a1c  5.6  %$losartan potassium  25  mg ; nadolol  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin sodium  25,000  unit ; 
 
white m 60 $nan$nan$losartan potassium  25  mg ; nadolol  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin sodium  25,000  unit ; tramadol (ultram)  50  mg ; mupirocin nasal ointment 2%  1  appl ; 
 
white m 60 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  123  k ul; hematology blood inr(pt)  1.4  ; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood albumin  3.0  g dl; blood gas blood free calcium  1.22  mmol l; blood gas blood free calcium  0.85  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood chloride, whole blood  104  meq l; blood gas blood glucose  109  mg dl; blood gas blood glucose  125  mg dl; blood gas blood glucose  143  mg dl; blood gas blood glucose  166  mg dl; blood gas blood glucose  171  mg dl; blood gas blood hematocrit, calculated  44  %; blood gas blood hematocrit, calculated  30  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  28  %; blood gas blood hematocrit, calculated  30  %; blood gas blood hemoglobin  14.8  g dl; blood gas blood hemoglobin  9.9  g dl; blood gas blood hemoglobin  9.7  g dl; blood gas blood hemoglobin  9.3  g dl; blood gas blood hemoglobin  10.0  g dl; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  5.1  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  135  meq l$losartan potassium  25  mg ; nadolol  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; tramadol (ultram)  50  mg ; mupirocin nasal ointment 2%  1  appl ; atropine sulfate  0.5  mg ; 
 
white m 60 $nan$hematology blood hematocrit  35.3  %; hematology blood hematocrit  35.6  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  116  k ul; hematology blood platelet count  94  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.4  ; blood gas blood free calcium  1.35  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood glucose  88  mg dl; blood gas blood glucose  131  mg dl; blood gas blood glucose  118  mg dl; blood gas blood potassium, whole blood  3.2  meq l; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  135  meq l$iso-osmotic dextrose  200  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; propofol  1000  mg ; propofol  200  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; meperidine  12.5  mg ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; milk of magnesia  30  ml ; cefazolin  2  g ; warfarin  1  dose ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium (liquid)  100  mg ; docusate sodium  100  mg ; vancomycin  1000  mg ; ketorolac  15  mg ; aspirin  81  mg ; aspirin ec  81  mg ; 
 
white m 60 $nan$hematology blood hematocrit  35.2  %; hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  60  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  162  mg dl$iso-osmotic dextrose  200  ml ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; milk of magnesia  30  ml ; cefazolin  2  g ; warfarin  1  dose ; ranitidine  150  mg ; docusate sodium  100  mg ; vancomycin  1000  mg ; ketorolac  15  mg ; aspirin ec  81  mg ; 0.9% sodium chloride  1000  ml ; warfarin  5  mg ; albumin 5% (25g   500ml)  25  g ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; furosemide  20  mg ; warfarin  4  mg ; bisacodyl  10  mg ; 
 
white m 60 $nan$hematology blood hematocrit  34.5  %; hematology blood hematocrit  31.7  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  77  k ul; hematology blood platelet count  73  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; chemistry blood glucose  118  mg dl; chemistry blood glucose  169  mg dl$furosemide  20  mg ; warfarin  4  mg ; bisacodyl  10  mg ; ketorolac  30  mg ; metoprolol tartrate  12.5  mg ; 
 
white m 60 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  79  k ul; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.7  $furosemide  20  mg ; bisacodyl  10  mg ; ketorolac  30  mg ; metoprolol tartrate  12.5  mg ; warfarin  2  mg ; 
 
white m 60 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  109  k ul; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.6  $5% dextrose  250  ml ; furosemide  20  mg ; bisacodyl  10  mg ; warfarin  2  mg ; lactulose  30  ml ; 
 
white m 60 $nan$chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.6  $furosemide  20  mg ; bisacodyl  10  mg ; lactulose  30  ml ; warfarin  10  mg ; 
 
white m 60 $nan$chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.9  $furosemide  20  mg ; bisacodyl  10  mg ; lactulose  30  ml ; warfarin  10  mg ; 
 
white m 60 $nan$nan$furosemide  20  mg ; bisacodyl  10  mg ; lactulose  30  ml ; 
 
white m 85 $nan$nan$ferrous sulfate  325  mg ; multivitamins  1  tab ; lisinopril  1.25  mg ; atorvastatin  40  mg ; prednisone  7.5  mg ; levothyroxine sodium  200  mcg ; allopurinol  400  mg ; warfarin  4  mg ; docusate sodium  100  mg ; calcium carbonate  1000  mg ; torsemide  40  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids unspecified glaucoma coronary atherosclerosis of native coronary artery personal history of tobacco use contact dermatitis and other eczema, unspecified cause chronic kidney disease, unspecified primary hypercoagulable state acute on chronic systolic heart failure unspecified acquired hypothyroidism congestive heart failure, unspecified secondary cardiomyopathy, unspecified hyposmolality and/or hyponatremia pseudomonas infection in conditions classified elsewhere and of unspecified site hypopotassemia urinary tract infection, site not specified fall from other slipping, tripping, or stumbling antineoplastic antibiotics causing adverse effects in therapeutic use old myocardial infarction automatic implantable cardiac defibrillator in situ other persistent mental disorders due to conditions classified elsewhere pure hypercholesterolemia large cell lymphoma, unspecified site, extranodal and solid organ sites personal history of venous thrombosis and embolism gouty arthropathy personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits congestive heart failure, unspecified unspecified acquired hypothyroidism other malignant lymphomas, unspecified site, extranodal and solid organ sites automatic implantable cardiac defibrillator in situ other specified retention of urine pressure ulcer, lower back chronic systolic heart failure pressure ulcer, stage iii pure hypercholesterolemia coronary atherosclerosis of native coronary artery gouty tophi of other sites, except ear other malignant lymphomas, unspecified site, extranodal and solid organ sites congestive heart failure, unspecified late effects of cerebrovascular disease, aphasia pneumonia, organism unspecified pressure ulcer, stage ii coronary atherosclerosis of native coronary artery acute on chronic systolic heart failure pure hypercholesterolemia automatic implantable cardiac defibrillator in situ other primary cardiomyopathies personal history of venous thrombosis and embolism
white m 85 $nan$hematology blood hematocrit  43.1  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood glucose  101  mg dl$ferrous sulfate  325  mg ; multivitamins  1  tab ; lisinopril  1.25  mg ; atorvastatin  40  mg ; prednisone  7.5  mg ; levothyroxine sodium  200  mcg ; allopurinol  400  mg ; warfarin  4  mg ; docusate sodium  100  mg ; calcium carbonate  1000  mg ; torsemide  40  mg ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  3  ml ; triamcinolone acetonide 0.1% cream  1  appl ; senna  1  tab ; acetaminophen  325-650  mg ; colchicine  0.6  mg ; levofloxacin  750  mg ; 1 2 ns  1000  ml ; digoxin  0.125  mg ; warfarin  6  mg ; 5% dextrose  50  ml ; aztreonam  1000  mg ; iso-osmotic dextrose  50  ml ; torsemide  20  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids unspecified glaucoma coronary atherosclerosis of native coronary artery personal history of tobacco use contact dermatitis and other eczema, unspecified cause chronic kidney disease, unspecified primary hypercoagulable state acute on chronic systolic heart failure unspecified acquired hypothyroidism congestive heart failure, unspecified secondary cardiomyopathy, unspecified hyposmolality and/or hyponatremia pseudomonas infection in conditions classified elsewhere and of unspecified site hypopotassemia urinary tract infection, site not specified fall from other slipping, tripping, or stumbling antineoplastic antibiotics causing adverse effects in therapeutic use old myocardial infarction automatic implantable cardiac defibrillator in situ other persistent mental disorders due to conditions classified elsewhere pure hypercholesterolemia large cell lymphoma, unspecified site, extranodal and solid organ sites personal history of venous thrombosis and embolism gouty arthropathy personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits congestive heart failure, unspecified unspecified acquired hypothyroidism other malignant lymphomas, unspecified site, extranodal and solid organ sites automatic implantable cardiac defibrillator in situ other specified retention of urine pressure ulcer, lower back chronic systolic heart failure pressure ulcer, stage iii pure hypercholesterolemia coronary atherosclerosis of native coronary artery gouty tophi of other sites, except ear other malignant lymphomas, unspecified site, extranodal and solid organ sites congestive heart failure, unspecified late effects of cerebrovascular disease, aphasia pneumonia, organism unspecified pressure ulcer, stage ii coronary atherosclerosis of native coronary artery acute on chronic systolic heart failure pure hypercholesterolemia automatic implantable cardiac defibrillator in situ other primary cardiomyopathies personal history of venous thrombosis and embolism
white m 85 $nan$hematology blood hematocrit  42.6  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  3.1  ; chemistry urine creatinine, urine  63  mg dl; chemistry urine sodium, urine  24  meq l; chemistry urine urea nitrogen, urine  842  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  84  mg dl$ferrous sulfate  325  mg ; multivitamins  1  tab ; lisinopril  1.25  mg ; atorvastatin  40  mg ; prednisone  7.5  mg ; levothyroxine sodium  200  mcg ; allopurinol  400  mg ; warfarin  4  mg ; docusate sodium  100  mg ; calcium carbonate  1000  mg ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  3  ml ; triamcinolone acetonide 0.1% cream  1  appl ; senna  1  tab ; acetaminophen  325-650  mg ; colchicine  0.6  mg ; levofloxacin  750  mg ; digoxin  0.125  mg ; warfarin  6  mg ; 5% dextrose  50  ml ; aztreonam  1000  mg ; iso-osmotic dextrose  50  ml ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids unspecified glaucoma coronary atherosclerosis of native coronary artery personal history of tobacco use contact dermatitis and other eczema, unspecified cause chronic kidney disease, unspecified primary hypercoagulable state acute on chronic systolic heart failure unspecified acquired hypothyroidism congestive heart failure, unspecified secondary cardiomyopathy, unspecified hyposmolality and/or hyponatremia pseudomonas infection in conditions classified elsewhere and of unspecified site hypopotassemia urinary tract infection, site not specified fall from other slipping, tripping, or stumbling antineoplastic antibiotics causing adverse effects in therapeutic use old myocardial infarction automatic implantable cardiac defibrillator in situ other persistent mental disorders due to conditions classified elsewhere pure hypercholesterolemia large cell lymphoma, unspecified site, extranodal and solid organ sites personal history of venous thrombosis and embolism gouty arthropathy personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits congestive heart failure, unspecified unspecified acquired hypothyroidism other malignant lymphomas, unspecified site, extranodal and solid organ sites automatic implantable cardiac defibrillator in situ other specified retention of urine pressure ulcer, lower back chronic systolic heart failure pressure ulcer, stage iii pure hypercholesterolemia coronary atherosclerosis of native coronary artery gouty tophi of other sites, except ear other malignant lymphomas, unspecified site, extranodal and solid organ sites congestive heart failure, unspecified late effects of cerebrovascular disease, aphasia pneumonia, organism unspecified pressure ulcer, stage ii coronary atherosclerosis of native coronary artery acute on chronic systolic heart failure pure hypercholesterolemia automatic implantable cardiac defibrillator in situ other primary cardiomyopathies personal history of venous thrombosis and embolism
white m 85 $nan$hematology blood hematocrit  40.2  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  3.5  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  81  mg dl$ferrous sulfate  325  mg ; multivitamins  1  tab ; lisinopril  1.25  mg ; atorvastatin  40  mg ; prednisone  7.5  mg ; levothyroxine sodium  200  mcg ; allopurinol  400  mg ; warfarin  4  mg ; docusate sodium  100  mg ; calcium carbonate  1000  mg ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  3  ml ; triamcinolone acetonide 0.1% cream  1  appl ; senna  1  tab ; acetaminophen  325-650  mg ; colchicine  0.6  mg ; digoxin  0.125  mg ; warfarin  6  mg ; iso-osmotic dextrose  50  ml ; potassium chloride  40  meq ; sw  50  ml ; magnesium sulfate  2  gm ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids unspecified glaucoma coronary atherosclerosis of native coronary artery personal history of tobacco use contact dermatitis and other eczema, unspecified cause chronic kidney disease, unspecified primary hypercoagulable state acute on chronic systolic heart failure unspecified acquired hypothyroidism congestive heart failure, unspecified secondary cardiomyopathy, unspecified hyposmolality and/or hyponatremia pseudomonas infection in conditions classified elsewhere and of unspecified site hypopotassemia urinary tract infection, site not specified fall from other slipping, tripping, or stumbling antineoplastic antibiotics causing adverse effects in therapeutic use old myocardial infarction automatic implantable cardiac defibrillator in situ other persistent mental disorders due to conditions classified elsewhere pure hypercholesterolemia large cell lymphoma, unspecified site, extranodal and solid organ sites personal history of venous thrombosis and embolism gouty arthropathy personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits congestive heart failure, unspecified unspecified acquired hypothyroidism other malignant lymphomas, unspecified site, extranodal and solid organ sites automatic implantable cardiac defibrillator in situ other specified retention of urine pressure ulcer, lower back chronic systolic heart failure pressure ulcer, stage iii pure hypercholesterolemia coronary atherosclerosis of native coronary artery gouty tophi of other sites, except ear other malignant lymphomas, unspecified site, extranodal and solid organ sites congestive heart failure, unspecified late effects of cerebrovascular disease, aphasia pneumonia, organism unspecified pressure ulcer, stage ii coronary atherosclerosis of native coronary artery acute on chronic systolic heart failure pure hypercholesterolemia automatic implantable cardiac defibrillator in situ other primary cardiomyopathies personal history of venous thrombosis and embolism
white m 85 $nan$hematology blood hematocrit  41.2  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  3.1  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  83  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$ferrous sulfate  325  mg ; multivitamins  1  tab ; lisinopril  1.25  mg ; atorvastatin  40  mg ; prednisone  7.5  mg ; levothyroxine sodium  200  mcg ; allopurinol  400  mg ; warfarin  4  mg ; docusate sodium  100  mg ; calcium carbonate  1000  mg ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  3  ml ; triamcinolone acetonide 0.1% cream  1  appl ; senna  1  tab ; acetaminophen  325-650  mg ; colchicine  0.6  mg ; digoxin  0.125  mg ; warfarin  6  mg ; iso-osmotic dextrose  50  ml ; potassium chloride  40  meq ; sw  50  ml ; magnesium sulfate  2  gm ; levothyroxine sodium  250  mcg ; levothyroxine sodium  400  mcg ; sodium chloride 0.9%  flush  10  ml ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids unspecified glaucoma coronary atherosclerosis of native coronary artery personal history of tobacco use contact dermatitis and other eczema, unspecified cause chronic kidney disease, unspecified primary hypercoagulable state acute on chronic systolic heart failure unspecified acquired hypothyroidism congestive heart failure, unspecified secondary cardiomyopathy, unspecified hyposmolality and/or hyponatremia pseudomonas infection in conditions classified elsewhere and of unspecified site hypopotassemia urinary tract infection, site not specified fall from other slipping, tripping, or stumbling antineoplastic antibiotics causing adverse effects in therapeutic use old myocardial infarction automatic implantable cardiac defibrillator in situ other persistent mental disorders due to conditions classified elsewhere pure hypercholesterolemia large cell lymphoma, unspecified site, extranodal and solid organ sites personal history of venous thrombosis and embolism gouty arthropathy personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits congestive heart failure, unspecified unspecified acquired hypothyroidism other malignant lymphomas, unspecified site, extranodal and solid organ sites automatic implantable cardiac defibrillator in situ other specified retention of urine pressure ulcer, lower back chronic systolic heart failure pressure ulcer, stage iii pure hypercholesterolemia coronary atherosclerosis of native coronary artery gouty tophi of other sites, except ear other malignant lymphomas, unspecified site, extranodal and solid organ sites congestive heart failure, unspecified late effects of cerebrovascular disease, aphasia pneumonia, organism unspecified pressure ulcer, stage ii coronary atherosclerosis of native coronary artery acute on chronic systolic heart failure pure hypercholesterolemia automatic implantable cardiac defibrillator in situ other primary cardiomyopathies personal history of venous thrombosis and embolism
white m 85 $nan$hematology blood hematocrit  40.6  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  4.6  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  89  mg dl$ferrous sulfate  325  mg ; multivitamins  1  tab ; lisinopril  1.25  mg ; atorvastatin  40  mg ; prednisone  7.5  mg ; allopurinol  400  mg ; warfarin  4  mg ; docusate sodium  100  mg ; calcium carbonate  1000  mg ; latanoprost 0.005% ophth. soln.  1  drop ; sodium chloride 0.9%  flush  3  ml ; triamcinolone acetonide 0.1% cream  1  appl ; senna  1  tab ; acetaminophen  325-650  mg ; colchicine  0.6  mg ; digoxin  0.125  mg ; warfarin  6  mg ; iso-osmotic dextrose  50  ml ; levothyroxine sodium  400  mcg ; sodium chloride 0.9%  flush  10  ml ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids unspecified glaucoma coronary atherosclerosis of native coronary artery personal history of tobacco use contact dermatitis and other eczema, unspecified cause chronic kidney disease, unspecified primary hypercoagulable state acute on chronic systolic heart failure unspecified acquired hypothyroidism congestive heart failure, unspecified secondary cardiomyopathy, unspecified hyposmolality and/or hyponatremia pseudomonas infection in conditions classified elsewhere and of unspecified site hypopotassemia urinary tract infection, site not specified fall from other slipping, tripping, or stumbling antineoplastic antibiotics causing adverse effects in therapeutic use old myocardial infarction automatic implantable cardiac defibrillator in situ other persistent mental disorders due to conditions classified elsewhere pure hypercholesterolemia large cell lymphoma, unspecified site, extranodal and solid organ sites personal history of venous thrombosis and embolism gouty arthropathy personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits congestive heart failure, unspecified unspecified acquired hypothyroidism other malignant lymphomas, unspecified site, extranodal and solid organ sites automatic implantable cardiac defibrillator in situ other specified retention of urine pressure ulcer, lower back chronic systolic heart failure pressure ulcer, stage iii pure hypercholesterolemia coronary atherosclerosis of native coronary artery gouty tophi of other sites, except ear other malignant lymphomas, unspecified site, extranodal and solid organ sites congestive heart failure, unspecified late effects of cerebrovascular disease, aphasia pneumonia, organism unspecified pressure ulcer, stage ii coronary atherosclerosis of native coronary artery acute on chronic systolic heart failure pure hypercholesterolemia automatic implantable cardiac defibrillator in situ other primary cardiomyopathies personal history of venous thrombosis and embolism
black african american m 60 $nan$hematology blood hematocrit  33.3  %; hematology blood hematocrit  40.0  %; hematology blood hematocrit  46.3  %; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  100  k ul; hematology blood platelet count  93  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.41  mmol l; blood gas blood free calcium  1.27  mmol l; blood gas blood free calcium  1.23  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  79  mg dl; blood gas blood glucose  93  mg dl; blood gas blood glucose  99  mg dl; blood gas blood glucose  113  mg dl; blood gas blood glucose  101  mg dl; blood gas blood glucose  105  mg dl; blood gas blood hematocrit, calculated  44  %; blood gas blood hematocrit, calculated  34  %; blood gas blood hematocrit, calculated  34  %; blood gas blood hematocrit, calculated  36  %; blood gas blood hemoglobin  14.5  g dl; blood gas blood hemoglobin  11.3  g dl; blood gas blood hemoglobin  11.3  g dl; blood gas blood hemoglobin  11.9  g dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  5.2  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  133  meq l; blood gas blood sodium, whole blood  134  meq l$sodium chloride 0.9%  flush  10  ml ; finasteride  5  mg ; emtricitabine-tenofovir (truvada)  1  tab ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; syringe (iso-osmotic dextrose)  50  ml ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; fentanyl citrate  12.5-50  mcg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; gabapentin  600  mg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; neostigmine (cvicu reversal protocol)  2  mg ; glycopyrrolate (cvicu reversal protocol)  0.4  mg ; docusate sodium  100  mg ; ranitidine  150  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; bupropion (sustained release)  150  mg ; rosuvastatin calcium  40  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; raltegravir  400  mg ; d5w  250  ml ; nitroglycerin  100  mg ; tamsulosin  0.4  mg ; acetaminophen iv  1000  mg ; 
peripheral vascular disease, unspecified closed fracture of upper end of tibia alone percutaneous transluminal coronary angioplasty status pure hypercholesterolemia lipomatosis, not elsewhere classified old myocardial infarction accidental fall from or out of building or other structure coronary atherosclerosis of native coronary artery asymptomatic human immunodeficiency virus [hiv] infection status impotence of organic origin other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asymptomatic human immunodeficiency virus [hiv] infection status other postoperative infection coronary atherosclerosis of native coronary artery chronic hepatitis c without mention of hepatic coma major depressive affective disorder, single episode, unspecified other and unspecified disc disorder, lumbar region unspecified essential hypertension peripheral vascular disease, unspecified percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery body mass index 40.0-44.9, adult major depressive affective disorder, single episode, unspecified chronic hepatitis c without mention of hepatic coma unspecified essential hypertension obesity, unspecified impotence of organic origin atherosclerosis of native arteries of the extremities with intermittent claudication asymptomatic human immunodeficiency virus [hiv] infection status examination of participant in clinical trial percutaneous transluminal coronary angioplasty status other and unspecified disc disorder, lumbar region old myocardial infarction personal history of tobacco use person on outside of bus injured in collision with pedestrian or animal in traffic accident 
black african american m 60 $nan$hematology blood hematocrit  43.2  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  133  mg dl$sodium chloride 0.9%  flush  10  ml ; finasteride  5  mg ; emtricitabine-tenofovir (truvada)  1  tab ; dextrose 5%  1000  ml ; propofol  1000  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; fentanyl citrate  12.5-50  mcg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; gabapentin  600  mg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; ranitidine  150  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; bupropion (sustained release)  150  mg ; rosuvastatin calcium  40  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; raltegravir  400  mg ; d5w  250  ml ; nitroglycerin  100  mg ; tamsulosin  0.4  mg ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  2-4  mg ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; insulin  0  unit ; milk of magnesia  30  ml ; aspirin ec  81  mg ; aspirin  81  mg ; furosemide  20  mg ; insulin  10  unit ; 
peripheral vascular disease, unspecified closed fracture of upper end of tibia alone percutaneous transluminal coronary angioplasty status pure hypercholesterolemia lipomatosis, not elsewhere classified old myocardial infarction accidental fall from or out of building or other structure coronary atherosclerosis of native coronary artery asymptomatic human immunodeficiency virus [hiv] infection status impotence of organic origin other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asymptomatic human immunodeficiency virus [hiv] infection status other postoperative infection coronary atherosclerosis of native coronary artery chronic hepatitis c without mention of hepatic coma major depressive affective disorder, single episode, unspecified other and unspecified disc disorder, lumbar region unspecified essential hypertension peripheral vascular disease, unspecified percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery body mass index 40.0-44.9, adult major depressive affective disorder, single episode, unspecified chronic hepatitis c without mention of hepatic coma unspecified essential hypertension obesity, unspecified impotence of organic origin atherosclerosis of native arteries of the extremities with intermittent claudication asymptomatic human immunodeficiency virus [hiv] infection status examination of participant in clinical trial percutaneous transluminal coronary angioplasty status other and unspecified disc disorder, lumbar region old myocardial infarction personal history of tobacco use person on outside of bus injured in collision with pedestrian or animal in traffic accident 
black african american m 60 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  80  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  117  mg dl; blood gas blood free calcium  1.04  mmol l$sodium chloride 0.9%  flush  10  ml ; finasteride  5  mg ; emtricitabine-tenofovir (truvada)  1  tab ; dextrose 5%  1000  ml ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; fentanyl citrate  12.5-50  mcg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; gabapentin  600  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; ranitidine  150  mg ; bupropion (sustained release)  150  mg ; rosuvastatin calcium  40  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; raltegravir  400  mg ; d5w  250  ml ; nitroglycerin  100  mg ; tamsulosin  0.4  mg ; hydromorphone (dilaudid)  2-4  mg ; insulin  0  unit ; milk of magnesia  30  ml ; aspirin ec  81  mg ; furosemide  20  mg ; insulin  10  unit ; simethicone  120  mg ; metoclopramide  10  mg ; metoprolol tartrate  2.5  mg ; ibuprofen  600  mg ; senna  8.6  mg ; metoprolol tartrate  12.5  mg ; bag  500  ml ; albumin 5%  25  g ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
peripheral vascular disease, unspecified closed fracture of upper end of tibia alone percutaneous transluminal coronary angioplasty status pure hypercholesterolemia lipomatosis, not elsewhere classified old myocardial infarction accidental fall from or out of building or other structure coronary atherosclerosis of native coronary artery asymptomatic human immunodeficiency virus [hiv] infection status impotence of organic origin other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asymptomatic human immunodeficiency virus [hiv] infection status other postoperative infection coronary atherosclerosis of native coronary artery chronic hepatitis c without mention of hepatic coma major depressive affective disorder, single episode, unspecified other and unspecified disc disorder, lumbar region unspecified essential hypertension peripheral vascular disease, unspecified percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery body mass index 40.0-44.9, adult major depressive affective disorder, single episode, unspecified chronic hepatitis c without mention of hepatic coma unspecified essential hypertension obesity, unspecified impotence of organic origin atherosclerosis of native arteries of the extremities with intermittent claudication asymptomatic human immunodeficiency virus [hiv] infection status examination of participant in clinical trial percutaneous transluminal coronary angioplasty status other and unspecified disc disorder, lumbar region old myocardial infarction personal history of tobacco use person on outside of bus injured in collision with pedestrian or animal in traffic accident 
black african american m 60 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  66  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood glucose  107  mg dl$finasteride  5  mg ; emtricitabine-tenofovir (truvada)  1  tab ; glucagon  1  mg ; glucose gel  15  g ; gabapentin  600  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; ranitidine  150  mg ; bupropion (sustained release)  150  mg ; rosuvastatin calcium  40  mg ; raltegravir  400  mg ; tamsulosin  0.4  mg ; hydromorphone (dilaudid)  2-4  mg ; insulin  0  unit ; milk of magnesia  30  ml ; aspirin ec  81  mg ; furosemide  20  mg ; insulin  10  unit ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
peripheral vascular disease, unspecified closed fracture of upper end of tibia alone percutaneous transluminal coronary angioplasty status pure hypercholesterolemia lipomatosis, not elsewhere classified old myocardial infarction accidental fall from or out of building or other structure coronary atherosclerosis of native coronary artery asymptomatic human immunodeficiency virus [hiv] infection status impotence of organic origin other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asymptomatic human immunodeficiency virus [hiv] infection status other postoperative infection coronary atherosclerosis of native coronary artery chronic hepatitis c without mention of hepatic coma major depressive affective disorder, single episode, unspecified other and unspecified disc disorder, lumbar region unspecified essential hypertension peripheral vascular disease, unspecified percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery body mass index 40.0-44.9, adult major depressive affective disorder, single episode, unspecified chronic hepatitis c without mention of hepatic coma unspecified essential hypertension obesity, unspecified impotence of organic origin atherosclerosis of native arteries of the extremities with intermittent claudication asymptomatic human immunodeficiency virus [hiv] infection status examination of participant in clinical trial percutaneous transluminal coronary angioplasty status other and unspecified disc disorder, lumbar region old myocardial infarction personal history of tobacco use person on outside of bus injured in collision with pedestrian or animal in traffic accident 
black african american m 60 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  80  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  116  mg dl$finasteride  5  mg ; emtricitabine-tenofovir (truvada)  1  tab ; glucagon  1  mg ; glucose gel  15  g ; gabapentin  600  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; ranitidine  150  mg ; bupropion (sustained release)  150  mg ; rosuvastatin calcium  40  mg ; raltegravir  400  mg ; tamsulosin  0.4  mg ; hydromorphone (dilaudid)  2-4  mg ; milk of magnesia  30  ml ; aspirin ec  81  mg ; furosemide  20  mg ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; potassium chloride  40  meq ; magnesium citrate  300  ml ; 
peripheral vascular disease, unspecified closed fracture of upper end of tibia alone percutaneous transluminal coronary angioplasty status pure hypercholesterolemia lipomatosis, not elsewhere classified old myocardial infarction accidental fall from or out of building or other structure coronary atherosclerosis of native coronary artery asymptomatic human immunodeficiency virus [hiv] infection status impotence of organic origin other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asymptomatic human immunodeficiency virus [hiv] infection status other postoperative infection coronary atherosclerosis of native coronary artery chronic hepatitis c without mention of hepatic coma major depressive affective disorder, single episode, unspecified other and unspecified disc disorder, lumbar region unspecified essential hypertension peripheral vascular disease, unspecified percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery body mass index 40.0-44.9, adult major depressive affective disorder, single episode, unspecified chronic hepatitis c without mention of hepatic coma unspecified essential hypertension obesity, unspecified impotence of organic origin atherosclerosis of native arteries of the extremities with intermittent claudication asymptomatic human immunodeficiency virus [hiv] infection status examination of participant in clinical trial percutaneous transluminal coronary angioplasty status other and unspecified disc disorder, lumbar region old myocardial infarction personal history of tobacco use person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white f 51 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  61  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  112  mg dl; chemistry blood albumin  2.6  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; acetaminophen  325  mg ; omeprazole  40  mg ; pregabalin  150  mg ; propranolol  10  mg ; rifaximin  550  mg ; senna  1  tab ; docusate sodium  100  mg ; escitalopram oxalate  20  mg ; lactulose  30  ml ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; spironolactone  50  mg ; furosemide  20  mg ; ondansetron  4  mg ; heparin  5000  unit ; albumin 25% (12.5g   50ml)  50  g ; ciprofloxacin hcl  250  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  37  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  91  mg dl; chemistry blood lactate dehydrogenase (ld)  134  iu l; chemistry blood albumin  3.0  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; acetaminophen  325  mg ; omeprazole  40  mg ; pregabalin  150  mg ; propranolol  10  mg ; rifaximin  550  mg ; senna  1  tab ; docusate sodium  100  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; spironolactone  50  mg ; furosemide  20  mg ; ondansetron  4  mg ; heparin  5000  unit ; albumin 25% (12.5g   50ml)  50  g ; ciprofloxacin hcl  250  mg ; acetaminophen  650  mg ; potassium chloride  20  meq ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  56  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.5  ; chemistry urine chloride, urine  19  meq l; chemistry urine creatinine, urine  269  mg dl; chemistry urine potassium, urine  45  meq l; chemistry urine urea nitrogen, urine  953  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; propranolol  10  mg ; rifaximin  550  mg ; senna  1  tab ; docusate sodium  100  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; spironolactone  50  mg ; furosemide  20  mg ; ondansetron  4  mg ; heparin  5000  unit ; ciprofloxacin hcl  250  mg ; acetaminophen  650  mg ; potassium chloride  20  meq ; cosyntropin  250  mcg ; albumin   25  g ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  38  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; propranolol  10  mg ; rifaximin  550  mg ; senna  1  tab ; docusate sodium  100  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; spironolactone  50  mg ; furosemide  20  mg ; ondansetron  4  mg ; heparin  5000  unit ; ciprofloxacin hcl  250  mg ; acetaminophen  650  mg ; cosyntropin  250  mcg ; albumin   25  g ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; albumin 25% (12.5g   50ml)  75  g ; prochlorperazine  10  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  30  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; propranolol  10  mg ; rifaximin  550  mg ; senna  1  tab ; docusate sodium  100  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; spironolactone  50  mg ; furosemide  20  mg ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; prochlorperazine  10  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  40  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  91  mg dl; chemistry blood albumin  3.1  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; propranolol  10  mg ; rifaximin  550  mg ; senna  1  tab ; docusate sodium  100  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; spironolactone  50  mg ; furosemide  20  mg ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  42  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; senna  1  tab ; docusate sodium  100  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; metronidazole (flagyl)  500  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; vancomycin  1000  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  39  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; senna  1  tab ; docusate sodium  100  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; metronidazole (flagyl)  500  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; vancomycin  1000  mg ; potassium chloride  40  meq ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  45  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; senna  1  tab ; docusate sodium  100  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; metronidazole (flagyl)  500  mg ; vancomycin  1000  mg ; potassium chloride  40  meq ; lorazepam  0.25  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  47  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  126  iu l; chemistry blood albumin  3.3  g dl$iso-osmotic dextrose  200  ml ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; senna  1  tab ; docusate sodium  100  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; metronidazole (flagyl)  500  mg ; vancomycin  1000  mg ; lorazepam  0.25  mg ; lorazepam  0.5  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  60  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.8  ; chemistry urine creatinine, urine  342  mg dl; chemistry urine potassium, urine  47  meq l; chemistry urine urea nitrogen, urine  475  mg dl; hematology urine wbc  3  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  112  mg dl; chemistry blood lactate dehydrogenase (ld)  108  iu l; chemistry blood albumin  3.3  g dl$iso-osmotic dextrose  200  ml ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; senna  1  tab ; docusate sodium  100  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; metronidazole (flagyl)  500  mg ; vancomycin  1000  mg ; lorazepam  0.5  mg ; albumin 5% (25g   500ml)  25  g ; albumin 25% (12.5g   50ml)  25  g ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  46  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  103  iu l; chemistry blood albumin  4.0  g dl$iso-osmotic dextrose  200  ml ; sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; senna  1  tab ; docusate sodium  100  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; metronidazole (flagyl)  500  mg ; albumin 5% (25g   500ml)  25  g ; albumin 25% (12.5g   50ml)  25  g ; albumin 25% (12.5g   50ml)  12.5  g ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  38  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.8  ; chemistry urine creatinine, urine  295  mg dl; chemistry urine potassium, urine  45  meq l; chemistry urine urea nitrogen, urine  346  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  96  iu l; chemistry blood albumin  4.4  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; metronidazole (flagyl)  500  mg ; albumin 25% (12.5g   50ml)  12.5  g ; amp  1  amp ; octreotide acetate  100  mcg ; neutra-phos  1  pkt ; chloraseptic throat spray  1  spry ; midodrine  5  mg ; albumin 5%   25  g ; maalox diphenhydramine lidocaine  15-30  ml ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  45  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  134  mg dl; chemistry blood lactate dehydrogenase (ld)  89  iu l; chemistry blood albumin  4.4  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; metronidazole (flagyl)  500  mg ; neutra-phos  1  pkt ; chloraseptic throat spray  1  spry ; albumin 5%   25  g ; maalox diphenhydramine lidocaine  15-30  ml ; midodrine  10  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  52  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  121  mg dl; chemistry blood lactate dehydrogenase (ld)  109  iu l; chemistry blood albumin  4.3  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; polyethylene glycol  17  g ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; metronidazole (flagyl)  500  mg ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; midodrine  10  mg ; nystatin oral suspension  5  ml ; syringe  0.4  ml ; octreotide acetate  200  mcg ; midodrine  2.5  mg ; carbamide peroxide 6.5%  5-10  drop ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; oxycodone (immediate release)   2.5  mg ; oxycodone liquid  2.5  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  70  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  122  mg dl; chemistry blood lactate dehydrogenase (ld)  95  iu l; chemistry blood albumin  4.6  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; nystatin oral suspension  5  ml ; syringe  0.4  ml ; octreotide acetate  200  mcg ; midodrine  2.5  mg ; carbamide peroxide 6.5%  5-10  drop ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; oxycodone liquid  2.5  mg ; midodrine  15  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  81  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  54  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  114  iu l; chemistry blood albumin  4.5  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; nystatin oral suspension  5  ml ; carbamide peroxide 6.5%  5-10  drop ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; midodrine  15  mg ; syringe  0.6  ml ; octreotide acetate  300  mcg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  70  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  56  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  112  mg dl; chemistry blood lactate dehydrogenase (ld)  108  iu l; chemistry blood albumin  4.8  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; nystatin oral suspension  5  ml ; carbamide peroxide 6.5%  5-10  drop ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; midodrine  15  mg ; syringe  0.6  ml ; octreotide acetate  300  mcg ; albuterol 0.083% neb soln  1  neb ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  58  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  59  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  114  mg dl; chemistry blood lactate dehydrogenase (ld)  99  iu l; chemistry blood albumin  4.5  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; nystatin oral suspension  5  ml ; carbamide peroxide 6.5%  5-10  drop ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; midodrine  15  mg ; syringe  0.6  ml ; octreotide acetate  300  mcg ; albuterol 0.083% neb soln  1  neb ; creon 12  1  cap ; sodium bicarbonate  650  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  53  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  58  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  101  iu l; chemistry blood albumin  4.6  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; nystatin oral suspension  5  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; midodrine  15  mg ; syringe  0.6  ml ; octreotide acetate  300  mcg ; creon 12  1  cap ; sodium bicarbonate  650  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  55  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  101  iu l; chemistry blood albumin  4.3  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; midodrine  15  mg ; syringe  0.6  ml ; octreotide acetate  300  mcg ; lidocaine jelly 2% (urojet)  1  appl ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  50  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  119  mg dl; chemistry blood lactate dehydrogenase (ld)  92  iu l; chemistry blood albumin  4.6  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; midodrine  15  mg ; syringe  0.6  ml ; octreotide acetate  300  mcg ; lidocaine jelly 2% (urojet)  1  appl ; morphine sulfate  1  mg ; spironolactone  25  mg ; miconazole powder 2%  1  appl ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  53  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  130  mg dl; chemistry blood lactate dehydrogenase (ld)  111  iu l; chemistry blood albumin  4.9  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; morphine sulfate  1  mg ; spironolactone  25  mg ; miconazole powder 2%  1  appl ; albumin 25% (12.5g   50ml)  87.5  g ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  32  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  52  mg dl; hematology blood inr(pt)  1.8  ; chemistry urine chloride, urine  18  meq l; chemistry urine creatinine, urine  207  mg dl; chemistry urine potassium, urine  84  meq l; chemistry urine sodium, urine  74  meq l; chemistry urine urea nitrogen, urine  437  mg dl; hematology urine wbc  61  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  124  mg dl; chemistry blood albumin  4.9  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; miconazole powder 2%  1  appl ; albumin 25% (12.5g   50ml)  87.5  g ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; midodrine  7.5  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  38  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  56  mg dl; hematology blood inr(pt)  1.8  ; hematology urine wbc  148  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  141  mg dl; chemistry blood lactate dehydrogenase (ld)  91  iu l; chemistry blood albumin  4.8  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; miconazole powder 2%  1  appl ; albumin 25% (12.5g   50ml)  87.5  g ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; midodrine  7.5  mg ; potassium chloride  60  meq ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  46  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  58  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  101  iu l; chemistry blood albumin  4.8  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; miconazole powder 2%  1  appl ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; potassium chloride  60  meq ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  46  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  56  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  128  mg dl; chemistry blood lactate dehydrogenase (ld)  103  iu l$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; miconazole powder 2%  1  appl ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; megestrol acetate  40  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  42  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  58  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  127  mg dl; chemistry blood lactate dehydrogenase (ld)  119  iu l; chemistry blood albumin  4.3  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; miconazole powder 2%  1  appl ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; megestrol acetate  40  mg ; megestrol acetate  80  mg ; ciprofloxacin hcl  500  mg ; cefpodoxime proxetil  200  mg ; megestrol acetate  400  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  47  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  111  mg dl; chemistry blood lactate dehydrogenase (ld)  100  iu l; chemistry blood albumin  4.1  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; miconazole powder 2%  1  appl ; cefpodoxime proxetil  200  mg ; megestrol acetate  400  mg ; potassium chloride (powder)  40  meq ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  45  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  100  iu l; chemistry blood albumin  4.4  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; miconazole powder 2%  1  appl ; cefpodoxime proxetil  200  mg ; megestrol acetate  400  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; lidocaine 1%  2  ml ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  48  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  122  iu l; chemistry blood albumin  4.3  g dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; chloraseptic throat spray  1  spry ; maalox diphenhydramine lidocaine  15-30  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; miconazole powder 2%  1  appl ; megestrol acetate  400  mg ; potassium chloride (powder)  60  meq ; lidocaine 1%  2  ml ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$nan$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; miconazole powder 2%  1  appl ; megestrol acetate  400  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$nan$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; miconazole powder 2%  1  appl ; megestrol acetate  400  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  29.8  %; hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  41  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; miconazole powder 2%  1  appl ; megestrol acetate  400  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  40  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood bilirubin, total  1.4  mg dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; megestrol acetate  400  mg ; miconazole nitrate vag cream 2%  1  appl ; trazodone  25  mg ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  45  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; megestrol acetate  400  mg ; miconazole nitrate vag cream 2%  1  appl ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  40  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood bilirubin, total  1.3  mg dl; blood gas blood potassium, whole blood  3.2  meq l$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; megestrol acetate  400  mg ; miconazole nitrate vag cream 2%  1  appl ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 51 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  38  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.5  ; hematology urine wbc  3-5  # hpf; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  120  mg dl$sodium chloride 0.9%  flush  3  ml ; sarna lotion  1  appl ; simethicone  40-80  mg ; omeprazole  40  mg ; pregabalin  150  mg ; rifaximin  550  mg ; escitalopram oxalate  20  mg ; zonisamide  50  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; cepacol (menthol)  1  loz ; megestrol acetate  400  mg ; miconazole nitrate vag cream 2%  1  appl ; neutra-phos  2  pkt ; 
chronic hepatitis c with hepatic coma alcoholic cirrhosis of liver hepatorenal syndrome carrier or suspected carrier of methicillin resistant staphylococcus aureus awaiting organ transplant status other and unspecified alcohol dependence, unspecified other ascites abdominal pain, unspecified site pancytopenia hypersplenism acute respiratory failure other specified cardiac dysrhythmias depressive disorder, not elsewhere classified acute and subacute necrosis of liver herpetic meningoencephalitis methicillin resistant pneumonia due to staphylococcus aureus pedal cycle passenger injured in collision with other nonmotor vehicle in nontraffic accident family history of malignant neoplasm of trachea, bronchus, and lung other ascites alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding other convulsions alkalosis cerebral edema foreign body accidentally entering other orifice hyperosmolality and/or hypernatremia secondary thrombocytopenia chronic hepatitis c with hepatic coma anoxic brain damage foreign body in larynx
white f 24 $temp  97.8  heartrate  66.0  resprate  16.0  o2sat  99.0  sbp  115.0  dbp  61.0  rhythm    pain    $hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  93  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; heparin  5000  unit ; ondansetron  4  mg ; 
 
white f 24 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; heparin  5000  unit ; ondansetron  4  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 
 
white f 24 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; soln  100  ml ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.5-1  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ibuprofen  600  mg ; 
 
white f 24 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ibuprofen  600  mg ; docusate sodium  100  mg ; 
 
white m 34 $temp  97.2  heartrate  69.0  resprate  18.0  o2sat  97.0  sbp  134.0  dbp  63.0  rhythm    pain  3  $hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  267  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  97  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aripiprazole  5  mg ; lorazepam  1  mg ; albuterol inhaler  2  puff ; topiramate (topamax)  100  mg ; gabapentin  400  mg ; prazosin  1  mg ; prazosin  2  mg ; tizanidine  4  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)  5  mg ; sodium chloride 0.9%  1000  ml ; oxycodone (immediate release)  5-10  mg ; escitalopram oxalate  20  mg ; hydralazine  10  mg ; 
generalized anxiety disorder other chronic pain post-traumatic stress disorder, unspecified suicidal ideations major depressive disorder, single episode, unspecified dorsalgia, unspecified nicotine dependence, cigarettes, uncomplicated exposure to other specified factors, sequela post-traumatic stress disorder, unspecified nicotine dependence, cigarettes, uncomplicated major depressive disorder, single episode, unspecified suicidal ideations anxiety disorder, unspecified bipolar disorder, unspecified infection following a procedure, initial encounter post-traumatic stress disorder, unspecified prosthetic and other implants, materials and neurological devices associated with adverse incidents methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere operating room of hospital as the place of occurrence of the external cause other chronic pain nicotine dependence, cigarettes, uncomplicated sciatica, unspecified side dorsalgia, unspecified presence of other specified functional implants dorsalgia, unspecified elevated white blood cell count, unspecified post-traumatic stress disorder, unspecified bipolar disorder, unspecified pain in left thigh 
white m 34 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  109  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aripiprazole  5  mg ; albuterol inhaler  2  puff ; topiramate (topamax)  100  mg ; prazosin  1  mg ; prazosin  2  mg ; tizanidine  4  mg ; acetaminophen  325-650  mg ; sodium chloride 0.9%  1000  ml ; oxycodone (immediate release)  5-10  mg ; escitalopram oxalate  20  mg ; hydralazine  10  mg ; docusate sodium  100  mg ; gabapentin  1200  mg ; prazosin  5  mg ; acetaminophen  1000  mg ; metronidazole  500  mg ; lorazepam  0.5  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; iso-osmotic dextrose  100  ml ; cefepime  2  g ; senna  17.2  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; ketorolac  15  mg ; acetaminophen  650  mg ; fexofenadine  60  mg ; 
generalized anxiety disorder other chronic pain post-traumatic stress disorder, unspecified suicidal ideations major depressive disorder, single episode, unspecified dorsalgia, unspecified nicotine dependence, cigarettes, uncomplicated exposure to other specified factors, sequela post-traumatic stress disorder, unspecified nicotine dependence, cigarettes, uncomplicated major depressive disorder, single episode, unspecified suicidal ideations anxiety disorder, unspecified bipolar disorder, unspecified infection following a procedure, initial encounter post-traumatic stress disorder, unspecified prosthetic and other implants, materials and neurological devices associated with adverse incidents methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere operating room of hospital as the place of occurrence of the external cause other chronic pain nicotine dependence, cigarettes, uncomplicated sciatica, unspecified side dorsalgia, unspecified presence of other specified functional implants dorsalgia, unspecified elevated white blood cell count, unspecified post-traumatic stress disorder, unspecified bipolar disorder, unspecified pain in left thigh 
white m 34 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  6  mg dl; hematology urine wbc  4  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  189  iu l; chemistry blood albumin  3.5  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aripiprazole  5  mg ; albuterol inhaler  2  puff ; topiramate (topamax)  100  mg ; prazosin  1  mg ; escitalopram oxalate  20  mg ; hydralazine  10  mg ; docusate sodium  100  mg ; gabapentin  1200  mg ; prazosin  5  mg ; metronidazole  500  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; iso-osmotic dextrose  100  ml ; cefepime  2  g ; senna  17.2  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; ketorolac  15  mg ; acetaminophen  650  mg ; lidocaine jelly 2% (glydo)  1  appl ; cromolyn sodium (nasal inhalation)  1  spry ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; hydromorphone (dilaudid)  0.36  mg ; morphine sr (ms contin)  15  mg ; 
generalized anxiety disorder other chronic pain post-traumatic stress disorder, unspecified suicidal ideations major depressive disorder, single episode, unspecified dorsalgia, unspecified nicotine dependence, cigarettes, uncomplicated exposure to other specified factors, sequela post-traumatic stress disorder, unspecified nicotine dependence, cigarettes, uncomplicated major depressive disorder, single episode, unspecified suicidal ideations anxiety disorder, unspecified bipolar disorder, unspecified infection following a procedure, initial encounter post-traumatic stress disorder, unspecified prosthetic and other implants, materials and neurological devices associated with adverse incidents methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere operating room of hospital as the place of occurrence of the external cause other chronic pain nicotine dependence, cigarettes, uncomplicated sciatica, unspecified side dorsalgia, unspecified presence of other specified functional implants dorsalgia, unspecified elevated white blood cell count, unspecified post-traumatic stress disorder, unspecified bipolar disorder, unspecified pain in left thigh 
white m 34 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  105  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aripiprazole  5  mg ; albuterol inhaler  2  puff ; topiramate (topamax)  100  mg ; prazosin  1  mg ; escitalopram oxalate  20  mg ; hydralazine  10  mg ; docusate sodium  100  mg ; gabapentin  1200  mg ; prazosin  5  mg ; metronidazole  500  mg ; iso-osmotic dextrose  100  ml ; cefepime  2  g ; senna  17.2  mg ; heparin  5000  unit ; acetaminophen  650  mg ; cromolyn sodium (nasal inhalation)  1  spry ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; hydromorphone (dilaudid)  0.36  mg ; morphine sr (ms contin)  15  mg ; hydromorphone (dilaudid)  1-2  mg ; oxycodone (immediate release)  15-20  mg ; 
generalized anxiety disorder other chronic pain post-traumatic stress disorder, unspecified suicidal ideations major depressive disorder, single episode, unspecified dorsalgia, unspecified nicotine dependence, cigarettes, uncomplicated exposure to other specified factors, sequela post-traumatic stress disorder, unspecified nicotine dependence, cigarettes, uncomplicated major depressive disorder, single episode, unspecified suicidal ideations anxiety disorder, unspecified bipolar disorder, unspecified infection following a procedure, initial encounter post-traumatic stress disorder, unspecified prosthetic and other implants, materials and neurological devices associated with adverse incidents methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere operating room of hospital as the place of occurrence of the external cause other chronic pain nicotine dependence, cigarettes, uncomplicated sciatica, unspecified side dorsalgia, unspecified presence of other specified functional implants dorsalgia, unspecified elevated white blood cell count, unspecified post-traumatic stress disorder, unspecified bipolar disorder, unspecified pain in left thigh 
white m 34 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  188  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aripiprazole  5  mg ; albuterol inhaler  2  puff ; topiramate (topamax)  100  mg ; prazosin  1  mg ; escitalopram oxalate  20  mg ; hydralazine  10  mg ; docusate sodium  100  mg ; gabapentin  1200  mg ; prazosin  5  mg ; metronidazole  500  mg ; iso-osmotic dextrose  100  ml ; cefepime  2  g ; senna  17.2  mg ; heparin  5000  unit ; acetaminophen  650  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; morphine sr (ms contin)  15  mg ; hydromorphone (dilaudid)  1-2  mg ; oxycodone (immediate release)  15-20  mg ; cefazolin  2  g ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; loperamide  4  mg ; loperamide  2  mg ; 
generalized anxiety disorder other chronic pain post-traumatic stress disorder, unspecified suicidal ideations major depressive disorder, single episode, unspecified dorsalgia, unspecified nicotine dependence, cigarettes, uncomplicated exposure to other specified factors, sequela post-traumatic stress disorder, unspecified nicotine dependence, cigarettes, uncomplicated major depressive disorder, single episode, unspecified suicidal ideations anxiety disorder, unspecified bipolar disorder, unspecified infection following a procedure, initial encounter post-traumatic stress disorder, unspecified prosthetic and other implants, materials and neurological devices associated with adverse incidents methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere operating room of hospital as the place of occurrence of the external cause other chronic pain nicotine dependence, cigarettes, uncomplicated sciatica, unspecified side dorsalgia, unspecified presence of other specified functional implants dorsalgia, unspecified elevated white blood cell count, unspecified post-traumatic stress disorder, unspecified bipolar disorder, unspecified pain in left thigh 
white m 34 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  104  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aripiprazole  5  mg ; albuterol inhaler  2  puff ; topiramate (topamax)  100  mg ; prazosin  1  mg ; escitalopram oxalate  20  mg ; hydralazine  10  mg ; docusate sodium  100  mg ; gabapentin  1200  mg ; prazosin  5  mg ; senna  17.2  mg ; heparin  5000  unit ; acetaminophen  650  mg ; morphine sr (ms contin)  15  mg ; hydromorphone (dilaudid)  1-2  mg ; oxycodone (immediate release)  15-20  mg ; cefazolin  2  g ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; loperamide  4  mg ; loperamide  2  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
generalized anxiety disorder other chronic pain post-traumatic stress disorder, unspecified suicidal ideations major depressive disorder, single episode, unspecified dorsalgia, unspecified nicotine dependence, cigarettes, uncomplicated exposure to other specified factors, sequela post-traumatic stress disorder, unspecified nicotine dependence, cigarettes, uncomplicated major depressive disorder, single episode, unspecified suicidal ideations anxiety disorder, unspecified bipolar disorder, unspecified infection following a procedure, initial encounter post-traumatic stress disorder, unspecified prosthetic and other implants, materials and neurological devices associated with adverse incidents methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere operating room of hospital as the place of occurrence of the external cause other chronic pain nicotine dependence, cigarettes, uncomplicated sciatica, unspecified side dorsalgia, unspecified presence of other specified functional implants dorsalgia, unspecified elevated white blood cell count, unspecified post-traumatic stress disorder, unspecified bipolar disorder, unspecified pain in left thigh 
white m 34 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aripiprazole  5  mg ; albuterol inhaler  2  puff ; topiramate (topamax)  100  mg ; prazosin  1  mg ; escitalopram oxalate  20  mg ; hydralazine  10  mg ; docusate sodium  100  mg ; gabapentin  1200  mg ; prazosin  5  mg ; senna  17.2  mg ; heparin  5000  unit ; acetaminophen  650  mg ; morphine sr (ms contin)  15  mg ; hydromorphone (dilaudid)  1-2  mg ; oxycodone (immediate release)  15-20  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; loperamide  4  mg ; loperamide  2  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
generalized anxiety disorder other chronic pain post-traumatic stress disorder, unspecified suicidal ideations major depressive disorder, single episode, unspecified dorsalgia, unspecified nicotine dependence, cigarettes, uncomplicated exposure to other specified factors, sequela post-traumatic stress disorder, unspecified nicotine dependence, cigarettes, uncomplicated major depressive disorder, single episode, unspecified suicidal ideations anxiety disorder, unspecified bipolar disorder, unspecified infection following a procedure, initial encounter post-traumatic stress disorder, unspecified prosthetic and other implants, materials and neurological devices associated with adverse incidents methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere operating room of hospital as the place of occurrence of the external cause other chronic pain nicotine dependence, cigarettes, uncomplicated sciatica, unspecified side dorsalgia, unspecified presence of other specified functional implants dorsalgia, unspecified elevated white blood cell count, unspecified post-traumatic stress disorder, unspecified bipolar disorder, unspecified pain in left thigh 
white f 71 $nan$nan$acetaminophen  1000  mg ; 
 
white f 71 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; oxycodone (immediate release)  2.5  mg ; docusate   100  mg ; atorvastatin  40  mg ; 
 
white f 71 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; oxycodone (immediate release)  2.5  mg ; docusate   100  mg ; atorvastatin  40  mg ; atenolol  50  mg ; chlorthalidone  25  mg ; 
 
other m 51 $nan$nan$bisacodyl  10  mg ; docusate sodium  100  mg ; gabapentin  600  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 
constipation, unspecified drug-induced psychotic disorder with hallucinations adrenal cortical steroids causing adverse effects in therapeutic use degeneration of cervical intervertebral disc
other m 51 $nan$hematology blood hematocrit  40.2  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  114  mg dl$bisacodyl  10  mg ; docusate sodium  100  mg ; gabapentin  600  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; acetaminophen  325-650  mg ; diazepam  2-5  mg ; morphine sulfate ir  15-30  mg ; cyclobenzaprine  10  mg ; lorazepam  0.5  mg ; senna  1  tab ; amitriptyline  10  mg ; morphine sulfate ir  15  mg ; oxycodone (immediate release)   5-15  mg ; 
constipation, unspecified drug-induced psychotic disorder with hallucinations adrenal cortical steroids causing adverse effects in therapeutic use degeneration of cervical intervertebral disc
white m 56 $nan$nan$aspirin  325  mg ; clopidogrel  75  mg ; lisinopril  10  mg ; docusate sodium  100  mg ; 
 
white m 56 $nan$hematology blood hematocrit  41.9  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  94  mg dl$aspirin  325  mg ; clopidogrel  75  mg ; lisinopril  10  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; nitroglycerin sl  0.4  mg ; acetaminophen  650  mg ; heparin  1200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  25  mg ; 
 
white m 56 $nan$hematology blood hematocrit  44.6  %; hematology blood hematocrit  39.0  %; hematology blood hemoglobin  15.0  g dl; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  248  k ul; hematology blood platelet count  220  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  120  mg dl; chemistry blood albumin  4.2  g dl; chemistry blood % hemoglobin a1c  5.4  %$aspirin  325  mg ; clopidogrel  75  mg ; lisinopril  10  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; nitroglycerin sl  0.4  mg ; acetaminophen  650  mg ; heparin  1200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  25  mg ; atorvastatin  80  mg ; metoprolol succinate xl  25  mg ; lisinopril  20  mg ; 1 2 ns  1000  ml ; 
 
white m 56 $nan$hematology blood hematocrit  42.5  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  121  mg dl$aspirin  325  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; nitroglycerin sl  0.4  mg ; acetaminophen  650  mg ; atorvastatin  80  mg ; metoprolol succinate xl  25  mg ; lisinopril  20  mg ; 1 2 ns  1000  ml ; heparin  5000  unit ; 
 
white m 81 $nan$nan$furosemide  40  mg ; atenolol  50  mg ; digoxin  0.125  mg ; simvastatin  80  mg ; enalapril maleate  2.5  mg ; 
 
white m 81 $nan$hematology blood hematocrit  24.6  %; hematology blood hematocrit  22.3  %; hematology blood hematocrit  23.3  %; hematology blood hematocrit  23.4  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  138  k ul; hematology blood platelet count  125  k ul; hematology blood platelet count  154  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  2.2  ; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.8  ; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  108  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$furosemide  40  mg ; atenolol  50  mg ; digoxin  0.125  mg ; simvastatin  80  mg ; enalapril maleate  2.5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  1000  mg ; 5% dextrose  50  ml ; phytonadione  5  mg ; morphine sulfate  2-4  mg ; senna  1  tab ; pantoprazole  40  mg ; docusate sodium  100  mg ; furosemide  20  mg ; hydromorphone (dilaudid)  2  mg ; 
 
white m 81 $nan$hematology blood hematocrit  25.5  %; hematology blood inr(pt)  2.5  $furosemide  40  mg ; atenolol  50  mg ; digoxin  0.125  mg ; simvastatin  80  mg ; enalapril maleate  2.5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; morphine sulfate  2-4  mg ; senna  1  tab ; pantoprazole  40  mg ; docusate sodium  100  mg ; furosemide  20  mg ; hydromorphone (dilaudid)  2  mg ; metoprolol tartrate  5  mg ; metoprolol tartrate  25  mg ; heparin  5000  unit ; oxycodone (immediate release)   5-10  mg ; 
 
white m 81 $nan$hematology blood hematocrit  21.0  %; hematology blood inr(pt)  3.1  $furosemide  40  mg ; atenolol  50  mg ; digoxin  0.125  mg ; simvastatin  80  mg ; enalapril maleate  2.5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; morphine sulfate  2-4  mg ; senna  1  tab ; pantoprazole  40  mg ; docusate sodium  100  mg ; metoprolol tartrate  5  mg ; metoprolol tartrate  25  mg ; heparin  5000  unit ; oxycodone (immediate release)   5-10  mg ; 
 
white m 81 $nan$hematology blood hematocrit  21.6  %; hematology blood hematocrit  23.8  %; hematology blood hematocrit  26.7  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  185  k ul; hematology blood platelet count  215  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, indirect  1.5  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  150  mg dl; chemistry blood glucose  131  mg dl; chemistry blood bilirubin, direct  0.7  mg dl$furosemide  40  mg ; atenolol  50  mg ; digoxin  0.125  mg ; simvastatin  80  mg ; enalapril maleate  2.5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; morphine sulfate  2-4  mg ; senna  1  tab ; pantoprazole  40  mg ; docusate sodium  100  mg ; oxycodone (immediate release)   5-10  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; lidocaine 5% patch  1  ptch ; tramadol (ultram)  25  mg ; 
 
white m 81 $nan$hematology blood hematocrit  25.8  %; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  119  mg dl$furosemide  40  mg ; atenolol  50  mg ; digoxin  0.125  mg ; simvastatin  80  mg ; enalapril maleate  2.5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; pantoprazole  40  mg ; docusate sodium  100  mg ; oxycodone (immediate release)   5-10  mg ; bisacodyl  10  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  650  mg ; atenolol  25  mg ; atenolol  75  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
 
white m 81 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  92  mg dl$furosemide  40  mg ; digoxin  0.125  mg ; simvastatin  80  mg ; enalapril maleate  2.5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; pantoprazole  40  mg ; docusate sodium  100  mg ; oxycodone (immediate release)   5-10  mg ; bisacodyl  10  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  650  mg ; atenolol  25  mg ; atenolol  75  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; warfarin  5  mg ; enoxaparin sodium  70  mg ; 
 
white m 81 $nan$nan$furosemide  40  mg ; digoxin  0.125  mg ; simvastatin  80  mg ; enalapril maleate  2.5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; pantoprazole  40  mg ; docusate sodium  100  mg ; oxycodone (immediate release)   5-10  mg ; bisacodyl  10  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  650  mg ; atenolol  75  mg ; 
 
white f 90 $temp  97.6  heartrate  80.0  resprate  18.0  o2sat  99.0  sbp  184.0  dbp  72.0  rhythm    pain  7  ; temp  98.9  heartrate  97.0  resprate  16.0  o2sat  91.0  sbp  186.0  dbp  94.0  rhythm    pain    $hematology blood hematocrit  44.7  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  24  # hpf; chemistry blood calcium, total  10.2  mg dl; chemistry blood bilirubin, indirect  0.5  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  137  mg dl; chemistry blood albumin  4.2  g dl; blood gas blood lactate  1.5  mmol l; chemistry blood bilirubin, direct  0.2  mg dl$nan
anxiety state, unspecified venous (peripheral) insufficiency, unspecified hyposmolality and/or hyponatremia other and unspecified hyperlipidemia long-term (current) use of aspirin mild cognitive impairment, so stated do not resuscitate status personal history of other malignant neoplasm of skin constipation, unspecified hypovolemia unspecified glaucoma pure hypercholesterolemia intestinal infection due to other organism, not elsewhere classified esophageal reflux unspecified essential hypertension other chronic nonalcoholic liver disease esophagitis, unspecified 
white f 90 $temp  99.2  heartrate  96.0  resprate  16.0  o2sat  95.0  sbp  189.0  dbp  101.0  rhythm    pain    $hematology blood hematocrit  43.8  %; hematology blood hematocrit  41.2  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  182  mg dl; chemistry blood glucose  161  mg dl$heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  20  mg ; metoprolol tartrate  5  mg ; hydralazine  10  mg ; acetaminophen  1000  mg ; acetaminophen iv  1000  mg ; morphine sulfate  1-2  mg ; d5lr  1000  ml ; chloraseptic throat spray  1  spry ; d5 1 2ns  1000  ml ; 
anxiety state, unspecified venous (peripheral) insufficiency, unspecified hyposmolality and/or hyponatremia other and unspecified hyperlipidemia long-term (current) use of aspirin mild cognitive impairment, so stated do not resuscitate status personal history of other malignant neoplasm of skin constipation, unspecified hypovolemia unspecified glaucoma pure hypercholesterolemia intestinal infection due to other organism, not elsewhere classified esophageal reflux unspecified essential hypertension other chronic nonalcoholic liver disease esophagitis, unspecified 
white f 90 $nan$hematology blood hematocrit  40.0  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  138  mg dl$metoprolol tartrate  5  mg ; hydralazine  10  mg ; morphine sulfate  1-2  mg ; chloraseptic throat spray  1  spry ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; vial  1  vial ; pantoprazole  40  mg ; 
anxiety state, unspecified venous (peripheral) insufficiency, unspecified hyposmolality and/or hyponatremia other and unspecified hyperlipidemia long-term (current) use of aspirin mild cognitive impairment, so stated do not resuscitate status personal history of other malignant neoplasm of skin constipation, unspecified hypovolemia unspecified glaucoma pure hypercholesterolemia intestinal infection due to other organism, not elsewhere classified esophageal reflux unspecified essential hypertension other chronic nonalcoholic liver disease esophagitis, unspecified 
white f 90 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  13  mg dl; hematology urine wbc  43  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  119  mg dl$hydralazine  10  mg ; morphine sulfate  1-2  mg ; chloraseptic throat spray  1  spry ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; vial  1  vial ; pantoprazole  40  mg ; sodium phosphate  15  mmol ; 
anxiety state, unspecified venous (peripheral) insufficiency, unspecified hyposmolality and/or hyponatremia other and unspecified hyperlipidemia long-term (current) use of aspirin mild cognitive impairment, so stated do not resuscitate status personal history of other malignant neoplasm of skin constipation, unspecified hypovolemia unspecified glaucoma pure hypercholesterolemia intestinal infection due to other organism, not elsewhere classified esophageal reflux unspecified essential hypertension other chronic nonalcoholic liver disease esophagitis, unspecified 
white f 90 $nan$hematology blood hematocrit  37.9  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; hematology urine wbc  53  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  89  mg dl$hydralazine  10  mg ; morphine sulfate  1-2  mg ; chloraseptic throat spray  1  spry ; vial  1  vial ; pantoprazole  40  mg ; sodium phosphate  15  mmol ; metoprolol tartrate  7.5  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; hydralazine  20  mg ; 5% dextrose  50  ml ; enalaprilat  0.625  mg ; metoprolol tartrate  10  mg ; 
anxiety state, unspecified venous (peripheral) insufficiency, unspecified hyposmolality and/or hyponatremia other and unspecified hyperlipidemia long-term (current) use of aspirin mild cognitive impairment, so stated do not resuscitate status personal history of other malignant neoplasm of skin constipation, unspecified hypovolemia unspecified glaucoma pure hypercholesterolemia intestinal infection due to other organism, not elsewhere classified esophageal reflux unspecified essential hypertension other chronic nonalcoholic liver disease esophagitis, unspecified 
white f 90 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  105  mg dl$morphine sulfate  1-2  mg ; chloraseptic throat spray  1  spry ; vial  1  vial ; pantoprazole  40  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; 5% dextrose  50  ml ; enalaprilat  0.625  mg ; metoprolol tartrate  10  mg ; enalaprilat  1.25  mg ; bisacodyl  10  mg ; sodium phosphate  30  mmol ; hydromorphone (dilaudid)  0.125  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; fleet enema  1  enema ; ethacrynic acid  25  mg ; mineral oil  30  ml ; diltiazem  90  mg ; ondansetron  4  mg ; 
anxiety state, unspecified venous (peripheral) insufficiency, unspecified hyposmolality and/or hyponatremia other and unspecified hyperlipidemia long-term (current) use of aspirin mild cognitive impairment, so stated do not resuscitate status personal history of other malignant neoplasm of skin constipation, unspecified hypovolemia unspecified glaucoma pure hypercholesterolemia intestinal infection due to other organism, not elsewhere classified esophageal reflux unspecified essential hypertension other chronic nonalcoholic liver disease esophagitis, unspecified 
white f 90 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  110  mg dl; blood gas blood lactate  2.0  mmol l$senna  8.6  mg ; morphine sulfate  1-2  mg ; chloraseptic throat spray  1  spry ; vial  1  vial ; pantoprazole  40  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; metoprolol tartrate  10  mg ; enalaprilat  1.25  mg ; bisacodyl  10  mg ; sodium phosphate  30  mmol ; ethacrynic acid  25  mg ; diltiazem  90  mg ; ondansetron  4  mg ; losartan potassium  50  mg ; mineral oil  15-30  ml ; potassium chloride  20  meq ; milk of magnesia  30  ml ; bag  2  bag ; magnesium sulfate  4  gm ; docusate sodium  100  mg ; 
anxiety state, unspecified venous (peripheral) insufficiency, unspecified hyposmolality and/or hyponatremia other and unspecified hyperlipidemia long-term (current) use of aspirin mild cognitive impairment, so stated do not resuscitate status personal history of other malignant neoplasm of skin constipation, unspecified hypovolemia unspecified glaucoma pure hypercholesterolemia intestinal infection due to other organism, not elsewhere classified esophageal reflux unspecified essential hypertension other chronic nonalcoholic liver disease esophagitis, unspecified 
white f 90 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  295  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  9  mg dl; hematology urine wbc  17  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  110  mg dl$senna  8.6  mg ; morphine sulfate  1-2  mg ; chloraseptic throat spray  1  spry ; vial  1  vial ; pantoprazole  40  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; diltiazem  90  mg ; losartan potassium  50  mg ; bag  2  bag ; magnesium sulfate  4  gm ; docusate sodium  100  mg ; aspirin  81  mg ; carvedilol  25  mg ; tramadol (ultram)  25  mg ; tramadol (ultram)  12.5  mg ; pravastatin  10  mg ; acetaminophen  650  mg ; 
anxiety state, unspecified venous (peripheral) insufficiency, unspecified hyposmolality and/or hyponatremia other and unspecified hyperlipidemia long-term (current) use of aspirin mild cognitive impairment, so stated do not resuscitate status personal history of other malignant neoplasm of skin constipation, unspecified hypovolemia unspecified glaucoma pure hypercholesterolemia intestinal infection due to other organism, not elsewhere classified esophageal reflux unspecified essential hypertension other chronic nonalcoholic liver disease esophagitis, unspecified 
white f 90 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  139  mg dl$chloraseptic throat spray  1  spry ; losartan potassium  50  mg ; aspirin  81  mg ; tramadol (ultram)  12.5  mg ; pravastatin  10  mg ; acetaminophen  650  mg ; isosorbide mononitrate (extended release)  90  mg ; 
anxiety state, unspecified venous (peripheral) insufficiency, unspecified hyposmolality and/or hyponatremia other and unspecified hyperlipidemia long-term (current) use of aspirin mild cognitive impairment, so stated do not resuscitate status personal history of other malignant neoplasm of skin constipation, unspecified hypovolemia unspecified glaucoma pure hypercholesterolemia intestinal infection due to other organism, not elsewhere classified esophageal reflux unspecified essential hypertension other chronic nonalcoholic liver disease esophagitis, unspecified 
white f 90 $nan$nan$losartan potassium  50  mg ; aspirin  81  mg ; tramadol (ultram)  12.5  mg ; pravastatin  10  mg ; acetaminophen  650  mg ; 
anxiety state, unspecified venous (peripheral) insufficiency, unspecified hyposmolality and/or hyponatremia other and unspecified hyperlipidemia long-term (current) use of aspirin mild cognitive impairment, so stated do not resuscitate status personal history of other malignant neoplasm of skin constipation, unspecified hypovolemia unspecified glaucoma pure hypercholesterolemia intestinal infection due to other organism, not elsewhere classified esophageal reflux unspecified essential hypertension other chronic nonalcoholic liver disease esophagitis, unspecified 
white m 57 $nan$hematology blood hematocrit  35.1  %; hematology blood hematocrit  25.7  %; hematology blood hematocrit  21.8  %; hematology blood hemoglobin  12.0  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  371  k ul; hematology blood platelet count  376  k ul; hematology blood platelet count  439  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  200  mg dl; chemistry blood glucose  256  mg dl; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.02  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood chloride, whole blood  106  meq l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  136  mg dl; blood gas blood glucose  121  mg dl; blood gas blood hematocrit, calculated  39  %; blood gas blood hematocrit, calculated  41  %; blood gas blood hemoglobin  13.0  g dl; blood gas blood hemoglobin  13.5  g dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood carboxyhemoglobin  1  %; blood gas blood carboxyhemoglobin  0  %$sw  100  ml ; morphine sulfate  0.7  mg ; naloxone  80  mcg ; 5% dextrose  100  ml ; naloxone  2  mg ; ondansetron  4  mg ; heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; amp  1  amp ; octreotide acetate  100  mcg ; lr  1000  ml ; magnesium sulfate  4  gm ; hydromorphone (dilaudid)  12.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; metoclopramide  10  mg ; 
malignant neoplasm of head of pancreas syncope and collapse hemorrhage complicating a procedure acute posthemorrhagic anemia obstruction of bile duct other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure anemia, unspecified benign neoplasm of liver and biliary passages nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] unspecified disease of pancreas obstruction of bile duct 
white m 57 $nan$hematology blood hematocrit  37.6  %; hematology blood hematocrit  30.0  %; hematology blood hematocrit  26.4  %; hematology blood hematocrit  25.1  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  440  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  109  mg dl$sw  100  ml ; morphine sulfate  0.7  mg ; naloxone  80  mcg ; 5% dextrose  100  ml ; naloxone  2  mg ; ondansetron  4  mg ; heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; amp  1  amp ; octreotide acetate  100  mcg ; lr  1000  ml ; magnesium sulfate  4  gm ; hydromorphone (dilaudid)  12.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; metoclopramide  10  mg ; sw  50  ml ; magnesium sulfate  2  gm ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
malignant neoplasm of head of pancreas syncope and collapse hemorrhage complicating a procedure acute posthemorrhagic anemia obstruction of bile duct other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure anemia, unspecified benign neoplasm of liver and biliary passages nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] unspecified disease of pancreas obstruction of bile duct 
white m 57 $nan$hematology blood hematocrit  23.3  %; hematology blood hematocrit  23.9  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  132  mg dl$5% dextrose  100  ml ; naloxone  2  mg ; ondansetron  4  mg ; heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; amp  1  amp ; octreotide acetate  100  mcg ; hydromorphone (dilaudid)  12.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; metoclopramide  10  mg ; sw  50  ml ; magnesium sulfate  2  gm ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
malignant neoplasm of head of pancreas syncope and collapse hemorrhage complicating a procedure acute posthemorrhagic anemia obstruction of bile duct other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure anemia, unspecified benign neoplasm of liver and biliary passages nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] unspecified disease of pancreas obstruction of bile duct 
white m 57 $nan$hematology blood hematocrit  31.4  %; hematology blood hematocrit  31.7  %; hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  144  mg dl$5% dextrose  100  ml ; naloxone  2  mg ; ondansetron  4  mg ; heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole  40  mg ; amp  1  amp ; octreotide acetate  100  mcg ; hydromorphone (dilaudid)  12.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; 
malignant neoplasm of head of pancreas syncope and collapse hemorrhage complicating a procedure acute posthemorrhagic anemia obstruction of bile duct other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure anemia, unspecified benign neoplasm of liver and biliary passages nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] unspecified disease of pancreas obstruction of bile duct 
white m 57 $nan$hematology blood hematocrit  29.2  %; hematology blood hematocrit  26.5  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  208  k ul; hematology blood platelet count  222  k ul; hematology urine wbc  3-5  # hpf; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$5% dextrose  100  ml ; naloxone  2  mg ; ondansetron  4  mg ; heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole  40  mg ; amp  1  amp ; octreotide acetate  100  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; 5% dextrose  500  ml ; sodium phosphate  30  mmol ; 
malignant neoplasm of head of pancreas syncope and collapse hemorrhage complicating a procedure acute posthemorrhagic anemia obstruction of bile duct other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure anemia, unspecified benign neoplasm of liver and biliary passages nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] unspecified disease of pancreas obstruction of bile duct 
white m 57 $nan$hematology blood hematocrit  27.5  %; hematology blood hematocrit  29.4  %; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  132  mg dl$5% dextrose  100  ml ; naloxone  2  mg ; ondansetron  4  mg ; heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole  40  mg ; amp  1  amp ; octreotide acetate  100  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; ciprofloxacin hcl  500  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; hydromorphone (dilaudid)  0.5-1  mg ; ondansetron odt  4  mg ; 
malignant neoplasm of head of pancreas syncope and collapse hemorrhage complicating a procedure acute posthemorrhagic anemia obstruction of bile duct other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure anemia, unspecified benign neoplasm of liver and biliary passages nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] unspecified disease of pancreas obstruction of bile duct 
white m 57 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  158  mg dl$amp  1  amp ; octreotide acetate  100  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; hydromorphone (dilaudid)  0.5-1  mg ; ondansetron odt  4  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  1000  mg ; prochlorperazine  10  mg ; hydromorphone (dilaudid)  0.5  mg ; 
malignant neoplasm of head of pancreas syncope and collapse hemorrhage complicating a procedure acute posthemorrhagic anemia obstruction of bile duct other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure anemia, unspecified benign neoplasm of liver and biliary passages nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] unspecified disease of pancreas obstruction of bile duct 
white m 57 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  309  k ul$amp  1  amp ; octreotide acetate  100  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ondansetron odt  4  mg ; acetaminophen  1000  mg ; prochlorperazine  10  mg ; 
malignant neoplasm of head of pancreas syncope and collapse hemorrhage complicating a procedure acute posthemorrhagic anemia obstruction of bile duct other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure anemia, unspecified benign neoplasm of liver and biliary passages nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] unspecified disease of pancreas obstruction of bile duct 
white m 57 $nan$nan$amp  1  amp ; octreotide acetate  100  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; ondansetron odt  4  mg ; acetaminophen  1000  mg ; prochlorperazine  10  mg ; lidocaine 1%  1  ml ; 
malignant neoplasm of head of pancreas syncope and collapse hemorrhage complicating a procedure acute posthemorrhagic anemia obstruction of bile duct other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure anemia, unspecified benign neoplasm of liver and biliary passages nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] unspecified disease of pancreas obstruction of bile duct 
white m 84 $nan$nan$heparin  5000  unit ; 
 
white m 84 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  122  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood chloride, whole blood  102  meq l; blood gas blood glucose  125  mg dl; blood gas blood hematocrit, calculated  34  %; blood gas blood hemoglobin  11.3  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood sodium, whole blood  135  meq l$heparin  5000  unit ; docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; albuterol 0.083% neb soln  1  neb ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; pantoprazole  40  mg ; 
 
white m 84 $nan$hematology blood hematocrit  28.5  %; hematology blood hematocrit  27.3  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  141  k ul; hematology blood platelet count  149  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry urine creatinine, urine  170  mg dl; chemistry urine sodium, urine  28  meq l; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  110  mg dl$docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; albuterol 0.083% neb soln  1  neb ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; pantoprazole  40  mg ; albumin 5% (25g   500ml)  25  g ; sodium chloride 0.9%  1000  ml ; atenolol  50  mg ; aspirin  325  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; d5 1 2ns  1000  ml ; trazodone  25  mg ; furosemide  40  mg ; simvastatin  80  mg ; ipratropium-albuterol neb  1  neb ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
 
white m 84 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  69  mg dl; chemistry blood glucose  77  mg dl; chemistry blood lactate dehydrogenase (ld)  272  iu l; chemistry blood albumin  3.8  g dl$docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  1000  ml ; atenolol  50  mg ; aspirin  325  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; trazodone  25  mg ; furosemide  40  mg ; simvastatin  80  mg ; ipratropium-albuterol neb  1  neb ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  25  mg ; bisacodyl  10  mg ; risperidone (disintegrating tablet)  0.5  mg ; risperidone  0.5  mg ; oxycodone (immediate release)  5  mg ; 
 
white m 84 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  98  mg dl; blood gas blood free calcium  1.16  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  0.9  mmol l$docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; pantoprazole  40  mg ; aspirin  325  mg ; trazodone  25  mg ; simvastatin  80  mg ; ipratropium-albuterol neb  1  neb ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  25  mg ; bisacodyl  10  mg ; risperidone (disintegrating tablet)  0.5  mg ; risperidone  0.5  mg ; oxycodone (immediate release)  5  mg ; haloperidol  0.5  mg ; haloperidol  1  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ceftazidime  2  g ; soln  50  ml ; fentanyl citrate  2.5  mg ; lactated ringers  1000  ml ; propofol  1000  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; albuterol inhaler  4  puff ; ipratropium bromide mdi  4  puff ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
 
white m 84 $nan$hematology blood hematocrit  22.1  %; hematology blood hematocrit  21.5  %; hematology blood hematocrit  29.7  %; hematology blood hematocrit  25.5  %; hematology blood hemoglobin  7.0  g dl; hematology blood hemoglobin  7.0  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  148  k ul; hematology blood platelet count  130  k ul; hematology blood platelet count  167  k ul; hematology blood platelet count  137  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  46  mg dl; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  82  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  100  mg dl; blood gas blood free calcium  1.17  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood potassium, whole blood  3.6  meq l$docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; pantoprazole  40  mg ; aspirin  325  mg ; trazodone  25  mg ; simvastatin  80  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  25  mg ; bisacodyl  10  mg ; risperidone  0.5  mg ; haloperidol  1  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ceftazidime  2  g ; soln  50  ml ; fentanyl citrate  2.5  mg ; lactated ringers  1000  ml ; propofol  1000  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; albuterol inhaler  4  puff ; ipratropium bromide mdi  4  puff ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; vial  1  vial ; sterile water  50  ml ; potassium chloride  20  meq ; hydromorphone (dilaudid)  0.25  mg ; quetiapine fumarate  50  mg ; meropenem  1000  mg ; 
 
white m 84 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  147  k ul$docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; aspirin  325  mg ; trazodone  25  mg ; simvastatin  80  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  25  mg ; bisacodyl  10  mg ; risperidone  0.5  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; propofol  1000  mg ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; vial  1  vial ; sterile water  50  ml ; potassium chloride  20  meq ; hydromorphone (dilaudid)  0.25  mg ; quetiapine fumarate  50  mg ; meropenem  1000  mg ; sarna lotion  1  appl ; 
 
white m 84 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  145  mg dl; blood gas blood free calcium  1.18  mmol l; blood gas blood potassium, whole blood  3.4  meq l$docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; aspirin  325  mg ; trazodone  25  mg ; simvastatin  80  mg ; metoprolol tartrate  25  mg ; bisacodyl  10  mg ; propofol  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; vial  1  vial ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; sterile water  100  ml ; potassium chloride  40  meq ; polyethylene glycol  17  g ; neutra-phos  2  pkt ; phosphorus  500  mg ; sterile water  150  ml ; potassium chloride  60  meq ; 
 
white m 84 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  101  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; aspirin  325  mg ; trazodone  25  mg ; simvastatin  80  mg ; metoprolol tartrate  25  mg ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; vial  1  vial ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; sterile water  100  ml ; potassium chloride  40  meq ; polyethylene glycol  17  g ; neutra-phos  2  pkt ; phosphorus  500  mg ; sterile water  150  ml ; potassium chloride  60  meq ; ceftriaxone  1  gm ; lidocaine jelly 2% (urojet)  1  appl ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; 
 
white m 84 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, indirect  1.5  mg dl; chemistry blood bilirubin, total  4.6  mg dl; chemistry blood glucose  108  mg dl; chemistry blood bilirubin, direct  3.1  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; aspirin  325  mg ; trazodone  25  mg ; simvastatin  80  mg ; metoprolol tartrate  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; vial  1  vial ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; polyethylene glycol  17  g ; phosphorus  500  mg ; sterile water  150  ml ; potassium chloride  60  meq ; lidocaine jelly 2% (urojet)  1  appl ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; levothyroxine sodium  25  mcg ; 
 
white m 84 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, indirect  0.9  mg dl; chemistry blood bilirubin, total  3.3  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  277  iu l; chemistry blood bilirubin, direct  2.4  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; aspirin  325  mg ; trazodone  25  mg ; simvastatin  80  mg ; metoprolol tartrate  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; vial  1  vial ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; polyethylene glycol  17  g ; phosphorus  500  mg ; sterile water  150  ml ; potassium chloride  60  meq ; levothyroxine sodium  25  mcg ; acetaminophen iv  1000  mg ; miconazole 2% cream  1  appl ; fluticasone propionate 110mcg  2  puff ; 
 
white m 84 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  84  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; aspirin  325  mg ; simvastatin  80  mg ; metoprolol tartrate  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; hydromorphone (dilaudid)  0.25  mg ; sarna lotion  1  appl ; polyethylene glycol  17  g ; levothyroxine sodium  25  mcg ; miconazole 2% cream  1  appl ; fluticasone propionate 110mcg  2  puff ; enoxaparin sodium  30  mg ; 
 
white m 84 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  102  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; aspirin  325  mg ; simvastatin  80  mg ; metoprolol tartrate  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; sarna lotion  1  appl ; polyethylene glycol  17  g ; levothyroxine sodium  25  mcg ; miconazole 2% cream  1  appl ; fluticasone propionate 110mcg  2  puff ; enoxaparin sodium  30  mg ; tamsulosin  0.4  mg ; 
 
white m 84 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.1  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; aspirin  325  mg ; simvastatin  80  mg ; metoprolol tartrate  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; sarna lotion  1  appl ; polyethylene glycol  17  g ; levothyroxine sodium  25  mcg ; miconazole 2% cream  1  appl ; fluticasone propionate 110mcg  2  puff ; enoxaparin sodium  30  mg ; tamsulosin  0.4  mg ; 
 
white m 84 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  33  mg dl; chemistry blood glucose  116  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; aspirin  325  mg ; simvastatin  80  mg ; metoprolol tartrate  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; sarna lotion  1  appl ; polyethylene glycol  17  g ; levothyroxine sodium  25  mcg ; miconazole 2% cream  1  appl ; fluticasone propionate 110mcg  2  puff ; enoxaparin sodium  30  mg ; dextrose 5%  1000  ml ; 
 
white m 84 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood glucose  107  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; aspirin  325  mg ; simvastatin  80  mg ; metoprolol tartrate  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; sarna lotion  1  appl ; polyethylene glycol  17  g ; levothyroxine sodium  25  mcg ; miconazole 2% cream  1  appl ; fluticasone propionate 110mcg  2  puff ; enoxaparin sodium  30  mg ; dextrose 5%  1000  ml ; 
 
white m 84 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  96  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; aspirin  325  mg ; simvastatin  80  mg ; metoprolol tartrate  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; sarna lotion  1  appl ; polyethylene glycol  17  g ; levothyroxine sodium  25  mcg ; miconazole 2% cream  1  appl ; fluticasone propionate 110mcg  2  puff ; enoxaparin sodium  30  mg ; 
 
hispanic latino f 25 $nan$hematology blood hematocrit  37.9  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  107  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; hydromorphone (dilaudid)  2  mg ; diazepam  10  mg ; albuterol-ipratropium  1-2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ibuprofen suspension  600  mg ; senna  1  tab ; prochlorperazine  10  mg ; insulin  0  unit ; trazodone  200  mg ; mirtazapine  30  mg ; zolpidem tartrate  10  mg ; diphenhydramine  100  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; heparin  5000  unit ; syringe (0.9% sodium chloride)  5  ml ; alteplase (catheter clearance)  1  mg ; aspirin  81  mg ; omeprazole  40  mg ; potassium chloride (powder)  40  meq ; insulin  70  unit ; gabapentin  500  mg ; sw  100  ml ; potassium chloride  10  meq ; 
asthma, unspecified type, unspecified chronic pancreatitis diabetes with ketoacidosis, type i [juvenile type], uncontrolled abdominal pain, unspecified site gastroparesis iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], uncontrolled asthma, unspecified type, unspecified abdominal pain, unspecified site gastroparesis long-term (current) use of insulin other chronic pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled borderline personality disorder chronic pancreatitis long-term (current) use of insulin insomnia, unspecified tobacco use disorder chronic pancreatitis asthma, unspecified type, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis anxiety state, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled abdominal pain, unspecified site asthma, unspecified type, unspecified gastroparesis chronic pancreatitis depressive disorder, not elsewhere classified dehydration asthma, unspecified type, unspecified insomnia, unspecified chronic pancreatitis acute pancreatitis gastroparesis iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled acute upper respiratory infections of unspecified site acute pancreatitis diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic pancreatitis anomalies of pancreas mechanical complication of gastrostomy gastroparesis asthma, unspecified type, unspecified personal history of noncompliance with medical treatment, presenting hazards to health
hispanic latino f 25 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  340  mg dl; hematology urine glucose  150  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; hydromorphone (dilaudid)  2  mg ; diazepam  10  mg ; albuterol-ipratropium  1-2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ibuprofen suspension  600  mg ; senna  1  tab ; prochlorperazine  10  mg ; insulin  0  unit ; trazodone  200  mg ; mirtazapine  30  mg ; zolpidem tartrate  10  mg ; diphenhydramine  100  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; heparin  5000  unit ; syringe (0.9% sodium chloride)  5  ml ; alteplase (catheter clearance)  1  mg ; aspirin  81  mg ; omeprazole  40  mg ; insulin  70  unit ; gabapentin  500  mg ; sw  100  ml ; potassium chloride  10  meq ; diphenhydramine  50  mg ; magnesium oxide  800  mg ; insulin  35  unit ; 
asthma, unspecified type, unspecified chronic pancreatitis diabetes with ketoacidosis, type i [juvenile type], uncontrolled abdominal pain, unspecified site gastroparesis iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], uncontrolled asthma, unspecified type, unspecified abdominal pain, unspecified site gastroparesis long-term (current) use of insulin other chronic pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled borderline personality disorder chronic pancreatitis long-term (current) use of insulin insomnia, unspecified tobacco use disorder chronic pancreatitis asthma, unspecified type, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis anxiety state, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled abdominal pain, unspecified site asthma, unspecified type, unspecified gastroparesis chronic pancreatitis depressive disorder, not elsewhere classified dehydration asthma, unspecified type, unspecified insomnia, unspecified chronic pancreatitis acute pancreatitis gastroparesis iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled acute upper respiratory infections of unspecified site acute pancreatitis diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic pancreatitis anomalies of pancreas mechanical complication of gastrostomy gastroparesis asthma, unspecified type, unspecified personal history of noncompliance with medical treatment, presenting hazards to health
hispanic latino f 25 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  164  mg dl; blood gas blood free calcium  1.20  mmol l$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; hydromorphone (dilaudid)  2  mg ; diazepam  10  mg ; albuterol-ipratropium  1-2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ibuprofen suspension  600  mg ; senna  1  tab ; prochlorperazine  10  mg ; trazodone  200  mg ; mirtazapine  30  mg ; zolpidem tartrate  10  mg ; diphenhydramine  100  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; heparin  5000  unit ; aspirin  81  mg ; omeprazole  40  mg ; gabapentin  500  mg ; diphenhydramine  50  mg ; magnesium oxide  800  mg ; insulin  35  unit ; diphenhydramine  25  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; insulin  50  unit ; 
asthma, unspecified type, unspecified chronic pancreatitis diabetes with ketoacidosis, type i [juvenile type], uncontrolled abdominal pain, unspecified site gastroparesis iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], uncontrolled asthma, unspecified type, unspecified abdominal pain, unspecified site gastroparesis long-term (current) use of insulin other chronic pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled borderline personality disorder chronic pancreatitis long-term (current) use of insulin insomnia, unspecified tobacco use disorder chronic pancreatitis asthma, unspecified type, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis anxiety state, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled abdominal pain, unspecified site asthma, unspecified type, unspecified gastroparesis chronic pancreatitis depressive disorder, not elsewhere classified dehydration asthma, unspecified type, unspecified insomnia, unspecified chronic pancreatitis acute pancreatitis gastroparesis iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled acute upper respiratory infections of unspecified site acute pancreatitis diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic pancreatitis anomalies of pancreas mechanical complication of gastrostomy gastroparesis asthma, unspecified type, unspecified personal history of noncompliance with medical treatment, presenting hazards to health
hispanic latino f 25 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  335  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; hydromorphone (dilaudid)  2  mg ; diazepam  10  mg ; albuterol-ipratropium  1-2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ibuprofen suspension  600  mg ; senna  1  tab ; prochlorperazine  10  mg ; trazodone  200  mg ; mirtazapine  30  mg ; zolpidem tartrate  10  mg ; diphenhydramine  100  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; heparin  5000  unit ; aspirin  81  mg ; omeprazole  40  mg ; gabapentin  500  mg ; diphenhydramine  25  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; insulin  50  unit ; 
asthma, unspecified type, unspecified chronic pancreatitis diabetes with ketoacidosis, type i [juvenile type], uncontrolled abdominal pain, unspecified site gastroparesis iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], uncontrolled asthma, unspecified type, unspecified abdominal pain, unspecified site gastroparesis long-term (current) use of insulin other chronic pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled borderline personality disorder chronic pancreatitis long-term (current) use of insulin insomnia, unspecified tobacco use disorder chronic pancreatitis asthma, unspecified type, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis anxiety state, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled abdominal pain, unspecified site asthma, unspecified type, unspecified gastroparesis chronic pancreatitis depressive disorder, not elsewhere classified dehydration asthma, unspecified type, unspecified insomnia, unspecified chronic pancreatitis acute pancreatitis gastroparesis iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled acute upper respiratory infections of unspecified site acute pancreatitis diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic pancreatitis anomalies of pancreas mechanical complication of gastrostomy gastroparesis asthma, unspecified type, unspecified personal history of noncompliance with medical treatment, presenting hazards to health
hispanic latino f 25 $nan$nan$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; hydromorphone (dilaudid)  2  mg ; diazepam  10  mg ; albuterol-ipratropium  1-2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ibuprofen suspension  600  mg ; senna  1  tab ; prochlorperazine  10  mg ; trazodone  200  mg ; mirtazapine  30  mg ; zolpidem tartrate  10  mg ; diphenhydramine  100  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; heparin  5000  unit ; aspirin  81  mg ; omeprazole  40  mg ; gabapentin  500  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; insulin  50  unit ; lidocaine viscous 2%  20  ml ; 
asthma, unspecified type, unspecified chronic pancreatitis diabetes with ketoacidosis, type i [juvenile type], uncontrolled abdominal pain, unspecified site gastroparesis iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], uncontrolled asthma, unspecified type, unspecified abdominal pain, unspecified site gastroparesis long-term (current) use of insulin other chronic pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled borderline personality disorder chronic pancreatitis long-term (current) use of insulin insomnia, unspecified tobacco use disorder chronic pancreatitis asthma, unspecified type, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis anxiety state, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled abdominal pain, unspecified site asthma, unspecified type, unspecified gastroparesis chronic pancreatitis depressive disorder, not elsewhere classified dehydration asthma, unspecified type, unspecified insomnia, unspecified chronic pancreatitis acute pancreatitis gastroparesis iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled acute upper respiratory infections of unspecified site acute pancreatitis diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic pancreatitis anomalies of pancreas mechanical complication of gastrostomy gastroparesis asthma, unspecified type, unspecified personal history of noncompliance with medical treatment, presenting hazards to health
hispanic latino f 25 $nan$nan$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; hydromorphone (dilaudid)  2  mg ; diazepam  10  mg ; albuterol-ipratropium  1-2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; ibuprofen suspension  600  mg ; senna  1  tab ; prochlorperazine  10  mg ; trazodone  200  mg ; mirtazapine  30  mg ; zolpidem tartrate  10  mg ; diphenhydramine  100  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; heparin  5000  unit ; aspirin  81  mg ; omeprazole  40  mg ; gabapentin  500  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; insulin  50  unit ; lidocaine viscous 2%  20  ml ; lidocaine 1%  1  ml ; 
asthma, unspecified type, unspecified chronic pancreatitis diabetes with ketoacidosis, type i [juvenile type], uncontrolled abdominal pain, unspecified site gastroparesis iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin diabetes with neurological manifestations, type i [juvenile type], uncontrolled asthma, unspecified type, unspecified abdominal pain, unspecified site gastroparesis long-term (current) use of insulin other chronic pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled borderline personality disorder chronic pancreatitis long-term (current) use of insulin insomnia, unspecified tobacco use disorder chronic pancreatitis asthma, unspecified type, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled gastroparesis anxiety state, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled abdominal pain, unspecified site asthma, unspecified type, unspecified gastroparesis chronic pancreatitis depressive disorder, not elsewhere classified dehydration asthma, unspecified type, unspecified insomnia, unspecified chronic pancreatitis acute pancreatitis gastroparesis iron deficiency anemia, unspecified diabetes with neurological manifestations, type i [juvenile type], uncontrolled acute upper respiratory infections of unspecified site acute pancreatitis diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic pancreatitis anomalies of pancreas mechanical complication of gastrostomy gastroparesis asthma, unspecified type, unspecified personal history of noncompliance with medical treatment, presenting hazards to health
white f 76 $nan$nan$quetiapine fumarate  12.5  mg ; multivitamins  1  tab ; duloxetine  30  mg ; zinc sulfate  220  mg ; levothyroxine sodium  75  mcg ; heparin  5000  unit ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; miconazole powder 2%  1  appl ; gabapentin  200  mg ; 
 
white f 76 $nan$hematology blood hematocrit  31.6  %; hematology blood hematocrit  28.6  %; hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  692  k ul; hematology blood platelet count  644  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.4  ; hematology urine wbc  6-10  # hpf; chemistry blood calcium, total  10.1  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  118  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$quetiapine fumarate  12.5  mg ; multivitamins  1  tab ; duloxetine  30  mg ; zinc sulfate  220  mg ; levothyroxine sodium  75  mcg ; heparin  5000  unit ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; miconazole powder 2%  1  appl ; gabapentin  200  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; clonazepam  0.25  mg ; quetiapine fumarate  25  mg ; propoxyphene nap.-apap (n-100)  1  tab ; prochlorperazine  5  mg ; albuterol inhaler  2  puff ; lidocaine 5% patch  1  ptch ; sw  200-400  ml ; potassium chloride  20-40  meq ; sw  400-600  ml ; potassium chloride  40-60  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam na  2.25  g ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 0.9% sodium chloride  500  ml ; 5% dextrose  250  ml ; vancomycin  750  mg ; aspirin  81  mg ; mult  5  ml ; acetylcysteine 20%  600  mg ; 0.9% sodium chloride  1000  ml ; acetaminophen (liquid)  650  mg ; 
 
white f 76 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  603  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  149  mg dl$quetiapine fumarate  12.5  mg ; duloxetine  30  mg ; zinc sulfate  220  mg ; levothyroxine sodium  75  mcg ; heparin  5000  unit ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; miconazole powder 2%  1  appl ; gabapentin  200  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; clonazepam  0.25  mg ; quetiapine fumarate  25  mg ; propoxyphene nap.-apap (n-100)  1  tab ; prochlorperazine  5  mg ; albuterol inhaler  2  puff ; lidocaine 5% patch  1  ptch ; sw  200-400  ml ; potassium chloride  20-40  meq ; sw  400-600  ml ; potassium chloride  40-60  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam na  2.25  g ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 0.9% sodium chloride  500  ml ; 5% dextrose  250  ml ; vancomycin  750  mg ; aspirin  81  mg ; mult  5  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen (liquid)  650  mg ; morphine sulfate  0.5  mg ; lorazepam  2  mg ; fentanyl citrate  75  mcg ; 
 
white f 76 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  486  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  104  mg dl$quetiapine fumarate  12.5  mg ; duloxetine  30  mg ; zinc sulfate  220  mg ; levothyroxine sodium  75  mcg ; heparin  5000  unit ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; miconazole powder 2%  1  appl ; gabapentin  200  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; clonazepam  0.25  mg ; quetiapine fumarate  25  mg ; propoxyphene nap.-apap (n-100)  1  tab ; prochlorperazine  5  mg ; albuterol inhaler  2  puff ; lidocaine 5% patch  1  ptch ; sw  200-400  ml ; potassium chloride  20-40  meq ; sw  400-600  ml ; potassium chloride  40-60  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  250  ml ; vancomycin  750  mg ; aspirin  81  mg ; mult  5  ml ; acetaminophen (liquid)  650  mg ; morphine sulfate  0.5  mg ; lorazepam  2  mg ; fentanyl citrate  75  mcg ; lorazepam  1  mg ; 0.9% sodium chloride  100  ml ; doripenem *nf*  500  mg ; ns (mini bag plus)  100  ml ; ceftazidime  2  g ; morphine sulfate  1  mg ; heparin flush (10 units ml)  2  ml ; 
 
white f 76 $nan$hematology blood hematocrit  24.1  %; hematology blood hematocrit  22.5  %; hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  6.7  g dl; hematology blood platelet count  433  k ul; hematology blood platelet count  350  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  138  mg dl; chemistry blood lactate dehydrogenase (ld)  180  iu l; chemistry blood albumin  2.9  g dl; blood gas blood lactate  0.9  mmol l; blood gas blood chloride, whole blood  107  meq l; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  8.9  g dl; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood sodium, whole blood  137  meq l$quetiapine fumarate  12.5  mg ; duloxetine  30  mg ; zinc sulfate  220  mg ; levothyroxine sodium  75  mcg ; heparin  5000  unit ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; miconazole powder 2%  1  appl ; gabapentin  200  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; clonazepam  0.25  mg ; quetiapine fumarate  25  mg ; propoxyphene nap.-apap (n-100)  1  tab ; prochlorperazine  5  mg ; albuterol inhaler  2  puff ; lidocaine 5% patch  1  ptch ; sw  200-400  ml ; potassium chloride  20-40  meq ; sw  400-600  ml ; potassium chloride  40-60  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; aspirin  81  mg ; mult  5  ml ; acetaminophen (liquid)  650  mg ; lorazepam  1  mg ; 0.9% sodium chloride  100  ml ; doripenem *nf*  500  mg ; ns (mini bag plus)  100  ml ; ceftazidime  2  g ; morphine sulfate  1  mg ; heparin flush (10 units ml)  2  ml ; diltiazem  30  mg ; potassium chloride  40  meq ; neutra-phos  2  pkt ; fentanyl patch  25  mcg hr ; morphine sulfate  0.5-1  mg ; 
 
white f 76 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  437  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  100  mg dl$quetiapine fumarate  12.5  mg ; duloxetine  30  mg ; zinc sulfate  220  mg ; levothyroxine sodium  75  mcg ; heparin  5000  unit ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; miconazole powder 2%  1  appl ; gabapentin  200  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; clonazepam  0.25  mg ; quetiapine fumarate  25  mg ; propoxyphene nap.-apap (n-100)  1  tab ; prochlorperazine  5  mg ; albuterol inhaler  2  puff ; lidocaine 5% patch  1  ptch ; sw  400-600  ml ; potassium chloride  40-60  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; aspirin  81  mg ; mult  5  ml ; acetaminophen (liquid)  650  mg ; 0.9% sodium chloride  100  ml ; doripenem *nf*  500  mg ; heparin flush (10 units ml)  2  ml ; potassium chloride  40  meq ; neutra-phos  2  pkt ; fentanyl patch  25  mcg hr ; morphine sulfate  0.5-1  mg ; 
 
black african american m 65 $temp  97.3  heartrate  92.0  resprate  20.0  o2sat  96.0  sbp  119.0  dbp  88.0  rhythm  atrial fibrillation  pain  0  $hematology blood hematocrit  43.5  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  347  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  261  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; furosemide  100  mg ; heparin  5000  unit ; potassium chloride  40  meq ; amiodarone  200  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; digoxin  0.0625  mg ; hydralazine  20  mg ; isosorbide mononitrate (extended release)  60  mg ; metoprolol succinate xl  75  mg ; ranitidine  150  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  55  unit ; 
pulmonary collapse percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use chronic kidney disease, unspecified body mass index 40.0-44.9, adult cough cardiac pacemaker in situ other and unspecified hyperlipidemia esophageal reflux congestive heart failure, unspecified other chronic pulmonary heart diseases pure hypercholesterolemia paroxysmal ventricular tachycardia unspecified hereditary and idiopathic peripheral neuropathy mitral valve disorders long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled impotence of organic origin coronary atherosclerosis of native coronary artery personal history of noncompliance with medical treatment, presenting hazards to health acute kidney failure, unspecified personal history of tobacco use acute on chronic systolic heart failure long-term (current) use of antiplatelet/antithrombotic chest pain, unspecified obesity, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases long-term (current) use of aspirin other specified forms of chronic ischemic heart disease personal history of noncompliance with medical treatment, presenting hazards to health congestive heart failure, unspecified other and unspecified hyperlipidemia atrial fibrillation coronary atherosclerosis of native coronary artery personal history of tobacco use percutaneous transluminal coronary angioplasty status acute on chronic systolic heart failure esophageal reflux chronic kidney disease, unspecified automatic implantable cardiac defibrillator in situ hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other acute and subacute forms of ischemic heart disease, other other specified pruritic conditions coronary atherosclerosis of native coronary artery eosinophilia long-term (current) use of insulin
black african american m 65 $nan$hematology blood hematocrit  45.5  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  363  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  172  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; furosemide  100  mg ; heparin  5000  unit ; potassium chloride  40  meq ; amiodarone  200  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; digoxin  0.0625  mg ; hydralazine  20  mg ; isosorbide mononitrate (extended release)  60  mg ; metoprolol succinate xl  75  mg ; ranitidine  150  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  55  unit ; potassium chloride  20  meq ; potassium chloride  60  meq ; 
pulmonary collapse percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use chronic kidney disease, unspecified body mass index 40.0-44.9, adult cough cardiac pacemaker in situ other and unspecified hyperlipidemia esophageal reflux congestive heart failure, unspecified other chronic pulmonary heart diseases pure hypercholesterolemia paroxysmal ventricular tachycardia unspecified hereditary and idiopathic peripheral neuropathy mitral valve disorders long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled impotence of organic origin coronary atherosclerosis of native coronary artery personal history of noncompliance with medical treatment, presenting hazards to health acute kidney failure, unspecified personal history of tobacco use acute on chronic systolic heart failure long-term (current) use of antiplatelet/antithrombotic chest pain, unspecified obesity, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases long-term (current) use of aspirin other specified forms of chronic ischemic heart disease personal history of noncompliance with medical treatment, presenting hazards to health congestive heart failure, unspecified other and unspecified hyperlipidemia atrial fibrillation coronary atherosclerosis of native coronary artery personal history of tobacco use percutaneous transluminal coronary angioplasty status acute on chronic systolic heart failure esophageal reflux chronic kidney disease, unspecified automatic implantable cardiac defibrillator in situ hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other acute and subacute forms of ischemic heart disease, other other specified pruritic conditions coronary atherosclerosis of native coronary artery eosinophilia long-term (current) use of insulin
black african american m 65 $nan$chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  111  mg dl; blood gas blood lactate  3.1  mmol l$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; heparin  5000  unit ; amiodarone  200  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; digoxin  0.0625  mg ; hydralazine  20  mg ; isosorbide mononitrate (extended release)  60  mg ; metoprolol succinate xl  75  mg ; ranitidine  150  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  55  unit ; potassium chloride  20  meq ; potassium chloride  60  meq ; hydralazine  30  mg ; 
pulmonary collapse percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use chronic kidney disease, unspecified body mass index 40.0-44.9, adult cough cardiac pacemaker in situ other and unspecified hyperlipidemia esophageal reflux congestive heart failure, unspecified other chronic pulmonary heart diseases pure hypercholesterolemia paroxysmal ventricular tachycardia unspecified hereditary and idiopathic peripheral neuropathy mitral valve disorders long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled impotence of organic origin coronary atherosclerosis of native coronary artery personal history of noncompliance with medical treatment, presenting hazards to health acute kidney failure, unspecified personal history of tobacco use acute on chronic systolic heart failure long-term (current) use of antiplatelet/antithrombotic chest pain, unspecified obesity, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases long-term (current) use of aspirin other specified forms of chronic ischemic heart disease personal history of noncompliance with medical treatment, presenting hazards to health congestive heart failure, unspecified other and unspecified hyperlipidemia atrial fibrillation coronary atherosclerosis of native coronary artery personal history of tobacco use percutaneous transluminal coronary angioplasty status acute on chronic systolic heart failure esophageal reflux chronic kidney disease, unspecified automatic implantable cardiac defibrillator in situ hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other acute and subacute forms of ischemic heart disease, other other specified pruritic conditions coronary atherosclerosis of native coronary artery eosinophilia long-term (current) use of insulin
black african american m 65 $nan$hematology blood hematocrit  46.1  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  348  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  81  mg dl; blood gas blood lactate  2.2  mmol l$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; heparin  5000  unit ; amiodarone  200  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; digoxin  0.0625  mg ; isosorbide mononitrate (extended release)  60  mg ; metoprolol succinate xl  75  mg ; ranitidine  150  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  55  unit ; hydralazine  30  mg ; 
pulmonary collapse percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use chronic kidney disease, unspecified body mass index 40.0-44.9, adult cough cardiac pacemaker in situ other and unspecified hyperlipidemia esophageal reflux congestive heart failure, unspecified other chronic pulmonary heart diseases pure hypercholesterolemia paroxysmal ventricular tachycardia unspecified hereditary and idiopathic peripheral neuropathy mitral valve disorders long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled impotence of organic origin coronary atherosclerosis of native coronary artery personal history of noncompliance with medical treatment, presenting hazards to health acute kidney failure, unspecified personal history of tobacco use acute on chronic systolic heart failure long-term (current) use of antiplatelet/antithrombotic chest pain, unspecified obesity, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases long-term (current) use of aspirin other specified forms of chronic ischemic heart disease personal history of noncompliance with medical treatment, presenting hazards to health congestive heart failure, unspecified other and unspecified hyperlipidemia atrial fibrillation coronary atherosclerosis of native coronary artery personal history of tobacco use percutaneous transluminal coronary angioplasty status acute on chronic systolic heart failure esophageal reflux chronic kidney disease, unspecified automatic implantable cardiac defibrillator in situ hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other acute and subacute forms of ischemic heart disease, other other specified pruritic conditions coronary atherosclerosis of native coronary artery eosinophilia long-term (current) use of insulin
black african american m 65 $nan$hematology blood hematocrit  45.9  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  376  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  148  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; heparin  5000  unit ; amiodarone  200  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; digoxin  0.0625  mg ; isosorbide mononitrate (extended release)  60  mg ; metoprolol succinate xl  75  mg ; ranitidine  150  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  55  unit ; hydralazine  30  mg ; torsemide  100  mg ; torsemide  60  mg ; 
pulmonary collapse percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use chronic kidney disease, unspecified body mass index 40.0-44.9, adult cough cardiac pacemaker in situ other and unspecified hyperlipidemia esophageal reflux congestive heart failure, unspecified other chronic pulmonary heart diseases pure hypercholesterolemia paroxysmal ventricular tachycardia unspecified hereditary and idiopathic peripheral neuropathy mitral valve disorders long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled impotence of organic origin coronary atherosclerosis of native coronary artery personal history of noncompliance with medical treatment, presenting hazards to health acute kidney failure, unspecified personal history of tobacco use acute on chronic systolic heart failure long-term (current) use of antiplatelet/antithrombotic chest pain, unspecified obesity, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases long-term (current) use of aspirin other specified forms of chronic ischemic heart disease personal history of noncompliance with medical treatment, presenting hazards to health congestive heart failure, unspecified other and unspecified hyperlipidemia atrial fibrillation coronary atherosclerosis of native coronary artery personal history of tobacco use percutaneous transluminal coronary angioplasty status acute on chronic systolic heart failure esophageal reflux chronic kidney disease, unspecified automatic implantable cardiac defibrillator in situ hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other acute and subacute forms of ischemic heart disease, other other specified pruritic conditions coronary atherosclerosis of native coronary artery eosinophilia long-term (current) use of insulin
black african american m 65 $nan$hematology blood hematocrit  51.7  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  339  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  170  mg dl; chemistry blood glucose  169  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; heparin  5000  unit ; amiodarone  200  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; digoxin  0.0625  mg ; isosorbide mononitrate (extended release)  60  mg ; metoprolol succinate xl  75  mg ; ranitidine  150  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  55  unit ; hydralazine  30  mg ; torsemide  100  mg ; torsemide  60  mg ; 
pulmonary collapse percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use chronic kidney disease, unspecified body mass index 40.0-44.9, adult cough cardiac pacemaker in situ other and unspecified hyperlipidemia esophageal reflux congestive heart failure, unspecified other chronic pulmonary heart diseases pure hypercholesterolemia paroxysmal ventricular tachycardia unspecified hereditary and idiopathic peripheral neuropathy mitral valve disorders long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled impotence of organic origin coronary atherosclerosis of native coronary artery personal history of noncompliance with medical treatment, presenting hazards to health acute kidney failure, unspecified personal history of tobacco use acute on chronic systolic heart failure long-term (current) use of antiplatelet/antithrombotic chest pain, unspecified obesity, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases long-term (current) use of aspirin other specified forms of chronic ischemic heart disease personal history of noncompliance with medical treatment, presenting hazards to health congestive heart failure, unspecified other and unspecified hyperlipidemia atrial fibrillation coronary atherosclerosis of native coronary artery personal history of tobacco use percutaneous transluminal coronary angioplasty status acute on chronic systolic heart failure esophageal reflux chronic kidney disease, unspecified automatic implantable cardiac defibrillator in situ hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other acute and subacute forms of ischemic heart disease, other other specified pruritic conditions coronary atherosclerosis of native coronary artery eosinophilia long-term (current) use of insulin
black african american m 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; amiodarone  200  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; digoxin  0.0625  mg ; isosorbide mononitrate (extended release)  60  mg ; metoprolol succinate xl  75  mg ; ranitidine  150  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  55  unit ; hydralazine  30  mg ; torsemide  100  mg ; torsemide  60  mg ; 
pulmonary collapse percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use chronic kidney disease, unspecified body mass index 40.0-44.9, adult cough cardiac pacemaker in situ other and unspecified hyperlipidemia esophageal reflux congestive heart failure, unspecified other chronic pulmonary heart diseases pure hypercholesterolemia paroxysmal ventricular tachycardia unspecified hereditary and idiopathic peripheral neuropathy mitral valve disorders long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled impotence of organic origin coronary atherosclerosis of native coronary artery personal history of noncompliance with medical treatment, presenting hazards to health acute kidney failure, unspecified personal history of tobacco use acute on chronic systolic heart failure long-term (current) use of antiplatelet/antithrombotic chest pain, unspecified obesity, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases long-term (current) use of aspirin other specified forms of chronic ischemic heart disease personal history of noncompliance with medical treatment, presenting hazards to health congestive heart failure, unspecified other and unspecified hyperlipidemia atrial fibrillation coronary atherosclerosis of native coronary artery personal history of tobacco use percutaneous transluminal coronary angioplasty status acute on chronic systolic heart failure esophageal reflux chronic kidney disease, unspecified automatic implantable cardiac defibrillator in situ hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other acute and subacute forms of ischemic heart disease, other other specified pruritic conditions coronary atherosclerosis of native coronary artery eosinophilia long-term (current) use of insulin
white f 29 $nan$nan$prednisone  20  mg ; 
hypoxemia pressure ulcer, ankle leukocytosis, unspecified neutropenia, unspecified depressive disorder, not elsewhere classified pneumonia, organism unspecified schilder's disease other and unspecified complications of medical care, not elsewhere classified acute kidney failure, unspecified hematuria escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use tachycardia, unspecified urinary tract infection, site not specified accidents occurring in residential institution acute respiratory failure
white f 29 $nan$hematology blood hematocrit  38.9  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  547  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  99  mg dl$prednisone  20  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; lorazepam  0.25  mg ; prednisone  5  mg ; duloxetine  40  mg ; lidocaine 1%  4  ml ; d5w  1000  ml ; methylprednisolone sodium succ  1000  mg ; tuberculin protein  0.1  ml ; 
hypoxemia pressure ulcer, ankle leukocytosis, unspecified neutropenia, unspecified depressive disorder, not elsewhere classified pneumonia, organism unspecified schilder's disease other and unspecified complications of medical care, not elsewhere classified acute kidney failure, unspecified hematuria escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use tachycardia, unspecified urinary tract infection, site not specified accidents occurring in residential institution acute respiratory failure
white f 29 $nan$nan$prednisone  20  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; lorazepam  0.25  mg ; prednisone  5  mg ; duloxetine  40  mg ; lidocaine 1%  4  ml ; d5w  1000  ml ; methylprednisolone sodium succ  1000  mg ; tuberculin protein  0.1  ml ; lorazepam  1-2  mg ; ibuprofen  400  mg ; potassium chloride  10  meq ; zolpidem tartrate  5  mg ; lithium carbonate  300  mg ; 
hypoxemia pressure ulcer, ankle leukocytosis, unspecified neutropenia, unspecified depressive disorder, not elsewhere classified pneumonia, organism unspecified schilder's disease other and unspecified complications of medical care, not elsewhere classified acute kidney failure, unspecified hematuria escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use tachycardia, unspecified urinary tract infection, site not specified accidents occurring in residential institution acute respiratory failure
white f 29 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  121  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; duloxetine  40  mg ; lorazepam  1-2  mg ; ibuprofen  400  mg ; potassium chloride  10  meq ; zolpidem tartrate  5  mg ; lithium carbonate  300  mg ; insulin  0  unit ; heparin flush (10 units ml)  2  ml ; 
hypoxemia pressure ulcer, ankle leukocytosis, unspecified neutropenia, unspecified depressive disorder, not elsewhere classified pneumonia, organism unspecified schilder's disease other and unspecified complications of medical care, not elsewhere classified acute kidney failure, unspecified hematuria escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use tachycardia, unspecified urinary tract infection, site not specified accidents occurring in residential institution acute respiratory failure
white f 29 $nan$nan$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; duloxetine  40  mg ; lorazepam  1-2  mg ; ibuprofen  400  mg ; potassium chloride  10  meq ; zolpidem tartrate  5  mg ; lithium carbonate  300  mg ; insulin  0  unit ; heparin flush (10 units ml)  2  ml ; 
hypoxemia pressure ulcer, ankle leukocytosis, unspecified neutropenia, unspecified depressive disorder, not elsewhere classified pneumonia, organism unspecified schilder's disease other and unspecified complications of medical care, not elsewhere classified acute kidney failure, unspecified hematuria escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use tachycardia, unspecified urinary tract infection, site not specified accidents occurring in residential institution acute respiratory failure
white f 65 $nan$nan$acetaminophen iv  1000  mg ; venlafaxine  150  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; heparin  5000  unit ; sodium chloride 0.9%  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; clonazepam  1  mg ; clonazepam  2  mg ; metoclopramide  10  mg ; quetiapine fumarate  25  mg ; 

white f 65 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; clonazepam  1  mg ; clonazepam  2  mg ; metoclopramide  10  mg ; quetiapine fumarate  25  mg ; acetaminophen-caff-butalbital  1  tab ; venlafaxine xr  150  mg ; ondansetron  4  mg ; oxycodone (immediate release)  5  mg ; 

white f 65 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; clonazepam  1  mg ; clonazepam  2  mg ; quetiapine fumarate  25  mg ; venlafaxine xr  150  mg ; ondansetron  4  mg ; oxycodone (immediate release)  5  mg ; acetaminophen  1000  mg ; neutra-phos  2  pkt ; oxycodone (immediate release)  5-10  mg ; 

white f 65 $nan$nan$senna  8.6  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; clonazepam  1  mg ; clonazepam  2  mg ; quetiapine fumarate  25  mg ; venlafaxine xr  150  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; neutra-phos  2  pkt ; oxycodone (immediate release)  5-10  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; simethicone  40-80  mg ; 

white f 65 $nan$nan$senna  8.6  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; clonazepam  1  mg ; clonazepam  2  mg ; quetiapine fumarate  25  mg ; venlafaxine xr  150  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)  5-10  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; simethicone  40-80  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 

unable to obtain f 38 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  2-4  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; thiamine  100  mg ; multivitamins  1  tab ; folic acid  1  mg ; ibuprofen  400  mg ; docusate sodium  100  mg ; albuterol 0.083% neb soln  1  neb ; 
 
unable to obtain f 38 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  2-4  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; thiamine  100  mg ; multivitamins  1  tab ; folic acid  1  mg ; ibuprofen  400  mg ; docusate sodium  100  mg ; albuterol 0.083% neb soln  1  neb ; fluticasone-salmeterol diskus (500 50)   1  inh ; 
 
white m 91 $nan$hematology blood hematocrit  39.7  %; hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.7  g dl; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  190  k ul; hematology blood platelet count  180  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  111  mg dl$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; triazolam  0.25  mg ; hydralazine  10  mg ; vitamin d  800  unit ; bag  1  bag ; magnesium sulfate  2  gm ; 
atrioventricular block, complete chronic obstructive asthma, unspecified personal history of malignant neoplasm of prostate mechanical complication due to cardiac pacemaker (electrode) chronic systolic heart failure other and unspecified hyperlipidemia aortocoronary bypass status congestive heart failure, unspecified
white m 91 $nan$hematology blood hematocrit  37.9  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; triazolam  0.25  mg ; hydralazine  10  mg ; vitamin d  800  unit ; bag  1  bag ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; potassium chloride  20  meq ; 
atrioventricular block, complete chronic obstructive asthma, unspecified personal history of malignant neoplasm of prostate mechanical complication due to cardiac pacemaker (electrode) chronic systolic heart failure other and unspecified hyperlipidemia aortocoronary bypass status congestive heart failure, unspecified
white m 91 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; vitamin d  800  unit ; acetaminophen  650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; potassium chloride  20  meq ; clindamycin  300  mg ; trazodone  25  mg ; carvedilol  3.125  mg ; sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; triazolam  0.125-0.25  mg ; 
atrioventricular block, complete chronic obstructive asthma, unspecified personal history of malignant neoplasm of prostate mechanical complication due to cardiac pacemaker (electrode) chronic systolic heart failure other and unspecified hyperlipidemia aortocoronary bypass status congestive heart failure, unspecified
white m 91 $nan$nan$lorazepam  0.5  mg ; vitamin d  800  unit ; clindamycin  300  mg ; heparin  5000  unit ; triazolam  0.125-0.25  mg ; 
atrioventricular block, complete chronic obstructive asthma, unspecified personal history of malignant neoplasm of prostate mechanical complication due to cardiac pacemaker (electrode) chronic systolic heart failure other and unspecified hyperlipidemia aortocoronary bypass status congestive heart failure, unspecified
white m 91 $nan$nan$lorazepam  0.5  mg ; vitamin d  800  unit ; clindamycin  300  mg ; heparin  5000  unit ; triazolam  0.125-0.25  mg ; 
atrioventricular block, complete chronic obstructive asthma, unspecified personal history of malignant neoplasm of prostate mechanical complication due to cardiac pacemaker (electrode) chronic systolic heart failure other and unspecified hyperlipidemia aortocoronary bypass status congestive heart failure, unspecified
black african american f 78 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  118  mg dl; chemistry blood % hemoglobin a1c  7.3  %$0.45% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; trazodone  25  mg ; polyethylene glycol  17  g ; insulin  0  unit ; acetaminophen  1000  mg ; heparin  5000  unit ; docusate sodium  100  mg ; calcium carbonate  500  mg ; citalopram  20  mg ; fluticasone propionate nasal  2  spry ; aspirin  81  mg ; vitamin d  800  unit ; lisinopril  10  mg ; simvastatin  10  mg ; ciprofloxacin hcl  500  mg ; metformin (glucophage)  1000  mg ; 
chest pain, unspecified urinary tract infection, site not specified diarrhea constipation, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled syncope and collapse dehydration polymyalgia rheumatica depressive disorder, not elsewhere classified unspecified essential hypertension long-term (current) use of steroids unspecified essential hypertension hyposmolality and/or hyponatremia acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polymyalgia rheumatica unspecified essential hypertension urinary tract infection, site not specified dehydration diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified polymyalgia rheumatica 
black african american f 78 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood glucose  116  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; trazodone  25  mg ; polyethylene glycol  17  g ; insulin  0  unit ; acetaminophen  1000  mg ; heparin  5000  unit ; docusate sodium  100  mg ; calcium carbonate  500  mg ; citalopram  20  mg ; fluticasone propionate nasal  2  spry ; aspirin  81  mg ; vitamin d  800  unit ; simvastatin  10  mg ; ciprofloxacin hcl  500  mg ; metformin (glucophage)  1000  mg ; amlodipine  5  mg ; metformin (glucophage)  500  mg ; ondansetron  4  mg ; 
chest pain, unspecified urinary tract infection, site not specified diarrhea constipation, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled syncope and collapse dehydration polymyalgia rheumatica depressive disorder, not elsewhere classified unspecified essential hypertension long-term (current) use of steroids unspecified essential hypertension hyposmolality and/or hyponatremia acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polymyalgia rheumatica unspecified essential hypertension urinary tract infection, site not specified dehydration diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified polymyalgia rheumatica 
black african american f 78 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; trazodone  25  mg ; polyethylene glycol  17  g ; insulin  0  unit ; acetaminophen  1000  mg ; heparin  5000  unit ; docusate sodium  100  mg ; calcium carbonate  500  mg ; citalopram  20  mg ; fluticasone propionate nasal  2  spry ; aspirin  81  mg ; vitamin d  800  unit ; simvastatin  10  mg ; ciprofloxacin hcl  500  mg ; amlodipine  5  mg ; metformin (glucophage)  500  mg ; ondansetron  4  mg ; naproxen  500  mg ; 
chest pain, unspecified urinary tract infection, site not specified diarrhea constipation, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled syncope and collapse dehydration polymyalgia rheumatica depressive disorder, not elsewhere classified unspecified essential hypertension long-term (current) use of steroids unspecified essential hypertension hyposmolality and/or hyponatremia acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled polymyalgia rheumatica unspecified essential hypertension urinary tract infection, site not specified dehydration diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified polymyalgia rheumatica 
hispanic latino f 42 $nan$hematology blood hematocrit  38.7  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  5.7  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  69  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  92  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; oxycodone (immediate release)  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lorazepam  1  mg ; amlodipine  2.5  mg ; aspirin  81  mg ; levothyroxine sodium  50  mcg ; furosemide  80  mg ; sevelamer carbonate  3200  mg ; pregabalin  25  mg ; omeprazole  20  mg ; nephrocaps  1  cap ; metoprolol succinate xl  50  mg ; lactated ringers  1000  ml ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other disorders of phosphorus metabolism hypotension of hemodialysis hypo-osmolality and hyponatremia acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with other circulatory complications gastro-esophageal reflux disease without esophagitis supraventricular tachycardia unspecified place in hospital as the place of occurrence of the external cause hypoxemia major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified body mass index (bmi) 45.0-49.9, adult non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified dependence on renal dialysis anemia in chronic kidney disease pain in leg, unspecified long term (current) use of antithrombotics/antiplatelets end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene acquired absence of left leg below knee kidney dialysis as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure type 2 diabetes mellitus with diabetic chronic kidney disease fall on stairs or ladders in water transport injuring unspecified person morbid (severe) obesity due to excess calories hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease long term (current) use of insulin personal history of nicotine dependence subsequent non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified peripheral vascular disease, unspecified hypo-osmolality and hyponatremia acquired absence of left leg below knee personal history of nicotine dependence urinary tract infection, site not specified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of insulin gastro-esophageal reflux disease without esophagitis other chronic pain acute on chronic diastolic (congestive) heart failure hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease body mass index (bmi) 50.0-59.9, adult morbid (severe) obesity due to excess calories type 2 diabetes mellitus with diabetic neuropathy, unspecified major depressive disorder, single episode, unspecified
hispanic latino f 42 $nan$hematology blood hematocrit  38.1  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  32  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  7.5  mg dl; chemistry blood potassium  8.7  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  87  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  257  mg dl; blood gas blood potassium, whole blood  8.0  meq l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; amlodipine  2.5  mg ; aspirin  81  mg ; levothyroxine sodium  50  mcg ; furosemide  80  mg ; sevelamer carbonate  3200  mg ; pregabalin  25  mg ; omeprazole  20  mg ; nephrocaps  1  cap ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; atorvastatin  40  mg ; ropinirole  0.25  mg ; hydromorphone (dilaudid)  0.125  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; albuterol inhaler  1-2  puff ; ipratropium-albuterol neb  1  neb ; insulin  10  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; clopidogrel  75  mg ; heparin dwell (1000 units ml)  2000-8000  unit ; epoetin alfa  2000  unit ; doxercalciferol  0.5  mcg ; ferric gluconate  62.5  mg ; heparin (hemodialysis)  4000  unit ; sodium chloride 0.9%  1000  ml ; diphenhydramine  25  mg ; 
nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other disorders of phosphorus metabolism hypotension of hemodialysis hypo-osmolality and hyponatremia acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with other circulatory complications gastro-esophageal reflux disease without esophagitis supraventricular tachycardia unspecified place in hospital as the place of occurrence of the external cause hypoxemia major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified body mass index (bmi) 45.0-49.9, adult non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified dependence on renal dialysis anemia in chronic kidney disease pain in leg, unspecified long term (current) use of antithrombotics/antiplatelets end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene acquired absence of left leg below knee kidney dialysis as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure type 2 diabetes mellitus with diabetic chronic kidney disease fall on stairs or ladders in water transport injuring unspecified person morbid (severe) obesity due to excess calories hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease long term (current) use of insulin personal history of nicotine dependence subsequent non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified peripheral vascular disease, unspecified hypo-osmolality and hyponatremia acquired absence of left leg below knee personal history of nicotine dependence urinary tract infection, site not specified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of insulin gastro-esophageal reflux disease without esophagitis other chronic pain acute on chronic diastolic (congestive) heart failure hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease body mass index (bmi) 50.0-59.9, adult morbid (severe) obesity due to excess calories type 2 diabetes mellitus with diabetic neuropathy, unspecified major depressive disorder, single episode, unspecified
hispanic latino f 42 $nan$hematology blood hematocrit  30.8  %; hematology blood hematocrit  32.2  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  172  k ul; hematology blood platelet count  153  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  4.3  mg dl; chemistry blood creatinine  4.8  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  175  mg dl; chemistry blood glucose  186  mg dl; blood gas blood free calcium  1.01  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  81  mg ; levothyroxine sodium  50  mcg ; furosemide  80  mg ; sevelamer carbonate  3200  mg ; pregabalin  25  mg ; omeprazole  20  mg ; nephrocaps  1  cap ; atorvastatin  40  mg ; ropinirole  0.25  mg ; ondansetron  4  mg ; albuterol inhaler  1-2  puff ; ipratropium-albuterol neb  1  neb ; clopidogrel  75  mg ; heparin dwell (1000 units ml)  2000-8000  unit ; epoetin alfa  2000  unit ; doxercalciferol  0.5  mcg ; ferric gluconate  62.5  mg ; heparin (hemodialysis)  4000  unit ; sodium chloride 0.9%  1000  ml ; diphenhydramine  25  mg ; hydromorphone (dilaudid)  2-4  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 
nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other disorders of phosphorus metabolism hypotension of hemodialysis hypo-osmolality and hyponatremia acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with other circulatory complications gastro-esophageal reflux disease without esophagitis supraventricular tachycardia unspecified place in hospital as the place of occurrence of the external cause hypoxemia major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified body mass index (bmi) 45.0-49.9, adult non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified dependence on renal dialysis anemia in chronic kidney disease pain in leg, unspecified long term (current) use of antithrombotics/antiplatelets end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene acquired absence of left leg below knee kidney dialysis as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure type 2 diabetes mellitus with diabetic chronic kidney disease fall on stairs or ladders in water transport injuring unspecified person morbid (severe) obesity due to excess calories hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease long term (current) use of insulin personal history of nicotine dependence subsequent non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified peripheral vascular disease, unspecified hypo-osmolality and hyponatremia acquired absence of left leg below knee personal history of nicotine dependence urinary tract infection, site not specified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of insulin gastro-esophageal reflux disease without esophagitis other chronic pain acute on chronic diastolic (congestive) heart failure hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease body mass index (bmi) 50.0-59.9, adult morbid (severe) obesity due to excess calories type 2 diabetes mellitus with diabetic neuropathy, unspecified major depressive disorder, single episode, unspecified
hispanic latino f 42 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  5.9  mg dl; chemistry blood creatinine  6.4  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  5.8  meq l; chemistry blood sodium  122  meq l; chemistry blood sodium  122  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood urea nitrogen  51  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  177  mg dl; chemistry blood glucose  191  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  81  mg ; furosemide  80  mg ; sevelamer carbonate  3200  mg ; pregabalin  25  mg ; omeprazole  20  mg ; nephrocaps  1  cap ; atorvastatin  40  mg ; ropinirole  0.25  mg ; ondansetron  4  mg ; albuterol inhaler  1-2  puff ; ipratropium-albuterol neb  1  neb ; clopidogrel  75  mg ; hydromorphone (dilaudid)  2-4  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; metoclopramide  5  mg ; heparin flush (1000 units ml)  4000-11000  unit ; sodium chloride 0.9%  flush  10  ml ; zolpidem tartrate  5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; levothyroxine sodium  75  mcg ; warfarin  7.5  mg ; warfarin  1  dose ; warfarin  5  mg ; 
nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other disorders of phosphorus metabolism hypotension of hemodialysis hypo-osmolality and hyponatremia acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with other circulatory complications gastro-esophageal reflux disease without esophagitis supraventricular tachycardia unspecified place in hospital as the place of occurrence of the external cause hypoxemia major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified body mass index (bmi) 45.0-49.9, adult non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified dependence on renal dialysis anemia in chronic kidney disease pain in leg, unspecified long term (current) use of antithrombotics/antiplatelets end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene acquired absence of left leg below knee kidney dialysis as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure type 2 diabetes mellitus with diabetic chronic kidney disease fall on stairs or ladders in water transport injuring unspecified person morbid (severe) obesity due to excess calories hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease long term (current) use of insulin personal history of nicotine dependence subsequent non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified peripheral vascular disease, unspecified hypo-osmolality and hyponatremia acquired absence of left leg below knee personal history of nicotine dependence urinary tract infection, site not specified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of insulin gastro-esophageal reflux disease without esophagitis other chronic pain acute on chronic diastolic (congestive) heart failure hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease body mass index (bmi) 50.0-59.9, adult morbid (severe) obesity due to excess calories type 2 diabetes mellitus with diabetic neuropathy, unspecified major depressive disorder, single episode, unspecified
hispanic latino f 42 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  4.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  256  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  81  mg ; sevelamer carbonate  3200  mg ; pregabalin  25  mg ; omeprazole  20  mg ; nephrocaps  1  cap ; atorvastatin  40  mg ; ropinirole  0.25  mg ; ondansetron  4  mg ; ipratropium-albuterol neb  1  neb ; clopidogrel  75  mg ; hydromorphone (dilaudid)  2-4  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (1000 units ml)  4000-11000  unit ; sodium chloride 0.9%  flush  10  ml ; zolpidem tartrate  5  mg ; levothyroxine sodium  75  mcg ; warfarin  1  dose ; warfarin  5  mg ; warfarin  10  mg ; 
nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other disorders of phosphorus metabolism hypotension of hemodialysis hypo-osmolality and hyponatremia acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with other circulatory complications gastro-esophageal reflux disease without esophagitis supraventricular tachycardia unspecified place in hospital as the place of occurrence of the external cause hypoxemia major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified body mass index (bmi) 45.0-49.9, adult non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified dependence on renal dialysis anemia in chronic kidney disease pain in leg, unspecified long term (current) use of antithrombotics/antiplatelets end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene acquired absence of left leg below knee kidney dialysis as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure type 2 diabetes mellitus with diabetic chronic kidney disease fall on stairs or ladders in water transport injuring unspecified person morbid (severe) obesity due to excess calories hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease long term (current) use of insulin personal history of nicotine dependence subsequent non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified peripheral vascular disease, unspecified hypo-osmolality and hyponatremia acquired absence of left leg below knee personal history of nicotine dependence urinary tract infection, site not specified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of insulin gastro-esophageal reflux disease without esophagitis other chronic pain acute on chronic diastolic (congestive) heart failure hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease body mass index (bmi) 50.0-59.9, adult morbid (severe) obesity due to excess calories type 2 diabetes mellitus with diabetic neuropathy, unspecified major depressive disorder, single episode, unspecified
hispanic latino f 42 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  119  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  84  meq l; chemistry blood creatinine  6.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  250  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  81  mg ; sevelamer carbonate  3200  mg ; pregabalin  25  mg ; omeprazole  20  mg ; nephrocaps  1  cap ; atorvastatin  40  mg ; ropinirole  0.25  mg ; ondansetron  4  mg ; ipratropium-albuterol neb  1  neb ; clopidogrel  75  mg ; hydromorphone (dilaudid)  2-4  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (1000 units ml)  4000-11000  unit ; sodium chloride 0.9%  flush  10  ml ; zolpidem tartrate  5  mg ; levothyroxine sodium  75  mcg ; oxycodone (immediate release)  5-10  mg ; diphenhydramine  12.5  mg ; nitroglycerin sl  0.4  mg ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; 
nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other disorders of phosphorus metabolism hypotension of hemodialysis hypo-osmolality and hyponatremia acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with other circulatory complications gastro-esophageal reflux disease without esophagitis supraventricular tachycardia unspecified place in hospital as the place of occurrence of the external cause hypoxemia major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified body mass index (bmi) 45.0-49.9, adult non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified dependence on renal dialysis anemia in chronic kidney disease pain in leg, unspecified long term (current) use of antithrombotics/antiplatelets end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene acquired absence of left leg below knee kidney dialysis as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure type 2 diabetes mellitus with diabetic chronic kidney disease fall on stairs or ladders in water transport injuring unspecified person morbid (severe) obesity due to excess calories hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease long term (current) use of insulin personal history of nicotine dependence subsequent non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified peripheral vascular disease, unspecified hypo-osmolality and hyponatremia acquired absence of left leg below knee personal history of nicotine dependence urinary tract infection, site not specified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of insulin gastro-esophageal reflux disease without esophagitis other chronic pain acute on chronic diastolic (congestive) heart failure hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease body mass index (bmi) 50.0-59.9, adult morbid (severe) obesity due to excess calories type 2 diabetes mellitus with diabetic neuropathy, unspecified major depressive disorder, single episode, unspecified
hispanic latino f 42 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  4.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  3.8  ; hematology blood inr(pt)  5.06  ; chemistry blood glucose  314  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  81  mg ; sevelamer carbonate  3200  mg ; pregabalin  25  mg ; omeprazole  20  mg ; nephrocaps  1  cap ; atorvastatin  40  mg ; ropinirole  0.25  mg ; ondansetron  4  mg ; ipratropium-albuterol neb  1  neb ; clopidogrel  75  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (1000 units ml)  4000-11000  unit ; sodium chloride 0.9%  flush  10  ml ; zolpidem tartrate  5  mg ; levothyroxine sodium  75  mcg ; oxycodone (immediate release)  5-10  mg ; diphenhydramine  12.5  mg ; nitroglycerin sl  0.4  mg ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; hydralazine  25  mg ; 
nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other disorders of phosphorus metabolism hypotension of hemodialysis hypo-osmolality and hyponatremia acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with other circulatory complications gastro-esophageal reflux disease without esophagitis supraventricular tachycardia unspecified place in hospital as the place of occurrence of the external cause hypoxemia major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified body mass index (bmi) 45.0-49.9, adult non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified dependence on renal dialysis anemia in chronic kidney disease pain in leg, unspecified long term (current) use of antithrombotics/antiplatelets end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene acquired absence of left leg below knee kidney dialysis as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure type 2 diabetes mellitus with diabetic chronic kidney disease fall on stairs or ladders in water transport injuring unspecified person morbid (severe) obesity due to excess calories hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease long term (current) use of insulin personal history of nicotine dependence subsequent non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified peripheral vascular disease, unspecified hypo-osmolality and hyponatremia acquired absence of left leg below knee personal history of nicotine dependence urinary tract infection, site not specified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of insulin gastro-esophageal reflux disease without esophagitis other chronic pain acute on chronic diastolic (congestive) heart failure hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease body mass index (bmi) 50.0-59.9, adult morbid (severe) obesity due to excess calories type 2 diabetes mellitus with diabetic neuropathy, unspecified major depressive disorder, single episode, unspecified
hispanic latino f 42 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  5.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  5.4  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  247  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; sevelamer carbonate  3200  mg ; pregabalin  25  mg ; omeprazole  20  mg ; nephrocaps  1  cap ; atorvastatin  40  mg ; ropinirole  0.25  mg ; ondansetron  4  mg ; ipratropium-albuterol neb  1  neb ; clopidogrel  75  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (1000 units ml)  4000-11000  unit ; sodium chloride 0.9%  flush  10  ml ; zolpidem tartrate  5  mg ; levothyroxine sodium  75  mcg ; oxycodone (immediate release)  5-10  mg ; diphenhydramine  12.5  mg ; nitroglycerin sl  0.4  mg ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; hydralazine  25  mg ; 5% dextrose  50  ml ; phytonadione  2.5  mg ; 
nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other disorders of phosphorus metabolism hypotension of hemodialysis hypo-osmolality and hyponatremia acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with other circulatory complications gastro-esophageal reflux disease without esophagitis supraventricular tachycardia unspecified place in hospital as the place of occurrence of the external cause hypoxemia major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified body mass index (bmi) 45.0-49.9, adult non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified dependence on renal dialysis anemia in chronic kidney disease pain in leg, unspecified long term (current) use of antithrombotics/antiplatelets end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene acquired absence of left leg below knee kidney dialysis as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure type 2 diabetes mellitus with diabetic chronic kidney disease fall on stairs or ladders in water transport injuring unspecified person morbid (severe) obesity due to excess calories hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease long term (current) use of insulin personal history of nicotine dependence subsequent non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified peripheral vascular disease, unspecified hypo-osmolality and hyponatremia acquired absence of left leg below knee personal history of nicotine dependence urinary tract infection, site not specified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of insulin gastro-esophageal reflux disease without esophagitis other chronic pain acute on chronic diastolic (congestive) heart failure hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease body mass index (bmi) 50.0-59.9, adult morbid (severe) obesity due to excess calories type 2 diabetes mellitus with diabetic neuropathy, unspecified major depressive disorder, single episode, unspecified
hispanic latino f 42 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; sevelamer carbonate  3200  mg ; pregabalin  25  mg ; omeprazole  20  mg ; nephrocaps  1  cap ; atorvastatin  40  mg ; ropinirole  0.25  mg ; ondansetron  4  mg ; ipratropium-albuterol neb  1  neb ; clopidogrel  75  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (1000 units ml)  4000-11000  unit ; sodium chloride 0.9%  flush  10  ml ; zolpidem tartrate  5  mg ; levothyroxine sodium  75  mcg ; oxycodone (immediate release)  5-10  mg ; diphenhydramine  12.5  mg ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; 
nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other disorders of phosphorus metabolism hypotension of hemodialysis hypo-osmolality and hyponatremia acute on chronic diastolic (congestive) heart failure type 2 diabetes mellitus with other circulatory complications gastro-esophageal reflux disease without esophagitis supraventricular tachycardia unspecified place in hospital as the place of occurrence of the external cause hypoxemia major depressive disorder, single episode, unspecified fatty (change of) liver, not elsewhere classified body mass index (bmi) 45.0-49.9, adult non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified dependence on renal dialysis anemia in chronic kidney disease pain in leg, unspecified long term (current) use of antithrombotics/antiplatelets end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene acquired absence of left leg below knee kidney dialysis as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure type 2 diabetes mellitus with diabetic chronic kidney disease fall on stairs or ladders in water transport injuring unspecified person morbid (severe) obesity due to excess calories hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease long term (current) use of insulin personal history of nicotine dependence subsequent non-st elevation (nstemi) myocardial infarction hypothyroidism, unspecified peripheral vascular disease, unspecified hypo-osmolality and hyponatremia acquired absence of left leg below knee personal history of nicotine dependence urinary tract infection, site not specified type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema long term (current) use of insulin gastro-esophageal reflux disease without esophagitis other chronic pain acute on chronic diastolic (congestive) heart failure hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease body mass index (bmi) 50.0-59.9, adult morbid (severe) obesity due to excess calories type 2 diabetes mellitus with diabetic neuropathy, unspecified major depressive disorder, single episode, unspecified
white f 37 $nan$nan$nephrocaps  1  cap ; 
 
white f 37 $nan$nan$nephrocaps  1  cap ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; 
 
white f 37 $nan$nan$nephrocaps  1  cap ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; 
 
black african american f 32 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  4  unit ; d10w  1000  ml ; prenatal vitamins  1  tab ; 0.9% sodium chloride  100  ml ; insulin reg human (novolin r)  100  unit ; insulin  20  unit ; insulin  0  unit ; insulin  22  unit ; acetaminophen  650  mg ; insulin  10  unit ; 
generalized abdominal pain nausea with vomiting, unspecified type 1 diabetes mellitus with diabetic polyneuropathy underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter anorexia personal history of urinary calculi type 1 diabetes mellitus with hyperglycemia major depressive disorder, single episode, unspecified migraine, unspecified, not intractable, without status migrainosus type 1 diabetes mellitus with ketoacidosis without coma body mass index (bmi) 27.0-27.9, adult periapical abscess without sinus tobacco use long term (current) use of insulin tobacco use disorder hypotension, unspecified urinary tract infection, site not specified diabetes with ketoacidosis, type i [juvenile type], uncontrolled long-term (current) use of insulin personal history of noncompliance with medical treatment, presenting hazards to health long-term (current) use of insulin diabetes mellitus without mention of complication, type i [juvenile type], uncontrolled
black african american f 32 $nan$chemistry urine creatinine, urine  64  mg dl; chemistry urine protein creatinine ratio  0.1  mg mg$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; prenatal vitamins  1  tab ; insulin  22  unit ; acetaminophen  650  mg ; one-a-day women vitacraves  2  gum ; 
generalized abdominal pain nausea with vomiting, unspecified type 1 diabetes mellitus with diabetic polyneuropathy underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter anorexia personal history of urinary calculi type 1 diabetes mellitus with hyperglycemia major depressive disorder, single episode, unspecified migraine, unspecified, not intractable, without status migrainosus type 1 diabetes mellitus with ketoacidosis without coma body mass index (bmi) 27.0-27.9, adult periapical abscess without sinus tobacco use long term (current) use of insulin tobacco use disorder hypotension, unspecified urinary tract infection, site not specified diabetes with ketoacidosis, type i [juvenile type], uncontrolled long-term (current) use of insulin personal history of noncompliance with medical treatment, presenting hazards to health long-term (current) use of insulin diabetes mellitus without mention of complication, type i [juvenile type], uncontrolled
white f 45 $nan$nan$thiamine  100  mg ; cyanocobalamin  50  mcg ; folic acid  1  mg ; multivitamins  1  cap ; 
suicide and self-inflicted poisoning by other and unspecified solid and liquid substances unspecified essential hypertension toxic effect of ethyl alcohol unspecified episodic mood disorder acute alcoholic intoxication in alcoholism, continuous eating disorder, unspecified
white f 45 $nan$nan$thiamine  100  mg ; cyanocobalamin  50  mcg ; folic acid  1  mg ; multivitamins  1  cap ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; tuberculin protein  0.1  ml ; lorazepam  2  mg ; citalopram hydrobromide  20  mg ; 
suicide and self-inflicted poisoning by other and unspecified solid and liquid substances unspecified essential hypertension toxic effect of ethyl alcohol unspecified episodic mood disorder acute alcoholic intoxication in alcoholism, continuous eating disorder, unspecified
white f 45 $nan$nan$thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  cap ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; tuberculin protein  0.1  ml ; citalopram hydrobromide  20  mg ; 
suicide and self-inflicted poisoning by other and unspecified solid and liquid substances unspecified essential hypertension toxic effect of ethyl alcohol unspecified episodic mood disorder acute alcoholic intoxication in alcoholism, continuous eating disorder, unspecified
white m 52 $nan$hematology blood hematocrit  33.5  %; hematology blood hematocrit  32.8  %; hematology blood hemoglobin  12.4  g dl; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  90  k ul; hematology blood platelet count  93  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  97  mg dl; chemistry blood albumin  3.8  g dl; hematology urine glucose  70  mg dl$heparin  5000  unit ; morphine sulfate  2  mg ; 0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; lidocaine jelly 2% (urojet)  1  appl ; metoprolol tartrate  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; lorazepam  1  mg ; vial  1  vial ; pantoprazole  40  mg ; 0.9% sodium chloride  500  ml ; 
 
white m 52 $nan$hematology blood hematocrit  30.8  %; hematology blood hematocrit  31.5  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  79  k ul; hematology blood platelet count  163  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  76  mg dl; chemistry blood lactate dehydrogenase (ld)  223  iu l; chemistry blood albumin  3.3  g dl; blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood glucose  84  mg dl; blood gas blood hematocrit, calculated  33  %; blood gas blood hemoglobin  10.9  g dl; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood sodium, whole blood  133  meq l$heparin  5000  unit ; morphine sulfate  2  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine jelly 2% (urojet)  1  appl ; metoprolol tartrate  2.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; lorazepam  1  mg ; vial  1  vial ; pantoprazole  40  mg ; 0.9% sodium chloride  500  ml ; chloraseptic throat spray  1  spry ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  5  mg ; hydromorphone (dilaudid)  0.5  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; bag  50  ml ; magnesium sulfate  2  gm ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; albumin 25% (12.5g   50ml)  12.5  g ; hydromorphone (dilaudid)  0.5-1.0  mg ; 
 
white m 52 $nan$hematology blood hematocrit  28.6  %; hematology blood hematocrit  26.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  106  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  2.5  mg dl; chemistry blood glucose  226  mg dl; chemistry blood glucose  205  mg dl; chemistry blood albumin  3.3  g dl$heparin flush (10 units ml)  1  ml ; metoprolol tartrate  5  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; bag  50  ml ; magnesium sulfate  2  gm ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; albumin 25% (12.5g   50ml)  12.5  g ; hydromorphone (dilaudid)  0.5-1.0  mg ; 0.9% sodium chloride  1000  ml ; 
 
white m 52 $nan$hematology blood hematocrit  24.4  %; hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  75  k ul; hematology blood platelet count  75  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  199  mg dl; chemistry blood lactate dehydrogenase (ld)  202  iu l$heparin flush (10 units ml)  1  ml ; metoprolol tartrate  5  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; 0.9% sodium chloride  1000  ml ; potassium phosphate  30  mmol ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 5% dextrose  500  ml ; potassium chloride  40  meq ; 
 
white m 52 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  78  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  3.5  mg dl; chemistry blood glucose  170  mg dl; chemistry blood glucose  221  mg dl; chemistry blood albumin  3.0  g dl$heparin flush (10 units ml)  1  ml ; metoprolol tartrate  5  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; potassium phosphate  30  mmol ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 5% dextrose  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 
 
white m 52 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  87  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  2.8  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  2.8  mg dl; chemistry blood glucose  155  mg dl$heparin flush (10 units ml)  1  ml ; metoprolol tartrate  5  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sterile water  100  ml ; 
 
white m 52 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  94  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  2.7  mg dl; chemistry blood glucose  153  mg dl$heparin flush (10 units ml)  1  ml ; metoprolol tartrate  5  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sterile water  100  ml ; lisinopril  40  mg ; fluoxetine  10  mg ; nadolol  40  mg ; pravastatin  40  mg ; 
 
white m 52 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  2.5  mg dl; chemistry blood glucose  154  mg dl$heparin flush (10 units ml)  1  ml ; hydromorphone (dilaudid)  0.5-1.0  mg ; lisinopril  40  mg ; fluoxetine  10  mg ; nadolol  40  mg ; pravastatin  40  mg ; trazodone  100  mg ; ezetimibe  10  mg ; spironolactone  100  mg ; oxycodone (immediate release)   5-10  mg ; 
 
white m 52 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  101  mg dl; chemistry blood albumin  2.6  g dl$heparin flush (10 units ml)  1  ml ; lisinopril  40  mg ; fluoxetine  10  mg ; nadolol  40  mg ; pravastatin  40  mg ; trazodone  100  mg ; ezetimibe  10  mg ; spironolactone  100  mg ; oxycodone (immediate release)   5-10  mg ; glyburide  7.5  mg ; furosemide  20  mg ; lidocaine 1%  10  ml ; glyburide  5  mg ; 
 
white m 52 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  96  mg dl$heparin flush (10 units ml)  1  ml ; lisinopril  40  mg ; fluoxetine  10  mg ; nadolol  40  mg ; pravastatin  40  mg ; trazodone  100  mg ; ezetimibe  10  mg ; spironolactone  100  mg ; oxycodone (immediate release)   5-10  mg ; furosemide  20  mg ; lidocaine 1%  10  ml ; glyburide  5  mg ; 
 
white m 52 $nan$nan$heparin flush (10 units ml)  1  ml ; lisinopril  40  mg ; fluoxetine  10  mg ; nadolol  40  mg ; pravastatin  40  mg ; trazodone  100  mg ; ezetimibe  10  mg ; spironolactone  100  mg ; oxycodone (immediate release)   5-10  mg ; furosemide  20  mg ; glyburide  5  mg ; 
 
white m 58 $nan$nan$enoxaparin sodium  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; oxycodone sr (oxycontin)  60  mg ; gabapentin  800  mg ; acetaminophen  500-1000  mg ; pneumococcal vac polyvalent  0.5  ml ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  4-10  mg ; hydromorphone (dilaudid)  1-2  mg ; milk of magnesia  30  ml ; 
urinary incontinence, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] mononeuritis of unspecified site sepsis accidents occurring in other specified places amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation infection (chronic) of amputation stump pressure ulcer, unstageable pressure ulcer, stage ii other and unspecified alcohol dependence, continuous cocaine dependence, continuous other amputation stump complication unspecified septicemia hyposmolality and/or hyponatremia pneumonitis due to inhalation of food or vomitus accidents occurring in residential institution pressure ulcer, buttock subendocardial infarction, initial episode of care human immunodeficiency virus [hiv] disease atherosclerosis of native arteries of the extremities, unspecified anemia of other chronic disease personal history of noncompliance with medical treatment, presenting hazards to health acidosis acute osteomyelitis, lower leg acute kidney failure, unspecified tobacco use disorder pressure ulcer, other site diarrhea urinary tract infection, site not specified unspecified disease of spinal cord cocaine abuse, unspecified above knee amputation status human immunodeficiency virus [hiv] disease other chronic pain chronic osteomyelitis, pelvic region and thigh other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute osteomyelitis, pelvic region and thigh streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus unspecified disease of spinal cord pyogenic arthritis, lower leg pressure ulcer, stage i unspecified viral hepatitis c without hepatic coma pressure ulcer, unspecified stage ulcer of other part of lower limb opioid type dependence, continuous pressure ulcer, lower back accidents occurring in residential institution pressure ulcer, other site
white m 58 $nan$nan$enoxaparin sodium  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; oxycodone sr (oxycontin)  60  mg ; gabapentin  800  mg ; acetaminophen  500-1000  mg ; pneumococcal vac polyvalent  0.5  ml ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  4-10  mg ; hydromorphone (dilaudid)  1-2  mg ; milk of magnesia  30  ml ; tizanidine  4  mg ; docusate sodium  100  mg ; senna  2  tab ; polyethylene glycol  17  g ; emtricitabine-tenofovir (truvada)  1  tab ; citalopram  40  mg ; darunavir  600  mg ; ritonavir  100  mg ; clonazepam  1  mg ; 
urinary incontinence, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] mononeuritis of unspecified site sepsis accidents occurring in other specified places amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation infection (chronic) of amputation stump pressure ulcer, unstageable pressure ulcer, stage ii other and unspecified alcohol dependence, continuous cocaine dependence, continuous other amputation stump complication unspecified septicemia hyposmolality and/or hyponatremia pneumonitis due to inhalation of food or vomitus accidents occurring in residential institution pressure ulcer, buttock subendocardial infarction, initial episode of care human immunodeficiency virus [hiv] disease atherosclerosis of native arteries of the extremities, unspecified anemia of other chronic disease personal history of noncompliance with medical treatment, presenting hazards to health acidosis acute osteomyelitis, lower leg acute kidney failure, unspecified tobacco use disorder pressure ulcer, other site diarrhea urinary tract infection, site not specified unspecified disease of spinal cord cocaine abuse, unspecified above knee amputation status human immunodeficiency virus [hiv] disease other chronic pain chronic osteomyelitis, pelvic region and thigh other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute osteomyelitis, pelvic region and thigh streptococcus infection in conditions classified elsewhere and of unspecified site, other streptococcus unspecified disease of spinal cord pyogenic arthritis, lower leg pressure ulcer, stage i unspecified viral hepatitis c without hepatic coma pressure ulcer, unspecified stage ulcer of other part of lower limb opioid type dependence, continuous pressure ulcer, lower back accidents occurring in residential institution pressure ulcer, other site
white f 52 $nan$nan$lithium carbonate  600  mg ; oxcarbazepine  300  mg ; influenza vaccine quadrivalent  0.5  ml ; lidocaine viscous 2%  15  ml ; nicotine polacrilex  2  mg ; diazepam  10  mg ; albuterol inhaler  2  puff ; 
family history of other mental and behavioral disorders bipolar disorder, current episode manic without psychotic features, severe gastro-esophageal reflux disease without esophagitis alcohol dependence, uncomplicated patient's other noncompliance with medication regimen alcohol dependence with intoxication, unspecified bipolar disorder, unspecified exposure to other specified factors, initial encounter laceration without foreign body of left hand, initial encounter cocaine dependence, uncomplicated unspecified place or not applicable gastro-esophageal reflux disease without esophagitis other psoriasis esophageal reflux brachial neuritis or radiculitis nos personal history of noncompliance with medical treatment, presenting hazards to health diffuse cystic mastopathy bipolar i disorder, most recent episode (or current) manic, severe, specified as with psychotic behavior bipolar i disorder, most recent episode (or current) manic, severe, specified as with psychotic behavior bipolar i disorder, most recent episode (or current) manic, unspecified
white f 52 $nan$nan$lithium carbonate  600  mg ; oxcarbazepine  300  mg ; influenza vaccine quadrivalent  0.5  ml ; lidocaine viscous 2%  15  ml ; nicotine polacrilex  2  mg ; diazepam  10  mg ; albuterol inhaler  2  puff ; calcium carbonate  500  mg ; hydroxyzine  50  mg ; ibuprofen  400  mg ; nicotine patch  14  mg ; lamotrigine  25  mg ; clonazepam  2  mg ; hydrocerin  1  appl ; 
family history of other mental and behavioral disorders bipolar disorder, current episode manic without psychotic features, severe gastro-esophageal reflux disease without esophagitis alcohol dependence, uncomplicated patient's other noncompliance with medication regimen alcohol dependence with intoxication, unspecified bipolar disorder, unspecified exposure to other specified factors, initial encounter laceration without foreign body of left hand, initial encounter cocaine dependence, uncomplicated unspecified place or not applicable gastro-esophageal reflux disease without esophagitis other psoriasis esophageal reflux brachial neuritis or radiculitis nos personal history of noncompliance with medical treatment, presenting hazards to health diffuse cystic mastopathy bipolar i disorder, most recent episode (or current) manic, severe, specified as with psychotic behavior bipolar i disorder, most recent episode (or current) manic, severe, specified as with psychotic behavior bipolar i disorder, most recent episode (or current) manic, unspecified
white f 52 $nan$nan$lithium carbonate  600  mg ; oxcarbazepine  300  mg ; lidocaine viscous 2%  15  ml ; nicotine polacrilex  2  mg ; albuterol inhaler  2  puff ; calcium carbonate  500  mg ; hydroxyzine  50  mg ; ibuprofen  400  mg ; nicotine patch  14  mg ; lamotrigine  25  mg ; clonazepam  2  mg ; hydrocerin  1  appl ; 
family history of other mental and behavioral disorders bipolar disorder, current episode manic without psychotic features, severe gastro-esophageal reflux disease without esophagitis alcohol dependence, uncomplicated patient's other noncompliance with medication regimen alcohol dependence with intoxication, unspecified bipolar disorder, unspecified exposure to other specified factors, initial encounter laceration without foreign body of left hand, initial encounter cocaine dependence, uncomplicated unspecified place or not applicable gastro-esophageal reflux disease without esophagitis other psoriasis esophageal reflux brachial neuritis or radiculitis nos personal history of noncompliance with medical treatment, presenting hazards to health diffuse cystic mastopathy bipolar i disorder, most recent episode (or current) manic, severe, specified as with psychotic behavior bipolar i disorder, most recent episode (or current) manic, severe, specified as with psychotic behavior bipolar i disorder, most recent episode (or current) manic, unspecified
white f 52 $nan$nan$lithium carbonate  600  mg ; oxcarbazepine  300  mg ; lidocaine viscous 2%  15  ml ; nicotine polacrilex  2  mg ; albuterol inhaler  2  puff ; ibuprofen  400  mg ; nicotine patch  14  mg ; lamotrigine  25  mg ; clonazepam  2  mg ; hydrocerin  1  appl ; 
family history of other mental and behavioral disorders bipolar disorder, current episode manic without psychotic features, severe gastro-esophageal reflux disease without esophagitis alcohol dependence, uncomplicated patient's other noncompliance with medication regimen alcohol dependence with intoxication, unspecified bipolar disorder, unspecified exposure to other specified factors, initial encounter laceration without foreign body of left hand, initial encounter cocaine dependence, uncomplicated unspecified place or not applicable gastro-esophageal reflux disease without esophagitis other psoriasis esophageal reflux brachial neuritis or radiculitis nos personal history of noncompliance with medical treatment, presenting hazards to health diffuse cystic mastopathy bipolar i disorder, most recent episode (or current) manic, severe, specified as with psychotic behavior bipolar i disorder, most recent episode (or current) manic, severe, specified as with psychotic behavior bipolar i disorder, most recent episode (or current) manic, unspecified
white f 52 $nan$nan$lithium carbonate  600  mg ; oxcarbazepine  300  mg ; lidocaine viscous 2%  15  ml ; nicotine polacrilex  2  mg ; albuterol inhaler  2  puff ; ibuprofen  400  mg ; nicotine patch  14  mg ; lamotrigine  25  mg ; clonazepam  2  mg ; hydrocerin  1  appl ; 
family history of other mental and behavioral disorders bipolar disorder, current episode manic without psychotic features, severe gastro-esophageal reflux disease without esophagitis alcohol dependence, uncomplicated patient's other noncompliance with medication regimen alcohol dependence with intoxication, unspecified bipolar disorder, unspecified exposure to other specified factors, initial encounter laceration without foreign body of left hand, initial encounter cocaine dependence, uncomplicated unspecified place or not applicable gastro-esophageal reflux disease without esophagitis other psoriasis esophageal reflux brachial neuritis or radiculitis nos personal history of noncompliance with medical treatment, presenting hazards to health diffuse cystic mastopathy bipolar i disorder, most recent episode (or current) manic, severe, specified as with psychotic behavior bipolar i disorder, most recent episode (or current) manic, severe, specified as with psychotic behavior bipolar i disorder, most recent episode (or current) manic, unspecified
white f 34 $nan$hematology blood hematocrit  37.3  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  313  k ul$naloxone hcl  40-80  mcg ; naloxone hcl  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; d5w  100  ml ; gentamicin sulfate  450  mg ; 
 
white f 34 $nan$nan$naloxone hcl  40-80  mcg ; naloxone hcl  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; d5w  100  ml ; gentamicin sulfate  450  mg ; 
 
white f 34 $nan$nan$naloxone hcl  40-80  mcg ; naloxone hcl  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
white f 34 $nan$nan$naloxone hcl  40-80  mcg ; naloxone hcl  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
white f 34 $nan$nan$naloxone hcl  40-80  mcg ; naloxone hcl  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
white m 91 $temp    heartrate  96.0  resprate  21.0  o2sat  93.0  sbp  104.0  dbp  71.0  rhythm    pain    ; temp    heartrate  95.0  resprate  20.0  o2sat  93.0  sbp  104.0  dbp  71.0  rhythm  nsr  pain  0  $hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  110  mg dl; chemistry blood lactate dehydrogenase (ld)  214  iu l$sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; omeprazole  20  mg ; fluoxetine  10  mg ; atenolol  50  mg ; aspirin  81  mg ; vial  1  vial ; meropenem  500  mg ; heparin  5000  unit ; simvastatin  10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; azithromycin  500  mg ; sodium chloride 0.9%  1000  ml ; methylprednisolone sodium succ  125  mg ; lidocaine jelly 2% (glydo)  1  appl ; 
actinic keratosis personal history of nicotine dependence abnormal weight loss thrombocytopenia, unspecified myelodysplastic syndrome, unspecified personal history of pneumonia (recurrent) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease esophageal obstruction obesity, unspecified dependence on supplemental oxygen unilateral primary osteoarthritis, right knee seborrheic dermatitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris constipation, unspecified hyperlipidemia, unspecified unspecified hearing loss, bilateral other dysphagia barrett's esophagus without dysplasia pneumonitis due to inhalation of food and vomit spinal stenosis, cervical region chronic kidney disease, stage 2 (mild) hypovolemia chronic obstructive pulmonary disease with (acute) exacerbation major depressive disorder, single episode, unspecified acute and chronic respiratory failure with hypoxia alcohol dependence, in remission history of falling dependence on supplemental oxygen unilateral primary osteoarthritis, right knee major depressive disorder, single episode, unspecified obesity, unspecified esophageal obstruction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease peripheral vascular disease, unspecified idiopathic gout, right ankle and foot chronic obstructive pulmonary disease, unspecified history of falling dysphagia, unspecified idiopathic gout, left ankle and foot pneumonitis due to inhalation of food and vomit body mass index (bmi) 32.0-32.9, adult barrett's esophagus without dysplasia chronic respiratory failure with hypoxia other specified hearing loss, bilateral atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified chronic kidney disease, stage 2 (mild) hyperlipidemia, unspecified
white m 91 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  117  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.4  ; hematology urine wbc  13  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  132  mg dl; hematology blood bands  8  %$sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; omeprazole  20  mg ; fluoxetine  10  mg ; atenolol  50  mg ; aspirin  81  mg ; vial  1  vial ; meropenem  500  mg ; heparin  5000  unit ; simvastatin  10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; azithromycin  500  mg ; sodium chloride 0.9%  1000  ml ; methylprednisolone sodium succ  125  mg ; lidocaine jelly 2% (glydo)  1  appl ; azithromycin  250  mg ; prednisone  40  mg ; lactated ringers  1000  ml ; 
actinic keratosis personal history of nicotine dependence abnormal weight loss thrombocytopenia, unspecified myelodysplastic syndrome, unspecified personal history of pneumonia (recurrent) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease esophageal obstruction obesity, unspecified dependence on supplemental oxygen unilateral primary osteoarthritis, right knee seborrheic dermatitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris constipation, unspecified hyperlipidemia, unspecified unspecified hearing loss, bilateral other dysphagia barrett's esophagus without dysplasia pneumonitis due to inhalation of food and vomit spinal stenosis, cervical region chronic kidney disease, stage 2 (mild) hypovolemia chronic obstructive pulmonary disease with (acute) exacerbation major depressive disorder, single episode, unspecified acute and chronic respiratory failure with hypoxia alcohol dependence, in remission history of falling dependence on supplemental oxygen unilateral primary osteoarthritis, right knee major depressive disorder, single episode, unspecified obesity, unspecified esophageal obstruction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease peripheral vascular disease, unspecified idiopathic gout, right ankle and foot chronic obstructive pulmonary disease, unspecified history of falling dysphagia, unspecified idiopathic gout, left ankle and foot pneumonitis due to inhalation of food and vomit body mass index (bmi) 32.0-32.9, adult barrett's esophagus without dysplasia chronic respiratory failure with hypoxia other specified hearing loss, bilateral atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified chronic kidney disease, stage 2 (mild) hyperlipidemia, unspecified
white m 91 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  124  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  93  mg dl; chemistry blood albumin  3.2  g dl$sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; omeprazole  20  mg ; fluoxetine  10  mg ; atenolol  50  mg ; aspirin  81  mg ; vial  1  vial ; meropenem  500  mg ; heparin  5000  unit ; simvastatin  10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; azithromycin  250  mg ; prednisone  40  mg ; lactated ringers  1000  ml ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; trazodone  50  mg ; multivitamins w minerals  1  tab ; vancomycin oral liquid  125  mg ; metronidazole  500  mg ; 
actinic keratosis personal history of nicotine dependence abnormal weight loss thrombocytopenia, unspecified myelodysplastic syndrome, unspecified personal history of pneumonia (recurrent) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease esophageal obstruction obesity, unspecified dependence on supplemental oxygen unilateral primary osteoarthritis, right knee seborrheic dermatitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris constipation, unspecified hyperlipidemia, unspecified unspecified hearing loss, bilateral other dysphagia barrett's esophagus without dysplasia pneumonitis due to inhalation of food and vomit spinal stenosis, cervical region chronic kidney disease, stage 2 (mild) hypovolemia chronic obstructive pulmonary disease with (acute) exacerbation major depressive disorder, single episode, unspecified acute and chronic respiratory failure with hypoxia alcohol dependence, in remission history of falling dependence on supplemental oxygen unilateral primary osteoarthritis, right knee major depressive disorder, single episode, unspecified obesity, unspecified esophageal obstruction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease peripheral vascular disease, unspecified idiopathic gout, right ankle and foot chronic obstructive pulmonary disease, unspecified history of falling dysphagia, unspecified idiopathic gout, left ankle and foot pneumonitis due to inhalation of food and vomit body mass index (bmi) 32.0-32.9, adult barrett's esophagus without dysplasia chronic respiratory failure with hypoxia other specified hearing loss, bilateral atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified chronic kidney disease, stage 2 (mild) hyperlipidemia, unspecified
white m 91 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; omeprazole  20  mg ; fluoxetine  10  mg ; atenolol  50  mg ; aspirin  81  mg ; heparin  5000  unit ; simvastatin  10  mg ; prednisone  40  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; trazodone  50  mg ; multivitamins w minerals  1  tab ; metronidazole  500  mg ; phosphorus  500  mg ; levofloxacin  750  mg ; 
actinic keratosis personal history of nicotine dependence abnormal weight loss thrombocytopenia, unspecified myelodysplastic syndrome, unspecified personal history of pneumonia (recurrent) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease esophageal obstruction obesity, unspecified dependence on supplemental oxygen unilateral primary osteoarthritis, right knee seborrheic dermatitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris constipation, unspecified hyperlipidemia, unspecified unspecified hearing loss, bilateral other dysphagia barrett's esophagus without dysplasia pneumonitis due to inhalation of food and vomit spinal stenosis, cervical region chronic kidney disease, stage 2 (mild) hypovolemia chronic obstructive pulmonary disease with (acute) exacerbation major depressive disorder, single episode, unspecified acute and chronic respiratory failure with hypoxia alcohol dependence, in remission history of falling dependence on supplemental oxygen unilateral primary osteoarthritis, right knee major depressive disorder, single episode, unspecified obesity, unspecified esophageal obstruction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease peripheral vascular disease, unspecified idiopathic gout, right ankle and foot chronic obstructive pulmonary disease, unspecified history of falling dysphagia, unspecified idiopathic gout, left ankle and foot pneumonitis due to inhalation of food and vomit body mass index (bmi) 32.0-32.9, adult barrett's esophagus without dysplasia chronic respiratory failure with hypoxia other specified hearing loss, bilateral atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified chronic kidney disease, stage 2 (mild) hyperlipidemia, unspecified
white m 91 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  94  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; omeprazole  20  mg ; fluoxetine  10  mg ; atenolol  50  mg ; aspirin  81  mg ; heparin  5000  unit ; simvastatin  10  mg ; prednisone  40  mg ; multivitamins w minerals  1  tab ; metronidazole  500  mg ; phosphorus  500  mg ; levofloxacin  750  mg ; 
actinic keratosis personal history of nicotine dependence abnormal weight loss thrombocytopenia, unspecified myelodysplastic syndrome, unspecified personal history of pneumonia (recurrent) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease esophageal obstruction obesity, unspecified dependence on supplemental oxygen unilateral primary osteoarthritis, right knee seborrheic dermatitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris constipation, unspecified hyperlipidemia, unspecified unspecified hearing loss, bilateral other dysphagia barrett's esophagus without dysplasia pneumonitis due to inhalation of food and vomit spinal stenosis, cervical region chronic kidney disease, stage 2 (mild) hypovolemia chronic obstructive pulmonary disease with (acute) exacerbation major depressive disorder, single episode, unspecified acute and chronic respiratory failure with hypoxia alcohol dependence, in remission history of falling dependence on supplemental oxygen unilateral primary osteoarthritis, right knee major depressive disorder, single episode, unspecified obesity, unspecified esophageal obstruction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease peripheral vascular disease, unspecified idiopathic gout, right ankle and foot chronic obstructive pulmonary disease, unspecified history of falling dysphagia, unspecified idiopathic gout, left ankle and foot pneumonitis due to inhalation of food and vomit body mass index (bmi) 32.0-32.9, adult barrett's esophagus without dysplasia chronic respiratory failure with hypoxia other specified hearing loss, bilateral atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified chronic kidney disease, stage 2 (mild) hyperlipidemia, unspecified
white m 91 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; omeprazole  20  mg ; fluoxetine  10  mg ; atenolol  50  mg ; aspirin  81  mg ; heparin  5000  unit ; simvastatin  10  mg ; prednisone  40  mg ; multivitamins w minerals  1  tab ; metronidazole  500  mg ; phosphorus  500  mg ; levofloxacin  750  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
actinic keratosis personal history of nicotine dependence abnormal weight loss thrombocytopenia, unspecified myelodysplastic syndrome, unspecified personal history of pneumonia (recurrent) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease esophageal obstruction obesity, unspecified dependence on supplemental oxygen unilateral primary osteoarthritis, right knee seborrheic dermatitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris constipation, unspecified hyperlipidemia, unspecified unspecified hearing loss, bilateral other dysphagia barrett's esophagus without dysplasia pneumonitis due to inhalation of food and vomit spinal stenosis, cervical region chronic kidney disease, stage 2 (mild) hypovolemia chronic obstructive pulmonary disease with (acute) exacerbation major depressive disorder, single episode, unspecified acute and chronic respiratory failure with hypoxia alcohol dependence, in remission history of falling dependence on supplemental oxygen unilateral primary osteoarthritis, right knee major depressive disorder, single episode, unspecified obesity, unspecified esophageal obstruction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease peripheral vascular disease, unspecified idiopathic gout, right ankle and foot chronic obstructive pulmonary disease, unspecified history of falling dysphagia, unspecified idiopathic gout, left ankle and foot pneumonitis due to inhalation of food and vomit body mass index (bmi) 32.0-32.9, adult barrett's esophagus without dysplasia chronic respiratory failure with hypoxia other specified hearing loss, bilateral atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified chronic kidney disease, stage 2 (mild) hyperlipidemia, unspecified
white m 91 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  95  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  85  mg dl; hematology blood bands  1  %$sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; omeprazole  20  mg ; fluoxetine  10  mg ; atenolol  50  mg ; aspirin  81  mg ; heparin  5000  unit ; simvastatin  10  mg ; multivitamins w minerals  1  tab ; metronidazole  500  mg ; levofloxacin  750  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
actinic keratosis personal history of nicotine dependence abnormal weight loss thrombocytopenia, unspecified myelodysplastic syndrome, unspecified personal history of pneumonia (recurrent) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease esophageal obstruction obesity, unspecified dependence on supplemental oxygen unilateral primary osteoarthritis, right knee seborrheic dermatitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris constipation, unspecified hyperlipidemia, unspecified unspecified hearing loss, bilateral other dysphagia barrett's esophagus without dysplasia pneumonitis due to inhalation of food and vomit spinal stenosis, cervical region chronic kidney disease, stage 2 (mild) hypovolemia chronic obstructive pulmonary disease with (acute) exacerbation major depressive disorder, single episode, unspecified acute and chronic respiratory failure with hypoxia alcohol dependence, in remission history of falling dependence on supplemental oxygen unilateral primary osteoarthritis, right knee major depressive disorder, single episode, unspecified obesity, unspecified esophageal obstruction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease peripheral vascular disease, unspecified idiopathic gout, right ankle and foot chronic obstructive pulmonary disease, unspecified history of falling dysphagia, unspecified idiopathic gout, left ankle and foot pneumonitis due to inhalation of food and vomit body mass index (bmi) 32.0-32.9, adult barrett's esophagus without dysplasia chronic respiratory failure with hypoxia other specified hearing loss, bilateral atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified chronic kidney disease, stage 2 (mild) hyperlipidemia, unspecified
white m 91 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  84  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; omeprazole  20  mg ; fluoxetine  10  mg ; atenolol  50  mg ; aspirin  81  mg ; heparin  5000  unit ; simvastatin  10  mg ; multivitamins w minerals  1  tab ; metronidazole  500  mg ; levofloxacin  750  mg ; 
actinic keratosis personal history of nicotine dependence abnormal weight loss thrombocytopenia, unspecified myelodysplastic syndrome, unspecified personal history of pneumonia (recurrent) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease esophageal obstruction obesity, unspecified dependence on supplemental oxygen unilateral primary osteoarthritis, right knee seborrheic dermatitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris constipation, unspecified hyperlipidemia, unspecified unspecified hearing loss, bilateral other dysphagia barrett's esophagus without dysplasia pneumonitis due to inhalation of food and vomit spinal stenosis, cervical region chronic kidney disease, stage 2 (mild) hypovolemia chronic obstructive pulmonary disease with (acute) exacerbation major depressive disorder, single episode, unspecified acute and chronic respiratory failure with hypoxia alcohol dependence, in remission history of falling dependence on supplemental oxygen unilateral primary osteoarthritis, right knee major depressive disorder, single episode, unspecified obesity, unspecified esophageal obstruction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease peripheral vascular disease, unspecified idiopathic gout, right ankle and foot chronic obstructive pulmonary disease, unspecified history of falling dysphagia, unspecified idiopathic gout, left ankle and foot pneumonitis due to inhalation of food and vomit body mass index (bmi) 32.0-32.9, adult barrett's esophagus without dysplasia chronic respiratory failure with hypoxia other specified hearing loss, bilateral atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified chronic kidney disease, stage 2 (mild) hyperlipidemia, unspecified
white m 91 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; omeprazole  20  mg ; fluoxetine  10  mg ; atenolol  50  mg ; aspirin  81  mg ; heparin  5000  unit ; simvastatin  10  mg ; multivitamins w minerals  1  tab ; 
actinic keratosis personal history of nicotine dependence abnormal weight loss thrombocytopenia, unspecified myelodysplastic syndrome, unspecified personal history of pneumonia (recurrent) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease esophageal obstruction obesity, unspecified dependence on supplemental oxygen unilateral primary osteoarthritis, right knee seborrheic dermatitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris constipation, unspecified hyperlipidemia, unspecified unspecified hearing loss, bilateral other dysphagia barrett's esophagus without dysplasia pneumonitis due to inhalation of food and vomit spinal stenosis, cervical region chronic kidney disease, stage 2 (mild) hypovolemia chronic obstructive pulmonary disease with (acute) exacerbation major depressive disorder, single episode, unspecified acute and chronic respiratory failure with hypoxia alcohol dependence, in remission history of falling dependence on supplemental oxygen unilateral primary osteoarthritis, right knee major depressive disorder, single episode, unspecified obesity, unspecified esophageal obstruction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease peripheral vascular disease, unspecified idiopathic gout, right ankle and foot chronic obstructive pulmonary disease, unspecified history of falling dysphagia, unspecified idiopathic gout, left ankle and foot pneumonitis due to inhalation of food and vomit body mass index (bmi) 32.0-32.9, adult barrett's esophagus without dysplasia chronic respiratory failure with hypoxia other specified hearing loss, bilateral atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified chronic kidney disease, stage 2 (mild) hyperlipidemia, unspecified
white m 91 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; omeprazole  20  mg ; fluoxetine  10  mg ; atenolol  50  mg ; aspirin  81  mg ; heparin  5000  unit ; simvastatin  10  mg ; multivitamins w minerals  1  tab ; 
actinic keratosis personal history of nicotine dependence abnormal weight loss thrombocytopenia, unspecified myelodysplastic syndrome, unspecified personal history of pneumonia (recurrent) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease esophageal obstruction obesity, unspecified dependence on supplemental oxygen unilateral primary osteoarthritis, right knee seborrheic dermatitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris constipation, unspecified hyperlipidemia, unspecified unspecified hearing loss, bilateral other dysphagia barrett's esophagus without dysplasia pneumonitis due to inhalation of food and vomit spinal stenosis, cervical region chronic kidney disease, stage 2 (mild) hypovolemia chronic obstructive pulmonary disease with (acute) exacerbation major depressive disorder, single episode, unspecified acute and chronic respiratory failure with hypoxia alcohol dependence, in remission history of falling dependence on supplemental oxygen unilateral primary osteoarthritis, right knee major depressive disorder, single episode, unspecified obesity, unspecified esophageal obstruction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease peripheral vascular disease, unspecified idiopathic gout, right ankle and foot chronic obstructive pulmonary disease, unspecified history of falling dysphagia, unspecified idiopathic gout, left ankle and foot pneumonitis due to inhalation of food and vomit body mass index (bmi) 32.0-32.9, adult barrett's esophagus without dysplasia chronic respiratory failure with hypoxia other specified hearing loss, bilateral atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified chronic kidney disease, stage 2 (mild) hyperlipidemia, unspecified
white m 91 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; omeprazole  20  mg ; fluoxetine  10  mg ; atenolol  50  mg ; aspirin  81  mg ; heparin  5000  unit ; simvastatin  10  mg ; multivitamins w minerals  1  tab ; 
actinic keratosis personal history of nicotine dependence abnormal weight loss thrombocytopenia, unspecified myelodysplastic syndrome, unspecified personal history of pneumonia (recurrent) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease esophageal obstruction obesity, unspecified dependence on supplemental oxygen unilateral primary osteoarthritis, right knee seborrheic dermatitis, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris constipation, unspecified hyperlipidemia, unspecified unspecified hearing loss, bilateral other dysphagia barrett's esophagus without dysplasia pneumonitis due to inhalation of food and vomit spinal stenosis, cervical region chronic kidney disease, stage 2 (mild) hypovolemia chronic obstructive pulmonary disease with (acute) exacerbation major depressive disorder, single episode, unspecified acute and chronic respiratory failure with hypoxia alcohol dependence, in remission history of falling dependence on supplemental oxygen unilateral primary osteoarthritis, right knee major depressive disorder, single episode, unspecified obesity, unspecified esophageal obstruction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease peripheral vascular disease, unspecified idiopathic gout, right ankle and foot chronic obstructive pulmonary disease, unspecified history of falling dysphagia, unspecified idiopathic gout, left ankle and foot pneumonitis due to inhalation of food and vomit body mass index (bmi) 32.0-32.9, adult barrett's esophagus without dysplasia chronic respiratory failure with hypoxia other specified hearing loss, bilateral atherosclerotic heart disease of native coronary artery without angina pectoris hypotension, unspecified chronic kidney disease, stage 2 (mild) hyperlipidemia, unspecified
white f 91 $temp  97.2  heartrate  75.0  resprate  18.0  o2sat  88.0  sbp  156.0  dbp  67.0  rhythm    pain  uta  ; temp    heartrate  73.0  resprate  17.0  o2sat  95.0  sbp  158.0  dbp  62.0  rhythm    pain  uta  ; temp  97.6  heartrate  75.0  resprate  16.0  o2sat  99.0  sbp  121.0  dbp  49.0  rhythm    pain  sleeping  ; temp  97.6  heartrate  79.0  resprate  18.0  o2sat  93.0  sbp  157.0  dbp  81.0  rhythm    pain    ; temp  98.4  heartrate  79.0  resprate  16.0  o2sat  96.0  sbp  157.0  dbp  61.0  rhythm    pain    ; temp  98.4  heartrate  75.0  resprate  16.0  o2sat  94.0  sbp  152.0  dbp  61.0  rhythm    pain    ; temp  98.4  heartrate  78.0  resprate  20.0  o2sat  97.0  sbp  130.0  dbp  62.0  rhythm    pain    ; temp    heartrate  80.0  resprate  22.0  o2sat  94.0  sbp  123.0  dbp  58.0  rhythm    pain    ; temp    heartrate  75.0  resprate  18.0  o2sat  94.0  sbp  125.0  dbp  56.0  rhythm    pain    ; temp    heartrate  75.0  resprate  18.0  o2sat  94.0  sbp  124.0  dbp  52.0  rhythm    pain    ; temp  98.4  heartrate  73.0  resprate  17.0  o2sat  96.0  sbp  124.0  dbp  48.0  rhythm    pain  sleeping  ; temp    heartrate  77.0  resprate  17.0  o2sat    sbp  139.0  dbp  57.0  rhythm    pain  0  $hematology blood hematocrit  39.8  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  92  mg dl; chemistry blood albumin  3.7  g dl; blood gas blood lactate  0.5  mmol l; blood gas blood potassium, whole blood  5.2  meq l$nan
 
white f 91 $temp    heartrate  77.0  resprate  22.0  o2sat  96.0  sbp  152.0  dbp  54.0  rhythm    pain  0  $hematology blood hematocrit  37.1  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  41  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  111  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  1000  mg ; senna  8.6  mg ; ondansetron  4-8  mg ; vial  1  vial ; ceftriaxone  1  gm ; enoxaparin (prophylaxis)  40  mg ; trazodone  12.5  mg ; mirtazapine  30  mg ; ipratropium-albuterol neb  1  neb ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; quetiapine fumarate  25  mg ; amlodipine  2.5  mg ; polyethylene glycol  17  g ; calcium carbonate  500  mg ; miconazole powder 2%  1  appl ; 
 
white f 91 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood glucose  97  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  1000  mg ; senna  8.6  mg ; ondansetron  4-8  mg ; enoxaparin (prophylaxis)  40  mg ; trazodone  12.5  mg ; mirtazapine  30  mg ; ipratropium-albuterol neb  1  neb ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; quetiapine fumarate  25  mg ; amlodipine  2.5  mg ; polyethylene glycol  17  g ; calcium carbonate  500  mg ; miconazole powder 2%  1  appl ; artificial tears  1-2  drop ; 
 
white f 91 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  1000  mg ; senna  8.6  mg ; ondansetron  4-8  mg ; enoxaparin (prophylaxis)  40  mg ; mirtazapine  30  mg ; ipratropium-albuterol neb  1  neb ; amlodipine  2.5  mg ; polyethylene glycol  17  g ; calcium carbonate  500  mg ; miconazole powder 2%  1  appl ; artificial tears  1-2  drop ; 
 
black african american f 24 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  286  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; hematology urine wbc  0-2  # hpf; hematology urine wbc  3-5  # hpf; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  162  mg dl; hematology urine glucose  neg  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl; hematology urine bilirubin  neg  mg dl$nan
 
black african american f 24 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  101  mg dl$docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; nephrocaps  1  cap ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  1000  mg ; 
 
black african american f 24 $nan$nan$docusate sodium  100  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; nephrocaps  1  cap ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  1000  mg ; ondansetron  4  mg ; 
 
black african american f 24 $nan$nan$docusate sodium  100  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; nephrocaps  1  cap ; 0.9% sodium chloride  1000  ml ; acetaminophen  1000  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; 
 
black african american f 24 $nan$nan$docusate sodium  100  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; nephrocaps  1  cap ; 0.9% sodium chloride  1000  ml ; acetaminophen  1000  mg ; metoclopramide  10  mg ; 
 
white m 47 $temp  99.0  heartrate  95.0  resprate  18.0  o2sat  98.0  sbp  126.0  dbp  73.0  rhythm    pain  4  ; temp  98.9  heartrate  90.0  resprate  16.0  o2sat  100.0  sbp  130.0  dbp  76.0  rhythm    pain    $hematology blood hematocrit  41.3  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  238  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  93  mg dl; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.1  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; escitalopram oxalate  10  mg ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; bupropion  150  mg ; sodium chloride 0.9%  1000  ml ; oxycodone (immediate release)   5  mg ; bisacodyl  10  mg ; 
microscopic hematuria acute kidney failure, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other and unspecified noninfectious gastroenteritis and colitis shortness of breath asymptomatic human immunodeficiency virus [hiv] infection status hemangioma of other sites leukocytosis, unspecified depressive disorder, not elsewhere classified acidosis personal history of other infectious and parasitic diseases dehydration long-term (current) use of other medications unspecified hearing loss
white m 47 $nan$hematology blood hematocrit  47.6  %; hematology blood hemoglobin  15.6  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  78  mg dl; blood gas blood lactate  1.2  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; escitalopram oxalate  10  mg ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; bupropion  150  mg ; oxycodone (immediate release)   5  mg ; bisacodyl  10  mg ; complera  1  mg ; 
microscopic hematuria acute kidney failure, unspecified nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other and unspecified noninfectious gastroenteritis and colitis shortness of breath asymptomatic human immunodeficiency virus [hiv] infection status hemangioma of other sites leukocytosis, unspecified depressive disorder, not elsewhere classified acidosis personal history of other infectious and parasitic diseases dehydration long-term (current) use of other medications unspecified hearing loss
white m 73 $temp  98.6  heartrate  100.0  resprate  18.0  o2sat  99.0  sbp  101.0  dbp  64.0  rhythm    pain  0 10  $hematology blood hematocrit  48.1  %; hematology blood hemoglobin  15.7  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  4.7  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  130  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; atenolol  50  mg ; tiotropium bromide  1  cap ; azithromycin  250  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; levalbuterol neb  3  ml ; prednisone  40  mg ; albuterol inhaler  1-2  puff ; chloraseptic throat spray  1  spry ; cepastat (phenol) lozenge  1  loz ; 
 
white m 73 $nan$hematology blood hematocrit  47.8  %; hematology blood hemoglobin  15.6  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  4.7  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  109  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; atenolol  50  mg ; tiotropium bromide  1  cap ; azithromycin  250  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; levalbuterol neb  3  ml ; prednisone  40  mg ; albuterol inhaler  1-2  puff ; chloraseptic throat spray  1  spry ; cepastat (phenol) lozenge  1  loz ; metoprolol tartrate  12.5  mg ; calcium carbonate  500  mg ; 
 
white m 73 $nan$hematology blood hematocrit  48.0  %; hematology blood hemoglobin  15.6  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  4.1  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  100  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; tiotropium bromide  1  cap ; azithromycin  250  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; levalbuterol neb  3  ml ; prednisone  40  mg ; albuterol inhaler  1-2  puff ; chloraseptic throat spray  1  spry ; cepastat (phenol) lozenge  1  loz ; metoprolol tartrate  12.5  mg ; calcium carbonate  500  mg ; sodium chloride nasal  1-2  spry ; metoprolol tartrate  25  mg ; 
 
white m 53 $nan$nan$multivitamin iv  10  ml ; thiamine  100  mg ; 0.9% sodium chloride  1000  ml ; folic acid  1  mg ; oxycodone-acetaminophen  1-2  tab ; morphine sulfate  2  mg ; phenytoin sodium extended  100  mg ; 
 
white f 81 $temp  99.1  heartrate  61.0  resprate  16.0  o2sat  98.0  sbp  135.0  dbp  58.0  rhythm    pain  10  ; temp  98.9  heartrate  64.0  resprate  18.0  o2sat  98.0  sbp  151.0  dbp  78.0  rhythm    pain    $hematology blood hematocrit  39.7  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  21  mg dl; hematology urine wbc  1  # hpf; chemistry blood glucose  102  mg dl$nan
saluretics causing adverse effects in therapeutic use hypopotassemia unspecified essential hypertension other and unspecified hyperlipidemia headache other specified cardiac dysrhythmias hyposmolality and/or hyponatremia spinal stenosis in cervical region hyposmolality and/or hyponatremia unspecified accident accidents occurring in unspecified place other chronic pain unspecified essential hypertension rheumatoid arthritis long-term (current) use of non-steroidal anti-inflammatories (nsaid) pure hypercholesterolemia hydronephrosis other specified sites of sprains and strains long-term (current) use of aspirin lumbago osteoarthrosis, unspecified whether generalized or localized, lower leg 
white m 28 $temp    heartrate  85.0  resprate  16.0  o2sat    sbp  114.0  dbp  73.0  rhythm    pain    ; temp    heartrate  81.0  resprate  14.0  o2sat    sbp  117.0  dbp  68.0  rhythm    pain    ; temp    heartrate  87.0  resprate  13.0  o2sat    sbp  109.0  dbp  66.0  rhythm    pain    ; temp    heartrate  88.0  resprate    o2sat    sbp    dbp    rhythm    pain  0  ; temp    heartrate    resprate    o2sat    sbp  122.0  dbp  76.0  rhythm    pain    ; temp  98.4  heartrate  94.0  resprate  19.0  o2sat  96.0  sbp  124.0  dbp  46.0  rhythm    pain  0  ; temp  98.4  heartrate  90.0  resprate  19.0  o2sat  96.0  sbp  117.0  dbp  49.0  rhythm    pain  0  $hematology blood hematocrit  47.9  %; hematology blood hemoglobin  15.6  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  68  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  500  mg ; heparin  5000  unit ; docusate sodium  100  mg ; lorazepam  0.5-1  mg ; nicotine patch  14  mg ; 
 
white m 28 $nan$hematology blood hematocrit  42.2  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  7  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  91  mg dl; chemistry blood albumin  2.9  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; lorazepam  0.5-1  mg ; nicotine patch  14  mg ; lactated ringers  1000  ml ; ondansetron  4-8  mg ; neutra-phos  2  pkt ; 
 
white m 28 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; nicotine patch  14  mg ; ondansetron  4-8  mg ; neutra-phos  2  pkt ; 
 
black african american f 70 $nan$hematology blood hematocrit  23.0  %; hematology blood hematocrit  23.2  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  101  k ul; hematology blood platelet count  125  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  116  meq l; chemistry blood creatinine  5.8  mg dl; chemistry blood creatinine  6.3  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.3  ; chemistry urine chloride, urine  65  meq l; chemistry urine creatinine, urine  90  mg dl; chemistry urine potassium, urine  27  meq l; chemistry urine sodium, urine  39  meq l; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  356  mg dl; chemistry blood glucose  189  mg dl; chemistry blood albumin  2.5  g dl; chemistry urine protein creatinine ratio  0.8  ratio; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood chloride, whole blood  121  meq l; blood gas blood chloride, whole blood  114  meq l; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  3.0  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  135  meq l$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; bisacodyl  10  mg ; heparin  5000  unit ; vial  1  vial ; pantoprazole sodium  40  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; 0.9% sodium chloride  50  ml ; cefepime  250  mg ; cosyntropin  250  mcg ; docusate sodium  100  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; 5% dextrose  500  ml ; potassium chloride  40  meq ; miconazole powder 2%  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
 
black african american f 70 $nan$hematology blood hematocrit  23.1  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  111  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  6.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  101  mg dl; blood gas blood lactate  1.0  mmol l$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; bisacodyl  10  mg ; heparin  5000  unit ; vial  1  vial ; pantoprazole sodium  40  mg ; 0.9% sodium chloride  50  ml ; cefepime  250  mg ; cosyntropin  250  mcg ; docusate sodium  100  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; 5% dextrose  500  ml ; potassium chloride  40  meq ; miconazole powder 2%  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  500  ml ; 
 
black african american f 70 $nan$hematology blood hematocrit  22.0  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  106  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  6.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  95  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; bisacodyl  10  mg ; heparin  5000  unit ; docusate sodium  100  mg ; insulin  0  unit ; miconazole powder 2%  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; docusate sodium (liquid)  100  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  22.7  %; hematology blood hematocrit  22.1  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  108  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  116  meq l; chemistry blood chloride  116  meq l; chemistry blood creatinine  6.0  mg dl; chemistry blood creatinine  5.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  62  mg dl; chemistry blood urea nitrogen  65  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  151  mg dl; chemistry blood lactate dehydrogenase (ld)  262  iu l; chemistry blood albumin  2.5  g dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; bisacodyl  10  mg ; heparin  5000  unit ; insulin  0  unit ; miconazole powder 2%  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  1000  ml ; docusate sodium (liquid)  100  mg ; nifedipine cr  30  mg ; nifedipine  10  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; hydralazine  10  mg ; piperacillin-tazobactam na  2.25  g ; 1 2 ns  1000  ml ; sodium bicarbonate  50  meq ; 
 
black african american f 70 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  120  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  117  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  5.5  mg dl; chemistry blood creatinine  5.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.1  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  67  mg dl; chemistry blood urea nitrogen  65  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  514  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; bisacodyl  10  mg ; heparin  5000  unit ; insulin  0  unit ; miconazole powder 2%  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; hydralazine  10  mg ; piperacillin-tazobactam na  2.25  g ; 1 2 ns  1000  ml ; sodium bicarbonate  50  meq ; sodium chloride nasal  1-2  spry ; azithromycin  250  mg ; sw  50  ml ; magnesium sulfate  2  gm ; 
 
black african american f 70 $nan$hematology blood hematocrit  24.6  %; hematology blood hematocrit  24.4  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  111  k ul; hematology blood platelet count  117  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  4.6  mg dl; chemistry blood creatinine  5.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  61  mg dl; chemistry blood urea nitrogen  70  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  476  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; bisacodyl  10  mg ; heparin  5000  unit ; insulin  0  unit ; miconazole powder 2%  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; 1 2 ns  1000  ml ; sodium bicarbonate  50  meq ; sodium chloride nasal  1-2  spry ; azithromycin  250  mg ; sw  50  ml ; magnesium sulfate  2  gm ; lansoprazole oral disintegrating tab  30  mg ; furosemide  40  mg ; furosemide  10  mg ; sodium chloride 0.9%  flush  3  ml ; calcium acetate  667  mg ; metoprolol tartrate  25  mg ; sodium bicarbonate  650  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  4.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  74  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  84  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; heparin  5000  unit ; insulin  0  unit ; miconazole powder 2%  1  appl ; docusate sodium (liquid)  100  mg ; sodium chloride nasal  1-2  spry ; azithromycin  250  mg ; lansoprazole oral disintegrating tab  30  mg ; furosemide  40  mg ; furosemide  10  mg ; sodium chloride 0.9%  flush  3  ml ; calcium acetate  667  mg ; sodium bicarbonate  650  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  4.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  73  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  105  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; heparin  5000  unit ; insulin  0  unit ; miconazole powder 2%  1  appl ; docusate sodium (liquid)  100  mg ; sodium chloride nasal  1-2  spry ; azithromycin  250  mg ; lansoprazole oral disintegrating tab  30  mg ; sodium chloride 0.9%  flush  3  ml ; calcium acetate  667  mg ; sodium bicarbonate  650  mg ; bacitracin ointment  1  appl ; risperidone  1  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  20.8  %; hematology blood hematocrit  20.7  %; hematology blood hematocrit  21.6  %; hematology blood hematocrit  23.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  6.6  g dl; hematology blood hemoglobin  6.8  g dl; hematology blood platelet count  229  k ul; hematology blood platelet count  172  k ul; hematology blood platelet count  193  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  4.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  76  mg dl; chemistry blood urea nitrogen  81  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  111  mg dl; hematology blood bands  0  %$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; heparin  5000  unit ; insulin  0  unit ; miconazole powder 2%  1  appl ; docusate sodium (liquid)  100  mg ; sodium chloride nasal  1-2  spry ; azithromycin  250  mg ; lansoprazole oral disintegrating tab  30  mg ; sodium chloride 0.9%  flush  3  ml ; calcium acetate  667  mg ; sodium bicarbonate  650  mg ; bacitracin ointment  1  appl ; risperidone  1  mg ; oxymetazoline  2  spry ; oxymetazoline  3  spry ; cephalexin  500  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  22.4  %; hematology blood hematocrit  23.5  %; hematology blood hematocrit  23.4  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  72  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  99  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; docusate sodium (liquid)  100  mg ; sodium chloride nasal  1-2  spry ; azithromycin  250  mg ; lansoprazole oral disintegrating tab  30  mg ; calcium acetate  667  mg ; sodium bicarbonate  650  mg ; bacitracin ointment  1  appl ; risperidone  1  mg ; oxymetazoline  3  spry ; cephalexin  500  mg ; metoprolol tartrate  12.5  mg ; epoetin alfa  4000  unit ; 
 
black african american f 70 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  286  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  62  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  101  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; docusate sodium (liquid)  100  mg ; sodium chloride nasal  1-2  spry ; azithromycin  250  mg ; lansoprazole oral disintegrating tab  30  mg ; calcium acetate  667  mg ; sodium bicarbonate  650  mg ; bacitracin ointment  1  appl ; risperidone  1  mg ; oxymetazoline  3  spry ; cephalexin  500  mg ; metoprolol tartrate  12.5  mg ; epoetin alfa  4000  unit ; 
 
black african american f 70 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; docusate sodium (liquid)  100  mg ; sodium chloride nasal  1-2  spry ; lansoprazole oral disintegrating tab  30  mg ; calcium acetate  667  mg ; sodium bicarbonate  650  mg ; bacitracin ointment  1  appl ; risperidone  1  mg ; oxymetazoline  3  spry ; cephalexin  500  mg ; epoetin alfa  4000  unit ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  346  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  60  mg dl; hematology urine wbc  23  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  112  mg dl; chemistry blood albumin  2.9  g dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; docusate sodium (liquid)  100  mg ; sodium chloride nasal  1-2  spry ; lansoprazole oral disintegrating tab  30  mg ; calcium acetate  667  mg ; sodium bicarbonate  650  mg ; bacitracin ointment  1  appl ; risperidone  1  mg ; cephalexin  500  mg ; epoetin alfa  4000  unit ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; prochlorperazine  10  mg ; magnesium oxide  400  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  29.3  %; hematology blood hematocrit  22.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  416  k ul; hematology blood platelet count  348  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  8  # hpf; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  151  mg dl; blood gas blood lactate  1.0  mmol l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  106  mg dl; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  8.5  g dl; blood gas blood hemoglobin  9.1  g dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  145  meq l$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; docusate sodium (liquid)  100  mg ; sodium chloride nasal  1-2  spry ; lansoprazole oral disintegrating tab  30  mg ; calcium acetate  667  mg ; sodium bicarbonate  650  mg ; bacitracin ointment  1  appl ; risperidone  1  mg ; cephalexin  500  mg ; epoetin alfa  4000  unit ; albuterol 0.083% neb soln  1  neb ; prochlorperazine  10  mg ; magnesium oxide  400  mg ; oxymetazoline  1  spry ; cefazolin  1  g ; d5 1 2ns  1000  ml ; metoprolol tartrate  5  mg ; risperidone (disintegrating tablet)  1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  26.0  %; hematology blood hematocrit  29.5  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  305  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  58  mg dl; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  103  mg dl$pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; docusate sodium (liquid)  100  mg ; sodium chloride nasal  1-2  spry ; lansoprazole oral disintegrating tab  30  mg ; calcium acetate  667  mg ; sodium bicarbonate  650  mg ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; albuterol 0.083% neb soln  1  neb ; prochlorperazine  10  mg ; oxymetazoline  1  spry ; cefazolin  1  g ; metoprolol tartrate  5  mg ; risperidone (disintegrating tablet)  1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetylcysteine 20%  600  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  27.0  %; hematology blood hematocrit  29.3  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  330  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  418  mg dl$bisacodyl  10  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; docusate sodium (liquid)  100  mg ; calcium acetate  667  mg ; sodium bicarbonate  650  mg ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; albuterol 0.083% neb soln  1  neb ; prochlorperazine  10  mg ; oxymetazoline  1  spry ; metoprolol tartrate  5  mg ; risperidone (disintegrating tablet)  1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetylcysteine 20%  600  mg ; risperidone (disintegrating tablet)  0.5  mg ; haloperidol  0.5  mg ; metoprolol tartrate  10  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  29.1  %; hematology blood hematocrit  24.5  %; hematology blood hematocrit  25.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  352  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  126  mg dl$bisacodyl  10  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; docusate sodium (liquid)  100  mg ; calcium acetate  667  mg ; sodium bicarbonate  650  mg ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; albuterol 0.083% neb soln  1  neb ; prochlorperazine  10  mg ; oxymetazoline  1  spry ; risperidone (disintegrating tablet)  1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetylcysteine 20%  600  mg ; risperidone (disintegrating tablet)  0.5  mg ; haloperidol  0.5  mg ; metoprolol tartrate  10  mg ; acetaminophen (liquid)  325-650  mg ; 5% dextrose  100  ml ; acetylcysteine (iv)  600  mg ; 5% dextrose  50  ml ; phytonadione  2  mg ; heparin flush (10 units ml)  2  ml ; propofol  1000  mg ; propofol  200  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  24.0  %; hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  299  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  82  mg dl; chemistry blood albumin  2.5  g dl$bisacodyl  10  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; docusate sodium (liquid)  100  mg ; calcium acetate  667  mg ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; albuterol 0.083% neb soln  1  neb ; prochlorperazine  10  mg ; risperidone (disintegrating tablet)  1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; metoprolol tartrate  10  mg ; acetaminophen (liquid)  325-650  mg ; 5% dextrose  100  ml ; acetylcysteine (iv)  600  mg ; heparin flush (10 units ml)  2  ml ; propofol  1000  mg ; propofol  200  mg ; 0.9% sodium chloride  250  ml ; acetaminophen  650  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  279  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  92  mg dl$bisacodyl  10  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; albuterol 0.083% neb soln  1  neb ; risperidone (disintegrating tablet)  1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; metoprolol tartrate  10  mg ; 5% dextrose  100  ml ; acetylcysteine (iv)  600  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  650  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  296  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  92  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$bisacodyl  10  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; albuterol 0.083% neb soln  1  neb ; risperidone (disintegrating tablet)  1  mg ; metoprolol tartrate  10  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  650  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  3.1  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine creatinine, urine  128  mg dl; chemistry urine sodium, urine  48  meq l; chemistry blood glucose  106  mg dl$bisacodyl  10  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; albuterol 0.083% neb soln  1  neb ; risperidone (disintegrating tablet)  1  mg ; metoprolol tartrate  10  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  650  mg ; trazodone  25  mg ; pantoprazole  40  mg ; metoprolol tartrate  50  mg ; metoprolol tartrate  75  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  3.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood glucose  106  mg dl$bisacodyl  10  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; albuterol 0.083% neb soln  1  neb ; risperidone (disintegrating tablet)  1  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  650  mg ; trazodone  25  mg ; pantoprazole  40  mg ; metoprolol tartrate  75  mg ; oxycodone (immediate release)   5  mg ; morphine sulfate  1  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  35  mg dl; hematology urine wbc  6-10  # hpf; chemistry blood glucose  86  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$bisacodyl  10  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; albuterol 0.083% neb soln  1  neb ; risperidone (disintegrating tablet)  1  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; morphine sulfate  1  mg ; 
 
black african american f 70 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  3.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood glucose  92  mg dl$bisacodyl  10  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; bacitracin ointment  1  appl ; epoetin alfa  4000  unit ; albuterol 0.083% neb soln  1  neb ; risperidone (disintegrating tablet)  1  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; 
 
white m 80 $nan$hematology blood hematocrit  40.3  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  124  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  110  mg dl$aspirin  81  mg ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride  20  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; dofetilide  500  mcg ; metoprolol tartrate  12.5  mg ; losartan potassium  25  mg ; 
long-term (current) use of aspirin long-term (current) use of anticoagulants paroxysmal ventricular tachycardia other and unspecified hyperlipidemia fitting and adjustment of automatic implantable cardiac defibrillator unspecified essential hypertension unspecified essential hypertension long-term (current) use of aspirin automatic implantable cardiac defibrillator in situ old myocardial infarction coronary atherosclerosis of native coronary artery obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified solitary pulmonary nodule paroxysmal ventricular tachycardia hypoxemia nontoxic uninodular goiter other and unspecified hyperlipidemia insomnia, unspecified paralytic ileus percutaneous transluminal coronary angioplasty status paroxysmal ventricular tachycardia other specified forms of chronic ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation automatic implantable cardiac defibrillator in situ unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) osteoarthrosis, localized, not specified whether primary or secondary, lower leg coronary atherosclerosis of native coronary artery intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) pure hypercholesterolemia coronary atherosclerosis of native coronary artery old myocardial infarction dehydration percutaneous transluminal coronary angioplasty status 
white m 80 $nan$hematology blood hematocrit  41.7  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  108  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  106  mg dl$aspirin  81  mg ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride  20  meq ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; dofetilide  500  mcg ; atorvastatin  40  mg ; quetiapine fumarate  25  mg ; acetaminophen  1000  mg ; 
long-term (current) use of aspirin long-term (current) use of anticoagulants paroxysmal ventricular tachycardia other and unspecified hyperlipidemia fitting and adjustment of automatic implantable cardiac defibrillator unspecified essential hypertension unspecified essential hypertension long-term (current) use of aspirin automatic implantable cardiac defibrillator in situ old myocardial infarction coronary atherosclerosis of native coronary artery obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified solitary pulmonary nodule paroxysmal ventricular tachycardia hypoxemia nontoxic uninodular goiter other and unspecified hyperlipidemia insomnia, unspecified paralytic ileus percutaneous transluminal coronary angioplasty status paroxysmal ventricular tachycardia other specified forms of chronic ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation automatic implantable cardiac defibrillator in situ unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) osteoarthrosis, localized, not specified whether primary or secondary, lower leg coronary atherosclerosis of native coronary artery intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) pure hypercholesterolemia coronary atherosclerosis of native coronary artery old myocardial infarction dehydration percutaneous transluminal coronary angioplasty status 
white m 80 $nan$nan$aspirin  81  mg ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; dofetilide  500  mcg ; atorvastatin  40  mg ; quetiapine fumarate  25  mg ; acetaminophen  1000  mg ; spironolactone  25  mg ; 
long-term (current) use of aspirin long-term (current) use of anticoagulants paroxysmal ventricular tachycardia other and unspecified hyperlipidemia fitting and adjustment of automatic implantable cardiac defibrillator unspecified essential hypertension unspecified essential hypertension long-term (current) use of aspirin automatic implantable cardiac defibrillator in situ old myocardial infarction coronary atherosclerosis of native coronary artery obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified solitary pulmonary nodule paroxysmal ventricular tachycardia hypoxemia nontoxic uninodular goiter other and unspecified hyperlipidemia insomnia, unspecified paralytic ileus percutaneous transluminal coronary angioplasty status paroxysmal ventricular tachycardia other specified forms of chronic ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation automatic implantable cardiac defibrillator in situ unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) osteoarthrosis, localized, not specified whether primary or secondary, lower leg coronary atherosclerosis of native coronary artery intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) pure hypercholesterolemia coronary atherosclerosis of native coronary artery old myocardial infarction dehydration percutaneous transluminal coronary angioplasty status 
black african american m 44 $nan$hematology blood hematocrit  48.8  %; hematology blood hematocrit  48.2  %; hematology blood hematocrit  45.2  %; hematology blood hemoglobin  16.0  g dl; hematology blood hemoglobin  15.4  g dl; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  215  k ul; hematology blood platelet count  195  k ul; hematology blood platelet count  168  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  11.9  mg dl; chemistry blood creatinine  10.7  mg dl; chemistry blood creatinine  11.5  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  7.0  meq l; chemistry blood potassium  6.3  meq l; chemistry blood potassium  7.2  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  4.4  ; hematology blood inr(pt)  4.8  ; hematology blood inr(pt)  4.9  ; hematology blood inr(pt)  5.0  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  85  mg dl; chemistry blood glucose  62  mg dl; blood gas blood lactate  2.8  mmol l$sodium chloride 0.9%  flush  3  ml ; ns  1000  ml ; sevelamer  800  mg ; calcium acetate  1334  mg ; metoprolol tartrate  5  mg ; heparin  1500-3100  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; hydromorphone (dilaudid)  12.5  mg ; risperidone  2  mg ; nephrocaps  1  cap ; hydrocodone-acetaminophen  1-2  tab ; 
 
black african american m 44 $nan$hematology blood hematocrit  43.0  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  9.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  3.4  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  75  mg dl$sodium chloride 0.9%  flush  3  ml ; sevelamer  800  mg ; calcium acetate  1334  mg ; metoprolol tartrate  5  mg ; risperidone  2  mg ; nephrocaps  1  cap ; hydrocodone-acetaminophen  1-2  tab ; allopurinol  100  mg ; olanzapine  15  mg ; warfarin  5  mg ; warfarin  2  mg ; 
 
black african american m 44 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  12.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  10.3  mg dl; chemistry blood glucose  77  mg dl$sodium chloride 0.9%  flush  3  ml ; sevelamer  800  mg ; calcium acetate  1334  mg ; metoprolol tartrate  5  mg ; risperidone  2  mg ; nephrocaps  1  cap ; allopurinol  100  mg ; olanzapine  15  mg ; warfarin  2  mg ; zolpidem tartrate  5  mg ; warfarin  7.5  mg ; nicotine patch  14  mg ; 
 
black african american m 44 $nan$chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  15.2  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  3  ml ; sevelamer  800  mg ; calcium acetate  1334  mg ; metoprolol tartrate  5  mg ; risperidone  2  mg ; nephrocaps  1  cap ; allopurinol  100  mg ; olanzapine  15  mg ; zolpidem tartrate  5  mg ; warfarin  7.5  mg ; nicotine patch  14  mg ; metoprolol tartrate  25  mg ; lorazepam  1  mg ; 
 
black african american m 44 $nan$hematology blood hematocrit  40.8  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  10.4  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  3  ml ; sevelamer  800  mg ; calcium acetate  1334  mg ; risperidone  2  mg ; nephrocaps  1  cap ; allopurinol  100  mg ; olanzapine  15  mg ; zolpidem tartrate  5  mg ; nicotine patch  14  mg ; metoprolol tartrate  25  mg ; lorazepam  1  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; warfarin  1  dose ; heparin  700-1400  unit ; 
 
black african american m 44 $nan$nan$sevelamer  800  mg ; calcium acetate  1334  mg ; risperidone  2  mg ; nephrocaps  1  cap ; allopurinol  100  mg ; olanzapine  15  mg ; zolpidem tartrate  5  mg ; nicotine patch  14  mg ; metoprolol tartrate  25  mg ; lorazepam  1  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; 
 
white m 46 $nan$nan$insulin  11  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled attention deficit disorder with hyperactivity obsessive-compulsive disorders amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation non-healing surgical wound polyneuropathy in diabetes tobacco use disorder other acquired deformities of ankle and foot family history of diabetes mellitus pedal cycle driver injured in noncollision transport accident in nontraffic accident long-term (current) use of insulin infection (chronic) of amputation stump tobacco use disorder other bone involvement in diseases classified elsewhere ulcer of other part of lower limb diabetes with other specified manifestations, type i [juvenile type], not stated as uncontrolled long-term (current) use of insulin infection (chronic) of amputation stump below knee amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hyposmolality and/or hyponatremia polyneuropathy in diabetes unspecified osteomyelitis, lower leg diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled
white m 46 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  393  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  68  mg dl$glucagon  1  mg ; insulin  11  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucose gel  15  g ; ferrous sulfate  325  mg ; cyanocobalamin  50  mcg ; oxycodone (immediate release)   5-10  mg ; insulin  0  unit ; ascorbic acid  500  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; insulin  10  unit ; d5 1 2ns  1000  ml ; 0.45% sodium chloride  1000  ml ; insulin  4  unit ; heparin  5000  unit ; insulin  21  unit ; d5lr  1000  ml ; 
diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled attention deficit disorder with hyperactivity obsessive-compulsive disorders amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation non-healing surgical wound polyneuropathy in diabetes tobacco use disorder other acquired deformities of ankle and foot family history of diabetes mellitus pedal cycle driver injured in noncollision transport accident in nontraffic accident long-term (current) use of insulin infection (chronic) of amputation stump tobacco use disorder other bone involvement in diseases classified elsewhere ulcer of other part of lower limb diabetes with other specified manifestations, type i [juvenile type], not stated as uncontrolled long-term (current) use of insulin infection (chronic) of amputation stump below knee amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hyposmolality and/or hyponatremia polyneuropathy in diabetes unspecified osteomyelitis, lower leg diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled
white m 46 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  430  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  248  mg dl$glucagon  1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucose gel  15  g ; ferrous sulfate  325  mg ; cyanocobalamin  50  mcg ; oxycodone (immediate release)   5-10  mg ; ascorbic acid  500  mg ; heparin  5000  unit ; insulin  21  unit ; d5lr  1000  ml ; lorazepam  0.5  mg ; sodium chloride 0.9%  1000  ml ; 
diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled attention deficit disorder with hyperactivity obsessive-compulsive disorders amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation non-healing surgical wound polyneuropathy in diabetes tobacco use disorder other acquired deformities of ankle and foot family history of diabetes mellitus pedal cycle driver injured in noncollision transport accident in nontraffic accident long-term (current) use of insulin infection (chronic) of amputation stump tobacco use disorder other bone involvement in diseases classified elsewhere ulcer of other part of lower limb diabetes with other specified manifestations, type i [juvenile type], not stated as uncontrolled long-term (current) use of insulin infection (chronic) of amputation stump below knee amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hyposmolality and/or hyponatremia polyneuropathy in diabetes unspecified osteomyelitis, lower leg diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled
white m 46 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  446  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  182  mg dl$glucagon  1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; aspirin  81  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucose gel  15  g ; ferrous sulfate  325  mg ; cyanocobalamin  50  mcg ; oxycodone (immediate release)   5-10  mg ; ascorbic acid  500  mg ; heparin  5000  unit ; insulin  21  unit ; lorazepam  0.5  mg ; sodium chloride 0.9%  1000  ml ; strattera  25  mg ; hydralazine  10  mg ; 
diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled attention deficit disorder with hyperactivity obsessive-compulsive disorders amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation non-healing surgical wound polyneuropathy in diabetes tobacco use disorder other acquired deformities of ankle and foot family history of diabetes mellitus pedal cycle driver injured in noncollision transport accident in nontraffic accident long-term (current) use of insulin infection (chronic) of amputation stump tobacco use disorder other bone involvement in diseases classified elsewhere ulcer of other part of lower limb diabetes with other specified manifestations, type i [juvenile type], not stated as uncontrolled long-term (current) use of insulin infection (chronic) of amputation stump below knee amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hyposmolality and/or hyponatremia polyneuropathy in diabetes unspecified osteomyelitis, lower leg diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled
white m 46 $nan$nan$glucagon  1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; aspirin  81  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucose gel  15  g ; ferrous sulfate  325  mg ; cyanocobalamin  50  mcg ; oxycodone (immediate release)   5-10  mg ; ascorbic acid  500  mg ; heparin  5000  unit ; insulin  21  unit ; lorazepam  0.5  mg ; strattera  25  mg ; lisinopril  20  mg ; insulin  6  unit ; 
diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled attention deficit disorder with hyperactivity obsessive-compulsive disorders amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation non-healing surgical wound polyneuropathy in diabetes tobacco use disorder other acquired deformities of ankle and foot family history of diabetes mellitus pedal cycle driver injured in noncollision transport accident in nontraffic accident long-term (current) use of insulin infection (chronic) of amputation stump tobacco use disorder other bone involvement in diseases classified elsewhere ulcer of other part of lower limb diabetes with other specified manifestations, type i [juvenile type], not stated as uncontrolled long-term (current) use of insulin infection (chronic) of amputation stump below knee amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hyposmolality and/or hyponatremia polyneuropathy in diabetes unspecified osteomyelitis, lower leg diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled
white m 46 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  549  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  96  mg dl$glucagon  1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; aspirin  81  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucose gel  15  g ; ferrous sulfate  325  mg ; cyanocobalamin  50  mcg ; oxycodone (immediate release)   5-10  mg ; ascorbic acid  500  mg ; heparin  5000  unit ; insulin  21  unit ; lorazepam  0.5  mg ; strattera  25  mg ; lisinopril  20  mg ; insulin  6  unit ; 
diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled attention deficit disorder with hyperactivity obsessive-compulsive disorders amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation non-healing surgical wound polyneuropathy in diabetes tobacco use disorder other acquired deformities of ankle and foot family history of diabetes mellitus pedal cycle driver injured in noncollision transport accident in nontraffic accident long-term (current) use of insulin infection (chronic) of amputation stump tobacco use disorder other bone involvement in diseases classified elsewhere ulcer of other part of lower limb diabetes with other specified manifestations, type i [juvenile type], not stated as uncontrolled long-term (current) use of insulin infection (chronic) of amputation stump below knee amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hyposmolality and/or hyponatremia polyneuropathy in diabetes unspecified osteomyelitis, lower leg diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled
white m 46 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  698  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  201  mg dl; chemistry blood glucose  123  mg dl$glucagon  1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; aspirin  81  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucose gel  15  g ; ferrous sulfate  325  mg ; cyanocobalamin  50  mcg ; oxycodone (immediate release)   5-10  mg ; ascorbic acid  500  mg ; heparin  5000  unit ; insulin  21  unit ; lorazepam  0.5  mg ; strattera  25  mg ; lisinopril  20  mg ; 
diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled attention deficit disorder with hyperactivity obsessive-compulsive disorders amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation non-healing surgical wound polyneuropathy in diabetes tobacco use disorder other acquired deformities of ankle and foot family history of diabetes mellitus pedal cycle driver injured in noncollision transport accident in nontraffic accident long-term (current) use of insulin infection (chronic) of amputation stump tobacco use disorder other bone involvement in diseases classified elsewhere ulcer of other part of lower limb diabetes with other specified manifestations, type i [juvenile type], not stated as uncontrolled long-term (current) use of insulin infection (chronic) of amputation stump below knee amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hyposmolality and/or hyponatremia polyneuropathy in diabetes unspecified osteomyelitis, lower leg diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled
white m 46 $nan$nan$glucagon  1  mg ; aspirin  81  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucose gel  15  g ; ferrous sulfate  325  mg ; cyanocobalamin  50  mcg ; oxycodone (immediate release)   5-10  mg ; ascorbic acid  500  mg ; heparin  5000  unit ; insulin  21  unit ; lorazepam  0.5  mg ; strattera  25  mg ; lisinopril  20  mg ; 
diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled attention deficit disorder with hyperactivity obsessive-compulsive disorders amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation non-healing surgical wound polyneuropathy in diabetes tobacco use disorder other acquired deformities of ankle and foot family history of diabetes mellitus pedal cycle driver injured in noncollision transport accident in nontraffic accident long-term (current) use of insulin infection (chronic) of amputation stump tobacco use disorder other bone involvement in diseases classified elsewhere ulcer of other part of lower limb diabetes with other specified manifestations, type i [juvenile type], not stated as uncontrolled long-term (current) use of insulin infection (chronic) of amputation stump below knee amputation status amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hyposmolality and/or hyponatremia polyneuropathy in diabetes unspecified osteomyelitis, lower leg diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled
white m 63 $nan$nan$citalopram hydrobromide  20  mg ; rosuvastatin calcium  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; multivitamins  1  tab ; omeprazole  20  mg ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 63 $nan$hematology blood hematocrit  29.5  %; hematology blood hematocrit  28.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  113  k ul; hematology blood platelet count  114  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  29  mg dl; chemistry urine creatinine, urine  155  mg dl; chemistry urine sodium, urine  18  meq l; chemistry urine urea nitrogen, urine  799  mg dl; hematology urine wbc  6  # hpf; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  99  mg dl; hematology blood bands  8  %; blood gas blood lactate  2.3  mmol l$citalopram hydrobromide  20  mg ; rosuvastatin calcium  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; multivitamins  1  tab ; omeprazole  20  mg ; heparin  5000  unit ; fluticasone-salmeterol (250 50)   1  inh ; fluticasone propionate 110mcg  2  puff ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; albuterol mdi  2  puff ; lorazepam  0.5  mg ; gabapentin  300  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; vancomycin oral liquid  250  mg ; ns  1000  ml ; ns (mini bag plus)  100  ml ; ceftazidime  2  g ; sw  100  ml ; magnesium sulfate  4  gm ; ns  500  ml ; potassium chloride  40  meq ; acetaminophen  500-1000  mg ; morphine sulfate  2-4  mg ; potassium chloride  60  meq ; acetaminophen  1000  mg ; vial  1  vial ; filgrastim  480  mcg ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 63 $nan$hematology blood hematocrit  28.4  %; hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  110  k ul; hematology blood platelet count  100  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  91  iu l; chemistry blood albumin  2.6  g dl; hematology blood bands  16  %; hematology blood bands  6  %; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood lactate  3.2  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood potassium, whole blood  3.6  meq l$citalopram hydrobromide  20  mg ; rosuvastatin calcium  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; multivitamins  1  tab ; omeprazole  20  mg ; heparin  5000  unit ; fluticasone-salmeterol (250 50)   1  inh ; fluticasone propionate 110mcg  2  puff ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; albuterol mdi  2  puff ; gabapentin  300  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; vancomycin oral liquid  250  mg ; ns (mini bag plus)  100  ml ; ceftazidime  2  g ; sw  100  ml ; magnesium sulfate  4  gm ; ns  500  ml ; potassium chloride  40  meq ; morphine sulfate  2-4  mg ; potassium chloride  60  meq ; acetaminophen  1000  mg ; vial  1  vial ; filgrastim  480  mcg ; lr  1000  ml ; neutra-phos  1  pkt ; oxycodone (immediate release)   5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; metoprolol tartrate  5  mg ; diltiazem  10  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; metoprolol tartrate  25  mg ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 63 $nan$hematology blood hematocrit  30.7  %; hematology blood hematocrit  26.2  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  87  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  76  mg dl$citalopram hydrobromide  20  mg ; rosuvastatin calcium  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; multivitamins  1  tab ; omeprazole  20  mg ; heparin  5000  unit ; fluticasone-salmeterol (250 50)   1  inh ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; morphine sulfate  2-4  mg ; acetaminophen  1000  mg ; vial  1  vial ; filgrastim  480  mcg ; lr  1000  ml ; neutra-phos  1  pkt ; oxycodone (immediate release)   5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; metoprolol tartrate  5  mg ; diltiazem  10  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; metoprolol tartrate  25  mg ; heparin flush (10 units ml)  2  ml ; lorazepam  1  mg ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 63 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  110  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  72  mg dl; chemistry blood albumin  2.6  g dl$citalopram hydrobromide  20  mg ; rosuvastatin calcium  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; multivitamins  1  tab ; omeprazole  20  mg ; heparin  5000  unit ; fluticasone-salmeterol (250 50)   1  inh ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; morphine sulfate  2-4  mg ; acetaminophen  1000  mg ; vial  1  vial ; filgrastim  480  mcg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; metoprolol tartrate  25  mg ; lorazepam  1  mg ; simethicone  40-80  mg ; oxycodone (immediate release)   10  mg ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 63 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry urine chloride, urine  104  meq l; chemistry urine creatinine, urine  210  mg dl; chemistry urine potassium, urine  34  meq l; chemistry urine sodium, urine  23  meq l; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  68  mg dl$citalopram hydrobromide  20  mg ; rosuvastatin calcium  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; multivitamins  1  tab ; omeprazole  20  mg ; heparin  5000  unit ; fluticasone-salmeterol (250 50)   1  inh ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; morphine sulfate  2-4  mg ; acetaminophen  1000  mg ; vial  1  vial ; filgrastim  480  mcg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; metoprolol tartrate  25  mg ; lorazepam  1  mg ; simethicone  40-80  mg ; oxycodone (immediate release)   10  mg ; simethicone  80  mg ; vancomycin oral liquid  500  mg ; oxycodone (immediate release)   5-10  mg ; sw  50  ml ; potassium chloride  20  meq ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 63 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  88  mg dl$citalopram hydrobromide  20  mg ; rosuvastatin calcium  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; multivitamins  1  tab ; omeprazole  20  mg ; heparin  5000  unit ; fluticasone-salmeterol (250 50)   1  inh ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; morphine sulfate  2-4  mg ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; metoprolol tartrate  25  mg ; lorazepam  1  mg ; simethicone  80  mg ; vancomycin oral liquid  500  mg ; oxycodone (immediate release)   5-10  mg ; sw  50  ml ; potassium chloride  20  meq ; metoprolol tartrate  2.5  mg ; pantoprazole sodium  40  mg ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 63 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  72  mg dl$citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; heparin  5000  unit ; fluticasone-salmeterol (250 50)   1  inh ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; morphine sulfate  2-4  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; lorazepam  1  mg ; vancomycin oral liquid  500  mg ; sw  50  ml ; potassium chloride  20  meq ; metoprolol tartrate  2.5  mg ; pantoprazole sodium  40  mg ; lorazepam  0.5-1  mg ; nystatin oral suspension  5  ml ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 63 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  299  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  147  mg dl$citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; heparin  5000  unit ; fluticasone-salmeterol (250 50)   1  inh ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; morphine sulfate  2-4  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; vancomycin oral liquid  500  mg ; sw  50  ml ; potassium chloride  20  meq ; metoprolol tartrate  2.5  mg ; pantoprazole sodium  40  mg ; lorazepam  0.5-1  mg ; nystatin oral suspension  5  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; tramadol (ultram)  50  mg ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 63 $nan$hematology blood hematocrit  31.0  %; hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  351  k ul; hematology blood platelet count  399  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  107  mg dl$citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; heparin  5000  unit ; fluticasone-salmeterol (250 50)   1  inh ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; vancomycin oral liquid  500  mg ; sw  50  ml ; potassium chloride  20  meq ; metoprolol tartrate  2.5  mg ; nystatin oral suspension  5  ml ; acetaminophen  325-650  mg ; tramadol (ultram)  50  mg ; gabapentin  600  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 63 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  442  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  85  mg dl; chemistry blood lactate dehydrogenase (ld)  116  iu l; chemistry blood albumin  2.9  g dl$citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; heparin  5000  unit ; fluticasone-salmeterol (250 50)   1  inh ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; vancomycin oral liquid  500  mg ; sw  50  ml ; potassium chloride  20  meq ; metoprolol tartrate  2.5  mg ; nystatin oral suspension  5  ml ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 63 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  474  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  89  mg dl$citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; fluticasone-salmeterol (250 50)   1  inh ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; vancomycin oral liquid  500  mg ; sw  50  ml ; potassium chloride  20  meq ; metoprolol tartrate  2.5  mg ; nystatin oral suspension  5  ml ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; rifaximin  400  mg ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 63 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  483  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  122  mg dl$citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; fluticasone-salmeterol (250 50)   1  inh ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; vancomycin oral liquid  500  mg ; sw  50  ml ; potassium chloride  20  meq ; metoprolol tartrate  2.5  mg ; nystatin oral suspension  5  ml ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; rifaximin  400  mg ; furosemide  20  mg ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 63 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  467  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  115  mg dl$citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; fluticasone-salmeterol (250 50)   1  inh ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; vancomycin oral liquid  500  mg ; sw  50  ml ; potassium chloride  20  meq ; metoprolol tartrate  2.5  mg ; nystatin oral suspension  5  ml ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; rifaximin  400  mg ; furosemide  20  mg ; maalox diphenhydramine lidocaine  15-30  ml ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 63 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  469  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  101  mg dl$citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; fluticasone-salmeterol (250 50)   1  inh ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; vancomycin oral liquid  500  mg ; sw  50  ml ; potassium chloride  20  meq ; metoprolol tartrate  2.5  mg ; nystatin oral suspension  5  ml ; acetaminophen  325-650  mg ; rifaximin  400  mg ; furosemide  20  mg ; maalox diphenhydramine lidocaine  15-30  ml ; olanzapine  5  mg ; pantoprazole  40  mg ; metoprolol succinate xl  50  mg ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 63 $nan$nan$citalopram hydrobromide  20  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; fluticasone-salmeterol (250 50)   1  inh ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; vancomycin oral liquid  500  mg ; sw  50  ml ; potassium chloride  20  meq ; nystatin oral suspension  5  ml ; acetaminophen  325-650  mg ; rifaximin  400  mg ; furosemide  20  mg ; maalox diphenhydramine lidocaine  15-30  ml ; olanzapine  5  mg ; pantoprazole  40  mg ; metoprolol succinate xl  50  mg ; 
malignant neoplasm of bronchus and lung, unspecified unspecified essential hypertension cerebral aneurysm, nonruptured esophageal reflux other postprocedural status dyskinesia of esophagus atrial fibrillation other chest pain personal history of tobacco use diarrhea asthma, unspecified type, unspecified cerebral atherosclerosis diaphragmatic hernia without mention of obstruction or gangrene headache peripheral vascular disease, unspecified anxiety state, unspecified esophageal reflux unspecified essential hypertension acquired absence of organ, lung peripheral vascular disease, unspecified personal history of tobacco use personal history of malignant neoplasm of bronchus and lung dizziness and giddiness shortness of breath chest pain, unspecified pure hypercholesterolemia pressure ulcer, lower back personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified personal history of malignant neoplasm of bronchus and lung unspecified essential hypertension personal history of tobacco use dizziness and giddiness pure hypercholesterolemia shortness of breath asthma, unspecified type, unspecified esophageal reflux other chest pain secondary malignant neoplasm of other specified sites malignant neoplasm of other parts of bronchus or lung asthma, unspecified type, unspecified esophageal reflux other complications due to other internal prosthetic device, implant, and graft unspecified essential hypertension disruption of external operation (surgical) wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation empyema with fistula unspecified cerebrovascular disease
white m 52 $temp    heartrate  117.0  resprate  24.0  o2sat  98.0  sbp  130.0  dbp  84.0  rhythm    pain    ; temp  98.2  heartrate  118.0  resprate  21.0  o2sat  97.0  sbp  139.0  dbp  94.0  rhythm    pain  denies  ; temp    heartrate  116.0  resprate  24.0  o2sat  97.0  sbp  135.0  dbp  89.0  rhythm    pain  denies  $hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  296  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  4.6  ; hematology blood inr(pt)  3.3  ; chemistry urine creatinine, urine  151  mg dl; chemistry urine urea nitrogen, urine  1148  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  6.0  mg dl; chemistry blood glucose  122  mg dl; chemistry blood lactate dehydrogenase (ld)  1181  iu l; chemistry blood albumin  2.7  g dl; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood lactate  4.0  mmol l$0.9% sodium chloride  250  ml ; thiamine  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 5% dextrose  50  ml ; phytonadione  10  mg ; sodium chloride 0.9%  flush  3  ml ; ns  100  ml ; metronidazole  500  mg ; sodium chloride 0.9%  flush  10  ml ; dexamethasone  2  mg ; docusate sodium  200  mg ; lorazepam  1-2  mg ; ondansetron  4  mg ; oxycodone (immediate release)  5  mg ; tramadol  50  mg ; bag  2  bag ; magnesium sulfate  4  gm ; sodium phosphate  30  mmol ; lactated ringers  1000  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; glucose gel  15  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; heparin  5000  unit ; 
 
white m 52 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  296  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, indirect  2.0  mg dl; chemistry blood bilirubin, total  8.4  mg dl; chemistry blood glucose  96  mg dl; chemistry blood albumin  2.5  g dl; blood gas blood lactate  2.4  mmol l; chemistry blood bilirubin, direct  6.4  mg dl$0.9% sodium chloride  1  bag ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; sodium chloride 0.9%  flush  3  ml ; ns  100  ml ; metronidazole  500  mg ; sodium chloride 0.9%  flush  10  ml ; dexamethasone  2  mg ; docusate sodium  200  mg ; lorazepam  1-2  mg ; ondansetron  4  mg ; oxycodone (immediate release)  5  mg ; tramadol  50  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; heparin  5000  unit ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; lactulose  30  ml ; calcium carbonate  500  mg ; 
 
white m 52 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood bilirubin, indirect  1.5  mg dl; chemistry blood bilirubin, total  8.2  mg dl; chemistry blood glucose  82  mg dl; chemistry blood bilirubin, direct  6.7  mg dl$0.9% sodium chloride  1  bag ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; sodium chloride 0.9%  flush  3  ml ; ns  100  ml ; metronidazole  500  mg ; sodium chloride 0.9%  flush  10  ml ; dexamethasone  2  mg ; docusate sodium  200  mg ; lorazepam  1-2  mg ; ondansetron  4  mg ; oxycodone (immediate release)  5  mg ; tramadol  50  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; heparin  5000  unit ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; lactulose  30  ml ; calcium carbonate  500  mg ; hydromorphone (dilaudid)  0.125  mg ; 
 
white m 52 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  8.1  mg dl; chemistry blood glucose  71  mg dl$0.9% sodium chloride  250  ml ; thiamine  500  mg ; sodium chloride 0.9%  flush  3  ml ; ns  100  ml ; metronidazole  500  mg ; sodium chloride 0.9%  flush  10  ml ; dexamethasone  2  mg ; docusate sodium  200  mg ; ondansetron  4  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; neutra-phos  1  pkt ; 
 
white m 52 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  10.2  mg dl; chemistry blood bilirubin, total  8.3  mg dl; chemistry blood glucose  70  mg dl$sodium chloride 0.9%  flush  3  ml ; ns  100  ml ; metronidazole  500  mg ; sodium chloride 0.9%  flush  10  ml ; dexamethasone  2  mg ; docusate sodium  200  mg ; ondansetron  4  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; neutra-phos  1  pkt ; ciprofloxacin hcl  500  mg ; hydromorphone (dilaudid)  2  mg ; heparin flush (10 units ml)  10  ml ; 
 
white m 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; dexamethasone  2  mg ; docusate sodium  200  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lactulose  30  ml ; calcium carbonate  500  mg ; ciprofloxacin hcl  500  mg ; heparin flush (10 units ml)  10  ml ; 
 
white f 56 $nan$nan$0.45% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; nitroglycerin sl  0.3  mg ; trazodone  25  mg ; simethicone  40-80  mg ; gabapentin  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  3  mg ; insulin  0  unit ; buprenorphine-naloxone (8mg-2mg)  1  tab ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; lorazepam  0.5-1  mg ; insulin  30  unit ; 
atrial fibrillation coronary atherosclerosis of unspecified type of vessel, native or graft occlusion and stenosis of carotid artery without mention of cerebral infarction tobacco use disorder aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 56 $nan$hematology blood hematocrit  38.1  %; hematology blood platelet count  174  k ul; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.6  $0.45% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; nitroglycerin sl  0.3  mg ; trazodone  25  mg ; simethicone  40-80  mg ; gabapentin  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  3  mg ; insulin  0  unit ; buprenorphine-naloxone (8mg-2mg)  1  tab ; lorazepam  0.5-1  mg ; insulin  30  unit ; aspirin ec  81  mg ; clopidogrel  75  mg ; atorvastatin  20  mg ; ferrous gluconate  324  mg ; folic acid  1  mg ; furosemide  40  mg ; quetiapine fumarate  25  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
atrial fibrillation coronary atherosclerosis of unspecified type of vessel, native or graft occlusion and stenosis of carotid artery without mention of cerebral infarction tobacco use disorder aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 56 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.9  ; chemistry blood glucose  255  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; nitroglycerin sl  0.3  mg ; trazodone  25  mg ; simethicone  40-80  mg ; gabapentin  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; buprenorphine-naloxone (8mg-2mg)  1  tab ; lorazepam  0.5-1  mg ; insulin  30  unit ; aspirin ec  81  mg ; clopidogrel  75  mg ; ferrous gluconate  324  mg ; folic acid  1  mg ; furosemide  40  mg ; quetiapine fumarate  25  mg ; senna  8.6  mg ; docusate sodium  100  mg ; simvastatin  40  mg ; metoprolol tartrate  12.5  mg ; warfarin  2.5  mg ; phytonadione  5  mg ; heparin  1400-2800  unit ; 
atrial fibrillation coronary atherosclerosis of unspecified type of vessel, native or graft occlusion and stenosis of carotid artery without mention of cerebral infarction tobacco use disorder aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 56 $nan$hematology blood hematocrit  30.1  %; hematology blood hematocrit  29.6  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  120  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; nitroglycerin sl  0.3  mg ; trazodone  25  mg ; simethicone  40-80  mg ; gabapentin  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; buprenorphine-naloxone (8mg-2mg)  1  tab ; lorazepam  0.5-1  mg ; insulin  30  unit ; aspirin ec  81  mg ; clopidogrel  75  mg ; ferrous gluconate  324  mg ; folic acid  1  mg ; furosemide  40  mg ; quetiapine fumarate  25  mg ; senna  8.6  mg ; docusate sodium  100  mg ; simvastatin  40  mg ; phytonadione  5  mg ; heparin  1400-2800  unit ; metoprolol succinate xl  25  mg ; lisinopril  2.5  mg ; bag  1  bag ; magnesium sulfate  2  gm ; albuterol 0.083% neb soln  1  neb ; 
atrial fibrillation coronary atherosclerosis of unspecified type of vessel, native or graft occlusion and stenosis of carotid artery without mention of cerebral infarction tobacco use disorder aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 56 $nan$hematology blood hematocrit  28.6  %; hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  149  k ul; hematology blood platelet count  113  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  2  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  11  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  130  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.3  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  1.8  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  3.2  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  90  mg dl; chemistry blood glucose  183  mg dl; hematology blood bands  0  %; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  115  mg dl; blood gas blood glucose  137  mg dl; blood gas blood hematocrit, calculated  27  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hemoglobin  9.0  g dl; blood gas blood hemoglobin  8.5  g dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  134  meq l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; nitroglycerin sl  0.3  mg ; trazodone  25  mg ; simethicone  40-80  mg ; gabapentin  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; buprenorphine-naloxone (8mg-2mg)  1  tab ; lorazepam  0.5-1  mg ; insulin  30  unit ; aspirin ec  81  mg ; clopidogrel  75  mg ; ferrous gluconate  324  mg ; folic acid  1  mg ; furosemide  40  mg ; quetiapine fumarate  25  mg ; senna  8.6  mg ; docusate sodium  100  mg ; simvastatin  40  mg ; heparin  1400-2800  unit ; metoprolol succinate xl  25  mg ; lisinopril  2.5  mg ; bag  1  bag ; magnesium sulfate  2  gm ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
atrial fibrillation coronary atherosclerosis of unspecified type of vessel, native or graft occlusion and stenosis of carotid artery without mention of cerebral infarction tobacco use disorder aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 56 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  134  mg dl$aspirin  81  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; oxycodone (immediate release)   5-10  mg ; warfarin  1  dose ; insulin  15  unit ; 
atrial fibrillation coronary atherosclerosis of unspecified type of vessel, native or graft occlusion and stenosis of carotid artery without mention of cerebral infarction tobacco use disorder aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 56 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  89  mg dl$aspirin  81  mg ; oxycodone (immediate release)   5-10  mg ; warfarin  1  dose ; insulin  15  unit ; insulin  20  unit ; warfarin  5  mg ; 
atrial fibrillation coronary atherosclerosis of unspecified type of vessel, native or graft occlusion and stenosis of carotid artery without mention of cerebral infarction tobacco use disorder aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 56 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  69  mg dl; chemistry blood % hemoglobin a1c  6.8  %$aspirin  81  mg ; oxycodone (immediate release)   5-10  mg ; warfarin  1  dose ; insulin  20  unit ; metformin xr (glucophage xr)  1000  mg ; 
atrial fibrillation coronary atherosclerosis of unspecified type of vessel, native or graft occlusion and stenosis of carotid artery without mention of cerebral infarction tobacco use disorder aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 56 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  91  mg dl$aspirin  81  mg ; oxycodone (immediate release)   5-10  mg ; warfarin  1  dose ; metformin xr (glucophage xr)  1000  mg ; 
atrial fibrillation coronary atherosclerosis of unspecified type of vessel, native or graft occlusion and stenosis of carotid artery without mention of cerebral infarction tobacco use disorder aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 56 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  2.9  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  85  mg dl$aspirin  81  mg ; oxycodone (immediate release)   5-10  mg ; warfarin  1  dose ; magnesium oxide  400  mg ; 
atrial fibrillation coronary atherosclerosis of unspecified type of vessel, native or graft occlusion and stenosis of carotid artery without mention of cerebral infarction tobacco use disorder aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 58 $nan$nan$citalopram hydrobromide  40  mg ; prednisone  60  mg ; simvastatin  40  mg ; levofloxacin  250  mg ; levofloxacin  500  mg ; travatan  1  drop ; 
 
white m 58 $nan$nan$citalopram hydrobromide  40  mg ; prednisone  60  mg ; simvastatin  40  mg ; levofloxacin  250  mg ; levofloxacin  500  mg ; travatan  1  drop ; 1 2 ns  1000  ml ; albuterol-ipratropium  1-2  puff ; fluticasone-salmeterol (250 50)   1  inh ; mucinex  600  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen  1-2  tab ; trazodone  100  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; pantoprazole  40  mg ; quetiapine fumarate  75  mg ; clonazepam  0.5  mg ; 
 
white m 58 $nan$nan$citalopram hydrobromide  40  mg ; simvastatin  40  mg ; levofloxacin  250  mg ; levofloxacin  500  mg ; travatan  1  drop ; fluticasone-salmeterol (250 50)   1  inh ; mucinex  600  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen  1-2  tab ; trazodone  100  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; pantoprazole  40  mg ; quetiapine fumarate  75  mg ; clonazepam  0.5  mg ; oxycodone-acetaminophen  1  tab ; 
 
white m 58 $nan$nan$citalopram hydrobromide  40  mg ; simvastatin  40  mg ; levofloxacin  250  mg ; levofloxacin  500  mg ; travatan  1  drop ; fluticasone-salmeterol (250 50)   1  inh ; mucinex  600  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen  1-2  tab ; trazodone  100  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; pantoprazole  40  mg ; quetiapine fumarate  75  mg ; clonazepam  0.5  mg ; 
 
other f 44 $nan$nan$levothyroxine sodium  25  mcg ; gabapentin  800  mg ; 
acute posthemorrhagic anemia osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh hypovolemia other acute postoperative pain other congenital deformity of hip (joint) other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
other f 44 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  366  k ul$levothyroxine sodium  25  mcg ; gabapentin  800  mg ; hydromorphone (dilaudid)  12.5  mg ; cyclobenzaprine  10  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; bisacodyl  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; oxycodone sr (oxycontin)  40  mg ; enoxaparin sodium  30  mg ; amitriptyline  50  mg ; zolpidem tartrate  10  mg ; fentanyl patch  25  mcg hr ; hydromorphone (dilaudid)  8-12  mg ; 
acute posthemorrhagic anemia osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh hypovolemia other acute postoperative pain other congenital deformity of hip (joint) other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
other f 44 $nan$nan$levothyroxine sodium  25  mcg ; gabapentin  800  mg ; hydromorphone (dilaudid)  12.5  mg ; cyclobenzaprine  10  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; bisacodyl  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; oxycodone sr (oxycontin)  40  mg ; enoxaparin sodium  30  mg ; amitriptyline  50  mg ; zolpidem tartrate  10  mg ; fentanyl patch  25  mcg hr ; hydromorphone (dilaudid)  8-12  mg ; enoxaparin sodium  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
acute posthemorrhagic anemia osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh hypovolemia other acute postoperative pain other congenital deformity of hip (joint) other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
other f 44 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  108  mg dl$levothyroxine sodium  25  mcg ; gabapentin  800  mg ; hydromorphone (dilaudid)  12.5  mg ; cyclobenzaprine  10  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; bisacodyl  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; oxycodone sr (oxycontin)  40  mg ; amitriptyline  50  mg ; zolpidem tartrate  10  mg ; fentanyl patch  25  mcg hr ; hydromorphone (dilaudid)  8-12  mg ; enoxaparin sodium  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ondansetron  4  mg ; 
acute posthemorrhagic anemia osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh hypovolemia other acute postoperative pain other congenital deformity of hip (joint) other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
other f 44 $nan$nan$levothyroxine sodium  25  mcg ; gabapentin  800  mg ; hydromorphone (dilaudid)  12.5  mg ; cyclobenzaprine  10  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; bisacodyl  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; oxycodone sr (oxycontin)  40  mg ; amitriptyline  50  mg ; zolpidem tartrate  10  mg ; fentanyl patch  25  mcg hr ; hydromorphone (dilaudid)  8-12  mg ; enoxaparin sodium  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
acute posthemorrhagic anemia osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh hypovolemia other acute postoperative pain other congenital deformity of hip (joint) other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american f 65 $nan$nan$acetaminophen (liquid)  650  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; oxycodone liquid  10  mg ; heparin  5000  unit ; docusate sodium  100  mg ; acetaminophen  1000  mg ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$hematology blood hematocrit  23.1  %; hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  374  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  116  mg dl$acetaminophen (liquid)  650  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  347  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  152  mg dl$acetaminophen (liquid)  650  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; 0.9% sodium chloride  1000  ml ; risperidone  0.5  mg ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$hematology blood hematocrit  21.9  %; hematology blood hematocrit  21.9  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  408  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  126  mg dl$acetaminophen (liquid)  650  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; 0.9% sodium chloride  1000  ml ; risperidone  0.5  mg ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  403  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  117  mg dl$acetaminophen (liquid)  650  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; risperidone  0.5  mg ; morphine sulfate  0.5  mg ; oxycodone sr (oxycontin)  10  mg ; oxycodone liquid  5-10  mg ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  444  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  138  mg dl$acetaminophen (liquid)  650  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; morphine sulfate  0.5  mg ; oxycodone sr (oxycontin)  10  mg ; oxycodone liquid  5-10  mg ; oxycodone-acetaminophen  1-2  tab ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$hematology blood hematocrit  21.5  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  395  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  116  mg dl$acetaminophen (liquid)  650  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; oxycodone sr (oxycontin)  10  mg ; oxycodone liquid  5-10  mg ; oxycodone-acetaminophen  1-2  tab ; oxycodone-acetaminophen  1  tab ; morphine sr (ms contin)  30  mg ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; morphine sr (ms contin)  30  mg ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$hematology blood hematocrit  19.3  %; hematology blood hemoglobin  6.2  g dl; hematology blood platelet count  388  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; morphine sr (ms contin)  30  mg ; acetaminophen  325-650  mg ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$hematology blood hematocrit  19.9  %; hematology blood hemoglobin  6.5  g dl; hematology blood platelet count  373  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  123  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; morphine sr (ms contin)  30  mg ; acetaminophen  325-650  mg ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$hematology blood hematocrit  20.2  %; hematology blood hemoglobin  6.3  g dl; hematology blood platelet count  402  k ul$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; morphine sr (ms contin)  30  mg ; acetaminophen  325-650  mg ; furosemide  20  mg ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; morphine sr (ms contin)  30  mg ; acetaminophen  325-650  mg ; furosemide  20  mg ; morphine sulfate ir  15  mg ; risperidone  1  mg ; morphine sulfate ir  15-30  mg ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$hematology blood hematocrit  21.1  %; hematology blood hemoglobin  6.7  g dl; hematology blood platelet count  460  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  142  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; morphine sr (ms contin)  30  mg ; acetaminophen  325-650  mg ; morphine sulfate ir  15  mg ; risperidone  1  mg ; morphine sulfate ir  15-30  mg ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; morphine sr (ms contin)  30  mg ; acetaminophen  325-650  mg ; risperidone  1  mg ; morphine sulfate ir  15-30  mg ; lidocaine 5% patch  2  ptch ; morphine sulfate (oral soln.)  10-15  mg ; ibuprofen  400  mg ; fentanyl patch  12  mcg hr ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$hematology blood hematocrit  19.4  %; hematology blood hemoglobin  6.1  g dl; hematology blood platelet count  461  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  132  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; risperidone  1  mg ; lidocaine 5% patch  2  ptch ; morphine sulfate (oral soln.)  10-15  mg ; ibuprofen  400  mg ; fentanyl patch  12  mcg hr ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; risperidone  1  mg ; lidocaine 5% patch  2  ptch ; morphine sulfate (oral soln.)  10-15  mg ; ibuprofen  400  mg ; fentanyl patch  12  mcg hr ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$hematology blood hematocrit  17.9  %$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; risperidone  1  mg ; lidocaine 5% patch  2  ptch ; morphine sulfate (oral soln.)  10-15  mg ; ibuprofen  400  mg ; fentanyl patch  12  mcg hr ; oxycodone-acetaminophen  2  tab ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
black african american f 65 $nan$hematology blood hematocrit  17.7  %$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; risperidone  1  mg ; lidocaine 5% patch  2  ptch ; morphine sulfate (oral soln.)  10-15  mg ; ibuprofen  400  mg ; fentanyl patch  12  mcg hr ; oxycodone-acetaminophen  2  tab ; 
personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal secondary and unspecified malignant neoplasm of lymph nodes of multiple sites unspecified psychosis unspecified essential hypertension malignant neoplasm of liver, secondary anemia in neoplastic disease pathologic fracture of vertebrae secondary malignant neoplasm of lung acute kidney failure, unspecified other and unspecified hyperlipidemia secondary malignant neoplasm of bone and bone marrow secondary malignant neoplasm of other specified sites 
white f 38 $nan$nan$ketorolac  15-30  mg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; hydromorphone (dilaudid)  20  mg ; oxycodone (immediate release)   5-10  mg ; escitalopram oxalate  10  mg ; levothyroxine sodium  125  mcg ; 
 
white f 38 $nan$nan$ketorolac  15-30  mg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)   5-10  mg ; escitalopram oxalate  10  mg ; levothyroxine sodium  125  mcg ; 
 
white f 38 $nan$nan$ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)   5-10  mg ; escitalopram oxalate  10  mg ; levothyroxine sodium  125  mcg ; 
 
white f 38 $nan$nan$ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)   5-10  mg ; escitalopram oxalate  10  mg ; levothyroxine sodium  125  mcg ; 
 
white f 38 $nan$nan$ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)   5-10  mg ; escitalopram oxalate  10  mg ; levothyroxine sodium  125  mcg ; 
 
white f 23 $nan$nan$insulin  10  unit ; 
 
white f 23 $nan$nan$insulin  10  unit ; docusate sodium  100  mg ; calcium carbonate  500  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  30  unit ; 
 
white f 23 $nan$chemistry urine creatinine, urine  64  mg dl; chemistry urine protein creatinine ratio  0.3  ratio; chemistry urine 24 hr creatinine  1344  mg 24hr$docusate sodium  100  mg ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  26  unit ; 
 
white f 23 $nan$hematology blood hematocrit  37.3  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  191  k ul; chemistry blood creatinine  0.5  mg dl; chemistry urine creatinine, urine  76  mg dl; hematology urine wbc  5  # hpf; chemistry urine protein creatinine ratio  0.4  ratio$docusate sodium  100  mg ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  24  unit ; insulin  6  unit ; 
 
white f 23 $nan$nan$docusate sodium  100  mg ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  6  unit ; prenatal  1  tab ; 
 
white f 23 $nan$nan$docusate sodium  100  mg ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prenatal  1  tab ; 
 
white f 23 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  176  k ul; chemistry blood creatinine  0.5  mg dl$docusate sodium  100  mg ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prenatal  1  tab ; 
 
white f 23 $nan$nan$docusate sodium  100  mg ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prenatal  1  tab ; insulin  20  unit ; 
 
white f 23 $nan$nan$docusate sodium  100  mg ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prenatal  1  tab ; insulin  22  unit ; 
 
white f 23 $nan$nan$docusate sodium  100  mg ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prenatal  1  tab ; insulin  22  unit ; acetaminophen  500  mg ; 
 
white f 23 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  178  k ul; chemistry blood creatinine  0.6  mg dl; hematology blood inr(pt)  0.9  $docusate sodium  100  mg ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prenatal  1  tab ; acetaminophen  500  mg ; insulin  23  unit ; misoprostol  25  mcg ; 
 
white f 23 $nan$hematology blood hematocrit  32.9  %; hematology blood hematocrit  32.1  %; hematology blood hemoglobin  11.7  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  190  k ul; hematology blood platelet count  163  k ul; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  $docusate sodium  100  mg ; calcium carbonate  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prenatal  1  tab ; acetaminophen  500  mg ; insulin  23  unit ; misoprostol  25  mcg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; sw  500  ml ; magnesium sulfate (ob)  20  gm ; lr  1000  ml ; d10w  1000  ml ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white f 23 $nan$hematology blood hematocrit  29.8  %$metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; sw  500  ml ; magnesium sulfate (ob)  20  gm ; lr  1000  ml ; d10w  1000  ml ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; insulin  2  unit ; 
 
white f 23 $nan$nan$metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; sw  500  ml ; magnesium sulfate (ob)  20  gm ; lr  1000  ml ; d10w  1000  ml ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; insulin  2  unit ; 
 
white f 23 $nan$nan$metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; sw  500  ml ; magnesium sulfate (ob)  20  gm ; lr  1000  ml ; d10w  1000  ml ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; insulin  12  unit ; 
 
white f 23 $nan$nan$metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; sw  500  ml ; magnesium sulfate (ob)  20  gm ; lr  1000  ml ; d10w  1000  ml ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; insulin  12  unit ; 
 
white f 23 $nan$nan$metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; sw  500  ml ; magnesium sulfate (ob)  20  gm ; lr  1000  ml ; d10w  1000  ml ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; insulin  12  unit ; 
 
white m 73 $nan$nan$insulin  25  unit ; atorvastatin  40  mg ; polyethylene glycol  17  g ; aspirin  81  mg ; vitamin d  800  unit ; omeprazole  20  mg ; triamterene-hydrochlorothiazide  1  cap ; 
 
white m 73 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  238  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  8.7  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  103  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  62  mg dl$insulin  25  unit ; atorvastatin  40  mg ; polyethylene glycol  17  g ; aspirin  81  mg ; vitamin d  800  unit ; omeprazole  20  mg ; triamterene-hydrochlorothiazide  1  cap ; 0.45% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; calcium acetate  1334  mg ; nicotine lozenge  2  mg ; heparin  5000  unit ; docusate sodium  100  mg ; metoprolol tartrate  37.5  mg ; amitriptyline  25  mg ; trazodone  100  mg ; sodium polystyrene sulfonate  30  gm ; 
 
white m 73 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  8.6  mg dl; chemistry blood creatinine  8.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  97  mg dl; chemistry blood urea nitrogen  99  mg dl; chemistry urine creatinine, urine  61  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  98  mg dl; chemistry blood lactate dehydrogenase (ld)  258  iu l; chemistry blood albumin  4.2  g dl; chemistry urine albumin, urine  33.0  mg dl; chemistry urine albumin creatinine, urine  541.0  mg g; chemistry urine 24 hr creatinine  1922  mg 24hr$insulin  25  unit ; atorvastatin  40  mg ; polyethylene glycol  17  g ; aspirin  81  mg ; vitamin d  800  unit ; omeprazole  20  mg ; triamterene-hydrochlorothiazide  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; calcium acetate  1334  mg ; nicotine lozenge  2  mg ; heparin  5000  unit ; docusate sodium  100  mg ; amitriptyline  25  mg ; trazodone  100  mg ; sodium polystyrene sulfonate  30  gm ; hydralazine  10  mg ; amlodipine  5  mg ; 
 
white m 73 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  8.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  101  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  91  mg dl$insulin  25  unit ; atorvastatin  40  mg ; polyethylene glycol  17  g ; aspirin  81  mg ; vitamin d  800  unit ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; calcium acetate  1334  mg ; nicotine lozenge  2  mg ; heparin  5000  unit ; docusate sodium  100  mg ; amitriptyline  25  mg ; trazodone  100  mg ; hydralazine  10  mg ; amlodipine  5  mg ; 
 
white m 73 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  8.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  100  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  73  mg dl; chemistry blood lactate dehydrogenase (ld)  222  iu l; chemistry blood albumin  4.1  g dl$insulin  25  unit ; atorvastatin  40  mg ; polyethylene glycol  17  g ; aspirin  81  mg ; vitamin d  800  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; calcium acetate  1334  mg ; nicotine lozenge  2  mg ; heparin  5000  unit ; docusate sodium  100  mg ; amitriptyline  25  mg ; trazodone  100  mg ; amlodipine  5  mg ; 
 
white m 73 $nan$nan$insulin  25  unit ; atorvastatin  40  mg ; polyethylene glycol  17  g ; aspirin  81  mg ; vitamin d  800  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; calcium acetate  1334  mg ; nicotine lozenge  2  mg ; heparin  5000  unit ; docusate sodium  100  mg ; amitriptyline  25  mg ; trazodone  100  mg ; amlodipine  5  mg ; 
 
white f 57 $temp    heartrate  72.0  resprate  11.0  o2sat  95.0  sbp  120.0  dbp  50.0  rhythm    pain  0  ; temp    heartrate  68.0  resprate  18.0  o2sat  98.0  sbp  124.0  dbp  39.0  rhythm    pain  0  ; temp  98.2  heartrate  72.0  resprate  17.0  o2sat  99.0  sbp  114.0  dbp  43.0  rhythm    pain  0  $nan$aspirin  325  mg ; clopidogrel  75  mg ; 
atrial fibrillation diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled chronic total occlusion of artery of the extremities diabetes with neurological manifestations, type ii or unspecified type, uncontrolled chronic systolic heart failure unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants congestive heart failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident peripheral angiopathy in diseases classified elsewhere aortocoronary bypass status long-term (current) use of insulin tobacco use disorder heart valve replaced by other means subendocardial infarction, initial episode of care other and unspecified hyperlipidemia atherosclerosis of other specified arteries polyneuropathy in diabetes coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction atrial fibrillation 
white f 57 $nan$hematology blood hematocrit  28.6  %; hematology blood hematocrit  26.7  %; hematology blood hematocrit  23.9  %; hematology blood hematocrit  23.4  %; hematology blood hematocrit  24.5  %; hematology blood hematocrit  29.0  %; hematology blood hematocrit  29.5  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  268  k ul; hematology blood platelet count  246  k ul; hematology blood platelet count  141  k ul; hematology blood platelet count  134  k ul; hematology blood platelet count  117  k ul; hematology blood platelet count  137  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  2.0  ; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry urine potassium, urine  80  meq l; chemistry urine sodium, urine  13  meq l; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  298  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  115  mg dl; blood gas blood free calcium  1.01  mmol l; blood gas blood free calcium  0.97  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood chloride, whole blood  100  meq l; blood gas blood glucose  230  mg dl; blood gas blood glucose  281  mg dl; blood gas blood glucose  215  mg dl; blood gas blood hematocrit, calculated  30  %; blood gas blood hematocrit, calculated  28  %; blood gas blood hemoglobin  9.9  g dl; blood gas blood hemoglobin  9.2  g dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  134  meq l$aspirin  325  mg ; clopidogrel  75  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; fentanyl citrate  25-100  mcg ; propofol  1000  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; ns  100  ml ; esmolol  2000  mg ; famotidine  20  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic sodium chloride  1  bag ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; metoprolol tartrate  5  mg ; acetaminophen iv  1000  mg ; simvastatin  40  mg ; sodium chloride 0.9%  1000  ml ; lactated ringers  1000  ml ; heparin sodium  25,000  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; norepinephrine  8  mg ; heparin  1000  unit ; 
atrial fibrillation diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled chronic total occlusion of artery of the extremities diabetes with neurological manifestations, type ii or unspecified type, uncontrolled chronic systolic heart failure unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants congestive heart failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident peripheral angiopathy in diseases classified elsewhere aortocoronary bypass status long-term (current) use of insulin tobacco use disorder heart valve replaced by other means subendocardial infarction, initial episode of care other and unspecified hyperlipidemia atherosclerosis of other specified arteries polyneuropathy in diabetes coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction atrial fibrillation 
white f 57 $nan$hematology blood hematocrit  28.7  %; hematology blood hematocrit  27.0  %; hematology blood hematocrit  27.3  %; hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  127  k ul; hematology blood platelet count  112  k ul; hematology blood platelet count  122  k ul; hematology blood platelet count  108  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  170  mg dl; chemistry blood lactate dehydrogenase (ld)  428  iu l; blood gas blood free calcium  1.03  mmol l; blood gas blood free calcium  1.04  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood glucose  123  mg dl; blood gas blood potassium, whole blood  4.0  meq l$aspirin  325  mg ; clopidogrel  75  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; fentanyl citrate  25-100  mcg ; propofol  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic sodium chloride  1  bag ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; metoprolol tartrate  5  mg ; acetaminophen iv  1000  mg ; simvastatin  40  mg ; lactated ringers  1000  ml ; norepinephrine  8  mg ; heparin  1000  unit ; furosemide  20  mg ; 
atrial fibrillation diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled chronic total occlusion of artery of the extremities diabetes with neurological manifestations, type ii or unspecified type, uncontrolled chronic systolic heart failure unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants congestive heart failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident peripheral angiopathy in diseases classified elsewhere aortocoronary bypass status long-term (current) use of insulin tobacco use disorder heart valve replaced by other means subendocardial infarction, initial episode of care other and unspecified hyperlipidemia atherosclerosis of other specified arteries polyneuropathy in diabetes coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction atrial fibrillation 
white f 57 $nan$hematology blood hematocrit  25.5  %; hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  93  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  132  mg dl; chemistry blood glucose  160  mg dl; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood glucose  92  mg dl; blood gas blood glucose  97  mg dl$aspirin  325  mg ; clopidogrel  75  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; fentanyl citrate  25-100  mcg ; propofol  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; metoprolol tartrate  5  mg ; acetaminophen iv  1000  mg ; simvastatin  40  mg ; norepinephrine  8  mg ; heparin  1000  unit ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; quetiapine fumarate  25  mg ; 
atrial fibrillation diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled chronic total occlusion of artery of the extremities diabetes with neurological manifestations, type ii or unspecified type, uncontrolled chronic systolic heart failure unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants congestive heart failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident peripheral angiopathy in diseases classified elsewhere aortocoronary bypass status long-term (current) use of insulin tobacco use disorder heart valve replaced by other means subendocardial infarction, initial episode of care other and unspecified hyperlipidemia atherosclerosis of other specified arteries polyneuropathy in diabetes coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction atrial fibrillation 
white f 57 $nan$hematology blood hematocrit  31.1  %; hematology blood hematocrit  33.1  %; hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  104  k ul; hematology blood platelet count  116  k ul; hematology blood platelet count  104  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  205  mg dl; chemistry blood glucose  154  mg dl; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood glucose  157  mg dl; blood gas blood potassium, whole blood  3.7  meq l$aspirin  325  mg ; clopidogrel  75  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; metoprolol tartrate  5  mg ; acetaminophen iv  1000  mg ; simvastatin  40  mg ; quetiapine fumarate  25  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; morphine sulfate  2-4  mg ; 5% dextrose  40  ml ; furosemide  40  mg ; albuterol-ipratropium  1-2  puff ; metoclopramide  10  mg ; 
atrial fibrillation diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled chronic total occlusion of artery of the extremities diabetes with neurological manifestations, type ii or unspecified type, uncontrolled chronic systolic heart failure unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants congestive heart failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident peripheral angiopathy in diseases classified elsewhere aortocoronary bypass status long-term (current) use of insulin tobacco use disorder heart valve replaced by other means subendocardial infarction, initial episode of care other and unspecified hyperlipidemia atherosclerosis of other specified arteries polyneuropathy in diabetes coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction atrial fibrillation 
white f 57 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  116  mg dl$aspirin  325  mg ; clopidogrel  75  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; metoprolol tartrate  5  mg ; acetaminophen iv  1000  mg ; simvastatin  40  mg ; quetiapine fumarate  25  mg ; albuterol-ipratropium  1-2  puff ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)   10  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; warfarin  2  mg ; 
atrial fibrillation diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled chronic total occlusion of artery of the extremities diabetes with neurological manifestations, type ii or unspecified type, uncontrolled chronic systolic heart failure unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants congestive heart failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident peripheral angiopathy in diseases classified elsewhere aortocoronary bypass status long-term (current) use of insulin tobacco use disorder heart valve replaced by other means subendocardial infarction, initial episode of care other and unspecified hyperlipidemia atherosclerosis of other specified arteries polyneuropathy in diabetes coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction atrial fibrillation 
white f 57 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  141  mg dl$aspirin  325  mg ; clopidogrel  75  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; metoprolol tartrate  5  mg ; simvastatin  40  mg ; quetiapine fumarate  25  mg ; albuterol-ipratropium  1-2  puff ; sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)   10  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; warfarin  2  mg ; ondansetron  4  mg ; nicotine patch  21  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; warfarin  1  mg ; 
atrial fibrillation diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled chronic total occlusion of artery of the extremities diabetes with neurological manifestations, type ii or unspecified type, uncontrolled chronic systolic heart failure unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants congestive heart failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident peripheral angiopathy in diseases classified elsewhere aortocoronary bypass status long-term (current) use of insulin tobacco use disorder heart valve replaced by other means subendocardial infarction, initial episode of care other and unspecified hyperlipidemia atherosclerosis of other specified arteries polyneuropathy in diabetes coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction atrial fibrillation 
white f 57 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  89  mg dl$aspirin  325  mg ; clopidogrel  75  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; metoprolol tartrate  5  mg ; simvastatin  40  mg ; quetiapine fumarate  25  mg ; albuterol-ipratropium  1-2  puff ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; nicotine patch  21  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; warfarin  1  mg ; buprenorphine-naloxone (8mg-2mg)  1  tab ; metoprolol succinate xl  25  mg ; lisinopril  2.5  mg ; metformin (glucophage)  1000  mg ; warfarin  3  mg ; warfarin  4  mg ; 
atrial fibrillation diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled chronic total occlusion of artery of the extremities diabetes with neurological manifestations, type ii or unspecified type, uncontrolled chronic systolic heart failure unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants congestive heart failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident peripheral angiopathy in diseases classified elsewhere aortocoronary bypass status long-term (current) use of insulin tobacco use disorder heart valve replaced by other means subendocardial infarction, initial episode of care other and unspecified hyperlipidemia atherosclerosis of other specified arteries polyneuropathy in diabetes coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction atrial fibrillation 
white f 57 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  194  k ul; hematology blood inr(pt)  1.8  $aspirin  325  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simvastatin  40  mg ; quetiapine fumarate  25  mg ; albuterol-ipratropium  1-2  puff ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  325-650  mg ; nicotine patch  21  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; metoprolol succinate xl  25  mg ; lisinopril  2.5  mg ; metformin (glucophage)  1000  mg ; warfarin  4  mg ; 
atrial fibrillation diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled chronic total occlusion of artery of the extremities diabetes with neurological manifestations, type ii or unspecified type, uncontrolled chronic systolic heart failure unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants congestive heart failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident peripheral angiopathy in diseases classified elsewhere aortocoronary bypass status long-term (current) use of insulin tobacco use disorder heart valve replaced by other means subendocardial infarction, initial episode of care other and unspecified hyperlipidemia atherosclerosis of other specified arteries polyneuropathy in diabetes coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction atrial fibrillation 
white f 57 $nan$hematology blood inr(pt)  3.4  $aspirin  325  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simvastatin  40  mg ; quetiapine fumarate  25  mg ; albuterol-ipratropium  1-2  puff ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  325-650  mg ; nicotine patch  21  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; metoprolol succinate xl  25  mg ; lisinopril  2.5  mg ; metformin (glucophage)  1000  mg ; 
atrial fibrillation diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled chronic total occlusion of artery of the extremities diabetes with neurological manifestations, type ii or unspecified type, uncontrolled chronic systolic heart failure unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants congestive heart failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident peripheral angiopathy in diseases classified elsewhere aortocoronary bypass status long-term (current) use of insulin tobacco use disorder heart valve replaced by other means subendocardial infarction, initial episode of care other and unspecified hyperlipidemia atherosclerosis of other specified arteries polyneuropathy in diabetes coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction atrial fibrillation 
white f 57 $nan$hematology blood inr(pt)  4.9  $aspirin  325  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simvastatin  40  mg ; quetiapine fumarate  25  mg ; albuterol-ipratropium  1-2  puff ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  325-650  mg ; nicotine patch  21  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; metoprolol succinate xl  25  mg ; lisinopril  2.5  mg ; metformin (glucophage)  1000  mg ; 
atrial fibrillation diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled chronic total occlusion of artery of the extremities diabetes with neurological manifestations, type ii or unspecified type, uncontrolled chronic systolic heart failure unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants congestive heart failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident peripheral angiopathy in diseases classified elsewhere aortocoronary bypass status long-term (current) use of insulin tobacco use disorder heart valve replaced by other means subendocardial infarction, initial episode of care other and unspecified hyperlipidemia atherosclerosis of other specified arteries polyneuropathy in diabetes coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction atrial fibrillation 
white f 57 $nan$hematology blood inr(pt)  4.4  $aspirin  325  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simvastatin  40  mg ; quetiapine fumarate  25  mg ; albuterol-ipratropium  1-2  puff ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  325-650  mg ; nicotine patch  21  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; metoprolol succinate xl  25  mg ; lisinopril  2.5  mg ; metformin (glucophage)  1000  mg ; 
atrial fibrillation diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled chronic total occlusion of artery of the extremities diabetes with neurological manifestations, type ii or unspecified type, uncontrolled chronic systolic heart failure unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants congestive heart failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident peripheral angiopathy in diseases classified elsewhere aortocoronary bypass status long-term (current) use of insulin tobacco use disorder heart valve replaced by other means subendocardial infarction, initial episode of care other and unspecified hyperlipidemia atherosclerosis of other specified arteries polyneuropathy in diabetes coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction atrial fibrillation 
white f 57 $nan$hematology blood inr(pt)  3.4  $aspirin  325  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simvastatin  40  mg ; quetiapine fumarate  25  mg ; albuterol-ipratropium  1-2  puff ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  325-650  mg ; nicotine patch  21  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; metoprolol succinate xl  25  mg ; lisinopril  2.5  mg ; metformin (glucophage)  1000  mg ; 
atrial fibrillation diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled chronic total occlusion of artery of the extremities diabetes with neurological manifestations, type ii or unspecified type, uncontrolled chronic systolic heart failure unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants congestive heart failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident peripheral angiopathy in diseases classified elsewhere aortocoronary bypass status long-term (current) use of insulin tobacco use disorder heart valve replaced by other means subendocardial infarction, initial episode of care other and unspecified hyperlipidemia atherosclerosis of other specified arteries polyneuropathy in diabetes coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction atrial fibrillation 
white f 57 $nan$hematology blood inr(pt)  3.1  $aspirin  325  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simvastatin  40  mg ; quetiapine fumarate  25  mg ; albuterol-ipratropium  1-2  puff ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  325-650  mg ; nicotine patch  21  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; metoprolol succinate xl  25  mg ; lisinopril  2.5  mg ; metformin (glucophage)  1000  mg ; 
atrial fibrillation diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled chronic total occlusion of artery of the extremities diabetes with neurological manifestations, type ii or unspecified type, uncontrolled chronic systolic heart failure unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants congestive heart failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident peripheral angiopathy in diseases classified elsewhere aortocoronary bypass status long-term (current) use of insulin tobacco use disorder heart valve replaced by other means subendocardial infarction, initial episode of care other and unspecified hyperlipidemia atherosclerosis of other specified arteries polyneuropathy in diabetes coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction atrial fibrillation 
white f 57 $nan$nan$aspirin  325  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simvastatin  40  mg ; quetiapine fumarate  25  mg ; albuterol-ipratropium  1-2  puff ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  325-650  mg ; nicotine patch  21  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; metoprolol succinate xl  25  mg ; lisinopril  2.5  mg ; metformin (glucophage)  1000  mg ; 
atrial fibrillation diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled chronic total occlusion of artery of the extremities diabetes with neurological manifestations, type ii or unspecified type, uncontrolled chronic systolic heart failure unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants congestive heart failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident peripheral angiopathy in diseases classified elsewhere aortocoronary bypass status long-term (current) use of insulin tobacco use disorder heart valve replaced by other means subendocardial infarction, initial episode of care other and unspecified hyperlipidemia atherosclerosis of other specified arteries polyneuropathy in diabetes coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction atrial fibrillation 
white f 81 $nan$hematology blood hematocrit  49.4  %; hematology blood hemoglobin  16.3  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  151  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; simethicone  40-80  mg ; ramelteon  8  mg ; simvastatin  10  mg ; metoprolol tartrate  12.5  mg ; magnesium oxide  800  mg ; amlodipine  5  mg ; apixaban  5  mg ; vitamin d  2000  unit ; losartan potassium  100  mg ; hydrochlorothiazide  12.5  mg ; metoprolol succinate xl  25  mg ; flecainide acetate  50  mg ; 
shortness of breath unspecified essential hypertension chest pain, unspecified 
white f 81 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; simethicone  40-80  mg ; ramelteon  8  mg ; simvastatin  10  mg ; magnesium oxide  800  mg ; amlodipine  5  mg ; apixaban  5  mg ; vitamin d  2000  unit ; losartan potassium  100  mg ; hydrochlorothiazide  12.5  mg ; metoprolol succinate xl  25  mg ; flecainide acetate  50  mg ; 
shortness of breath unspecified essential hypertension chest pain, unspecified 
white m 78 $nan$nan$levofloxacin  250  mg ; levofloxacin  500  mg ; levofloxacin  750  mg ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use adrenal cortical steroids causing adverse effects in therapeutic use diarrhea other and unspecified hyperlipidemia pancytopenia coronary atherosclerosis of native coronary artery abdominal pain, other specified site personal history of other malignant neoplasm of skin antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use fever presenting with conditions classified elsewhere encounter for antineoplastic chemotherapy other abnormal glucose drug induced neutropenia acute lymphoid leukemia, in relapse unspecified essential hypertension nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] fluid overload disorder lumbago coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia acute lymphoid leukemia, without mention of having achieved remission pure hypercholesterolemia person boarding or alighting a pedal cycle injured in collision with fixed or stationary object family history of ischemic heart disease unspecified essential hypertension pneumonia, organism unspecified
white m 78 $nan$hematology blood hematocrit  23.3  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  50  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; hematology urine wbc  10  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  184  iu l; chemistry blood albumin  3.3  g dl; hematology blood bands  3  %$levofloxacin  250  mg ; levofloxacin  500  mg ; levofloxacin  750  mg ; sodium chloride 0.9%  flush  3  ml ; acyclovir  200  mg ; fluconazole  200  mg ; lorazepam  0.5  mg ; metoprolol tartrate  12.5  mg ; nystatin oral suspension  5  ml ; senna  1  tab ; docusate sodium  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; vial  1  vial ; filgrastim  300  mcg ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use adrenal cortical steroids causing adverse effects in therapeutic use diarrhea other and unspecified hyperlipidemia pancytopenia coronary atherosclerosis of native coronary artery abdominal pain, other specified site personal history of other malignant neoplasm of skin antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use fever presenting with conditions classified elsewhere encounter for antineoplastic chemotherapy other abnormal glucose drug induced neutropenia acute lymphoid leukemia, in relapse unspecified essential hypertension nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] fluid overload disorder lumbago coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia acute lymphoid leukemia, without mention of having achieved remission pure hypercholesterolemia person boarding or alighting a pedal cycle injured in collision with fixed or stationary object family history of ischemic heart disease unspecified essential hypertension pneumonia, organism unspecified
white m 78 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  34  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  187  iu l; chemistry blood albumin  3.3  g dl; hematology blood bands  0  %$levofloxacin  750  mg ; sodium chloride 0.9%  flush  3  ml ; acyclovir  200  mg ; fluconazole  200  mg ; lorazepam  0.5  mg ; nystatin oral suspension  5  ml ; senna  1  tab ; docusate sodium  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; vial  1  vial ; filgrastim  300  mcg ; potassium chloride  40  meq ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use adrenal cortical steroids causing adverse effects in therapeutic use diarrhea other and unspecified hyperlipidemia pancytopenia coronary atherosclerosis of native coronary artery abdominal pain, other specified site personal history of other malignant neoplasm of skin antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use fever presenting with conditions classified elsewhere encounter for antineoplastic chemotherapy other abnormal glucose drug induced neutropenia acute lymphoid leukemia, in relapse unspecified essential hypertension nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] fluid overload disorder lumbago coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia acute lymphoid leukemia, without mention of having achieved remission pure hypercholesterolemia person boarding or alighting a pedal cycle injured in collision with fixed or stationary object family history of ischemic heart disease unspecified essential hypertension pneumonia, organism unspecified
white m 78 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  36  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  102  mg dl$levofloxacin  750  mg ; sodium chloride 0.9%  flush  3  ml ; acyclovir  200  mg ; fluconazole  200  mg ; lorazepam  0.5  mg ; nystatin oral suspension  5  ml ; senna  1  tab ; docusate sodium  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; potassium chloride  40  meq ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use adrenal cortical steroids causing adverse effects in therapeutic use diarrhea other and unspecified hyperlipidemia pancytopenia coronary atherosclerosis of native coronary artery abdominal pain, other specified site personal history of other malignant neoplasm of skin antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use fever presenting with conditions classified elsewhere encounter for antineoplastic chemotherapy other abnormal glucose drug induced neutropenia acute lymphoid leukemia, in relapse unspecified essential hypertension nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] fluid overload disorder lumbago coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia acute lymphoid leukemia, without mention of having achieved remission pure hypercholesterolemia person boarding or alighting a pedal cycle injured in collision with fixed or stationary object family history of ischemic heart disease unspecified essential hypertension pneumonia, organism unspecified
white m 78 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  40  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  183  iu l; chemistry blood albumin  3.4  g dl$levofloxacin  750  mg ; sodium chloride 0.9%  flush  3  ml ; acyclovir  200  mg ; fluconazole  200  mg ; lorazepam  0.5  mg ; nystatin oral suspension  5  ml ; senna  1  tab ; docusate sodium  100  mg ; potassium chloride  20  meq ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use adrenal cortical steroids causing adverse effects in therapeutic use diarrhea other and unspecified hyperlipidemia pancytopenia coronary atherosclerosis of native coronary artery abdominal pain, other specified site personal history of other malignant neoplasm of skin antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use fever presenting with conditions classified elsewhere encounter for antineoplastic chemotherapy other abnormal glucose drug induced neutropenia acute lymphoid leukemia, in relapse unspecified essential hypertension nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] fluid overload disorder lumbago coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia acute lymphoid leukemia, without mention of having achieved remission pure hypercholesterolemia person boarding or alighting a pedal cycle injured in collision with fixed or stationary object family history of ischemic heart disease unspecified essential hypertension pneumonia, organism unspecified
white m 78 $nan$nan$levofloxacin  750  mg ; sodium chloride 0.9%  flush  3  ml ; acyclovir  200  mg ; fluconazole  200  mg ; lorazepam  0.5  mg ; nystatin oral suspension  5  ml ; senna  1  tab ; docusate sodium  100  mg ; potassium chloride  20  meq ; 
antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use adrenal cortical steroids causing adverse effects in therapeutic use diarrhea other and unspecified hyperlipidemia pancytopenia coronary atherosclerosis of native coronary artery abdominal pain, other specified site personal history of other malignant neoplasm of skin antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use fever presenting with conditions classified elsewhere encounter for antineoplastic chemotherapy other abnormal glucose drug induced neutropenia acute lymphoid leukemia, in relapse unspecified essential hypertension nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] fluid overload disorder lumbago coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia acute lymphoid leukemia, without mention of having achieved remission pure hypercholesterolemia person boarding or alighting a pedal cycle injured in collision with fixed or stationary object family history of ischemic heart disease unspecified essential hypertension pneumonia, organism unspecified
black african american m 36 $temp    heartrate  93.0  resprate  18.0  o2sat  100.0  sbp  129.0  dbp  81.0  rhythm    pain    ; temp  98.5  heartrate  128.0  resprate  20.0  o2sat  100.0  sbp  134.0  dbp  68.0  rhythm    pain  4  ; temp  98.4  heartrate  92.0  resprate  20.0  o2sat  100.0  sbp  132.0  dbp  62.0  rhythm    pain    ; temp  98.7  heartrate  91.0  resprate  18.0  o2sat  98.0  sbp  129.0  dbp  85.0  rhythm    pain    ; temp  98.4  heartrate  87.0  resprate  18.0  o2sat  99.0  sbp  133.0  dbp  72.0  rhythm    pain    ; temp    heartrate  72.0  resprate  19.0  o2sat  98.0  sbp  121.0  dbp  67.0  rhythm    pain    ; temp  98.2  heartrate  78.0  resprate  18.0  o2sat  98.0  sbp  120.0  dbp  80.0  rhythm    pain    ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  5  ; temp  98.5  heartrate  90.0  resprate  18.0  o2sat  98.0  sbp  138.0  dbp  81.0  rhythm    pain    $hematology blood hematocrit  36.5  %; hematology blood hematocrit  42.3  %; hematology blood hematocrit  36.5  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  13.6  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  340  k ul; hematology blood platelet count  388  k ul; hematology blood platelet count  361  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  4.3  g dl; blood gas blood lactate  1.3  mmol l$nan
intervertebral disc disorders with radiculopathy, lumbar region spinal stenosis, lumbar region without neurogenic claudication thrombocytopenia, unspecified intervertebral disc disorders with radiculopathy, lumbosacral region spinal stenosis, lumbar region with neurogenic claudication 
black african american m 36 $temp  98.8  heartrate  101.0  resprate  18.0  o2sat  98.0  sbp  128.0  dbp  86.0  rhythm    pain    $hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  317  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  140  iu l$sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; cyclobenzaprine  10  mg ; hydromorphone (dilaudid)  4  mg ; 
intervertebral disc disorders with radiculopathy, lumbar region spinal stenosis, lumbar region without neurogenic claudication thrombocytopenia, unspecified intervertebral disc disorders with radiculopathy, lumbosacral region spinal stenosis, lumbar region with neurogenic claudication 
black african american m 36 $nan$hematology blood hematocrit  41.5  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  359  k ul$sodium chloride 0.9%  flush  3-10  ml ; cyclobenzaprine  10  mg ; hydromorphone (dilaudid)  4  mg ; 
intervertebral disc disorders with radiculopathy, lumbar region spinal stenosis, lumbar region without neurogenic claudication thrombocytopenia, unspecified intervertebral disc disorders with radiculopathy, lumbosacral region spinal stenosis, lumbar region with neurogenic claudication 
black african american m 36 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; cyclobenzaprine  10  mg ; hydromorphone (dilaudid)  4  mg ; 
intervertebral disc disorders with radiculopathy, lumbar region spinal stenosis, lumbar region without neurogenic claudication thrombocytopenia, unspecified intervertebral disc disorders with radiculopathy, lumbosacral region spinal stenosis, lumbar region with neurogenic claudication 
black african american f 33 $temp  98.7  heartrate  88.0  resprate  19.0  o2sat    sbp  176.0  dbp  81.0  rhythm    pain    $nan$divalproex (extended release)  500  mg ; insulin  95  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; albuterol 0.083% neb soln  1  neb ; brimonidine tartrate 0.15% ophth.  1  drop ; calcium carbonate  500  mg ; gabapentin  300  mg ; levothyroxine sodium  100  mcg ; omeprazole  20  mg ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; losartan potassium  25  mg ; azathioprine  50  mg ; azathioprine  150  mg ; prednisone  10  mg ; heparin  5000  unit ; insulin  75  unit ; 0.9% sodium chloride  1000  ml ; insulin  12  unit ; docusate sodium  100  mg ; benztropine mesylate  1  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; divalproex (extended release)  1000  mg ; fluphenazine  5  mg ; 
obstructive sleep apnea (adult)(pediatric) mild intellectual disabilities chronic kidney disease, unspecified suicidal ideation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus schizoaffective disorder, chronic asthma, unspecified type, unspecified other conduct disorder unspecified persistent mental disorders due to conditions classified elsewhere diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled unspecified episodic mood disorder long-term (current) use of insulin chronic kidney disease, stage ii (mild) unspecified disturbance of conduct other and unspecified noninfectious gastroenteritis and colitis acute upper respiratory infections of unspecified site major depressive affective disorder, single episode, unspecified unspecified intellectual disabilities bipolar disorder, unspecified unspecified acquired hypothyroidism anemia, unspecified physical restraints status sarcoidosis lung involvement in other diseases classified elsewhere unspecified acquired hypothyroidism chronic kidney disease, unspecified bipolar disorder, unspecified other and unspecified noninfectious gastroenteritis and colitis diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled other and unspecified special symptoms or syndromes, not elsewhere classified diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled anemia in chronic kidney disease major depressive affective disorder, single episode, unspecified chronic kidney disease, unspecified unspecified acquired hypothyroidism sarcoidosis unspecified delay in development 
black african american f 33 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  78  mg dl$divalproex (extended release)  500  mg ; insulin  95  unit ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; albuterol 0.083% neb soln  1  neb ; brimonidine tartrate 0.15% ophth.  1  drop ; calcium carbonate  500  mg ; gabapentin  300  mg ; levothyroxine sodium  100  mcg ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; azathioprine  50  mg ; azathioprine  150  mg ; prednisone  10  mg ; heparin  5000  unit ; insulin  75  unit ; insulin  12  unit ; docusate sodium  100  mg ; benztropine mesylate  1  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; divalproex (extended release)  1000  mg ; fluphenazine  5  mg ; 
obstructive sleep apnea (adult)(pediatric) mild intellectual disabilities chronic kidney disease, unspecified suicidal ideation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus schizoaffective disorder, chronic asthma, unspecified type, unspecified other conduct disorder unspecified persistent mental disorders due to conditions classified elsewhere diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled unspecified episodic mood disorder long-term (current) use of insulin chronic kidney disease, stage ii (mild) unspecified disturbance of conduct other and unspecified noninfectious gastroenteritis and colitis acute upper respiratory infections of unspecified site major depressive affective disorder, single episode, unspecified unspecified intellectual disabilities bipolar disorder, unspecified unspecified acquired hypothyroidism anemia, unspecified physical restraints status sarcoidosis lung involvement in other diseases classified elsewhere unspecified acquired hypothyroidism chronic kidney disease, unspecified bipolar disorder, unspecified other and unspecified noninfectious gastroenteritis and colitis diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled other and unspecified special symptoms or syndromes, not elsewhere classified diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled anemia in chronic kidney disease major depressive affective disorder, single episode, unspecified chronic kidney disease, unspecified unspecified acquired hypothyroidism sarcoidosis unspecified delay in development 
black african american m 49 $nan$hematology blood hematocrit  41.4  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  141  mg dl$nan
 
hispanic latino f 52 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  87  mg dl$docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; senna  1  tab ; 
 
white f 38 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  123  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; clonazepam  0.5  mg ; ketorolac  15  mg ; nicotine patch  21  mg day ; heparin  5000  unit ; escitalopram oxalate  20  mg ; lisinopril  10  mg ; acetaminophen  1000  mg ; acetaminophen  650  mg ; 0.45% sodium chloride  1000  ml ; gabapentin  100  mg ; senna  8.6  mg ; docusate sodium  100  mg ; diphenhydramine  25  mg ; 
 
white f 38 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  85  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; ketorolac  15  mg ; nicotine patch  21  mg day ; heparin  5000  unit ; escitalopram oxalate  20  mg ; lisinopril  10  mg ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; diphenhydramine  25  mg ; vitamin d  5000  unit ; polyethylene glycol  17  g ; oxycodone (immediate release)  5-10  mg ; 
 
white f 38 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  75  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; ketorolac  15  mg ; nicotine patch  21  mg day ; heparin  5000  unit ; escitalopram oxalate  20  mg ; lisinopril  10  mg ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; diphenhydramine  25  mg ; vitamin d  5000  unit ; polyethylene glycol  17  g ; 
 
white m 78 $nan$nan$amiodarone  200  mg ; furosemide  40  mg ; levothyroxine sodium  75  mcg ; metoprolol succinate xl  100  mg ; lisinopril  10  mg ; thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; lorazepam  0.5  mg ; mupirocin nasal ointment 2%  1  appl ; 
 
white m 78 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood glucose  88  mg dl$amiodarone  200  mg ; furosemide  40  mg ; levothyroxine sodium  75  mcg ; metoprolol succinate xl  100  mg ; lisinopril  10  mg ; thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; mupirocin nasal ointment 2%  1  appl ; spironolactone  25  mg ; 
 
white m 78 $nan$hematology blood hematocrit  25.8  %; hematology blood hematocrit  27.8  %; hematology blood hematocrit  28.1  %; hematology blood hematocrit  30.4  %; hematology blood hematocrit  28.7  %; hematology blood hematocrit  20.5  %; hematology blood hematocrit  22.7  %; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  123  k ul; hematology blood platelet count  88  k ul; hematology blood platelet count  100  k ul; hematology blood platelet count  67  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  2.2  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.4  ; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  91  mg dl; chemistry blood glucose  128  mg dl; chemistry blood lactate dehydrogenase (ld)  237  iu l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.23  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  0.86  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  3.2  mmol l; blood gas blood lactate  3.9  mmol l; blood gas blood lactate  3.6  mmol l; blood gas blood lactate  3.6  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  2.6  mmol l; blood gas blood chloride, whole blood  102  meq l; blood gas blood chloride, whole blood  106  meq l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  94  mg dl; blood gas blood glucose  101  mg dl; blood gas blood glucose  112  mg dl; blood gas blood glucose  117  mg dl; blood gas blood glucose  137  mg dl; blood gas blood glucose  196  mg dl; blood gas blood glucose  205  mg dl; blood gas blood glucose  145  mg dl; blood gas blood glucose  126  mg dl; blood gas blood glucose  109  mg dl; blood gas blood glucose  118  mg dl; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hematocrit, calculated  25  %; blood gas blood hematocrit, calculated  21  %; blood gas blood hematocrit, calculated  24  %; blood gas blood hemoglobin  11.6  g dl; blood gas blood hemoglobin  9.7  g dl; blood gas blood hemoglobin  9.0  g dl; blood gas blood hemoglobin  8.4  g dl; blood gas blood hemoglobin  6.9  g dl; blood gas blood hemoglobin  7.9  g dl; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood sodium, whole blood  132  meq l; blood gas blood sodium, whole blood  133  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  133  meq l$amiodarone  200  mg ; furosemide  40  mg ; levothyroxine sodium  75  mcg ; metoprolol succinate xl  100  mg ; lisinopril  10  mg ; thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; mupirocin nasal ointment 2%  1  appl ; spironolactone  25  mg ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; lactated ringers  1000  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; phenylephrine  60  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; hydromorphone (dilaudid)  2-4  mg ; fentanyl citrate  12.5-25  mcg ; metoclopramide  10  mg ; d5w  100  ml ; milrinone  20  mg ; epinephrine  2  mg ; albumin 5% (25g   500ml)  500  g ; norepinephrine  8  mg ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; calcium chloride  1  gm ; albumin 5% (25g   500ml)  25  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; ranitidine  150  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ranitidine (liquid)  150  mg ; acetaminophen iv  1000  mg ; furosemide  20  mg ; 
 
white m 78 $nan$hematology blood hematocrit  31.6  %; hematology blood hematocrit  29.9  %; hematology blood hematocrit  29.8  %; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  63  k ul; hematology blood platelet count  71  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  293  iu l; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood glucose  133  mg dl; blood gas blood glucose  152  mg dl; blood gas blood glucose  116  mg dl; blood gas blood glucose  93  mg dl; blood gas blood glucose  94  mg dl; blood gas blood glucose  90  mg dl; blood gas blood glucose  103  mg dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.6  meq l$milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; phenylephrine  60  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; hydromorphone (dilaudid)  2-4  mg ; fentanyl citrate  12.5-25  mcg ; metoclopramide  10  mg ; d5w  100  ml ; milrinone  20  mg ; epinephrine  2  mg ; norepinephrine  8  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; ranitidine  150  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ranitidine (liquid)  150  mg ; acetaminophen iv  1000  mg ; furosemide  20  mg ; nitroprusside sodium  50  mg ; hydralazine  10  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; hydralazine  20  mg ; fentanyl citrate  25  mcg ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; 
 
white m 78 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  74  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood albumin  3.5  g dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood glucose  113  mg dl; blood gas blood glucose  89  mg dl; blood gas blood glucose  76  mg dl; blood gas blood glucose  109  mg dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  2.6  meq l$milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; d5w  250  ml ; nitroglycerin  100  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; fentanyl citrate  12.5-25  mcg ; metoclopramide  10  mg ; d5w  100  ml ; milrinone  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ranitidine (liquid)  150  mg ; acetaminophen iv  1000  mg ; metoprolol tartrate  5  mg ; hydralazine  20  mg ; fentanyl citrate  25  mcg ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; lactulose  30  ml ; warfarin  1  mg ; senna  1  tab ; 
 
white m 78 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  80  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  102  mg dl; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood glucose  109  mg dl; blood gas blood glucose  112  mg dl; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.6  meq l$milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; d5w  250  ml ; nitroglycerin  100  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; fentanyl citrate  12.5-25  mcg ; metoclopramide  10  mg ; d5w  100  ml ; milrinone  20  mg ; ranitidine (liquid)  150  mg ; acetaminophen iv  1000  mg ; metoprolol tartrate  5  mg ; hydralazine  20  mg ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; senna  1  tab ; 
 
white m 78 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  92  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  109  mg dl$milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; metoclopramide  10  mg ; ranitidine (liquid)  150  mg ; acetaminophen iv  1000  mg ; metoprolol tartrate  5  mg ; hydralazine  20  mg ; senna  1  tab ; amiodarone  400  mg ; guaifenesin  5-10  ml ; polyethylene glycol  17  g ; potassium chloride  40  meq ; warfarin  2  mg ; warfarin  1  dose ; haloperidol  0.5-5  mg ; fentanyl citrate  50  mcg ; potassium chloride (powder)  60  meq ; albumin 25% (12.5g   50ml)  25  g ; 
 
white m 78 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.8  ; hematology urine wbc  10  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  107  mg dl; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood glucose  100  mg dl$milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; metoclopramide  10  mg ; acetaminophen iv  1000  mg ; hydralazine  20  mg ; senna  1  tab ; polyethylene glycol  17  g ; warfarin  2  mg ; warfarin  1  dose ; metoprolol tartrate  25  mg ; lisinopril  5  mg ; aspirin  81  mg ; quetiapine fumarate  25  mg ; olanzapine  2.5  mg ; potassium chloride (powder)  40  meq ; 
 
white m 78 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  104  mg dl; blood gas blood free calcium  1.06  mmol l$milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; hydralazine  20  mg ; senna  1  tab ; polyethylene glycol  17  g ; warfarin  1  dose ; aspirin  81  mg ; potassium chloride (powder)  40  meq ; metoprolol tartrate  50  mg ; cefazolin  1  g ; lisinopril  2.5  mg ; heparin flush (10 units ml)  2  ml ; 
 
white m 78 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  3.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  75  mg dl; blood gas blood free calcium  1.11  mmol l; blood gas blood glucose  97  mg dl$milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; hydralazine  20  mg ; senna  1  tab ; polyethylene glycol  17  g ; warfarin  1  dose ; aspirin  81  mg ; metoprolol tartrate  50  mg ; cefazolin  1  g ; lisinopril  2.5  mg ; heparin flush (10 units ml)  2  ml ; warfarin  0.5  mg ; olanzapine  5  mg ; lorazepam  0.5-2  mg ; trazodone  25  mg ; 
 
white m 78 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  298  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  4.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  87  mg dl; chemistry blood glucose  103  mg dl; blood gas blood free calcium  1.13  mmol l; blood gas blood glucose  75  mg dl; blood gas blood potassium, whole blood  3.8  meq l$milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; hydralazine  20  mg ; senna  1  tab ; polyethylene glycol  17  g ; warfarin  1  dose ; aspirin  81  mg ; cefazolin  1  g ; lisinopril  2.5  mg ; heparin flush (10 units ml)  2  ml ; warfarin  0.5  mg ; olanzapine  5  mg ; lorazepam  0.5-2  mg ; warfarin  0  mg ; 
 
white m 78 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  328  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  4.1  ; hematology blood inr(pt)  3.7  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  97  mg dl; blood gas blood free calcium  1.06  mmol l; blood gas blood glucose  143  mg dl; blood gas blood potassium, whole blood  4.1  meq l$milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; hydralazine  20  mg ; senna  1  tab ; polyethylene glycol  17  g ; warfarin  1  dose ; aspirin  81  mg ; cefazolin  1  g ; lisinopril  2.5  mg ; heparin flush (10 units ml)  2  ml ; warfarin  0  mg ; olanzapine  10  mg ; soln  100  ml ; 
 
white m 78 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  385  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  3.4  ; hematology urine wbc  5  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  108  mg dl$milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; hydralazine  20  mg ; senna  1  tab ; polyethylene glycol  17  g ; warfarin  1  dose ; aspirin  81  mg ; cefazolin  1  g ; lisinopril  2.5  mg ; heparin flush (10 units ml)  2  ml ; olanzapine  10  mg ; soln  100  ml ; haloperidol  1  mg ; haloperidol  2.5  mg ; haloperidol  5  mg ; haloperidol  2.5-5.0  mg ; 
 
white m 78 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  394  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  3.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  100  mg dl$milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; hydralazine  20  mg ; senna  1  tab ; polyethylene glycol  17  g ; warfarin  1  dose ; aspirin  81  mg ; cefazolin  1  g ; lisinopril  2.5  mg ; heparin flush (10 units ml)  2  ml ; olanzapine  10  mg ; soln  100  ml ; haloperidol  1  mg ; haloperidol  2.5  mg ; haloperidol  5  mg ; haloperidol  2.5-5.0  mg ; cyanocobalamin  100  mcg ; albumin 5% (12.5g   250ml)  12.5  g ; albumin 25% (12.5g   50ml)  12.5  g ; metoprolol tartrate  12.5  mg ; 
 
white m 78 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  443  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood glucose  91  mg dl$milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; hydralazine  20  mg ; senna  1  tab ; polyethylene glycol  17  g ; warfarin  1  dose ; aspirin  81  mg ; lisinopril  2.5  mg ; heparin flush (10 units ml)  2  ml ; soln  100  ml ; cyanocobalamin  100  mcg ; albumin 5% (12.5g   250ml)  12.5  g ; albumin 25% (12.5g   50ml)  12.5  g ; metoprolol tartrate  12.5  mg ; 
 
white m 78 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  431  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  102  mg dl$polyethylene glycol  17  g ; warfarin  1  dose ; aspirin  81  mg ; lisinopril  2.5  mg ; heparin flush (10 units ml)  2  ml ; cyanocobalamin  100  mcg ; metoprolol tartrate  12.5  mg ; 
 
white m 78 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  407  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood glucose  89  mg dl$polyethylene glycol  17  g ; warfarin  1  dose ; aspirin  81  mg ; lisinopril  2.5  mg ; heparin flush (10 units ml)  2  ml ; cyanocobalamin  100  mcg ; metoprolol tartrate  12.5  mg ; haloperidol  0.5  mg ; trazodone  50  mg ; 
 
white m 78 $nan$nan$polyethylene glycol  17  g ; warfarin  1  dose ; aspirin  81  mg ; lisinopril  2.5  mg ; heparin flush (10 units ml)  2  ml ; cyanocobalamin  100  mcg ; metoprolol tartrate  12.5  mg ; haloperidol  0.5  mg ; trazodone  50  mg ; 
 
white f 89 $temp    heartrate  94.0  resprate  16.0  o2sat  100.0  sbp    dbp    rhythm    pain    ; temp  97.2  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp  97.1  heartrate  68.0  resprate  15.0  o2sat  100.0  sbp    dbp    rhythm    pain    ; temp    heartrate  71.0  resprate  17.0  o2sat  100.0  sbp  136.0  dbp  76.0  rhythm    pain  0  $hematology blood hematocrit  24.0  %; hematology blood hematocrit  31.5  %; hematology blood hematocrit  34.6  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  262  k ul; hematology blood platelet count  220  k ul; hematology blood platelet count  244  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  6.8  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  142  mg dl; chemistry blood albumin  2.9  g dl; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  0.9  mmol l$sterile water  50  ml ; senna  8.6  mg ; bisacodyl  10  mg ; vial  1  vial ; pantoprazole  40  mg ; propofol  1000  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  4  gm ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; escitalopram oxalate  10  mg ; levothyroxine sodium  100  mcg ; lactated ringers  1000  ml ; ceftriaxone  1  gm ; 5% dextrose  100  ml ; doxycycline hyclate  100  mg ; 5% dextrose  50  ml ; phytonadione  5  mg ; mouth care oral rinse  7-15  ml ; memantine  10  mg ; quetiapine fumarate  25  mg ; dexmedetomidine  0.4  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 
 
white f 89 $nan$hematology blood hematocrit  28.8  %; hematology blood hematocrit  24.6  %; hematology blood hematocrit  24.8  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  229  k ul; hematology blood platelet count  185  k ul; hematology blood platelet count  178  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood glucose  102  mg dl$sterile water  50  ml ; senna  8.6  mg ; bisacodyl  10  mg ; vial  1  vial ; pantoprazole  40  mg ; propofol  1000  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  4  gm ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; escitalopram oxalate  10  mg ; levothyroxine sodium  100  mcg ; lactated ringers  1000  ml ; ceftriaxone  1  gm ; 5% dextrose  50  ml ; phytonadione  5  mg ; mouth care oral rinse  7-15  ml ; memantine  10  mg ; dexmedetomidine  0.4  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; sodium chloride 0.9%  1000  ml ; olanzapine  5  mg ; neutra-phos  1  pkt ; 
 
white f 89 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  94  mg dl$sterile water  50  ml ; senna  8.6  mg ; bisacodyl  10  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  4  gm ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; escitalopram oxalate  10  mg ; levothyroxine sodium  100  mcg ; mouth care oral rinse  7-15  ml ; memantine  10  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; neutra-phos  1  pkt ; cefpodoxime proxetil  400  mg ; ondansetron  4  mg ; lorazepam  0.25  mg ; 
 
white f 89 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  141  mg dl$sterile water  50  ml ; senna  8.6  mg ; bisacodyl  10  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  4  gm ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; escitalopram oxalate  10  mg ; levothyroxine sodium  100  mcg ; mouth care oral rinse  7-15  ml ; memantine  10  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; ondansetron  4  mg ; lorazepam  0.25  mg ; ondansetron  8  mg ; pyridoxine  25  mg ; scopolamine patch  1  ptch ; heparin  5000  unit ; ramelteon  8  mg ; 
 
white f 89 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  117  mg dl$senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; escitalopram oxalate  10  mg ; levothyroxine sodium  100  mcg ; memantine  10  mg ; lorazepam  0.25  mg ; pyridoxine  25  mg ; scopolamine patch  1  ptch ; heparin  5000  unit ; ramelteon  8  mg ; calcium carbonate  500  mg ; ceftriaxone  2  gm ; ns  100  ml ; metronidazole  500  mg ; 
 
white f 89 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  24.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  291  k ul; hematology blood platelet count  274  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  130  mg dl; chemistry blood albumin  2.7  g dl$senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; escitalopram oxalate  10  mg ; levothyroxine sodium  100  mcg ; memantine  10  mg ; pyridoxine  25  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; ceftriaxone  2  gm ; ns  100  ml ; metronidazole  500  mg ; chloraseptic throat spray  1  spry ; metoprolol tartrate  6.25  mg ; metoprolol tartrate  5  mg ; potassium chloride  80  meq ; magnesium oxide  400  mg ; potassium chloride (powder)  80  meq ; metoprolol tartrate  12.5  mg ; iohexol 240  50  ml ; 
 
white f 89 $nan$hematology blood hematocrit  22.0  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  90  mg dl$senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; escitalopram oxalate  10  mg ; levothyroxine sodium  100  mcg ; memantine  10  mg ; pyridoxine  25  mg ; heparin  5000  unit ; ceftriaxone  2  gm ; ns  100  ml ; metronidazole  500  mg ; chloraseptic throat spray  1  spry ; magnesium oxide  400  mg ; potassium chloride (powder)  80  meq ; iohexol 240  50  ml ; hydrocortisone cream 0.5%  1  appl ; hydrocortisone cream 1%  1  appl ; furosemide  20  mg ; 
 
white f 89 $nan$hematology blood hematocrit  26.0  %; hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  241  k ul; hematology blood platelet count  232  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  79  mg dl$senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; escitalopram oxalate  10  mg ; levothyroxine sodium  100  mcg ; memantine  10  mg ; pyridoxine  25  mg ; heparin  5000  unit ; ceftriaxone  2  gm ; ns  100  ml ; metronidazole  500  mg ; chloraseptic throat spray  1  spry ; hydrocortisone cream 1%  1  appl ; furosemide  20  mg ; 
 
white f 89 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  208  iu l$senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; escitalopram oxalate  10  mg ; levothyroxine sodium  100  mcg ; memantine  10  mg ; pyridoxine  25  mg ; heparin  5000  unit ; ceftriaxone  2  gm ; ns  100  ml ; metronidazole  500  mg ; chloraseptic throat spray  1  spry ; hydrocortisone cream 1%  1  appl ; 0.9% sodium chloride  500  ml ; 
 
white f 89 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  217  iu l$senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; escitalopram oxalate  10  mg ; levothyroxine sodium  100  mcg ; memantine  10  mg ; pyridoxine  25  mg ; heparin  5000  unit ; ceftriaxone  2  gm ; ns  100  ml ; metronidazole  500  mg ; chloraseptic throat spray  1  spry ; hydrocortisone cream 1%  1  appl ; 0.9% sodium chloride  500  ml ; neutra-phos  2  pkt ; 
 
white f 89 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  117  mg dl$senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; escitalopram oxalate  10  mg ; levothyroxine sodium  100  mcg ; memantine  10  mg ; heparin  5000  unit ; ceftriaxone  2  gm ; ns  100  ml ; metronidazole  500  mg ; neutra-phos  2  pkt ; 
 
white f 89 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  111  mg dl$senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; escitalopram oxalate  10  mg ; levothyroxine sodium  100  mcg ; memantine  10  mg ; heparin  5000  unit ; ceftriaxone  2  gm ; ns  100  ml ; metronidazole  500  mg ; 
 
white f 89 $nan$hematology blood hematocrit  33.6  %; hematology blood hematocrit  33.0  %; hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  298  k ul; hematology blood platelet count  320  k ul; hematology blood platelet count  178  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  193  mg dl; chemistry blood glucose  213  mg dl; chemistry blood glucose  135  mg dl; blood gas blood lactate  1.7  mmol l$senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  3-10  ml ; escitalopram oxalate  10  mg ; levothyroxine sodium  100  mcg ; memantine  10  mg ; heparin  5000  unit ; ceftriaxone  2  gm ; ns  100  ml ; metronidazole  500  mg ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.125  mg ; levothyroxine sodium  50  mcg ; d5 1 2ns  1000  ml ; 
 
white f 89 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  128  mg dl$senna  8.6  mg ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; ceftriaxone  2  gm ; ns  100  ml ; metronidazole  500  mg ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.125  mg ; levothyroxine sodium  50  mcg ; d5 1 2ns  1000  ml ; 
 
white f 89 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  132  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ceftriaxone  2  gm ; ns  100  ml ; metronidazole  500  mg ; polyethylene glycol  17  g ; magnesium sulfate  2  gm ; phosphorus  500  mg ; 
 
white f 89 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  295  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  127  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ceftriaxone  2  gm ; ns  100  ml ; metronidazole  500  mg ; polyethylene glycol  17  g ; magnesium sulfate  2  gm ; phosphorus  500  mg ; lidocaine 2%  2  ml ; aspirin  81  mg ; 
 
white f 89 $nan$hematology blood hematocrit  30.0  %; hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  321  k ul; hematology blood platelet count  318  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  9  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  130  mg dl$sodium chloride 0.9%  flush  3-10  ml ; polyethylene glycol  17  g ; magnesium sulfate  2  gm ; phosphorus  500  mg ; lidocaine 2%  2  ml ; aspirin  81  mg ; diltiazem  125  mg ; 
 
white f 89 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  313  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3-10  ml ; polyethylene glycol  17  g ; aspirin  81  mg ; 
 
white f 89 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; metoprolol tartrate  25  mg ; 
 
white m 77 $temp  98.5  heartrate  73.0  resprate  16.0  o2sat  96.0  sbp  109.0  dbp  61.0  rhythm    pain  5  $hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  148  mg dl$ascorbic acid  500  mg ; calcium carbonate  500  mg ; ferrous sulfate  325  mg ; prednisone  5  mg ; vitamin d  1000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled attention to other artificial opening of urinary tract passenger in pick-up truck or van injured in collision with railway train or railway vehicle in traffic accident other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified severe sepsis unspecified septicemia chronic kidney disease, unspecified malignant neoplasm of prostate friedländer's bacillus infection in conditions classified elsewhere and of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hydronephrosis anemia, unspecified urinary tract infection, site not specified urinary complications, not elsewhere classified infection and inflammatory reaction due to other genitourinary device, implant, and graft do not resuscitate status personal history of antineoplastic chemotherapy fever, unspecified do not resuscitate status hyposmolality and/or hyponatremia secondary malignant neoplasm of other urinary organs personal history of malignant neoplasm of prostate long-term (current) use of other medications family history of malignant neoplasm of prostate urinary tract infection, site not specified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypopotassemia unspecified essential hypertension streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified chronic kidney disease, stage iii (moderate) hydronephrosis acute kidney failure, unspecified long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled secondary malignant neoplasm of other urinary organs hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of malignant neoplasm of prostate other specified retention of urine irradiation cystitis late effect of radiation hydronephrosis radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure
white m 77 $nan$nan$ascorbic acid  500  mg ; calcium carbonate  500  mg ; ferrous sulfate  325  mg ; prednisone  5  mg ; vitamin d  1000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled attention to other artificial opening of urinary tract passenger in pick-up truck or van injured in collision with railway train or railway vehicle in traffic accident other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified severe sepsis unspecified septicemia chronic kidney disease, unspecified malignant neoplasm of prostate friedländer's bacillus infection in conditions classified elsewhere and of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hydronephrosis anemia, unspecified urinary tract infection, site not specified urinary complications, not elsewhere classified infection and inflammatory reaction due to other genitourinary device, implant, and graft do not resuscitate status personal history of antineoplastic chemotherapy fever, unspecified do not resuscitate status hyposmolality and/or hyponatremia secondary malignant neoplasm of other urinary organs personal history of malignant neoplasm of prostate long-term (current) use of other medications family history of malignant neoplasm of prostate urinary tract infection, site not specified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypopotassemia unspecified essential hypertension streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified chronic kidney disease, stage iii (moderate) hydronephrosis acute kidney failure, unspecified long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled secondary malignant neoplasm of other urinary organs hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of malignant neoplasm of prostate other specified retention of urine irradiation cystitis late effect of radiation hydronephrosis radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure
white m 77 $nan$nan$ascorbic acid  500  mg ; calcium carbonate  500  mg ; ferrous sulfate  325  mg ; prednisone  5  mg ; vitamin d  1000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled attention to other artificial opening of urinary tract passenger in pick-up truck or van injured in collision with railway train or railway vehicle in traffic accident other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified severe sepsis unspecified septicemia chronic kidney disease, unspecified malignant neoplasm of prostate friedländer's bacillus infection in conditions classified elsewhere and of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hydronephrosis anemia, unspecified urinary tract infection, site not specified urinary complications, not elsewhere classified infection and inflammatory reaction due to other genitourinary device, implant, and graft do not resuscitate status personal history of antineoplastic chemotherapy fever, unspecified do not resuscitate status hyposmolality and/or hyponatremia secondary malignant neoplasm of other urinary organs personal history of malignant neoplasm of prostate long-term (current) use of other medications family history of malignant neoplasm of prostate urinary tract infection, site not specified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypopotassemia unspecified essential hypertension streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified chronic kidney disease, stage iii (moderate) hydronephrosis acute kidney failure, unspecified long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled secondary malignant neoplasm of other urinary organs hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of malignant neoplasm of prostate other specified retention of urine irradiation cystitis late effect of radiation hydronephrosis radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure
white f 74 $nan$nan$simvastatin  40  mg ; 
benign essential hypertension toxic encephalopathy iron deficiency anemia, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified constipation, unspecified aortic valve disorders depressive disorder, not elsewhere classified unspecified persistent mental disorders due to conditions classified elsewhere other and unspecified hyperlipidemia 
white f 74 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  309  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  127  mg dl; chemistry blood lactate dehydrogenase (ld)  189  iu l; chemistry blood albumin  3.9  g dl; chemistry blood % hemoglobin a1c  5.4  %$simvastatin  40  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; polyethylene glycol  17  g ; fentanyl patch  12  mcg h ; acetaminophen  325  mg ; hydralazine  25  mg ; dicyclomine  10  mg ; labetalol  200  mg ; docusate sodium  100  mg ; mupirocin nasal ointment 2%  1  appl ; 
benign essential hypertension toxic encephalopathy iron deficiency anemia, unspecified osteoarthrosis, unspecified whether generalized or localized, site unspecified constipation, unspecified aortic valve disorders depressive disorder, not elsewhere classified unspecified persistent mental disorders due to conditions classified elsewhere other and unspecified hyperlipidemia 
black african american m 37 $nan$hematology blood hematocrit  41.1  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  93  mg dl; blood gas blood lactate  0.8  mmol l$nan
 
white m 82 $temp  98.1  heartrate  62.0  resprate  16.0  o2sat  97.0  sbp  117.0  dbp  59.0  rhythm    pain  2  ; temp    heartrate  62.0  resprate  18.0  o2sat  95.0  sbp  111.0  dbp  65.0  rhythm    pain  2  ; temp    heartrate  62.0  resprate  18.0  o2sat  97.0  sbp  107.0  dbp  61.0  rhythm    pain  0  ; temp    heartrate  62.0  resprate  18.0  o2sat  95.0  sbp  123.0  dbp  67.0  rhythm    pain  0  ; temp    heartrate  60.0  resprate  18.0  o2sat  95.0  sbp  124.0  dbp  79.0  rhythm    pain  0  $hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  86  mg dl; blood gas blood lactate  2.9  mmol l$nan
panic disorder [episodic paroxysmal anxiety] thoracic aortic aneurysm, without rupture hyperlipidemia, unspecified pure hypercholesterolemia, unspecified disease of pericardium, unspecified benign prostatic hyperplasia without lower urinary tract symptoms type 2 diabetes mellitus with diabetic polyneuropathy secondary esophageal varices without bleeding alcoholic cirrhosis of liver without ascites personal history of nicotine dependence essential (primary) hypertension unspecified glaucoma gastro-esophageal reflux disease without esophagitis other constipation personal history of allergy to other antibiotic agent pedal cycle passenger injured in collision with heavy transport vehicle or bus in nontraffic accident retention of urine, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux infection with microorganisms with resistance to multiple quinolones and fluroquinolones urinary tract infection, site not specified other and unspecified hyperlipidemia other constipation other specified cardiac dysrhythmias abdominal aneurysm without mention of rupture unspecified glaucoma personal history of tobacco use panic disorder without agoraphobia urgency of urination hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) dysuria hyperplasia of prostate, unspecified, with urinary obstruction and other lower urinary symptoms (luts) pseudomonas infection in conditions classified elsewhere and of unspecified site unspecified essential hypertension panic disorder without agoraphobia cellulitis and abscess of trunk pure hypercholesterolemia esophageal varices in diseases classified elsewhere, without mention of bleeding diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cyst and pseudocyst of pancreas
white m 59 $temp  97.8  heartrate  93.0  resprate  18.0  o2sat  95.0  sbp  165.0  dbp  103.0  rhythm    pain  7  $nan$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5-15  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ondansetron  4  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; lisinopril  40  mg ; lorazepam  0.5-1  mg ; sodium chloride 0.9%  1000  ml ; hydromorphone (dilaudid)  0.25-0.5  mg ; lorazepam  1  mg ; hydromorphone (dilaudid)  0.12  mg ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; milk of magnesia  30  ml ; hydromorphone (dilaudid)  0.5  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; enoxaparin sodium  40  mg ; hydroxyzine  25  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; 
 
white m 59 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ondansetron  4  mg ; lisinopril  40  mg ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; milk of magnesia  30  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; enoxaparin sodium  40  mg ; hydroxyzine  25  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; cepacol (sore throat lozenge)  1  loz ; morphine sulfate  4  mg ; trazodone  25  mg ; 
 
white m 59 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ondansetron  4  mg ; lisinopril  40  mg ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; milk of magnesia  30  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; enoxaparin sodium  40  mg ; cepacol (sore throat lozenge)  1  loz ; morphine sulfate  4  mg ; trazodone  25  mg ; 
 
white f 69 $nan$hematology blood hematocrit  43.2  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  127  mg dl$ascorbic acid  250  mg ; multivitamins  1  cap ; vitamin d  400  unit ; calcitonin salmon  200  unit ; 
 
white f 69 $nan$hematology blood hematocrit  37.2  %; hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.5  g dl; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  170  k ul; hematology blood platelet count  194  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  3  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  153  mg dl; chemistry blood glucose  108  mg dl; blood gas blood lactate  0.7  mmol l$ascorbic acid  250  mg ; multivitamins  1  cap ; vitamin d  400  unit ; calcitonin salmon  200  unit ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; ns  1000  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  650  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  1  mg ; pantoprazole  40  mg ; ciprofloxacin hcl  500  mg ; aspirin  81  mg ; gabapentin  300  mg ; metronidazole (flagyl)  500  mg ; promethazine  6.25  mg ; calcium carbonate  500  mg ; diphenhydramine  12.5  mg ; potassium chloride  20  meq ; d5ns  1000  ml ; loratadine  10  mg ; vitamin d  800  unit ; 
 
white f 69 $nan$hematology blood hematocrit  33.7  %; hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  2  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  126  mg dl$ascorbic acid  250  mg ; multivitamins  1  cap ; vitamin d  400  unit ; calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  650  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  1  mg ; pantoprazole  40  mg ; ciprofloxacin hcl  500  mg ; gabapentin  300  mg ; metronidazole (flagyl)  500  mg ; promethazine  6.25  mg ; calcium carbonate  500  mg ; diphenhydramine  12.5  mg ; potassium chloride  20  meq ; d5ns  1000  ml ; loratadine  10  mg ; vitamin d  800  unit ; tramadol (ultram)  50  mg ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  2  mg ; promethazine  25  mg ; ondansetron odt  4  mg ; potassium chloride  40  meq ; 
 
white f 69 $nan$hematology blood hematocrit  41.1  %; hematology blood hematocrit  36.7  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  113  mg dl$calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; pantoprazole  40  mg ; ciprofloxacin hcl  500  mg ; gabapentin  300  mg ; metronidazole (flagyl)  500  mg ; calcium carbonate  500  mg ; diphenhydramine  12.5  mg ; loratadine  10  mg ; vitamin d  800  unit ; tramadol (ultram)  50  mg ; hydromorphone (dilaudid)  2  mg ; promethazine  25  mg ; ondansetron odt  4  mg ; potassium chloride  40  meq ; bisacodyl  10  mg ; docusate sodium  100  mg ; albuterol mdi  1-2  puff ; 
 
white f 69 $nan$nan$calcitonin salmon  200  unit ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; pantoprazole  40  mg ; ciprofloxacin hcl  500  mg ; gabapentin  300  mg ; metronidazole (flagyl)  500  mg ; calcium carbonate  500  mg ; loratadine  10  mg ; vitamin d  800  unit ; tramadol (ultram)  50  mg ; promethazine  25  mg ; ondansetron odt  4  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; albuterol mdi  1-2  puff ; 
 
white f 91 $nan$nan$lisinopril  40  mg ; aspirin  325  mg ; simvastatin  20  mg ; 
dizziness and giddiness iron deficiency anemia, unspecified pure hypercholesterolemia chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, infected abnormality of gait constipation, unspecified car passenger injured in collision with van in traffic accident osteoporosis, unspecified hip joint replacement venous (peripheral) insufficiency, unspecified occlusion and stenosis of carotid artery without mention of cerebral infarction other specified metabolic disorders allergic rhinitis, cause unspecified internal hemorrhoids without mention of complication macular degeneration (senile), unspecified sleep disturbance, unspecified unspecified fall hypoxemia cellulitis and abscess of leg, except foot personal history of tobacco use aortic valve disorders unspecified essential hypertension 
white f 91 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  283  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  102  mg dl$lisinopril  40  mg ; aspirin  325  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; metoprolol tartrate  12.5  mg ; bisacodyl  10  mg ; senna  2  tab ; docusate sodium  100  mg ; lactulose  30  ml ; doxycycline hyclate  100  mg ; amoxicillin-clavulanic acid  875  mg ; meclizine  12.5  mg ; metoprolol tartrate  25  mg ; d5w  200  ml ; ciprofloxacin iv  400  mg ; ns  1000  ml ; 
dizziness and giddiness iron deficiency anemia, unspecified pure hypercholesterolemia chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, infected abnormality of gait constipation, unspecified car passenger injured in collision with van in traffic accident osteoporosis, unspecified hip joint replacement venous (peripheral) insufficiency, unspecified occlusion and stenosis of carotid artery without mention of cerebral infarction other specified metabolic disorders allergic rhinitis, cause unspecified internal hemorrhoids without mention of complication macular degeneration (senile), unspecified sleep disturbance, unspecified unspecified fall hypoxemia cellulitis and abscess of leg, except foot personal history of tobacco use aortic valve disorders unspecified essential hypertension 
white f 91 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  102  mg dl$lisinopril  40  mg ; aspirin  325  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; bisacodyl  10  mg ; senna  2  tab ; docusate sodium  100  mg ; lactulose  30  ml ; meclizine  12.5  mg ; metoprolol tartrate  25  mg ; ns  1000  ml ; d5 1 2ns  1000  ml ; ns  500  ml ; potassium chloride  40  meq ; metoprolol tartrate  37.5  mg ; syringe  1  syr ; heparin sodium  4800  unit ; heparin sodium  2400  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; 
dizziness and giddiness iron deficiency anemia, unspecified pure hypercholesterolemia chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, infected abnormality of gait constipation, unspecified car passenger injured in collision with van in traffic accident osteoporosis, unspecified hip joint replacement venous (peripheral) insufficiency, unspecified occlusion and stenosis of carotid artery without mention of cerebral infarction other specified metabolic disorders allergic rhinitis, cause unspecified internal hemorrhoids without mention of complication macular degeneration (senile), unspecified sleep disturbance, unspecified unspecified fall hypoxemia cellulitis and abscess of leg, except foot personal history of tobacco use aortic valve disorders unspecified essential hypertension 
white f 91 $nan$hematology blood hematocrit  25.8  %; hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.4  ; hematology urine wbc  2  # hpf; chemistry blood glucose  123  mg dl$sw  50  ml ; lisinopril  40  mg ; aspirin  325  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  2  tab ; docusate sodium  100  mg ; lactulose  30  ml ; meclizine  12.5  mg ; d5 1 2ns  1000  ml ; ns  500  ml ; potassium chloride  40  meq ; metoprolol tartrate  37.5  mg ; syringe  1  syr ; heparin sodium  4800  unit ; heparin sodium  2400  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; syringe  0  ml ; heparin sodium  0  unit ; warfarin  2  mg ; trazodone  25  mg ; syringe  0.24  ml ; heparin sodium  1200  unit ; metoprolol tartrate  5  mg ; magnesium sulfate  2  gm ; 
dizziness and giddiness iron deficiency anemia, unspecified pure hypercholesterolemia chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, infected abnormality of gait constipation, unspecified car passenger injured in collision with van in traffic accident osteoporosis, unspecified hip joint replacement venous (peripheral) insufficiency, unspecified occlusion and stenosis of carotid artery without mention of cerebral infarction other specified metabolic disorders allergic rhinitis, cause unspecified internal hemorrhoids without mention of complication macular degeneration (senile), unspecified sleep disturbance, unspecified unspecified fall hypoxemia cellulitis and abscess of leg, except foot personal history of tobacco use aortic valve disorders unspecified essential hypertension 
white f 91 $nan$hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.5  ; hematology urine wbc  6-10  # hpf; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sw  50  ml ; lisinopril  40  mg ; aspirin  325  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  2  tab ; docusate sodium  100  mg ; lactulose  30  ml ; meclizine  12.5  mg ; metoprolol tartrate  37.5  mg ; heparin sodium  2400  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; warfarin  2  mg ; trazodone  25  mg ; syringe  0.24  ml ; heparin sodium  1200  unit ; metoprolol tartrate  5  mg ; magnesium sulfate  2  gm ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; metoprolol tartrate  50  mg ; 
dizziness and giddiness iron deficiency anemia, unspecified pure hypercholesterolemia chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, infected abnormality of gait constipation, unspecified car passenger injured in collision with van in traffic accident osteoporosis, unspecified hip joint replacement venous (peripheral) insufficiency, unspecified occlusion and stenosis of carotid artery without mention of cerebral infarction other specified metabolic disorders allergic rhinitis, cause unspecified internal hemorrhoids without mention of complication macular degeneration (senile), unspecified sleep disturbance, unspecified unspecified fall hypoxemia cellulitis and abscess of leg, except foot personal history of tobacco use aortic valve disorders unspecified essential hypertension 
white f 91 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  225  k ul; hematology blood platelet count  230  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  2.0  $lisinopril  40  mg ; aspirin  325  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  2  tab ; docusate sodium  100  mg ; lactulose  30  ml ; meclizine  12.5  mg ; heparin sodium  2400  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; warfarin  2  mg ; syringe  0.24  ml ; heparin sodium  1200  unit ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; metoprolol tartrate  50  mg ; cefpodoxime proxetil  200  mg ; pantoprazole  40  mg ; calcium carbonate  500  mg ; metoprolol tartrate  75  mg ; 
dizziness and giddiness iron deficiency anemia, unspecified pure hypercholesterolemia chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, infected abnormality of gait constipation, unspecified car passenger injured in collision with van in traffic accident osteoporosis, unspecified hip joint replacement venous (peripheral) insufficiency, unspecified occlusion and stenosis of carotid artery without mention of cerebral infarction other specified metabolic disorders allergic rhinitis, cause unspecified internal hemorrhoids without mention of complication macular degeneration (senile), unspecified sleep disturbance, unspecified unspecified fall hypoxemia cellulitis and abscess of leg, except foot personal history of tobacco use aortic valve disorders unspecified essential hypertension 
white f 91 $nan$nan$lisinopril  40  mg ; aspirin  325  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  2  tab ; docusate sodium  100  mg ; lactulose  30  ml ; meclizine  12.5  mg ; warfarin  2  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; cefpodoxime proxetil  200  mg ; pantoprazole  40  mg ; calcium carbonate  500  mg ; metoprolol tartrate  75  mg ; 
dizziness and giddiness iron deficiency anemia, unspecified pure hypercholesterolemia chronic airway obstruction, not elsewhere classified abrasion or friction burn of hip, thigh, leg, and ankle, infected abnormality of gait constipation, unspecified car passenger injured in collision with van in traffic accident osteoporosis, unspecified hip joint replacement venous (peripheral) insufficiency, unspecified occlusion and stenosis of carotid artery without mention of cerebral infarction other specified metabolic disorders allergic rhinitis, cause unspecified internal hemorrhoids without mention of complication macular degeneration (senile), unspecified sleep disturbance, unspecified unspecified fall hypoxemia cellulitis and abscess of leg, except foot personal history of tobacco use aortic valve disorders unspecified essential hypertension 
white m 81 $temp  98.1  heartrate  68.0  resprate  16.0  o2sat  96.0  sbp  155.0  dbp  86.0  rhythm    pain  0  ; temp    heartrate  67.0  resprate  16.0  o2sat  100.0  sbp  144.0  dbp  83.0  rhythm    pain  0  ; temp  98.6  heartrate  76.0  resprate  16.0  o2sat  100.0  sbp  165.0  dbp  89.0  rhythm    pain  0  $hematology blood hematocrit  39.1  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  92  mg dl; chemistry blood albumin  3.9  g dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; carbidopa-levodopa (25-100)  1  tab ; apixaban  5  mg ; sertraline  50  mg ; carvedilol  25  mg ; quetiapine fumarate  25  mg ; atorvastatin  80  mg ; levothyroxine sodium  100  mcg ; hydralazine  10-20  mg ; lisinopril  10  mg ; sodium chloride 0.9%  1000  ml ; ramelteon  8  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status atrial fibrillation acute diastolic heart failure congestive heart failure, unspecified systemic lupus erythematosus other and unspecified angina pectoris unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery history of fall unspecified essential hypertension
white m 81 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; carbidopa-levodopa (25-100)  1  tab ; apixaban  5  mg ; sertraline  50  mg ; carvedilol  25  mg ; quetiapine fumarate  25  mg ; atorvastatin  80  mg ; levothyroxine sodium  100  mcg ; hydralazine  10-20  mg ; lisinopril  10  mg ; sodium chloride 0.9%  1000  ml ; ramelteon  8  mg ; sarna lotion  1  appl ; warfarin  5  mg ; enoxaparin sodium  100  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status atrial fibrillation acute diastolic heart failure congestive heart failure, unspecified systemic lupus erythematosus other and unspecified angina pectoris unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery history of fall unspecified essential hypertension
white m 81 $nan$hematology blood hematocrit  39.4  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; carbidopa-levodopa (25-100)  1  tab ; sertraline  50  mg ; carvedilol  25  mg ; quetiapine fumarate  25  mg ; atorvastatin  80  mg ; levothyroxine sodium  100  mcg ; hydralazine  10-20  mg ; sodium chloride 0.9%  1000  ml ; sarna lotion  1  appl ; warfarin  5  mg ; enoxaparin sodium  100  mg ; lisinopril  20  mg ; enoxaparin sodium  150  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status atrial fibrillation acute diastolic heart failure congestive heart failure, unspecified systemic lupus erythematosus other and unspecified angina pectoris unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery history of fall unspecified essential hypertension
white m 81 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  96  mg dl; chemistry blood % hemoglobin a1c  6.0  %$hydralazine  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; carbidopa-levodopa (25-100)  1  tab ; sertraline  50  mg ; carvedilol  25  mg ; quetiapine fumarate  25  mg ; atorvastatin  80  mg ; levothyroxine sodium  100  mcg ; hydralazine  10-20  mg ; sodium chloride 0.9%  1000  ml ; sarna lotion  1  appl ; warfarin  5  mg ; lisinopril  20  mg ; enoxaparin sodium  150  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status atrial fibrillation acute diastolic heart failure congestive heart failure, unspecified systemic lupus erythematosus other and unspecified angina pectoris unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery history of fall unspecified essential hypertension
white m 81 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  149  mg dl$hydralazine  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; carbidopa-levodopa (25-100)  1  tab ; sertraline  50  mg ; carvedilol  25  mg ; quetiapine fumarate  25  mg ; atorvastatin  80  mg ; levothyroxine sodium  100  mcg ; sodium chloride 0.9%  1000  ml ; sarna lotion  1  appl ; warfarin  5  mg ; lisinopril  20  mg ; enoxaparin sodium  150  mg ; albuterol 0.083% neb soln  1  neb ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status atrial fibrillation acute diastolic heart failure congestive heart failure, unspecified systemic lupus erythematosus other and unspecified angina pectoris unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery history of fall unspecified essential hypertension
white m 81 $nan$hematology blood inr(pt)  2.0  $hydralazine  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; carbidopa-levodopa (25-100)  1  tab ; sertraline  50  mg ; carvedilol  25  mg ; quetiapine fumarate  25  mg ; atorvastatin  80  mg ; levothyroxine sodium  100  mcg ; sodium chloride 0.9%  1000  ml ; sarna lotion  1  appl ; warfarin  5  mg ; lisinopril  20  mg ; enoxaparin sodium  150  mg ; albuterol 0.083% neb soln  1  neb ; lisinopril  30  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status atrial fibrillation acute diastolic heart failure congestive heart failure, unspecified systemic lupus erythematosus other and unspecified angina pectoris unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery history of fall unspecified essential hypertension
white m 42 $temp  98.3  heartrate  77.0  resprate  18.0  o2sat  98.0  sbp  143.0  dbp  98.0  rhythm    pain  0  $hematology blood hematocrit  37.0  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  14.2  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  55  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  70  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; lidocaine 1%  1  ml ; hydromorphone (dilaudid)  0.125  mg ; acetaminophen  650  mg ; heparin (hemodialysis)  2000  unit ; 0.9% sodium chloride  250  ml ; sevelamer carbonate  3200  mg ; 
 
white m 42 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  11.8  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  89  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; heparin (hemodialysis)  2000  unit ; 0.9% sodium chloride  250  ml ; sevelamer carbonate  3200  mg ; gabapentin  300  mg ; hydromorphone (dilaudid)  0.25  mg ; allopurinol  100  mg ; atorvastatin  20  mg ; cinacalcet  30  mg ; oxycodone (immediate release)   5  mg ; 
 
white m 42 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; sevelamer carbonate  3200  mg ; gabapentin  300  mg ; hydromorphone (dilaudid)  0.25  mg ; allopurinol  100  mg ; atorvastatin  20  mg ; cinacalcet  30  mg ; oxycodone (immediate release)   5  mg ; 
 
white f 56 $nan$hematology blood hematocrit  29.6  %; hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  278  k ul; hematology blood platelet count  256  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  88  mg dl$0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; fentanyl patch  75  mcg hr ; ondansetron  4  mg ; zolpidem tartrate  5-10  mg ; gabapentin  600  mg ; morphine sulfate  4-6  mg ; heparin  5000  unit ; sucralfate  1  gm ; triamcinolone acetonide 0.1% cream  1  appl ; clonazepam  1  mg ; calcium carbonate  500  mg ; clindamycin  1  appl ; lansoprazole oral disintegrating tab  30  mg ; bupropion (sustained release)  300  mg ; citalopram  40  mg ; multivitamins  1  tab ; simvastatin  20  mg ; thiamine  100  mg ; fluticasone propionate nasal  2  spry ; oxycodone (immediate release)   5  mg ; vitamin d  800  unit ; ondansetron odt  4  mg ; 
bariatric surgery status unspecified essential hypertension iron deficiency anemia, unspecified other b-complex deficiencies dysthymic disorder abdominal pain, unspecified site migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other chronic pain pure hypercholesterolemia irritable bowel syndrome bariatric surgery status migraine, unspecified, without mention of intractable migraine without mention of status migrainosus abdominal pain, other specified site irritable bowel syndrome unspecified vitamin d deficiency dehydration iron deficiency anemia, unspecified pure hypercholesterolemia degeneration of lumbar or lumbosacral intervertebral disc other acne dysthymic disorder contact dermatitis and other eczema, unspecified cause personal history of methicillin resistant staphylococcus aureus other b-complex deficiencies unspecified essential hypertension personal history of venous thrombosis and embolism pure hypercholesterolemia other b-complex deficiencies irritable bowel syndrome migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified vitamin d deficiency retention of urine, unspecified acute upper respiratory infections of unspecified site other acne personal history of venous thrombosis and embolism bariatric surgery status myalgia and myositis, unspecified iron deficiency anemia, unspecified esophageal reflux dysthymic disorder other chronic pain unspecified essential hypertension long-term (current) use of anticoagulants dehydration swelling of limb bariatric surgery status unspecified essential hypertension insomnia, unspecified
white f 56 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  279  k ul$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; fentanyl patch  75  mcg hr ; zolpidem tartrate  5-10  mg ; gabapentin  600  mg ; heparin  5000  unit ; sucralfate  1  gm ; triamcinolone acetonide 0.1% cream  1  appl ; clonazepam  1  mg ; calcium carbonate  500  mg ; clindamycin  1  appl ; lansoprazole oral disintegrating tab  30  mg ; bupropion (sustained release)  300  mg ; citalopram  40  mg ; multivitamins  1  tab ; simvastatin  20  mg ; thiamine  100  mg ; fluticasone propionate nasal  2  spry ; vitamin d  800  unit ; ondansetron odt  4  mg ; tretinoin 0.1% cream  1  appl ; cyanocobalamin  1000  mcg ; 
bariatric surgery status unspecified essential hypertension iron deficiency anemia, unspecified other b-complex deficiencies dysthymic disorder abdominal pain, unspecified site migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other chronic pain pure hypercholesterolemia irritable bowel syndrome bariatric surgery status migraine, unspecified, without mention of intractable migraine without mention of status migrainosus abdominal pain, other specified site irritable bowel syndrome unspecified vitamin d deficiency dehydration iron deficiency anemia, unspecified pure hypercholesterolemia degeneration of lumbar or lumbosacral intervertebral disc other acne dysthymic disorder contact dermatitis and other eczema, unspecified cause personal history of methicillin resistant staphylococcus aureus other b-complex deficiencies unspecified essential hypertension personal history of venous thrombosis and embolism pure hypercholesterolemia other b-complex deficiencies irritable bowel syndrome migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified vitamin d deficiency retention of urine, unspecified acute upper respiratory infections of unspecified site other acne personal history of venous thrombosis and embolism bariatric surgery status myalgia and myositis, unspecified iron deficiency anemia, unspecified esophageal reflux dysthymic disorder other chronic pain unspecified essential hypertension long-term (current) use of anticoagulants dehydration swelling of limb bariatric surgery status unspecified essential hypertension insomnia, unspecified
white f 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; fentanyl patch  75  mcg hr ; zolpidem tartrate  5-10  mg ; gabapentin  600  mg ; heparin  5000  unit ; sucralfate  1  gm ; triamcinolone acetonide 0.1% cream  1  appl ; clonazepam  1  mg ; calcium carbonate  500  mg ; clindamycin  1  appl ; lansoprazole oral disintegrating tab  30  mg ; bupropion (sustained release)  300  mg ; citalopram  40  mg ; multivitamins  1  tab ; simvastatin  20  mg ; thiamine  100  mg ; fluticasone propionate nasal  2  spry ; vitamin d  800  unit ; tretinoin 0.1% cream  1  appl ; cyanocobalamin  1000  mcg ; 
bariatric surgery status unspecified essential hypertension iron deficiency anemia, unspecified other b-complex deficiencies dysthymic disorder abdominal pain, unspecified site migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other chronic pain pure hypercholesterolemia irritable bowel syndrome bariatric surgery status migraine, unspecified, without mention of intractable migraine without mention of status migrainosus abdominal pain, other specified site irritable bowel syndrome unspecified vitamin d deficiency dehydration iron deficiency anemia, unspecified pure hypercholesterolemia degeneration of lumbar or lumbosacral intervertebral disc other acne dysthymic disorder contact dermatitis and other eczema, unspecified cause personal history of methicillin resistant staphylococcus aureus other b-complex deficiencies unspecified essential hypertension personal history of venous thrombosis and embolism pure hypercholesterolemia other b-complex deficiencies irritable bowel syndrome migraine, unspecified, without mention of intractable migraine without mention of status migrainosus unspecified vitamin d deficiency retention of urine, unspecified acute upper respiratory infections of unspecified site other acne personal history of venous thrombosis and embolism bariatric surgery status myalgia and myositis, unspecified iron deficiency anemia, unspecified esophageal reflux dysthymic disorder other chronic pain unspecified essential hypertension long-term (current) use of anticoagulants dehydration swelling of limb bariatric surgery status unspecified essential hypertension insomnia, unspecified
white m 67 $nan$nan$omeprazole  40  mg ; 
pulmonary collapse malignant neoplasm of liver, secondary foreign body in respiratory tree, unspecified secondary malignant neoplasm of bone and bone marrow malignant neoplasm of gallbladder malignant pleural effusion secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acute venous embolism and thrombosis of deep vessels of proximal lower extremity secondary malignant neoplasm of bone and bone marrow malignant neoplasm of liver, secondary accidents occurring in other specified places hyposmolality and/or hyponatremia unspecified pleural effusion knee joint replacement malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum other septicemia due to gram-negative organisms pure hypercholesterolemia other specified aplastic anemias antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use digestive system complications, not elsewhere classified cholangitis other specified disorders of biliary tract knee joint replacement pure hypercholesterolemia obstruction of bile duct malignant neoplasm of gallbladder secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
white m 67 $nan$hematology blood hematocrit  25.3  %; hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  190  k ul; hematology blood platelet count  170  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.0  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  6.7  mg dl; chemistry blood calcium, total  6.8  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  71  mg dl; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.0  mmol l$omeprazole  40  mg ; 0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; lidocaine jelly 2% (urojet)  1  appl ; lorazepam  1  mg ; oxycodone (immediate release)   5  mg ; trazodone  50  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; vial  1  vial ; heparin sodium  5500  unit ; heparin sodium  1400-2800  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; pantoprazole  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; 0.9% sodium chloride  1000  ml ; 5% dextrose  500  ml ; potassium chloride  40  meq ; meropenem  500  mg ; sterile water  100  ml ; neutra-phos  2  pkt ; lidocaine 1%  20  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 
pulmonary collapse malignant neoplasm of liver, secondary foreign body in respiratory tree, unspecified secondary malignant neoplasm of bone and bone marrow malignant neoplasm of gallbladder malignant pleural effusion secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acute venous embolism and thrombosis of deep vessels of proximal lower extremity secondary malignant neoplasm of bone and bone marrow malignant neoplasm of liver, secondary accidents occurring in other specified places hyposmolality and/or hyponatremia unspecified pleural effusion knee joint replacement malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum other septicemia due to gram-negative organisms pure hypercholesterolemia other specified aplastic anemias antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use digestive system complications, not elsewhere classified cholangitis other specified disorders of biliary tract knee joint replacement pure hypercholesterolemia obstruction of bile duct malignant neoplasm of gallbladder secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
white m 67 $nan$hematology blood hematocrit  30.8  %; hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  178  k ul; hematology blood platelet count  171  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, indirect  0.6  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  78  mg dl; blood gas blood free calcium  1.15  mmol l; blood gas blood lactate  1.2  mmol l; chemistry blood bilirubin, direct  1.7  mg dl$sodium chloride 0.9%  flush  3  ml ; lidocaine jelly 2% (urojet)  1  appl ; trazodone  50  mg ; acetaminophen  325-650  mg ; vial  1  vial ; heparin sodium  5500  unit ; heparin sodium  1400-2800  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; pantoprazole  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; 0.9% sodium chloride  1000  ml ; 5% dextrose  500  ml ; potassium chloride  40  meq ; meropenem  500  mg ; sterile water  100  ml ; neutra-phos  2  pkt ; lidocaine 1%  20  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; potassium chl 40 meq   1000 ml ns  1000  ml ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; 
pulmonary collapse malignant neoplasm of liver, secondary foreign body in respiratory tree, unspecified secondary malignant neoplasm of bone and bone marrow malignant neoplasm of gallbladder malignant pleural effusion secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acute venous embolism and thrombosis of deep vessels of proximal lower extremity secondary malignant neoplasm of bone and bone marrow malignant neoplasm of liver, secondary accidents occurring in other specified places hyposmolality and/or hyponatremia unspecified pleural effusion knee joint replacement malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum other septicemia due to gram-negative organisms pure hypercholesterolemia other specified aplastic anemias antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use digestive system complications, not elsewhere classified cholangitis other specified disorders of biliary tract knee joint replacement pure hypercholesterolemia obstruction of bile duct malignant neoplasm of gallbladder secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
white m 67 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  101  mg dl$5% dextrose  200  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  50  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; meropenem  500  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; enoxaparin sodium  70  mg ; ciprofloxacin iv  400  mg ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; sterile water  50  ml ; potassium chloride  60  meq ; 
pulmonary collapse malignant neoplasm of liver, secondary foreign body in respiratory tree, unspecified secondary malignant neoplasm of bone and bone marrow malignant neoplasm of gallbladder malignant pleural effusion secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acute venous embolism and thrombosis of deep vessels of proximal lower extremity secondary malignant neoplasm of bone and bone marrow malignant neoplasm of liver, secondary accidents occurring in other specified places hyposmolality and/or hyponatremia unspecified pleural effusion knee joint replacement malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum other septicemia due to gram-negative organisms pure hypercholesterolemia other specified aplastic anemias antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use digestive system complications, not elsewhere classified cholangitis other specified disorders of biliary tract knee joint replacement pure hypercholesterolemia obstruction of bile duct malignant neoplasm of gallbladder secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
white m 67 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  92  mg dl$5% dextrose  200  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  50  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; enoxaparin sodium  70  mg ; ciprofloxacin iv  400  mg ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; sterile water  50  ml ; potassium chloride  60  meq ; morphine sulfate  1-2  mg ; 
pulmonary collapse malignant neoplasm of liver, secondary foreign body in respiratory tree, unspecified secondary malignant neoplasm of bone and bone marrow malignant neoplasm of gallbladder malignant pleural effusion secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acute venous embolism and thrombosis of deep vessels of proximal lower extremity secondary malignant neoplasm of bone and bone marrow malignant neoplasm of liver, secondary accidents occurring in other specified places hyposmolality and/or hyponatremia unspecified pleural effusion knee joint replacement malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum other septicemia due to gram-negative organisms pure hypercholesterolemia other specified aplastic anemias antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use digestive system complications, not elsewhere classified cholangitis other specified disorders of biliary tract knee joint replacement pure hypercholesterolemia obstruction of bile duct malignant neoplasm of gallbladder secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
white m 67 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  3.0  mg dl; chemistry blood glucose  84  mg dl$5% dextrose  200  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  50  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; enoxaparin sodium  70  mg ; ciprofloxacin iv  400  mg ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; sterile water  50  ml ; potassium chloride  60  meq ; morphine sulfate  1-2  mg ; 
pulmonary collapse malignant neoplasm of liver, secondary foreign body in respiratory tree, unspecified secondary malignant neoplasm of bone and bone marrow malignant neoplasm of gallbladder malignant pleural effusion secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acute venous embolism and thrombosis of deep vessels of proximal lower extremity secondary malignant neoplasm of bone and bone marrow malignant neoplasm of liver, secondary accidents occurring in other specified places hyposmolality and/or hyponatremia unspecified pleural effusion knee joint replacement malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum other septicemia due to gram-negative organisms pure hypercholesterolemia other specified aplastic anemias antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use digestive system complications, not elsewhere classified cholangitis other specified disorders of biliary tract knee joint replacement pure hypercholesterolemia obstruction of bile duct malignant neoplasm of gallbladder secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
white m 67 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  3.3  mg dl; chemistry blood glucose  79  mg dl; chemistry blood lactate dehydrogenase (ld)  656  iu l; chemistry blood albumin  2.5  g dl$5% dextrose  200  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  50  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; enoxaparin sodium  70  mg ; ciprofloxacin iv  400  mg ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; sterile water  50  ml ; potassium chloride  60  meq ; morphine sulfate  1-2  mg ; 
pulmonary collapse malignant neoplasm of liver, secondary foreign body in respiratory tree, unspecified secondary malignant neoplasm of bone and bone marrow malignant neoplasm of gallbladder malignant pleural effusion secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acute venous embolism and thrombosis of deep vessels of proximal lower extremity secondary malignant neoplasm of bone and bone marrow malignant neoplasm of liver, secondary accidents occurring in other specified places hyposmolality and/or hyponatremia unspecified pleural effusion knee joint replacement malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum other septicemia due to gram-negative organisms pure hypercholesterolemia other specified aplastic anemias antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use digestive system complications, not elsewhere classified cholangitis other specified disorders of biliary tract knee joint replacement pure hypercholesterolemia obstruction of bile duct malignant neoplasm of gallbladder secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
white m 67 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  81  mg dl$5% dextrose  200  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  50  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; enoxaparin sodium  70  mg ; ciprofloxacin iv  400  mg ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; sterile water  50  ml ; potassium chloride  60  meq ; zolpidem tartrate  5  mg ; 
pulmonary collapse malignant neoplasm of liver, secondary foreign body in respiratory tree, unspecified secondary malignant neoplasm of bone and bone marrow malignant neoplasm of gallbladder malignant pleural effusion secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acute venous embolism and thrombosis of deep vessels of proximal lower extremity secondary malignant neoplasm of bone and bone marrow malignant neoplasm of liver, secondary accidents occurring in other specified places hyposmolality and/or hyponatremia unspecified pleural effusion knee joint replacement malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum other septicemia due to gram-negative organisms pure hypercholesterolemia other specified aplastic anemias antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use digestive system complications, not elsewhere classified cholangitis other specified disorders of biliary tract knee joint replacement pure hypercholesterolemia obstruction of bile duct malignant neoplasm of gallbladder secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
white m 67 $nan$nan$5% dextrose  200  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  50  mg ; acetaminophen  325-650  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; enoxaparin sodium  70  mg ; ciprofloxacin iv  400  mg ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; sterile water  50  ml ; potassium chloride  60  meq ; zolpidem tartrate  5  mg ; sucralfate  1  gm ; lansoprazole oral disintegrating tab  30  mg ; 
pulmonary collapse malignant neoplasm of liver, secondary foreign body in respiratory tree, unspecified secondary malignant neoplasm of bone and bone marrow malignant neoplasm of gallbladder malignant pleural effusion secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acute venous embolism and thrombosis of deep vessels of proximal lower extremity secondary malignant neoplasm of bone and bone marrow malignant neoplasm of liver, secondary accidents occurring in other specified places hyposmolality and/or hyponatremia unspecified pleural effusion knee joint replacement malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum other septicemia due to gram-negative organisms pure hypercholesterolemia other specified aplastic anemias antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use digestive system complications, not elsewhere classified cholangitis other specified disorders of biliary tract knee joint replacement pure hypercholesterolemia obstruction of bile duct malignant neoplasm of gallbladder secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
white m 67 $nan$nan$5% dextrose  200  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  50  mg ; acetaminophen  325-650  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; enoxaparin sodium  70  mg ; ciprofloxacin iv  400  mg ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; sterile water  50  ml ; potassium chloride  60  meq ; sucralfate  1  gm ; lansoprazole oral disintegrating tab  30  mg ; lorazepam  0.5-2  mg ; 
pulmonary collapse malignant neoplasm of liver, secondary foreign body in respiratory tree, unspecified secondary malignant neoplasm of bone and bone marrow malignant neoplasm of gallbladder malignant pleural effusion secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acute venous embolism and thrombosis of deep vessels of proximal lower extremity secondary malignant neoplasm of bone and bone marrow malignant neoplasm of liver, secondary accidents occurring in other specified places hyposmolality and/or hyponatremia unspecified pleural effusion knee joint replacement malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum other septicemia due to gram-negative organisms pure hypercholesterolemia other specified aplastic anemias antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use digestive system complications, not elsewhere classified cholangitis other specified disorders of biliary tract knee joint replacement pure hypercholesterolemia obstruction of bile duct malignant neoplasm of gallbladder secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
white m 67 $nan$nan$5% dextrose  200  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  50  mg ; acetaminophen  325-650  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; enoxaparin sodium  70  mg ; ciprofloxacin iv  400  mg ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; sterile water  50  ml ; potassium chloride  60  meq ; sucralfate  1  gm ; lansoprazole oral disintegrating tab  30  mg ; lorazepam  0.5-2  mg ; 
pulmonary collapse malignant neoplasm of liver, secondary foreign body in respiratory tree, unspecified secondary malignant neoplasm of bone and bone marrow malignant neoplasm of gallbladder malignant pleural effusion secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acute venous embolism and thrombosis of deep vessels of proximal lower extremity secondary malignant neoplasm of bone and bone marrow malignant neoplasm of liver, secondary accidents occurring in other specified places hyposmolality and/or hyponatremia unspecified pleural effusion knee joint replacement malignant neoplasm of gallbladder secondary malignant neoplasm of retroperitoneum and peritoneum other septicemia due to gram-negative organisms pure hypercholesterolemia other specified aplastic anemias antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use digestive system complications, not elsewhere classified cholangitis other specified disorders of biliary tract knee joint replacement pure hypercholesterolemia obstruction of bile duct malignant neoplasm of gallbladder secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
white f 72 $temp    heartrate  72.0  resprate  18.0  o2sat  99.0  sbp  144.0  dbp  82.0  rhythm    pain  0  ; temp  97.8  heartrate  68.0  resprate  18.0  o2sat  99.0  sbp  139.0  dbp  78.0  rhythm    pain  0  ; temp    heartrate  65.0  resprate  16.0  o2sat  98.0  sbp  134.0  dbp  72.0  rhythm    pain  0  ; temp    heartrate  67.0  resprate  18.0  o2sat  97.0  sbp  129.0  dbp  78.0  rhythm    pain  0  ; temp  97.8  heartrate  47.0  resprate  14.0  o2sat  97.0  sbp  115.0  dbp  61.0  rhythm    pain    ; temp  97.8  heartrate  56.0  resprate  14.0  o2sat  97.0  sbp  128.0  dbp  63.0  rhythm    pain  0  $hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  242  k ul; hematology urine wbc  33  # hpf$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  50  mg ; dexamethasone  4  mg ; ziprasidone hydrochloride  80  mg ; levetiracetam  500  mg ; metoprolol tartrate  25  mg ; levothyroxine sodium  200  mcg ; omeprazole  20  mg ; 0.9% sodium chloride  1000  ml ; multivitamins  1  tab ; folic acid  1  mg ; fluticasone propionate nasal  1  spry ; vitamin d  400  unit ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; calcitriol  0.25  mcg ; desonide 0.05% cream  1  appl ; 
do not resuscitate status chronic kidney disease, unspecified unspecified acquired hypothyroidism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified cerebral edema urinary tract infection, site not specified encephalopathy, unspecified acidosis secondary neuroendocrine tumor of bone secondary neuroendocrine tumor of other sites personal history of malignant neuroendocrine tumor secondary neuroendocrine tumor of distant lymph nodes other psoriasis hypercalcemia swelling, mass, or lump in head and neck other convulsions dermatophytosis of other specified sites secondary malignant neoplasm of brain and spinal cord mild intellectual disabilities schizoaffective disorder, unspecified pure hypercholesterolemia cellulitis and abscess of trunk removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation schizoaffective disorder, chronic mild intellectual disabilities hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other postoperative infection unspecified acquired hypothyroidism chronic kidney disease, unspecified incisional hernia without mention of obstruction or gangrene calculus of gallbladder with other cholecystitis, without mention of obstruction mild intellectual disabilities hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified acquired hypothyroidism subacute dyskinesia due to drugs schizoaffective disorder, chronic secondary neuroendocrine tumor of other sites candidiasis of skin and nails chronic kidney disease, stage iii (moderate) other psychotropic agents causing adverse effects in therapeutic use other emphysema personal history of malignant neuroendocrine tumor
white f 72 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  96  mg dl$multivitamins  1  tab ; folic acid  1  mg ; fluticasone propionate nasal  1  spry ; vitamin d  400  unit ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; calcitriol  0.25  mcg ; desonide 0.05% cream  1  appl ; calcium carbonate  500  mg ; miconazole powder 2%  1  appl ; trazodone  75  mg ; nitrofurantoin (macrodantin)  50  mg ; 
do not resuscitate status chronic kidney disease, unspecified unspecified acquired hypothyroidism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified cerebral edema urinary tract infection, site not specified encephalopathy, unspecified acidosis secondary neuroendocrine tumor of bone secondary neuroendocrine tumor of other sites personal history of malignant neuroendocrine tumor secondary neuroendocrine tumor of distant lymph nodes other psoriasis hypercalcemia swelling, mass, or lump in head and neck other convulsions dermatophytosis of other specified sites secondary malignant neoplasm of brain and spinal cord mild intellectual disabilities schizoaffective disorder, unspecified pure hypercholesterolemia cellulitis and abscess of trunk removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation schizoaffective disorder, chronic mild intellectual disabilities hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other postoperative infection unspecified acquired hypothyroidism chronic kidney disease, unspecified incisional hernia without mention of obstruction or gangrene calculus of gallbladder with other cholecystitis, without mention of obstruction mild intellectual disabilities hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified acquired hypothyroidism subacute dyskinesia due to drugs schizoaffective disorder, chronic secondary neuroendocrine tumor of other sites candidiasis of skin and nails chronic kidney disease, stage iii (moderate) other psychotropic agents causing adverse effects in therapeutic use other emphysema personal history of malignant neuroendocrine tumor
white f 72 $nan$nan$multivitamins  1  tab ; folic acid  1  mg ; fluticasone propionate nasal  1  spry ; vitamin d  400  unit ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; calcitriol  0.25  mcg ; desonide 0.05% cream  1  appl ; calcium carbonate  500  mg ; miconazole powder 2%  1  appl ; trazodone  75  mg ; nitrofurantoin (macrodantin)  50  mg ; 
do not resuscitate status chronic kidney disease, unspecified unspecified acquired hypothyroidism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified cerebral edema urinary tract infection, site not specified encephalopathy, unspecified acidosis secondary neuroendocrine tumor of bone secondary neuroendocrine tumor of other sites personal history of malignant neuroendocrine tumor secondary neuroendocrine tumor of distant lymph nodes other psoriasis hypercalcemia swelling, mass, or lump in head and neck other convulsions dermatophytosis of other specified sites secondary malignant neoplasm of brain and spinal cord mild intellectual disabilities schizoaffective disorder, unspecified pure hypercholesterolemia cellulitis and abscess of trunk removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation schizoaffective disorder, chronic mild intellectual disabilities hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other postoperative infection unspecified acquired hypothyroidism chronic kidney disease, unspecified incisional hernia without mention of obstruction or gangrene calculus of gallbladder with other cholecystitis, without mention of obstruction mild intellectual disabilities hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified acquired hypothyroidism subacute dyskinesia due to drugs schizoaffective disorder, chronic secondary neuroendocrine tumor of other sites candidiasis of skin and nails chronic kidney disease, stage iii (moderate) other psychotropic agents causing adverse effects in therapeutic use other emphysema personal history of malignant neuroendocrine tumor
hispanic latino m 48 $temp  101.2  heartrate  79.0  resprate  23.0  o2sat  99.0  sbp  133.0  dbp  80.0  rhythm    pain  ua  ; temp  100.6  heartrate  80.0  resprate  26.0  o2sat  99.0  sbp  143.0  dbp  82.0  rhythm    pain  ua  ; temp    heartrate  82.0  resprate  25.0  o2sat  100.0  sbp  136.0  dbp  80.0  rhythm    pain  u  ; temp  100.0  heartrate  81.0  resprate  14.0  o2sat  100.0  sbp  130.0  dbp  78.0  rhythm    pain    ; temp  99.8  heartrate  81.0  resprate  14.0  o2sat  100.0  sbp  152.0  dbp  87.0  rhythm    pain  unable  $hematology blood hematocrit  26.6  %; hematology blood hematocrit  24.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  120  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  59  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  10  # hpf; chemistry blood glucose  66  mg dl; blood gas blood lactate  1.1  mmol l$nan
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $temp  98.9  heartrate  81.0  resprate  14.0  o2sat  100.0  sbp  147.0  dbp  85.0  rhythm    pain    ; temp    heartrate  88.0  resprate  16.0  o2sat  100.0  sbp  143.0  dbp  80.0  rhythm    pain  unable  $hematology blood hematocrit  23.5  %; hematology blood hematocrit  22.6  %; hematology blood hematocrit  21.7  %; hematology blood hematocrit  21.2  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  117  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  3.7  mg dl; chemistry blood creatinine  4.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  66  mg dl; chemistry blood urea nitrogen  73  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  86  mg dl; chemistry blood albumin  1.8  g dl$sodium chloride 0.9%  flush  3  ml ; loperamide  4  mg ; senna  8.6  mg ; hydralazine  100  mg ; isosorbide dinitrate  40  mg ; valproic acid  1500  mg ; creon 12  1  cap ; sodium bicarbonate  650  mg ; lacosamide  200  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; multivitamins w minerals  1  tab ; losartan potassium  100  mg ; carvedilol  50  mg ; lanthanum  500  mg ; clonidine  0.2  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; clonidine  0.1  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  21.3  %; hematology blood hematocrit  22.5  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  112  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  4.5  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  79  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  79  mg dl$sodium chloride 0.9%  flush  3  ml ; loperamide  4  mg ; senna  8.6  mg ; valproic acid  1500  mg ; creon 12  1  cap ; sodium bicarbonate  650  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; multivitamins w minerals  1  tab ; losartan potassium  100  mg ; carvedilol  50  mg ; lanthanum  500  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; clonidine  0.1  mg ; sodium chloride 0.9%  1000  ml ; epoetin alfa  10,000  unit ; emtricitabine oral solution  240  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  23.0  %; hematology blood hematocrit  22.4  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  112  k ul; hematology blood platelet count  116  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; loperamide  4  mg ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; multivitamins w minerals  1  tab ; carvedilol  50  mg ; lanthanum  500  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; emtricitabine oral solution  240  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  22.6  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  112  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  3.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  74  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; lanthanum  500  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; emtricitabine oral solution  240  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; multivitamins  5  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  21.6  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  100  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  39  mg dl; hematology urine wbc  123  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  74  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; lanthanum  500  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; emtricitabine oral solution  240  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; multivitamins  5  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; potassium chloride  20  meq ; ns  100  ml ; metronidazole (flagyl)  500  mg ; lanthanum  1000  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  23.1  %; hematology blood hematocrit  22.0  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  84  k ul; hematology blood platelet count  95  k ul; hematology blood platelet count  84  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  61  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  70  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; emtricitabine oral solution  240  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; multivitamins  5  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; lanthanum  1000  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  24.6  %; hematology blood hematocrit  22.6  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  69  k ul; hematology blood platelet count  74  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.1  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  139  mg dl; chemistry blood lactate dehydrogenase (ld)  191  iu l; blood gas blood lactate  2.1  mmol l$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; emtricitabine oral solution  240  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; multivitamins  5  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; lanthanum  1000  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  21.9  %; hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.1  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  68  k ul; hematology blood platelet count  75  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  119  mg dl; blood gas blood lactate  1.9  mmol l$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; emtricitabine oral solution  240  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; multivitamins  5  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  22.1  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  74  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; emtricitabine oral solution  240  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; multivitamins  5  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  20.9  %; hematology blood hematocrit  25.3  %; hematology blood hematocrit  22.4  %; hematology blood hemoglobin  6.6  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  78  k ul; hematology blood platelet count  89  k ul; hematology blood platelet count  101  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  55  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  117  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; emtricitabine oral solution  240  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; multivitamins  5  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; neomycin-polymyxin-bacitracin  1  appl ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  21.3  %; hematology blood hematocrit  20.3  %; hematology blood hemoglobin  6.7  g dl; hematology blood hemoglobin  6.4  g dl; hematology blood platelet count  116  k ul; hematology blood platelet count  112  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  75  mg dl; chemistry blood albumin  1.4  g dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; emtricitabine oral solution  240  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; multivitamins  5  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; neomycin-polymyxin-bacitracin  1  appl ; ondansetron  4  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  20.8  %; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  71  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; multivitamins  5  ml ; ondansetron  4  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  21.3  %; hematology blood hemoglobin  6.8  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; multivitamins  5  ml ; ondansetron  4  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  22.0  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; multivitamins  5  ml ; ondansetron  4  mg ; emtricitabine oral solution  60  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  18.2  %; hematology blood hematocrit  25.4  %; hematology blood hematocrit  24.8  %; hematology blood hematocrit  23.9  %; hematology blood hemoglobin  6.0  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  165  k ul; hematology blood platelet count  152  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  62  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  69  mg dl; chemistry blood lactate dehydrogenase (ld)  246  iu l$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; multivitamins  5  ml ; ondansetron  4  mg ; emtricitabine oral solution  60  mg ; zinc sulfate  220  mg ; ascorbic acid (liquid)  500  mg ; heparin  5000  unit ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  116  mg dl; chemistry blood albumin  1.2  g dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; multivitamins  5  ml ; ondansetron  4  mg ; emtricitabine oral solution  60  mg ; zinc sulfate  220  mg ; ascorbic acid (liquid)  500  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  19.6  %; hematology blood hematocrit  24.1  %; hematology blood hematocrit  25.0  %; hematology blood hemoglobin  6.8  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  169  k ul; hematology blood platelet count  163  k ul; hematology blood platelet count  170  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  82  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  289  iu l; chemistry blood lactate dehydrogenase (ld)  342  iu l; chemistry blood albumin  1.3  g dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; multivitamins  5  ml ; ondansetron  4  mg ; emtricitabine oral solution  60  mg ; zinc sulfate  220  mg ; ascorbic acid (liquid)  500  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  21.7  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  70  mg dl; chemistry blood lactate dehydrogenase (ld)  265  iu l$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; multivitamins  5  ml ; ondansetron  4  mg ; emtricitabine oral solution  60  mg ; zinc sulfate  220  mg ; ascorbic acid (liquid)  500  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  22.0  %; hematology blood hematocrit  20.9  %; hematology blood hemoglobin  7.1  g dl; hematology blood hemoglobin  6.7  g dl; hematology blood platelet count  140  k ul; hematology blood platelet count  152  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood urea nitrogen  51  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  139  mg dl; chemistry blood glucose  131  mg dl; hematology blood wbc count  5.5  k ul$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; multivitamins  5  ml ; ondansetron  4  mg ; emtricitabine oral solution  60  mg ; zinc sulfate  220  mg ; ascorbic acid (liquid)  500  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  21.8  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  118  mg dl$senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; multivitamins  5  ml ; ondansetron  4  mg ; emtricitabine oral solution  60  mg ; zinc sulfate  220  mg ; ascorbic acid (liquid)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  21.7  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  57  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  108  mg dl$senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; multivitamins  5  ml ; ondansetron  4  mg ; emtricitabine oral solution  60  mg ; zinc sulfate  220  mg ; ascorbic acid (liquid)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  86  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  104  mg dl; chemistry blood albumin  1.4  g dl$senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; multivitamins  5  ml ; ondansetron  4  mg ; emtricitabine oral solution  60  mg ; zinc sulfate  220  mg ; ascorbic acid (liquid)  500  mg ; cefepime  250  mg ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; ciprofloxacin hcl  500  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  22.1  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  96  mg dl$senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; multivitamins  5  ml ; ondansetron  4  mg ; emtricitabine oral solution  60  mg ; zinc sulfate  220  mg ; ascorbic acid (liquid)  500  mg ; ciprofloxacin hcl  500  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
hispanic latino m 48 $nan$hematology blood hematocrit  22.3  %; hematology blood hematocrit  20.9  %; hematology blood hemoglobin  6.5  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  77  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  118  mg dl; blood gas blood lactate  1.2  mmol l$senna  8.6  mg ; valproic acid  1500  mg ; lansoprazole oral disintegrating tab  30  mg ; thiamine  100  mg ; amlodipine  10  mg ; carvedilol  50  mg ; abacavir sulfate  600  mg ; levetiracetam oral solution  1000  mg ; raltegravir  400  mg ; phenobarbital  32.4  mg ; phenobarbital  97.2  mg ; levetiracetam oral solution  500  mg ; sarna lotion  1  appl ; acetaminophen  325  mg ; multivitamins  5  ml ; ondansetron  4  mg ; emtricitabine oral solution  60  mg ; zinc sulfate  220  mg ; ascorbic acid (liquid)  500  mg ; ciprofloxacin hcl  500  mg ; 
urinary tract infection, site not specified hypoxemia alcohol abuse, unspecified acute respiratory failure pressure ulcer, unspecified stage pneumonitis due to inhalation of food or vomitus other and unspecified coagulation defects genital herpes, unspecified cardiac arrest unspecified viral hepatitis c without hepatic coma other, mixed, or unspecified drug abuse, unspecified anemia in chronic kidney disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hydantoin derivatives causing adverse effects in therapeutic use anemia of other chronic disease other specified hypotension human immunodeficiency virus [hiv] disease do not resuscitate status pneumonia, organism unspecified pressure ulcer, lower back anoxic brain damage grand mal status other specified iron deficiency anemias congestive heart failure, unspecified pressure ulcer, stage iv constipation, unspecified bed confinement status renal dialysis status thrombocytopenia, unspecified other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms depressive disorder, not elsewhere classified renal sclerosis, unspecified tobacco use disorder other primary cardiomyopathies pressure ulcer, other site unspecified protein-calorie malnutrition other encephalopathy chronic systolic heart failure unspecified viral hepatitis c without hepatic coma end stage renal disease cocaine abuse, unspecified congestive heart failure, unspecified anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident counseling on substance use and abuse renal dialysis status
white f 32 $temp  98.4  heartrate  103.0  resprate  16.0  o2sat  98.0  sbp  128.0  dbp  91.0  rhythm    pain  8  ; temp  97.7  heartrate  78.0  resprate  16.0  o2sat  98.0  sbp  107.0  dbp  59.0  rhythm    pain  0  $hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  102  mg dl; blood gas blood lactate  1.1  mmol l$nan
follicular cyst of ovary endometriosis, site unspecified
white m 79 $temp  98.0  heartrate  66.0  resprate  14.0  o2sat  99.0  sbp  147.0  dbp  68.0  rhythm    pain  0  ; temp  97.9  heartrate  55.0  resprate  16.0  o2sat  95.0  sbp  149.0  dbp  66.0  rhythm    pain  0  ; temp  97.9  heartrate  52.0  resprate  16.0  o2sat  97.0  sbp  132.0  dbp  61.0  rhythm    pain  0  ; temp  98.0  heartrate  55.0  resprate  15.0  o2sat  95.0  sbp  134.0  dbp  76.0  rhythm    pain  0  ; temp    heartrate  60.0  resprate  16.0  o2sat  98.0  sbp  159.0  dbp  77.0  rhythm    pain    ; temp  98.1  heartrate  55.0  resprate  16.0  o2sat  97.0  sbp  140.0  dbp  65.0  rhythm    pain  0  ; temp  98.1  heartrate  55.0  resprate  16.0  o2sat  97.0  sbp  140.0  dbp  59.0  rhythm    pain    $hematology blood hematocrit  41.1  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  106  mg dl$nan
 
white m 79 $temp  97.8  heartrate  55.0  resprate  16.0  o2sat  98.0  sbp  137.0  dbp  72.0  rhythm    pain  0  $hematology blood hematocrit  39.9  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3-10  ml ; d5 1 2ns  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; tramadol  50  mg ; lorazepam  0.25  mg ; senna  8.6  mg ; metronidazole  500  mg ; aspirin  81  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; amlodipine  5  mg ; levothyroxine sodium  12.5  mcg ; atorvastatin  80  mg ; ciprofloxacin hcl  750  mg ; 
 
white m 79 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; tramadol  50  mg ; lorazepam  0.25  mg ; senna  8.6  mg ; metronidazole  500  mg ; aspirin  81  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; amlodipine  5  mg ; levothyroxine sodium  12.5  mcg ; ciprofloxacin hcl  750  mg ; rosuvastatin calcium  40  mg ; lorazepam  1.5  mg ; 
 
white m 79 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; tramadol  50  mg ; senna  8.6  mg ; metronidazole  500  mg ; aspirin  81  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; amlodipine  5  mg ; levothyroxine sodium  12.5  mcg ; ciprofloxacin hcl  750  mg ; rosuvastatin calcium  40  mg ; lorazepam  1.5  mg ; chlorthalidone  25  mg ; 
 
white m 79 $nan$hematology blood hematocrit  40.7  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  127  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; tramadol  50  mg ; senna  8.6  mg ; metronidazole  500  mg ; aspirin  81  mg ; heparin  5000  unit ; amlodipine  5  mg ; levothyroxine sodium  12.5  mcg ; ciprofloxacin hcl  750  mg ; rosuvastatin calcium  40  mg ; lorazepam  1.5  mg ; chlorthalidone  25  mg ; hydralazine  20  mg ; ondansetron  4  mg ; cepacol (sore throat lozenge)  2  loz ; clopidogrel  75  mg ; 
 
white m 40 $nan$hematology blood hematocrit  40.9  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  330  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  173  mg dl; hematology blood bands  0  %$nan
 
white m 40 $nan$hematology blood hematocrit  38.7  %; hematology blood hematocrit  38.9  %; hematology blood hemoglobin  13.2  g dl; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  331  k ul; hematology blood platelet count  308  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  89  mg dl$1 2 ns  1000  ml ; heparin  4000  unit ; heparin  1200  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; atropine sulfate  0.5  mg ; aspirin ec  325  mg ; eptifibatide  20  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; lisinopril  5  mg ; lorazepam  0.5  mg ; metoprolol tartrate  25  mg ; metoprolol tartrate  12.5  mg ; metoprolol tartrate  5  mg ; metoprolol tartrate  37.5  mg ; 
 
white m 40 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  97  mg dl$atropine sulfate  0.5  mg ; aspirin ec  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; lisinopril  5  mg ; lorazepam  0.5  mg ; metoprolol tartrate  5  mg ; metoprolol tartrate  37.5  mg ; metoprolol tartrate  50  mg ; sodium chloride 0.9%  flush  3  ml ; 
 
white m 40 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  50  mg dl$atropine sulfate  0.5  mg ; aspirin ec  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; lisinopril  5  mg ; metoprolol tartrate  50  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol succinate xl  75  mg ; 
 
white m 40 $nan$nan$atropine sulfate  0.5  mg ; aspirin ec  325  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol succinate xl  75  mg ; 
 
white f 45 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  94  mg dl$influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  20  mg ; acetaminophen iv  1000  mg ; cepastat (phenol) lozenge  1-2  loz ; ketorolac  15  mg ; d5 1 2ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; bisacodyl  10  mg ; hydromorphone (dilaudid)  2  mg ; simethicone  40-80  mg ; 
other known or suspected fetal abnormality, not elsewhere classified, affecting management of mother, delivered, with or without mention of antepartum condition unspecified motorcycle rider injured in collision with fixed or stationary object in nontraffic accident abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition supervision of high-risk pregnancy with history of infertility motorcycle driver injured in collision with car, pick-up truck or van in nontraffic accident outcome of delivery, twins, both liveborn prolapsed arm of fetus, delivered, with or without mention of antepartum condition obstruction caused by malposition of fetus at onset of labor, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition multiple gestation with malpresentation of one fetus or more, delivered, with or without mention of antepartum condition twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication constipation, unspecified
white f 45 $nan$hematology blood hematocrit  25.8  %; hematology blood hematocrit  24.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  100  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; acetaminophen iv  1000  mg ; cepastat (phenol) lozenge  1-2  loz ; ketorolac  15  mg ; d5 1 2ns  1000  ml ; bisacodyl  10  mg ; hydromorphone (dilaudid)  2  mg ; simethicone  40-80  mg ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; acetaminophen  1000  mg ; acetaminophen-caff-butalbital  1-2  tab ; neutra-phos  2  pkt ; 
other known or suspected fetal abnormality, not elsewhere classified, affecting management of mother, delivered, with or without mention of antepartum condition unspecified motorcycle rider injured in collision with fixed or stationary object in nontraffic accident abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition supervision of high-risk pregnancy with history of infertility motorcycle driver injured in collision with car, pick-up truck or van in nontraffic accident outcome of delivery, twins, both liveborn prolapsed arm of fetus, delivered, with or without mention of antepartum condition obstruction caused by malposition of fetus at onset of labor, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition multiple gestation with malpresentation of one fetus or more, delivered, with or without mention of antepartum condition twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication constipation, unspecified
white f 45 $nan$hematology blood hematocrit  24.6  %; hematology blood hematocrit  21.9  %; hematology blood hematocrit  27.0  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  156  k ul; hematology blood platelet count  195  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  100  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; cepastat (phenol) lozenge  1-2  loz ; ketorolac  15  mg ; hydromorphone (dilaudid)  2  mg ; simethicone  40-80  mg ; docusate sodium  100  mg ; acetaminophen  1000  mg ; acetaminophen-caff-butalbital  1-2  tab ; neutra-phos  2  pkt ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; neutra-phos  1  pkt ; hydromorphone (dilaudid)  2-6  mg ; 
other known or suspected fetal abnormality, not elsewhere classified, affecting management of mother, delivered, with or without mention of antepartum condition unspecified motorcycle rider injured in collision with fixed or stationary object in nontraffic accident abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition supervision of high-risk pregnancy with history of infertility motorcycle driver injured in collision with car, pick-up truck or van in nontraffic accident outcome of delivery, twins, both liveborn prolapsed arm of fetus, delivered, with or without mention of antepartum condition obstruction caused by malposition of fetus at onset of labor, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition multiple gestation with malpresentation of one fetus or more, delivered, with or without mention of antepartum condition twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication constipation, unspecified
white f 45 $nan$hematology blood hematocrit  25.5  %; hematology blood hematocrit  25.6  %; hematology blood hematocrit  28.7  %; hematology blood hematocrit  29.6  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  97  mg dl$heparin  5000  unit ; cepastat (phenol) lozenge  1-2  loz ; simethicone  40-80  mg ; docusate sodium  100  mg ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; neutra-phos  1  pkt ; 
other known or suspected fetal abnormality, not elsewhere classified, affecting management of mother, delivered, with or without mention of antepartum condition unspecified motorcycle rider injured in collision with fixed or stationary object in nontraffic accident abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition supervision of high-risk pregnancy with history of infertility motorcycle driver injured in collision with car, pick-up truck or van in nontraffic accident outcome of delivery, twins, both liveborn prolapsed arm of fetus, delivered, with or without mention of antepartum condition obstruction caused by malposition of fetus at onset of labor, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition multiple gestation with malpresentation of one fetus or more, delivered, with or without mention of antepartum condition twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication constipation, unspecified
white f 45 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  269  k ul$heparin  5000  unit ; cepastat (phenol) lozenge  1-2  loz ; simethicone  40-80  mg ; docusate sodium  100  mg ; diphenhydramine  12.5  mg ; 
other known or suspected fetal abnormality, not elsewhere classified, affecting management of mother, delivered, with or without mention of antepartum condition unspecified motorcycle rider injured in collision with fixed or stationary object in nontraffic accident abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition supervision of high-risk pregnancy with history of infertility motorcycle driver injured in collision with car, pick-up truck or van in nontraffic accident outcome of delivery, twins, both liveborn prolapsed arm of fetus, delivered, with or without mention of antepartum condition obstruction caused by malposition of fetus at onset of labor, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition multiple gestation with malpresentation of one fetus or more, delivered, with or without mention of antepartum condition twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication constipation, unspecified
white f 45 $nan$nan$heparin  5000  unit ; cepastat (phenol) lozenge  1-2  loz ; simethicone  40-80  mg ; docusate sodium  100  mg ; diphenhydramine  12.5  mg ; 
other known or suspected fetal abnormality, not elsewhere classified, affecting management of mother, delivered, with or without mention of antepartum condition unspecified motorcycle rider injured in collision with fixed or stationary object in nontraffic accident abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition supervision of high-risk pregnancy with history of infertility motorcycle driver injured in collision with car, pick-up truck or van in nontraffic accident outcome of delivery, twins, both liveborn prolapsed arm of fetus, delivered, with or without mention of antepartum condition obstruction caused by malposition of fetus at onset of labor, delivered, with or without mention of antepartum condition early onset of delivery, delivered, with or without mention of antepartum condition elderly primigravida, delivered, with or without mention of antepartum condition multiple gestation with malpresentation of one fetus or more, delivered, with or without mention of antepartum condition twin pregnancy, antepartum condition or complication threatened premature labor, antepartum condition or complication constipation, unspecified
white m 49 $temp    heartrate  60.0  resprate  18.0  o2sat  98.0  sbp  125.0  dbp  86.0  rhythm    pain  3  $hematology blood hematocrit  37.8  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; heparin  2300-4600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; acyclovir  400  mg ; fluticasone propionate nasal  2  spry ; multivitamins  1  tab ; sertraline  100  mg ; docusate sodium  100  mg ; enoxaparin sodium  120  mg ; 
 
white m 33 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl$aspirin  325  mg ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  800  mg ; heparin  5000  unit ; morphine sulfate  1  mg ; acetaminophen  325-650  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; metoprolol tartrate  12.5  mg ; oxycodone (immediate release)   5  mg ; 
 
white m 33 $nan$nan$aspirin  325  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; morphine sulfate  1  mg ; acetaminophen  325-650  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; metoprolol tartrate  12.5  mg ; oxycodone (immediate release)   5  mg ; oxycodone (immediate release)   2.5  mg ; lisinopril  2.5  mg ; 
 
white f 71 $temp  98.0  heartrate  58.0  resprate  18.0  o2sat  100.0  sbp  123.0  dbp  90.0  rhythm    pain  0  $hematology blood hematocrit  23.6  %; hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  364  k ul; hematology blood platelet count  334  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  76  meq l; chemistry blood chloride  70  meq l; chemistry blood chloride  77  meq l; chemistry blood chloride  69  meq l; chemistry blood chloride  72  meq l; chemistry blood chloride  76  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  2.8  meq l; chemistry blood potassium  2.8  meq l; chemistry blood sodium  102  meq l; chemistry blood sodium  108  meq l; chemistry blood sodium  109  meq l; chemistry blood sodium  102  meq l; chemistry blood sodium  104  meq l; chemistry blood sodium  109  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  10  meq l; chemistry urine potassium, urine  9  meq l; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  90  mg dl; chemistry blood glucose  100  mg dl; chemistry blood albumin  3.6  g dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; bag  500  ml ; sodium chloride 3% (hypertonic)  500  ml ; acetaminophen  650  mg ; potassium chloride  60  meq ; phosphorus  500  mg ; divalproex (delayed release)  500  mg ; lamotrigine  50  mg ; 0.9% sodium chloride  50  ml ; desmopressin acetate  10  mcg ; potassium chloride (powder)  60  meq ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; creon 12  1  cap ; ferrous sulfate  325  mg ; 
 
white f 71 $nan$hematology blood hematocrit  21.5  %; hematology blood hematocrit  21.7  %; hematology blood hemoglobin  6.7  g dl; hematology blood hemoglobin  6.7  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  80  meq l; chemistry blood chloride  80  meq l; chemistry blood chloride  81  meq l; chemistry blood chloride  78  meq l; chemistry blood chloride  78  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  109  meq l; chemistry blood sodium  109  meq l; chemistry blood sodium  109  meq l; chemistry blood sodium  113  meq l; chemistry blood sodium  114  meq l; chemistry blood sodium  110  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  99  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; acetaminophen  650  mg ; potassium chloride  60  meq ; phosphorus  500  mg ; divalproex (delayed release)  500  mg ; lamotrigine  50  mg ; 0.9% sodium chloride  50  ml ; desmopressin acetate  10  mcg ; potassium chloride (powder)  60  meq ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; creon 12  1  cap ; ferrous sulfate  325  mg ; lorazepam  0.5  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; lorazepam  1  mg ; omeprazole  40  mg ; 
 
white f 71 $nan$hematology blood hematocrit  26.3  %; hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  289  k ul; hematology blood platelet count  254  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  84  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  72  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  2.9  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  121  meq l; chemistry blood sodium  116  meq l; chemistry blood sodium  118  meq l; chemistry blood sodium  100  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  6.8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  126  mg dl; blood gas blood chloride, whole blood  92  meq l; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood sodium, whole blood  121  meq l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; acetaminophen  650  mg ; divalproex (delayed release)  500  mg ; lamotrigine  50  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; creon 12  1  cap ; ferrous sulfate  325  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; lorazepam  1  mg ; omeprazole  40  mg ; vial  1  vial ; pantoprazole  40  mg ; desmopressin acetate  2  mcg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
 
white f 71 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  93  mg dl$dextrose 5%  1000  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; acetaminophen  650  mg ; divalproex (delayed release)  500  mg ; lamotrigine  50  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; creon 12  1  cap ; ferrous sulfate  325  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; vial  1  vial ; pantoprazole  40  mg ; desmopressin acetate  2  mcg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
 
white f 71 $nan$hematology blood hematocrit  26.8  %; hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  285  k ul; hematology blood platelet count  315  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  87  mg dl; chemistry blood glucose  87  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; acetaminophen  650  mg ; divalproex (delayed release)  500  mg ; lamotrigine  50  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; creon 12  1  cap ; ferrous sulfate  325  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; vial  1  vial ; pantoprazole  40  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; 
 
white f 71 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  291  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  87  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; acetaminophen  650  mg ; lamotrigine  50  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; creon 12  1  cap ; ferrous sulfate  325  mg ; vial  1  vial ; pantoprazole  40  mg ; amlodipine  10  mg ; 
 
white f 71 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  83  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; acetaminophen  650  mg ; lamotrigine  50  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; creon 12  1  cap ; ferrous sulfate  325  mg ; vial  1  vial ; pantoprazole  40  mg ; amlodipine  10  mg ; ondansetron  4  mg ; 
 
white f 71 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; acetaminophen  650  mg ; lamotrigine  50  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; creon 12  1  cap ; ferrous sulfate  325  mg ; amlodipine  10  mg ; ondansetron  4  mg ; 
 
white m 63 $nan$hematology blood hematocrit  39.0  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  111  mg dl$nan
 
white m 63 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; 0.9% sodium chloride  250  ml ; phenytoin sodium  1000  mg ; levetiracetam  500  mg ; diphenhydramine  25  mg ; phenytoin sodium extended  100  mg ; 
 
white f 76 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  323  mg dl$insulin  20  unit ; citalopram hydrobromide  20  mg ; levothyroxine sodium  25  mcg ; tiotropium bromide  1  cap ; enalapril maleate  10  mg ; furosemide  20  mg ; artificial tears  1-2  drop ; brimonidine tartrate 0.15% ophth.  1  drop ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol  25  mg ; senna  1  tab ; acetaminophen  325-650  mg ; hydralazine  25  mg ; insulin  0  unit ; acetaminophen  650  mg ; docusate sodium  100  mg ; artificial tears preserv. free  1-2  drop ; heparin  5000  unit ; insulin  8  unit ; 
 
white f 76 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  140  mg dl$furosemide  20  mg ; artificial tears  1-2  drop ; acetaminophen  650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; insulin  12  unit ; atenolol  50  mg ; aspirin  81  mg ; nicotine patch  14  mg ; ns  1000  ml ; hydralazine  10  mg ; 
 
white f 76 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  58  mg dl$artificial tears  1-2  drop ; acetaminophen  650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; atenolol  50  mg ; aspirin  81  mg ; nicotine patch  14  mg ; hydralazine  10  mg ; metoprolol  37.5  mg ; metoprolol  5  mg ; hydralazine  20  mg ; nitroglycerin ointment  2%  1  in ; lorazepam  0.25  mg ; 
 
white f 76 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry urine creatinine, urine  49  mg dl; hematology urine wbc  3-5  # hpf; chemistry blood glucose  404  mg dl; chemistry blood glucose  491  mg dl; chemistry urine protein creatinine ratio  2.0  ratio; hematology urine glucose  1000  mg dl; chemistry urine albumin, urine  59.7  mg dl; chemistry urine albumin creatinine, urine  1218.4  mg g; hematology urine bilirubin  neg  mg dl$artificial tears  1-2  drop ; acetaminophen  650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; nicotine patch  14  mg ; metoprolol  37.5  mg ; metoprolol  5  mg ; hydralazine  20  mg ; nitroglycerin ointment  2%  1  in ; lorazepam  0.25  mg ; dextrose 50%  12.5  gm ; ns  500  ml ; insulin  14  unit ; enalapril maleate  20  mg ; metoprolol  12.5  mg ; insulin  5  unit ; 
 
white f 76 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood glucose  209  mg dl$artificial tears  1-2  drop ; acetaminophen  650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; nicotine patch  14  mg ; ns  500  ml ; insulin  14  unit ; enalapril maleate  20  mg ; metoprolol  12.5  mg ; insulin  5  unit ; metoprolol  50  mg ; 
 
white f 76 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood glucose  105  mg dl$artificial tears  1-2  drop ; acetaminophen  650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; nicotine patch  14  mg ; metoprolol  50  mg ; enalapril maleate  40  mg ; 
 
white m 45 $temp  98.4  heartrate  83.0  resprate  16.0  o2sat  99.0  sbp  126.0  dbp  78.0  rhythm    pain  1  $nan$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; docusate sodium  100  mg ; milk of magnesia  30  ml ; multivitamins  1  tab ; vitamin d  400  unit ; ondansetron  4  mg ; enoxaparin sodium  40  mg ; 
 
white m 74 $temp  98.0  heartrate  96.0  resprate  15.0  o2sat  94.0  sbp  124.0  dbp  77.0  rhythm    pain  0  $hematology blood hematocrit  37.2  %; hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.0  g dl; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  255  k ul; hematology blood platelet count  250  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  139  mg dl; blood gas blood free calcium  1.02  mmol l$sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; albuterol 0.083% neb soln  1  neb ; atorvastatin  40  mg ; heparin  5000  unit ; ns  100  ml ; metronidazole  500  mg ; vial  1  vial ; ceftriaxone  1  gm ; acetaminophen  1000  mg ; ondansetron  4  mg ; d5 1 2ns  1000  ml ; bag  1  bag ; magnesium sulfate  2  gm ; 0.9% sodium chloride  500  ml ; sodium phosphate  15  mmol ; 
diverticulitis of small intestine with perforation and abscess without bleeding personal history of nicotine dependence essential (primary) hypertension chronic obstructive pulmonary disease, unspecified
white m 74 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; atorvastatin  40  mg ; heparin  5000  unit ; ns  100  ml ; metronidazole  500  mg ; vial  1  vial ; ceftriaxone  1  gm ; acetaminophen  1000  mg ; ondansetron  4  mg ; d5 1 2ns  1000  ml ; bag  1  bag ; magnesium sulfate  2  gm ; 0.9% sodium chloride  500  ml ; sodium phosphate  15  mmol ; acetaminophen iv  1000  mg ; 
diverticulitis of small intestine with perforation and abscess without bleeding personal history of nicotine dependence essential (primary) hypertension chronic obstructive pulmonary disease, unspecified
white m 74 $nan$hematology blood hematocrit  40.0  %; hematology blood hematocrit  39.1  %; hematology blood hemoglobin  12.5  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  260  k ul; hematology blood platelet count  244  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ns  100  ml ; metronidazole  500  mg ; vial  1  vial ; ceftriaxone  1  gm ; ondansetron  4  mg ; d5 1 2ns  1000  ml ; acetaminophen iv  1000  mg ; lidocaine jelly 2% (glydo)  1  appl ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 
diverticulitis of small intestine with perforation and abscess without bleeding personal history of nicotine dependence essential (primary) hypertension chronic obstructive pulmonary disease, unspecified
white m 74 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ns  100  ml ; metronidazole  500  mg ; vial  1  vial ; ceftriaxone  1  gm ; ondansetron  4  mg ; lidocaine jelly 2% (glydo)  1  appl ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; 
diverticulitis of small intestine with perforation and abscess without bleeding personal history of nicotine dependence essential (primary) hypertension chronic obstructive pulmonary disease, unspecified
white m 74 $nan$hematology blood hematocrit  36.9  %; hematology blood hematocrit  35.4  %; hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  229  k ul; hematology blood platelet count  253  k ul; hematology blood platelet count  256  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  8  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.8  ; hematology urine wbc  31  # hpf; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  132  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ns  100  ml ; metronidazole  500  mg ; vial  1  vial ; ceftriaxone  1  gm ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; calcium gluconate  2  g ; ipratropium bromide neb  1  neb ; potassium phosphate  30  mmol ; 
diverticulitis of small intestine with perforation and abscess without bleeding personal history of nicotine dependence essential (primary) hypertension chronic obstructive pulmonary disease, unspecified
white m 74 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ns  100  ml ; metronidazole  500  mg ; vial  1  vial ; ceftriaxone  1  gm ; ondansetron  4  mg ; calcium gluconate  2  g ; ipratropium bromide neb  1  neb ; potassium phosphate  30  mmol ; furosemide  10  mg ; 
diverticulitis of small intestine with perforation and abscess without bleeding personal history of nicotine dependence essential (primary) hypertension chronic obstructive pulmonary disease, unspecified
white m 74 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  115  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ns  100  ml ; metronidazole  500  mg ; vial  1  vial ; ceftriaxone  1  gm ; ondansetron  4  mg ; ipratropium bromide neb  1  neb ; furosemide  10  mg ; potassium chloride  40  meq ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 
diverticulitis of small intestine with perforation and abscess without bleeding personal history of nicotine dependence essential (primary) hypertension chronic obstructive pulmonary disease, unspecified
white m 74 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ns  100  ml ; metronidazole  500  mg ; vial  1  vial ; ceftriaxone  1  gm ; ondansetron  4  mg ; ipratropium bromide neb  1  neb ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 
diverticulitis of small intestine with perforation and abscess without bleeding personal history of nicotine dependence essential (primary) hypertension chronic obstructive pulmonary disease, unspecified
white m 74 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  110  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ns  100  ml ; metronidazole  500  mg ; vial  1  vial ; ceftriaxone  1  gm ; ondansetron  4  mg ; ipratropium bromide neb  1  neb ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; neutra-phos  1  pkt ; 
diverticulitis of small intestine with perforation and abscess without bleeding personal history of nicotine dependence essential (primary) hypertension chronic obstructive pulmonary disease, unspecified
white m 74 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ondansetron  4  mg ; ipratropium bromide neb  1  neb ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; neutra-phos  1  pkt ; iohexol 240  50  ml ; calcium carbonate  500  mg ; 
diverticulitis of small intestine with perforation and abscess without bleeding personal history of nicotine dependence essential (primary) hypertension chronic obstructive pulmonary disease, unspecified
white m 74 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ondansetron  4  mg ; ipratropium bromide neb  1  neb ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; iohexol 240  50  ml ; calcium carbonate  500  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 
diverticulitis of small intestine with perforation and abscess without bleeding personal history of nicotine dependence essential (primary) hypertension chronic obstructive pulmonary disease, unspecified
white m 74 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ondansetron  4  mg ; ipratropium bromide neb  1  neb ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; calcium carbonate  500  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
diverticulitis of small intestine with perforation and abscess without bleeding personal history of nicotine dependence essential (primary) hypertension chronic obstructive pulmonary disease, unspecified
white m 74 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  280  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  111  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ondansetron  4  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; magnesium sulfate  4  gm ; furosemide  20  mg ; simethicone  40-80  mg ; 
diverticulitis of small intestine with perforation and abscess without bleeding personal history of nicotine dependence essential (primary) hypertension chronic obstructive pulmonary disease, unspecified
white m 74 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  344  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ondansetron  4  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; simethicone  40-80  mg ; 
diverticulitis of small intestine with perforation and abscess without bleeding personal history of nicotine dependence essential (primary) hypertension chronic obstructive pulmonary disease, unspecified
white m 74 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ondansetron  4  mg ; ipratropium bromide neb  1  neb ; calcium carbonate  500  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; simethicone  40-80  mg ; ciprofloxacin hcl  500  mg ; 
diverticulitis of small intestine with perforation and abscess without bleeding personal history of nicotine dependence essential (primary) hypertension chronic obstructive pulmonary disease, unspecified
unable to obtain f 64 $nan$nan$chlorthalidone  25  mg ; atenolol  50  mg ; 
 
unable to obtain f 64 $nan$nan$chlorthalidone  25  mg ; atenolol  50  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  600  mg ; lr  1000  ml ; acetaminophen  500  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; oxycodone-acetaminophen  1-2  tab ; hydromorphone (dilaudid)  0.25-0.5  mg ; heparin  5000  unit ; 
 
unable to obtain f 64 $nan$nan$chlorthalidone  25  mg ; atenolol  50  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  600  mg ; acetaminophen  500  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; oxycodone-acetaminophen  1-2  tab ; hydromorphone (dilaudid)  0.25-0.5  mg ; heparin  5000  unit ; 
 
other f 33 $temp  98.0  heartrate  124.0  resprate  18.0  o2sat  99.0  sbp  116.0  dbp  78.0  rhythm    pain  10  ; temp  98.3  heartrate  103.0  resprate  18.0  o2sat  100.0  sbp  124.0  dbp  77.0  rhythm    pain    $hematology blood hematocrit  31.0  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  6.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  6  mg dl; hematology urine wbc  34  # hpf; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  75  mg dl; chemistry blood albumin  3.1  g dl; blood gas blood lactate  0.8  mmol l; blood gas blood potassium, whole blood  4.9  meq l$nan
 
other f 33 $temp  98.7  heartrate  110.0  resprate  16.0  o2sat  100.0  sbp  112.0  dbp  76.0  rhythm    pain  8  $hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  76  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ondansetron  4  mg ; oxybutynin  5  mg ; oxycodone (immediate release)  5  mg ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; morphine sulfate  4  mg ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; lactated ringers  1000  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; 
 
other f 33 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  77  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ondansetron  4  mg ; oxybutynin  5  mg ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; bag  2  bag ; magnesium sulfate  4  gm ; mirtazapine  7.5  mg ; 
 
other f 33 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  90  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxybutynin  5  mg ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; bag  2  bag ; magnesium sulfate  4  gm ; mirtazapine  7.5  mg ; 
 
other f 33 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  2.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  87  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxybutynin  5  mg ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; polyethylene glycol  17  g ; oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; mirtazapine  7.5  mg ; potassium chloride  60  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; levofloxacin  500  mg ; lorazepam  0.5  mg ; 
 
other f 33 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  80  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxybutynin  5  mg ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; polyethylene glycol  17  g ; oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; mirtazapine  7.5  mg ; potassium chloride  60  meq ; levofloxacin  500  mg ; lorazepam  0.5  mg ; 
 
white m 72 $nan$hematology blood hematocrit  40.6  %; hematology blood hematocrit  37.6  %; hematology blood hematocrit  38.2  %; hematology blood hemoglobin  13.2  g dl; hematology blood hemoglobin  12.4  g dl; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  122  k ul; hematology blood platelet count  105  k ul; hematology blood platelet count  126  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  141  mg dl; chemistry blood glucose  129  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; heparin  5000  unit ; ns  100  ml ; cefazolin  2  g ; metronidazole (flagyl)  500  mg ; hydromorphone (dilaudid)  0.5  mg ; insulin  0  unit ; metoprolol tartrate  5  mg ; sw  100  ml ; magnesium sulfate  4  gm ; labetalol  10-20  mg ; metoprolol tartrate  10  mg ; d5w  200  ml ; ciprofloxacin iv  400  mg ; hydromorphone (dilaudid)  12.5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
unspecified essential hypertension regional enteritis of unspecified site calculus of gallbladder with acute cholecystitis, without mention of obstruction calculus of gallbladder with other cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis pure hypercholesterolemia unspecified essential hypertension fitting and adjustment of nonvascular catheter, nec acute pancreatitis regional enteritis of unspecified site person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified sepsis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) urinary tract infection, site not specified personal history of malignant melanoma of skin knee joint replacement gout, unspecified unspecified essential hypertension hypotension, unspecified calculus of gallbladder with acute cholecystitis, without mention of obstruction escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site unspecified septicemia dehydration other and unspecified hyperlipidemia ileostomy status 
white m 72 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  123  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ns  100  ml ; cefazolin  2  g ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; labetalol  10-20  mg ; metoprolol tartrate  10  mg ; d5w  200  ml ; ciprofloxacin iv  400  mg ; hydromorphone (dilaudid)  12.5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lorazepam  0.5  mg ; 
unspecified essential hypertension regional enteritis of unspecified site calculus of gallbladder with acute cholecystitis, without mention of obstruction calculus of gallbladder with other cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis pure hypercholesterolemia unspecified essential hypertension fitting and adjustment of nonvascular catheter, nec acute pancreatitis regional enteritis of unspecified site person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified sepsis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) urinary tract infection, site not specified personal history of malignant melanoma of skin knee joint replacement gout, unspecified unspecified essential hypertension hypotension, unspecified calculus of gallbladder with acute cholecystitis, without mention of obstruction escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site unspecified septicemia dehydration other and unspecified hyperlipidemia ileostomy status 
white m 72 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  150  k ul$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; insulin  0  unit ; d5w  200  ml ; ciprofloxacin iv  400  mg ; hydromorphone (dilaudid)  12.5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lorazepam  0.5  mg ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; atenolol  50  mg ; simvastatin  40  mg ; morphine sulfate ir  15-30  mg ; 
unspecified essential hypertension regional enteritis of unspecified site calculus of gallbladder with acute cholecystitis, without mention of obstruction calculus of gallbladder with other cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis pure hypercholesterolemia unspecified essential hypertension fitting and adjustment of nonvascular catheter, nec acute pancreatitis regional enteritis of unspecified site person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified sepsis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) urinary tract infection, site not specified personal history of malignant melanoma of skin knee joint replacement gout, unspecified unspecified essential hypertension hypotension, unspecified calculus of gallbladder with acute cholecystitis, without mention of obstruction escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site unspecified septicemia dehydration other and unspecified hyperlipidemia ileostomy status 
white m 72 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  152  k ul$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; insulin  0  unit ; lorazepam  0.5  mg ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; atenolol  50  mg ; simvastatin  40  mg ; morphine sulfate ir  15-30  mg ; glyburide  2.5  mg ; doxazosin  4  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; 
unspecified essential hypertension regional enteritis of unspecified site calculus of gallbladder with acute cholecystitis, without mention of obstruction calculus of gallbladder with other cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis pure hypercholesterolemia unspecified essential hypertension fitting and adjustment of nonvascular catheter, nec acute pancreatitis regional enteritis of unspecified site person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified sepsis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) urinary tract infection, site not specified personal history of malignant melanoma of skin knee joint replacement gout, unspecified unspecified essential hypertension hypotension, unspecified calculus of gallbladder with acute cholecystitis, without mention of obstruction escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site unspecified septicemia dehydration other and unspecified hyperlipidemia ileostomy status 
white m 72 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  186  k ul$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; insulin  0  unit ; lorazepam  0.5  mg ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; atenolol  50  mg ; simvastatin  40  mg ; morphine sulfate ir  15-30  mg ; glyburide  2.5  mg ; doxazosin  4  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  1000  mg ; ibuprofen  400  mg ; 
unspecified essential hypertension regional enteritis of unspecified site calculus of gallbladder with acute cholecystitis, without mention of obstruction calculus of gallbladder with other cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis pure hypercholesterolemia unspecified essential hypertension fitting and adjustment of nonvascular catheter, nec acute pancreatitis regional enteritis of unspecified site person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified sepsis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) urinary tract infection, site not specified personal history of malignant melanoma of skin knee joint replacement gout, unspecified unspecified essential hypertension hypotension, unspecified calculus of gallbladder with acute cholecystitis, without mention of obstruction escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site unspecified septicemia dehydration other and unspecified hyperlipidemia ileostomy status 
white m 72 $nan$hematology blood hematocrit  37.5  %; hematology blood hematocrit  37.4  %; hematology blood hemoglobin  13.0  g dl; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  209  k ul; hematology blood platelet count  236  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  118  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; insulin  0  unit ; lorazepam  0.5  mg ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; atenolol  50  mg ; simvastatin  40  mg ; glyburide  2.5  mg ; doxazosin  4  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  1000  mg ; ibuprofen  400  mg ; amoxicillin-clavulanic acid  500  mg ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  gm ; furosemide  10  mg ; 
unspecified essential hypertension regional enteritis of unspecified site calculus of gallbladder with acute cholecystitis, without mention of obstruction calculus of gallbladder with other cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis pure hypercholesterolemia unspecified essential hypertension fitting and adjustment of nonvascular catheter, nec acute pancreatitis regional enteritis of unspecified site person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified sepsis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) urinary tract infection, site not specified personal history of malignant melanoma of skin knee joint replacement gout, unspecified unspecified essential hypertension hypotension, unspecified calculus of gallbladder with acute cholecystitis, without mention of obstruction escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site unspecified septicemia dehydration other and unspecified hyperlipidemia ileostomy status 
white m 72 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; insulin  0  unit ; lorazepam  0.5  mg ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; atenolol  50  mg ; simvastatin  40  mg ; glyburide  2.5  mg ; doxazosin  4  mg ; acetaminophen  1000  mg ; ibuprofen  400  mg ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  gm ; furosemide  10  mg ; furosemide  20  mg ; 
unspecified essential hypertension regional enteritis of unspecified site calculus of gallbladder with acute cholecystitis, without mention of obstruction calculus of gallbladder with other cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis pure hypercholesterolemia unspecified essential hypertension fitting and adjustment of nonvascular catheter, nec acute pancreatitis regional enteritis of unspecified site person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified sepsis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) urinary tract infection, site not specified personal history of malignant melanoma of skin knee joint replacement gout, unspecified unspecified essential hypertension hypotension, unspecified calculus of gallbladder with acute cholecystitis, without mention of obstruction escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site unspecified septicemia dehydration other and unspecified hyperlipidemia ileostomy status 
white m 72 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  243  k ul$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; insulin  0  unit ; lorazepam  0.5  mg ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; atenolol  50  mg ; simvastatin  40  mg ; glyburide  2.5  mg ; doxazosin  4  mg ; acetaminophen  1000  mg ; ibuprofen  400  mg ; furosemide  20  mg ; 
unspecified essential hypertension regional enteritis of unspecified site calculus of gallbladder with acute cholecystitis, without mention of obstruction calculus of gallbladder with other cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis pure hypercholesterolemia unspecified essential hypertension fitting and adjustment of nonvascular catheter, nec acute pancreatitis regional enteritis of unspecified site person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified sepsis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) urinary tract infection, site not specified personal history of malignant melanoma of skin knee joint replacement gout, unspecified unspecified essential hypertension hypotension, unspecified calculus of gallbladder with acute cholecystitis, without mention of obstruction escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site unspecified septicemia dehydration other and unspecified hyperlipidemia ileostomy status 
white m 72 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; insulin  0  unit ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; atenolol  50  mg ; simvastatin  40  mg ; glyburide  2.5  mg ; doxazosin  4  mg ; acetaminophen  1000  mg ; ibuprofen  400  mg ; 
unspecified essential hypertension regional enteritis of unspecified site calculus of gallbladder with acute cholecystitis, without mention of obstruction calculus of gallbladder with other cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis pure hypercholesterolemia unspecified essential hypertension fitting and adjustment of nonvascular catheter, nec acute pancreatitis regional enteritis of unspecified site person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified sepsis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) urinary tract infection, site not specified personal history of malignant melanoma of skin knee joint replacement gout, unspecified unspecified essential hypertension hypotension, unspecified calculus of gallbladder with acute cholecystitis, without mention of obstruction escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site unspecified septicemia dehydration other and unspecified hyperlipidemia ileostomy status 
white m 72 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; insulin  0  unit ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; atenolol  50  mg ; simvastatin  40  mg ; glyburide  2.5  mg ; doxazosin  4  mg ; acetaminophen  1000  mg ; ibuprofen  400  mg ; 
unspecified essential hypertension regional enteritis of unspecified site calculus of gallbladder with acute cholecystitis, without mention of obstruction calculus of gallbladder with other cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cholangitis pure hypercholesterolemia unspecified essential hypertension fitting and adjustment of nonvascular catheter, nec acute pancreatitis regional enteritis of unspecified site person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident thrombocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified sepsis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) urinary tract infection, site not specified personal history of malignant melanoma of skin knee joint replacement gout, unspecified unspecified essential hypertension hypotension, unspecified calculus of gallbladder with acute cholecystitis, without mention of obstruction escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site unspecified septicemia dehydration other and unspecified hyperlipidemia ileostomy status 
white f 29 $temp  98.3  heartrate  95.0  resprate  20.0  o2sat    sbp  155.0  dbp  78.0  rhythm    pain    $hematology blood hematocrit  25.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry urine chloride, urine  69  meq l; chemistry urine creatinine, urine  79  mg dl; chemistry urine potassium, urine  22  meq l; chemistry urine sodium, urine  48  meq l; chemistry urine urea nitrogen, urine  482  mg dl; hematology urine wbc  49  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  69  mg dl$sodium chloride 0.9%  flush  3  ml ; collagenase ointment  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; furosemide  20  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; docusate sodium  100  mg ; fluconazole  200  mg ; magnesium oxide  400  mg ; thiamine  100  mg ; lorazepam  0.5  mg ; oxycodone (immediate release)   5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; insulin  80  unit ; oxycodone-acetaminophen (5mg-325mg)  2  tab ; insulin  40  unit ; furosemide  40  mg ; tramadol (ultram)  50  mg ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peritoneal abscess morbid obesity acute posthemorrhagic anemia unspecified essential hypertension hyperpotassemia hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of large intestine other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection acute kidney failure, unspecified unspecified essential hypertension friedländer's bacillus infection in conditions classified elsewhere and of unspecified site personal history of tobacco use polyneuropathy in diabetes other postoperative infection hyposmolality and/or hyponatremia urinary tract infection, site not specified bacteremia long-term (current) use of insulin other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled body mass index 70 and over, adult personal history of malignant neoplasm of large intestine other and unspecified escherichia coli [e. coli] disruption of external operation (surgical) wound other chest pain unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity acute posthemorrhagic anemia removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of sigmoid colon body mass index 70 and over, adult 
white f 29 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  164  mg dl; chemistry blood glucose  183  mg dl$sodium chloride 0.9%  flush  3  ml ; collagenase ointment  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; heparin  5000  unit ; docusate sodium  100  mg ; magnesium oxide  400  mg ; thiamine  100  mg ; lorazepam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  80  unit ; oxycodone-acetaminophen (5mg-325mg)  2  tab ; furosemide  40  mg ; tramadol (ultram)  50  mg ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; oxycodone (immediate release)   10  mg ; lisinopril  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; bag  2  bag ; magnesium sulfate  4  gm ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peritoneal abscess morbid obesity acute posthemorrhagic anemia unspecified essential hypertension hyperpotassemia hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of large intestine other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection acute kidney failure, unspecified unspecified essential hypertension friedländer's bacillus infection in conditions classified elsewhere and of unspecified site personal history of tobacco use polyneuropathy in diabetes other postoperative infection hyposmolality and/or hyponatremia urinary tract infection, site not specified bacteremia long-term (current) use of insulin other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled body mass index 70 and over, adult personal history of malignant neoplasm of large intestine other and unspecified escherichia coli [e. coli] disruption of external operation (surgical) wound other chest pain unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity acute posthemorrhagic anemia removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of sigmoid colon body mass index 70 and over, adult 
white f 29 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  142  mg dl$sodium chloride 0.9%  flush  3  ml ; collagenase ointment  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; heparin  5000  unit ; docusate sodium  100  mg ; magnesium oxide  400  mg ; thiamine  100  mg ; lorazepam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  80  unit ; tramadol (ultram)  50  mg ; senna  8.6  mg ; lisinopril  10  mg ; bag  2  bag ; magnesium sulfate  4  gm ; simethicone  40-80  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peritoneal abscess morbid obesity acute posthemorrhagic anemia unspecified essential hypertension hyperpotassemia hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of large intestine other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection acute kidney failure, unspecified unspecified essential hypertension friedländer's bacillus infection in conditions classified elsewhere and of unspecified site personal history of tobacco use polyneuropathy in diabetes other postoperative infection hyposmolality and/or hyponatremia urinary tract infection, site not specified bacteremia long-term (current) use of insulin other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled body mass index 70 and over, adult personal history of malignant neoplasm of large intestine other and unspecified escherichia coli [e. coli] disruption of external operation (surgical) wound other chest pain unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity acute posthemorrhagic anemia removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of sigmoid colon body mass index 70 and over, adult 
white f 29 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  130  mg dl$sodium chloride 0.9%  flush  3  ml ; collagenase ointment  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; heparin  5000  unit ; docusate sodium  100  mg ; magnesium oxide  400  mg ; thiamine  100  mg ; lorazepam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  80  unit ; tramadol (ultram)  50  mg ; senna  8.6  mg ; lisinopril  10  mg ; simethicone  40-80  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peritoneal abscess morbid obesity acute posthemorrhagic anemia unspecified essential hypertension hyperpotassemia hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of large intestine other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection acute kidney failure, unspecified unspecified essential hypertension friedländer's bacillus infection in conditions classified elsewhere and of unspecified site personal history of tobacco use polyneuropathy in diabetes other postoperative infection hyposmolality and/or hyponatremia urinary tract infection, site not specified bacteremia long-term (current) use of insulin other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled body mass index 70 and over, adult personal history of malignant neoplasm of large intestine other and unspecified escherichia coli [e. coli] disruption of external operation (surgical) wound other chest pain unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity acute posthemorrhagic anemia removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of sigmoid colon body mass index 70 and over, adult 
white f 29 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  163  mg dl$sodium chloride 0.9%  flush  3  ml ; collagenase ointment  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; heparin  5000  unit ; docusate sodium  100  mg ; magnesium oxide  400  mg ; thiamine  100  mg ; lorazepam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  80  unit ; tramadol (ultram)  50  mg ; senna  8.6  mg ; lisinopril  10  mg ; simethicone  40-80  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peritoneal abscess morbid obesity acute posthemorrhagic anemia unspecified essential hypertension hyperpotassemia hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of large intestine other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection acute kidney failure, unspecified unspecified essential hypertension friedländer's bacillus infection in conditions classified elsewhere and of unspecified site personal history of tobacco use polyneuropathy in diabetes other postoperative infection hyposmolality and/or hyponatremia urinary tract infection, site not specified bacteremia long-term (current) use of insulin other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled body mass index 70 and over, adult personal history of malignant neoplasm of large intestine other and unspecified escherichia coli [e. coli] disruption of external operation (surgical) wound other chest pain unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity acute posthemorrhagic anemia removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of sigmoid colon body mass index 70 and over, adult 
white f 29 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  225  mg dl$sodium chloride 0.9%  flush  3  ml ; collagenase ointment  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; heparin  5000  unit ; docusate sodium  100  mg ; magnesium oxide  400  mg ; thiamine  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  80  unit ; tramadol (ultram)  50  mg ; senna  8.6  mg ; lisinopril  10  mg ; simethicone  40-80  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peritoneal abscess morbid obesity acute posthemorrhagic anemia unspecified essential hypertension hyperpotassemia hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of large intestine other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection acute kidney failure, unspecified unspecified essential hypertension friedländer's bacillus infection in conditions classified elsewhere and of unspecified site personal history of tobacco use polyneuropathy in diabetes other postoperative infection hyposmolality and/or hyponatremia urinary tract infection, site not specified bacteremia long-term (current) use of insulin other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled body mass index 70 and over, adult personal history of malignant neoplasm of large intestine other and unspecified escherichia coli [e. coli] disruption of external operation (surgical) wound other chest pain unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity acute posthemorrhagic anemia removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of sigmoid colon body mass index 70 and over, adult 
white f 29 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  221  mg dl$sodium chloride 0.9%  flush  3  ml ; collagenase ointment  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; heparin  5000  unit ; docusate sodium  100  mg ; magnesium oxide  400  mg ; thiamine  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  80  unit ; tramadol (ultram)  50  mg ; senna  8.6  mg ; lisinopril  10  mg ; simethicone  40-80  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peritoneal abscess morbid obesity acute posthemorrhagic anemia unspecified essential hypertension hyperpotassemia hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of large intestine other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection acute kidney failure, unspecified unspecified essential hypertension friedländer's bacillus infection in conditions classified elsewhere and of unspecified site personal history of tobacco use polyneuropathy in diabetes other postoperative infection hyposmolality and/or hyponatremia urinary tract infection, site not specified bacteremia long-term (current) use of insulin other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled body mass index 70 and over, adult personal history of malignant neoplasm of large intestine other and unspecified escherichia coli [e. coli] disruption of external operation (surgical) wound other chest pain unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity acute posthemorrhagic anemia removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of sigmoid colon body mass index 70 and over, adult 
white f 29 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  375  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  28  mg dl; hematology urine wbc  20  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  172  mg dl$sodium chloride 0.9%  flush  3  ml ; collagenase ointment  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; heparin  5000  unit ; magnesium oxide  400  mg ; thiamine  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  80  unit ; tramadol (ultram)  50  mg ; lisinopril  10  mg ; simethicone  40-80  mg ; insulin  2  unit ; hydromorphone (dilaudid)  0.125  mg ; lorazepam  0.25  mg ; hydromorphone (dilaudid)  0.25  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peritoneal abscess morbid obesity acute posthemorrhagic anemia unspecified essential hypertension hyperpotassemia hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of large intestine other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection acute kidney failure, unspecified unspecified essential hypertension friedländer's bacillus infection in conditions classified elsewhere and of unspecified site personal history of tobacco use polyneuropathy in diabetes other postoperative infection hyposmolality and/or hyponatremia urinary tract infection, site not specified bacteremia long-term (current) use of insulin other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled body mass index 70 and over, adult personal history of malignant neoplasm of large intestine other and unspecified escherichia coli [e. coli] disruption of external operation (surgical) wound other chest pain unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity acute posthemorrhagic anemia removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of sigmoid colon body mass index 70 and over, adult 
white f 29 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  399  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  182  mg dl$sodium chloride 0.9%  flush  3  ml ; collagenase ointment  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; heparin  5000  unit ; magnesium oxide  400  mg ; thiamine  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  80  unit ; tramadol (ultram)  50  mg ; lisinopril  10  mg ; simethicone  40-80  mg ; insulin  2  unit ; hydromorphone (dilaudid)  0.125  mg ; lorazepam  0.25  mg ; hydromorphone (dilaudid)  0.25  mg ; magnesium oxide  800  mg ; ciprofloxacin hcl  500  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peritoneal abscess morbid obesity acute posthemorrhagic anemia unspecified essential hypertension hyperpotassemia hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of large intestine other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection acute kidney failure, unspecified unspecified essential hypertension friedländer's bacillus infection in conditions classified elsewhere and of unspecified site personal history of tobacco use polyneuropathy in diabetes other postoperative infection hyposmolality and/or hyponatremia urinary tract infection, site not specified bacteremia long-term (current) use of insulin other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled body mass index 70 and over, adult personal history of malignant neoplasm of large intestine other and unspecified escherichia coli [e. coli] disruption of external operation (surgical) wound other chest pain unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity acute posthemorrhagic anemia removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of sigmoid colon body mass index 70 and over, adult 
white f 29 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  371  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  140  mg dl$sodium chloride 0.9%  flush  3  ml ; collagenase ointment  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; heparin  5000  unit ; magnesium oxide  400  mg ; thiamine  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  80  unit ; tramadol (ultram)  50  mg ; lisinopril  10  mg ; simethicone  40-80  mg ; hydromorphone (dilaudid)  0.25  mg ; ciprofloxacin hcl  500  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peritoneal abscess morbid obesity acute posthemorrhagic anemia unspecified essential hypertension hyperpotassemia hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of large intestine other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection acute kidney failure, unspecified unspecified essential hypertension friedländer's bacillus infection in conditions classified elsewhere and of unspecified site personal history of tobacco use polyneuropathy in diabetes other postoperative infection hyposmolality and/or hyponatremia urinary tract infection, site not specified bacteremia long-term (current) use of insulin other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled body mass index 70 and over, adult personal history of malignant neoplasm of large intestine other and unspecified escherichia coli [e. coli] disruption of external operation (surgical) wound other chest pain unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity acute posthemorrhagic anemia removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of sigmoid colon body mass index 70 and over, adult 
white f 29 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  391  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  168  mg dl$sodium chloride 0.9%  flush  3  ml ; collagenase ointment  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; heparin  5000  unit ; magnesium oxide  400  mg ; thiamine  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  80  unit ; lisinopril  10  mg ; simethicone  40-80  mg ; hydromorphone (dilaudid)  0.25  mg ; ciprofloxacin hcl  500  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peritoneal abscess morbid obesity acute posthemorrhagic anemia unspecified essential hypertension hyperpotassemia hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of large intestine other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection acute kidney failure, unspecified unspecified essential hypertension friedländer's bacillus infection in conditions classified elsewhere and of unspecified site personal history of tobacco use polyneuropathy in diabetes other postoperative infection hyposmolality and/or hyponatremia urinary tract infection, site not specified bacteremia long-term (current) use of insulin other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled body mass index 70 and over, adult personal history of malignant neoplasm of large intestine other and unspecified escherichia coli [e. coli] disruption of external operation (surgical) wound other chest pain unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity acute posthemorrhagic anemia removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of sigmoid colon body mass index 70 and over, adult 
white f 29 $nan$nan$sodium chloride 0.9%  flush  3  ml ; collagenase ointment  1  appl ; clobetasol propionate 0.05% ointment  1  appl ; heparin  5000  unit ; magnesium oxide  400  mg ; thiamine  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  80  unit ; lisinopril  10  mg ; simethicone  40-80  mg ; hydromorphone (dilaudid)  0.25  mg ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peritoneal abscess morbid obesity acute posthemorrhagic anemia unspecified essential hypertension hyperpotassemia hemorrhage of gastrointestinal tract, unspecified personal history of malignant neoplasm of large intestine other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection acute kidney failure, unspecified unspecified essential hypertension friedländer's bacillus infection in conditions classified elsewhere and of unspecified site personal history of tobacco use polyneuropathy in diabetes other postoperative infection hyposmolality and/or hyponatremia urinary tract infection, site not specified bacteremia long-term (current) use of insulin other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled body mass index 70 and over, adult personal history of malignant neoplasm of large intestine other and unspecified escherichia coli [e. coli] disruption of external operation (surgical) wound other chest pain unspecified essential hypertension personal history of tobacco use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity acute posthemorrhagic anemia removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation malignant neoplasm of sigmoid colon body mass index 70 and over, adult 
asian f 51 $nan$nan$hydrochlorothiazide  25  mg ; lisinopril  10  mg ; 
 
asian f 51 $nan$hematology blood hematocrit  41.2  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  98  mg dl$hydrochlorothiazide  25  mg ; lisinopril  10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; ibuprofen  400  mg ; heparin  5000  unit ; omeprazole  20  mg ; 
 
asian f 51 $nan$nan$hydrochlorothiazide  25  mg ; lisinopril  10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; ibuprofen  400  mg ; heparin  5000  unit ; omeprazole  20  mg ; 
 
other m 56 $nan$hematology blood hematocrit  37.4  %; hematology blood hematocrit  38.4  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; vial  1  vial ; pantoprazole  40  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
 
other m 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  12.5  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; vial  1  vial ; pantoprazole  40  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ketorolac  30  mg ; 0.9% sodium chloride  1000  ml ; hydromorphone (dilaudid)  2-4  mg ; 
 
other m 56 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  123  mg dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  12.5  mg ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ketorolac  30  mg ; 0.9% sodium chloride  1000  ml ; hydromorphone (dilaudid)  2-4  mg ; neutra-phos  2  pkt ; calcium gluconate  2  g ; zolpidem tartrate  10  mg ; 
 
other m 56 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry urine creatinine, urine  351  mg dl; chemistry urine sodium, urine  76  meq l; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  145  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  12.5  mg ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ketorolac  30  mg ; hydromorphone (dilaudid)  2-4  mg ; neutra-phos  2  pkt ; calcium gluconate  2  g ; zolpidem tartrate  10  mg ; hydromorphone (dilaudid)  0.25  mg ; 
 
other m 56 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  288  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  148  mg dl$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  2-4  mg ; zolpidem tartrate  10  mg ; hydromorphone (dilaudid)  0.25  mg ; senna  1  tab ; milk of magnesia  30  ml ; docusate sodium  100  mg ; 
 
other m 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; hydromorphone (dilaudid)  2-4  mg ; zolpidem tartrate  10  mg ; hydromorphone (dilaudid)  0.25  mg ; senna  1  tab ; milk of magnesia  30  ml ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-6  mg ; ondansetron  4  mg ; 
 
other m 56 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  406  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; zolpidem tartrate  10  mg ; hydromorphone (dilaudid)  0.25  mg ; senna  1  tab ; milk of magnesia  30  ml ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-6  mg ; ondansetron  4  mg ; 
 
other m 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; zolpidem tartrate  10  mg ; hydromorphone (dilaudid)  0.25  mg ; senna  1  tab ; milk of magnesia  30  ml ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-6  mg ; ondansetron  4  mg ; simethicone  40-80  mg ; 
 
white m 74 $temp  98.1  heartrate  77.0  resprate  19.0  o2sat  99.0  sbp  111.0  dbp  68.0  rhythm    pain    $hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  294  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  56  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  136  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; metoprolol tartrate  5  mg ; simvastatin  10  mg ; aspirin  81  mg ; hydromorphone (dilaudid)  0.25  mg ; d5 1 2ns  1000  ml ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; calcium carbonate  500  mg ; metoprolol tartrate  50  mg ; amoxicillin-clavulanic acid  875  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
type 2 diabetes mellitus with unspecified complications essential (primary) hypertension surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable chronic obstructive pulmonary disease, unspecified hyperlipidemia, unspecified stricture of artery thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter heart failure, unspecified other complications due to other vascular device, implant, and graft unspecified essential hypertension surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other acquired deformities of ankle and foot long-term (current) use of anticoagulants chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia arterial embolism and thrombosis of lower extremity